ATBC {published data only}|Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study|/resolve/reference/PMED?id=7495243
ATBC {published data only}|Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance|/resolve/reference/PMED?id=8901854
ATBC {published data only}|Pilot study: The US-Finland lung cancer prevention trial|
ATBC {published data only}|Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study|/resolve/reference/PMED?id=9250116
ATBC {published data only}|The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finland|
ATBC {published data only}|The alpha-tocopherol, beta-carotene lung cancer prevention trial of vitamin E and beta-carotene: the beginning of the answers|/resolve/reference/PMED?id=8205274
ATBC {published data only}|Alcohol consumption and risk of colorectal cancer in a cohort of Finnish men|/resolve/reference/PMED?id=8740734
ATBC {published data only}|The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study|/resolve/reference/PMED?id=9568790
ATBC {published data only}|Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial|/resolve/reference/PMED?id=9521168
ATBC {published data only}|Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer|
ATBC {published data only}|Long-term supplementation with alpha-tocopherol and beta-carotene and prevalence of oral mucosal lesions in smokers|
ATBC {published data only}|Beta-carotene concentration in buccal mucosal cells with and without dysplastic oral leukoplakia after long-term beta-carotene supplementation in male smokers|
ATBC {published data only}|Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid|/resolve/reference/PMED?id=9920356
ATBC {published data only}|Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study|/resolve/reference/PMED?id=8941095
ATBC {published data only}|Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial|/resolve/reference/PMED?id=8594266
ATBC {published data only}|Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris|/resolve/reference/PMED?id=9659191
ATBC {published data only}|Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction|/resolve/reference/PMED?id=9193380
ATBC {published data only}|Retinal vascular changes following supplementation with alpha-tocopherol or beta-carotene|
ATBC {published data only}|Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy|
ATBC {published data only}|Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements|/resolve/reference/PMED?id=9799882
ATBC {published data only}|Long-term supplementation with alpha-tocopherol and beta-carotene and age-related cataract|
ATBC {published data only}|The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers|/resolve/reference/PMED?id=8127329
ATBC {published data only}|The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance|/resolve/reference/PMED?id=8205268
ATBC {published data only}|Effect of alpha-tocopherol (vitamin E) and beta-carotene supplementation on the incidence of intermittent claudication in male smokers|
ATBC {published data only}|Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group|/resolve/reference/PMED?id=9548624
ATBC {published data only}|Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease|/resolve/reference/PMED?id=9521232
PHS I {published data only}|Final report on the aspirin component of the ongoing physicians' health study|/resolve/reference/PMED?id=2664509
PHS I {published data only}|Interobserver agreement in the classification of stroke in the physicians' health study|/resolve/reference/PMED?id=8571416
PHS I {published data only}|Migraine and subsequent risk of stroke in the Physicians' Health Study|/resolve/reference/PMED?id=7848119
PHS I {published data only}|Cost and efficiency in clinical trials: The U.S. physicians' health study|
PHS I {published data only}|Issues in the early termination of the aspirin component of the Physicians' Health Study|/resolve/reference/PMED?id=1669520
PHS I {published data only}|Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians|/resolve/reference/PMED?id=9024142
PHS I {published data only}|Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy|/resolve/reference/PMED?id=10067908
PHS I {published data only}|A prospective study of cigarette smoking and risk of age-related macular degeneration in men|/resolve/reference/PMED?id=8827967
PHS I {published data only}|Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians|/resolve/reference/PMED?id=9805346
PHS I {published data only}|Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians|/resolve/reference/PMED?id=17353403
PHS I {published data only}|A prospective study of cigarette smoking and risk of cataract in men|/resolve/reference/PMED?id=1501324
PHS I {published data only}|Carotenoid and tocopherol concentrations in plasma, peripheral blood mononuclear cells, and red blood cells after long-term beta-carotene supplementation in men|/resolve/reference/PMED?id=8599319
PHS I {published data only}|Low-dose aspirin and incidence of colorectal tumors in a randomized trial|/resolve/reference/PMED?id=8331682
PHS I {published data only}|Body mass index. An independent predictor of cataract|/resolve/reference/PMED?id=7661746
PHS I {published data only}|A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians|/resolve/reference/PMED?id=7829792
PHS I {published data only}|Height and incidence of cardiovascular disease in male physicians|/resolve/reference/PMED?id=8403290
PHS I {published data only}|Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease|/resolve/reference/PMED?id=8602179
PHS I {published data only}|A randomized trial of aspirin and beta-carotene among U.S. physicians|/resolve/reference/PMED?id=3900975
PHS I {published data only}|Estimating the effect of the run-in on the power of the Physicians' Health Study|
PHS I {published data only}|Exercise and risk of stroke in male physicians|/resolve/reference/PMED?id=9880379
PHS I {published data only}|Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer|/resolve/reference/PMED?id=9067278
PHS I {published data only}|Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians|/resolve/reference/PMED?id=1931143
PHS I {published data only}|A prospective study of alcohol consumption and risk of cataract|/resolve/reference/PMED?id=7917442
PHS I {published data only}|Fish consumption and cardiovascular disease in the physicians' health study: A prospective study|/resolve/reference/PMED?id=7598116
PHS I {published data only}|Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians|/resolve/reference/PMED?id=9054841
PHS I {published data only}|Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease|/resolve/reference/PMED?id=9490235
PHS I {published data only}|Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men|/resolve/reference/PMED?id=9439492
PHS I {published data only}|Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial|/resolve/reference/PMED?id=2014943
PHS I {published data only}|Cigarette smoking and stroke in a cohort of U.S. male physicians|/resolve/reference/PMED?id=8311368
PHS I {published data only}|Effects of age, smoking and vitamins on plasma DHEAS levels: a cross-sectional study in men|/resolve/reference/PMED?id=1530789
PHS I {published data only}|Beta-carotene-induced enhancement of natural killer cell activity in elderly men: an investigation of the role of cytokines|/resolve/reference/PMED?id=9665110
PHS I {published data only}|Short- and long-term beta-carotene supplementation do not influence T cell-mediated immunity in healthy elderly persons|/resolve/reference/PMED?id=9322568
PHS I {published data only}|Natural killer cell activity in elderly men is enhanced by beta-carotene supplementation|/resolve/reference/PMED?id=8901800
PHS I {published data only}|Biochemical markers of compliance in the Physicians' Health Study|/resolve/reference/PMED?id=2268456
PHS I {published data only}|Effect of 12 Years of Beta-Carotene Supplementation on Malignant Non-Melanoma Skin Cancer: Results from the Physicians' Health Study|
PHS I {published data only}|The use of vitamin supplements and the risk of cataract among US male physicians|/resolve/reference/PMED?id=8179050
PHS I {published data only}|The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians|
PHS I {published data only}|A prospective study of plasma homocyst(e)ine and risk of ischemic stroke|/resolve/reference/PMED?id=8091435
PHS I {published data only}|Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke|/resolve/reference/PMED?id=9918518
VECAT {unpublished data only}|Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy|/resolve/reference/PMED?id=10487974
VECAT {unpublished data only}|Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study|
VECAT {unpublished data only}|Vitamin E supplementation and macular degeneration: randomised controlled trial|
VECAT {unpublished data only}|Vitamin E supplementation and age-related maculopathy (abstract)|
ADSC {published data only}|A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study|/resolve/reference/PMED?id=9110909
Andrews 1969 {published data only}|Vitamin C supplementation in the elderly: a 17-month trial in an old persons' home|/resolve/reference/PMED?id=5781487
AREDS {published data only}|A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8|/resolve/reference/PMED?id=11594942
Benner 1994 {published data only}|Retinoid chemoprevention of second primary tumors|/resolve/reference/PMED?id=7831582
Benton 1995 {published data only}|The impact of long-term vitamin supplementation on cognitive functioning|/resolve/reference/PMED?id=7770605
Blok 1997 {published data only}|Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year|
Bogden 1990 {published data only}|Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly|/resolve/reference/PMED?id=2358617
Brewer 1997 {published data only}|Treatment of Wilson's disease with zinc: XIV. Studies of the effect of zinc on lymphocyte function|/resolve/reference/PMED?id=9178732
Brown 1998 {published data only}|Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design|/resolve/reference/PMED?id=9594927
Bussey 1982 {published data only}|A randomized trial of ascorbic acid in polyposis coli|
Caligiuri 1997 {published data only}|Reliability of an instrumental assessment of tardive dyskinesia: Results from VA Cooperative Study 394|/resolve/reference/PMED?id=9272760
CARET {published data only}|Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease|/resolve/reference/PMED?id=8602180
CCSG {published data only}|Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16|/resolve/reference/PMED?id=8449125
Chandra 1992 {published data only}|Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects|/resolve/reference/PMED?id=1359211
CHAOS {published data only}|Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)|/resolve/reference/PMED?id=8622332
Clausen 1989 {published data only}|Biochemical and clinical effects of an antioxidative supplementation of geriatric patients. A double blind study|/resolve/reference/PMED?id=2484393
Constans 1996 {published data only}|One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study|/resolve/reference/PMED?id=8879807
Constantino 1988 {published data only}|Serum level changes after administration of a pharmacologic dose of beta-carotene|/resolve/reference/PMED?id=3055930
Cucinotta 1994 {published data only}|Posatirelin effect on patients with senile dementia of alzheimer type (SDAT): a double blind multicentre trial versus ascorbic acid and citicoline|
DATATOP {published data only}|DATATOP: A multicenter controlled clinical trial in early Parkinson's disease|/resolve/reference/PMED?id=2508608
de Klerk 1998 {published data only}|Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene|
DeCosse 1989 {published data only}|Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis|/resolve/reference/PMED?id=2549261
Dobson 1984 {published data only}|The effect of ascorbic acid on the seasonal variations in serum cholesterol levels|/resolve/reference/PMED?id=6533789
ECP-IM {published data only}|Primary prevention of gastric cancer - The ECP-IM intervention study|
EUROSCAN {published data only}|The chemoprevention of oral carcinoma with vitamin A and/or N-acetylcysteine|/resolve/reference/PMED?id=7935276
Fairley 1996 {published data only}|A randomized clinical trial of beta carotene vs placebo for the treatment of cervical HPV infection|
Fontham 1995 {published data only}|Effect of beta-carotene supplementation on serum alpha-tocopherol concentration|
Galan 1997 {published data only}|Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX|/resolve/reference/PMED?id=9433680
Garawal 1995 {published data only}|Beta-carotene produces sustained remissions in oral leukoplakia: results of a 1 year randomized, controlled trial|
GISSI {published data only}|The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico|/resolve/reference/PMED?id=8119523
HOPE {published data only}|Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation|/resolve/reference/PMED?id=8908384
Johnson 1997 {published data only}|Micronutrient supplementation and infection in institutionalized elders|
Jyothirmayi 1996 {published data only}|Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer|/resolve/reference/PMED?id=9039219
Kuklinski 1994 {published data only}|Coenzyme Q10 and antioxidants in acute myocardial infarction|
Leng 1997 {published data only}|Randomized controlled trial of antioxidants in intermittent claudication|/resolve/reference/PMED?id=9575599
Li 1992 {published data only}|Preliminary observations on effect of selenium yeast on high risk populations with primary liver cancer|/resolve/reference/PMED?id=1298601
LINXIAN {published data only}|Preliminary report on the results of nutrition prevention trials of cancer and other common diseases among residents in Linxian, China|/resolve/reference/PMED?id=8261860
LINXIAN {published data only}|The Linxian cataract studies. Two nutrition intervention trials|/resolve/reference/PMED?id=8363468
Mayne 1998 {published data only}|Effect of supplemental beta-carotene on plasma concentrations of carotenoids, retinol, and alpha-tocopherol in humans|/resolve/reference/PMED?id=9734742
McKeown 1988 {published data only}|A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps|/resolve/reference/PMED?id=3293777
Meyskens 1994 {published data only}|Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study|/resolve/reference/PMED?id=7931474
Munoz 1987 {published data only}|No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China|
Munoz 1996 {published data only}|Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data|/resolve/reference/PMED?id=8923024
Nambour 1995 {published data only}|The Nambour study of ocular disease. I. Design, study population and methodology|/resolve/reference/PMED?id=8963917
NPCSG {published data only}|Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group|/resolve/reference/PMED?id=8971064
Pastorino 1991 {published data only}|Lung cancer chemoprevention with retinol palmitate. Preliminary data from a randomized trial on stage Ia non small-cell lung cancer|/resolve/reference/PMED?id=2852945
Peng 1993 {published data only}|Micronutrient concentrations in paired skin and plasma of patients with actinic keratoses: effect of prolonged retinol supplementation|
PPP {published data only}|Primary prevention project (PPP) in the Mario Negri Institute in Milan|
PPSG {published data only}|A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group|/resolve/reference/PMED?id=8008027
Prasad 1995 {published data only}|Micronuclei and carcinogen DNA adducts as intermediate end points in nutrient intervention trial of precancerous lesions in the oral cavity|/resolve/reference/PMED?id=7549753
Qidong 1997 {published data only}|A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China|/resolve/reference/PMED?id=1726411
REACT {published data only}|Validation of methods for the assessment of cataract progression in the Roche European-American Anticataract Trial (REACT)|/resolve/reference/PMED?id=7585237
Recchia 1995 {published data only}|Interferon-beta, retinoids, and tamoxifen in the treatment of metastatic breast cancer: a phase II study|/resolve/reference/PMED?id=7553230
Ret Pig 1993 {published data only}|Randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa|/resolve/reference/PMED?id=8512476
Ret Pig 1993 {published data only}|A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa (2)|/resolve/reference/PMED?id=8240093
SCPS 1989 {published data only}|The Skin Cancer Prevention Study: design of a clinical trial of beta-carotene among persons at high risk for nonmelanoma skin cancer|/resolve/reference/PMED?id=2666024
SCPS 1989 {published data only}|A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin|/resolve/reference/PMED?id=2202901
SECURE {published data only}|Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE|/resolve/reference/PMED?id=8888665
Shandong 1998 {published data only}|Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data|/resolve/reference/PMED?id=9683311
Sharma 1989 {published data only}|Systemic aspirin and systemic vitamin E in senile cataracts: cataract V|/resolve/reference/PMED?id=2632449
Steiner 1995 {published data only}|Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks|/resolve/reference/PMED?id=7495235
SUVIMAX {published data only}|Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters|/resolve/reference/PMED?id=9263186
SUVIMAX {published data only}|Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Mineraux AntioXydants Study|/resolve/reference/PMED?id=9503043
SWSCPSG {published data only}|Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group|/resolve/reference/PMED?id=9367070
Takamatsu 1995 {published data only}|Effects on health of dietary supplementation with 100 mg d-alpha-tocopheryl acetate, daily for 6 years|/resolve/reference/PMED?id=8529777
Tomeo 1995 {published data only}|Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis|/resolve/reference/PMED?id=8614310
Tsubono 1997 {published data only}|A randomized controlled trial for chemoprevention of gastric cancer in high-risk Japanese population; study design, feasibility and protocol modification|
Wahlqvist 1994 {published data only}|Changes in serum carotenoids in subjects with colorectal adenomas after 24 mo of beta-carotene supplementation. Australian Polyp Prevention Project Investigators|/resolve/reference/PMED?id=7985637
Wright 1985 {published data only}|Vitamin A therapy in patients with Crohn's disease|/resolve/reference/PMED?id=3965341
YUNNAN {published data only}|Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study|/resolve/reference/PMED?id=1702663
Zaridze 1993 {published data only}|Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer|/resolve/reference/PMED?id=8275193
PHS II {published data only}|Design of Physicians' Health Study II - a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease and review of results of completed trials|/resolve/reference/PMED?id=10691066
WACS {unpublished data only}|A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group|/resolve/reference/PMED?id=8520707
WHS {published data only}|Randomized trials of primary prevention of cardiovascular disease in women. An investigator's view|/resolve/reference/PMED?id=8205276
AREDS 2001a|A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8|/resolve/reference/PMED?id=11594942
ARM Study Group 1995|An international classification and grading system for age-related maculopathy and age-related macular degeneration|
ATBC 1994|The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers|/resolve/reference/PMED?id=8127329
Chong 2007|Dietary antioxidants and primary prevention of age-related macular degeneration: a systematic review and meta-analysis|/resolve/reference/PMED?id=17923720
Christen 1996|Antioxidants and age-related eye disease. Current and future perspectives|/resolve/reference/PMED?id=8680627
Evans 1996|Causes of blindness and partial sight in England and Wales|
Evans 2001|Risk factors for age-related macular degeneration|/resolve/reference/PMED?id=11173253
Evans 2006|Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration|
Glanville 2006|How to identify randomized controlled trials in MEDLINE: ten years on|/resolve/reference/PMED?id=16636704
Higgins 2006|Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6|
Klein 1992|Prevalence of age-related maculopathy. The Beaver Dam Eye Study|/resolve/reference/PMED?id=1630784
Klein 1993|The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking|/resolve/reference/PMED?id=8452123
Omenn 1996|Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease|/resolve/reference/PMED?id=8602188
Evans 1999|Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration|
AMDSG {published data only}|Multicenter ophthalmic and nutritional age-related macular degeneration study-part 1: design, subjects and procedures|/resolve/reference/PMED?id=8825016
AMDSG {published data only}|Multicenter ophthalmic and nutritional age-related macular degeneration study-part 2: antioxidant intervention and conclusions|/resolve/reference/PMED?id=8825017
AREDS {published data only}|A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8|/resolve/reference/PMED?id=11594942
AREDS {published data only}|The Age-Related Eye Disease Study (AREDS) system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The Age-Related Eye Disease Study Report No. 6|/resolve/reference/PMED?id=11704028
AREDS {published data only}|Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13|/resolve/reference/PMED?id=15136320
AREDS {published data only}|High dose zinc increases hospital admissions due to genitourinary complications|/resolve/reference/PMED?id=17222649
AREDS {published data only}|Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration|/resolve/reference/PMED?id=17157802
AREDS {published data only}|The Age-Related Eye Disease Study (AREDS): Design Implications AREDS Report No. 1|/resolve/reference/PMED?id=10588299
Holz 1993 {published data only}|Oral zinc-therapy in age-related macular degeneration: a double-blind study (abstract)|
Kaiser 1995 {published and unpublished data}|Visaline in the treatment of age-related macular degeneration: a pilot study|/resolve/reference/PMED?id=8751336
Newsome 1988 {published data only}|Oral zinc in macular degeneration|/resolve/reference/PMED?id=3277606
Stur 1996 {published data only}|Oral zinc and the second eye in age-related macular degeneration|/resolve/reference/PMED?id=8641826
VECAT {unpublished data only}|Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy|/resolve/reference/PMED?id=10487974
VECAT {unpublished data only}|Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study|
VECAT {unpublished data only}|Vitamin E supplementation and age-related maculopathy (abstract)|
Veterans LAST study {published data only}|LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls|/resolve/reference/PMED?id=17478338
Veterans LAST study {published data only}|Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial)|/resolve/reference/PMED?id=15117055
Wang 2004 {published data only}|Effects of zinc and antioxidant on visual function of patients with age-related macular degeneration|
Bahrami 2006 {published data only}|Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial|/resolve/reference/PMED?id=16759390
Barakat 2006 {published data only}|Effect of niacin on retinal vascular diameter in patients with age-related macular degeneration|/resolve/reference/PMED?id=16877271
Benzie 2006 {published data only}|Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L.)|/resolve/reference/PMED?id=16870004
Bone 2007 {published data only}|Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Cangemi 2007 {published data only}|TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD|/resolve/reference/PMED?id=17324285
Christen 2007 {published data only}|Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians|/resolve/reference/PMED?id=17353403
Cumurcu 2006 {published data only}|Serum zinc and copper level in age-related macular degeneration|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Franciose 2006 {published data only}|Serum and macular responses to antioxidant supplementation versus a carotenoid-rich dietary intervention in the elderly|
Goodrow 2006 {published data only}|Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations|/resolve/reference/PMED?id=16988120
Kamburoglu 2006 {published data only}|Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration|/resolve/reference/PMED?id=16163497
Khachik 2006 {published data only}|The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older|/resolve/reference/PMED?id=17122108
Kopsell 2006 {published data only}|Spinach cultigen variation for tissue carotenoid concentrations influences human serum carotenoid levels and macular pigment optical density following a 12-week dietary intervention|/resolve/reference/PMED?id=17032001
Lim 2006 {published data only}|One-year results of a pilot study using oral 13-cis retinoic acid as a treatment for subfoveal predominantly occult choroidal neovascularization in patients with age-related macular degeneration|/resolve/reference/PMED?id=16508432
LUNA study {published data only}|Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study|/resolve/reference/PMED?id=17306793
LUXEA {published data only}|Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance|
LUXEA {published data only}|The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision|
LUXEA {published data only}|Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study|/resolve/reference/PMED?id=17084803
Moeller 2006 {published data only}|Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative|/resolve/reference/PMED?id=16908818
Nolan 2006 {published data only}|Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin|/resolve/reference/PMED?id=16500771
Nolan 2007 {published data only}|Risk factors for age-related maculopathy are associated with a relative lack of macular pigment|/resolve/reference/PMED?id=17083932
Nussenblatt 2006 {published data only}|Vitamin E in the treatment of uveitis-associated macular edema|/resolve/reference/PMED?id=16386999
Owsley 2006 {published data only}|Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy|/resolve/reference/PMED?id=16565362
Rosenthal 2006 {published data only}|Dose-ranging study of lutein supplementation in persons aged 60 years or older|/resolve/reference/PMED?id=17122107
Vannas 1958 {published data only}|On the treatment of arteriosclerotic chorioretinopathy|
Wang 2007 {published data only}|Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration|/resolve/reference/PMED?id=17344498
Wenzel 2006 {published data only}|A 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in women|/resolve/reference/PMED?id=16988128
Zhao 2006 {published data only}|Carotenoids and ocular health|
France 1998 {unpublished data only}|Zinc supplementation|
ARMSG 1995|An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group|
ATBC|The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers|/resolve/reference/PMED?id=8127329
Bressler 1989|The grading and prevalence of macular degeneration in Chesapeake Bay watermen|/resolve/reference/PMED?id=2786408
Christen 1996|Antioxidants and age-related eye disease. Current and future perspectives|
ETDRS 1980||
Evans 1996|Causes of blindness and partial sight in England and Wales|
Evans 2008|Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration|
Glanville 2006|How to identify randomized controlled trials in MEDLINE: ten years on|/resolve/reference/PMED?id=16636704
Higgins 2006|Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6|
Hope 2005|Effects of long term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial|/resolve/reference/PMED?id=15769967
Johnson 2007|High dose zinc increases hospital admissions due to genitourinary complications|/resolve/reference/PMED?id=17222649
Klein 1991|The Wisconsin age-related maculopathy grading system|/resolve/reference/PMED?id=1843453
Klein 1992|Prevalence of age-related maculopathy. The Beaver Dam Eye Study|/resolve/reference/PMED?id=1630784
Omenn 1996|Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease|/resolve/reference/PMED?id=8602188
Anderson 1994 {published data only}|Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism|/resolve/reference/PMED?id=8129501
Anderson 1996 {published data only}|Effectiveness of notification and group education in modifying prescribing of regulated analgesics|/resolve/reference/PMED?id=8542565
Baker 1997 {published data only}|Randomised controlled trial of reminders to enhance the impact of audit in general practice on management of patients who use benzodiazepines|/resolve/reference/PMED?id=10166596
Baker 2003 {published data only}|Randomized controlled trial of the effectiveness of feedback in improving test ordering in general practice|/resolve/reference/PMED?id=14695072
Baker 2003A {published data only}|Randomised controlled trial of the impact of guidelines, prioritised review criteria and feedback on implementation of recommendations for angina and asthma.|/resolve/reference/PMED?id=12879828
Balas 1998 {published data only}|Effect of linking practice data to published evidence: A randomized controlled trial of clinical direct reports|/resolve/reference/PMED?id=9431333
Belcher 1990 {published data only}|Implementing preventive services success and failure in an outpatient trial|/resolve/reference/PMED?id=2244769
Berman 1998 {published data only}|The effect of a drug and supply cost feedback system on the use of intraoperative resources by anesthesiologists|/resolve/reference/PMED?id=9495403
Boekeloo 1990 {published data only}|Strategies for increasing house staff management of cholesterol with inpatients|/resolve/reference/PMED?id=2383413
Bonevski 1999 {published data only}|Randomized controlled trial of a computer strategy to increase general practitioner preventive care|/resolve/reference/PMED?id=10600428
Borgiel 1999 {published data only}|Evaluating the effectiveness of 2 educational interventions on family practice|
Brady 1988 {published data only}|Should physicians perform their own quality assurance audits?|/resolve/reference/PMED?id=3230459
Brown 1994 {published data only}|Evaluation of a continuing education intervention "Periodontics in General Practice"|
Buffington 1991 {published data only}|A target-based model for increasing influenza immunizations in private practice|/resolve/reference/PMED?id=2066823
Buntinx 1993 {published data only}|Does feedback improve the quality of cervical smears? A randomized controlled trial|/resolve/reference/PMED?id=8347386
Buntinx 1993 {published data only}|Reactions of doctors to various forms of feedback designed to improve the sampling quality of cervical smears|/resolve/reference/PMED?id=1511150
Chassin 1986 {published data only}|A randomized trial of medical quality assurance. Improving physicians' use of pelvimetry|/resolve/reference/PMED?id=3735627
Cohen 1982 {published data only}|Does cost information availability reduce physician test usage? A randomized clinical trial with unexpected findings|/resolve/reference/PMED?id=7078287
De Almeida Neto 2000 {published data only}|A pharmacy based protocol and training program for non-prescription analgesics|
Dickinson 1981 {published data only}|Improving hypertension control: impact of computer feedback and physician education|/resolve/reference/PMED?id=6153057
Eccles 2001 {published data only}|Effect of audit and feedback, and reminder messages on primary-care radiology referrals: a randomised trial|/resolve/reference/PMED?id=11356439
Everett 1983 {published data only}|Effect of cost education, cost audits, and faculty chart review on the use of laboratory services|/resolve/reference/PMED?id=6679239
Fairbrother 1999 {published data only}|The impact of physician bonuses, enhanced fees, and feedback on childhood immunization coverage rates|/resolve/reference/PMED?id=9949744
Fallowfield 2002 {published data only}|Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial|/resolve/reference/PMED?id=11879860
Feder 1995 {published data only}|Do clinical guidelines intorduced with practice based education improve care of asthmatic and dibetic patients? A randomised controlled trial in general practices in east London|/resolve/reference/PMED?id=8520339
Ferguson 2003 {published data only}|Use of contiouous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery|/resolve/reference/PMED?id=12837711
Finkelstein 2001 {published data only}|Reducing antibiotic use in children: a randomized trial in 12 practices|/resolve/reference/PMED?id=11433046
Frijiling 2002 {published data only}|Multifaceted support to improve clinical decision making in diabetes care: a randomized controlled trial in general practice.|
Frijiling 2002 {published data only}|Intensive support to improve clinical decision making in cardiovascular care: a randomised controlled trial in general practice.|/resolve/reference/PMED?id=12792007
Gama 1991 {published data only}|Feedback of laboratory usage and cost data to clinicians: does it alter requesting behavior?|/resolve/reference/PMED?id=1907120
Gehlbach 1984 {published data only}|Improving drug prescribing in a primary care practice|/resolve/reference/PMED?id=6700282
Goff 2002a {published data only}|Enchancing the quality of care for patients with coronary heart disease: The design and baseline results of the hastening the effective application of research through technology (HEART) trial.|/resolve/reference/PMED?id=12500883
Goff 2002a {published data only}|Quality of care for secondary prevention for patients with coronary heart disease: Results of the hastening the effective application of research through technology (HEART) trial.|/resolve/reference/PMED?id=14660997
Goldberg 1998 {published data only}|A randomized controlled trial of QI teams and academic detailing: can they alter compliance with guidelines?|/resolve/reference/PMED?id=9568553
Grady 1997 {published data only}|Enhancing mammography referral in primary care|/resolve/reference/PMED?id=9388790
Guagagnoli 2000 {published data only}|Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback|/resolve/reference/PMED?id=10942103
Gullion 1988 {published data only}|Management of hypertension in private practice: a randomized controlled trial in continuing medical education|
Hayes 2001 {published data only}|Comparison of an enhanced versus written feedback model on the management of Medicare inpatients with venous thrombosis|/resolve/reference/PMED?id=11242721
Heller 2001 {published data only}|Randomised controlled trial to change hospital management of unstable angina|
Hemminiki 1992 {published data only}|Need for and influence or feedback from the Finnish birth register to data providers|/resolve/reference/PMED?id=1511147
Henderson 1979 {published data only}|Hospital cost containment: a little knowledge helps|
Hendryx 1998 {published data only}|Outreach education to improve quality of rural icu care|/resolve/reference/PMED?id=9700115
Hershey 1986 {published data only}|Influence of simple computerized feedback on prescription charges in an ambulatory clinic. A randomized clinical trial|/resolve/reference/PMED?id=3520177
Hillman 1998 {published data only}|Physician financial incentives and feedback: Failure to increase cancer screening in medicaid managed care|
Hillman 1999 {published data only}|The use of physician financial incentives and feedback to improve pediatric preventive care in Medicaid care|/resolve/reference/PMED?id=10506237
Holm 1990 {published data only}|Intervention against long-term use if hypnotics/sedatives in general practice|/resolve/reference/PMED?id=2218150
Howe 1996 {published data only}|Detecting psychological distress: can general practitioners improve their performance?|/resolve/reference/PMED?id=8776911
Hux 1999 {published data only}|Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial|/resolve/reference/PMED?id=10478162
Jones 1996 {published data only}|Efficacy of feedback from quarterly laboratory comparison in maintaining quality of a hospital capillary blood glucose monitoring program|/resolve/reference/PMED?id=8718440
Kafuko 1999 {published data only}|Rational drug use in rural health units of Uganda:effect of national standard treatment guidelines on rational drug use|
Katz 2004 {published data only}|Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: A randomized, controlled trial.|/resolve/reference/PMED?id=15100337
Kerry 2000 {published data only}|Influence of postal distribution of the royal college of radiologists guidelines, together with feedback on radiological referral rates, on x-ray referrals from general practice: a randomized controlled trial|/resolve/reference/PMED?id=10673488
Kerse 1999 {published data only}|Improving the health behaviours of elderly people: randomised controlled trial of a general practice education programme|/resolve/reference/PMED?id=10480825
Kiefe 2001 {published data only}|Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial|/resolve/reference/PMED?id=11401608
Kim 1999 {published data only}|Physician education and report cards: do they make the grade? Results from a randomized controlled trial|/resolve/reference/PMED?id=10625023
Kinsinger 1998 {published data only}|Using an office system intervention to increase breast cancer screening|
Kogan 2003 {published data only}|Effectiveness of report cards based on chart audits of residents adherence to practice guidelines on practice performance: a randomized controlled trial|/resolve/reference/PMED?id=12632705
Lemelin 2001 {published data only}|Evidence to action: a tailored multifaceted approach to changing family physician practice patterns and improving preventive care|/resolve/reference/PMED?id=11276541
Leviton 1999 {published data only}|Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation|/resolve/reference/PMED?id=9892450
Linn BS 1980 {published data only}|Continuing medical education. Impact on emergency room burn care|/resolve/reference/PMED?id=7392153
Lobach 1996 {published data only}|Electronically distributed computer-generated feedback enhances the use of a computarized practice guidelines|
Lomas 1991 {published data only}|Making clinical policy explicit. Legislative policy making and lessons for developing practice guidelines|/resolve/reference/PMED?id=8423109
Lomas 1991 {published data only}|Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section|/resolve/reference/PMED?id=2013952
Mainous 2000 {published data only}|An evaluation of statewide strategies to reduce antibiotic overuse|/resolve/reference/PMED?id=10645510
Manfredi 1998 {published data only}|Improving cancer screening in physcians practices serving low-income and minority populations|/resolve/reference/PMED?id=9682686
Manheim 1990 {published data only}|Training house officers to be cost conscious. Effects of an educational intervention on charges and length of stay|/resolve/reference/PMED?id=2296215
Martin 1980 {published data only}|A trial of two strategies to modify the test-ordering behavior of medical residents|/resolve/reference/PMED?id=7432374
Marton 1985 {published data only}|Modifying test-ordering behavior in the outpatient medical clinic. A controlled trial of two educational interventions|/resolve/reference/PMED?id=3888133
Mayefsky 1993 {published data only}|Use of a chart audit: teaching well child care to paediatric house officers|
Mayer 1998 {published data only}|Promoting skin cancer prevention counseling|/resolve/reference/PMED?id=9663162
McAlister 1986 {published data only}|Randomised controlled trial of computer assisted management of hypertension in primary care|/resolve/reference/PMED?id=3092976
McCartney 1997 {published data only}|A randomised controlled trial of feedback to general, practitioners of their prophylactic aspirin prescribing|/resolve/reference/PMED?id=9233326
McCartney 1997 {published data only}|Feedback in primary care can improve the prescribtion of hormon replacement therapy in women with a history of hyeterectomy|
McConnell 1982 {published data only}|Physician behavior modification using claims data: tetracycline for upper respiratory infection|/resolve/reference/PMED?id=6891147
Meyer 1991 {published data only}|Reduction of polypharmacy by feedback to clinicians|/resolve/reference/PMED?id=2023020
Moher 2001 {published data only}|Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary hearth disease in primary care|/resolve/reference/PMED?id=11387182
Moongtui 2000 {published data only}|Using peer feedback to improve handwashing and glove usage among Thai health care workers|/resolve/reference/PMED?id=11029136
Nilsson 2001 {published data only}|Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing among general practitioners|/resolve/reference/PMED?id=11294376
Norton 1985 {published data only}|Self-audit: its effect on quality of care|/resolve/reference/PMED?id=4045397
O`Connell 1999 {published data only}|Randomised controlled trial of effect of feedback on general practitioners prescribing in Australia|/resolve/reference/PMED?id=10024260
Palmer 1985 {published data only}|A randomized controlled trial of quality assurance in sixteen ambulatory care practices|/resolve/reference/PMED?id=3892184
Pimlott 2003 {published data only}|Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial|/resolve/reference/PMED?id=12668540
Quinley 2004 {published data only}|Improving physician coverage of pneumcoccal vaccine: a randomized trial of telephone intervention|/resolve/reference/PMED?id=15065730
Raasch 2000 {published data only}|An educational intervention to improve diagnosis and management of suspicious skin lesions|
Rantz 2001 {published data only}|Randomized clinical trial of quality improvement intervention in nursing homes|/resolve/reference/PMED?id=11490051
Reid 1977 {published data only}|Physician profiles in training the graduate internist|
Robling 2002 {published data only}|General practitioners' use of magnetic resonance imaging: an open randomized trial comparing telephone and written requests and an open randomized controlled trial of different methods of local guideline dissemination|/resolve/reference/PMED?id=12014939
Roski 1998 {published data only}|Changing practice patterns as a result of implementing the Agency for Health Care Policy and Research guidelines in 20 primary care clinics|
Ruangkanchanastr 19 {published data only}|Laboratory investigation utilization in pediatric out-patient department ramathibodi hospital|/resolve/reference/PMED?id=7822993
Rust 1999 {published data only}|Impact of resident feedback on immunization outcomes|/resolve/reference/PMED?id=10555719
Sanazaro 1978 {published data only}|Concurrent quality assurance in hospital care. Report of a study by Private Initiative in PSRO|/resolve/reference/PMED?id=349379
Sandbaek 1999 {published data only}|Randomized controlled trial of the effect of medical audit on aids prevention in general practice|/resolve/reference/PMED?id=10533949
Sauaia 2000 {published data only}|Influencing care in acute myocardial infarction: a randomized trial comparing 2 types of intervention|/resolve/reference/PMED?id=11022366
Schectman 1995 {published data only}|The effect of an education and feedback intervention on group-model and network-model health maintenance organization physician prescribing behavior|/resolve/reference/PMED?id=7837822
Schectman 2003 {published data only}|Randomized controlled trial of education and feedback for implementation of guidelines for acute low back pain.|
Simon 2000 {published data only}|Randomised trial in monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care|/resolve/reference/PMED?id=10688563
Sinclair 1982 {published data only}|The effect of quality assurance activities on the quality of mental health services|/resolve/reference/PMED?id=6811994
Siriwardena 2002 {published data only}|Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care|/resolve/reference/PMED?id=12236277
Smith 1995 {published data only}|A randomized controlled trial of a drug use review intervention for sedative hypnotic medications|
Smith 1998 {published data only}|Training obstetricians and midwives to present screening tests evaluation of two brief interventions|
Socolar 1998 {published data only}|Intervention to improve physician documentation and knowledge of child sexual abuse: a randomized, controlled trial|/resolve/reference/PMED?id=9565408
Sommers 1984 {published data only}|Physician involvement in quality assurance|/resolve/reference/PMED?id=6513620
Soumerai 1998 {published data only}|Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial|/resolve/reference/PMED?id=9582043
Steele 1989 {published data only}|Cost effectiveness of two interventions for reducing outpatient prescribing costs|/resolve/reference/PMED?id=2500784
Sndergaard 2002 {published data only}|Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed no impact: a randomised controlled trial|/resolve/reference/PMED?id=12012145
Sndergaard 2003 {published data only}|Mailed prescribed feedback in addition to a clinical guideline has no impact: a randomised, controlled trial.|/resolve/reference/PMED?id=12718461
Thompson 2000 {published data only}|Identification and management of domestic violence: a randomized trial|/resolve/reference/PMED?id=11064229
Tierney 1986 {published data only}|Delayed feedback of physician performance versus immediate reminders to perform preventive care. Effects on physician compliance|/resolve/reference/PMED?id=3736141
van den Hombergh 99 {published data only}|Practice visits as a tool in quality improvement: mutual visits and feedback by peers compared with visits and feedback by non-physician observers|/resolve/reference/PMED?id=10847872
van den Hombergh 99 {published data only}|Practice visits. Assessing and improving management in general practice|
van der Weijden 1999 {published data only}|Feasibility of a national cholestrol guideline in daily practice. A randomized controlled trial in 20 general practices|/resolve/reference/PMED?id=10442843
Veninga 1999 {published data only}|Improving doctors prescribing behaviour through reflection on guidelines and prescribing feedback: a randomised controlled trial|/resolve/reference/PMED?id=10980076
Veninga 1999 {published data only}|Influencing prescribing for urinary tract infection and asthma in primary care in Sweden: a randomized controlled trial of an interactive educational intervention|/resolve/reference/PMED?id=10465325
Veninga 1999 {published data only}|Improving drug treatment in general practice|/resolve/reference/PMED?id=10941955
Veninga 1999 {published data only}|Evaluating an educational intervention to improve the treatment of asthma in four European countries|/resolve/reference/PMED?id=10508816
Veninga 1999 {published data only}|Improving prescribing in general practice|
Verstappen 2003 {published data only}|Effect of a practice-based strategy on test ordering performance of primary care physicians|/resolve/reference/PMED?id=12746365
Vingerhoets 2001 {published data only}|Feedback of patients ' evaluations of general practice care: a randomised trial|/resolve/reference/PMED?id=11743151
Vinicor 1987 {published data only}|DIABEDS: a randomized trial of the effects of physician and/or patient education on diabetes patient outcomes|/resolve/reference/PMED?id=3549757
Wahlstrm 2003 {published data only}|Effectiveness of feedback for improving case management of malaria, diarrhoea and pneumonia - a randomized controlled trial at provincial hospitals in Lao PDR|
Ward 1996 {published data only}|Educational feedback in management of diabetes in general practice|
Wells 2000 {published data only}|Impact of disseminating quality improvement programs for depression in managed primary care|/resolve/reference/PMED?id=10634337
Winickoff 1984 {published data only}|Improving physician performance through peer comparison feedback|/resolve/reference/PMED?id=6738143
Winickoff 1985 {published data only}|Limitations of provider interventions in hypertension quality assurance|/resolve/reference/PMED?id=3966597
Winkens 1995 {published data only}|Randomised controlled trial of routine individual feedback to improve rationality and reduce numbers of test requests|/resolve/reference/PMED?id=7861879
Wones 1987 {published data only}|Failure of low-cost audits with feedback to reduce laboratory test utilization|/resolve/reference/PMED?id=3807449
Young 2002 {published data only}|Improving family physicians' Use of evidence-based smoking cessation strategies: A cluster randomization trial|/resolve/reference/PMED?id=12460525
Young 2002 {published data only}|Randomised trial of intensive academic detailing to promote opportunistic recruitment of women to cervical screening by general practitioners.|
Zwar 1999 {published data only}|Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines|/resolve/reference/PMED?id=10533946
Anonymous I 1990 {published data only}|North of England study of standards and performence in general practice|
Ballard 2002 {published data only}|Health care provider quality improvement organization medicare data sharing: A diabetes quality improvement initiative|
Berwick 1986 {published data only}|Feedback reduces test use in a health maintenance organization|/resolve/reference/PMED?id=3951079
Billi 1987 {published data only}|The effects of a cost-education program on hospital charges|/resolve/reference/PMED?id=3655956
Brown 1988 {published data only}|Evaluation of a continuing medical education program for primary care physcicians on the management of alcoholism|/resolve/reference/PMED?id=3286871
Buekens 1993 {published data only}|Does awareness of rates of obstetric interventions change practice?|/resolve/reference/PMED?id=8461814
Carney 1992 {published data only}|Tools, teamwork and tenacity: An office system for cancer prevention|/resolve/reference/PMED?id=1402726
De Silva 1994 {published data only}|Does medical audit change practice?|
Del Mar 1998 {published data only}|Improving general practitioner clinical records with a quality assurance minimal intervention|/resolve/reference/PMED?id=9747547
Denton 2001 {published data only}|Comparing the efficacy of staff versus housestaff instruction in an intervention to improve hypertension management|/resolve/reference/PMED?id=11739054
Dranitsaris 1995 {published data only}|A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron|/resolve/reference/PMED?id=7655779
Everett {published data only}|Effect of cost education, cost audits, and faculty chart review on the use of laboratory services|/resolve/reference/PMED?id=6679239
Fihn 2004 {published data only}|Effects of sustained audit/feedback on self-reported health status of primary care patients|/resolve/reference/PMED?id=14969652
Furniss 2000 {published data only}|Effects of a pharmacists medication review in nursing homes|/resolve/reference/PMED?id=10974963
Gask 1991 {published data only}|Training general practitioners to teach psychiatric interviewing skills: an evaluation of group training|
Gerbert 1988 {published data only}|Changing dentists' knowledge, attitudes and behaviours relating to AIDS: a controlled educational intervention|/resolve/reference/PMED?id=2969015
Goldberg 1980 {published data only}|Training family doctors to recognise psychiatric illness with increased accuracy|
Grimshaw 1998 {published data only}|Evaluation of four quality assurance initiatives to improve out-patient referrals from general practice to hospital|
Gunn 2003 {published data only}|Guidelines for assessing postnatal problems: introducing evidence-based guidelines in Australian general practice|/resolve/reference/PMED?id=12876107
Hall 2001 {published data only}|Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial|/resolve/reference/PMED?id=11450926
Hampshire 1999 {published data only}|Action research: a useful method of promoting change in primary care?|/resolve/reference/PMED?id=10439987
Hanlon 1996 {published data only}|A randomized controlled trial of a clinical pharmacists intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy|/resolve/reference/PMED?id=8610730
Hargraves 1996 {published data only}|Practice characteristics and performance of primary care practitioners|
Hershey 1988 {published data only}|The effect of computerized feedback coupled with a newsletter upon outpatient prescribing charges. A randomized controlled trial|/resolve/reference/PMED?id=3336248
Hetlevik 1998 {published data only}|Implementing clinical guidelines in the treatment of hypertension in general practice|/resolve/reference/PMED?id=10229991
Hetlevik 1998 {published data only}|Implementing clinical guidelines in the treatment of hypertension in general practice|/resolve/reference/PMED?id=10321438
Horowitz 1996 {published data only}|Conducting a randomized controlled trial of CQI and academic detailing to implement clinical guidelines|/resolve/reference/PMED?id=8937948
Johansen 1997 {published data only}|Using audit to improve senior officer training|/resolve/reference/PMED?id=9497949
Johnson 1976 {published data only}|Studying the impact of patient drug profile in an HMO|/resolve/reference/PMED?id=909322
Kroenke 1990 {published data only}|Reducing polypharmacy in the elderly|/resolve/reference/PMED?id=2404053
Linn 1980 {published data only}|The effect of screening, sensitization, and feedback on notation of depression|/resolve/reference/PMED?id=7441675
MacCosbe 1985 {published data only}|Modifying empiric antibiotic prescribing: Experience with one strategy in a medical residency program|/resolve/reference/PMED?id=10274168
Mandel 1985 {published data only}|Improving physician compliance with preventive medicine guidelines|/resolve/reference/PMED?id=2993472
Mazzuca 1988 {published data only}|The Diabetes Education study: a controlled trial of the effects of intensive instructions of internal medicine residents on the management of diabetes mellitus|/resolve/reference/PMED?id=3339482
McDermott 2003 {published data only}|Sustaining better diabetes care in remote indigenous Australian communities.|/resolve/reference/PMED?id=12933731
McDonel 1997 {published data only}|Implementing assertive community treatment programs in rural settings|/resolve/reference/PMED?id=9727214
McPhee 1989 {published data only}|The cancer prevention reminder system|
McPhee 1989 {published data only}|Promoting cancer screening. A randomized controlled trial of three interventions|
Munroe 1997 {published data only}|Economic evaluation of pharmacist involving in disease management in a community pharmacy setting|/resolve/reference/PMED?id=9083713
Nattinger 1989 {published data only}|Improving the utilization of screening mammography in primary care practices|/resolve/reference/PMED?id=2774785
North of England1992 {published data only}|Medical audit in general practice. I: Effects on doctors' clinical behaviour for common childhood conditions|/resolve/reference/PMED?id=1611372
North of England1992 {published data only}|Medical audit in general practice. II: Effects on health of patients with common childhood conditions|/resolve/reference/PMED?id=1611373
Ogwal-Okeng 2001 {published data only}|Prescribing audit with feedback intervention in six regional hospitals and Mulagi referral/teaching hospitals|
Ottolini 1998 {published data only}|Development and evaluation of a CD-ROM computer program to teach residents telephone management|/resolve/reference/PMED?id=9481021
Pearson 2001 {published data only}|Critical pathways intervention to reduce length of hospital stay|/resolve/reference/PMED?id=11182102
Putnam 1985 {published data only}|Impact of patient care appraisal on physicians behaviour in the office setting|/resolve/reference/PMED?id=3986727
Putnam 1985 {published data only}|Primary care appraisal in the ambulatory setting: effectiveness of a continuing medical education tool|
Restuccia 1982 {published data only}|The effect of concurrent feedback in reducing inappropriate hospital utilization|/resolve/reference/PMED?id=7043116
Rollman 2002 {published data only}|A randomized trial using computerized decision support to improve treatment of major depression in primary care|
Rubenstein 1989 {published data only}|Improving patient function: a randomized trial of functional disability screening|/resolve/reference/PMED?id=2683917
Rubenstein 1999 {published data only}|Evidence-based care for depression in managed primary care practices|/resolve/reference/PMED?id=10495595
Shaughnessy 1991 {published data only}|Improving prescription-writing skills in a family practice residency|/resolve/reference/PMED?id=2008781
Spector 1989 {published data only}|Reforming nursing home quality regulation. Impact on cited deficiencies and nursing home outcomes|/resolve/reference/PMED?id=2755219
Szczepura 1994 {published data only}|Effectiveness and cost of different strategies for information feedback in general practice|/resolve/reference/PMED?id=8312032
Taylor 1997 {published data only}|Changes in prescribing following a pharmicists-led audit of ulcer-healing therapy in general practice|
The SUPPORT 1995 {published data only}|A controlled trial to improve care for seriously ill hospitalized patients|/resolve/reference/PMED?id=7474243
Velikova 2004 {published data only}|Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial|/resolve/reference/PMED?id=14966096
Weingarten 2000 {published data only}|Can peer-comparison feedback improve patient functional status?|/resolve/reference/PMED?id=11009745
White 1995 {published data only}|Using information from asthma patients: a trial of information feedback in primary care|/resolve/reference/PMED?id=7580666
Wing 1987 {published data only}|Impact of a therapeutic drug monitoring program for digoxin|/resolve/reference/PMED?id=3632149
Wing 1987 (II) {published data only}|Evaluation of a therapeutic drug monitoring program frotheophylline in a teaching hospital|/resolve/reference/PMED?id=3652932
Winkens 1997 {published data only}|Fitting a routine health-care activity into a randomized trial: an experiment possible without informed consent?|/resolve/reference/PMED?id=9179102
Bahrami 2004 {published data only}|Effectiveness of strategies to disseminate and implement clinical guidelines for the management of impacted and unrupted third molars in primary dental care: a cluster randomised controlled trial|/resolve/reference/PMED?id=15592551
Curtis 2005 {published data only}|A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs|/resolve/reference/PMED?id=16159043
Foy 2004 {published data only}|A randomised controlled trial of a tailored multifacted strategy to promote implementation of a clinical guideline on induced abortion care|/resolve/reference/PMED?id=15198764
Horbar 2004 {published data only}|Collaborative quality improvement to promote evidence-based surfactant for preterm infants: a cluster randomised trial|/resolve/reference/PMED?id=15514344
Joseph 2004 {published data only}|Results of a randomised controlled trial of intervention to implement smoking guidelines in Veterans Affairs medical centers: increased use of medications without cessation benefit|/resolve/reference/PMED?id=15586837
Mitchell 2005 {published data only}|Improving management of hypertension in general practice: a randomised controlled trial of feedback derived from electronic patient data|
Solomon 2004 {published data only}|Multifacted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomised controlled trial|
Axt-Adam 1993|Influencing behavior of physicians ordering laboratory tests: a literature study|/resolve/reference/PMED?id=8366680
Balas 1996|Effect of physician profiling on utilization. Meta-analysis of randomized clinical trials|/resolve/reference/PMED?id=8945689
Bandura 1986||
Davis 1991||
Davis 1992|Evidence for the effectiveness of CME. A review of 50 randomized controlled trials|/resolve/reference/PMED?id=1501333
Davis 1995|Changing physician performance. A systematic review of the effect of continuing medical education strategies|/resolve/reference/PMED?id=7650822
Fox 1989||
Foy 2002|Attributes of clinical recommendations that influence change in practice following audit and feedback|/resolve/reference/PMED?id=12160920
Freemantle 1997|Printed educational materials: effects on professional practice and health care outcomes (Cochrane Review)|
Goff 2002b|Enchancing the quality of care for patients with coronary heart disease: The design and baseline results of the hastening the effective application of research through technology (HEART) trial|/resolve/reference/PMED?id=12500883
Goff 2003|Quality of care for secondary prevention for patients with coronary heart disease: Results of the hastening the effective application of research through technology (HEART) trial|/resolve/reference/PMED?id=14660997
Green 1988|Preventive practices by physicians: behavioural determinants and potential interventions|/resolve/reference/PMED?id=3079134
Grimshaw 2001|Changing provider behavior: An overview of systematic reviews of interventions|
Grimshaw 2002|Effectiveness and efficiency of guideline dissemination and implementation strategies|
Grimshaw 2004|Effectiveness and efficiency of guideline dissemination and implementation strategies|/resolve/reference/PMED?id=14960256
Jamtvedt 2003|Audit and feedback: effects on professional practice and health care outcomes|
Juni 1999|The hazards of scoring the quality of clinical trials for meta-analysis|/resolve/reference/PMED?id=10591373
Juni 2001|Assessing the quality of controlled trials|
Kanouse 1988|When does information change practitioners' behavior?|/resolve/reference/PMED?id=10287110
Kunz 2002|Randomisation to protect against selection bias in healthcare trials|
Mugford 1991|Effects of feedback of information on clinical practice: a review|/resolve/reference/PMED?id=1912809
Oxman 1995|No magic bullets: a systematic review of 102 trials of interventions to improve professional practice|/resolve/reference/PMED?id=7585368
Oxman 2001|An overview of strategies to promote implementation of evidence based health care|
Prochaska 1992|In search of how people change. Applications to addictive behaviors|/resolve/reference/PMED?id=1329589
Shaw 2005|Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes|
Sibley 1982|A randomized trial of continuing medical education|/resolve/reference/PMED?id=7057858
Stone 2002|Interventions that increase use of adult immunization and cancer screening services: a meta-analysis|/resolve/reference/PMED?id=11992299
Thomson 1995|A systematic review of three interventions to improve health professional practice|
Thomson O'Brien 2001|Continuing education meetings and workshops: effect on professional practice and health care outcomes|
Thomson OBrien 1997a|Audit and feedback versus alternative strategies: effects on professional practice and health care outcomes|
Thomson OBrien 1997b|Audit and feedback: effects on professional practice and health care outcomes|
Bar-Meir 1998 {published and unpublished data}|Budesonide versus prednisone in the treatment of active Crohn's disease|/resolve/reference/PMED?id=9753485
Campieri 1997 {published data only}|Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group|/resolve/reference/PMED?id=9301500
D'Haens 1998 {published data only}|Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease|
Escher 2004 {published data only}|Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial|/resolve/reference/PMED?id=15095852
Greenberg 1994 {published data only}|Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group|/resolve/reference/PMED?id=8078529
Gross 1996 {published and unpublished data}|Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group|/resolve/reference/PMED?id=8889459
Irvine 2000 {published data only}|Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group|
Levine 2003 {published data only}|A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease|/resolve/reference/PMED?id=12548062
Rutgeerts 1994 {published data only}|A comparison of budesonide with prednisolone for active Crohn's disease|/resolve/reference/PMED?id=8078530
Thomsen 1998 {published data only}|A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group|
Thomsen 2002 {published data only}|Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life|
Tremaine 2002 {published and unpublished data}|Budesonide CIR capsules one or twice daily in active Crohn's disease. A randomized placebo controlled study in the USA|
Tursi 2006 {published and unpublished data}|Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study|/resolve/reference/PMED?id=16733496
Van Ierssel 1995 {published data only}|Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease|
Anonymous 1999 {published data only}|Comparison of budesonide with mesalazine in Crohn's disease. [Dutch]|
Caesar 1997 {published data only}|Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group|/resolve/reference/PMED?id=9164517
Cortot 2001 {published data only}|Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease|/resolve/reference/PMED?id=11156638
Ecker 2003 {published data only}|Oral budesonide significantly improves water absorption in patients with ileostomy for Crohn disease|/resolve/reference/PMED?id=12737444
Ewe 1999 {published data only}|Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group|/resolve/reference/PMED?id=10333200
Ferguson 1998 {published data only}|Oral budesonide as maintenance therapy in Crohn's disease--results of a 12-month study. Global Budesonide Study Group|
Florin 2000 {published data only}|Treatment of joint pain in Crohn's patients with budesonide controlled ileal release|
Gelbmann 2001 {published data only}|Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease|/resolve/reference/PMED?id=11742191
Green 2001 {published data only}|Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules|
Greenberg 1996 {published data only}|Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group|/resolve/reference/PMED?id=8536887
Gross 1997a {published data only}|Replacement of systemic steroids by oral budesonide in patients with post-active or chronic Crohn's ileocolitis - a dose-finding study|
Gross 1997b {published data only}|Dose-finding study with oral budesonide in patients with active Crohn's ileocolitis|
Gross 1998 {published data only}|Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group|/resolve/reference/PMED?id=9616309
Hanauer 2005 {published data only}|Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial|
Hellers 1999 {published data only}|Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group|/resolve/reference/PMED?id=9922309
Herfarth 2004 {published data only}|Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization|/resolve/reference/PMED?id=13680283
Irvine 1996 {published data only}|Effects of budesonide therapy on quality of life in active Crohn's disease|
Kundhal 2001 {published data only}|Controlled ileal release budesonide in pediatric Crohn disease: efficacy and effect on growth|/resolve/reference/PMED?id=11479412
Levine 2002 {published data only}|Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children|/resolve/reference/PMED?id=11815767
Lofberg 1993 {published data only}|Oral budesonide in active Crohn's disease|
Lofberg 1996 {published data only}|Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study|/resolve/reference/PMED?id=8881815
Lowry 1999 {published data only}|A comparison of budesonide and mesalamine for active Crohn's disease|/resolve/reference/PMED?id=10220523
Mantzaris 2003 {published data only}|Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease|/resolve/reference/PMED?id=15017504
Novacek 1995 {published data only}|Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study|/resolve/reference/PMED?id=7610692
Roth 1993 {published data only}|Treatment of active Crohn's disease with an oral slow-release budesonide formulation|/resolve/reference/PMED?id=8503403
Sandborn 2005 {published data only}|Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials|
Schoon 2005 {published data only}|Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease|/resolve/reference/PMED?id=15704045
Simms 2001 {published data only}|Budesonide for maintenance of remission in Crohn's disease|/resolve/reference/PMED?id=11279777
Steinhart 2002 {published data only}|Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial|/resolve/reference/PMED?id=12105831
Tillinger 1998 {published data only}|Influence of topically and systemically active steroids on circulating leukocytes in Crohn's disease|
Astra Zeneca {published data only}|Efficacy and safety study of D9421-C 9 mg and 15 mg versus placebo in Japanese patients with active Crohn's disease.|
Belgian IBD Research {unpublished data only}|The ideal management of Crohn's disease: Top down versus step up strategies. A prospective controlled trial in the Benelux|
Falk Pharma GmbH {unpublished data only}|Oral budesonide vs. oral mesalazine in active CD|
Barnes 2005|Molecular mechanisms and cellular effects of glucocorticosteroids|/resolve/reference/PMED?id=16054537
Baumgart 2007|Inflammatory bowel disease: clinical aspects and established and evolving therapies|/resolve/reference/PMED?id=17499606
Best 1976|Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study|/resolve/reference/PMED?id=1248701
Clark 1999|Assessing the quality of randomized trials: reliability of the Jadad scale|/resolve/reference/PMED?id=10503804
Fedorak 2005|Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide|/resolve/reference/PMED?id=15555744
Follmann 1992|Variance imputation for overviews of clinical trials with continuous response|/resolve/reference/PMED?id=1619456
Hanauer 2006|Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial|
Harvey 1980|A simple index of Crohn's-disease activity|/resolve/reference/PMED?id=6102236
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2005|Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6|
Hyams 1991|Development and validation of a pediatric Crohn's disease activity index|/resolve/reference/PMED?id=1678008
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Juni 2001|Systematic reviews in health care: Assessing the quality of controlled clinical trials|/resolve/reference/PMED?id=11440947
Kane 2002|The effectiveness of budesonide therapy for Crohn's disease|
Malchow 1984|European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment|/resolve/reference/PMED?id=6140202
Otley 2005|Budesonide for induction of remission in Crohn's disease|/resolve/reference/PMED?id=16235274
Papi 2000|Budesonide in the treatment of Crohn's disease: a meta-analysis|
Sandborn 2007|Certolizumab pegol for the treatment of Crohn's disease|/resolve/reference/PMED?id=17634458
Singleton 1979|National Cooperative Crohn's Disease Study: adverse reactions to study drugs|/resolve/reference/PMED?id=38177
Summers 1979|National Cooperative Crohn's Disease Study: results of drug treatment|/resolve/reference/PMED?id=38176
Targan 1997|A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group|/resolve/reference/PMED?id=9321530
van Hees 1980|An index of inflammatory activity in patients with Crohn's disease|/resolve/reference/PMED?id=7429289
Winship 1979|National Cooperative Crohn's Disease Study: study design and conduct of the study|/resolve/reference/PMED?id=38175
Balaban 2008 {published data only}|Redefining and redesigning hospital discharge to enhance patient care: a randomized controlled study|/resolve/reference/PMED?id=18452048
Bolas 2004 {published data only}|Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland|/resolve/reference/PMED?id=15085948
Evans 1993 {published data only}|Evaluating hospital discharge planning: a randomised controlled trial|/resolve/reference/PMED?id=8464252
Harrison 2002 {published data only}|Quality of life of the effectiveness of two models of hospital-to-home transition|/resolve/reference/PMED?id=12021683
Hendriksen 1990 {published data only}|Current cooperation concerning admission to and discharge from geriatric hospitals [Danish]|/resolve/reference/PMED?id=2304838
Hendriksen 1990 {published data only}|Cooperation concerning admission to and discharge of elderly people from the hospital. 1. The coordinated contributions of home care personnel|/resolve/reference/PMED?id=2551083
Jack 2009 {published data only}|A reengineered hospital discharge program to decrease rehospitalization|/resolve/reference/PMED?id=19189907
Kennedy 1987 {published data only}|Effective comprehensive discharge planning|/resolve/reference/PMED?id=3678895
Laramee 2003 {published data only}|Case management in a heterogeneous congestive heart failure population|/resolve/reference/PMED?id=12695272
Moher 1992 {published data only}|Effects of a medical team coordinator on length of hospital stay|/resolve/reference/PMED?id=1737315
Naji 1999 {published data only}|Discharging psychiatric in-patients back to primary care: a pragmatic randomized controlled trial of a novel discharge protocol|
Naughton 1994 {published data only}|Reducing hospital costs for the geriatric patient admitted from the emergency department: a randomised trial|/resolve/reference/PMED?id=7930327
Naylor 1994 {published data only}|Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial|/resolve/reference/PMED?id=8185149
Nazareth 2001 {published data only}|A pharmacy discharge plan for hospitalized elderly patients - a randomized controlled trial|/resolve/reference/PMED?id=11322670
Pardessus 2002 {published data only}|Benefits of home visits for falls and autonomy in the elderly: a randomized trial study|/resolve/reference/PMED?id=11953541
Parfrey 1994 {published data only}|The feasibility and efficacy of early discharge planning initiated by the admitting department in two acute care hospitals|/resolve/reference/PMED?id=8004854
Preen 2005 {published data only}|Effects of a multidisciplinary, post discharge continuance of care intervention on quality of life, discharge satisfaction, and hospital length of stay: a randomized controlled trial|/resolve/reference/PMED?id=15668310
Rich 1993 {published data only}|Prevention of readmission in elderly patients with congestive heart failure: results of a prospective randomised pilot study|/resolve/reference/PMED?id=8289096
Rich 1995 {published data only}|A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure|/resolve/reference/PMED?id=7565975
Shaw 2000 {published data only}|Evaluation of effect of pharmacy discharge planning on medication problems experienced by discharged acute admission mental health patients|
Sulch 2000 {published data only}|Randomized controlled trial of integrated (managed) care pathway for stroke rehabilitation|/resolve/reference/PMED?id=10926959
Weinberger 1996 {published data only}|Does increased access to primary care reduce hospital admissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmissions|/resolve/reference/PMED?id=8618584
Applegate 1990 {published data only}|A randomized controlled trial of a geriatric assessment unit in a community rehabilitation hospital|/resolve/reference/PMED?id=2186276
Brooten 1987 {published data only}|A randomized clinical trial of early hospital discharge and home follow-up of very-low-birth-weight infants|/resolve/reference/PMED?id=3317272
Brooten 1994 {published data only}|A randomized trial of early hospital discharge and home follow-up of women having cesarean birth|/resolve/reference/PMED?id=7936522
Carty 1990 {published data only}|A randomized, controlled evaluation of early postpartum hospital discharge|
Casiro 1993 {published data only}|Earlier discharge with community-based intervention for low birth weight infants: a randomized trial|/resolve/reference/PMED?id=8390644
Choong 2000 {published data only}|Clinical pathway for fractured neck of femur: a prospective controlled study|/resolve/reference/PMED?id=10870534
Donahue 1994 {published data only}|Acute care visits and rehospitalization in women and infants after cesarean birth|/resolve/reference/PMED?id=8169676
Dudas 2001 {published data only}|The impact of follow-up telephone calls to patients after hospitalization|/resolve/reference/PMED?id=11790365
Epstein 1990 {published data only}|Consultative geriatric assessment for ambulatory patients. A randomized trial in a health maintenance organization|/resolve/reference/PMED?id=2294326
Fretwell 1990 {published data only}|The Senior Care Study. A controlled trial of a consultative/unit-based geriatric assessment program in acute care|/resolve/reference/PMED?id=2229859
Gayton 1987 {published data only}|Trial of a geriatric consultation team in an acute care hospital|/resolve/reference/PMED?id=3301989
Germain 1995 {published data only}|A geriatric assessment and intervention team for hospital inpatients awaiting transfer to a geriatric unit: a randomized trial|/resolve/reference/PMED?id=7599249
Gillette 1991 {published data only}|Hospital-based case management for medically fragile infants: results of a randomized trial|/resolve/reference/PMED?id=1705348
Haggmark 1997 {published data only}|Effects of an intervention programme for improved discharge planning|
Hansen 1992 {published data only}|Geriatric follow-up by home visits after discharge from hospital: a randomized controlled trial|/resolve/reference/PMED?id=1471584
Hickey 2000 {published data only}|Effect of case managers with a general medical patient population|
Hogan 1990 {published data only}|A prospective controlled trial of a geriatric consultation team in an acute-care hospital|/resolve/reference/PMED?id=2337005
Jenkins 1996 {published data only}|A randomized single-blind evaluation of a discharge teaching book for pediatric patients with burns|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Karppi 1995 {published data only}|Effectiveness of a Finnish geriatric inpatient assessment. Two-year follow up of a randomized clinical trial on community-dwelling patients|/resolve/reference/PMED?id=7569485
Kleinpell 2004 {published data only}|Randomized trial of an intensive care unit-based early discharge planning intervention for critically ill elderly patients|/resolve/reference/PMED?id=15293587
Kravitz 1994 {published data only}|Geriatric home assessment after hospital discharge|/resolve/reference/PMED?id=7983283
Landefield 1995 {published data only}|A randomized controlled trial of care in a hospital medical unit especially designed to improve functional outcomes of acutely ill older patients|/resolve/reference/PMED?id=7715644
Martin 1994 {published data only}|A randomized controlled trial of a high support hospital discharge team for elderly people|/resolve/reference/PMED?id=8085509
McGrory 1994 {published data only}|A study investigating primary nursing, discharge teaching, and patient satisfaction of ambulatory cataract patients|/resolve/reference/PMED?id=8006492
McInnes 1999 {published data only}|Can GP input into discharge planning result in better outcomes for the frail aged: results from a randomized controlled trial|/resolve/reference/PMED?id=10439984
Melin 1993 {published data only}|The cost-effectiveness of rehabilitation in the home: a study of Swedish elderly|/resolve/reference/PMED?id=8438972
Melin 1995a {published data only}|A randomized trial of multidisciplinary in-home care for frail elderly patients awaiting hospital discharge|/resolve/reference/PMED?id=8547388
Melin 1995b {published data only}|Health outcomes of a post-hospital in-home team care: secondary analysis of a Swedish trial|/resolve/reference/PMED?id=7884123
Murray 1995 {published data only}|Communication between home and hospital in the management of acute stroke in the elderly: results from a controlled trial|/resolve/reference/PMED?id=6757182
Naylor 1999 {published data only}|Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized controlled trial|/resolve/reference/PMED?id=10029122
Naylor 2004 {published data only}|Transitional care of older adults hospitalized with heart failure: a randomised controlled trial|
Nickerson 2005 {published data only}|Drug therapy problems, inconsistencies and omissions identified during a medication reconciliation and seamless care service|/resolve/reference/PMED?id=16334075
Nikolaus 1995 {published data only}|Effectiveness of hospital-based geriatric evaluation and management and home intervention team (GEM-HIT): rationale and design of a 5-year randomized trial|/resolve/reference/PMED?id=7773832
Reuben 1995 {published data only}|A randomized trial of comprehensive geriatric assessment in the care of hospitalized patients|/resolve/reference/PMED?id=7715645
Rich 1993b {published data only}|Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study|/resolve/reference/PMED?id=8289096
Rich 1995b {published data only}|A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure|/resolve/reference/PMED?id=7565975
Rubenstein 1984 {published data only}|Effectiveness of a geriatric evaluation unit. A randomized clinical trial|/resolve/reference/PMED?id=6390207
Saltz 1988 {published data only}|Impact of a geriatric consultation team on discharge placement and repeat hospitalization|/resolve/reference/PMED?id=3294117
Siu 1996 {published data only}|Postdischarge geriatric assessment of hospitalized frail elderly patients|/resolve/reference/PMED?id=8526700
Smith 1988 {published data only}|Postdischarge care and readmissions|/resolve/reference/PMED?id=2839742
Thomas 1993 {published data only}|Inpatient community-based geriatric assessment reduces subsequent mortality|/resolve/reference/PMED?id=8426028
Townsend 1988 {published data only}|Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme: a randomized controlled trial|/resolve/reference/PMED?id=2844356
Victor 1988 {published data only}|Rearranging the deckchairs on the Titanic: failure of an augmented home help scheme after discharge to reduce the length of stay in hospital|/resolve/reference/PMED?id=2835020
Voirol 2004 {published data only}|Impact of pharmacists' interventions on the pediatric discharge medication process|/resolve/reference/PMED?id=15328395
Winograd 1993 {published data only}|A negative trial of inpatient geriatric consultation. Lessons learned and recommendations for future research|/resolve/reference/PMED?id=8357287
Anderson 1984|Hospital readmissions in the Medicare population|/resolve/reference/PMED?id=6436703
Anderson 1985|Predicting hospital readmissions in the Medicare population|/resolve/reference/PMED?id=2931368
Barker 1985|Geriatric consultation teams in acute hospitals: impact on back-up of elderly patients|/resolve/reference/PMED?id=3923086
Brent Soc Ser 1991||
Cochrane 1954|The combination of estimates from different experiments|
Cochrane Handbook|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration|
Dept of Health 2003|Discharge from hospital: pathway, process and practice. A manual of discharge practice for health and social care commissioners, managers and practitioners|
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Kwan 2004|In hospital care pathways for stroke|
Marks 1994||
Parker 2002|A systematic review of discharge arrangements for older people|/resolve/reference/PMED?id=12065067
Phillips 2004|Comprehensive discharge planning with post discharge support for older patients with congestive heart failure: a meta-analysis|/resolve/reference/PMED?id=14734599
Schwartz 1991|Hospital cost containment in the 1980s. Hard lessons learned and prospects for the 1990s|/resolve/reference/PMED?id=2005941
Selker 1989|The epidemiology of delays in a teaching hospital|/resolve/reference/PMED?id=2918764
Stuck 1993|Comprehensive geriatric assessment: a meta analysis of controlled trials|/resolve/reference/PMED?id=8105269
Townsend 1988|Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme: a randomised controlled trial|/resolve/reference/PMED?id=2844356
Victor 1988|Preparing the elderly for discharge from hospital: a neglected aspect of patient care?|/resolve/reference/PMED?id=3389244
Aviles 2001 {published data only}|Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial|/resolve/reference/PMED?id=11761499
Benson 2006 {published data only}|Study of the therapeutic effects of intercessory prayer (STEP) in cardiac bypass patients: A multicenter randomised trial of uncertainty and certainty of receiving intercessory prayer|/resolve/reference/PMED?id=16569567
Benson 2006 {published data only}|Study of the therapeutic effects of intercessory prayer (STEP) study design and research methods|/resolve/reference/PMED?id=11923793
Byrd 1988 {published data only}|Positive therapeutic effects of intercessory prayer in a coronary care unit population|/resolve/reference/PMED?id=3393937
Collipp 1969 {published data only}|The efficacy of prayer: a triple-blind study|/resolve/reference/PMED?id=5786487
Harris 1999 {published data only}|A randomized, controlled trial of the effects of remote intercessory prayer on outcomes in patients admitted to the coronary care unit|/resolve/reference/PMED?id=10547166
Joyce 1964 {published data only}|The objective efficacy of prayer|/resolve/reference/PMED?id=14273699
Krucoff 2001 {published data only}|Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilot|/resolve/reference/PMED?id=11685160
Leibovici 2001 {published data only}|Effects of remote, retroactive intercessory prayer on outcomes in patients with bloodstream infection: randomised controlled trial|/resolve/reference/PMED?id=11751349
Walker 1997 {published data only}|Intercessory prayer in the treatment of alcohol abuse and independence: A pilot investigation|/resolve/reference/PMED?id=9375433
Abbot 2000 {published data only}|Healing as a therapy for human disease: A systematic review|/resolve/reference/PMED?id=10784273
Cha 2001 {published data only}|Does prayer influence the success of in vitro fertilization-embryo transfer: report of a masked, randomized trial|/resolve/reference/PMED?id=11584476
Conti 1999 {unpublished data only}||
Galton 1883 {published data only}||
Green 1993 {unpublished data only}||
Greyson 1997 {published data only}|Distance healing of patients with major depression|
Harrison 1999a {published data only (unpublished sought but not used)}||
Lilliston 1981 {published data only}|Perceived effectiveness of religious solutions to personal problems|
Lilliston 1982 {published data only}|Perceptions of religious solutions to personal problems of women|
O'Mathuna 1999 {published data only}|Prayer Research. What are we measuring?|
Sicher 1998 {published data only}|A randomized double-blind study of the effect of distant healing in a population with advanced AIDS|/resolve/reference/PMED?id=9866433
Toth 1999 {published data only}|Faith in God: Help for partners in pain|/resolve/reference/PMED?id=11912572
Wiesendanger 2001 {published data only}|Chronically ill patients treated by spiritual healing improve in quality of life: Results of a randomised waiting-list controlled study|/resolve/reference/PMED?id=11246935
Wirth 1994a {published data only}|Complementary healing therapies|/resolve/reference/PMED?id=7843869
Wirth 1994b {published data only}|The psychophysiology of nontraditional prayer|/resolve/reference/PMED?id=7843870
Altman 1996|Detecting skewness from summary information.|/resolve/reference/PMED?id=8916759
Anonymous 1995|AIDS daily summary|
Barnes 2004|Complementary and alternative medicine use among adults: United States, 2002|
Bender 2008|Attention should be given to multiplicity issues in systematic reviews|/resolve/reference/PMED?id=18687287
Bland 1997|Statistics notes. Trials randomised in clusters|/resolve/reference/PMED?id=9302962
Boissel 1999|The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use|/resolve/reference/PMED?id=10667106
Chibnall 2001|Experiments on distant intercessory prayer: God, science, and the lesson of Massah|/resolve/reference/PMED?id=11718583
Choi 1997|Hippocrates|
Deeks 2000|Issues in the selection for meta-analyses of binary data|
Deuteronomy 6:16|Old Testament|
Divine 1992|The unit of analysis error in studies about physicians' patient care behavior|/resolve/reference/PMED?id=1453246
Donner 2002|Issues in the meta-analysis of cluster randomized trials|
Egger 1995|Misleading meta-analysis|/resolve/reference/PMED?id=7711568
Elbourne 2002|Meta-analyses involving cross-over trials: methodological issues|/resolve/reference/PMED?id=11914310
Gulliford 1999|Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994|/resolve/reference/PMED?id=10221325
Hegel 2008||
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2009|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jni 2001|Systematic reviews in health care: Assessing the quality of controlled clinical trials|/resolve/reference/PMED?id=11440947
Koenig 2000||
Larson 1997|Hippocrates|
Leibovici 2002|Author's reply|/resolve/reference/PMED?id=11977263
Marshall 2000|Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?|/resolve/reference/PMED?id=10755072
McCaffrey 2004|Prayer for health concerns: results of a national survey on prevalence and patterns of use|/resolve/reference/PMED?id=15111371
OED 1989||
RevMan 2008|Review Manager (RevMan)|
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Turner 2004||
Ukoumunne 1999|Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review|/resolve/reference/PMED?id=10982317
Wittgenstein 1974||
Xia 2007|The Leeds Outcomes Stakeholders Survey (LOSS) Study|
Roberts 2000|Intercessory prayer for the alleviation of ill health|
Roberts 2007|Intercessory prayer for the alleviation of ill health|
Hanning 1993 {published data only}|Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?|/resolve/reference/PMED?id=8460615
Kalnins 2005 {published and unpublished data}|Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis|/resolve/reference/PMED?id=16182685
Kalnins 2005 {published and unpublished data}|Oral supplements vs normal food intake in children and adults [abstract]|
Kalnins 2005 {published and unpublished data}|Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF? [abstract]|
Poustie 2006 {published and unpublished data}|Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis [abstract]|
Poustie 2006 {published and unpublished data}|Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis [abstract]|
Poustie 2006 {published and unpublished data}|Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial|/resolve/reference/PMED?id=16467348
Poustie 2006 {published and unpublished data}|The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis [abstract]|
Abdulhamid 2008 {published data only}|Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis|
Abdulhamid 2008 {published data only}|Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis [abstract]|
Best 2004 {published data only}|Copper enzyme activities in cystic fibrosis before and after supplementation plus or minus zinc|/resolve/reference/PMED?id=14681839
Bruzzese 2007 {published data only}|Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study|/resolve/reference/PMED?id=17360077
Caramia 2003 {published data only}|Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture|/resolve/reference/PMED?id=12920976
Ellis 1998 {published data only}|Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study|/resolve/reference/PMED?id=9506640
Grey 2003 {published data only}|Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein|/resolve/reference/PMED?id=15463873
Grey 2003 {published data only}|Oral supplementation with a bovine whey protein isolate can increase intracellular and sputum glutathione levels in patients with cystic fibrosis [abstract]|
Haworth 2004 {published data only}|Randomised, double blind, placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adults with cystic fibrosis [abstract]|
Haworth 2004 {published data only}|Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis|/resolve/reference/PMED?id=15698940
Kane 1991 {published data only}|Energy and respiratory metabolism in cystic fibrosis: the influence of carbohydrate content of nutritional supplements|/resolve/reference/PMED?id=2051272
Lepage 2002 {published data only}|Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis|/resolve/reference/PMED?id=12183711
Lloyd-Still 2001 {published data only}|A randomized, controlled study examining the bioavailability and safety of an algal docosahexaenoic acid (DHA) triacylglycerol in cystic fibrosis (CF) patients [abstract]|
Lloyd-Still 2001 {published data only}|Bioavailability and safety of an algal docosahexaenoic acid (DHA) triglyceride in cystic fibrosis (CF) [abstract]|
Lloyd-Still 2001 {published data only}|Blood and tissue essential fatty acids after docosahexaenoic acid supplementation in cystic fibrosis [abstract]|
Lloyd-Still 2001 {published data only}|Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study|/resolve/reference/PMED?id=16226012
Lloyd-Still 2001 {published data only}|Lipid soluble antioxidant status during supplementation with algal docosahexaenoic acid triglyceride in CF [abstract]|
McKenna 1985 {published data only}|Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects|/resolve/reference/PMED?id=3981368
Milla 1996 {published data only}|Glycemic response to dietary supplements in cystic fibrosis is dependent on the carbohydrate content of the formula|/resolve/reference/PMED?id=8776690
Oudshoorn 2007 {published data only}|Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients|/resolve/reference/PMED?id=16784903
Papas 2007 {published data only}|Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients|/resolve/reference/PMED?id=17216337
Patchell 2001 {published data only (unpublished sought but not used)}|A study to assess the efficacy of Healthshake in the nutritional management of children and adults with cystic fibrosis. Start date: 1/7/98; End date: 30/6/99|
Patchell 2001 {published data only (unpublished sought but not used)}||
Sondel 1987 {published data only}|Oral nutritional supplementation in cystic fibrosis|
Steinkamp 2000 {published data only}|Effects of a formula supplement rich in linoleic acid on the essential fatty acid status of cystic fibrosis patients [abstract]|/resolve/reference/PMED?id=16839968
Steinkamp 2000 {published data only}|Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients|/resolve/reference/PMED?id=11045840
MacDonald 2001 {published data only}|Evaluation of supplementary feed (Healthshake) in the nutritional management of children with cystic fibrosis. Start date: 1/1/97; End date: 1/1/98|
MacDonald 1996|Nutritional management of cystic fibrosis|/resolve/reference/PMED?id=8660059
Marin 2004|Energy expenditure, nutrition status and body composition in children with cystic fibrosis|/resolve/reference/PMED?id=14962683
Murray 1991|Statistical aspects of research methodology|
Poustie 1999|Oral protein calorie supplementation for children with chronic disease|
RLCH 2006||
Shepherd 1980|Improved growth and clinical, nutritional and respiratory changes in response to nutritional therapy in cystic fibrosis|/resolve/reference/PMED?id=6774070
Shepherd 1988|Increased energy expenditure in young children with cystic fibrosis|
Sinaasappel 2002|Nutrition in patients with cystic fibrosis; a European consensus|/resolve/reference/PMED?id=15463811
Smyth 2000|Oral calorie supplements for cystic fibrosis|
Australia 1999 {published data only}|A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour|
Belgium 1999 {published data only}|Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial|
Canada 2002 {published data only}|Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management|/resolve/reference/PMED?id=12196880
Canada 2005 {published and unpublished data}|Prophylactic use of misoprostol in the third stage of labor [abstract]|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
China 2004a {published data only}|A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor|
Colombia 2002 {published data only}|Active management of the childbirth with sublingual misoprostol: a clinical controlled trial in the Hospital de Maternidad Rafael Calvo|
Egypt 1993 {published data only}|Carboprost trometamol in the management of the third stage of labor|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Egypt 1997 {unpublished data only}|Management of the third stage of labour with carboprost trometamol in high risk patients for postpartum hemorrhage|
Egypt 1997 {unpublished data only}|Management of the third stage of labour with carboprost trometamol in high risk patients for postpartum hemorrhage|
France 2001 {published data only}|Role of misoprostol in controlled delivery|/resolve/reference/PMED?id=11883025
Gambia 2005 {published data only}|Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial|
Ghana 2000 {published data only}|A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour|
Ghana 2006 {published data only}|Rectal misoprostol vs intramuscular oxytocin in the routine management of the third stage of labour|
Ghana 2006 {published data only}|Oral misoprostol versus oxytocin in the management of the third stage of labour|/resolve/reference/PMED?id=16533451
Guinea-Bissau 2005 {published data only}|Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial|/resolve/reference/PMED?id=16195287
Guinea-Bissau 2005 {published data only}|Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country - secondary publication|/resolve/reference/PMED?id=16579891
Holland 1991 {published data only}|A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour|
Holland 1991 {published data only}|Oxytocin and sulprostone reduce postpartum blood los and shorten the third stage in low risk term women|
Holland 1991 {published data only}|Oxytocin and sulprostone reduce postpartum blood loss in low risk term women compared to saline|
Holland 1995 {published data only}|Preventing the recurrence of atonic postpartum hemorrhage: a double blind trial|
Hong Kong 2001 {published data only}|A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour|/resolve/reference/PMED?id=11139532
Hong Kong 2001 {published data only}|Comparison of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor a multicenter randomised controlled trial|
India 1988c {published data only}|Prophylactic use of 15(S)15 methyl PGF2alpha by intramuscular route for control of postpartum bleeding - a comparative trial with methylergometrine|
India 2001b {published data only}|Active management of third stage of labour. A comparative study in high risk patients for atonic postpartum haemorrhage|
India 2004b {published data only}|Sublingual misoprostol versus methlergometrine for active management of third stage of labor|/resolve/reference/PMED?id=15464767
India 2005a {published data only}|Oral misoprostol versus injectable methyergometrine in management of the third stage of labour|/resolve/reference/PMED?id=16126208
India 2006a {published data only}|Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section|/resolve/reference/PMED?id=16343498
India 2006b {published data only}|Oral misoprostol in the third stage of labour|/resolve/reference/PMED?id=16271721
India 2006c {unpublished data only}|Oral misoprostol in preventing postpartum hemorrhage in a community setting|
India 2006c {unpublished data only}|Oral misoprostol in preventing postpartum hemorrhage in a community setting|
India 2006c {unpublished data only}|Conducting international collaborative research in developing nations|/resolve/reference/PMED?id=15548406
India 2006c {unpublished data only}|Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
India 2006d {published data only}|Rectal misoprostol vs. 15-methyl prostaglandin F2-alpha for the prevention of postpartum hemorrhage|/resolve/reference/PMED?id=16764879
Mozambique 2001 {published data only}|Misoprostol for prevention of postpartum haemorrhage|/resolve/reference/PMED?id=11336714
Nigeria 2003 {published data only}|A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour|/resolve/reference/PMED?id=12623474
Singapore 1995 {published data only}|A randomized controlled study of prostaglandin 15-methyl F2alpha compared with syntometrine for prophylactic use in the third stage of labour|
South Africa 1998a {published data only}|Randomized comparison of rectal misoprostol with syntometrine for management of third stage of labor|/resolve/reference/PMED?id=9512323
South Africa 1998b {published data only}|Misoprostol for third stage of labour management: a double blind, placebo controlled clinical trial.|
South Africa 1998b {published data only}|A randomised placebo controlled trial of oral misoprostol in the third stage of labour|
South Africa 1998c {published data only}|Rectal misoprostol in the prevention of postpartum haemorrhage: a placebo controlled trial.|
South Africa 1998c {published data only}|Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial|/resolve/reference/PMED?id=9790395
South Africa 1998d {published and unpublished data}|Oral misoprostol for labour third stage management: randomised assessment of side effects (part 2)|
South Africa 2001 {published and unpublished data}|Side effects of oral misoprostol in the third stage of labour: a random allocation placebo controlled trial|
South Africa 2001 {published and unpublished data}|Oral misoprostol for labour third stage management: randomised assessment of side effects (part 1)|
South Africa 2001 {published and unpublished data}|Side-effects of oral misoprostol in the third stage of labour: a randomised placebo controlled trial|/resolve/reference/PMED?id=11455810
Switzerland 1999 {published data only}|Oral misoprostol for third stage of labor: a randomized placebo-controlled trial|/resolve/reference/PMED?id=10432138
Switzerland 1999 {published data only}|Oral misoprostol vs placebo for third stage of labor|
Turkey 2002 {published data only}|Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial|/resolve/reference/PMED?id=12389002
Turkey 2003 {published data only}|Oral misoprostol for the third stage of labor: a randomized controlled trial|/resolve/reference/PMED?id=12738151
United Kingdom 1994 {published data only}|A prospective, double blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2alpha, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section|/resolve/reference/PMED?id=7977546
United Kingdom 2000 {unpublished data only}|The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management|
United Kingdom 2001b {published data only}|Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon|
United Kingdom 2001b {published data only}|Active management of the third stage at caesarean section: misoprostol vs syntocinon|
United Kingdom 2003 {published data only}|Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor|/resolve/reference/PMED?id=12738159
USA 1990 {published data only}|Prophylactic intramyometrial carboprost tromethamine does not substantially reduce blood loss relative to intramyometrial oxytocin at routine cesarean section|/resolve/reference/PMED?id=2403792
USA 2001 {published data only}|Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery|/resolve/reference/PMED?id=11641670
USA 2004 {published data only}|Buccal misoprostol to decrease blood loss after vaginal delivery: a randomized trial|/resolve/reference/PMED?id=15572491
USA 2005 {published data only}|Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study|/resolve/reference/PMED?id=15902121
WHO 1999 {published and unpublished data}|Misoprostol dose-related shivering and pyrexia in the third stage of labour|
WHO 2001 {published and unpublished data}|The WHO multicentre double-blind randomized controlled trial to evaluate the use of misoprostol in the management of the third stage of labour|/resolve/reference/PMED?id=11551574
WHO 2001 {published and unpublished data}|Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour|
Zimbabwe 2001 {published data only}|Misoprostol versus oxytocin in the third stage of labor|/resolve/reference/PMED?id=11728483
Austria 1983 {published data only}|Uterine motility after post-partum application of sulprostone and other oxytocics|/resolve/reference/PMED?id=6662263
Canada 2004 {published data only}|A preliminary study of cutaneous blood flow associated with postpartum use of oral misoprostol|/resolve/reference/PMED?id=15607043
China 1997 {published data only}|Clinical study on reduction of postpartum bleeding by methyl carprost suppository|/resolve/reference/PMED?id=9596865
China 1998 {published data only}|Clinical study on reduction of postpartum bleeding in cesarean section by misoprostol|/resolve/reference/PMED?id=10806698
China 1998b {published data only}|Preventing of postpartum haemorrhage by Carboprost Methylate suppository administered through vagina or sublingually|
China 2001 {published data only}|Effect on different doses of misoprostol to prevent postpartum hemorrhage|
China 2004b {published data only}|Comparison of oral misoprostol and intravascular syntocinon in the management of the third stage of labour - a double-blind randomised controlled trial|
China 2004c {published data only}|A double-blind randomised controlled trial of oral misoprostol in addition to intra-muscular syntometrine in the management of the third stage of labour|
Egypt 1999 {published data only}|The use of rectal misoprostol as active pharmacological management of the third stage of labor|
Hungary 1979 {published data only}|The effect of prostaglandin F2alpha on third stage of labour|/resolve/reference/PMED?id=392622
India 1988a {published data only}|Prophylactic use of 15(S)15 methyl PGF2alpha for control of postpartum bleeding|
India 1988b {published data only}|Prophylactic use of 15(S)15 methyl PGF2alpha by intramuscular route - a controlled clinical trial|
India 2000a {published data only}|Misoprostol and the third stage|
India 2000b {published data only}|Comparative study on role of syntometrine and prostaglandin in the prevention of PPH|
India 2000c {published data only}|Active management of third stage of labor - a comparative study|
India 2001a {published data only}|Misoprostol and third stage of labour|
India 2005b {published data only}|Methylergometrine and carboprost tromethamine prophylaxis for postpartum hemorrhage|
India 2006e {published data only}|Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India|/resolve/reference/PMED?id=16371228
Indonesia 2002 {published data only}|Randomized clinical trial: the effectiveness of oral misoprostol versus oxytocin in prevention of postpartum hemorrhage [abstract]|
Israel 1992 {published data only}|Effect of intraumbilical prostaglandin F2alpha injection on the third stage of labour|/resolve/reference/PMED?id=1593552
Italy 1988 {published data only}|Prevention of primary post-partum haemorrhage (PPH). Controlled clinical trial: sulprostone vs metilergometrina|
Japan 1976 {published data only}|The effects of intramyometrial injection of prostaglandin F2alpha on severe post-partum hemorrhage|/resolve/reference/PMED?id=1085940
Singapore 1990 {published data only}|Effects of oxytocics on prostaglandin levels in the third stage of labour|/resolve/reference/PMED?id=2358192
Singapore 2001 {published and unpublished data}|Can oral misoprostol be used as an alternative to parenteral oxytocics in the active management of the third stage of labour? A preliminary study of its effect on the postpartum uterus|
Singapore 2001 {published and unpublished data}|Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine|
South Africa 1999 {published data only}|The Durham primary postpartum haemorrhage study|
South Africa 1999 {published data only}|A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage|
Turkey 2005 {published data only}|Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage|
United Kingdom 2001a {published data only}|A randomised, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during caesarean section|
USA 1983 {published data only}|Use of 15-Methyl prostaglandin F2alpha postpartum to contract the uterus in normal pregnant women|/resolve/reference/PMED?id=6644193
USA 1999 {published data only}|A randomized controlled trial of misoprostol versus oxytocin in preventing postpartum blood loss|
Al-Harazi 2009 {published data only}|Sublingual misoprostol for the prevention of postpartum hemorrhage|/resolve/reference/PMED?id=19618006
Baskett 2007 {published data only}|Misoprostol versus oxytocin for the reduction of postpartum blood loss|/resolve/reference/PMED?id=17321529
Bellad 2009 {published data only}|Sublingual (SL) powdered misoprostol (400 mcg) vs IM oxytocin (10 IU) for prevention of postpartum blood loss - a randomized controlled trial|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Biswas 2007 {published data only}|A study of prophylactic use of 15-methyl prostaglandin f2alpha in the active management of third stage of labour|/resolve/reference/PMED?id=18338474
Chhabra 2008 {published data only}|Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor|
Dickinson 2009 {published data only}|Optimization of third-stage management after second-trimester medical pregnancy termination|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Eftekhari 2009 {published data only}|The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section|/resolve/reference/PMED?id=19757270
Enakpene 2007 {published data only}|Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor|
Fawole 2011 {published data only}|A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Fekih 2009 {published data only}|Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial|/resolve/reference/PMED?id=19833454
Fu 2003 {published data only}|Prevention of early postpartum hemorrhage by way of oral misoprostol|
Geller 2008 {published data only}|Factors associated with acute postpartum hemorrhage in low-risk women delivering in rural India|/resolve/reference/PMED?id=18291401
Goudar 2008 {published data only}|Variation in the postpartum hemorrhage rate in a clinical trial of oral misoprostol|/resolve/reference/PMED?id=18609354
Gupta 2006 {published data only}|Rectal misoprostol versus oxytocin in the prevention of postpartum hemorrhage - a pilot study|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Harriott 2009 {published data only}|A randomized comparison of rectal misoprostol with syntometrine on blood loss in the third stage of labour|/resolve/reference/PMED?id=20043525
Hofmeyr 2008 {published data only}|Misoprostol for preventing postpartum hemorrhage|
Hofmeyr 2011 {published data only}|Administration of 400mug of misoprostol to augment routine active management of the third stage of labor|/resolve/reference/PMED?id=21130990
Hong 2007 {published data only}|Additional rectal misoprostol plus intravenous oxytocin versus intravenous oxytocin for the prevention of postpartum hemorrhage after cesarean section|
Jin 2000 {published data only}|Application of anus misoprostol to decrease the volume of post partum hemorrhage|
Jirakulsawas 2000 {published data only}|Comparison of oral misoprostol and intramuscular methylergonovine for prevention of postpartum hemorrhage|
Kalahroudi 2010 {published data only}|Comparison of the effect of rectal misoprostol and syntometrin in prevention of post partum hemorrhage|
Kodkany 2006 {published data only}|The efficacy of oral misoprostol in preventing postpartum hemorrhage in a community setting: a randomized double-blind placebo-controlled trial|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Kurshid 2010 {published data only}|To assess the efficacy of two regimens of misoprostol for second trimester pregnancy termination-a randomized comparison|
Kushtagi 2006 {published data only}|Evaluation of two uterotonic medications for the management of the third stage of labor|/resolve/reference/PMED?id=16762355
Lamont 2001 {published data only}|A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage|/resolve/reference/PMED?id=11577783
Lapaire 2006 {published data only}|Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery|/resolve/reference/PMED?id=16934269
Li 2002 {published data only}|Prophylactic and therapeutic effect of misoprofil plus oxytocin on postpartum hemorrhage in patients with pregnancy-induced hypertension syndrome|
Li 2003 {published data only}|Clinical study on reduction of postpartum bleeding in the risk factors by misoprostol|
Miller 2009 {published data only}|Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet|
Mobeen 2006 {published data only}|Misoprostol for the prevention of postpartum hemorrhage in rural Pakistan (ongoing trial)|
Mobeen 2009 {published data only}|Use of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage during home deliveries in Pakistan: a randomised placebo-controlled trial|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Moradi 2010 {published data only}|Comparison of misoprostol and oxytocin in reduction of postpartum hemorrhage|
Moss 2006 {published data only}|Oral misoprostol for prevention of postpartum hemorrhage (ongoing trial)|
Nagaria 2006 {published data only}|Intramuscular PGF2 a 125 microg versus intravenous methyl ergometrine 0.2mg in the active management of third stage of labor|
Nasr 2009 {published data only}|Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage|/resolve/reference/PMED?id=19249048
Ng 2007 {published data only}|A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor|/resolve/reference/PMED?id=16940738
Ozalp 2010 {published data only}|Dinoprostone vaginal insert versus intravenous oxytocin to reduce postpartum blood loss following vaginal or cesarean delivery|
Parsons 2007 {published data only}|Rectal misoprostol versus oxytocin in the management of the third stage of labour|/resolve/reference/PMED?id=17825135
Patted 2009 {published data only}|Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India|/resolve/reference/PMED?id=19089777
Quiroga 2009 {published data only}|Intrauterine misoprostol for the prevention of bleeding cesarean|/resolve/reference/PMED?id=19902675
Singh 2009 {published data only}|Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Sultana 2007 {published data only}|Misoprostol versus oxytocin in the active management of the third stage of labour|
Tanir 2009 {published data only}|Dinoprostone vaginal insert versus intravenous oxytocin to reduce the postpartum blood loss following vaginal or cesarean delivery|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Tripti 2009 {published data only}|400 ug oral misoprostol versus 0.2mg intravenous methyl ergometrine for the active management of third stage of labor|
Tudor 2006 {published data only}|Preliminary progress report: randomized double-blind trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Vaid 2009 {published data only}|A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor|/resolve/reference/PMED?id=19277690
Verghese 2008 {published data only}|Evaluation of carboprost as a prophylactic oxytocic in the management of third stage of labour|
Verma 2006 {published data only}|A double-blind randomized controlled trial to compare sublingual misoprostol with methylergometrine for prevention of postpartum hemorrhage|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Wright 2006 {published data only}|Preventing postpartum hemorrhage using a Tibetan traditional medicine (ongoing trial)|
Xu 2003 {published data only}|Misoprostol on preventing postpartum bleeding in cesarean|
Yuan 2003 {published data only}|Clinical observation of treatment for 60 cases of postpartum hemorrhage with misoprostol tablets combined with jiashenshenghuatang|
Zhao 2003 {published data only}|Clinical study on preventing and curing postpartum hemorrhage in the third stage of labor|
Amant 2001|The misoprostol third stage study: a randomised controlled comparison between orally administered misoprostol and standard management. [letter]|
Andolina 1999|Objective measurement of blood loss at delivery: is it more than a guess?|
Carroli 2001|RHL practical aspects: oxytocin or oxytocin+ergot alkaloids in active management of the third stage of labour|
Chong 1997|Severe hyperthermia following oral misoprostol in the immediate postpartum period|/resolve/reference/PMED?id=11770608
Cotter 2001|Prophylactic oxytocin for the third stage of labour|
El-Refaey 1997|Use of misoprostol in the prevention of postpartum haemorrhage|
Fawcus 1995|A community based investigation of causes of maternal mortality in rural and urban Zimbabwe|
Gibbens 1972|The circulating levels of oxytocin following intravenous and intramuscular administration of syntometrine|
Higgins 2005|Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]|
Hogerzeil 1996|Instability of (methyl)ergometrine in tropical climates: an overview|/resolve/reference/PMED?id=8909953
Khan 2006|WHO analysis of causes of maternal death: a systematic review|/resolve/reference/PMED?id=16581405
McDonald 2004|Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour|
PATH 2001||
Prendiville 2000|Active versus expectant management in the third stage of labour|
WHO 1994||
Zieman 1997|Absorption kinetics of misoprostol with oral or vaginal administration|/resolve/reference/PMED?id=9207820
CDSR 1997|Prostaglandins in third stage of labour|
CDSR 1998|Prostaglandins in third stage of labour|
CDSR 2000|Prostaglandins for prevention of postpartum haemorrhage (Cochrane Review)|
CDSR 2002|Prostaglandins for prevention of postpartum haemorrhage (Cochrane Review)|
CDSR 2003|Prostaglandins for prevention of postpartum haemorrhage|
CDSR 2004|Prostaglandins for prevention of postpartum haemorrhage|
Buchkremer 1997 {published data only}|Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: Results of a two year follow-up|
Buchkremer 1997 {published data only}|Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients - results of 2-year follow-up|/resolve/reference/PMED?id=10369152
Daniels 1998 {published data only}|A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness|/resolve/reference/PMED?id=9527960
Drury 2000 {published and unpublished data}|Cognitive therapy and recovery from acute psychosis: a controlled trial|/resolve/reference/PMED?id=10945081
Drury 2000 {published and unpublished data}|Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms|/resolve/reference/PMED?id=8932888
Drury 2000 {published and unpublished data}|Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time|/resolve/reference/PMED?id=8932889
Durham 2003 {published data only}|Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic syptoms|/resolve/reference/PMED?id=12668405
Garety 1998 {published data only}|London East-Anglia randomised controlled trial of cognitive behavioural therapy for psychosis: II. Predictors of outcome|/resolve/reference/PMED?id=9463599
Garety 1998 {published data only}|London-East Anglia randomised control trial of cognitive behavioural therapy for psychosis III: Follow-up and economic evaluation at 18 months|/resolve/reference/PMED?id=9850205
Garety 1998 {published data only}|London East-Anglia randomised controlled trial of cognitive behavioural therapy for psychosis: I. Effects of the treatment Phase|/resolve/reference/PMED?id=9373419
Gumley 2003 {published data only}|Early intervention for relapse in schizophrenia: Results of a twelve month randomized controlled trial of cognitive behavioural therapy|/resolve/reference/PMED?id=12701663
Haddock 1999 {published data only}|A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis|/resolve/reference/PMED?id=10396167
Hogarty 1997 {published data only}|Three-year trials of personal therapy among schizophrenic patients living with or independent of family. I: Description of study and effects on relapse rates|/resolve/reference/PMED?id=9356557
Hogarty 1997 {published data only}|Three-year trials of personal therapy among schizophrenic patients living with or independent of family. II: Effects on adjustment of patients|/resolve/reference/PMED?id=9356558
Kemp 1998 {published data only}|Compliance therapy in psychotic patients: a randomised controlled trial|/resolve/reference/PMED?id=8611831
Kemp 1998 {published data only}|Randomised controlled trial of compliance therapy|/resolve/reference/PMED?id=9747403
Lecompte 1996 {published data only}|A cognitive-behavioral program to improve compliance with medication in patients with schizophrenia|
Levine 1998 {published data only}|Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance|
Lewis 2002 {published data only}|Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes|
Lewis 2002 {published data only}|Cognitive-behavioural therapy in first-episode and early schizophrenia|/resolve/reference/PMED?id=14990521
Pinto 1999 {published data only}|Cognitive-behavioural therapy and clozapine for clients with treatment refactory schizophrena|/resolve/reference/PMED?id=10402608
Rector 2003 {published data only}|Cognitive Therapy for Schizophrenia: a preliminary randomized controlled trial|/resolve/reference/PMED?id=12892853
Sensky 2000 {published data only}|A randomized controlled trial of cognitive-behavioural therapy for persistant symptoms in schizophrenia resistant to medication|/resolve/reference/PMED?id=10665619
Startup 1998 {unpublished data only}|End of Grant (Final) Report|
Startup 1998 {unpublished data only}|A controlled trial of cognitive behaviour therapy for schizophrenia and related disorders|
Tarrier 1999 {published data only}|A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: 1. Outcome|/resolve/reference/PMED?id=8481745
Tarrier 1999 {published data only}|Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up|/resolve/reference/PMED?id=10616627
Tarrier 1999 {published data only}|Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia|/resolve/reference/PMED?id=9685273
Turkington 2000 {published data only}|Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses|/resolve/reference/PMED?id=11026947
Turkington 2002 {published data only}|Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia|/resolve/reference/PMED?id=12042231
Anzai 2002 {published data only}|Training persons with schizophrenia in illness self-management: A randomised controlled trial in Japan|/resolve/reference/PMED?id=11986501
Arlow 1997 {published data only}|Cognitive-behavioural treatment of panic attacks in chronic schizophrenia|/resolve/reference/PMED?id=9071665
Bach 2002 {published data only}|The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: A randomized controlled trial|/resolve/reference/PMED?id=12362963
Bellucci 2002 {published data only}|Computer assisted cognitive rehabilitation reduces negative symptoms in the severely mentally ill|
Bouchaud 1996 {published data only}|Cognitive restructuring in the treatment of psychotic symptoms in schizophrenia: a critical analysis|
Bradshaw 1993 {published data only}|Coping-skills, training versus a problem-solving approach with schizophrenic patients|
Buchanan 1992 {published data only}|A two year prospective study of treatment compliance in patients with schizophrenia|/resolve/reference/PMED?id=1357703
Castle 2002 {published data only}|Treating social anxiety in schizophrenia: a group based cognitive behaviour therapy approach|
Chadwick 1994 {published data only}|The omnipotence of voices: A cognitive approach to auditory hallucinations|/resolve/reference/PMED?id=8173822
Chadwick 1994 {published data only}|A cognitive approach to measuring and modifying delusions|/resolve/reference/PMED?id=8192635
Claghorn 1974 {published data only}|Group therapy and maintenance treatment of schizophrenics|/resolve/reference/PMED?id=4606594
Drake 1993 {published data only}|A research evaluation of social network case management for homeless persons with dual disorders|
Edwards 2003 {published data only}|Enduring positive symptoms in first episode psychosis: a randomised controlled trial of clozapine and CBT|
Evins 2001 {published data only}|A pilot trial of bupropion added to cognitive behavioural therapy for smoking cessation in schizophrenia|/resolve/reference/PMED?id=11694208
Fritze 1988 {published data only}|Cognitive training adjunctive to pharmacotherapy in schizophrenia and depression: a pilot study on the lateralization hypothesis of schizophrenia and depression and on cognitive therapy as adjunctive to pharmacotherapy|/resolve/reference/PMED?id=3185895
Garety 1994 {published data only}|Cognitive behavioural therapy for drug-resistant psychosis|
Haldun 2002 {published data only}|Optimal treatment of schizophrenia|
Hartman 1983 {published data only}|Cognitive-behavioral and psychopharmacological treatment of delusional symptoms: a preliminary report|
Hayward 1995 {published data only}|Medication self-management: A preliminary report on an intervention to improve medication compliance|
Hodel 1994 {published data only}|Cognitive therapy with schizophrenic patients: conceptual basis, present state, future directions|
Hogarty 1991 {published data only}|Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia: II Two year effects of a controlled study on relapse and adjustment|/resolve/reference/PMED?id=1672589
Jackson 1998 {published data only}|Cognitively oriented psychotherapy for early psychosis (COPE): Priminary results|/resolve/reference/PMED?id=9764134
Jackson 2001 {published data only}|Promoting personal recovery from psychosis: a randomised control trial in first episode schizophrenia|
Kemp 1996b {published data only}|Compliance therpy: An intervention targeting insight and treatment adherence in psychotic patients|
Kingdon 1991 {published data only}|The use of cognitive behavior therapy with a normalizing rationale in schizophrenia|
Kuipers 1996 {published data only}|The management of difficult to treat patients with schizophrenia, using non-drug therapies|
MacPherson 1996 {published data only}|A controlled study of education about drug treatment of schizophrenia|/resolve/reference/PMED?id=8773813
May 1984 {published data only}|A step forward in research on psychotherapy of schizophrenia|/resolve/reference/PMED?id=6393324
McGorry 2002 {published data only}|Randomised controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms|/resolve/reference/PMED?id=12365879
Morrison 2002 {published data only}|Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals|
Olbrich 1990 {published data only}|Reducton of schizophrenic deficits by cognitive training: an evaluative study|/resolve/reference/PMED?id=2144236
Perris 1992 {published data only}|A cognitive-behavioral treatment program for patients with a schizophrenic disorders|
Roder 2002 {published data only}|Development of specific social skills training programmes for schizophrenia patients: results of a multi-centre study|
Shon 2002 {published data only}|Medication and Sympton management education program for the rehabilitation of psychiatric patients in Korea: The effects of promoting schedule on self-efficacy theory|/resolve/reference/PMED?id=12402370
Spaulding 1992 {published data only}|Design prerequisites for research on cognitive therapy for schizophrenia|
Tarrier 1993 {published data only}|A trial of two cognitive behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome|/resolve/reference/PMED?id=8481745
Tarrier 1993 {published data only}|A trial of two cognitive behavioural methods of treating drug resistant residual psychotic symptoms in schizophrenic patients: II. Treatment specific changes in coping and problem solving skills|/resolve/reference/PMED?id=8096654
van der Gaag {published data only}|A controlled trial of cognitive remediation in schizophrenia|
Velligan 2002 {published data only}|A randomized single blind pilot study of compensatory strategies in schizophrenia out-patients|/resolve/reference/PMED?id=12693434
Wirshing 1992 {published data only}|Technique for training schizophrenic patients in illness self-management: a controlled trial|/resolve/reference/PMED?id=1384364
Wirshing 1992 {published data only}|Acquisition and retention of skills training methods in chronic schizophrenic outpatients|/resolve/reference/PMED?id=1480726
Wykes 2002 {published data only}|The effectiveness of cognitive remediation theratpy (CRT) for patients with schizophrenia|
Wykes 2003 {published data only}|Changing voices: a randomised control trail of group cognitive behavioural treatment|
Wykes 2003 {published data only}|Changing voices: a randomised control trial of group cognitive treatment|
Darlegungen 1989 {published data only}|Cognitve training in schizophrenia illness|
LeCompte 1997 {published data only}|Impact of individual cognitive behavioural treatment on the direct psychiatric cost-effectiveness for none compliant schizophrenics|
Smeraldi 1991 {published data only}|Cognitive therapy in rehabilitation|
Theilemann 1993 {published data only}|Reduction of cognitive disorders of schizophrenia and schizoaffective pychosis by cognitive therapy as compared to sociotherapy|/resolve/reference/PMED?id=8413760
Vauth 2001 {published data only}|Short differention and long-term effect of emotional intelligence training and of the integration of psychological therapy - programs for schizophrenic patients?|/resolve/reference/PMED?id=11704899
Dan 2002 {published data only}|CBT in schizophrenia: a six months controlled trial|
Farhall J 2003 {published data only}|Recovery therapy: a dissemination and effectiveness trial of a broad CBT for psychosis|
Gaither 2003 {published data only}|A randomized clinical trial of a brief congitive-behavioural treatment for the chronic phase of schizophrenia|
Alderson 2004|Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]|
Alford 1994|Cognitive therapy of delusional beliefs|/resolve/reference/PMED?id=8192636
Altman 1996|Detecting skewness from summary information|/resolve/reference/PMED?id=8916759
Andreasen 1983|Scale for the assessment of negative symptoms (SANS)|
Andreasen 1984|The scale for the asessment of postive symptoms (SAPS)|
APA 1995|Diagnostic and Statistical Manual of Mental Disorders. 4th ed. International version.|
Asberg 1979|A comprehensive psychopathological rating scale|
Beck 1961|An inventory for measuring depression|/resolve/reference/PMED?id=13688369
Begg 1996|Improving the quality of randomized controlled trials. The CONSORT statement|/resolve/reference/PMED?id=8773637
Birchwood 1990|The social functioning scale: the development and validation of a new scale of social adjustment for use in family intervention programmes with schizophenic patients|/resolve/reference/PMED?id=2289094
Bland 1997|Statistics notes. Trials randomised in clusters|/resolve/reference/PMED?id=9302962
Brett-Jones 1987|Measuring delusional experiences: a method and it's application|
Christison 1991|When symptoms persist: choosing among alternative somatic symptoms for schizophrenia|/resolve/reference/PMED?id=1679252
David 1990|Insight and psychosis|/resolve/reference/PMED?id=2207510
Davis 1997|Antipsycotic drugs: clinical pharmacology and therapeutic use|/resolve/reference/PMED?id=21069
Divine 1992|The unit of analysis error in studies about physicians' patient care behavior|/resolve/reference/PMED?id=1453246
Donner 2002|Issues in the meta-analysis of cluster randomized trials|
Drake 1986|Depression, hopelessness and suicide in chronic schizophrenia|/resolve/reference/PMED?id=3779226
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
Endicott 1976|The global assessment scale. A proceddure to measuring overall severity of psychiatric disturbance|/resolve/reference/PMED?id=938196
Gulliford 1999|Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994|
Haddock 1999b|Scales to measure dimensions of hallucination and delusions: the psychotic symptom rating scales (PSYRATS)|/resolve/reference/PMED?id=10473315
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Hogan 1983|A self report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity|/resolve/reference/PMED?id=6133297
Kay 1987|The positive and negative syndrome scale (PANSS) for schizophrenia|/resolve/reference/PMED?id=3616518
Krawiecka 1977|Standardised psychiatric assessment scale for chronic psychiatric patients|
Marshall 2000|Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?|/resolve/reference/PMED?id=10755072
Meltzer 1992|Treatment of the neuroleptic-nonresponsive schizophrenic patient|/resolve/reference/PMED?id=1357741
Moher 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials|/resolve/reference/PMED?id=11308435
Montgomery 1979|A new depression scale designed to be sensitive to change|
NICE 2002||
Overall 1962|The Brief Psychiattric Rating Scale|
Tarrier 1993|A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome|/resolve/reference/PMED?id=8481745
Ukoumunne 1999|Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review|
WHO 1973|Report of the International Pilot Study of Schizophrenia|
Cormac 2002|Cognitive behaviour therapy for schizophrenia|
Jones 2000|Cognitive behaviour therapy for schizophrenia|
Becquemin 1997 {published data only}|Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs|/resolve/reference/PMED?id=9392698
BOA 2000 {published data only}|Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial|/resolve/reference/PMED?id=10665553
Clyne 1987 {published data only}|Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts|
D' Addato 1992 {published data only}|Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass|/resolve/reference/PMED?id=1402213
Donaldson 1985 {published data only}|The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts|
Edmondson 1994 {published data only}|Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting|/resolve/reference/PMED?id=7934346
Goldman 1984 {published data only}|A prospective randomized study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popliteal grafts|
Green 1982 {published data only}|Effects of aspirin and dipyridamole on expanded polytetrafluoethylene graft patency|/resolve/reference/PMED?id=6755786
Gruss 1991 {published data only}|Experiences with adjuvant prostaglandin therapy in vascular surgery interventions|/resolve/reference/PMED?id=1788755
Kohler 1984 {published data only}|Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts|/resolve/reference/PMED?id=6474351
Lucas 1984 {published data only}|Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs conventional antiaggregants: a six-month randomized follow-up study|/resolve/reference/PMED?id=6465619
McCollum 1991 {published data only}|Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial|/resolve/reference/PMED?id=1987387
Noppeney 1988 {published data only}|Naftidrofuryl in postoperative treatment after femoropopliteal bypass|
Raithel 1987 {published data only}|Prevention of reocclusion after prosthetic bypass operations in the femoro-popliteal region: a comparative study of pentoxifylline versus acetylsalicylic acid|
Schneider 1979 {published data only}|No english title available|
Ariesen 2005 {published data only}|Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: Therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) study|/resolve/reference/PMED?id=15996602
Bhmig 1995 {published data only}|Orthograde vein bypass procedure for inguinal arterial reconstructions - 20 years experience|/resolve/reference/PMED?id=7712854
DeWeese 1971 {published data only}|Autogenous venous bypass grafts five years later|/resolve/reference/PMED?id=5111278
Ehersmann 1977 {published data only}|Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double blind long term study|/resolve/reference/PMED?id=886967
Franks 1991 {published data only}|Aspirin usage and its influence on femoropopliteal vein graft patency|
Gorter 2001 {published data only}|Costs of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease|/resolve/reference/PMED?id=11204588
Harjola 1981 {published data only}|Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery|/resolve/reference/PMED?id=7014570
Jivegard 2005 {published data only}|Effects of three months of low molecular weight heparin (Dalteparin) treatment after bypass surgery for lower limb ischemia - A randomised placebo-controlled double blind multicentre trial|/resolve/reference/PMED?id=15649728
Johnson 2002 {published data only}|Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study|/resolve/reference/PMED?id=11877686
Johnson 2004 {published data only}|Hemorrhagic complications during long-term postoperative warfarin administration in patients undergoing lower extremity arterial bypass surgery|/resolve/reference/PMED?id=15895759
Kibbe 2002 {published data only}|Can screening for genetic markers improve peripheral artery bypass patency?|/resolve/reference/PMED?id=12469051
Lassila 1991 {published data only}|The effect of acetylicsalicylic acid on the outcome after lower limb arterial surgery with special reference to cigarette smoking|/resolve/reference/PMED?id=1853617
Nevelsteen 1991 {published data only}|Effect of ticlopidine on blood loss, platelet turnover and platelet deposition on prosthetic surfaces in patients undergoing aorto-femoral bypass grafting|/resolve/reference/PMED?id=1839585
Oostenbrink 2001 {published data only}|Cost effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery|/resolve/reference/PMED?id=11496277
Powell 1992 {published data only}|Smoking and factors influencing the outcome of arterial reconstruction|/resolve/reference/PMED?id=1622089
Raithel 1987 b {published data only}||
Reichle 1979 {published data only}|Long-term results of 474 arterial reconstructions for severly ischemic limbs: A fourteen year follow-up|/resolve/reference/PMED?id=758718
Rosenthal 1987 {published data only}|The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: Long-term results|/resolve/reference/PMED?id=3631756
Satiani 1985 {published data only}|A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts|/resolve/reference/PMED?id=3901826
Shionoya 1990 {published data only}|Effect of ticlopidine on graft patency following arterial reconstructive surgery in the lower extremity: a multicenter three-year prospective study|
Smeets 2005 {published data only}|Outcome after occlusion of infrainguinal bypasses in the Dutch BOA Study: comparison of amputation rate in venous and prosthetic grafts|/resolve/reference/PMED?id=16098774
Smout 2004 {published data only}|Combination antiplatelet therapy in patients with peripheral vascular bypass grafts|/resolve/reference/PMED?id=14979400
Tangelder 1995 {published data only}|Preventi van occlusies na perifere bypass-chirurgie met orale anticoagulantia of acetylsalicylzuur: een gerandomiseerde vergelijking in het Nederlands BOA-onderzoek|/resolve/reference/PMED?id=7630459
Tangelder 1999 {published data only}|Quality of life after infrainguinal bypass grafting surgery. Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group|/resolve/reference/PMED?id=10233784
Tangelder 2000a {published data only}|Risk factors for occlusion of infrainguinal bypass grafts|/resolve/reference/PMED?id=10944100
Tangelder 2001 {published data only}|Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study Group|/resolve/reference/PMED?id=11241122
Abbott 1997|Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group|/resolve/reference/PMED?id=9013904
Altman 1999|Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregation and ATP release in normal volunteers: why aspirin improves ticlopidine antiplatelet activity|/resolve/reference/PMED?id=10726021
Bertrand 2000|Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS)|/resolve/reference/PMED?id=10931801
Consensus 1991|Second European Consensus Document on Chronic Critical Leg Ischemia|
Cooper 1990|Outflow resistance and early occlusion of infrainguinal bypass grafts|/resolve/reference/PMED?id=2354723
Fujitani 1988|Perioperative suppression of platelet adherence to small-diameter polytetrafluoroethylene (PTFE) grafts|/resolve/reference/PMED?id=3361888
Mishkel 1999|Clopidogrel as adjunctive antiplatelet therapy during coronary stenting|/resolve/reference/PMED?id=10588198
Moshfegh 2000|Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy|/resolve/reference/PMED?id=10987587
Muluk 1998|Enhancement of tissue factor expression by vein segments exposed to coronary arterial hemodynamics|/resolve/reference/PMED?id=9546239
Nielsen 1997|Scintigraphic assessment of focal platelet accumulations following infrainguinal bypass surgery in humans|
Rutherford 1988|Factors affecting the patency of infrainguinal bypass|/resolve/reference/PMED?id=2458492
Tangelder 2000|Risk factors for occlusion of infrainguinal bypass grafts|/resolve/reference/PMED?id=10944100
Cochrane 2003|Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery|
Arfvidsson 1990 {published data only}|Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery|/resolve/reference/PMED?id=1693474
BOA 2000 {published data only}|A randomised trial of oral anticoagulants versus aspirin after infrainguinal bypass surgery|
BOA 2000 {published data only}|Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) study|/resolve/reference/PMED?id=15996602
BOA 2000 {published data only}|Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial|/resolve/reference/PMED?id=10665553
BOA 2000 {published data only}|Prevention of occlusions after infrainguinal bypass surgery with oral anticoagulants or acetylsalicylic acid: A randomised trial|
BOA 2000 {published data only}|Costs of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease|/resolve/reference/PMED?id=11204588
BOA 2000 {published data only}|Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery|/resolve/reference/PMED?id=11496277
BOA 2000 {published data only}|Outcome after occlusion of infrainguinal bypasses in the Dutch BOA Study: comparison of amputation rate in venous and prosthetic grafts|/resolve/reference/PMED?id=16098774
BOA 2000 {published data only}|Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study Group|/resolve/reference/PMED?id=11241122
Cole 1993 {published data only}|Ancrod versus heparin for anticoagulation during vascular surgical procedures|/resolve/reference/PMED?id=8433424
Edmondson 1994 {published data only}|Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting|/resolve/reference/PMED?id=7934346
Edmondson 1994 {published data only}|A prospective, randomized trial of low molecular weight heparin (LMWH) versus persantin in femoropopliteal bypass grafts|
Jivegard 2005 {published and unpublished data}|Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia - A randomised placebo-controlled double blind multicentre trial|/resolve/reference/PMED?id=15649728
Johnson 2002 {published data only}|The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial|/resolve/reference/PMED?id=11854727
Johnson 2002 {published data only}|Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: A prospective randomized study|/resolve/reference/PMED?id=11877686
Johnson 2002 {published data only}|Hemorrhagic complications during long-term postoperative warfarin administration in patients undergoing lower extremity arterial bypass surgery|/resolve/reference/PMED?id=11877686
Johnson 2002 {published data only}|Can screening for genetic markers improve peripheral artery bypass patency?|/resolve/reference/PMED?id=12469051
Kretschmer 1992 {published data only}|A decade of oral anticoagulants treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis|/resolve/reference/PMED?id=1514915
Kretschmer 1992 {published data only}|Can anticoagulants prevent graft reocclusion?|
Logason 2001 {published data only}|Low-molecular weight heparin versus dextran in the prevention of early occlusion following arterial bypass surgery distal to the groin|/resolve/reference/PMED?id=9755408
Logason 2001 {published data only}|Low molecular weight heparin (enoxaparin) versus dextran in the prevention of early occlusion following arterial bypass surgery distal to the groin|/resolve/reference/PMED?id=11357851
Norgren 2004 {published data only}|Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial|/resolve/reference/PMED?id=15111848
Nydahl 1992 {published data only}|Peroperative anticoagulation with antithrombin or heparin in infrainguinal bypass surgery|/resolve/reference/PMED?id=1451816
Samama 1994 {published data only}|Low molecular weight heparin (enoxaparin) versus unfractionated heparin during and after arterial reconstructive surgery; A multicenter randomized study|
Samama 1994 {published data only}|Low-molecular weight heparin vs. unfractionated heparin in femorodistal reconstructive surgery: a multicenter open randomized study|
Sarac 1998 {published data only}|Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure|/resolve/reference/PMED?id=9737454
Schneider 1979 {published data only}|Antiplatelet drugs and anticoagulants after reconstructive surgery of the femoro-popliteal arteries. Results of a prospective study|
Schneider 1979 {published data only}|Medical treatment for preventing recurrence after femoro-popliteal arterial reconstruction|
Swedenborg 1996 {published data only}|Low molecular mass heparin can be used as peri-operative anticoagulant during infrainguinal bypass surgery|
Swedenborg 1996 {published data only}|Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery|/resolve/reference/PMED?id=8564488
Alja-Kulju 1990 {published data only}|Effect of antiplatelet and anticoagulant therapy on patency of femorotibial bypass grafts|/resolve/reference/PMED?id=2229166
Benedetti 1988 {published data only}|Arterial repair of the lower limbs: prevention of prosthetic grafts occlusion by LMW-heparin|
Evans 1966 {published data only}|Long-term arterial-graft patency in relation to platelet adhesiveness, biochemical factors, and anticoagulant therapy|/resolve/reference/PMED?id=4161718
Fietze-Fischer 1987 {published data only}|Prostaglandin E1 as an adjuvant therapy in the event of femoropopliteal and crural great saphenous vein in situ bypass surgery|
Fietze-Fischer 1987 {published data only}|Prostaglandin E1 as an adjuvant therapy in the event of femoropopliteal and crural great saphenous vein in situ bypass surgery|
Gruss 1991 {published data only}|Experience with adjuvant prostaglandin therapy in vascular surgery|
Kretschmer 1987 {published data only}|The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: Analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial|/resolve/reference/PMED?id=2442826
Kretschmer 1988 {published data only}|Vein bypass surgery for femoro-popliteal ateriosclerosis: influence of different risk factors on patient survival and the importance of anticoagulant treatment|/resolve/reference/PMED?id=3169276
Kujath 2002 {published data only}|Low-molecular-weight heparin in arterial reconstructive surgery: a double-blind, randomized dose-finding trial|/resolve/reference/PMED?id=12516683
McMillan 1997 {published data only}|Perioperative low molecular weight heparin for infrageniculate bypass|/resolve/reference/PMED?id=9152306
Ohtake 1997 {published data only}|Comparison of cilostazol with warfarin as antithrombotic therapy after femoro-popliteal bypass surgery using an e-PTFE graft|/resolve/reference/PMED?id=9549283
Ray 1997 {published data only}|Hypercoagulable abnormalities and postoperative failure of arterial reconstruction|/resolve/reference/PMED?id=9133987
Rosenthal 1987 {published data only}|The effects of aspirin, dipyridamole and warfarin in femorodistal reconstructions: long-term results|/resolve/reference/PMED?id=3631756
Waibel 1981 {published data only}|Late results of anticoagulation in arterial reconstructions|
Abbott 1997|Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group|/resolve/reference/PMED?id=9013904
Achermann 1998|Supragenicular bypass: venous in comparison with synthetic prosthesis (PTFE)|/resolve/reference/PMED?id=9655007
Alback 1998|Immediate occlusion of in situ saphenous vein bypass grafts: a survey of 329 reconstructions|
Bandyk 1987|Durability of the in situ saphenous vein arterial bypass: a comparison of primary and secondary patency|/resolve/reference/PMED?id=3546739
CASPAR 2010|Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial|
Channon 1997|Modulation of tissue factor protein expression in experimental venous bypass grafts|/resolve/reference/PMED?id=9261261
Cochrane 2008|Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery|
Cochrane 2010|Graft type for femoro-popliteal bypass surgery|
Consensus 1991|Second European Consensus Document on chronic critical leg ischaemia|
Davies 1994|Pathobiology of intimal hyperplasia|
Fontaine 1954|Surgical treatment for peripheral vascular disease|
Girolami 2000|Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis|/resolve/reference/PMED?id=10801370
Hanson 1987|Vascular graft thrombus formation|
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2|
Jacot 2004|Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling|/resolve/reference/PMED?id=14981447
Johnson 2000|A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study|/resolve/reference/PMED?id=10917986
Kissin 2000|Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts|/resolve/reference/PMED?id=10642710
Kraiss 1995|Pharmacologic intervention to prevent graft failure|/resolve/reference/PMED?id=7638720
Kretschmer 1999|Oral anticoagulation in peripheral vascular surgery: how intense, for how long, or at all?|
Lindblad 1995|Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: a world-wide survey|/resolve/reference/PMED?id=7620951
Muluk 1998|Enhancement of tissue factor expression by vein segments exposed to coronary arterial hemodynamics|/resolve/reference/PMED?id=9546239
Norgren 2007|Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)|
Owens 2010|Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications|/resolve/reference/PMED?id=19837532
Parsons 1996|Polytetrafluoroethylene bypasses to infrapopliteal arteries without cuffs or patches: a better option than amputation in patients without autologous vein|/resolve/reference/PMED?id=8637113
Robinson 1997|Long-term outcome after early infrainguinal graft failure|/resolve/reference/PMED?id=9308588
Sarkar 2006|The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency|/resolve/reference/PMED?id=16513376
Sasaki 2000|Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications|/resolve/reference/PMED?id=10618339
Schoder 2001|Interventions in infrainguinal bypass grafts|/resolve/reference/PMED?id=11740664
Stept 1987|Technical defects as a cause of early graft failure after femorodistal bypass|/resolve/reference/PMED?id=3579569
Tangelder 1999|Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery|/resolve/reference/PMED?id=10514209
Watson 1999|Adjuvant medical therapy in peripheral bypass surgery|
Woodburn 1996|Clinical, biochemical, and rheological factors affecting the outcome of infrainguinal bypass grafting|/resolve/reference/PMED?id=8911413
Cochrane 2003|Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery|
Candy 1995 {published data only}|A controlled double blind study of azathioprine in the management of Crohn's disease|/resolve/reference/PMED?id=8549944
Ewe 1993 {published data only}|Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease|/resolve/reference/PMED?id=8335191
Klein 1974 {published data only}|Treatment of Crohn's disease with azathioprine: a controlled evaluation|/resolve/reference/PMED?id=4597093
Oren 1997 {published data only}|Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial|/resolve/reference/PMED?id=9399753
Present 1980 {published data only}|Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study|/resolve/reference/PMED?id=6102739
Rhodes 1971 {published data only}|Controlled trial of azathioprine in Crohn's disease|/resolve/reference/PMED?id=4143532
Summers 1979 {published data only}|National Cooperative Crohn's Disease Study: results of drug treatment|/resolve/reference/PMED?id=38176
Willoughby 1971 {published data only}|Controlled trial of azathioprine in Crohn's disease|/resolve/reference/PMED?id=4107900
Ardizzone 2003 {published data only}|Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomized, investigator-blind study|/resolve/reference/PMED?id=14563183
Ludwig 1999 {published data only}|Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group|/resolve/reference/PMED?id=10604222
Mantzaris 2004 {published data only}|A prospective, randomized trial of infliximab and azathioprine for the induction and maintenance of remisssion of steroid-dependent Crohn's disease|
Markowitz 2000 {published data only}|A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease|/resolve/reference/PMED?id=11040176
Mate Jimenez 2000 {published data only}|6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease|/resolve/reference/PMED?id=11111780
Miehsler 2001 {published data only}|Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?|
Neurath 1999 {published data only}|Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease|
Neurath 1999 {published data only}|Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.|/resolve/reference/PMED?id=10205197
Watson 1974 {published data only}|Azathioprine in management of Crohn's disease: A randomized cross-over study|
SONIC 2008 {published data only}|Multicenter, Randomized, Double-Blind, Active Controlled Trial Comparing REMICADE (Infliximab) and REMICADE Plus Azathioprine to Azathioprine in the Treatment of Patients With Crohn's Disease Naive to Both Immunomodulators and Biologic Therapy|
Alstead 1990|Safety of azathioprine in pregnancy in inflammatory bowel disease|/resolve/reference/PMED?id=2365192
Avery-Jones 1966|Dangers of immuno-suppressive drugs in Ulcerative Colitis (letter)|
Berg 1996|6MP - is leukopenia required to induce remission in the treatment of ulcerative colitis?|
Bouhnik 1996|Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine|/resolve/reference/PMED?id=8551879
Brooke 1969|Azathioprine for Crohn's disease|/resolve/reference/PMED?id=4185592
Brooke 1970|Further experience with azathioprine for Crohn's disease|/resolve/reference/PMED?id=4098349
Brooke 1976|Place of azathioprine for Crohn's disease|/resolve/reference/PMED?id=57449
Brown 1970|Azathioprine therapy for inflammatory bowel disease. A preliminary report|/resolve/reference/PMED?id=5478849
Chalmers 1981|A method for assessing the quality of a randomized control trial|/resolve/reference/PMED?id=7261638
Colonna 1994|The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease|/resolve/reference/PMED?id=8122645
Connell 1993|Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience|/resolve/reference/PMED?id=8174958
Connell 1994|Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease|/resolve/reference/PMED?id=7910274
Cuffari 1996|6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity|/resolve/reference/PMED?id=8949645
D'Haens 1995|Reduction of neutrophil and not lymphocyte count is associated with favourable response to azathioprine therapy in refractory Crohn's disease|
D'Haens 1997|Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease|/resolve/reference/PMED?id=9136824
Drucker 1970|Azathioprine: an adjunct to surgical therapy of granulomatous enteritis|/resolve/reference/PMED?id=5458618
Fausa 1971|Azathioprine (Imurel) therapy in Crohn's disease|/resolve/reference/PMED?id=5120971
Haber 1986|Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease|/resolve/reference/PMED?id=2427386
Javett 1972|Azathioprine in acute Crohn's disease|/resolve/reference/PMED?id=4638224
Kessler 1995|6-Mercaptopurine (6-MP) in pediatric Crohn's disease: high dose versus conventional dose|
Korelitz 1981|Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial|/resolve/reference/PMED?id=6108892
Korelitz 1985|Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease|/resolve/reference/PMED?id=2856904
Korelitz 1993|Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease|/resolve/reference/PMED?id=8338087
Lemann 1990|Traitment de la maladie de Crohn par l'azathioprine ou la 6-mercaptopurine|/resolve/reference/PMED?id=2397863
Lennard 1983|Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia|
Lennard 1989|Pharmacogenitics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism|
Lennard 1990|Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia|/resolve/reference/PMED?id=1973780
Lennard 1992|The clinical pharmacology of 6-mercaptopurine|/resolve/reference/PMED?id=1451710
Lennard-Jones 1972|Azathioprine in the treatment of Crohn's disease|/resolve/reference/PMED?id=5083325
Lennard-Jones 1981|Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease|/resolve/reference/PMED?id=7016483
Markowitz 1990|Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease|/resolve/reference/PMED?id=1976562
Nyman 1985|Long-term immunosuppressive treatment in Crohn's disease|/resolve/reference/PMED?id=3912958
O'Brien 1991|Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease|/resolve/reference/PMED?id=2044925
Papp 1974|Azathioprine treatment in Crohn's disease|/resolve/reference/PMED?id=4595064
Patterson 1971|Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis|/resolve/reference/PMED?id=5554838
Perrault 1991|6-Mercaptopurine therapy in selected cases of corticosteroid-dependent Crohn's disease|/resolve/reference/PMED?id=1674293
Present 1989|6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity|/resolve/reference/PMED?id=2802419
Rhodes 1970|Azathioprine in Crohn's disease|/resolve/reference/PMED?id=4097954
Rosman 1973|Azathioprine|/resolve/reference/PMED?id=4584569
Sandborn 1995|An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease|/resolve/reference/PMED?id=7498645
Sandborn 1996|A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate|/resolve/reference/PMED?id=8633486
Sandborn 1999|Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group|/resolve/reference/PMED?id=10464128
Shah 1991|Use of azathioprine in nine children with Crohn's disease|/resolve/reference/PMED?id=1678282
Singleton 1981|Azathioprine has a very limited role in the treatment of Crohn's disease|/resolve/reference/PMED?id=6113105
Van Os 1996|Azathioprine pharmacokinetics after intravenous, oral, delayed release oral, and rectal foam administration|/resolve/reference/PMED?id=8881811
Verhave 1990|Azathioprine in the treatment of children with inflammatory bowel disease|/resolve/reference/PMED?id=2231216
Wallensten 1972|Azathioprine therapy for Crohn's disease|/resolve/reference/PMED?id=5055985
Weinshilboum 1980|Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity|/resolve/reference/PMED?id=7191632
Zins 1997|A dose-ranging study of azathioprine pharmacokinetics after single-dose administration of a delayed-release oral formulation|
Pearson 1995|Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis|/resolve/reference/PMED?id=7778826
DeLetter 1991 {unpublished data only}||
Efthimiou 1988 {published and unpublished data}|The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3057956
Fuenzalida 1990 {published data only}|The immune response to short nutritional intervention in advanced COPD|/resolve/reference/PMED?id=2368979
Goris 2003 {published data only}|Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: The effect of physical activity and oral nutritional supplementation|/resolve/reference/PMED?id=12720592
Knowles 1988 {published data only}|Dietary supplementation and respiratory muscle performance in patients with COPD|/resolve/reference/PMED?id=3282825
Lewis 1987 {published data only}|Nutritional supplementation in ambulatory patients with COPD|/resolve/reference/PMED?id=3579004
Otte 1989 {published data only}|Nutritional repletion in malnourished patients with emphysema|
Rogers 1992 {published data only}|Physiologic effects of oral supplementation feeding in malnourished patients with COPD - a randomized control study|/resolve/reference/PMED?id=1456568
Schols 1995 {published and unpublished data}|Physiologic effects of nutritional support and anabolic steroids in patients with COPD - a placebo controlled randomized trial|/resolve/reference/PMED?id=7551381
Schols 1995a {published data only}|Physiologic effects of nutritional support and anabolic steroids in patients with COPD - a placebo controlled randomized trial|/resolve/reference/PMED?id=7551381
Steiner 2003 {published data only}|Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: A randomised controlled trial|/resolve/reference/PMED?id=12947128
Steiner 2003 {published data only}|The effect of nutritional supplementation on body weight and composition in COPD patients participating in rehabilitation|
Steiner 2003 {published data only}|The effect of nutritional supplementation on body weight and composition in COPD patients participating in rehabilitation [abstract]|
Teramoto 2004 {published data only}|[C22] [Poster: 522] Effects of Feeding a High-Fat, Low-Carbohydrate Nutritional Supplement (Racol R), on Lung Function, Dyspnea, HRQOL in Patients with COPD|
Weekes 2004 {published data only}|Tailored dietary advice and food fortification results in weight gain and clinical benefit in malnourished patients with chronic obstructive pulmonary disease [Abstract]|
Whittaker 1990 {published data only}|Energy balance in stable malnourished patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8131435
Whittaker 1990 {published data only}|The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive disease patients|/resolve/reference/PMED?id=2116747
Akrabawi 1996 {published data only}|Gastric emptying, pulmonary function, gas exchange and respiratory quotient after feeding a moderate versus high fat enteral formula meal in chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=8862532
Angelillo 1985 {published data only}|Effects of low and high carbohydrate feeding in ambulatory patients with chronic obstructive pulmonary disease and chronic hypercapnia|/resolve/reference/PMED?id=3933397
Broekhuizen 2005 {published data only}|Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15860712
Brown 1985 {published data only}|Effects of large carbohydrate load on walking performance in chronic air-flow obstruction|/resolve/reference/PMED?id=4062049
Burdet 1997 {published data only}|Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease - a prospective randomized controlled study|/resolve/reference/PMED?id=9412558
Cai 2003 {published data only}|Effect of supplementing a high-fat, low-carbohydrate enteral formula in COPD patients|/resolve/reference/PMED?id=12620524
Casaburi 2004 {published data only}|Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15271690
Casaburi 2004 {published data only}|Randomized controlled trial of growth hormone in severe COPD patients undergoing endurance exercise training|
Creutzberg 2003 {published data only}|A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial|/resolve/reference/PMED?id=14605042
De Benedeto 1993 {published data only}|Body weight alone is not an index of nutritional imbalance in the nature course of chronic obstructive lung disease|/resolve/reference/PMED?id=8312924
Donahoe 1992 {published data only}|Is loss of body weight in chronic obstructive pulmonary disease patients with emphysema secondary to low tissue oxygenation?|/resolve/reference/PMED?id=1513971
Donahoe 1994 b {published data only}|The effect of an agressive nutritional support regimen on body composition in patients with severe COPD and weight loss|
Dore 1997 {published data only}|Role of thermic effect of food in malnutrition of patients with COPD|/resolve/reference/PMED?id=9154854
Efthimiou 1992 {published data only}|Effect of carbohydrate rich versus fat rich loads on gas exchange and walking performance in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=1496505
Eliraz 1994 {published data only}|Glycemic and insulinic postprandial response of subjects with chronic obstructive pulmonary disease|
Engelen 1994 {published data only}|Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in outpatients with COPD|/resolve/reference/PMED?id=7828687
Ferreira 1998 {published data only}|The influence of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients|/resolve/reference/PMED?id=9674442
Fiaccadory 1994 {published data only}|Hypophosphatemia and phosphorus depletion in respiratory and peripheral muscles of patients with respiratory failure due to COPD|/resolve/reference/PMED?id=8181325
Forli 2001 {published data only}|Dietary support to underweight patients with end-stage pulmonary disease assessed for lung transplantation|/resolve/reference/PMED?id=11223731
Frankfort 1991 {published data only}|Effects of high and low carbohydrate meals on maximum exercise performance in chronic airflow obstruction|/resolve/reference/PMED?id=1889274
Ganzoni 1994 {published data only}|High caloric nutrition in chronic obstructive lung disease|/resolve/reference/PMED?id=8029587
Goldstein 1997 {published data only}|Energy expenditure in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3100146
Goldstein 1988 {published data only}|Nitrogen and energy relationship in malnourished patienst with emphysema|
Goldstein 1989 {published data only}|Submaximal exercise in emphysema and malnutrition at two levels of CHO and fat intake|/resolve/reference/PMED?id=2793699
Gray Donald 1996 {published data only}|Nutritional status and mortality in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8630580
Green 1992 {published data only}|Comparisons between basal metabolic rate and diet induced thermogenesis in different types of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=1325314
Hoekstra 2005 {published data only}|Nutritional intervention versus standard nutritional advice in malnourished COPD patients [Abstract]|
Hugli 1993 {published data only}|Diet induced thermogenesis in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8256887
Hugli 1996 {published data only}|The daily energy expenditure in stable chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8542132
Laaban 1989 {published data only}|Comparison between parenteral and enteral feeding durnig acute decompensation of COPD|
Laaban 1993 {published data only}|Nutritional status of patients with chronic obstructive pulmonary disease and acute respiratory failure|/resolve/reference/PMED?id=8486011
Le Bricon 1994 {published data only}|Biochemical assessment of nutritional status in patients with chronic obstrucitve pulmonary disease and acute respiratory failure on admission to an intensive care unit|/resolve/reference/PMED?id=16843367
Li 2001 {published data only}|Short-term nutritional support in treating COPD and respiratory insufficiency with severely malnutrition|
Liu 1997 {published data only}|The clinical study on total parateral nuitrition support in chronic obstructive pulmonary disease|
Marchesani 2000 {unpublished data only}|Can I.V. fructose-1.6-diphosphate (FDP) administration be useful in COPD patients with signs of malnutrition?|
Martuci 1995 {published data only}|Nutritional and metabolic effects of growth hormone administration in underweight COPD patients|
Nishimura 1993 {published data only}|Bone mineral loss in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8121091
Openbrier 1983 {published data only}|Nutritional status and lung function in patients with emphysema and chronic bronchitis|/resolve/reference/PMED?id=6848330
Orlandi 1990 {published data only}|Additional nutritional diet in the treatment of chronic respiratory failure: personal data [abstract]|
Paiva 1992 {published data only}|The use of skinfold and muscle circumference of the upper arm in the diagnosis of protein energy malnutrition in adults patients: a critical study|/resolve/reference/PMED?id=1340606
Paiva 1996 {published data only}|Assessment of vitamin A status in chronic obstructive pulmonary disease and healthy smokers|/resolve/reference/PMED?id=8942419
Palange 1993 {published data only}|Nutritional status and exercise performance in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8312923
Pape 1991 {published data only}|The effects of GH on weight gain and pulmonary function in patients with COPD|/resolve/reference/PMED?id=2036835
Planas 1995 {published data only}|Fat-rich diets in patients with mild chronic obstructive lung disease (COPD)|/resolve/reference/PMED?id=7711155
Planas 2005 {published data only}|Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients|/resolve/reference/PMED?id=15896431
Qin 1996 {published data only}|Observation on therapeutic effect of megestrol acetate on patients with chronic obstructive pulmonary disease at remission stage|
Sahebjami 1993 {published data only}|Anthropometric and pulmonary function test profile of outpatients with stable chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8498391
Saudny-Unterberger {published data only}|Impact of nutritional support on funcional status during acute exacerbation of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9309995
Schols 1991 {published data only}|Resting energy expenditure in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=1957831
Schols 1991 b {published data only}|Body composition by bioeletrical impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with COPD|
Schols 1993 {published data only}|Plasma amino acid levels in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8312924
Seersholm 1997 {published data only}|Body mass index and mortality in patients with severe alpha 1-antitripsin deficiency|/resolve/reference/PMED?id=9122515
Sharma 2001 {published data only}|Effects of anabolic steroids on patients with severe COPD undergoing pulmonary rehabilitation|
Slinde 2002 {published data only}|Individual dietary intervention in patients with COPD during multidisciplinary rehabilitation|/resolve/reference/PMED?id=12113383
Song 1993 {published data only}|Clinical observation on short term nutritional support in the treatment of advanced chronic obstructive pulmonary diease|/resolve/reference/PMED?id=8033658
Sridhar 1994a {published data only}|An outpatient nutritional supplementation programme in COPD patients|/resolve/reference/PMED?id=8005255
Sridhar 1994b {published data only}|Resting energy expenditure and nutritional state of patients with increase oxygen cost of breathing due to emphysema, scoliosis and toracoplasty|/resolve/reference/PMED?id=8091323
Tanchoco 2001 {published data only}|Enteral feeding in stable chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=11264762
Vargas 1995 {published data only}|Patients with chronic airflow limitation: effects of the inspiratory muscle training with threshold load valve, built with appropriate technology, associated to nutritional support [Spanish]|/resolve/reference/PMED?id=8733313
Vermeeren 1999 {published data only}|Immediate postprandial effects of a nutritional supplement on symptoms and exercise capacity in patients with chronic obstructive pulmonary disease (COPD)|
Vermeeren 2004 {published data only}|Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial|/resolve/reference/PMED?id=15380912
Whitsel 1998 {unpublished data only}||
Wilson 1986 {published data only}|Nutritional Intervention in malnourished patients with emphysema|/resolve/reference/PMED?id=3767123
Wilson 1989 {published data only}|Body weight in chronic obstructive pulmonary disease- The National Institutes of Health Intermittent Positive-Pressure Breathing Trial|/resolve/reference/PMED?id=2658702
Xiao 2000 {published data only}|Research of nutritional support in COPD patients|
Yeh 2002 {published data only}|Reversal of COPD-associated weight loss using the anabolic agent oxandrolone|/resolve/reference/PMED?id=12171812
Yoshikawa 1996 {published data only}|Analysis of body composition by dual energy x-ray absortiometry and its relation to pulmonary function in patients with emphysema|/resolve/reference/PMED?id=8937137
Zhu 1998 {published data only}|Nutritional therapy of severe chronical obstructive pulmonary disease|
Zussman 2000 {unpublished data only}|Food and antacids do not affect the systemic availability of SB-207499|
Entrenas 1991 {published data only}|Is nutritional support useful in chronic obstructive pulmonary disease (COPD)?|
Fukuoka 2001 {published data only}|The effect of fat-based nutritional support on patients with chronic obstructive pulmonary disease in Japan - a randomized controlled study|
Frost 2002 {published data only}|Pilot study|
Pison 2004 {published data only}|Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion|/resolve/reference/PMED?id=15292850
Angelillo 1993|Nutrition and the pulmonary patient|
Arora 1982|Respiratory muscle strength and maximal voluntary ventilation in undernourished patients|/resolve/reference/PMED?id=7091909
Borghi Silva 2006|L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs|/resolve/reference/PMED?id=16612469
De Godoy 1996|Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients|/resolve/reference/PMED?id=8564110
Di Francia 1994|Tumor necrosis alpha levels and weight loss in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7952575
Donahoe 1995|Nutrition in end stage pulmonary disease|/resolve/reference/PMED?id=7742824
Fiaccadori 1992|A preliminary report on the effects of malnutrition on the skeletal muscle composition in chronic obstructive pulmonary disease|
Fleiss 1993|The statistical basis of meta-analysis|/resolve/reference/PMED?id=8261254
Fuld 2005|Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15994258
Goris 1997|Tissue depletion in relation to physical function and quality of life in patients with severe COPD|
Jadad 1996|Assessing the quality of reports of randomized clinical trials - is blinding necessary?|/resolve/reference/PMED?id=8721797
Lacasse 1996|Meta-analysis of respiratory rehabilitation in chronic obstructive disease|/resolve/reference/PMED?id=8888163
Lewis 1996|Nutrition and chronic obstructive pulmonary disease - a clinical overview|
Moher 1998|Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analysis ?|/resolve/reference/PMED?id=9746022
Pogue 1998|Overcoming the limitations of current meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=9433436
Redelmeier 1996|Spirometry and dyspnea in patients with COPD- When small differences mean little|/resolve/reference/PMED?id=8625661
Redelmeier 1997|Interpreting small differences in functional status: The six minute walk test in chronic lung disease patients|/resolve/reference/PMED?id=9105067
Rochester 1992|Nutritional Depletion|
Sacks 1987|Meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=3807986
Schols 1993 b|Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation|/resolve/reference/PMED?id=8484624
Schols 1996|Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8795671
Schols 1998|Weight loss is a reversible factor in the prognosis of chronic obstructive disease|/resolve/reference/PMED?id=9620907
Wiebe 2006|A systematic review identifies a lack of standardization in methods for handling missing variance data|/resolve/reference/PMED?id=16549255
Ferreira 2000|Nutritional support for individuals with COPD - A Meta-analysis|/resolve/reference/PMED?id=10712990
Braudo 1969 {published data only}|The value of digitalis in the respiratory distress syndrome: a controlled study|/resolve/reference/PMED?id=4883855
Martin 1963 {published data only}|A controlled trial of digoxin in the prevention of the respiratory distress syndrome|/resolve/reference/PMED?id=14076169
Lendrum 1955|The 'pulmonary hyaline membrane' as a manifestation of heart failure in the newborn infant|/resolve/reference/PMED?id=13243213
Stahlman 1959|Adaptation to extra-uterine life|
Soll 1998|Digoxin for preventing or treating neonatal respiratory distress syndrome|
Soll 2009|Digoxin for preventing or treating neonatal respiratory distress syndrome|
Ahmaidi 1980 {published data only}|Cardiorespiratory fitness evaluation by the shuttle test in asthmatic subjects during aerobic training|
Cochrane 1990 {published data only}|Benefits and problems of a physical training programme for asthmatic patients|/resolve/reference/PMED?id=2116678
Cochrane 1990 {published data only}|Physical training improves perception of breathlessness during exercise in asthmatics|
Cochrane 1990 {published data only}|The metabolic and ventilatory consequences of an exercise rehabilitation programme for adult asthmatics|
Counil 2003 {published data only}|Training of aerobic and anaerobic fitness in children with asthma|/resolve/reference/PMED?id=12584541
Fitch 1986 {published data only}|The effect of running training on exercise-induced asthma|/resolve/reference/PMED?id=3740562
Girodo 1992 {published data only}|Deep diaphragmatic breathing: rehabilitation exercises for the asthmatic patient|/resolve/reference/PMED?id=1642520
Huang 1989 {published data only}|The effect of swimming in asthmatic children--participants in a swimming program in the city of Baltimore|/resolve/reference/PMED?id=2702218
Matsumoto 1999 {published data only}|Effects of swimming training on aerobic capacity and exercise induced bronchoconstriction in children with bronchial asthma|/resolve/reference/PMED?id=10325893
Sly 1972 {published data only}|The effect of physical conditioning upon asthmatic children|/resolve/reference/PMED?id=4551436
Swann 1983 {published data only}|Double-blind prospective study of the effect of physical training on childhood asthma|
van Veldhoven 2001 {published data only}|Children with asthma and physical exercise: effects of an exercise programme|/resolve/reference/PMED?id=11518437
Varray 1991 {published and unpublished data}|Individualised aerobic and high intensity training for asthmatic children in an exercise readaptation program - Is training always helpful for better adaptation to exercise?|/resolve/reference/PMED?id=1995211
Varray 1995 {published and unpublished data}|Individualised training reduces excessive exercise hyperventilation in asthmatics|/resolve/reference/PMED?id=8748052
Weisgerber 2003 {published data only}|Benefits of swimming in asthma: effect of a session of swimming lessons on symptoms and PFTs with review of the literature|/resolve/reference/PMED?id=14529095
Altintas 2003 {published data only}|The effect of swimming training on aerobic capacity and pulmonary functions in children with asthma|
Bauer 2002 {published data only}|Long-term effect of indoor rehabilitation on children and young people with moderate and severe asthma|/resolve/reference/PMED?id=12174332
Bundgaard 1983 {published data only}|Short-term phyiscal training in bronchial asthma|/resolve/reference/PMED?id=6135442
Cambach 1997 {published data only}|The effects of community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial|/resolve/reference/PMED?id=9032501
Cox 1989 {published data only}|Results of lung rehabilitation on the short and long term|
Dean 1988 {published data only}|A short exercise and living course for asthmatics|/resolve/reference/PMED?id=3048364
Edenbrandt 1990 {published data only}|Effect of physiotherapy in asthmatic children - a one year follow-up after physical training once a week|
Emtner 1998 {published data only}|A 3-year follow-up of asthmatic patients participating in a 10-week rehabilitation program with emphasis on physical training|/resolve/reference/PMED?id=9596396
Emtner 1998 {published data only}|High-intensity physical training in adults with asthma. A comparison between training on land and in water|/resolve/reference/PMED?id=9825384
Emtner 1998 {published data only}|Asthmatic patients' views of a comprehensive asthma rehabilitation programme: a three-year follow-up|
Emtner 1998 {published data only}|High-intensity physical training in adults with asthma. A 10-week rehabilitation program|/resolve/reference/PMED?id=8620700
Emtner 1999 {published data only}|Physiotherapy and intensive physical training in rehabilitation of adults with asthma|
Foglio 2001 {published data only}|Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study|/resolve/reference/PMED?id=11399693
Graff-Lonnevig 1980 {published data only}|Two years follow-up of asthmatic boys participating in a physical activity programme|
Hallstrand 2000 {published data only}|Aerobic conditioning in mild asthma decreases the hyperpnea of exercise and improves exercise and ventilatory capacity|/resolve/reference/PMED?id=11083702
Henriksen 1983 {published data only}|Effect of physical address on exercise-induced bronchoconstriction|
Hirt 1964 {published data only}|Physical conditioning in asthma|/resolve/reference/PMED?id=14169841
Kendrick 2000 {published data only}|Decreasing activity limits for asthma patients|
Kennedy 2002 {published data only}|Exercise and children with asthma|/resolve/reference/PMED?id=11935705
Kriegel 1998 {published data only}|Experience with and impact of six years of judo training in ambulatory rehabilitation of childhood bronchial asthma|/resolve/reference/PMED?id=9551506
Malkia 1998 {published data only}|Intensity of physical activity and respiratory function in subjects with and without bronchial asthma|/resolve/reference/PMED?id=9502307
Meyer 1999 {published data only}|Weekly training improves physical capacity in older asthmatics|
Meyer 2002 {published data only}|Participation of asthmatic children in gymnastic lessons at school|/resolve/reference/PMED?id=12174333
Muzembo 2001 {published data only}|Respiratory rehabilitation in patients with bronchial asthma and chronic obstructive pulmonary disease (COPD) in Kinshasa|/resolve/reference/PMED?id=11416804
Neder 1999 {published data only}|Short term effects of aerobic training in the clinical management of moderate to severe asthma in children|/resolve/reference/PMED?id=10325894
Orenstein 1985 {published data only}|Exercise conditioning in children with asthma|/resolve/reference/PMED?id=3981308
Pin 1993 {published data only}|Effect of 2 physical training programmes on oxygen consumption and exercise-induced asthma in asthmatic teenagers|
Postolache 2002 {published data only}|Long-term benefits of pulmonary rehabilitation in patients with chronic asthma|
Riegels-Nielsen 2000 {published data only}|Improved lung function and exercise tolerance in adult asthmatics following 7 weeks of strenuous bicycle training|
Rosimini 2003 {published data only}|Benefits of swim training for children and adolescents with asthma|
Rothe 1990 {published data only}|Controlled study of the effect of sports training on cardiopulmonary functions in asthmatic children and adolescents|/resolve/reference/PMED?id=2263585
Satta 2000 {published data only}|Exercise training in asthma|/resolve/reference/PMED?id=11296996
Schmidt 1997 {published data only}|Effect of ambulatory sports therapy on bronchial asthma in children|/resolve/reference/PMED?id=9380659
Stiefelhagen 2003 {published data only}|Physical exercise and bronchial obstruction: sports for asthmatic patients|
Svenonius 1983 {published data only}|Improvement after training of children with exercise-induced asthma|
Turchetta 2002 {published data only}|Physical activity and sport in the asthmatic child|
van Veldhoven 2000 {published data only}|Effects of an exercise program (PEP) for children with asthma: results of a pilot study|
Weller 1999 {published data only}|Exercise in the management of asthma in children|
Worth 2000 {published data only}|Asthma training in Germany: first standardized program|
Arborelius 1984|Decrease of exercise-induced asthma after physical training|
Brooks 1996|Exercise Physiology|
Clark 1988|Assessment of work performance in asthma for determination of cardiorespiratory fitness and training capacity|/resolve/reference/PMED?id=3206382
Garfinkel 1992|Physiologic and nonphysiologic determinants of aerobic fitness in mild to moderate asthma|/resolve/reference/PMED?id=1554194
Haas 1987|Effect of aerobic training on forced expiratory airflow in exercising asthmatic humans|/resolve/reference/PMED?id=3654468
Nickerson 1983|Distance running improves fitness in asthmatic children without pulmonary complications or changes in exercise-induced bronchospasm|/resolve/reference/PMED?id=6823415
Orenstein 1996|The child and the adolescent athlete|
Robinson 1992|Effects of physical conditioning programme on asthmatic patients|/resolve/reference/PMED?id=1620508
Santuz 1997|Exercise performance in children with asthma: Is it different from that of healthy controls?|/resolve/reference/PMED?id=9192925
Spooner 1999|Nedocromil sodium for preventing exercise-induced bronchoconstriction|
Ram 2000|Effects of physical training in asthma: a systematic review|/resolve/reference/PMED?id=10854014
Ram 2002|Does regular exercise help in the treatment and management of bronchial asthma?|
Ram 2005|Benefits of regular exercise in the treatment and management of bronchial asthma|
Bertrand 1984 {published data only}|Short-term, clinical, nutrional, and functional effects of continuous elemental enteral alimentation in children with cystic fibrosis|/resolve/reference/PMED?id=6418872
Boland 1986 {published data only}|Chronic jejunostomy feeding with a non-elemental formula in undernourished patients with cystic fibrosis|/resolve/reference/PMED?id=2868253
Daniels 1989 {published data only}|Supplemental nasogastric feeding in cystic fibrosis patients during treatment for acute exacerbation of chest disease|/resolve/reference/PMED?id=2504140
Daniels 1989 {published data only}|An evaluation of supplemental overnight nasogastric feeding in children with cystic fibrosis (CF) [abstract]|
Daniels 1989 {published data only}|An evaluation of supplemental overnight nasogastric feeding in children with cystic fibrosis [abstract]|
Erskine 1995 {published data only}|Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and non-elemental formula [abstract]|
Erskine 1995 {published data only}|Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and nonelemental formula|/resolve/reference/PMED?id=9506639
Geukers 2005 {published data only}|Optimal protein load in children with cystic fibrosis [abstract]|/resolve/reference/PMED?id=12950050
Geukers 2005 {published data only}|Short-term protein intake and stimulation of protein synthesis in stunted children with cystic fibrosis|/resolve/reference/PMED?id=15755829
Gottrand 1999 {published data only}|Comparison of medium and high fat formulas for nighttime enteral feedings in CF children and adolescents [abstract]|/resolve/reference/PMED?id=3926979
Gottrand 1999 {published data only}|Effect of glucose to fat ratio on energy substrate disposal in children with cystic fibrosis fed enterally|/resolve/reference/PMED?id=10601537
Kane 1991 {published data only}|Energy and respiratory metabolism in cystic fibrosis: the influence of carbohydrate content of nutritional supplements|/resolve/reference/PMED?id=2051272
Levy 1985 {published data only}|Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis|/resolve/reference/PMED?id=3926979
Moore 1986 {published data only}|Enteral-tube feeding as adjunct therapy in malnourished patients with cystic fibrosis: a clinical study and literature review|/resolve/reference/PMED?id=3088970
O'Loughlin 1986 {published data only}|Nutritional rehabilitation of malnourished patients with cystic fibrosis|/resolve/reference/PMED?id=3085467
Pelekanos 1990 {published data only}|Protein turnover in malnourished patients with cystic fibrosis: effects of elemental and non elemental nutritional supplements|/resolve/reference/PMED?id=2109053
Pencharz 1984 {published data only}|Energy needs and nutritional rehabilitation in under-nourished adolescents and young adult patients with cystic patients|/resolve/reference/PMED?id=6438297
Shepherd 1983 {published data only}|Changes in body composition and muscle protein dedregation during nutritional supplement in nutritionally growth-retarded children with cystic fibrosis|/resolve/reference/PMED?id=6620051
Shepherd 1988 {published data only}|Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study including effects of protein turnover|/resolve/reference/PMED?id=3136639
Shepherd 1988 {published data only}|Nutritional supplementation during management of pulmonary exacerbations in CF: a controlled study including effects on protein turnover [abstract]|
Steinkamp 1990 {published data only}|Stabilization of lung function in cystic fibrosis during long-term tube feeding via a percutaneous endoscopic gastrostomy|/resolve/reference/PMED?id=2126371
Truby 2009 {published data only}|The long term efficacy of gastrostomy feeding in children with cystic fibrosis on anthropometric markers of nutritional status and pulmonary function|/resolve/reference/PMED?id=19834580
Beker 2001|Stature as a prognostic factor in cystic fibrosis survival|/resolve/reference/PMED?id=11320950
Bell 2000|Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis|
Corey 1998|A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto|/resolve/reference/PMED?id=3260274
Dorlochter 2002|Resting energy expenditure and lung disease in cystic fibrosis|/resolve/reference/PMED?id=15463819
Elborn 1996|Nutrition and survival in cystic fibrosis|
Giradet 1994|Resting energy expenditure in infants with cystic fibrosis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2008|/resolve/reference/PMED?id=9669726
Kawchak 1996|Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis|/resolve/reference/PMED?id=8757571
Morrison 1994|Energy intakes and losses in cystic fibrosis|
Oliver 2004|Factors affecting clinical outcome in gastrostomy-fed children with cystic fibrosis|
Sharma 2000|Wasting as an independent predictor of mortality in patients with cystic fibrosis|/resolve/reference/PMED?id=11562511
Walker 1998|Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings|/resolve/reference/PMED?id=9669726
Zemel 2000|Longitudinal relationship between growth, nutritional status and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National Patient Registry|/resolve/reference/PMED?id=10969263
Broberger 1986 {published data only}|Ketotifen in pollen-induced asthma: a double blind placebo-controlled study|
Canny 1997 {published data only}|Does ketotifen have a steroid-sparing effect in childhood asthma?|/resolve/reference/PMED?id=9032494
Chay 1992 {published data only}|Efficacy of Zaditen (ketotifen) in wheezy infants and young children|/resolve/reference/PMED?id=1305670
Croce 1995 {published data only}|A double-blind, placebo-controlled comparison of sodium cromoglycate and ketotifen in the treatment of childhood asthma|
Dawson 1989 {published data only}|Ketotifen in asthma|/resolve/reference/PMED?id=2660783
de Benedictis 1990 {published data only}|Prophylactic treatment of wheezy infants with ketotifen. A multicenter controlled study|
de Benedictis 1990 {published data only}|Prophylactic treatment of wheezy infants with ketotifen|
Graff Lonnevig 1985 {published data only}|The effect of ketotifen on bronchial hyperreactivity in childhood asthma|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Kabra 2000 {published data only}|Ketotifen for asthma in children aged 5 to 15 years: a randomized placebo-controlled trial|/resolve/reference/PMED?id=10923604
Kelly 1982 {published and unpublished data}|Interim report of a double-blind controlled study of ketotifen in childhood asthma|
Loftus 1987 {published and unpublished data}|Long-term, placebo-controlled trial of ketotifen in the management of preschool children with asthma|/resolve/reference/PMED?id=3546465
Longo 1986 {published data only}|Double-blind controlled study by Ketotifen in childhood asthma|
Montoya 1988 {published data only}|Asthma and nifedipine: comparative study of the profilactic effect of nifedipine against ketotifen and placebo in child's allergic asthma|
Montoya 1988 {published data only}|Asthma and nifedipine. Comparison of nifedipine, ketotifen and placebo in the prophylaxis of childhood extrinsic asthma|/resolve/reference/PMED?id=3067566
Mulhern 1982 {published data only}|A double blind placebo controlled study on the use of ketotifen in childhood asthma|/resolve/reference/PMED?id=7085236
Myloma 1990 {published data only}|Effect of ketotifen on childhood asthma: a double-blind study|/resolve/reference/PMED?id=2189866
Neijens 1988 {published data only}|Oral prophylactic treatment in wheezy infants|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Rackham 1989 {published data only}|A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years|/resolve/reference/PMED?id=2674262
Rebmann 1987 {published data only}|Ketotifen in a combination therapy of bronchial asthma in children: influence on lung-function parameters of small airways|
Reid 1989 {published data only}|Double-blind trial of Ketotifen in childhood chronic cough and wheeze|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Salmon 1982 {published data only}|Multicentre study for the evaluation of ketotifen in the prophylaxis of extrinsic asthma in children|
Santos 1999 {published data only}|Double blind study with ketotifen and placebo in asthmatic children|
Simons 1982 {published data only}|Ketotifen: a new drug for prophylaxis of asthma in children|/resolve/reference/PMED?id=6121527
Spicak 1983 {published data only}|The prophylactic treatment of bronchial asthma in children with ketotifen: a double-blind comparison with placebo|/resolve/reference/PMED?id=6347749
Van Asperen 1992 {published and unpublished data}|A multicentre randomized placebo-controlled double-blind study on the efficacy of Ketotifen in infants with chronic cough or wheeze|
Varsano 1993 {published and unpublished data}|Multicenter study with ketotifen (Zaditen) oral drop solution in the treatment of wheezy children aged 6 months to 3 years|
Volovitz 1988 {published data only}|Efficacy and safety of ketotifen in young children with asthma|/resolve/reference/PMED?id=3279095
White 1988 {published data only}|Ketotifen in the young asthmatic - a double-blind placebo-controlled trial|/resolve/reference/PMED?id=3288523
Botey 1983 {published data only}|Ketotifen in childhood asthma|/resolve/reference/PMED?id=6660172
Gonzalez 1988 {published data only}|A clinical trial of Ketotifen in the management of asthma in infants|
Gbel 1979 {published data only}|Efficacy and tolerability of oral ketotifen in the long-term prophylactic treatment of bronchial asthma in children|
Hoshino 1997 {published data only}|Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma|
Huerta 1985 {published data only}|Ketotifen in the prophylaxis of child asthma. A controlled clinical test|/resolve/reference/PMED?id=3890497
Mathov 1983 {published data only}|A long-term treatment of bronchial.asthma with ketotifen. Relationships with bronchial hypersensitivity|/resolve/reference/PMED?id=6346930
Medici 1989 {published data only}|Ketotifen in the prophylaxis of extrensic asthma. A multicenter double-blind study with a modified-release formulation|/resolve/reference/PMED?id=2684551
Miraglia 1986 {published data only}|Study of the efficacy of Ketotifen treatment in asthmatic children under 3 years of age|
Naspitz 1988 {published data only}|Evaluation of ketotifen in the prophylactic treatment of bronchial asthma in children|/resolve/reference/PMED?id=3381712
Poder 1982 {published and unpublished data}|Development of clinical symptoms in asthmatic children under long-term treatment of ketotifen|/resolve/reference/PMED?id=3991218
Poder 1982 {published and unpublished data}|Development of clinical symptoms in asthmatic children under long-term treatment of ketotifen|
Podleski 1984 {published data only}|Long term trial of Ketotifen in bronchial asthma|/resolve/reference/PMED?id=6428279
Polverino 1994 {published data only}|A correct diagnosis for a correct treatment: preventive therapy in asthma|
Tinkelmann 1985 {published data only}|A multicenter trial of the prophylactic effect of ketotifen, theophylline, and placebo in atopic asthma|/resolve/reference/PMED?id=3897345
Weheba 1979 {published data only}|Prophylactic treatment of bronchial asthma in children with a new, orally active agent, ketotifen|
Wenz 1986 {published data only}|Experiences with Ketotifen in diseases of the respiratory tract|/resolve/reference/PMED?id=2947446
Begg 1996|Improving the quality of reporting of randomized controlled trials. The CONSORT statement|/resolve/reference/PMED?id=8773637
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Ihaka 1996|A language for data analysis and graphics|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Moher 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials|/resolve/reference/PMED?id=11304106
Pao 2002|Randomized controlled trial of fluticasone in pre school children with intermittenet wheeze|/resolve/reference/PMED?id=12359651
Pauwels 2003|Early intervention with budenoside in mild persistent asthma: a randomised, double-blind trial|/resolve/reference/PMED?id=12672309
Suissa 2002|Regular use of inhaled corticosteroids and the long term prevention of hospitalisation of asthma|/resolve/reference/PMED?id=12324675
Allen 2010 {published data only}|A randomized trial of a computer-tailored decision aid to improve prostate cancer screening decisions: results from the take the wheel trial|
Arterburn 2011 {published data only}|Randomized trial of a video-based patient decision aid for bariatric surgery|
Auvinen 2004 {published data only}|A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen|
Auvinen 2004 {published data only}|A randomized trial of the choice of treatment in prostate cancer: design and baseline characteristics|
Barry 1997 {published and unpublished data}|A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia|
Barry 1997 {published and unpublished data}|Decision aids for benign prostatic hyperplasia: applicability across race and education|/resolve/reference/PMED?id=15271274
Bekker 2004 {published data only}|Applying decision analysis to facilitate informed decision making about prenatal diagnosis for Down syndrome: a randomised controlled trial|
Bekker 2004 {published data only}|Understanding why decision aids work: linking process with outcome|/resolve/reference/PMED?id=12900106
Bernstein 1998 {published and unpublished data}|A randomized controlled trial of information-giving to patients referred for coronary angiography: effects on outcomes of care|
Berry 2013 {published data only}|The personal patient profile-prostate decision support for men with localized prostate cancer: a multi-center randomized trial|/resolve/reference/PMED?id=22153756
Berry 2013 {published data only}|Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer|/resolve/reference/PMED?id=22608696
Bjorklund 2012 {published data only}|Audiovisual information affects informed choice and experience of information in antenatal Down syndrome screening-a randomized controlled trial|/resolve/reference/PMED?id=21807474
Chambers 2012 {published data only}|Impact of the Ottawa influenza decision aid on healthcare personnel's influenza immunization decision: a randomized trial|/resolve/reference/PMED?id=23017384
Clancy 1988 {published data only}|Guiding individual decisions: a randomized, controlled trial of decision analysis|/resolve/reference/PMED?id=2970220
Davison 1997 {published data only}|Empowerment of men newly diagnosed with prostate cancer|/resolve/reference/PMED?id=9190093
de Achaval 2012 {published data only}|Impact of educational and patient decision aids on decisional conflict associated with total knee arthroplasty|
Deschamps 2004 {published and unpublished data}|Impact of pharmacist consultation versus a decision aid on decision making regarding hormone replacement therapy|
Deyo 2000 {published and unpublished data}|Involving patients in clinical decisions: impact of an interactive video program on use of back surgery|/resolve/reference/PMED?id=10982117
Deyo 2000 {published and unpublished data}|Helping patients decide about back surgery: a randomized trial of an interactive video program|/resolve/reference/PMED?id=11154542
Dodin 2001 {published and unpublished data}|Making a decision about hormone replacement therapy. A randomized controlled trial|/resolve/reference/PMED?id=11561335
Dolan 2002 {published data only}|Randomized controlled trial of a patient decision aid for colorectal cancer screening|/resolve/reference/PMED?id=11958495
Evans 2010 {published data only}|Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial|/resolve/reference/PMED?id=20693148
Fagerlin 2011 {published data only}|Randomization for Guide to Decide Phase II|
Fagerlin 2011 {published data only}|Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid|/resolve/reference/PMED?id=21442198
Fraenkel 2007 {published data only}|Improving informed decision-making for patients with knee pain|/resolve/reference/PMED?id=17696268
Frosch 2008 {published data only}|Internet patient decision support: a randomized controlled trial comparing alternative approaches for men considering prostate cancer screening|/resolve/reference/PMED?id=18299490
Gattellari 2003 {published data only}|Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial|/resolve/reference/PMED?id=12790313
Gattellari 2005 {published data only}|A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening|/resolve/reference/PMED?id=15911190
Goel 2001 {published and unpublished data}|Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer|/resolve/reference/PMED?id=11206942
Green 2001a {published data only}|An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility|
Green 2004 {published data only}|Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions|/resolve/reference/PMED?id=15834239
Green 2004 {published data only}|Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial|/resolve/reference/PMED?id=15280342
Hamann 2006 {published data only}|Shared decision making and long-term outcome in schizophrenia treatment|/resolve/reference/PMED?id=17685733
Hamann 2006 {published data only}|Shared decision making for in-patients with schizophrenia|
Hanson 2011 {published data only}|Improving decision making for feeding options in advanced dementia: a randomized, controlled trial|
Heller 2008 {published data only}|Interactive digital education aid in breast reconstruction|/resolve/reference/PMED?id=18766034
Hess 2012 {published data only}|The chest pain choice decision aid: a randomized trial|/resolve/reference/PMED?id=22496116
Hunter 2005 {published data only}|A randomized trial comparing alternative approaches to prenatal diagnosis counseling in advanced maternal age patients|
Jibaja-Weiss 2011 {published data only}|Entertainment education for breast cancer surgery decisions: a randomized trial among patients with low health literacy|/resolve/reference/PMED?id=20609546
Johnson 2006 {published data only}|A chairside aid for shared decision making in dentistry: a randomized controlled trial|/resolve/reference/PMED?id=16478927
Kasper 2008 {published data only}|Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): A randomized controlled trial|
Kennedy 2002 {published data only}|Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial|/resolve/reference/PMED?id=12460093
Krist 2007 {published data only}|Patient education on prostate cancer screening and involvement in decision making|/resolve/reference/PMED?id=17389534
Kuppermann 2009 {published data only}|Computerized prenatal genetic testing decision-assisting tool: a randomized controlled trial|/resolve/reference/PMED?id=19104360
Labrecque 2010 {published data only}|Evaluation of the effect of a patient decision aid about vasectomy on the decision-making process: a randomized trial|/resolve/reference/PMED?id=21074020
Lalonde 2006 {published data only}|Evaluation of a decision aid and a personal risk profile in community pharmacy for patients considering options to improve cardiovascular health: The OPTIONS pilot study|
Langston 2010 {published data only}|Structured contraceptive counseling: a randomised controlled trial|/resolve/reference/PMED?id=20869187
Laupacis 2006 {published data only}|A decision aid for autologous pre-donation in cardiac surgery - a randomized trial|/resolve/reference/PMED?id=16024212
Legare 2003 {published data only}|The effect of decision aids on the agreement between women's and physicians' decisional conflict about hormone replacement therapy|/resolve/reference/PMED?id=12781936
Legare 2008a {published data only}|Patient decision aid on natural health products for menopausal symptoms: randomized controlled trial|/resolve/reference/PMED?id=18714075
Legare 2011 {published data only}|Training family physicians in shared decision making for the use of antibiotics for acute respiratory infections: a pilot clustered randomized controlled trial|
Leighl 2011 {published data only}|Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy|/resolve/reference/PMED?id=21483008
Lerman 1997 {published data only}|Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing|/resolve/reference/PMED?id=8998184
Leung 2004 {published data only}|Randomised trial comparing an interactive multimedia decision aid with a leaflet and a video to give information about prenatal screening for Down syndrome|
Lewis 2010 {published data only}|Effectiveness of a patient and practice-level colorectal cancer screening intervention in health plan members: design and baseline findings of the CHOICE trial|
Lewis 2010 {published data only}|Effectiveness of a patient and practice-level colorectal cancer screening intervention in health plan members|
Lewis 2010 {published data only}|Conjoint analysis versus rating and ranking for values elicitation and clarification in colorectal cancer screening|/resolve/reference/PMED?id=21870192
Loh 2007 {published data only}|Effects of shared decision making in primary care of depressive patients - Better compliance and treatment effects|
Loh 2007 {published data only}|The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial|/resolve/reference/PMED?id=17509808
Mann D 2010 {published data only}|The Statin choice decision aid in primary care: a randomized trial|/resolve/reference/PMED?id=19959322
Mann E 2010 {published data only}|Impact of informed-choice invitations on diabetes screening knowledge, attitude and intentions: an analogue study|/resolve/reference/PMED?id=21167033
Man-Son-Hing 1999 {published and unpublished data}|A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial|/resolve/reference/PMED?id=10463708
Marteau 2010 {published data only}|Can informed choice invitations lead to inequities in intentions to make lifestyle changes among participants in a primary care diabetes screening programme? Evidence from a randomized trial|/resolve/reference/PMED?id=21764087
Marteau 2010 {published data only}|Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial|/resolve/reference/PMED?id=20466791
Mathieu 2007 {published data only}|Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women|/resolve/reference/PMED?id=17954796
Mathieu 2010 {published data only}|Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women|/resolve/reference/PMED?id=20149953
McAlister 2005 {published data only}|Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial|/resolve/reference/PMED?id=16129870
McBride 2002 {published data only}|Evaluating participants' use of a hormone replacement therapy decision-making intervention|/resolve/reference/PMED?id=12477613
McBride 2002 {published data only}|A tailored intervention to aid decision making about hormone replacement therapy|/resolve/reference/PMED?id=12084693
McCaffery 2010 {published data only}|Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial|/resolve/reference/PMED?id=20179125
Miller 2005 {published data only}|Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service|/resolve/reference/PMED?id=16377604
Miller 2011 {published data only}|Effectiveness of a web-based colorectal cancer screening patient decision aid: a randomized controlled trial in a mixed-literacy population|/resolve/reference/PMED?id=21565651
Montgomery 2003 {published and unpublished data}|Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients|/resolve/reference/PMED?id=16004744
Montgomery 2003 {published and unpublished data}|A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients|/resolve/reference/PMED?id=12939889
Montgomery 2007 {published data only}|Women's views on the use of decision aids for decision making about the method of delivery following a previous caesarean section: qualitative interview study|
Montgomery 2007 {published data only}|Economic evaluation of the DIAMOND randomized trial: cost and outcomes of 2 decision aids for mode of delivery among women with previous caesarian section|
Montgomery 2007 {published data only}|Two decision aids for mode of delivery among women with previous caesarean section: randomised controlled trial|/resolve/reference/PMED?id=17540908
Montori 2011 {published data only}|Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial|/resolve/reference/PMED?id=21605732
Montori 2011 {published data only}|Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice|/resolve/reference/PMED?id=20003299
Morgan 2000 {published and unpublished data}|A randomized trial of the ischemic heart disease shared decision making program: an evaluation of a decision aid|
Morgan 2000 {published and unpublished data}|Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease|
Mullan 2009 {published data only}|The diabetes mellitus medication choice decision aid: a randomized trial|/resolve/reference/PMED?id=19786674
Murray 2001a {published and unpublished data}|Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care|/resolve/reference/PMED?id=11532845
Murray 2001b {published and unpublished data}|Randomized controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care|/resolve/reference/PMED?id=11532844
Myers 2005a {published data only}|Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening|/resolve/reference/PMED?id=16173330
Myers 2011 {published data only}|Mediated decision support in prostate cancer screening: a randomized controlled trial of decision counseling|/resolve/reference/PMED?id=20619576
Nagle 2008 {published data only}|Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial|
Nagle 2008 {published data only}|Evaluation of a decision aid for prenatal testing of fetal abnormalities: a cluster randomised trial [ISRCTN22532458]|/resolve/reference/PMED?id=16611368
Nassar 2007 {published data only}|Evaluation of a decision aid for women with breech presentation at term: a randomised controlled trial [ISRCTN14570598]|
O'Connor 1998a {published and unpublished data}|Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy|/resolve/reference/PMED?id=9679994
O'Connor 1999a {published data only}|The effects of an 'explicit' values clarification exercise in a women's decision aid regarding postmenopausal hormone therapy|
Oakley 2006 {published data only}|A pilot study assessing the effectiveness of a decision aid on patient adherence with oral bisphosphonate medication|
Ozanne 2007 {published data only}|Pilot trial of a computerized decision aid for breast cancer prevention|
Partin 2004 {published and unpublished data}|Who uses decision aids? Subgroup analyses from a randomized controlled effectiveness trial of two prostate cancer screening decision support interventions|
Partin 2004 {published and unpublished data}|Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors|
Pignone 2000 {published data only}|Videotape-based decision aid for colon cancer screening. A randomized, controlled trial|/resolve/reference/PMED?id=11085838
Protheroe 2007 {published data only}|The use of mixed methodology in evaluating complex interventions: Identifying patient factors that moderate the effects of a decision aid|
Protheroe 2007 {published data only}|Effectiveness of a computerized decision aid in primary care on decision making and quality of life in menorrhagia: results of the MENTIP randomized controlled trial|/resolve/reference/PMED?id=17898242
Raynes-Greenow 2010 {published data only}|Assisting informed decision making for labour analgesia: a randomised controlled trial of a decision aid for labour analgesia versus a pamphlet|/resolve/reference/PMED?id=20377844
Rostom 2002 {published data only}|A randomized trial of a computerized versus an audio-booklet decision aid for women considering post-menopausal hormone replacement therapy|/resolve/reference/PMED?id=11804772
Rothert 1997 {published and unpublished data}|Patient decision support intervention: increased consistency with decision analytic models|/resolve/reference/PMED?id=10098571
Rothert 1997 {published and unpublished data}|An educational intervention as decision support for menopausal women|
Rubel 2010 {published data only}|Testing the effects of a decision aid for prostate cancer screening|/resolve/reference/PMED?id=20432110
Ruffin 2007 {published data only}|Preference-based electronic decision aid to promote colorectal cancer screening: results of a randomized controlled trial|/resolve/reference/PMED?id=17689600
Schapira 2000 {published data only}|The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests|/resolve/reference/PMED?id=10836772
Schapira 2007 {published data only}|Decision-making at menopause: a randomized controlled trial of a computer-based hormone therapy decision-aid|/resolve/reference/PMED?id=17400413
Schroy 2011 {published data only}|The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial|/resolve/reference/PMED?id=20484090
Schroy 2011 {published data only}|Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial|/resolve/reference/PMED?id=23159252
Schwalm 2012 {published data only}|Radial artery versus femoral artery access options in coronary angiogram procedures: randomized controlled trial of a patient-decision aid|/resolve/reference/PMED?id=22496115
Schwartz 2001 {published data only}|Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women|
Schwartz 2009 {published data only}|Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial|/resolve/reference/PMED?id=20876346
Schwartz 2009 {published data only}|Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction|/resolve/reference/PMED?id=19210013
Sheridan 2006 {published data only}|The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial|/resolve/reference/PMED?id=17005051
Sheridan 2011 {published data only}|A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies|/resolve/reference/PMED?id=22141447
Shorten 2005 {published and unpublished data}|Making choices for childbirth: a randomized controlled trial of a decision-aid for informed birth after cesarean|
Smith 2010 {published data only}|A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial|/resolve/reference/PMED?id=20978060
Solberg 2010 {published data only}|Informed choice assistance for women making uterine fibroid treatment decisions: a practical clinical trial|/resolve/reference/PMED?id=19949063
Steckelberg 2011 {published data only}|Effect of evidence based risk information on "informed choice" in colorectal cancer screening: randomised controlled trial|/resolve/reference/PMED?id=21636633
Street 1995 {published data only}|Increasing patient involvement in choosing treatment for early breast cancer|
Thomson 2007 {published data only}|Medical communication and technology: a video-based process study of the use of decision aids in primary care consultations|/resolve/reference/PMED?id=17214888
Thomson 2007 {published data only}|A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial|/resolve/reference/PMED?id=17545350
Tiller 2006 {published data only}|A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer|/resolve/reference/PMED?id=16855125
Trevena 2008 {published data only}|Randomized trial of a self-administered decision aid for colorectal cancer screening|/resolve/reference/PMED?id=18573775
Vandemheen 2009 {published data only}|Randomized trial of a decision aid for patients with cystic fibrosis considering lung transplantation|
van Peperstraten 2010 {published data only}|The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in in vitro fertilisation: randomised controlled trial|/resolve/reference/PMED?id=20884700
van Roosmalen 2004 {published and unpublished data}|Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation|/resolve/reference/PMED?id=14735173
van Roosmalen 2004 {published and unpublished data}|Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers|/resolve/reference/PMED?id=15310772
Vodermaier 2009 {published data only}|Contextual factors in shared decision making: a randomised controlled trial in women with a strong suspicion of breast cancer|/resolve/reference/PMED?id=19209172
Volk 1999 {published and unpublished data}|A randomized controlled trial of shared decision making for prostate cancer screening|/resolve/reference/PMED?id=10418541
Volk 1999 {published and unpublished data}|Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up|/resolve/reference/PMED?id=15043176
Volk 2008 {published data only}|Entertainment education for prostate cancer screening: a randomized trial among primary care patients with low health literacy|/resolve/reference/PMED?id=18760888
Vuorma 2003 {published data only}|Impact of patient information booklet on treatment decision - a randomized trial among women with heavy menstruation|
Vuorma 2003 {published data only}|A randomized trial among women with heavy menstruation - impact of a decision aid on treatment outcomes and costs|
Wakefield 2008 {published data only}|Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk|
Wakefield 2008a {published data only}|A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk|/resolve/reference/PMED?id=17333332
Wakefield 2008b {published data only}|A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling|
Watson 2006 {published data only}|Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested|/resolve/reference/PMED?id=16875796
Weymiller 2007 {published data only}|Should clinicians deliver decision aids? further exploration of the statin choice randomized trial results|/resolve/reference/PMED?id=19605885
Weymiller 2007 {published data only}|A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial|
Weymiller 2007 {published data only}|Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial|/resolve/reference/PMED?id=17533211
Whelan 2003 {published and unpublished data}|Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer|/resolve/reference/PMED?id=12697850
Whelan 2004 {published and unpublished data}|Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial|/resolve/reference/PMED?id=15280341
Wolf 1996 {published data only}|The impact of informed consent on patient interest in prostate-specific antigen screening|/resolve/reference/PMED?id=8651843
Wolf 1996 {published data only}|Preferences of elderly men for prostate-specific antigen screening and the impact of informed consent|/resolve/reference/PMED?id=9597051
Wolf 2000 {published and unpublished data}|Does informed consent alter elderly patients' preferences for colorectal cancer screening? Results of a randomized trial|
Wong 2006 {published data only}|A randomised controlled trial of a decision-aid leaflet to facilitate women's choice between pregnancy termination methods|
Abadie 2009 {published data only}|Clinician's use of the Statin Choice decision aid in patients with diabetes: a videographic study nested in a randomized trial|
Adab 2003 {published data only}|Randomised controlled trial of the effect of evidence based information on women's willingness to participate in cervical cancer screening|/resolve/reference/PMED?id=12883063
Al Saffar 2008 {published data only}|Depressed patients' preferences for education about medications by pharmacists in Kuwait|/resolve/reference/PMED?id=18337052
Altiner 2007 {published data only}|Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study|/resolve/reference/PMED?id=17626023
Anderson 2011 {published data only}|"The booklet helped me not to panic": a pilot of a decision aid for asymptomatic women with ovarian cancer and with rising CA-125 levels|/resolve/reference/PMED?id=21412158
Arimori 2006 {published data only}|Randomized controlled trial of decision aids for women considering prenatal testing: the effect of the Ottawa Personal Decision Guide on decisional conflict|
Armstrong 2005 {published data only}|Individualized survival curves improve satisfaction with cancer risk management decisions in women with BRCA1/2 mutations|/resolve/reference/PMED?id=16361631
Au 2011 {published data only}|Development and pilot-testing of a decision aid for use among Chinese women facing breast cancer surgery|
Becker 2009 {published data only}|The effects of hormone therapy decision support for women with mobility impairments|/resolve/reference/PMED?id=19657820
Bellmunt 2010 {published data only}|A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options|
Bieber 2006 {published data only}|Shared decision making improves the physician-patient interaction with fibromyalgia patients|
Bieber 2006 {published data only}|A shared decision-making communication training program for physicians treating fibromyalgia patients: effects of a randomized controlled trial|/resolve/reference/PMED?id=18157994
Breslin 2008 {published data only}|The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes|/resolve/reference/PMED?id=18771876
Brown 2004 {published data only}|Education and role modelling for clinical decisions with female cancer patients|
Brundage 2001 {published data only}|Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer|/resolve/reference/PMED?id=11230475
Burton 2007 {published data only}|Booklet-based education in vestibular rehabilitation or symptom control improved subjective health in Meniere disease|/resolve/reference/PMED?id=17885159
Carling 2008 {published data only}|How should the impact of different presentations of treatment effects on patient choice be evaluated? A pilot randomized trial|/resolve/reference/PMED?id=19030110
Chadwick 1991 {published data only}|Medical or surgical orchidectomy: the patients' choice|/resolve/reference/PMED?id=1827036
Chan 2011 {published data only}|A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT|/resolve/reference/PMED?id=21237611
Chewning 1999 {published data only}|Evaluation of a computerized contraceptive decision aid for adolescent patients|/resolve/reference/PMED?id=10865688
Chiew 2008 {published data only}|Development and evaluation of a decision aid for patients considering first-line chemotherapy for metastatic breast cancer|
Col 2007 {published data only}|Can computerized decision support help patients make complex treatment decisions? A randomized controlled trial of an individualized menopause decision aid|/resolve/reference/PMED?id=17873260
Colella 2004 {published data only}|Shared decision making in patients with newly diagnosed prostate cancer: a model for treatment education and support|/resolve/reference/PMED?id=15311487
Costanza 2011 {published data only}|Helping men make an informed decision about prostate cancer screening: a pilot study of telephone counseling|/resolve/reference/PMED?id=20554423
Coulter 2003 {published data only}|Patient information and shared decision-making in cancer care|/resolve/reference/PMED?id=12915899
Crang-Svalenius 1996 {published data only}|Women's informed choice of prenatal diagnosis: early ultrasound examination-routine ultrasound examination-age-independent amniocentesis|
Davison 1999 {published data only}|Information and patient participation in screening for prostate cancer|/resolve/reference/PMED?id=14528551
Davison 2007 {published data only}|Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer|/resolve/reference/PMED?id=17876177
Deen 2012 {published data only}|The impact of different modalities for activating patients in a community health center setting|/resolve/reference/PMED?id=22683294
Deinzer 2009 {published data only}|Is a shared decision-making approach effective in improving hypertension management?|
Diefenbach 2012 {published data only}|Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study|/resolve/reference/PMED?id=22246148
Dobke 2008 {published data only}|Pilot trial of telemedicine as a decision aid for patients with chronic wounds|/resolve/reference/PMED?id=18570547
Driscoll 2008 {published data only}|Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions|/resolve/reference/PMED?id=18617077
Dunn 1998 {published and unpublished data}|Videotape increases parent knowledge about poliovirus vaccines and choices of polio vaccination schedules|/resolve/reference/PMED?id=9685472
Eaton 2011 {published data only}|A novel approach to prevention for at-risk HIV negative men who have sex with men: creating a teachable moment to promote informed sexual decision making|/resolve/reference/PMED?id=21233441
Eden 2009 {published data only}|Patients were more consistent in randomized trial at prioritizing childbirth preferences using graphic-numeric than verbal formats|/resolve/reference/PMED?id=19008073
El-Jawahri 2010 {published data only}|Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial|/resolve/reference/PMED?id=19949010
Ellison 2008 {published data only}|A randomized trial comparing web-based decision aids on prostate cancer knowledge for African-American men|/resolve/reference/PMED?id=18942274
Elwyn 2004 {published data only}|Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice|/resolve/reference/PMED?id=15249520
Emery 2007 {published data only}|The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care|/resolve/reference/PMED?id=17700548
Emmett 2007 {published data only}|Decision-making about mode of delivery after previous caesarean section: development and piloting of two computer-based decision aids|
Feldman-Stewart 2006 {published data only}|An explicit values clarification task: development and validation|/resolve/reference/PMED?id=16860521
Flood 1996 {published data only}|The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team|/resolve/reference/PMED?id=8803740
Francis 2009 {published data only}|Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial|/resolve/reference/PMED?id=19640941
Frosch 2001 {published data only}|Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test|
Frosch 2003 {published data only}|A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test|
Frosch 2008a {published data only}|Using decision aids in community-based primary care: a theory-driven evaluation with ethnically diverse patients|/resolve/reference/PMED?id=18771875
Frost 2009 {published data only}|Women's views on the use of decision aids for decision making about the method of delivery following a previous caesarean section: qualitative interview study|
Graham 2000 {published data only}|Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests|/resolve/reference/PMED?id=10634736
Gray 2009 {published data only}|Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer|/resolve/reference/PMED?id=19318436
Green 2001b {published data only}|Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor|
Greenfield 1985 {published data only}|Expanding patient involvement in care. Effects on patient outcomes|/resolve/reference/PMED?id=3977198
Griffith 2008a {published data only}|The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial|/resolve/reference/PMED?id=18218084
Griffith 2008b {published data only}|Should a colon cancer screening decision aid include the option of no testing? A comparative trial of two decision aids|/resolve/reference/PMED?id=18321377
Gruppen 1994 {published data only}|Outcome bias and cognitive dissonance in evaluating treatment decisions|/resolve/reference/PMED?id=7916829
Hall 2007 {published data only}|Undergoing prenatal screening for Down's syndrome: presentation of choice and information in Europe and Asia|/resolve/reference/PMED?id=17311082
Hall 2011 {published data only}|Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing|
Harwood 2011 {published data only}|Decision aids for breast and nodal surgery in patients with early breast cancer: development and a pilot study|/resolve/reference/PMED?id=21585690
Healton 1999 {published data only}|Effects of ZDV-based patient education on intentions toward ZDV use, HIV testing and reproduction among a US cohort of women|/resolve/reference/PMED?id=10716008
Herrera 1983 {published data only}|Parental information and circumcision in highly motivated couples with higher education|/resolve/reference/PMED?id=6823425
Hewison 2001 {published data only}|Use of videotapes for viewing at home to inform choice in Down syndrome screening: a randomised controlled trial|
Hickish 1995 {published data only}|Patient preference for extended palliative chemotherapy for non-small cell lung cancer|/resolve/reference/PMED?id=7534859
Hochlehnert 2006 {published data only}|A computer-based information-tool for chronic pain patients: computerized information to support the process of shared decision-making|/resolve/reference/PMED?id=16533681
Hofbauer 2008 {published data only}|Patient-centered care in dermatology: an online system that provides accessible and appropriate information to guide patients' decision making|/resolve/reference/PMED?id=18794475
Hoffman 2009 {published data only}|Colorectal cancer screening in the elderly: the need for informed decision making|/resolve/reference/PMED?id=19798537
Holbrook 2007 {published data only}|Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial|/resolve/reference/PMED?id=17515584
Holloway 2003 {published data only}|Cluster-randomised trial of risk communication to enhance informed uptake of cervical screening|/resolve/reference/PMED?id=14601338
Holmes-Rovner 2011 {published data only}|Shared decision making guidance reminders in practice (SDM-GRIP)|/resolve/reference/PMED?id=21282030
Holt 2009 {published data only}|A comparison of a spiritually based and non-spiritually based educational intervention for informed decision making for prostate cancer screening among church-attending African-American men|/resolve/reference/PMED?id=19718941
Hope 2010 {published data only}|Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study|/resolve/reference/PMED?id=19442970
Hunt 2005 {published data only}|The routine and the traumatic in prenatal genetic diagnosis: does clinical information inform patient decision-making?|/resolve/reference/PMED?id=15721973
Hunter 1999 {published data only}|An evaluation of a health education intervention for mid-aged women: five year follow-up of effects upon knowledge, impact of menopause and health|/resolve/reference/PMED?id=10865690
Huyghe 2009 {published data only}|Banking on Fatherhood: pilot studies of a computerized educational tool on sperm banking before cancer treatment|
Ilic 2008 {published data only}|Informing men about prostate cancer screening: a randomized controlled trial of patient education materials|/resolve/reference/PMED?id=18373146
Isebaert 2007 {published data only}|A decision aid for patients with localized prostate cancer: first results|
Jackson 2011 {published data only}|Randomised cluster trial to support informed parental decision-making for the MMR vaccine|/resolve/reference/PMED?id=21679432
Jerant 2007 {published data only}|Effects of a tailored interactive multimedia computer program on determinants of colorectal cancer screening: a randomized controlled pilot study in physician offices|/resolve/reference/PMED?id=17156968
Jibaja-Weiss 2006 {published data only}|Entertainment education for informed breast cancer treatment decisions in low-literate women: development and initial evaluation of a patient decision aid|/resolve/reference/PMED?id=17371175
Joosten 2009 {published data only}|Shared decision-making reduces drug use and psychiatric severity in substance-dependent patients|/resolve/reference/PMED?id=19468259
Joosten 2011 {published data only}|Shared decision-making: increases autonomy in substance-dependent patients|
Jorm 2003 {published data only}|Providing information about the effectiveness of treatment options to depressed people in the community: a randomized controlled trial of effects on mental health literacy, help-seeking and symptoms|/resolve/reference/PMED?id=12946091
Kakkilaya 2011 {published data only}|Use of a visual aid to improve counseling at the threshold of viability|/resolve/reference/PMED?id=22106080
Kellar 2008 {published data only}|Evaluation of an informed choice invitation for type 2 diabetes screening|/resolve/reference/PMED?id=18513916
Kobelka 2009 {published data only}|An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result|
Kopke 2009 {published data only}|Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial|/resolve/reference/PMED?id=18845657
Kripalani 2007 {published data only}|Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial|/resolve/reference/PMED?id=17673094
Krones 2008 {published data only}|The theory of planned behaviour in a randomized trial of a decision aid on cardiovascular risk prevention|/resolve/reference/PMED?id=19665340
Krones 2008 {published data only}|Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial|/resolve/reference/PMED?id=18474884
Kurian 2009 {published data only}|A computerized decision support system for depression in primary care|/resolve/reference/PMED?id=19750065
LaCroix 1999 {published data only}|Population-based strategy for improving informed decision making about hormone replacement therapy in managed care settings|
Lairson 2011 {published data only}|Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States|/resolve/reference/PMED?id=20810168
Lancaster 2009 {published data only}|Physician training in the use of a decision aid increased patient participation in decision making for CVD prevention|/resolve/reference/PMED?id=19181956
Lazcano Ponce 2000 {published data only}|The power of information and contraceptive choice in a family planning setting in Mexico|/resolve/reference/PMED?id=11026883
Levin 2011 {published data only}|A computer-assisted depression intervention in primary care|/resolve/reference/PMED?id=20961474
Lewis 2003 {published data only}|A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old|
Loon 2009 {published data only}|Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial|/resolve/reference/PMED?id=19948811
Lurie 2011 {published data only}|Effects of viewing an evidence based video decision aid on patients' treatment preferences for spine surgery|/resolve/reference/PMED?id=21358485
Maisels 1983 {published data only}|Circumcision: the effect of information on parental decision making|/resolve/reference/PMED?id=6828353
Mancini 2006 {published data only}|Cross-cultural validation of the Decisional Conflict Scale in a sample of French patients|/resolve/reference/PMED?id=16900286
Manne 2009 {published data only}|A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings|/resolve/reference/PMED?id=19418107
Manns 2005 {published data only}|The impact of education on chronic kidney disease patients'' plans to initiate dialysis with self-care dialysis: a randomized trial|/resolve/reference/PMED?id=16164654
Markham 2003 {published data only}|Limits to patient choice: example from anaesthesia|/resolve/reference/PMED?id=12702623
Martin 2012 {published data only}|An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis|/resolve/reference/PMED?id=21752570
Maslin 1998 {published data only}|Shared decision-making using an interactive video disk system for women with early breast cancer|
Maslin 1998 {published data only}|Using an interactive video disk in breast cancer patient support|/resolve/reference/PMED?id=9739268
Matloff 2006 {published data only}|Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making|/resolve/reference/PMED?id=16999640
Mazur 1994 {published data only}|The effect of physician's explanations on patients' treatment preferences: five-year survival data|/resolve/reference/PMED?id=7934712
McCaffery 2007 {published data only}|Patient decision aids to support clinical decision making: evaluating the decision or the outcomes of the decision|/resolve/reference/PMED?id=17873254
McGinley 2002 {published data only}|Effect of web-based computer-tailoring on women's intention to continue or begin to use hormone replacement therapy to lower their risk for osteoporosis|
McGowan 2008 {published data only}|Just-in-time information improved decision-making in primary care: a randomized controlled trial|/resolve/reference/PMED?id=19023446
McInerney-Leo 2004 {published data only}|BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention|
Mclaren 2012 {published data only}|Exploring the role of gender and risk perceptions in people's decisions to register as a bone marrow donor|/resolve/reference/PMED?id=22156070
Michie 1997 {published data only}|Patient decision making: An evaluation of two different methods of presenting information about a screening test|
Mishel 2009 {published data only}|Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial|/resolve/reference/PMED?id=19819096
Molenaar 2001 {published data only}|Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life|/resolve/reference/PMED?id=11250997
Mulley 2006 {published data only}|Developing skills for evidence-based surgery: ensuring that patients make informed decisions|/resolve/reference/PMED?id=16442428
Myers 2005b {published data only}|Decision counseling in cancer prevention and control|/resolve/reference/PMED?id=16045422
Myers 2007 {published data only}|A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening|
Neubeck 2008 {published data only}|The CHOICE (Choice of Health Options In prevention of Cardiovascular Events) replication trial: study protocol|/resolve/reference/PMED?id=18838009
Newton 2001 {published data only}|Women's responses to a mailed hormone replacement therapy workbook|/resolve/reference/PMED?id=11528363
O'Cathain 2002 {published data only}|Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice|/resolve/reference/PMED?id=11895822
O'Connor 1996 {published data only}|Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization|
O'Connor 2009 {published data only}|Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial|/resolve/reference/PMED?id=19366977
O'Connor 2011 {published data only}|Impact of electronic health record clinical decision support on diabetes care: a randomized trial|/resolve/reference/PMED?id=21242556
Pearson 2005 {published data only}|Interacting effects of preoperative information and patient choice in adaptation to colonoscopy|/resolve/reference/PMED?id=16228834
Peele 2005 {published data only}|Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information|/resolve/reference/PMED?id=15951457
Philip 2010 {published data only}|Evaluating the impact of an educational intervention to increase CRC screening rates in the African American community: a preliminary study|/resolve/reference/PMED?id=20535541
Phillips 1995 {published data only}|The influence of video imaging on patients' perceptions and expectations|/resolve/reference/PMED?id=7486240
Pinto 2008 {published data only}|A pilot study for a randomized controlled and patient preference trial of buprenorphine versus methadone maintenance treatment in the management of opiate dependent patients|
Powers 2011 {published data only}|The effectiveness of personalized coronary heart disease and stroke risk communication|/resolve/reference/PMED?id=21473965
Proctor 2006 {published data only}|Patient satisfaction with 3 methods of postpartum contraceptive counseling: a randomized, prospective trial|/resolve/reference/PMED?id=16779983
Prunty 2008 {published data only}|The motherhood choice: a decision aid for women with multiple sclerosis|/resolve/reference/PMED?id=18160245
Rapley 2006 {published data only}|Doctor-patient interaction in a randomised controlled trial of decision-support tools|/resolve/reference/PMED?id=16290918
Raynes-Greenow 2009 {published data only}|Do audio-guided decision aids improve outcomes? A randomized controlled trial of an audio-guided decision aid compared with a booklet decision aid for Australian women considering labour analgesia|
Rimer 2001 {published data only}|The short-term impact of tailored mammography decision-making interventions|/resolve/reference/PMED?id=11384825
Rimer 2002 {published data only}|Effects of a mammography decision-making intervention at 12 and 24 months|/resolve/reference/PMED?id=11988381
Rovner 2004 {published data only}|Decision aids for benign prostatic hyperplasia: applicability across race and education|/resolve/reference/PMED?id=15271274
Rubinstein 2011 {published data only}|Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial|/resolve/reference/PMED?id=22075527
Ruddy 2009 {published data only}|Breast cancer in young women: clinical decision-making in the face of uncertainty|/resolve/reference/PMED?id=19544686
Ryser 2004 {published data only}|Breastfeeding attitudes, intention, and initiation in low-income women: the effect of the best start program|/resolve/reference/PMED?id=15296584
Saver 2007 {published data only}|A tale of two studies: the importance of setting, subjects and context in two randomized, controlled trials of a web-based decision support for perimenopausal and postmenopausal health decisions|/resolve/reference/PMED?id=17317080
Sawka 2011 {published data only}|How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?|
Schwartz 2009a {published data only}|Using a drug facts box to communicate drug benefits and harms: two randomized trials|/resolve/reference/PMED?id=19221371
Sears 2007 {published data only}|What do I have to lose? effects of a psycho-educational intervention on cancer patient preference for resuscitation|/resolve/reference/PMED?id=17712617
Sequist 2011 {published data only}|Electronic patient message to promote colorectal cancer screening|/resolve/reference/PMED?id=21149743
Sheppard 2012 {published data only}|A decision-support intervention for black women eligible for adjuvant systematic therapy: Sisters informing sisters about breast cancer treatment - An intervention to reduce treatment disparities|
Sheridan 2004 {published data only}|Information needs of men regarding prostate cancer screening and the effect of a brief decision aid|/resolve/reference/PMED?id=15324986
Sheridan 2010 {published data only}|Effect of adding a values clarification exercise to a decision aid on heart disease prevention: a randomized trial|/resolve/reference/PMED?id=20484089
Silver 2012 {published data only}|A randomized trial of decision-making in asymptomatic carotid stenosis|/resolve/reference/PMED?id=22218277
Siminoff 2006 {published data only}|A decision aid to assist in adjuvant therapy choices for breast cancer|
Siminoff 2006 {published data only}|Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! in women with localized breast cancer|/resolve/reference/PMED?id=19270108
Simon 2012 {published data only}|Effectiveness of a web-based, individually tailored decision aid for depression or acute low back pain: a randomized controlled trial|/resolve/reference/PMED?id=22154867
Smith 2011 {published data only}|A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer|/resolve/reference/PMED?id=4962535
Sorenson 2004 {published data only}|Assessment of a decision aid to assist genetic testing research participants in the informed consent process|/resolve/reference/PMED?id=15727260
Sparano 2006 {published data only}|TAILORx: trial assigning individualized options for treatment (Rx)|/resolve/reference/PMED?id=17092406
Stalmeier 2009 {published data only}|Concise evaluation of decision aids|/resolve/reference/PMED?id=18775622
Steiner 2003 {published data only}|Understanding risk: a randomized controlled trial of communicating contraceptive effectiveness|/resolve/reference/PMED?id=14551000
Stephens 2008 {published data only}|Influence of a patient decision aid on decisional conflict related to PSA testing: a structural equation model|/resolve/reference/PMED?id=19025266
Stiggelbout 2008 {published data only}|The impact of individualized evidence-based decision support on aneurysm patients' decision making, ideals of autonomy, and quality of life|/resolve/reference/PMED?id=18626126
Street 1998 {published data only}|Preconsultation education promoting breast cancer screening: does the choice of media make a difference?|/resolve/reference/PMED?id=10898560
Sundaresan 2011 {published data only}|Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03)|/resolve/reference/PMED?id=21985948
Tabak 1995 {published data only}|Decision making in consenting to experimental cancer therapy|/resolve/reference/PMED?id=7720055
Ten 2008 {published data only}|Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial|
Thomson 2006 {published data only}|A computerised guidance tree (decision aid) for hypertension, based on decision analysis: development and preliminary evaluation|/resolve/reference/PMED?id=16309966
Thornton 1995 {published data only}|A randomised trial of three methods of giving information about prenatal testing|/resolve/reference/PMED?id=7580707
Valdez 2001 {published data only}|Impact of a multimedia breast cancer education intervention on use of mammography by low-income Latinas|/resolve/reference/PMED?id=11848671
van Steenkiste 2008 {published data only}|Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care|/resolve/reference/PMED?id=18395393
van Til 2009 {published data only}|The effect of information on preferences stated in a choice-based conjoint analysis|/resolve/reference/PMED?id=18954956
Veroff 2012 {published data only}|Improving self-care for heart failure for seniors: Impact of video and written education and decision aids|/resolve/reference/PMED?id=22004181
Volandes 2009 {published data only}|Video decision support tool for advance care planning in dementia: randomised controlled trial|/resolve/reference/PMED?id=19477893
Volandes 2011 {published data only}|Assessing end-of-life preferences for advanced dementia in rural patients using an educational video: a randomised controlled trial|/resolve/reference/PMED?id=21254815
von Wagner 2011 {published data only}|A decision aid to support informed choice about bowel cancer screening in people with low educational level improves knowledge but reduces screening uptake|/resolve/reference/PMED?id=21421966
Wagner 1995 {published data only}|The effect of a shared decision making program on rates of surgery for benign prostatic hyperplasia. Pilot results|/resolve/reference/PMED?id=7543638
Wallston 1991 {published data only}|Desire for control and choice of antiemetic treatment for cancer chemotherapy|/resolve/reference/PMED?id=1998252
Wang 2004 {published data only}|Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process|
Wennberg 2010 {published data only}|A randomized trial of a telephone care-management strategy|/resolve/reference/PMED?id=20860506
Wilhelm 2009 {published data only}|Extended preoperative patient education using a multimedia DVD: impact on patients receiving a laparoscopic cholecystectomy: a randomised controlled trial|/resolve/reference/PMED?id=19151995
Wilkins 2006 {published data only}|Impact of an educational video on patient decision making in early breast cancer treatment|/resolve/reference/PMED?id=17099197
Willemsen 2006 {published data only}|Helping smokers to decide on the use of efficacious smoking cessation methods: a randomized controlled trial of a decision aid|
Williams-Piehota 2008 {published data only}|Health information styles among participants in a prostate cancer screening informed decision-making intervention|/resolve/reference/PMED?id=18385197
Woltmann 2011 {published data only}|Trial of an electronic decision support system to facilitate shared decision making in community mental health|/resolve/reference/PMED?id=21209300
Wroe 2005 {published data only}|Evaluation of a decision-making aid for parents regarding childhood immunizations|/resolve/reference/PMED?id=16287399
Yun 2011 {published data only}|Use of a decision aid to help caregivers discuss terminal disease status with a family member with cancer: a randomized controlled trial|/resolve/reference/PMED?id=22105823
Zapka 2004 {published data only}|Patient education for colon cancer screening: a randomized trial of a video mailed before a physical examination|/resolve/reference/PMED?id=15520425
Zikmund-Fisher 2008 {published data only}|Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs|/resolve/reference/PMED?id=18602242
Zoffman 2012 {published data only}|Realizing empowerment in difficult diabetes care: a guided self-determination intervention|/resolve/reference/PMED?id=21876206
Allen 2012 {published data only}|Evaluation of DVD and Internet decision aids for hip and knee osteoarthritis: focus on health literacy|
Bozic 2011 {published data only}|Emerging ideas: shared decision making in patients with osteoarthritis of the hip and knee|/resolve/reference/PMED?id=21161733
Brazell 2012 {published data only}|Effect of a decision aid on decision making for the treatment of pelvic organ prolapse|
Carroll 2012 {published data only}|Development of and feasibility testing of decision support for patients who are candidates for an implantable defibrillator|
Chambers 2008 {published data only}|ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer|/resolve/reference/PMED?id=18651985
Denig 2009 {published data only}|Risk management in patients with diabetes mellitus: development and evaluation of a treatment oriented decision aid [DUTCH]|
Geiger 2011 {published data only}|Investigating a training supporting Shared Decision Making (IT'S SDM 2011): study protocol for a randomized controlled trial|/resolve/reference/PMED?id=22029737
Goossens 2008 {published data only}|Decision aid evaluation by a clinical trial in abdominal aortic aneurysms: Improving decision making|
Ibrahim 2010 {published data only}|Behavioral & social science research on understanding and reducing health disparities: African American preference for knee replacement: a patient-centred intervention (ACTION)|
Ickenroth 2012 {published data only}|A single-blind randomised controlled trial of the effect of a web-based decision aid on self-testing for cholesterol and diabetes. Study protocol|/resolve/reference/PMED?id=22216905
Jimbo 2012 {published data only}|Decision aid to technologically enhance shared decision making|
Juraskova 2009 {published data only}|Improving communication about treatment options for asymptomatic ovarian cancer patients with rising CA125: RCT of patient decision aid|
Kuppermann 2011 {published data only}|Development and pilot test of an elective bilateral salpingo-oophorectomy (BSO) decision support guide|
Leighl 2007 {unpublished data only}|Breast cancer metastatic decision aid|
Lurie 2010 {published data only}|Helping patients with spinal stenosis make a treatment decision: a randomized study assessing the benefits of health coaching|
Mann 2012 {published data only}|Increasing efficacy of primary care-based counseling for diabetes prevention: rationale and design of the ADAPT (Avoiding Diabetes Thru Action Plan Targeting) trial|/resolve/reference/PMED?id=3169789
Montori 2011b {published data only}|Translating comparative effectiveness of depression medications into practice by comparing the depression medication choice decision aid to usual care: study protocol for a randomised controlled trial|
Neilan 2008 {published data only}|Use of a patient decision aid for gastrologic endoscopy in a paediatric setting|
Oostendorp 2011 {published data only}|Assessing the information desire of patients with advanced cancer by providing information with a decision aid, which is evaluated in a randomized trial: a study protocol|
Parow 2007 {published data only}|Testing the helpfulness of 2 decision aids for prostate cancer|
Patel 2011 {published data only}|Study protocol: Improving patient choice in treating low back pain (IMPACT-LBP): a randomised controlled trial of a decision support package for use in physical therapy|/resolve/reference/PMED?id=21199576
Sawka 2010 {published data only}|Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial|/resolve/reference/PMED?id=20659341
Schroy 2012 {published data only}|Impact of risk stratification on shared decision making for colorectal cancer screening|
Sepucha 2010a {published data only}|Measuring quality of decisions about treatment of menopausal symptoms|
Sepucha 2010b {published data only}|Measuring quality of decisions about treatment of depression|
Shah 2011 {published data only}|Study to test use of a decision aid in a clinical visit to help patients choose a diabetes medication. Translating Information on Comparative Effectiveness Into Practice (TRICEP)|
Sherman 2009 {published data only}|Evaluating an online decision aid for women considering breast reconstruction following mastectomy|
Smits 2009 {published data only}|Shared decision making: the effects of a decision aid for Turkish and Morocan mental health care clients with depression on the client-caregiver relationship|
Stacey 2009 {published data only (unpublished sought but not used)}|Comparison of ways to prepare patients for decisions about joint replacement surgery|
Zayed 2009 {published data only}|Decision aid in veterans with PTSD|
Andrews 2013|GRADE guidelines 15: Going from evidence to recommendation - determinants of a recommendation's direction and strength|/resolve/reference/PMED?id=23570745
Barry 2008|Reactions of potential jurors to a hypothetical malpractice suit. Alleging failing to perform a prostate-specific-antigen test|
Bekker 1999|Informed decision making: an annotated bibliography and systematic review|
Bekker 2003|Is anxiety a suitable measure of decision aid effectiveness: A systematic review|/resolve/reference/PMED?id=12900095
Bekker 2010|The loss of reason in patient decision aid research: do checklists damage the quality of informed choice interventions?|/resolve/reference/PMED?id=20171821
Bennett 2010|Validation of a Preparation for Decision Making scale|/resolve/reference/PMED?id=19560303
Braddock III 1997|How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting|/resolve/reference/PMED?id=9192250
Braddock III 1999|Informeddecision making in outpatient practice: time to get back to basics|/resolve/reference/PMED?id=10612318
Brehaut 2003|Validation of a Decision Regret Scale|/resolve/reference/PMED?id=12926578
Briss 2004|Promoting informed decisions about cancer screening in communities and healthcare systems|/resolve/reference/PMED?id=14700715
Brouwers 2010|Knowledge creation: synthesis, tools and products|/resolve/reference/PMED?id=19884300
Charles 1997|Shared decision-making in the medical encounter: what does it mean?|/resolve/reference/PMED?id=9032835
Charles 2010|Implementing shared treatment decision making and treatment decision aids: a cautionary tale|
Clinical Evidence 2013|How much do we know? [2013]|
Coyne 2013|Interventions for promoting participation in shared decision-making for children with cancer|/resolve/reference/PMED?id=23740765
Degner 1992|Decision making during serious illness: what role do patients really want to play|/resolve/reference/PMED?id=1432023
Duncan 2010|Shared decision making interventions for people with mental health conditions|/resolve/reference/PMED?id=20091628
Durand 2008|Where is the theory? Evaluating the theoretical frameworks described in decision support technologies|/resolve/reference/PMED?id=18242040
Elwyn 2006|Developing a quality criteria framework for patient decision aids: online international Delphi consensus process|/resolve/reference/PMED?id=16908462
Elwyn 2013|"Many miles to go...": A systematic review of the implementation of patient decision support interventions into routine clinical practice|
Estabrooks 2000|Consumer decision aids: where do we stand? A systematic review of structured consumer decision aids|
Gentles 2013|Factors explaining the heterogeneity of effects of patient decision aids on knowledge of outcome probabilities: a systematic review sub-analysis|/resolve/reference/PMED?id=24143875
Gravel 2006|Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals' perceptions|/resolve/reference/PMED?id=16899124
Hays 1993|The RAND 36-item Health Survey 1.0|
Hibbard 1997|Informing consumer decisions in health care: Implications from decision-making research|
Hibbard 2013|What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs|/resolve/reference/PMED?id=23381511
Higgins 2011||
Hollinghurst 2010|Economic evaluation of the DIAMOND randomized trial: Cost and outcomes of 2 decision aids for mode of delivery among women with previous caesarian section|
IPDAS 2005a|Background Document [2005]|
IPDAS 2005b|IPDAS Voting Document - 2nd Round [2005]|
IPDAS 2013|Ten years of the International Patient Decision Aid Standards collaboration: evolution of the core dimensions for assessing the quality of patient decision aids|
Joseph-Williams 2013|Toward minimum standards for certifying patient decision aids: a modified Delphi consensus process|
Kiesler 2006|Optimal matches of patient preferences for information, decision-making and interpersonal behavior: evidence, models and interventions|/resolve/reference/PMED?id=16368220
LeBlanc 2010|Decisional conflict in patients and their physicians: a dyadic approach to shared decision making|/resolve/reference/PMED?id=19196706
Legare 2008b|Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions|/resolve/reference/PMED?id=18752915
Legare 2010|Interventions for improving the adoption of shared decision making by healthcare professionals|/resolve/reference/PMED?id=20464744
Makoul 2006|An integrative model of shared decision making in medical encounters|/resolve/reference/PMED?id=16051459
Michie 2002|The multi-dimensional measure of informed choice: a validation study|/resolve/reference/PMED?id=12220754
Molenaar 2000|Feasibility and effects of decision aids|/resolve/reference/PMED?id=10638544
Mulley 1995|Outcomes research: Implications for policy and practice|
NCGC/NICE 2012|Patient experience in adult NHS services: improving the experience of care for people using adult NHS services|
O'Connor 1995|Validation of a decisional conflict scale|/resolve/reference/PMED?id=7898294
O'Connor 1997a|Annotated bibliography of studies evaluating decision support interventions for patients|/resolve/reference/PMED?id=9505587
O'Connor 1997b|Physicians' opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer|/resolve/reference/PMED?id=9128616
O'Connor 1998b|A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation|/resolve/reference/PMED?id=9731164
O'Connor 1999c|Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications|
O'Connor 2001a|Validation of a decision regret scale|
O'Connor 2003a|A survey of the decision-making needs of Canadians faced with complex health decisions|
O'Connor 2007|Toward the 'tipping point': decision aids and informed patient choice|/resolve/reference/PMED?id=17485749
Price 2012|New elements for informed decision making: a qualitative study of older adults' views|/resolve/reference/PMED?id=21757315
RevMan 2013|Review Manager (RevMan)|
RNAO 2009|Decision support for adults living with chronic kidney disease|
Roland 1983|A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain|/resolve/reference/PMED?id=6222486
Rothert 1987|Patient compliance and the decision making process of clinicians and patients|
RTI 1997||
Sepucha 2004|Policy support for patient-centered care: the need for measurable improvements in decision quality|/resolve/reference/PMED?id=15471772
Sepucha 2013|Establishing the effectiveness of patient decision aids: key constructs and measurement instruments|
Spielberger 1970||
Sterne 2011|Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials|/resolve/reference/PMED?id=21784880
Stewart 1992||
Thomson 2005|Tensions in public health policy: patient engagement, evidence-based public health and health inequalities|/resolve/reference/PMED?id=16326781
Weston 2001|Informed and shared decision-making: the crux of patient-centered care|/resolve/reference/PMED?id=11531054
Whelan 2002||
O'Connor 1999b|Decision aids for patients facing health treatment or screening decisions: systematic review|/resolve/reference/PMED?id=10487995
O'Connor 2001b|Decision aids for people facing health treatment or screening decisions|/resolve/reference/PMED?id=11686990
O'Connor 2003b|Decision aids for people facing health treatment or screening decisions|
O'Connor 2009|Decision aids for people facing health treatment or screening decisions|
Stacey 2011|Decision aids for people facing health treatment or screening decisions|/resolve/reference/PMED?id=21975733
Aalders 1992 {published and unpublished data}|Polytetrafluoroethylene versus human umbilical vein in above-knee femoro-popliteal bypass: Six-year results of a randomized clinical trial|/resolve/reference/PMED?id=1460707
Abbot 1997 {published data only}|Prosthetic above-knee femoro-popliteal bypass grafting: results of a multicenter randomized prospective trial|/resolve/reference/PMED?id=9013904
Abbot 1997 {published data only}|Prosthetic above-knee femoro-popliteal bypass grafting: Five-year results of a randomized trial|/resolve/reference/PMED?id=10709052
Ballotta 2003 {published data only}|Prospective randomized study on bilateral above-knee femoro-popliteal revascularization: Polytetrafluoroethylene graft versus reversed saphenous vein|/resolve/reference/PMED?id=14603216
Devine 2004 {published data only}|Heparin-bonded Dacron or polytetrafluorethylene for femoro-popliteal bypass: Five-year results of a prospective randomized multicenter clinical trial|/resolve/reference/PMED?id=15557906
Devine 2004 {published data only}|Heparin-bonded Dacron or polytetrafluoroethylene for femoro-popliteal bypass grafting: a multicenter trial|/resolve/reference/PMED?id=11241124
Eickhoff 1987 {published data only}|Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoro-popliteal bypass|/resolve/reference/PMED?id=3669200
Eickhoff 1987 {published data only}|A randomized clinical trial of PTFE versus human umbilical vein for femoro-popliteal bypass surgery. Preliminary results|
Jensen 2007 {published data only}|Dacron or PTFE for above-knee femoro-popliteal bypass. a multicenter randomised study|/resolve/reference/PMED?id=17400486
Klinkert 2003 {published data only}|A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoro-popliteal bypass grafting|/resolve/reference/PMED?id=10917987
Klinkert 2003 {published data only}|Vein versus polytetrafluoroethylene in above-knee femoro-popliteal bypass grafting: five-year results of a randomized controlled trial|/resolve/reference/PMED?id=12514593
Post 2001 {published data only}|Dacron vs polytetrafluoroethylene grafts for femoro-popliteal bypass: a prospective randomised multicentre trial|/resolve/reference/PMED?id=11506515
Scharn 2008 {published data only}|Human umbilical vein versus heparin-bonded polyester for femoro-popliteal bypass: 5-year results of a prospective randomized multicentre trial|/resolve/reference/PMED?id=17936036
Stonebridge 1997 {published data only}|Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting|
Stonebridge 1997 {published data only}|Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastamosis|/resolve/reference/PMED?id=9357453
Tofigh 2007 {published data only}|Comparing vein with collagen impregnated woven polyester prosthesis in above-knee femoro-popliteal bypass grafting|/resolve/reference/PMED?id=17448975
van Det 2009 {published data only}|Dacron or ePTFE for Femoro-popliteal above knee bypass grafting: Short- and Long-term results of a multicentre randomised trial|/resolve/reference/PMED?id=19231253
Watelet 1997 {published and unpublished data}|In situ versus reversed saphenous vein for femoro-popliteal bypass: a prospective randomized study of 100 cases|
Watelet 1997 {published and unpublished data}|Femoropopliteal bypass: in situ or reversed vein grafts? Ten-year results of a randomized prospective study|/resolve/reference/PMED?id=9302064
Bennion 1985 {published data only}|Patency of autogenous saphenous vein versus polytetrafluoroethylene grafts in femoro-popliteal bypass for advanced ischaemia of the extremity|/resolve/reference/PMED?id=3975795
Chikiar 2003 {published data only}|Femoropoliteal bypass grafting for arterial occlusive disease. Patency and complications. Randomised retrospective study|
Erasmi 1996 {published data only}|Preliminary results of a prospective randomised study regarding femoro-popliteal bypass material|/resolve/reference/PMED?id=8867350
Gloor 1996 {published data only}|Polyurethane small artery substitutes for femoro-popliteal above knee bypass|
Gupta 1991 {published data only}|Prospective randomized comparison of ringed and nonringed polytetrafluoroethylene femoro-popliteal bypass grafts: A preliminary report|
Hamann 1998 {published data only}|Above knee femoropopliteal vein bypasses versus vascular prostheses|
Hobson 1980 {published data only}|Below knee bypass for limb salvage|/resolve/reference/PMED?id=6446269
Johnson 2000 {published data only}|A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization:a prospective randomized Department of Veterans Affairs cooperative study|/resolve/reference/PMED?id=10917986
Johnson 2000 {published data only}|Comparative evaluation of PTFE, HUV and saphenous vein bypasses in fem-pop AK vascular reconstructions|
Kreienberg 2002 {published data only}|Early results of a prospective randomized trial of spliced vein versus polytetrafluoroethylene graft with a distal vein cuff for limb-threatening ischemia|/resolve/reference/PMED?id=11854728
Kumar 1995 {published data only}|Vein, PTFE or Dacron for above-knee femoro-popliteal bypass?|
Kumar 1995 {published data only}|Femoro-popliteal bypass grafting: fact or fiction?|
McCollum 1991 {published data only}|PTFE or HUV for femoro-popliteal bypass: A multicentre trial|/resolve/reference/PMED?id=1915909
McCollum 1991 {published data only}|PTFE or HUV for femoro-popliteal bypass: a multi-centre trial|
Moody 1992 {published data only}|Prospectively randomized clinical trial to compare in situ and reversed saphenous vein grafts for femoro-popliteal bypass|
Moody 1992 {published data only}|In situ versus reversed femoro-popliteal vein grafts: long-term follow up of a prospective randomized trial|
Motta 1989 {published data only}|Long term evaluation of human umbilical vein as small caliber arterial substitute|
Robinson 1999 {published data only}|A prospective randomised comparison of PTFE and Dacron for femoro-popliteal bypass|
Robinson 1999 {published data only}|A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoro-popliteal bypass|/resolve/reference/PMED?id=10353674
Robinson 2003 {published data only}|Fluoropolymer coated Dacron or polytetrafluoroethylene for femoro-popliteal bypass grafting: a multicentre trial|
Schulman 1987 {published data only}|Superficial femoro-popliteal veins and reversed saphenous veins as primary femoro-popliteal bypass grafts: A randomized comparative study|/resolve/reference/PMED?id=3599276
Schulman 1987 {published data only}|An 11-year experience with deep leg veins as femoro-popliteal bypass grafts|/resolve/reference/PMED?id=3741095
Solakovic 2008 {published data only}|Femoro-popliteal bypass above knee with saphenous vein vs synthetic graft|/resolve/reference/PMED?id=19125710
Tilanus 1985 {published data only}|Saphenous vein or PTFE for femoro-popliteal bypass. A prospective randomized trial|/resolve/reference/PMED?id=3907550
Veith 1986 {published and unpublished data}|Randomization of autogenous vein and polytetrafluoroethylene grafts in femoro-distal construction|/resolve/reference/PMED?id=6755789
Veith 1986 {published and unpublished data}|Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial constructions|/resolve/reference/PMED?id=3510323
Zilla 1994 {published data only}|Clinical in vitro endothelialization of femoro-popliteal bypass grafts: an actuarial follow-up over three years|/resolve/reference/PMED?id=8126869
Ascher 2007 {published data only}|GORE-TEX PROPATEN Vascular Graft Study|
Midy 2007 {published data only}|Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous Vein (REVA)|
Neville 2008 {published data only}|GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft (PRODIGY)|
Vermassen 2007 {published data only}|Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE|
Albers 2005|Meta-analysis of alternative autologous vein bypass grafts to infra popliteal arteries|/resolve/reference/PMED?id=16171586
Brown 2008|Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery|
Consensus Document|Second European Consensus Document on chronic critical leg ischemia|
Cranley 1982|Revascularisation of the femoro-popliteal arteries using saphenous vein, polytetrafluoroethylene and umbilical vein grafts|/resolve/reference/PMED?id=7149974
Dardik 2002|Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases|/resolve/reference/PMED?id=11802134
Dorffler-Melly 2003|Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery|
Eiberg 2006|Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial|/resolve/reference/PMED?id=16807001
Fowkes 2008|Bypass surgery for chronic lower limb ischaemia|
Luther 1997|Surgical treatment for chronic critical leg ischaemia: a 5 year follow-up of socioeconomic outcome|/resolve/reference/PMED?id=9166267
NICE 2003||
Nolan 2007|The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease--decision analysis|/resolve/reference/PMED?id=17543682
Pereira 2006|Meta-analysis of femoro-popliteal bypass grafts for lower extremity arterial insufficiency|/resolve/reference/PMED?id=16950427
Perler 1995|Cost-efficacy issues in the treatment of peripheral vascular disease: primary amputation or revascularization for limb-threatening ischemia|
Roll 2008|Dacron vs. PTFE as bypass materials in peripheral vascular surgery--systematic review and meta-analysis|/resolve/reference/PMED?id=19099583
Twine 2009|Angioplasty versus stenting for superficial femoral artery lesions|/resolve/reference/PMED?id=19370653
Vogt 2007|Moist wound healing compared with standard care of treatment of primary closed vascular surgical wounds: a prospective randomized controlled study|
Cochrane 2000|Graft type for femoro-popliteal bypass surgery|/resolve/reference/PMED?id=10796649
Baigis 2002 {published data only}|Effectiveness of a home-based exercise intervention for HIV-infected adults: a randomized trial|/resolve/reference/PMED?id=11936063
Dolan 2006 {published data only}|Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus. A randomized trial|/resolve/reference/PMED?id=16772251
Driscoll 2004a {published data only}|Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients|/resolve/reference/PMED?id=15090799
Grinspoon 2000 {published data only}|Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting|/resolve/reference/PMED?id=10979879
LaPerriere 1990 {published data only}|Exercise Intervention Attenuates Emotional Distress and Natural Killer Cell Decrements Following Notification of Positive Serologic Status for HIV-1|/resolve/reference/PMED?id=2223891
Lox 1995 {published data only}|Exercise as an intervention for enhancing subjective well-being in an HIV-1 population|
MacArthur 1993 {published data only}|Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons|/resolve/reference/PMED?id=8100607
Mutimura 2008a {published data only}|The effects of exercise training on quality of life in HAART-treated HIV-positive Rwandan subjects with body fat redistribution|/resolve/reference/PMED?id=18320351
Perna 1999 {published data only}|Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infection|/resolve/reference/PMED?id=10416558
Rigsby 1992 {published data only}|Effects of exercise training on men seropositive for the human immunodeficiency virus-1|/resolve/reference/PMED?id=1548998
Smith 2001 {published data only}|Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults|/resolve/reference/PMED?id=11371683
Stringer 1998 {published data only}|The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients|/resolve/reference/PMED?id=9475639
Terry 1999 {published data only}|Moderate and High Intensity Exercise Training in HIV-1 Seropositive Individuals: a Randomized Trial|/resolve/reference/PMED?id=10190777
Terry 2006 {published data only}|Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy|/resolve/reference/PMED?id=16540826
Agin 2001 {published data only}|Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV|/resolve/reference/PMED?id=11740194
Batterham 2000 {published data only}|Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy 'Diet FRS Study'|/resolve/reference/PMED?id=10985322
Bhasin 2000 {published data only}|Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels|/resolve/reference/PMED?id=10683055
Birk 2000 {published data only}|The effects of massage therapy alone and in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus|/resolve/reference/PMED?id=11059502
Driscoll 2004b {published data only}|Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients|/resolve/reference/PMED?id=15126538
Engelson 2006 {published data only}|Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women|/resolve/reference/PMED?id=16979403
Fairfield 2001 {published data only}|Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting|/resolve/reference/PMED?id=11356779
Galantino 2005 {published data only}|The effect of group aerobic exercise and T'ai Chi on functional outcomes and quality of life for persons living with acquired immunodeficiency syndrome|/resolve/reference/PMED?id=16398601
Greene 1999 {published data only}|Most frequently used alternative and complementary therapies and activities by participants in the AMCOA study|
Hand 2008 {published data only}|Moderate intensity training reverses functional aerobic impairment in HIV-infected individuals|/resolve/reference/PMED?id=18608063
Henry 1999 {published data only}|Experience with the national cholesterol education program (NCEP) guidelines for the identification and treatment of protease inhibitor related lipid abnormalities|
Lane 2000 {published data only}|Resting energy expenditure in asymptomatic HIV-infected females|/resolve/reference/PMED?id=10787229
LaPerriere 1991 {published data only}|Aerobic Exercise Training in an AIDS Risk Group|/resolve/reference/PMED?id=1680108
Lox 1996 {published data only}|Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population|/resolve/reference/PMED?id=16250767
McCain 2008 {published data only}|A randomized clinical trial of alternative stress management interventions in persons with HIV infection|/resolve/reference/PMED?id=18540736
Melroe 1999 {published data only}|Intervention for hyperlipidemia associated with protease inhibitors.|
Mustafa 1999 {published data only}|Association between exercise and HIV disease progression in a cohort of homosexual men|/resolve/reference/PMED?id=10037557
Mutimura 2008b {published data only}|Exercise training reduces central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: A randomized controlled trial|/resolve/reference/PMED?id=18275343
Neidig 2003 {published data only}|Aerobic exercise training for depressive symptom management in adults living with HIV infection|/resolve/reference/PMED?id=12698764
Nieman 1999 {published data only}|Exercise and immune function|
Robins 2006 {published data only}|Research on psychoneuroimmunology: tai chi as a stress management approach for individuals with HIV disease|/resolve/reference/PMED?id=16455435
Robinson 2007 {published data only}|Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study|/resolve/reference/PMED?id=17172316
Romeyn 2000 {unpublished data only}|Resistance exercise and oxandrolone for men with HIV-related weight loss|
Roubenoff 1999 {published data only}|A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution|/resolve/reference/PMED?id=10449291
Roubenoff 2000 {published data only}|Acquired immunodeficiency syndrome wasting, functional performance, and quality of life|/resolve/reference/PMED?id=11184062
Samson 2006 {published data only}|Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy / dyslipidemia|/resolve/reference/PMED?id=16914390
Sattler 1999 {published data only}|Effects of pharmacological doses of nandrolene decanoate and progressive resistance training in immunodeficient patients infected with HIV|/resolve/reference/PMED?id=10199766
American College of Sports Medicine 2010||
Bouchard 1993||
Cade 2004|Aerobic exercise dysfunction in human immunodeficiency virus: a potential link to physical disability|/resolve/reference/PMED?id=15225084
Dudgeon 2004|Physiological and psychological effects of exercise interventions in HIV disease|/resolve/reference/PMED?id=15006183
Fraser 1998|Identifying non-randomized studies in Medline|
Hand 2009|Impact of aerobic and resistance exercise on the health of HIV-infected persons|/resolve/reference/PMED?id=20508736
Jadad 1996|Assessing the quality of reports or randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Lau 1997|Quantitative synthesis in systematic reviews|/resolve/reference/PMED?id=9382404
Managing Your Health 2009||
Pollock 1998|ACSM position stand: the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Robinson 1998|Development of an optimal search strategy for the retrieval of controlled trials using PubMed|
Rusch 2004|Impairments, activity limitations and participation restrictions: Prevalence and associations among persons living with HIV/AIDS in British Columbia|
Scevola 2003|Effect of exercise and strength training on cardiovascular status in HIV-imnfected patients receiving highly active antiretroviral therapy|/resolve/reference/PMED?id=12870538
Schwartz 2002|Measurement of fatigue determining minimally important clinical differences|/resolve/reference/PMED?id=11864794
UNAIDS 2008|UNAIDS Terminology Guidelines|
World Health Organization 2001||
O'Brien 2006|Aerobic exercise interventions for people living with HIV/AIDS: Implications for practice, education and research|
Andersen 1981 {published data only}|The value of regular, supervised physical training after acute myocardial infarction|/resolve/reference/PMED?id=7330986
Belardinelli 2001 {published data only}|Exercise training intervention after coronary angioplasty: The ETICA Trial|/resolve/reference/PMED?id=11401128
Bell 1998 {unpublished data only}|A comparison of a multi-disciplinary home based cardiac rehabilitation programme with comprehensive conventional rehabilitation in post-myocardial infarction patients|
Bengtsson 1983 {published data only}|Rehabilitation after myocardial infarction|/resolve/reference/PMED?id=6828827
Bertie 1992 {published data only}|Benefits and weaknesses of a cardiac rehabilitation programme|/resolve/reference/PMED?id=1588521
Bethell 1990 {published and unpublished data}|A controlled trial of community based coronary rehabilitation|/resolve/reference/PMED?id=2271343
Bck 2008 {published data only}|Effects of high frequency exercise in patients before and after elective percutaneous coronary intervention|/resolve/reference/PMED?id=18372218
Carlsson 1998 {published data only}|Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme|/resolve/reference/PMED?id=9802147
Carson 1982 {published data only}|Exercise after myocardial infarction: a controlled trial|/resolve/reference/PMED?id=7050369
DeBusk 1994 {published data only}|A case management system for coronary risk factor modification following acute myocardial infarction|/resolve/reference/PMED?id=8147544
DeBusk 1994 {published data only}|The effect of a home-based, case-managed, multifactorial risk-reduction program on reducing psychological distress in patients with cardiovascular disease|/resolve/reference/PMED?id=9187981
Dugmore 1999 {published data only}|Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme|/resolve/reference/PMED?id=10092561
Engblom 1996 {published data only}|Quality of life during rehabilitation after coronary bypass surgery|/resolve/reference/PMED?id=1301126
Engblom 1996 {published data only}|Exercise habits and physical performance during comprehensive rehabilitation after coronary artery bypass surgery|/resolve/reference/PMED?id=1505554
Engblom 1996 {published data only}|Effects of five years of cardiac rehabilitation after coronary artery bypass grafting on coronary risk factors|/resolve/reference/PMED?id=8970420
Engblom 1996 {published data only}|Quality of life and return to work 5 years after coronary artery bypass surgery|/resolve/reference/PMED?id=9041068
Engblom 1996 {published data only}|Coronary heart disease risk factors before and after bypass surgery: results of a controlled trial on multifactorial rehabilitation|/resolve/reference/PMED?id=1348226
Erdman 1986 {published data only}|Predictability of beneficial effects in cardiac rehabilitation: A randomized clinical trial of psychosocial variables|
Fletcher 1994 {published data only}|Exercise testing and training in physically disabled men with clinical evidence of coronary artery disease|/resolve/reference/PMED?id=8296738
Fridlund 1991 {published data only}|Recovery after myocardial infarction: Effects of a caring rehabilitation programme|
Fridlund 1991 {published data only}|A caring perspective on rehabilitation after myocardial infarction: A theoretical framework and a suggestion for a rehabilitation programme|
Fridlund 1991 {published data only}|A supportive - educative caring rehabilitation programme: improvements of physical health after myocardial infarction|
Fridlund 1991 {published data only}|Long-term effects of a comprehensive rehabilitation programme after myocardial infarction|
Giallauria 2008 {published data only}|Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide|/resolve/reference/PMED?id=18277196
Haskell 1994 {published data only}|Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project (SCRIP)|/resolve/reference/PMED?id=8124838
Heller 1993 {published data only}|Secondary prevention after acute myocardial infarction|/resolve/reference/PMED?id=8105673
Hofman-Bang 1999 {published data only}|Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme|/resolve/reference/PMED?id=10493845
Hofman-Bang 1999 {published data only}|Behavioral effects of a comprehensive multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: A prospective randomized, controlled study|/resolve/reference/PMED?id=10098823
Hofman-Bang 1999 {published data only}|Long-term effects of lifestyle behavior change in coronary artery disease: Effects on recurrent coronary events after percutaneous coronary intervention|/resolve/reference/PMED?id=15631561
Holmbck 1994 {published data only}|Training after myocardial infarction: Lack of long-term effects on physical capacity and psychological variables|/resolve/reference/PMED?id=8185448
Kallio 1979 {published data only}|Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction|/resolve/reference/PMED?id=91836
Kovoor 2006 {published data only}|Return to full normal activities including work at two weeks after acute myocardial infarction|/resolve/reference/PMED?id=16563893
La Rovere 2002 {published data only}|Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction|/resolve/reference/PMED?id=12186798
Leizorovicz 1991 {published data only}|Comparison of a rehabilitation programme, a counselling programme and usual care after an acute myocardial infarction: Results of a long-term randomized trial. P.RE.COR. Group|/resolve/reference/PMED?id=1874262
Lewin 1992 {published data only}|Effects of self-help post-myocardial infarction rehabilitation on psychological adjustment and use of health services|/resolve/reference/PMED?id=1349062
Manchanda 2000 {published data only}|Retardation of coronary atherosclerosis with yoga lifestyle intervention|/resolve/reference/PMED?id=11273502
Marchionni 2003 {published data only}|Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: Results of a randomized, controlled trial|/resolve/reference/PMED?id=12707240
Miller 1984 {published data only}|Medically directed at-home rehabilitation soon after clinically uncomplicated acute myocardial infarction: a new model for patient care|/resolve/reference/PMED?id=3969859
Miller 1984 {published data only}|Home versus group exercise training for increasing functional capacity after myocardial infarction|/resolve/reference/PMED?id=6478567
Miller 1984 {published data only}|The effects of exercise training programs on psychosocial improvement in uncomplicated postmyocardial infarction patients|/resolve/reference/PMED?id=3772840
Miller 1984 {published data only}|Smoking cessation after acute myocardial infarction: The effects of exercise training|/resolve/reference/PMED?id=3239464
Oldridge 1991 {published and unpublished data}|Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction|/resolve/reference/PMED?id=2024598
Oldridge 1991 {published and unpublished data}|Profile of mood states and cardiac rehabilitation after acute myocardial infarction|/resolve/reference/PMED?id=7658953
Ornish 1990 {published data only}|Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial|/resolve/reference/PMED?id=1973470
Ornish 1990 {published data only}|Intensive lifestyle changes for reversal of coronary heart disease|/resolve/reference/PMED?id=9863851
Ornish 1990 {published data only}|Long-term effects of lifestyle changes on well-being and cardiac variables among coronary heart disease patients|/resolve/reference/PMED?id=18823185
Schuler 1992 {published data only}|Various intensities of leisure time physical activity in patients with coronary artery disease: Effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions|/resolve/reference/PMED?id=8335816
Schuler 1992 {published data only}|Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease|/resolve/reference/PMED?id=7572652
Schuler 1992 {published data only}|Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise|/resolve/reference/PMED?id=9355890
Schuler 1992 {published data only}|Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low-fat diet and physical exercise program|/resolve/reference/PMED?id=8712137
Schuler 1992 {published data only}|Treatment of coronary heart disease with diet and exercise: problems of compliance|/resolve/reference/PMED?id=2058997
Schuler 1992 {published data only}|Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease|/resolve/reference/PMED?id=1617762
Seki 2003 {published data only}|Effects of phase III cardiac rehabilitation programs on health-related quality of life in elderly patients with coronary artery disease: Juntendo Cardiac Rehabilitation Program (J-CARP)|/resolve/reference/PMED?id=12520156
Seki 2008 {published data only}|Effects of a phase III cardiac rehabilitation program on physical status and lipid profiles in elderly patients with coronary artery disease: Juntendo Cardiac Rehabilitation Program (J-CARP)|/resolve/reference/PMED?id=18654005
Shaw 1981 {published data only}|The National Exercise and Heart Disease Project. The pre-randomization exercise program. Report number 2|/resolve/reference/PMED?id=359140
Shaw 1981 {published data only}|Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction. The National Exercise and Heart Disease Project|/resolve/reference/PMED?id=6972693
Shaw 1981 {published data only}|The National Exercise and Heart Disease Project: Long-term psychosocial outcome|/resolve/reference/PMED?id=7092423
Sivarajan 1982 {published data only}|A controlled randomized study of early cardiac rehabilitation: The sickness impact profile as an assessment tool|/resolve/reference/PMED?id=6550047
Sivarajan 1982 {published data only}|In-hospital exercise after myocardial infarction does not improve treadmill performance|/resolve/reference/PMED?id=7019706
Sivarajan 1982 {published data only}|Treadmill test responses to an early exercise program after myocardial infarction: A randomized study|/resolve/reference/PMED?id=7074797
Sivarajan 1982 {published data only}|Limited effects of outpatient teaching and counselling after myocardial infarction: A controlled study|/resolve/reference/PMED?id=6549638
Specchia 1996 {published data only}|Interaction between exercise training and ejection fraction in predicting prognosis after a first myocardial infarction|/resolve/reference/PMED?id=8790035
Stern 1983 {published data only}|The group counseling v exercise therapy study. A controlled intervention with subjects following myocardial infarction|/resolve/reference/PMED?id=6615094
Sthle 1999 {published data only}|Long term effects of exercise training on physical activity level and quality of life in elderly coronary patients - a three- to six-year follow-up|
Sthle 1999 {published data only}|Important factors for physical activity among elderly patients one year after an acute myocardial infarction|/resolve/reference/PMED?id=11028795
Sthle 1999 {published data only}|Improved physical fitness and quality of life following training of elderly patients after acute coronary events. A 1 year follow-up randomized controlled study|/resolve/reference/PMED?id=10493846
Sthle 1999 {published data only}|Effects of organized aerobic group training in elderly patients discharged after an acute coronary syndrome. A randomized controlled study.|/resolve/reference/PMED?id=10380726
Sthle 1999 {published data only}|Effects of aerobic group training on exercise capacity, muscular endurance and recovery in elderly patients with recent coronary events: A randomized, controlled study|
Toobert 2000 {published data only}|Behavioral and psychosocial effects of intensive lifestyle management for women with coronary heart disease|/resolve/reference/PMED?id=9887850
Toobert 2000 {published data only}|Physiologic and related behavioral outcomes from the Women's Lifestyle Heart Trial. Toobert DJ. Glasgow RE. Radcliffe JL.|/resolve/reference/PMED?id=10892523
Vecchio 1981 {published data only}|Early functional evaluation and physical rehabilitation in patients with wide myocardial infarction|/resolve/reference/PMED?id=6456960
Vermeulen 1983 {published data only}|Effects of cardiac rehabilitation after myocardial infarction: changes in coronary risk factors and long-term prognosis|/resolve/reference/PMED?id=6846123
VHSG 2003 {published data only}|Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease|/resolve/reference/PMED?id=14671465
WHO 1983 {published data only}|Rehabilitation and comprehensive secondary prevention after acute myocardial infarction|
Wilhelmsen 1975 {published data only}|Exercise tolerance and physical training of non-selected patients after myocardial infarction|
Wilhelmsen 1975 {published data only}|A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death|/resolve/reference/PMED?id=1208362
Yu 2003 {published data only}|Long-term changes in exercise capacity, quality of life, body anthropometry, and lipid profiles after a cardiac rehabilitation program in obese patients with coronary heart disease|/resolve/reference/PMED?id=12565088
Yu 2004 {published data only}|Effect of a cardiac rehabilitation program on left ventricular diastolic function and its relationship to exercise capacity in patients with coronary heart disease: experience from a randomized, controlled study|/resolve/reference/PMED?id=15131559
Yu 2004 {published data only}|A short course of cardiac rehabilitation program is highly cost effective in improving long-term quality of life in patients with recent myocardial infarction or percutaneous coronary intervention|/resolve/reference/PMED?id=15605326
Zwisler 2008 {published and unpublished data}|Comprehensive cardiac rehabilitation: A cost assessment based on a randomized clinical trial|/resolve/reference/PMED?id=16984681
Zwisler 2008 {published and unpublished data}|Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial|/resolve/reference/PMED?id=18513526
Agren 1989 {published data only}|Improvements of the lipoprotein profile after coronary bypass surgery: additional effects of an exercise training program|/resolve/reference/PMED?id=2788085
Aronov 2006 {published data only}|Exercise in outpatient complex rehabilitation and secondary prophylaxis in patients with ischemic heart disease after acute coronary events (a cooperative trial in Russia)|/resolve/reference/PMED?id=17076222
Ballantyne 1982 {published data only}|The effect of moderate physical exercise on the plasma lipoprotein subfractions of male survivors of myocardial infarction|/resolve/reference/PMED?id=7074752
Belardinelli 2007 {published data only}|Long-term benefits of cardiac rehabilitation in patients with incomplete revascularization: 5-year follow-up|
Bettencourt 2005 {published data only}|Impact of cardiac rehabilitation on quality of life and depression after acute coronary syndrome|/resolve/reference/PMED?id=16041965
Bjrntorp 1972 {published data only}|Effects of physical training on glucose tolerance, plasma insulin and lipids and on body composition in men after myocardial infarction|/resolve/reference/PMED?id=5083385
Blumenthal 1997 {published data only}|Stress management and exercise training in cardiac patients with myocardial ischemia: effects on prognosis and evaluation of mechanisms|/resolve/reference/PMED?id=9342998
Br 1992 {published data only}|Cardiac rehabilitation contributes to the restoration of leisure and social activities|
Carlsson 1997 {published data only}|Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction|/resolve/reference/PMED?id=9093045
Gao 2007 {published data only}|Effect of health management on the rehabilitation of patients undergoing coronary artery bypass graft|
Giannuzzi 2008 {published data only}|Global secondary prevention strategies to limit event recurrence after myocardial infarction: Results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network|/resolve/reference/PMED?id=19001195
Gielen 2003 {published data only}|Home-based versus hospital-based exercise programs in patients with coronary artery disease: effects on coronary vasomotion|/resolve/reference/PMED?id=12514675
Heldal 2000 {published data only}|Randomised training after myocardial infarction: Short and long-term effects of exercise training after myocardial infarction in patients on beta-blocker treatment. A randomized, controlled study|/resolve/reference/PMED?id=10816062
Higgins 2001 {published data only}|Rehabilitation outcomes following percutaneous coronary interventions (PCI)|/resolve/reference/PMED?id=11384820
Jiang 2007 {published data only}|A nurse-led cardiac rehabilitation programme improves health behaviours and cardiac physiological risk parameters: evidence from Chengdu, China|
Kentala 1972 {published data only}|Physical fitness and feasibility of physical rehabilitation after myocardial infarction in men of working age|/resolve/reference/PMED?id=5020655
Krachler 1997 {published data only}|Trace elements in coronary heart disease|/resolve/reference/PMED?id=9494056
Li 2004 {published data only}|Effect of exercise therapy on the quality of life in patients after successful percutaneous transluminal coronary angioplasty|
Liao 2003 {published data only}|Effects of early rehabilitation programme on heart rate variability and quality of life in patients with uncomplicated acute myocardial infarction|
Mezey 2008 {published data only}|Outpatient cardiac rehabilitation: initial experience in the first Hungarian multicenter study|/resolve/reference/PMED?id=18281231
Peschel 2007 {published data only}|High, but not moderate frequency and duration of exercise training induces downregulation of the expression of inflammatory and atherogenic adhesion molecules|/resolve/reference/PMED?id=17568252
Piestrzeniewicz 2004 {published data only}|The impact of comprehensive cardiac rehabilitation in young patients after acute myocardial infarction treated with primary coronary intervention on the clinical outcome and leading again a "normal" life|/resolve/reference/PMED?id=15230212
Roviaro 1984 {published data only}|Influence of a cardiac rehabilitation program on the cardiovascular, psychological, and social functioning of cardiac patients|/resolve/reference/PMED?id=6609243
Schumacher 2006 {published data only}|Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease|/resolve/reference/PMED?id=16926664
Stenlund 2005 {published data only}|Cardiac rehabilitation for the elderly: Qi Gong and group discussions|/resolve/reference/PMED?id=15703500
Takeyama 2000 {published data only}|Effects of physical training on the recovery of the autonomic nervous activity during exercise after coronary artery bypass grafting: effects of physical training after CABG|/resolve/reference/PMED?id=11110422
Tokmakidis 2003 {published data only}|Training and detaining effects of a combined-strength and aerobic exercise program on blood lipids in patients with coronary artery disease|/resolve/reference/PMED?id=12782903
Tokmakidis 2003 {published data only}|Physiological alterations to detraining following prolonged combined strength and aerobic training in cardiac patients|/resolve/reference/PMED?id=16926667
Wosornu 1996 {published data only}|A comparison of the effects of strength and aerobic exercise training on exercise capacity and lipids after coronary artery bypass surgery|/resolve/reference/PMED?id=8781824
Zheng 2008 {published data only}|Effects of 6 months exercise training on ventricular remodelling and autonomic tone in patients with acute myocardial infarction and percutaneous coronary intervention|/resolve/reference/PMED?id=18843433
Son 2008 {published data only}|The development and effects of an integrated symptom management program for prevention of recurrent cardiac events after percutaneous coronary intervention|/resolve/reference/PMED?id=18458518
Blumenthal 2007 {published data only}|Understanding prognostic benefits of exercise and antidepressant therapy for person with depression and heart disease: the UPBEAT study - rationale, design, and methodological issues|/resolve/reference/PMED?id=17942470
Pater 2000 {published data only}|Design of a randomized controlled trial of comprehensive rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus Comprehensive Cardiac Rehabilitation Trial (the CORE Study)|/resolve/reference/PMED?id=11714435
Balady 2007|Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; theCouncils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation|/resolve/reference/PMED?id=17513578
Beswick 2004|Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups|
Bethall 2008|Outpatient cardiac rehabilitation attendance in England: variability by region and clinical characteristics|/resolve/reference/PMED?id=19008693
British Heart Foundation 2005||
Brown 2010|Patient education in the contemporary management of coronary heart disease|
Clark 2005|Meta-analysis: secondary prevention programs for patients with coronary artery disease|/resolve/reference/PMED?id=16263889
Clausen 1976|Heart rate and arterial blood pressure during exercise in patients with angina pectoris: effects of exercise training and of nitroglycerin|/resolve/reference/PMED?id=813911
Davies 2010a|Exercise-based rehabilitation for heart failure|
Davies 2010b|Promoting patient uptake and adherence in cardiac rehabilitation|
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
Evans 2002|Cardiacrehabilitation: are the NSF milestones achievable?|/resolve/reference/PMED?id=11751663
Fletcher 2001|Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association|/resolve/reference/PMED?id=11581152
Graham 2007|European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)|
Hambrecht 2000|Effect of exercise on coronary endothelial function in patients with coronary artery disease|/resolve/reference/PMED?id=10675425
Heran 2008a|Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension|
Heran 2008b|Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension|
Higgins 2011| Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
NICE 2007|Secondary prevention in primary and secondary care for patients following a myocardial infarction|
O'Connor 1989|An overview of randomized trials of rehabilitation with exercise after myocardial infarction|/resolve/reference/PMED?id=2665973
Oldridge 1988|Cardiac rehabilitation after myocardial infarction. Combined experience of randomised clinical trials|/resolve/reference/PMED?id=3398199
Oldridge 1993|Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction|/resolve/reference/PMED?id=8328376
Oldridge 2003|Assessing health-related quality of life: it is important when evaluating the effectiveness of cardiac rehabilitation?|/resolve/reference/PMED?id=12576909
Peterssen 2005||
Rees 2004|Psychological interventions for coronary heart disease|
Taylor 1998|The assessment of recovery in post-myocardial infarction patients using three generic quality of life measures|/resolve/reference/PMED?id=9559451
Taylor 2006|Mortality reductions in patients receiving exercise-based cardiac rehabilitation: How much can be attributed to cardiovascular risk factors improvements?|
Taylor 2010|A home-based versus centre-based cardiac rehabilitation|
Unal 2000|Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000|/resolve/reference/PMED?id=14993137
WHO 2004||
Jolliffe 2001|Exercise-based rehabilitation for coronary heart disease|/resolve/reference/PMED?id=11279730
Taylor 2004|Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=15121495
ATTMH {published data only}|The Australian Therapeutic Trial in Mild Hypertension|/resolve/reference/PMED?id=6389339
ATTMH {published data only}|The need to treat mild hypertension. Misinterpretation of results from the Australian trial|/resolve/reference/PMED?id=3783849
ATTMH {published data only}|Untreated mild hypertension|
ATTMH {published data only}|Cardiovascular morbidity and mortality in mild hypertension: The Australian Trial|/resolve/reference/PMED?id=2409356
ATTMH {published data only}|The Australian Therapeutic Trial in Mild Hypertension|/resolve/reference/PMED?id=3696314
ATTMH {published data only}|Treatment of mild hypertension in the elderly|/resolve/reference/PMED?id=7033745
ATTMH {published data only}|Australian Therapeutic Trial in Mild Hypertension. [Letter]|/resolve/reference/PMED?id=6105544
ATTMH {published data only}|Australian Therapeutic Trial in Mild Hypertension|/resolve/reference/PMED?id=6374398
ATTMH {published data only}|Initial results of the Australian Therapeutic Trial in mild hypertension (ATTMH)|/resolve/reference/PMED?id=396088
ATTMH {published data only}|Report by the management committee|
Barraclough {published data only}|Control of moderately raised blood pressure|
Carter {published data only}|Hypotensive therapy in stroke survivors|
Dutch TIA {published data only}|Trial of secondary prevention with atenolol after transient ischemic attack or non-disabling ischemic stroke|/resolve/reference/PMED?id=8465360
EWPHBPE {published data only}|Antihypertensive therapy in patients above age 60|
EWPHBPE {published data only}|Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the EWPHE|/resolve/reference/PMED?id=3534842
EWPHBPE {published data only}|Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial|
EWPHBPE {published data only}|EWPHE: organization of a double-blind multicenter trial on antihypertensive therapy in elderly patients|
EWPHBPE {published data only}|The European Working party on High Blood Pressuire in the Elderly|/resolve/reference/PMED?id=2006651
EWPHBPE {published data only}|Antihypertensiver therapy in elderly patients. Pilot trial of the EWPHE|/resolve/reference/PMED?id=330322
EWPHBPE {published data only}|Antihypertensive therapy in patients above age 60 years (Fourth interim report of the EWPHE)|
EWPHBPE {published data only}|Efficacy of antihypertensive drug treatment according to age, sex, blood pressure and previous cardiovascular disease in patients over age of 60|/resolve/reference/PMED?id=2875317
EWPHBPE {published data only}|Influence of antihypertensive drug treatment on morbidity and mortality in patients over age of 60 years. EWPHE results: sub-group analysis based on entry stratification|/resolve/reference/PMED?id=3475430
EWPHBPE {published data only}|Inluence of hypotensive drug treatment in elderly hypertensives: study terminating events in the trial of the European working party on High Blood Pressure in the Elderly|/resolve/reference/PMED?id=2856778
EWPHBPE {published data only}|Renal function in the elderly: results from the EWPHE trial|/resolve/reference/PMED?id=2006660
EWPHBPE {published data only}|Antihypertensive therapy in the elderly. Ninth interim report|/resolve/reference/PMED?id=6377103
EWPHBPE {published data only}|An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization|/resolve/reference/PMED?id=3896176
EWPHBPE {published data only}|Discussion after the presentation of the results of the European Working Party on high blood pressure in the elderly trial (EWPHE)|
EWPHBPE {published data only}|Serum cholesterol levels and survival in elderly hypertensive patients: analysis of data from the EWPHE trial|
EWPHBPE {published data only}|Experience with diuretics in the study conducted by the European working party on High Blood Pressure in the Elderly (EPWHE)|
EWPHBPE {published data only}|Risks and benefits in the trial of the European working party on High Blood Pressure in the Elderly|/resolve/reference/PMED?id=1851785
EWPHBPE {published data only}|Adverse treatment effects in the trial of the European working party on High Blood Pressure in the Elderly|/resolve/reference/PMED?id=2006659
EWPHBPE {published data only}|Further learnings from the European working party on High Blood Pressure in the Elderly (EWPHE) study: Focus on systolic hypertension|
EWPHBPE {published data only}|Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly|
EWPHBPE {published data only}|Overview of the findings of the European Party on High Blood Pressure in the Elderly|
EWPHBPE {published data only}|The determinants and prognostic significance of serum uric acid in elderly patients of the EWPHE trial|
EWPHBPE {published data only}|Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly|/resolve/reference/PMED?id=2503114
EWPHBPE {published data only}|Mortality and treatment of blood pressure in patients of the EWPHE|/resolve/reference/PMED?id=2006663
EWPHBPE {published data only}|Age-related hypotensive effect of placebo and active treatment in patients older than 60 years|/resolve/reference/PMED?id=2006656
EWPHBPE {published data only}|Body mass index and prognosis in elderly hypertensive patients: a report from the EWPHE|/resolve/reference/PMED?id=2006658
EWPHBPE {published data only}|Left ventricular hypertrophy in elderly hypertensive patients: a report from the EWPHE trial|/resolve/reference/PMED?id=1826071
EWPHBPE {published data only}|The effect of antihypertensive treatment on electrocardiogram voltages in the EWPHE trial|
HOPE HYP {published data only}|Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Outcomes Study Investigators.|/resolve/reference/PMED?id=10639539
HSCSG {published data only}|Effect of antihypertensive treatment on stroke recurrence|/resolve/reference/PMED?id=4599980
HYVET {published data only}|Treatment of hypertension in patients 80 years of age or older.|/resolve/reference/PMED?id=18378519
HYVET {published data only}|Orthostatic fall in blood pressure in the very elderly: results from the hypertension in the very Elderly trial (HYVET) - pilot|
HYVET {published data only}|The Hypertension in the Very Elderly Trial (HYVET)|/resolve/reference/PMED?id=7990098
HYVET {published data only}|The Hypertension in the Very Elderly Trial (HYVET): rationale, methodology and comparison with previous trials|/resolve/reference/PMED?id=7803945
HYVET pilot {published data only}|Results of the pilot study for the Hypertension in the Very Elderly Trial|/resolve/reference/PMED?id=14654762
Kuramoto {published data only}|Prospective study on the treatment of mild hypertension in the aged|/resolve/reference/PMED?id=7012398
MRC-O {published data only}|Medical Research Council trial of treatment of hypertension in older adults: principal results|
MRC-TMH {published data only}|Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension|
MRC-TMH {published data only}|Comparison of the antihypertensive efficacy and adverse reactions of two doses of bendrofluazide and hydrochlorothiazide and the effect of potasium supplementation on the hypotensive action of bendrofluazide: substudies of the Medical Research Council's trials of treatment of mild hypertension: Medical Research Council Working Party|/resolve/reference/PMED?id=3316309
MRC-TMH {published data only}|Coronary heart disease in Medical Research Council trial of mild hypertension. Medical Research Council Working Party on Mild Hypertension|/resolve/reference/PMED?id=2895662
MRC-TMH {published data only}|Course of blood pressure in mild hypertension after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension|/resolve/reference/PMED?id=2876745
MRC-TMH {published data only}|Randomised controlled trial of treatment of mild hypertension: design and pilot trial. Report of the Medical Research Council Working party on mild to Moderate Hypertension.|/resolve/reference/PMED?id=324577
MRC-TMH {published data only}|Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party on Mild Hypertension|/resolve/reference/PMED?id=3135010
MRC-TMH {published data only}|MRC trial of treatment of mild hypertension: principal results|
MRC-TMH {published data only}|Medical research Council's Treatment Trial for mild hypertension: an interim report|
MRC-TMH {published data only}|Results of the MRC (UK) trial of drug therapy for mild hypertension|/resolve/reference/PMED?id=3326701
MRC-TMH {published data only}|Comparison of the antihypertensive efficacy and adverse reactions to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: substudies of the Medical Reasearch Concil's trials of treatment of hypertension: Medical Research Council Working Party|/resolve/reference/PMED?id=3316309
OSLO {published data only}|Treatment of mild hypertension: A five year controlled drug trial. The Oslo study|/resolve/reference/PMED?id=7001898
OSLO {published data only}|Mild hypertension - early drug treatment or follow-up only? the Oslo study|/resolve/reference/PMED?id=285589
OSLO {published data only}|Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension|/resolve/reference/PMED?id=623136
OSLO {published data only}|Serum glucose levels during long-term observation of treated and untreated men with mild hypertension|/resolve/reference/PMED?id=6720727
OSLO {published data only}|Oslo study: Treatment of mild hypertension|/resolve/reference/PMED?id=3320783
OSLO {published data only}|Coronary risk factors and their possible causal role in the development of coronary heart disease|
OSLO {published data only}|Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial|/resolve/reference/PMED?id=3354541
OSLO {published data only}|Coronary heart disease and treatment of hypertension. Some Oslo data|/resolve/reference/PMED?id=2868657
OSLO {published data only}|Blood lipids and antihypertensive drugs|
OSLO {published data only}|Oslo hypertension study|/resolve/reference/PMED?id=2873015
OSLO {published data only}|The Oslo study: CHD risk factors, socioeconomic influences, and interventions|/resolve/reference/PMED?id=6637785
PATS {published data only}|Post-stroke antihypertensive treatment study. A preliminary result|/resolve/reference/PMED?id=8575241
SHEP {published data only}|Prevalence of postural hypotension at baseline in the systolic hypertension in the elderly program (SHEP) cohort|
SHEP {published data only}|Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP|
SHEP {published data only}|Part 6: Baseline physical examination findings|
SHEP {published data only}|Part 1: rationale and design|
SHEP {published data only}|Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the systolic hypertension in the elderly program (SHEP)|
SHEP {published data only}|Part 4: baseline medical history findings|
SHEP {published data only}|Effect of diuretic based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension|/resolve/reference/PMED?id=8968014
SHEP {published data only}|Statistical considerations in monitoring the systolic hypertension in the elderly program (SHEP)|/resolve/reference/PMED?id=8222667
SHEP {published data only}|serum uric acid, diuretic treatment and risk of cardiovascular events in the systolic hypertension in the elderly program|/resolve/reference/PMED?id=10954008
SHEP {published data only}|Serum lipids and incidence of coronary heart disease. Findings from the systolic hypertension in the elderly program|/resolve/reference/PMED?id=8921777
SHEP {published data only}|Part 7: Baseline laboratory characteristics|
SHEP {published data only}|Isolated systolic hypertension, morbidity and mortality: The SHEP experience|
SHEP {published data only}|Correlates of ventricular ectopic activity in isolated systolic hypertension|/resolve/reference/PMED?id=7506007
SHEP {published data only}|Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension|/resolve/reference/PMED?id=9218667
SHEP {published data only}|The effect of chlorthalidone on ventricular ectopic activity in patients with isolated systolic hypertension|/resolve/reference/PMED?id=7520210
SHEP {published data only}|Part 8: Electrocardiographic characteristics|
SHEP {published data only}|Some lessons from systolic hypertension in the elderly program (SHEP)|/resolve/reference/PMED?id=1349813
SHEP {published data only}|Mortality over four years in SHEOP participants with a low ankle-arm index|
SHEP {published data only}|Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke|/resolve/reference/PMED?id=10904510
SHEP {published data only}|Part 2: screening and recruitment|
SHEP {published data only}|The systolic hypertension in the elderly program (SHEP): an intervention trial on isolated systolic hypertension|
SHEP {published data only}|Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension|/resolve/reference/PMED?id=9554680
SHEP {published data only}|Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the SHEP|
SHEP {published data only}|Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program|/resolve/reference/PMED?id=2046107
SHEP {published data only}|Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension|/resolve/reference/PMED?id=2905387
SHEP {published data only}|Part 3: sociodemographic characteristics|
SHEP {published data only}|Change in depression as a precursor of cardiovascular events|/resolve/reference/PMED?id=8604962
SHEP {published data only}|Relation of low body mass to death and stroke in the systolic hypertension in the elderly program|/resolve/reference/PMED?id=10695689
SHEP {published data only}|Part 9: Behavorial characteristics|
SHEP {published data only}|Part 10: Analysis|
SHEP-P {published data only}|Compliance to treatment for hypertension in elderly patients: The SHEP pilot study|/resolve/reference/PMED?id=3624815
SHEP-P {published data only}|The systolic hypertension in the elderly program: Methodological issues|/resolve/reference/PMED?id=3350031
SHEP-P {published data only}|Systolic hypertension in the elderly program (SHEP)|
SHEP-P {published data only}|Systolic Hypertension in the Elderly (SHEP): antihypertensive efficacy of chlorthalidone|/resolve/reference/PMED?id=4072925
SHEP-P {published data only}|Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) Pilot study|/resolve/reference/PMED?id=2911834
SHEP-P {published data only}|Systolic hypertension in the elderly program, pilot study (SHEP-PS): morbidity and mortality experience|
SHEP-P {published data only}|Recruitment of elderly volunteers for a multicenter clinical trial: The SHEP pilot study|/resolve/reference/PMED?id=3743091
SHEP-P {published data only}|Relation of life events to blood pressure control in the SHEP trial|/resolve/reference/PMED?id=3274747
SYST-EUR {published data only}|Syst-Eur. A multicenter trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol and organization|/resolve/reference/PMED?id=1764497
SYST-EUR {published data only}|Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the systolic hypertension in Europe (Syst-Eur) trial|/resolve/reference/PMED?id=10928302
SYST-EUR {published data only}|Benefit of antihypertensive treatment in diabetic patients enrolled in the systolic hypertension in Europe (Sys-Eur) trial|/resolve/reference/PMED?id=10755200
SYST-EUR {published data only}|Treatment of isolated systolic hypertension|
SYST-EUR {published data only}|Syst-Eur- a multicenter trial on treatment of isolated systolic hypertension in the elderly: first interim report|/resolve/reference/PMED?id=1375678
SYST-EUR {published data only}|Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension|/resolve/reference/PMED?id=9297994
SYST-EUR {published data only}|Subgroup and per protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly|/resolve/reference/PMED?id=9701103
TEST {published data only}|Atenolol for secondary prevention after stroke|
UKPDS 39 {published data only}|Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39|/resolve/reference/PMED?id=9732338
UKPDS 39 {published data only}|Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38|/resolve/reference/PMED?id=9732337
USPHSHCSG {published data only}|Treatment of mild hypertension. Results of a ten-year intervention trial|/resolve/reference/PMED?id=830442
VA-I {published data only}|A double-blind control study of antihypertensive agents. III. Chlorothiazide alone and in combination with other agents: preliminary results|
VA-I {published data only}|Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg|/resolve/reference/PMED?id=4862069
VA-II {published data only}|Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg|/resolve/reference/PMED?id=4914579
VA-NHLBI {published data only}|Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial|/resolve/reference/PMED?id=360921
VA-NHLBI {published data only}|Treatment of mild hypertension. Preliminary results of a two year feasibility trial|
Wolff {published data only}|Effects of treatment in hypertension. Results of a controlled study|/resolve/reference/PMED?id=5325993
ALLHAT {published data only}|Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)|/resolve/reference/PMED?id=10789664
ALLHAT {published data only}|Rationale and design for the Antihypertensive and Lipid Lowering Treatment to prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=8722437
Berglund {published data only}|Beta-blockers of diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects|
Berglund {published data only}|Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic|
CASTEL {published data only}|Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL)|/resolve/reference/PMED?id=7830324
CASTEL {published data only}|The CASTEL project (CArdiovascular STudy in the ELderly): protocol, study design, and preliminary results of the initial survey|/resolve/reference/PMED?id=1790539
Coope 1986 {published data only}|Randomised trial of treatment of hypertension in elderly patients in primary care|/resolve/reference/PMED?id=3094811
GLANT {published data only}|A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension- the GLANT study|/resolve/reference/PMED?id=7584934
HANE {published data only}|Randomised , double blind, multicenter comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study|/resolve/reference/PMED?id=9251545
HAPPHY {published data only}|Beta-blockers versus diuretics in hypertensive men: Main results from the HAPPHY trial|/resolve/reference/PMED?id=2892881
HDFP {published data only}|Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-year findings of the hypertension detection and follow-up program|
HDFP {published data only}|Five-year findings of the hypertension detection and follow-up program III. Reduction in stroke incidence among persons with high blood pressure|/resolve/reference/PMED?id=7033578
HDFP {published data only}|The effect of treatment on mortality in mildhypertension Results of the hypertension detection and follow-up program|/resolve/reference/PMED?id=7110301
HDFP {published data only}|Five-year findings of the hypertension detection and follow-up program I. Reduction in mortality of persons with high blood pressure, including mild hypertension|/resolve/reference/PMED?id=490882
HDFP {published data only}|Five-year findings of the hypertension detection and follow-up program II Mortality by race-sex and age|
IDM {published data only}|The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes|/resolve/reference/PMED?id=11565519
INSIGHT {published data only}|INSIGHT: International Nifedipine GITS study: Intervention as a goal in hypertension treatment|/resolve/reference/PMED?id=8872850
INSIGHT {published data only}|Study population and treatment titration in the International Nifedepine GITS study: intervention as a goal in hypertension treatment (INSIGHT)|/resolve/reference/PMED?id=9886905
INSIGHT {published data only}|Morbidity and mortality in patients randomised to double-blind treatment with long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study|/resolve/reference/PMED?id=10972368
IPPPSH {published data only}|Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker, oxprenolol: The international prospective primary prevention study in hypertension (IPPPSH)|/resolve/reference/PMED?id=2864374
Kuramoto-2 {published data only}|Treatment of the elderly hypertensives in Japan: National Intervention Cooperative Study in Elderly Hypertensives. The National Intervention Cooperative study Group|/resolve/reference/PMED?id=7799108
Lewis {published data only}|Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to Type 2 Diabetes|/resolve/reference/PMED?id=11565517
MAPHY {published data only}|Metoprolol versus thiazide diuretics in hypertension|/resolve/reference/PMED?id=2013485
MAPHY {published data only}|Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study|/resolve/reference/PMED?id=3346979
Materson {published data only}|Department of Veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents|
Materson {published data only}|Single drug therapy for hypertension in men: a comparison of six antihypertensives agents with placebo|/resolve/reference/PMED?id=8446138
Materson {published data only}|Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo|
MIDAS {published data only}|Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS) A randomised controlled trial|/resolve/reference/PMED?id=8769587
Morgan {published data only}|Failure of therapy to improve prognosis in elderly males with hypertension|/resolve/reference/PMED?id=7432261
NORDIL {published data only}|Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Dilitazem (NORDIL) study|/resolve/reference/PMED?id=10972367
PROGRESS {published data only}|Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack.|/resolve/reference/PMED?id=11589932
QUIET {published data only}|The QUinapril Ischemic Event Trial (QUIET): Evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function|/resolve/reference/PMED?id=11348602
SCAT {published data only}|Long-term effects of cholesterol lowering and angiotensin converting enzyme inhibition on coronary atherosclerosis.|/resolve/reference/PMED?id=11023927
SCOPE {published data only}|The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial|/resolve/reference/PMED?id=12714861
SHELL {published data only}|Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and European Lacidipine Study on Atherosclerosis (ELSA)|/resolve/reference/PMED?id=8824685
Sprackling {published data only}|Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa|/resolve/reference/PMED?id=6794796
STONE {published data only}|Shanghai Trial of Nifedipine in the Elderly (STONE) Study|/resolve/reference/PMED?id=8906524
STOP 1991 {published data only}|Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOPHypertension)|/resolve/reference/PMED?id=1682683
STOP-2 {published data only}|STOP - Hypertension 2: A prospective intervention trial of "newer" vs "older" treatment alternatives in old patients with hypertension|/resolve/reference/PMED?id=8180726
Strandberg {published data only}|Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men|
SYST-CHINA {published data only}|[Systolic hypertension in the elderly: Chinese trial (Syst-China). Interim report]|
SYST-CHINA {published data only}|[Systolic hypertension in the elderly: Chinese trial (Syst-China)--second interim report]|
TOMHS {published data only}|Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS)|/resolve/reference/PMED?id=7479629
TOMHS {published data only}|Treatment of mild hypertension study. Final results|/resolve/reference/PMED?id=8336373
TOMHS {published data only}|The Treatment of Mild Hypertension Study: a randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies|/resolve/reference/PMED?id=2064494
VACS {published data only}|Comparison of propanolol and hydrochlorothiazide for the initial treatment of hypertension. II Results of long term therapy|/resolve/reference/PMED?id=6750167
VHAS {published data only}|Clinical results of the verapamil in hypertension and atherosclerosis study.|/resolve/reference/PMED?id=9383184
White WB {published data only}|Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension|/resolve/reference/PMED?id=8583466
BBLTTC|Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.|/resolve/reference/PMED?id=15983291
Boissel 2005|Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments.|
Collins 1990|Blood pressure, stroke, and coronary heart disease- Part2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context|/resolve/reference/PMED?id=1969567
Gueyffier 1996|New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit|
Insua 1994|Drug treatment of hypertension in the elderly: A meta-analysis|/resolve/reference/PMED?id=7726892
MacMahon 1993|The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives|/resolve/reference/PMED?id=8268901
Mulrow 1994|Hypertension in the elderly: Implications and generalizability of randomized trials|/resolve/reference/PMED?id=7990246
Mulrow 1998|Pharmacotherapy for hypertension in the elderly|
Psaty 1997|Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.|/resolve/reference/PMED?id=9042847
Psaty 2003|Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis|/resolve/reference/PMED?id=12759325
QUOROM 1999|Improving the quality of reports of meta-analyses of randomisedcontrolled trials: the QUOROM statement|/resolve/reference/PMED?id=10584742
Thijs 1992|A meta-analysis of outcome trials in elderly hypertensives|/resolve/reference/PMED?id=1334990
Wiysonge|Beta-blockers for hypertension|
Wright 1999|Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?|/resolve/reference/PMED?id=10420860
Bastani 1999 {published data only}|Tailored risk notification for women with a family history of breast cancer|/resolve/reference/PMED?id=10564627
Bowen 2002 {published data only}|Effects of risk counseling on interest in breast cancer genetic testing for lower risk women|/resolve/reference/PMED?id=12394349
Campbell 1997 {published data only}|Encouraging underscreened women to have cervical cancer screening: the effectiveness of a computer strategy|/resolve/reference/PMED?id=9388791
Champion 1994 {published data only}|Strategies to increase mammography utilization|/resolve/reference/PMED?id=8302104
Champion 1995 {published data only}|Effect of interventions on stage of mammography adoption|/resolve/reference/PMED?id=7563045
Champion 2000a {published data only}|A tailored intervention for mammography among low-income African-American women|
Champion 2002 {published data only (unpublished sought but not used)}|Comparisons of tailored mammography interventions at two months postintervention|/resolve/reference/PMED?id=12173678
Champion 2003 {published data only}|Comparison of tailored interventions to increase mammography screening in nonadherent older women|/resolve/reference/PMED?id=12590989
Curry 1993 {published data only}|A randomized trial of the impact of risk assessment and feedback on participation in mammography screening|/resolve/reference/PMED?id=8327418
Hutchison 1998 {published data only}|Screening for hypercholesterolaemia in primary care: randomised controlled trial of postal questionnaire appraising risk of coronary heart disease|/resolve/reference/PMED?id=9552998
Jibaja-Weiss 2003 {published data only}|Tailored messages for breast and cervical cancer screening of low-income and minority women using medical records data|/resolve/reference/PMED?id=12781927
Jibaja-Weiss 2003 {published data only}|Differential effects of messages for breast and cervical cancer screening|/resolve/reference/PMED?id=15741708
Kreuter 1996 {published data only}|Do tailored behaviour change messages enhance the effectiveness of health risk appraisal? Results from a randomized trial|/resolve/reference/PMED?id=10160231
Lee 1991 {published data only}|A randomized controlled trial to motivate worksite fecal occult blood testing|/resolve/reference/PMED?id=1949916
Lerman 1995 {published data only}|Effects of individualized breast cancer risk counseling: a randomised trial|/resolve/reference/PMED?id=7707420
Lerman 1995 {published data only}|A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style|/resolve/reference/PMED?id=8681923
Lerman 1997 {published data only}|Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing|/resolve/reference/PMED?id=8998184
Lipkus 2005 {published data only}|Increasing colorectal cancer screening among individuals in the carpentry trade: test of risk communication interventions|/resolve/reference/PMED?id=15749130
Lipkus 2005 {published data only}|Modifying attributions of colorectal cancer risk|
Myers 1999 {published data only}|Adherence by African American men to prostate cancer education and early detection|
Rimer 2002 {published data only}|Effects of a mammography decision-making intervention at 12 and 24 months|/resolve/reference/PMED?id=11988381
Rimer 2002 {published data only}|The short-term impact of tailored mammography decision-making interventions|/resolve/reference/PMED?id=11384825
Saywell 1999 {published data only}|Cost-effectiveness comparison of five interventions to increase mammography screening|/resolve/reference/PMED?id=10564629
Schwartz 1999 {published data only}|A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use|/resolve/reference/PMED?id=10358689
Skinner 1994 {published data only (unpublished sought but not used)}|Physicians' recommendations for mammography: do tailored messages make a difference?|/resolve/reference/PMED?id=8279610
Skinner 2002 {published data only}|Pre-counseling education materials for BRCA testing: does tailoring make a difference?|/resolve/reference/PMED?id=12215248
Alexander 1996 {published data only}|The effect of an educational intervention on the perceived risk of breast cancer|/resolve/reference/PMED?id=8833016
Champion 2000b {published data only}|The effects of standard care counseling or telephone/in-person counseling on beliefs, knowledge, and behavior related to mammography screening|/resolve/reference/PMED?id=11103375
Dignan 1996 {published data only}|Effectiveness of health education to increase screening for cervical cancer among eastern band Cherokee Indian women in North Carolina|/resolve/reference/PMED?id=8931612
Engelstad 2005 {published data only}|The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer|/resolve/reference/PMED?id=16125761
Gagnon 1996 {published data only}|Perception of breast cancer risk and psychological distress in women attending a surveillance program|
Giles 2001 {published data only}|Results of a community pharmacy-based breast cancer risk-assessment and education program|
Kadison 1998 {published data only}|Improved screening for breast cancer associated with a telephone-based risk assessment|/resolve/reference/PMED?id=9612841
Kreuter 2005 {published data only}|Cultural tailoring for mammography and fruit and vegetable intake among low-income African-American women in urban public health centers|/resolve/reference/PMED?id=15916993
Leigh 1991 {published data only}|Reduction of ischaemic heart disease risk factors following direct probabilistic risk communication in the workplace|
Lipkus 2000 {published data only}|Can tailored interventions increase mammography use among HMO women?|/resolve/reference/PMED?id=10808977
Miller 2005 {published data only}|Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service|/resolve/reference/PMED?id=16377604
Pye 1988 {published data only}|A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload|/resolve/reference/PMED?id=3418289
Rakowski 1998 {published data only}|Increasing mammography among women aged 40-74 by use of a stage-matched, tailored intervention|/resolve/reference/PMED?id=9808807
Rhodes 2001 {published data only}|Better health while you wait: a controlled trial of a computer-based intervention for screening and health promotion in the emergency department|/resolve/reference/PMED?id=11223765
Rimer 1999 {published data only}|The impact of tailored interventions on a community health center population|/resolve/reference/PMED?id=14528540
Weber 1997 {published data only}|Enhancing mammography use in the inner city: a randomized trial of intensive case management|/resolve/reference/PMED?id=9361575
Barry 1997|A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia|
Bottorff 1996||
Briss 2004|Promoting informed decisions about cancer screening in communities and healthcare systems|/resolve/reference/PMED?id=14700715
Covello 1986|Risk communication: a review of the literature|
Edwards 1999|How should 'effectiveness' of risk communication to aid patients' decisions be judged? A review of the literature|/resolve/reference/PMED?id=10520681
Edwards 2000a|The effectiveness of one-to-one risk communication interventions in health care: a systematic review|/resolve/reference/PMED?id=10929851
Edwards 2000b|Judging the 'weight of evidence' in systematic reviews: introducing rigour into the qualitative overview stage by assessing signal and noise|
Edwards 2001|Presenting risk information - a review of the effects of 'framing' and other manipulations on patient outcomes|/resolve/reference/PMED?id=11317424
Edwards 2003a|The development of COMRADE  a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations|/resolve/reference/PMED?id=12900105
Elwyn 2000|Shared decision-making and the concept of equipoise: defining the 'competences' of involving patients in health care choices|/resolve/reference/PMED?id=11141876
Fischhoff 1979|Which risks are acceptable?|
Foster 1998|Reaching targets in the national cervical screening programme: are current practices unethical?|/resolve/reference/PMED?id=9650108
Gail 1989|Projecting individualized probabilities of developing breast cancer for white females who are being examined annually|/resolve/reference/PMED?id=2593165
Guadagnoli 1998|Patient participation in decision-making|/resolve/reference/PMED?id=9681902
Heart 1999|Joint British recommendations on prevention of coronary heart disease in clinical practice|
Holland 2005|Key issues in screening: genetics, information and economics|
Holmes-Rovner 1996|Patient satisfaction with health care decisions: the satisfaction with decision scale|/resolve/reference/PMED?id=8717600
Irwig 2006|Screening and choice: informed choice for screening: implications for evaluation|/resolve/reference/PMED?id=16690676
Jadad 1996|Assessing the quality of reports of randomised clinical trials; is blinding necessary?|/resolve/reference/PMED?id=8721797
Jepson 2000|The determinants of screening uptake and interventions for increasing uptake: a systematic review|
Jepson 2005|How should we measure informed choice? The case of cancer screening|/resolve/reference/PMED?id=15800356
Keeney 1986|Improving risk communication|
Liao 1996|Impact of an interactive video on decision making of patients with ischemic heart disease|/resolve/reference/PMED?id=8803746
Llewelyn-Thomas 1995|Patients' health care decision-making: a framework for descriptive and experimental investigations|/resolve/reference/PMED?id=7783569
Marteau 1992|The development of a six-item short form of the state scale of the Spielberger state-trait anxiety inventory|
Marteau 2001|A multi-dimensional measure of informed choice|
Marteau 2002|Screening for cardiovascular risk: public health imperative or matter for individual informed choice?|/resolve/reference/PMED?id=12114238
Matthews 1999|Efficient literature searching in diffuse topics: lessons from a systematic review of research on communicating risk to patients in primary care|
O'Connor 1995|Validation of a decisional conflict scale|/resolve/reference/PMED?id=7898294
O'Connor 2003|Decision aids for people facing health treatment or screening decisions|
Oncology 1994|Genetic testing for cancer risk: research projects being funded|
Prochaska 1992|Stages of change in the modification of problem behaviors|/resolve/reference/PMED?id=1620663
Raffle 2001|Information about screening - is it to achieve high uptake or to ensure informed choice?|
Rogers 2002|Are guidelines ethical? Some considerations for general practice|/resolve/reference/PMED?id=12171228
Rose 1978|Epidemiology for the uninitiated: screening|/resolve/reference/PMED?id=719432
Sarfati 1998|Does the frame affect the picture? A study into how attitudes to screening for cancer are affected by the way benefits are expressed|/resolve/reference/PMED?id=9795874
Slaytor 1998|How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets|/resolve/reference/PMED?id=9677220
Stewart-Brown 1997|Screening could seriously damage your health [Editorial]|/resolve/reference/PMED?id=9055702
Thomson 2005|Tensions in public health policy: patient engagement, evidence-based public health and health inequalities|/resolve/reference/PMED?id=16326781
Vlek 1987|Risk assessment, risk perception and decision making about courses of action involving genetic risk: an overview of concepts and methods|/resolve/reference/PMED?id=3593910
Wilson 1968||
Edwards 2003b|Effects of communicating individual risks in screening programmes: Cochrane systematic review|/resolve/reference/PMED?id=14512475
Edwards 2003c|Personalised risk communication for informed decision making about entering screening programs|
Bastani 1999 {published data only}|Tailored risk notification for women with a family history of breast cancer|/resolve/reference/PMED?id=10564627
Bloom 2006 {published data only}|Effects of a telephone counseling intervention on sisters of young women with breast cancer|/resolve/reference/PMED?id=16916540
Bodurtha 2009 {published data only}|Mammography screening after risk-tailored messages: the Women Improving Screening through Education and Risk assessment (WISER) randomized controlled trial|
Bowen 2002 {published data only}|Effects of risk counseling on interest in breast cancer genetic testing for lower risk women|
Bowen 2006 {published data only}|Effects of breast cancer risk counseling for sexual minority women|/resolve/reference/PMED?id=16338740
Bowen 2010 {published data only}|Effects of a mail and telephone intervention on breast health behaviors|
Campbell 1997 {published data only}|Encouraging underscreened women to have cervical cancer screening: the effectiveness of a computer strategy|
Champion 1994 {published data only}|Strategies to increase mammography utilization|/resolve/reference/PMED?id=8302104
Champion 1995 {published data only}|Effect of interventions on stage of mammography adoption|/resolve/reference/PMED?id=7563045
Champion 2000a {published data only}|A tailored intervention for mammography among low-income African-American women|
Champion 2002 {published data only (unpublished sought but not used)}|Comparisons of tailored mammography interventions at two months postintervention|/resolve/reference/PMED?id=12173678
Champion 2003 {published data only}|Comparison of tailored interventions to increase mammography screening in nonadherent older women|/resolve/reference/PMED?id=12590989
Champion 2007 {published data only}|The effect of telephone versus print tailoring for mammography adherence|/resolve/reference/PMED?id=17196358
Curry 1993 {published data only}|A randomized trial of the impact of risk assessment and feedback on participation in mammography screening|/resolve/reference/PMED?id=8327418
Geller 2006 {published data only}|A randomized trial to improve early detection and prevention practices among siblings of melanoma patients|
Glanz 2007 {published data only}|Effects of colon cancer risk counseling for first-degree relatives|/resolve/reference/PMED?id=17627015
Glazebrook 2006 {published data only}|Impact of multimedia intervention "Skinsafe" on patients' knowledge and protective behaviours|/resolve/reference/PMED?id=16580059
Helmes 2006 {published data only}|Results of a randomized study of telephone versus in-person breast cancer risk counseling|/resolve/reference/PMED?id=16427245
Hutchison 1998 {published data only}|Screening for hypercholesterolaemia in primary care: randomised controlled trial of postal questionnaire appraising risk of coronary heart disease|/resolve/reference/PMED?id=9552998
Jibaja-Weiss 2003 {published data only}|Tailored messages for breast and cervical cancer screening of low-income and minority women using medical records data|/resolve/reference/PMED?id=12781927
Jibaja-Weiss 2003 {published data only}|Differential effects of messages for breast and cervical cancer screening|/resolve/reference/PMED?id=15741708
Kreuter 1996 {published data only}|Do tailored behaviour change messages enhance the effectiveness of health risk appraisal? Results from a randomized trial|/resolve/reference/PMED?id=10160231
Lee 1991 {published data only}|A randomized controlled trial to motivate work site fecal occult blood testing|/resolve/reference/PMED?id=1949916
Lerman 1995 {published data only}|Effects of individualized breast cancer risk counseling: a randomised trial|/resolve/reference/PMED?id=7707420
Lerman 1995 {published data only}|A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style|/resolve/reference/PMED?id=8681923
Lerman 1997 {published data only}|Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing|/resolve/reference/PMED?id=8998184
Lipkus 2005 {published data only}|Increasing colorectal cancer screening among individuals in the carpentry trade: test of risk communication interventions|/resolve/reference/PMED?id=15749130
Lipkus 2005 {published data only}|Modifying attributions of colorectal cancer risk|
Lipkus 2007b {published data only}|Effects of communicating social comparison information on risk perceptions for colorectal cancer|
Manne 2009 {published data only}|A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings|/resolve/reference/PMED?id=19418107
Manne 2010 {published data only}|Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients|
Marcus 2005 {published data only}|The efficacy of tailored print materials in promoting colorectal cancer screening: results from a randomized trial involving callers to the National Cancer Institute's cancer information service|
Myers 1999 {published data only}|Adherence by African American men to prostate cancer education and early detection|
Nagle 2008 {published data only}|Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial|
Rawl 2008 {published data only}|A randomized trial of two print interventions to increase colon cancer screening among first degree relatives|/resolve/reference/PMED?id=18308500
Rimer 2002 {published data only}|Effects of a mammography decision-making intervention at 12 and 24 months|/resolve/reference/PMED?id=11988381
Rimer 2002 {published data only}|The short-term impact of tailored mammography decision-making interventions|/resolve/reference/PMED?id=11384825
Saywell 1999 {published data only}|Cost-effectiveness comparison of five interventions to increase mammography screening|/resolve/reference/PMED?id=10564629
Schwartz 1999 {published data only}|A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use|/resolve/reference/PMED?id=10358689
Sequist 2011 {published data only}|Electronic patient messages and personalized risk assessments to promote colorectal cancer screening: a randomised controlled trial|
Skinner 1994 {published data only (unpublished sought but not used)}|Physicians' recommendations for mammography: do tailored messages make a difference?|/resolve/reference/PMED?id=8279610
Skinner 2002 {published data only}|Pre-counseling education materials for BRCA testing: does tailoring make a difference?|/resolve/reference/PMED?id=12215248
Smith 2010 {published data only}|A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial|
Steckelberg 2011 {published data only}|Effect of evidence based risk information on "informed choice" in colorectal cancer screening: randomised controlled trial|
Trevena 2008 {published data only}|Randomized trial of a self-administered decision aid for colorectal cancer screening|/resolve/reference/PMED?id=18573775
Alexander 1996 {published data only}|The effect of an educational intervention on the perceived risk of breast cancer|/resolve/reference/PMED?id=8833016
Arimori 2006 {published data only}|Randomized controlled trial of decision aids for women considering prenatal testing: the effect of the Ottawa Personal Decision Guide on decisional conflict|
Champion 2000b {published data only}|The effects of standard care counseling or telephone/in-person counseling on beliefs, knowledge, and behavior related to mammography screening|
Champion 2006b {published data only}|Comparison of three interventions to increase Mammography screening in low income African American women|/resolve/reference/PMED?id=17110056
Chan 2011 {published data only}|A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT|
Costanza 2007 {published data only}|Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening|/resolve/reference/PMED?id=17646058
Dignan 1996 {published data only}|Effectiveness of health education to increase screening for cervical cancer among eastern band Cherokee Indian women in North Carolina|/resolve/reference/PMED?id=8931612
Engelstad 2005 {published data only}|The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer|
Gagnon 1996 {published data only}|Perception of breast cancer risk and psychological distress in women attending a surveillance program|
Giles 2001 {published data only}|Results of a community pharmacy-based breast cancer risk-assessment and education program|
Jerant 2007 {published data only}|Effects of a tailored interactive multimedia computer program on determinants of colorectal cancer screening: a randomized controlled pilot study in physician offices|/resolve/reference/PMED?id=17156968
Kadison 1998 {published data only}|Improved screening for breast cancer associated with a telephone-based risk assessment|
Kreuter 2005 {published data only}|Cultural tailoring for mammography and fruit and vegetable intake among low-income African-American women in urban public health centers|/resolve/reference/PMED?id=15916993
Leigh 1991 {published data only}|Reduction of ischaemic heart disease risk factors following direct probabilistic risk communication in the workplace|
Lipkus 2000 {published data only}|Can tailored interventions increase mammography use among HMO women?|/resolve/reference/PMED?id=10808977
Miller 2005 {published data only}|Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service|
Misra 2011 {published data only}|Cost effectiveness of interventions to promote screening for colorectal cancer: a randomized trial|
Myers 2007 {published data only}|A randomized control trial of the impact of targeted and tailored interventions on colorectal cancer screening|
Ockhuysen-Vermey 2008 {published data only}|Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counseling|
Pye 1988 {published data only}|A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload|/resolve/reference/PMED?id=3418289
Rakowski 1998 {published data only}|Increasing mammography among women aged 40-74 by use of a stage-matched, tailored intervention|
Rhodes 2001 {published data only}|Better health while you wait: a controlled trial of a computer-based intervention for screening and health promotion in the emergency department|/resolve/reference/PMED?id=11223765
Rimer 1999 {published data only}|The impact of tailored interventions on a community health center population|/resolve/reference/PMED?id=14528540
Russell 2010 {published data only}|Randomized trial of a lay health adviser and computer intervention to increase mammography screening in African American women|
Schroy 2008 {published data only}|An effective educational strategy for improving knowledge, risk perception and risk communication among colorectal adenoma patients|/resolve/reference/PMED?id=18574393
Vernon 2011 {published data only}|A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same|
Walker 2008 {published data only}|Telephone intervention to promote diabetic retinopathy screening among the urban poor|/resolve/reference/PMED?id=18312805
Walsh 2010 {published data only}|Healthy Colon, Healthy Life: a novel colorectal cancer screening intervention|
Weber 1997 {published data only}|Enhancing mammography use in the inner city: a randomized trial of intensive case management|/resolve/reference/PMED?id=9361575
Glenn 2011 {published data only}|Changes in risk perceptions in relation to self-reported colorectal cancer screening among first-degree relatives of colorectal cancer cases enrolled in a randomized trial|
Lowery 2012 {published data only}|The family health promotion project (FHPP): Design and baseline data from a randomized trial to increase colonoscopy screening in high risk families|
Ahmed 2012|Communicating risk|
Albada 2009|Tailored information about cancer risk and screening: a systematic review|
Barratt 1999|Users' Guides to the Medical Literature XVII. How to Use Guidelines and Recommendations About Screening. Evidence-Based Medicine Working Group|
Barratt 2005|Presenting probabilities|
Barry 1997|A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia|
Beauchamp 2001||
Becker 1974||
Bekker 1999|Informed decision making: an annotated bibliography and systematic review|/resolve/reference/PMED?id=10350446
Bewley 2011|The NHS breast screening programme needs independent review|
Bonfill 2001|Strategies for increasing the participation of women in community breast cancer screening|
Bottorff 1996||
Brawley 2012|New American Cancer Society process for creating trustworthy cancer screening guidelines|
Briss 2004|Promoting informed decisions about cancer screening in communities and healthcare systems|/resolve/reference/PMED?id=14700715
Cacioppo 1984|The Elaboration Likelihood model of persuasion|
Collins 2011|Emotional impact of screening: a systematic review and meta-analysis|
Covello 1986|Risk communication: a review of the literature|
Deeks 2011|Chapter 9: Analysing data and undertaking meta-analyses|
Edwards 1999a|How should 'effectiveness' of risk communication to aid patients' decisions be judged? A review of the literature|
Edwards 2003a|The development of COMRADE  a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations|/resolve/reference/PMED?id=12900105
Elwyn 2000|Shared decision-making and the concept of equipoise: defining the 'competences' of involving patients in health care choices|/resolve/reference/PMED?id=11141876
Everett 2011|Interventions targeted at women to encourage the uptake of cervical screening|
Fischhoff 1979|Which risks are acceptable?|
Fishbein 1975||
Flight 2004|Interventions for improving uptake of population-based screening for colorectal cancer using fecal occult blood testing|
Foster 1998|Reaching targets in the national cervical screening programme: are current practices unethical?|/resolve/reference/PMED?id=9650108
Gail 1989|Projecting individualized probabilities of developing breast cancer for white females who are being examined annually|/resolve/reference/PMED?id=2593165
Ghosh 2005|Translating evidence-based information into effective risk communication: current challenges and opportunities|/resolve/reference/PMED?id=15962835
GMC 1998||
Guadagnoli 1998|Patient participation in decision-making|/resolve/reference/PMED?id=9681902
Guyatt 2008|GRADE: an emerging consensus on rating quality of evidence and strength of recommendations|/resolve/reference/PMED?id=18436948
Gtzsche 2011|Screening for breast cancer with mammography|
Hackshaw 2012|Benefits and harms of mammography screening|
Heart 1999|Joint British recommendations on prevention of coronary heart disease in clinical practice|
Higgins 2011|Chapter 8: Assessing risk of bias in included studies|
Hippisley-Cox 2008|Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2|/resolve/reference/PMED?id=18573856
Holland 2005|Key issues in screening: genetics, information and economics|
Holmes-Rovner 1996|Patient satisfaction with health care decisions: the satisfaction with decision scale|
Jepson 2000|The determinants of screening uptake and interventions for increasing uptake: a systematic review|
Jepson 2005|How should we measure informed choice? The case of cancer screening|/resolve/reference/PMED?id=15800356
Kanis 2009|FRAX|/resolve/reference/PMED?id=19195497
Keeney 1986|Improving risk communication|
Kellar 2011|Can informed choice invitations lead to inequities in intentions to make lifestyle changes among participants in a primary care diabetes screening programme? Evidence from a randomized trial|
Kreuter 1999a||
Kreuter 1999b|Understanding how people process health information: a comparison of tailored and nontailored weight-loss materials|/resolve/reference/PMED?id=10519465
Liao 1996|Impact of an interactive video on decision making of patients with ischaemic heart disease|/resolve/reference/PMED?id=8803746
Lipkus 2007a|Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations|
Llewelyn-Thomas 1995|Patients' health care decision-making: a framework for descriptive and experimental investigations|
Marteau 2001|A multi-dimensional measure of informed choice|
Marteau 2002|Screening for cardiovascular risk: public health imperative or matter for individual informed choice?|/resolve/reference/PMED?id=12114238
Matthews 1999|Efficient literature searching in diffuse topics: lessons from a systematic review of research on communicating risk to patients in primary care|
McPherson 2010|Screening for breast cancerbalancing the debate|
Michie 2002|The multi-dimensional measure of informed choice: a validation study|/resolve/reference/PMED?id=12220754
Mullen 2006|Measures used in studies of informed decision making about cancer screening: a systematic review|/resolve/reference/PMED?id=17107291
Naik 2012|Communicating risk to patients and the public|
Nelson 2009|Screening for breast cancer: an update for the US Preventive Services Task Force|
NHS Information Centre 2011a|Breast Screening Programme, England 2009-10 [Online]|
NHS Information Centre 2011b|Cervical Screening Programme, England 2010-11 [Online]|
Noar 2007|Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions|/resolve/reference/PMED?id=17592961
O'Connor 1995|Validation of a decisional conflict scale|
Prochaska 1992|Stages of change in the modification of problem behaviors|/resolve/reference/PMED?id=1620663
Prochaska 1997|The transtheoretical model of health behavior change|
Raffle 2001|Information about screening - is it to achieve high uptake or to ensure informed choice?|
RCGP 2002||
Richards 2011|Breast cancer screening; an independent review is under way|
Rogers 2002|Are guidelines ethical? Some considerations for general practice|/resolve/reference/PMED?id=12171228
Rose 1978|Epidemiology for the uninitiated: screening|/resolve/reference/PMED?id=719432
Rosenstock 1988|Social learning theory and the Health Belief Model|/resolve/reference/PMED?id=3378902
Rosenstock 2000|Health Belief model|
Sarfati 1998|Does the frame affect the picture? A study into how attitudes to screening for cancer are affected by the way benefits are expressed|/resolve/reference/PMED?id=9795874
Slaytor 1998|How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets|/resolve/reference/PMED?id=9677220
Stacey 2011|Decision aids for people facing health treatment or screening decisions|
Stefanek 2011|Uninformed Compliance or Informed Choice? A Needed Shift in our Approach to Cancer Screening|
Stewart-Brown 1997|Screening could seriously damage your health [Editorial]|/resolve/reference/PMED?id=9055702
Thomson 2005|Tensions in public health policy: patient engagement, evidence-based public health and health inequalities|/resolve/reference/PMED?id=16326781
UK National Screening Portal|UK Screening Portal (Online)|
UKNSC 1998|First Report|
UKNSC 2000|Second Report|
US PSTF 2005|Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement|
Vlek 1987|Risk assessment, risk perception and decision making about courses of action involving genetic risk: an overview of concepts and methods|/resolve/reference/PMED?id=3593910
Weinstein 2002|The precaution adoption process model|
Wilson 1968||
Edwards 1999b|Personalised risk communication in health screening programs|
Edwards 2003b|Effects of communicating individual risks in screening programmes: Cochrane systematic review|/resolve/reference/PMED?id=14512475
Edwards 2003c|Personalised risk communication for informed decision making about entering screening programs|
Edwards 2006|Personalised risk communication for informed decision making about taking screening tests|
Bourke 2006 {published data only}|Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial|/resolve/reference/PMED?id=16426990
Ellis 1987 {published data only}|Treatment of respiratory failure during sleep in patients with neuromuscular disease: positive pressure ventilation through a nose mask|/resolve/reference/PMED?id=3541713
Laserna 2003 {published data only}|Non-invasive ventilation in kyphoscoliosis. A comparison of a volumetric ventilator and a BiPAP support pressure device|/resolve/reference/PMED?id=12550014
Pinto 1995 {published data only}|Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial|/resolve/reference/PMED?id=7595610
Raphal 1994 {published and unpublished data}|Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy|/resolve/reference/PMED?id=7911921
Restrick 1993 {published data only}|Comparison of nasal pressure support ventilation with nasal intermittent positive pressure ventilation in patients with nocturnal hypoventilation|/resolve/reference/PMED?id=8472827
Ward 2005 {published data only}|Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia|/resolve/reference/PMED?id=16299118
Willson 2004 {published data only}|Nasal versus full face mask for noninvasive ventilation in chronic respiratory failure|/resolve/reference/PMED?id=15083762
Aboussouan 1997 {published data only}|Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=9313002
Ambrosino 1997 {published data only}|Short term effects of nasal proportional assist ventilation in patients with chronic hypercapnic respiratory insufficiency|/resolve/reference/PMED?id=9493669
Bach 1998 {published data only}|Neuromuscular ventilatory insufficiency: effect of home mechanical ventilator use versus oxygen therapy on pneumonia and hospitalization rates|/resolve/reference/PMED?id=9482374
Celikel 1998 {published data only}|Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure|/resolve/reference/PMED?id=9872200
Elliott 1994 {published data only}|A comparison of different modes of noninvasive ventilatory support: effects on ventilation and inspiratory muscle effort|
Masa 1997 {published data only}|Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases|/resolve/reference/PMED?id=9228378
Meecham Jones 1993 {published data only}|Comparison of pressure and volume preset nasal ventilator systems in stable chronic respiratory failure|/resolve/reference/PMED?id=8370432
Padman 1998 {published data only}|Noninvasive ventilation via bilevel positive airway pressure support in pediatric practice|/resolve/reference/PMED?id=9428561
Annane 1999|Mechanisms underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases|/resolve/reference/PMED?id=10836341
Arras 1995||
Bach 1987|Intermittent positive pressure ventilation via nasal access in the management of respiratory insufficiency|
Barb 1996|Long term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases|/resolve/reference/PMED?id=8915217
Carroll 1988|Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation|/resolve/reference/PMED?id=3143160
Chailleux 1996|Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation|/resolve/reference/PMED?id=8617085
Claman 1996|Nocturnal non-invasive positive pressure ventilatory assistance|/resolve/reference/PMED?id=8989081
Heckmatt 1990|Night time nasal ventilation in neuromuscular disease|/resolve/reference/PMED?id=1968582
Hoeppner 1984|Nighttime ventilation improves respiratory failure in secondary kyphoscoliosis|/resolve/reference/PMED?id=6696324
Lloyd-Owen 2005|Patterns of home mechanical ventilation use in Europe: results of the European Survey|/resolve/reference/PMED?id=15929957
Loh 1979|Gas exchange problems in bilateral diaphragm paralysis|/resolve/reference/PMED?id=122063
Make 1998|Mechanical ventilation beyond the intensive care unit: report of a consensus conference of the American College of Chest Physicians|/resolve/reference/PMED?id=9599593
Milligan 1991|American Association for Respiratory Care and Gallup estimate numbers and costs of caring for chronic ventilator patients|
Newsom-Davis 1980|The respiratory system in muscular dystrophy|/resolve/reference/PMED?id=7020839
Orlikowski 2005|Long term domiciliary mechanical ventilation in patients with neuromuscular diseases (indications, establishment and follow up)|/resolve/reference/PMED?id=16598862
Raphal 1987||
Raphal 1999|Is early noninvasive mechanical ventilation of first choice in stable restrictive patients with chronic respiratory failure?|/resolve/reference/PMED?id=10218381
Simonds 2003|Home ventilation|/resolve/reference/PMED?id=14621116
Skatrud 1980|Determinants of hypoventilation during wakefulness and sleep in diaphragmatic paralysis|/resolve/reference/PMED?id=7416586
Smith 1987|Practical problems in the respiratory care of patients with muscular dystrophy|/resolve/reference/PMED?id=3553943
AASK 2002 {published data only}|Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial|/resolve/reference/PMED?id=12435255
AASK 2002 {published data only}|Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study|/resolve/reference/PMED?id=8889350
ASCOT 2005 {published and unpublished data}|Anglo Scandinavian Cardiac Outcomes Trial. ASCOT-BPLA preliminary results|
ASCOT 2005 {published and unpublished data}|Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial|/resolve/reference/PMED?id=16154016
ASCOT 2005 {published and unpublished data}|Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial|/resolve/reference/PMED?id=12686036
ASCOT 2005 {published and unpublished data}|Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial|/resolve/reference/PMED?id=11403364
Berglund 1981 {published data only}|Beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolice side effects|/resolve/reference/PMED?id=6110954
Berglund 1981 {published data only}|Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide|
Coope 1986 {published data only}|Randomised trial of treatment of hypertension in elderly patients in primary care|/resolve/reference/PMED?id=3094811
ELSA 2002 {published data only}|Calcium antagonist Lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial|/resolve/reference/PMED?id=12417537
ELSA 2002 {published data only}|Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atherosclerosis (ELSA)|/resolve/reference/PMED?id=8973780
ELSA 2002 {published data only}|Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis|/resolve/reference/PMED?id=9794735
HAPPHY 1987 {published data only}|Beta-blockers versus saluretics in hypertension. Comparison of total mortality, myocardial infarction, and sudden death: study design and early results on blood pressure reduction|/resolve/reference/PMED?id=6112739
HAPPHY 1987 {published data only}|Beta-blockers versus diuretics in hypertensive men: Main results from the HAPPHY trial|/resolve/reference/PMED?id=2892881
INVEST 2003 {published data only}|Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study|/resolve/reference/PMED?id=15381674
INVEST 2003 {published data only}|A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial|/resolve/reference/PMED?id=14657064
INVEST 2003 {published data only}|Rationale and design of the International Verapamil SR/Trandolapril (INVEST)|/resolve/reference/PMED?id=9809930
IPPPSH 1985 {published data only}|The IPPPSH Collaborative Group|/resolve/reference/PMED?id=2864374
IPPPSH 1985 {published data only}|The International Prospective Primary Prevention Study in Hypertension (IPPPSH): objectives and methods|
LIFE 2002 {published data only}|The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group|/resolve/reference/PMED?id=9234823
LIFE 2002 {published data only}|Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension|/resolve/reference/PMED?id=9856962
LIFE 2002 {published data only}|Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol|/resolve/reference/PMED?id=11937178
LIFE 2002 {published data only}|Cardiovascular morbdity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol|/resolve/reference/PMED?id=11937179
MRC 1985 {published data only}|Report of Medical Research Council Working Party on Mild to Moderate Hypertension|
MRC 1985 {published data only}|Medical Research Council Working Party on Mild Hypertension|/resolve/reference/PMED?id=2895662
MRC 1985 {published data only}|The Medical Research Council Hypertension Trial: the smoking patient|/resolve/reference/PMED?id=3336995
MRC 1985 {published data only}|An update on the Medical Research Council Trial|/resolve/reference/PMED?id=3312530
MRC 1985 {published data only}|MRC trial of treatment of mild hypertension: principal results|
MRC 1985 {published data only}|A randomized, placebo- controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group|/resolve/reference/PMED?id=2064494
MRCOA 1992 {published data only}|MRC Working Party|
UKPDS-39-1998 {published data only}|Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39|/resolve/reference/PMED?id=9732338
UKPDS-39-1998 {published data only}|Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)|/resolve/reference/PMED?id=9742976
UKPDS-39-1998 {published data only}|Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPRDS 38|/resolve/reference/PMED?id=9732337
VA COOP 1982 {published data only}|Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial difference in response|/resolve/reference/PMED?id=6750166
VA COOP 1982 {published data only}|Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy|/resolve/reference/PMED?id=6750167
CAPP 1999 {published data only}|Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomised trial|/resolve/reference/PMED?id=10030325
CAPP 1999 {published data only}|The Captopril Prevention Project: a prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension|/resolve/reference/PMED?id=1981218
CONVINCE 1998 {published data only}|Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascualr Endpoints (CONVINCE) Trial|/resolve/reference/PMED?id=9683312
CONVINCE 1998 {published data only}|Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial|/resolve/reference/PMED?id=12709465
MAPHY 1988 {published data only}|Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study|/resolve/reference/PMED?id=2021446
MAPHY 1988 {published data only}|Decreased coronary heart disease in hypertensive smokers. Mortality results from the MAPHY study|/resolve/reference/PMED?id=2737719
MAPHY 1988 {published data only}|Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study|/resolve/reference/PMED?id=3346979
MAPHY 1988 {published data only}|Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study|/resolve/reference/PMED?id=2013485
NORDIL 2000 {published data only}|Randomised trial of the effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study|/resolve/reference/PMED?id=10972367
NORDIL 2000 {published data only}|A prospective intervention trial of calcium antagonist therapy in hypertension|/resolve/reference/PMED?id=8173702
STOP 1991 {published data only}|STOP-Hypertension: Swedish Trial in Old Patients with Hypertension|/resolve/reference/PMED?id=3534088
STOP 1991 {published data only}|STOP-Hypertension - Preliminary Communication from the Pilot Study of the Swedish Trial in Old Patients with Hypertension|
STOP 1991 {published data only}|Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)|/resolve/reference/PMED?id=1682683
STOP 1991 {published data only}|Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study|
STOP 1991 {published data only}|Antihypertensive efficacy and side-effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study|/resolve/reference/PMED?id=1338084
STOP-2 1999 {published data only}|Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study|/resolve/reference/PMED?id=10577635
Angeli 2004|Calcium channel blockade to prevent stroke in hypertension: A meta-analysis of 13 studies with 103,793 subjects|/resolve/reference/PMED?id=15363825
Breslow-Day 1980|Combination of results from a series of 2 X 2 tables; control of confounding|
Broeders 2000|Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production|/resolve/reference/PMED?id=10931809
Brown 1997|Science, medicine and the future - Hypertension|/resolve/reference/PMED?id=9154032
Carlberg 2004|Atenolol in hypertension: is it a wise choice?|/resolve/reference/PMED?id=15530629
Collins 1990|Blood pressure, stroke, and coronary heart disease. Part 2|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Dutch TIA 1993|Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke|/resolve/reference/PMED?id=8465360
Eriksson 1995|Atenolol in the secondary prevention after stroke|
Ezzati 2005|Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development|/resolve/reference/PMED?id=15916467
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2005|Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]|
JNC-6 1997|The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure|/resolve/reference/PMED?id=9385294
Kalinowski 2003|Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action|/resolve/reference/PMED?id=12742996
Kearney 2005|Global burden of hypertension: analysis of worldwide data|/resolve/reference/PMED?id=15652604
Khan 2006|Re-examining the efficacy of [beta]-blockers for the treatment of hypertension: a meta-analysis|/resolve/reference/PMED?id=16754904
Lindhom 2005|Should [beta] blockers remain first choice in the treatment of primary hypertension? A meta-analysis|/resolve/reference/PMED?id=16257341
Mancia 1997|Blood pressure control in the hypertensive population|/resolve/reference/PMED?id=9040574
Mantel-Haenszel 1959|Statistical aspects of the analysis of data from retrospective studies of disease|/resolve/reference/PMED?id=13655060
Materson 1993|Single-drug therapy for hypertension in men. A compariaon of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents|/resolve/reference/PMED?id=8446138
Messerli 1998|Are beta-blockers efficacious as first-line therapy for hypertension in the elderly?|/resolve/reference/PMED?id=9634263
Messerli 2003|[beta]-blockers in hypertension--the emperor has no clothes: an open letter to present and prospective drafters of new guidelines for the treatment of hypertension|/resolve/reference/PMED?id=14553968
Opie 1997|Evidence is needed that beta blockade alone reduces mortality in hypertension|/resolve/reference/PMED?id=9420520
Opie 2002|Evidence-based evaluation of calcium channel blockers for hypertension: Equality of mortality and cardiovascular risk relative to conventional therapy|/resolve/reference/PMED?id=11788225
Opie 2004|Old antihypertensives and new diabetes|/resolve/reference/PMED?id=15257162
Philipp 1997|Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nifedipine and enalapril in antihypertensive treatment: results of the HANE study|/resolve/reference/PMED?id=9251545
Psaty 1997|Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis|/resolve/reference/PMED?id=9042847
Ramsay 1999|British Hypertension Society Guidelines for Hypertension Management 1999; Summary|/resolve/reference/PMED?id=10473485
Staessen 2003|Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003|/resolve/reference/PMED?id=12777939
Verdecchia 2004|Adverse prognostic significance of new diabetes in treated hypertensive subjects|/resolve/reference/PMED?id=15037557
Verdecchia 2005|Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention|/resolve/reference/PMED?id=16009786
Weber 2005|The role of the new [beta]-blockers in treating cardiovascular disease|/resolve/reference/PMED?id=16373195
Williams 2006|Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes:principal results of the Conduit Artery Function Evaluation (CAFE) study|/resolve/reference/PMED?id=16476843
Wright 1999|Systematic review of anti-hypertensive therapies: Does the evidence assist in choosing a first-line drug?|/resolve/reference/PMED?id=10420860
Wright 2000|Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2: Beta-blockers|/resolve/reference/PMED?id=10934984
Zanchetti 2005|Evidence-based medicine in hypertension: what type of evidence?|/resolve/reference/PMED?id=15894883
Bradley 2006|How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis|/resolve/reference/PMED?id=17053529
AASK 2002 {published data only}|Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial|/resolve/reference/PMED?id=11386927
AASK 2002 {published data only}|Comparison of Measured GFR, Serum Creatinine, Cystatin C, and Beta-Trace Protein to Predict ESRD in African Americans With Hypertensive CKD|
AASK 2002 {published data only}|Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial|
AASK 2002 {published data only}|Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial|/resolve/reference/PMED?id=17059993
AASK 2002 {published data only}|Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial|/resolve/reference/PMED?id=12435255
AASK 2002 {published data only}|Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study|/resolve/reference/PMED?id=8889350
ASCOT 2005 {published and unpublished data}|Anglo Scandinavian Cardiac Outcomes Trial. ASCOT-BPLA preliminary results|
ASCOT 2005 {published and unpublished data}|Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial|/resolve/reference/PMED?id=16154016
ASCOT 2005 {published and unpublished data}|Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk|
ASCOT 2005 {published and unpublished data}|Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach|
ASCOT 2005 {published and unpublished data}|Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial|/resolve/reference/PMED?id=12686036
ASCOT 2005 {published and unpublished data}|Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial|/resolve/reference/PMED?id=11403364
Berglund 1981 {published data only}|Beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects|/resolve/reference/PMED?id=6110954
Berglund 1981 {published data only}|Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide|
Coope 1986 {published data only}|Randomised trial of treatment of hypertension in elderly patients in primary care|/resolve/reference/PMED?id=3094811
ELSA 2002 {published data only}|Calcium antagonist Lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial|/resolve/reference/PMED?id=12417537
ELSA 2002 {published data only}|Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atherosclerosis (ELSA)|/resolve/reference/PMED?id=8973780
ELSA 2002 {published data only}|Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis|/resolve/reference/PMED?id=9794735
HAPPHY 1987 {published data only}|Beta-blockers versus saluretics in hypertension. Comparison of total mortality, myocardial infarction, and sudden death: study design and early results on blood pressure reduction|/resolve/reference/PMED?id=6112739
HAPPHY 1987 {published data only}|Beta-blockers versus diuretics in hypertensive men: Main results from the HAPPHY trial|/resolve/reference/PMED?id=2892881
INVEST 2003 {published data only}|Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study|/resolve/reference/PMED?id=15381674
INVEST 2003 {published data only}|A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial|/resolve/reference/PMED?id=14657064
INVEST 2003 {published data only}|Rationale and design of the International Verapamil SR/Trandolapril (INVEST)|/resolve/reference/PMED?id=9809930
IPPPSH 1985 {published data only}|The IPPPSH Collaborative Group|/resolve/reference/PMED?id=2864374
IPPPSH 1985 {published data only}|The International Prospective Primary Prevention Study in Hypertension (IPPPSH): objectives and methods|
LIFE 2002 {published data only}|The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group|/resolve/reference/PMED?id=9234823
LIFE 2002 {published data only}|Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension|/resolve/reference/PMED?id=9856962
LIFE 2002 {published data only}|Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol|/resolve/reference/PMED?id=11937178
LIFE 2002 {published data only}|Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol|/resolve/reference/PMED?id=11937179
MRC 1985 {published data only}|Report of Medical Research Council Working Party on Mild to Moderate Hypertension|
MRC 1985 {published data only}|Medical Research Council Working Party on Mild Hypertension|
MRC 1985 {published data only}|The Medical Research Council Hypertension Trial: the smoking patient|/resolve/reference/PMED?id=3336995
MRC 1985 {published data only}|An update on the Medical Research Council Trial|/resolve/reference/PMED?id=3312530
MRC 1985 {published data only}|MRC trial of treatment of mild hypertension: principal results|
MRC 1985 {published data only}|A randomized, placebo- controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group|/resolve/reference/PMED?id=2064494
MRCOA 1992 {published data only}|MRC Working Party|
UKPDS-39-1998 {published data only}|Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39|
UKPDS-39-1998 {published data only}|Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)|/resolve/reference/PMED?id=9742976
UKPDS-39-1998 {published data only}|Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPRDS 38|
VA COOP 1982 {published data only}|Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial difference in response|/resolve/reference/PMED?id=6750166
VA COOP 1982 {published data only}|Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy|/resolve/reference/PMED?id=6750167
ACCORD 2010 {published data only}|Effects of Intensive Blood-Pressure Controlin Type 2 Diabetes Mellitus|
ADaPT 2008 {published data only}|First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation|/resolve/reference/PMED?id=18652658
APSIS 2006 {published data only}|Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS)|/resolve/reference/PMED?id=15951393
CAPP 1999 {published data only}|Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomised trial|/resolve/reference/PMED?id=10030325
CAPP 1999 {published data only}|The Captopril Prevention Project: a prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension|/resolve/reference/PMED?id=1981218
CAPRICORN 2001 {published data only}|Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial|/resolve/reference/PMED?id=11356434
CARDHIAC 2008 {published data only}|Comparison of the Effects of Doxazosin and Atenololon Target Organ Damage in Adults with Type 2 DiabetesMellitus and Hypertension in the CARDHIAC Study:A 9-Month, Prospective, Randomized, Open-Label,Blinded-Evaluation Trial|/resolve/reference/PMED?id=18343246
CHHIPS 2009 {published data only}|Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial|/resolve/reference/PMED?id=19058760
CIBIS-II 1999 {published data only}|The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial|
COMET 2007 {published data only}|Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in theCarvedilol or Metoprolol European Trial (COMET): randomised controlled trial|
CONVINCE 1998 {published data only}|Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascualr Endpoints (CONVINCE) Trial|/resolve/reference/PMED?id=9683312
CONVINCE 1998 {published data only}|Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial|/resolve/reference/PMED?id=12709465
COPE 2005 {published data only}|The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: rationale and design.|/resolve/reference/PMED?id=16138563
COPERNICUS 2006 {published data only}|Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the CarvedilolProspective Randomized Cumulative Survival (COPERNICUS)study|/resolve/reference/PMED?id=15093878
COSMOS 2010 {published data only}|Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study|
Dietz 2008 {published data only}|Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension|/resolve/reference/PMED?id=18957387
Dutch TIA 1993 {published data only}|Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke|/resolve/reference/PMED?id=8465360
GEMINI 2008 {published data only}|Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.|
IMPACT-HF 2004 {published data only}|Predischargeinitiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation ManagementPredischarge: Process for Assessment of Carvedilol Therapyin Heart Failure (IMPACT-HF) trial|/resolve/reference/PMED?id=15120808
MAPHY 1988 {published data only}|Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study|/resolve/reference/PMED?id=2021446
MAPHY 1988 {published data only}|Decreased coronary heart disease in hypertensive smokers. Mortality results from the MAPHY study|/resolve/reference/PMED?id=2737719
MAPHY 1988 {published data only}|Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study|/resolve/reference/PMED?id=3346979
MAPHY 1988 {published data only}|Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study|/resolve/reference/PMED?id=2013485
Marazzi 2011 {published data only}|Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients|
MERIT-HF 2000 {published data only}|Tolerability of beta blocker initiation and titration in the MetoprololCR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT- HF)|
Nilsson 2007 {published data only}|Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension|/resolve/reference/PMED?id=18046976
NORDIL 2000 {published data only}|Randomised trial of the effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study|/resolve/reference/PMED?id=10972367
NORDIL 2000 {published data only}|A prospective intervention trial of calcium antagonist therapy in hypertension|/resolve/reference/PMED?id=8173702
REASON 2009 {published data only}|Blood Pressure Response UnderChronic Antihypertensive Drug TherapyThe Role of Aortic Stiffness in the REASON (Preterax inRegression of Arterial Stiffness in a Controlled Double-Blind) Study|/resolve/reference/PMED?id=19179203
RESOLVD 2000 {published data only}|Effects of metoprolol CR inpatients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies for left ventricular dysfunction pilot study|
SENIORS 2005 {published data only}|Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure(SENIORS)|
STOP 1991 {published data only}|STOP-Hypertension: Swedish Trial in Old Patients with Hypertension|/resolve/reference/PMED?id=3534088
STOP 1991 {published data only}|STOP-Hypertension - Preliminary Communication from the Pilot Study of the Swedish Trial in Old Patients with Hypertension|
STOP 1991 {published data only}|Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)|/resolve/reference/PMED?id=1682683
STOP 1991 {published data only}|Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study|
STOP 1991 {published data only}|Antihypertensive efficacy and side-effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study|/resolve/reference/PMED?id=1338084
STOP-2 1999 {published data only}|Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study|/resolve/reference/PMED?id=10577635
TEST 1995 {published data only}|Atenolol in the secondary prevention after stroke|
Angeli 2004|Calcium channel blockade to prevent stroke in hypertension: A meta-analysis of 13 studies with 103,793 subjects|/resolve/reference/PMED?id=15363825
Balamuthusamy 2009|Comparative analysis of beta-blockers with other antihypertensive agents on cardiovascular outcomes in hypertensive patients with diabetes mellitus: a systematic review and meta-analysis|
Balshem 2011|GRADE guidelines: 3. Rating the quality of evidence|
Bangalore 2007|A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus|/resolve/reference/PMED?id=17920367
Bangalore 2008|Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis|
Breslow-Day 1980|Combination of results from a series of 2 X 2 tables; control of confounding|
Broeders 2000|Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production|/resolve/reference/PMED?id=10931809
Brown 1997|Science, medicine and the future - Hypertension|/resolve/reference/PMED?id=9154032
Carlberg 2004|Atenolol in hypertension: is it a wise choice?|/resolve/reference/PMED?id=15530629
Chen 2010|Calcium channel blockers versus other classes of drugs for hypertension|
Collins 1990|Blood pressure, stroke, and coronary heart disease. Part 2|
Dahlof 2007|Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?|/resolve/reference/PMED?id=17453746
Danaei 2011|National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 54 million participants|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Ezzati 2005|Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development|/resolve/reference/PMED?id=15916467
Gradman 2010|Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies|
Guyatt 2011|GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions|
JNC-6 1997|The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure|/resolve/reference/PMED?id=9385294
Kalinowski 2003|Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action|/resolve/reference/PMED?id=12742996
Kamp 2010|Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release|
Kearney 2005|Global burden of hypertension: analysis of worldwide data|/resolve/reference/PMED?id=15652604
Khan 2006|Re-examining the efficacy of [beta]-blockers for the treatment of hypertension: a meta-analysis|/resolve/reference/PMED?id=16754904
Lindhom 2005|Should [beta] blockers remain first choice in the treatment of primary hypertension? A meta-analysis|/resolve/reference/PMED?id=16257341
Mancia 1997|Blood pressure control in the hypertensive population|/resolve/reference/PMED?id=9040574
Mantel-Haenszel 1959|Statistical aspects of the analysis of data from retrospective studies of disease|/resolve/reference/PMED?id=13655060
Materson 1993|Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents|/resolve/reference/PMED?id=8446138
Messerli 2003|[beta]-blockers in hypertension--the emperor has no clothes: an open letter to present and prospective drafters of new guidelines for the treatment of hypertension|/resolve/reference/PMED?id=14553968
NICE 2006||
Opie 1997|Evidence is needed that beta blockade alone reduces mortality in hypertension|/resolve/reference/PMED?id=9420520
Opie 2002|Evidence-based evaluation of calcium channel blockers for hypertension: Equality of mortality and cardiovascular risk relative to conventional therapy|/resolve/reference/PMED?id=11788225
Opie 2004|Old antihypertensives and new diabetes|/resolve/reference/PMED?id=15257162
Park 2007|Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review|
Pedersen 2007|The vasodilatory beta-blockers.|/resolve/reference/PMED?id=17686376
Philipp 1997|Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nifedipine and enalapril in antihypertensive treatment: results of the HANE study|/resolve/reference/PMED?id=9251545
Polnia 2010|Different patterns of peripheral versus central blood pressure in hypertensive patients treated with -blockers either with or without vasodilator properties or with angiotensin receptor blockers|
Psaty 1997|Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis|/resolve/reference/PMED?id=9042847
Ramsay 1999|British Hypertension Society Guidelines for Hypertension Management 1999; Summary|/resolve/reference/PMED?id=10473485
Sander 2011|Thiazide diuretics and -blockers in the treatment of hypertension in diabetes mellitus|
Sciarretta 2011|Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk|
Staessen 2003|Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003|/resolve/reference/PMED?id=12777939
Verdecchia 2004|Adverse prognostic significance of new diabetes in treated hypertensive subjects|/resolve/reference/PMED?id=15037557
Verdecchia 2005|Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention|/resolve/reference/PMED?id=16009786
Williams 2006|Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes:principal results of the Conduit Artery Function Evaluation (CAFE) study|/resolve/reference/PMED?id=16476843
Wiysonge 2007b|Beta-blockers and the treatment of hypertension: it is time to move on|
Wright 1999|Systematic review of anti-hypertensive therapies: Does the evidence assist in choosing a first-line drug?|/resolve/reference/PMED?id=10420860
Wright 2000|Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2: Beta-blockers|/resolve/reference/PMED?id=10934984
Wright 2009|First-line drugs for hypertension|
Zanchetti 2005|Evidence-based medicine in hypertension: what type of evidence?|/resolve/reference/PMED?id=15894883
Bradley 2006|How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis|/resolve/reference/PMED?id=17053529
Wiysonge 2007|Beta-blockers for hypertension|
Antila 1993 {published data only}|The effect of intermaxillary fixation on leukocyte zinc, serum trace elements and nutritional status of patients undergoing maxillofacial surgery|/resolve/reference/PMED?id=16843316
Arnold 1989 {published data only}|The effect of oral nutritional supplements on head and neck cancer|/resolve/reference/PMED?id=2656603
Beattie 2000 {published data only}|A randomised controlled trial evaluating the use of enteral nutritional supplements postoperatively in malnourished surgical patients|/resolve/reference/PMED?id=10807893
Berneis 2000 {published data only}|Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients|
de Luis 2003 {published and unpublished data}|Isolated dietary counselling program versus supplement and dietary counselling in patients with human immunodeficiency virus infection|/resolve/reference/PMED?id=12729523
Dixon 1984 {published data only}|Effect of nursing interventions on nutritional and performance status in cancer patients|/resolve/reference/PMED?id=6387632
Evans 1987 {published data only}|A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer|/resolve/reference/PMED?id=3027267
Evans 1987 {published data only}|Effectiveness of nutritional counseling on caloric intake, weight change, and percent protein intake in patients with advanced colorectal and lung cancer|
Forli 2001 {published and unpublished data}|A study of intensified dietary support in underweight candidates for lung transplantation|/resolve/reference/PMED?id=11463999
Fuenzalida 1990 {published data only}|The immune response to short-term nutritional intervention in advanced chronic obstructive pulmonary disease|/resolve/reference/PMED?id=2368979
Ganzoni 1994 {published and unpublished data}|High-caloric nutrition in chronic obstructive lung disease|/resolve/reference/PMED?id=8029587
Gray-Donald 1995 {published and unpublished data}|Randomized clinical trial of nutritional supplementation shows little effect on functional status among free-living frail elderly|/resolve/reference/PMED?id=7500174
Hampson 2003 {published and unpublished data}|Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial|/resolve/reference/PMED?id=12904840
Hickson 2004 {published data only}|Does intensive feeding support provided by healthcare assistants improve nutritional status and outcome in acutely ill older in-patients? - a randomised controlled trial [unpublished]|
Imes 1988 {published and unpublished data}|Effect of Ensure, a defined formula diet, in patients with Crohn's disease|/resolve/reference/PMED?id=3536644
Imes 1988 {published and unpublished data}|Diet counselling improves the clinical course of patients with Crohn's disease|/resolve/reference/PMED?id=2899528
Imes 1988 {published and unpublished data}|Diet counseling modifies nutrient intake of patients with Crohn's disease|/resolve/reference/PMED?id=3559004
Isenring 2004 {published and unpublished data}|Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area|/resolve/reference/PMED?id=15226773
Jensen 1997 {published data only}|Dietary supplementation at home improves the regain of lean body mass after surgery|/resolve/reference/PMED?id=9225334
Jensen 1997 {published data only}|Randomization to nutritional intervention at home did not improve postoperative function, fatigue or well-being|/resolve/reference/PMED?id=9043473
Kalnins 2005 {published and unpublished data}|Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis|/resolve/reference/PMED?id=16182685
Kalnins 2005 {published and unpublished data}|Oral supplements vs normal food intake in children and adults [abstract]|
Kalnins 2005 {published and unpublished data}|Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF? [abstract]|
Kendell 1982 {published data only}|Postoperative nutritional supplementation for the orthognathic surgery patient|/resolve/reference/PMED?id=6951009
Lovik 1996 {published data only}|Dietary information after radiotherapy of head and neck cancer|/resolve/reference/PMED?id=8848781
Macia 1991 {published data only}|Nutritional evaluation and dietetic care in cancer patients treated with radiotherapy: prospective study|/resolve/reference/PMED?id=1802209
McCarthy 1999 {published and unpublished data}|The effect of nutritional supplements on food intake in patients undergoing radiotherapy|/resolve/reference/PMED?id=10382188
Moloney 1983 {published data only}|Controlled studies of nutritional intake in patients with malignant disease undergoing treatment|
Murphy 1992 {published data only}|Dietary counselling and nutritional supplementation in HIV infection|
Olejko 1984 {published data only}|Preoperative nutritional supplementation for the orthognathic surgery patient|/resolve/reference/PMED?id=6590808
Ollenschlager 1992 {published data only}|Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia|
Ovesen 1993 {published data only}|Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study|/resolve/reference/PMED?id=8410128
Paton 2004 {published and unpublished data}|Randomised controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting|/resolve/reference/PMED?id=15277171
Persson 2002 {published and unpublished data}|A randomized study of nutritional support in patients with colorectal and gastric cancer|/resolve/reference/PMED?id=12235650
Rabeneck 1998 {published data only}|A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patients|/resolve/reference/PMED?id=9550167
Ravasco 2005 {published and unpublished data}|Dietary counselling improves patient outcomes: A prospective, randomised, controlled trial in colorectal cancer patients undergoing radiotherapy|/resolve/reference/PMED?id=15684319
Rogers 1992 {published data only}|Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study|/resolve/reference/PMED?id=1456568
Schwenk 1999 {published and unpublished data}|Oral supplements as adjunctive treatment to nutritional counseling in malnourished HIV-infected patients: randomized controlled trial|/resolve/reference/PMED?id=10634923
Turic 1998 {published and unpublished data}|Nutrition supplementation enables elderly residents of long-term-care facilities to meet or exceed RDA's without displacing energy or nutrient intakes from meals|/resolve/reference/PMED?id=9850117
Weekes 2006 {unpublished data only}|Nutritional intervention in COPD|
Wilson 2001 {published data only}|Comparison of the effects of two early intervention strategies on the health outcomes of malnourished hemodialysis patients|/resolve/reference/PMED?id=11466668
Wong 2004 {published and unpublished data}|Is dietary couselling effective in increasing dietary calcium, protein and energy intakes in patients with osteoporotic fractures? A randomised controlled clinical trial|
Bachmann 1998 {published data only}|Assessment of indication and quality of nutritional support in medical oncology|
Bauer 1994 {published data only}|Energy and nutrient intake in adolescent weight-lifters before and after nutritional counselling|/resolve/reference/PMED?id=7921793
Beange 1995 {published data only}|Project renourish: A dietary intervention to improve nutritional status in people with multiple disabilities|
Bills 1993 {published data only}|Impact of dietitians on quality of care in 16 nursing homes in east central Indiana|/resolve/reference/PMED?id=8417098
Bolton 1990 {published data only}|Comparison of short-term and long-term palatability of six commercially available oral supplements|
Bories 1994 {published data only}|One-month regular oral nutrition in alcoholic cirrhotic patients. Changes of nutritional status, hepatic function and serum lipid pattern|/resolve/reference/PMED?id=7827013
Bozzetti 1998 {published data only}|Comments on: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies, [comment on: Andreyev et al., European Journal of Cancer 1998, 34, pp. 503-509] (multiple letters)|/resolve/reference/PMED?id=10070324
Bugge 1997 {published data only}|Developing a research-based innovation protocol on nutritional support to patients with cancer in the gastrointestinal tract [Norwegian]|
Bunout 1989 {published data only}|Nutritional support in hospitalized patients with alcoholic liver disease|/resolve/reference/PMED?id=2691239
Burger 1993 {published data only}|Nutrition behavior of malnourished HIV-infected patients and intensified oral nutritional intervention|/resolve/reference/PMED?id=8467111
Efthimiou 1988 {published data only}|The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3057956
Elbanna 1996 {published data only}|Dietary management of surgical patients: effects on incisional wound healing|
Elkort 1981 {published data only}|Long-term nutritional support as an adjunct to chemotherapy for breast cancer|/resolve/reference/PMED?id=6796711
Elmstaahl 1987 {published data only}|Hospital nutrition in geriatric long-term care medicine: II. Effects of dietary supplements|/resolve/reference/PMED?id=3107353
Eneroth 1997 {published data only}|Improved wound healing in transtibial amputees receiving supplementary nutrition|/resolve/reference/PMED?id=9195264
Engel 1995 {published data only}|Strategies to identify and correct malnutrition in hemodialysis patients|
Flynn 1987 {published data only}|Preoperative outpatient nutritional support of patients with squamous cancer of the upper aerodigestive tract|/resolve/reference/PMED?id=3661837
Franzoni 1996 {published data only}|Good nutritional oral intake is associated with equal survival in demented and nondemented very old patients|/resolve/reference/PMED?id=8909354
Glimelius 1992 {published data only}|Improved care of patients with small cell lung cancer. Nutritional and quality of life aspects.|/resolve/reference/PMED?id=1337831
Heberer 1984 {published data only}|Oropharyngoesophageal carcinoma - aspects of the nutritional status and immunoresistance|/resolve/reference/PMED?id=6423573
Henquin 1989 {published data only}|Nutritional monitoring and counselling for cancer patients during chemotherapy|/resolve/reference/PMED?id=2717128
Hogan 1997 {published data only}|A nutritional rehabilitation program for persons with severe physical and developmental disabilities|/resolve/reference/PMED?id=9020244
Hulsewe 1997 {published data only}|Assessment of outcome of perioperative nutritional interventions|/resolve/reference/PMED?id=9433722
Ireton 1995 {published data only}|Nutrition intervention in cancer patients: does the registered dietitian make a difference?|
Jamieson 1997 {published data only}|The quantitative effect of nutrition support on quality of life in outpatients|/resolve/reference/PMED?id=16844618
Johnson 1993 {published data only}|Oral nutritional supplement use in elderly nursing home patients|/resolve/reference/PMED?id=8409181
Keller 1995 {published data only}|Weight gain impacts morbidity and mortality in institutionalized older persons|/resolve/reference/PMED?id=7836642
Knowles 1988 {published data only}|Dietary supplementation and respiratory muscle performance in patients with COPD|/resolve/reference/PMED?id=3282825
Kondrup 1998 {published data only}|Outcome from nutritional support using hospital food|/resolve/reference/PMED?id=9583380
Levine 1982 {published data only}|Controlled clinical trials of nutritional intervention as an adjunct to chemotherapy, with a comment on nutrition and drug resistance|/resolve/reference/PMED?id=6799196
Lipschitz 1985 {published data only}|Nutritional evaluation and supplementation of elderly subjects participating in a 'meals on wheels' program|
Lynch 1983 {published data only}|Clinical trial with oral carbohydrate supplement in hemodialysis patients: A nutritional evaluation|
McWhirter 1996 {published data only}|A comparison between oral and nasogastric nutritional supplements in malnourished patients|/resolve/reference/PMED?id=8878142
Mendenhall 1993 {published data only}|A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: Results of a Department of Veterans Affairs cooperative study|
Mendenhall 1995 {published data only}|Protein energy malnutrition in severe alcoholic hepatitis: Diagnosis and response to treatment|/resolve/reference/PMED?id=8523623
Monnin 1993 {published data only}|Nutrition counseling for breast cancer patients|/resolve/reference/PMED?id=8417097
Munck 1998 {published data only}|Cystic fibrosis: Dietary counseling and nutritional support|
Neidich 1985 {published data only}|Noninvasive outpatient nutritional therapy in inflammatory bowel disease|/resolve/reference/PMED?id=3925180
Newmark 1981 {published data only}|Nutritional support in an inpatient rehabilitation unit|/resolve/reference/PMED?id=6797382
Neyman 1996 {published data only}|Effect of participation in congregate-site meal programs on nutritional status of the healthy elderly|/resolve/reference/PMED?id=8621873
Openbrier 1984 {published data only}|Factors affecting nutritional status and the impact of nutritional support in patients with emphysema|
Ottery 1996 {published data only}|Definition of standardized nutritional assessment and interventional pathways in oncology|/resolve/reference/PMED?id=8850213
Patel 1998 {published data only}|The effect of dietary intervention on weight gains after renal transplantation|/resolve/reference/PMED?id=9724503
Payette 2002 {published data only}|Benefits of nutritional supplementation in free-living, frail, undernourished elderly people: A prospective randomised community trial|/resolve/reference/PMED?id=12171453
Saudny 1997 {published data only}|Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9309995
Solomon 1978 {published data only}|Optimal nutritional support in surgery for bladder cancer: preservation of visceral protein by amino acid infusions|/resolve/reference/PMED?id=565418
Sridar 1994 {published data only}|An out-patient nutritional supplementation programme in COPD patients|/resolve/reference/PMED?id=8005255
Stack 1996 {published data only}|High-energy, high-protein, oral, liquid, nutrition supplementation in patients with HIV infection: effect on weight status in relation to incidence of secondary infection|/resolve/reference/PMED?id=8598433
Stark 1990 {published data only}|A behavioral approach to increasing calorie consumption in children with cystic fibrosis|/resolve/reference/PMED?id=2380876
Unosson 1992 {published data only}|Effects of dietary supplement on functional condition and clinical outcome measured with a modified Norton scale|/resolve/reference/PMED?id=16839988
Vargas 1995 {published data only}|Patients with chronic airflow limitation: effects of the inspiratory muscle training with threshold load valve, built with appropriate technology, associated to nutritional support|/resolve/reference/PMED?id=8733313
Volkert 1996 {published data only}|Nutrition support and functional status in undernourished geriatric patients during hospitalization and 6-month follow-up|/resolve/reference/PMED?id=9061125
Williams 1989a {published data only}|Improving oral energy intake in older children with cystic fibrosis|
Williams 1989b {published data only}|A controlled trial of sip-feed supplements in elderly orthopaedic patients|/resolve/reference/PMED?id=2737169
Woo 1994 {published data only}|Nutritional status of elderly patients during recovery from chest infection and the role of nutritional supplements assessed by a prospective randomised single-blind trial|
Yoneda 1992a {published data only}|Supplementary nutrition therapy is effective in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=1464980
Yoneda 1992b {published data only}|Nutritional assessment and the effect of supplementary oral nutrition in patients with pulmonary emphysema|/resolve/reference/PMED?id=1434221
Braunschweig 1999|Creating a clinical nutrition registry: prospects, problems and preliminary results|/resolve/reference/PMED?id=10207401
Edington 1996|Prevalence of malnutrition in patients in general practice|/resolve/reference/PMED?id=16843999
Edington 1997|Prevalence of malnutrition after major surgery|
Foltz 1987|Effectiveness of nutritional counseling on caloric intake, weight change, and percent protein intake in patients with advanced colorectal and lung cancer|
Guigoz 1997|Malnutrition in the elderly: the Mini Nutritional Assessment (MNA)|/resolve/reference/PMED?id=9289873
Hanger 1999|The prevalence of malnutrition in elderly hip fracture patients|/resolve/reference/PMED?id=10210293
Keele 1997|Two phase randomised controlled clinical trial of postoperative oral dietary supplements in surgical patients|/resolve/reference/PMED?id=9135531
Lennard-Jones 1992|A positive approach to nutrition as treatment|
Manual of Dietetics||
McCormack 1997|Undernutrition in the elderly population living at home in the community: a review of the literature|
McWhirter 1994|Incidence and recognition of malnutrition in hospital|/resolve/reference/PMED?id=8173401
Munro 1998|Value-added benefits. Are nutritional supplements used effectively|/resolve/reference/PMED?id=9934179
Naber 1997|Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications|/resolve/reference/PMED?id=9356543
NICE 2006|Nutrition support in adults: oral supplements, enteral and parenteral feeding|
Olin 1996|Energy-enriched hospital food to improve energy intake in elderly patients|/resolve/reference/PMED?id=8676539
PCA 2002|Prescription Cost Analysis|
Peake 1998a|Determining the incidence of malnutrition to plan and target nutritional support strategies [Abstract OC28]|
Peake 1998b|Nutritional supplementation: how much do people drink [abstract]|
Potter 1998|Routine protein energy supplementation adults: a systematic review|/resolve/reference/PMED?id=9712593
Prieto 1996|Incidence of malnutrition in surgical departments of the Reina Sofia hospital of Cordoba|
Review Manager 2008|Review Manager (RevMan)|
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Stratton 1999|A critical systematic analysis of the use of oral nutritional supplements in the community|/resolve/reference/PMED?id=10459079
Stratton 2003||
Watson 1998|The prevalence of malnutrition in patients admitted to Care of the Elderly wards [abstract]|
Weekes 1998|The incidence of malnutrition in medical patients admitted to a hospital in south London [abstract]|
Wilson 1998|Prevalence and causes of undernutrition in medical outpatients|/resolve/reference/PMED?id=9528720
Baldwin 2001|Dietary advice for illness-related malnutrition in adults|
Blair 1986 {published data only}|Effect of early blood transfusion on gastrointestinal haemorrhage|
Bracey 1999 {published data only}|Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome|
Bush 1997 {published data only}|A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients|/resolve/reference/PMED?id=9293831
Carson 1998 {published data only}|A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture|
Colomo 2008 {published data only}|Transfusion strategies in patients with cirrhosis and acute gastrointestinal bleeding|
Fortune 1987 {published data only}|Influence of hematocrit on cardiopulmonary function after acute hemorrhage|/resolve/reference/PMED?id=3560265
Foss 2009 {published data only}|The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery|
Grover 2005 {published data only}|Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty|
Grover 2005 {published data only}|Blood transfusion threshold and silent myocardial ischemia after lower limb arthroplasty: a randomized controlled trial of transfusion strategy|
Hebert 1995 {published data only}|Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group [published erratum appears in JAMA 1995 Sep 27;274(12):944]|/resolve/reference/PMED?id=7723158
Hebert 1999 {published data only}|A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care|/resolve/reference/PMED?id=9971864
Hebert 1999 {published data only}|Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients?|/resolve/reference/PMED?id=15454803
Hebert 1999 {published data only}|A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture|
Johnson 1992 {published data only}|Comparison of two transfusion strategies after elective operations for myocardial revascularization|/resolve/reference/PMED?id=1495291
Lacroix 2007 {published data only}|Transfusion strategies for patients in pediatric intensive care units|/resolve/reference/PMED?id=17442904
Lotke 1999 {published data only}|Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration|/resolve/reference/PMED?id=10512433
So-Osman 2010 {published data only}|A restrictive transfusion trigger is a method for blood saving in elective orthopaedic surgery|/resolve/reference/PMED?id=15209879
So-Osman 2010 {published data only}|A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells|
Topley 1956 {published data only}|The illness of trauma|/resolve/reference/PMED?id=13374186
Webert 2008 {published data only}|A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation|/resolve/reference/PMED?id=17894791
Zygun 2009 {published data only}|The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury|/resolve/reference/PMED?id=19237920
Vichinsky 1995 {published data only}|A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group|/resolve/reference/PMED?id=7791837
Slight 2008 {published data only}|Rationalizing blood transfusion in cardiac surgery: The impact of a red cell volume-based guideline on blood usage and clinical outcome|
FOCUS {published data only}|Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS)|
MINT {published data only}|Myocardial Ischemia and Transfusion (MINT)|
TITRe 2 {published data only}|A multi-centre randomised controlled trial of the effects of a reduction in the threshold for blood transfusion following heart surgery|
AAGBI 2008|Blood Transfusion and the Anaesthetist - Red Cell Transfusion|
Amin 2004|The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada|
ASA 2006|Practice guidelines for perioperative blood transfusion and adjuvant therapies|/resolve/reference/PMED?id=16810012
BCTMAG 2003|Guidelines for Red Blood Cell Transfusion|
Benson 2000|A comparison of observational studies and randomized, controlled trials|/resolve/reference/PMED?id=10861324
Carless 2010|Cell salvage for minimising perioperative allogeneic blood transfusion|
Carson 1996|Effect of anaemia and cardiovascular disease on surgical mortality and morbidity|/resolve/reference/PMED?id=8874456
Concato 2000|Randomized, controlled trials, observational studies, and the hierarchy of research designs|/resolve/reference/PMED?id=10861325
Der Simonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Dzik 2000|Leukocyte reduction of blood components: public policy and new technology|/resolve/reference/PMED?id=10669939
Goodnough 2008|Risks and complications of blood transfusions: optimizing outcomes for patients with chemotherapy-induced anemia|
Hagl 1977|The effect of hemodilution on regional myocardial function in the presence of coronary stenosis|/resolve/reference/PMED?id=901378
Hebert 1997|Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group|/resolve/reference/PMED?id=9154866
Henry 2001a|Agreement between randomised and non-randomised studies - the effects of bias and confounding|
Henry 2001b|Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion|
Higgins 2008||
Hogue 1998|Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy|
Ioannidis 2001|Comparison of evidence of treatment effects in randomised and nonrandomised studies|/resolve/reference/PMED?id=11497536
Jayaraman 2010|The risk of transfusion-transmitted infections in sub-Saharan Africa. [Review] [40 refs]|
Kitchen 2008|Current information on the infectious risks of allogeneic blood transfusion|
Klein 2007|Red blood cell transfusion in clinical practice|/resolve/reference/PMED?id=17679019
Madjdpour 2005|Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications|/resolve/reference/PMED?id=15486006
McClelland 2005|Appropriateness and safety of blood transfusion|/resolve/reference/PMED?id=15649906
Napolitano 2009|Clinical practice guideline: red blood cell transfusion in adult trauma and critical care|/resolve/reference/PMED?id=19773646
NBUGI 2001|A Guideline for Transfusion of Red Bllod Cells in Surgical Patients|
Nelson 1993|Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit|/resolve/reference/PMED?id=8504653
NHMRC and ASBT 2001|Clinical Practice Guidelines on the Use of Blood Components (red blood cells, platelets, fresh frozen plasma, cryoprecipitate)|
NIH 1988|Perioperative red blood cell transfusion|/resolve/reference/PMED?id=3054179
O'Brien 2007|Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services|
Review Manager|Review Manager|
Schulz 1995|Epirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled clinical trials|/resolve/reference/PMED?id=7823387
Spiess 1998|Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group|/resolve/reference/PMED?id=9731788
Sullivan 2007|Blood collection and transfusion in the United States in 2001|
Takei 2009|Progress in global blood safety for HIV|
Varney 2003|The annual cost of blood transfusions in the UK|
Wang 2010|Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger|
Weiskopf 2000|Acute severe isovolemic anemia impairs cognitive function and memory in humans|/resolve/reference/PMED?id=10839915
Wilkerson 1988|Limits of cardiac compensation in anemic baboons|/resolve/reference/PMED?id=3375993
Wilson 2003|The challenge of an increasingly expensive blood system|/resolve/reference/PMED?id=12719320
Wu 2001|Blood transfusion in elderly patients with acute myocardial infarction|/resolve/reference/PMED?id=11680442
Yoshikawa 1973|Effect of acute anemia on experimental myocardial ischemia|/resolve/reference/PMED?id=4744695
Blair 1986 {published data only}|Effect of early blood transfusion on gastrointestinal haemorrhage|
Bracey 1999 {published data only}|Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome|
Bush 1997 {published data only}|A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients|/resolve/reference/PMED?id=9293831
Carson 1998 {published data only}|A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture|
Carson 2011 {published data only}|Liberal or restrictive transfusion in high-risk patients after hip surgery|/resolve/reference/PMED?id=22168590
Colomo 2008 {published data only}|Transfusion strategies in patients with cirrhosis and acute gastrointestinal bleeding|
Fortune 1987 {published data only}|Influence of hematocrit on cardiopulmonary function after acute hemorrhage|/resolve/reference/PMED?id=3560265
Foss 2009 {published data only}|The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery|
Grover 2005 {published data only}|Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty|
Grover 2005 {published data only}|Blood transfusion threshold and silent myocardial ischemia after lower limb arthroplasty: a randomized controlled trial of transfusion strategy|
Hajjar 2010 {published data only}|Transfusion requirements after cardiac surgery. The TRACS randomized controlled trial|/resolve/reference/PMED?id=20940381
Hebert 1995 {published data only}|Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group [published erratum appears in JAMA 1995 Sep 27;274(12):944]|/resolve/reference/PMED?id=7723158
Hebert 1999 {published data only}|A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care|/resolve/reference/PMED?id=9971864
Hebert 1999 {published data only}|Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients?|/resolve/reference/PMED?id=15454803
Hebert 1999 {published data only}|A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture|
Johnson 1992 {published data only}|Comparison of two transfusion strategies after elective operations for myocardial revascularization|/resolve/reference/PMED?id=1495291
Lacroix 2007 {published data only}|Transfusion strategies for patients in pediatric intensive care units|/resolve/reference/PMED?id=17442904
Lotke 1999 {published data only}|Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration|/resolve/reference/PMED?id=10512433
So-Osman 2010 {published data only}|A restrictive transfusion trigger is a method for blood saving in elective orthopaedic surgery|/resolve/reference/PMED?id=15209879
So-Osman 2010 {published data only}|A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells|
Topley 1956 {published data only}|The illness of trauma|/resolve/reference/PMED?id=13374186
Webert 2008 {published data only}|A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation|/resolve/reference/PMED?id=17894791
Zygun 2009 {published data only}|The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury|/resolve/reference/PMED?id=19237920
Vichinsky 1995 {published data only}|A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group|/resolve/reference/PMED?id=7791837
Cooper 2011 {published data only}|Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT randomized pilot study)|/resolve/reference/PMED?id=21791325
MINT {published data only}|Myocardial Ischemia and Transfusion (MINT)|
TITRe 2 {published data only}|A multi-centre randomised controlled trial of the effects of a reduction in the threshold for blood transfusion following heart surgery|
AAGBI 2008|Blood transfusion and the anaesthetist - red cell transfusion|
Amin 2004|The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada|
ASA 2006|Practice guidelines for perioperative blood transfusion and adjuvant therapies|/resolve/reference/PMED?id=16810012
ASBT 2001|Clinical Practice Guidelines:Appropriate Use of Red Blood Cells|
BCTMAG 2003|Guidelines for Red Blood Cell Transfusion|
Benson 2000|A comparison of observational studies and randomized, controlled trials|/resolve/reference/PMED?id=10861324
Carless 2010|Cell salvage for minimising perioperative allogeneic blood transfusion|
Concato 2000|Randomized, controlled trials, observational studies, and the hierarchy of research designs|/resolve/reference/PMED?id=10861325
Der Simonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Goodnough 2008|Risks and complications of blood transfusions: optimizing outcomes for patients with chemotherapy-induced anemia|
Hebert 1997|Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group|/resolve/reference/PMED?id=9154866
Henry 2001a|Agreement between randomised and non-randomised studies - the effects of bias and confounding|
Henry 2011b|Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Ioannidis 2001|Comparison of evidence of treatment effects in randomised and nonrandomised studies|/resolve/reference/PMED?id=11497536
Kitchen 2008|Current information on the infectious risks of allogeneic blood transfusion|
Klein 2007|Red blood cell transfusion in clinical practice|/resolve/reference/PMED?id=17679019
Madjdpour 2005|Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications|/resolve/reference/PMED?id=15486006
Napolitano 2009|Clinical practice guideline: red blood cell transfusion in adult trauma and critical care|/resolve/reference/PMED?id=19773646
NBUGI 2001|A Guideline for Transfusion of Red Blood Cells in Surgical Patients|
NIH 1988|Perioperative red blood cell transfusion|/resolve/reference/PMED?id=3054179
O'Brien 2007|Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services|
Review Manager|Review Manager (RevMan)|
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled clinical trials|/resolve/reference/PMED?id=7823387
Shander 2010|Activity-based costs of blood transfusions in surgical patients at four hospitals|
Spiess 1998|Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group|/resolve/reference/PMED?id=9731788
Wang 2010|Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger|
Weiskopf 2000|Acute severe isovolemic anemia impairs cognitive function and memory in humans|/resolve/reference/PMED?id=10839915
Whitaker 2011|Report of the US Department of Health and Human Services. The 2009 national blood collection and utilization survey report|
WHO 2011|Blood safety: key global facts and figures in 2011|
Wu 2001|Blood transfusion in elderly patients with acute myocardial infarction|/resolve/reference/PMED?id=11680442
Wu 2007|Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery|/resolve/reference/PMED?id=17565082
Wu 2010|Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery|/resolve/reference/PMED?id=20505504
Zou 2009|Current incidence and residual risk of hepatitis B infection among blood donors in the United States|
Zou 2010|Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing|
Do 1994 {published data only}|Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty|/resolve/reference/PMED?id=7972781
Duda 2001 {published data only}|Peripheral artery occlusion: treatment with abciximab plus urokinase versus urokinase alone--a randomized pilot trial (the PROMPT Study)|/resolve/reference/PMED?id=11719664
Drffler-Melly 2004 {published data only}|Adjunctive abciximab improves patency and functional outcome in patients undergoing endovascular treatment of femoropopliteal occlusions|
Heinz 1996 {published data only}|The effect of Taprostene on platelet activation and clinical course after percutaneous transluminal angioplasty|/resolve/reference/PMED?id=8851268
Heiss 1990 {published data only}|Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA|/resolve/reference/PMED?id=2140251
Hess 1978 {published data only}|Prevention of re-occlusion after recanalisation of occluded arteries by the catheter method|/resolve/reference/PMED?id=720236
Mahler 1987 {published data only}|Combination of suloctidil and anticoagulation in the prevention of reocclusion after femoropopliteal PTA|/resolve/reference/PMED?id=2827398
Minar 1995 {published data only}|Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty|/resolve/reference/PMED?id=7697845
Pilger 1991 {published data only}|Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results|/resolve/reference/PMED?id=1824621
Ranke 1994 {published data only}|Controlled trial of high-versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease|/resolve/reference/PMED?id=7849445
Schneider 1987 {published data only}|Zur Rezidivprophylaxe nach perkutaner transluminaler Angioplastie (PTA): Antikoagulation versus Ticlopidin|
Schweizer 2001 {published data only}|Potential use of a low-molecular-weight heparin to prevent restenosis in patients with extensive wall damage following peripheral angioplasty|/resolve/reference/PMED?id=11666130
Study group 1994 {published data only}|Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease. A prospective double-blind trial. Study group on pharmacological treatment after PTA|/resolve/reference/PMED?id=8307222
Weichert 1994 {published data only}|Acetylsalicylic acid reocclusion prophylaxis after angioplasty (ARPA-study). A randomized double-blind trial of two different dosages of ASA in patients with peripheral occlusive arterial disease|/resolve/reference/PMED?id=8154176
Allie 2003 {published data only}|Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal iliac interventions|/resolve/reference/PMED?id=12777673
Bulvas 1996 {published data only}|The effect of heparin sulphate on percutaneous transluminal angioplasty in the vessels supplying the lower extremities|/resolve/reference/PMED?id=8925544
Horrocks 1997 {published data only}|The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty|/resolve/reference/PMED?id=9257670
Mueller 1997 {published data only}|Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty|/resolve/reference/PMED?id=9308744
Ranke 1993 {published data only}|Dose-dependent side effects of acetylsalicylic acid therapy. Results of a prospective randomized clinical study in patients with peripheral arterial occlusive disease|/resolve/reference/PMED?id=8272018
Shammas 2003 {published data only}|Bivalirudin in peripheral vascular interventions: a single center experience|/resolve/reference/PMED?id=12840239
Stavropoulos 2003 {published data only}|Use of abciximab during infrainguinal peripheral vascular interventions: initial experience|/resolve/reference/PMED?id=12773673
Strecker 2004 {published data only}|Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results|/resolve/reference/PMED?id=12856136
Tetteroo 1995 {published data only}|The significance of coumarin anticoagulation in laser assisted percutaneous transluminal angioplasty of femoropopliteal arterial obstructions|/resolve/reference/PMED?id=7713093
Zeitler 1973 {published data only}|Effect of acetylsalicylic acid on earlyresults following percutaneous recanalisation of arterial occlusions (Dotter's method)|/resolve/reference/PMED?id=4714027
Block 1981|Morphology after transluminal angioplasty in human beings|/resolve/reference/PMED?id=6973087
CAMPER|Press releases|
CURE 2003|Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study|/resolve/reference/PMED?id=14504182
Decrinis 1993|A simplified procedure for intra-arterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results|/resolve/reference/PMED?id=8458348
Do 1992|A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions|
Dotter 1989|Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. 1964|/resolve/reference/PMED?id=2528161
Duda 2002|Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results|/resolve/reference/PMED?id=12234956
Ellis 1989|Effect of 18 to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty|/resolve/reference/PMED?id=2522716
Ferns 1992|Arterial response to mechanical injury: balloon catheter de-endothelialization|
Fontaine 1954|Surgical treatment for peripheral vascular disease|
Fuster 1995|The three processes leading to post PTCA restenosis: dependence on the lesion substrate|/resolve/reference/PMED?id=8578523
Gallino 1984|Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up|/resolve/reference/PMED?id=6236912
Grntzig 1974|Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique)|/resolve/reference/PMED?id=4434847
Haudenschild 1995|Pathophysiology of reocclusion and restenosis|
Hess 1985|Drug-induced inhibition of platelet function delays progression of peripheral arterial occlusive disease|/resolve/reference/PMED?id=2857803
Jadad 1996|Assessing the quality of reports of randomised clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jorgensen 1990|Early rethrombosis in femoropopliteal occlusions treated with percutaneous transluminal angioplasty|/resolve/reference/PMED?id=2140988
Mahler 1999|Stenting of the peripheral renal and supraaortic arteries and the aorta|/resolve/reference/PMED?id=10212974
Mahler 2001|Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial|/resolve/reference/PMED?id=11797982
Mewissen 2004|Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results|/resolve/reference/PMED?id=15071774
Minar 2000|Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study|/resolve/reference/PMED?id=11094034
Moneta 1987|Peripheral arterial duplex scanning|
Palmaz 1985|Expandable intraluminal graft: a preliminary study. Work in progress|/resolve/reference/PMED?id=3159043
Parent 1989|Fibrinolytic treatment of residual thrombus after catheter embolectomy for severe lower limb ischemia|/resolve/reference/PMED?id=2911135
Ranke 1992|Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction|/resolve/reference/PMED?id=1509618
Sabeti 2004|Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis|/resolve/reference/PMED?id=15286322
Schillinger 2003|Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up|/resolve/reference/PMED?id=12877612
Schneider 1989|Percutaneous transluminal angioplasty, local thrombolysis and percutnaeous thrombus extraction in the treatment of arterial occlusions of the extremities|/resolve/reference/PMED?id=2527833
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Schwartz 1998|Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling|/resolve/reference/PMED?id=9551589
Shammas 2003b|In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant|/resolve/reference/PMED?id=12730630
Strecker 1988|A new vascular balloon-expandable prosthesis: Experimental studies and first clinical results|
TASC 2000|Management of peripheral arterial disease. Treatment of intermittent claudication|
Tsakiris 1999|Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease|/resolve/reference/PMED?id=9920521
Tschpl 1997|Role of haemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty|
Vogel 2003|Efficacious use of nitinol stents in the femoral and popliteal arteries|/resolve/reference/PMED?id=14681606
Ward 2001|Low blood flow after angioplasty augments mechanisms of restenosis: inward vessel remodeling, cell migration, and activity of genes regulating migration|/resolve/reference/PMED?id=11156854
Watson 2000|Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use|/resolve/reference/PMED?id=10828222
Wentzel 2003|Shear stress, vascular remodeling and neointimal formation|/resolve/reference/PMED?id=12694998
Working Party 1998|Thrombolysis in the management of lower limb peripheral arterial occlusion -- a consensus document. Working Party on Thrombolysis and Management of Limb Ischemia|/resolve/reference/PMED?id=9591906
Zehnder 2000|Percutaneous catheter thrombus aspiration for acute or subacute arterial occlusion of the legs: how much thrombolysis is needed?|/resolve/reference/PMED?id=10906296
AMTG 1985 {published data only}|Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a muticenter controlled trial|/resolve/reference/PMED?id=3886191
AMTG 1985 {published data only}|Multicenter controlled trial of oral amrinone in congestive heart failure : lack of benefit compared to placebo|
Bergler-Klein 1992 {published data only}|Pimobendan (UDCG 115 BS) in long-term therapy of chronic heart failure|/resolve/reference/PMED?id=1441695
Cowley 1993 {published data only}|Placebo-controlled trial of flosequinan in moderate heart failure. The possible importance of aetiology and method of analysis in the interpretation of the results of heart failure trials|/resolve/reference/PMED?id=8454379
Cowley 1994 {published data only}|Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators|/resolve/reference/PMED?id=7946771
Dies 1989 {published data only}|Indolidan (a new phosphodiesterase inhibitor) in chronic heart failure|
EMTG 1990 {published data only}|Multicenter trial of oral enoximone in patients with moderately severe congestive heart failure: lack of benefit compared to placebo|
EMTG 1990 {published data only}|Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure|/resolve/reference/PMED?id=2144216
EPOCH 2002 {published data only}|Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: the effects of pimobendan on chronic heart failure study (EPOCH study)|/resolve/reference/PMED?id=11999639
ESG 2000 {published data only}|Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group|/resolve/reference/PMED?id=10933364
ESG 2000 {published data only}|Double-blind placebo-controlled 12 week trial of low dose enoximone in patients with mild to moderate congestive heart failure|
FACET 1993 {published data only}|Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)|/resolve/reference/PMED?id=8339411
IRG 1991 {published data only}|Effectiveness of imazodan for treatment of chronic congestive heart failure. The Imazodan Research Group|/resolve/reference/PMED?id=1715125
IRG 1991 {published data only}|Multicenter trial of imazodan in patients with chronic congestive heart failure|
IRG 1991 {published data only}|Mulicenter trial of imazadan in patients with chronic congestive heart failure|
Lardoux 1987 {published data only}|Multicentric, double blind and controlled study of oral enoximone (MDL 17043) in chronic heart failure|
MMTG 1989 {published data only}|Oral milrinone and digoxin in heart failure: results of a placebo-controlled, prospective trial of each agent and the combination|
MMTG 1989 {published data only}|A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure|/resolve/reference/PMED?id=2646536
OPC-8212 MRG 1990 {published data only}|A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure|
PICO 1996 {published data only}|Pimobendan in congestive heart failure : results of the PICO trial|
PICO 1996 {published data only}|Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial|/resolve/reference/PMED?id=8868980
PMRG 1992 {published data only}|Beneficial effects of pimobendan in patients with chronic heart failure: results of a multicenter trial|
PMRG 1992 {published data only}|Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial|/resolve/reference/PMED?id=1537130
PMRG 1992 {published data only}|Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: eliability and validity during a randomized, double placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group|/resolve/reference/PMED?id=1529875
PROMISE 1991 {published data only}|Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study|/resolve/reference/PMED?id=8436744
PROMISE 1991 {published data only}|Effect of oral milrinone on mortality in severe chronic heart failure|/resolve/reference/PMED?id=1944425
PROMISE 1991 {published data only}|Oral milrinone increases the risk of sudden death in severe chronic heart failure : the PROMISE trial|
PROMISE 1991 {published data only}|Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators|/resolve/reference/PMED?id=10618302
REFLECT 1993 {published data only}|Influence of flosequinan on autonomic tone in congestive heart failure: implications for the mechanism of the positive chronotropic effect and survival influence of long-term vasodilator administration|/resolve/reference/PMED?id=7985595
REFLECT 1993 {published data only}|Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study|/resolve/reference/PMED?id=8509565
REFLECT II 1991 {published data only}|A randomized, multicenter, double-blind placebo controlled study of the efficacy of Flosequinan in patients with chronic heart failure|
VEST 1998 {published data only}|A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators|/resolve/reference/PMED?id=9854116
VSG 1993 {published data only}|Lack of proarrhythmia reduction by vesnarinone in advanced heart failure|
VSG 1993 {published data only}|Effects of vesnarinone on morbidity and mortality in patients with heart failure|/resolve/reference/PMED?id=8515787
WESG 1991 {published data only}|Enoximone versus placebo: a double-blind trial in chronic congestive heart failure|
WESG 1991 {published data only}|Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial|/resolve/reference/PMED?id=1826806
Assmann 1991 {published data only}|Akut-und langzeiteffekte von pimobendan (UD-DG 115) bei herzinsuffizienz NYHA II und III. Ergebnisse einer randomisierten multizentrischen doppelblindstudie|/resolve/reference/PMED?id=1792811
Banning 1996 {published data only}|Flosequinan in chronic heart failure: how is exercise capacity improved?|/resolve/reference/PMED?id=8911877
Binkley 1989 {published data only}|Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure|/resolve/reference/PMED?id=2527935
Corder 1992 {published data only}|Clinical effect of indolidan in congestive heart failure|/resolve/reference/PMED?id=1446958
Cowley 1989 {published data only}|Exercise tolerence in patients with heart failure - how should it be measured?|/resolve/reference/PMED?id=2527829
Cowley 1991 {published data only}|Exercise tolerance in patients with heart failure - how should it be measured?|/resolve/reference/PMED?id=2009893
Crawford 1989 {published data only}|Comparative efficacy of enoximone versus captopril in moderate heart failure|
DiBianco 1983 {published data only}|Oral amrinone for congestive heart failure : preliminary results of a multicenter double blind and placebo controlled withdrawal|
DiBianco 1984 {published data only}|Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study|/resolve/reference/PMED?id=6386932
Dickstein 1990 {published data only}|Effect of IV milrinone on submaximal exercise endurance in heart failure|
DuBourg 1990 {published data only}|Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment|/resolve/reference/PMED?id=2145237
Elborn 1989 {published data only}|Effect of flosequinan on exercise capacity and symptoms in severe heart failure|/resolve/reference/PMED?id=2653391
Elborn 1990 {published data only}|The effects of flosequinan on submaximal exercise in patients with chronic cardiac failure|
Evans 1984 {published data only}|Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study|/resolve/reference/PMED?id=6381344
Feldman 1991 {published data only}|Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=1951080
Galinier 1989 {published data only}|Hemodynamics effects of enoximone in severe congestive heart failure with low cardiac output|
Gilbert 1991 {published data only}|Double-blind, placebo-controlled (P), comparison of enoximone (E) and dobutamine (D) infusions in moderate to severe congestive heart failure patients (NYHA III-IV)|
Haas 1990 {published data only}|Chronic vasodilator therapy with flosequinan in congestive heart failure|
Hori 1992 {published data only}|Effect of flosequinan on exercise capacity and cardiac function in patients with chronic mild heart failure: a double-blind placebo-controlled study|/resolve/reference/PMED?id=1500398
Huanqlong 2000 {published data only}|Response to milrinone treatment in patients with chronic congestive heart failure|
Jondeau 1993 {published data only}|Is there any indication for oral phosphodiesterase inhibitor today?|
Karlsberg 1992 {published data only}|Milrinone is superior to dobutamine in heart failure complicating myocardial infarction|
Katz 1987 {published data only}|Double-blind, randomized evaluation of pimobendan, a new inotrope and vasodilator agent for refractory heart failure|
Katz 1992 {published data only}|A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure|/resolve/reference/PMED?id=1729854
Khalife 1987 {published data only}|Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation|/resolve/reference/PMED?id=2956874
Kneissl 1990 {published data only}|Efficacy of enoximone in comparison with captopril in congestive heart failure|
Konstam 1985 {published data only}|Multicenter comparison of milrinone and dobutamine in congestive heart failure|
Leier 1987 {published data only}|Regional hemodynamic effects of enoximone in congestive heart failure|
Leier 1988 {published data only}|Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study|/resolve/reference/PMED?id=2966546
Leier 1989 {published data only}|Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy|/resolve/reference/PMED?id=2523634
Likoff 1985 {published data only}|Milrinone in the treatment of chronic cardiac failure: a controlled trial|/resolve/reference/PMED?id=3904373
Orie 1989 {published data only}|A double blind comparison of enoximone (Enox) and Captopril (Cap) in CHF|
Pilcher 1985 {published data only}|Enoximone (MDL 17043) and left ventricular function. A placebo controlled trial|
Raw 1989 {published data only}|Amrinone vs dobutamine in congestive heart failure due to dilated cardiomyopathy - differences in hemodynamic effects and therapeutic implications|
Remme 1992 {published data only}|Discordant hemodynamic and clinical efficacy of enalapril in moderate heart failure. Is pimobendan superior?|
Rettig 1986 {published data only}|Withdrawal of long-term amrinone therapy in patients with congestive heart failure: a placebo controlled trial|/resolve/reference/PMED?id=3530768
Ruegg 1987 {published data only}|Assessment of a new inotropic agent, DPN 205-734, by means of systolic time intervals (STIs) in healthy volunteers|
Schoeller 1986 {published data only}|Long-term oral administration of milrinone for dilated cardiomyopathy|
Sridhara 1994 {published data only}|Saterinone, a dual-action drug ofr the management of congestive heart failure|
Voelker 1989 {published data only}|Acute hemodynamic effects of abidendan, a new phosphodiesteras inhibitor, in patients with severe heart failure|
Weber 1990 {published data only}|Acute hemodynamic effects of saterinone in patients with severe chronic heart failure|
Yoshikawa 2000 {published data only}|Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group|/resolve/reference/PMED?id=10856401
Zipperle 1987 {published data only}|A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure|/resolve/reference/PMED?id=2956873
Goldberg 1990 {published data only}|Multicenter trial of imazadan in patients with chronic congestive heart failure|
Japanese's Studies {published data only}|Evaluation of the efficacy and safety of pimobendan (UD-CG 115 BS) in treatment of chronic heart failure. A multicenter placebo-controlled, double-blind study|
Japanese's Studies {published data only}|Clinical efficacy of pimobendan for patients with chronic heart failure. A dose-finding study by a multicenter double-blind comparison trial|
MIL 1077-1078 {published data only}|Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials Investigators|/resolve/reference/PMED?id=8376682
MIL 1077-1078 {published data only}|Oral milrinone as adjunctive therapy for CHF|
PROFILE 1993 {published data only}|Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan|/resolve/reference/PMED?id=12398964
PROFILE 1993 {published data only}|Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan|/resolve/reference/PMED?id=10740139
PROFILE 1993 {published data only}|Effect of flosequinan on survival in chronic heart failure: preliminary results of the PROFILE study|
EMOTE {published and unpublished data}|EMOTE|
EMOTE {published and unpublished data}|EMOTE|
ESSENTIAL {published and unpublished data}|ESSENTIAL|
Baptista 1977|Exact two-sided confidence limits for the odds ratio in a 2 x 2 table. Algorithm AS 115|
Boissel 1989|Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion|/resolve/reference/PMED?id=2791560
Braunwald 1991|ACE inhibitors - a cornerstone of the treatment of heart failure|/resolve/reference/PMED?id=2057038
Chatterjee 1980|Vasodilator therapy for chronic heart failure|/resolve/reference/PMED?id=6770743
Chesebro 1988|The hemodynamic effects of chronic oral milrinone therapy: a multicenter controlled trial|
CIBIS II 1999|The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial|/resolve/reference/PMED?id=10023943
Cochran 1954|The combination of estimates from different experiments|
Cohn 1973|Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance|/resolve/reference/PMED?id=4781249
Cohn 1977|Vasodilatator therapy of cardiac failure|/resolve/reference/PMED?id=327319
Cohn 1986|Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study|/resolve/reference/PMED?id=3520315
Cohn 1991|A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure|/resolve/reference/PMED?id=2057035
Colucci 1991|Cardiovascular effects of milrinone|/resolve/reference/PMED?id=2035424
CONSENSUS 1987|Effects of Enalapril on mortality in severe congestive heart failure|/resolve/reference/PMED?id=2883575
Curfman 1991|Inotropic therapy for heart failure - an unfulfilled promise|/resolve/reference/PMED?id=1944430
Der Simonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
DiBianco 1991|Acute positic inotropic intervention: the phosphoesterase inhibitors|/resolve/reference/PMED?id=2035420
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Feldman 1987|Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure|/resolve/reference/PMED?id=2433073
Fleiss 1973||
Furberg 1988|Effect of drug therapy on survival in chronic congestive heart failure|/resolve/reference/PMED?id=2898890
Galbraith 1988|A note on graphical presentation of estimated odds ratios from several clinical trials|
Garg 1995|Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials|/resolve/reference/PMED?id=7654275
Gilfrich 1991|Tolerance of enoximone in patients with heart failure|/resolve/reference/PMED?id=1833904
Hood 1989|Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine|/resolve/reference/PMED?id=2521268
Katz 1990|Cardiomyopathy of overload : a major determinant of prognosis in congestive heart failure|/resolve/reference/PMED?id=2403651
LeJemtel 1980|Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure|/resolve/reference/PMED?id=7350759
Ludmer 1986|Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique|/resolve/reference/PMED?id=3940664
Mancini 1985|Intravenous use of amrinone for the treatment of the failing heart|/resolve/reference/PMED?id=2411122
Mantel 1959|Statistical aspects of the analysis of data from retrospective studies of disease|/resolve/reference/PMED?id=13655060
MERIT-HF 1999|Effect of metoprolol CR/XL in chronic heart failure|/resolve/reference/PMED?id=10376614
Mikulic 1977|Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure|/resolve/reference/PMED?id=902377
Mulrow 1988|Relative efficacy of vasodilator therapy in chronic congestive heart failure. Implications of randomized trials|/resolve/reference/PMED?id=3286914
Nony 1995|Introduction  la mthodologie mta-analytique|/resolve/reference/PMED?id=7569424
Nony 1997|Standardization of terminology in meta-analysis: a proposal for working definitions|
Nony 1999|Implication of evidence-based medicine in prescription guidelines taught to French medical students: current status in the cardiovascular field|/resolve/reference/PMED?id=10460071
Packer 1984|Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure|/resolve/reference/PMED?id=6388899
Packer 1988a|Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure|/resolve/reference/PMED?id=2901957
Packer 1988b|Vasodilator and inotropic drugs for chronic heart failure: distinguishing hype from hope|/resolve/reference/PMED?id=2844873
Packer 2001|Effect of carvedilol on survival in severe chronic heart failure|/resolve/reference/PMED?id=11386263
Peto 1978|Clinical trial methodology|/resolve/reference/PMED?id=363191
Rosenthal 1979|The "file drawer" problem and tolerance for null results|
Simonton 1985|Milrinone in congestive heart failure : acute and chronic hemodynamic and clinical evaluation|/resolve/reference/PMED?id=4019930
SOLVD 1991|Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure|/resolve/reference/PMED?id=2057034
Storstein 1988|Non-receptor-mediated inotropic drugs|/resolve/reference/PMED?id=3049098
Tukey 1977|Some thoughts on clinical trials, especially problems of multiplicity|/resolve/reference/PMED?id=333584
Weber 1987|Newer positive inotropic agents in the treatment of chronic cardiac failure. Current status and future directions|/resolve/reference/PMED?id=3297622
Wilmshurst 1984|Inotropic and vasodilator effects of amrinone on isolated human tissue|/resolve/reference/PMED?id=6733734
Wood 1989|Review: long-term oral therapy of congestive heart failure with phosphodiesterase inhibitors|/resolve/reference/PMED?id=2521982
Yusuf 1987|Proceedings of "Methodological Issues in Overviews of Randomized Clinical Trials"|
Yusuf 1990|Inotropic agents increase mortality in patients with congestive heart failure|
Nony 1994|Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients: a meta-analysis|/resolve/reference/PMED?id=8070498
Blue 2001 {published data only}|Randomised controlled trial of specialist nurse intervention in heart failure|/resolve/reference/PMED?id=11576977
Blue 2001 {published data only}|A specialist nurse-led, home-based intervention in Scotland|
Capomolla 2002 {published data only}|Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care|/resolve/reference/PMED?id=12383573
Cline 1998 {published data only}|Nurse-led clinics for the management of heart failure in Sweden|
Cline 1998 {published data only}|Cost effective management programme for heart failure reduces hospitalisation|/resolve/reference/PMED?id=9930041
Doughty 2002 {published data only}|Randomized, controlled trial of integrated heart failure management. The Auckland Heart Failure Management Study|/resolve/reference/PMED?id=11785996
Doughty 2002 {published data only}|Integrated care for patients with chronic heart failure: the New Zealand experience|
Ekman 1998 {published data only}|Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure|/resolve/reference/PMED?id=9740348
Ekman 1998 {published data only}|Outpatient care programmes for the elderly [letter]|/resolve/reference/PMED?id=10206388
Harrison 2002 {published data only}|Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition|/resolve/reference/PMED?id=12021683
Jaarsma 2000 {published data only}|Self-care and quality of life in patients with advanced heart failure: the effect of a supportive educational intervention|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Jaarsma 2000 {published data only}|Effects of education and support on self-care and resource utilization in patients with heart failure|/resolve/reference/PMED?id=10208788
Kasper 2002 {published data only}|A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital re-admission|/resolve/reference/PMED?id=11823086
Krumholz 2002 {published data only}|Randomized trial of an education and support intervention to prevent readmission of patients with heart failure|/resolve/reference/PMED?id=11755291
Laramee 2003 {published data only}|Case management in a heterogeneous congestive heart failure population: A randomized controlled trial|/resolve/reference/PMED?id=12695272
McDonald 2002 {published data only}|Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge|
McDonald 2002 {published data only}|Heart failure management: Multidisciplinary care has intrinsic benefit above the optimization of medical care|/resolve/reference/PMED?id=12140806
Rainville 1999 {published data only}|Impact of pharmacist interventions on hospital re-admissions for heart failure|/resolve/reference/PMED?id=10683133
Rich 1993 {published data only}|Prevention of re-admission in elderly patients with congestive heart failure: Results of a prospective, randomized pilot study|/resolve/reference/PMED?id=8289096
Rich 1995 {published data only}|A multidisciplinary intervention to prevent the re-admission of elderly patients with congestive heart failure|/resolve/reference/PMED?id=7565975
Rich 1995 {published data only}|Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure|/resolve/reference/PMED?id=8873488
Riegel 2002 {published data only}|Standardized telephonic case management in a Hispanic heart failure population: An effective intervention|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Riegel 2002 {published data only}|Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure|/resolve/reference/PMED?id=11911726
Stewart 1999a {published data only}|A specialist nurse-led intervention in Australia|
Stewart 1999a {published data only}|Effects of a multidisciplinary, home-based intervention on unplanned re-admissions and survival among patients with chronic congestive heart failure: a randomised controlled study|/resolve/reference/PMED?id=10509499
Akosah 2002 {published data only}|Improving care for patients with chronic heart failure in the community: The importance of a disease management program|/resolve/reference/PMED?id=12226031
Azevedo 2002 {published data only}|Effect of a heart failure clinic on survival and hospital readmission in patients discharged from acute hospital care|/resolve/reference/PMED?id=12034162
Barth 2001 {published data only}|A nurse-managed discharge program for congestive heart failure patients: outcomes and costs|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Benatar 2003 {published data only}|Outcomes of chronic heart failure|/resolve/reference/PMED?id=12578516
Cordisco 1999 {published data only}|Use of telemonitoring to decrease the rate of hospitalization in patients with severe congestive heart failure|/resolve/reference/PMED?id=10513789
Costantini 2001 {published data only}|Impact of a guideline-based disease management team on outcomes of hospitalized patients with congestive heart failure|/resolve/reference/PMED?id=11176730
de Lusignan 1999 {published data only}|A controlled pilot study in the use of telemedicine in the community on the management of heart failure-a report of the first three months|/resolve/reference/PMED?id=10747531
Evans 1993 {published data only}|Evaluating hospital discharge planning: a randomized clinical trial|/resolve/reference/PMED?id=8464252
Farag 1967 {published data only}|Preventing recurrences of congestive heart failure|/resolve/reference/PMED?id=6027630
Fitzgerald 1994 {published data only}|A case manager intervention to reduce readmissions|/resolve/reference/PMED?id=8042889
Gattis 1999 {published data only}|Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study|/resolve/reference/PMED?id=10493325
Goodyer 1995 {published data only}|Does encouraging good compliance improve patients' clinical condition in heart failure?|/resolve/reference/PMED?id=7547154
Grancelli 2003 {published data only}|Randomized controlled trial of telephone intervention in chronic heart failure (DIAL): study design and preliminary observations|/resolve/reference/PMED?id=12815566
Hanchett 1967 {published data only}|A public health home nursing program for outpatients with heart diseases|/resolve/reference/PMED?id=4962116
Hansen 1992 {published data only}|Geriatric follow-up by home visits after discharge from hospital: a randomized controlled trial|/resolve/reference/PMED?id=1471584
Heidenreich 1999 {published data only}|Effect of a home monitoring system on hospitalization and resource use for patients with heart failure|/resolve/reference/PMED?id=10502207
Hughes 2000 {published data only}|Effectiveness of team-managed home-based primary care: A randomized multicenter trial|/resolve/reference/PMED?id=11147984
Jerant 2001 {published data only}|Reducing the cost of frequent hospital admissions for congestive heart failure: a randomized trial of a home telecare intervention|/resolve/reference/PMED?id=11606877
Johnson 2000 {published data only}|Outcomes of the Kaiser Permanente Tele-Home Health Research Project|/resolve/reference/PMED?id=10664641
Lin 2001 {published data only}|Effects of systematic nursing interventions on knowledge, attitude and self-care behaviors of patients with heart failure|
Naylor 1994 {published data only}|Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial|/resolve/reference/PMED?id=8185149
Naylor 1999 {published data only}|Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial|/resolve/reference/PMED?id=10029122
Naylor 1999 {published data only}|The effects of a discharge planning and home follow-up intervention on elders hospitalized with common medical and surgical cardiac conditions|/resolve/reference/PMED?id=10533691
Philbin 2000 {published data only}|The results of a randomized trial of a quality improvement intervention in the care of patients with heart failure|/resolve/reference/PMED?id=11042232
Riegel 2000 {published data only}|Which patents with heart failure respond best to multidisciplinary disease management?|/resolve/reference/PMED?id=11145753
Rubin 1992 {published data only}|The effect of geriatric evaluation and management on Medicare reimbursement in a large public hospital: a randomized clinical trial|/resolve/reference/PMED?id=1401688
Schneider 1993 {published data only}|A medication discharge planning program: measuring the effect on readmissions|/resolve/reference/PMED?id=8453387
Serxner 1998 {published data only}|Congestive heart failure disease management study: a patient education intervention|
Stewart 1998a {published data only}|Effects of home-based intervention on unplanned re-admissions and out-of-hospital deaths|/resolve/reference/PMED?id=9475445
Stewart 1998b {published data only}|Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care|/resolve/reference/PMED?id=9605777
Stewart 1999b {published data only}|Prolonged beneficial effects of a home-based intervention on unplanned re-admissions and mortality among patients with congestive heart failure|/resolve/reference/PMED?id=9989537
Stewart 2002b {published data only}|Home-based intervention in congestive heart failure: long-term implications on readmission and survival|/resolve/reference/PMED?id=12070114
Topp 1998 {published data only}|Effect of a clinical case manager/clinical nurse specialist on patients hospitalized with congestive heart failure|/resolve/reference/PMED?id=9856058
Townend 1988 {published data only}|Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme: a randomised controlled trial|/resolve/reference/PMED?id=2844356
van Rossum 1993 {published data only}|Effects of preventive home visits to elderly people|/resolve/reference/PMED?id=8343668
Weinberger 1996 {published data only}|Does increased access to primary care reduce hospital re-admissions?|/resolve/reference/PMED?id=8618584
Williams 1994 {published data only}|Do follow-up home visits by military nurses of chronically ill medical patients reduce readmissions?|/resolve/reference/PMED?id=8202242
Goldberg 2003 {published data only}|Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: The Weight Monitoring in Heart Failure (WHARF) trial|/resolve/reference/PMED?id=14564327
Ledwidge {published data only}|Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?|/resolve/reference/PMED?id=12798838
REACT {published data only}|Multicentre disease management program for hospitalized patients with heart failure: the Review of Education on ACE inhibitors in Congestive heart failure Treatment (REACT) Study|/resolve/reference/PMED?id=15599837
Stromberg {published data only}|Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure|/resolve/reference/PMED?id=12788301
Trochu {published and unpublished data}|Efficacy of a multidisciplinary management of chronic heart failure patients: one year results of a multicentre randomized trial in French medical practice|
Hardman S {published data only}|The evaluation of a nurse-led intervention to improve self-management for patients admitted to hospital with a diagnosis of heart failure (due to left ventricular systolic dysfunction).|
Massie 2001 {published data only}|A controlled trial of heart failure management programs|
Moser 2000 {published data only}|Community case management decreases rehospitalisation rates and costs and improves quality of life in heart failure patients with preserved and non-preserved left ventricular function: a randomised controlled trial|
Pugh 1999 {published data only}|Partners in care: a model of collaboration|/resolve/reference/PMED?id=10196904
TEN-HMS {published data only}|Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II|/resolve/reference/PMED?id=12413511
Thompson {unpublished data only}|Effects of a nurse-led, clinic and home-based intervention on recurrent hospital use in chronic heart failure (in press)|/resolve/reference/PMED?id=AMBIGUOUS%20(4%20citations)
AHA 2004|Heart disease and stroke statistics - 2004 update|
Clarke 1994|Evidence of inadequate investigation and treatment of patients with heart failure|/resolve/reference/PMED?id=8043344
Cleland 1999|Is the prognosis of heart failure improving?|/resolve/reference/PMED?id=10935669
Cleland 2003|The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe|/resolve/reference/PMED?id=12633546
Cowie 1997|The epidemiology of heart failure|/resolve/reference/PMED?id=9043837
Cowie 1999|Annotated references in epidemiology|/resolve/reference/PMED?id=10937987
Cowie 2000|Survival of patients with a new diagnosis of heart failure: a population based study|/resolve/reference/PMED?id=10768897
Eriksson 1995|Heart failure: a growing public health problem|
Feenstra 1998|Prevention of relapse in patients with congestive heart failure: the role of precipitating factors|/resolve/reference/PMED?id=9930039
Havranek 2002|Spectrum of heart failure in older patients: results from the National Heart Failure project|/resolve/reference/PMED?id=11868045
Jong 2002|Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study|/resolve/reference/PMED?id=12153371
Kannel 1991|Epidemiology of heart failure|/resolve/reference/PMED?id=2000773
Krumholz 1997|Readmission after hospitalization for congestive heart failure among Medicare beneficiaries|/resolve/reference/PMED?id=8996046
Levy 2002|Long term trends in incidence and survival with heart failure|/resolve/reference/PMED?id=12409541
McMurray 1993|Trends in hospitalization rates for heart failure in Scotland 1980-1990|/resolve/reference/PMED?id=8223728
Michalsen 1998|Preventable causative factors leading to hospital admission with decompemsated heart failure|/resolve/reference/PMED?id=9930040
NICE 2003|Chronic heart failure. Clinical Guideline 5|
Riegel 2001|Heart failure disease management models|
Stewart 1989|Functional status and well-being of patients with chronic conditions|/resolve/reference/PMED?id=2754790
Stewart 2001b|More 'malignant' than cancer? Five-year survival following a first admission for heart failure|/resolve/reference/PMED?id=11378002
Stewart 2002a|The current cost of heart failure to the National Health Service in the UK|/resolve/reference/PMED?id=12034163
Verhagen 1998|The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus|/resolve/reference/PMED?id=10086815
Vinson 1990|Early re-admission of elderly patients with congestive heart failure|/resolve/reference/PMED?id=2254567
Aldamiz-Echevarria 2007 {published data only}|Randomized controlled clinical trial of a home care unit intervention to reduce readmission and death rates in patients discharged from hospital following admission for heart failure|
Atienza 2004 {published data only}|Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program|/resolve/reference/PMED?id=15302014
Blue 2001 {published data only}|Randomised controlled trial of specialist nurse intervention in heart failure|/resolve/reference/PMED?id=11576977
Blue 2001 {published data only}|A specialist nurse-led, home-based intervention in Scotland|
Capomolla 2002 {published data only}|Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care|/resolve/reference/PMED?id=12383573
Cline 1998 {published data only}|Nurse-led clinics for the management of heart failure in Sweden|
Cline 1998 {published data only}|Cost effective management programme for heart failure reduces hospitalisation|/resolve/reference/PMED?id=9930041
De Busk 2004 {published data only}|Care management for low-risk patients with heart failure: A randomized, controlled trial|/resolve/reference/PMED?id=15492340
Del Sindaco 2007 {published data only}|Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure|
Doughty 2002 {published data only}|Randomized, controlled trial of integrated heart failure management. The Auckland Heart Failure Management Study|/resolve/reference/PMED?id=11785996
Doughty 2002 {published data only}|Integrated care for patients with chronic heart failure: the New Zealand experience|
Ducharme 2005 {published data only}|Impact of care at a multidisciplinary congestive heart failure clinic: A randomized trial|/resolve/reference/PMED?id=15997043
Holland 2007 {published data only}|Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial|/resolve/reference/PMED?id=17452390
Jaarsma 2000 {published data only}|Self-care and quality of life in patients with advanced heart failure: the effect of a supportive educational intervention|
Jaarsma 2000 {published data only}|Effects of education and support on self-care and resource utilization in patients with heart failure|/resolve/reference/PMED?id=10208788
Jaarsma 2008 {published data only}|Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)|/resolve/reference/PMED?id=18268174
Kasper 2002 {published data only}|A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital re-admission|/resolve/reference/PMED?id=11823086
Kimmelstiel 2004 {published data only}|Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: The SPAN-CHF trial|/resolve/reference/PMED?id=15313938
Krumholz 2002 {published data only}|Randomized trial of an education and support intervention to prevent readmission of patients with heart failure|/resolve/reference/PMED?id=11755291
Kwok 2008 {published data only}|A randomized controlled trial of a community nurse-supported hospital discharge programme in older patients with chronic heart failure|
Lopez 2006 {published data only}|Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure|
Mejhert 2004 {published data only}|A nurse-based management program in heart failure patients affects females and persons with cognitive dysfunction most|/resolve/reference/PMED?id=16009290
Mejhert 2004 {published data only}|Limited long term effects of a management programme for heart failure|/resolve/reference/PMED?id=15310688
Naylor 2004 {published data only}|Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure|/resolve/reference/PMED?id=17044764
Naylor 2004 {published data only}|Transitional Care of Older Adults Hospitalized with Heart Failure: A Randomized, Controlled Trial|
Nucifora 2006 {published data only}|Lack of improvement of clinical outcomes by a low-cost, hospital-based heart failure management programme|/resolve/reference/PMED?id=16858241
Rainville 1999 {published data only}|Impact of pharmacist interventions on hospital re-admissions for heart failure|/resolve/reference/PMED?id=10683133
Stewart 1999a {published data only}|A specialist nurse-led intervention in Australia|
Stewart 1999a {published data only}|Effects of a multidisciplinary, home-based intervention on unplanned re-admissions and survival among patients with chronic congestive heart failure: a randomised controlled study|/resolve/reference/PMED?id=10509499
Stromberg 2003 {published data only}|Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: Results from a prospective, randomised trial|/resolve/reference/PMED?id=12788301
Thompson 2005 {published data only}|Effects of a nurse-led, clinic and home-based intervention on recurrent hospital use in chronic heart failure|/resolve/reference/PMED?id=15718178
Tsuyuki 2004 {published data only}|A multicenter disease management program for hospitalized patients with heart failure|/resolve/reference/PMED?id=15599837
Aiken 2006 {published data only}|Outcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill|/resolve/reference/PMED?id=16430351
Akosah 2002 {published data only}|Improving care for patients with chronic heart failure in the community: The importance of a disease management program|/resolve/reference/PMED?id=12226031
Akosah 2004 {published data only}|Short-term aggressive disease management programs for heart failure: Effect on drug utilization, clinical outcomes, and costs|
Artinian 2003 {published data only}|Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure|
Austin 2007 {published data only}|Randomised controlled trial of cardiac rehabilitation in elderly patients with heart failure|/resolve/reference/PMED?id=15718182
Azad 2008 {published data only}|Lessons learned from a multidisciplinary heart failure clinic for older women: a randomised controlled trial|/resolve/reference/PMED?id=18285347
Azevedo 2002 {published data only}|Effect of a heart failure clinic on survival and hospital readmission in patients discharged from acute hospital care|/resolve/reference/PMED?id=12034162
Barth 2001 {published data only}|A nurse-managed discharge program for congestive heart failure patients: outcomes and costs|
Benatar 2003 {published data only}|Outcomes of chronic heart failure|/resolve/reference/PMED?id=12578516
Blaha 2000 {published data only}|Longitudinal nursing case management for elderly heart failure patients: notes from the field|
Bondmass 2007 {published data only}|Improving outcomes for African Americans with chronic heart failure: a comparison of two home care management delivery methods|
Bouvy 2003 {published data only}|Effect of a Pharmacist-Led Intervention on Diuretic Compliance in Heart Failure Patients: A Randomized Controlled Study|/resolve/reference/PMED?id=14583903
Bucci 2003 {published data only}|Pharmacist's contribution in a heart function clinic: Patient perception and medication appropriateness|/resolve/reference/PMED?id=12704485
Cleland 2005 {published data only}|Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: The Trans-European Network-Home-Care Management System (TEN-HMS) study|/resolve/reference/PMED?id=15893183
Cordisco 1999 {published data only}|Use of telemonitoring to decrease the rate of hospitalization in patients with severe congestive heart failure|/resolve/reference/PMED?id=10513789
Costantini 2001 {published data only}|Impact of a guideline-based disease management team on outcomes of hospitalized patients with congestive heart failure|/resolve/reference/PMED?id=11176730
de la Porte 2007 {published data only}|Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study|/resolve/reference/PMED?id=17065182
de Lusignan 1999 {published data only}|A controlled pilot study in the use of telemedicine in the community on the management of heart failure-a report of the first three months|/resolve/reference/PMED?id=10747531
Dewalt 2006 {published data only}|A heart failure self-management program for patients of all literacy levels: a randomized, controlled trial [ISRCTN11535170]|/resolve/reference/PMED?id=16533388
Discher 2003 {published data only}|Heart failure disease management: Impact on hospital care, length of stay, and reimbursement|
Duffy 2005 {published data only}|Development and testing of a caring-based intervention for older adults with heart failure|
Ekman 1998 {published data only}|Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure|/resolve/reference/PMED?id=9740348
Ekman 1998 {published data only}|Outpatient care programmes for the elderly [letter]|/resolve/reference/PMED?id=10206388
Evans 1993 {published data only}|Evaluating hospital discharge planning: a randomized clinical trial|/resolve/reference/PMED?id=8464252
Farag 1967 {published data only}|Preventing recurrences of congestive heart failure|/resolve/reference/PMED?id=6027630
Feldman 2004 {published data only}|A randomized intervention to improve heart failure outcomes in community-based home health care|/resolve/reference/PMED?id=15160686
Fitzgerald 1994 {published data only}|A case manager intervention to reduce readmissions|/resolve/reference/PMED?id=8042889
Flynn 2005 {published data only}|Increasing self-management skills in heart failure patients: a pilot study|
Foley 2008 {published data only}|In the news. Heart failure study: nurse-led management proves disheartening.|
Fonarow 2004 {published data only}|Heart failure disease management programs not a class effect|/resolve/reference/PMED?id=15583088
Galbreath 2004 {published data only}|Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure|/resolve/reference/PMED?id=15531765
Gattis 1999 {published data only}|Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study|/resolve/reference/PMED?id=10493325
GESICA 2005 {published data only}|Randomised trial of telephone intervention in chronic heart failure: DIAL trial|/resolve/reference/PMED?id=16061499
Goldberg 2003 {published data only}|Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: The Weight Monitoring in Heart Failure (WHARF) trial|/resolve/reference/PMED?id=14564327
Goodyer 1995 {published data only}|Does encouraging good compliance improve patients' clinical condition in heart failure?|
Grancelli 2003 {published data only}|Randomized controlled trial of telephone intervention in chronic heart failure (DIAL): study design and preliminary observations|/resolve/reference/PMED?id=12815566
Gregory 2006 {published data only}|Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial|/resolve/reference/PMED?id=16644325
Hanchett 1967 {published data only}|A public health home nursing program for outpatients with heart diseases|/resolve/reference/PMED?id=4962116
Hansen 1992 {published data only}|Geriatric follow-up by home visits after discharge from hospital: a randomized controlled trial|/resolve/reference/PMED?id=1471584
Harrison 2002 {published data only}|Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition|/resolve/reference/PMED?id=12021683
Heidenreich 1999 {published data only}|Effect of a home monitoring system on hospitalization and resource use for patients with heart failure|/resolve/reference/PMED?id=10502207
Hughes 2000 {published data only}|Effectiveness of team-managed home-based primary care: A randomized multicenter trial|/resolve/reference/PMED?id=11147984
Inglis 2006 {published data only}|Extending the horizon in chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care|/resolve/reference/PMED?id=17116767
Jaarsma 2004 {published data only}|Design and methodology of the COACH study: A multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure|/resolve/reference/PMED?id=14984731
Jain 2005 {published data only}|Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents|/resolve/reference/PMED?id=15718181
Jerant 2001 {published data only}|Reducing the cost of frequent hospital admissions for congestive heart failure: a randomized trial of a home telecare intervention|/resolve/reference/PMED?id=11606877
Johnson 2000 {published data only}|Outcomes of the Kaiser Permanente Tele-Home Health Research Project|/resolve/reference/PMED?id=10664641
Karlsson 2005 {published data only}|A nurse-based management program in heart failure patients affects females and persons with cognitive dysfunction most|/resolve/reference/PMED?id=16009290
Khunti 2007 {published data only}|Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial|/resolve/reference/PMED?id=17309907
Khunti 2007 {published data only}|Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care|/resolve/reference/PMED?id=18450843
Laramee 2003 {published data only}|Case management in a heterogeneous congestive heart failure population: A randomized controlled trial|/resolve/reference/PMED?id=12695272
Ledwidge 2003 {published data only}|Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care|/resolve/reference/PMED?id=12798838
Ledwidge 2003 {published data only}|Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care|/resolve/reference/PMED?id=12798838
Lin 2001 {published data only}|Effects of systematic nursing interventions on knowledge, attitude and self-care behaviors of patients with heart failure|
Linden 2005 {published data only}|Using propensity scores to construct comparable control groups for disease management program evaluation|
Martensson 2005 {published data only}|Patients with heart failure in primary health care: Effects of a nurse-led intervention on health-related quality of life and depression.|
McCoy 2007 {published data only}|A Correlational Pilot Study of Home Health Nurse Management of Heart Failure Patients and Hospital Readmissions|
McDonald 2002 {published data only}|Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge|
McDonald 2002 {published data only}|Heart failure management: Multidisciplinary care has intrinsic benefit above the optimization of medical care|/resolve/reference/PMED?id=12140806
Murray 2007 {published data only}|Pharmacist intervention to improve medication adherence in heart failure: a randomized trial|/resolve/reference/PMED?id=17502632
Naylor 1994 {published data only}|Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial|/resolve/reference/PMED?id=8185149
Naylor 1999 {published data only}|Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial|/resolve/reference/PMED?id=10029122
Naylor 1999 {published data only}|The effects of a discharge planning and home follow-up intervention on elders hospitalized with common medical and surgical cardiac conditions|/resolve/reference/PMED?id=10533691
Nguyen 2007 {published data only}|Lack of long-term benefits of a 6-month heart failure disease management program|/resolve/reference/PMED?id=17517349
Ojeda 2005 {published data only}|Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: are effects maintained after stopping the programme?|/resolve/reference/PMED?id=16051519
Palmer 2003 {published data only}|Specialist Nurse-Led Intervention in Outpatients with Congestive Heart Failure: Impact on Clinical and Economic Outcomes|
Panella 2005 {published data only}|The effectiveness of an integrated care pathway for inpatient heart failure treatment: results of a trial in a community hospital|
Patel 2008 {published data only}|Home care as an option in worsening chronic heart failure -- a pilot study to evaluate feasibility, quality adjusted life years and cost-effectiveness|/resolve/reference/PMED?id=18573692
Peters-Klimm 2007 {published data only}|Rationale, design and conduct of a randomised controlled trial evaluating a primary care-based complex intervention to improve the quality of life of heart failure patients: HICMan (Heidelberg Integrated Case Management)|/resolve/reference/PMED?id=17716364
Philbin 2000 {published data only}|The results of a randomized trial of a quality improvement intervention in the care of patients with heart failure|/resolve/reference/PMED?id=11042232
Powell 2008 {published data only}|The Heart Failure Adherence and Retention Trial (HART): design and rationale|/resolve/reference/PMED?id=18760125
Quinn 2006 {published data only}|Low-technology heart failure care in home health: improving patient outcomes|/resolve/reference/PMED?id=17012959
Ramachandran 2007 {published data only}|Impact of a comprehensive telephone-based disease management programme on quality-of-life in patients with heart failure|
Rao 2007 {published data only}|Impact of specialist care in patients with newly diagnosed heart failure: A randomised controlled study|/resolve/reference/PMED?id=16814411
Rich 1993 {published data only}|Prevention of re-admission in elderly patients with congestive heart failure: Results of a prospective, randomized pilot study|/resolve/reference/PMED?id=8289096
Rich 1995 {published data only}|A multidisciplinary intervention to prevent the re-admission of elderly patients with congestive heart failure|/resolve/reference/PMED?id=7565975
Rich 1995 {published data only}|Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure|/resolve/reference/PMED?id=8873488
Riegel 2000 {published data only}|Which patents with heart failure respond best to multidisciplinary disease management?|/resolve/reference/PMED?id=11145753
Riegel 2002 {published data only}|Standardized telephonic case management in a Hispanic heart failure population: An effective intervention|
Riegel 2002 {published data only}|Standardized telephonic case management in a Hispanic heart failure population: An effective intervention|
Riegel 2002 {published data only}|Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure|/resolve/reference/PMED?id=11911726
Riegel 2002 {published data only}|Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure|/resolve/reference/PMED?id=11911726
Rondinini 2008 {published data only}|Survival and hospitalization in a nurse-led domiciliary intervention for elderly heart failure patients|/resolve/reference/PMED?id=18403998
Rubin 1992 {published data only}|The effect of geriatric evaluation and management on Medicare reimbursement in a large public hospital: a randomized clinical trial|/resolve/reference/PMED?id=1401688
Schneider 1993 {published data only}|A medication discharge planning program: measuring the effect on readmissions|/resolve/reference/PMED?id=8453387
Serxner 1998 {published data only}|Congestive heart failure disease management study: a patient education intervention|
Shively 2005 {published data only}|Effect of behavioral management on quality of life in mild heart failure: A randomized controlled trial|/resolve/reference/PMED?id=15950833
Sisk 2006 {published data only}|Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community|/resolve/reference/PMED?id=18936502
Sisk 2006 {published data only}|Improving patient care. Effects of nurse management on the quality of heart failure care in minority communities: a randomized trial|/resolve/reference/PMED?id=16908918
Smeulders 2006 {published data only}|Evaluation of a self-management programme for congestive heart failure patients: design of a randomised controlled trial|/resolve/reference/PMED?id=16857049
Smith 2005 {published data only}|Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients|/resolve/reference/PMED?id=16268753
Stewart 1998a {published data only}|Effects of home-based intervention on unplanned re-admissions and out-of-hospital deaths|/resolve/reference/PMED?id=9475445
Stewart 1998b {published data only}|Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care|/resolve/reference/PMED?id=9605777
Stewart 1999b {published data only}|Prolonged beneficial effects of a home-based intervention on unplanned re-admissions and mortality among patients with congestive heart failure|/resolve/reference/PMED?id=9989537
Stewart 2002b {published data only}|Home-based intervention in congestive heart failure: long-term implications on readmission and survival|/resolve/reference/PMED?id=12070114
Topp 1998 {published data only}|Effect of a clinical case manager/clinical nurse specialist on patients hospitalized with congestive heart failure|
Townsend 1988 {published data only}|Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme: a randomised controlled trial|/resolve/reference/PMED?id=2844356
Trochu 2003 {published data only}|Efficacy of a multidisciplinary management of chronic heart failure patients: one year results of a multicentre randomized trial in French medical practice|
van Rossum 1993 {published data only}|Effects of preventive home visits to elderly people|/resolve/reference/PMED?id=8343668
Weinberger 1996 {published data only}|Does increased access to primary care reduce hospital re-admissions?|/resolve/reference/PMED?id=8618584
Williams 1994 {published data only}|Do follow-up home visits by military nurses of chronically ill medical patients reduce readmissions?|/resolve/reference/PMED?id=8202242
Wongpiriyayothar 2008 {published data only}|Effects of home-based care program on symptom alleviation and well-being among persons with chronic heart failure|
Wright 2003 {published data only}|Uptake of self-management strategies in a heart failure management programme|/resolve/reference/PMED?id=12798837
Alcides2004 {published data only}|Heart failure clinics: The Brazilian experience|
Anguita 2005 {published data only}|A cost-benefit analysis of disease management programs for preventing rehospitalizations in patients with heart failure. Economic impact of new organizative forms of heart failure management|
Brotons 2005 {published data only}|Randomised clinical trial to evaluate the efficacy of a multi-factorial intervention to reduce hospitalisation and improve the quality of life of patients with heart failure|/resolve/reference/PMED?id=16194498
Fabbri 2007 {published data only}|Heart failure: the importance of a disease management program|/resolve/reference/PMED?id=17633908
Jaarsma 2003 {published data only}|Effectiveness of heart failure clinics in the Netherlands: Research program set-up|/resolve/reference/PMED?id=12677952
Valle 2004 {published data only}|A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization|
Wierzchowiecki 2006a {published data only}|[New multidisciplinary heart failure care program (six-month preliminary observation)]|/resolve/reference/PMED?id=17405287
Wierzchowiecki 2006b {published data only}|A new programme of multidisciplinary care for patients with heart failure in Poznan: one-year follow-up|/resolve/reference/PMED?id=17089238
Hardman S {published data only}|The evaluation of a nurse-led intervention to improve self-management for patients admitted to hospital with a diagnosis of heart failure (due to left ventricular systolic dysfunction).|
Massie 2001 {published data only}|A controlled trial of heart failure management programs.|
Moser 2000 {published data only}|Community case management decreases rehospitalisation rates and costs and improves quality of life in heart failure patients with preserved and non-preserved left ventricular function: a randomised controlled trial|
Pugh 1999 {published data only}|Partners in care: a model of collaboration|/resolve/reference/PMED?id=10196904
AHA 2004|Heart disease and stroke statistics - 2004 update|
Clark 2007|Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis|/resolve/reference/PMED?id=17426062
Clarke 1994|Evidence of inadequate investigation and treatment of patients with heart failure|/resolve/reference/PMED?id=8043344
Cleland 1999|Is the prognosis of heart failure improving?|/resolve/reference/PMED?id=10935669
Cleland 2003|The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe|/resolve/reference/PMED?id=12633546
Cowie 1997|The epidemiology of heart failure|/resolve/reference/PMED?id=9043837
Cowie 1999|Annotated references in epidemiology|/resolve/reference/PMED?id=10937987
Cowie 2000|Survival of patients with a new diagnosis of heart failure: a population based study|/resolve/reference/PMED?id=10768897
DoH 2004|Improving chronic disease management|
Eriksson 1995|Heart failure: a growing public health problem|
Feenstra 1998|Prevention of relapse in patients with congestive heart failure: the role of precipitating factors|/resolve/reference/PMED?id=9930039
Havranek 2002|Spectrum of heart failure in older patients: results from the National Heart Failure project|/resolve/reference/PMED?id=11868045
Higgins 2011|Chapter 8: Assessing risk of bias in included studies|
Inglis 2010|Structured telephone support or telemonitoring programmes for patients with chronic heart failure|
Jong 2002|Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study|/resolve/reference/PMED?id=12153371
Kannel 1991|Epidemiology of heart failure|/resolve/reference/PMED?id=2000773
Krumholz 1997|Readmission after hospitalization for congestive heart failure among Medicare beneficiaries|/resolve/reference/PMED?id=8996046
Levy 2002|Long term trends in incidence and survival with heart failure|/resolve/reference/PMED?id=12409541
McMurray 1993|Trends in hospitalization rates for heart failure in Scotland 1980-1990|/resolve/reference/PMED?id=8223728
Michalsen 1998|Preventable causative factors leading to hospital admission with decompensated heart failure|/resolve/reference/PMED?id=9930040
NICE 2010|Chronic heart failure: the management of chronic heart failure in adults in primary and secondary care|
Riegel 2001|Heart failure disease management models|
Royal College of Physicians 2004|Clinicians, services and commissioning in chronic disease management in the NHS: the need for coordinated management programmes|
Stewart 1989|Functional status and well-being of patients with chronic conditions|/resolve/reference/PMED?id=2754790
Stewart 2001b|More 'malignant' than cancer? Five-year survival following a first admission for heart failure|/resolve/reference/PMED?id=11378002
Stewart 2002a|The current cost of heart failure to the National Health Service in the UK|/resolve/reference/PMED?id=12034163
Taylor 2010|Home-based versus centre-based cardiac rehabilitation|
Verhagen 1998|The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus|/resolve/reference/PMED?id=10086815
Vinson 1990|Early re-admission of elderly patients with congestive heart failure|/resolve/reference/PMED?id=2254567
Taylor 2005|Clinical service organisation for heart failure|
Ades 1996 {published data only}|Weight training improves walking endurance in healthy elderly persons|/resolve/reference/PMED?id=8597320
Baker 2001 {published data only}|The efficacy of home based progressive strength training in older adults with knee osteoarthritis: A randomized controlled trial|/resolve/reference/PMED?id=11469475
Balagopal 2001 {published data only}|Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise|/resolve/reference/PMED?id=11158921
Ballor 1996 {published data only}|Contrasting effects of resistance and aerobic training on body composition and metabolism after diet-induced weight loss|/resolve/reference/PMED?id=8596486
Barrett 2002 {published data only}|A comparison of community-based resistance exercise and flexibility exercise for seniors|/resolve/reference/PMED?id=12217071
Baum 2003 {published data only}|Effectiveness of a group exercise program in a long-term care facility: a randomized pilot trial|/resolve/reference/PMED?id=12807578
Bean 2004 {published data only}|Increased Velocity Exercise Specific to Task (InVEST) training: a pilot study exploring effects on leg power, balance, and mobility in community-dwelling older women|
Beneka 2005 {published data only}|Resistance training effects on muscular strength of elderly are related to intensity and gender|/resolve/reference/PMED?id=16248468
Bermon 1999 {published data only}|Effects of a short-term strength training programme on lymphocyte subsets at rest in elderly humans|/resolve/reference/PMED?id=10090633
Boshuizen 2005 {published data only}|The effects of physical therapists' guidance on improvement in a strength-training program for the frail elderly|/resolve/reference/PMED?id=15677832
Brandon 2000 {published data only}|Effects of lower extremity strength training on functional mobility in older adults|
Brandon 2003 {published data only}|Effects of long-term resistive training on mobility and strength in older adults with diabetes|/resolve/reference/PMED?id=12902533
Brochu 2002 {published data only}|Resistance training increases total daily energy expenditure in disabled older women with coronary heart disease|/resolve/reference/PMED?id=15772059
Brochu 2002 {published data only}|Resistance training on physical performance in disabled older female cardiac patients|/resolve/reference/PMED?id=12900677
Brochu 2002 {published data only}|Effects of resistance training on physical function in older disabled women with coronary heart disease|/resolve/reference/PMED?id=11796680
Bruunsgaard 2004 {published data only}|Muscle strength after resistance training is inversely correlated with baseline levels of soluble tumor necrosis factor receptors in the oldest old|
Buchner 1997 {published data only}|The effect of strength and endurance training on gait, balance, fall risk and health services use in community-living older adults|/resolve/reference/PMED?id=9224433
Buchner 1997 {published data only}|Variability in the effect of strength training on skeletal muscle in older adults|
Buchner 1997 {published data only}|The relationship of joint symptoms with exercise performance in older adults|/resolve/reference/PMED?id=8537585
Casaburi 2004 {published data only}|Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15271690
Castaneda 2001 {published data only}|Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency|/resolve/reference/PMED?id=11730397
Castaneda 2004 {published data only}|Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease|/resolve/reference/PMED?id=15042537
Chandler 1998 {published and unpublished data}|Is lower extremity strength gain associated with improvement in physical performance and disability in frail, community-dwelling elders?|/resolve/reference/PMED?id=9440412
Charette 1991 {published data only}|Muscle hypertrophy response to resistance training in older women|/resolve/reference/PMED?id=1864770
Chin A Paw 2006 {published data only}|Effects of resistance and all-round, functional training on quality of life, vitality and depression of older adults living in long-term care facilities: A 'randomized' controlled trial [ISRCTN87177281]|/resolve/reference/PMED?id=15050032
Chin A Paw 2006 {published data only}|Once a week not enough, twice a week not feasible? A randomised controlled exercise trial in long-term care facilities [ISRCTN87177281]|/resolve/reference/PMED?id=16426800
Chin A Paw 2006 {published data only}|Effects of resistance and functional-skills training on habitual activity and constipation among older adults living in long-term care facilities: A randomized controlled trial|/resolve/reference/PMED?id=16875507
Collier 1997 {unpublished data only}||
Damush 1999 {published data only}|The effects of strength training on strength and health-related quality of life in older adult women|/resolve/reference/PMED?id=10650680
de Vos 2005 {published data only}|Optimal load for increasing muscle power during explosive resistance training in older adults|
de Vos 2005 {published data only}|Power training improves balance in healthy older adults|/resolve/reference/PMED?id=16456197
de Vreede 2007 {published data only}|Functional tasks exercise versus resistance exercise to improve daily function in older women: a feasibility study|/resolve/reference/PMED?id=15605332
de Vreede 2007 {published data only}|Functional-task exercise versus resistance strength exercise to improve daily function in older women: A randomized, controlled trial|
de Vreede 2007 {published data only}|The effect of functional tasks exercise and resistance exercise on health-related quality of life and physical activity: A randomized controlled trial|/resolve/reference/PMED?id=16940735
DeBeliso 2005 {published data only}|A comparison of periodised and fixed repetition training protocol on strength in older adults|/resolve/reference/PMED?id=16075779
DiFrancisco 2007 {published data only}|Comparison of once-weekly and twice-weekly strength training in older adults|/resolve/reference/PMED?id=17062657
Donald 2000 {published and unpublished data}|Preventing falls on an elderly care rehabilitation ward|/resolve/reference/PMED?id=10763795
Earles 2001 {published data only}|Velocity training induces power-specific adaptations in highly functioning older adults|/resolve/reference/PMED?id=11441371
Ettinger 1997 {published data only}|A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST)|/resolve/reference/PMED?id=8980206
Ettinger 1997 {published data only}|Physical exercise and comorbidity. Results from the Fitness and Arthritis in Seniors Trial (FAST)|/resolve/reference/PMED?id=17167301
Ettinger 1997 {published data only}|Long-term exercise and its effect on balance in older, osteoarthritic adults: results from the Fitness, Arthritis and Seniors Trial (FAST)|/resolve/reference/PMED?id=10682941
Ettinger 1997 {published data only}|Exercise and depressive symptoms: A comparison of aerobic and resistance exercise effects on emotional and physical function in older persons with high and low depressive symptomatology|
Ettinger 1997 {published data only}|Treating disability in knee osteoarthritis with exercise therapy: a central role for self-efficacy and pain|
Ettinger 1997 {published data only}|Cost-effectiveness of aerobic and resistance exercise in seniors with knee osteoarthritis|/resolve/reference/PMED?id=10994901
Fahlman 2002 {published data only}|Effects of endurance training and resistance training on plasma lipoprotein profiles in elderly women|/resolve/reference/PMED?id=11818424
Fatouros 2002 {published data only}|The effects of strength training, cardiovascular training and their combination on flexibility of inactive older adults|/resolve/reference/PMED?id=11842358
Fatouros 2005 {published data only}|Resistance training and detraining effects on flexibility performance in the elderly are intensity-dependent|/resolve/reference/PMED?id=16937978
Fatouros 2005 {published data only}|Strength training and detraining effects on muscular strength, anaerobic power, and mobility of inactive older men are intensity dependent|/resolve/reference/PMED?id=16183776
Fatouros 2005 {published data only}|Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related|/resolve/reference/PMED?id=16091494
Fiatarone 1994 {published data only}|Exercise training and nutritional supplementation for physical frailty in very elderly people|/resolve/reference/PMED?id=8190152
Fiatarone 1994 {published data only}|Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders|/resolve/reference/PMED?id=10409137
Fiatarone 1997 {published data only}|Efficacy of home-based resistance training in frail elders|
Fielding 2002 {published data only}|High-velocity resistance training increases skeletal muscle peak power in older women.[see comment]|
Fielding 2002 {published data only}|Changes in function and disability after resistance training: does velocity matter? A pilot study|/resolve/reference/PMED?id=12872017
Flynn 1999 {published data only}|Effects of resistance training on selected indexes of immune function in elderly women|/resolve/reference/PMED?id=10368355
Foley 2003 {published data only}|Does hydrotherapy improve strength and physical function in patients with osteoarthritis - A randomised controlled trial comparing a gym based and a hydrotherapy based strengthening programme|/resolve/reference/PMED?id=14644853
Frontera 2003 {published data only}|Strength training in older women: early and late changes in whole muscle and single cells|
Galvao 2005 {published data only}|Resistance exercise dosage in older adults: Single- versus multiset effects on physical performance and body composition|
Hagerman 2000 {published data only}|Effects of high-intensity resistance strength training on untrained older men 1. Strength, cardiovascular and metabolic responses|
Harris 2004 {published data only}|The effect of resistance-training intensity on strength-gain response in the older adult|/resolve/reference/PMED?id=15574091
Haykowsky 2000 {published data only}|Effects of 16 weeks of resistance training on left ventricular morphology and systolic function in healthy men >60 years of age|/resolve/reference/PMED?id=10760343
Haykowsky 2005 {published data only}|Effect of exercise training on peak aerobic power, left ventricular morphology, and muscle strength in healthy older women|/resolve/reference/PMED?id=15860465
Hennessey 2001 {published data only}|Growth hormone administration and exercise effects on muscle fibre type and diameter in moderately frail older people|
Hepple 1997 {published data only}|Resistance and aerobic training in older men: effects on VO2 peak and the capillary supply to skeletal muscle|/resolve/reference/PMED?id=9104869
Hiatt 1994 {published data only}|Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease|/resolve/reference/PMED?id=7923674
Hiatt 1994 {published data only}|Exercise training improves functional status in patients with peripheral arterial disease|/resolve/reference/PMED?id=8558725
Hortobagyi 2001 {published data only}|Low- or high-intensity strength training partially restores impaired quadriceps force accuracy and steadiness in aged adults|
Hruda 2003 {published data only}|Training for muscle power in older adults: effects on functional abilities|/resolve/reference/PMED?id=12825328
Hunter 2001 {published data only}|High-resistance versus variable-resistance training in older adults|/resolve/reference/PMED?id=11581563
Izquierdo 2004 {published data only}|Once weekly combined resistance and cardiovascular training in healthy older men|/resolve/reference/PMED?id=15076785
Jette 1996 {published data only}|A home-based exercise program for nondisabled older adults|/resolve/reference/PMED?id=8642153
Jette 1999 {published and unpublished data}|Lower-limb extensor power and lifting characteristics in disabled elders|/resolve/reference/PMED?id=15074445
Jette 1999 {published and unpublished data}|Exercise - it's never too late: The strong-for-life program|/resolve/reference/PMED?id=9987467
Jette 1999 {published and unpublished data}|Moderate exercise improves gait stability in disabled elders|/resolve/reference/PMED?id=9862288
Jones 1994 {published data only}|Effects of a resistance training program on leg strength and muscular endurance in older women|/resolve/reference/PMED?id=8775717
Jubrias 2001 {published data only}|Large energetic adaptations of elderly muscle to resistance and endurance training|/resolve/reference/PMED?id=11299253
Judge 1994 {published data only}|Effects of resistance and balance exercises on isokinetic strength in older persons|/resolve/reference/PMED?id=8064101
Judge 1994 {published data only}|Balance and strength training in older adults: intervention gains and tai chi maintenance|/resolve/reference/PMED?id=8617896
Kalapotharakos 2005 {published data only}|Effects of a heavy and a moderate resistance training on functional performance in older adults|/resolve/reference/PMED?id=16095421
Kalapotharakos 2005 {published data only}|The effects of high- and moderate-resistance training on muscle function in the elderly|/resolve/reference/PMED?id=15223882
Kalapotharakos 2005 {published data only}|Effects of a resistance exercise programme on the performance of inactive older adults|
Kalapotharakos 2005 {published data only}|Resistance training in older women: effect on vertical jump and functional performance|/resolve/reference/PMED?id=16446692
Kallinen 2002 {published data only}|Improving cardiovascular fitness by strength or endurance training in women aged 76-78 years. A population-based, randomized controlled trial|/resolve/reference/PMED?id=12147561
Katznelson 2006 {published data only}|Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men|/resolve/reference/PMED?id=17132757
Kongsgaard 2004 {published data only}|Heavy resistance training increases muscle size, strength and physical function in elderly male COPD-patients - a pilot study|/resolve/reference/PMED?id=15481277
Krebs 2007 {published data only}|Functional vs. strength training in disabled elderly outpatients|/resolve/reference/PMED?id=17251692
Lamoureux 2003 {published data only}|The effects of improved strength on obstacle negotiation in community-living older adults|/resolve/reference/PMED?id=12770641
Lamoureux 2003 {published data only}|The effects of progressive resistance training on obstructed-gait tasks in community-living older adults|
Latham 2001 {published and unpublished data}|Progressive resistance strength training in hospitalised older people: a preliminary investigation|
Latham 2003 {published data only}|A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS)|
Liu-Ambrose 2005 {published data only}|Resistance and agility training reduce fall risk in women aged 75 to 85 with low bone mass: a 6-month randomized, controlled trial|
Liu-Ambrose 2005 {published data only}|Balance confidence improves with resistance or agility training: Increase is not correlated with objective changes in fall risk and physical abilities|/resolve/reference/PMED?id=15477698
Liu-Ambrose 2005 {published data only}|Both resistance and agility training reduce back pain and improve health-related quality of life in older women with low bone mass|/resolve/reference/PMED?id=15702262
Liu-Ambrose 2005 {published data only}||
Macaluso 2003 {published data only}|Cycling as a novel approach to resistance training increases muscle strength, power, and selected functional abilities in healthy older women|/resolve/reference/PMED?id=12937026
Madden 2006 {published data only}|Exercise training and heart rate variability in older adult female subjects|/resolve/reference/PMED?id=16553360
Maiorana 1997 {published data only}|A controlled trial of circuit weight training on aerobic capacity and myocardial oxygen demand in men after coronary artery bypass surgery|/resolve/reference/PMED?id=9271767
Malliou 2003 {published data only}|Different training programs for improving muscular performance in healthy inactive elderly|
Mangione 2005 {published data only}|Can elderly patients who have had a hip fracture perform moderate- to high-intensity exercise at home?|/resolve/reference/PMED?id=16048421
Manini 2005 {published data only}|Resistance and functional training reduces knee extensor position fluctuations in functionally limited older adults|/resolve/reference/PMED?id=16193338
Maurer 1999 {published data only}|Osteoarthritis of the knee: isokinetic quadriceps exercise versus an educational intervention|/resolve/reference/PMED?id=10527090
McCartney 1995 {published data only}|A longitudinal trial of weight training in the elderly: continued improvements in year 2|/resolve/reference/PMED?id=8914492
McCartney 1995 {published data only}|Long-term resistance training in elderly: Effects on dynamic strength, exercise capacity, muscle and bone|/resolve/reference/PMED?id=7874586
McGuigan 2001 {published data only}|Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, fiber type distribution and capillary supply to skeletal muscle|/resolve/reference/PMED?id=11445595
McMurdo 1995 {published data only}|A randomized controlled trial of a home exercise programme for elderly people with poor mobility|/resolve/reference/PMED?id=8669348
Mihalko 1996 {published data only}|Strength training effects on subjective well-being and physical function in the elderly|
Mikesky 2006 {published data only}|Effects of strength training on the incidence and progression of knee osteoarthritis|
Miller 2006 {published data only}|Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial|/resolve/reference/PMED?id=16719029
Miszko 2003 {published data only}|Effect of strength and power training on physical function in community-dwelling older adults|/resolve/reference/PMED?id=12586856
Moreland 2001 {unpublished data only}||
Moreland 2001 {unpublished data only}|Progressive resistance strengthening exercises after stroke: a single-blind randomized controlled trial|/resolve/reference/PMED?id=14586909
Nelson 1994 {published data only}|Strength improvements with 1 yr of progressive resistance training in older women|/resolve/reference/PMED?id=7658954
Nelson 1994 {published data only}|Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures|/resolve/reference/PMED?id=7990242
Newnham 1995 {unpublished data only}||
Nichols 1993 {published data only}|Efficacy of heavy-resistance training for active women over sixty: Muscular strength, body composition and program adherence|/resolve/reference/PMED?id=8440838
Ouellette 2004 {published data only}|High-intensity resistance training improves muscle strength, self-reported function, and disability in long-term stroke survivors|/resolve/reference/PMED?id=15105515
Parkhouse 2000 {published data only}|IGF-1 bioavailabililty is increased by resistance training in older women with low bone mineral density|/resolve/reference/PMED?id=10708256
Pollock 1991 {published data only}|Cardiovascular responses of 70- to 79-year-old mean and women to exercise training|/resolve/reference/PMED?id=2745320
Pollock 1991 {published data only}|Effect of aerobic and resistance training on fractionated reaction time and speed of movement|/resolve/reference/PMED?id=2295775
Pollock 1991 {published data only}|Injuries and adherence to walk/jog and resistance training programs in the elderly|/resolve/reference/PMED?id=1758297
Pu 2001 {published data only}|Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure|/resolve/reference/PMED?id=11356801
Rall 1996 {published data only}|The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition|
Rall 1996 {published data only}|Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor alpha|
Rall 1996 {published data only}|Effects of progressive resistance training on immune response in aging and chronic inflammation|/resolve/reference/PMED?id=8933485
Reeves 2004 {published data only}|In vivo human muscle structure and function: adaptations to resistance training in old age|
Reeves 2004 {published data only}|Strength training alters the viscoelastic properties of tendons in elderly humans|
Rhodes 2000 {published data only}|Effects of one year of resistance training on the relation between muscular strength and bone density in elderly women|/resolve/reference/PMED?id=10690445
Schilke 1996 {published data only}|Effects of muscle-strength training on the functional status of patients with osteoarthritis of the knee joint|/resolve/reference/PMED?id=8604366
Schlicht 1999 {published and unpublished data}||
Schlicht 1999 {published and unpublished data}|Effect of intense strength training on standing balance, walking speed and sit-to-stand performance in older adults|/resolve/reference/PMED?id=11320107
Segal 2003 {published data only}|Resistance exercise in men receiving androgen deprivation therapy for prostate cancer|/resolve/reference/PMED?id=12721238
Selig 2004 {published data only}|Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow|/resolve/reference/PMED?id=14966771
Seynnes 2004 {published data only}|Physiological and functional responses to low-moderate versus high-intensity progressive resistance training in frail elders|/resolve/reference/PMED?id=15123761
Simoneau 2006 {published data only}|Strength training in old age: adaptation of antagonist muscles at the ankle joint|
Simons 2006 {published data only}|The effects of resistance training and walking on functional fitness in advanced old age|/resolve/reference/PMED?id=16470977
Simpson 1992 {published data only}|Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation|/resolve/reference/PMED?id=1549826
Sims 2006 {published data only}|Exploring the feasibility of a community-based strength training program for older people with depressive symptoms and its impact on depressive symptoms|/resolve/reference/PMED?id=17134517
Singh 1997 {published data only}|A randomised trial of progressive resistance training in depressed elders|/resolve/reference/PMED?id=9008666
Singh 1997 {published data only}|The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized controlled trial|
Singh 2005 {published data only}|A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults|/resolve/reference/PMED?id=15983181
Sipila 1996 {published data only}|Effects of strength and endurance training on isometric muscle strength and walking speed in elderly women|
Skelton 1995 {published and unpublished data}|Effects of resistance training on strength, power, and functional abilities of women aged 75 and older|/resolve/reference/PMED?id=7560695
Skelton 1996 {published and unpublished data}|Training functional ability in old age|
Sousa 2005 {published data only}|Effects of progressive strength training on the performance of the Functional Reach Test and the Timed Get-Up-and-Go Test in an elderly population from the rural north of Portugal|
Suetta 2004 {published data only}|Training-induced changes in muscle CSA, muscle strength, EMG, and rate of force development in elderly subjects after long-term unilateral disuse|/resolve/reference/PMED?id=15247162
Suetta 2004 {published data only}|Resistance training in the early postoperative phase reduces hospitalization and leads to muscle hypertrophy in elderly hip surgery patients - A controlled, randomized study|
Sullivan 2005 {published data only}|Effects of muscle strength training and testosterone in frail elderly males|/resolve/reference/PMED?id=16260965
Sullivan 2005 {published data only}|Effects of muscle strength training and megestrol acetate on strength, muscle mass, and function in frail older people|
Symons 2005 {published data only}|Effects of maximal isometric and isokinetic resistance training on strength and functional mobility in older adults|/resolve/reference/PMED?id=15983182
Taaffe 1996 {published data only}|Effects of a one-year high-intensity versus low-intensity resistance training program on bone mineral density in older women|
Taaffe 1996 {published data only}|Comparative effects of high- and low- intensity resistance training on thigh muscle strength, fiber area, and tissue composition in elderly women|
Taaffe 1996 {published data only}|Effect of sustained resistance training on basal metabolic rate in older women|/resolve/reference/PMED?id=7730525
Taaffe 1999 {published data only}|Once-weekly resistance exercise improves strength and neuromuscular performance in older adults|/resolve/reference/PMED?id=10522954
Topp 1993 {published data only}|Efficacy of a home-based training program for older adults using elastic tubing|/resolve/reference/PMED?id=7851367
Topp 1993 {published data only}|The effect of a 12-week dynamic resistance strength training on gait velocity and balance in older adults|/resolve/reference/PMED?id=8375679
Topp 1996 {published data only}|Effect of resistance training on strength, postural control and gait velocity in older adults|/resolve/reference/PMED?id=8970279
Topp 2002 {published data only}|The effect of dynamic versus isometric resistance training on pain and functioning among adults with osteoarthritis of the knee|/resolve/reference/PMED?id=12235596
Topp 2005 {published data only}|Exercise and functional tasks among adults who are functionally limited|/resolve/reference/PMED?id=15781902
Tracy 2004 {published data only}|Strength training reduces force fluctuations during anisometric contractions of the quadriceps femoris muscles in old adults|/resolve/reference/PMED?id=14565966
Tsutsumi 1997 {published and unpublished data}||
Tsutsumi 1997 {published and unpublished data}|Physical fitness and psychological benefits of strength training in community dwelling older adults|/resolve/reference/PMED?id=9545677
Tsutsumi 1997 {published and unpublished data}|Comparison of high and moderate intensity of strength training on mood and anxiety in older adults|/resolve/reference/PMED?id=9885072
Tyni-Lenne 2001 {published data only}|Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure|
Vincent 2002 {published data only}|Resistance exercise and bone turnover in elderly men and women|/resolve/reference/PMED?id=11782642
Vincent 2002 {published data only}|Homocysteine and lipoprotein levels following resistance training in older adults|
Vincent 2002 {published data only}|Improved cardiorespiratory endurance following 6 months of resistance exercise in elderly men and women|/resolve/reference/PMED?id=11911721
Vincent 2002 {published data only}|Resistance exercise and physical performance in adults aged 60 to 83|
Westhoff 2000 {published data only}|Effects of a low-intensity strength-training program on knee-extensor strength and functional ability of frail older people|
Wieser 2007 {published data only}|The effects of systematic resistance training in the elderly|/resolve/reference/PMED?id=16761216
Wood 2001 {published data only}|Concurrent cardiovascular and resistance training in healthy older adults|/resolve/reference/PMED?id=11581562
Adami 1999 {published data only}|Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women|
Adams 2001 {published data only}|Progressive strength training in sedentary older African American women|/resolve/reference/PMED?id=11528347
Agre 1988 {published data only}|Light resistance and stretching exercise in elderly women: effect upon strength|/resolve/reference/PMED?id=3355357
Agre 1988 {published data only}|Light resistance and stretching exercise in elderly women: effect upon flexibility|/resolve/reference/PMED?id=3355356
Alexander 2003 {published data only}||
Aniansson 1981 {published data only}|Physical training in elderly men with special reference to quadriceps muscle strength and morphology|
Annesi 2004 {published data only}|Preliminary evaluation of a 10-wk. resistance and cardiovascular exercise protocol on physiological and psychological measures for a sample of older women|/resolve/reference/PMED?id=15058879
Ardman 1998 {published data only}||
Ballard 2004 {published data only}|The effect of 15 weeks of exercise on balance, leg strength, and reduction in falls in 40 women aged 65 to 89 years|/resolve/reference/PMED?id=16845754
Barbosa 2002 {published data only}|Effects of resistance training on the sit-and-reach test in elderly women|/resolve/reference/PMED?id=11834101
Baum 2003b {published data only}|Reduction of blood pressure response during strength training through intermittent muscle relaxations|/resolve/reference/PMED?id=12905093
Bean 2002 {published data only}|Weighted stair climbing in mobility-limited older people: a pilot study|
Bellew 2003 {published data only}|The initial effects of low-volume strength training on balance in untrained older men and women|/resolve/reference/PMED?id=12580667
Beniamini 1997 {published data only}|Effects of high-intensity strength training on quality-of-life parameters in cardiac rehabilitation patients|/resolve/reference/PMED?id=9381995
Beniamini 1999 {published data only}|High-intensity strength training of patients enrolled in an outpatient cardiac rehabilitation program|/resolve/reference/PMED?id=10079415
Berg 1998 {published data only}|The effect of a "practical" resistance training intervention on mobility in independent, community-dwelling older adults|
Bernard 1999 {published data only}|Aerobic and strength training in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10051269
Bilodeau 2000 {published data only}|Strength training can improve steadiness in persons with essential tremor|
Binda 2003 {published data only}|Balance, muscle strength, and fear of falling in older adults|/resolve/reference/PMED?id=12623729
Binder 2002 {published data only}|Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial|
Binder 2002 {published data only}|Effects of progressive resistance training on body composition in frail older adults: Results of a randomized, controlled trial|/resolve/reference/PMED?id=16339329
Boardley 2007 {published data only}|The impact of exercise training on blood lipids in older adults|
Braith 2005 {published data only}|Effect of resistance exercise on skeletal muscle myopathy in heart transplant recipients|/resolve/reference/PMED?id=15877992
Brandon 2003b {published data only}|Effects of long-term resistive training on mobility and strength in older adults with diabetes|/resolve/reference/PMED?id=12902533
Brandon 2004 {published data only}|Resistive training and long-term function in older adults|/resolve/reference/PMED?id=15211018
Brill 1998 {published data only}|Improving functional performance through a group-based free weight strength training program in residents of two assisted living communities|
Brill 1998 {published data only}|Clinical feasibility of a free-weight strength-training program for older adults|/resolve/reference/PMED?id=9875999
Brose 2003 {published data only}|Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults|/resolve/reference/PMED?id=12560406
Brown 1990 {published data only}|Positive adaptations to weight-lifting in the elderly|/resolve/reference/PMED?id=2272965
Brown 1991 {published data only}|Effects of a low intensity exercise program on selected physical performance characteristics of 60- to 70- year olds|/resolve/reference/PMED?id=1911901
Brown 2000 {published data only}|Low-intensity exercise as a modifier of physical frailty in older adults|/resolve/reference/PMED?id=10896013
Bunout 2001 {published data only}|Effects of nutritional supplementation and resistance training on muscle strength in free living elders. Results of one year follow|/resolve/reference/PMED?id=14978601
Bunout 2001 {published data only}|Results of a community-based weight-bearing resistance training programme for healthy Chilean elderly subjects|/resolve/reference/PMED?id=15591487
Bunout 2001 {published data only}|The impact of nutritional supplementation and resistance training on the health and function of free-living Chilean elders: results of 18 months of follow-up|/resolve/reference/PMED?id=11533291
Bunout 2001 {published data only}|Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects|/resolve/reference/PMED?id=16797903
Campbell 2002 {published data only}|Effects of resistive training and chromium picolinate on body composition and skeletal muscle size in older women|/resolve/reference/PMED?id=12187613
Campbell 2004 {published data only}|Resistive training and chromium picolinate: Effects on inositols and liver and kidney functions in older adults|/resolve/reference/PMED?id=15467101
Cancela 2003 {published data only}|Effect of strength program on a 65 years old elderly woman [Spanish]|
Candow 2004 {published data only}|Effect of ceasing creatine supplementation while maintaining resistance training in older men|/resolve/reference/PMED?id=15263100
Capodaglio 2002 {published data only}|Effectiveness of a home-based strengthening program for elderly males in Italy. A preliminary study|/resolve/reference/PMED?id=12027149
Carter 2002 {published data only}|Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial|/resolve/reference/PMED?id=12403738
Carter 2005 {published data only}|Does nutritional supplementation influence adaptability of muscle to resistance training in men aged 48 to 72 years|/resolve/reference/PMED?id=16236227
Carvalho 2002 {published data only}||
Cauza 2005 {published data only}|Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system|
Cauza 2005b {published data only}|The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus|/resolve/reference/PMED?id=16084803
Chaloupka 2000 {published data only}|Strength training in patients after myocardial infarct|/resolve/reference/PMED?id=11214360
Chetlin 2004 {published data only}|Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription|/resolve/reference/PMED?id=15295743
Chiba 2006 {published data only}|Positive effects of resistance training on QOL in the frail elderly|/resolve/reference/PMED?id=17228754
Chien 2005 {published data only}|Home-based trunk-strengthening exercise for osteoporotic and osteopenic postmenopausal women without fracture - A pilot study|/resolve/reference/PMED?id=15704506
Connelly 1995 {published data only}|Effects of detraining on knee extensor strength and functional mobility in a group of elderly women|/resolve/reference/PMED?id=9402571
Connelly 1995 {published data only}|Improvement in knee extensor strength of institutionalized elderly women after exercise with ankle weights|
Connelly 2000 {published data only}|Effects of isokinetic strength training on concentric and eccentric torque development in the ankle dorsiflexors of older adults|/resolve/reference/PMED?id=11034219
Cramp 2006 {published data only}|Low intensity strength training for ambulatory stroke patients|
Cress 1991 {published data only}|Effect of training on VO2 max, thigh strength and muscle morphology in septuagenarian women|/resolve/reference/PMED?id=1886486
Cress 1999 {published data only}|Exercise: effects on physical functional performance in older adults|/resolve/reference/PMED?id=10362007
Daepp 2006 {published data only}|Slimmer and stronger - the effect of eccentric exercise in the elderly|
Daly 2005 {published data only}|Does high-intensity resistance training maintain bone mass during moderate weight loss in older overweight adults with type 2 diabetes?|/resolve/reference/PMED?id=15937634
de Bruin 2007 {published data only}|Strength training and balance performance compared to combined strength and agility training in elderly over 80 years: a three months RCT|
de Bruin 2007 {published data only}|Effect of additional functional exercises on balance in elderly people|/resolve/reference/PMED?id=17264105
de Vito 1999 {published data only}|Effects of a low-intensity programme on VO2 max and maximal instantaneous peak power in elderly women|/resolve/reference/PMED?id=10453925
DeBolt 2004 {published data only}|The effects of home-based resistance exercise on balance, power, and mobility in adults with multiple sclerosis|/resolve/reference/PMED?id=14966716
Delagardelle 2002 {published data only}|Strength/endurance training versus endurance training in congestive heart failure|/resolve/reference/PMED?id=12471289
Delecluse 2004 {published data only}|Exercise programs for older men: mode and intensity to induce the highest possible health-related benefits|/resolve/reference/PMED?id=15351552
DeVito 2003 {published data only}|Physical performance effects of low-intensity exercise among clinically defined high-risk elders|/resolve/reference/PMED?id=12679604
Dibble 2006 {published data only}|The safety and feasibility of high-force eccentric resistance exercise in persons with Parkinson's disease|/resolve/reference/PMED?id=16935068
Dibble 2006b {published data only}|High-intensity resistance training amplifies muscle hypertrophy and functional gains in persons with Parkinson's disease|
Dunstan 2002 {published data only}|High-intensity resistance training improves glycemic control in older patients with type 2 diabetes|/resolve/reference/PMED?id=12351469
Dunstan 2005 {published data only}|Home-based resistance training is not sufficient to maintain improved glycemic control following supervised training in older individuals with type 2 diabetes|/resolve/reference/PMED?id=15616225
Dupler 1993 {published data only}|Effects of a whole-body resistive training regimen in the elderly|/resolve/reference/PMED?id=8144045
Fernandez Ramirez 99 {published data only}|Effect of an exercise program on physical fitness of institutionalized elderly men|
Ferrara 2006 {published data only}|Effects of aerobic and resistive exercise training on glucose disposal and skeletal muscle metabolism in older men|/resolve/reference/PMED?id=16720745
Ferri 2003 {published data only}|Strength and power changes of the human plantar flexors and knee extensors in response to resistance training in old age|
Fiatarone 1990 {published data only}|High-intensity strength training in nonagenarians. Effects on skeletal muscle|/resolve/reference/PMED?id=2342214
Fisher 1991 {published data only}|Muscle rehabilitation in impaired elderly nursing home residents|/resolve/reference/PMED?id=1998450
Fisher 1991 {published data only}|Muscle rehabilitation: its effect on muscular and functional performance of patients with knee osteoarthritis|/resolve/reference/PMED?id=2059102
Forte 2003 {published data only}|Effects of dynamic resistance training on heart rate variability in healthy older women|/resolve/reference/PMED?id=12627310
Frontera 1988 {published data only}|Strength conditioning in older men: skeletal muscle hypertrophy and improved function|/resolve/reference/PMED?id=3366726
Frontera 1990 {published data only}|Strength training and determinants of VO2 Max in older men|/resolve/reference/PMED?id=2312474
Galvao 2006 {published data only}|Resistance training and reduction of treatment side effects in prostate cancer patients|/resolve/reference/PMED?id=17146309
Grimby 1992 {published data only}|Training can improve muscle strength and endurance in 78- to 84-year-old men|/resolve/reference/PMED?id=1490965
Gur 2002 {published data only}|Concentric versus combined concentric-eccentric isokinetic training: effects on functional capacity and symptoms in patients with osteoarthritis of the knee|/resolve/reference/PMED?id=11887109
Hageman 2002 {published data only}|Gait performance in dementia: the effects of a 6-week resistance training program in an adult day-care setting|
Hakkinen 1999 {published data only}|Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density|/resolve/reference/PMED?id=10381039
Hameed 2004 {published data only}|The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men|
Hartard 1996 {published data only}|Systematic strength training as a model of therapeutic intervention. A controlled trial in postmenopausal women with osteopenia|
Haub 2002 {published data only}|Effect of protein source on resistive-training-induced changes in body composition and muscle size in older men|/resolve/reference/PMED?id=12197993
Heiwe 2005 {published data only}|Effects of regular resistance training on muscle histopathology and morphometry in elderly patients with chronic kidney disease|/resolve/reference/PMED?id=16244524
Henwood 2006 {published data only}|Short-term resistance training and the older adult: The effect of varied programmes for the enhancement of muscle strength and functional performance|
Hess 2005 {published data only}|Effect of high-intensity strength-training on functional measures of balance ability in balance-impaired older adults|/resolve/reference/PMED?id=16226626
Hess 2006 {published data only}|Ankle force and rate of force production increase following high intensity strength training in frail older adults|/resolve/reference/PMED?id=16702779
Hirsch 2003 {published data only}|The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson's disease|/resolve/reference/PMED?id=12917847
Host 2007 {published data only}|Training-induced strength and functional adaptations after hip fracture|/resolve/reference/PMED?id=17284548
Huggett 2004 {published data only}|Comparison of heart-rate and blood-pressure increases during isokinetic eccentric versus isometric exercise in older adults|/resolve/reference/PMED?id=15223884
Hughes 2004 {published data only}|Impact of the fit and strong intervention on older adults with osteoarthritis|/resolve/reference/PMED?id=15075418
Hughes 2004 {published data only}|Long-term impact of fit and strong! On older adults with osteoarthritis|/resolve/reference/PMED?id=17169935
Humphries 2000 {published data only}|Effect of exercise intensity on bone density, strength, and calcium turnover in older women|/resolve/reference/PMED?id=10862528
Hung 2004 {published data only}|Exercise training improves overall physical fitness and quality of life in older women with coronary artery disease.[see comment]|/resolve/reference/PMED?id=15486358
Hunter 1995 {published data only}|The effects of strength conditioning on older women's ability to perform daily tasks|/resolve/reference/PMED?id=7602026
Hunter 2002 {published data only}|Resistance training and intra-abdominal adipose tissue in older men and women|/resolve/reference/PMED?id=12048332
Ibanez 2005 {published data only}|Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes|/resolve/reference/PMED?id=15735205
Ivey 2000 {published data only}|Effects of strength training and detraining on muscle quality: age and gender comparisons|/resolve/reference/PMED?id=10795719
Johansen 2006 {published data only}|Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial|/resolve/reference/PMED?id=16825332
Jones 1987 {published data only}|Human muscle strength training: The effects of three different regimes and the nature of the resultant changes|/resolve/reference/PMED?id=3443943
Judge 2005 {published data only}|Home-based resistance training improves femoral bone mineral density in women on hormone therapy|/resolve/reference/PMED?id=15754082
Katula 2006 {published data only}|Strength training in older adults: an empowering intervention|/resolve/reference/PMED?id=16394961
Kerr 2001 {published data only}|Resistance training over 2 years increases bone mass in calcium-replete postmenopausal women|
Kolbe-Alexander 2006 {published data only}|Effectiveness of a community based low intensity exercise program for older adults|
Komatireddy 1997 {published data only}|Efficacy of low load resistive muscle training in patients with rheumatoid arthritis functional class II and III|/resolve/reference/PMED?id=9263147
La Forge 2002 {published data only}|Effect of high-intensity resistance exercise on elderly bones|
Labarque 2002 {published data only}|Resistance training alters torque-velocity relation of elbow flexors in elderly men|/resolve/reference/PMED?id=11984305
Lambert 2002 {published data only}|Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: A randomized controlled trial|/resolve/reference/PMED?id=11994348
Lambert 2003 {published data only}|Megestrol acetate-induced weight gain does not negatively affect blood lipids in elderly men: Effects of resistance training and testosterone replacement|/resolve/reference/PMED?id=12865481
Lamotte 2005 {published data only}|The effect of different intensity modalities of resistance training on beat-to-beat blood pressure in cardiac patients|/resolve/reference/PMED?id=15703501
Levinger 2005 {published data only}|Resistance training for chronic heart failure patients on beta blocker medications|/resolve/reference/PMED?id=16004896
Lexell 1992 {published data only}|Effects of strength training in elderly women [letter]|/resolve/reference/PMED?id=1740607
Lexell 1995 {published data only}|Heavy-resistance training in older Scandinavian men and women: short- and long-term effects on arm and leg muscles|/resolve/reference/PMED?id=8775717
Littbrand 2006 {published data only}|A high-intensity functional weight-bearing exercise program for older people dependent in activities of daily living and living in residential care facilities: evaluation of the applicability with focus on cognitive function|/resolve/reference/PMED?id=16579666
Liu 2004 {published data only}|Strengthened training of knee joint isolated movement for ambulation ability in patients with stroke. [Chinese]|
Liu-Ambrose 2004 {published data only}|Both resistance and agility training increase cortical bone density in 75- to 85-year-old women with low bone mass: A 6-month randomized controlled trial|/resolve/reference/PMED?id=15618599
Loeppky 2005 {published data only}|Effects of ischemic training on leg exercise endurance|/resolve/reference/PMED?id=16320146
Lohman 1995 {published data only}|Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomized prospective study|
Maddalozzo 2000 {published data only}|High intensity resistance training: effects on bone in older men and women|
Magnusson 1996 {published data only}|High intensity knee extensor training in patients with chronic heart failure|/resolve/reference/PMED?id=8809523
Marcora 2005 {published data only}|Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study|/resolve/reference/PMED?id=15940763
Martin Ginis 2006 {published data only}|Weight training to activities of daily living: Helping older adults make a connection|/resolve/reference/PMED?id=16394963
McCool 1991 {published data only}|Home-based leg strengthening for older adults initiated through private practice|
McMurdo 1994 {published data only}|Improvements in quadriceps strength with regular seated exercise in the institutionalised elderly|/resolve/reference/PMED?id=8185457
Mobily 2004 {published data only}|Strength training and falls among older adults: a community-based TR intervention|
Morey 1989 {published data only}|Evaluation of a supervised exercise program in a geriatric population|/resolve/reference/PMED?id=2921457
Morey 1991 {published data only}|Two-year trends in physical performance following supervised exercise among community-dwelling older veterans|/resolve/reference/PMED?id=2037744
Morse 2005 {published data only}|Muscle strength, volume and activation following 12-month resistance training in 70-year-old males|/resolve/reference/PMED?id=16003538
Narici 1989 {published data only}|Changes in force, cross-sectional area and neural activation during strength training and detraining of the human quadriceps|/resolve/reference/PMED?id=2583179
Nelson 1997 {published data only}|Etiology and modification of gait instability in older adults: A randomized controlled trial of exercise|/resolve/reference/PMED?id=11356774
Nelson 1997 {published data only}|Home-based exercise training in the frail elderly: Effects on physical performance|
Ochala 2005 {published data only}|Effect of strength training on musculotendinous stiffness in elderly individuals|/resolve/reference/PMED?id=15702341
Ohira 2006 {published data only}|Effects of weight training on quality of life in recent breast cancer survivors: the Weight Training for Breast Cancer Survivors (WTBS) study|
Oka 2000 {published data only}|Impact of a home-based walking and resistance training program on quality of life in patients with heart failure|/resolve/reference/PMED?id=11078308
Okawa 2004 {published data only}|Effect of exercises on bone mineral density and physical strength in elderly women|/resolve/reference/PMED?id=15035182
Okumiya 1996 {published data only}|Effects of exercise on neurobehavioral function in community-dwelling older people more than 75 years of age|/resolve/reference/PMED?id=8617907
Panton 2004 {published data only}|The effects of resistance training on functional outcomes in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=14639479
Parsons 1992 {published data only}|Balance and strength changes in elderly subjects after heavy resistance strength training [abstract]|
Perhonen 1992 {published data only}|Strength training and neuromuscular function in elderly people with total knee endoprosthesis|
Perkins 1961 {published data only}|Results of short-term isotonic and isometric exercise programs in persons over sixty|/resolve/reference/PMED?id=13734405
Perrig-Chiello 1998 {published data only}|The effects of resistance training on well-being and memory in elderly volunteers|/resolve/reference/PMED?id=9884004
Petrella 2000 {published data only}|Home based exercise therapy for older patients with knee osteoarthritis: a randomized clinical trial|/resolve/reference/PMED?id=10990236
Phillips 2004 {published data only}|Energy cost of single-set resistance training in older adults|/resolve/reference/PMED?id=15320686
Pyka 1994 {published data only}|Muscle strength and fiber adaptations to a year-long resistance training program|/resolve/reference/PMED?id=8282977
Rabelo 2004 {published data only}|Effects of resistance training on activities of daily living in older women|
Ramsbottom 2004 {published data only}|The effect of 6 months training on leg power, balance, and functional mobility of independently living adults over 70 years old|/resolve/reference/PMED?id=15851822
Reeves 2004b {published data only}|Effect of resistance training on skeletal muscle-specific force in elderly humans. [Abstract]|
Reeves 2005 {published data only}|Plasticity of dynamic muscle performance with strength training in elderly humans|
Reeves 2006 {published data only}|Musculoskeletal adaptations to resistance training in old age|/resolve/reference/PMED?id=16782393
Richards 1996 {published data only}||
Roman 1993 {published data only}|Adaptations in the elbow flexors of elderly males after heavy-resistance training|/resolve/reference/PMED?id=8458791
Rooks 1997 {published data only}|Self-paced resistance training and walking exercise in community-dwelling older adults: effects on neuromotor performance|/resolve/reference/PMED?id=9158558
Salli 2006 {published data only}|Comparison of the effectiveness of concentric, combined concentric-eccentric and isometric exercises on symptoms and functional capacity in patients with knee osteoarthritis|
Sallinen 2006 {published data only}|Serum basal hormone concentrations and muscle mass in aging women: effects of strength training and diet|/resolve/reference/PMED?id=16948487
Sanders 1998 {published data only}||
Sartorio 2001 {published data only}|Effects of a 16-week progressive high-intensity strength training (HIST) on indexes of bone turnover in men over 65 years: A randomized controlled study|/resolve/reference/PMED?id=11817713
Sauvage 1992 {published data only}|A clinical trial of strengthening and aerobic exercise to improve gait and balance in elderly male nursing home residents|/resolve/reference/PMED?id=1466871
Sayers 2003 {published data only}|Changes in function and disability after resistance training: does velocity matter? A pilot study|/resolve/reference/PMED?id=12872017
Schott 2006 {published data only}|Red ginseng enhances the effectiveness of strength training in elderly: A randomized placebo-controlled double-blind trial|
Sharp 1997 {published data only}|Isokinetic strength training of the hemiparetic knee: effects on function and spasticity|/resolve/reference/PMED?id=9365354
Shaw 1998 {published data only}|Weighted vest exercise improves indices of fall risk in older women|/resolve/reference/PMED?id=9467434
Sherrington 1997 {published data only}|Home exercise to improve strength and walking velocity after hip fracture: a randomized controlled trial|/resolve/reference/PMED?id=9041904
Signorile 2005 {published data only}|Early plateaus of power and torque gains during high- and low-speed resistance training of older women|/resolve/reference/PMED?id=15772058
Sinaki 1996 {published data only}|Three-year controlled, randomized trial of the effect of dose-specified loading and strengthening exercises on bone mineral density of spine and femur in nonalthletic, physically active women|/resolve/reference/PMED?id=8873964
Sipila 1994 {published data only}|Knee extension strength and walking speed in relation to quadriceps muscle composition and training in elderly women|
Spruit 2002 {published data only}|Resistance versus endurance training in patients with COPD and peripheral muscle weakness|/resolve/reference/PMED?id=12108859
Sullivan 2001 {published data only}|Progressive resistance muscle strength training of hospitalized frail elderly|/resolve/reference/PMED?id=11421518
Taaffe 1997 {published data only}|Dynamic muscle strength alterations to detraining and retraining in elderly men|
Teixeira 2002 {published data only}|Influence of age on physical fitness improvements after training on elderly women. [Abstract]|
Teixeira 2003 {published data only}|Resistance training in postmenopausal women with and without hormone therapy|/resolve/reference/PMED?id=12673136
Teixeira-Salm. 2005 {published data only}|Functional performance and quality of life related to training and detraining of community-dwelling elderly|/resolve/reference/PMED?id=16096254
Thielman 2004 {published data only}|Rehabilitation of reaching after stroke: Task-related training versus progressive resistive exercise|/resolve/reference/PMED?id=15468020
Thomas 2004 {published data only}|Does participation in light to moderate strength and endurance exercise result in measurable physical benefits for older adults?|
Thomas 2005 {published data only}|Effects of Tai Chi and resistance training on cardiovascular risk factors in elderly Chinese subjects: a 12-month longitudinal, randomized, controlled intervention study|
Thompson 1988 {published data only}|Effects of physical exercise for elderly patients with physical impairments|/resolve/reference/PMED?id=3339217
Timonen 2002 {published data only}|A randomized controlled trial of rehabilitation after hospitalization in frail older women: effects on strength, balance and mobility|
Timonen 2006 {published data only}|Effects of group-based exercise program on functional abilities in frail older women after hospital discharge|/resolve/reference/PMED?id=16608136
Timonen 2006b {published data only}|Effects of a group-based exercise program on the mood state of frail older women after discharge from hospital|
Treuth 1994 {published data only}|Effects of strength training on total and regional body composition in older men|/resolve/reference/PMED?id=8002507
Trudelle-Jack. 2004 {published data only}|Effects of a late-phase exercise program after total hip arthroplasty: a randomized controlled trial|/resolve/reference/PMED?id=15241750
Tsuji 2000 {published data only}|Randomised controlled trial of exercise training for older people: study design and primary outcome|/resolve/reference/PMED?id=10695262
Vad 2002 {published data only}|Physical training as treatment of reduced functional ability in frail 75+ year-olds living at home. A randomized intervention study in general practice with technological assessment elements|/resolve/reference/PMED?id=12448161
Vale 2003 {published data only}|Effects of supine resistance strength training in independent elderly women|
Valkeinen 2005 {published data only}|Muscle hypertrophy, strength development, and serum hormones during strength training in elderly women with fibromyalgia|/resolve/reference/PMED?id=16195165
Van den Ende 2000 {published data only}|Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial|/resolve/reference/PMED?id=10913058
Vanbiervliet 2003 {published data only}|Strength training with elastic bands: measure of its effects in cardiac rehabilitation after coronary diseases|/resolve/reference/PMED?id=14585532
Veloso 2003 {published data only}|Do continuous and intermittent exercises sets induce similar cardiovascular responses in the elderly women?|
Verfaillie 1997 {published data only}|Effects of resistance, balance and gait training on reduction of risk factors leading to falls in elders|
Villareal 2003 {published data only}|Effects of exercise training added to ongoing hormone replacement therapy on bone mineral density in frail elderly women|
Villareal 2006b {published data only}|DHEA enhances effects of weight training on muscle mass and strength in elderly women and men|/resolve/reference/PMED?id=16787962
Vincent 2002b {published data only}|Resistance exercise training attenuates exercise-induced lipid peroxidation in the elderly|/resolve/reference/PMED?id=12172882
Vincent 2003 {published data only}|Strength training and hemodynamic responses to exercise|
Vincent 2006 {published data only}|Influence of resistance exercise on lumbar strength in older, overweight adults|/resolve/reference/PMED?id=16500173
Woo 2007 {published data only}|A randomised controlled trials of Tai Chi and resistance exercise on bone health, muscle strength and balance in community-living elderly people|/resolve/reference/PMED?id=17356003
Yang 2006 {published data only}|Task-oriented progressive resistance strength training improves muscle strength and functional performance in individuals with stroke|/resolve/reference/PMED?id=17008338
Zion 2003 {published data only}|A home-based resistance-training program using elastic bands for elderly patients with orthostatic hypotension|/resolve/reference/PMED?id=12955554
Bennell 2007 {published data only}|The effects of hip muscle strengthening on knee load, pain, and function in people with knee osteoarthritis: a protocol for a randomised, single-blind controlled trial|/resolve/reference/PMED?id=18067658
Cheema 2007 {published data only}|Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis|/resolve/reference/PMED?id=17409306
Fahlman 2007 {published data only}|Combination training and resistance training as effective interventions to improve functioning in elders|/resolve/reference/PMED?id=17556785
Henwood 2008 {published data only}|Strength versus muscle power-specific resistance training in community-dwelling older adults|/resolve/reference/PMED?id=18245765
Karinkanta 2007 {published data only}|A multi-component exercise regimen to prevent functional decline and bone fragility in home-dwelling elderly women: randomized, controlled trial|/resolve/reference/PMED?id=17103296
Lin 2007 {published data only}|Comparison of proprioceptive functions between computerized proprioception facilitation exercise and closed kinetic chain exercise in patients with knee osteoarthritis.[erratum appears in Clin Rheumatol. 2007 Apr;26(4):617 Note: Chai, Hei-Min [corrected to Chai, Huei-Ming]]|/resolve/reference/PMED?id=16786252
Mitchell 2001 {published data only}|Randomized controlled trial of quadriceps training after proximal femoral fracture|/resolve/reference/PMED?id=11386398
O'Shea 2007 {published data only}|A predominantly home-based progressive resistance exercise program increases knee extensor strength in the short-term in people with chronic obstructive pulmonary disease: a randomised controlled trial|/resolve/reference/PMED?id=18047457
Raso 2007 {published data only}|Effect of resistance training on immunological parameters of healthy elderly women|/resolve/reference/PMED?id=18046186
Williams 2007 {published data only}|Circuit resistance training in chronic heart failure improves skeletal muscle mitochondrial ATP production rate - a randomized controlled trial|/resolve/reference/PMED?id=17395046
Anonymous 2001|Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention|/resolve/reference/PMED?id=11380764
Brosseau 2003|Intensity of exercise for the treatment of osteoarthritis|
Buchner 1993|Understanding variability in studies of strength training in older adults: a meta-analytic perspective|
Buchner 1996|Evidence for a non-linear relationship between leg strength and gait speed|/resolve/reference/PMED?id=8921145
Chandler 1996|Exercise to improve physiologic and functional performance in old age|/resolve/reference/PMED?id=8890115
Doherty 1993|Effects of ageing on the motor unit: A brief review|/resolve/reference/PMED?id=8275048
Fiatarone 1993|The etiology and reversibility of muscle dysfunction in the aged|
Frontera 1988|Strength conditioning in older men: skeletal muscle hypertrophy and improved function|/resolve/reference/PMED?id=3366726
Gillespie 2003|Interventions for preventing falls in elderly people|
Guralnik 1995|Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability|/resolve/reference/PMED?id=7838189
Higgins 2006|Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE|
Howe 2007|Exercise for improving balance in older people|
Keysor 2001|Have we oversold the benefit of late-life exercise?|
King 1998|Physical activity interventions targeting older adults: a critical review and recommendations|/resolve/reference/PMED?id=9838975
King 2001|Interventions to promote physical activity by older adults|/resolve/reference/PMED?id=11730236
Mazzeo 1998|American College of Sports Medicine position stand: exercise and physical activity for older adults|/resolve/reference/PMED?id=9624662
Nagi 1991|Disability concepts revisited: Implications for prevention|
Province 1995|The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT trials|/resolve/reference/PMED?id=7715058
Singh 2002|Exercise comes of age: rationale and recommendations for a geriatric exercise prescription|/resolve/reference/PMED?id=11983720
Tinetti 1986|Fall risk index for elderly patients based on number of chronic disabilities|/resolve/reference/PMED?id=3953620
WHO 2001||
Latham 2003a|Progressive resistance strength training for physical disability in older people|/resolve/reference/PMED?id=12804434
Latham 2004|Systematic review of progressive resistance strength training in older adults|/resolve/reference/PMED?id=14718486
Cerny 1989 {published data only}|Relative effects of bronchial drainage and exercise for in-hospital care of patients with cystic fibrosis|/resolve/reference/PMED?id=2748718
Klijn 2004 {published data only}|Effects of anaerobic training in children with cystic fibrosis: a randomised controlled study|/resolve/reference/PMED?id=15078738
Michel 1989 {published data only}|Exercise, body composition and strength in cystic fibrosis [abstract]|
Moorcroft 2004 {published data only}|Improved fitness and decreased symptoms of muscle fatigue for upper and lower body following an individualised unsupervised home exercise training programme in adults with cystic fibrosis [abstract]|
Moorcroft 2004 {published data only}|Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial|/resolve/reference/PMED?id=15563708
Moorcroft 2004 {published data only}|Individualised home exercise training in CF - a one- year trial [abstract]|
Schneiderman 2000 {published data only}|The role of an organised exercise program in CF - a three year study [abstract]|
Schneiderman 2000 {published data only}|A randomised controlled trial of a 3-year home exercise program in cystic fibrosis|/resolve/reference/PMED?id=10700685
Selvadurai 2002 {published data only}|Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis|
Selvadurai 2002 {published data only}|A randomised controlled study of in-hospital exercise training programs in children with cystic fibrosis (CF) [abstract]|
Turchetta 1991 {published data only}|Effect of controlled physical activity on lung function test of cystic fibrosis children [abstract]|
Albinni 2004 {published data only}|Additional inspiratory muscle training intensifies the beneficial effects of cycle ergometer training in patients with cystic fibrosis [abstract]|
Albinni 2004 {published data only}|Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis [abstract]|
Andreasson 1987 {published data only}|Long-term effects of physical exercise on working capacity and pulmonary function in cystic fibrosis|
Aquino 2006 {published data only}|Efficacy of physical exercise playing a video game for mucus clearance in patients with CF|
Balestri 2004 {published data only}|Efficacy of physical exercise for mucus clearance in patients with cystic fibrosis (CF)|
Barry 2001 {published data only}|Benefits of high intensity strength training in adults with cystic fibrosis [abstract]|
Barry 2001 {published data only}|High intensity strength training improves fitness levels in adults with cystic fibrosis [abstract]|
Bilton 1992 {published data only}|The benefits of exercise combined with physiotherapy in cystic fibrosis [abstract]|/resolve/reference/PMED?id=2259556
Bilton 1992 {published data only}|The benefits of exercise combined with physiotherapy in the treatment of adults with cystic fibrosis|/resolve/reference/PMED?id=1470709
Chatham 1997 {published data only}|Through range computer generated inspiratory muscle training in cystic fibrosis [abstract]|
de Jong 1994 {published data only}|Effect of a home exercise training program in patients with cystic fibrosis|/resolve/reference/PMED?id=8306748
Edlund 1986 {published data only}|Effects of a swimming program on children with cystic fibrosis [abstract]|
Edlund 1986 {published data only}|Effects of a swimming program on children with cystic fibrosis|/resolve/reference/PMED?id=3942116
Falk 1988 {published data only}|PEP treatment or physical exercise - Effects on secretions expectorated and indices of central and peripheral airway function. A controlled study [abstract]|
Hall 2010 {published data only}|The effects of Nintendo Wii exercise training in adults with cystic fibrosis|
Hebestreit 2003 {published data only}|Effects of different conditioning programmes on aerobic capacity in CF|
Heijerman 1992 {published data only}|Long-term effects of exercise training and hyperlimentation in adult cystic fibrosis patients with severe pulmonary dysfunction|/resolve/reference/PMED?id=1428393
Kriemler 2001 {published data only}|Six months of training improves lung function and aerobic performance in CF [abstract]|
Lannefors 1992 {published data only}|Mucus clearance in cystic fibrosis (CF) - a comparison between postural drainage, PEP-mask and physical exercise [abstract]|
Lannefors 1992 {published data only}|Mucus clearance with three chest physiotherapy regimes in CF: a comparison between postural drainage, PEP and physical exercise|/resolve/reference/PMED?id=1628733
Oreinstein 2004 {published data only}|Strength vs aerobic training in children with cystic fibrosis: a randomised controlled trial|/resolve/reference/PMED?id=15486384
Orenstein 1981 {published data only}|Exercise conditioning and cardiopulmonary fitness in CF. The effects of a three-month supervised running program|/resolve/reference/PMED?id=7023863
Salh 1989 {published data only}|Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis|/resolve/reference/PMED?id=2617441
Stanghelle 1998 {published data only}|EFfect of short bouts of trampoline exercise during 8 weeks on the pulmonary function and the maximal oxygen uptake of children with cystic fibrosis|
Tuzin 1998 {published data only}|Increasing physical activity of children with cystic fibrosis: A home based family intervention|
Phillips 2008 {published data only}|Efficacy of a standardised exercise protocol in inpatient care of patients with cystic fibrosis [abstract]|
ACSM 2010||
Casaburi 1992|Principles of exercise training|/resolve/reference/PMED?id=1576847
CF Foundation 2009|Patient Registry: Annual Data Report|
CF Trust 2010||
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2009|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009|
Lloyd 2010|Provision of structured exercise in specialist UK cystic fibrosis centres|
Mazzeo 1998||
McArdle 2001||
Nixon 1992|The prognostic value of exercise testing in patients with cystic fibrosis|/resolve/reference/PMED?id=1435933
O'Neill 1987|Regular exercise and reduction of breathlessness in patients with cystic fibrosis|/resolve/reference/PMED?id=3663492
Peebles 1998|Physiotherapy (Chapter 5)|
Primos 1996|Sports exercise during acute illness: recommending the right course for the patient|
Review Manager 2008|Review Manager (RevMan)|
Shephard 1994||
Wolman 1995|Osteoporosis and exercise|
CMSRG 1987 {published data only}|A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis|/resolve/reference/PMED?id=2889518
Cohen 1989 {published data only}|Amantadine treatment of fatigue associated with multiple sclerosis|/resolve/reference/PMED?id=2730380
Krupp 1995 {published data only}|Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine pemoline, and placebo|/resolve/reference/PMED?id=7501140
Rosenberg 1988 {published data only}|Amantadine, fatigue and multiple sclerosis|/resolve/reference/PMED?id=2972270
Tomassini 2004 {published data only}|Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial|/resolve/reference/PMED?id=14759641
Chiba 1992 {published data only}|Amantadine treatment for refractory pain and fatigue in patients with multiple sclerosis|/resolve/reference/PMED?id=1623455
Geisler 1996 {published data only}|The effects of amantadine and pemoline on cognitie functioning in multiple sclerosis|/resolve/reference/PMED?id=8639070
Kemp 1993 {published data only}|Amantadine and Fatigue of Multiple Sclerosis|/resolve/reference/PMED?id=8364274
Maciejek 1989 {published data only}|Changes in visual ovoked potentials in patients with multiple sclerosis treated with isoprinosine and amantadine|/resolve/reference/PMED?id=2484835
Murray 1985 {published data only}|Amantadine therapy for fatigue in multiple sclerosis|
Plaut 1987 {published data only}|Effectiveness of amantadine in reducing relapses in multiple sclerosis|/resolve/reference/PMED?id=3550084
Sailer 1996 {published data only}|Effect of amantadine on cognitive processes in multiple sclerosis with fatigue: A double-blind placebo controlled cross-over study|
Sailer 2000 {published data only}|Amantidine influences cognitive processing in patients with multiple sclerosis|/resolve/reference/PMED?id=10721881
Anonymous 1998|Fatigue and Multiple Sclerosis. Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis|
Beck 1961|An inventory for measuring depression|
Bertolone 1993|Cytokine correlates of fatigue in multiple sclerosis|
Branas 2000|Treatments for fatigue in multiple sclerosis: a rapid and systematic review|/resolve/reference/PMED?id=11074395
Bryson 1980|A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis|/resolve/reference/PMED?id=7373087
Crosby 2003a|Amantadine for diskynesia in Parkinson's disease|
Crosby 2003b|Amantadine in Parkinson's disease.|
Curtin 2002 A|Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes|
Curtin 2002 B|Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes|
Dolin 1982|A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection|/resolve/reference/PMED?id=7050702
Fischer 1999|The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment|/resolve/reference/PMED?id=10467383
Fisk 1994|Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale|/resolve/reference/PMED?id=8148458
Flensner 2005|Reliability and validity of the Swedish version of the Fatigue Impact Scale (FIS)|/resolve/reference/PMED?id=16457090
Hauser 1983|Intensive immunosuppression in progressive multiple sclerosis|/resolve/reference/PMED?id=6294517
Hauser 2003|Validation of a German Version of the Fatigue Impact Scale FIS-D|
Hayden 1996|Antimicrobial Agents|
Higgins 2005|Formulating the problem. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005], Section 4|
Jadad 1996|Assessing the quality of reports of Randomised Clinical Trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jefferson 2006a|Amantadine and rimantadine for influenza A in adults|
Jefferson 2006b|Antivirals for influenza in healthy adults: systematic review|/resolve/reference/PMED?id=16443037
Kamps 2006|Influenza Report 2006|
Kos 2005|Evaluation of the Modified Fatigue Impact Scale in four different European countries. Evaluation of the Modified Fatigue Impact Scale in four different European countries|/resolve/reference/PMED?id=15732270
Krupp 1997|Mechanism, measurement, and management of fatigue in multiple sclerosis|
Krupp1989|The fatigue severity scale: application to patients with Multiple Sclerosis and Systemic Lupus Erythematosus|/resolve/reference/PMED?id=2803071
Kurtzke 1983|Rating neurologic impairment in Multiple Sclerosis: An Expanded Disability Status Scale (EDSS)|/resolve/reference/PMED?id=6685237
Lim 2005|Amantadine in treatment of chronic hepatitis C virus infection?|
Mathiowetz 2003|Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis|/resolve/reference/PMED?id=12911080
McDonald 2001|Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis|
Pittion-Vouyovitch06|Fatigue in multiple sclerosis is related to disability, depression and quality of life|
Poser 1983|New diagnostic criteria for Multiple Sclerosis: guide-lines for research protocols|
Radloff 1977|The CES-D Scale: a self-report depression scale for research in the general population|
Schumacher 1965|Problems of experimental trials of therapy in Multiple Sclerosis: Report by the panel of the evaluetion of experimental trials in Multiple Sclerosis|
Schwab 1972|Amantadine in Parkinson's disease. Review of more than two years experience|/resolve/reference/PMED?id=4677928
Schwartz 1993|The measurment of fatigue: a new scale|/resolve/reference/PMED?id=8229906
Stoof 1992|Amantadine as N-methyl-D-aspartic acid receptor antagonist: new possibilities for therapeutic applications?|
Tempelaar 1989|The social experiences of cancer patients under treatment: a comparative study|/resolve/reference/PMED?id=2799413
Blackwood 1990 {published data only}|Exercise capacity and quality of life in the treatment of heart failure|/resolve/reference/PMED?id=2144803
Dig captopril 1988 {published data only}|Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure|/resolve/reference/PMED?id=2447297
Dig milrinone 1989 {published data only}|A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure|/resolve/reference/PMED?id=2646536
DIG study 1997 {published data only}|Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure|/resolve/reference/PMED?id=8721804
DIG study 1997 {published data only}|The effect of digoxin on mortality and morbidity in patients with heart failure|/resolve/reference/PMED?id=9036306
DIG study 1997 {published data only}|Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure|/resolve/reference/PMED?id=1626493
Dig xamoterol 1988 {published data only}|Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure|/resolve/reference/PMED?id=2893916
DIMT 1993 {published data only}|Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)|/resolve/reference/PMED?id=7901256
Fleg 1982 {published data only}|Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm|/resolve/reference/PMED?id=7051826
Guyatt 1988 {published data only}|A controlled trial of digoxin in congestive heart failure|/resolve/reference/PMED?id=3277366
Lee 1982 {published data only}|Heart failure in outpatients. A randomized trial of digoxin versus placebo|/resolve/reference/PMED?id=7038483
PROVED 1993 {published data only}|Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group|/resolve/reference/PMED?id=8409069
Pugh 1989 {published data only}|Clinical, hemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment|/resolve/reference/PMED?id=2503017
RADIANCE 1993 {published data only}|Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study|/resolve/reference/PMED?id=8505940
Taggart 1983 {published data only}|Digoxin withdrawal after cardiac failure in patients with sinus rhythm|/resolve/reference/PMED?id=6188895
Dobbs 1977 {published data only}|Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients|/resolve/reference/PMED?id=322793
Fleg 1991 {published data only}|Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease; a randomized, placebo-controlled, crossover trial|/resolve/reference/PMED?id=1993796
Just 1993 {published data only}|Captopril versus digoxin in patients with coronary artery disease and mild heart failure|/resolve/reference/PMED?id=8125424
Kostis 1994 {published data only}|Nonpharmacologic therapy improves functional and emotional status in congestive heart failure|/resolve/reference/PMED?id=7924541
ACC/AHA Guidelines 2005|ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society|/resolve/reference/PMED?id=16160202
Adams 1998|Clinical predictors of worsening heart failure during withdrawal from digoxin therapy|/resolve/reference/PMED?id=9506323
Adams 2002|Clinical benefits of low serum digoxin concentrations in heart failure|/resolve/reference/PMED?id=11897434
Adams 2005|Relationship of serum digoxin concentration to mortality and morbidity in women in the Digitalis Investigation Group Trial|/resolve/reference/PMED?id=16053964
Ahmed 2006|Effects of digoxin on morbidity and mortality in diastolic heart failure. The Ancillary Digitalis Investigation Group Trial|/resolve/reference/PMED?id=16864724
Ahmed 2007|Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations|/resolve/reference/PMED?id=17389731
Ahmed 2009|Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial|/resolve/reference/PMED?id=19101235
Arnold 1980|Long-term digitalis therapy improves left ventricular function in heart failure|/resolve/reference/PMED?id=6776403
Bigger 1985|Effect of digitalis treatment on survival after acute myocardial infarction|/resolve/reference/PMED?id=3976501
Byington 1985|Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial|/resolve/reference/PMED?id=4045047
Carvedilol 1996|The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group|/resolve/reference/PMED?id=8614419
CHARM 2003|Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme|/resolve/reference/PMED?id=13678868
Chew 1975|The functional defect in amyloid heart disease: The "stiff heart" syndrome|/resolve/reference/PMED?id=1190048
CIBIS II 1999|The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial|/resolve/reference/PMED?id=10023943
Cohn 1998|A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone trial investigators|/resolve/reference/PMED?id=9854116
Cohn 2001|A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure|/resolve/reference/PMED?id=11759645
CONSENSUS 1987|Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)|/resolve/reference/PMED?id=2883575
COPERNICUS 2002|Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study|/resolve/reference/PMED?id=12390947
Covit 1983|Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure|/resolve/reference/PMED?id=6351608
Cowley 1994|Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators|/resolve/reference/PMED?id=7946771
DAAF Trial 1997|Intravenous digoxin in acute atrial fibrillation. Results of a randomized placebo-controlled multicentre trial in 239 patients|/resolve/reference/PMED?id=9129897
Dall 1970|Maintenance digoxin in elderly patients|/resolve/reference/PMED?id=5429654
De Bono 1994|Digoxin in eurhythmic heart failure: PROVED or "not proven?"|/resolve/reference/PMED?id=7903996
Dhaliwal 2008|Digoxin and clinical outcomes in systolic heart failure patients|
DIG study 1999|Effects of digoxin on worsening of symptoms of congestive heart failure in the Digitalis Investigation Group (DIG) Trial|
DIMT 1995|Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group|/resolve/reference/PMED?id=7560628
Domanski 2005|The effect of gender on outcome in digitalis-treated heart failure patients|/resolve/reference/PMED?id=15732025
ESC Guidelines 2008|ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)|
Falk 1987|Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized double-blinded trial|/resolve/reference/PMED?id=3548521
Ferguson 1989|Sympathoinhibitory responses to digitalis glycosides in heart failure patients: Direct evidence from sympathetic neural recordings|/resolve/reference/PMED?id=2736756
Firth 1980|Effect of chronic oral digoxin therapy on ventricular function at rest and peak exercise in patients with ischemic heart disease|/resolve/reference/PMED?id=7415994
Fonrose 1974|The efficacy of digitalis withdrawal in an institutional aged population|/resolve/reference/PMED?id=4819523
Gaasch 1994|Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction|/resolve/reference/PMED?id=8151903
Gheorghiade 1983|Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm|/resolve/reference/PMED?id=6846152
Gheorghiade 1991|Digoxin. A neurohumoral modulator in heart failure?|/resolve/reference/PMED?id=1834367
Gheorghiade 2009|Reconsidering the role for digoxin in the management of acute heart failure syndromes|/resolve/reference/PMED?id=19920240
Hauptman 1999|Cardiac glycosides in the next millennium|/resolve/reference/PMED?id=10362347
HFSA Guideline 2006|HFSA 2006 Comprehensive heart failure practice guideline. Section 7: Heart failure in patients with left ventricular systolic dysfunction|
Hull 1977|Discontinuation of maintenance digoxin therapy in general practice|/resolve/reference/PMED?id=72958
Jaeschke 1990|To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis|/resolve/reference/PMED?id=2178412
Johnston 1979|Is maintenance digoxin necessary in patients with sinus rhythm?|/resolve/reference/PMED?id=85161
Jones 2004|Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group Trial|/resolve/reference/PMED?id=15337214
Jordaens 1997|Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo|/resolve/reference/PMED?id=9129896
Kirsten 1973|Digoxin in the aged|/resolve/reference/PMED?id=4683094
Lader 2003|The effect of digoxin on the quality of life in patients with heart failure|/resolve/reference/PMED?id=12612867
McHaffie 1978|The clinical value of digoxin in patients with heart failure and sinus rhythm|/resolve/reference/PMED?id=751085
MERIT-HF 1999|Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)|/resolve/reference/PMED?id=10376614
Moss 1981|Digitalis-associated cardiac mortality after myocardial infarction|/resolve/reference/PMED?id=7296788
O'Rourke 1976|Favorable effects of orally administered digoxin on left heart size and ventricular wall motion in patients with previous myocardial infarction|/resolve/reference/PMED?id=131484
Packer 1991|Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Research Group|/resolve/reference/PMED?id=1944425
Packer 1992|The neurohumoral hypothesis: a theory to explain the mechanism of disease progression in heart failure|/resolve/reference/PMED?id=1351488
Packer 1999|Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure|/resolve/reference/PMED?id=10072251
Packer 2001|Effect of carvedilol on survival in severe chronic heart failure|/resolve/reference/PMED?id=11386263
RALES 1999|The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators|/resolve/reference/PMED?id=10471456
Rathore 2002|Sex-based differences in the effect of digoxin for the treatment of heart failure|/resolve/reference/PMED?id=12409542
Rathore 2003|Association of serum digoxin concentration and outcomes in patients with heart failure|/resolve/reference/PMED?id=12588271
Rich 2001|Effect of age on mortality, hospitalizations, and response to digoxin in patients with heart failure: the DIG study|/resolve/reference/PMED?id=11527638
SENIORS 2005|Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)|/resolve/reference/PMED?id=15642700
Slatton 1997|Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?|/resolve/reference/PMED?id=9137214
SOLVD 1991|Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure|/resolve/reference/PMED?id=2057034
Starr 1969|Blind study on the action of digitoxin on elderly women|/resolve/reference/PMED?id=5352988
van Veldhuisen 2002|Low-dose digoxin in patients with heart failure. Less toxic and at least as effective?|/resolve/reference/PMED?id=11897435
Vasan 1999|Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort|/resolve/reference/PMED?id=10362198
Vogel 1977|Short- and long-term effects of digitalis on resting and posthandgrip hemodynamics in patients with coronary artery disease|/resolve/reference/PMED?id=879022
Wasserstrom 2005|Digitalis: new actions for an old drug|/resolve/reference/PMED?id=16219807
Zannad 2011|Eplerenone in patients with systolic heart failure and mild symptoms|
Blackwood 1990 {published data only}|Exercise capacity and quality of life in the treatment of heart failure|/resolve/reference/PMED?id=2144803
Dig captopril 1988 {published data only}|Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure|/resolve/reference/PMED?id=2447297
Dig milrinone 1989 {published data only}|A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure|/resolve/reference/PMED?id=2646536
DIG study 1997 {published data only}|Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure|/resolve/reference/PMED?id=8721804
DIG study 1997 {published data only}|The effect of digoxin on mortality and morbidity in patients with heart failure|
DIG study 1997 {published data only}|Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure|/resolve/reference/PMED?id=1626493
Dig xamoterol 1988 {published data only}|Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure|/resolve/reference/PMED?id=2893916
DIMT 1993 {published data only}|Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)|/resolve/reference/PMED?id=7901256
Fleg 1982 {published data only}|Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm|/resolve/reference/PMED?id=7051826
Guyatt 1988 {published data only}|A controlled trial of digoxin in congestive heart failure|/resolve/reference/PMED?id=3277366
Lee 1982 {published data only}|Heart failure in outpatients. A randomized trial of digoxin versus placebo|/resolve/reference/PMED?id=7038483
PROVED 1993 {published data only}|Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group|/resolve/reference/PMED?id=8409069
Pugh 1989 {published data only}|Clinical, hemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment|/resolve/reference/PMED?id=2503017
RADIANCE 1993 {published data only}|Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE study|/resolve/reference/PMED?id=8505940
Taggart 1983 {published data only}|Digoxin withdrawal after cardiac failure in patients with sinus rhythm|
Dobbs 1977 {published data only}|Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients|/resolve/reference/PMED?id=322793
Fleg 1991 {published data only}|Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease; a randomized, placebo-controlled, crossover trial|/resolve/reference/PMED?id=1993796
Just 1993 {published data only}|Captopril versus digoxin in patients with coronary artery disease and mild heart failure|/resolve/reference/PMED?id=8125424
Kostis 1994 {published data only}|Nonpharmacologic therapy improves functional and emotional status in congestive heart failure|/resolve/reference/PMED?id=7924541
ACC/AHA Guidelines 2005|ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society|/resolve/reference/PMED?id=16160202
Adams 1998|Clinical predictors of worsening heart failure during withdrawal from digoxin therapy|/resolve/reference/PMED?id=9506323
Adams 2002|Clinical benefits of low serum digoxin concentrations in heart failure|/resolve/reference/PMED?id=11897434
Adams 2005|Relationship of serum digoxin concentration to mortality and morbidity in women in the Digitalis Investigation Group Trial|/resolve/reference/PMED?id=16053964
Ahmed 2006|Effects of digoxin on morbidity and mortality in diastolic heart failure. The Ancillary Digitalis Investigation Group Trial|/resolve/reference/PMED?id=16864724
Ahmed 2007|Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations|/resolve/reference/PMED?id=17389731
Ahmed 2009|Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial|/resolve/reference/PMED?id=19101235
Arnold 1980|Long-term digitalis therapy improves left ventricular function in heart failure|/resolve/reference/PMED?id=6776403
Ather 2011|Digoxin treatment in heart failureUnveiling risk by cluster analysis of DIG data|
Bigger 1985|Effect of digitalis treatment on survival after acute myocardial infarction|/resolve/reference/PMED?id=3976501
Bourge 2013|Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure|
Byington 1985|Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial|/resolve/reference/PMED?id=4045047
Carvedilol 1996|The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group|/resolve/reference/PMED?id=8614419
Castagno 2012|Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure|
CHARM 2003|Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme|/resolve/reference/PMED?id=13678868
Chew 1975|The functional defect in amyloid heart disease: the "stiff heart" syndrome|/resolve/reference/PMED?id=1190048
CIBIS II 1999|The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial|/resolve/reference/PMED?id=10023943
Cohn 1998|A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure|/resolve/reference/PMED?id=9854116
Cohn 2001|A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure|/resolve/reference/PMED?id=11759645
CONSENSUS 1987|Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)|
COPERNICUS 2002|Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study|/resolve/reference/PMED?id=12390947
Covit 1983|Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure|/resolve/reference/PMED?id=6351608
Cowley 1994|Treatment of severe heart failure: quantity or quality of life? A trial of enoximone|/resolve/reference/PMED?id=7946771
DAAF Trial 1997|Intravenous digoxin in acute atrial fibrillation. Results of a randomized placebo-controlled multicentre trial in 239 patients|/resolve/reference/PMED?id=9129897
Dall 1970|Maintenance digoxin in elderly patients|/resolve/reference/PMED?id=5429654
De Bono 1994|Digoxin in eurhythmic heart failure: PROVED or "not proven?"|/resolve/reference/PMED?id=7903996
Dhaliwal 2008|Digoxin and clinical outcomes in systolic heart failure patients|
DIG study 1999|Effects of digoxin on worsening of symptoms of congestive heart failure in the Digitalis Investigation Group (DIG) Trial|
DIMT 1995|Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group|/resolve/reference/PMED?id=7560628
Domanski 2005|The effect of gender on outcome in digitalis-treated heart failure patients|/resolve/reference/PMED?id=15732025
ESC Guidelines 2008|ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)|
Falk 1987|Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized double-blinded trial|/resolve/reference/PMED?id=3548521
Ferguson 1989|Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings|/resolve/reference/PMED?id=2736756
Firth 1980|Effect of chronic oral digoxin therapy on ventricular function at rest and peak exercise in patients with ischemic heart disease|/resolve/reference/PMED?id=7415994
Fonrose 1974|The efficacy of digitalis withdrawal in an institutional aged population|/resolve/reference/PMED?id=4819523
Gaasch 1994|Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction|/resolve/reference/PMED?id=8151903
Gheorghiade 1983|Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm|/resolve/reference/PMED?id=6846152
Gheorghiade 1991|Digoxin. A neurohumoral modulator in heart failure?|/resolve/reference/PMED?id=1834367
Gheorghiade 2009|Reconsidering the role for digoxin in the management of acute heart failure syndromes|
Gheorghiade 2013|Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial|
Hauptman 1999|Cardiac glycosides in the next millennium|
HFSA Guideline 2006|HFSA 2006 comprehensive heart failure practice guideline. Section 7: Heart failure in patients with left ventricular systolic dysfunction|
Hull 1977|Discontinuation of maintenance digoxin therapy in general practice|/resolve/reference/PMED?id=72958
Jaeschke 1990|To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis|/resolve/reference/PMED?id=2178412
Johnston 1979|Is maintenance digoxin necessary in patients with sinus rhythm?|/resolve/reference/PMED?id=85161
Jones 2004|Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group Trial|/resolve/reference/PMED?id=15337214
Jordaens 1997|Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo|/resolve/reference/PMED?id=9129896
Kirsten 1973|Digoxin in the aged|/resolve/reference/PMED?id=4683094
Lader 2003|The effect of digoxin on the quality of life in patients with heart failure|/resolve/reference/PMED?id=12612867
McHaffie 1978|The clinical value of digoxin in patients with heart failure and sinus rhythm|/resolve/reference/PMED?id=751085
MERIT-HF 1999|Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)|/resolve/reference/PMED?id=10376614
Moss 1981|Digitalis-associated cardiac mortality after myocardial infarction|/resolve/reference/PMED?id=7296788
O'Rourke 1976|Favorable effects of orally administered digoxin on left heart size and ventricular wall motion in patients with previous myocardial infarction|/resolve/reference/PMED?id=131484
Packer 1991|Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Research Group|/resolve/reference/PMED?id=1944425
Packer 1992|The neurohumoral hypothesis: a theory to explain the mechanism of disease progression in heart failure|/resolve/reference/PMED?id=1351488
Packer 1999|Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure|
Packer 2001|Effect of carvedilol on survival in severe chronic heart failure|/resolve/reference/PMED?id=11386263
RALES 1999|The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators|/resolve/reference/PMED?id=10471456
Rathore 2002|Sex-based differences in the effect of digoxin for the treatment of heart failure|/resolve/reference/PMED?id=12409542
Rathore 2003|Association of serum digoxin concentration and outcomes in patients with heart failure|/resolve/reference/PMED?id=12588271
Review Manager|Review Manager (RevMan)|
Rich 2001|Effect of age on mortality, hospitalizations, and response to digoxin in patients with heart failure: the DIG study|/resolve/reference/PMED?id=11527638
SENIORS 2005|Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)|/resolve/reference/PMED?id=15642700
Slatton 1997|Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?|/resolve/reference/PMED?id=9137214
SOLVD 1991|Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure|
Starr 1969|Blind study on the action of digitoxin on elderly women|/resolve/reference/PMED?id=5352988
Testani 2011|Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure|
van Veldhuisen 2002|Low-dose digoxin in patients with heart failure. Less toxic and at least as effective?|/resolve/reference/PMED?id=11897435
Vasan 1999|Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort|/resolve/reference/PMED?id=10362198
Vogel 1977|Short- and long-term effects of digitalis on resting and posthandgrip hemodynamics in patients with coronary artery disease|/resolve/reference/PMED?id=879022
Wasserstrom 2005|Digitalis: new actions for an old drug|/resolve/reference/PMED?id=16219807
Zannad 2011|Eplerenone in patients with systolic heart failure and mild symptoms|
Allison {published data only}|Management of coronary risk factors by trained nurses versus usual care in patients with unstabel angina pectoris (a chest pain evaluation in the emergency room (CHEER) substudy)|/resolve/reference/PMED?id=10913471
Black {published data only}|Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients|/resolve/reference/PMED?id=9584539
Brown {published data only}|Behavior therapy of psychological distress in patients after myocardial infarction or coronary bypass|
Burell {published data only}|Behaviour modification after coronary artery bypass graft surgery: effects on cardiac morbidity and mortality|
Burell {published data only}|Group psychotherapy in Project New Life: Treatment of coronary-prone behaviors for patients who have had coronary artery bypass graft surgery|
Burgess {published data only}|A randomized control trial of cardiac rehabilitation|/resolve/reference/PMED?id=3551088
Cowan {published data only}|Psychosocial nursing therapy following sudden cardiac arrest: impact on two-year survival|/resolve/reference/PMED?id=11302295
Debusk {published data only}|A case-management system for coronary risk factor modification after acute myocardial infarction|/resolve/reference/PMED?id=8147544
Elderen {published data only}|Effects of a health education programme with telephone follow-up during cardiac rehabilitation|
ENRICHD {published data only}|Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators|/resolve/reference/PMED?id=10618555
ENRICHD {published data only}|Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH|/resolve/reference/PMED?id=11812672
ENRICHD {published data only}|Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial Infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial|/resolve/reference/PMED?id=12813116
Erdman {published data only}|Psychologic evaluation of a cardiac rehabilitation program: A randomized clinical trial in patients with myocardial infarction|
Erdman {published data only}|Predictability of beneficial effects in cardiac rehabilitation: A randomized clinical trial of psychosocial variables|
Frasure Smith {published data only}|Long-term follow-up of the Ischemic Heart Disease Life Stress Monitoring Program|/resolve/reference/PMED?id=2798700
Frasure Smith {published data only}|The ischemic heart disease life stress monitoring program: Impact on mortality|/resolve/reference/PMED?id=6484101
Frasure Smith {published data only}|The Ischemic Heart Disease Life Stress Monitoring Program: Possible therapeutic mechanisms|
Frasure Smith 1997 {published data only}|Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction|/resolve/reference/PMED?id=9274583
Fridlund {published data only}|Recovery after myocardial infarction. Effects of a caring rehabilitation programme|/resolve/reference/PMED?id=2011669
Gallacher {published data only}|Effect of stress management on angina|
Gutschker {published data only}|Results of a territorial random long-term study on the comprehensive rehabilitation of patients after acute myocardial infarction|
HofmanBang {published data only}|Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty - A randomized study of a multifactorial programme|/resolve/reference/PMED?id=10493845
HofmanBang {published data only}|Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: A prospective, randomized, controlled study|/resolve/reference/PMED?id=10098823
Ibrahim {published data only}|Management after myocardial infarction: A controlled trial of the effect of group psychotherapy|/resolve/reference/PMED?id=9335919
Johnston {published data only}|Impact on patients and partners of inpatient and extended cardiac counseling and rehabilitation: A controlled trial|/resolve/reference/PMED?id=10204976
Jolly {published data only}|Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial|/resolve/reference/PMED?id=10078796
Jolly {published data only}|Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP)|/resolve/reference/PMED?id=10074017
Jones {published data only}|Psychological rehabilitation after myocardial infarction: Multicentre randomised controlled trial|/resolve/reference/PMED?id=8978226
Lewin {published data only}|Effects of self-help post-myocardial-infarction rehabilitation on psychological adjustment and use of health services|
Lidell {published data only}|A supportive-educative caring rehabilitation programme; improvements of physical health after myocardial infarction|
Lidell {published data only}|Long-term effects of a comprehensive rehabilitation programme after myocardial infarction|/resolve/reference/PMED?id=8717802
McHugh {published data only}|Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial|/resolve/reference/PMED?id=11514487
Mitsibounas 1992 {published data only}|Effect of group psychosocial intervention on coronary risk factors|/resolve/reference/PMED?id=1484925
Nordmann {published data only}|A case management programme of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: The Heartcare 1 Trial|/resolve/reference/PMED?id=11343668
Oldenburg 1985 {published data only}|Controlled trial of psychological intervention in myocardial infarction|/resolve/reference/PMED?id=3910679
Oldenburg 1995 {published data only}|A controlled trial of a behavioral and educational intervention following coronary artery bypass surgery|/resolve/reference/PMED?id=8529086
Ornish {published data only}|Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial|/resolve/reference/PMED?id=1973470
Ornish {published data only}|Intensive lifestyle changes for reversal of coronary heart disease|/resolve/reference/PMED?id=9863851
PRECOR {published data only}|Comparison of a rehabilitation programme, a counselling programme and usual care after an acute myocardial infarction: Results of a long-term randomized trial|/resolve/reference/PMED?id=1874262
Rahe {published data only}|Brief group therapy in myocardial infarction rehabilitation: Three- to four-year follow-up of a controlled trial|
RCCP {published data only}|Alteration of Type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: Summary results of the recurrent coronary prevention project|/resolve/reference/PMED?id=3766365
RCCP {published data only}|Feasibility of altering type A behaviour pattern after myocardial infarction|/resolve/reference/PMED?id=7083525
RCCP {published data only}|Change in coronary-prone behaviors in the recurrent coronary prevention project|/resolve/reference/PMED?id=1924653
RCCP {published data only}|Can the Type A behavior pattern be altered after myocardial infarction? A second year report from the Recurrent Coronary Prevention Project|/resolve/reference/PMED?id=6484101
RCCP {published data only}|Effects of type A behavioral counseling and severity of prior acute myocardial infarction on survival|/resolve/reference/PMED?id=3195476
Stern {published data only}|The group counseling v exercise therapy study. A controlled intervention with subjects following myocardial infarction|/resolve/reference/PMED?id=6615094
Thompson {published data only}|A randomized controlled trial of in-hospital nursing support for first time myocardial infarction patients and their partners: effects on anxiety and depression|
Thompson {published data only}|Effect of in-hospital counseling on knowledge in myocardial infarction patients and spouses|
Thompson {published data only}|A prospective evaluation of in-hospital counselling for first time myocardial infarction men|/resolve/reference/PMED?id=2341993
Thompson {published data only}|In-hospital counselling for first-time myocardial infarction patients and spouses: effects on satisfaction|
Toobert {published data only}|Behavioral and psychosocial effects of intensive lifestyle management for women with coronary heart disease|/resolve/reference/PMED?id=9887850
Van Dixhoorn {published data only}|Psychic effects of physical training and relaxation therapy after myocardial infarction|/resolve/reference/PMED?id=2187982
Van Dixhoorn {published data only}|Physical training and relaxation therapy in cardiac rehabilitation assessed through a composite criterion for training outcome|/resolve/reference/PMED?id=2672755
Van Dixhoorn {published data only}|Cardiac events after myocardial infarction: possible effect of relaxation therapy|/resolve/reference/PMED?id=3319629
Van Dixhoorn {published data only}|Effect of relaxation therapy on cardiac events after myocardial infarction: a 5-year follow-up study|/resolve/reference/PMED?id=10361649
Vermeulen {published data only}|Effects of cardiac rehabilitation after myocardial infarction: changes in coronary risk factors and long-term prognosis|/resolve/reference/PMED?id=6846123
Amerosa Tupler {published data only}|Stress management through relaxation and imagery in the treatment of angina pectoris|
Ashton {published data only}|Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial|/resolve/reference/PMED?id=9128126
Ashton {published data only}|The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial|/resolve/reference/PMED?id=9395624
Beresnevaite {published data only}|Exploring the benefits of group psychotherapy in reducing alexithymia in coronary heart disease patients|/resolve/reference/PMED?id=10773774
Blankfield {published data only}|Taped therapeutic suggestions and taped music as adjuncts in the care of coronary-artery-bypass patients|/resolve/reference/PMED?id=7879724
Blumenthal {published data only}|Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms|/resolve/reference/PMED?id=9342998
Bundy {published data only}|Psychological treatment of chronic stable angina pectoris|
Bundy {published data only}|Stress management and exercise training in chronic stable angina pectoris|
Clark {published data only}|Impact of self-management education on the functional health status of older adults with heart disease|/resolve/reference/PMED?id=1427244
Egger {published data only}|Coronary-prone behaviour: An attempt to modify type A behaviour in myocardial infarction patients|/resolve/reference/PMED?id=3532242
Elliot {published data only}|The effects of music and muscle relaxation on patient anxiety in a coronary care unit|/resolve/reference/PMED?id=8150641
Fielding {published data only}|A note on behavioural treatment in the rehabilitation of myocardial infarction patients|
Fletcher {published data only}|An individualized teaching programme following primary uncomplicated myocardial infarction|
Garding {published data only}|Effectiveness of a program of information and support for myocardial infarction patients recovering at home|/resolve/reference/PMED?id=2839433
Gidron {published data only}|The short-term effects of a hostility-reduction intervention on male coronary heart disease patients|/resolve/reference/PMED?id=10431944
Gortner {published data only}|Improving recovery following cardiac surgery: a randomized clinical trial|
Gruen {published data only}|Effects of brief psychotherapy during the hospitalization period on the recovery process in heart attacks|/resolve/reference/PMED?id=1120833
Guzzetta {published data only}|Effects of relaxation and music therapy on patients in a coronary care unit with presumptive acute myocardial infarction|/resolve/reference/PMED?id=2684920
Heller {published data only}|A randomised controlled trial of community based counselling among those discharged from hospital with ischaemic heart disease|
Horlick {published data only}|The effects of education and group discussion in the post myocardial infarction patient|/resolve/reference/PMED?id=6520804
Israelsson {published data only}|Social rehabilitation of patients with coronary disease. A new type of cooperation improves the results|/resolve/reference/PMED?id=7490979
Langosch {published data only}|Behavior therapy with coronary heart disease patients: results of a comparative study|/resolve/reference/PMED?id=6759642
Naismith {published data only}|Psychological rehabilitation after myocardial infarction|/resolve/reference/PMED?id=427400
Ohm {published data only}|Relaxation training and hypnotherapy in coronary patients with high internal control beliefs|
Oldridge {published data only}|Goal attainment in a randomized controlled trial of rehabilitation after myocardial infarction|
Oldridge {published data only}|Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction|/resolve/reference/PMED?id=2024598
Oldridge {published data only}|Profile of mood states and cardiac rehabilitation after acute myocardial infarction|/resolve/reference/PMED?id=7658953
Rakov {published data only}|The results of autogenic training in patients with ischemic heart disease after an aortocoronary bypass operation|/resolve/reference/PMED?id=9148578
Schindler {published data only}|Beneficial effects of psychiatric intervention on recovery after coronary artery bypass graft surgery|/resolve/reference/PMED?id=2792747
Taylor {published data only}|The effect of a home-based, case-managed, multifactorial risk-reduction program on reducing psychological distress in patients with cardiovascular disease|/resolve/reference/PMED?id=9187981
Thomas {published data only}|Cardiac inpatient education: The impact of educational methodology on self-efficacy|
Trzcieniecka-Green {published data only}|The effects of stress management on the quality of life of patients following acute myocardial infarction or coronary bypass surgery|/resolve/reference/PMED?id=8922914
Turner {published data only}|Stress management for patients with heart disease: A pilot study|/resolve/reference/PMED?id=7759275
Zamarra {published data only}|Usefulness of the transcendental meditation program in the treatment of patients with coronary artery disease|/resolve/reference/PMED?id=8623742
Collins {published data only}|An investigation into the use of relaxation techniques in the treatment of myocardial infarction|
Priebe {published data only}|Effects of brief couple therapy intervention in cardiac rehabilitation - a controlled trial|/resolve/reference/PMED?id=11496446
CORE {published data only}|Design of a randomised controlled trial of comprehensive cardiac rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus Comprehensive Cardiac Rehabilitation Trial (the CORE Study)|
Barefoot 1996|Symptoms of depression, acute myocardial infarction, and total mortality in a community sample|/resolve/reference/PMED?id=8640971
Beck 1961|An inventory for measuring depression|
Beck 1997|Cognitive Therapy: Reflections|
Bedford 1976|A new personal disturbance scale (DSSI/sAD)|
Bennett 1990|Type A behaviours and heart disease: epidemiological and experimental foundations|/resolve/reference/PMED?id=24487300
Bennett 1994|Cognitive-behavioural interventions in cardiac rehabilitation|
BHF 2003|Coronary Heart Disease statistics|
Burrell 1986|Heart and Lifestyle: A Type A treatment program for myocardial infarction patients|
CES-D 1977|A The CES-D Scale self-report depression scale for research in the general population|
Cochrane Heart Group|Preferred method for handling continuous variables|
Davidson 1995|Report of the working group of the British Cardiac Society: cardiac rehabilitation services in the United Kingdom|/resolve/reference/PMED?id=7696040
DeBusk 1994|A case-management system for coronary risk factor modification after acute myocardial infarction|/resolve/reference/PMED?id=8147544
Derogatis 1987|The Derogatis Stress Profile (DSP): Quantification of psychologic stress|/resolve/reference/PMED?id=3591564
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Dracup 1984|Group counselling in cardiac rehabilitation: Effect on patient compliance|/resolve/reference/PMED?id=10269521
Dusseldorp 1999|A meta-analysis of psychoeducational programs for coronary heart disease patients|/resolve/reference/PMED?id=10519467
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
Follmann 1992|Variance imputation for overviews of clinical trials with continuous response|/resolve/reference/PMED?id=1619456
Ford 1998|Depression is a risk factor for coronary artery disease in men: the precursors study|/resolve/reference/PMED?id=9665350
Friedman 1986|Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: Summary results of the recurrent coronary prevention project|/resolve/reference/PMED?id=3766365
Gillis 1993|A randomized clinical trial of nursing care for recovery from cardiac surgery|/resolve/reference/PMED?id=7680641
HAD 1983|The Hospital and Anxiety Depression Scale|
HAM-D|A structured interview for the Hamilton Depression Rating Scale|/resolve/reference/PMED?id=3395203
Hemingway 1999|Psychological factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective studies|
Horlick 1984|The effects of education and group discussion in the post myocardial infarction patient|/resolve/reference/PMED?id=6520804
Horowitz 1979|Impact of Events Scale: a measure of subjective stress|/resolve/reference/PMED?id=472086
Karvetti 1981|Changes in the diet of myocardial infarction patients: Effects of nutrition education|/resolve/reference/PMED?id=7310031
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Linden 1996|Psychosocial interventions for patients with coronary artery disease: a meta-analysis|/resolve/reference/PMED?id=8615707
Macleod 2002|Psychological stress and cardiovascular disease: empirical demonstration of bias in a prospective observational study of Scottish men|/resolve/reference/PMED?id=12028978
Maes 1992|Cardiac Rehabilitation in Europe|
Meichenbaum 1985||
Mitsibounas 1992|Effect of group psychosocial intervention on coronary risk factors|/resolve/reference/PMED?id=1484925
MOS SF36|The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection|/resolve/reference/PMED?id=1593914
Parrott 1995|Stress modulation over the day in cigarette smokers|/resolve/reference/PMED?id=7703817
SCL-90-R||
STAI 1970||
Stansfeld 2002||
Taylor 1953|A personality scale of manifest anxiety|/resolve/reference/PMED?id=13052352
Todd 1996|Role stress, role socialization, and cigarette smoking: Examining multiple roles and moderating variables|
West 1995|Evaluation of cardiac rehabilitation programmes|
Zung 1965|A self-rating depression scale|/resolve/reference/PMED?id=14221692
Appels 2005 {published data only}|Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized exhaustion intervention trial (EXIT)|/resolve/reference/PMED?id=15784786
Appels 2005 {published data only}|Effects of a behavioural intervention on quality of life and related variables in angioplasty patients: results of the exhaustion intervention trial|/resolve/reference/PMED?id=16813838
Black 1998 {published data only}|Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients|/resolve/reference/PMED?id=9584539
Brown 1993 {published data only}|Behavior therapy of psychological distress in patients after myocardial infarction or coronary bypass|
Burell 1996a {published data only}|Behaviour modification after coronary artery bypass graft surgery: effects on cardiac morbidity and mortality|
Burell 1996a {published data only}|Group psychotherapy in Project New Life: treatment of coronary-prone behaviors for patients who have had coronary artery bypass graft surgery|
Burgess 1987 {published data only}|A randomized control trial of cardiac rehabilitation|/resolve/reference/PMED?id=3551088
Claesson 2005 {published data only}|Women's hearts need special treatment|/resolve/reference/PMED?id=12360839
Claesson 2005 {published data only}|Women's hearts: stress management for women with ischemic heart disease: explanatory analyses of a randomized controlled trial|/resolve/reference/PMED?id=15818198
Claesson 2005 {published data only}|Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial|
Cowan 2001 {published data only}|Psychosocial nursing therapy following sudden cardiac arrest: impact on two-year survival|/resolve/reference/PMED?id=11302295
Elderen 1994 {published data only}|Effects of a health education programme with telephone follow-up during cardiac rehabilitation|
ENRICHD 2000 {published data only}|Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial|/resolve/reference/PMED?id=15126705
ENRICHD 2000 {published data only}|Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease ENRICHD study|/resolve/reference/PMED?id=15272090
ENRICHD 2000 {published data only}|Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial|/resolve/reference/PMED?id=18087205
ENRICHD 2000 {published data only}|Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design|/resolve/reference/PMED?id=11573023
ENRICHD 2000 {published data only}|Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial|/resolve/reference/PMED?id=12813116
ENRICHD 2000 {published data only}|Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial|/resolve/reference/PMED?id=12813116
ENRICHD 2000 {published data only}|The Enhancing Recovery in Coronary Heart Disease Trial ENRICHD: strategies and techniques for enhancing retention of patients with acute myocardial infarction and depression or social isolation|/resolve/reference/PMED?id=12894001
ENRICHD 2000 {published data only}|Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction|/resolve/reference/PMED?id=17605561
ENRICHD 2000 {published data only}|An intervention to treat depression and increase social support did not prolong event-free survival in coronary heart disease|
ENRICHD 2000 {published data only}|Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. Enhancing Recovery In Coronary Heart Disease patients. Assessment of Cardioversion Using Transoesophageal Echocardiography. AzimiLide post-Infarct surVival Evaluation. Randomised Evaluation of Mechanical Assistance for Treatment of Chronic Heart failure|/resolve/reference/PMED?id=11812672
ENRICHD 2000 {published data only}|The effect of a psychosocial intervention and quality of life after acute myocardial infarction: the Enhancing Recovery in Coronary Heart Disease ENRICHD clinical trial|/resolve/reference/PMED?id=16617220
ENRICHD 2000 {published data only}|Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial|/resolve/reference/PMED?id=15272091
ENRICHD 2000 {published data only}|Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods|/resolve/reference/PMED?id=10618555
ENRICHD 2000 {published data only}|Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual|/resolve/reference/PMED?id=18842753
Gallacher 1997 {published data only}|Effect of stress management on angina|
HofmanBang 1999 {published data only}|Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty - a randomized study of a multifactorial programme|/resolve/reference/PMED?id=10493845
HofmanBang 1999 {published data only}|Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: A prospective, randomized, controlled study|/resolve/reference/PMED?id=10098823
HofmanBang 1999 {published data only}|Long-term effects of lifestyle behavior change in coronary artery disease: effects on recurrent coronary events after percutaneous coronary intervention|/resolve/reference/PMED?id=15631561
Ibrahim 1974 {published data only}|Management after myocardial infarction: A controlled trial of the effect of group psychotherapy|/resolve/reference/PMED?id=9335919
Jones 1996 {published data only}|Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial|/resolve/reference/PMED?id=8978226
Koertge 2008 {published data only}|Effects of a stress management program on vital exhaustion and depression in women with coronary heart disease: a randomized controlled intervention study|
Mayou 2002 {published data only}|Guideline-based early rehabilitation after myocardial infarction: a pragmatic randomised controlled trial|/resolve/reference/PMED?id=11832254
McLaughlin 2005 {published data only}|The effect of a telephone counseling intervention on self-rated health of cardiac patients|/resolve/reference/PMED?id=16046365
McLaughlin 2005 {published data only}|Improving psychologic adjustment to chronic illness in cardiac patients: the role of depression and anxiety|
Michalsen 2005 {published data only}|Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial|/resolve/reference/PMED?id=16244510
Oldenburg 1985 {published data only}|Controlled trial of psychological intervention in myocardial infarction|/resolve/reference/PMED?id=3910679
Peng 2005 {published data only}|Psychotherapy on negative emotions for the incidence of ischemia-related events in patients with coronary heart disease|
Rahe 1979 {published data only}|Brief group therapy in myocardial infarction rehabilitation: three- to four-year follow-up of a controlled trial|
RCCP 1982 {published data only}|Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project|/resolve/reference/PMED?id=3766365
RCCP 1982 {published data only}|Feasibility of altering type A behaviour pattern after myocardial infarction|/resolve/reference/PMED?id=7083525
RCCP 1982 {published data only}|Change in coronary-prone behaviors in the recurrent coronary prevention project|/resolve/reference/PMED?id=1924653
RCCP 1982 {published data only}|Can the type A behavior pattern be altered after myocardial infarction? A second year report from the Recurrent Coronary Prevention Project|/resolve/reference/PMED?id=6484101
RCCP 1982 {published data only}|Effects of type A behavioral counseling and severity of prior acute myocardial infarction on survival|/resolve/reference/PMED?id=3195476
Sebregts 2005 {published data only}|Psychological effects of a short behavior modification program in patients with acute myocardial infarction or coronary artery bypass grafting A randomized controlled trial|/resolve/reference/PMED?id=16026656
Stern 1983 {published data only}|The group counseling v exercise therapy study. A controlled intervention with subjects following myocardial infarction|/resolve/reference/PMED?id=6615094
Van Dixhoorn 1999 {published data only}|Psychic effects of physical training and relaxation therapy after myocardial infarction|/resolve/reference/PMED?id=2187982
Van Dixhoorn 1999 {published data only}|Physical training and relaxation therapy in cardiac rehabilitation assessed through a composite criterion for training outcome|/resolve/reference/PMED?id=2672755
Van Dixhoorn 1999 {published data only}|Cardiac events after myocardial infarction: possible effect of relaxation therapy|/resolve/reference/PMED?id=3319629
Van Dixhoorn 1999 {published data only}|Effect of relaxation therapy on cardiac events after myocardial infarction: a 5-year follow-up study|/resolve/reference/PMED?id=10361649
-Vestfold-Heartcare-Study-Group 2003 {published data only}|Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease|/resolve/reference/PMED?id=14671465
Allison 2000 {published data only}|Management of coronary risk factors by registered nurses versus usual care in patients with unstable angina pectoris (a chest pain evaluation in the emergency room [CHEER] substudy)|/resolve/reference/PMED?id=10913471
Bagheri 2007 {published data only}|Evaluation of the effect of group counselling on post myocardial infarction patients: determined by an analysis of quality of life|
Bay 2008 {published data only}|The effect of pastoral care services on anxiety, depression, hope, religious coping, and religious problem solving styles: a randomized controlled study|/resolve/reference/PMED?id=19105001
Bettencourt 2005 {published data only}|Impact of cardiac rehabilitation on quality of life and depression after acute coronary syndrome|/resolve/reference/PMED?id=16041965
Bishop 2005 {published data only}|Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting|/resolve/reference/PMED?id=16169348
Blumenthal 2005 {published data only}|Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial|/resolve/reference/PMED?id=15811982
Brodie 2008 {published data only}|Motivational interviewing to change quality of life for people with chronic heart failure: a randomised controlled trial|/resolve/reference/PMED?id=17258218
Buckley 2007 {published data only}|The effect of education and counselling on knowledge, attitudes and beliefs about responses to acute myocardial infarction symptoms|/resolve/reference/PMED?id=16839819
Burell 1996b {published data only}|Group psychotherapy in Project New Life: treatment of coronary-prone behaviors for patients who have had coronary artery bypass graft surgery|
Carson 1988 {published data only}|The effect of a relaxation technique on coronary risk factors|/resolve/reference/PMED?id=3289645
Chen 2005 {published data only}|Effect of cognitive education on the physical and psychological rehabilitation of patients with coronary heart disease after interventional therapy|
Clark 2007 {published data only}|Heart disease management by women: does intervention format matter?|
de-Klerk 2004 {published data only}|Hypnotherapeutic ego strengthening with male South African coronary artery bypass patients|/resolve/reference/PMED?id=15554461
DeBusk 1994a {published data only}|A case-management system for coronary risk factor modification after acute myocardial infarction|/resolve/reference/PMED?id=8147544
del Pino 2005 {published data only}|Modification of coronary-prone behaviors in coronary patients of low socio-economic status|/resolve/reference/PMED?id=15875459
Dusseldorp 1999 {published data only}|A meta-analysis of psychoeducational programs for coronary heart disease patients|/resolve/reference/PMED?id=10519467
Erdman 1983 {published data only}|Predictability of beneficial effects in cardiac rehabilitation: a randomized clinical trial of psychosocial variables|
Erdman 1983 {published data only}|Psychologic evaluation of a cardiac rehabilitation program: a randomized clinical trial in patients with myocardial infarction|
Fang 2003 {published data only}|Control study of general psychological intervention for patients with myocardial infarction|
Focht 2004 {published data only}|Group-mediated activity counseling and traditional exercise therapy programs: effects on health-related quality of life among older adults in cardiac rehabilitation|/resolve/reference/PMED?id=15249259
Frasure-Smith 1985 {published data only}|Long-term follow-up of the Ischemic Heart Disease Life Stress Monitoring Program|/resolve/reference/PMED?id=2798700
Frasure-Smith 1985 {published data only}|The ischemic heart disease life stress monitoring program: impact on mortality|/resolve/reference/PMED?id=4059478
Frasure-Smith 1985 {published data only}|The Ischemic Heart Disease Life Stress Monitoring Program: possible therapeutic mechanisms|
Frasure-Smith 1997 {published data only}|Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction|/resolve/reference/PMED?id=9274583
Fridlund 1991 {published data only}|Recovery after myocardial infarction: effects of a caring rehabilitation programme|/resolve/reference/PMED?id=2011669
Friedman 1986 {published data only}|Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project|/resolve/reference/PMED?id=3766365
Gallagher 2003 {published data only}|Effects of a telephone counseling intervention on psychosocial adjustment in women following a cardiac event|/resolve/reference/PMED?id=12734530
Giannuzzi 2008 {published data only}|Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network|/resolve/reference/PMED?id=19001195
Goodman 2008 {published data only}|A randomised controlled trial to evaluate a nurse-led programme of support and lifestyle management for patients awaiting cardiac surgery 'Fit for surgery: Fit for life' study|/resolve/reference/PMED?id=18160344
Gruen 1975 {published data only}|Effects of brief psychotherapy during the hospitalization period on the recovery process in heart attacks|/resolve/reference/PMED?id=1120833
Gunnarsdottir 2007 {published data only}|Does the experimental design capture the effects of complementary therapy? A study using reflexology for patients undergoing coronary artery bypass graft surgery|
Gutschker 1982 {published data only}|Results of a territorial random long-term study on the comprehensive rehabilitation of patients after acute myocardial infarction|
Hardcastle 2008 {published data only}|A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors|/resolve/reference/PMED?id=17997263
Harting 2006 {published data only}|Effects of health counseling on behavioural risk factors in a high-risk cardiology outpatient population: a randomized clinical trial|/resolve/reference/PMED?id=16575275
Hattan 2002 {published data only}|The impact of foot massage and guided relaxation following cardiac surgery: a randomized controlled trial|
Higgins 2001 {published data only}|Rehabilitation outcomes following percutaneous coronary interventions (PCI)|/resolve/reference/PMED?id=11384820
Izawa 2005 {published data only}|Effect of the self-monitoring approach on exercise maintenance during cardiac rehabilitation: a randomized, controlled trial|/resolve/reference/PMED?id=15829777
Jaarsma 2008 {published data only}|Value of basic and intensive management of patients with heart failure; results of a randomised controlled clinical trial|/resolve/reference/PMED?id=18825890
Jiang 2007 {published data only}|A nurse-led cardiac rehabilitation programme improves health behaviours and cardiac physiological risk parameters: evidence from Chengdu, China|
Johansen 2003 {published data only}|The effect of psychosocial rehabilitation after acute myocardial infarction A randomized controlled trial|/resolve/reference/PMED?id=12970994
Johnston 1999 {published data only}|Impact on patients and partners of inpatient and extended cardiac counseling and rehabilitation: a controlled trial|/resolve/reference/PMED?id=10204976
Jolly 1998 {published data only}|Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial. Southampton Heart Integrated Care Project|/resolve/reference/PMED?id=10078796
Jolly 1998 {published data only}|Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group|/resolve/reference/PMED?id=10074017
Kanji 2004 {published data only}|Autogenic training reduces anxiety after coronary angioplasty: a randomized clinical trial|/resolve/reference/PMED?id=14999212
Karlsson 2007 {published data only}|Effects of expanded cardiac rehabilitation on psychosocial status in coronary artery disease with focus on type D characteristics|/resolve/reference/PMED?id=17417723
King 1988 {published data only}|A system of cardiac rehabilitation: Psychophysiological basis and practice|
Klein 2007 {published data only}|The impact of sexual therapy on patients after cardiac events participating in a cardiac rehabilitation program|/resolve/reference/PMED?id=17925627
Ku 2002 {published data only}|Effects of phase I cardiac rehabilitation on anxiety of patients hospitalized for coronary artery bypass graft in Taiwan|/resolve/reference/PMED?id=11910388
Kummel 2008 {published data only}|Effects of an intervention on health behaviors of older coronary artery bypass (CAB) patients|
Lahmann 2008 {published data only}|Efficacy of functional relaxation and patient education in the treatment of somatoform heart disorders: a randomized, controlled clinical investigation|/resolve/reference/PMED?id=18794505
Lewin 2002 {published data only}|A randomised controlled trial of a self-management plan for patients with newly diagnosed angina|/resolve/reference/PMED?id=12030661
Lewin 2009 {published data only}|A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions|/resolve/reference/PMED?id=18070951
Lidell 1996 {published data only}|A supportive-educative caring rehabilitation programme; improvements of physical health after myocardial infarction|
Lidell 1996 {published data only}|Long-term effects of a comprehensive rehabilitation programme after myocardial infarction|/resolve/reference/PMED?id=8717802
Luszczynska 2006 {published data only}|An implementation intentions intervention, the use of a planning strategy, and physical activity after myocardial infarction|/resolve/reference/PMED?id=16095786
Luszczynska 2007 {published data only}|Planning to change diet: A controlled trial of an implementation intentions training intervention to reduce saturated fat intake among patients after myocardial infarction|/resolve/reference/PMED?id=17980221
MacIntyre 2008 {published data only}|The efficacy of healing touch in coronary artery bypass surgery recovery: a randomized clinical trial|
Mandel 2007 {published data only}|Effects of music therapy on health-related outcomes in cardiac rehabilitation: a randomized controlled trial|/resolve/reference/PMED?id=17645384
Mandel 2008 {published data only}||
Maroto 2005 {published data only}|Cardiac rehabilitation in patients with myocardial infarction: a 10- year follow-up study|/resolve/reference/PMED?id=16238986
McGillion 2008 {published data only}|Randomized controlled trial of a psychoeducation program for the self-management of chronic cardiac pain|/resolve/reference/PMED?id=18395397
McHugh 2001 {published data only}|Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial|/resolve/reference/PMED?id=11514487
Mitsibounas 1992 {published data only}|Effects of group psychosocial intervention on coronary risk factors|/resolve/reference/PMED?id=1484925
Mohiuddin 2007 {published data only}|Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease|/resolve/reference/PMED?id=17296646
Nordmann 2001 {published data only}|A case-management program of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: the Heartcare I trial|/resolve/reference/PMED?id=11343668
Novoa 2008 {published data only}|Clinical hypnosis for reduction of atrial fibrillation after coronary artery bypass graft surgery|/resolve/reference/PMED?id=18540146
Oldenburg 1995 {published data only}|A controlled trial of a behavioral and educational intervention following coronary artery bypass surgery|/resolve/reference/PMED?id=8529086
Oldridge 1995 {published data only}|Quality of life after myocardial infarction|
Oldridge 1995 {published data only}|Profile of mood states and cardiac rehabilitation after acute myocardial infarction|/resolve/reference/PMED?id=7658953
Ornish 1990 {published data only}|Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial|/resolve/reference/PMED?id=1973470
Ornish 1998 {published data only}|Intensive lifestyle changes for reversal of coronary heart disease|/resolve/reference/PMED?id=9863851
Parent 2000 {published data only}|A randomized, controlled trial of vicarious experience through peer support for male first-time cardiac surgery patients: impact on anxiety, self-efficacy expectation, and self-reported activity|/resolve/reference/PMED?id=11080319
Paul 2006 {published data only}|Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease|/resolve/reference/PMED?id=16772250
Petrie 2002 {published data only}|Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial|/resolve/reference/PMED?id=12140347
PRECOR Group 1991 {published data only}|Comparison of a rehabilitation programme, a counselling programme and usual care after an acute myocardial infarction: results of a long-term randomized trial|
Price 2004 {published data only}|Treating low perceived social support and depression after myocardial infarction does not increase event-free survival|
Pullen 2008 {published data only}|Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure|/resolve/reference/PMED?id=18514933
Quist 2003 {published data only}|Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease|/resolve/reference/PMED?id=14644967
Reid 2003 {published data only}|Stepped care approach to smoking cessation in patients hospitalized for coronary artery disease|/resolve/reference/PMED?id=12782900
Robert-McComb 2004 {published data only}|A pilot study to examine the effects of a mindfulness-based stress- reduction and relaxation program on levels of stress hormones, physical functioning, and submaximal exercise responses|
Salminen 2005 {published data only}|Effects of health advocacy, counseling, and activation among older coronary heart disease (CHD) patients|/resolve/reference/PMED?id=16485865
Scholz 2006 {published data only}|Physical activity and depressive symptoms in cardiac rehabilitation: long-term effects of a self-management intervention|/resolve/reference/PMED?id=16388882
Senuzun 2006 {published data only}|Effects of home-based cardiac exercise program on the exercise tolerance, serum lipid values and self-efficacy of coronary patients|/resolve/reference/PMED?id=16874157
Seskevich 2004 {published data only}|Beneficial effects of noetic therapies on mood before percutaneous intervention for unstable coronary syndromes|/resolve/reference/PMED?id=15084996
Sheps 2004 {published data only}|The INTERHEART study: intersection between behavioral and general medicine|/resolve/reference/PMED?id=15564341
Sinclair 2005 {published data only}|Post-discharge home-based support for older cardiac patients: a randomised controlled trial|/resolve/reference/PMED?id=15955757
Sniehotta 2006 {published data only}|Action plans and coping plans for physical exercise: A longitudinal intervention study in cardiac rehabilitation|/resolve/reference/PMED?id=16480553
Stenlund 2005 {published data only}|Cardiac rehabilitation for the elderly: Qi Gong and group discussions|/resolve/reference/PMED?id=15703500
Thompson 1989 {published data only}|A randomized controlled trial of in-hospital nursing support for first time myocardial infarction patients and their partners: effects on anxiety and depression|
Thompson 1989 {published data only}|Effect of in-hospital counseling on knowledge in myocardial infarction patients and spouses|
Thompson 1989 {published data only}|A prospective evaluation of in-hospital counselling for first time myocardial infarction men|/resolve/reference/PMED?id=2341993
Thompson 1989 {published data only}|In-hospital counselling for first-time myocardial infarction patients and spouses: effects on satisfaction|
Toobert 1998 {published data only}|Behavioral and psychosocial effects of intensive lifestyle management for women with coronary heart disease|/resolve/reference/PMED?id=9887850
van Dixhoorn 1991 {published data only}|Self-observation in cardiac rehabilitation|
van Dixhoorn, 1983 {published data only}|Contribution of relaxation technique training to the rehabilitation of myocardial infarction patients|/resolve/reference/PMED?id=6361837
van Elderen 2001 {published data only}|Lifestyle effects of group health education for patients with coronary heart disease|
Vermeulen 1983 {published data only}|Effects of cardiac rehabilitation after myocardial infarction: changes in coronary risk factors and long-term prognosis|/resolve/reference/PMED?id=6846123
Wan 2005 {published data only}|Influence of psychological intervention on the negative emotion of patients with coronary heart disease|
Wyer 2001 {published data only}|Increasing attendance at a cardiac rehabilitation programme: an intervention study using the theory of planned behaviour|
Xue 2008 {published data only}|A randomised trial of a 5 week, manual based, self-management programme for hypertension delivered in a cardiac patient club in Shanghai|
Yeh 2008 {published data only}|T'ai Chi exercise in patients with chronic heart failure|/resolve/reference/PMED?id=18487899
Zeng 2001 {published data only}|The influence of antidepressive therapy on short-term prognosis in elderly patients with unstable angina and depression|/resolve/reference/PMED?id=16206668
Zhu 2006 {published data only}|Interventional effect of Chinese daoistic cognitive therapy on type-A behavior of patients with coronary heart disease|
James 2006 {published data only}|Effect of a psychosocial intervention on inflammatory markers in patients with coronary artery disease|
Zetta 2006 {published data only}|Randomised controlled trial comparing a self-help cognitive behavioural programme, the Angina Plan, with standard care for angina patients admitted to hospital [abstract]|
Beckie 2006 {published data only}|A behavior change intervention for women in cardiac rehabilitation|/resolve/reference/PMED?id=16601534
Burg 2007 {published data only}|Treating persistent depressive symptoms in post-ACS patients: The project COPES phase-I randomized controlled trial|
CORE {published data only}|Design of a randomised controlled trial of comprehensive cardiac rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus Comprehensive Cardiac Rehabilitation Trial (the CORE Study)|/resolve/reference/PMED?id=11714435
Frasure 2006 {published data only}|Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE)|/resolve/reference/PMED?id=16449416
Beck 1961|An inventory for measuring depression|
Beck 1997|Cognitive Therapy: Reflections|
BHF 2009|Numbers dying from CVD and CHD|
Butler 2006|The empirical status of cognitive-behavioral therapy: a review of meta-analyses|/resolve/reference/PMED?id=16199119
Carney 2002|Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms|
Cochrane Heart Group 2003|Preferred method for handling continuous variables|
Cohen-Cole 1993|Assessment of depression and grief reaction in the medically ill|
DeBusk 1994b|A case-management system for coronary risk factor modification after acute myocardial infarction|/resolve/reference/PMED?id=8147544
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
DSSI/sAD 1976|A new personal disturbance scale (DSSI/sAD)|
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
Follmann 1992|Variance imputation for overviews of clinical trials with continuous response|/resolve/reference/PMED?id=1619456
HADS 1983|The hospital and anxiety depression scale|
Halaris 2009|Comorbidity between depression and cardiovascular disease|/resolve/reference/PMED?id=19367238
HAM-D 1988|A structured interview for the Hamilton Depression Rating Scale|/resolve/reference/PMED?id=3395203
Hersen 2004||
Higgins 2011|iggins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). |
Jacobson 1996|A component analysis of cognitive-behavioral treatment for depression|/resolve/reference/PMED?id=8871414
Kuper 2009|Evaluating the causal relevance of diverse risk markers: horizontal systematic review|/resolve/reference/PMED?id=19892791
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Lesperance 2000|Depression in patients with cardiac disease: a practical review|/resolve/reference/PMED?id=10880660
Lim 1993|A self-administered quality-of-life questionnaire after acute myocardial infarction|/resolve/reference/PMED?id=8229102
Linden 2007|Psychological treatment of cardiac patients: a meta-analysis|/resolve/reference/PMED?id=17984133
Meichenbaum 1985||
MIVE 1996|An interview to measure vital exhaustion. I. development and comparison with the Maastricht questionnaire|
MQ 1987|A questionnaire to assess premonitory symptoms of myocardial infarction|/resolve/reference/PMED?id=3666994
SCL-90-R 1983||
STAI 1970||
STAXI 1985|The experience and expression of anger: Construction and validation of an anger expression scale|
Taylor 1953|A personality scale of manifest anxiety|/resolve/reference/PMED?id=13052352
Welton 2009|Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease|
Zung 1965|A self-rating depression scale|/resolve/reference/PMED?id=14221692
Rees 2004|Psychological interventions for coronary heart disease|
Baker 1998 {published data only}|Acute stroke patients. Comparing outcomes with and without case management|/resolve/reference/PMED?id=9832763
Bowen 1994 {published data only}|Effect of a stroke protocol on hospital costs of stroke patients|/resolve/reference/PMED?id=7936257
Crawley 1996 {published data only}|Case management: improving outcomes of care for ischaemic stroke patients|/resolve/reference/PMED?id=8852193
Falconer 1993 {published data only}|The critical path method in stroke rehabilitation: Lessons from an experiment in cost containment and outcome improvement|/resolve/reference/PMED?id=8455920
Hamrin 1990 {published data only}|The effect of systematic care planning after acute stroke in general hospital medical wards|
Kwan 2004 {published and unpublished data}||
Kwan 2004 {published and unpublished data}|Effects of introducing an integrated care pathway in an acute stroke unit|/resolve/reference/PMED?id=15047573
Kwan 2004 {published and unpublished data}|What are the effects of introducing a care pathway in an acute stroke unit? Results of a before-and-after study of 351 patients|
Mosimaneotsile 2000 {published data only}|Stroke patient outcomes: does an integrated delivery model of care make a difference?|
Odderson 1993 {published data only}|A model for management of patients with stroke during the acute phase. Outcome and economic implications|/resolve/reference/PMED?id=8248962
Pasquarello 1990 {published data only}|Measuring the impact of an acute stroke program on patient outcomes|/resolve/reference/PMED?id=2139685
Ross 1997 {published data only}|Evaluation of a critical pathway for stroke|/resolve/reference/PMED?id=9195788
Schull 1992 {published data only}|Clinical nurse specialists as collaborative care managers|/resolve/reference/PMED?id=1553138
Sulch 2000 {published data only}|Does an integrated care pathway improve process of care in stroke rehabilitation? A randomized controlled trial|/resolve/reference/PMED?id=12006305
Sulch 2000 {published data only}|Integrated care pathways and quality of life on a stroke rehabilitation unit|/resolve/reference/PMED?id=12052998
Sulch 2000 {published data only}|Evaluation of an integrated care pathway for stroke unit rehabilitation|
Sulch 2000 {published data only}|Randomised controlled trial of integrated (managed) care pathway for stroke rehabilitation|/resolve/reference/PMED?id=10926959
Wee 2000 {published data only}|The development of a stroke clinical pathway: an experience in a medium-sized community hospital|/resolve/reference/PMED?id=10918757
Widjaja 2002 {published data only}|Variance analysis applied to a stroke pathway: how this can improve efficiency of healthcare delivery|/resolve/reference/PMED?id=12161876
Wilkinson 2000 {published data only}|Finalist: ACHS Quality Improvement Award. Cerebrovascular accident clinical pathway|
Abissi 1995 {published data only}|Cerebral infarction: comparison of a care plan with case management to traditional care|
Alberts 1996 {published data only}|Hospital charges for stroke patients|/resolve/reference/PMED?id=8841339
Allen 2002 {published data only}|Effectiveness of a postdischarge care management model for stroke and transient ischaemic attack: a randomized trial|/resolve/reference/PMED?id=17903862
Bokemark 1995 {published data only}|How are guidelines for the management of acute stroke optimally implemented in clinical practice|
Chui 1997 {published data only}|The effectiveness of systematic stroke care|/resolve/reference/PMED?id=9311201
Dignan 1986 {published data only}|Evaluation of the North Carolina stroke care program|/resolve/reference/PMED?id=3715932
Duryee 1996 {published data only}|The impact of a stroke clinical pathway: measuring effectiveness|
Edwards 1996 {published data only}|Resource utilization and pathways: meeting the challenge of cost containment|/resolve/reference/PMED?id=8813165
Englander 1998 {published data only}|Accelerating the evaluation of acute stroke patients in a community hospital|
Evans 1995 {published data only}|Meta-analysis of stroke outcome: survival, function, and residence|
Friedman 1990 {published data only}|Stroke rehabilitation in the elderly: a new patient management system|/resolve/reference/PMED?id=2342704
Goldberg 1997 {published data only}|Stroke transition after inpatient rehabilitation|
Goldstein 1998 {published data only}|North Carolina stroke prevention and treatment facilities survey. rtPA therapy for acute stroke|/resolve/reference/PMED?id=9756583
Hainsworth 1997 {published data only}|Development and implementation of clinical pathways for stroke on a multihospital basis|/resolve/reference/PMED?id=9220362
Hashimoto 2000 {published data only}|Critical pathway and hospital-hospital cooperation in acute stroke|/resolve/reference/PMED?id=20667258
Horgan 1996 {published data only}|The development of a comprehensive stroke programme in the acute hospital|/resolve/reference/PMED?id=8996952
Ivey 1995 {published data only}|Critical pathways at University of Cincinnati hospital|/resolve/reference/PMED?id=7656090
Jahnke 2003 {published data only}|Stroke teams and acute stroke pathways: one emergency department's two-year experience|/resolve/reference/PMED?id=12660695
Jungkind 1999 {published data only}|Pilot acute ischemic stroke program saves $9,756 per case|/resolve/reference/PMED?id=10557708
Karanjia 1997 {published data only}|Validation of the ACAS TIA/stroke algorithm|/resolve/reference/PMED?id=9040719
Lagoe 1997 {published data only}|Benchmarking and clinical pathway implementation on a multihospital basis|/resolve/reference/PMED?id=9305113
Lagoe 1998 {published data only}|Basic statistics for clinical pathway evaluation|/resolve/reference/PMED?id=9748975
Langhorne 2001 {published data only}|Evaluation of an acute care protocol for stroke patients; a controlled clinical trial|
MacKenzie 1998 {published data only}|The effectiveness of nursing care: use of a protocol to promote stroke rehabilitation|
Moloney 1999 {published data only}|A multidisciplinary care pathway in stroke - does it improve care?|
Monane 1996 {published data only}|Variability in length of hospitization for stroke. The role of managed care in an elderly population|/resolve/reference/PMED?id=8815852
Odderson 1995 {published data only}|Swallow management in patients on an acute stroke pathway: quality is cost effective|/resolve/reference/PMED?id=8540789
Patel 2001 {unpublished data only}|Organised care for acute stroke|
Pearson 1988 {published data only}|Effects of admission to a nursing unit|/resolve/reference/PMED?id=2980629
Quigley 1998 {published data only}|Successful experiences with clinical pathways in rehabilitation|
Ramachandran 1996 {published data only}|Development and implementation of a clinical pathway for stroke in acute care|
Retchin 1997 {published data only}|Outcomes of stroke patients in medicare fee for service and managed care|/resolve/reference/PMED?id=9214526
Reuben 1995 {published data only}|A randomized trial of comprehensive geriatric assessment in the care of hospitalized patients|/resolve/reference/PMED?id=7715645
Romito 1990 {published data only}|A critical path for CVA patients|/resolve/reference/PMED?id=2343179
Rosenberger 1999 {published data only}|CareMaps in medical rehabilitation|
Rossiter 1995 {published data only}|Introduction of integrated care pathways for patients with multiple sclerosis in an inpatient neurorehabilitation setting|/resolve/reference/PMED?id=8573707
Schmidt 1999 {published data only}|Epidemiological determination of community-based nursing case management for stroke|/resolve/reference/PMED?id=10377924
Sulch 2000 (SR) {published data only}|Integrated care pathways in stroke management|/resolve/reference/PMED?id=10985445
Summers 1998 {published data only}|Development of clinical pathways for stroke management. An example from Saint Luke's Hospital, Kansas City|/resolve/reference/PMED?id=10499933
Summers 1998 {published data only}|Implementation and evaluation of stroke clinical pathways and the impact on cost of stroke care|/resolve/reference/PMED?id=9785207
Underwood 1999 {published data only}|Developing and evaluating an acute stroke care pathway through action research|
van Straten 1997 {published data only}|Quality of hospital care for stroke patients in The Netherlands|
von Reutern 1998 {published data only}|Stroke treatment with stroke unit and rehabilitation by a team. A model for a staged management|/resolve/reference/PMED?id=10098150
Wentworth 1996 {published data only}|Implementation of an acute stroke program decreases hospitalization costs and length of stay|/resolve/reference/PMED?id=8650711
Wood-Dauphinee 1984 {published data only}|A randomized trial of team care following stroke|/resolve/reference/PMED?id=6382700
Zander 1988 {published data only}|Nursing case management: strategic management of cost and quality outcomes|/resolve/reference/PMED?id=3367227
Bamford 1991|Classification and natural history of clinically identifiable subtypes of cerebral infarction|/resolve/reference/PMED?id=1675378
Campbell 2000|Framework for design and evaluation of complex interventions to improve health|/resolve/reference/PMED?id=10987780
Chalmers 1983|Bias in treatment assignment in controlled clinical trials|/resolve/reference/PMED?id=6633598
Deeks 2003|Evaluating non-randomised intervention studies|
Ebrahim 1999||
Egger 1998|Spurious precision? Meta-analysis of observational studies|/resolve/reference/PMED?id=9462324
Hydo 1995|Designing an effective clinical pathway for stroke|/resolve/reference/PMED?id=7717439
Kaste 1998|Economic burden of stroke and the evaluation of new therapies|/resolve/reference/PMED?id=9581452
Lanska 1998|The role of clinical pathways in reducing the economic burden of stroke|/resolve/reference/PMED?id=10186455
McNaughton 2003|Relationship between process and outcome in stroke care|/resolve/reference/PMED?id=12624296
Mulrow 1999|Cochrane Collaboration Handbook|
Murray 1997|Mortality by cause for eight regions of the world: Global Burden of Disease Study|/resolve/reference/PMED?id=9142060
Overill 1998|A practical guide to care pathways|
Pearson 1995|Critical pathways as a strategy for improving care: Problems and potential|/resolve/reference/PMED?id=7486490
RCP 2001||
Rothwell 2001|The high cost of not funding stroke research: a comparison with heart disease and cancer|/resolve/reference/PMED?id=11377668
Rudd 1999|The national sentinel audit of stroke: a tool for raising standards of care|
Sacks 1982|Randomized versus historical controls for clinical trials|/resolve/reference/PMED?id=7058834
SUTC 2000|Organised inpatient (stroke unit) care for stroke|
Sutton 2000|Empirical assessment of effect of publication bias on meta-analyses|/resolve/reference/PMED?id=10845965
Wade 1992||
WHO 1989|Stroke 1989. Recommendations on stroke prevention, diagnosis, and therapy: Report of the WHO Task Force on stroke and other cerebrovascular disorders|/resolve/reference/PMED?id=2799873
Kwan ACPJC 2002|Review: In-hospital care pathways for acute stroke do not improve clinical outcomes and lower quality of life|/resolve/reference/PMED?id=12207455
Kwan Stroke 2003|In-hospital care pathways for stroke: a Cochrane systematic review|/resolve/reference/PMED?id=12574581
Blake 1990 {published data only}|A randomized controlled evaluation of a psychosocial intervention in adults with chronic lung disease|/resolve/reference/PMED?id=2227172
Bourbeau 2003 {published data only}|Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention|/resolve/reference/PMED?id=12622605
Bourbeau 2003 {published data only}|Self-management reduces both short- and long-term hospitalisation in COPD|/resolve/reference/PMED?id=16264046
Boxall 2005 {published data only}|Managing chronic obstructive pulmonary disease in the community. A randomized controlled trial of home-based pulmonary rehabilitation for elderly housebound patients|/resolve/reference/PMED?id=16327534
Cockcroft 1987 {published data only}|Controlled trial of respiratory health worker visiting patients with chronic respiratory disability|/resolve/reference/PMED?id=3101821
Coultas 2005a {published and unpublished data}|A randomized trial of two types of nurse-assisted home care for patients with COPD|/resolve/reference/PMED?id=16236850
Coultas 2005b {published and unpublished data}|A randomized trial of two types of nurse-assisted home care for patients with COPD|/resolve/reference/PMED?id=16236850
Emery 1998 {published data only}|Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9619472
Gallefoss 1999 {published data only}|How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?|/resolve/reference/PMED?id=10588620
Gallefoss 1999 {published data only}|Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10783940
Gallefoss 1999 {published data only}|Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10051255
Gourley 1998 {published data only}|Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study|/resolve/reference/PMED?id=9782692
Gourley 1998 {published data only}|Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study|/resolve/reference/PMED?id=9782691
Howland 1986 {published data only}|Chronic obstructive airway disease. Impact of health education|/resolve/reference/PMED?id=3731895
Littlejohns 1991 {published data only}|Randomised controlled trial of the effectiveness of a respiratory health worker in reducing impairment, disability, and handicap due to chronic airflow limitation|/resolve/reference/PMED?id=1926024
Martin 2004 {published data only}|Care plans for acutely deteriorating COPD: a randomized controlled trial|/resolve/reference/PMED?id=16281645
Monninkhof 2003 {published data only}|Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease.|/resolve/reference/PMED?id=16281663
Monninkhof 2003 {published data only}|Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=14621090
Rea 2004 {published data only}|A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease|
Watson 1997 {published data only}|Evaluation of a self-management plan for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9192927
Ashikaga 1980 {published data only}|Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7392019
Brough 1982 {published data only}|Comparison of two teaching methods for self-care training for patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10258418
Brundage 1993 {published data only}|Self-care instruction for patients with COPD|
Carone 2002 {published data only}|EDU-CARE, a randomised, multicentre, parallel group study on education and quality of life in COPD|/resolve/reference/PMED?id=12174697
Carriei 2005 {published data only}|Impact of brief or extended exercise training on the benefit of a dyspnea self-management program in COPD|/resolve/reference/PMED?id=16217231
Chavannes 2002 {published data only}|Effects of physical activity in mild to moderate COPD: a systematic review|/resolve/reference/PMED?id=12120721
De Assuncao 1999 {published data only}|Educational program at hospital Universitario, Universidade de Sao Paulo, for patients suffering from chronic obstructive pulmonary disease (COPD) and asthma|
Devine 1996 {published data only}|Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9006233
Ferrari 2004 {published data only}|Minimally supervised home rehabilitation improves exercise capacity and health status in patients with COPD|/resolve/reference/PMED?id=15100621
Gallefoss 2000b {published data only}|Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education|/resolve/reference/PMED?id=11127492
Garrod 1997 {unpublished data only}|Randomised controlled trial of hospital out-patient pulmonary rehabilitaion in moderate COPD. Early effects|
Gibbons 2001a {published data only}|A nurse-led pulmonary rehabilitation programme for patient with COPD|/resolve/reference/PMED?id=12029897
Gibbons 2001b {published data only}|Developing a nurse-led service for COPD patients|/resolve/reference/PMED?id=12029730
Griffiths 2005 {published data only}|Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease|/resolve/reference/PMED?id=16281998
Grosbois 1996 {published data only}|Effects of ambulatory respiratory rehabilitation on exercise tolerance and quality of life in chronic obstructive lung disease patients|/resolve/reference/PMED?id=8650419
Hausen 1998 {published data only}|Brief education in comparison to combination of brief and education in groups in patients with chronic airway disease|
Hausen 1999 {published data only}|Patient education-- how can the long-term effect be analyzed and how does it last?|/resolve/reference/PMED?id=10431556
Janelli 1991 {published data only}|Can a pulmonary health teaching program alter patients' ability to cope with COPD?|
Lorig 2003 {published data only}|Hispanic chronic disease self-management: a randomized community-based outcome trial|/resolve/reference/PMED?id=14639082
Macfarlane 2002 {published data only}|Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet|/resolve/reference/PMED?id=11786454
Maltais 2005 {published data only}|A Canadian, multicentre, randomized clinical trial of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease: rationale and methods|/resolve/reference/PMED?id=16089027
Muller 1996 {published data only}|Patient training reduces the fear of cortisone in chronic obstructive respiratory tract diseases|
Murphy 2005a {published data only}|Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation|/resolve/reference/PMED?id=16140230
Murphy 2005b {published data only}|The process of implementing a nurse-coordinated multidisciplinary pulmonary rehabilitation program in Melbourne|/resolve/reference/PMED?id=16167450
Nguyen 2005 {published data only}|Dyspnea self-management in patients with chronic obstructive pulmonary disease: moderating effects of depressed mood|/resolve/reference/PMED?id=16145184
Pande 2005 {published data only}|Effect of home-based pulmonary rehabilitation programme on disability in patients with chronic obstructive pulmonary disease|
Ries 1995 {published data only}|Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7741366
Sassi-Dambron 1995 {published data only}|Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies|/resolve/reference/PMED?id=7874944
Scherer 1996 {published data only}|The role of self-efficacy in assisting patients with chronic obstructivepulmonary disease to manage breathing difficulty|
Scherer 1998 {published data only}|The effects of education alone and in combination with pulmonary rehabilitation on self-efficacy in patients with COPD|
Stulbarg 2002 {published data only}|Exercise training improves outcomes of a dyspnea self-management program|/resolve/reference/PMED?id=11984209
Toshima 1990 {published data only}|Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status|/resolve/reference/PMED?id=2187694
Tougaard 1992 {published data only}|Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness. The PASTMA Group|/resolve/reference/PMED?id=1351196
Tougaard 1993 {published data only}|Health economical benefits of personalized hospital treatment of chronic bronchitis|/resolve/reference/PMED?id=8256357
van den Broek 1995 {published data only}|Patient education and Chronic Obstructive Pulmonary Disease|
Wedzicha 1998 {published data only}|Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale|/resolve/reference/PMED?id=9727786
Worth 1997 {published data only}|Self management in COPD: one step beyond?|/resolve/reference/PMED?id=9516766
Annesi 2006|Epidemiology of chronic obstructive pulmonary disease|
ATS 1981|Position statement on pulmonary rehabilitation|/resolve/reference/PMED?id=7305126
ATS 1995|Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.|
Bandura 1986|Social foundations of thought and action: A social cognitive theory.|
Curtis 1994|Pulmonary rehabilitation in chronic respiratory insuffiency|/resolve/reference/PMED?id=8128407
Feenstra 2001|The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease. A model analysis in the Netherlands|/resolve/reference/PMED?id=11520721
Fletcher 1977|The natural history of chronic airflow obstruction|/resolve/reference/PMED?id=871704
Gibson 2000|Self-management education and regular practitioner review for adults with asthma|
Goldstein 1994|Randomised controlled trial of respiratory rehabilitation|/resolve/reference/PMED?id=7968075
Griffiths 2000|Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial|/resolve/reference/PMED?id=10665556
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Ketelaars 1996|Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8658367
Klein 2001|Benefit from the inclusion of self-treatment guidelines to a self- management programme for adults with asthma|/resolve/reference/PMED?id=11405516
Lacasse 2006|Pulmorary rehabilitation for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=17054186
Lahdensuo 1996|Randomised comparison of guided self management and traditional treatment of asthma over one year|/resolve/reference/PMED?id=8605463
Murray 1996|Evidence-based health policy--lessons from the Global Burden of Disease Study|/resolve/reference/PMED?id=8966556
Seemungal 2000|Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10806163
Siafakas 2006|Overall management of stable chronic obstructive pulmonary disease|
Spohn 2000||/resolve/reference/PMED?id=10731761
Turnock 2005|Action plans for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=16235392
Visual Rx|Visual Rx 2.0|
Worth 1996|Evaluation of a structured education program for patients with COPD; a pilot study|
Wouters 1999|Pulmonary rehabilitation in chronic obstructive pulmonary disease|
Yang 2007|Inhaled corticosteroids for stable chronic obstructive pulmonary disease|
Monninkhof 2002c|Self-management education for chronic obstructive pulmonary disease|
Monninkhof 2003b|Self-management education for patients with chronic obstructive pulmonary disease: a systematic review|/resolve/reference/PMED?id=12728158
Badesch 2000 {published and unpublished data}|Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease|/resolve/reference/PMED?id=10733441
Barst 1996 {published data only}|Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin|/resolve/reference/PMED?id=8053614
Barst 2003 {published data only}|Beraprost therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=12821234
Gali 2002 {published data only}|Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized,double-blind, placebo-controlled trial|/resolve/reference/PMED?id=11985913
Gali 2002 {published data only}|Effects of beraprost sodium, an oral prostacyclin analogue in patients with pulmonary arterial hypertension: a randomised, double-blind, placebo-controlled trial|
McLaughlin 2003 {published data only}|Efficacy and safety of treprostinil: an epoprostenol analogue for primary pulmonary hypertension|/resolve/reference/PMED?id=12548091
Olschewski 2002 {published data only}|Positive outcome of the aerosolized iloprost randomised trial for treatment of severe pulmonary hypertension (AIR study) [Abstract]|
Olschewski 2002 {published data only}|Inhaled Iloprost for severe pulmonary hypertension|/resolve/reference/PMED?id=12151469
Rubin 1990 {published and unpublished data}|Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (Epoprostenol)|/resolve/reference/PMED?id=2107780
Simonneau 2002 {published data only}|Improvement in exercise tolerance with treprostinil is dose related for pulmonary arterial hypertension|
Simonneau 2002 {published data only}|Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with collagen vascular disease|/resolve/reference/PMED?id=15302727
Simonneau 2002 {published data only}|Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension|/resolve/reference/PMED?id=11897647
Thurm 1991 {published data only}|Failure of vasodilator infusion to alter pulmonary diffusing capacity in systemic sclerosis|/resolve/reference/PMED?id=1709338
Anonymous 2002 {published data only}|Treprostinil (Remodulin) for pulmonary arterial hypertension|
Badesch 2002 {published data only}|Complete results of the first randomised placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension|
Barst 1994 {published data only}|Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin|/resolve/reference/PMED?id=8053614
Bartosik 1996 {published data only}|Intermittent Iloprost infusion therapy of pulmonary hypertension in scleroderma - a pilot study|/resolve/reference/PMED?id=8948314
Bendayan 2002 {published data only}|Continuous intravenous epoprostenol in pulmonary hypertension|/resolve/reference/PMED?id=12001697
Brenot 1995 {published data only}|Influence of long term continous infusion of epoprostenol on survival in patients wiht primary pulmonary hypertension: the French experience|
Bresser 2004 {published data only}|Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension|/resolve/reference/PMED?id=15083760
Budev 2004 {published data only}|Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension|/resolve/reference/PMED?id=15148531
Castelain 2001 {published data only}|Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension|/resolve/reference/PMED?id=11818317
Cea-Calvo 2003 {published data only}|Treatment of HIV-associated pulmonary hypertension with treprostinil|/resolve/reference/PMED?id=12689580
Chua 2005 {published data only}|Combining treprostinil and sildenafil in the treatment of pulmonary hypertension|
Cneva 2002 {published data only}|Comparison of the acute hemodinamics effects of oxygen 100% and inhaled iloprost in severe and refractory pulmonary hypertension|
Dandel 2003 {published data only}|Primary pulmonary hypertension: survival benefits of therapy with prostacyclin analogs and transplantation|/resolve/reference/PMED?id=14529860
de la Mata 1994 {published data only}|Long-term Iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue disease|
Ewert 2001 {published data only}|Iloprost in intensive medicine|
Gali 2003 {published data only}|Prostanoids for pulmonary arterial hypertension|/resolve/reference/PMED?id=14720012
Gerlach 2002 {published data only}|Intraoperative inhalation of nebulized iloprost during OLT reduces pulmonary hypertension after reperfusion|
Gessler 2001 {published data only}|Ultrasonic versus jet nebulisation of iloprost in severe pulmonary hypertension|/resolve/reference/PMED?id=11307743
Ghofrani 2002 {published data only}|Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension|/resolve/reference/PMED?id=11926786
Ghofrani 2005 {published data only}|Imatinib for the treatment of pulmonary arterial hypertension|/resolve/reference/PMED?id=16192491
Hache 2003 {published data only}|Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery|
Hallioglu 2003 {published data only}|Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease|/resolve/reference/PMED?id=14556887
Higenbottam 1998 {published data only}|Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost|/resolve/reference/PMED?id=9538312
Higenbottam 2001 {published data only}|Trials of inhaled Iloprost and other new vasodilating prostaglandins|/resolve/reference/PMED?id=11307757
Highland 2003 {published data only}|Treatment of pulmonary arterial hypertension: a preliminary decision analysis|/resolve/reference/PMED?id=14665484
Hoeper 2000 {published data only}|Long term tratment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue|/resolve/reference/PMED?id=10861321
Hoeper 2000 {published data only}|Long-term treatment of primary pulmonary hypertension with Iloprost|/resolve/reference/PMED?id=11236355
Hoeper 2002 {published data only}|Pulmonary hypertension in collagen vascular disease|/resolve/reference/PMED?id=11936539
Humbert 1998 {published data only}|Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study|/resolve/reference/PMED?id=10445611
Humbert 2003 {published data only}|Safety & efficacy of bosentan combined with epoprostenol in patients with severe pulmonary arterial hypertension|
Jones 1987 {published data only}|Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin)|/resolve/reference/PMED?id=3552006
Kramm 2002 {published data only}|The use of inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension after pulmonary thromboendarterectomy - a randomized double-blind study|
Langer 2003 {published data only}|Intraoperative inhalation of the long-acting prostacyclin analog iloprost for pulmonary hypertension|/resolve/reference/PMED?id=14502175
Langleben 2002 {published data only}|Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension|/resolve/reference/PMED?id=12040360
Leuchte 2002 {published data only}|Acute hemodynamics effects of inhaled oxygen, nitric oxide and iloprost in patients with severe pulmonary hypertension|
McLaughlin 1998 {published data only}|Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmoanry hypertension|/resolve/reference/PMED?id=9445406
McLaughlin 2005 {published data only}|A randomsed, double-blind, placebo-controlled study of iloprost inhalation as add-on therapy to Bosentan in pulmonary arterial hypertensions (PAH)|
Menon 1998 {published data only}|The acute effects of prostacyclin on pulmonary haemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis|
Mikhail 1997 {published data only}|An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension|/resolve/reference/PMED?id=9458458
Mikhail 2002 {published data only}|Management of primary pulmonary hypertension|
Nagaya 2002 {published data only}|Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension|/resolve/reference/PMED?id=11907007
Nagaya 2004 {published data only}|Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension|/resolve/reference/PMED?id=14718403
Nakayama 2001 {published data only}|Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension|/resolve/reference/PMED?id=11729726
Okano 1996 {published data only}|Short-term effect of continuous intravenous prostacyclin (Epoprostenol) in patients with primary pulmonary hypertension|
Olschewski 1996 {published data only}|Aerosolized prostacyclin and iloprost in severe pulmonary hypertension|/resolve/reference/PMED?id=8610951
Olschewski 1999 {published data only}|Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis|/resolve/reference/PMED?id=10430735
Olschewski 1999 {published data only}|Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis|
Olschewski 2000 {published data only}|Inhaled iloprost to treat severe pulmonary hypertension|/resolve/reference/PMED?id=10733442
Olschewski 2003 {published data only}|Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension|/resolve/reference/PMED?id=14555558
Olschewski 2004 {published data only}|Prostacyclin and its analogues in the treatment of pulmonary hypertension|/resolve/reference/PMED?id=15163595
Ono 2003 {published data only}|Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension|/resolve/reference/PMED?id=12736472
Ono 2003a {published data only}|Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction|/resolve/reference/PMED?id=12740277
Opitz 2005 {published data only}|Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension|/resolve/reference/PMED?id=15888496
Robbins 2000 {published data only}|Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus|/resolve/reference/PMED?id=10631192
Rubin 2005 {published data only}|Epoprostenol and nesiritide in pulmonary hypertension|/resolve/reference/PMED?id=15888882
Saadjian 1997 {published data only}|Long-term effects of cicletanine on secondary pulmonary hypertension|
Scorza 2001 {published data only}|Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study|/resolve/reference/PMED?id=11579708
Shapiro 1997 {published data only}|Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion|/resolve/reference/PMED?id=9247503
Stiebellehner 2003 {published data only}|Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension|/resolve/reference/PMED?id=12684325
Stricker 1999 {published data only}|Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension|/resolve/reference/PMED?id=10413827
Tapson 2006 {published data only}|Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.|/resolve/reference/PMED?id=16537868
Vizza 2001 {published data only}|Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue|/resolve/reference/PMED?id=11711462
Voswinckel 2006 {published data only}|Inhaled trepostinil for treatment of chronic pulmonary arterial hypertension|/resolve/reference/PMED?id=16418424
Wilkens 2001 {published data only}|Effect of inhaled Iloprost plus oral sildenafil in patients with primary pulmonary hypertension|/resolve/reference/PMED?id=11551870
Yap 2003 {published data only}|Micrococcus infection in patients receiving epoprostenol by continuous infusion|/resolve/reference/PMED?id=14576986
ACCP 2004|Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines|/resolve/reference/PMED?id=15249494
Bandolier 2000|Bias|
Berkenboom 1982|Failure of nifedipine treatment in primary pulmonary hypertension|
Black 2001||
Brundage 1990|Pulmonary hypertension in collagen vascular disease|
Christman 1992|An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension|/resolve/reference/PMED?id=1603138
D'Alonzo 1986|Noninvasive assessment of haemodynamic improvement during chronic vasodilator therapy in obliterative pulmonary hypertension|/resolve/reference/PMED?id=3954246
D'Alonzo 1991|Survival in patients with PPH. Results from a national prospective registry|/resolve/reference/PMED?id=1863023
Farber 1983|Fatal outcome following nifedipine for pulmonary hypertension|/resolve/reference/PMED?id=6831965
Furst 1981|Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis|
Grant 1992|Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures|/resolve/reference/PMED?id=1379160
Higenbottam 1987|The place of prostacyclin in the clinical management of primary pulmonary hypertension|/resolve/reference/PMED?id=3307576
Higenbottam 1993|Prostacyclin (epoprostenol) heart-lung transplantation as treatments for severe pulmonary hypertension|/resolve/reference/PMED?id=8217447
Higenbottam 1995|Prostacyclin|
Humbert 1999|Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study|/resolve/reference/PMED?id=10445611
Jadad 1996|Assessing the quality of reports of randomised controlled trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Kanthapillai 2004|Sildenafil for pulmonary hypertension (Cochrane review)|/resolve/reference/PMED?id=15495058
Liu 2004|Endothelin receptor antagonists for pulmonary arterial hypertension (Cochrane review)|
Loscalzo 1997|Endothelial dysfunction in pulmonary hypertension|
Moncada 1976|An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibts platelet aggregation|/resolve/reference/PMED?id=802670
Palmer 1988|Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease|
Pope 2001|Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis (Cochrane review)|
Rich 1987|High dose channel blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy|/resolve/reference/PMED?id=2954725
Robin 1982|Some basic and clinical challenges in the pulmonary circulation|/resolve/reference/PMED?id=6173172
Rubin 1997|Primary pulmonary hypertension|/resolve/reference/PMED?id=8988890
Salerni 1977|Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)|/resolve/reference/PMED?id=848800
Stupi 1986|Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis|
Ungerer 1983|Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis|/resolve/reference/PMED?id=6859087
Wells 2000|Lung disease in association with connective tissue diseases|
Yousem 1990|The pulmonary pathologic manifestations of the CREST syndrome|/resolve/reference/PMED?id=2186993
ADEPT 2001 {published data only}|ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACEI inhibitor therapy in chronic heart failure trial: Hemodynamic and neurohormonal effects|/resolve/reference/PMED?id=11320369
ARCH-J 2003 {published data only}|Efficacy and safety of oral candesartan cilexitil in patients with congestive heart failure|/resolve/reference/PMED?id=14607207
CHARM-Added 2003 {published data only}|Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial|
CHARM-Added 2003 {published data only}|Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial|/resolve/reference/PMED?id=18242128
CHARM-Alternative 2003 {published data only}|Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial|/resolve/reference/PMED?id=13678870
CHARM-Preserved 2003 {published data only}|Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial|/resolve/reference/PMED?id=13678871
Crozier 1995 {published data only}|Losartan in heart failure. Hemodynamic effects and tolerability|/resolve/reference/PMED?id=7828295
Crozier 1995 {published data only}|Effects of angiotensin II receptor blockade on N-terminal proatrial natriuretic factor plasma levels in chronic heart failure|/resolve/reference/PMED?id=9220306
Crozier 1995 {published data only}|Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure|/resolve/reference/PMED?id=10955375
Crozier 1995 {published data only}|Clinical safety and tolerability of losartan|
Dickstein 1995 {published data only}|Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure|/resolve/reference/PMED?id=7608448
Dickstein 1995 {published data only}|Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure|/resolve/reference/PMED?id=10955375
ELITE 1997 {published data only}|Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan In the Elderly Study, ELITE)|/resolve/reference/PMED?id=9074572
ELITE 1997 {published data only}|Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure|/resolve/reference/PMED?id=10955375
ELITE II 2000 {published data only}|Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II|/resolve/reference/PMED?id=10821361
Hamroff 1999 {published data only}|Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure|/resolve/reference/PMED?id=10051289
HEAVEN 2002 {published data only}|Safety and efficacy of valsartan versus enalapril in heart failure patients|/resolve/reference/PMED?id=12208593
I-PRESERVE 2008 {published data only}|Irbesartan in patients with heart failure and preserved ejection fraction|/resolve/reference/PMED?id=19001508
I-PRESERVE 2008 {published data only}|Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial|/resolve/reference/PMED?id=20231531
Lang 1997 {published data only}|Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure|/resolve/reference/PMED?id=9316528
Lang 1997 {published data only}|Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure|/resolve/reference/PMED?id=10955375
Mazayev 1998 {published data only}|Valsartan in heart failure patients previously untreated with an ACE inhibitor|/resolve/reference/PMED?id=9740480
Mitrovic 2003 {published data only}|Acute and 3-month treatment effects of candesartan cilexitil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure|
REPLACE 2001 {published data only}|Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators|/resolve/reference/PMED?id=11182175
RESOLVD 1999 {published data only}|Comparison of candesartan, enalapril, and their combination in congestive heart failure. Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study|/resolve/reference/PMED?id=10477530
Sharma 2000, III-Int'l {published data only}|Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure|/resolve/reference/PMED?id=10955375
Sharma 2000, III-US {published data only}|Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure|/resolve/reference/PMED?id=10955375
SPICE 2000 {published data only}|Randomized trial of candesartan cilexitil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors|/resolve/reference/PMED?id=10740141
STRETCH 1999 {published data only}|Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexitil|/resolve/reference/PMED?id=10577995
Tonkon 2000 {published data only}|A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure|/resolve/reference/PMED?id=10750252
V-HeFT 1999 {published data only}|Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure|/resolve/reference/PMED?id=10338459
Val-HeFT 2001 {published data only}|A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure|/resolve/reference/PMED?id=11759645
Belousov 2005 {published data only}|[Effect of long-term therapy with contemporary drugs on diastolic cardiac function in patients with chronic heart failure]|/resolve/reference/PMED?id=15798702
Berezin 2001 {published data only}|Angiotensin-II receptor antagonist losartan dose-dependently improves the left ventricular remodelling in patients with congestive heart failure|
Berezin 2001 {published data only}|Losartan in the therapy of heart failure patients|
Blanchet 2005 {published data only}|Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure|/resolve/reference/PMED?id=15894946
De Tommasi 2003 {published data only}|Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure|/resolve/reference/PMED?id=14597946
Ellis 2002 {published data only}|Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress|/resolve/reference/PMED?id=11959049
Guazzi 1999 {published data only}|Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure|/resolve/reference/PMED?id=10569660
HEAAL 2009 {published data only}|Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial|
HEAAL 2009 {published data only}|Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor|/resolve/reference/PMED?id=18768350
Hikosaka 2002 {published data only}|Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure|/resolve/reference/PMED?id=12451320
Houghton 2000 {published data only}|Combined treatment with losartan and an ACE inhibitor in mild to moderate heart failure: results of a double-blind, randomized, placebo-controlled trial|/resolve/reference/PMED?id=11054627
Kasama 2003 {published data only}|Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure|/resolve/reference/PMED?id=12791814
Kasama 2005 {published data only}|Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction|/resolve/reference/PMED?id=15734608
Ki 2008 {published data only}|[The comparative clinical effects of valsartan and ramipril in patients with heart failure]|
Nakamura 2002 {published data only}|Effects of chronic subdepressor dose of angiotensin II type 1 receptor antagonist on endothelium-dependent vasodilation in patients with congestive heart failure|/resolve/reference/PMED?id=12198327
Parthasarathy 2009 {published data only}|A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction|/resolve/reference/PMED?id=19789402
SADKO-CHF 2005 {published data only}|[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)]|/resolve/reference/PMED?id=16206603
SADKO-CHF 2005 {published data only}|[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study]|/resolve/reference/PMED?id=16883264
Tang 2003 {published data only}|Effect of losartan and captopril on congestive heart failure|
Tsutamoto 2000 {published data only}|Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure|/resolve/reference/PMED?id=10716475
Vaile 2001 {published data only}|Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure|/resolve/reference/PMED?id=11724639
Vizir 2000 {published data only}|[Losartan in therapy of chronic heart failure]|
Vizir 2002 {published data only}|[Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure]|/resolve/reference/PMED?id=11878061
Ye 2005 {published data only}|Effects of benazepril combined with valsartan on congestive heart failure|/resolve/reference/PMED?id=16305977
ACCF/AHA 2009|Focused Update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation|/resolve/reference/PMED?id=19324967
AIRE 1993|Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure|/resolve/reference/PMED?id=8104270
Azizi 2004|Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 antagonists|/resolve/reference/PMED?id=15173039
CCS 2006|Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management|/resolve/reference/PMED?id=16450016
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Erhardt 2005|A review of the current evidence for the use of angiotensin receptor blockers in chronic heart failure|
ESC 2008|ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008|/resolve/reference/PMED?id=18799522
Flather 2000|Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients|/resolve/reference/PMED?id=10821360
Heran 2008a|Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension|
Heran 2008b|Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0.|
Jong 2002b|Angiotensin receptor blockers for heart failure|
Lakhdar 2008|Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=18381180
Lee 2004|Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction|/resolve/reference/PMED?id=15520426
Lefebvre 2011|Chapter 6: Searching for studies|
Mancia 2009|Targeting blood pressure in the management of total cardiovascular risk|
McMurray 2005|Heart failure|/resolve/reference/PMED?id=15924986
SAVE 1992|Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial|/resolve/reference/PMED?id=1386652
Shah 2010|The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis|/resolve/reference/PMED?id=20206902
Sharma 2000|Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure|/resolve/reference/PMED?id=10955375
Shibata 2008|The effects of angiotensin-receptor blockers on mortality and morbidity in heart failure: a systematic review|
Smith 2008|Comparison of angiotensin II type 1 receptor antagonists in the treatment of essential hypertension|/resolve/reference/PMED?id=18547132
SOLVD prevention 1992|Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions|/resolve/reference/PMED?id=1463530
SOLVD treatment 1991|Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure|/resolve/reference/PMED?id=2057034
TRACE 1995|A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction|/resolve/reference/PMED?id=7477219
Volpe 2009|Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials|/resolve/reference/PMED?id=19381108
Weber 1997|Clinical safety and tolerability of losartan|/resolve/reference/PMED?id=9377606
White 2011|Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension|/resolve/reference/PMED?id=21282560
Wolny 1997|Functional and biochemical analysis of angiotensin II forming pathways in the human heart|/resolve/reference/PMED?id=9012744
Jong 2002|Angiotensin receptor blockers in heart failure: Meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=11823085
Balestri 2004 {published data only}|Efficacy of physical exercise for mucus clearance in patients with cystic fibrosis (CF) [abstract]|
Battistini 2001 {published data only}|Efficacy of underwater positive expiratory pressure therapy (UPEP) for mucus clearance in patients with cystic fibrosis [abstract]|
Braggion 1995 {published data only}|Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over study|
Braggion 1995 {published data only}|Short-term effects of 3 physiotherapy (CPT) regimens in cystic fibrosis (CF) patients hospitalized for a pulmonary exacerbation: a cross-over randomized trial [abstract]|
Costantini 2001 {published data only (unpublished sought but not used)}|PEP-mask versus postural drainage in CF infants a long-term comparative trial [abstract]|
Costantini 2001 {published data only (unpublished sought but not used)}|PEP-mask versus postural drainage in CF infants a long-term comparative trial [abstract]|
Costantini 2001 {published data only (unpublished sought but not used)}|PEP mask versus postural drainage in CF infants [abstract]|
Darbee 1990 {published and unpublished data}|Tc-DTPA aerosol ventilation evaluates the effectiveness of PEP mask in the treatment of cystic fibrosis|
Darbee 1990 {published and unpublished data}|Radionuclide assessment of the comparative effects of chest physical therapy and positive expiratory pressure mask in cystic fibrosis [abstract]|
Darbee 2004 {published data only}|Positive expiratory pressure breathing and gas distribution in cystic fibrosis [abstract]|
Darbee 2004 {published data only}|Physiologic Evidence for the Efficacy of Positive Expiratory Pressure as an Airway Clearance Technique in Patients with Cystic Fibrosis|/resolve/reference/PMED?id=15161418
Falk 1984 {published data only}|Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis|/resolve/reference/PMED?id=6381081
Falk 1993 {published data only}|Short-term effects of positive expiratory pressure and the forced expiration technique on mucus clearance and lung function in CF [abstract]|
Falk 1993 {published data only}|Radiolabelled mucus clearance in patients with cystic fibrosis is improved by physiotherapy with positive expiratory pressure and the forced expiration technique [abstract]|
Falk 1993 {published data only}|Effect of positive expiratory pressure and the forced expiration technique on mucus clearance in patients with cystic fibrosis [abstract]|
Gaskin 1998 {published and unpublished data}|Long term trial of conventional postural drainage and percussion vs. positive expiratory pressure [abstract]|
Hofmeyr 1986 {published data only}|Evaluation of positive expiratory pressure as an adjunct to chest physiotherapy in the treatment of cystic fibrosis|/resolve/reference/PMED?id=3296295
Hofmeyr 1986 {published data only}|Evaluation of positive expiratory pressure as an adjunct to postural drainage [abstract]|
Kofler 1998 {published data only}|BiPAP versus PEP as chest physiotherapy in patients with cystic fibrosis [abstract]|
Lannefors 1992 {published data only}|Mucus clearance in Cystic Fibrosis (CF) - a comparison between postural drainage, PEP-mask and physical exercise [abstract]|
Lannefors 1992 {published data only}|Mucus clearance with three chest physiotherapy regimes in cystic fibrosis: a comparison between postural drainage, PEP and physical exercise|/resolve/reference/PMED?id=1628733
McIlwaine 1991 {published and unpublished data}|A comparative trial of positive expiratory pressure, autogenic drainage and conventional percussion and drainage techniques [abstract]|
McIlwaine 1991 {published and unpublished data}|Comparison of positive expiratory pressure and autogenic drainage with conventional percussion and drainage therapy in the treatment of CF [abstract]|
McIlwaine 1991 {published and unpublished data}|Comparison of positive expiratory pressure and autogenic drainage with conventional percussion and drainage therapy in the treatment of CF [abstract]|
McIlwaine 1997 {published and unpublished data}|Positive expiratory pressure therapy better maintains pulmonary function than postural drainage and percussion in patients with cystic fibrosis [comment]|
McIlwaine 1997 {published and unpublished data}|Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis|/resolve/reference/PMED?id=9386661
McIlwaine 1997 {published and unpublished data}|Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis [abstract]|
McIlwaine 1997 {published and unpublished data}|Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis [abstract]|
McIlwaine 2001 {published data only}|"Flutter versus PEP": A long-term comparative trial of positive expiratory pressure (PEP) versus oscillating positive pressure (Flutter) physiotherapy techniques [abstract]|
McIlwaine 2001 {published data only}|Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis|/resolve/reference/PMED?id=11391327
McIlwaine 2001 {published data only}|"Flutter versus PEP": A long-term comparative trial of positive expiratory pressure (PEP) versus oscillating positive expiratory pressure (Flutter) physiotherapy techniques [abstract]|
Mortensen 1991 {published data only}|Postural drainage or PEP: effects on tracheobronchial clearance in cystic fibrosis [abstract]|
Mortensen 1991 {published data only}|The effects of postural drainage and positive expiratory pressure physiotherapy on tracheobronchial clearance in cystic fibrosis|/resolve/reference/PMED?id=1935294
Mortensen 1991 {published data only}|Assessment of tracheobronchial clearance by sputum expectorated during chest physiotherapy in cystic fibrosis [abstract]|
Newbold 2005 {published data only}|Effectiveness of the flutter device versus the PEP mask in the treatment of adult cystic fibrosis [abstract]|
Newbold 2005 {published data only}|The Flutter Device versus the PEP Mask in the Treatment of Adults with Cystic Fibrosis|
Padman 1999 {published data only}|Effects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients|/resolve/reference/PMED?id=10024754
Pfleger 1992 {published data only}|Self-administered chest physiotherapy in cystic fibrosis: a comparative study of high-pressure PEP and autogenic drainage|/resolve/reference/PMED?id=1434782
Pfleger 1992 {published data only}|Chest physiotherapy (PT) in Cystic Fibrosis (CF) - a comparative study of high-pressure PEP and autogenic drainage [abstract]|
Placidi 2001 {published data only}|Short-term effects of positive airway pressure on sputum clearance by directed coughing: A cross-over, randomized study [abstract]|
Steen 1991 {published data only}|Evaluation of the PEP mask in cystic fibrosis|
Steen 1991 {published data only}|Has the PEP mask a role in the management of teenage patients? [abstract]|
Tyrrell 1986 {published and unpublished data}|Face mask physiotherapy in cystic fibrosis|/resolve/reference/PMED?id=3524474
Tyrrell 1986 {published and unpublished data}|'PEP' mask physiotherapy in cystic fibrosis [abstract]|
van Asperen 1987 {published and unpublished data}|Comparison of a positive expiratory pressure (PEP) mask with postural drainage in patients with cystic fibrosis|
van der Schans 1991 {published data only}|Effect of positive expiratory pressure breathing in patients with cystic fibrosis|/resolve/reference/PMED?id=2038733
van Winden 1998 {published data only}|Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis|/resolve/reference/PMED?id=9701429
van Winden 1998 {published data only}|Effects of Flutter and PEP-MASK on expectoration and lung function in cystic fibrosis [abstract]|
Castle 1994 {published data only}|A comparison between the active cycle of breathing technique (A.C.B.T.) and positive expiratory pressure (PEP) mask plus A.C.B.T. on sputum production and lung volumes in adults with Cystic Fibrosis [abstract]|
Dosman 2003 {published data only}|Effects of positive end-expiratory pressure on oscillated volume during high frequency chest compression in children with cystic fibrosis|/resolve/reference/PMED?id=12687028
Fitzgerald 2001 {published data only}|Is dornase alpha (Pulmozyme) more effective before or after physiotherapy? A cross-over, randomised, placebo-controlled trial [abstract]|
Fitzgerald 2001 {published data only}|Dornase alpha and physiotherapy - which should be first? A randomised, double-blind, placebo-controlled trial in CF adults [abstract]|
Gotz 1995 {published data only}|Physiotherapy in cystic fibrosis: intrapulmonary percussive ventilation (IPV) versus positive expiratory pressure (PEP) [abstract]|
Laube 2000 {published data only}|Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis|/resolve/reference/PMED?id=16253150
Laube 2000 {published data only}|Positive expiratory pressure alters aerosol distribution in CF [abstract]|
Oermann 2001 {published data only}|Comparison of high-frequency chest wall oscillation and oscillating positive expiratory pressure in the home management of cystic fibrosis: a pilot study|
Orlik 2000 {published data only}|Evaluation of autodrainage methods in a selected group of cystic fibrosis patients with home environment factors taken into consideration|/resolve/reference/PMED?id=11093342
van Hengstum 1987 {published data only}|The effect of positive expiratory pressure (PEP) versus forced expiration technique (FET) on tracheobronchial clearance in chronic bronchitics [abstract]|
Znotina 2000 {published data only}|The effectiveness of physiotherapy for children with cystic fibrosis [abstract]|
Falk 1988 {published data only}|PEP treatment or physical exercise. Effects on secretions expectorated and indices of central and peripheral airway function. A controlled study [abstract]|
Kofler 1994 {published data only}|PEP-mask and active cycle of breathing techniques. What is better in children with cystic fibrosis [abstract]|
Lagerkvist 1997 {published data only}|Chest physiotherapy with positive expiratory pressure (PEP) and oscillating positive expiratory pressure (flutter) in patients with cystic fibrosis - a comparative study [abstract]|
Sanchez Riera 1999 {published data only}|Comparative study of the efficacy of 2 respiratory physiotherapy protocols for patients with cystic fibrosis|/resolve/reference/PMED?id=10410207
Tonnesen 1982 {published data only}|Self-administered positive end expiratory pressure (PEEP) using a face mask as an alternative to conventional lung physiotherapy|/resolve/reference/PMED?id=6753285
Wong 2000 {published data only}|Gastroesophageal reflux during chest physiotherapy: a comparison of positive expiratory pressure and postural drainage with percussion [abstract]|
Wong 2000 {published data only}|Gastroesophageal reflux during chest physiotherapy: a comparison of positive expiratory pressure and postural drainage with percussion [abstract]|
Andersen 1979|Recruiting collapsed lung through collateral channels with positive end-expiratory pressure|/resolve/reference/PMED?id=392747
Cantin 1995|Cystic fibrosis lung inflammation: Early, sustained, and severe|/resolve/reference/PMED?id=7697269
Elbourne 2002|Meta-analysis involving cross-over trials: methodological issues|/resolve/reference/PMED?id=11914310
Groth 1985|Positive expiratory pressure (PEP-Mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis|/resolve/reference/PMED?id=3899222
Konstan 1997|Curent understanding of the inflammatory process in cystic fibrosis: onset and etiology|
Liou 2001|Predictive 5-year survivorship model of cystic fibrosis|/resolve/reference/PMED?id=11207152
Maher 2003|Reliability of the PEDro scale for rating quality of randomized controlled trials|/resolve/reference/PMED?id=12882612
Main 2005|Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis|/resolve/reference/PMED?id=15674888
McIlwaine 1996|Airway clearance techniques in the treatment of cystic fibrosis|/resolve/reference/PMED?id=9363183
Oberwaldner 1986|Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis|
Prasad 1993|Current concepts in physiotherapy|/resolve/reference/PMED?id=8501759
Prasad 2000|Physiotherapy in cystic fibrosis|/resolve/reference/PMED?id=10911816
Review Manager 2008|Review Manager (RevMan)|
Southern 2003|Design of clinical trials in cystic fibrosis|/resolve/reference/PMED?id=12559892
van der Schans 2004|Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis|/resolve/reference/PMED?id=10796781
Verhagen 1998|The Delphi list: a criteria list for quality assessment of randomised clinical trials for conducting systematic reviews developed by Delphi consensus|/resolve/reference/PMED?id=10086815
Williams 1994|Chest physiotherapy and cystic fibrosis. Why is the most effective form of treatment still unclear?|/resolve/reference/PMED?id=7988215
Zach 1987|Chest physiotherapy: the mechanical approach to antiinfective therapy in cystic fibrosis|/resolve/reference/PMED?id=3319913
Zach 1990|Lung disease in cystic fibrosis - an updated concept|
Chernoff 2002 {published data only}|A randomized, controlled trial of a community-based support program for families of children with chronic illness: Pediatric outcomes|/resolve/reference/PMED?id=12038883
Chernoff 2002 {published data only}|Maternal outcomes of a randomized controlled trial of a community-based support program for families of children with chronic illnesses|/resolve/reference/PMED?id=11434842
Cheuvront 1998 {published data only}|Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives|
Cheuvront 1998 {published data only}|Proband and parent assistance in identifying relatives for cystic fibrosis carrier testing|
Cheuvront 1998 {published data only}|Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients|
Davis 2002 {published data only}|Controlled evaluation of the STARBRIGHT Explorer Series CD-ROM program for children and adolescents with cystic fibrosis|
Davis 2002 {published data only}|Controlled evaluation of the STARBRIGHT CD-ROM program for children and adolescents with cystic fibrosis|/resolve/reference/PMED?id=15148348
Davis 2002 {published data only}|Controlled trial of family interventions for cystic fibrosis|
Davis 2002 {published data only}|Commentary: Computer-based interventions in pediatric psychology|/resolve/reference/PMED?id=15148349
Delk 1994 {published data only}|The effects of biofeedback assisted breathing retraining on lung functions in patients with cystic fibrosis|/resolve/reference/PMED?id=8275737
Downs 2006 {published data only}|Benefits of an education programme on the self-management of aerosol and airway treatments for children with cystic fibrosis|/resolve/reference/PMED?id=16509174
Grasso 2000 {published data only}|Benefits of music therapy as an adjunct to chest physiotherapy in infants and toddles with cystic fibrosis|
Grasso 2000 {published data only}|Music: Meeting the challenge of adherence to chest physiotherapy for infants and toddlers with cystic fibrosis [abstract]|
Hernandez-Reif 1999 {published data only}|Children with cystic fibrosis benefit from massage therapy|/resolve/reference/PMED?id=10361400
Powers 2003 {published and unpublished data}|A randomized pilot study of behavioral treatment to increase calorie intake in toddlers with cystic fibrosis|
Powers 2003 {published and unpublished data}|Nutritional benefits of two early intervention programs for toddlers with cystic fibrosis: A randomized pilot study|
Powers 2003 {published and unpublished data}|Behavioral treatment to improve nutrition in toddlers with cystic fibrosis [abstract]|
Powers 2005 {published data only}|Nutrition in early childhood: focus on parent interaction [abstract]|
Powers 2005 {published data only}|Behavioural treatment for toddlers and pre-schoolers with cystic fibrosis produces recommended energy intake and normal rates of growth [abstract]|
Powers 2005 {published data only}|Overcoming barriers to evidence-based nutrition treatment for preschoolers such as distance from cystic fibrosis center and multiple food allergies [abstract]|
Powers 2005 {published data only}|Randomized clinical trial of behavioral and nutrition treatment to improve energy intake and growth in toddlers and preschoolers with cystic fibrosis|/resolve/reference/PMED?id=16322169
Powers 2005 {published data only}|Impact of behavioral and nutrition treatment for toddlers and preschoolers with CF on erergy intake and growth maintains for 12 and 18 months [abstract]|
Stapleton 2001 {published data only}|Development of a nutrition and behaviour intervention program: Go and Grow with CF|
Stapleton 2001 {published data only}|What do children with cystic fibrosis and their parents know about nutrition and pancreatic enzymes?|/resolve/reference/PMED?id=11138442
Stapleton 2001 {published data only}|The effect of 'Go and Grow with CF' on nutrition and pancreatic enzyme knowledge of children with cystic fibrosis|
Stark 1996 {published data only}|Behavioral intervention to improve calorie intake of children with cystic fibrosis: Treatment versus wait list control|/resolve/reference/PMED?id=8708877
Stark 2003 {published and unpublished data}|Contribution of behavior therapy to nutrition adherence in cystic fibrosis: A two-year randomized controlled study|
Stark 2003 {published and unpublished data}|Contribution of behavior therapy to dietary treatment in cystic fibrosis: A randomized controlled study within 2-year follow-up|
Trapp 1998 {published and unpublished data}|Self-administration of drugs for cystic fibrosis|/resolve/reference/PMED?id=10095691
Barbero 1996 {published data only}|The science and humanity of cystic fibrosis|/resolve/reference/PMED?id=8970771
Bartholomew 1997 {published data only}|Self-management of cystic fibrosis: Short-term outcomes of the Cystic Fibrosis Family Education Program|/resolve/reference/PMED?id=9307900
Brady 1991 {published data only}|Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis|
Brandt 1996 {published data only}|A follow-up study of carriers of cystic fibrosis|/resolve/reference/PMED?id=8760517
Brown 1994 {published data only}|Evidence of increased oxidative damage in patients with cystic fibrosis|/resolve/reference/PMED?id=7816524
Clayton 1995 {published data only}|Teaching about cystic fibrosis carrier screening by using written and video information|/resolve/reference/PMED?id=7611285
Dodd 1997 {published data only}|Validity of a visual numerical general quality of life scale and chest scale in adults with cystic fibrosis [abstract]|
Donaldson 1995 {published data only}|Willingness to pay for antenatal carrier screening for cystic fibrosis|
Donaldson 1995 {published data only}|Incorrect recall of residual risk three years after carrier screening for cystic fibrosis: A comparison of two-step and couple screening|/resolve/reference/PMED?id=10411814
Donaldson 1995 {published data only}|Two approaches to ante-natal carrier screening for cystic fibrosis [abstract]|
Donaldson 1995 {published data only}|Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise versus couple screening|/resolve/reference/PMED?id=7866213
Donaldson 1995 {published data only}|Recall of residual risk three years after carrier screening for CF: a comparison of two-step and couple screening [abstract]|
Donaldson 1995 {published data only}|Antenatal screening for cystic fibrosis [letter]|/resolve/reference/PMED?id=7767177
Eng 1997 {published data only}|Prenatal genetic carrier testing using triple disease screening|/resolve/reference/PMED?id=9333269
Falkman 1977 {published data only}|Cystic fibrosis - A psychological study of 52 children and their families|
Gee 2000 {published data only}|Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis|/resolve/reference/PMED?id=11050265
Goa 1997 {published data only}|Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis|/resolve/reference/PMED?id=10170464
Goldbeck 2001 {published data only}|Development and evaluation of a multi-family psychoeducational program for cystic fibrosis|/resolve/reference/PMED?id=11479059
Gonciartz 1988 {published data only}|Randomised placebo-controlled double blind trial on 'essential' phospholipids in the treatment of fatty liver associated with diabetes|
Green 1995 {published data only}|Obstetricians' views on prenatal diagnosis and termination of pregnancy: 1980 compared with 1993|
Gremse 1998 {published data only}|Characterization of failure to imbibe in infants|/resolve/reference/PMED?id=9597297
Grody 1997 {published data only}|PCR based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population|/resolve/reference/PMED?id=9106541
Gulmans 1999 {published data only}|Outpatient Exercise training in Children with Cystic Fibrosis: Physiological Effects, Perceived Competence, and Acceptability|
Haddow 1999 {published data only}|Issues for implementing prenatal screening for cystic fibrosis: results of a working conference|/resolve/reference/PMED?id=10444721
Hains 2001 {published data only}|Effectiveness of a cognitive behavioral intervention for adults with cystic fibrosis|
Hains 1997 {published data only}|Cognitive behavioral interventions for adolescents with cystic fibrosis|/resolve/reference/PMED?id=9383929
Hodson 1997 {published data only}|Psychosocial aspects for the management of adults with cystic fibrosis|
Jelalian 1998 {published data only}|Nutrition intervention for weight gain in cystic fibrosis: A meta-analysis|/resolve/reference/PMED?id=9544906
Johnson 2001 {published data only}|Hopkins Teen Central: Assessment of an internet-based support system for children with cystic fibrosis|/resolve/reference/PMED?id=11158498
Kollberg 1982 {published data only}|Sociomedical conditions for Swedish patients with cystic fibrosis. A review of the past twelve years|/resolve/reference/PMED?id=7174175
Krauth 1999 {published data only}|Cost comparison of hospital and ambulatory I.V. therapy in adult cystic fibrosis patients: Results of a controlled prospective study|/resolve/reference/PMED?id=10554512
Le Heuzey 1997 {published data only}|Psychological adjustment of children and adolescents with cystic fibrosis [abstract]|
Leonard 1995 {published data only}|A comparison of two approaches to education about carrier testing for cystic fibrosis|
Lindstrm 1994 {published data only}|The essence of existence. On the quality of life of children in the Nordic countries|
Loader 1996 {published data only}|Cystic fibrosis carrier population screening in the primary care setting|/resolve/reference/PMED?id=8659530
Magnussen 1992 {published data only}|The effect of flupertine on respiratory drive in healthy probands and patients with various lung diseases|/resolve/reference/PMED?id=1475268
Phillipson 2000 {published data only}|Congenital bilateral absence of the vas deferens, cystic fibrosis mutation analysis and intracytoplasmic sperm injection|/resolve/reference/PMED?id=10655317
Pollitt 1997 {published data only}|Neonatal screening for inborn errors of metabolism: cost, yield and outcome|
Ramstrm 2000 {published data only}|Pharmaceutical intervention in the care of cystic fibrosis patients|
Thompson 1990 {published data only}|A matched comparison of adjustment in children with cystic fibrosis and psychiatrically referred and nonreferred children|/resolve/reference/PMED?id=2283579
Thornton 1995 {published data only}|A randomised trial of three methods of giving information about prenatal testing|/resolve/reference/PMED?id=7580707
Tullis 1995 {published data only}|Quality of life in cystic fibrosis|/resolve/reference/PMED?id=10155599
Villari 1994 {published data only}|Heart function in chronic pressure overload caused by aortic stenosis: The role of collagen tissue|/resolve/reference/PMED?id=7923255
Ward 1999 {published data only}|Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus|/resolve/reference/PMED?id=10232630
Welkenhuysen 1996 {published data only}|Adolescents' attitudes towards carrier testing for cystic fibrosis and its relative stability over time|/resolve/reference/PMED?id=8800929
Williams 1997 {published data only}|Outcomes of a nursing intervention for siblings of chronically ill children: A pilot study|
Wolter 1997 {published data only}|Home versus hospital therapy including intravenous antibiotics in cystic fibrosis [abstract]|
Wolter 1997 {published data only}|Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects|/resolve/reference/PMED?id=9150331
Wolter 1997 {published data only}|Intravenous home therapy - a randomised trial in adult cystic fibrosis patients [abstract]|
Bryon 2000 {published data only}|A home visit programme to improve health status and psychosocial functioning of families with a child with cystic fibrosis [abstract]|
Cannon 1999 {published data only}|In-home videoconferencing for cystic fibrosis patient education [abstract]|
Christian 1999 {published data only}|Psychosocial status of school-age children with cystic fibrosis [abstract]|
Davis 1990 {published data only}|A randomized trial of home intravenous antibiotic therapy (HIVAT) in cystic fibrosis (CF): Short-term psychological effects [abstract]|
Davis 1990 {published data only}|A randomized trial of home intravenous antibiotic therapy (HIVAT) in cystic fibrosis (CF): Short-term safety and efficacy [abstract]|
Klig 1989 {published data only}|Biopsychosocial examination of two methods of pulmonary therapy [abstract]|
Mischler 1998 {published data only}|Nutritional benefits of neonatal screening for cystic fibrosis|/resolve/reference/PMED?id=9395429
Mischler 1998 {published data only}|Newborn screening for cystic fibrosis|
Mischler 1998 {published data only}|A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: A unique ethical dilemma|/resolve/reference/PMED?id=2673641
Mischler 1998 {published data only}|Cystic fibrosis newborn screening: Impact on reproductive behavior and implications for genetic counseling|
Petzel 1991 {published data only}|Adherence in cystic fibrosis [abstract]|
Powers 2003a {published data only}|Nutrition in early childhood: Focus on parent interaction|
Stark 1998 {published data only}|The contribution of behavior therapy to enhancing adherence in school-age children with CF: The example of diet [abstract]|
Williams 1987 {published data only}|Intensive dietary counselling with adolescents with cystic fibrosis: What are the effects? [abstract]|
Williams 1987 {published data only}|Intensive dietary counselling In adolescents with cystic fibrosis|
Kalnins 1996 {published data only}|Oral supplements vs. normal food intake in children and adults [abstract]|
Kalnins 1996 {published data only}|Are oral dietary supplements effective in the nutritional management of adolescents and adults with cystic fibrosis? [abstract]|
Quinn 2004 {published data only}|Measuring, predicting and improving adherence to inhalation therapy in patients with CF: Randomised controlled study of motivational interviewing|
Quittner 2000 {published data only}|Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis|/resolve/reference/PMED?id=15187173
Quittner 2000 {published data only}|Intervention to increase adolescent adherence to treatment: preliminary comparisons of family therapy and cystic fibrosis family education [abstract]|
Quittner 2000 {published data only}|Adherence to medical treatments in adolescents with cystic fibrosis: The development and evaluation of family-based interventions|
Quittner 2000 {published data only}|Measuring adherence to treatment in adolescents with cystic fibrosis: Pros and cons of electronic monitoring [abstract]|
Quittner 2000 {published data only}|Controlled evaluation of a clinic-based intervention to promote adherence in children with cystic fibrosis|
Watson 2004 {published data only}|Pilot study to evaluate a home-based behavioural nutrition programme for adults|
Watson 2006 {published data only}|A randomised controlled trial of a behavioural nutrition education programme "Eat Well with CF" for adults with CF|
Banerjee 1996|Randomised controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home|/resolve/reference/PMED?id=8898601
Barlow 2003|Parent-training programmes for improving maternal psychosocial health|
Bartholomew 1991|Development of a health education program to promote the self-management of cystic fibrosis.|/resolve/reference/PMED?id=1757266
Beale 2006|Scholarly literature review: Efficacy of psychological interventions for pediatric chronic illnesses|/resolve/reference/PMED?id=16162841
Bluebond-Langner1991|Living with cystic fibrosis: a family affair.|
Bluebond-Langner2001||
Bobadilla 2002|Cystic Fibrosis: A worldwide analysis of CFTR mutations - correlation with incidence data and application to screening|
CFF Consensus 2001||
Christopherson 1994||
Cohen 1992|Quantitative Methods in Psychology: A Power Primer|/resolve/reference/PMED?id=19565683
Coren 2001|Individual and group-based parenting programmes for improving psychosocial outcomes for teenage parents and their children|
Dahlquist 1992|Coping with Aversive Medical Treatments|
DiGirolamo 1997|Identification and assessment of ongoing stressors in adolescents with a chronic illness: An application of the behavior analytic model|/resolve/reference/PMED?id=9118176
Dodge 2007|Cystic fibrosis mortality and survival in the UK: 1947-2003|/resolve/reference/PMED?id=17182652
Donner 2001|Statistical methods for the meta-analysis of cluster randomization trials|/resolve/reference/PMED?id=11697225
Field 1992|Infants' and Children's Responses to Invasive Procedures|
FitzSimmons 1993|The changing epidemiology of cystic fibrosis|/resolve/reference/PMED?id=8419592
Gudas 1991|Perceptions of medical compliance in children and adolescents with cystic fibrosis|/resolve/reference/PMED?id=1939678
Ilfeld 1976|Further validation of a psychiatric symptom index in a normal population|
Kibby 1998|Effectiveness of psychological intervention for children and adolescents with chronic medical illness: A meta-analysis|/resolve/reference/PMED?id=9455625
Lavigne 1992|Psychological adjustment to pediatric physical disorders: A meta-analytic review|/resolve/reference/PMED?id=1534367
Mackner 2001|Dietary Recommendations to Prevent and Manage Chronic Pediatric Health Conditions: Adherence, intervention, and future directions|/resolve/reference/PMED?id=11332783
McNair 1971||
Michie 2004|Evidence into practice: A theory based study of achieving national health targets in primary care|
Miller 1999|Cystic Fibrosis|
Miller 2002|Empirically validated interventions: Face-to-face and web-based|
Moher 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials|/resolve/reference/PMED?id=11323066
Passero 1981|Patient-reported compliance with cystic fibrosis therapy|/resolve/reference/PMED?id=7214782
Pearson 1991|The development of psychiatric symptomatology in patients with cystic fibrosis|/resolve/reference/PMED?id=2016234
Proos 1992|A study of the effects of self-medication on patients' knowledge of and compliance with their medical regimen|
Quittner 1992a|Parental Response to Cystic Fibrosis: A Contextual Analysis of the Diagnosis Phase|/resolve/reference/PMED?id=1484333
Quittner 1992b|The impact of caregiving and role strain on family life: Comparisons between mothers of children with cystic fibrosis and matched controls|
Quittner 1997|Controlled trial of family interventions for cystic fibrosis|
Quittner 1998|Role strain in couples with and without a child with a chronic illness: Associations with marital satisfaction, intimacy, and daily mood|/resolve/reference/PMED?id=9548702
Quittner 2000|Adherence to Medical Treatments in Adolescents with Cystic Fibrosis: The Development and Evaluation of Family-Based Interventions|
Schulz 1995|Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Sorenson 1997|Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients|
Spielberger 1970||
Spielberger 1973||
Spielberger 1979||
Spielberger 1985|Assessment of State and Trait Anxiety: Conceptual and methodological issues|
Stapleton 2000|What do children with cystic fibrosis and their parents know about nutrition and pancreatic enzymes?|/resolve/reference/PMED?id=11138442
Stark 1987|Behavioral contracting to increase chest physiotherapy: a study of a young cystic fibrosis patient|/resolve/reference/PMED?id=3508377
Stark 1990|A behavioral approach to increasing calorie consumption in children with cystic fibrosis|/resolve/reference/PMED?id=2380876
Stark 1995|Cystic Fibrosis|
Sumner 1994||
Thompson 1990|A matched comparison of adjustment in children with cystic fibrosis and psychiatrically referred and nonreferred children|/resolve/reference/PMED?id=2283579
Tsui 1990|Population Analysis of the Major Mutation in Cystic Fibrosis|/resolve/reference/PMED?id=2210738
Watson 1988|Development and validation of a brief measure of positive and negative affect: The PANAS scales|/resolve/reference/PMED?id=3397865
Aaser 1997{published data only}|Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure|
Bagatin 1993{published data only}|Diuretic efficiency of furosemide in continuous intravenous infusion vs. bolus injection in congestive heart failure: results of a pilot study|
Dormans 1996{published data only}|Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion|
Kramer 1996{published data only}|Pharmacodynamics of torsemide administered as as intravenous injection and as a continuous infusion to patients with congestive heart failure|
Lahav 1992{published data only}|Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure|
Licata 2003{published data only}|Effects of high-doses furosemide and small volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects|
Licata 2003{published data only}|Effects of high-dose furosemide and small volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure|
Pivac 1998{published data only}|Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure|
Schuller 1997{published data only}|Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus|
Andreucci 1999|Diuretics in renal failure|
Bateman 1999|Efficacy of continuous vs. intermittent furosemide|
Ferguson 1997|Role of duration of diuretic effect in preventing sodium retention|
Howard 1997|Severe musculoskeletal symptoms during continuous infusion of bumetanide|
Howard 2001|Aggressive diuresis for severe heart failure in the elderly|
Martin 1994|Continuous infusion of loop diuretics in the critically ill: a review of the literature|
Ravnan 2000|Management of adult heart failure: bolus vs continuous infusion loop diuretics, a review of the literature|
Yelton 1995|The role of continuous infusion loop diuretics|
Salvador 2002|Comparison of furosemide as continuous infusion vs intermittent administration in patients with congestive heart failure|
Alejandria 2003|Intravenous immunoglobulin for treating sepsis and septic shock|
Branck 1977|Determinants of response to furosemide in normal subjects|
Brater 1985|Resistance to loop diuretics: why it happens and what to do about it|
Cook 1987|Development of acute tolerance to bumetanide: bolus injection studies|
Cook 1988|Development of acute tolerance to bumetanide: constant-rate infusion studies|
Copeland 1983|Diuresis with continuous infusion of furosemide after cardiac surgery|
Dickersin 1994|Identifying relevant studies for systematic reviews|
Hammarlund 1985|Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling|
Krasna 1986|Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy|
Lawson 1978|Continuous infusion of furosemide in refractory edema|
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Paterna 2000|Effects of high-dose furosemide and small volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure|
Rudy 1991|Loop diuretics for chronic renal insufficiency: continuous infusion is more efficacious than bolus therapy|
Wilcox 1983|Response to furosemide. I.  Effects of salt intake and renal compensation|
Aaser 1997 {published data only}|Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure|/resolve/reference/PMED?id=9249883
Bagatin 1993 {published data only}|Diuretic efficiency of furosemide in continuous intravenous infusion vs. bolus injection in congestive heart failure: results of a pilot study|
Dormans 1996 {published data only}|Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion|/resolve/reference/PMED?id=8800113
Kramer 1996 {published data only}|Pharmacodynamics of torsemide administered as as intravenous injection and as a continuous infusion to patients with congestive heart failure|/resolve/reference/PMED?id=8690821
Lahav 1992 {published data only}|Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure|/resolve/reference/PMED?id=1516394
Licata 2003 {published data only}|Effects of high-doses furosemide and small volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects|/resolve/reference/PMED?id=12660669
Licata 2003 {published data only}|Effects of high-dose furosemide and small volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure|
Pivac 1998 {published data only}|Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure|/resolve/reference/PMED?id=9825268
Schuller 1997 {published data only}|Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus|/resolve/reference/PMED?id=9403744
Andreucci 1999 {published data only}|Diuretics in renal failure|/resolve/reference/PMED?id=10207256
Bateman 1999 {published data only}|Efficacy of continuous vs. intermittent furosemide|
Ferguson 1997 {published data only}|Role of duration of diuretic effect in preventing sodium retention|/resolve/reference/PMED?id=9284857
Howard 1997 {published data only}|Severe musculoskeletal symptoms during continuous infusion of bumetanide|/resolve/reference/PMED?id=9041982
Howard 2001 {published data only}|Aggressive diuresis for severe heart failure in the elderly|/resolve/reference/PMED?id=11243961
Martin 1994 {published data only}|Continuous infusion of loop diuretics in the critically ill: a review of the literature|/resolve/reference/PMED?id=8045153
Ravnan 2000 {published data only}|Management of adult heart failure: bolus vs continuous infusion loop diuretics, a review of the literature|
Yelton 1995 {published data only}|The role of continuous infusion loop diuretics|/resolve/reference/PMED?id=8845538
Salvador 2002 {published data only}|Comparison of furosemide as continuous infusion vs intermittent administration in patients with congestive heart failure|
Alejandria 2003|Intravenous immunoglobulin for treating sepsis and septic shock|
Branck 1977|Determinants of response to furosemide in normal subjects|/resolve/reference/PMED?id=861127
Brater 1985|Resistance to loop diuretics: why it happens and what to do about it|/resolve/reference/PMED?id=3905337
Cook 1987|Development of acute tolerance to bumetanide: bolus injection studies|/resolve/reference/PMED?id=3508546
Cook 1988|Development of acute tolerance to bumetanide: constant-rate infusion studies|/resolve/reference/PMED?id=3247297
Copeland 1983|Diuresis with continuous infusion of furosemide after cardiac surgery|/resolve/reference/PMED?id=6650766
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Hammarlund 1985|Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling|/resolve/reference/PMED?id=3999028
Krasna 1986|Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy|
Lawson 1978|Continuous infusion of furosemide in refractory edema|/resolve/reference/PMED?id=678930
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Paterna 2000|Effects of high-dose furosemide and small volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure|
Rudy 1991|Loop diuretics for chronic renal insufficiency: continuous infusion is more efficacious than bolus therapy|/resolve/reference/PMED?id=1863026
Wilcox 1983|Response to furosemide. I. Effects of salt intake and renal compensation|/resolve/reference/PMED?id=6886524
CAPRIE 1996 {published data only}|A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)|/resolve/reference/PMED?id=8918275
HOT {published data only}|Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: pinciple results of the Hypertension Optimal Treatment randomised trial|/resolve/reference/PMED?id=9635947
Huynh {published data only}|Aspirin, warfarin or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery|/resolve/reference/PMED?id=11425770
Throm Prev Trial '00 {published data only}|Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a rabdomised controlled trial|/resolve/reference/PMED?id=10875825
Throm Prev Trial '98 {published data only}|Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk|/resolve/reference/PMED?id=9457092
Ajani et al 2000 {published data only}|Alcohol consumption and risk of coronary heart disease by diabetes status|/resolve/reference/PMED?id=10920060
APTC 1994 {published and unpublished data}|Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration|/resolve/reference/PMED?id=8298418
Bhatt et al 2000 {published data only}|Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators|/resolve/reference/PMED?id=10874265
Bhatt et al 2001 {published data only}|Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery|/resolve/reference/PMED?id=11157686
Califf et al 2000 {published data only}|Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial|/resolve/reference/PMED?id=10811588
Caravaca et al 1995 {published data only}|Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy|/resolve/reference/PMED?id=8559495
CARS 2001 {published data only}|Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Infarction Study (CARS)|/resolve/reference/PMED?id=11524065
Cook et al 1997 {published data only}|Comparative effects of nabumetone, sulindac, and ibuprofen on renal function|/resolve/reference/PMED?id=9195523
Cusson et al 1992 {published data only}|Effect of ketoprofen on blood pressure, endocrine and renal responses to chronic dosing with captopril in patients with essential hypertension|/resolve/reference/PMED?id=1345049
Drapkin et al 1972 {published data only}|Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction|/resolve/reference/PMED?id=4117261
EPIC 1999 {published data only}|Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators|/resolve/reference/PMED?id=9924160
EPILOG 1998 {published data only}|Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators|/resolve/reference/PMED?id=9609084
ESPS-2 1998 {published data only}|Secondary stroke prevention with low-dose Aspirin, sustained release Dipyridamol alone and in combination|/resolve/reference/PMED?id=9781830
Ferri et al 1993 {published data only}|Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension|/resolve/reference/PMED?id=8500867
Finelli et al 1991 {published data only}|Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled study|/resolve/reference/PMED?id=2042443
Fisher et al 2001 {published data only}|Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo|/resolve/reference/PMED?id=11136483
Forbes 1999 {published data only}|Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist|/resolve/reference/PMED?id=10440425
Furey et al 1993 {published data only}|Renovascular effects of nonprescription ibuprofen in elderly hypertensive patients with mild renal impairment|/resolve/reference/PMED?id=8469621
Gurwitz et al 1996 {published data only}|The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons|/resolve/reference/PMED?id=8612107
Harker et al 1999 {published data only}|Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events|/resolve/reference/PMED?id=10514023
Harpaz et al 2000 {published data only}|Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia|/resolve/reference/PMED?id=8960577
Hartmann et al 1995 {published data only}|Study on the possible interaction between tenoxicam and atenolol in hypertensive patients|/resolve/reference/PMED?id=7779149
Harvey et al 1995 {published data only}|Effect of indomethacin on blood pressure control during treatment with nitrendipine|/resolve/reference/PMED?id=8535553
Hermida et al 1997 {published data only}|Influence of Aspirin usage on blod pressure: dose and administration-time dependencies|/resolve/reference/PMED?id=9360028
Herskovits et al1985 {published data only}|Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants|/resolve/reference/PMED?id=3881263
Hess et al 1985 {published data only}|Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial|/resolve/reference/PMED?id=2857803
Houston et al 1995 {published data only}|The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil|/resolve/reference/PMED?id=7748048
Houtsmuller 1984 {published data only}|The influence of teiclopidine on the natural course of retinal vein occlusion|/resolve/reference/PMED?id=6385648
Johnson et al 1996 {published data only}|Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1|/resolve/reference/PMED?id=8736458
Klassen 1995 {published data only}|Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine|/resolve/reference/PMED?id=7755942
Klassen et al 1993 {published data only}|Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide|/resolve/reference/PMED?id=8227469
Lee et al 1999 {published data only}|Exercise and risk of stroke in male physicians|/resolve/reference/PMED?id=9880379
Lemak et al 1986 {published data only}|Controlled trial of aspirin in cerebral ischemia: an addendum|/resolve/reference/PMED?id=3517694
Magagna et al 1991 {published data only}|Indomethacin raises blood pressure in untreated essential hypertensives: a double-blind randomly allocated study versus placebo|/resolve/reference/PMED?id=1818960
Magagna et al 1994 {published data only}|Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients|/resolve/reference/PMED?id=7994448
Maggioni et al 1992 {published data only}|The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group|/resolve/reference/PMED?id=1598096
Mehta et al 2001 {published data only}|Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study|/resolve/reference/PMED?id=11520521
Mills et al 1982 {published data only}|Non-steroidal anti-inflammatory drugs and blood pressure|
Minuz et al 1990 {published data only}|Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension|/resolve/reference/PMED?id=2291866
Minuz et al 1995 {published data only}|Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition|/resolve/reference/PMED?id=7756098
Morgan et al 1993 {published data only}|Interaction of indomethacin with felodipine and enalapril|
Morgan et al 2000 {published data only}|Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril|/resolve/reference/PMED?id=11078175
Nawarskas et al 1999 {published data only}|Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan|/resolve/reference/PMED?id=10480471
Novo et al 1996 {published data only}|Effects of captopril and ticlopidine, alone or in combination, in hypertensive patients with intermittent claudication|/resolve/reference/PMED?id=8803643
Oosterga et al 1998 {published data only}|Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction|/resolve/reference/PMED?id=9604941
Pancera et al 1996 {published data only}|Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients|/resolve/reference/PMED?id=8860111
Peto R et al 1998 {published data only}|Randomised trial of prophyllactic daily aspirin in British male doctors|/resolve/reference/PMED?id=3125882
PHS (Ajani 2000) {published data only}|Alcohol consumption and risk of coronary heart disease by diabetes status|/resolve/reference/PMED?id=10920060
PHS 1989 {published data only}|Final report on the Aspirin component of the ongoing Physicians' Health Study|/resolve/reference/PMED?id=2664509
Polonia et al 1995 {published data only}|Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients|/resolve/reference/PMED?id=8557971
Polonia et al 1996 {published data only}|[Reduction of the antihypertensive effects of enalapril by indomethacin. Its independence from renal sodium retention]|/resolve/reference/PMED?id=8755685
PPP 2001 {published data only}|Low-dose aspirin and vitamine E in people at cardiovascular risk: a randomised trial in general practice|/resolve/reference/PMED?id=11197445
Pritchard et al 1997 {published data only}|Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?|
Proudman et al 2000 {published data only}|Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone|
Puranen et al 1998 {published data only}|Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke|/resolve/reference/PMED?id=9700992
PURSUIT 1999 {published data only}|Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators|/resolve/reference/PMED?id=10318656
Saloheimo et al 2001 {published data only}|Use of aspirin, epistaxis and untreated hypertension as risk factors for primary intracerebral hemorrhage in middle-aged and elderly people|/resolve/reference/PMED?id=11157173
Schreiber et al 1992 {published data only}|Randomized trial of thrombolysis versus heparin in unstable angina|/resolve/reference/PMED?id=1423953
Schuhlen et al 2001 {published data only}|Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen|/resolve/reference/PMED?id=11419889
Sivenius et al 1993 {published data only}|Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event|/resolve/reference/PMED?id=8323473
Smith et al 1993 {published data only}|Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril|/resolve/reference/PMED?id=8305640
SPIRIT 1997 {published data only}|A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) study group.|/resolve/reference/PMED?id=9403477
Sturrock et al 1994 {published data only}|Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans|/resolve/reference/PMED?id=7814851
Takeuchi et al 1991 {published data only}|No adverse effect of non-steroidal anti-inflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients|/resolve/reference/PMED?id=1807007
TASS 1998 {published data only}|A randomised trial compairing ticlopidine hydrocloride with aspirin for the prevention of stroke in high-riskk patients|/resolve/reference/PMED?id=2761587
Thakur et al 1999 {published data only}|Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs|/resolve/reference/PMED?id=10509552
Tison et al 1994 {published data only}|Treatment of hypertension with dihydropyridine calcium antagonists and aspirin|/resolve/reference/PMED?id=8205303
Tsuji et al 2000 {published data only}|Different patterns of renal prostaglandins I2 and E2 in patients with essential hypertension with low to normal or high renin activity|/resolve/reference/PMED?id=10954001
UK-TIA 1991 {published data only}|The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results|
Walter et al 1981 {published data only}|Does chronic Aspirin treatment increase blood pressure in man?|/resolve/reference/PMED?id=7230728
WARS 2001 {published data only}|A comparision of warfarin and aspirin for the prevention of recurrent ischemic stroke|/resolve/reference/PMED?id=11794192
Whelton et al 2001 {published data only}|Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients|/resolve/reference/PMED?id=11304662
Abu-Zeid 1971|The relative role of risk factors associated with cerebral infarction and cerebral hemorrhage: a matched pair case-control study|
Avanzini 2000|Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study|/resolve/reference/PMED?id=10912743
Collins 1990a|Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context|/resolve/reference/PMED?id=1969567
Collins 1990b|Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias|/resolve/reference/PMED?id=1969518
Collins 1994|Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease|/resolve/reference/PMED?id=8205459
Dickersin 1996|Introduction: the quality of the medical evidence: is it good enough?|/resolve/reference/PMED?id=8707493
EXCITE|Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events|/resolve/reference/PMED?id=10793164
Fork|Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study|/resolve/reference/PMED?id=10868447
Lee 1997|The role of rheological and haemostatic factors in hypertension|/resolve/reference/PMED?id=9468002
Lefebvre 1996|Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE|
Lip 1994|Abnormalities of rheology and coagulation in hypertension|/resolve/reference/PMED?id=7807500
Lip 1997|Relationship of endothelium, thrombogenesis, and haemorrheology in systemic hypertension to ethnicity and left ventricular hypertrophy|/resolve/reference/PMED?id=9416937
Lip 2000|Does hypertension confer a prothrombotic state? Virchow's triad revisited|/resolve/reference/PMED?id=10645912
Lip 2001|Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (Cochrane Review)|
Lip 2001a|Should patients with hypertension receive antithrombotic therapy?|/resolve/reference/PMED?id=11285041
Lubianca-Neto 1998|A study of the association between epistaxis and the severity of hypertension|/resolve/reference/PMED?id=9740920
Mulrow 1997|Systematic reviews: critical links in the great chain of evidence|/resolve/reference/PMED?id=9054284
Prosp Stud Coll 2002|Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies|/resolve/reference/PMED?id=12493255
Qureshi 1997|Intracerebral hemorrhage in blacks. Risk factors, subtypes, and outcome|/resolve/reference/PMED?id=9158633
Ramsay 1999|Guidelines for management of hypertension: report of the third working party of the British Hypertension Society|/resolve/reference/PMED?id=10482967
Saloheimo 2001|Use of aspirin, epistaxis, and untreated hypertension as risk factors for primary intracerebral hemorrhage in middle-aged and elderly people|/resolve/reference/PMED?id=11157173
Segal 2001|Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter (Cochrane Review)|/resolve/reference/PMED?id=11279741
SPAF II Study 1994|Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study|/resolve/reference/PMED?id=7907677
Syst-Eur 2001|Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial|/resolve/reference/PMED?id=11550107
Thirft 1998|Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage|/resolve/reference/PMED?id=9622133
Thrift 1999|Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-contrl study|
Vanhoutte 1996|Endothelial dysfunction in hypertension|/resolve/reference/PMED?id=9120689
WHO - ISHGMH 1999|1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee|/resolve/reference/PMED?id=10067786
WHO-ISH 1993|1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting|/resolve/reference/PMED?id=8254173
CAPRIE 1996 {published data only}|A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)|/resolve/reference/PMED?id=8918275
HOT 1998 {published data only}|Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment randomised trial|/resolve/reference/PMED?id=9635947
Huynh 2001 {published data only}|Aspirin, warfarin or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery|/resolve/reference/PMED?id=11425770
TPT 1998 {published data only}|Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial|/resolve/reference/PMED?id=10875825
TPT 1998 {published data only}|Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk|/resolve/reference/PMED?id=9457092
Ajani 2000 {published data only}|Alcohol consumption and risk of coronary heart disease by diabetes status|/resolve/reference/PMED?id=10920060
APTC 1994 {published and unpublished data}|Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration|/resolve/reference/PMED?id=8298418
Bhatt 2000 {published data only}|Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators|/resolve/reference/PMED?id=10874265
Bhatt 2001 {published data only}|Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery|/resolve/reference/PMED?id=11157686
Califf 2000 {published data only}|Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial|/resolve/reference/PMED?id=10811588
Caravaca 1995 {published data only}|Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy|/resolve/reference/PMED?id=8559495
CARS 2001 {published data only}|Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Infarction Study (CARS)|/resolve/reference/PMED?id=11524065
Cook 1997 {published data only}|Comparative effects of nabumetone, sulindac, and ibuprofen on renal function|/resolve/reference/PMED?id=9195523
Cusson 1992 {published data only}|Effect of ketoprofen on blood pressure, endocrine and renal responses to chronic dosing with captopril in patients with essential hypertension|/resolve/reference/PMED?id=1345049
Drapkin 1972 {published data only}|Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction|/resolve/reference/PMED?id=4117261
EPIC 1999 {published data only}|Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators|/resolve/reference/PMED?id=9924160
EPILOG 1998 {published data only}|Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators|/resolve/reference/PMED?id=9609084
ESPS-2 1998 {published data only}|Secondary stroke prevention with low-dose Aspirin, sustained release Dipyridamol alone and in combination|/resolve/reference/PMED?id=9781830
Ferri 1993 {published data only}|Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension|/resolve/reference/PMED?id=8500867
Finelli 1991 {published data only}|Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled study|/resolve/reference/PMED?id=2042443
Fisher 2001 {published data only}|Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo|/resolve/reference/PMED?id=11136483
Forbes 1999 {published data only}|Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist|/resolve/reference/PMED?id=10440425
Furey 1993 {published data only}|Renovascular effects of nonprescription ibuprofen in elderly hypertensive patients with mild renal impairment|/resolve/reference/PMED?id=8469621
Gurwitz 1996 {published data only}|The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons|/resolve/reference/PMED?id=8612107
Harker 1999 {published data only}|Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events|/resolve/reference/PMED?id=10514023
Harpaz 2000 {published data only}|Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia|/resolve/reference/PMED?id=8960577
Hartmann 1995 {published data only}|Study on the possible interaction between tenoxicam and atenolol in hypertensive patients|/resolve/reference/PMED?id=7779149
Harvey 1995 {published data only}|Effect of indomethacin on blood pressure control during treatment with nitrendipine|/resolve/reference/PMED?id=8535553
Hermida 1997 {published data only}|Influence of Aspirin usage on blood pressure: dose and administration-time dependencies|/resolve/reference/PMED?id=9360028
Herskovits 1985 {published data only}|Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants|/resolve/reference/PMED?id=3881263
Hess 1985 {published data only}|Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial|/resolve/reference/PMED?id=2857803
Houston 1995 {published data only}|The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil|/resolve/reference/PMED?id=7748048
Houtsmuller 1984 {published data only}|The influence of ticlopidine on the natural course of retinal vein occlusion|/resolve/reference/PMED?id=6385648
Johnson 1996 {published data only}|Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1|/resolve/reference/PMED?id=8736458
Klassen 1993 {published data only}|Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide|/resolve/reference/PMED?id=8227469
Klassen 1995 {published data only}|Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine|/resolve/reference/PMED?id=7755942
Lee 1999 {published data only}|Exercise and risk of stroke in male physicians|/resolve/reference/PMED?id=9880379
Lemak 1986 {published data only}|Controlled trial of aspirin in cerebral ischemia: an addendum|/resolve/reference/PMED?id=3517694
Magagna 1991 {published data only}|Indomethacin raises blood pressure in untreated essential hypertensives: a double-blind randomly allocated study versus placebo|/resolve/reference/PMED?id=1818960
Magagna 1994 {published data only}|Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients|/resolve/reference/PMED?id=7994448
Maggioni 1992 {published data only}|The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group|/resolve/reference/PMED?id=1598096
Mehta 2001 {published data only}|Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study|/resolve/reference/PMED?id=11520521
Mills 1982 {published data only}|Non-steroidal anti-inflammatory drugs and blood pressure|
Minuz 1990 {published data only}|Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension|/resolve/reference/PMED?id=2291866
Minuz 1995 {published data only}|Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition|/resolve/reference/PMED?id=7756098
Morgan 1993 {published data only}|Interaction of indomethacin with felodipine and enalapril|
Morgan 2000 {published data only}|Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril|/resolve/reference/PMED?id=11078175
Nawarskas 1999 {published data only}|Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan|/resolve/reference/PMED?id=10480471
Novo 1996 {published data only}|Effects of captopril and ticlopidine, alone or in combination, in hypertensive patients with intermittent claudication|/resolve/reference/PMED?id=8803643
Oosterga 1998 {published data only}|Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction|/resolve/reference/PMED?id=9604941
Pancera 1996 {published data only}|Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients|/resolve/reference/PMED?id=8860111
Peto 1998 {published data only}|Randomised trial of prophylactic daily aspirin in British male doctors|/resolve/reference/PMED?id=3125882
PHS 1989 {published data only}|Final report on the Aspirin component of the ongoing Physicians' Health Study|/resolve/reference/PMED?id=2664509
Polonia 1995 {published data only}|Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients|/resolve/reference/PMED?id=8557971
Polonia 1996 {published data only}|[Reduction of the antihypertensive effects of enalapril by indomethacin. Its independence from renal sodium retention]|/resolve/reference/PMED?id=8755685
PPP 2001 {published data only}|Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice|/resolve/reference/PMED?id=11197445
Pritchard 1997 {published data only}|Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?|
Proudman 2000 {published data only}|Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone|
Puranen 1998 {published data only}|Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke|/resolve/reference/PMED?id=9700992
PURSUIT 1999 {published data only}|Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators|/resolve/reference/PMED?id=10318656
Saloheimo 2001 {published data only}|Use of aspirin, epistaxis and untreated hypertension as risk factors for primary intracerebral hemorrhage in middle-aged and elderly people|/resolve/reference/PMED?id=11157173
Schreiber 1992 {published data only}|Randomized trial of thrombolysis versus heparin in unstable angina|/resolve/reference/PMED?id=1423953
Schuhlen 2001 {published data only}|Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen|/resolve/reference/PMED?id=11419889
Sivenius 1993 {published data only}|Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event|/resolve/reference/PMED?id=8323473
Smith 1993 {published data only}|Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril|/resolve/reference/PMED?id=8305640
SPIRIT 1997 {published data only}|A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) study group.|/resolve/reference/PMED?id=9403477
Sturrock 1994 {published data only}|Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans|/resolve/reference/PMED?id=7814851
Takeuchi 1991 {published data only}|No adverse effect of non-steroidal anti-inflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients|/resolve/reference/PMED?id=1807007
TASS 1998 {published data only}|A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients|/resolve/reference/PMED?id=2761587
Thakur 1999 {published data only}|Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs|/resolve/reference/PMED?id=10509552
Tison 1994 {published data only}|Treatment of hypertension with dihydropyridine calcium antagonists and aspirin|/resolve/reference/PMED?id=8205303
Tsuji 2000 {published data only}|Different patterns of renal prostaglandins I2 and E2 in patients with essential hypertension with low to normal or high renin activity|/resolve/reference/PMED?id=10954001
UK-TIA 1991 {published data only}|The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results|
Walter 1981 {published data only}|Does chronic Aspirin treatment increase blood pressure in man?|/resolve/reference/PMED?id=7230728
WARS 2001 {published data only}|A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke|/resolve/reference/PMED?id=11794192
Whelton 2001 {published data only}|Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients|/resolve/reference/PMED?id=11304662
Aguilar 2009|Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks|
Collins 1990a|Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context|/resolve/reference/PMED?id=1969567
Collins 1990b|Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias|/resolve/reference/PMED?id=1969518
Collins 1994|Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease|/resolve/reference/PMED?id=8205459
Dickersin 1996|Introduction: the quality of the medical evidence: is it good enough?|/resolve/reference/PMED?id=8707493
Duley 2004|Antiplatelet agents for preventing pre-eclampsia and its complications|
EXCITE 2000|Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events|/resolve/reference/PMED?id=10793164
Higgins 2011||
Lee 1997|The role of rheological and haemostatic factors in hypertension|/resolve/reference/PMED?id=9468002
Lefebvre 1996|Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE|
Lip 1994|Abnormalities of rheology and coagulation in hypertension|/resolve/reference/PMED?id=7807500
Lip 1997|Relationship of endothelium, thrombogenesis, and haemorrheology in systemic hypertension to ethnicity and left ventricular hypertrophy|/resolve/reference/PMED?id=9416937
Lip 2000|Does hypertension confer a prothrombotic state? Virchow's triad revisited|/resolve/reference/PMED?id=10645912
Lip 2001|Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm|
Lip 2001a|Should patients with hypertension receive antithrombotic therapy?|/resolve/reference/PMED?id=11285041
PSC 2002|Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies|/resolve/reference/PMED?id=12493255
SPAF-II 1994|Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study|/resolve/reference/PMED?id=7907677
Vanhoutte 1996|Endothelial dysfunction in hypertension|/resolve/reference/PMED?id=9120689
WHO-ISH 1993|1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting|/resolve/reference/PMED?id=8254173
WHO-ISHGMH 1999|1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee|/resolve/reference/PMED?id=10067786
Williams 2004|British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary|
Alamo 2002 {published data only}|Evaluation of a patient-centred approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care|/resolve/reference/PMED?id=12220747
Alamo 2002 {published data only}|Effectiveness of a learner-centred training programme for primary care physicians in using a patient-centred consultation style|
Alder 2007 {published data only}|Communication skills training in obstetrics and gynaecology: whom should we train? A randomised controlled trial|/resolve/reference/PMED?id=17576587
Bieber 2008 {published data only}|Long-term effects of a shared decision-making intervention on physician-patient interaction and outcome in fibromyalgia - a qualitative and quantitative 1 year follow-up of a randomised controlled trial|/resolve/reference/PMED?id=16872795
Bieber 2008 {published data only}|A shared decision-making communication training program for physicianstreating fibromyalgia patients: Effects of a randomised controlled trial|/resolve/reference/PMED?id=18157994
Bieber 2008 {published data only}|Shared decision making (SDM) with chronic pain patients. The patient as a partner in the medical decision making process|/resolve/reference/PMED?id=15521115
Briel 2006 {published data only}|Communication training and antibiotic use in acute respiratory tract infections. A cluster randomised controlled trial in general practice|/resolve/reference/PMED?id=16708309
Brown 2001 {published data only}|Promoting patient participation and shortening cancer consultations: a randomised trial|/resolve/reference/PMED?id=11720460
Chassany 2006 {published data only}|Effects of training on general practitioners' management of pain in osteoarthritis: A randomised multicenter study|/resolve/reference/PMED?id=16724375
Chenoweth 2009 {published data only}|Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial|/resolve/reference/PMED?id=19282246
Clark 2000 {published data only}|Physician asthma education program improves outcomes for children of low-income families|/resolve/reference/PMED?id=15302719
Clark 2000 {published data only}|Impact of education for physicians on patient outcomes|/resolve/reference/PMED?id=9565410
Clark 2000 {published data only}|Long-term effects of asthma education on patient satisfaction and use of health services|
Clark 2000 {published data only}|Physician-patient partnership in managing chronic illness|/resolve/reference/PMED?id=7575946
Dijkstra 2006 {published data only}|Introduction of diabetes passports involving both patient and professionals to improve hospital outpatient diabetes care|/resolve/reference/PMED?id=15860240
Dijkstra 2006 {published data only}|Patient centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis|
Fallowfield 2002 {published data only}|Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial|/resolve/reference/PMED?id=11879860
Fallowfield 2002 {published data only}|Enduring impact of communication skills training: Results of a 12-month follow-up|/resolve/reference/PMED?id=14562015
Fallowfield 2002 {published data only}|Teaching senior oncologists communication skills: results from phase 1 of a comprehensive longitudinal program in the UK|/resolve/reference/PMED?id=9586916
Fallowfield 2002 {published data only}|The Medical Interaction Process System (MIPS): an instrument for analysing interviews of oncologists and patients with cancer|/resolve/reference/PMED?id=10641807
Glasgow 2004 {published data only}|Self-management aspects of improving chronic illness care breakthrough series implementation with diabetes and heart failure teams|/resolve/reference/PMED?id=12054323
Glasgow 2004 {published data only}|A practical randomised trial to improve diabetes care|
Harmsen 2005 {published data only}|The effect of educational intervention on intercultural communication: results of a randomised controlled trial|/resolve/reference/PMED?id=15904552
Haskard 2008 {published data only}|Physician and patient communication training in primary care: effects on participation and satisfaction|/resolve/reference/PMED?id=18823177
Heaven 2006 {published data only}|Transfer of communication skills training from workshop to workplace: the impact of clinical supervision|/resolve/reference/PMED?id=16242900
Ho 2008 {published data only}|Cross-cultural medical education: can patient-centred cultural competency training be effective in non-Western countries?|/resolve/reference/PMED?id=18777429
Hobma 2006 {published data only}|Effective improvement of doctor-patient communication: a randomised controlled trial|/resolve/reference/PMED?id=16882375
Howe 1996 {published data only}|Detecting psychological distress: Can general practitioners improve their own performance?|/resolve/reference/PMED?id=8776911
Joos 1996 {published data only}|Effects of a physician communication intervention on patient care outcomes|/resolve/reference/PMED?id=8667091
Kennedy 2004 {published data only}|A cluster-randomised controlled trial of a patient-centred guidebook for patients with ulcerative colitis: Effect on knowledge, anxiety and quality of life|
Kennedy 2004 {published data only}|A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease|/resolve/reference/PMED?id=15479685
Kennedy 2004 {published data only}|Uncovering the limits of patient-centeredness: Implementing a self-management trial for chronic illness|/resolve/reference/PMED?id=15611205
Kinmonth 1998 {published data only}|Developing a training programme in patient-centred consulting for evaluation in a randomised controlled trial; diabetes care from diagnosis in British primary care|/resolve/reference/PMED?id=9006224
Kinmonth 1998 {published data only}|Randomised controlled trial of patient centred care of diabetes in general practice: impact on current well being and future disease risk|/resolve/reference/PMED?id=9794859
Kinmonth 1998 {published data only}|Diabetes care from diagnosis: effects of training in patient-centred care on beliefs, attitudes and behaviour of primary care professionals|/resolve/reference/PMED?id=10640121
Krones 2008 {published data only}|Absolute cardiovascular disease risk and shared decision making inprimary care: A randomised controlled trial|
Langewitz 1998 {published data only}|Improving communication skills: a randomised controlled behaviorally oriented intervention study for residents in internal medicine|/resolve/reference/PMED?id=9625213
Levinson 1993 {published data only}|The effects of two continuing medical education programs on communication skills of practicing primary care physicians|/resolve/reference/PMED?id=8320576
Lewis 1991 {published data only}|Increasing patient knowledge, satisfaction, and involvement: randomized trial of a communication intervention|/resolve/reference/PMED?id=1861939
Loh 2007 {published data only}|Measuring patients' desire for autonomy: Decision making and information-seeking preferences among medical patients|
Loh 2007 {published data only}|Patients' perceived involvement in care scale: Relationship to attitudes about illness and medical care|
Loh 2007 {published data only}|Information and participation interests of patients with depression in clinical decision making in primary care|/resolve/reference/PMED?id=15106488
Loh 2007 {published data only}|The effects of a shared decision-making intervention in primary care of depression: a cluster-randomised controlled trial|/resolve/reference/PMED?id=17509808
Longo 2006 {published data only}|Patient-based outcome results from a cluster randomised trial of shared decision making skill development and use of risk communication aids in general practice|/resolve/reference/PMED?id=15249521
Longo 2006 {published data only}|Achieving involvement: process outcomes from a cluster randomised trial of shared decision making skill development and use of risk communication aids in general practice|/resolve/reference/PMED?id=15249520
Longo 2006 {published data only}|Involving patients in primary care consultations: assessing preferences using discrete choice experiments|/resolve/reference/PMED?id=16438813
Margalit 2005 {published data only}|Short Family Therapy in Ambulatory Medicine (SFAT-AM): Treatment approach in 10-15 minute encounters|/resolve/reference/PMED?id=8359608
Margalit 2005 {published data only}|Promoting a biopsychosocial orientation in family practice: effect of two teaching programs on the knowledge and attitudes of practising primary care physicians|/resolve/reference/PMED?id=16332553
McLean 2004 {published data only}|Eliciting patients' concerns: a randomised controlled trial of different approaches by the doctor|/resolve/reference/PMED?id=15353051
Meland 1997 {published data only}|Effectiveness of two preventive interventions for coronary heart disease in primary care|/resolve/reference/PMED?id=9101627
Merckaert 2008 {published data only}|Effects of a 105 hours psychological training program on attitudes, communication skills and occupational stress in oncology: a randomised study|/resolve/reference/PMED?id=14710215
Merckaert 2008 {published data only}|Factors that influence cancer patients' and relatives' anxiety following a three-person medical consultation: impact of a communication skills training program for physicians|
Merckaert 2008 {published data only}|Factors influencing physicians' detection of cancer patients' and relatives' distress: can a communication skills training program improve physicians' detection?|
Merckaert 2008 {published data only}|Factors that influence physicians' detection of distress in patients with cancer - Can a communication skills training program improve physicians' detection?|
Merckaert 2008 {published data only}|How to optimise physicians' communication skills in cancer care: Results of a randomised study assessing the usefulness of post training consolidation workshops|/resolve/reference/PMED?id=12915605
Moral 2003 {published data only}|Effectiveness of a clinical interviewing training program for family practice residents: a randomised controlled trial|
Pill 1998 {published data only}|A randomized controlled trial of an intervention designed to improve the care given in general practice to type II diabetic patients: Patient outcomes and professional ability to change behaviour|/resolve/reference/PMED?id=9694180
Pill 1998 {published data only}|Professional responses to innovation in clinical method: Diabetes care and negotiating skills|/resolve/reference/PMED?id=9006223
Pill 1998 {published data only}|Innovation in clinical method: diabetes care and negotiating skills|/resolve/reference/PMED?id=8826057
Putnam 1988 {published data only}|Teaching the medical interview: an intervention study|
Robbins 1979 {published data only}|Interpersonal skills training: evaluation in an internal medicine residency|/resolve/reference/PMED?id=501719
Roter 1995 {published data only}|Improving physicians' interviewing skills and reducing patients' emotional distress|/resolve/reference/PMED?id=7677554
Smith 1998 {published data only}|The effectiveness of intensive training for residents in interviewing: A randomized controlled study|/resolve/reference/PMED?id=9441572
Smith 1998 {published data only}|A strategy for improving patient satisfaction by the intensive training of residents in psychosocial medicine: a controlled, randomized study|/resolve/reference/PMED?id=7646751
Smith 1998 {published data only}|Improving residents' confidence in using psychosocial skills|/resolve/reference/PMED?id=7562122
Smith 2006 {published data only}|Using nurse practitioners to implement an intervention in primary care for high-utilizing patients with medically unexplained symptoms|
Smith 2006 {published data only}|Primary care clinicians treat patients with medically unexplained symptoms: a randomised controlledtrial|
Song 2005 {published data only}|A randomised, controlled trial to improve advance care planning among patients undergoing cardiac surgery|/resolve/reference/PMED?id=16166875
Sorlie 2007 {published data only}|Video information combined with individualized information sessions: effects upon emotional well being following coronary bypass surgery. A randomised trial|/resolve/reference/PMED?id=16959466
Stewart 2007 {published data only}|Improving communication between doctors and breast cancer patients|
Thom 1999 {published data only}|Training physicians to increase patient trust|
Thom 1999 {published data only}|An intervention to increase patients' trust in their physicians|/resolve/reference/PMED?id=10065061
Wilkinson 2008 {published data only}|Effectiveness of a three-day communication skills course in changing nurses' communication skills with cancer/palliative care patients: a randomised controlled trial|/resolve/reference/PMED?id=18541641
Wolf 2008 {published data only}|Can nurses impact patient outcomes using a patient-centred care model?|/resolve/reference/PMED?id=19060642
Alroy 1984 {published data only}|An evaluation of the short-term effects of an interpersonal skills course|
Baile 1997 {published data only}|Improving physician-patient communication in cancer care|/resolve/reference/PMED?id=9376255
Baile 1999 {published data only}|Communication skills training in oncology|/resolve/reference/PMED?id=10463990
Beckman 1990 {published data only}|Measurement and improvement of humanistic skills in first-year trainees|
Bensing 1985 {published data only}|Evaluation of an interview training course for general practitioners|/resolve/reference/PMED?id=4012361
Berg 1983 {published data only}|Evaluation of a successful biosocial rotation|/resolve/reference/PMED?id=6637908
Blaasvaer 1998 {published data only}|A patient-centred approach to health care: the effects on health-related behaviour, consultation satisfaction and psychological well-being|/resolve/reference/PMED?id=9499724
Bohme 1998 {published data only}|Effects of inpatient client-centred psychotherapy in various illness: 1-year follow-up|
Boscart 2009 {published data only}|A communication intervention for nursing staff in chronic care|
Breunlin 1990 {published data only}|An evaluation strategy for behavioural pediatrics training|
Calhoun 1985 {published data only}|Changing orientations of medical students to patients' care: biomedical versus biopsychosocial models|/resolve/reference/PMED?id=3983327
Caris-Verhallen 2000 {published data only}|Effects of video interaction analysis training on nurse-patient communication in the care of the elderly|/resolve/reference/PMED?id=11013551
Cope 1986 {published data only}|Modification of residents' behavior by preceptor feedback of patient satisfaction|
Covinsky 1998 {published data only}|Improving functional outcomes in older patients: Lessons from an acute care for elders unit|
Cox 1981 {published data only}|Psychiatric interviewing techniques VI. Experimental study: Eliciting feelings|/resolve/reference/PMED?id=7306753
Cummings 1989 {published data only}|Training physicians about smoking cessation: A controlled trial in private practices|
Dick 1997 {published data only}|Shared vision - a health education project designed to enhance adherence to anti-tuberculosis treatment|/resolve/reference/PMED?id=9441085
Dougherty 1998 {published data only}|Community-based nursing: continence care for older rural women|
Douglas 1996 {published data only}|Survical experience of chronically critically ill patients|
Edberg 1996 {published data only}|Effects of clinical supervision on nurse-patient cooperation quality|/resolve/reference/PMED?id=8704662
Eijkman 1977 {published data only}|Experiences with a training course in patient counselling|/resolve/reference/PMED?id=270519
Ericson 1997 {published data only}|Clinical guidelines and self-assessment in dental education|
Evans 1987 {published data only}|A communication skills programme for increasing patients' satisfaction with general practice consultations|
Evans 1991 {published data only}|Effects of communication skills training on students' diagnostic efficiency|
Evans 1992 {published data only}|Communication skills training and patients' satisfaction|
Evans 1992 {published data only}|Lectures and skills workshops as teaching formats in a history-taking skills course for medical students|
Evans 1993 {published data only}|Behavioural assessment of the effectiveness of a communication programme for medical students|
Fallowfield 1998 {published data only}|Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom|/resolve/reference/PMED?id=9586916
Family Heart Study {published data only}|Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study|
Farhall 1998 {published data only}|Training to enhance partnerships between mental health professionals and family caregivers: A comparative study|/resolve/reference/PMED?id=9826255
Farsad 1978 {published data only}|Teaching interviewing skills to paediatric house officers|/resolve/reference/PMED?id=643413
Fine 1977 {published data only}|Empathy in the doctor-patient relationship: skill training for medical students|/resolve/reference/PMED?id=886588
Finnema 2000 {published data only}|The effect of emotion-oriented care on nursing home residents with dementia and their nursing assistants: a randomised clinical trial|
Foley 1997 {published data only}|Using standardized patients and standardized physicians to improve patient-care quality: results of a pilot study|
Fox 1997 {published data only}|Effects of a health promotion program on sustaining health behaviours in older adults|
Goldberg 1980 {published data only}|Training family doctors to recognise psychiatric illness with increased accuracy|/resolve/reference/PMED?id=6105569
Greenberg 1999 {published data only}|Communicating bad news: a paediatric department's evaluation of a simulated intervention|/resolve/reference/PMED?id=10353931
Greenfield 1988 {published data only}|Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes|
Guillory-Dunbar 1994 {published data only}|Effects of staff-patient relations training on employees and their feelings about their work|
Haisch 1996 {published data only}|Effects of patient education in type II diabetic patients after clinic admission. Results of a 3 month catamnesis after new patient-centred education|/resolve/reference/PMED?id=9036414
Handmaker 1999 {published data only}|Findings of a pilot study of motivational interviewing with pregnant drinkers|/resolve/reference/PMED?id=10091968
Hebert 1992 {published data only}|Patient characteristics and the effect of three physician-delivered smoking interventions|/resolve/reference/PMED?id=1438106
Hunsdon 1984 {published data only}|The impact of illness on patients and families: social workers teach medical students|/resolve/reference/PMED?id=6528305
Inui 1976 {published data only}|Improved outcomes in hypertension after physician tutorials: A controlled trial|/resolve/reference/PMED?id=937876
Jacob 1988 {published data only}|Putting research into practice: the impact of interpersonal skills training on responses to patients' emotional concerns by nursing staff in a general hospital|/resolve/reference/PMED?id=3197868
Jacob 1988 {published data only}|The impact of interpersonal skills training on responses to patients' emotional concerns by nursing staff in a general hospital|
Johnson 1996 {published data only}|Effectiveness of standardized patient instruction|/resolve/reference/PMED?id=8594109
Kauss 1980 {published data only}|The long-term effectiveness of interpersonal skills training in medical schools|/resolve/reference/PMED?id=7411560
Kihlgren 1990 {published data only}|Effects of the training of integrity-promoting care on the interaction at a long-term ward|
Kihlgren 1992 {published data only}|The content of the oral daily reports at a long-term ward before and after staff training in integrity promoting care|
Kihlgren 1993 {published data only}|Nurse-patient interaction after training in integrity promoting care at a long-term ward: analysis of video-recorded morning care sessions|/resolve/reference/PMED?id=8449654
Kosower 1996 {published data only}|Evaluating telephone T.A.L.K|/resolve/reference/PMED?id=8723549
Kramer 1987 {published data only}|Impact of workshop on students' and physicians' rejecting behaviours in patient interviews|/resolve/reference/PMED?id=3681918
Ladyshewsky 1997 {published data only}|Communication skill development in health professional education: the use of standardised patients in combination with a peer assessment strategy|/resolve/reference/PMED?id=9451588
Landefeld 1995 {published data only}|A randomised trial of care in a hospital medical unit especially designed to improve the functional outcomes of acutely ill older patients|/resolve/reference/PMED?id=7715644
Llewellyn-Jones 1999 {published data only}|Multifaceted shared care intervention for late life depression in residential care: Randomised controlled trial|/resolve/reference/PMED?id=10480824
Maguire 1977 {published data only}|An experimental comparison of three courses in history-taking skills for medical students|
Maguire 1986 {published data only}|Consultation skills of young doctors: I - Benefits of feedback training in interviewing as students persist|/resolve/reference/PMED?id=3719282
Maiman 1988 {published data only}|Improving paediatrician's compliance-enhancing practices|/resolve/reference/PMED?id=3381783
Maisiak 1996 {published data only}|The effect of person-centred counselling on the psychological status of persons with systemic lupus erythematosus or rheumatoid arthritis|
Martin 1998 {published data only}|Randomized trial of a patient-centred hospital unit|/resolve/reference/PMED?id=9731172
Mayer 1998 {published data only}|Emergency department patient satisfaction: customer service training improves patient satisfaction and ratings of physician and nurse skill|
McCourt 1998 {published data only}|Evaluation of one-to-one midwifery: Women's responses to care|
McManus 1993 {published data only}|Teaching communication skills to clinical students|/resolve/reference/PMED?id=8518575
Meland 1996 {published data only}|Life style intervention in general practice: effects on psychological well-being and patient satisfaction|/resolve/reference/PMED?id=8763803
Miller 1993 {published data only}|Enhancing motivation for change in problem drinking: a controlled comparison of two therapist styles|/resolve/reference/PMED?id=8326047
Morgan 1996 {published data only}|Teaching communication skills|/resolve/reference/PMED?id=8646316
Myers 1991 {published data only}|Educating allied health professionals to provide care for cancer patients and their families|/resolve/reference/PMED?id=10116581
Nathan 1991 {published data only}|Initial evaluation of a hidden agenda - method of teaching the interview|
Novack 1992 {published data only}|Teaching medical interviewing: a basic course on interviewing and the physician-patient relationship|/resolve/reference/PMED?id=1520048
Ockene 1988 {published data only}|A residents' training program for the development of smoking intervention skills|/resolve/reference/PMED?id=3365074
Ockene 1991 {published data only}|Increasing the efficacy of physician-delivered smoking interventions: a randomised clinical trial|
Ockene 1994 {published data only}|The physician-delivered smoking intervention project: factors that determine how much the physician intervenes with smokers|/resolve/reference/PMED?id=7931747
Ockene 1995 {published data only}|Physician training for patient-centred nutrition counselling in a lipid intervention trial|/resolve/reference/PMED?id=8610079
Ockene 1997 {published data only}|Provider training for patient-centred alcohol counselling in a primary care setting|/resolve/reference/PMED?id=9361574
Ockene 1999 {published data only}|Effect of training and a structured office practice on physician-delivered nutrition counselling: the Worchester-area trial for counselling in hyperlipidaemia (WATCH)|
Ockene 1999 {published data only}|Effect of physician-delivered nutrition counselling training and an office-support program on saturated fat intake, weight, and serum lipid measurements in a hyperlipidaemic population|/resolve/reference/PMED?id=10218753
Ockene 1999b {published data only}|Brief physician- and nurse practitioner-delivered counselling for high-risk drinkers|/resolve/reference/PMED?id=10527297
Ogden 1997 {published data only}|The relative effectiveness of two styles of educational package to change practice nurses' management of obesity|/resolve/reference/PMED?id=9368818
Olson 1987 {published data only}|Effects of a training model on active listening skills of post-RN students|/resolve/reference/PMED?id=3035116
OXCHECK study group {published data only}|Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year|
Perkonigg 1995 {published data only}|The "patient anxiety seminar" as a graduate education program - effectiveness and use in general practice|/resolve/reference/PMED?id=7571737
Phillips 1997 {published data only}|Teaching psychosocial care to long-term care nursing assistants|
Poole 1979 {published data only}|Understanding the patient: a neglected aspect of medical education|/resolve/reference/PMED?id=551524
Poole 1979 {published data only}|Long-term effects of empathy training on the interview skills of medical students|
Quirk 1993 {published data only}|Evaluation of two AIDS prevention interventions for inner-city adolescent and young adult women|
Rabinowitz 1994 {published data only}|Developing psychosocial mindedness and sensitivity to mental health issues among primary care nurses using the balint group method|/resolve/reference/PMED?id=7875952
Razavi 1988 {published data only}|Immediate effectiveness of brief psychological training for health professionals dealing with terminally ill cancer patients: a controlled study|/resolve/reference/PMED?id=3175719
Robins 1989 {published data only}|The effect of training on medical students' responses to geriatric patient concerns: results of a linguistic analysis|/resolve/reference/PMED?id=2759456
Roche 1996 {published data only}|Teaching smoking cessation skills to senior medical students: a block-randomised controlled trial of four different approaches|
Rollnick 1997 {published data only}|Helping smokers make decisions: the enhancement of brief intervention for general medical practice|/resolve/reference/PMED?id=9277242
Roter 1990 {published data only}|An evaluation of residency training in interviewing skills and the psychosocial domain of medical practice|
Roter 1998 {published data only}|The effects of a continuing medical education programme in interpersonal communication skills on doctor practice and patient satisfaction in Trinidad and Tobago|
Saltmarche 1998 {published data only}|An educational approach for patient-focused care|
Sanson-Fisher 1978 {published data only}|Training medical students to empathize: an experimental study|
Scheidt 1986 {published data only}|Evaluation of system providing feedback to students on videotaped patient encounters|/resolve/reference/PMED?id=3723570
Schubert 1989 {published data only}|Effect of liaison psychiatry on attitudes toward psychiatry, rate of consultation, and psychosocial documentation|/resolve/reference/PMED?id=2785070
Seim 1995 {published data only}|Comparison of training techniques using a patient-centred approach to smoking cessation|
Sidorov 1997 {published data only}|A successful tobacco cessation program led by primary care nurses in a managed care setting|/resolve/reference/PMED?id=10169255
Simek-Downing 1985 {published data only}|Videotape analyses of medical students' interviewing skills|
Simkin-Silverman1997 {published data only}|Management of obesity in primary care|
Smith 1991 {published data only}|Efficacy of a one-month training block in psychosocial medicine for residents: a controlled study|
Snoek 1986 {published data only}|Learning cooperation. An evaluation of a training programme in co-operative skills for dental students|/resolve/reference/PMED?id=3459054
Stein 1999 {published data only}|Thriving in a busy practice: physician-patient communication training|
Steyn 1997 {published data only}|Communication with TB patients; a neglected dimension of effective treatment?|/resolve/reference/PMED?id=9287555
Stillman 1977 {published data only}|Use of trained mothers to teach interviewing skills to first-year medical students: A follow-up study|/resolve/reference/PMED?id=887330
Szekely 1986 {published data only}|Nonpharmacological treatment of menstrual headache: relaxation-biofeedback behavior therapy and person-centred insight therapy|
Ter Horst 1980 {published data only}|Communication skills training by means of videotaped interaction of dental students with their patients. Development, realisation and evaluation of a trial educational method|/resolve/reference/PMED?id=6163996
Ter Horst 1984 {published data only}|Effectiveness of communication skills training for dental students|/resolve/reference/PMED?id=6484096
Teusch 1997 {published data only}|The benefit of an insight-oriented and experiential approach on panic and agoraphobia symptoms|/resolve/reference/PMED?id=9403918
Thompson 1982 {published data only}|Effects of a psychiatric liaison program on internists' ability to assess psychosocial problems|
Thompson 1990 {published data only}|Patient-oriented interventions to improve communication in a medical office visit|/resolve/reference/PMED?id=2373065
Utting 2000 {published data only}|Consultation skills of medical students before and after changes in curriculum|/resolve/reference/PMED?id=10884769
Vaidya 1999 {published data only}|Teaching physicians how to break bad news|/resolve/reference/PMED?id=10201727
Vail 1996 {published data only}|Patients as teachers: an integrated approach to teaching medical students about the ambulatory care of HIV infected patients|/resolve/reference/PMED?id=8788753
Verhaak 1988 {published data only}|Detection of psychologic complaints by general practitioners|/resolve/reference/PMED?id=3172865
Ward 1975 {published data only}|Reducing emotional distance: a new method to teach interviewing skills|/resolve/reference/PMED?id=1133830
Ward 1996 {published data only}|Does a 3-day workshop for family medicine trainees improve preventive care? A randomised control trial|/resolve/reference/PMED?id=8936577
White 1999 {published data only}|Teaching clinician-patient communication in the treatment of breast diseases|
Wilkinson 1998 {published data only}|Nurse-patient communication in palliative care: an evaluation of a communication skills programme|/resolve/reference/PMED?id=9616455
Willetts 1997 {published data only}|Expressed emotion and schizophrenia: the efficacy of a staff training programme|/resolve/reference/PMED?id=9429962
Wist 1993 {published data only}|Teaching communication with cancer patients and terminally ill patients to medical students|/resolve/reference/PMED?id=8363937
Anderson 1990|Development of the trust in physician scale: a measure to assess interpersonal trust in patient-physician relationships|/resolve/reference/PMED?id=2084735
Balint 1955|The doctor, his patient and the illness|
Balint 1956||
Balint 1969|Training medical students in patient-centered medicine|/resolve/reference/PMED?id=5810538
Bjartveit 1987||
Blair 1985|Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments|/resolve/reference/PMED?id=3876763
Bradley 1994||
Brockway 1978|Evaluating physician competency: what difference does it make?|/resolve/reference/PMED?id=10239082
Brown 1999|Patient-centred communication|/resolve/reference/PMED?id=10418654
Byrne 1976||
Carter 1989|How patients judge the humanistic skills of their physicians|
Coulter 1998||
Craig 2008|Developing and evaluating complex interventions: the new Medical Research Council guidance|
Crossley 1992|Assessment of psychological care in general practice|/resolve/reference/PMED?id=1483082
Davis 1991|GHAA's consumer satisfaction survey|
Epstein 2007||
Epstein 2011|The values and value of patient-centered care|
Godin 1985|A simple method to assess exercise behaviour in the community|/resolve/reference/PMED?id=4053261
Goldberg 1979|A scaled version of the General Health Questionnaire|/resolve/reference/PMED?id=424481
Goldberg 1988||
Greenfield 1985|Expanding patient involvement in care. Effects on patient outcomes|/resolve/reference/PMED?id=3977198
Griffin 2004|Effect on health-related outcomes of interventions to alter the interaction between patients and practitioners: a systematic review of trials|
Grol 1990|Attitudes to risk taking in medical decision making among British, Dutch and Belgian general practitioners|/resolve/reference/PMED?id=2115347
Hackett 1996|Tests for diabetes treatment satisfaction tested|
Henbest 1989|Patient-centredness in the consultation: a method for measurement|/resolve/reference/PMED?id=2632300
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
IAPO 2007||
IOM 2001||
Kagan 1975|Influencing human interaction: eleven years with IPR|
Kiresuk 1986|Goal attainment scaling: A general method for evaluating comprehensive community mental health programs|
Laine 1996|Patient-centered medicine: a professional evolution|/resolve/reference/PMED?id=8531314
Lewis 1986|Parent satisfaction with children's medical care: development, field test and validation of a questionnaire|/resolve/reference/PMED?id=3951263
Lipkin 1984|The medical interview: a core curriculum for residencies in internal medicine|/resolve/reference/PMED?id=6362513
Maere 1991|Physical activity among adults in a Norwegian county|/resolve/reference/PMED?id=1780832
Matthews 1989|A new instrument for patients' ratings of physician performance in the hospital setting|
Mazor 2005|The relationship between checklist scores on a communication OSCE and analogue patients' perceptions of communication|/resolve/reference/PMED?id=15912283
McWhinney 1989|The need for a transformed clinical method|
Mead 2000|Patient-centredness: a conceptual framework and review of the empirical literature|/resolve/reference/PMED?id=11005395
Moral 2001|Effectiveness of a learner-centred training programme for primary care physicians in using a patient-centred consultation style|/resolve/reference/PMED?id=11145630
Murphy 1992|Lay health concepts and response to medical advice about lifestyle modification: the case of people with a diagnosis of non insulin dependent diabetes|
Ong 1995|Doctor-patient communication: a review of the literature|/resolve/reference/PMED?id=7792630
Rao 2007|Communication interventions make a difference in conversations between physicians and patients: a systematic review of the evidence|/resolve/reference/PMED?id=17496718
Rifkin 1988|Children's perceptions of physicians and medical care: Two measures|/resolve/reference/PMED?id=3171817
Roe 1994|Dietary interventions in primary care: validity of the DINE method for dietary assessment|/resolve/reference/PMED?id=7895964
Roter 1977|Patient participation in the patient-provider interaction: the effects of patient question asking on the quality of interaction, satisfaction and compliance|/resolve/reference/PMED?id=346537
Roter 1991||
Shojania 2005|Evidence-based quality improvement: the state of the science|
Stacey 2011|Decision aids for people facing health treatment or screening decisions|
Stewart 1981|Children as patients: a communications process study in family practice|/resolve/reference/PMED?id=7031173
Stewart 1995a|Effective physician-patient communication and health outcomes: a review|/resolve/reference/PMED?id=7728691
Stewart 1995b||
Stiles 1978||
Truax 1967||
US 2012||
van Thiel 1991|Reliability and feasibility in measuring medical interviewing skills: the revised Maastricht History-Taking and Advice Checklist (MAAS-R)|
Venham 1979|A self-report measure of situational anxiety for young children|
Verghese 2011|The bedside evaluation: ritual and reason|
Weaver 1993|A questionnaire for patients' evaluations of their physicians' humanistic behaviours|/resolve/reference/PMED?id=8455109
Winefield 1995|The usefulness of distinguishing different types of general practice consultation, or are needed skills always the same?|/resolve/reference/PMED?id=8826055
Wolf 1978|The medical interview satisfaction scale: development of a scale to measure patient perceptions of physician behaviour|/resolve/reference/PMED?id=755868
Wolf 1980|Patient beliefs, personality traits, health perceptions, and response biases are predictors of medical interview satisfaction|
Wolf 1981||
Lewin 2001|Interventions for providers to promote a patient-centered approach in clinical consultations|
Banerjee 1978 {published and unpublished data}|Nutritional status of long-stay geriatric inpatients: effects of a food supplement (Complan)|/resolve/reference/PMED?id=103378
Barr 2000 {published data only}|Effects of increased consumption of fluid milk on energy and nutrient intake, body weight and cardiovascular risk factors in healthy older adults|
Barr 2000 {published data only}|Dietary changes favorably affect bone remodeling in older adults|/resolve/reference/PMED?id=10524386
Benati 2001 {published data only}|Impact on pressure ulcer healing of an arginine-enriched nutritional solution in patients with severe cognitive impairment|
Bonnefoy 2003 {published data only}|The effects of exercise and protein-energy supplements on body composition and muscle function in frail elderly individuals: a long-term controlled randomised study|/resolve/reference/PMED?id=12720593
Bourdel 2000 {published data only}|A multi-center trial of the effects of oral nutritional supplementation in critically ill older inpatients. GAGE Group. Groupe Aquitaine Geriatrique d'Evaluation|/resolve/reference/PMED?id=10674226
Broqvist 1994 {published data only}|Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure - effects of long term dietary supplementation|/resolve/reference/PMED?id=7698134
Brown 1992 {published and unpublished data}|Effect of nutrition on recovery after fractured femur|
Brown 1992 {published and unpublished data}|Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture|
Bruce 2003 {published and unpublished data}|Nutritional supplements after hip fracture: poor compliance limits effectiveness|/resolve/reference/PMED?id=14512038
Carver 1995 {published data only}|Effect of dietary supplementation of elderly demented hospital residents|
Collins 2005 {published data only}||/resolve/reference/PMED?id=AMBIGUOUS%20(23714%20citations)
Daniels 2003 {published data only}|Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention|
Daniels 2003 {published data only}||/resolve/reference/PMED?id=AMBIGUOUS%20(5761%20citations)
Daniels 2003 {published data only}||/resolve/reference/PMED?id=AMBIGUOUS%20(86362%20citations)
Daniels 2003 {published data only}||/resolve/reference/PMED?id=AMBIGUOUS%20(86362%20citations)
Daniels 2003 {published data only}||/resolve/reference/PMED?id=AMBIGUOUS%20(86362%20citations)
Deletter 1991 {unpublished data only}||
Delmi 1990 {published data only}|Protein intake, IGF-1 and osteoporosis|/resolve/reference/PMED?id=9536300
Delmi 1990 {published data only}|Proteins and bone health|/resolve/reference/PMED?id=9097848
Delmi 1990 {published data only}|Dietary supplementation in elderly patients with fractured neck of the femur|/resolve/reference/PMED?id=1970070
Edington 2004 {published data only}|A prospective randomised controlled trial of nutritional supplementation in malnourished elderly in the community: clinical and health economic outcomes|/resolve/reference/PMED?id=15030959
Edington 2004 {published data only}|A prospective randomised controlled trial of nutritional supplementation in malnourished elderly in the community: clinical and health economic outcomes|
Eneroth 2004 {published data only}||/resolve/reference/PMED?id=AMBIGUOUS%20(534%20citations)
Fiatarone 1994 {published data only}|The Boston FICSIT study: the effects of resistance training and nutritional supplementation of physical frailty in the oldest old|/resolve/reference/PMED?id=8440860
Fiatarone 1994 {published data only}|Exercise training and nutritional supplementation for physical frailty in very elderly people|/resolve/reference/PMED?id=8190152
Fiatarone 1994 {published data only}|The effect of oral nutritional supplements on habitual dietary quality and quantity in frail elders|/resolve/reference/PMED?id=10828934
Fiatarone 1994 {published data only}|Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders|/resolve/reference/PMED?id=10409137
FOOD trial 2005 {published data only}||
Gariballa 1998 {published data only}|A randomised controlled trial of nutritional supplementation after stroke|
Gariballa 1998 {published data only}|A randomised controlled trial of nutritional supplements following acute stroke|
Gariballa 1998 {published data only}|A randomized controlled a single-blind trial of nutritional supplementation after acute stroke|
Gariballa 2006 {published data only}|Associations between underlying disease and nutritional status following acute illness in older people|/resolve/reference/PMED?id=17383777
Gariballa 2006 {published data only}|Dietary supplementation and quality of life of older patients: a randomized, double-blind, placebo-controlled trial|
Gariballa 2006 {published data only}|Effects of acute-phase response on nutritional status and clinical outcome of hospitalized patients|/resolve/reference/PMED?id=16815489
Gariballa 2006 {published data only}|Effects of dietary supplements on depressive symptoms in older patients: a randomised double-blind placebo-controlled trial|/resolve/reference/PMED?id=17662509
Gariballa 2006 {published data only}|Malnutrition is an independent predictor of 1-year mortality following acute illness|/resolve/reference/PMED?id=17391564
Gariballa 2006 {published data only}|A randomized, double-blind, placebo-controlled trial of nutritional supplementation during acute illness|/resolve/reference/PMED?id=16887416
Gazzotti 2003 {published data only}|Prevention of malnutrition in older people during and after hospitalisation: results from a randomised controlled clinical trial|/resolve/reference/PMED?id=12720620
Gegerle 1986 {published data only}|Dietary survey on the effect of an oral nutritional supplement after femoral neck fracture|/resolve/reference/PMED?id=3749675
Gray-Donald 1995 {published data only}|Randomized clinical trial of nutritional supplementation shows little effect on functional status among free-living frail elderly|
Gray-Donald 1995 {published data only}|Predictors of dietary intake in a functionally dependent elderly population in the community|/resolve/reference/PMED?id=7733428
Hampson 2003 {published data only}|Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial|/resolve/reference/PMED?id=12904840
Hankey 1993 {published and unpublished data}|The effect of dietary supplementation in continuing care elderly people: nutritional anthropometric and biochemical parameters|
Hankey 1993 {published and unpublished data}|The effect of age and frailty upon blood esterase activities and their response to dietary supplementation|/resolve/reference/PMED?id=12959286
Hankins 1996 {unpublished data only}|Dietary supplementation with sustagen in elderly patients with fractured neck of femur (PhD Thesis)|
Hubsch 1992 {published data only}|Effect of dietary supplementation on weight and protein status in undernourished geriatric patients|/resolve/reference/PMED?id=16839980
Jensen 1997 {published and unpublished data}|Dietary supplementation at home improves the regain of lean body mass after surgery|/resolve/reference/PMED?id=9225334
Jensen 1997 {published and unpublished data}|Randomization to nutritional intervention at home did not improve postoperative function fatigue or well being|/resolve/reference/PMED?id=9043473
Knowles 1988 {published data only}|Dietary supplementation and respiratory muscle performance in patients with COPD|/resolve/reference/PMED?id=3282825
Krondl 1999 {published and unpublished data}|Subjectively healthy elderly consuming a liquid nutrition supplement maintained body mass index and improved some nutritional parameters and perceived well-being|/resolve/reference/PMED?id=10608948
Kwok 2001 {published and unpublished data}|Does low lactose milk powder improve the nutritional intake and nutritional status of frail older Chinese people living in nursing homes?|/resolve/reference/PMED?id=11250664
Larsson 1990 {published data only}|The correlation between anergy, malnutrition and clinical outcome in an elderly hospital population|/resolve/reference/PMED?id=16837354
Larsson 1990 {published data only}|The development and healing of pressure sores related to the nutritional state|/resolve/reference/PMED?id=16839927
Larsson 1990 {published data only}|Effect of dietary supplementation on nutritional status and clinical outcome in 501 geriatric patients - a randomised study|/resolve/reference/PMED?id=16837353
Larsson 1990 {published data only}|Effects of dietary supplementation on functional condition and clinical outcome measured with a modified Norton scale|/resolve/reference/PMED?id=16839988
Lauque 2000 {published and unpublished data}|Protein-energy oral supplementation in malnourished nursing-home residents. A controlled trial|/resolve/reference/PMED?id=10690696
Lauque 2004 {published data only}|Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: A prospective randomized study|
MacFie 2000 {published and unpublished data}|Oral dietary supplements before and after surgery|/resolve/reference/PMED?id=11300095
MacFie 2000 {published and unpublished data}|Oral dietary supplements in pre- and postoperative surgical patients: a prospective and randomized clinical trial|/resolve/reference/PMED?id=10978851
Madigan 1994 {unpublished data only}|Benefits of dietary supplementation in elderly patients with fractured neck of femur (MSc dissertation)|
Manders 2006 {published data only}|Nutritional care in old age: the effect of supplementation on nutritional status and performance|
McEvoy 1982 {published data only}|The effect of a dietary supplement (Build-up) on nutritional status in hospitalized elderly patients|
McWhirter 1996 {published data only}|A comparison between oral and enteral nutritional supplements in malnourished patients|
McWhirter 1996 {published data only}|The influence of supplemental feeding and a comparison of methods in malnourished hospital patients|
Meredith 1992 {published data only}|Body composition in elderly men: effect of dietary modification during strength training|/resolve/reference/PMED?id=1740600
Ovesen 1992 {published data only}|Palatability and intake of two commercial liquid diets in patients with poor appetite|/resolve/reference/PMED?id=1915199
Ovesen 1992 {published data only}|The effect of a supplement which is nutrient dense compared to standard concentration on the total nutritional intake of anorectic patients|/resolve/reference/PMED?id=16839991
Payette 2002 {published data only}|Benefits of nutritional supplementation in free-living, frail, undernoursihed elderly people: a prospective randomized community trial|/resolve/reference/PMED?id=12171453
Payette 2004 {published and unpublished data}|Efficacy of nutritional intervention in the free-living frail elderly|
Potter 2001 {published and unpublished data}|Protein energy supplements in unwell elderly patients - a randomised controlled trial|/resolve/reference/PMED?id=11688936
Potter 2001 {published and unpublished data}|A evaluation of protein energy supplementation in medically ill admissions to a geriatric unit|
Potter 2001 {published and unpublished data}|Randomised controlled trial of protein energy supplementation in elderly emergency admissions (abstract)|
Potter 2001 {published and unpublished data}|Can prescription of sip-feed supplements increase energy intake in hospitalised older people with medical problems|/resolve/reference/PMED?id=12908904
Price 2005 {published and unpublished data}||/resolve/reference/PMED?id=AMBIGUOUS%20(18260%20citations)
Rosendahl 2006 {published data only}|High-intensity functional exercise program and protein-enriched energy supplement for older persons dependent in activities in daily living: a randomised controlled trial|/resolve/reference/PMED?id=16764547
Salas-Salvado 2005 {published data only}|Effect of a whole formula diet on nutritional status in institutionalized patients with alzheimer disease|
Salas-Salvado 2005 {published data only}|Effect of oral administration of a whole formula diet on nutritional and cognitive status in patients with Alzheimer's disease|/resolve/reference/PMED?id=15896425
Saudny 1997 {published and unpublished data}|Impact of nutritional support on functional status during acute exacerbation of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9309995
Schols 1995 {published and unpublished data}|Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9620907
Schols 1995 {published and unpublished data}|Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial|/resolve/reference/PMED?id=7551381
Scorer 1990 {unpublished data only}|The effect of nutritional supplementation with Ensure on the general health of undernourished elderly patients in the community|
SG Larsson malnour {published data only}||
SG Larsson nourished {published data only}||
SG Potter malnourish {published and unpublished data}||
SG Potter moder maln {published data only}||
SG Potter nourished {published and unpublished data}||
SG Potter very maln {published data only}||
SG Volkert comply {published data only}||
SG Volkert non compl {published data only}||
Stableforth 1986 {published data only}|Supplement feeds and nitrogen and calorie balance following femoral neck fracture|
Steiner 2003 {published data only}|Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial|/resolve/reference/PMED?id=12947128
Tidermark 2004 {published data only}|Nutritional status, insulin-like growth factor-1 and quality of life in elderly women with hip fractures|/resolve/reference/PMED?id=10578024
Tidermark 2004 {published data only}|Effects of protein-rich supplementation and nandrolone on bone tissure after a hip fracture|/resolve/reference/PMED?id=17498850
Tidermark 2004 {published data only}|Quality of life and femoral neck fractures|/resolve/reference/PMED?id=12811943
Tidermark 2004 {published data only}|Effects of protein-rich supplementation and nandrolone in lean elderly women with femoral neck fractures|/resolve/reference/PMED?id=15297095
Tidermark 2004 {published data only}|Liquid supplementation and nandrolone to elderly women|
Vermeeren 2004 {published data only}||/resolve/reference/PMED?id=AMBIGUOUS%20(109%20citations)
Vlaming 2001 {published data only}|Should the food intake of patients admitted to acute hospital services be routinely supplemented? A randomized placebo controlled trial|/resolve/reference/PMED?id=11884000
Volkert 1996 {published data only}|Nutritional support and functional status in undernourished geriatric patients during hospitalisation and 6-month follow-up|/resolve/reference/PMED?id=9061125
Woo 1994 {published and unpublished data}|Nutritional status of elderly patients during recovery from chest infection|/resolve/reference/PMED?id=8010171
Wouters 2002 {published data only}|Study of the effect of a liquid nutrition supplement on the nutritional status of psycho-geriatric nursing home patients|/resolve/reference/PMED?id=11960300
Wouters 2002 {published data only}|Study on the use of a nutrient-enriched food supplement in psycho-geriatric nursing home patients|
Wouters 2003 {published data only}|The effect of a liquid nutrition supplement on body composition and physical functioning in elderly people|/resolve/reference/PMED?id=12880604
Wouters 2005 {published data only}|The effect of supplementation with an enriched drink on indices of immune function in frail elderly|
Wouters 2005 {published data only}|Effect of an enriched drink on cognitive function in frail elderly persons|
Wouters 2006 {published data only}|Early nutritional supplementation immediately after diagnosis of infectious disease improves body weight in psychogeriatric nursing home residents|/resolve/reference/PMED?id=16608139
Yamaguchi 1998 {published and unpublished data}|Dietary intake of at-risk, free-living, elderly subjects receiving meals on wheels and a dietary supplement|
Yamaguchi 1998 {published and unpublished data}|Improvement in nutrient intake by elderly meals-on-wheels participants receiving a liquid nutrition supplement|
Young 2004 {published data only}|Energy-containing nutritional supplements can affect usual energy intake postsupplementation in institutionalized seniors with probable Alzheimer's disease|
Young 2004 {published data only}|Providing nutrition supplements to institutionalized seniors with probable Alzheimer's disease is least beneficial to those with low body weight status|
Bachrach 2000 {published data only}|Nutritional status and functional capacity after femoral neck fractures: A prospective randomized one-year follow-up study|
Barateau 1998 {published data only}|Multicenter nursing study on the importance of nutritional support for the prevention of bedsores in the elderly at risk|/resolve/reference/PMED?id=10661294
Barton 2000 {published data only}|High food wastage and low nutritional intakes in hospital patients|/resolve/reference/PMED?id=11104596
Barton 2000 {published data only}|A recipe for improving intakes of elderly hospitalized patients|/resolve/reference/PMED?id=11104597
Bastow 1983 {published data only}|Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial|/resolve/reference/PMED?id=6416514
Bean 1994 {published data only}|Double-blind pilot trial in elderly women with fractured femur of ornithine alpha-ketoglutarate versus a defined formula peptide oral supplement|
Beattie 2000 {published data only}|A randomised controlled trial evaluating the use of enteral nutritional supplements postoperatively in malnourished surgical patients|/resolve/reference/PMED?id=10807893
Beier 1996 {published data only}|Influence of postoperative enteral nutrition on postsurgical infections|/resolve/reference/PMED?id=9038665
Beier 1996 {published data only}|Influence of early postoperative enteral nutrition versus placebo on cell-mediated immunity, as measured with the Multitest(R) CMI|/resolve/reference/PMED?id=10048740
Bernstein 2002 {published data only}|A home based nutrition intervention to increase consumption of fruits, vegetables, and calcium rich foods in community dwelling elders|/resolve/reference/PMED?id=12396159
Borum 2000 {published data only}|The effect of nutritional supplementation on survival in seriously ill hospitalized adults|/resolve/reference/PMED?id=10809454
Bos 2000 {published data only}|Short-term protein and energy supplementation activates nitrogen kinetics and accretion in poorly nourished elderly subjects|/resolve/reference/PMED?id=10799375
Breslow 1993 {published data only}|The importance of dietary protein in healing pressure ulcers|/resolve/reference/PMED?id=8463519
Brocker 1994 {published data only}|A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects|/resolve/reference/PMED?id=7976777
Brown 1995 {published data only}|Safety of early feeding after percutaneous endoscopic gastrostomy|/resolve/reference/PMED?id=8583114
Bunker 1994 {published data only}|Dietary supplementation and immunocompetence in housebound elderly subjects|/resolve/reference/PMED?id=8049610
Bunout 1989 {published data only}|Nutritional support in hospitalized patients with alcoholic liver disease|/resolve/reference/PMED?id=2691239
Bunout 2001 {published data only}|The impact of nutritional supplementation and resistance training on the health functioning of free-living Chilean elders: results of 18 months of follow-up|/resolve/reference/PMED?id=11533291
Bunout 2004 {published data only}|Effects of nutritional supplementation and resistance training on muscle strength in free living elders. Results of one year follow|/resolve/reference/PMED?id=14978601
Cabre 1990 {published data only}|Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial|/resolve/reference/PMED?id=2105256
Caglar 2002 {published data only}|Therapeutic effects of oral nutritional supplementation during haemodialysis|/resolve/reference/PMED?id=12164890
Calvey 1985 {published data only}|Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis|/resolve/reference/PMED?id=3932509
Campbell 1995 {published data only}|Increased protein requirements in elderly people: new data and retrospective reassessments|/resolve/reference/PMED?id=8092084
Campbell 1995 {published data only}|Increased energy requirements and changes in body composition with resistance training in older adults|/resolve/reference/PMED?id=8030593
Campbell 1995 {published data only}|Effects of resistance training and dietary protein intake on protein metabolism in older adults|/resolve/reference/PMED?id=7611390
Campbell 1995 {published data only}|Dietary protein intake influences resistance training-induced changes in whole-body protein turnover|
Carr 1996 {published data only}|Randomised trial of safety and efficacy of immediate postoperative enteral feeding in patients undergoing gastrointestinal resection|/resolve/reference/PMED?id=8611872
Chee 2003 {published data only}|The effect of milk supplementation on bone mineral density in postmenopausal Chinese women in Malaysia|/resolve/reference/PMED?id=12915959
Creutzberg 2000 {published data only}|Characterisation of non response to high caloric oral nutrition therapy in depleted patients with COPD|/resolve/reference/PMED?id=10712317
Daly 1992 {published data only}|Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome|/resolve/reference/PMED?id=1377838
Danhof 1982 {published data only}|Nutritional support of geriatric patients|
de Jong 2000 {published data only}|Effect of dietary supplements and physical exercise on sensory perception|/resolve/reference/PMED?id=10911768
de Jong 2000 {published data only}|Functional biochemical and nutrient indices in frail elderly people are partly affected by dietary supplements but not by exercise|/resolve/reference/PMED?id=10539780
de Jong 2000 {published data only}|Dietary supplements and physical exercise affecting bone and body composition|/resolve/reference/PMED?id=10846514
de Jong 2000 {published data only}|Immunity in frail elderly: A randomized controlled trial of exercise and enriched foods|/resolve/reference/PMED?id=11128843
Devine 1996 {published data only}|Nutritional effect of calcium supplementation by skim milk powder or by calcium tablets on total nutrient intake in postmenopausal women|/resolve/reference/PMED?id=8901793
Duncan 2006 {published data only}|Using dietetic assistants to improve the outcome of hip fracture - a randomised controlled trial of nutritional support in an acute trauma ward|/resolve/reference/PMED?id=16354710
Efthimou 1988 {published data only}|The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3057956
Elmstahl 1987 {published data only}|Hospital nutrition in geriatric long-term care in medicine: II. Effects of dietary supplements|/resolve/reference/PMED?id=3107353
Eneroth 1997 {published data only}|Improved wound healing in transtibial amputees receiving supplementary nutrition|/resolve/reference/PMED?id=9195264
Eneroth 2006 {published data only}|Nutritional supplementation decreases hip fracture-related complications|/resolve/reference/PMED?id=16770284
Espaulella 2000 {published data only}|Nutritional supplementation of elderly hip fracture patients. A randomized double-blind placebo-controlled trial|/resolve/reference/PMED?id=11108415
Eyer 1993 {published data only}|Early enteral feeding does not attenuate metabolic response after blunt trauma|/resolve/reference/PMED?id=8496997
Forli 2001 {published data only}|Dietary support to underweight patients with end-stage pulmonary disease assessed for lung transplantation|/resolve/reference/PMED?id=11223731
Fuenzalida 1990 {published data only}|The immune response to short-term nutritional intervention in advanced chronic obstructive pulmonary disease|/resolve/reference/PMED?id=2368979
Gall 1998 {published data only}|Effect of providing fortified meals and between-meal snacks on energy and protein intake of hospital patients|/resolve/reference/PMED?id=10205348
Gallager 1992 {published data only}|Aggressive early management of malnutrition in hip fracture patients|
Ganzoni 1994 {published data only}|High-caloric nutrition in chronic obstructive lung disease|/resolve/reference/PMED?id=8029587
Goris 2003 {published data only}|Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: the effect of physical activity and oral nutritional supplementation|/resolve/reference/PMED?id=12720592
Harrington 2004 {published data only}|The effect of a high-protein, high sodium diet on calcium and bone metabolism in post-menopausal women and its interaction with vitamin D receptor genotype|/resolve/reference/PMED?id=14748937
Hartgrink 1998 {published data only}|Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial|/resolve/reference/PMED?id=10205352
Hickson 2004 {published data only}|Does additional feeding support provided by health care assistants improve nutritional status and outcome in acutely ill older in-patients? - A randomised control trial|/resolve/reference/PMED?id=14757395
Hogarth 1996 {published data only}|Nutritional supplementation in elderly medical in-patients: a double-blind placebo-controlled trial|/resolve/reference/PMED?id=9003882
Houwing 2003 {published data only}|A randomised, double-blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip-fracture patients|/resolve/reference/PMED?id=12880608
Hurson 1995 {published data only}|Metabolic effects of arginine in a healthy elderly population|
Jamieson 1997 {published data only}|The quantitative effect of nutrition support on quality of life in outpatients|/resolve/reference/PMED?id=16844618
Johansen 2004 {published data only}|Effect of nutritional support on clinical outcome in patients at risk|/resolve/reference/PMED?id=15297090
Johansson 2002 {unpublished data only}|Displaced femoral neck fractures: A prospective randomized study of clinical outcome, nutrition and costs|
Keane 1998 {published data only}|Vitamin D-fortified liquid milk: benefits for the elderly community-based population|/resolve/reference/PMED?id=9504953
Keele 1997 {published data only}|Two phase randomised controlled trial of post operative dietary supplements in surgical patients|/resolve/reference/PMED?id=9135531
Keele 1997 {published data only}|A randomised controlled clinical trial of post operative oral dietary supplements in surgical patients|
Kemen 1991 {published data only}|Is intact protein superior for postoperative enteral nutrition than hydrolyzed protein?|
Kerrigan 1996 {published data only}|Dispensing of a calorically dense oral supplement with medication pass: a creative approach to oral supplementation|
Kiel 1992 {published data only}|Enhancing weight gain in long-term care residents through a protein-calorie supplemented mechanically altered diet|
Kretser 2000 {published and unpublished data}|Improving nutritional and functional outcomes in homebound elders via an aggressive 21 meal per week home delivery program|
Kumagai 1999 {published data only}|An intervention trial to postpone aging in competent elderly. Trial of nutritional improvement in the retirement home|/resolve/reference/PMED?id=10624105
Lau 2001 {published data only}|Milk supplementation of the diet of postmenopausal Chinese women on a low calcium intake retards bone loss|
Lawson 2000 {published data only}|Effect of nutritional supplementation on clinical outcome in post-operative orthopaedic patients|
Lawson 2000 {published data only}|Compliance of orthopaedic patients with post operative oral nutritional supplementation|/resolve/reference/PMED?id=10895107
Lewis 1987 {published data only}|Nutritional supplementation in ambulatory patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3579004
Neumann 2004 {published and unpublished data}||
Neumann 2004 {published and unpublished data}|Provision of high-protein supplement for patients recovering from hip fracture|/resolve/reference/PMED?id=15105027
Neumann 2004 {published and unpublished data}||
Nickerson 1998 {published data only}|Oral and metabolic tolerance of supplemental arginine in elderly nursing home residents with pressure ulcers|
Olin 1998 {published data only}|Energy enriched meals improve energy intake in elderly residents in a nursing home|
Otte 1989 {published data only}|Nutrition repletion in malnourished patients with emphysema|
Pardy 1986 {published data only}|Supplemental nutrition does not alter respiratory muscle strength (RMS) or endurance (RME) in ambulatory COPD|
Paton 2004 {published data only}|Randomised controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting|/resolve/reference/PMED?id=15277171
Planas 2005 {published data only}|Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients|/resolve/reference/PMED?id=15896431
Price 2006 {published data only}|A personalized snack-based intervention for hip fracture patients: development, feasibility and acceptability|
Pupim 2002 {published data only}||
Rana 1992 {published data only}|Short term benefits of post-operative oral dietary supplements in surgical patients|/resolve/reference/PMED?id=16840018
Remsburg 2001 {published data only}|Impact of a buffet-style dining program on weight and biochemical indicators of nutritional status in nursing home residents: A pilot study|/resolve/reference/PMED?id=11762743
Rogers 1992 {published data only}|Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease: a randomised control study|/resolve/reference/PMED?id=1456568
Schurch 1998 {published data only}|Protein Intake, IGF-1 and osteoporosis|/resolve/reference/PMED?id=9536300
Schurch 1998 {published data only}|Protein supplements after osteoporotic hip fracture [letter]|
Schurch 1998 {published data only}|Protein supplements increase serum IGF-1 and decrease proximal femur bone loss in patients with recent hip fracture|
Schurch 1998 {published data only}|Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized double-blind placebo-controlled trial|/resolve/reference/PMED?id=9599191
Seri 1984 {published data only}|Effects of early nutritional support in patients with abdominal trauma|/resolve/reference/PMED?id=6438014
Seven 2003 {published data only}|A randomised controlled trial of early oral feeding in laryngectomized patients|
Slodkowski 1994 {published data only}|Clinical evaluation of the manufactured Terapin II diet|/resolve/reference/PMED?id=7675705
Smedley 2004 {published data only}|Randomised clinical trial of the effects of pre-operative and postoperative oral nutritional supplements on clinical course and cost of care|
Stauffer 1986 {published data only}|Effects of diet supplementation on anthropometric and laboratory nutritional parameters in malnourished ambulatory patients with severe chronic obstructive pulmonary disease (COPD)|
Storm 1998 {published data only}|Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial|/resolve/reference/PMED?id=9814452
Sullivan 1998 {published data only}|Nightly enteral nutrition support of elderly fracture patients: a phase I trial|/resolve/reference/PMED?id=9550459
Tkatch 1992 {published data only}|Hip fracture, femoral bone mineral density, and protein supply in elderly patients|
Tkatch 1992 {published data only}|Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur|/resolve/reference/PMED?id=1452950
Tschepe 1985 {published data only}|Oral administration of branched chain amino acids (BCAA) in patients with liver cirrhosis. A double-blind, randomized crossover study|
Vargas 1995 {published data only}|Effects of an inspiratory muscle training program and nutritional support in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=8733313
Vermeeren 2001 {published data only}|Acute effect of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11157327
Von Meyenfeldt 1990 {published data only}|Effect of branched chain amino acid enrichment of total parenteral nutrition on nitrogen sparing and clinical outcome of sepsis and trauma: a prospective randomized double blind trial|
Wachtler 1995 {published data only}|Influence of a pre-operative enteral supplement on functional activities of peripheral leukocytes from patients with major surgery|/resolve/reference/PMED?id=16843943
Wara 1985 {published data only}|Nutritional intake after colorectal surgery: a comparison of a traditional and new post operative regime|/resolve/reference/PMED?id=16831736
Williams 1989 {published data only}||
Williams 1989 {published data only}|A controlled trial of sip-feed supplements and compliance|
Williams 1989 {published data only}|The use of a nutritional risk score in identifying patients who may benefit from sip-feed supplementation in hospital|
Williams 1989 {published data only}|A controlled trial of sip-feed supplements in elderly orthopaedic patients|/resolve/reference/PMED?id=2737169
Wilson 1986 {published data only}|Nutritional intervention in malnourished patients with emphysema|/resolve/reference/PMED?id=3767123
Wisten 2005 {published data only}|Fruit and fibre (Pajala porridge) in the prevention of constipation|
Wong 2004 {published data only}|Is dietary counselling effective in increasing dietary calcium, protein and energy intake in patients with osteoporotic fractures? A randomized controlled clinical trial|
Yeh 2000 {published data only}|Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study|/resolve/reference/PMED?id=10811540
Cameron 2003 {published data only}|Effectiveness of oral nutritional supplementation for older women with hip and other fractures|
CENEX 2007 {published data only}|A factorial-design cluster randomised controlled trial investigating the cost-effectiveness of a nutrition supplement and an exercise programme on pneumonia incidence, walking capacity and body mass index in older people living in Santiago, Chile: the CENEX study protocol|/resolve/reference/PMED?id=17615064
Elia 2007 {published data only}|Community nutrition support trial|
Kvamme 2007 {published data only}|Nutritional intervention in malnourished elderly patients|
Akner 2001|Treatment of protein-energy malnutrition in chronic nonmalignant disorders|/resolve/reference/PMED?id=11451713
Alderson 2004|Medline highly sensitive search strategies for identifying reports of randomized controlled trials in Medline|
Allison 2000|Malnutrition, disease and outcome|/resolve/reference/PMED?id=10906565
Avenell 2004|Nutritional supplementation for hip fracture aftercare in the elderly. (Cochrane Review)|
Avenell 2006||/resolve/reference/PMED?id=AMBIGUOUS%20(118%20citations)
Baldwin 2000|Dietary advice and oral nutritional supplements for illness-related malnutrition in adults (Cochrane Review)|
Baldwin 2008||/resolve/reference/PMED?id=AMBIGUOUS%20(8116%20citations)
BAPEN 2003|Malnutrition Universal Screening Tool (MUST)|
Bistrian 1976|Prevalence of malnutrition in general medical patients|
Bruun 1999|Prevalence of malnutrition in surgical patients: evaluation of nutritional support and documentation|/resolve/reference/PMED?id=10451474
Corish 2000|Apparent low frequency of undernutrition in Dublin hospital in-patients: should we review the anthropometric thresholds for clinical practice?|/resolve/reference/PMED?id=10967611
Council Europe 2002|Food and nutritional care in hospitals. How to prevent undernutrition|
DoH 1992|The nutrition of elderly people. Report on health and social subjects No 43|
Edington 2000|Prevalence of malnutrition on admission to four hospitals in England|/resolve/reference/PMED?id=10895110
Elia 2001|The Malnutrition Advisory Group consensus guidelines for the detection and management of malnutrition in the community|
Elia 2005||
Flodin 2000|Body Mass Index as a predictor of 1 year mortality in geriatric patients|/resolve/reference/PMED?id=10867730
Gallager-Allred 1996|Malnutrition and clinical outcomes: the case for medical nutrition therapy|/resolve/reference/PMED?id=8598437
Gurney 1973|Arm anthropometry in nutritional assessment: nomogram for rapid calculation of muscle circumference and cross-sectional muscle and fat areas|/resolve/reference/PMED?id=4727749
HCUP 2002|HCUPnet: A tool for identifying, tracking, and analyzing national hospital statistics 2002|
Higgins 2003|Measuring consistency in meta-analysis|/resolve/reference/PMED?id=12958120
Katz 1963|Studies of illness in the aged. The index of ADL: a standard measure of biological and physical function|
Kelly 1984|Respiratory muscle strength and body composition in patients receiving total parenteral nutrition therapy|/resolve/reference/PMED?id=6430137
Keys 1950|The biology of human starvation|
Kruizenga 2003|Screening of nutritional status in The Netherlands|/resolve/reference/PMED?id=12706131
Lennard-Jones 1992||
Mahoney 1965|Functional evaluation: The Barthel Index|
McCormack 1997|Undernutrition in the elderly population living at home in the community: a review of the literature|
McWhirter 1994|The incidence and recognition of malnutrition in hospital|/resolve/reference/PMED?id=8173401
NHSQIS 2003|The National Standards for Food, Fluid and Nutritional Care in Hospitals|
NICE 2006||
Peake 1998|Nutritional supplementation: how much do people drink?|
Podsiadlo 1991|The timed 'Up & Go' : a test of basic functional mobilitty for frail elderly persons|
Potter 1988|In-hospital mortality as a function of body mass index: An age dependant variable|
Potter 1995|The nutritional status and clinical course of acute admissions to a geriatric unit|/resolve/reference/PMED?id=7793335
Potter 1998|Routine protein energy supplementation in adults: systematic review|/resolve/reference/PMED?id=9712593
Robinson 1987|Impact of nutritional status on DRG length of stay|
Stratton 2003|Disease-related malnutrition: an evidence based approach to treatment|
Sullivan 1990|Impact of nutritional status on morbidity and mortality in a select population of geriatric rehabilitation patients|/resolve/reference/PMED?id=2110413
Sullivan 1999|Protein-energy undernutrition among elderly hospitalised patients: a prospective study|/resolve/reference/PMED?id=10359390
Wilson 2002|Effect of liquid dietary supplements on energy intake in the elderly|/resolve/reference/PMED?id=11976171
Windsor 1988|Risk factors for post operative pneumonia|/resolve/reference/PMED?id=3401064
Wolfe 1997|Clinical practice guidelines in nutrition support: can they be based on randomized clinical trials?|
Zador 1987|Nutritional status on admission to a general surgical ward in a Sydney hospital|
Auerbach 2005 {published data only}||
Borrelli 1999 {published data only}|Evaluation of the quality of life in breast cancer patients undergoing lectin standardized mistletoe therapy|
Borrelli 1999 {published data only}|Valutazione della qualita` di vita in pazienti affette da adenocarcinoma mammario sottoposte a terapia con Viscum album|
Cazacu 2003 {published data only}|The influence of isorel on the advanced colorectal cancer|/resolve/reference/PMED?id=12667306
Dold 1991 {published data only}||
Douwes 1986a {published data only}|Results of a prospective randomized study on chemotherapy versus chemotherapy plus "biological response modifier" in metastatic colorectal carcinoma|
Goebell 2002 {published data only}|Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial|/resolve/reference/PMED?id=12050495
Grossarth 2001a {published and unpublished data}||
Grossarth 2001a {published and unpublished data}|Use of Iscador, an Extract of European Mistletoe (Viscum Album), in Cancer Treatment: Prospective nonrandomized and randomized Matched-Pair Studies Nested within a Cohort Study|/resolve/reference/PMED?id=11347286
Grossarth 2001b {published and unpublished data}||
Grossarth 2001b {published and unpublished data}|Use of Iscador, an Extract of European Mistletoe (Viscum Album), in Cancer Treatment: Prospective nonrandomized and randomized Matched-Pair Studies Nested within a Cohort Study|/resolve/reference/PMED?id=11347286
Heiny 1991 {published and unpublished data}||
Heiny 1991 {published and unpublished data}|Misteltoe Extract Standardized for the Galactoside - Specific Lectin (ML-1) Induces beta-Endorphin Release and Immunopotentiation in Breast Cancer Patients|
Heiny 1997 {published and unpublished data}||
Heiny 1997 {published and unpublished data}|Lebensqualittsstabilisierung durch Mistellektin1-normierten Extrakt beim fortgeschrittenen kolorektalen Karzinom|
Kleeberg 2004 {published and unpublished data}|European Organization for Research and Treatment of Cancer Melanoma Group Trial Experience With More Than 2,000 Patients, Evaluating Adjuvant Treatment With Low or Intermediate Doses of Interferon Alpha - 2b|
Kleeberg 2004 {published and unpublished data}|Clinical trial in patients with malignant melanoma: Comparison of adjuvant Interferon-alpha-2 with Interferon-gamma with Iscador M and a control group without treatment after resection of high-risk primaries (+ 3mm) of stage I and/or lymph-node metastases (stage IIb)|
Kleeberg 2004 {published and unpublished data}|Adjuvant trial in melanoma patients comparing rIFN-a to rIFN-g to Iscador to a control group after curative resection of high risk primary (>3 MM) or regional lymphnode metastasis (EORTC 18871)|
Kleeberg 2004 {published and unpublished data}|Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis|/resolve/reference/PMED?id=14746858
Lange 1993 {unpublished data only}|Modulation of the subjective and objective toxicity of an aggressive chemoradiotherapy with Helixor|
Lenartz 2000 {published and unpublished data}|Einfluss der komplementren Mistellektintherapie in der Behandlung maligner Gliome|
Lenartz 2000 {published and unpublished data}||
Lenartz 2000 {published and unpublished data}|Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe|/resolve/reference/PMED?id=10928154
Lenartz 2000 {published and unpublished data}|Immunoprotective Activity of the Galactoside-Specific Lectin from Mistletoe after Tumor Destructive Therapy in Glioma Patients|/resolve/reference/PMED?id=9042260
Luemmen 2001 {published data only}|Prospective trial on Immunotherapy for metastatic renal cell carcinoma: Interferon alpha, interleukin 2 and 5-fluorouracil compared with mistletoe lectin in metastatic renal cell carcinoma (MRCC)|
Luemmen 2001 {published data only}|Interferon-a, Interleukin-2 and 5-fluorouracil compared with mistletoe lectin in metastatic renal cell carcinoma (MRCC)|
Luemmen 2001 {published data only}|Interferon a, Interleukin 2 and 5-Fluorouracil versus Mistletoe Lectin in metastatic renal cell carcinoma - long term results|
Piao 2004 {published and unpublished data}|Medical Study Report on the Prospectively-randomized clinical multicenter study for the investigation of efficacy and safety of Helixor in comparison to Lentinan in patients with non small lung cancer, breast cancer or ovarian cancer|
Piao 2004 {published and unpublished data}|Multicentric, randomized, open, prospective clinical trial for the investigation of efficacy and tolerance and adverse drug reactions of HELIXOR A in comparison to Lentinan in patients with non small cell lung cancer, breast cancer or ovarian cancer|
Piao 2004 {published and unpublished data}|Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial|/resolve/reference/PMED?id=15015612
Salzer 1983 {published data only}||
Salzer 1983 {published data only}||
Salzer 1983 {published data only}||
Salzer 1983 {published data only}||
Salzer 1991 {published data only}||
Schwiersch 1999 {unpublished data only}||
Semiglasov 2004 {published and unpublished data}|The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial|/resolve/reference/PMED?id=15154663
Semiglasov 2004 {published and unpublished data}|Results of a randomised placebo-controlled multicentre study with PS76A2 (standardised mistletoe preparation) in patients with breast cancer receiving chemotherapy|
Semiglasov 2006 {published data only}|Quality of Life is Improved in Breast Cancer Patients by Standardised Mistletoe Extract PS76A2 during Chemotherapy and Follow-up: A Randomised, Placebo-controlled, Double-blind, Multicentre Clinicel Trial|/resolve/reference/PMED?id=16619567
Steuer-Vogt 2001 {published data only}||
Steuer-Vogt 2001 {published data only}|The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients. a randomised controlled clinical trial|/resolve/reference/PMED?id=11165126
Steuer-Vogt 2001 {published data only}||
Steuer-Vogt 2001 {published data only}|Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients|
Bar-Sela 2004 {published data only}|Abnoba-viscum (Mistletoe Extract) in Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil and Leucovorin-Based Chemotherapy|/resolve/reference/PMED?id=15456952
Dohmen 2004 {published data only}|Cellular immunomodulation and safety of standardized aqueous mistletoe extract PS76A2 in tumor patients treated for 48 weeks|/resolve/reference/PMED?id=15154652
Douwes 1986b {published data only}|Prospektive randomisierte Studie zur adjuvanten Therapie kolorektaler Karzinome mit einem "Biological Response Modifier"(BRM)|
Douwes 1988 {published data only}|Behandlung des fortgeschrittenen kolorektalen Karzinoms|
Esch 1985 {published data only (unpublished sought but not used)}||
Friess 1996 {published data only}|Treatment of Advanced Pancreatic Cancer with Mistletoe: Results of a Pilot Trial|/resolve/reference/PMED?id=8687151
Gorter 1996 {published data only}|Prospektive, longitudinale, Dosiseskalierende, randomisierte Phase-I/II-Studie mit Iscador QuFrF und Iscador Qu Spezial mit HIV-Positiven, Krebspatienten und gesunden, nichtrauchenden Probanden|
Gutsch 1988 {published data only}||
Gnczler 1968 {published data only}|Ergebnisse von Resektion und Nachbehandlung beim Magenkarzinom|
Gnczler 1971 {published data only}||
Gnczler 1971 {published data only}||
Gnczler 1971 {published data only}||
Gnczler 1974 {published data only}||/resolve/reference/PMED?id=7222966
Gnczler 1974 {published data only}||
Jach 1999 {published data only}|[Iscador QuS and human recombinant interferon alpha (Intron A) in cervical intraepithelial neoplasia (CIN)]|/resolve/reference/PMED?id=10375935
Jach 2003 {published data only}|[Role of immunomodulatory treatment with Iscador QuS and Intron A of women with CIN1 with concurrent HPV infection]|/resolve/reference/PMED?id=14674116
Kaiser 2001 {published data only}|Studiendesign und erste Ergebnisse einer prospektiven, placebokontrollierten, doppelblinden, randomisierten Studie mit ABNOBAviscum Mali 4|
Kjaer 1989 {published data only}|Mistletoe (Iscador) Therapy in Stage IV Renal Adenocarcinoma A phase II study in patients with measurable lung metastas|/resolve/reference/PMED?id=2477047
Klopp 2005 {published data only}|Influence of complementary Viscum album (Iscador) administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy|/resolve/reference/PMED?id=15816634
Krause 1983 {published data only}|Chronic adjuvant Therapy with Mistletoe Extract following Resection for Non Small Cell Bronchial Carcinoma|
Mansky 2005 {published data only}|Mistletoe extract/gemcitabine combination treatment: An interim report from the NCCAM/NCI phase I study in patients with advanced solid tumors|
Mansky 2007 {published data only}|A phase I study of the effect of mistletoe extract, a complementary medicine botanical, on pharmacokinetics, pharmacodynamics and safety of gemcitabine In patients with advanced solid tumors|
Salzer 1987 {published data only}||
Salzer 1990 {published data only}|Die Behandlung des operierten Magenkarzinoms am Ludwig Boltzmann- Institut fr klinische Onkologie|
Schoeffski 2005 {published data only}|Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumours|/resolve/reference/PMED?id=15913988
Schuppli 1990 {published data only}|Die adjuvante Behandlung des malignen Melanoms mit Iscador c.Hg|
von Hagens 2005 {published data only}||
Yoon 2005 {published data only}|The immunmodulatory effect of ABNOBAviscum mistletoe in the treatment of ovarian malignancy|
Enesel 2005 {published data only}|Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients|/resolve/reference/PMED?id=16334146
Grossarth 2006a {published data only}|Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis|/resolve/reference/PMED?id=17182361
Grossarth 2006b {published data only}|Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador)|
Grossarth 2007a {published data only}|Prospective controlled cohort studies on long-term therapy of ovarian cancer patients with mistletoe (Viscum album L.) extracts iscador|/resolve/reference/PMED?id=18074761
Grossarth 2007b {published data only}|Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (iscador(r))|
Grossarth 2007c {published data only}|Wirksamkeit und Unbedenklichkeit einer Langzeitbehandlung von Melanompatienten mit einem Mistelprparat (Iscador)|
Trger 2007 {published data only}|Additional therapy with mistletoe extracts in breast cancer patients receiving chemotherapy. A prospective randomized open label pilot study|
Wollermann 2002 {published data only}|Prospective, open, randomised, controlled clinical trial for theinvestigation of the efficacy and tolerability of a Mistletoepreparation in patients with malignant pleural effusions|
Bar-Sela 2007 {published data only}|Mistletoe as Complementary Treatment in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination: Randomized Phase II Study|
LaRocca 2006 {unpublished data only}|Randomized Pilot Study of Supplemental Iscar in Combination With Gemcitabine vs. Gemcitabine Alone as Second Line Treatment for Advanced Non-Small Cell Lung Cancer|
Augustin 2005|Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland|/resolve/reference/PMED?id=15727163
Becker 2000|European mistletoe: Taxonomy, host trees, parts used, physiology|
Brinkmann 2004|Kombinierte Zytokintherapie versus Misteltherapie bei metastasiertem Nierenzellkarzinom|
Bussing 1996|Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins|/resolve/reference/PMED?id=8564930
Bussing 1999|Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins|/resolve/reference/PMED?id=10226520
Cordier 2004|Diskussion zu dem Beitrag Mistel in der Krebstherapie - Fragwrdige Ergebnisse neuerer klinischer Studien von Dr. rer. nat. Lutz Edler|
Edler 2004||
Eggermont 2001|The trial authors reply|
Elsasser-Beile 2005|Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract|/resolve/reference/PMED?id=15947582
Ernst 2003|Mistletoe for cancer? A systematic Review of Randomised clinical trials|
Ernst 2006|Mistletoe as a treatment for cancer|/resolve/reference/PMED?id=17185706
Gagnier 2006|Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement|/resolve/reference/PMED?id=16520478
Hajto 1989|Modulatory Potency of the b-Galactoside-specific Lectin from Mistletoe Extract (Iscador) on the Host Defense System in Vivo in Rabbits and Patients|/resolve/reference/PMED?id=2758413
Hauser 1993|Mistel - Wunderkraut oder Medikament?|
Hayward 1978|Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland|/resolve/reference/PMED?id=738335
Heinzerling 2006|Immunologic Effector Mechanisms of a Standardized Mistletoe Extract on the Function of Human Monocytes and Lymphocytes in vitro, ex vivo, and in vivo|
Heusser 1998|[Anthroposophic expansion of medicine]|/resolve/reference/PMED?id=9745340
Higgins 2006|Assessment of Study Quality: Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated September 2006]; Section 6|
Hoffmann 1992||
Horneber 2009|Unkonventionelle Verfahren in der Onkologie|
Huber 2005|Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects|/resolve/reference/PMED?id=16287602
Jadad 1996|Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?|/resolve/reference/PMED?id=8721797
Joller 1996|Stimulation of Cytokine Production via a Special Standardized Misteletoe Preparation in an in vitro Human Skin Bioassay|
Kiene 1991|Klinische Studien zur Misteltherapie karzinomatser Erkrankungen - Eine bersicht|
Kiene 2001|EORTC mistletoe study (Letter)|
Kienle 2003a|Mistletoe in Cancer a Systematic Review on Controlled Clinical Trails|/resolve/reference/PMED?id=12730032
Kienle 2003b||
Kleijnen 1994|Mistletoe treatment for cancer - Review of controlled trials in humans|
Klein 2002|In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals|/resolve/reference/PMED?id=12010650
Lange-Lindberg 2006||
Mansky 2002|Mistletoe and cancer: controversies and perspectives|/resolve/reference/PMED?id=12516042
Moher 2001|The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials|/resolve/reference/PMED?id=11323066
Nartey 2007|Matched-pair study showed higher quality of placebo-controlled trials in Western phytotherapy than conventional medicine|
Ribereau-Gayon 1996|Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes|/resolve/reference/PMED?id=9020900
Schwabe 2003||
Silver 2001|Trial results warn of dangers in the use of mistletoe extract|
Spitzer 1981|Measuring the quality of life of cancer patients|/resolve/reference/PMED?id=7309824
van Tulder 2003|Updated method guidelines for systematic reviews in the cochrane collaboration back review group|/resolve/reference/PMED?id=12811274
Verhagen 1998|The Delphi List: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by delphi consensus|/resolve/reference/PMED?id=10086815
Wetzel 2000|Ca-ML-Studie (Zusammenfassung der Ergebnisse)|
Hawthorne 1994 {published data only}|Functional status, mood disturbance and quality of life in patients with heart failure|/resolve/reference/PMED?id=8058691
Jaarsma 2003 {published data only}|Effectiveness of heart failure clinics in the Netherlands: Research program set-up|/resolve/reference/PMED?id=12677952
Konstam 1999 {published data only}|Positive affect: A neglected group treatment outcome in assessing efficacy of psychosocial group interventions in individuals with heart failure|
Kostis 1994 {published data only}|Nonpharmacologic therapy improves functional and emotional status in congestive heart failure|/resolve/reference/PMED?id=7924541
Luskin 2002 {published data only}|A controlled pilot study of stress management training of elderly patients with congestive heart failure|
McCraty 2002 {published data only}|Effects of an emotional restructuring program on psychological functioning and functional capacity in patients with congestive heart failure|
Nelson 2001 {published data only}|Preliminary results of a pilot program on depression in patients with congestive heart failure|/resolve/reference/PMED?id=11293052
Abramson 2001|Depression and risk of heart failure among older persons with isolated systolic hypertension|/resolve/reference/PMED?id=11485505
Adams 1998|Clinical definition and etiology of advanced heart failure|/resolve/reference/PMED?id=9630086
Ahern 1990|Biobehavioural variables and mortality or cardiac arrest in the Cardiac Arrhythmias Pilot Study (CAPS)|/resolve/reference/PMED?id=2193497
Anda 1990|Depression and the dynamics of smoking: a national perspective|/resolve/reference/PMED?id=2395193
APACNS 1994||
Barefoot 1996|Symptoms of depression, acute myocardial infarction, and total mortality in a community sample|/resolve/reference/PMED?id=8640971
Berkman 2003|Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial|/resolve/reference/PMED?id=12813116
Blumenthal 1982|Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction|/resolve/reference/PMED?id=7163455
Broadley 2002|Arterial endothelial function is impaired in treated depression|/resolve/reference/PMED?id=12381649
Byrne 1993|The effect of exercise on depression, anxiety and other mood states|/resolve/reference/PMED?id=8410742
Carney 1995|Major depression and medication adherence in elderly patients with coronary artery disease|/resolve/reference/PMED?id=7737079
Clarke 2002||
Cleland 1995|Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology|/resolve/reference/PMED?id=7588917
Davis 2000|ABC of heart failure: history and epidemiology|/resolve/reference/PMED?id=10617530
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Faris 2002|Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure|
Frasure-Smith 1993|Depression following myocardial infarction|/resolve/reference/PMED?id=8411525
Frasure-Smith 1995|The impact of negative emotions on prognosis following myocardial infarction: is it more than just depression?|/resolve/reference/PMED?id=7498109
Freedland 1991|Depression in elderly patients with congestive heart failure|
Glassman 1990|Smoking, smoking cessation, and major depression|/resolve/reference/PMED?id=2395194
Grippo 2002|Cytokine mediation of experimental heart failure-induced anhedonia|/resolve/reference/PMED?id=12611391
Havranek 1999|Prevalence of depression in congestive heart failure|/resolve/reference/PMED?id=10496452
Jern 1989|Changes of plasma coagulation and fibrinolysis in response to mental stress|/resolve/reference/PMED?id=2814924
Jiang 2001|Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure|/resolve/reference/PMED?id=11493126
Jiang 2002|Patients with CHF and depression have greater risk of mortality and morbidity than patients without depression|/resolve/reference/PMED?id=11869868
Jones 2001|Cognitive behaviour therapy for schizophrenia (Cochrane Review)|
Kiecolt-Glaser 1992|Psychoneuroimmunology: can psychological interventions modulate immunity?|/resolve/reference/PMED?id=1506504
Koenig 1998|Depression in hospitalized older patients with congestive heart failure|/resolve/reference/PMED?id=9506252
Lane 2001|Mortality and quality of life twelve months after myocardial infarction: effects of depression and anxiety|/resolve/reference/PMED?id=11292269
Lane 2002|In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction|/resolve/reference/PMED?id=12540719
Mayou 2000|Depression and anxiety as predictors of outcomes after myocardial infarction|/resolve/reference/PMED?id=10772399
Mendes de Leon 1998|Depression and risk of coronary heart disease in elderly men and women|/resolve/reference/PMED?id=9827785
Milani 1996|Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events|/resolve/reference/PMED?id=8831359
Murberg 1999|Depressed mood and subjective symptoms as predictors of mortality in patients with congestive heart failure: A two-years follow-up study|/resolve/reference/PMED?id=10642905
Norris 1992|The effects of physical activity and exercise training on psychological stress and well-being in an adolescent population|/resolve/reference/PMED?id=1538350
NYHA 1964||
Penninx 1998|Depressive symptoms and physical decline in community-dwelling older persons|/resolve/reference/PMED?id=9624025
Rees 2004|Psychological interventions for coronary heart disease (Cochrane Review)|
Stewart 1989|Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study|/resolve/reference/PMED?id=2754790
Vaccarino 2001|Depressive symptoms and risk of functional decline and death in patients with heart failure|/resolve/reference/PMED?id=11451275
Wells 1989|The functioning and well-being of depressed patients: results from the Medical Outcomes Study|/resolve/reference/PMED?id=2754791
Zuccala 1995|The impact of depression on self-perceived health status|
Belardinelli 1992 {published data only}|Effects of aerobic training in patients with moderate chronic heart failure|/resolve/reference/PMED?id=1478392
Belardinelli 1995 {published data only}|Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications|/resolve/reference/PMED?id=7758184
Belardinelli 1999 {published data only}|Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome|/resolve/reference/PMED?id=10069785
Cider 1997 {published data only}|Peripheral muscle training in patients with clinical signs of heart failure|/resolve/reference/PMED?id=9198262
Coats 1990 {published data only}|A cross-over comparison of outpatient physical training versus rest in the treatment of moderate to severe heart failure [abstract]|
Coats 1990 {published data only}|Effects of physical training in chronic heart failure|/resolve/reference/PMED?id=1967416
Coats 1992 {published data only}|Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function|/resolve/reference/PMED?id=1591831
Dubach et al studies {published data only}|Influence of intensive physical training on urinary nitrate elimination and plasma endothelin-1 levels in patients with congestive heart failure|/resolve/reference/PMED?id=9857278
Dubach et al studies {published data only}|Effect of high intensity exercise training on central hemodynamic responses to exercise in men with reduced left ventricular function|/resolve/reference/PMED?id=9180124
Dubach et al studies {published data only}|Effect of exercise training on heart rate variability in patients with new-onset left ventricular dysfunction after myocardial infarction|/resolve/reference/PMED?id=10874279
Dubach et al studies {published data only}|Effects of exercise training on limb blood flow in patients with reduced ventricular function|/resolve/reference/PMED?id=9665214
Dubach et al studies {published data only}|A randomized comparison of exercise training in patients with normal vs reduced ventricular function|/resolve/reference/PMED?id=9596323
Dubach et al studies {published data only}|Effect of exercise training on postexercise oxygen uptake kinetics in patients with reduced ventricular function|/resolve/reference/PMED?id=11591562
Dubach et al studies {published data only}|Exercise training and myocardial remodeling in patients with reduced ventricular function: One-year follow-up with magnetic resonance imaging|/resolve/reference/PMED?id=10650298
Gottlieb 1999 {published data only}|Effects of exercise training on peak performance and quality of life in congestive heart failure patients|/resolve/reference/PMED?id=10496191
Hambrecht 1995 {published data only}|Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles|/resolve/reference/PMED?id=7722116
Hambrecht 1998 {published data only}|Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure|/resolve/reference/PMED?id=9851957
Hambrecht 2000 {published data only}|Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial|/resolve/reference/PMED?id=10865304
Jette 1991 {published data only}|Randomized 4 week exercise program in patients with impaired left ventricular function|/resolve/reference/PMED?id=1914097
Keteyian 1996 {published data only}|Exercise training in patients with heart failure. A randomized, controlled trial|/resolve/reference/PMED?id=8633818
Kiilavuori 1996 {published data only}|Effect of physical training on exercise capacity and gas exchange in patients with chronic heart failure|/resolve/reference/PMED?id=8874256
Maiorana 2000 {published data only}|Combined aerobic and resistance exercise training improves functional capacity and strength in CHF|/resolve/reference/PMED?id=10797113
Meyer 1996 {published data only}|Effects of short-term exercise training and activity restriction on functional capacity in patients with severe chronic congestive heart failure|/resolve/reference/PMED?id=8916481
Meyer 1996 {published data only}|Effects of exercise training and activity restriction on 6-minute walking test performance in patients with chronic heart failure|/resolve/reference/PMED?id=9124167
Oka 2000 {published data only}|Impact of a home-based walking and resistance training program on quality of life in patients with heart failure|/resolve/reference/PMED?id=11078308
Owen 2000 {published data only}|Effect of an exercise programme for elderly patients with heart failure|
Parnell 2002 {published data only}|Exercise training increases arterial compliance in patients with congestive heart failure|/resolve/reference/PMED?id=11749654
Ponikowski 1997 {published data only}|Exercise rehabilitation in patients with moderate-severe chronic heart failure.|
Pu 2001 {published data only}|Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure|/resolve/reference/PMED?id=11356801
Quittan 1999 {published data only}|Quality of life in patients with chronic heart failure: a randomized controlled trial of changes induced by a regular exercise program|/resolve/reference/PMED?id=10599899
Quittan 1999 {published data only}|Moderate-intensity exercise training with elements of step aerobics in patients with severe chronic heart failure|/resolve/reference/PMED?id=10414756
Teo 1995 EXERT {published data only}|Effects of exercise training in patients with heart failure: The Exercise Rehabilitation Trial (EXERT)|/resolve/reference/PMED?id=12094184
Teo 1995 EXERT {published data only}|Randomized controlled trial of aerobic plus resistance exercise training in patients with congestive heart failure. The Exercise Rehab Trial (EXERT) Investigators [abstract]|
Tyni-Lenne 1997 {published data only}|Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=9352972
Tyni-Lenne 2001 {published data only}|Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure|
Tyni-Lenne/Gordon 96 {published data only}|Markedly improved skeletal muscle function with local muscle training in patients with chronic heart failure|
Tyni-Lenne/Gordon 96 {published data only}|Improved quality of life in chronic heart failure patients following local endurance training with leg muscles|/resolve/reference/PMED?id=8798112
Wielenga 1998 {published data only}|Exercise training in elderly patients with chronic heart failure [published erratum appears in Coron Artery Dis 1999;10(1):57]|/resolve/reference/PMED?id=9919425
Wielenga 1999 CHANGE {published data only}|Safety and effects of physical training in chronic heart failure. Results of the Chronic Heart Failure and Graded Exercise study (CHANGE)|/resolve/reference/PMED?id=10329092
Willenheimer 1998 {published data only}|Exercise training in heart failure improves quality of life and exercise capacity|/resolve/reference/PMED?id=9717012
Adamopoulos 1995 {published data only}|Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training|/resolve/reference/PMED?id=8746907
Barnard 2000 {published data only}|Combined high-intensity strength and aerobic training in patients with congestive heart failure|
Belardinelli2 1995 {published data only}|Low intensity exercise training in patients with chronic heart failure|/resolve/reference/PMED?id=7560627
Cohen-Solal 1994 {published data only}|Can anaerobic threshold be used as an end-point for therapeutic trials in heart failure? Lessons from a multicentre randomized placebo-controlled trial. The VO2 French Study Group|/resolve/reference/PMED?id=8005126
Davey 1992 {published data only}|Ventilation in chronic heart failure: Effects of physical training|/resolve/reference/PMED?id=1467031
Gordon 1999 {published data only}|Beneficial effects of exercise training in heart failure patients with low cardiac output response to exercise - a comparison of two training models|
Johnson 1998 {published data only}|A randomized controlled trial of inspiratory muscle training in stable chronic heart failure|/resolve/reference/PMED?id=9740347
Kavanagh 1996 {published data only}|Quality of life and cardiorespiratory function in chronic heart failure: effects of 12 months' aerobic training|/resolve/reference/PMED?id=8774326
Koch 1992 {published data only}|The benefit of graded physical exercise in chronic heart failure|/resolve/reference/PMED?id=1576841
Metra 1998 {published data only}|Maximal and submaximal exercise testing in heart failure|/resolve/reference/PMED?id=9731694
Page 1994 {published data only}|Comparison of treadmill and bicycle exercise in patients with chronic heart failure|/resolve/reference/PMED?id=7924466
Taylor 1999 {published data only}|Physiological response to a short period of exercise training in patients with chronic heart failure|
Tokmakova 1999 {published data only}|Effects of short-term exercise training in patients with heart failure|/resolve/reference/PMED?id=10462926
Tyni-Lenne 1998 {published data only}|Exercise-based rehabilitation improves skeletal muscle capacity, exercise tolerance, and quality of life in both women and men with chronic heart failure|/resolve/reference/PMED?id=9573499
Tyni-Lenne 1999 {published data only}|Aerobic training involving a minor muscle mass shows greater efficiency than training involving a major muscle mass in chronic heart failure patients|/resolve/reference/PMED?id=10634671
Kayanakis 1994 {published data only}|[Rehabilitation of patients with chronic cardiac insufficiency. Immediate and midterm effects]. [French]|/resolve/reference/PMED?id=8177844
NRR ongoing trial 1 {published data only}|EXIST - Exercise Intervention Strategies in Heart Failure Trial|
NRR ongoing trial 2 {published data only}|A randomised trial of exercise intervention for older patients with heart failure|
AHA|www.americanheart.org|
CHF Guidelines 2001|Recommendations for exercise training in chronic heart failure patients|/resolve/reference/PMED?id=11161914
CHF Taskforce 2001|Guidelines for the diagnosis and treatment of chronic heart failure|/resolve/reference/PMED?id=11492984
Cochrane Heart Group|Preferred method for handling continuous variables|
Conn 1982|Exercise responses before and after physical conditioning in patients with severely depressed left ventricular function|/resolve/reference/PMED?id=7058745
Cowie 1997|Value of natriuretic peptides in the assessment of patients with possible new hear failure in primary care|/resolve/reference/PMED?id=9365448
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
DOH 2000||
Drexler 1992|Alterations of skeletal muscle in chronic heart failure|/resolve/reference/PMED?id=1315220
Dziekan 1998|Effects of exercise training on limb blood flow in patients with reduced ventricular function|/resolve/reference/PMED?id=9665214
Follmann 1992|Variance imputation for overviews of clinical trials with continuous response|/resolve/reference/PMED?id=1619456
Hlsmann 2002|Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota living with heart failure questionnaire in an outpatient cohort with congestive heart failure|/resolve/reference/PMED?id=12042010
Jadad 1996|Assessing the quality of reports of clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Jolliffe 2001|Exercise based rehabilitation for coronary heart disease (Cochrane Review)|
Kannel 1991|Epidemiology of heart failure|/resolve/reference/PMED?id=2000773
Kostis 1997|Prevention of heart failure antihypertensive drug treatment in older persons with isolated systemic hypertension. SHEP Cooperative Research Group|/resolve/reference/PMED?id=9218667
Lee 1979|Long term effects of physical training on coronary patients with impaired ventricular function|/resolve/reference/PMED?id=AMBIGUOUS%20498451,115617
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Lip 2000|Aetiology: ABC of heart failure|/resolve/reference/PMED?id=10625270
Lloyd-Williams 2002|Exercise training and heart failure: A systematic review of current evidence|/resolve/reference/PMED?id=11791816
Mancini 1992|Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure|/resolve/reference/PMED?id=1555280
McMurray 2000|Heart failure: Epidemiology, aetiology, and prognosis of heart failure|/resolve/reference/PMED?id=10768918
NHS 1998|Cardiac Rehabilitation|
O'Connor 1989|An overview of randomised trials of rehabilitation with exercise after myocardial infarction|/resolve/reference/PMED?id=2665973
Oldridge 1988|Cardiac rehabilitation after myocardial infarction. Combined experience of randomised clinical trials|/resolve/reference/PMED?id=3398199
Opasich 2001|Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?|/resolve/reference/PMED?id=11237537
Rees 2004|Psychological Interventions for coronary heart disease|
Sullivan 1988|Exercise training in patients with severe left ventricular dysfunction: hemodynamic and metabolic effects|/resolve/reference/PMED?id=3409495
Sullivan 1989|Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure|/resolve/reference/PMED?id=2791242
van den Brock 1992|Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=1632403
Watson 2000|ABC of heart failure: clinical features and complications|/resolve/reference/PMED?id=10642237
Austin 2005 {published data only}|Randomised controlled trial of cardiac rehabilitation in elderly patients with heart failure|
Austin 2005 {published data only}|Five-year follow-up findings from a randomized controlled trial of cardiac rehabilitation for heart failure|/resolve/reference/PMED?id=18391642
Belardinelli 1999 {published data only}|Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome|/resolve/reference/PMED?id=10069785
Belardinelli 1999 {published data only}|Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure|/resolve/reference/PMED?id=11305991
Dracup 2007 {published data only}|Effects of a home-based exercise program on clinical outcomes in heart failure|/resolve/reference/PMED?id=17967593
Giannuzzi 2003 {published data only}|Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial|/resolve/reference/PMED?id=12860904
Gielen 2003 {published data only}|Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure|/resolve/reference/PMED?id=12957433
Gottlieb 1999 {published data only}|Effects of exercise training on peak performance and quality of life in congestive heart failure patients|/resolve/reference/PMED?id=10496191
Hambrecht 1995 {published data only}|Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles|/resolve/reference/PMED?id=7722116
Hambrecht 1998 {published data only}|Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure|/resolve/reference/PMED?id=9851957
Hambrecht 2000 {published data only}|Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial|/resolve/reference/PMED?id=10865304
HF ACTION 2009 {published data only}|Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial|
HF ACTION 2009 {published data only}|Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial|/resolve/reference/PMED?id=19351941
HF ACTION 2009 {published data only}|Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale|/resolve/reference/PMED?id=17239677
Keteyian 1996 {published data only}|Exercise training in patients with heart failure. A randomized, controlled trial|/resolve/reference/PMED?id=8633818
Klecha 2007 {published data only}|Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling|/resolve/reference/PMED?id=17301632
Klocek 2005 (High) {published data only}|Effect of physical training on quality of life and oxygen consumption in patients with congestive heart failure|/resolve/reference/PMED?id=16098397
Klocek 2005 (Low) {published data only}|Effect of physical training on quality of life and oxygen consumption in patients with congestive heart failure|/resolve/reference/PMED?id=16098397
Koukouvou 2004 {published data only}|Quality of life, psychological and physiological changes following exercise training in patients with chronic heart failure|/resolve/reference/PMED?id=15074436
McKelvie 2002 {published data only}|Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT)|/resolve/reference/PMED?id=12094184
Mueller 2007 {published data only}|Exercise capacity, physical activity patterns and outcomes six years after cardiac rehabilitation in patients with heart failure|/resolve/reference/PMED?id=17981851
Passino 2006 {published data only}|Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure|/resolve/reference/PMED?id=16682309
Pozehl 2008 {published data only}|The effects of exercise training on fatigue and dyspnea in heart failure|/resolve/reference/PMED?id=17900989
Willenheimer 2000 {published data only}|Effects on quality of life, symptoms and daily activity 6 months after termination of an exercise training programme in heart failure patients|/resolve/reference/PMED?id=11150622
Adamopoulos 2001 {published data only}|Physical training reduces peripheral markers of inflammation in patients with chronic heart failure|/resolve/reference/PMED?id=11350112
Barrow 2008 {published data only}|An evaluation of the effects of Tai Chi Chuan and Chi Kung training in patients with symptomatic heart failure: a randomised controlled pilot study|
Belardinelli 2005 {published data only}|Effects of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure|/resolve/reference/PMED?id=15860388
Berg-Emons 2004 {published data only}|Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure?|
Briffa 2005 {published data only}|Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial|/resolve/reference/PMED?id=16274344
Chang 2004 {published data only}|Movement training for exercise tolerance and cardiac function in patients with chronic heart failure|
Coats 1992 {published data only}|Controlled trial of physical training in chronic heart failure. Exercise performance, haemodynamics, ventilation and autonomic function|/resolve/reference/PMED?id=1591831
Collins 2004 {published data only}|Effects of exercise training on aerobic capacity and quality of life in individuals with heart failure|/resolve/reference/PMED?id=15136775
Corvera-Tindel 2004 {published data only}|Effects of a home walking exercise program on functional status and symptoms in heart failure|/resolve/reference/PMED?id=14760334
Deng 2003 {published data only}|Effects of six-minutes walking training on left ventricular ejection fractions and motor ability in chronic heart failure patients|
Dingli 2002 {published data only}|The effects of exercise training on plasma tumor necrosis factor-alpha, blood leucocyte and its components in congestive heart failure patients|/resolve/reference/PMED?id=12133434
Erbs 2003 {published data only}|Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial|
ExTraMATCH 2004 {published data only}|Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)|/resolve/reference/PMED?id=14729656
Franco 2006 {published data only}|Effects of home-based exercise training on neurovascular control in patients with heart failure|
Gary 2004 {published data only}|Home-based exercise improves functional performance and quality of life in women with diastolic heart failure|/resolve/reference/PMED?id=15252410
Haykowsky 2007 {published data only}|A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed|
Inglis 2006 {published data only}|Extending the horizon in chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care|/resolve/reference/PMED?id=17116767
Jolly 2007 {published data only}|home based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehailitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial|/resolve/reference/PMED?id=17335586
Jnsdttir 2004 {published data only}|The effect of physical training in chronic heart failure|
Kilavouri 1999 {published data only}|The effect of physical training on hormonal status and exertional hormonal response in patients with chronic congestive heart failure|/resolve/reference/PMED?id=10213349
Kobayashi 2003 {published data only}|Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained extremities|/resolve/reference/PMED?id=12808267
Lloyd-Williams 2002 {published data only}|Exercise training and heart failure: A systematic review of current evidence|/resolve/reference/PMED?id=11791816
Meyer 2005 {published data only}|An alternative approach for exercise prescription and efficacy testing in patients with chronic heart failure: A randomized controlled training study|/resolve/reference/PMED?id=15894947
Molloy 2006 {published data only}|Effects of an exercise intervention for older heart failure patients on caregiver burden and emotional distress|/resolve/reference/PMED?id=16926668
Myers 2001 {published data only}|Reduced ventricular function oxygen uptake kinetics in patients with effect of exercise training on postexercise|/resolve/reference/PMED?id=11591562
Myers 2002 {published data only}|Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy: Application of magnetic resonance myocardial tagging|/resolve/reference/PMED?id=12360170
Myers 2007 {published data only}|Effects of exercise training on heart rate recovery in patients with chronic heart failure|
Niebauer 2005 {published data only}|Exercise training in chronic heart failure: effects on pro-inflammatory markers|
Niebauer 2005 (2) {published data only}|Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure|
Oka 2000 {published data only}|Impact of a home-based walking and resistance training program on quality of life in patients with heart failure|/resolve/reference/PMED?id=11078308
Owen 2000 {published data only}|Effect of an exercise programme for elderly patients with heart failure|
Parnell 2002 {published data only}|Exercise training increases arterial compliance in patients with congestive heart failure|/resolve/reference/PMED?id=11749654
Ponikowski 2007 {published data only}|Exercise rehabilitation in patients with moderate-severe chronic heart failure|
Pozehl 2003 {published data only}|Adjunctive effects of exercise training in heart failure patients receiving maximum pharmacologic therapy|
Pu 2001 {published data only}|Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure|/resolve/reference/PMED?id=11356801
Sabelis 2004 {published data only}|Does physical training increase insulin sensitivity in chronic heart failure patients?|/resolve/reference/PMED?id=14658999
Sarullo 2006 {published data only}|Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure|/resolve/reference/PMED?id=17001223
Selig 2004 {published data only}|Moderate- intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow|/resolve/reference/PMED?id=14966771
Senden 2005 {published data only}|The effect of physical training on workload, upper leg muscle function and muscle areas in patients with chronic heart failure|/resolve/reference/PMED?id=15823638
Smart 2004 {published data only}|Exercise training for patients with heart failure: A systematic review of factors that improve mortality and morbidity|/resolve/reference/PMED?id=15121496
Stewart 1998 {published data only}|Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care|/resolve/reference/PMED?id=9605777
Taylor-Piliae 2004 {published data only}|The effectiveness of Tai Chi exercise in improving aerobic capacity: A meta-analysis|
Tyni-Lenne 2001 {published data only}|Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure|
van Tol 2006 {published data only}|Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis.|
Wielenga 1998 {published data only}|Effect of exercise training on quality of life in patients with chronic heart failure|/resolve/reference/PMED?id=9835240
Williams 2007 {published data only}|Circuit resistance training in chronic heart failure improves skeletal muscle mitochondrial ATP production rated a randomized controlled trial|/resolve/reference/PMED?id=17395046
Wislff 2007 {published data only}|Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients|/resolve/reference/PMED?id=17576880
Yeh 2004 {published data only}|Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial|/resolve/reference/PMED?id=15465501
Zhang 2003 {published data only}|Effect of walking movement on plasma TNF and receptor in chronic heart failure patients|
Zhao 2005 {published data only}|Effects of exercise training on the improvement of cardiac fuction and exercise endurance in patients with chronic heart failure|
AHA 2009||
AHA 2010|Heart disease and stroke statistics--2010 Update. A report from the American Heart Association|
Belardinelli 1998|Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy|/resolve/reference/PMED?id=9494025
Berry 2001|Economics of chronic heart failure|
Campbell 2003|Heart failure: how can we prevent the epidemic?|/resolve/reference/PMED?id=14558866
CHF Taskforce 2001|Guidelines for the diagnosis and treatment of chronic heart failure|/resolve/reference/PMED?id=11492984
Chien 2008|Home-based exercise increases exercise capacity but not quality of life in people with chronic heart failure: a systematic review|/resolve/reference/PMED?id=18491999
Cowie 1999|Incidence and aetiology of heart failure; a population-based study|/resolve/reference/PMED?id=10213345
Cowie 2000|Survival of patients with a new diagnosis of heart failure: a population based study|/resolve/reference/PMED?id=10768897
Davies 2008|Promoting patient uptake and adherence in cardiac rehabilitation|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
ESC 1995|Guidelines for the diagnosis of heart failure|/resolve/reference/PMED?id=7588917
ExTraMatch 2004|Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)|/resolve/reference/PMED?id=14729656
Georgiou 2001|Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure|/resolve/reference/PMED?id=11305991
Gotzsche 2005|Does exercise training lower mortality in patients with chronic heart failure?|
Haykowsky 2007|A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed|
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions 5.1 [updated September 2008]|
Hunt 2001|ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines|/resolve/reference/PMED?id=11739319
Jolliffe 2001|Exercise based rehabilitation for coronary heart disease (Cochrane Review)|
Kostis 1997|Prevention of heart failure antihypertensive drug treatment in older persons with isolated systemic hypertension. SHEP Cooperative Research Group|/resolve/reference/PMED?id=9218667
Lip 2000|Aetiology: ABC of heart failure|/resolve/reference/PMED?id=10625270
Lloyd-Williams 2002|Exercise training and heart failure: A systematic review of current evidence|/resolve/reference/PMED?id=11791816
McAlister 2004||/resolve/reference/PMED?id=15612141
McMurray 2000|Heart failure: Epidemiology, aetiology, and prognosis of heart failure|/resolve/reference/PMED?id=10768918
Moreno 2009|Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications|/resolve/reference/PMED?id=19666685
NCCCC 2003||
NYHA 1994||
Opasich 2001|Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?|/resolve/reference/PMED?id=11237537
Piepoli 1998|Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance|/resolve/reference/PMED?id=9568451
Rees 2004a|Exercise based rehabilitation for heart failure|
Rees 2004b|Psychological interventions for coronary heart disease|
Remme 2001|Task Force for the Diagnosis and Treatment of Chronic Heart Failure. Guidelines for the diagnosis and treatment of chronic heart failure|/resolve/reference/PMED?id=11492984
Shekelle 2003|Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness|/resolve/reference/PMED?id=14571595
Smart 2004|Exercise Training for Patients with Heart Failure:A Systematic Review of Factors that ImproveMortality and Morbidity|/resolve/reference/PMED?id=15121496
Taylor 2010|Home-based versus centre-based cardiac rehabilitation|
van den Brock 1992|Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=1632403
van Tol 2006|Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis|
Watson 2000|ABC of heart failure: clinical features and complications|/resolve/reference/PMED?id=10642237
Wheelan 2007|Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale|/resolve/reference/PMED?id=17239677
Austin 2005 {published data only}|Randomised controlled trial of cardiac rehabilitation in elderly patients with heart failure|
Austin 2005 {published data only}|Multidisciplinary management of elderly patients with chronic heart failure: five year outcome measures in death and survivor groups|/resolve/reference/PMED?id=18534911
Austin 2005 {published data only}|Five-year follow-up findings from a randomized controlled trial of cardiac rehabilitation for heart failure|/resolve/reference/PMED?id=18391642
Belardinelli 1999 {published data only}|Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome|/resolve/reference/PMED?id=10069785
Belardinelli 1999 {published data only}|Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure|/resolve/reference/PMED?id=11305991
Belardinelli 2012 {published data only}|10-year exercise training in chronic heart failure: a randomized controlled trial|
Bocalini 2008 {published data only}|Physical exercise improves the functional capacity and quality of life in patients with heart failure|/resolve/reference/PMED?id=18719752
DANREHAB 2008 {published data only}|A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population|
DANREHAB 2008 {published data only}|Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial|/resolve/reference/PMED?id=18513526
Davidson 2010 {published data only}|Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?|
Dracup 2007 {published data only}|Effects of a home-based exercise program on clinical outcomes in heart failure|/resolve/reference/PMED?id=17967593
Dracup 2007 {published data only}|Usefulness of a home-based exercise program for overweight and obese patients with advanced heart failure|/resolve/reference/PMED?id=16516595
Dracup 2007 {published data only}|Is exercise adherence associated with clinical outcomes in patients with advanced heart failure?|
Gary 2010 (comp) {published data only}|Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure|
Gary 2010 (exalone) {published data only}|Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure|
Giannuzzi 2003 {published data only}|Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial|/resolve/reference/PMED?id=12860904
Gielen 2003 {published data only}|Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure|/resolve/reference/PMED?id=12957433
Gottlieb 1999 {published data only}|Effects of exercise training on peak performance and quality of life in congestive heart failure patients|/resolve/reference/PMED?id=10496191
Hambrecht 1995 {published data only}|Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles|/resolve/reference/PMED?id=7722116
Hambrecht 1998 {published data only}|Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure|/resolve/reference/PMED?id=9851957
Hambrecht 2000 {published data only}|Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial|/resolve/reference/PMED?id=10865304
HF ACTION 2009 {published data only}|Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial|
HF ACTION 2009 {published data only}|Relation between volume of exercise and clinical outcomes in patients with heart failure|
HF ACTION 2009 {published data only}|Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial|/resolve/reference/PMED?id=19351941
HF ACTION 2009 {published data only}|Economic evaluation of the HF-ACTION (Heart failure: a controlled trial investigating outcomes of exercise training) randomized controlled trial: an exercise training study of patients with chronic heart failure|
HF ACTION 2009 {published data only}|In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial)|
HF ACTION 2009 {published data only}|Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale|/resolve/reference/PMED?id=17239677
Jolly 2009 {published data only}|A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study|
Jnsdttir 2006a {published data only}|The effect of physical training in chronic heart failure|
Keteyian 1996 {published data only}|Exercise training in patients with heart failure. A randomized, controlled trial|/resolve/reference/PMED?id=8633818
Klecha 2007 {published data only}|Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling|/resolve/reference/PMED?id=17301632
Klocek 2005 (Const) {published data only}|Effect of physical training on quality of life and oxygen consumption in patients with congestive heart failure|/resolve/reference/PMED?id=16098397
Klocek 2005 (Prog) {published data only}|Effect of physical training on quality of life and oxygen consumption in patients with congestive heart failure|/resolve/reference/PMED?id=16098397
Koukouvou 2004 {published data only}|Quality of life, psychological and physiological changes following exercise training in patients with chronic heart failure|/resolve/reference/PMED?id=15074436
McKelvie 2002 {published data only}|Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT)|/resolve/reference/PMED?id=12094184
Mueller 2007 {published data only}|Exercise capacity, physical activity patterns and outcomes six years after cardiac rehabilitation in patients with heart failure|/resolve/reference/PMED?id=17981851
Myers 2000 {published data only}|Exercise training and myocardial remodeling in patients with reduced ventricular function: one-year follow-up with magnetic resonance imaging|/resolve/reference/PMED?id=10650298
Nilsson 2008 {published data only}|Long-term effects of a group-based high-intensity aerobic interval-training program in patients with chronic heart failure|/resolve/reference/PMED?id=18940296
Norman 2012 {published data only}|Effects of exercise training versus attention on plasma B-type natriuretic peptide, 6-minute walk test and quality of life in individuals with heart failure|
Norman 2012 {published data only}|Heart failure exercise and training camp: effects of a multicomponent exercise training intervention in patients with heart failure|
Passino 2006 {published data only}|Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure|/resolve/reference/PMED?id=16682309
Pozehl 2008 {published data only}|The effects of exercise training on fatigue and dyspnea in heart failure|/resolve/reference/PMED?id=17900989
Wall 2010 {published data only}|Impact of home-based, supervised exercise on congestive heart failure|
Willenheimer 2001 {published data only}|Effects on quality of life, symptoms and daily activity 6 months after termination of an exercise training programme in heart failure patients|/resolve/reference/PMED?id=11150622
Witham 2005 {published data only}|Effect of a seated exercise program to improve physical function and health status in frail patients > or = 70 years of age with heart failure|/resolve/reference/PMED?id=15842989
Witham 2012 {published data only}|Efficacy and cost of an exercise program for functionally impaired older patients with heart failure: a randomized controlled trial|
Yeh 2011 {published data only}|Tai chi exercise in patients with chronic heart failure: a randomized clinical trial|
Adamopoulos 2001 {published data only}|Physical training reduces peripheral markers of inflammation in patients with chronic heart failure|/resolve/reference/PMED?id=11350112
Alves 2012 {published data only}|Exercise training improves diastolic function in heart failure patients|
Barrow 2008 {published data only}|An evaluation of the effects of Tai Chi Chuan and Chi Kung training in patients with symptomatic heart failure: a randomised controlled pilot study|
Belardinelli 2005 {published data only}|Effects of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure|/resolve/reference/PMED?id=15860388
Briffa 2005 {published data only}|Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial|/resolve/reference/PMED?id=16274344
Brotons 2009 {published data only}|Randomized clinical trial of the effectiveness of a home-based intervention in patients with heart failure: the IC-DOM study|/resolve/reference/PMED?id=19401125
Chang 2005 {published data only}|Movement training for exercise tolerance and cardiac function in patients with chronic heart failure|
Coats 1992 {published data only}|Controlled trial of physical training in chronic heart failure. Exercise performance, haemodynamics, ventilation and autonomic function|/resolve/reference/PMED?id=1591831
Collins 2004 {published data only}|Effects of exercise training on aerobic capacity and quality of life in individuals with heart failure|
Corvera-Tindel 2004 {published data only}|Effects of a home walking exercise program on functional status and symptoms in heart failure|/resolve/reference/PMED?id=14760334
Cowie 2011 {published data only}|A comparison of home and hospital-based exercise training in heart failure: immediate and long-term effects upon physical activity level|
Deng 2006 {published data only}|Effects of six-minutes walking training on left ventricular ejection fractions and motor ability in chronic heart failure patients|
Dingli 2002 {published data only}|The effects of exercise training on plasma tumor necrosis factor-alpha, blood leucocyte and its components in congestive heart failure patients|/resolve/reference/PMED?id=12133434
Edelmann 2011 {published data only}|Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (exercise training in diastolic heart failure) pilot study|
Erbs 2003 {published data only}|Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial|
Erbs 2010 {published data only}|Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function|
ExTraMATCH 2004 {published data only}|Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)|/resolve/reference/PMED?id=14729656
Franco 2006 {published data only}|Effects of home-based exercise training on neurovascular control in patients with heart failure|
Gary 2004 {published data only}|Home-based exercise improves functional performance and quality of life in women with diastolic heart failure|
Gary 2007 {published data only}|Physical function and quality of life in older women with diastolic heart failure: effects of a progressive walking program on sleep patterns|
Haykowsky 2007 {published data only}|A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed|
Inglis 2006 {published data only}|Extending the horizon in chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care|/resolve/reference/PMED?id=17116767
Jolly 2007 {published data only}|home based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial|/resolve/reference/PMED?id=17335586
Jnsdttir 2006b {published data only}|The effect of physical training in chronic heart failure|
Kiilavuori 1999 {published data only}|The effect of physical training on hormonal status and exertional hormonal response in patients with chronic congestive heart failure|/resolve/reference/PMED?id=10213349
Kitzman 2010 {published data only}|Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial|
Kobayashi 2003 {published data only}|Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained extremities|/resolve/reference/PMED?id=12808267
Korzeniowska-Kubacka 2010 {published data only}|Influence of exercise training on left ventricular diastolic function and its relationship to exercise capacity in patients after myocardial infarction|
Lloyd-Williams 2002 {published data only}|Exercise training and heart failure: a systematic review of current evidence|
Meyer 2005 {published data only}|An alternative approach for exercise prescription and efficacy testing in patients with chronic heart failure: a randomized controlled training study|/resolve/reference/PMED?id=15894947
Molloy 2006 {published data only}|Effects of an exercise intervention for older heart failure patients on caregiver burden and emotional distress|/resolve/reference/PMED?id=16926668
Mudge 2011 {published data only}|Exercise training in recently hospitalized heart failure patients enrolled in a disease management programme: design of the EJECTION-HF randomized controlled trial|
Myers 2001 {published data only}|Reduced ventricular function oxygen uptake kinetics in patients with effect of exercise training on postexercise|/resolve/reference/PMED?id=11591562
Myers 2002 {published data only}|Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy: application of magnetic resonance myocardial tagging|/resolve/reference/PMED?id=12360170
Myers 2007 {published data only}|Effects of exercise training on heart rate recovery in patients with chronic heart failure|
Niebauer 2005a {published data only}|Exercise training in chronic heart failure: effects on pro-inflammatory markers|
Niebauer 2005b {published data only}|Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure|
Oka 2000 {published data only}|Impact of a home-based walking and resistance training program on quality of life in patients with heart failure|/resolve/reference/PMED?id=11078308
Owen 2000 {published data only}|Effect of an exercise programme for elderly patients with heart failure|
Parnell 2002 {published data only}|Exercise training increases arterial compliance in patients with congestive heart failure|/resolve/reference/PMED?id=11749654
Passino 2008 {published data only}|C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training|/resolve/reference/PMED?id=18391643
Ponikowski 1997 {published data only}|Exercise rehabilitation in patients with moderate-severe chronic heart failure|
Pozehl 2003 {published data only}|Adjunctive effects of exercise training in heart failure patients receiving maximum pharmacologic therapy|
Pu 2001 {published data only}|Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure|/resolve/reference/PMED?id=11356801
Sabelis 2004 {published data only}|Does physical training increase insulin sensitivity in chronic heart failure patients?|/resolve/reference/PMED?id=14658999
Sarullo 2006 {published data only}|Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure|
Selig 2004 {published data only}|Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow|/resolve/reference/PMED?id=14966771
Senden 2005 {published data only}|The effect of physical training on workload, upper leg muscle function and muscle areas in patients with chronic heart failure|/resolve/reference/PMED?id=15823638
Smart 2004 {published data only}|Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity|/resolve/reference/PMED?id=15121496
Smart 2007 {published data only}|Exercise training in systolic and diastolic dysfunction: effects on cardiac function, functional capacity, and quality of life|
Stewart 1998 {published data only}|Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care|/resolve/reference/PMED?id=9605777
Taylor-Piliae 2004 {published data only}|The effectiveness of Tai Chi exercise in improving aerobic capacity: a meta-analysis|
Tyni-Lenne 2001 {published data only}|Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure|
van den Berg-Emons 2004 {published data only}|Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure?|
van Tol 2006 {published data only}|Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis|
Vasiliauskas 2007 {published data only}|Exercise training after coronary angioplasty improves cardiorespiratory function|/resolve/reference/PMED?id=17487762
Wielenga 1998 {published data only}|Effect of exercise training on quality of life in patients with chronic heart failure|/resolve/reference/PMED?id=9835240
Williams 2007 {published data only}|Circuit resistance training in chronic heart failure improves skeletal muscle mitochondrial ATP production rated a randomized controlled trial|/resolve/reference/PMED?id=17395046
Wislff 2007 {published data only}|Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients|/resolve/reference/PMED?id=17576880
Yeh 2004 {published data only}|Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial|/resolve/reference/PMED?id=15465501
Zhang 2003 {published data only}|Effect of walking movement on plasma TNF and receptor in chronic heart failure patients|
Zhao 2005 {published data only}|Effects of exercise training on the improvement of cardiac function and exercise endurance in patients with chronic heart failure|
ISRCTN86879094 {published data only}|Exercise training in diastolic heart failure: a prospective, randomized, controlled study to determine the effects of exercise training in patients with heart failure and preserved ejection fraction (Ex-DHF)|
Mudge ongoing {published data only}|Exercise training in recently hospitalized heart failure patients enrolled in a disease management programme: design of the EJECTION-HF randomized controlled trial|
NCT00012883 {published data only}|Home walking exercise training in advanced heart failure|
NCT00013221 {published data only}|Exercise effect on aerobic capacity and QOL in heart failure|
NCT01033591 {published data only}|Exercise for patients with heart failure in primary care: the EFICAR|
ACCF/AHA 2013|2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines|
AHA 2014|Heart disease and stroke statistics - 2014 update: a report from the American Heart Association|
BACPR 2012|The BACPR standards and core components for cardiovascular disease prevention and rehabilitation, 2nd edition, 2012|
Belardinelli 1998|Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy|/resolve/reference/PMED?id=9494025
Chen 2011|National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008|
Chien 2008|Home-based exercise increases exercise capacity but not quality of life in people with chronic heart failure: a systematic review|/resolve/reference/PMED?id=18491999
Corra 2005|Executive summary of the position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology (ESC): core components of cardiac rehabilitation in chronic heart failure|
Dalal 2012|Why do so few patients with heart failure participate in cardiac rehabilitation? A cross-sectional survey from England, Wales and Northern Ireland|
Editorial 2011|On the horizon in heart failure|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Evangelista 2010|Is exercise adherence associated with clinical outcomes in patients with advanced heart failure?|
ExTraMatch 2004|Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)|/resolve/reference/PMED?id=14729656
Flynn 2009|Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. [Erratum in: JAMA 2009;302(21):2322]|/resolve/reference/PMED?id=19351942
Georgiou 2001|Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure|/resolve/reference/PMED?id=11305991
Gotzsche 2005|Does exercise training lower mortality in patients with chronic heart failure? 2005|
Heran 2011|Exercise-based cardiac rehabilitation for coronary heart disease|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Holland 2011|Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis|
Keteyian 2012|Relation between volume of exercise and clinical outcomes in patients with heart failure|
Kostis 1997|Prevention of heart failure antihypertensive drug treatment in older persons with isolated systemic hypertension. SHEP Cooperative Research Group|/resolve/reference/PMED?id=9218667
Lam 2011|Epidemiology and clinical course of heart failure with preserved ejection fraction|
McAlister 2004|Cardiac resynchronization therapy for congestive heart failure|
McMurray 2012|ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC|
NICE 2010|Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care|
NYHA 1994||
Owen 2006|Trends in prevalence and outcome of heart failure with preserved ejection fraction|/resolve/reference/PMED?id=16855265
Packer 2001|Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure.|/resolve/reference/PMED?id=11420770
Paulus 2007|How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology|/resolve/reference/PMED?id=17428822
Piepoli 1998|Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance|/resolve/reference/PMED?id=9568451
Shekelle 2003|Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness|
Somaratne 2009|The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis|
Taylor 2010|Home-based versus centre-based cardiac rehabilitation|
Tierney 2011|What can we learn from patients with heart failure about exercise adherence? A systematic review of qualitative papers|
Watson 2000|ABC of heart failure: clinical features and complications|/resolve/reference/PMED?id=10642237
WGCR 2001|Recommendations for exercise training in chronic heart failure patients|/resolve/reference/PMED?id=11161914
Whellan 2007|Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale|/resolve/reference/PMED?id=17239677
Davies 2010|Exercise based rehabilitation for heart failure|
Rees 2004|Exercise based rehabilitation for heart failure|
Anderson 1950 {published data only}|The effects of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure|/resolve/reference/PMED?id=15413578
Griffith 1952 {published data only}|A study of the beneficial effects of anticoagulant therapy in congestive heart failure|/resolve/reference/PMED?id=12986600
Harvey 1950 {published data only}|Dicumarol prophylaxis of thromboembolic disease in congestive heart failure|/resolve/reference/PMED?id=15403339
HELAS 2006 {published data only}|Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study|
WASH 2004 {published data only}|The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure|/resolve/reference/PMED?id=15215806
CONSENSUS 1987 {published data only}|Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)|/resolve/reference/PMED?id=2883575
EPICAL 2002 {published data only}|Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)|
Fuster 1981 {published data only}|The natural history of idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=7468489
Kyrle 1985 {published data only}|Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy|/resolve/reference/PMED?id=4082088
Natterson 1993 {published data only}|Low risk of arterial embolization in outpatients awaiting cardiac transplantation [abstract]|
PROMISE 1993 {published data only}|The effect of warfarin on prevalence of stroke in severe heart failure|
SAVE 1997 {published data only}|Ventricular dysfunction and the risk of stroke after myocardial infarction|/resolve/reference/PMED?id=8995087
SOLVD 1998 {published data only}|Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction|/resolve/reference/PMED?id=9525542
V-HeFT 1993 {published data only}|Incidence of thromboembolic events in congestive heart failure|/resolve/reference/PMED?id=8419029
Visser 2004 {published data only}|The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants|
WATCH 2009 {published data only}|Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial|/resolve/reference/PMED?id=19289640
Wishart 1948 {published data only}|Dicumarol therapy in congestive heart failure|/resolve/reference/PMED?id=18892580
WARCEF {published and unpublished data}|WARCEF: Warfarin-Aspirin Reduced Cardiac Ejection Fraction Study|
BAATAF 1990|The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation|/resolve/reference/PMED?id=2233931
Brown 1998|Influence of concomitant disease on patterns of hospitalisation in patients with heart failure discharged from Scottish hospitals in 1995|/resolve/reference/PMED?id=9717042
Davis 1977|Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting|/resolve/reference/PMED?id=300010
Edep 1997|Differences between primary care physicians and cardiologists in the management of congestive heart failure: relationship to practice guidelines|/resolve/reference/PMED?id=9247527
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions|
Husted 1976|Problems encountered in long-term treatment with anticoagulants|
Landefeld 1989|Major bleeding in outpatients treated with warfarin. Incidence and prediction by factors known at the start of outpatient therapy|/resolve/reference/PMED?id=2787958
Lefebvre 2011|Chapter 6: Searching for Studies|
Petersen 1989|Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study|
SPAF 1991|Stroke Prevention in Atrial Fibrillation Investigators|/resolve/reference/PMED?id=1860198
Anderson 1950 {published data only}|The effects of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure|/resolve/reference/PMED?id=15413578
Griffith 1952 {published data only}|A study of the beneficial effects of anticoagulant therapy in congestive heart failure|/resolve/reference/PMED?id=12986600
Harvey 1950 {published data only}|Dicumarol prophylaxis of thromboembolic disease in congestive heart failure|/resolve/reference/PMED?id=15403339
HELAS 2006 {published data only}|Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study|
WASH 2004 {published data only}|The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure|/resolve/reference/PMED?id=15215806
CONSENSUS 1987 {published data only}|Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)|/resolve/reference/PMED?id=2883575
EPICAL 2002 {published data only}|Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)|
Fuster 1981 {published data only}|The natural history of idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=7468489
Kyrle 1985 {published data only}|Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy|/resolve/reference/PMED?id=4082088
Natterson 1993 {published data only}|Low risk of arterial embolization in outpatients awaiting cardiac transplantation [abstract]|
PROMISE 1993 {published data only}|The effect of warfarin on prevalence of stroke in severe heart failure|
SAVE 1997 {published data only}|Ventricular dysfunction and the risk of stroke after myocardial infarction|/resolve/reference/PMED?id=8995087
SOLVD 1998 {published data only}|Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction|/resolve/reference/PMED?id=9525542
V-HeFT 1993 {published data only}|Incidence of thromboembolic events in congestive heart failure|
Visser 2004 {published data only}|The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants|
WARCEF 2012 {published data only}|Warfarin and aspirin in patients with heart failure and sinus rhythm|/resolve/reference/PMED?id=22551105
WATCH 2009 {published data only}|Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial|/resolve/reference/PMED?id=19289640
Wishart 1948 {published data only}|Dicumarol therapy in congestive heart failure|/resolve/reference/PMED?id=18892580
BAATAF 1990|The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation|/resolve/reference/PMED?id=2233931
Brown 1998|Influence of concomitant disease on patterns of hospitalisation in patients with heart failure discharged from Scottish hospitals in 1995|/resolve/reference/PMED?id=9717042
Davis 1977|Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting|/resolve/reference/PMED?id=300010
Edep 1997|Differences between primary care physicians and cardiologists in the management of congestive heart failure: relationship to practice guidelines|/resolve/reference/PMED?id=9247527
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions|
Husted 1976|Problems encountered in long-term treatment with anticoagulants|
Landefeld 1989|Major bleeding in outpatients treated with warfarin. Incidence and prediction by factors known at the start of outpatient therapy|/resolve/reference/PMED?id=2787958
Lefebvre 2011|Chapter 6: Searching for Studies|
Petersen 1989|Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study|
SPAF 1991|Stroke Prevention in Atrial Fibrillation Investigators|/resolve/reference/PMED?id=1860198
Abels 1993 {published and unpublished data}|Erythropoietin for anemia in cancer patients|
Abels 1993 {published and unpublished data}|Recombinant Human Erythropoietin in the Treatment of the Anaemia of Cancer|/resolve/reference/PMED?id=1574966
Abels J&J {published data only}||
Aravantinos 2003 {published data only}|Recombinant human erythropoietin for platinum-based chemotherapy-induced anaemia: A single-centre randomised study|/resolve/reference/PMED?id=17472238
Bamias 2003 {published data only}|Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group|/resolve/reference/PMED?id=12566906
Boogaerts 2003 {published data only}|Impact of epoetin beta on quality of life in patients with malignant disease|/resolve/reference/PMED?id=12671693
Carabantes 1999 {published data only}|Epoetin alfa in the Prevention of Anemia in Cancer Patients Undergoing Platinum-Based Chemotherapy (CT). A Prospective Randomized Study (Meeting abstract)|
Cascinu 1994 {published and unpublished data}|Recombinant Human Erythropoietin Treatment in Cisplatin-Associated Anemia: A Randomized, Double-Blind Trial With Placebo|/resolve/reference/PMED?id=8164030
Case 1993 {published and unpublished data}|Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy|/resolve/reference/PMED?id=8487324
Case J&J {published data only}||
Cazzola 1995 {published and unpublished data}|Recombinant Human Erythropoietin in the Anemia Associated With Multiple Myeloma or Non-Hodgkins Lymphoma: Dose Finding and Identification of Predictors of Response|/resolve/reference/PMED?id=8541533
Cazzola 1995a {published and unpublished data}|Recombinant Human Erythropoietin in the Anemia Associated With Multiple Myeloma or Non-Hodgkins Lymphoma: Dose Finding and Identification of Predictors of Response|/resolve/reference/PMED?id=8541533
Cazzola 1995b {published and unpublished data}|Recombinant Human Erythropoietin in the Anemia Associated With Multiple Myeloma or Non-Hodgkins Lymphoma: Dose Finding and Identification of Predictors of Response|/resolve/reference/PMED?id=8541533
Cazzola 1995c {published and unpublished data}|Recombinant Human Erythropoietin in the Anemia Associated With Multiple Myeloma or Non-Hodgkins Lymphoma: Dose Finding and Identification of Predictors of Response|/resolve/reference/PMED?id=8541533
Cazzola 1995d {published and unpublished data}|Recombinant Human Erythropoietin in the Anemia Associated With Multiple Myeloma or Non-Hodgkins Lymphoma: Dose Finding and Identification of Predictors of Response|/resolve/reference/PMED?id=8541533
Cazzola Roche {published data only}||
Chang 2005 {published data only}|Once Weekly Epoetin Alfa Maintains Hemoglobin, Improves Quality of Life, and Reduces Transfusion in Breast Cancer Patients Receiving Chemotherapy|/resolve/reference/PMED?id=15452188
Coiffier 2001 {published and unpublished data}|Impact of Epoetin Beta versus Standard Care on Quality of Life in Patients with Malignant Disease|
Coiffier Roche {published data only}||
Dammacco 2001 {published and unpublished data}|Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma|
Dammacco 2001 {published and unpublished data}|The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy|/resolve/reference/PMED?id=9689556
Dammacco J&J {published data only}||
Del Mastro 1997 {published and unpublished data}|Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia|/resolve/reference/PMED?id=9215845
Dunphy 1999 {published data only}|Erythropoietin Reduces Anemia and Transfusions|
EPO-CAN-15 FDA {published data only}||
EPO-CAN-15 J&J {unpublished data only}||
EPO-CAN-20 FDA {published data only}||
EPO-CAN-20 J&J {unpublished data only}||
EPO-GBR-7 FDA {published data only}||
EPO-GBR-7 J&J {published data only}||
GOG-0191 FDA {published data only}||
GOG-0191 J&J {published data only}||
Hedenus 2002 {published data only}|Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies|
Hedenus 2003 {published data only}|Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study|
Hedenus 2003 Amgen {published data only}||
Henke 1999 {published data only}|Erythropoietin for patients undergoing radiotherapy: a pilot study|/resolve/reference/PMED?id=10368042
Henke 1999a {published data only}|Erythropoietin for patients undergoing radiotherapy: a pilot study|/resolve/reference/PMED?id=10368042
Henke 1999b {published data only}|Erythropoietin for patients undergoing radiotherapy: a pilot study|/resolve/reference/PMED?id=10368042
Henke 1999c {published data only}|Erythropoietin for patients undergoing radiotherapy: a pilot study|/resolve/reference/PMED?id=10368042
Henke 2003 {published data only}|Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=14575968
Henke 2003 Roche {published data only}||
Henry 1995 {published and unpublished data}|Recombinant Human Erythropoietin in the Treatment of Cancer and Chemotherapy-Induced Anemia: Results of Double-Blind and Open-Label Follow-up Studies|/resolve/reference/PMED?id=8202722
Henry 1995 {published and unpublished data}|Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients Receiving Cisplatin Chemotherapy|/resolve/reference/PMED?id=9166485
Henry J&J {published data only}||
Henze 2002 {published data only}|Phase III randomized study: efficacy of epoetin alfa in reducing blood transfusions in newly diagnosed pediatric cancer patients receiving chemotherapy|
Huddart 2002 {published data only}|A prospective randomised comparative-group evaluation of epoetin alfa for the treatment of anaemia in UK cancer patients receiving platinum-based chemotherapy|
Iconomou 2003 {published data only}|Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial|/resolve/reference/PMED?id=12782431
INT-1 J&J {published data only}||
INT-3 J&J {published data only}||
Italian 1998 {published and unpublished data}|A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes|
Janinis 2003 {published data only}|Quality of life (QoL) outcome of epoietin-alfa (EPO-A) in anemic cancer patients undergoing platinum or non-platinum-based chemotherapy: a randomized study conducted by the Hellenic Cooperative Oncology Group|
Kotasek 2003 {published data only}|Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study|/resolve/reference/PMED?id=12957457
Kunikane 2001 {published data only}|Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer|/resolve/reference/PMED?id=11828949
Kunikane 2001a {published data only}|Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer|/resolve/reference/PMED?id=11828949
Kunikane 2001b {published data only}|Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer|/resolve/reference/PMED?id=11828949
Kurz 1997 {published and unpublished data}|Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study|/resolve/reference/PMED?id=9190976
Leyland-Jones 2003 {published data only}|Breast cancer trial with erythropoietin terminated unexpectedly|/resolve/reference/PMED?id=12901958
Leyland-Jones FDA {published data only}||
Leyland-Jones J&J {published data only}||
Littlewood 2001 {published and unpublished data}|Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial|/resolve/reference/PMED?id=11387359
Littlewood J&J {published data only}||
Machtay 2004 {published data only}|Definitive radiotherpay +/- erythropoietin for squamous cell carcinoma of the head and neck: preliminary report of RTOG 99-03|
Machtay FDA {published data only}||
Machtay J&J {unpublished data only}||
N93 004 FDA {published data only}||
N93 004 J&J {published data only}||
O'Shaughnessy 2005 {published data only}|Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy|/resolve/reference/PMED?id=15748464
Oberhoff 1998 {published and unpublished data}|Recombinant human erythropoietin in the treatment of chemotherapy- induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study|/resolve/reference/PMED?id=9602258
Oberhoff Roche {published data only}||
Osterborg 02 Roche {published data only}||
Osterborg 1996 {published and unpublished data}|Recombinant Human Erythropoietin in Transfusion-Dependent Anemic Patients With Multiple Myeloma and Non-Hodgkins Lymphoma - A Randomized Multicenter Study|/resolve/reference/PMED?id=8639883
Osterborg 1996a {published and unpublished data}|Recombinant Human Erythropoietin in Transfusion-Dependent Anemic Patients With Multiple Myeloma and Non-Hodgkins Lymphoma - A Randomized Multicenter Study|/resolve/reference/PMED?id=8639883
Osterborg 1996b {published and unpublished data}|Recombinant Human Erythropoietin in Transfusion-Dependent Anemic Patients With Multiple Myeloma and Non-Hodgkins Lymphoma - A Randomized Multicenter Study|/resolve/reference/PMED?id=8639883
Osterborg 2002 {published and unpublished data}|Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies|/resolve/reference/PMED?id=12011126
Osterborg 2005 {published data only}|Impact of epoetin- on survival of patients with lymphoproliferative malignanices: long-term follow up of a large randomized study|
Osterborg 96 Roche {published data only}||
P-174 J&J {published data only}||
Quirt 1996 {published data only}|The role of recombinant human erythropoietin (EPO) in reducing red blood cell transfusions and maintaining quality of life (QOL) in patients with lymphoma and solid tumors receiving cytotoxic chemotherapy. Results of a randomized, double-blind, placebo-controlled clinical trial|
Razzouk 2004 {published data only}|A double-blind, placebo-controlled study of once-weekly epoetin alfa in children with cancer undergoing myelosuppressive chemotherapy|
Rose 1994 {published and unpublished data}|Clinical and health status assessments in anemic chronic lymphocytic leukemia (CLL) patients treated with epoetin alfa (EPO)|
Rose J&J {published data only}||
Rosenzweig 2004 {published data only}|The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events|/resolve/reference/PMED?id=15157043
Savonije 2004 {published data only}|Early intervention with epoetin-alfa during platinum-based chemotherapy|
Silvestris 1995 {published data only}|Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma|/resolve/reference/PMED?id=7632811
Smith 2003 {published data only}|A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer|/resolve/reference/PMED?id=12799626
Ten Bokkel 1998 {published and unpublished data}|Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy|/resolve/reference/PMED?id=9819794
Ten Bokkel 1998a {published and unpublished data}|Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy|/resolve/reference/PMED?id=9819794
Ten Bokkel 1998b {published and unpublished data}|Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy|/resolve/reference/PMED?id=9819794
Ten Bokkel Roche {published data only}||
Thatcher 1999 {published and unpublished data}|Clinical and In Vitro Effects of Recombinant Human Erythropoietin in Patients Receiving Intensive Chemotherapy for Small-Cell Lung Cancer|/resolve/reference/PMED?id=7602351
Thatcher 1999 {published and unpublished data}|Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer|/resolve/reference/PMED?id=10408844
Thatcher 1999a {published and unpublished data}|Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer|/resolve/reference/PMED?id=10408844
Thatcher 1999b {published and unpublished data}|Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer|/resolve/reference/PMED?id=10408844
Thomas 2002 {published data only}|Early intervention with epoetin alfa for treatment of anaemia and improvement of quality of life in cancer patients undergoing myelotoxic chemotherapy|
Thompson 2000 {published and unpublished data}|Effect of recombinant human erythropoietin combined with granulocyte/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome|/resolve/reference/PMED?id=10666187
Throuvalas 2000 {published and unpublished data}|Erythropoietin decreases Transfusion Requirements during Radiochemotherapy|
Vadhan-Raj 2004 {published data only}|Randomized, double-blind, placebo-controlled trial of epoetin alfa (Procrit) in patients with rectal and gastric cancer undergoing chemo-radiotherapy (CT/RT) followed by surgery: early termination of the trial due to increased incidence of thrombo-embolic events (TEE)|
Vadhan-Raj FDA {published data only}||
Vadhan-Raj J&J {published data only}||
Vansteenkiste 2002 {published data only}|Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy.[see comment]|/resolve/reference/PMED?id=12189224
Vansteenkiste Amgen {published data only}||
Vansteenkiste FDA {published data only}||
Welch 1995 {published data only}|Recombinant Human Erythropoietin in Patients with Ovarian Carcinoma and Anaemia Secondary to Cisplatin and Carboplatin Chemotherapy: Preliminary Results|/resolve/reference/PMED?id=1574960
Welch 1995 {published data only}|Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer|
Witzig 2005 {published data only}|Phase III, Randomized, Double-Blind Study of Epoetin Alfa Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy|/resolve/reference/PMED?id=15452187
Witzig J&J {published data only}||
Wurnig 1996 {published data only}|Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study)|
Alexopoulos 2004 {published data only}|A randomized comparison of rHuEPO with darbepoetin for cancer related anemia|
Arslan 2004 {published data only}|Comparison of clinical outcomes of different erythropoietin usage strategies|/resolve/reference/PMED?id=15510982
Auerbach 2004 {published data only}|Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial|/resolve/reference/PMED?id=15051778
Aziz 2001 {published data only (unpublished sought but not used)}|Does Recombinant Human Erythropoietin Improve the Outcome of Radiation Therapy in Head and Neck Cancer Patients|
Beggs 2003 {published data only}|Fatigue and plasma cytokines in a randomized double-blind placebo-controlled trial of epoetin alfa in patients undergoing combined modality therapy for unreseactable non-small cell lung cancer (NSCLC)|
Bessho 1997 {published data only}|Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group|
Bindi 2004 {published data only}|Reticulocytes can represent an early indicator of te erythropoietic response to darbepoetin alfa in the anemia by chemotherapy|
Blayney 2003 {published data only}|Every-2-Week Darbepoetin Alfa improves hemoglobin in anemic patients with cancer undergoing chemotherapy: A stratified analysis by tumor type|
Blohmer 2004 {published data only}|Results with sequential adjuvant chemo-radiotherapy with vs. without epoetin alfa for patients with high-risk cervical cancer: results of a prospective, randomized, open and controlled AGO and NOGGO-intergroup study|
Buyukpamukcu 2002 {published data only}|Is epoetin alfa a treatment option for chemotherapy-related anemia in children?|
Casadevall 2004 {published data only}|Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial|/resolve/reference/PMED?id=15054036
Cazzola 2003 {published data only}|Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production|
Chan 1995 {published data only}|Recombinant human erythropoietin for anaemia in Chinese cancer patients on chemotherapy|/resolve/reference/PMED?id=8845332
Crawford 1997 {published data only}|Prevention of chemotherapy-related anemia by recombinant human erythropoietin (EPO) in patients with small cell lung cancer receiving cyclophosphamide, doxorubicin, and etoposide (CAE) chemotherapy with G-CSF support|
Crawford 2003 {published data only}|Epoetin alfa 40,000 u once weekly maintains hemoglobin in advanced non-small-cell lung cancer patients receiving first-line chemotherapy|
Daneryd 1998 {published data only}|Protection of Metabolic and Exercise Capacity in Unselected Weight-losing Cancer Patients following Treatment with Recombinant Erythropoietin: A Randomized Prospective Study|/resolve/reference/PMED?id=9850068
De Campos 1995 {published data only}|Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer|/resolve/reference/PMED?id=7602351
Demetri 1998 {published data only}|Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study|/resolve/reference/PMED?id=9779721
Dusenbery 1994 {published data only}|Erythropoietin increases hemoglobin during radiation therapy for cervical cancer|/resolve/reference/PMED?id=8083076
Gabrilove 2001 {published data only}|Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing|/resolve/reference/PMED?id=11387360
Gamucci 1993 {published data only}|Erythropoietin for the Prevention of Anaemia in Neoplastic Patients Treated with Cisplatin|
Garton 1995 {published data only}|Epoetin Alfa for the Treatment of the Anemia of Multiple Myeloma|/resolve/reference/PMED?id=7575066
Gebbia 1992 {published data only}|Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer|/resolve/reference/PMED?id=21584553
Glaser 1999 {published data only}|R-HuErythropoietin treatment increases efficacy of neo-adjuvant radiochemotherapy and improves cancer free survival of patient with oral squamous cell carcinoma: a 17 months follow-up|
Glaser 2001 {published data only}|Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx|/resolve/reference/PMED?id=11395239
Glaspy 1997b {published data only}|Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice|/resolve/reference/PMED?id=9060566
Glaspy 2001 {published data only}|A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy|/resolve/reference/PMED?id=11308270
Glaspy 2002 {published data only}|Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy|/resolve/reference/PMED?id=12177793
Glaspy 2002b {published data only}|Darbepoetin alfa administered every 2 weeks alleviates anemia in cancer patients receiving chemotherapy|/resolve/reference/PMED?id=12435170
Glaspy 2003 {published data only}|A randomized, active-control, pilot trial of front-loaded dosing regimens of darbeopetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease|
Glimelius 1998 {published data only}|Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer|/resolve/reference/PMED?id=9469326
Glossmann 2003 {published data only}|Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial|/resolve/reference/PMED?id=12910374
Granetto 2003 {published data only}|Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy|/resolve/reference/PMED?id=12883695
Hellstrm-L 1998 {published data only}|Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients|/resolve/reference/PMED?id=9639501
Hesketh 2004 {published data only}|A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies|
Jacubowski 2003 {published data only}|Head-to-head comparison of epoetin alfa 40,000 QW vs darbepoetin alfa 200 mcg Q2W in anemic patients with cancer receiving chemotherapy: preliminary results|
Jitnuyanont 2001 {published data only}|Impact of therapy with recombinant human erythropoietin (r-HuEPO) and Quality-of-life in anemic cancer patients|
Johansson 2001 {published data only}|Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer--a randomized study|/resolve/reference/PMED?id=11676354
Lavey 1993 {published data only}|Erythropoietin Increases Hemoglobin in Cancer Patients During Radiation Therapy|/resolve/reference/PMED?id=8262840
Lavey 2004 {published data only}|Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study|/resolve/reference/PMED?id=15385124
Leitgeb 1994 {published data only}|Quality of life in chronic anaemia of cancer during treatment with recombinant human erythropoietin|
Leon 1998 {published data only}|Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors|
Ludwig 1995 {published data only}|Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy|
Malik 1998 {published data only}|The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy|/resolve/reference/PMED?id=9813972
Mangiameli 2002 {published data only}|[Erythropoietin and cisplatin-induced neuropathies in cancer patients]. [Italian]|/resolve/reference/PMED?id=12161978
Mantovani 2000 {published data only}|Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin|
Marinaccio 2003 {published data only}|Pretreatment normalization of mild anemia with epoetin alfa: Impact on the outcome in epithelial ovarian cancer patients|
Markman 1993 {published data only}|The use of recombinant human erythropoietin to prevent carboplatin-induced anemia|/resolve/reference/PMED?id=8504984
Moebus 2001 {published data only}|Epoetin Alpha Prevents Anemia and Transfusions of RBCS in Patients Receiving Dose-Dense Sequential Chemotherapy|
Olsson 2002 {published data only}|Erythropoietin treatment in metastatic breast cancer--effects on Hb, quality of life and need for transfusion|/resolve/reference/PMED?id=12546524
Pierelli 1999 {published data only}|Erythropoietin Addition to Granulocyte Colony-Stimulating Factor Abrogates Life-Threatening Neutropenia and Increases Peripheral-Blood Progenitor-Cell Mobilization After Epirubucin, Paclitaxel and Cisplatin Combination Chemotherapy: Results of a Randomized Comparison|/resolve/reference/PMED?id=10561191
Porter 1996 {published data only}|Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: A randomized, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=8917229
Rearden 2004 {published data only}|Results of a randomized study of every three-week dosing (Q3W) of darepoetin alfa for chemotherapy-induced anemia (CIA)|
Rosen 2003 {published data only}|Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer|/resolve/reference/PMED?id=12738722
Samper 2002 {published data only}|Treatment of anemia in patients under radiotherapy with subcutaneous epoetenium alpha 10,000 iu three times a week and 40,000 iu once a week. [Spanish]|
Schwartzberg 2004 {published data only}|A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer|/resolve/reference/PMED?id=15561813
Scott 2002 {published data only}|The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study|
Shasha 2003 {published data only}|Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy|
Stein 1991 {published data only}|Pharmacologic Doses of Recombinant Human Erythropoietin in the Treatment of Myelodysplastic Syndromes|/resolve/reference/PMED?id=1912554
Straus 2002 {published data only}|Epoetin Alfa treatment Improves Quality of Life and Increases Hemoglobin Levels during Chemotherapy for Lymphoma, Chronic Lymphocytic Leukemia (CLL)., and Multiple Myeloma (MM) Patients with Mild-to-Moderate Anemia|
Sweeney 1998 {published data only}|Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open- labelled, phase II trial|/resolve/reference/PMED?id=9667681
Sweeney 1998 {published data only}|Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial|/resolve/reference/PMED?id=8331011
Tsukuda 1998 {published data only}|Effectiveness of weekly subcutaneous recombinant human erythropoietin administration for chemotherapy-induced anemia|/resolve/reference/PMED?id=9617462
Vadhan-Raj 2003 {published data only}|Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks|/resolve/reference/PMED?id=15352656
Varan 1999 {published data only (unpublished sought but not used)}|Recombinant human erythropoietin treatment for chemotherapy-related anemia in children|
Velilla Millan 2003 {published data only}|Effect of two administration schedules of erythropoietin upon hemoglobin in breast cancer patients treated with radiation therapy. [Spanish]|
Wagner 2004 {published data only}|Combined use of erythropoietin and granulocyte colony- stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: A randomized controlled trial|/resolve/reference/PMED?id=15143081
Waltzman 2004 a {published data only}|A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease|
Waltzman 2004 b {published data only}|Head-To-Head comparison of Epoetin Alfa (EPO) 40,000 QW vs Darbepoetin Alfa (DARB) 200 g Q2W in anemic cancer patients receiving Chemotherapy (CT): Final Results of a Planned Interim Analysis (IA)|
Yilmaz 2004 {published data only}|A single institutional experience: Is epoetin alpha effective in anemic children with cancer?|
Antonadou 2001 {published data only}|Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. Final results of a randomized phase III study|
Blackstock {unpublished data only}|1CDR0000069148CCCWFU-62299; NCI-P01-0200; CCCWFU-BG01-193|
Broadley {unpublished data only}|Double blind randomised placebo controlled trial of the effect of epoetin alfa on symptomatic anaemia and fatigue in cancer patients receiving ongoing care without planned chemotherapy|
CDR0000068669 {unpublished data only}|CDR0000068669|
Chapman 2004 {unpublished data only}|NRR 2004 Issue 2 Study ID numbers: N0123138194, REC 01/05/53.C|
Charu 2003 {published data only}||
Elsaid {unpublished data only}|Significance of anaemia and role of Erythropoietin in radiation induced Mucositis in head and neck cancer patients|
EORTC 22996-24002 {unpublished data only}|A phase III double-blind, randomised, placebo-controlled study of Erythropoietin when used as an adjuvant to radiation therapy in patients with head and neck squamous cell carcinoma|
EPO CAN 303 {unpublished data only}|EPO-CAN-303;NCT00083434R|
Famoyin 2004 {published data only}|A randomized phase II study of thalidomide with or without erythropoietin (EPO) in metastatic renal cell carcinoma (RCC)|
Fisch {unpublished data only}|CDR0000069409; MDA-DM-02331; MDA-DM-0038; NCI-P02-0225; NCI00052221MJ|
Gallagher {unpublished data only}|The role of epoetin alpha in anaemia and fatigue in cancer patients|
GM Thomas {unpublished data only}|Phase III randomised study of radiotherapy and cisplatin with or without epoetin alfa in patients with cervical cancer and anaemia|
H Thomas {unpublished data only}|Open label comparative evaluation of the effect of epoetin on quality of life and burden of illness in anaemic patients receiving platinum-containing chemotherapy|
Howell {unpublished data only}|A double blind, randomised, placebo-controlled study to evaluate the impact of maintaining haemoglobin using epoetin alpha in stage IV breast cancer subjects receiving chemotherapy|
Koelbl {unpublished data only}|CDR 0000257189;AGOSG-OVAR-MO16375-MARCH; EI20217; ROCHE-MO16375; ROCH-RO2053859|
Leonard 2004 {published data only}|Once weekly epoetin beta in patients with metastatic breast cancer receiving anthracycline- or taxane-based chemotherapy|
Miller {unpublished data only}|Phase III study of Epoetin alfa with or without Filgrastim (G-CSF) vs supportive therapy alone in patients with Myelodysplastic Syndromes|
OBrien {unpublished data only}|Open-label randomised group-comparative evaluation of the effect of epoetin on anaemia and fatigue in lung cancer patients receiving palliative platinum containing chemotherapy|
OConnell {unpublished data only}|Phase III randomised study of epoetin alfa in anemic patients with advanced cancer undergoing chemotherapy|
Parliament {unpublished data only}|Radiation therapy with or without Epoetin alfa in anaemic patients with head and neck cancer|
Prozanto 2002 {published data only}|Early intervention with epoetin alfa in breast cancer (BC) patients (pts) undergoing chemotherapy (CT): results of a randomized, multicenter, phase IIIb study (EPO-INT-47 Study Group)|
R Thomas {unpublished data only}|EPREX trial: Open-label comparative-group evaluation of the effect of epoetin alfa on quality of life and burden of illness in anaemic cancer patients receiving platinum containing chemotherapy|
Recasens 2003 {published data only}|A pharmacoeconomical analysis comparing Epoetin Alpha vs transfusion in patients with anemia associated to multiple myeloma|
Rudd {unpublished data only}|Evaluation of epoetin in lung cancer pts. receiving chemotherapy|
Steensma {unpublished data only}|CDR0000288821;NCCTG-N02C2; NCT00058331DDP|
Stewart {unpublished data only}|Open randomised comparative group evaluation of the effect of epoetin alfa on local disease free survival and quality of life in head and neck cancer patients receiving radical radiotherapy|
UKCCCR GN308 {unpublished data only}|A double-blind, placebo controlled study to assess the effects of early intervention and/or treatment with Epoetin alfa on anaemia in cancer patients receiving non platinum containing chemotherapy|
Ziras 2001 {published data only}|Soluble transferrin receptor (sTFR) as a predictor of response to prophylactic epoetin alfa (EPO) treatment in non-anemic cancer patients (pts) under chemotherapy (CT). Preliminary results|
Aaronson 1991|Methodologic issues in assessing the qualtiy of life in cancer patients|
Acs 2001|Erythropoietin and Erythropietin Receptor Expression in Human Cancer|/resolve/reference/PMED?id=11325818
Acs 2002|Immunohistochemical Expression of Erythropoietin and Erythropoietin Receptor in Breast Carcinoma|
Akaike 1969|Fitting Autoregressive Models for Prediction|
Alderson 2005|Assessment of study quality|
Amgen 2004|Aranesp (darbepoetin alfa) Safety|
Arcasoy 2002|Functional Significance of Erythropoietin Receptor Expression in Breast Cancer|/resolve/reference/PMED?id=12118093
Arcasoy 2005|Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia|/resolve/reference/PMED?id=15671524
Bauer 1992|Effects of recombinant human erythropoietin on clonogenic growth of primary human tumour specimens in vitro|/resolve/reference/PMED?id=1389501
Becker 2000|Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas|/resolve/reference/PMED?id=10661354
Begg 1996|Improving the qualtiy of reporting of randomized controlled trials: the CONSORT statement|/resolve/reference/PMED?id=8773637
Beguin 1998|A Risk-Benefit Assessment of Epoetin in the Management of Anaemia Associated with Cancer|/resolve/reference/PMED?id=9804442
Bennett 2004|Pure red-cell aplasia and epoetin therapy|/resolve/reference/PMED?id=15459301
Bottomley 2002|Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?|/resolve/reference/PMED?id=11902500
Brandberg 2000|Assessing the impact of cancer-related anaemia on quality of life and the role of rHuEPO|/resolve/reference/PMED?id=11188783
Casadevall 2002|Pure Red-Cell Aplasia And Antierythropoietin Antibodies In Patients Treated With Recombinant Erythropoietin|/resolve/reference/PMED?id=11844847
Cazzola 1992|Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial|/resolve/reference/PMED?id=1728318
Cazzola 1996|Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy|/resolve/reference/PMED?id=8952157
Cella 1998|Factors influencing Quality of Life in Cancer Patients: Anemia and Fatigue|/resolve/reference/PMED?id=9671330
Cella 1999|The Effect of Epoetin alfa on Quality of Life in Anemic Cancer Patients|
Cirillo 1993|Relationship between hematocrit and blood pressure: implications for primary hypertension|/resolve/reference/PMED?id=8302401
Clark 2002|Erythropoietin, uncertainty principle and cancer related anaemia|/resolve/reference/PMED?id=12270068
Couture 2005|Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management|/resolve/reference/PMED?id=15632253
Dalton 1998|Multicenter UK Audit of Anemia in Patients Receiving Cytotoxic Chemotherapy|
DAndrea 1989|Expression cloning of the murine erythropoietin receptor|/resolve/reference/PMED?id=2539263
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Engert 2000|Recombinant Human Erythropoietin as an Alternative to Blood Transfusion in Cancer-Related Anaemia|
Falanga 2005a|Deep vein thrombosis in cancer: the scale of the problem and approaches to management|/resolve/reference/PMED?id=15802275
Falanga 2005b|Mechanisms of thrombosis in cancer|/resolve/reference/PMED?id=15790145
Frommhold 1998|The Impact of Blood Hemoglobin Content on the Outcome of Radiotherapy|/resolve/reference/PMED?id=9879345
Glaspy 1997a|The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem|
Goodnough 1999|Transfusion medicine - blood transfusion - second of two parts|/resolve/reference/PMED?id=10021474
Grau 2000|Significance of hemoglobin concentration for treatment outcome|
Greenberg 1994|The myelodysplastic syndromes|
Groopman 1999|Chemotherapy-Induced Anemia in Adults: Incidence and Treatment|/resolve/reference/PMED?id=10511589
Gurevitch 1999|Statistical issues in ecological meta-analyses|
Halstenson 1991|Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta|/resolve/reference/PMED?id=1752115
Harrison 2001|Prevalence of Anemia in Cancer Patients Undergoing Radiation Therapy|/resolve/reference/PMED?id=11395854
Hasenclever 1998|A Prognostic Score for Advanced Hodgkins Disease|/resolve/reference/PMED?id=9819449
Hedges 1980|Vote-Counting Methods in Research Synthesis|
Hellstrm-L 1995|Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies|
Henke 2000|Erythropoietin in radiation oncology - a review|/resolve/reference/PMED?id=10705246
Henry 1992|Changing patterns of care in the management of anemia|/resolve/reference/PMED?id=1615338
Hirst 1984|The effect of alterations in haematocrit on tumour sensitivity to X-rays|/resolve/reference/PMED?id=6334047
Hockel 1993|Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix|
Hozo 2005|Estimating the mean and variance from the median, range, and the size of a sample|/resolve/reference/PMED?id=15840177
Ihaka 1996|R: A language for Data Analysis and Graphics|
Jacobson 2005|Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer|/resolve/reference/PMED?id=15661237
Jelkmann 2004|Beneficial and ominous aspects of the pleiotropic action of erythropoietin|/resolve/reference/PMED?id=15322761
Johnson & Johnson 04|Background Information For Oncologic Drugs Advisory Committee Meeting: Safety of Erythropoietin Receptor Agonists (ERAs) in Patients With Cancer|
Johnson 1990|In vivo supression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): Reversal with exogenous erythropoietin (EPO)|/resolve/reference/PMED?id=2303102
Joiner 1993|The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse|/resolve/reference/PMED?id=8398699
Jones 2004|Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis|
Joy 2002|Darbepoetin Alfa: A Novel Erythropoiesis-Stimulating Protein|/resolve/reference/PMED?id=12086553
Jni 1999|The hazards of scoring the quality of clinical trials for meta-analysis|/resolve/reference/PMED?id=10493204
Jni 2001|Assessing the quality of controlled clinical trials|/resolve/reference/PMED?id=11440947
Kelleher 1998|Can Erythropoietin Improve Tumor Oxygenation?|/resolve/reference/PMED?id=9879343
Knocke 1999|Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix|/resolve/reference/PMED?id=10665785
Koeller 1998|Clinical guidelines for the treatment of cancer-related anemia|/resolve/reference/PMED?id=9469689
Koong 1991|The influence of chronic anaemia on the radiosensitivity of two mouse tumours|/resolve/reference/PMED?id=2021532
Koury 1988|Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization|/resolve/reference/PMED?id=3337914
Koury 1990|Control of red cell production: the roles of programmed cell death (apoptosis) and erythropoietin|
Koury 1991|Localization of cells producing erythropoietin in murine liver by in situ hybridization|/resolve/reference/PMED?id=2039831
Landers 1996|Blood transfusion-induced immunomodulation|/resolve/reference/PMED?id=8712400
Littlewood 2003|Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patients|/resolve/reference/PMED?id=12604736
Ludwig 1990|Erythropoietin treatment of anemia associated with multiple myeloma|/resolve/reference/PMED?id=2342535
Ludwig 1994|Prediction of response to erythropoietin treatment in chronic anemia of cancer|/resolve/reference/PMED?id=7741835
Ludwig 1998|Anemia in Cancer Patients|/resolve/reference/PMED?id=9671322
Ludwig 2001|Symptomatology of anemia|/resolve/reference/PMED?id=11395846
Luksenburg 2004|FDA Briefing Document: Safety Concerns Associated with Aranesp (darbepoetin alfa) Amgen, Inc. and Procrit (epoetin alfa) Ortho Biotech, L.P., for the Treatment of Anemia Associated with Cancer Chemotherapy|
Marsh 1999|Meta-Analyses of the Effectiveness of Erythropoietin for End-Stage Renal Disease and Cancer|/resolve/reference/PMED?id=10509843
Mercadante 2000|Anaemia in cancer: pathophysiology and treatment|/resolve/reference/PMED?id=10913385
Michael 2005|Epoetin-alpha reduces red blood cell transfusions (RBC) in high-risk breast cancer patients with adjuvant dose-dense, sequential chemotherapy with epirubicin (E), paclitaxel (T) and cyclophosphamid (C) (ETC)|
Moher 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials|/resolve/reference/PMED?id=11323066
Monnerat 1999|Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO)in treatment of tumor anemia (in German)|/resolve/reference/PMED?id=10067375
Montagnac 1992|Sensitization to recombinant human erythropoietin in a woman under hemodialysis|/resolve/reference/PMED?id=1531529
Nissenson 1992|Epoetin and cognitive function|/resolve/reference/PMED?id=1626553
Nordsmark 1996|Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck|/resolve/reference/PMED?id=8961365
Nowrousian 2002a|Pathophysiology of cancer-related anemia|
Nowrousian 2002b|Prevalence, pathophysiology, predictive factors, and prognostic significance of anemia in cancer chemotherapy|
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Peces 1996|Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia|/resolve/reference/PMED?id=8676964
Prabhakar 1997|Antibodies to recombinant human erythropoietin causing pure red cell aplasia|/resolve/reference/PMED?id=9181281
Quirt 2003|The role of erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy|
Quirt 2005|The role of erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy. Practice Guideline Report #12-1|
Reed 1994|Implications of the anemia of chronic disorders in patients anticipating radiotherapy|/resolve/reference/PMED?id=8010342
Rizzo 2002|Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology|/resolve/reference/PMED?id=12351606
ROCHE 2004|RO 205-3859; NEORECORMON (EPOETIN BETA) Briefing Package for the FDA Oncologic Drugs Advisory Committee Meeting|
Ross 2003|The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review|/resolve/reference/PMED?id=12860499
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Seidenfeld 2001a|Epoetin Treatment of Anemia Associated With Cancer Therapy: a Systematic Review and Meta-analysis of Controlled Clinical Trials|/resolve/reference/PMED?id=11504766
Seidenfeld 2001b|Uses of erythropoietin for anemia in oncology|
Silver 1999|Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen Effect|/resolve/reference/PMED?id=10329047
Spivak 1994a|Recombinant human erythropoietin and the anemia of cancer|/resolve/reference/PMED?id=8049455
Spivak 1994b|Cancer-Related Anemia: Its Causes and Characteristics|/resolve/reference/PMED?id=8202724
Storring 1998|Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties|
Teicher 1981|Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells|/resolve/reference/PMED?id=7448778
Teicher 1994|Hypoxia and drug resistance|/resolve/reference/PMED?id=7923547
Thews 2001|Erythropoietin Restores the Anemia-induced Reducation in Cyclophosphamide Cytotoxicity in Rat Tumors|/resolve/reference/PMED?id=11245434
Thomas 1998|Impact of anemia and fatigue on quality of life in cancer patients: a brief review|
Thompson 1999|Explaining heterogeneity in meta-analysis: a comparison of methods|
Vaupel 1989|Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human Tumors: A Review|/resolve/reference/PMED?id=2684393
Vaupel 2000|Blood supply, oxygenation status and metabolic micromilieu of breast cancers: Characterization and therapeutic relevance|/resolve/reference/PMED?id=11029486
Vaupel 2001|Oxygen status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy|/resolve/reference/PMED?id=11395850
Verhagen 1998|The Delphi List: A Criteria List for Quality Assessment of Randomized Clinical Trials for Conducting Systematic Reviews Developed by Delphi Consensus|/resolve/reference/PMED?id=10086815
Williamson 1999|Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports|/resolve/reference/PMED?id=10390452
Wood 1995|Cisplatin-associated anemia: an erythropoietin deficiency syndrome|/resolve/reference/PMED?id=7706473
Yasuda 2003|Erythropoietin regulates tumour growth of human malignancies|/resolve/reference/PMED?id=12807756
Bohlius 2005|Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis|/resolve/reference/PMED?id=15812074
Bohlius 2006|Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients|/resolve/reference/PMED?id=16705125
Brown 2002 {published data only}|Culturally competent diabetes self-management education for Mexican Americans: the Starr County border health initiative|/resolve/reference/PMED?id=11815493
Deakin 2003 {published and unpublished data}|Empowered patients:better diabetes control, greater freedom to eat, no weight gain!|
Domenech 1994 {published data only}|Evaluation of effectiveness of an education program for non-insulin-dependent diabetic patients|
Domenech 1995 {published data only}|Evaluation of the effectiveness of an ambulatory teaching/treatment programme for non-insulin dependent (type 2) diabetic patients|/resolve/reference/PMED?id=8590781
Heller 1988 {published data only}|Group education for obese patients with type 2 diabetes: greater success at less cost|
Holtrop 2002 {published data only}|"Sticking to it - diabetes mellitus": a pilot study of an innovative behavior change program for women with type 2 diabetes|
Kronsbein 1988 {published data only}|Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes|/resolve/reference/PMED?id=2904532
Lozano 1999 {published data only}|The education of type-2 diabetics: why not in groups?|/resolve/reference/PMED?id=10394695
Pieber 1995 {published data only}|Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria|
Rickheim 2002 {published data only}|Assessment of group versus individual diabetes education: a randomized study|/resolve/reference/PMED?id=11815494
Trento 1998 {published data only}|Therapeutic group education in the follow-up of patients with non-insulin treated, non-insulin dependent diabetes mellitus|
Trento 2001 {published data only}|Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up|/resolve/reference/PMED?id=11375359
Trento 2002 {published data only}|Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial|/resolve/reference/PMED?id=12242455
Zapotoczky 2001 {published data only}|A controlled study of weight reduction in type 2 diabetics treated by two reinforcers|
ADA 2001 {published data only}|Third-party reimbursement for diabetes care, self-management education, and supplies|
Agurs-Collins 1997 {published data only}|A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects|/resolve/reference/PMED?id=9314625
Araujo 1989 {published data only}|Treatment of non insulin-dependent diabetes mellitus (NIDDM)|
Arauz 1997 {published data only}|Modificacin de prcticas alimeModification of alimentary practices in diabetic non insulin-dependiets: effects of an intervention|
Arauz 2001 {published data only}|Community diabetes educational intervention at the primary care level|/resolve/reference/PMED?id=11349349
Aruz 2001 {published data only}|Community diabetes education intervention at the primary care level|
Assal 1988 {published data only}|Education of the NIDDM|/resolve/reference/PMED?id=3402329
Barcelo 2001 {published data only}|An intervention to improve diabetes control in Chile|
Barnard 1982 {published data only}|Response of non-insulin-dependent diabetic patients to an intensive program of diet and exercise|/resolve/reference/PMED?id=7151652
Barnard 1992 {published data only}|The effects of an intensive diet and exercise program on patients with non-insulin-dependent diabetes mellitus and hypertension|
Basa 1995 {published data only}|Evaluation of a diabetes specialty centre: structure, process and outcome|/resolve/reference/PMED?id=7603930
Basina 2002 {published data only}|Effectiveness of diabetes management: Is improvement feasible?|/resolve/reference/PMED?id=12034419
Berger 1996 {published data only}|Health care for persons with non-insulin-dependent diabetes mellitus. The German experience|
Berger 1999 {published data only}|Diabetes care and patient-oriented outcomes|/resolve/reference/PMED?id=10328053
Blonk 1994 {published data only}|Influence on weight loss in Type 2 diabetic patients: Little long-term benefit from group behaviour therapy and exercise training|
Boehm 1993 {published data only}|Behavioral analysis and behavioral strategies to improve self-management of type II diabetes|/resolve/reference/PMED?id=8401245
Bouldin 2002 {published data only}|Quality of care in diabetes: Understanding the guidelines|/resolve/reference/PMED?id=12385492
Bradshaw 1999 {published data only}|Can we improve the education for type 2 diabetes patients in general practice? A pilot study of the effects of differing educational delivery methods|
Brown 1988 {published data only}|Effects of educational interventions in Diabetes Care: a meta-analysis of the findings|/resolve/reference/PMED?id=3293025
Brown 1995 {published data only}|A community-based, culturally sensitive education and group-support intervention for Mexican Americans with NIDDM: a pilot study of efficacy|/resolve/reference/PMED?id=7758387
Brown 1999 {published data only}|Culturally competent diabetes education for Mexican Americans: The Starr County Study|/resolve/reference/PMED?id=10531848
Bundo 1993 {published data only}|A re-evaluation of the diabetes mellitus type 2 program. A proposal for a quality indicator|/resolve/reference/PMED?id=8297997
Burden 2000 {published data only}|Diabetes in African Caribbean, and Indo-Asian ethnic minority people|/resolve/reference/PMED?id=11005069
Caballero 1998 {unpublished data only}|Self-care ability in non insulin-dependent diabetic patients|
Cabrera-Pivaral 2000 {published data only}|Effects of behavior-modifying education in the metabolic profile of the type 2 diabetes mellitus patient|/resolve/reference/PMED?id=11120456
Cabrera-Pivaral 2001 {published data only}|Effects of an educational intervention on plasma levels of LDL cholesterol in type 2 diabetics|/resolve/reference/PMED?id=11816230
Calle-Pascual 1992 {published data only}|Behaviour modification in obese subjects with type 2 diabetes mellitus|/resolve/reference/PMED?id=1563332
Campbell 1988 {published data only}|An effective approach to lipid improvement in poorly controlled noninsulin dependent diabetes mellitus|/resolve/reference/PMED?id=3371172
Campbell 1990 {published data only}|Impact of intensive educational approach to dietary change in NIDDM|/resolve/reference/PMED?id=2209318
Campbell 1996 {published data only}|The relative effectiveness of educational and behavioral instruction programs for patients with NIDDM: a randomized trial|/resolve/reference/PMED?id=8846745
Cetti 2002 {published data only}|Self-care plan for diabetic patients|
Clark 1999 {published data only}|The National Diabetes Education Program: Changing the way diabetes is treated|/resolve/reference/PMED?id=10068393
Clark 2001 {published data only}|Implementing a psychological intervention to improve lifestyle self-management in patients with type 2 diabetes|/resolve/reference/PMED?id=11164324
Clement 1995 {published data only}|Diabetes self-management education|/resolve/reference/PMED?id=7587866
Cohen 1982 {published data only}|The evaluation of a community-based group program for low-income diabetics and hypertensives|/resolve/reference/PMED?id=7158616
Cooper 2001 {published data only}|Chronic disease patient education: lessons from meta-analyses|/resolve/reference/PMED?id=11479051
Corabian 2001 {published data only}|Patient diabets education in the management of adult type 2 diabetes|
Corbett 1999 {published data only}|Research-based practice implications for patients with diabetes. Part II: Diabetes self-efficacy|/resolve/reference/PMED?id=10763657
D'Eramo-Melkus 1992 {published data only}|Metabolic impact of education in NIDDM|
de Weerdt 1991 {published data only}|Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy|
DPP Research GP 2002 {published data only}|Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin|/resolve/reference/PMED?id=11832527
Dunn 1988 {published data only}|Treatment - education|/resolve/reference/PMED?id=3075904
Eakin 2002 {published data only}|Reaching those most in need: a review of diabetes self-management interventions in disadvantaged populations|
Elshaw 1994 {published data only}|Utilizing a 24-hour dietary recall and culturally specific diabetes education in Mexican Americans with diabetes|/resolve/reference/PMED?id=7851238
Ezenwaka 2002 {published data only}|The importance of diabetes health education in developing countries|
Falkenberg 1986 {published data only}|Problem oriented participatory education in the guidance of adults with non-insulin-treated type-II diabetes mellitus|/resolve/reference/PMED?id=3775139
Fan 1999 {published data only}|Effect of diabetic education on patients' knowledge and self-management ability|
FEND 2000 {published data only}|Education: 2000 and beyond highlights from the 5th Annual Conference of the Federation of European Nurses in Diabetes (FEND): 14-15 September 2000, Jerusalem, Israel|
Ferreira 2001 {published data only}|Adoption to the treatment in diabetes patients:effects of a training in contingency analysis about self-managment cares|
Fishbein 1993 {published data only}|Patient outcomes research and type II diabetes: The agency for health care policy and research focuses on improving patient outcomes|/resolve/reference/PMED?id=8462397
Fritsche 1999 {published data only}|Long term effect of a structured inpatient diabetes teaching and treatment programme in type 2 diabetic patients: influence of mode of follow-up|/resolve/reference/PMED?id=10724092
Fukuda 1999 {published data only}|Evaluation of a diabetes patient education program consisting of a three-day hospitalization and a six-month follow-up by telephone counseling for mild type 2 diabetes and IGT|/resolve/reference/PMED?id=21432184
Funnell 1998 {published data only}|Participation in a diabetes education and care program: experience from the Diabetes Care for Older Adults Project|
Gaede 2001 {published data only}|Limited impact of lifestyle education in patients with Type 2 diabetes mellitus and microalbuminuria: results from a randomized intervention study|
Gagliardino 2001 {published data only}|A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA)|/resolve/reference/PMED?id=11375360
Gamsu 2002 {published data only}|The development of a psychoeducational group intervention for overweight women with type 2 diabetes mellitus: A service evaluation|
Garcia 1996 {published data only}|Diabetes education in the elderly: a 5-year follow-up of an interactive approach|/resolve/reference/PMED?id=9006225
Garca 1997 {published data only}|Health communication and interactive education and their application to control of the diabetic patient|/resolve/reference/PMED?id=9410587
Gillibrand 2001 {published data only}|Clinical effectiveness of nursing interventions based on psychosocial constructs in diabetes care: a proposed randomized controlled trial|
Girard 1986 {published data only}|Education of diabetics and medium-term metabolic control|
Glasgow 1989 {published data only}|Nutrition education and social learning interventions for type II diabetes|/resolve/reference/PMED?id=2702897
Glasgow 1992 {published data only}|Improving self-care among older patients with type II diabetes: the "Sixty Something..." Study|/resolve/reference/PMED?id=1298950
Glasgow 2002 {published data only}|Implementation, generalization and long-term results of the "choosing well" diabetes self-management intervention|/resolve/reference/PMED?id=12401414
Gough 1990 {published data only}|The evaluation of group education for patients with non-insulin dependent diabetes at Hollywood Repatriation Hospital in Western Australia|/resolve/reference/PMED?id=2094202
Griffin 1999 {published data only}|Improving education for type 2 diabetes patients in general practice|
Haapa 1999 {published data only}|One part vs. two part diabetes education courses for non-insulin-dependent diabetic patients|
Haisch 1996 {published data only}|Introducing a new patient-centred motivational support programme into an intensified patient-education therapy of type II diabetes. Results of a 3-months follow-up|/resolve/reference/PMED?id=9036414
Haisch 2000 {published data only}|Effectiveness and efficiency of ambulatory diabetes education programs. A comparison of specialty practice and general practice|/resolve/reference/PMED?id=10719390
Haisch 2002 {published data only}|Self-help based preparatory and follow-up outpatient diabetic instruction programmes|
Halle 1999 {published data only}|Concurrent reductions of serum leptin and lipids during weight loss in obese men with type II diabetes|/resolve/reference/PMED?id=10444423
Halle 1999b {published data only}|Influence of 4 weeks' intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes|/resolve/reference/PMED?id=10337867
Hampton 1988 {published data only}|Audit of an education programme for recently diagnosed Type II diabetic patients|
Hanefeld 1991 {published data only}|Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM|/resolve/reference/PMED?id=2060433
Hanefeld 1996 {published data only}|The diabetes intervention study (DIS): Course of diabetes and mortality, 11 year follow-up-study|
Hansen 2002 {published data only}|Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings|/resolve/reference/PMED?id=11871208
Hardinghaus 1996 {published data only}|Quality of life, disease coping, appropriate therapy and parameters of metabolism after structured Type II diabetic training|
Hartwell 1986 {published data only}|Comparison of behavioral interventions for control of type II diabetes mellitus|
Heath 1991 {published data only}|Community-based exercise and weight control: diabetes risk reduction and glycemic control in Zuni Indians|
Henry 1997 {published data only}|Cognitive-behavioural stress management for patients with non-insulin dependent diabetes mellitus|
Hughes 1999 {published data only}|'The Sugar Buddies': an intervention programme for 'obese' patients with poorly controlled diabetes|
Hunter 1999 {published data only}|Establishing a patient education program for type 2 diabetes|
Jaber 1996 {published data only}|Evaluation of a pharmaceutical care model on diabetes management|/resolve/reference/PMED?id=8833557
Jacobs 2000 {published data only}|Healthy lifestyles: a pilot program to influence behavior change|
Jennings 1990 {published data only}|Education for patients with established NIDDM. Disparities between patients who do and do not attend|/resolve/reference/PMED?id=2298114
Jiang 1999 {published data only}|Assessment of the function and effect of diabetes education programs in Taiwan|/resolve/reference/PMED?id=10724098
Julius 1993 {published data only}|Work absenteeism in type 2 diabetes mellitus: Results of the prospective Diabetes Intervention Study|/resolve/reference/PMED?id=8314427
Jungmann 1997 {published data only}|Patient education of non-insulin-dependent diabetic patients. Effect of an ambulatory educational program on metabolism and risk factors|/resolve/reference/PMED?id=9499634
Jungmann 1997b {published data only}|Favorable effect of improved metabolic control and weight reduction by a structured ambulatory treatment and teaching program on hypertension and microalbuminuria in type II diabetes mellitus|
Jungmann 1997c {published data only}|Management guidance for non-insulin-dependent type 2 diabetics. Effects of an outpatient instruction program on metabolism and risk factors|/resolve/reference/PMED?id=9499634
Kaplan 1985 {published data only}|Prospective evaluation of HDL cholesterol changes after diet and physical conditioning programs for patients with type II diabetes mellitus|/resolve/reference/PMED?id=4042800
Kaplan 1987 {published data only}|The cost-utility of diet and exercise interventions in non-insulin-dependent diabetes mellitus|
Kaplan 1987b {published data only}|Effects of diet and exercise interventions on control and quality of life in non-insulin-dependent diabetes mellitus|/resolve/reference/PMED?id=3302144
Kendall 1987 {published data only}|A comparison of nutrient-based and exchange-group methods of diet instruction for patients with non insulin-dependent diabetes|/resolve/reference/PMED?id=3825986
Kendall 1990 {published data only}|Educating patients with diabetes: comparison of nutrient-based and exchange group methods|/resolve/reference/PMED?id=2303659
Keyserling 2000 {published data only}|A diabetes management program for African American women with type 2 diabetes|/resolve/reference/PMED?id=11140007
Keyserling 2002 {published data only}|A randomized trial of an intervention to improve self-care behaviors of African-American women with type 2 diabetes: impact of physical activity|/resolve/reference/PMED?id=12196430
Krier 1999 {published data only}|Effect of diabetes education on glucose control|/resolve/reference/PMED?id=11280842
Lacey 2000 {published data only}|An integrative literature review of cardiac risk factor management in diabetes education interventions|/resolve/reference/PMED?id=11140009
Laitinen 1993 {published data only}|Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non-insulin-dependent diabetes mellitus|/resolve/reference/PMED?id=8382712
Laitinen 1994 {published data only}|Metabolic and dietary variables associated with glycaemic control in patients with recently diagnosed Type II diabetes mellitus|
Larme 1998 {published data only}|Use of qualitative methods to evaluate diabetes education programs|/resolve/reference/PMED?id=9830954
Lazcano 1999 {published data only}|Eficacia de la educacin en el control de la glucemia de|
Levenson 2002 {published data only}|Stress management helps control glucose in type 2 diabetics|/resolve/reference/PMED?id=AMBIGUOUS%20(10%20citations)
Ligtenberg 1998 {published data only}|Influence of a physical training program on psychological well-being in elderly type 2 diabetes patients. Psychological well-being, physical training, and type 2 diabetes|/resolve/reference/PMED?id=9839122
Llamas 2002 {published data only}|How to optimize the use of reactive strips when dealing with type 2 diabetes patients nurses' role|
Lo 1996 {published data only}|The development and evaluation of a computer-aided diabetes education program|/resolve/reference/PMED?id=8900703
Lozano 1996 {published data only}|Diabetes type II, non insulin-dependent. Group education|/resolve/reference/PMED?id=8718124
Luna Arriola 1994 {unpublished data only}|Selfcare in the diabetic patient: impact of an educative selfcare programme about the style of life of non-insulin dependant diabetes mellitus patients at IPSS Cajamarca distrit 1994|
Madjarof 2001 {published data only}|The nurse role in the diabetic elderlly patient's education|
Maljanian 2002 {published data only}|Improved diabetes control through a provider-based disease management program|
Mancino 2002 {published data only}|Comparison of type 2 diabetes medical nutrition therapy to practice guidelines in a community health system|/resolve/reference/PMED?id=12171459
Martinez 1999 {published data only}|Evaluation of a nursing intervention for improving self-care of patients with diabetes|
Maxwell 1992 {published data only}|Effects of a social support group, as an adjunct to diabetes training, on metabolic control and psychosocial outcomes|/resolve/reference/PMED?id=1628531
Mayer-Davis 2001 {published data only}|Pilot study of strategies for effective weight management in type 2 diabetes: Pounds Off with Empowerment (POWER)|/resolve/reference/PMED?id=11373164
Mazzuca 1986 {published data only}|The diabetes education study: a controlled trial of the effects of diabetes patient education|/resolve/reference/PMED?id=3948638
McMurray 2002 {published data only}|Diabetes education and care management significantly improve patient outcomes in the dialysis unit|/resolve/reference/PMED?id=12200809
McNabb 1993 {published data only}|Weight loss program for inner-city black women with non-insulin-dependent diabetes mellitus: PATHWAYS|/resolve/reference/PMED?id=8417099
Miller 1999 {published data only}|Evaluation of a food label nutrition intervention for women with type 2 diabetes mellitus|/resolve/reference/PMED?id=10076584
Miller 2002 {published data only}|Evaluation of a theory-based nutrition intervention for older adults with diabetes mellitus|/resolve/reference/PMED?id=12171451
Miller 2002b {published data only}|Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial|/resolve/reference/PMED?id=11817922
Miller 2002c {published data only}|Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial|/resolve/reference/PMED?id=11817922
Morgan 1988 {published data only}|A closer look at teaching and contingency contracting with type II diabetes 394|
Muhlhauser 2002 {published data only}|Patient education - evaluation of a complex intervention|/resolve/reference/PMED?id=12488964
Mulrow 1987 {published data only}|Evaluation of an audiovisual diabetes education program: negative results of a randomized trial of patients with non-insulin-dependent diabetes mellitus|/resolve/reference/PMED?id=2441013
Noel 1998 {published data only}|Patient choice in diabetes education curriculum. Nutritional versus standard content for type 2 diabetes|/resolve/reference/PMED?id=9614604
Norris 2001 {published data only}|Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials|/resolve/reference/PMED?id=11289485
Norris 2002 {published data only}|Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control|/resolve/reference/PMED?id=12087014
Norris 2002b {published data only}|The effectiveness of disease and case management for people with diabetes: A systematic review|/resolve/reference/PMED?id=11985933
Norris 2002c {published data only}|Increasing diabetes self-management education in community settings: A systematic review|/resolve/reference/PMED?id=11985934
Pacyk 2001 {published data only}|The effect of a group education on psychological well-being in type 2 diabetic patients under primary or secondary care|
Padgett 1988 {published data only}|Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus|/resolve/reference/PMED?id=3193136
Rabkin 1983 {published data only}|A randomized clinical trial comparing behavior modification and individual counseling in the nutritional therapy of non-insulin-dependent diabetes mellitus: comparison of the effect on blood sugar, body weight, and serum lipids|/resolve/reference/PMED?id=6341015
Rachmani 2002 {published data only}|Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus-a randomized prospective study|
Raji 2002 {published data only}|A Randomised Trial Comparing Intensive and Passive Education in Patients With Diabetes Mellitus|/resolve/reference/PMED?id=12038949
Raz 1988 {published data only}|Influence of small-group education sessions on glucose homeostasis in NIDDM|/resolve/reference/PMED?id=3338379
Rebell 2002 {published data only}|Long-term effects of behavior therapy on metabolic parameters and weight in overweight type 2 diabetic patients: Results of a study sponsored by the German Ministry of Health|
Renders 2000 {published data only}|Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings|
Ridgeway 1999 {published data only}|Improved control of type 2 diabetes mellitus: a practical education/behavior modification program in a primary care clinic|/resolve/reference/PMED?id=10414474
Rivera Tejada 1996 {published data only}|Self-care behavior assessment of non-insulin dependent diabetes patients that are attended at the programme of diabetes control at IPSS Trujillo, Per|
Rubin 1991 {published data only}|Differential effect of diabetes education on self-regulation and life-style behaviors|/resolve/reference/PMED?id=2060437
Saenz Hernaiz 1992 {published data only}|Effectiveness of health education given to type II, non insulin-dependent diabetics|/resolve/reference/PMED?id=1472603
Samaras 1997 {published data only}|Will older sedentary people with non-insulin-dependent diabetes mellitus start exercising? A health promotion model|/resolve/reference/PMED?id=9279482
Sarkadi 2001 {published data only}|Field test of a group education program for type 2 diabetes: measures and predictors of success on individual and group levels|/resolve/reference/PMED?id=11479053
Scain 1986 {published data only}|Education for the health for a group of clients of clients diabetics|
Schiel 1999 {published data only}|Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group|/resolve/reference/PMED?id=10566123
Scott 1984 {published data only}|The effectiveness of diabetes education for non-insulin-dependent diabetic persons|/resolve/reference/PMED?id=6562009
Simmons 1992 {published data only}|Diabetes self help facilitated by local diabetes research: the Coventry Asian Diabetes Support Group|
Simmons 1996 {published data only}|A pilot diabetes awareness and exercise programme in a multiethnic workforce|/resolve/reference/PMED?id=8890876
Steed 2003 {published and unpublished data}|Evaluation of the UCL Diabetes Self-Managment Programme (UCL-DSMP) in Patients with Type 2 Diabetes and Microalbuminuria: A Randomised Controlled Trial|
Surwit 2002 {published data only}|Stress management improves long-term glycemic control in type 2 diabetes|/resolve/reference/PMED?id=11772897
Swenson 2000 {published data only}|Improved glucose control associated with an educator-run diabetes education and management intervention|
Tankova 2001 {published data only}|Education of diabetic patients - a one year experience|/resolve/reference/PMED?id=11369147
Toobert 2002 {published data only}|Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial|/resolve/reference/PMED?id=12408202
Unknown 1994 {published data only}|Effect of patient education on quality of diabetes care|
Unknown 2002 {published data only}|'Health literacy' impacts on diabetes|
Uusitupa 1993 {published data only}|The maintenance of improved metabolic control after intensified diet therapy in recent type 2 diabetes|/resolve/reference/PMED?id=8319521
Uusitupa 1996 {published data only}|Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance|/resolve/reference/PMED?id=8949977
Vaaler 2000 {published data only}|Optimal glycemic control in type 2 diabetic patients. Does including insulin treatment mean a better outcome?|/resolve/reference/PMED?id=10860188
Van 2000 {published data only}|Education integrated into structured general practice care for Type 2 diabetic patients results in sustained improvement of disease knowledge and self-care|
Vanninen 1992 {published data only}|Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention|/resolve/reference/PMED?id=1516762
Vanninen 1993 {published data only}|Effect of metabolic control on autonomic function in obese patients with newly diagnosed type 2 diabetes|
Vazquez 1998 {published data only}|Buena Alimentacion, Buena Salud: a preventive nutrition intervention in Caribbean Latinos with type 2 diabetes|/resolve/reference/PMED?id=10346658
Veldhuizen1995 {published data only}|Developing and implementing a pharmaceutical care model in an ambulatory care setting for patients with diabetes... the Regional Diabetes Center (RDC) in Lafayette, Indiana|/resolve/reference/PMED?id=7698064
Wang 1998 {published data only}|Development of a community-based diabetes and hypertension preventive program|
Wheeler 2001 {published data only}|Diabetes education research|/resolve/reference/PMED?id=11289461
White 1986 {published data only}|Management of obese patients with diabetes mellitus: comparison of advice education with group management|/resolve/reference/PMED?id=3769719
Wierenga 1990 {published data only}|A descriptive study of how clients make life-style changes|/resolve/reference/PMED?id=2076627
Wilson 1987 {published data only}|The impact of diabetes education and peer support upon weight and glycemic control of elderly persons with non insulin dependent diabetes mellitus (NIDDM)|/resolve/reference/PMED?id=3565666
Wing 1985 {published data only}|Behavior change, weight loss, and physiological improvements in type II diabetic patients|/resolve/reference/PMED?id=3980816
Wing 1988 {published data only}|Self-regulation in the treatment of Type II diabetes|
Wing 1993b {published data only}|Behavioral treatment of obesity: Its application to type II diabetes|/resolve/reference/PMED?id=8422775
Wroe 1995 {published data only}|Diabetes care: a challenge for the 21st century. The 15th International Diabetes Federation Congress. 6-11 November, 1994, Kobe, Japan|
Wroe 2000 {published data only}|Diabetes research: Past and present: Highlights from a special symposium for past and present Novo Nordisk Research Fellows: Organised by the Novo Nordisk UK Research Foundation Stratford-upon-Avon, UK, 19-20 May 2000|
Wroe 2000b {published data only}|Highlights of the 60th Scientific Sessions of the American Diabetes Association 9-13 June 2000, San Antonio, Texas, USA|
Wroe 2001 {published data only}|New possibilities: prevention and intervention - highlights from the 6th Annual Conference of the Federation of European Nurses in Diabetes (FEND) 7-8 September 2001, Glasgow, UK|
Wroe 2001b {published data only}|Highlights of the Diabetes UK Annual Professional Meeting: 4-6 April 2001, Glasgow|
Wroe 2001c {published data only}|Highlights of the 17th International Diabetes Federation Congress Mexico City, November 5-10, 2000|
Wroe 2002 {published data only}|Highlights from the 38th Annual Meeting of the European Association for the Study of Diabetes (EASD): 1-5 September 2002, Budapest, Hungary|
Wroe 2002b {published data only}|Diabetes UK - 'largest ever meeting': A report from the Annual Professional Conference of Diabetes UK 13-15 March 2002, Birmingham, UK|
ADA 1997|Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus|/resolve/reference/PMED?id=9203460
Anderson 2000||
Anderson 2000b|The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy|/resolve/reference/PMED?id=10840988
Barlow 2000|A Randomised Controlled Study of the Arthritis Self-Management Program in the UK|/resolve/reference/PMED?id=11142075
Bradley 1999|The development of an individualised questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL|/resolve/reference/PMED?id=10457741
Brown 1988|Effects of educational interventions in diabetes care: a meta-analysis of findings|/resolve/reference/PMED?id=3293025
Brown 1990|Studies of educational interventions and outcomes in diabetic adults: a meta-analysis revistited|/resolve/reference/PMED?id=2149753
Brown 1992|Meta-analysis of diabetes patient education research: variations in intervention effects across studies|
Cohen 1960|A coefficient of agreement for normal scales|
CRD 2000|Complications of diabetes: renal disease and promotion of self-management|
DCCT 1988|Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT)|/resolve/reference/PMED?id=3066604
DCCT 1993|The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus|/resolve/reference/PMED?id=8366922
DECS 2002||
DECS 2003||
Diabetes UK 2000|T2ARDIS throws down the gauntlet|
Diabetes UK 2002||
DoH 1999|'Saving Lives: Our Healthier Nation'|
DOH 2001||
DOH 2001b||
DOH 2003||
DoH/Diabetes UK 1995|St Vincent Joint Task Force for Diabetes: The Report|
Domenech 1995|Evaluation of the effectiveness of an ambulatory teaching/treatment programme for non-insulin dependent (type 2) diabetic patients|
Funnell 1991|Empowerment: An idea whose time has come in diabetes education|/resolve/reference/PMED?id=1986902
Griffin 1998|Educational and psychosocial interventions for adults with diabetes|
Gruesser 1993|Evaluation of a structured treatment and teaching program for non-insulin-treated type II diabetic outpatients in Germany after the nationwide introduction of reimbursement policy for physicians|/resolve/reference/PMED?id=8404431
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
IDF 2001|Diabetes abd cardiovascular Disease: Time to Act|
Jadad 1996|Assessing the quality of reports of randomised clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Keen 1995|Diabetes in the United Kingdom - 1996|
Little 1999|The Validity of dietary assessment in general practice|/resolve/reference/PMED?id=10396494
Lorig 1999|Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization|/resolve/reference/PMED?id=10413387
Mazzuca 1982|Does patient education in chronic disease have any therapeutic value?|/resolve/reference/PMED?id=7085844
Mensing 2003|National Standards for Diabetes Self-Management Education|/resolve/reference/PMED?id=12502650
MRC 2000|A Framework for Development and Evaluation of RCTs for Complex Interventions to Improve Health|
Mullen 1985|Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types|/resolve/reference/PMED?id=2418436
Mhlhauser 1983|Bicentric evaluation of a teaching programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months|
NDAG 1979|Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance|/resolve/reference/PMED?id=510803
NICE 2003||
Padgett 1988|Meta-Analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus|/resolve/reference/PMED?id=3193136
Pieber 1995b|Evaluation of a structured outpatient group education program for intensive insulin therapy|/resolve/reference/PMED?id=8585999
Posavac 1980|Evaluations of patient education programs|/resolve/reference/PMED?id=10245789
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment in controlled trials|/resolve/reference/PMED?id=7823387
Sicree 2003|The Global Burden of Diabetes|
Tapp 2003|Complications of Diabetes|
Toobert 1994|Assessing diabetes self-management: The summary of diabetes self-care activities questionnaire|
UKPDS-33 1998|Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)|/resolve/reference/PMED?id=9742976
UKPDS-35 2000|Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study|/resolve/reference/PMED?id=10938048
UKPDS-36 2000|Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study|/resolve/reference/PMED?id=10938049
Van Dam 2003|Provider-patient interaction in diabetes care: effects on patient self-care and outcomes. A systematic review|
Ware 1994||
WHO 1978|The Alma Ata Declaration|
WHO 1980|Diabetes Mellitus: second report|
WHO 1985|Diabetes Mellitus: Report of a WHO Study Group|
WHO 1998|Therapeutic Patient Education: continuing education programmes for healthcare providers in the field of prevention of chronic diseases|
WHO 1999b|Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus|
Williams 2003|The Economic Impact of Diabetes|
Ardizzone 2003 {published data only}|Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study|/resolve/reference/PMED?id=14563183
Arora 1999 {published data only}|Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=10430331
Feagan 1995 {published data only}|Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators|/resolve/reference/PMED?id=7816064
Mate-Jimenez 2000 {published data only}|6-Mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease|/resolve/reference/PMED?id=11111780
Oren 1997 {published data only}|Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial|/resolve/reference/PMED?id=9399753
Baron 1993 {published data only}|Low-dose oral methotrexate in refractory inflammatory bowel disease|/resolve/reference/PMED?id=8404406
Egan 1999 {published data only}|A randomized dose-response and pharmacokinetic study of methrotrexate for refractory inflammatory Crohn's disease and ulcerative colitis|
Kozarek 1989 {published data only}|Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease|/resolve/reference/PMED?id=2492786
Lemann 1996 {published data only}|Methotrexate for the treatment of refractory Crohn's disease|
Lemann 2000 {published data only}|Methotrexate in Crohn's disease: long-term efficacy and toxicity|/resolve/reference/PMED?id=10925976
Vandeputte 1999 {published data only}|Methotrexate in refractory Crohn's disease|
Balis 1988|Pharmacokinetics of subcutaneous methotrexate|/resolve/reference/PMED?id=3199171
Beyea 1995|Administration of medications via the instramuscular route: an integrative review of the literature and research-based protocol for procedure|/resolve/reference/PMED?id=7695353
Binder 1985|Prognosis in Crohn's disease - based on result from a regional patient group from the country of Copenhagen|/resolve/reference/PMED?id=3967832
Brooks 1990|Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis|
Egan 1999b|Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease|/resolve/reference/PMED?id=9951428
Griffith 2000|Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?|/resolve/reference/PMED?id=11035130
Harvey 1980|A simple index of Crohn's-disease activity|/resolve/reference/PMED?id=6102236
Kremer 1994|Methotrexate for rheumatoid arthritis: Suggested guidelines for monitoring liver toxicity|
Lorenzi 2000|Daily folate supplementation is adequate prophylaxis against methotrexate-induced nausea and vomiting and avoids the need for expensive anti-emetic prescription|/resolve/reference/PMED?id=10908708
Present 1989|6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity|/resolve/reference/PMED?id=2802419
Roger 2000|Drawing up and administering intramuscular injections: a review of the literature|
Sandborn 1998|Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease|
Adam 1982 {published data only}|Labetalol, beta blockers, and acute deterioration of chronic airway obstruction|/resolve/reference/PMED?id=6126285
Anderson 1980 {published data only}|A comparison of oral metoprolol and propranolol in patients with chronic bronchitis|/resolve/reference/PMED?id=6989683
Beil 1977 {published data only}|Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease|/resolve/reference/PMED?id=324487
Butland 1983 {published data only}|Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema|/resolve/reference/PMED?id=6863097
Chang 2010 {published data only}|Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise|
Dorow 1986a {published data only}|A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction|/resolve/reference/PMED?id=2427835
Dorow 1986b {published data only}|Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris|/resolve/reference/PMED?id=2879733
Fenster 1983 {published data only}|Effect of metoprolol on cardiac and pulmonary function in chronic obstructive pulmonary disease|
Fogari 1990 {published data only}|Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease|/resolve/reference/PMED?id=1982059
Hawkins 2009 {published data only}|Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial|
Lammers 1985a {published data only}|Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease|/resolve/reference/PMED?id=4041341
Macquin-Mavier 1988 {published data only}|Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction|/resolve/reference/PMED?id=2902873
McGavin 1978 {published data only}|The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstruction|/resolve/reference/PMED?id=365214
Perks 1978 {published data only}|Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction|
Ranchod 1982 {published data only}|The effect of beta-blockers on ventilatory function in chronic bronchitis|/resolve/reference/PMED?id=7038918
Schanning 1976 {published data only}|Beta1-blocker (Practolol) and exercise in patients with chronic obstructive lung disease|
Sinclair 1979 {published data only}|Comparison of effects of propranolol and metoprolol on airways obstruction in chronic bronchitis|/resolve/reference/PMED?id=369647
Sorbini 1982 {published data only}|Acute effects of oral metoptolol on ventilatory function in patients with chronic obstructive lung disease|
Tivenius 1976 {published data only}|Effects of multiple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=790561
van der Woude 2005 {published data only}|Detrimental effects of beta-blockers in COPD. A concern for nonselective beta-blockers|/resolve/reference/PMED?id=15764762
von Wichert 1982 {published data only}|Reversibility of bronchospasm in airway obstruction|/resolve/reference/PMED?id=7102530
Wunderlich 1980 {published data only}|Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration|/resolve/reference/PMED?id=6107217
Abraham 1981 {published data only}|Effect of intravenous metoprolol on reversible obstructive airways disease|
Addis 1976 {published data only}|Effects of oxprenolol on the airways of normal and bronchitic subjects|/resolve/reference/PMED?id=786691
Anavekar 1982 {published data only}|A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease|/resolve/reference/PMED?id=6184571
Camsari 2003 {published data only}|Metoprolol, a beta-1 selective blocker, can be used safely in corornary artery disease patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=14520486
Chester 1981 {published data only}|Adverse effect of propranolol on airway function in nonasthmatic chronic obstructive lung disease|/resolve/reference/PMED?id=7014121
Clague 1984 {published data only}|Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade|/resolve/reference/PMED?id=6151505
Dal Negro 1981 {published data only}|Changes in alveolar ventilation distribution due to beta antagonists induced by four different drugs in patients with chronic obstructive lung disease|
Dal Negro 1986 {published data only}|Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease|/resolve/reference/PMED?id=2875954
Dorow 1984 {published data only}|Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis|/resolve/reference/PMED?id=6149938
Dorow 1986c {published data only}|Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=2871220
George 1983 {published data only}|Effects of labetalol in hypertensive patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=6337786
Jabbour 2010 {published data only}|Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15519007
Johnsson 1976 {published data only}|Use of beta-adrenergic blockers in combination with beta-stimulators in patients with obstructive lung disease|/resolve/reference/PMED?id=6250
Lois 1997 {published data only}|Beta-blockade post-MI: safe for patients with asthma or COPD?|
Lois 1999 {published data only}|Using beta-blockers for CHF in patients with COPD|
Meier 1966a {published data only}|[On the effect of adrenergic beta-receptor-blocking agents on the ventilatory function in obstructive lung diseases]|/resolve/reference/PMED?id=5902649
Meier 1966b {published data only}|The action of adrenergic beta-receptor blockers on ventilatory functions in obstructive lung diseases|/resolve/reference/PMED?id=5933449
Nordstrom 1975 {published data only}|Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=1112122
Quan 1983 {published data only}|Suppression of atrial ectopy with intravenous metoprolol in chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=6630583
Ulmer 1976 {published data only}|Propranolol and Pindolol in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=791605
van Herwaarden 1983 {published data only}|Beta-adrenocepptor blockade and pulmonary function in patients suffering from chronic obstructive lung disease|/resolve/reference/PMED?id=6188919
Wettengel 1970 {published data only}|Effect of different beta-receptor blocking agents on ventilation in obstructive respiratory tract disease. Comparative studies|/resolve/reference/PMED?id=4393828
Abdulla 2006|Effect of beta-blocker therapy on functional status in patients with heart failure - a meta-analysis|
Anderson 1979|Persistent asthma after treatment with beta-blocking agents|/resolve/reference/PMED?id=45308
ATS 1995|Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society|/resolve/reference/PMED?id=7582322
Au 2004|Beta-blockers as single-agent therapy for hypertension and the risk fo mortality among patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15629731
Beattie 2008|Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials|/resolve/reference/PMED?id=18349171
Belli 1995|Adjunctive pharmacologic strategies for acute MI|
Beto 1992|Quality of life in treatment of hypertension: A meta-analysis of clinical trials|/resolve/reference/PMED?id=1349484
Bright 1992|Beta-blockers and depression: Evidence against an assoication|/resolve/reference/PMED?id=1347572
Chafin 1999|Beta-blockers after myocardial infarction: Do benefits ever outweigh risks in asthma?|/resolve/reference/PMED?id=10702651
Chen 2001|Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma|/resolve/reference/PMED?id=11401137
Craig 1996|Problem drugs for the patient with asthma|/resolve/reference/PMED?id=8814381
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Doughty 1997|Effects of beta-blocker therapy on mortality in patients with heart failure|/resolve/reference/PMED?id=9129883
Dransfield 2008|Use of beta-blockers and the risk of death in hospitalized patients with acute exacerbations of COPD|/resolve/reference/PMED?id=17951276
Egred 2005|Under-use of beta-blockers in patients with ischemic heart disease and comcomitant chronic obstructive pulmonary disease|
Falliers 1985|The effects of treatments with labetalol and hydrochlorothiazide on ventilatory function of asthmatic hypertensive patients with demonstrated bronchosensitivity to propranolol|/resolve/reference/PMED?id=3836297
Fitzgerald 1991|The applied pharmacology of beta-adrenoceptor antagonist (beta-blockers) in relation to clinical outcomes|/resolve/reference/PMED?id=1678960
Formgren 1976|The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics|
Freemantle 1999|Beta blockade after myocardial infarction: systematic review and meta regression analysis|/resolve/reference/PMED?id=10381708
Gottlieb 1998|Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction|/resolve/reference/PMED?id=9709041
Heidenreich 1999|Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina|/resolve/reference/PMED?id=10349897
Heller 2000|Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarcion|/resolve/reference/PMED?id=11011343
Hulsmann 2001|Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction|/resolve/reference/PMED?id=11704477
Ionnidis 1999|Pooling research results: benefits and limitations of meta-analysis|/resolve/reference/PMED?id=10481815
IPPSH 1985|Cardiovascular risk and risk factors in a randonized trial of treatment based on the beta-blocker oxprenolo: The Internation Prospective Primary Prevention Study in Hypertension (IPPPSH)|/resolve/reference/PMED?id=2864374
JNC 1997|The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure|/resolve/reference/PMED?id=9385294
Jonas 1996|Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease|/resolve/reference/PMED?id=8677865
Jones 1980|The effect of oxprenolol, acebutolol and propranolol on thyroid hormones in hyperthyroid subjects|
Kendall 1997|Clinical relevance of pharmacokinetic differences between beta blockers|/resolve/reference/PMED?id=9375944
Kennedy 1995|Physician use of beta-adrenergic blocking therapy: A changing perspective|/resolve/reference/PMED?id=7608462
Kjekshus 1990|Diabetic patients and beta-blockers after acute myocardial infarction|/resolve/reference/PMED?id=1968386
Klein 1994|Treatment of hyperthyroid disease|/resolve/reference/PMED?id=7518659
Koch-Weser 1984|Beta-adrenergic blockade for survivors of acute myocardial infarction|/resolve/reference/PMED?id=6142420
Krauss 1984|Treatment of hypertension in mild asthmatic patients with atenolol|/resolve/reference/PMED?id=6507943
Krumholz 1998|National use and effectiveness of beta-blcokers for the treatment of elderly patients after acute myocardial infarction|/resolve/reference/PMED?id=9718054
Krumholz 1999|Early beta-blocker therapy for acute myocardial infarction in elderly patients|/resolve/reference/PMED?id=10577326
Lechat 1998|Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of placebo-controlled, randomized trials|/resolve/reference/PMED?id=9743509
Mangano 1996|Atenolol reduced mortality and cardiovascular events after noncardiac surgery|/resolve/reference/PMED?id=8929262
Mantel 1959|Statistical aspects of the analysis of data from retrospective studies of disease|/resolve/reference/PMED?id=13655060
McGory 2005|A meta-analysis of perioperative beta blockade: What is the actual risk reduction?|/resolve/reference/PMED?id=16153424
McNeill 1964|Effect of a beta-adrenergic-blocking agent, propranolol, on asthmatics|/resolve/reference/PMED?id=14207902
Mooss 1994|Safety of esmolol in patients with acute myocardial infaction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy|/resolve/reference/PMED?id=7919552
O'Malley 1991|Choice of drug treatment for elderly hypertensive patients|/resolve/reference/PMED?id=2006657
Opie 1990|Required beta blocker profile in the elderly|
Poulsen 2000|Improvement in exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction|/resolve/reference/PMED?id=10874255
Radack 1991|Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=1679624
Raine 1981|Near fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane|/resolve/reference/PMED?id=6109556
Rosenson 1993|The truth about beta-blocker adverse effects - depression, claudication, and lipids|
Rutten 2010|Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=20498416
Salpeter 2002|Cardioselective beta-blockers for reversible airway disease (Cochrane Review)|
Sial 1994|Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction|/resolve/reference/PMED?id=7853068
Soumerai 1997|Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction|/resolve/reference/PMED?id=8990335
Steinbeck 1992|A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias|/resolve/reference/PMED?id=1355595
Tattersfield 1986|Beta adrenergic antagonists and respiratory disease|/resolve/reference/PMED?id=2427850
Tattersfield 1990|Respiratory function in the elderly and the effects of beta blockade|
Van Gestel 2008|Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis|/resolve/reference/PMED?id=18565952
Viskin 1996|Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?|/resolve/reference/PMED?id=8857489
Wadworth 1991|Atenolol: A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders|/resolve/reference/PMED?id=1720383
Wang 1998|National patterns and predictors of beta-blocker use in patients with coronary artery disease|/resolve/reference/PMED?id=9759686
Wellstein 1987|Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy|/resolve/reference/PMED?id=2897299
Wicklmayr 1990|Effects of beta-blocking agents on insulin secretion and glucose disposal|/resolve/reference/PMED?id=1975244
Yusuf 1985|Beta-blockade during and after myocardial infarction: an overview of the randomized trials|/resolve/reference/PMED?id=2858114
Zaid 1966|Bronchial response to beta-adrenergic blockade|/resolve/reference/PMED?id=5920412
Sandborn 2001a {published data only}|An engineered human antibody to TNF (CDP571) for active Crohn's disease: A randomized double-blind placebo-controlled trial|/resolve/reference/PMED?id=11313302
Sandborn 2001b {published data only}|Etanercept for active Crohn's disease: A randomized double-blind, placebo-controlled trial|/resolve/reference/PMED?id=11677200
Stack 1997 {published data only}|Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease|/resolve/reference/PMED?id=9048788
Targan 1997 {published data only}|A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease|/resolve/reference/PMED?id=9321530
Baldassano 2003 {published data only}|Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease|
D'Haens 1999 {published data only}|Endoscopic and histologic healing with infliximab anti-tumor Necrosis factor antibodies in Crohn's Disease: a European multicentre trial|/resolve/reference/PMED?id=10220494
Hanauer 2002 {published data only}|Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial|/resolve/reference/PMED?id=12047962
Present 1999 {published data only}|Infliximab for the treatment of fistulas in patients with Crohn's disease|/resolve/reference/PMED?id=10228190
Rutgeerts 1999 {published data only}|Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease|/resolve/reference/PMED?id=10500056
Rutgeerts 2003 {published data only}|Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open label study|
Baert 1999|Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis|/resolve/reference/PMED?id=9869598
Bauditz 1997|Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease|/resolve/reference/PMED?id=9176073
Bell 2000|Review article: the clinical role of anti-TNF alpha antibody treatment in Crohn's disease|
Breese 1994|Tumor necrosis factor -alpha producing cells in the intestinal musosa of children with inflammatory bowel disease|/resolve/reference/PMED?id=8194690
Brown 2002|Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration|
Clarke 2001||
Jadad 1996|Assessing the quality of reports of randomized clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Keane 2001|Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent|/resolve/reference/PMED?id=11596589
MacDonald 1990|Tumour necrosis factor-alpha and interferon gamma production measured at the single cell level in normal and inflamed human intestine|
Murch 1991|Serum concentrations of tumour necrosis factor-alpha in childhood chronic inflammatory bowel disease|/resolve/reference/PMED?id=1885073
Papadikas 2000|Tumor necrosis factor: Biology and therapeutic inhibitors|
Pitkin 1999|Accuracy of data in abstracts of published research articles|/resolve/reference/PMED?id=10188662
Rampton 1999|Management of Crohn's disease|/resolve/reference/PMED?id=10582935
Reimund 1996|Increased production of tumour necrosis factor-a, interleukin 1b, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease|/resolve/reference/PMED?id=9026483
Scallon 1995|Chimeric anti TNF- alpha monoclonal antibody Ca2 binds recombinant trasmembrane TNF- alpha and activates immune effector functions|/resolve/reference/PMED?id=7640345
Shanahan 2001|Inflammatory bowel disease: immunodiagnostics, immunotherapeutics and ecotherapeutics|/resolve/reference/PMED?id=11179240
Siegel 1995|The mouse/human chimeric monoclonal antibody cA2 neutralizes in vitro and protects transgenic mice from cachexia and TNF- lethality in vivo|/resolve/reference/PMED?id=7538333
AASK {published data only}|Effect of Ramipril vs Amlodipine on RenalOutcomes in Hypertensive Nephrosclerosis: A Randomized Controlled Trial|/resolve/reference/PMED?id=11386927
AASK {published data only}|Effect of Blood Pressure Control andAntihypertensive Drug Regimen on Qualityof Life: The African American Study of KidneyDisease and Hypertension (AASK) Pilot Study|
AASK {published data only}|Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial|/resolve/reference/PMED?id=17059993
AASK {published data only}|Design and baseline characteristics of participants in the African American Study of Kidney disease and hypertension (AASK) pilot study|/resolve/reference/PMED?id=8889350
AASK {published data only}|Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial|/resolve/reference/PMED?id=12435255
ABCD {published data only}|The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension|/resolve/reference/PMED?id=9486993
ABCD {published data only}|The ABCD (AppropriateBlood Pressure Control in Diabetes) trial: rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes|
ABCD {published data only}|Additional Follow-Up from the ABCD Trial in Patients with Type 2 Diabetes and Hypertension|/resolve/reference/PMED?id=11186674
ALLHAT {published data only}|Rationaleand design for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=8722437
ALLHAT {published data only}|Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial|/resolve/reference/PMED?id=12479764
ALLHAT {published data only}|Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=12479763
ASCOT-BPLA {published data only}|Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-ScandinavianCardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOTBPLA): a multicentre randomised controlled trial|/resolve/reference/PMED?id=16154016
ASCOT-BPLA {published data only}|Rationale, design, methods and baseline demography of participants of the Anglo-ScandinavianCardiac Outcomes Trial|
CONVINCE {published data only}|Principal Results of the Controlled OnsetVerapamil Investigation of CardiovascularEnd Points (CONVINCE) Trial|/resolve/reference/PMED?id=12709465
CONVINCE {published data only}|Baseline characteristics and early blood pressure control in the CONVINCE trial|/resolve/reference/PMED?id=11208750
CONVINCE {published data only}|Rationale and design for the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) Trial|/resolve/reference/PMED?id=9683312
ELSA {published data only}|Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis(ELSA), a randomized, double-blind, long-term Trial|/resolve/reference/PMED?id=12417537
FACET {published data only}|Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM|/resolve/reference/PMED?id=9571349
IDNT {published data only}|Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy|/resolve/reference/PMED?id=12667024
IDNT {published data only}|Renoprotective effect of angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes|
IDNT {published data only}|The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics|/resolve/reference/PMED?id=10727543
INSIGHT {published data only}|Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal inHypertension Treatment (INSIGHT)|/resolve/reference/PMED?id=10972368
INVEST {published data only}|A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The international Verapamil-Trandolapril Study (INVEST): a randomized controlled trial|/resolve/reference/PMED?id=14657064
INVEST {published data only}|Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST)|/resolve/reference/PMED?id=9809930
MIDAS {published data only}|Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): a randomized controlled trial|/resolve/reference/PMED?id=8769587
MIDAS {published data only}|MIDAS: hypertension and atherosclerosis, a trial of the effect of antihypertensive drug treatment on atherosclerosis|
MIDAS {published data only}|Designfeatures: Multicenter Isradipine Diuretic AtherosclerosisStudy (MIDAS)|/resolve/reference/PMED?id=2523653
NICS-EH {published data only}|Treatment of elderly hypertensive in Japan: National Intervention Cooperative Study in Elderly Hypertensives|/resolve/reference/PMED?id=7799108
NICS-EH {published data only}|Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives|/resolve/reference/PMED?id=10567194
NORDIL {published data only}|Randomised trial of effects of calcium antagonists compared with diuretics and -blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study|/resolve/reference/PMED?id=10972367
NORDIL {published data only}|Progress report on the Nordic diltiazem study (NORDIL): an outcome study in hypertensive patients|/resolve/reference/PMED?id=10803490
NORDIL {published data only}|The Nordic Diltiazem Study (NORDIL). A Prospective Intervention Trial of of Calcium Antagonist Therapy in Hypertension|/resolve/reference/PMED?id=8173702
SHELL {published data only}|Treatment of Isolated Systolic Hypertension: The SHELL Study Results|/resolve/reference/PMED?id=12875478
STOP-Hypertension-2 {published data only}|STOP-Hypertension-2: a prospective intervention trial of "newer" versus"older" treatment alternatives in old patients with hypertension|/resolve/reference/PMED?id=8180726
STOP-Hypertension-2 {published data only}|Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study|/resolve/reference/PMED?id=10577635
STOP-Hypertension-2 {published data only}|The Swedish trial in Old Patients with Hypertension (STOP-Hypertension-2): a progress report|/resolve/reference/PMED?id=8879603
TOMHS {published data only}|TheTreatment of Mild Hypertension Study (TOMHS): characteristics of participants at baseline|/resolve/reference/PMED?id=2220647
TOMHS {published data only}|Treatment of Mild Hypertension Study: final results|/resolve/reference/PMED?id=8336373
TOMHS {published data only}|Background and design of the new US trial on diet and drug treatment of 'mild' hypertension (TOMHS)|/resolve/reference/PMED?id=3296721
TOMHS {published data only}|The Treatment of Mild Hypertension Study. Arandomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies|/resolve/reference/PMED?id=2064494
VALUE {published data only}|Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial|/resolve/reference/PMED?id=15207952
VALUE {published data only}|The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design|/resolve/reference/PMED?id=9758088
VHAS {published data only}|Clinical results of the Verapamil in Hypertension and Atherosclerosis Study|/resolve/reference/PMED?id=9383184
VHAS {published data only}|The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness|/resolve/reference/PMED?id=9856368
Abascal 1998 {published data only}|Calcium antagonists and mortality risk in men and women with hypertension in the Framingham Heart Study|/resolve/reference/PMED?id=9759683
Bakris 1996 {published data only}|Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy|/resolve/reference/PMED?id=8914031
Bakris 1997 {published data only}|Effect of calcium channel or -blockade on the progression of diabetic nephropathy in African Americans|/resolve/reference/PMED?id=9052890
DHCCP {published data only}|Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP)|/resolve/reference/PMED?id=9185024
FACTS {published data only}|Fosinopril versus Amlodipine Comparative Treatments Study: a randomized trial to assess effects on plasminogen activator inhibitor-1|/resolve/reference/PMED?id=11815428
Gottdiener 1997 {published data only}|Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension|/resolve/reference/PMED?id=9133508
HOT {published data only}|Effects of intensive blood-pressure lowering and low-dose aspirin inpatients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial|/resolve/reference/PMED?id=9635947
Kes 2003 {published data only}|Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine|/resolve/reference/PMED?id=12803737
Maharaj 1992 {published data only}|A comparison of the acute hypotensive effects of two different doses of nifedipine|/resolve/reference/PMED?id=1514500
Pahor 1995 {published data only}|Long-term survival and use of antihypertensive medications in older persons|/resolve/reference/PMED?id=7594151
Papademetriou 1997 {published data only}|Hydrochlorothiazide is superior to Isradipine for reduction of left ventricular mass: results of a multicenter trial|/resolve/reference/PMED?id=9385910
PRESERVE {published data only}|Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension. The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial|/resolve/reference/PMED?id=11551875
Psaty 1995 {published data only}|The risk of myocardial infarction associated with antihypertensive drug therapies|/resolve/reference/PMED?id=7637142
Radevski 1999 {published data only}|Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension|/resolve/reference/PMED?id=10090348
Schneider 1991 {published data only}|Captopril, nifedipine and their combination for therapy of hypertensive urgencies|/resolve/reference/PMED?id=1925820
STONE {published data only}|Shanghai trial of nifedipine in the elderly (STONE)|/resolve/reference/PMED?id=8906524
Syst-China {published data only}|Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group|/resolve/reference/PMED?id=9869017
Syst-Eur {published data only}|Syst-Eur: a multicentre trial on the treatment of isolated systolic hypertension in the elderly:objectives, protocol, and organization|
Syst-Eur {published data only}|Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension|/resolve/reference/PMED?id=9297994
Syst-Eur {published data only}|Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension|/resolve/reference/PMED?id=9740604
J-MIC(B) {published data only}|Long-term effects of nifedipine retard vs ACE inhibitors in hypertension with coronary artery disease: final reports of J-MIC(B)|/resolve/reference/PMED?id=11954949
Angeli 2004|Calcium channel blockade to prevent stroke in hypertension: A meta-analysis of 13 studies with 103,793 subjects|/resolve/reference/PMED?id=15363825
Black 2004|Calcium Channel Blockers in theTreatment of Hypertension andPrevention of Cardiovascular Disease: Results from Major Clinical Trials|/resolve/reference/PMED?id=15850766
BPLTTC 2000|Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: Results of prospectively designed overviews of randomized trials|/resolve/reference/PMED?id=10859041
BPLTTC 2003|Effectsof different blood pressure lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials|/resolve/reference/PMED?id=14615107
Chobanian 2003|Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure|/resolve/reference/PMED?id=14656957
Ezzati 2002|Selected major risk factors and global and regional burden of disease|/resolve/reference/PMED?id=12423980
Fergusson 2002|Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis|/resolve/reference/PMED?id=12242181
Haggins 2008 - Chap. 16|Chapter 16: Special topics in statistics|
Haggins 2008 - Chap. 8|Chapter 8: Assessing risk of bias in included studies|
Haller 2008|Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk|
Hansson 1992|Prospective Randomized Open Blinded End-point (PROBE) study|/resolve/reference/PMED?id=1366259
HOPE 2000|Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients|/resolve/reference/PMED?id=10639539
MacMahon 2000|Differences between blood-pressure-lowering drugs|/resolve/reference/PMED?id=10972362
Mancia 2007|2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)|/resolve/reference/PMED?id=17562668
Mantel 1959|Statistical aspects of the analysis of data from retrospective studies of disease.|/resolve/reference/PMED?id=13655060
Opie 2000|Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies|/resolve/reference/PMED?id=11014332
Opie 2002|Evidence-based evaluation of calcium channel blockers for hypertension: Equality of mortality and cardiovascular risk relative to conventional therapy|/resolve/reference/PMED?id=11788225
Psaty 1997|Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis|/resolve/reference/PMED?id=9042847
Staessen 2003|Cardiovascular prevention and blood pressure reduction: a quantitative overview|/resolve/reference/PMED?id=12777939
Triggle 2007|Calcium channel antagonists: Clinical uses-Past, present and future|/resolve/reference/PMED?id=17276408
Turnbull 2003|Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials|/resolve/reference/PMED?id=14615107
Verdecchia 2005|Angiotensin-Converting Enzyme Inhibitors and Calcium ChannelBlockers for Coronary Heart Disease and Stroke Prevention|/resolve/reference/PMED?id=16009786
Wiysonge 2007|Beta-blockers for hypertension|
Wright 1999|Systematic review of anti-hypertensive therapies: Does the evidence assist in choosing a first-line drug?|/resolve/reference/PMED?id=10420860
Wright 2009|First-line drugs for hypertension|
Zanchetti 2005|Evidence-based medicine in hypertension: what type of evidence?|/resolve/reference/PMED?id=15894883
Pahor 2000|Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials|/resolve/reference/PMED?id=11130522
Alli 1992 {published data only}|Feasibility of a long-term low-sodium diet in mild hypertension|/resolve/reference/PMED?id=1433163
Arroll 1995 {published and unpublished data}|Salt restriction and physical activity in treated hypertensives|/resolve/reference/PMED?id=7637923
Costa 1981 {published data only}|Effects of low-salt diet and of acute salt loading on blood pressure and intralymphatic sodium concentration in young subjects with borderline hypertension|/resolve/reference/PMED?id=7032811
HPT {published and unpublished data}|Recruitment in the Hypertension Prevention trial. Hypertension Prevention Trial Research Group|/resolve/reference/PMED?id=2680272
HPT {published and unpublished data}|Baseline characteristics in the hypertension prevention trial|/resolve/reference/PMED?id=2680273
HPT {published and unpublished data}|Hypertension prevention trial: do 24-h food records capture usual eating behavior in a dietary study?|/resolve/reference/PMED?id=2407098
HPT {published and unpublished data}|The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure|/resolve/reference/PMED?id=2404477
HPT {published and unpublished data}|Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial|/resolve/reference/PMED?id=2187695
HPT {published and unpublished data}|Treatment in the Hypertension Prevention Trial|/resolve/reference/PMED?id=2680274
HPT {published and unpublished data}|Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group|/resolve/reference/PMED?id=2680271
HPT {published and unpublished data}|Quality assurance and monitoring in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group|/resolve/reference/PMED?id=2680275
HPT {published and unpublished data}|Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension|/resolve/reference/PMED?id=2063702
HPT {published and unpublished data}|Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Hypertension Prevention Trial Research Group|/resolve/reference/PMED?id=2404050
Morgan 1978 {published and unpublished data}|Hypertension treated by salt restriction|/resolve/reference/PMED?id=74660
Morgan 1978 {published and unpublished data}|Failure of therapy to improve prognosis in elderly males with hypertension|/resolve/reference/PMED?id=7432261
Morgan 1987 {published data only}|Sodium restriction can delay the return of hypertension in patients previously well-controlled on drug therapy|/resolve/reference/PMED?id=3319111
Silman 1983 {published data only}|Salt restriction and no drug treatment in mild to moderate hypertension [letter]|/resolve/reference/PMED?id=6122114
Silman 1983 {published data only}|Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension|/resolve/reference/PMED?id=6133987
Thaler men 1982 {published and unpublished data}|A pilot study to test the feasibility of salt restriction in a community|/resolve/reference/PMED?id=6962371
Thaler women 1982 {published and unpublished data}|A pilot study to test the feasibility of salt restriction in a community|/resolve/reference/PMED?id=6962371
TOHP phase I {published data only}|Effect of change in sodium excretion on change in blood pressure corrected for measurement error|/resolve/reference/PMED?id=9737555
TOHP phase I {published data only}|Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.|/resolve/reference/PMED?id=10679495
TOHP phase I {published data only}|Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group|/resolve/reference/PMED?id=8406655
TOHP phase I {published data only}|The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group|/resolve/reference/PMED?id=7769501
TOHP phase I {published data only}|Trials of hypertension prevention. Phase I design|/resolve/reference/PMED?id=1669525
TOHP phase I {published data only}|Weight loss intervention in phase 1 of the Trials of Hypertension Prevention|/resolve/reference/PMED?id=8466377
TOHP phase I {published data only}|The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I|/resolve/reference/PMED?id=1586398
TOHP phase I {published data only}|The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOPH) Collaborative Research Group|/resolve/reference/PMED?id=7795836
TOHP phase I {published data only}|Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention|/resolve/reference/PMED?id=1342280
TOHP phase I {published data only}|Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group|/resolve/reference/PMED?id=9022561
TOHP phase I {published data only}|Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group|/resolve/reference/PMED?id=7795837
TOHP phase II {published data only}|Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group|/resolve/reference/PMED?id=7795833
TOHP phase II {published data only}|Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (Phase II).|/resolve/reference/PMED?id=7795831
TOHP phase II {published data only}|Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization.|/resolve/reference/PMED?id=7795832
TOHP phase II {published data only}|Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention, Phase II|/resolve/reference/PMED?id=9740601
TOHP phase II {published data only}|Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group|/resolve/reference/PMED?id=7795834
TOHP phase II {published data only}|Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II|/resolve/reference/PMED?id=9080920
TONE {published data only}|Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial|/resolve/reference/PMED?id=7795830
TONE {published data only}|Effects of redcued sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE)|/resolve/reference/PMED?id=11231700
TONE {published data only}|Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE)|
TONE {published data only}|Predictors and mediators of successful long-term withdrawal from antihypertensive medications|/resolve/reference/PMED?id=10333818
TONE {published data only}|Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?|/resolve/reference/PMED?id=9874055
TONE {published data only}|Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE)|/resolve/reference/PMED?id=9515998
TONE {published data only}|Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE)|/resolve/reference/PMED?id=9033517
Aberg 1989 {published data only}|Addition of non-pharmacological methods of treatment in patients on antihypertensive drugs: results of previous medication, laboratory tests and life quality|
Ambard 1904 {published data only}|Causes de l'hypertension arterielle|
Ambrosioni 1982 {published data only}|Effects of moderate salt restriction and high potassium intake on intralymphocytic sodium content and pressor response to stress in borderline hypertension|
Anderson 1990 {published data only}|Interaction of enalapril with sodium restriction, diuretics, and slow-channel calcium-blocking drugs|/resolve/reference/PMED?id=2345592
Berglund 1989 {published data only}|Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension|/resolve/reference/PMED?id=2507028
Bompiani 1988 {published data only}|Effects of moderate low sodium / high potassium diet on essential hypertension: results of a comparative study|/resolve/reference/PMED?id=3045025
Cappuccio 1997 {published data only}|Double-blind randomised trial of modest salt restriction in older people [see comments]|/resolve/reference/PMED?id=9310603
Carney 1975 {published data only}|Sodium restriction and thiazide diuretics in the treatment of hypertension|/resolve/reference/PMED?id=1152772
Corcoran 1951 {published data only}|Controlled observations on the effect of low sodium dietotherapy in essential hypertension|
Dahl 1958 {published data only}|The role of salt in teh fall of blood pressure accompanying reduction in obesity|/resolve/reference/PMED?id=13552941
DASH {published data only}|A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group|/resolve/reference/PMED?id=9099655
DASH {published data only}|A dietary approach to prevent hypertension: a review of the dietary approaches to stop hypertension (DASH) study|
DASH {published data only}|Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet|/resolve/reference/PMED?id=11136953
DASH {published data only}|Effects of dietary patterns on blood pressure: subgroup analysis of the dietary approaches to stop hypertension (DASH) randomized clinical trial|/resolve/reference/PMED?id=9989541
DISH {published data only}|Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension|/resolve/reference/PMED?id=6599665
DISH {published data only}|Dietary therapy slows the return of hypertension after stopping prolonged medication|/resolve/reference/PMED?id=3881608
DISH {published data only}|Prediction of response to sodium intervention for blood pressure control|
DISH {published data only}|Effective dietary intervention in hypertensives: sodium restriction and weight reduction|/resolve/reference/PMED?id=3884691
Dole 1951 {published data only}|Dietary treatment of hypertension. II Sodium depletion as related to the therapeutic effect|/resolve/reference/PMED?id=14841259
Dubbert 1995 {published data only}|Effects of dietary instruction and sodium excretion feedback in hypertension clinic patients|
Erwteman 1984 {published data only}|Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial|/resolve/reference/PMED?id=6432119
Evers 1987 {published data only}|Lack of impact of salt restriction advice on hypertensive patients|/resolve/reference/PMED?id=3588562
Fagerberg 1984 {published data only}|Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction|/resolve/reference/PMED?id=6418295
Geleijnse 1995 {published data only}|Long-term moderate sodium restriction does not adversely affect the serum HDL/total cholesterol ratio|/resolve/reference/PMED?id=8746642
Gillum 1983 {published data only}|Nonpharmacologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients|/resolve/reference/PMED?id=6849226
Grimm 1990 {published data only}|The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet|/resolve/reference/PMED?id=2406601
HCP {published data only}|Cardiac status after four years in a trial on nutritional therapy for high blood pressure|/resolve/reference/PMED?id=2645845
HCP {published data only}|Nonpharmacological control of hypertension|/resolve/reference/PMED?id=3903735
HCP {published data only}|Trial on control of hypertension by nutritional means: three-year results|/resolve/reference/PMED?id=6400365
HCP {published data only}|Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program|/resolve/reference/PMED?id=3546747
HCP {published data only}|Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program|/resolve/reference/PMED?id=3546747
Henningsen 1980 {published data only}|Salt and essential hypertension. [Swedish]|
Holly 1981 {published data only}|Re-analysis of data in two Lancet papers on the effect of dietary sodium and potassium on blood pressure|/resolve/reference/PMED?id=6118759
Iwaoka 1994 {published data only}|Dietary NaCl restriction deteriorates oral glucose tolerance in hypertensive patients with impairment of glucose tolerance|/resolve/reference/PMED?id=8060581
Jula 1990 {published data only}|Long-term nopharmacological treatment for mild to moderate hypertension|
Jula 1992a {published data only}|Responses of atrial natriuretic factor to long-term sodium restriction in mild to moderate hypertension|
Jula 1992b {published data only}|Response of diastolic blood pressure to long-term sodium restriction is posture related|/resolve/reference/PMED?id=1411248
Jula 1994 {published data only}|Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension|/resolve/reference/PMED?id=8124787
Koopman 1990 {published data only}|Dietary treatment of patients with mild to moderate hypertension in a general practice: a pilot intervention study (2). Beyond three months|/resolve/reference/PMED?id=2258877
Koopman 1990 {published data only}|Dietary treatment of patients with mild to moderate hypertension in a general practice: a pilot intervention study. (2) Beyond 3 months|/resolve/reference/PMED?id=2258877
Korhonen 1999 {published data only}|Adherence to the salt restriction diet among people with mildly elevated blood pressure|/resolve/reference/PMED?id=10557001
Logan 1986 {published and unpublished data}|Sodium manipulation in the management of hypertension. The view against its general use|/resolve/reference/PMED?id=3756634
Logan 1986 {published and unpublished data}|Effect of dietary sodium restriction alone in the treatment of mild hypertension|
MacGregor 1982a {published data only}|Dietary sodium restriction in normotensive subjects and patients with essential hypertension|
MacGregor 1982b {published data only}|Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension|/resolve/reference/PMED?id=6120346
MacGregor 1989 {published data only}|Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension|/resolve/reference/PMED?id=2573761
Magnani 1976 {published data only}|Comparison of the effects of pharmacological therapy anda low-sodium diet on mild hypertension|/resolve/reference/PMED?id=1071693
McDonald 1988 {published data only}|Sodium, lithium-countertransport and blood pressure control by nutritional intervention in 'mild' hypertension|/resolve/reference/PMED?id=2454254
Morgan 1988 {published data only}|Interaction in hypertensive men between sodium intake, converting enzyme inhibitor (enalapril), plasma renin and blood pressure control|/resolve/reference/PMED?id=2851654
Muhlhauser 1993 {published data only}|Evaluation of a structured treatment and teaching programme on hypertension in general practice|/resolve/reference/PMED?id=8467308
Myers 1989 {published data only}|Reduced sodium chloride intake normalises blood pressure distribution|/resolve/reference/PMED?id=2760911
Nestel 1993 {published data only}|Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio|/resolve/reference/PMED?id=8133020
Neyses 1985 {published data only}|Compliance with salt restriction as a limiting factor in the primary prevention of hypertension|/resolve/reference/PMED?id=3916444
Nicholson 1986 {published data only}|The impact of dietary sodium intake on the hypotensive response of verapamil in essential hypertension|/resolve/reference/PMED?id=3540224
Nicholson 1987 {published data only}|The antihypertensive effect of verapamil at extremes of dietary sodium intake|/resolve/reference/PMED?id=3619222
Nowson 1988 {published data only}|Change in blood pressure in relation to change in nutrients effected by manipulation of dietary sodium and potassium|
Nugent 1984 {published data only}|Salt restriction in hypertensive patients. Comparison of advice, education and group management.|/resolve/reference/PMED?id=6732403
ODES {published data only}|Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study. (ODES)|/resolve/reference/PMED?id=8746601
Omvik 1986 {published data only}|Is sodium restriction effective treatment of borderline and mild essential hypertension? A long-term haemodynamic study at rest and during exercise.|/resolve/reference/PMED?id=3794329
Omvik 1995 {published data only}|Unchanged central hemodynamics after six months of moderate sodium restriction with or without potassium supplement in essential hypertension|/resolve/reference/PMED?id=7735495
Parijs 1973 {published data only}|Moderate sodium restriction and diuretics in the treatment of hypertension|/resolve/reference/PMED?id=4564947
Perera 1947 {published data only}|The relationship of sodium choride to hypertension|/resolve/reference/PMED?id=16695512
Priddle 1962 {published data only}|Hypertension-sodium and potassium studies|/resolve/reference/PMED?id=14488753
Rissanen 1985 {published data only}|Treatment of hypertension in obese patients: efficacy and feasibility of weight and salt reduction programs|
Roca-Cusachs 1991 {published data only}|The impact of a patient education programme in the control of hypertension|/resolve/reference/PMED?id=1770472
Sagnella 1987 {published data only}|Plasma atrial natriuretic peptide in essential hypertension: effects of changes in dietary sodium|/resolve/reference/PMED?id=2958105
Shibata 1979 {published data only}|A salt restriction trial in Japan|
Singer 1984 {published data only}|Low-sodium diet versus low-sodium/high-potassium diet for treatment of hypertension|/resolve/reference/PMED?id=6708394
Singer 1995 {published data only}|Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide|/resolve/reference/PMED?id=7737713
Stamler 1989 {published data only}|Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial [published erratum appears in JAMA 1989 Dec 8;262(22):3132]|/resolve/reference/PMED?id=2778913
Stamler 1989 {published data only}|Primary prevention of hypertension--a randomized controlled trial|/resolve/reference/PMED?id=6398983
TAIM {published data only}|Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy|/resolve/reference/PMED?id=1538559
TAIM {published data only}|Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension|/resolve/reference/PMED?id=8333814
TAIM {published data only}|Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group|/resolve/reference/PMED?id=1555871
TAIM {published data only}|Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management|/resolve/reference/PMED?id=7826557
TAIM {published data only}|Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group|/resolve/reference/PMED?id=1671380
TAIM {published data only}|Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status [see comments]|/resolve/reference/PMED?id=1967210
TAIM {published data only}|Differences in precision of dietary estimates among different population subgroups|/resolve/reference/PMED?id=7921310
TAIM {published data only}|The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life [see comments]|/resolve/reference/PMED?id=1736933
TAIM {published data only}|Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention|/resolve/reference/PMED?id=8454808
TOMHS {published data only}|Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS)|/resolve/reference/PMED?id=7479629
TOMHS {published data only}|Treatment of mild hypertension study: final results|/resolve/reference/PMED?id=8336373
TOMHS {published data only}|Background and design of the new U.S. trial on diet and drug treatment of "mild" hypertension (TOMHS)|/resolve/reference/PMED?id=3296721
TOMHS {published data only}|The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies|/resolve/reference/PMED?id=2064494
Velloso 1991 {published data only}|[Diet with usual quantity of salt in hospital treatment of congestive heart insufficiency]|/resolve/reference/PMED?id=1824218
Watt 1983 {published data only}|Dietary sodium restriction for mild hypertension in general practice|/resolve/reference/PMED?id=6401551
Watt 1986 {published data only}|Dietary sodium and blood pressure in young people with and without familial predisposition to high blood pressure|/resolve/reference/PMED?id=3489817
Weinberger 1988 {published data only}|Dietary sodium restriction as adjunctive treatment of hypertension|/resolve/reference/PMED?id=3357230
Wing 1984 {published data only}|Dietary approaches to the reduction of blood pressure: the independence of weight and sodium/potassium interventions|/resolve/reference/PMED?id=6494106
Zoccali 1993 {published data only}|Randomly allocated crossover study of various levels of sodium intake in patients with mild hypertension|/resolve/reference/PMED?id=8158407
Alam 1999|A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet of blood pressure|/resolve/reference/PMED?id=10408586
Alderman 1995|Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men|/resolve/reference/PMED?id=7768554
Alderman 1997|Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients|/resolve/reference/PMED?id=9008242
Alderman 1998|Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I)|/resolve/reference/PMED?id=9519949
Allender 1996|Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials|/resolve/reference/PMED?id=8610952
Anonymous 2000|Assessment of study quality|
Barker 1998||
Berkley 1995|A random-effects regression model for meta-analysis|
Brand 1999|Dieting to reduce body weight for controlling hypertension in adults|
Cappuccio 1991|Does potassium supplementation lower blood pressure? A meta-analysis of published trials|/resolve/reference/PMED?id=1649867
Cutler 1997|Randomized trials of sodium reduction: an overview|/resolve/reference/PMED?id=9022560
DoH 2001|The Annual Report of the Chief Medical Officer of the Department on Health 2001|
Donner 1982|An empirical study of cluster randomization|/resolve/reference/PMED?id=7129743
Ebrahim 1996||
Ebrahim 1998|Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions|/resolve/reference/PMED?id=9923952
Elliott 1996|Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group.[erratum appears in BMJ 1997 Aug 23;315(7106):458.].|/resolve/reference/PMED?id=8634612
Follman 1992|Variance imputation for overviews of clinical trails with continuous response|/resolve/reference/PMED?id=1619456
Graudal 1998|Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols and triglyceride: a meta-analysis.|/resolve/reference/PMED?id=9582047
Griffith 1999|The influence of dietary and non-dietary calcium supplementation on blood pressure. An updated metaanalysis of randomized controlled trials|/resolve/reference/PMED?id=10075392
Hauck 1991|Randomization by cluster|/resolve/reference/PMED?id=1956815
He 1999|Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults|/resolve/reference/PMED?id=10591385
He 2001|Neonatal salt intake and blood pressure|/resolve/reference/PMED?id=11417571
Hofman 1983|A randomized trial of sodium intake and blood pressure in newborn infants|/resolve/reference/PMED?id=6343656
Hooper 2000|Reduced or modified dietary fat for preventing cardiovascular disease|
Jurgens 2003|Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride|
Law 1991|By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. [erratum appears in BMJ 1991 Apr 20;302(6782):939.].|/resolve/reference/PMED?id=1827353
Lucas 1988|Early sodium intake and later blood pressure in preterm infants|/resolve/reference/PMED?id=3389898
MacGregor 1996|Salt -- overwhelming evidence but still no action: can a consensus be reached with the food industry? CASH (Consensus Action on Salt and Hypertension).|/resolve/reference/PMED?id=8634621
MAFF 1999||
Midgley 1996|Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=8622251
Navar 1997|The kidney in blood pressure regulation and development of hypertension|/resolve/reference/PMED?id=9308604
Ramsay 1999|British Hypertension Society guidelines for hypertension management 1999: summary|/resolve/reference/PMED?id=10473485
Ramsay 1999a|Guidelines for management of hypertension: report of the third working party of the British Hypertension Society|/resolve/reference/PMED?id=10482967
Sacks 2001|Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group|/resolve/reference/PMED?id=11136953
Selmer 2000|Cost and health consequences of reducing the population intake of salt|/resolve/reference/PMED?id=10942450
Sharp 1998|Meta-analysis regression|
Singhal 2001|Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials|/resolve/reference/PMED?id=11273059
Stamler 1991|Implications of the INTERSALT study|
Taubes 1998|The (political) science of salt|/resolve/reference/PMED?id=9722464
Tunstall-Pedoe 1997|Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. [erratum appears in BMJ 1998 Jun 20;316(7148):1881.].|/resolve/reference/PMED?id=9314758
Tuomilehto 2001|Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study|/resolve/reference/PMED?id=11265954
Whelton 1997|Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials|/resolve/reference/PMED?id=9168293
Hooper 2002|Longer electronic version of this review on BMJ website, http://bmj.com/|/resolve/reference/PMED?id=12242173
Avery {published data only}|Physiological pacing improves symptoms and increases exercise capacity in the elderly patient|/resolve/reference/PMED?id=7814161
Boon {published data only}|An intra-patient comparison of ambulatory blood-pressure during chronic DDD and VVI pacing|
Boon {published data only}|A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing|/resolve/reference/PMED?id=3304370
Capucci {published data only}|DDDR versus DDD and VVIR pacing: A single blind randomised evaluation of symptoms and effort performance|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Channon {published data only}|DDD versus. VVI pacing in patients aged over 75 years with complete heart block: a double-blind crossover comparison|/resolve/reference/PMED?id=8208915
CTOPP {published data only}|Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators|/resolve/reference/PMED?id=10805823
CTOPP {published data only}|Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing|/resolve/reference/PMED?id=11451268
CTOPP {published data only}|Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes|/resolve/reference/PMED?id=11425772
Davis {published data only}|Functional benefits of physiologic compared with ventricular pacing in complete heart block|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Deharo {published data only}|A randomized, single-blind crossover comparison of the effects of chronic DDD and dual sensor VVIR pacing mode on quality-of-life and cardiopulmonary performance in complete heart block|
Hargreaves {published data only}|Comparison of dual chamber and ventricular rate responsive pacing in patients over 75 with complete heart block|/resolve/reference/PMED?id=7488454
Heldman {published data only}|True incidence of pacemaker syndrome|
Hijer {published data only}|Improved cardiac function and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation|/resolve/reference/PMED?id=11863352
Kamalvand {published data only}|Is mode switiching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias|/resolve/reference/PMED?id=9247524
Kenny {published data only}|Optimum pacing mode for patients with angina pectoris|/resolve/reference/PMED?id=3790382
Kristensson {published data only}|Physiological versus single-rate ventricular pacing: a double-blind crossover study|
Lau (1) {published data only}|Rate-adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life|/resolve/reference/PMED?id=7835358
Lau (2) {published data only}|Quality-of-life in DDDR pacing: atrioventricular synchrony or rate adaptation?|
Linde-Edelstam {published data only}|A double-blind study of submaximal exercise tolerance and variation in paced rate in atrial synchronous compared to activity sensor modulated ventricular pacing|
Linde-Edelstam {published data only}|Quality-of-life in patients treated with atrioventricular synchronous pacing compared to rate modulated ventricular pacing: a long-term, double-blind, crossover study|
Lukl {published data only}|Quality-of-life during DDD and dual sensor VVIR pacing|
Mattioli {published data only}|Prevalence of atrial fibrillation and stroke in paced patients without prior atrial fibrillation: a prospective study|
Menozzi {published data only}|Intrapatient comparison between chronic VVIR and DDD pacing in patients affected by high degree AV block without heart failure|
Mitsuoka {published data only}|Benefits of dual chamber pacing in sick sinus syndrome|/resolve/reference/PMED?id=3056477
MOST {published data only}|Ventricular pacing or dual-chamber pacing for sinus-node dysfunction|/resolve/reference/PMED?id=12063369
Oldroyd {published data only}|Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate-adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block|/resolve/reference/PMED?id=1827588
PASE {published data only}|Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing|/resolve/reference/PMED?id=9545357
Perrins {published data only}|Randomised controlled trial of physiological and ventricular pacing|/resolve/reference/PMED?id=6349666
Rediker {published data only}|Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers|/resolve/reference/PMED?id=3341209
Saner and Fricker {published data only}|Haemodynamic benefits and quality of life with DDD versus VVIR pacing: Evaluation by exercise Doppler echocardiography and quality-of-life score|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Sulke 1991 {published data only}|A randomized double-blind crossover comparison of four rate-responsive pacing modes|/resolve/reference/PMED?id=1993790
Sulke 1992 {published data only}|"Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices|/resolve/reference/PMED?id=1739528
Sulke 1994 {published data only}|Variability of left atrial bloodflow predicts intolerance of ventricular demand pacing and may cause pacemaker syndrome|
Wharton {published data only}|Effect of pacing modality on atrial tachyarrhythmia recurrence in the tachycardia-bradycardia syndrome: preliminary results of the Pacemaker Atrial Tachycardia Trial|
Yee {published data only}|Comparative functional effects of chronic ventricular demand and atrial synchronous ventricular inhibited pacing|
Abe 1992 {published data only}|[Secretion of atrial natriuretic peptide during artificial pacing: assessments including the influence of ventriculoatrial conduction]. [Japanese]|/resolve/reference/PMED?id=1307573
Adinolfi 1985 {published data only}|Radionuclide evaluation of DDD versus VVI pacing with a nonimaging probe - nuclear stethoscope|
Aggarwal 1995 {published data only}|Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems|/resolve/reference/PMED?id=7626359
Ahern 1992 {published data only}|Incidence and timing of activity parameter changes in activity responsive pacing systems|
Alpert 1986 {published data only}|Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure|/resolve/reference/PMED?id=3958351
Alpert 1987 {published data only}|Comparative survival following permanent ventricular and dual-chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure|/resolve/reference/PMED?id=3565245
Amici 1996 {published data only}|Transesophageal echocardiographic color Doppler evaluation of pulmonary vein flow during ventricular pacing|/resolve/reference/PMED?id=8680130
Azam 1998 {published data only}|'Subclinical' pacemaker syndrome - Further evidence using ambulatory blood pressure measurement to compare VVI and DDD pacing in asymptomatic patients|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Baldo 1996 {published data only}|Right ventricular echo-pacing test in the diagnosis of ischemic cardiopathy in patients with VVI|
Barrington 1995 {published data only}|Clinical comparison of acute single to dual chamber pacing in chronotropically incompetent patients with left ventricular dysfunction|
Batey 1990 {published data only}|Comparison of low rate dual chamber pacing to activity responsive rate variable ventricular pacing|
Been 1984 {published data only}|Effect of afterload reduction in patients with ventricular and physiological pacing|/resolve/reference/PMED?id=6696807
Blanc 1992 {published data only}|Atrial natriuretic factor release during exercise in patients successively paced in DDD and rate matched ventricular pacing|
Bosch 1990 {published data only}|[Evaluation of DDD and VVIR pacemakers with gated radionuclide ventriculography]. [Spanish]|/resolve/reference/PMED?id=2236794
Bren 1986 {published data only}|Comparison of DDD end rate responsive-VVI pacing during exercise|
Brignole 1988 {published data only}|Is DDD superior to VVI pacing in mixed carotid sinus syndrome? An acute and medium-term study|
Brignole 1989a {published data only}|Ventricular and dual chamber pacing for treatment of carotid sinus syndrome|
Brignole 1989b {published data only}|[The choice of stimulation mode in patients with cardioinhibitory or mixed carotid sinus hypersensitivity, with or without associated sinus dysfunction]. [Italian]|/resolve/reference/PMED?id=2744311
Brignole 1991 {published data only}|Validation of a method for choice of pacing mode in carotid sinus syndrome with or without sinus bradycardia|
Brignole 1992 {published data only}|Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome|/resolve/reference/PMED?id=1561975
Brunner-La 2000 {published data only}|Importance of ventricular rate after mode switching during low intensity exercise as assessed by clinical symptoms and ventilatory gas exchange|
Cabello 1990 {published data only}|[Long-term effects of cardiac pacing on natriuretic atrial peptide levels in patients with AV|/resolve/reference/PMED?id=2146721
Cabello 1996 {published data only}|Acute and chronic changes in atrial natriuretic factor induced by ventricular pacing: a self controlled clinical trial|
Candinas 1994 {published data only}|Does rate modulation with a minute ventilation pacemaker simulate the intrinsic heart rate response observed during representative patient daily activities?|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Chabernaud 1993 {published data only}|[Comparison of VVI and DDD cardiac stimulation during exercise test evaluated by respiratory gas exchange measurement. Study of patients with normal systolic function and complete atrioventricular block unchanged during exercise test]. [French]|/resolve/reference/PMED?id=8338403
Channon 1997 {published data only}|Noninvasive beat-to-beat arterial blood pressure measurement during VVI and DDD pacing: relationship to symptomatic benefit from DDD pacing|
Chauhan 1994 {published data only}|Early complications after dual chamber versus single chamber pacemaker implantation. [see comments]|
Chida 1993 {published data only}|[Long-term follow-up study after permanent pacemaker implantation in patients aged 60 years or over with sick sinus syndrome]. [Japanese]|/resolve/reference/PMED?id=8301858
Copperman 1993 {published data only}|The use of transcranial Doppler in the hemodynamic assessment of implanted pacemakers|
Daubert 1984 {published data only}|Haemodynamic and M mode echocardiographic study of the consequences of ventriculo-atrial conduction in man|/resolve/reference/PMED?id=6426428
Davies 1985 {published data only}|Non-invasive comparison of ventricular-function with atrioventricular sequential versus ventricular pacing in complete heart-block|
DeFilippi 1981 {published data only}|Acute and chronic hemodynamic aspects at rest and during exertion of patients using physiologic pacemakers (Funke Mod 5999) - comparison with synchronous ventricular pacing|
Douard 1995 {published data only}|Effect of atrioventricular synchronous pacing on cardiac output determined by CO2 rebreathing at constant submaximal exercise|/resolve/reference/PMED?id=7611161
Dritsas 1993 {published data only}|Beat-to-Beat variability in stroke volume during VVI pacing as predictor of hemodynamic benefit from DDD pacing|
Duan 2001 {published data only}|Incidence of atrial fibrillation in Chinese patients with different modes of pacing|
Eagle 1988 {published data only}|Single chamber and dual chamber pacing compared|
Ebagosti 1988 {published data only}|Long-term follow-up of patients treated with VVI pacing and sequential pacing with special reference to VA retrograde conduction|
Faerestrand 1985 {published data only}|A time-related study of the hemodynamic benefit of atrioventricular synchronous pacing evaluated by Doppler echocardiography|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Fananapazir 1983a {published data only}|Comparison of resting hemodynamic indices and exercise performance during atrial synchronized and asynchronous ventricular pacing|
Fananapazir 1983b {published data only}|Atrial synchronized ventricular pacing: contribution of the chronotropic response to improved exercise performance|
Faria 1991 {published data only}|[Assessment of the left ventricular function in patients with pacemakers VVI and DDD, using|/resolve/reference/PMED?id=2059468
Fishberger 1996 {published data only}|Long-term outcome in patients with pacemakers following the Fontan operation|/resolve/reference/PMED?id=8623749
French 1988 {published data only}|Physiological benefits of a pacemaker with dual chamber pacing at low heart rates and single chamber rate responsive pacing during exercise|
Frielingsdorf 1995 {published data only}|Physical work capacity with rate responsive ventricular pacing (VVIR) versus dual chamber pacing (DDD) in patients with normal and diminished left ventricular function|/resolve/reference/PMED?id=7649670
Fromer 1987 {published data only}|Subjective and objective response to single- versus dual-chamber pacing|
Fukumoto 1986 {published data only}|Myocardial metabolism and hemodynamics during exercise in patients with cardiac pacemaker for complete A-V block. A comparison of DDD mode and VVI mode|
Fukuoka 2000 {published data only}|Effect of long-term atrial-demand ventricular pacing on cardiac sympathetic activity|/resolve/reference/PMED?id=10823332
Gallik 1994 {published data only}|Comparison of ventricular function in atrial rate adaptive versus dual chamber rate adaptive pacing during exercise|
Ghio 1991 {published data only}|[Hemodynamic benefits of sequential atrioventricular pacing]. [Italian]|/resolve/reference/PMED?id=1790833
Gold 1995 {published data only}|Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. [see comments]|/resolve/reference/PMED?id=7560625
Gold 2000 {published data only}|Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=10781760
Griebenow 1984 {published data only}|Vasodepression in carotid sinus syndrome: Effect of ventricular and bifocal stimulation on arterial blood pressure in the supine position and during orthostasis|
Griebenow 1989 {published data only}|Quantification of the heart rate-independent vasodepressor component in carotid sinus syndrome|/resolve/reference/PMED?id=2586017
Hedman 1985 {published data only}|Changes in Q-T and Q-aT intervals at rest and during exercise with different modes of cardiac pacing|
Hedman 1988 {published data only}|Changes in QT and Q-aT intervals induced by mental and physical stress with fixed rate and atrial triggered ventricular inhibited cardiac pacing|
Hoeschen 1991 {published data only}|The effect of posture on the response to atrioventricular synchronous pacing in patients with underlying cardiovascular disease|
Horie 1999 {published data only}|Plasma brain natriuretic peptide as a biochemical marker for atrioventricular sequence in|
Ijiri 2000 {published data only}|Improvement of exercise tolerance by single lead VDD pacemaker: evaluation using cardiopulmonary exercise test|
Iliev 2000 {published data only}|Preserving normal ventricular activation versus atrioventricular delay optimization during pacing: the role of intrinsic atrioventricular conduction and pacing rate|
Ishikawa 1994 {published data only}|Left atrial and left ventricular diameters in patients treated with pacemakers|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Ishikawa 1995 {published data only}|Diastolic mitral regurgitation observed in patients with complete atrioventricular block during|
Ishikawa 1996 {published data only}|Diastolic mitral regurgitation when the heart rate is normalised by ventricular pacing|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Iwase 1986 {published data only}|Evaluation by pulsed Doppler echocardiography of the atrial contribution to left ventricular|/resolve/reference/PMED?id=3728309
Iwase 1991 {published data only}|[Evaluation of maintenance of cardiac output during DDD and VVI pacing by exercise Doppler echocardiography]. [Japanese]|/resolve/reference/PMED?id=1843523
Jordaens 1988 {published data only}|Physiologic pacing in the elderly. Effects on exercise capacity and exercise-induced arrhythmias|/resolve/reference/PMED?id=3398242
Jutzy 1990 {published data only}|Comparative evaluation of rate modulated dual chamber and VVIR pacing|
Jutzy 1991 {published data only}|Limitations of testing methods for evaluation of dual chamber versus single chamber adaptive rate pacing|/resolve/reference/PMED?id=1746477
Jutzy 1992a {published data only}|Evaluation of DDDR vs VVIR pacing in patients with associated cardiac and pulmonary disease|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Jutzy 1992b {published data only}|Advantages of dual chamber rate adaptive pacing compared with ventricular rate adaptive pacing in patients with pulmonary disease|
Jutzy 1992c {published data only}|Comparison of intrinsic versus paced ventricular function|
Jutzy 1994 {published data only}|Comparison of cardiac pacing modes in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8275792
Kamalvand 1996 {published data only}|Evaluation of a new pacing algorithm to prevent rapid tracking of atrial tachyarrhythmias|
Kano 1992 {published data only}|Left ventricular performance at rest and during exercise in patients with dual-chamber pacemakers|/resolve/reference/PMED?id=1568027
Kargul 1996 {published data only}|Simultaneous using of ECG and blood pressure holter registration in patients with pacemaker|
Kikis 1983 {published data only}|[Hemodynamics in ventricular and atrioventricular sequential stimulation in patients with|/resolve/reference/PMED?id=6839972
Kolettis 1995 {published data only}|Effects of atrial, ventricular, and atrioventricular sequential pacing on coronary flow reserve|
Kolettis 1998 {published data only}|Coronary blood flow velocity during apical versus septal pacing|/resolve/reference/PMED?id=9829336
Kolettis 2000 {published data only}|Improved left ventricular relaxation during short-term right ventricular outflow tract compared to apical pacing|/resolve/reference/PMED?id=10631200
Koller 1996a {published data only}|Atrial arrhythmias in pacemaker therapy: A randomized DDD vs VVI crossover trial in 50 patients|
Koller 1996 b {published data only}|Atrial arrhythmias in pacemaker therapy: A randomized DDD vs VVI crossover trial in 50 patients|
Kristensson 1983 {published data only}|Atrial synchronous ventricular pacing in ischaemic heart disease|/resolve/reference/PMED?id=6641759
Kristensson 1985 {published data only}|The haemodynamic importance of atrioventricular synchrony and rate increase at rest and during exercise|/resolve/reference/PMED?id=4076212
Kristensson 1986 {published data only}|Holter-monitored heart rhythm during atrioventricular synchronous and fixed-rate ventricular pacing|
Kruse 1982 {published data only}|A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing|/resolve/reference/PMED?id=7074746
Kyriakides 1994 {published data only}|Short-term effects of right atrial, right ventricular apical, and atrioventricular sequential pacing|/resolve/reference/PMED?id=8043333
Labovitz 1985 {published data only}|Noninvasive assessment of pacemaker hemodynamics by Doppler echocardiography|/resolve/reference/PMED?id=4008774
Lamaison 1993 {published data only}|A comparison between single atrial and dual chamber rate adaptive (AAIR and DDDR) and non adaptive AAI and DDD cardiac pacing using cardiopulmonary exercise testing in patients with atrial chronotropic incompetence|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Lascault 1989 {published data only}|Non-invasive study of dual chamber pacing by pulsed Doppler.|/resolve/reference/PMED?id=2759113
Lau 1990 {published data only}|Superior cardiac hemodynamics of atrioventricular synchrony over rate responsive pacing at submaximal exercise: observations in activity sensing DDDR pacemakers|
Lau 1992 {published data only}|Initial clinical experience with a single pass VDDR pacing system|
Lau 1997 {published data only}|Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients. [see comments]|/resolve/reference/PMED?id=9404251
LaVilla 1994 {published data only}|Plasma levels of natriuretic peptides during ventricular pacing in patients with a dual chamber|
Leclercq 1995 {published data only}|Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing|/resolve/reference/PMED?id=7754944
Leclercq 1998 {published data only}|Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure|/resolve/reference/PMED?id=9857858
Leman 1985 {published data only}|Radionuclide evaluation of dual chamber pacing: comparison between variable AV intervals and ventricular pacing|
Lemke 1990 {published data only}|[Effect of AV synchronization and rate increase on hemodynamics and on atrial natriuretic peptide in patients with total AV block]. [German]|/resolve/reference/PMED?id=2145704
Linde-Edelstam 1992 {published data only}|Is DDD pacing superior to VVI,R? A study on cardiac sympathetic nerve activity and myocardial oxygen consumption at rest and during exercise|
Lo 1993 {published data only}|Atrial natriuretic factor levels during DDD and VVI pacing|
Lo 1997 {published data only}|[Acute effects of ventricular and bicameral stimulation on plasma levels of natriuretic hormone]. [Italian]|/resolve/reference/PMED?id=9410771
Lotto 1985 {published data only}|DDD and rate incremental VVI pacing - hemodynamic evaluation during exercise|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Love 1984 {published data only}|Reversibility of hypotension and shock by atrial or atrioventricular sequential pacing in patients with right ventricular infarction|/resolve/reference/PMED?id=6731282
Lukl 1991 {published data only}|The effect of heart rate on the working capacity of patients with complete heart block and physiological pacemaker|/resolve/reference/PMED?id=1842943
Lukl 1992a {published data only}|[Relative contribution of standard and physiologic stimulation for maximal work capacity in patients with complete atrioventricular block]. [Czech]|/resolve/reference/PMED?id=1595197
Lukl 1992b {published data only}|[Permanent variable frequency cardiac pacing: which patients with chronic complete atrioventricular block profit most?]. [Czech]|/resolve/reference/PMED?id=1595213
Lukl 1994 {published data only}|Which patients are indicated for replacement of ventricular pacing for dual chamber pacing?|
Madigan 1984 {published data only}|Carotid sinus hypersensitivity: Beneficial effects of dual-chamber pacing|/resolve/reference/PMED?id=6702680
Mahmud 1983 {published data only}|Atrioventricular sequential pacing: Differential effect on retrograde conduction related to level of impulse collision|/resolve/reference/PMED?id=6851050
Mahy 1996 {published data only}|Disturbance of peripheral microvascular fluid permeability by the onset of atrioventricular asynchrony in patients with programmable pacemakers|/resolve/reference/PMED?id=8665346
Maity 1987 {published data only}|Haemodynamic advantage of AV sequential pacing--a comparison with ventricular pacing|/resolve/reference/PMED?id=3450556
Maity 1992 {published data only}|Haemodynamic advantage with single chamber rate responsive pacemakers over dual chamber pacemakers during exercise in chronotropic incompetence|/resolve/reference/PMED?id=1289220
Manolis 1998 {published data only}|Efficacy of different pacing modes in patients with intact sinus node function who underwent RF AV junction ablation due to drug refractory paroxysmal atrial fibrillation|
Manolis 2000 {published data only}|Diurnal dynamics of ventricular repolarization in paced patients with heart failure: The potential role of pacing mode|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Markewitz 1991 {published data only}|What's the price to be paid for rate response: AV sequential versus ventricular pacing?|
Maron 1999 {published data only}|Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)|/resolve/reference/PMED?id=10359738
Martinelli 2000 {published data only}|Neurohumoral behavior in recipients of cardiac pacemakers controlled by a closed-loop autonomic nervous system-driven sensor|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Maseki 1985 {published data only}|Evaluation of left ventricular function by multi-gated RI cardiac pool imaging in patients with VDD and DVI versus VVI pacemakers, at rest and at exercise|
Mattioli 1997 {published data only}|Stroke in paced patients with sick sinus syndrome: relevance of atrial mechanical function, pacing mode and clinical characteristics|/resolve/reference/PMED?id=9129848
Mattioli 1998 {published data only}|Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation. A prospective study|/resolve/reference/PMED?id=9519322
Mattioli 1999 {published data only}|Stroke in paced patients with sick sinus syndrome: influence of left atrial function and size|/resolve/reference/PMED?id=10516407
McIntosh 1997 {published data only}|A study comparing VVI and DDI pacing in elderly patients with carotid sinus syndrome|/resolve/reference/PMED?id=9227301
McMeekin 1990 {published data only}|Importance of heart rate response during exercise in patients using atrioventricular synchronous and ventricular pacemakers|
Meisel 2000 {published data only}|[Pacemaker therapy of hypertrophic obstructive cardiomyopathy. PIC (Pacing in Cardiomyopathy) Study Group]. [German]|/resolve/reference/PMED?id=10948782
Mizutani 1997 {published data only}|Optimal pacing mode for sick sinus syndrome|
Murphy 1997 {published data only}|Comparison of mode switching DDDR pacing versus VVIR pacing following atrioventricular node ablation for refractory atrial fibrillation and flutter|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Nielsen 2000 {published data only}|Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing - effect of pacing mode and rate|/resolve/reference/PMED?id=10807447
Nielson 1985 {published data only}|A prospective comparison of DDD and VVI pacing in patients with non-fixed heart-rates at rest and during exercise|
Nishimura 1982 {published data only}|Hemodynamic and symptomatic consequences of ventricular pacing|/resolve/reference/PMED?id=6184693
Nishimura 1997 {published data only}|Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial|/resolve/reference/PMED?id=9015001
Nitsch 1983 {published data only}|Effect of varied pacemaker stimulation on left ventricular volume data|/resolve/reference/PMED?id=6666206
Nitsch 1984a {published data only}|Cardiac activation patterns in patients with physiological and ventricular pacing|/resolve/reference/PMED?id=6521361
Nitsch 1984b {published data only}|Evaluation of left ventricular performance by radionuclide ventriculography in patients with|/resolve/reference/PMED?id=6720521
Noll 1990 {published data only}|Atrial natriuretic peptide levels reflect hemodynamic changes under pacemaker stimulation|
Nordlander 1987 {published data only}|Myocardial demands of atrial-triggered versus fixed-rate ventricular pacing in patients with complete heart block|
Nowak 1995 {published data only}|Cardiac output in single-lead VDD pacing versus rate-matched VVIR pacing|/resolve/reference/PMED?id=7732998
Occhetta 1997 {published data only}|[An intrapatient comparison of adaptation to aerobic and anaerobic exertion during 3 types of physiological cardiac stimulation in chronotropic failure of the sinus node: DDD, VVIR and DDDR]. [Italian]|/resolve/reference/PMED?id=9118155
Occhetta 1998 {published data only}|[Dual-chamber DDD pacing in NYHA III-IV functional class dilated cardiomyopathy: short and middle-term evaluation]. [Italian]|/resolve/reference/PMED?id=9988941
Oldroyd 1990 {published data only}|Double-blind crossover comparison of the effects of DDD vs VVIR pacing on neuroendocrine parameters, symptoms and exercise performance in complete heart-block|
Ovsyshcher 1992 {published data only}|Precision of impedance cardiography measurements of cardiac output in pacemaker patients|
Ovsyshcher 1993 {published data only}|Measurements of cardiac output by impedance cardiography in pacemaker patients at rest: effects of various atrioventricular delays|/resolve/reference/PMED?id=8436759
Papadopoulos 1997 {published data only}|ANP concentrations during interchanging DDD-VVI pacing modes in patients with retrograde ventriculoatrial conduction|/resolve/reference/PMED?id=9139520
Payne 1995 {published data only}|An approach in the assessment of pacing hemodynamics: a comparison of VVI and DDD|
Payne 1996 {published data only}|Shuttle walking test: a new approach for evaluating patients with pacemakers|/resolve/reference/PMED?id=8705773
Payne 1997 {published data only}|The optimal pacing rate: an unpredictable parameter|
Pearson 1989 {published data only}|Hemodynamic benefit of atrioventricular synchrony: Prediction from baseline Doppler-echocardiographic variables|/resolve/reference/PMED?id=2723274
Pehrsson 1983 {published data only}|Influence of heart rate and atrioventricular synchronization on maximal work tolerance in|
Pehrsson 1988 {published data only}|A comparison of sympathoadrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronous pacing|/resolve/reference/PMED?id=3179137
Perrins 1984 {published data only}|A randomized controlled trial ofand incremental VVI-rate responsive pacing|
Proctor 1991 {published data only}|Single- versus dual-chamber sensor-driven pacing: comparison of cardiac outputs|/resolve/reference/PMED?id=1877449
Providencia 1988 {published data only}|"Physiological pacing": comparison of DDD and VVI programming by three different non-invasive methods|/resolve/reference/PMED?id=3273436
Reynolds 1983 {published data only}|Hemodynamic evaluation of atrioventricular sequential versus ventricular pacing in patients with normal and poor ventricular-function at variable heart-rates and posture|
Rickli 2000 {published data only}|Importance of AV synchronous pacing during low intensity exercise evaluated by oxygen kinetics|
Ritter 1994 {published data only}|Comparison between DDD and VVIR pacing modes: Importance of atrioventricular delay programming. Implications for study protocols|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Roelke 1994 {published data only}|A comparison of VVIR and DDDR pacing following cardiac transplantation|
Romero 1981 {published data only}|Comparison of ventricular-function and volume with AV sequential and ventricular pacing|
Romero 1984 {published data only}|Non-invasive evaluation of ventricular function and volumes during atrioventricular sequential|
Rosenqvist 1991 {published data only}|Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function|/resolve/reference/PMED?id=1987716
Saccomamo 1995 {published data only}|Permanent cardiac pacing and thromboembolic risk in elderly patients|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Saccomanno 1989 {published data only}|Effects of mode and rate of pacing on atrial natriuretic peptide release in patients with permanent pacemakers|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Sack 1999 {published data only}|Can right-sided atrioventricular sequential pacing provide benefit for selected patients with severe congestive heart failure|/resolve/reference/PMED?id=10089854
Samoil 1993 {published data only}|Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Santini 1990 {published data only}|Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing|/resolve/reference/PMED?id=2316455
Schofield 1986 {published data only}|Exercise capacity and spontaneous heart rhythm after transvenous fulguration of atrioventricular conduction|/resolve/reference/PMED?id=3768215
Schwaab 1998 {published data only}|AAIR versus DDDR stimulation in patients with bradycardia-tachycardia syndrome and chronotropic incompetence: Prospective, randomized, double- blind, cross-over study regarding quality of life, incidence of atrial tachyarrhythmias and cardiopulmonary capacity|/resolve/reference/PMED?id=19484531
Sedney 1989 {published data only}|Short-term and long-term changes of left ventricular volumes during rate-adaptive and single-rate pacing|
Shigemura 1990 {published data only}|[Comparison of cardiac output between in DDD and in VVI by pulsed Doppler echocardiographic method (correction with Swan-Ganz catheter method)]. [Japanese]|/resolve/reference/PMED?id=2263768
Simantirakis 1997 {published data only}|Left atrial appendage function during DDD and VVI pacing|/resolve/reference/PMED?id=9196412
Snoeck 1992 {published data only}|[P wave changes and atrial fibrillation after implantation of VVI type pacemaker]. [French]|/resolve/reference/PMED?id=1297290
Sparks 1999 {published data only}|Mechanical remodeling of the left atrium after loss of atrioventricular synchrony. A long-term study in humans|/resolve/reference/PMED?id=10525491
Sparks PB, Mond2 {published data only}|Electrical remodeling of the atria following loss of atrioventricular synchrony: a long-term study in humans|/resolve/reference/PMED?id=10545434
Stangl 1988 {published data only}|Influence of AV synchrony on the plasma levels of atrial natriuretic peptide (ANP) in patients with total AV block|
Stewart 1984 {published data only}|Doppler ultrasound measurement of cardiac output in patients with physiologic pacemakers.|/resolve/reference/PMED?id=6465010
Stierle 1995 {published data only}|Adverse pacemaker hemodynamics evaluated by pulmonary venous flow monitoring|
Stojnic 1996 {published data only}|Evaluation of asynchronous left ventricular relaxation by Doppler echocardiography during|
Stone 1982 {published data only}|Dual chamber sequential pacing management of sinus node dysfunction: advantages over single-chamber pacing|/resolve/reference/PMED?id=7148650
Sulke 1990 {published data only}|Comparison of the normal sinus node with seven types of rate responsive pacemaker during everyday activity|/resolve/reference/PMED?id=2390399
Takeuchi 1990 {published data only}|Comparative studies of long term results on VVI and DDD type pacemaker|
Tani 1992 {published data only}|Effects of chronotropic responsive cardiac pacing on ventilatory response to exercise in patients with complete AV block|
Taylor 1996 {published data only}|Higher sympathetic nerve activity during ventricular (VVI) than during dual-chamber (DDD) pacing|/resolve/reference/PMED?id=8962562
Theodorakis 1990 {published data only}|C-AMP and ANP levels in VVI and DDD pacing with different AV delays during daily activity and exercise|
Theodorakis 1992a {published data only}|Resting echo-Doppler estimation of cardiac output during AAI and DDD pacing, with varying AV delay, at different pacing rates|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Theodorakis 1992b {published data only}|Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise|/resolve/reference/PMED?id=1334465
Vardas 1996 {published data only}|Twenty four hour variation in plasma atrial natriuretic factor during VVI and DDD pacing|/resolve/reference/PMED?id=8697168
Vardas 1997a {published data only}|Transoesophageal echocardiographic evaluation of left atrial appendage function during DDD and VVI pacing|
Vardas 1997b {published data only}|AAIR versus DDDR pacing in patients with impaired sinus node chronotropy: an echocardiographic and cardiopulmonary study|
Videen 1986 {published data only}|Hemodynamic comparison of ventricular pacing, atrioventricular sequential pacing, and atrial synchronous ventricular pacing using radionuclide ventriculography|/resolve/reference/PMED?id=3717030
Von 1984 {published data only}|Echocardiographic analysis of physiological pacemakers with respect to mitral valve movement|/resolve/reference/PMED?id=6485472
Wakakura 1992 {published data only}|[Radionuclide study of left ventricular function and regional myocardial perfusion in patients with a DDD pacemaker]. [Japanese]|/resolve/reference/PMED?id=1434070
Whiting 1983 {published data only}|Atrioventricular sequential pacing: comparison with ventricular pacing using systolic time|
Yoshida 1999 {published data only}|Assessment of myocardial fatty acid metabolism in atrioventricular synchronous pacing:|/resolve/reference/PMED?id=10070839
Yoshitomi 1998 {published data only}|Influence of cardiac pacing mode on left atrial appendage flow velocity: Implication to systemic|
Nielsen {published data only}|A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome|/resolve/reference/PMED?id=12932590
CTOPP extended {published data only}|Canadian Trial of Physiologic Pacing Investigators|
DANPACE {published data only}|The Danish multicentre randomized study on atrial inhibited versus dual-chamber pacing in sick sinus syndrome (the DANPACE study): Purpose and design of the study|
STOP-AF {unpublished data only}|Systematic trial of pacing to prevent atrial fibrillation|/resolve/reference/PMED?id=9391281
UKPACE {unpublished data only}|The United Kingdom pacing and cardiovascular events (UKPACE) trial|/resolve/reference/PMED?id=9391280
Ausubel 1985|The pacemaker syndrome|/resolve/reference/PMED?id=3896087
Bernstein 1987|The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices|
Bernstein 2001|Survey of cardiac pacing and implanted defibrillator practice patterns in the United States in 1997|
Bernstein 2002|The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing|
Bush 1994|Permanent cardiac pacemakers in the elderly|/resolve/reference/PMED?id=8120320
Clarke 1991|Recommendations for pacemaker prescription for symptomatic bradycardia|/resolve/reference/PMED?id=1883673
Connolly 1996|Dual-chamber versus ventricular pacing. Critical appraisal of current data|/resolve/reference/PMED?id=8759105
Egger 1998|Bias in location and selection of studies|/resolve/reference/PMED?id=9451274
Gregoratos 1998|ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)|/resolve/reference/PMED?id=9562026
Gregoratos 1999|Permanent pacemakers in older persons|/resolve/reference/PMED?id=10484258
Heldman 1990|True incidence of pacemaker syndrome|
Hills 1979|The two-period cross-over clinical trial|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Julian 1992||
Kusumoto 1996|Cardiac pacing|/resolve/reference/PMED?id=8531965
Lamas 1997|Pacemaker mode selection and survival: a plea to apply the principles of evidence based medicine to cardiac pacing practice|/resolve/reference/PMED?id=9391279
Mond 2001|The world survey of cardiac pacing and cardioverter defibrillators: calendar year 1997-Asian Pacific, Middle East, South America and Canada|
Morley-Davis 1997|Cardiac Pacing|/resolve/reference/PMED?id=8988130
NPD 2000|National Pacemaker Database. Annual Report 2000|
Tang 2000|Clinical trials of pacing mode selection|/resolve/reference/PMED?id=10709682
Travill 1992|Pacemaker syndrome: an iatrogenic condition|/resolve/reference/PMED?id=1389730
Tse 2002|Functional abnormalities in patients with permanent right ventricular pacing: The effect of sites of electrical stimulation|/resolve/reference/PMED?id=12392836
Aaberge 2000 {published data only}|Myocardial performance after transmyocardial revascularization with CO(2)laser. A dobutamine stress echocardiographic study|/resolve/reference/PMED?id=11882452
Aaberge 2000 {published data only}|Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian Randomized Trial|/resolve/reference/PMED?id=10758957
Aaberge 2000 {published data only}|Continued symptomatic improvement three to five years after transmyocardial laser revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial laser revascularization|/resolve/reference/PMED?id=12020484
Aaberge 2000 {published data only}|Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods|/resolve/reference/PMED?id=11354578
Allen 1999 {published data only}|Transmyocardial laser revascularization: 5 years follow-up of a prospective, randomized trial|/resolve/reference/PMED?id=15063241
Allen 1999 {published data only}|Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina|/resolve/reference/PMED?id=10502592
Burkhoff 1999 {published data only}|Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial|/resolve/reference/PMED?id=10489946
Frazier 1999 {published data only}|Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease|/resolve/reference/PMED?id=10502591
Frazier 1999 {published data only}|Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser|/resolve/reference/PMED?id=11568035
Frazier 1999 {published data only}|Transmyocardial laser revascularization with the CO2 laser: one year results of a randomized, controlled trial|/resolve/reference/PMED?id=9930706
Frazier 1999 {published data only}|Transmyocardial CO2 laser revascularization improves symptons, function and quality of life: 12-month results from a randomized controlled trial|/resolve/reference/PMED?id=11583635
Jones 1999 {published data only}|Holmium: YAG laser transmyocardial revasculariazation relieves angina and improves functional status|/resolve/reference/PMED?id=10391261
Schofield 1999 {published data only}|Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization|/resolve/reference/PMED?id=11274941
Schofield 1999 {published data only}|The UK trial of transmyocardial laser revascularisation (TMLR): cost effectiveness|
Schofield 1999 {published data only}|A UK trial-based cost-utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris|/resolve/reference/PMED?id=11463549
Schofield 1999 {published data only}|Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris|/resolve/reference/PMED?id=16195897
Schofield 1999 {published data only}|Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial|/resolve/reference/PMED?id=10028979
Schofield 1999 {published data only}|The UK trial of transmyocardial laser revascularisation (TMLR): health related quality of life (HRQOL) [abstract]|
van der Sloot 2004 {published data only}|Improved quality of life after XeCl excimer transmyocardial laser revascularization: results of a randomized trial|
van der Sloot 2004 {published data only}|Transmyocardial revascularization using an XeCl excimer laser: Results of a randomized trial|/resolve/reference/PMED?id=15337012
Allen 2000 {published data only}|Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial|/resolve/reference/PMED?id=10694615
Appelman 1996 {published data only}|Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease|/resolve/reference/PMED?id=8538345
Appelman 1998 {published data only}|Clinical events following excimer laser angioplasty or balloon angioplasty for complex coronary lesions: subanalysis of a randomised trial|/resolve/reference/PMED?id=9505916
Appelman 2000 {published data only}|Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions|/resolve/reference/PMED?id=11219598
Dixon 2001 {published data only}|Immediate effect of percutaneous myocardial laser revascularization on hemodynamics and left ventricular systolic function in severe angina pectoris|/resolve/reference/PMED?id=11230831
Dowling 2003 {published data only}|Improved pain control after cardiac surgery: results of a randomized, double-blind, clinical trial|/resolve/reference/PMED?id=14665996
Dziuk 2003 {published data only}|Clinical outcome of patients after transmyocardial laser revascularization alone and combined with coronary artery bypass grafting|/resolve/reference/PMED?id=15058255
Frazier 2004 {published data only}|Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up|/resolve/reference/PMED?id=15562842
Guleserian 2003 {published data only}|Quality of life and survival after transmyocardial laser revascularization with the holmium:YAG laser|
Horvath, 2000a {published data only}|Results of clinical trials of transmyocardial laser revascularization versus medical management for end-stage coronary disease|/resolve/reference/PMED?id=11572239
Horvath, 2000b {published data only}|Transmyocardial laser revascularization in the treatment of myocardial ischemia|
Horvath, 2002 {published data only}|Results of prospective randomized controlled trials of transmyocardial laser revascularization|/resolve/reference/PMED?id=11937460
Kniazeva 1994 {published data only}|The use of infrared laser radiation in the rehabilitation of IHD patients after the surgical revascularization of the myocardium|/resolve/reference/PMED?id=7762198
Leon 2005 {published data only}|A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease|/resolve/reference/PMED?id=16286164
Loubani 2003 {published data only}|Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass|/resolve/reference/PMED?id=14530005
McNab 2006 {published data only}|An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial|/resolve/reference/PMED?id=16554313
Milano 1997 {published data only}|Transmyocardial revascularization with a holmium laser: preliminary results|/resolve/reference/PMED?id=9410770
Myers 2002 {published data only}|Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing|/resolve/reference/PMED?id=12075263
Oesterle 1999 {published data only}|Laser percutaneous myocardial revascularization|
Oesterle 2000 {published data only}|Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels|/resolve/reference/PMED?id=11095257
Salem 2004 {published data only}|Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris|/resolve/reference/PMED?id=15110197
Salem 2005 {published data only}|Release of cardiac biochemical markers after percutaneous myocardial laser or sham procedures|/resolve/reference/PMED?id=16168806
Salem 2006 {published data only}|Long-term results following percutaneous myocardial laser therapy|/resolve/reference/PMED?id=16707963
Stone 2002 {published data only}|A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions|/resolve/reference/PMED?id=12020483
Vasil'ev 2003 {published data only}|Efficacy of laser therapy in patients with ischemic heart disease|
Aaberge 2002|Continued symptomatic improvement three to five years after transmyocardial laser revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial laser revascularization|/resolve/reference/PMED?id=12020484
Allen 2004|Adjunctive transmyocardial revascularization: five-year follow-up of a prospective, randomized trial|/resolve/reference/PMED?id=15276496
Bienenfeld 1996|The placebo effect in cardiovascular disease|/resolve/reference/PMED?id=8969573
Briones 2003||
Burkhoff 2001|Variability of myocardial perfusion defects by thallium 201 scintigraphy in patients with coronary artery disease not amenable to angioplasty or bypass surgery|/resolve/reference/PMED?id=11583878
Caine 1998|British trial of transmyocardial revascularisation is continuing|/resolve/reference/PMED?id=9492701
Cooley 1996|Transmyocardial laser revascularization: clinical experience with twelve-month follow-up|/resolve/reference/PMED?id=8614139
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Downing 2000|Transmyocardial laser revascularization|/resolve/reference/PMED?id=10681224
Frazier 1995|Myocardial revascularization with laser: preliminary findings|
Horvath 1996|Transmyocardial laser revascularization: operative techniques and clinical results at two years|/resolve/reference/PMED?id=8622302
Kim 2002|Refractory angina pectoris|/resolve/reference/PMED?id=11897431
Lange 1999|Transmyocardial laser revascularization|/resolve/reference/PMED?id=10502599
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Liao 2005|Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization|/resolve/reference/PMED?id=15878002
Macklin 1999|The ethical problems with sham surgery in clinical research|/resolve/reference/PMED?id=10498498
Mirhoseini 1982|Transventricular revascularization by laser|
Mirhoseini 1993|Transmyocardial laser revascularization: a review|/resolve/reference/PMED?id=10148536
MSAC 1999||
Mukherjee 1999|Direct myocardial revascularization and angiogenesis--how many patients might be eligible?|/resolve/reference/PMED?id=10482164
Ngele 1998|Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up|/resolve/reference/PMED?id=9820991
Peduzzi 1991|Intent-to-treat analysis and the problem of crossovers. An example from the Veterans Administration coronary bypass surgery study|/resolve/reference/PMED?id=1999942
Peterson 2003|From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes|/resolve/reference/PMED?id=14607448
Prtre 1999|Laser to the heart: magic but costly, or only costly?|/resolve/reference/PMED?id=10028973
Saririan 2003|Myocardial laser revascularization for the treatmen of end-stage coronary artery disease|/resolve/reference/PMED?id=12535804
Sharples 1999|Transmyocardial laser revascularisation in clinical practice|/resolve/reference/PMED?id=10622317
Smith 1995|Transmyocardial laser revascularization|
Williams 1999|Transmyocardial laser revascularisation in clinical practice|/resolve/reference/PMED?id=10622317
Williams 2000|Transmyocardial laser revascularization|/resolve/reference/PMED?id=10681225
Aaberge 2000 {published data only}|Myocardial performance after transmyocardial revascularization with CO(2) laser. A dobutamine stress echocardiographic study|/resolve/reference/PMED?id=11882452
Aaberge 2000 {published data only}|Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian Randomized Trial|/resolve/reference/PMED?id=10758957
Aaberge 2000 {published data only}|Continued symptomatic improvement three to five years after transmyocardial laser revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial laser revascularization|/resolve/reference/PMED?id=12020484
Aaberge 2000 {published data only}|Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods|/resolve/reference/PMED?id=11354578
Allen 1999 {published data only}|Transmyocardial laser revascularization: 5 years follow-up of a prospective, randomized trial|/resolve/reference/PMED?id=15063241
Allen 1999 {published data only}|Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina|/resolve/reference/PMED?id=10502592
Burkhoff 1999 {published data only}|Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial|/resolve/reference/PMED?id=10489946
Frazier 1999 {published data only}|Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease|/resolve/reference/PMED?id=10502591
Frazier 1999 {published data only}|Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser|/resolve/reference/PMED?id=11568035
Frazier 1999 {published data only}|Transmyocardial laser revascularization with the CO2 laser: one year results of a randomized, controlled trial|/resolve/reference/PMED?id=9930706
Frazier 1999 {published data only}|Transmyocardial CO2 laser revascularization improves symptoms, function and quality of life: 12-month results from a randomized controlled trial|/resolve/reference/PMED?id=11583635
Jones 1999 {published data only}|Holmium: YAG laser transmyocardial revascularization relieves angina and improves functional status|/resolve/reference/PMED?id=10391261
Schofield 1999 {published data only}|Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization|/resolve/reference/PMED?id=11274941
Schofield 1999 {published data only}|The UK trial of transmyocardial laser revascularisation (TMLR): cost effectiveness|
Schofield 1999 {published data only}|A UK trial-based cost-utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris|/resolve/reference/PMED?id=11463549
Schofield 1999 {published data only}|Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris|/resolve/reference/PMED?id=16195897
Schofield 1999 {published data only}|Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial|/resolve/reference/PMED?id=10028979
Schofield 1999 {published data only}|The UK trial of transmyocardial laser revascularisation (TMLR): health related quality of life (HRQOL) [abstract]|
van der Sloot 2004 {published data only}|Improved quality of life after XeCl excimer transmyocardial laser revascularization: results of a randomized trial|
van der Sloot 2004 {published data only}|Transmyocardial revascularization using an XeCl excimer laser: Results of a randomized trial|/resolve/reference/PMED?id=15337012
Allen 2000 {published data only}|Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial|/resolve/reference/PMED?id=10694615
Appelman 1996 {published data only}|Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease|/resolve/reference/PMED?id=8538345
Appelman 1998 {published data only}|Clinical events following excimer laser angioplasty or balloon angioplasty for complex coronary lesions: subanalysis of a randomised trial|/resolve/reference/PMED?id=9505916
Appelman 2000 {published data only}|Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions|/resolve/reference/PMED?id=11219598
Dixon 2001 {published data only}|Immediate effect of percutaneous myocardial laser revascularization on hemodynamics and left ventricular systolic function in severe angina pectoris|/resolve/reference/PMED?id=11230831
Dowling 2003 {published data only}|Improved pain control after cardiac surgery: results of a randomized, double-blind, clinical trial|/resolve/reference/PMED?id=14665996
Dziuk 2003 {published data only}|Clinical outcome of patients after transmyocardial laser revascularization alone and combined with coronary artery bypass grafting|/resolve/reference/PMED?id=15058255
Frazier 2004 {published data only}|Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up|/resolve/reference/PMED?id=15562842
Guleserian 2003 {published data only}|Quality of life and survival after transmyocardial laser revascularization with the holmium: YAG laser|
Horvath, 2000a {published data only}|Results of clinical trials of transmyocardial laser revascularization versus medical management for end-stage coronary disease|/resolve/reference/PMED?id=11572239
Horvath, 2000b {published data only}|Transmyocardial laser revascularization in the treatment of myocardial ischemia|
Horvath, 2002 {published data only}|Results of prospective randomized controlled trials of transmyocardial laser revascularization|/resolve/reference/PMED?id=11937460
Horvath, 2008 {published data only}|Transmyocardial laser revascularization|
Kniazeva 1994 {published data only}|The use of infrared laser radiation in the rehabilitation of IHD patients after the surgical revascularization of the myocardium|
Leon 2005 {published data only}|A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease|/resolve/reference/PMED?id=16286164
Loubani 2003 {published data only}|Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass|/resolve/reference/PMED?id=14530005
McNab 2006 {published data only}|An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial|/resolve/reference/PMED?id=16554313
Milano 1997 {published data only}|Transmyocardial revascularization with a holmium laser: preliminary results|/resolve/reference/PMED?id=9410770
Myers 2002 {published data only}|Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing|/resolve/reference/PMED?id=12075263
Oesterle 1999 {published data only}|Laser percutaneous myocardial revascularization|
Oesterle 2000 {published data only}|Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels|/resolve/reference/PMED?id=11095257
Salem 2004 {published data only}|Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris|/resolve/reference/PMED?id=15110197
Salem 2005 {published data only}|Release of cardiac biochemical markers after percutaneous myocardial laser or sham procedures|/resolve/reference/PMED?id=16168806
Salem 2006 {published data only}|Long-term results following percutaneous myocardial laser therapy|/resolve/reference/PMED?id=16707963
Stone 2002 {published data only}|A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecognizable chronic total occlusions|/resolve/reference/PMED?id=12020483
Vasil'ev 2003 {published data only}|Efficacy of laser therapy in patients with ischemic heart disease|
Yang 2007 {published data only}|Chronic effects of percutaneous transmyocardial laser revascularization in patients with refractory angina|/resolve/reference/PMED?id=17386166
Bienenfeld 1996|The placebo effect in cardiovascular disease|/resolve/reference/PMED?id=8969573
Borras 2012|Stable angina in Spain and its impact on quality of life. The AVANCE registry|
Briones 2003||
Burkhoff 2001|Variability of myocardial perfusion defects by thallium 201 scintigraphy in patients with coronary artery disease not amenable to angioplasty or bypass surgery|/resolve/reference/PMED?id=11583878
Caine 1998|British trial of transmyocardial revascularisation is continuing|/resolve/reference/PMED?id=9492701
Campbell 2008|Systematic review of the efficacy and safety of transmyocardial and percutaneous laser revascularisation for refractory angina pectoris|
Clifford 2012|Stem cell treatment for acute myocardial infarction|/resolve/reference/PMED?id=22336818
Cooley 1996|Transmyocardial laser revascularization: clinical experience with twelve-month follow-up|/resolve/reference/PMED?id=8614139
Downing 2000|Transmyocardial laser revascularization|/resolve/reference/PMED?id=10681224
Fihn 2012|2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons|/resolve/reference/PMED?id=23182125
Frazier 1995|Myocardial revascularization with laser: preliminary findings|
Higgins 2011|Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Horvath 1996|Transmyocardial laser revascularization: operative techniques and clinical results at two years|/resolve/reference/PMED?id=8622302
Jolicoeur 2012|Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification|/resolve/reference/PMED?id=22424284
Kim 2002|Refractory angina pectoris|/resolve/reference/PMED?id=11897431
Lange 1999|Transmyocardial laser revascularization|/resolve/reference/PMED?id=10502599
Liao 2005|Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization|/resolve/reference/PMED?id=15878002
Macklin 1999|The ethical problems with sham surgery in clinical research|/resolve/reference/PMED?id=10498498
Manchanda 2011|Management of refractory angina pectoris|/resolve/reference/PMED?id=21769814
McGuillion 2012|Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines|/resolve/reference/PMED?id=22424281
Mirhoseini 1982|Transventricular revascularization by laser|
Mirhoseini 1993|Transmyocardial laser revascularization: a review|/resolve/reference/PMED?id=10148536
MSAC 1999||
Ngele 1998|Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up|/resolve/reference/PMED?id=9820991
Peduzzi 1991|Intent-to-treat analysis and the problem of crossovers. An example from the Veterans Administration coronary bypass surgery study|/resolve/reference/PMED?id=1999942
Peterson 2003|From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes|/resolve/reference/PMED?id=14607448
Prtre 1999|Laser to the heart: magic but costly, or only costly?|/resolve/reference/PMED?id=10028973
Qaseen 2012|Management of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons|/resolve/reference/PMED?id=23165665
Saririan 2003|Myocardial laser revascularization for the treatment of end-stage coronary artery disease|/resolve/reference/PMED?id=12535804
Schofield 2010|NICE evaluation of transmyocardial laser revascularisation for refractory angina revascularisation and percutaneous laser|/resolve/reference/PMED?id=20194211
Sharples 1999|Transmyocardial laser revascularisation in clinical practice|/resolve/reference/PMED?id=10622317
Smith 1995|Transmyocardial laser revascularization|
Smolina 2012|Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study|/resolve/reference/PMED?id=22279113
Wijeysundera 2010|Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005|/resolve/reference/PMED?id=20460623
Williams 1999|Transmyocardial laser revascularisation in clinical practice|/resolve/reference/PMED?id=10622317
Williams 2000|Transmyocardial laser revascularization|/resolve/reference/PMED?id=10681225
Briones 2009|Transmyocardial laser revascularization versus medical therapy for refractory angina|/resolve/reference/PMED?id=19160223
AFFIRM {published and unpublished data}|The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation|/resolve/reference/PMED?id=12466506
PIAF {published data only}|Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomised trial|/resolve/reference/PMED?id=11117910
CHF-STAT {published data only}|Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observations from the Veterans Affairs Congestive Heart Failure Survival Trail of Antiarrhythmic Therapy (CHF-STAT)|/resolve/reference/PMED?id=9843465
CRRAFT {published data only}|Maintenance of sinus rhythm by amiodarone is superior to ventricular rate control in rheumatic atrial fibrillation: a blinded placebo-controlled study|
CRRAFT {published data only}|Control of rate versus rhythm in rheumatic atrial fibrillation trial - the CRRAFT study design|
DIAMOND {published data only}|Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function. A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) substudy|/resolve/reference/PMED?id=11457747
AF-CHF {published data only}|Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial|/resolve/reference/PMED?id=12360154
Alderson 2004|Cochrane Reviewers Handbook 4.2.2 [updated December 2003]|
Benavente 2000a|Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischaemic attacks (Cochrane Review)|
Benavente 2000b|Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischaemic attacks (Cochrane Review)|
Benjamin 1998|Impact of atrial fibrillation on the risk of death: The Framingham Heart Study|/resolve/reference/PMED?id=9737513
Boos 2003|Persistent atrial fibrillation: rate control or rhythm control|/resolve/reference/PMED?id=12829529
Carlsson 2003|Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillations: STAF (strategies of treatment of atrial fibrillation) study|/resolve/reference/PMED?id=12767648
Deeks 2004|Analysing and presenting results|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Dickersin 1994|Identifying relevant studies for systematic reviews reviews|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Jni 1999|The hazards of scoring the quality of clinical trials for meta-analysis|/resolve/reference/PMED?id=10493204
Jni 2001|Assessing the quality of randomised controlled trials|
Kannel 1982|Epidemiologic features of chronic atrial fibrillation|/resolve/reference/PMED?id=7062992
Khand 2000|Systematic review of the management of atrial fibrillation in patients with heart failure|/resolve/reference/PMED?id=10731399
Kilander 1998|Atrial Fibrillation is an independent determinant of low cognitive function. A cross-sectional study in elderly men|/resolve/reference/PMED?id=9731601
Lampert 1998|Long term management of atrial fibrillation: maintenance of sinus rhythm vs. rate control and anticoagulation|/resolve/reference/PMED?id=11416472
Lip 1995|Cardioversion of atrial fibrillation|/resolve/reference/PMED?id=7567751
Mantel 1959|Statistical aspects of the analysis of data from retrospective studies of disease|/resolve/reference/PMED?id=13655060
McNamara 2003|Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography|/resolve/reference/PMED?id=14678922
Moher 1999|Improving the quality of reporting of meta-analysis of randomised controlled trials: the QUOROM statement|/resolve/reference/PMED?id=10584742
Naccarelli 2000|Cost-effective management of acute atrial fibrillation: role of rate control,spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy|/resolve/reference/PMED?id=10822039
Opolski 2002|Rate control versus rhythm control in patients with nonvalvular chronic atrial fibrillation: The results of HOT CAFE Polish Study|
Ott 1997|Atrial fibrillation and dementia in a population based study. The Rotterdam Study|/resolve/reference/PMED?id=9040682
Prystowsky 2000|Management of atrial fibrillation: therapeutic options and clinical decisions|/resolve/reference/PMED?id=10822035
SPAF 1991|Stroke prevention in atrial fibrillation study. Final results|/resolve/reference/PMED?id=1860198
Stafford 1998|Rate control and sinus rhythm maintenance in atrial fibrillation: National trends in medication use,1980-1996|/resolve/reference/PMED?id=9801182
Sudlow 1998|Prevalence of atrial fibrillation in and eligibility of anticoagulation in the community|/resolve/reference/PMED?id=9777832
Van Gelder 2002|Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) Study Group.|/resolve/reference/PMED?id=12466507
Verheugt 2002|Stroke prevention by rhythm versus rate control in atrial fibrillation: insight from the randomized studies|
Wyse 1997|Atrial Fibrillation Follow-Up Investigation of Rhythm Management - The AFFIRM Study Design|/resolve/reference/PMED?id=9164885
Beebe 1999 {published data only}|A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial|/resolve/reference/PMED?id=10510990
Dawson 1998 {published data only}|Cilostazol has beneficial effects in treatment of intermittent claudication : results from a multicenter, randomized, prospective, double-blind trial|/resolve/reference/PMED?id=9715861
Dawson 2000 {published data only}|A comparison of cilostazol and pentoxifylline for treating intermittent claudication|/resolve/reference/PMED?id=11063952
Elam 1998 {published data only}|Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication|/resolve/reference/PMED?id=9848888
Money 1998 {published data only}|Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease|/resolve/reference/PMED?id=9510281
Otsuka 1996a {unpublished data only}|A randomised double-blind study of the safety and efficacy of two different doses of cilostazol versus placebo in patients with intermittent claudication secondary to peripheral vascular disease|
Otsuka 1996b {unpublished data only}|A randomised double blind study of the effect of cilostazol versus placebo on walking distances in patients with intermittent claudication secondary to peripheral vascular disease|
Strandness 2002 {published data only}|Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Samra 2003|Efficacy and safety of cilostazol, a novel phosphodiesterase inhibitor in patients with intermittent claudication|/resolve/reference/PMED?id=15168999
ATT 2002|Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients|/resolve/reference/PMED?id=11786451
Barnett 2004|The role of cilostazol in the treatment of intermittent claudication|/resolve/reference/PMED?id=15462700
Barradell 1996|Oral naftidrofuryl. A review of its pharmacology and its therapeutic use in the management of peripheral occlusive arterial disease|/resolve/reference/PMED?id=8920176
Chapman 2003|Cilostazol: a review of its use in intermittent claudication|/resolve/reference/PMED?id=14727939
Dawson 2001|Comparative effects of cilostazol and other therapies for intermittent claudication|/resolve/reference/PMED?id=11434896
Dormandy 1999|The natural history of claudication: risk to life and limb|/resolve/reference/PMED?id=10777239
Fontaine 1954|Surgical treatment for peripheral vascular disease|
Fowkes 1998|Angioplasty (versus non surgical management) for intermittent claudication|
Khan 2005|Life-style modification in peripheral arterial disease|/resolve/reference/PMED?id=15570264
Leng 1996|Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral artery disease in the general population|/resolve/reference/PMED?id=9027521
Leng 2000|Exercise for intermittent claudication|
PAD 2003|Antiplatelet therapy in peripheral arterial disease. Consensus statement|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Pratt 2001|Analysis of the cilostazol safety database|/resolve/reference/PMED?id=11434897
Regensteiner 2002|Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials|
Robless 2001|Systematic review of antiplatelet therapy for prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease|
SMC 2005|Cilostazol 100mg tablets (Pletal)|
Thompson 2002|Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication|/resolve/reference/PMED?id=12480040
McConnell 1998 {published data only}|Inspiratory muscle training improves lung function and reduces exertional dyspnoea in mild/moderate asthmatics|
Sampaio 2002 {published data only}|Respiratory muscle strength in asthmatic patient submitted by respiratory muscle training and physical training|
Weiner 2000 {published data only}|Specific inspiratory muscle training (SIMT) in patients with mild asthma, with high consumption of inhaled beta2-agonists|
Weiner 2000 {published data only}|Specific inspiratory muscle training in patients with mild asthma with high consumption of inhaled beta(2)-agonists|/resolve/reference/PMED?id=10712997
Weiner 2002 {published data only}|The relationship among inspiratory muscle strength, the perception of dyspnea and inhaled beta2-agonist use in patients with asthma|
Weiner 2002a {published data only}|Influence of gender and inspiratory muscle training on the perception of dyspnea in patients with asthma|
Weiner 2002a {published data only}|Influence of gender and inspiratory muscle training on the perception of dyspnea in patients with asthma|/resolve/reference/PMED?id=12114358
Flynn 1989 {published data only}|Threshold pressure training, breathing pattern, and exercise performance in chronic airflow obstruction|/resolve/reference/PMED?id=2920580
Guyatt 1992 {published data only}|Controlled trial of respiratory muscle training in chronic airflow limitation|/resolve/reference/PMED?id=1412115
Jones 1985 {published data only}|Physical exercise and resistive breathing training in severe chronic airways obstruction--are they effective?|/resolve/reference/PMED?id=4076354
Lima 2008 {published data only}|Inspiratory muscle training in children with asthma effect on muscle strength and pulmonary function|
Lima 2008 {published data only}|Inspiratory muscle training and respiratory exercises in children with asthma|/resolve/reference/PMED?id=18797738
Lisboa 1994 {published data only}|Inspiratory muscle training in chronic airflow limitation:comparison of two different training loads with a threshold device|/resolve/reference/PMED?id=7925905
Lisboa 1997 {published data only}|Inspiratory muscle training in chronic airflow limitation: effect on exercise performance|/resolve/reference/PMED?id=9072981
McKeon 1986 {published data only}|Does inspiratory muscle training improve exercise capacity in patients with severe stable chronic airflow limitation?|
McKeon 1986 {published data only}|The effect of inspiratory resistive training on exercise capacity in optimally treated patients with severe chronic airflow limitation|
Pardy 1981 {published data only}|The effects of inspiratory muscle training on exercise performance in chronic airflow limitation|/resolve/reference/PMED?id=7224355
Shaw 2011 {published data only}|Pulmonary function and abdominal and thoracic kinematic changes following aerobic and inspiratory resistive diaphragmatic breathing training in asthmatics|
Shaw 2011a {published data only}|Static standing posture and pulmonary function in moderate-persistent asthmatics following aerobic and diaphragmatic breathing training|
Turner 2011 {published data only}|Effect of inspiratory muscle training on exercise tolerance in asthmatic individuals|
Weiner 1992 {published data only}|Inspiratory muscle training for bronchial asthma|/resolve/reference/PMED?id=1563665
Weiner 1992 {published data only}|Inspiratory muscle training in patients with bronchial asthma|/resolve/reference/PMED?id=1424851
Bassler 2010|Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children|
Bateman 2008|Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study|
Bourdin 2012|Limited short-term steroid responsiveness is associated with thickening of bronchial basement membrane in severe asthma|
Brightling 2012|Lung damage and airway remodelling in severe asthma|
Burgel 2009|Update on the roles of distal airways in asthma|
Chiappa 2008|Inspiratory muscle training improves blood flow to resting and exercising limbs in patients with chronic heart failure|/resolve/reference/PMED?id=18436118
Clanton 2009|Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation?|/resolve/reference/PMED?id=19359619
Downey 2007|Effects of inspiratory muscle training on exercise responses in normoxia and hypoxia|/resolve/reference/PMED?id=16996322
Enright 2004|Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis|/resolve/reference/PMED?id=15302725
Enright 2006|Effect of high-intensity inspiratory muscle training on lung volumes,diaphragm thickness, and exercise capacity in subjects who are healthy|/resolve/reference/PMED?id=16506871
Geddes 2008|Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review|/resolve/reference/PMED?id=18708282
Gershon 2012|Pulmonary function testing in the diagnosis of asthma: a population study|
GINA 2011|Global strategy for asthma management and prevention|
Gosselink 2011|Impact of inspiratory muscle training in patients with COPD: what is the evidence?|
Hill 2004|Dyspnoea in COPD: can inspiratory muscle training help?|/resolve/reference/PMED?id=15482248
Hill 2010|Inspiratory muscle training for patients with chronic obstructive pulmonary disease: a practical guide for clinicians|
Huang 2003|Effect of inspiratory muscle strength training on inspiratory motor drive and RREP early peak components|/resolve/reference/PMED?id=12391135
Huang 2011|Comparison of inspiratory muscle strength training effects between older subjects with and without chronic obstructive pulmonary disease|
Illi 2012|Effectofrespiratory muscle trainingonexerciseperformanceinhealthyindividuals: a systematic review and meta-analysis|
Liaw 2011|Inspiratory muscle training in bronchiectasis patients: a prospective randomized controlled study|
Lopes 2007|Assessment of muscle shortening and static posture in children with persistent asthma|/resolve/reference/PMED?id=17109164
McConnell 2005|The role of inspiratory muscle function and training in the genesis of dyspnoea in asthma and COPD|/resolve/reference/PMED?id=16701724
McConnell 2005a|Inspiratory muscle training in obstructive lung disease: how to implement and what to expect|
Moher 2010|CONSORT2010explanationandelaboration:updatedguidelinesforreportingparallel grouprandomisedtrials|
Moodie 2011|Inspiratory muscle training to facilitate weaning from mechanical ventilation: protocol for a systematic review|
Ochmann 2012|Long-term efficacy of pulmonary rehabilitation in patients with occupational respiratory diseases|
Odgaard-Jensen 2011|Randomisation to protect against selection bias in healthcare trials|
Ramirez-Sarmiento 2002|Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes|/resolve/reference/PMED?id=12406842
Reddel 2009|An official American Thoracic Society/European Respiratory Societystatement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice|/resolve/reference/PMED?id=19535666
Romer 2003|Specificity and reversibility of inspiratory muscle training|/resolve/reference/PMED?id=12569211
Savovi 2012|Influenceofreportedstudy designcharacteristicsoninterventioneffectestimates fromrandomised controlled trials:combinedanalysisofmeta-epidemiologicalstudies|
Scherer 2000|Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life|/resolve/reference/PMED?id=11069801
To 2012|Global asthma prevalence in adults: findings from the cross-sectional world health survey|
Zhang 2010|A complex role for complement in allergic asthma|
Ram 2003|Inspiratory muscle training for asthma|
Behnke 2000a {published data only}|The effects of a home-based exercise training programme in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=10091510
Behnke 2000a {published data only}|Clinical benefits of a combined hospital and home-based exercise programme over 18 months in patients with severe COPD|/resolve/reference/PMED?id=14533282
Behnke 2000a {published data only}|Home-based exercise training in patients with severe COPD-global effects|
Behnke 2000a {published data only}|The effects of home-based exercise training on walking distance and quality of life in patients with severe COPD|
Behnke 2000a {published data only}|The long-term effects of domestic walking training in patients with severe COPD|
Behnke 2000a {published data only}|Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11192954
Bendstrup 1997 {published data only}|Out-patient rehabilitation improves activities of daily living, quality of life and exercise tolerance in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9493664
Booker 1984 {published data only}|Exercise training and breathing control in patients with chronic airflow limitation|/resolve/reference/PMED?id=6379707
Boxall 2005 {published and unpublished data}|A randomised controlled trial of home-based pulmonary rehabilitation for elderly, housebound COPD patients|
Boxall 2005 {published and unpublished data}|Managing chronic obstructive pulmonary disease in the community: A randomized controlled trial of home-based pulmonary rehabilitation for elderly housebound patients|/resolve/reference/PMED?id=16327534
Busch 1988 {published data only}|Effects of a supervised home exercise program on patients with severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3353456
Cambach 1997 {published data only}|The effects of a community-based pulmonary rehabilitation programme on exercsie capacity and quality of life: A randomized controlled trial|
Cambach 1997 {published data only}|Efficacy of a rehabilitation programme in patients with asthma and chronic obstructive pulmonary disease (COPD)|
Cambach 1997 {published data only}|The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial|/resolve/reference/PMED?id=9032501
Casaburi 2004 {published data only}|Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15271690
Casaburi 2004 {published data only}|A randomised trial of strength training and testosterone supplementation in men with chronic obstructive pulmonary disease|
Chlumsky 2001 {published data only}|The effect of pulmonary rehabilitation on exercise tolerance and quality of life in patients with COPD. Preliminary data|
Clark 1996 {published data only}|Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD|/resolve/reference/PMED?id=8980974
Cockcroft 1981 {published data only}|Psychological changes during a controlled trial of rehabilitation in chronic respiratory disability|/resolve/reference/PMED?id=6753223
Cockcroft 1981 {published data only}|Randomised controlled trial of rehabilitation in chronic respiratory disability|/resolve/reference/PMED?id=7025334
Emery 1998 {published data only}|Psychological and cognitive outcomes of a randomised trial of exercise among patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9619472
Engstrm 1999 {published data only}|Long-term effects of a pulmonary rehabilitation programme in outpatients with chronic obstructive pulmonary disease: A randomized controlled study|/resolve/reference/PMED?id=10599897
Finnerty 2001 {published data only}|The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease. A randomized controlled trial|/resolve/reference/PMED?id=11399694
Goldstein 1994 {published data only}|Economic analysis of respiratory rehabilitation|/resolve/reference/PMED?id=9266871
Goldstein 1994 {published data only}|Randomised controlled trial of respiratory rehabilitation|/resolve/reference/PMED?id=7968075
Goldstein 1994 {published data only}|Randomized controlled trial of respiratory rehabilitation|
Goldstein 1994 {published data only}|Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation|/resolve/reference/PMED?id=10210235
Gosselink 2000 {published data only}|Adaptations in breathing pattern after exercise training in patients with COPD|
Gosselink 2000 {published data only}|Improved exercise capacity after out-patient pulmonary rehabilitation in COPD patients|
Gosselink 2000 {published data only}|Pulmonary rehabilitation improves exercise capacity in COPD: preliminary results|
Gosselink 2000 {published data only}|Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial|/resolve/reference/PMED?id=10974183
Griffiths 2000 {published data only}|Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial|/resolve/reference/PMED?id=10665556
Griffiths 2000 {published data only}|Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme|/resolve/reference/PMED?id=11562517
Gell 1995 {published and unpublished data}|Effect of maintenance techniques on outcomes in a respiratory rehabilitation programme in COPD patients|/resolve/reference/PMED?id=9072139
Gell 1995 {published and unpublished data}|Long-term effects of outpatient rehabilitation of COPD: a randomized trial|/resolve/reference/PMED?id=10767227
Gell 1995 {published and unpublished data}|Effects of maintenance techniques on the results obtained in a respiratory rehabilitation programme for COPD patients|
Gell 1995 {published and unpublished data}|Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire (CRQ)|/resolve/reference/PMED?id=9543270
Gell 1995 {published and unpublished data}|Effects of respiratory rehabilitation on quality of life of patients with chronic obstructive pulmonary disease|
Gell 1995 {published and unpublished data}|Effects of respiratory rehabilitation on the effort capacity and on the health-related quality of life of patients with chronic obstructive pulmonary disease|
Gell 1998 {unpublished data only}|Impact of respiratory rehabilitation on personality traits and characteristics of patients with COPD|
Gell 1998 {unpublished data only}|Impact of pulmonary rehabilitation on personality traits and styles in COPD patients|
Gell 1998 {unpublished data only}|Impact of pulmonary rehabilitation on psychosocial morbidity in with severe COPD|/resolve/reference/PMED?id=16608936
Hernandez 2000 {published data only}|Results of a home-based training program applied to patients with chronic obstructive pulmonary disease (COPD)|
Hernandez 2000 {published data only}|Results of a home-based training program for patients with COPD|/resolve/reference/PMED?id=10893367
Hernandez 2000 {published data only}|Improvement in exercise tolerance and quality of life in COPD patients following a home training programme|
Hernandez 2000 {published data only}|Evaluation of a home training programme in patients with COPD (preliminary results)|/resolve/reference/PMED?id=9072126
Hernandez 2000 {published data only}|Results from a home-based exercise training program in patients with COPD|
Hernandez 2000 {published data only}|Improvement in exercise tolerance and quality of life in COPD patients following a home training programme|
Hernandez 2000 {published data only}|Evaluation of a home training programme in patients with COPD (preliminary results)|
Jones 1985 {published data only}|Physical exercise and resistive breathing in severe chronic airways obstruction - are they effective?|/resolve/reference/PMED?id=4076354
Lake 1990 {published data only}|Upper-limb and lower-limb exercise training in patients with chronic airflow obstruction|/resolve/reference/PMED?id=2184993
McGavin 1977 {published data only}|A controlled trial of self-regulated physical training in chronic bronchitis|
McGavin 1977 {published data only}|Physical rehabilitation for the chronic bronchitis: results of a controlled trial of exercises in the home|/resolve/reference/PMED?id=882944
Reardon 1994 {published data only}|The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea|/resolve/reference/PMED?id=8162723
Ringbaek 2000 {published data only}|Rehabilitation in patients with COPD - the effect of a "twice-a-week-programme"|
Ringbaek 2000 {published data only}|Rehabilitation of patients with chronic obstructive pulmonary disease. Exercise twice a week is not sufficient!|/resolve/reference/PMED?id=10714421
Simpson 1992 {published data only}|Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation|/resolve/reference/PMED?id=1549826
Singh 2003 {published data only}|Pulmonary rehabilitation in patients with chronic obstructive pulmonary diseases|/resolve/reference/PMED?id=12683707
Strijbos 1996 {published data only}|Home care rehabilitation and perception of dyspnea in chronic obstructive pulmonary disease|
Strijbos 1996 {published data only}|A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD|/resolve/reference/PMED?id=8620707
Strijbos 1996 {published data only}|Feasibility and effects of a home-care rehabilitation program in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8985797
Strijbos 1996 {published data only}|Five year effects of rehabilitation at different settings in patients with chronic obstructive pulmonary disease|
Vallet 1994 {published data only}|Interest of individualized training program at the ventilatory threshold in mild to moderate COPD patients|/resolve/reference/PMED?id=7816993
Weiner 1992 {published data only}|Inspiratory muscle training combined with general exercise reconditioning in patients with COPD|/resolve/reference/PMED?id=1424850
Wijkstra 1994 {published data only}|Long-term benefits of rehabilitation at home on inspiratory muscle function and dyspnoea in patients with chronic obstructive pulmonary disease (COPD)|
Wijkstra 1994 {published data only}|Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home|/resolve/reference/PMED?id=8162979
Wijkstra 1994 {published data only}|Long-term effects of home rehabilitation on physical performance in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8616547
Xie 2003 {published data only}|Influence of home-based training program on patients with COPD|
Ambrosino 1981 {published data only}|A study of short-term effect of rehabilitative therapy in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7244391
Arnadottir 2001 {published data only}|Endurance training compared to non-endurance training in chronic obstructive pulmonary disease (COPD). A randomized controlled trial|
Arnadottir 2001 {published data only}|Comparing interval and continuous endurance training in COPD|
Backer 2003 {published data only}|Resistance-training improves muscle strength, functional level and self-reported health in patients with chronic obstructive pulmonary disease [Abstract]|
Bauldoff 1996 {published data only}|Home-based, upper-arm exercise training for patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8836744
Bauldoff 2002 {published data only}|Exercise maintenance following pulmonary rehabilitation: effect of distractive stimuli|/resolve/reference/PMED?id=12226037
Behnke 2002 {published data only}|Monitoring home-based exercsie training in patients with stable COPD|
Behnke 2002a {published data only}|Combined exercise programs in patients with stable COPD: influence of psychological profile and monitoring|
Behnke 2003 {published data only}|Psychological profile but not monitoring predicts the outcome of exercise programs in COPD|
Bernard 1999 {published data only}|Aerobic and strength training in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10051269
Berry 1996 {published data only}|Inspiratory muscle training and whole-body reconditioning in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8665039
Bjerre-Jepsen 1981 {published data only}|Inspiratory resistance training in severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=6751839
Bourbeau 2000 {published data only}|Integrating rehabilitative elements into a COPD self-management program reduces exacerbations and health service utilization: a randomized clinical trial|
Bourbeau 2000 {published data only}|Impact of an integrated rehabilitative self-management program on health status of COPD patients: a multicentre randomised clinical trial|
Bourjeily-Habr 2002 {published data only}|Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12454299
Brooks 2000 {unpublished data only}|The influence of post-rehabilatation program on health related quality of life (HRQL) and functional exercise capacity in patients with chronic obstructive pulmonary disease (COPD)|
Bhning 1990 {published data only}|Physical exercise training in COPD during a 4 -week rehabilitation programme|
Cai 2003 {published data only}|Rehabilitation effect of combination of respiration exercise, Jinshuibao capsule and external application in stable stage of chronic obstructive pulmonary diseases|
Carrieri-Kohlman 96 {published data only}|Exercise training decreases dyspnea and the distress and anxiety associated with it. Monitoring alone may be as effective as coaching|/resolve/reference/PMED?id=8989072
Cegla 2002 {published data only}|Course of severe COPD with and without physiotherapy with the RC-Cornet: a randomized 2 years long-term study|/resolve/reference/PMED?id=12140795
Clark 2000 {published data only}|Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training|/resolve/reference/PMED?id=10678627
Clark 2000 {published data only}|The effect of a 12 week weight training programme in improving muscle endurance in patients with chronic obstructive pulmonary disease|
Cockcroft 1985 {published data only}|Effect of exercise training on walking distance, exercise ventilation and breathlessness in patients with COAD|/resolve/reference/PMED?id=4064556
Coppoolse 1999 {published data only}|Interval versus continuous training in patients with severe COPD: A randomized clinical trial|
Cox 1993 {published data only}|A pulmonary rehabilitation program for patients with asthma and mild chronic obstructive pulmonary diseases (COPD)|/resolve/reference/PMED?id=8341090
de Blasio 2000 {published data only}|A doubting Thomas dealing with pulmonary rehabilitation|/resolve/reference/PMED?id=10767218
de Lucas Ramos 1998 {published data only}|Training of inspiratory muscles in chronic obstructive lung disease. Its impact on functional changes and exercise tolerance|/resolve/reference/PMED?id=9557177
Dekhuijzen 1990 {published data only}|Psychological changes during pulmonary rehabilitation and target-flow inspiratory muscle training in COPD patients with a ventilatory limitation during exercise|/resolve/reference/PMED?id=2269555
Dekhuijzen 1991 {published data only}|Target-flow inspiratory muscle training during pulmonary rehabilitation in patients with COPD|/resolve/reference/PMED?id=1984942
Dekhuijzen 1991 {published data only}|Target-flow inspiratory muscle training (IMT) increases inspiratory muscle strength and endurance [Abstract]|
Demir-Deriven 2001 {published data only}|Long term effect of exercise on dyspnea and exercise performance in COPD: How much training is enough?|
Demir-Deriven 2002 {published data only}|Effects of gender on dyspnea with activities of daily living and health-related quality of life after long term exercise training in patients with COPD|
Dewse 1998 {published data only}|Improving pulmonary disease outcomes|/resolve/reference/PMED?id=10586771
Di Marzo 2000 {published data only}|Inspiratory muscles training and relaxation in COPD patients|
Di Marzo 2000 {published data only}|Inspiratory muscle training and relaxation therapy in advanced COPD patients|
Downes Vogel 2002 {published data only}|Effect of adding inspiratory muscle training to a pulmonary rehabilitation program for patients with COPD which includes upper extremity exercises|
Ellum 2002 {published data only}|Effect of forward lean sitting on work of breathing and breathless scores in stable, severe COPD patients following exercise induced breathlessness|
Emtner 1998 {published data only}|High-intensity physical training in adults with asthma. A comparison between training on land and in water|/resolve/reference/PMED?id=9825384
Epstein 1997 {published data only}|Arm training reduces the VO2 and VE cost of unsupported arm exercise and elevation in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9187983
Esteve 1996 {published data only}|The effects of breathing pattern training on ventilatory function in patients with COPD|
Foglio 2001 {published data only}|Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study|/resolve/reference/PMED?id=11399693
Gautier 1998 {unpublished data only}|Respiratory rehabilitation in chronic obstructive pulmonary disease (COPD) outpatients under long term oxygenotherapy|
Gautier 2002 {unpublished data only}|Home rehabilitation in COPD patients on long term oxygen therapy (LTOT): a multi-centre randomized controlled study [abstract]|
Gimenez 2000 {published data only}|Endurance training in patients with chronic obstructive pulmonary disease: A comparison of high versus moderate intensity|/resolve/reference/PMED?id=10638884
Girodo 1992 {published data only}|Deep diaphragmatic breathing: rehabilitation exercises for the asthmatic patient|/resolve/reference/PMED?id=1642520
Goldman 1997 {unpublished data only}|A randomised controlled trial of pulmonary rehabilitation (PR) in a district general hospital|
Goldman 1997 {unpublished data only}|Does pulmonary rehabilitation produce a lasting benefit in patients with COPD?|
Gormley 1993 {published data only}|Treadmill self-efficacy and walking performance in patients with COPD|
Gosselink 1990 {unpublished data only}|The relative efficacy of a rehabilitation-programme in COPD patients|
Green 1999 {published data only}|A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11209104
Green 1999 {published data only}|A randomised controlled trial of four weeks v seven weeks pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD)|
Griffiths 1996 {unpublished data only}|Effects of structured domicilliary exercise training programme on quality of life and walking tolerance in patients with severe COPD|
Grosbois 1999 {published data only}|Long-term benefits of exercise maintenance after outpatient rehabilitation program in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10453428
Harver 1989 {published data only}|Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=2742247
Hawkins 1999 {published data only}|Increased exercise capacity in patients with severe COPD after cycle training with porportional assist ventilation (PAV)|
Hawkins 1999 {published data only}|Physiological training in severe chronic obstructive pulmonary disease (COPD) is possible using proportional assist ventilation (PAV)|
Hentschel 2002 {published data only}|Effects of a high intensity training program on patients with chronic obstructive airways disease (COAD)|/resolve/reference/PMED?id=11951158
Holland 2003 {published data only}|Unsupported upper limb exercise training in chronic obstructive pulmonary disease - effect on endurance, symptoms and quality of life [Abstract]|
Innocenti 2000 {published data only}|Results of an outpatient pulmonary rehabilitation program in patients with COPD|
Jensen 1983 {published data only}|Risk, protective factors, and supportive interventions in chronic airway obstruction|/resolve/reference/PMED?id=6639290
Johnson 2000 {published data only}|The effects of pulmonary rehabilitation on inspiratory muscle loading in severe COPD|
Kaplan 1990 {published data only}|Randomized trial of rehabilitation in chronic obstructive pulmonary disease|
Katsura 2000 {published data only}|Effectiveness of a short-course inpatient comprehensive pulmonary rehabilitation program managed by the critical path for COPD in the elderly|
Kurabayashi 1998 {published data only}|Comparison of three protocols for breathing exercises during immersion in 38 degrees C water for chronic obstructive pulmonary disease|
Kurabayashi 2000 {published data only}|Breathing out into water during subtotal immersion: A therapy for chronic pulmonary emphysema|
Larson 1999 {published data only}|Cycle ergometer and inspiratory muscle training in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10430720
Laukandt 1998 {published data only}|Patiententraining in der pneumologischen rehabiltation verbessert die lebensqulitt bei patienten mit chronisch obstruktiven atemwegserkrankungen|
Levine 1986 {published data only}|Evaluation of a ventilatory muscle endurance training program in the rehabilitation of patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3954249
Lewczuk 1998 {published data only}|Impact of 2-year rehabilitation on exercise tolerance and transcutaneous oxygen saturation during exercise in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10335042
Lewczuk 1998 {published data only}|Oxygen saturation at rest, on exercise and during sleep in patients with COPD underogoing pulmonary rehabilitation program. Two years, prospective, controlled study|/resolve/reference/PMED?id=12518635
Lotshaw 2003 {published data only}|Land and water-based pulmonary rehabilitation; a comparison of physical performance and quality of life in patients with COPD [Abstract]|
Ma 2002 {published data only}|A randomised control study of 3-week versus 4-week pulmonary rehabilitation program (PRP) for moderate to severe geriatric COPDs in Hong Kong|
Mador 2002 {published data only}|Does strength training alter quadriceps fatigability in patients with COPD|
Mador 2004 {published data only}|Endurance and strength training in patients with COPD|/resolve/reference/PMED?id=15189919
Mador 2004 {published data only}|Effect of respiratory muscle endurance training in patients with COPD undergoing pulmonary rehabilitation [Abstract]|
Make 2000 {published data only}|Pulmonary rehabilitation improves exercise capacity and dyspnea in the national emphysema treatment trial (NETT)|
Martinez 1993 {published data only}|Supported arm exercise vs unsupported arm exercise in the rehabilitation of patients with severe chronic airflow obstruction|/resolve/reference/PMED?id=8486017
Morgan 1999 {published data only}|The prediction of benefit from pulmonary rehabilitation: Setting, training intensity and the effect of selection by disability|/resolve/reference/PMED?id=10451684
Moros Garcia 1996 {published data only}|Rehabilitation of disability in COPD|
Morris 2003 {published data only}|Improved exercise tolerance with intermittent exercise in patients with moderate COPD [Abstract]|
MTU 2003 {published data only}||
Murphy 2004 {published data only}|A randomised, controlled trial of pulmonary rehabilitation, weekly exercise and better health self-management in COPD [Abstract]|
Murphy 2004 {published data only}|A randomised trial to compare pulmonary rehabilitation (PRP) & the Stanford model chronic disease self management program (CDSMP) in COPD with 12 month follow-up|
Myers 2000 {published data only}|Pulmonary rehabilitation: outcome measures and maintenance|
Nava 1998 {published data only}|Rehabilitation of patients admitted to a respiratory intensive care unit|/resolve/reference/PMED?id=9685104
Ndundu 2001 {published data only}|Respiratory rehabilitation in patients with bronchial asthma and chronic obstructive pulmonary disease (COPD) in Kinshasa|/resolve/reference/PMED?id=11416804
Neder 2002 {published data only}|A new rehabilitative strategy for severely-disabled patients with advanced COPD: Neuromuscular electrical stimulation|
Neder 2002 {published data only}|Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD)|/resolve/reference/PMED?id=11923552
Newall 2000 {published data only}|Inspiratory muscle training (IMT) as an adjunct to a pulmonary rehabilitation programme in COPD|
Nosworthy 1992 {published data only}|An evaluation of three elements of pulmonary rehabilitation|/resolve/reference/PMED?id=25025791
Nygren-Bonnier 2002 {published data only}|Effects of a home-based training program and an outpatient hospital-based training program on patients with chronic obstructive pulmonary disease (COPD) [Abstract]|
O'Hara 1987 {published data only}|Weight training benefits in chronic obstructive pulmonary disease: a controlled crossover study|
Ortega 2002 {published data only}|Effects of peripheral muscle training on dyspnea and leg pain in patients with chronic obstructive pulmonary disease|
Ortega 2002 {published data only}|Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12204863
Ortega 2002 {published data only}|Effects of an exercise training programme on the quality of life of patients with COPD|/resolve/reference/PMED?id=9557177
Ortega 2002 {published data only}|Physiological effects of an exercise training programme in patients with stable COPD|
Patessio 1994 {published data only}|Selection criteria for exercise training in patients with COPD|/resolve/reference/PMED?id=7941664
Piantadosi 2000 {published data only}|A prospective randomized trial of lung volume reduction surgery|/resolve/reference/PMED?id=10680095
Pitta 2004 {unpublished data only}|Effects of isolated lower extremity training with cycle-ergometer in moderate/severe COPD patients [Abstract]|
Pitta 2004 {unpublished data only}|Effects of isolated cycle ergometer training on patients with moderate-to-severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15467325
Prince 1989 {published data only}|Effectiveness of a rehabilitation programme in chronic bronchitis and emphysema|
Probst 2003 {published data only}|Effects of a rollator on exercise capacity, gas exchange and ventilation in COPD patients [Abstract]|
Probst 2003 {published data only}|Mechanisms of improvement in exercise capacity using a rollator in patients with COPD|/resolve/reference/PMED?id=15486370
Puente 1996 {published data only}|Training effects of a partly supervised exercise program in COPD patients|
Raschke 1990 {published data only}|Development of nocturnal oxygen desaturation, sleep disorders, and pulmonary function during rehabilitation in chronic obstructive bronchitis|
Reilly 2000 {published data only}|Predictors of improved health-related quality of life (QOL) following pulmonary rehabilitation in the national emphysema treatment trial (NETT)|
Ries 1986 {published data only}|Comparison of isocapnic hyperventilation and walking exercise training at home in pulmonary rehabilitation|/resolve/reference/PMED?id=3731904
Ries 1988 {published data only}|Upper extremity exercise training in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3349825
Ries 1995 {published data only}|Effects of pulmonary rehabilitation on physiologic and psychological outcomes in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7741366
Roberts 1999 {published data only}|Do the effects of pulmonary rehabilitation (PR) last for 1 year in patients with COPD?|
Rooyackers 1996 {published data only}|Long-term effects of training in patients with COPD and exercise hypoxaemia|
Rudkin 1997 {published data only}|A randomised trial of hospital v home rehabilitation in severe chronic ostructive pulmonary disease (COPD)|
Sassi-Dambron 1995 {published data only}|Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies|/resolve/reference/PMED?id=7874944
Saunders 1965 {published data only}|Controlled trial of breathing exercises|
Scherer 1998 {published data only}|The effects of education alone and in combination with pulmonary rehabilitation on self-efficacy in patients with COPD|
Serres 1997 {published data only}|Improved skeletal muscle performance after individualized exercise training in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9271766
Sewell 2005 {published data only}|Goal directed pulmonary rehabilitation does not significantly improve health status and domestic function|
Sewell 2005 {published data only}|Can Individualized Rehabilitation Improve Functional Independence in Elderly Patients With COPD?|/resolve/reference/PMED?id=16162706
Sinclair 1980 {published data only}|Controlled trial of supervised exercise training in chronic bronchitis|/resolve/reference/PMED?id=6989433
Sivori 1998 {published data only}|Exercise training in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10347965
Sparrow 1997 {published data only}|Randomized controlled trial of upper-extremity exercise training in patients with COPD|
Spruit 2001 {published data only}|Rehabilitation of patients with moderate to severe COPD and muscle weakness|
Spruit 2001 {published data only}|Exercise training in patients with COPD and muscle weakness|
Sudo 1997 {published data only}|The effects of pulmonary rehabilitation combined with inspiratory muscle training on pulmonary function and inspiratory muscle strength in elderly patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9483953
Sun 2003 {published data only}|Effect of respiratory muscle gymnastics on lung function and quality of life in the old patients with chronic obstructive pulmonary disease|
Swerts 1990 {published data only}|Exercise reconditioning in the rehabilitation of patients with chronic obstructive pulmonary disease: a short- and long-term analysis|/resolve/reference/PMED?id=2369292
Toevs 1984 {published data only}|The costs and effects of behavioral programs in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=6439955
Troosters 1999 {published data only}|Pulmonary rehabilitation in patients with severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10695322
Tsang 2001 {published data only}|Effectiveness of three strengths of education and exercise on self-efficacy for walking in patients with COPD|
Ubaidullayev 1990 {published data only}|Rehabilitation of patients with chronic bronchitis|
Vargas 1998 {published data only}|Impacto of ventilatory muscle training on dysnea, exercise and quality of life in COPD|
Vargas 1998 {published data only}|Repercusion del entrenamiento muscular ventilatorio sobre la disnea, ejercicio y calidad de vida en la EPOC|
Vogiatzis 1999 {published data only}|Physiological effects of rehabilitative exercise training in patients with chronic obstructive pulmonary disease (COPD)|
Vogiatzis 1999 {published data only}|Effects of a 12-week supervised outpatient rehabilitation programme on physical performance in patients with COPD in the north east of England|
Vogiatzis 1999 {published data only}|Physiological response to moderate exercise workloads in a pulmonary rehabilitation program in patients with varying degrees of airflow obstruction|/resolve/reference/PMED?id=10559076
Vogiatzis 1999 {published data only}|Effects of rehabilitation on exercise tolerance & quality of life in patients with chronic obstructive pulmonary disease|
Vogiatzis 2001 {published data only}|Interval versus continuous rehabilitative exercise training at the same time maintained intensity in patients with COPD: A randomised trial of the effects on exercise tolerance and quality of life|
Vogiatzis 2002 {published data only}|Interval training as an alternative modality to contiuous exercise in patients with COPD|/resolve/reference/PMED?id=12166558
Vogiatzis 2002 {published data only}|Interval training as an alternative rehabilitative modality to continuous exercise in patients with COPD: a randomised trial|
Vogiatzis 2002 {published data only}|Interval versus continuous rehabilitative exercise training at the same maintained intensity in patients with COPD: A randomised trial of the effects on exercise tolerance and quality of life|
Vogiatzis 2002 {published data only}|Long-term benefits of supervised maintenance rehabilitation strategies in patients with COPD: a 12-month randomised trial at an outpatient setting|
Vogiatzis 2002 {published data only}|Long term benefits of pulmonary rehabilitation on exercise tolerance in patients with chronic obstructive pulmonary disease (COPD)|
Wadell 2004 {published data only}|Physical training in patients with chronic obstructive pulmonary disease [Dissertation]|
Wadell 2004 {published data only}|Training in water and on land in patients with COPD - short and long term perspective [Abstract]|
Wadell 2004 {published data only}|High intensity physical group training in water - An effective training modality for patients with COPD|/resolve/reference/PMED?id=15139572
Wadell 2004 {published data only}|Physical training in water is effective in patients with COPD - a randomised controlled study|
Wanke 1994 {published data only}|Effects of combined inspiratory muscle and cycle ergometer training on exercise performance in patients with COPD|/resolve/reference/PMED?id=7713205
Wedzicha 1998 {published data only}|Long term effects of pulmonary rehabilitation in patients with COPD|
Wedzicha 1998 {published data only}|Prolonged effects of pulmonary rehabilitation in patients with COPD|
Wedzicha 1998 {published data only}|Randomised controlled trial of pulmonary rehabilitation in house-bound patients with severe COPD|
Wedzicha 1998 {published data only}|Randomised controlled trial of pulmonary rehabilitation in moderate and severe COPD: prolonged benefits|
Wedzicha 1998 {published data only}|Randomised controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale|/resolve/reference/PMED?id=9727786
Weiner 1992a {published data only}|Inspiratory muscle training in patients with bronchial asthma|/resolve/reference/PMED?id=1424851
White 2002 {published data only}|Pulmonary rehabilitation compared with brief advice given for severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12370595
Worth 1985 {published data only}|Effects of physical training on respiratory muscle endurance in patients with chronic airflow obstruction|
Worth 1985 {published data only}|Effects of physical training on respiratory muscle endurance in patients with chronic airflow limitation|/resolve/reference/PMED?id=4034488
Yan 1996 {published data only}|Quantitative research for improving respiratory muscle contraction by breathing exercise|/resolve/reference/PMED?id=9275353
Yosbauran 1996 {published data only}|Evaluation of the impact of group exercises on the quality of life in patients with chronic obstructive pulmonary disease|
Zanini 2002 {published data only}|Efficacy of a rehabilitation program based on circuit training in COPD subjects: a preliminary report|
Corrado 1995 {published data only}|Effects of a short outpatient pulmonary rehabilitation program (PRP) in severe COPD patients with chronic respiratory insufficiency (CRI)|
Fernndez 1998 {published data only}|Evaluation of a home-based rehabilitation program controlled with pulse-meter in COPD|
Shu 1998 {published data only}|Upper arm exercise improves exercise tolerance and dyspnea sensation in patients with chronic obstructive airway disease (COAD)|
Tregonning 2000 {published data only}|Randomised controllled trial of home exercise and education in chronic obstructive pulmonary disease (COPD)|
Tregonning 2000 {published data only}|Randomised controlled trial of home exercise and education in chronic obstructive pulmonary disease|
Ward 1999 {published data only}|A randomised controlled trial of pulmonary rehabilitation in moderate to severe chronic airflow limitation (CAL)|
Wright 2002 {published data only}|Effect of a strength training on lung function parameters and performance in COPD patients|
Wright 2002 {published data only}|Effect of a resistance training on pulmonary function and performance measures in patients with COPD|/resolve/reference/PMED?id=12140794
Whiteford 2004 {published data only}|Evaluation of the effect of a home-based, cognitive-behavioural pulmonary rehabilitation programme on physiological and psychosocial outcomes in COPD patients [N0394118760]|
Agle 1977|Psychological aspects of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=559893
Anthonisen 1986|Prognosis in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3510578
ATS 1981|Pulmonary rehabilitation|/resolve/reference/PMED?id=7305126
ATS 1995|Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease|
ATS 1999|Pulmonary rehabilitation|/resolve/reference/PMED?id=10228143
Barr 2005|Tiotropium for stable chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15846642
Belman 1986|Exercise in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3539473
Bourbeau 2003|Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention|/resolve/reference/PMED?id=12622605
Brooks 1999|Pulmonary rehabilitation programs in Canada: national survey|/resolve/reference/PMED?id=10202221
Brooks 2002|The effect of post-rehabilitation programmes among individuals with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12166571
Brundin 1974|Physical training in severe chronic obstructive lung disease|/resolve/reference/PMED?id=4853635
Burrows 1987|The course and prognosis of different forms of chronic airways obstruction in a sample from the general population|/resolve/reference/PMED?id=3683459
Butland 1982|Two-, six-, and 12-minute walking test in respiratory diesase|/resolve/reference/PMED?id=6805625
Cahalin 1995|The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease|/resolve/reference/PMED?id=7634883
Casaburi 1991|Reductions in exercise lactic acidosis and ventialtion as a result of exercise training in patients with obstructive lung disease|/resolve/reference/PMED?id=1986689
Casaburi 1993|Exercise training in chronic obstructive lung disease|
Celli 2004|Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper|/resolve/reference/PMED?id=15219010
Chapman 2006|Epidemiology and costs of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=16387952
CTS 1992|Guidelines for the assessment and management of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=1498754
Detsky 1992|Incorporating variations in the quality of individual randomized trials into meta-analysis|/resolve/reference/PMED?id=1569422
Donner 1992|Pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD) with recommendations for its use. Report of the European Respiratory Society Rehabilitation and Chronic Care Scientific Group (S.E.P.C.R. Rehabilitation Working Group)|/resolve/reference/PMED?id=1559592
Donohue 2002|6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol|/resolve/reference/PMED?id=12114338
Feinlieb 1989|Trends in COPD morbidity and mortality in the United States|
Ferreira 2001|Nutritional supplementation in stable chronic obstructive pulmonary disease|
Ferreira 2005|Nutritional supplementation for stable chronic obstructive pulmonary disease|
Fishman 1994|Pulmonary rehabilitation research|/resolve/reference/PMED?id=8118655
Fleiss 1993|The statistical basis of meta-analysis|/resolve/reference/PMED?id=8261254
Glass 1981|Measuring study findings|
GOLD 2001|Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary|/resolve/reference/PMED?id=11316667
Goldstein 1995|Subjective comparison ratings of walking ability in patients with COPD|
Guell 2000|Long-term effects of outpatient rehabilitation of COPD: A randomized trial|/resolve/reference/PMED?id=10767227
Guyatt 1984|Effect of encouragement on walking test performance|/resolve/reference/PMED?id=6505988
Guyatt 1985|How should we measure function in patients with chronic heart and lung disease?|/resolve/reference/PMED?id=4008592
Guyatt 1987a|A measure of quality of life for clinical trials in chronic lung disease|/resolve/reference/PMED?id=3321537
Guyatt 1987b|Long-term outcome after respiratory rehabilitation|/resolve/reference/PMED?id=3676969
Haas 1969|Rehabilitation in chronic obstructive pulmonary disease: a five-year study of 252 male patients|
Harper 1997|Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting|/resolve/reference/PMED?id=9404375
Jadad 1996|Assessing the quality of reports of randomized clinical trials - is blinding necessary?|/resolve/reference/PMED?id=8721797
Jaeschke 1989|Measurement of health status: ascertaining the minimal clinically important difference|/resolve/reference/PMED?id=2691207
Jaeschke 1994|Effect of increasing dose of beta-antagonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation|/resolve/reference/PMED?id=8016770
Jones 1971|Exercise tolerance in chronic airway obstruction|/resolve/reference/PMED?id=5550344
Jones 1988|Approaches to clinical exercise testing|
Jones 1991|The St-George's Respiratory Questionnaire|/resolve/reference/PMED?id=1759018
Jones 1992|A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire|/resolve/reference/PMED?id=1595997
Jones 1997|Qualaity of life changes in COPD patients treated with salmeterol|/resolve/reference/PMED?id=9105068
Kinsman 1983|Symptoms and experiences in chronic bronchitis and emphysema|/resolve/reference/PMED?id=6839816
Kirshner 1985|A methodological framework for assessing health indices|/resolve/reference/PMED?id=3972947
Kramer 1981|Clinical biostatistics. LIV. The biostatistics of concordance|
L'Abb 1987|Meta-analysis in clinical research|/resolve/reference/PMED?id=3300460
Lacasse 1997a|Health-status measure instruments in chronic obstructive pulmonary disease|
Lacasse 1997b|A systematic overview of the measurement properties of the Chronic Respiratory Questionnaire|
Lacasse 1999|Trends in the epidemiology of chronic obstructive pulmonary disease in Canada, 1980-95|
Light 1985|Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity|/resolve/reference/PMED?id=3965263
Lotters 2002|Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis|/resolve/reference/PMED?id=12358330
Mahler 1984|The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes|/resolve/reference/PMED?id=6723384
Maltais 1996|Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8756820
Mannino 1997|Obstructive lung disease deaths in the United States from 1979 through 1993: an analysis using multiple-cause mortality data|/resolve/reference/PMED?id=9309998
Mathur 1995|Comparison of peak oxygen consumption during treadmill and treadmill exercise in severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7570432
McGavin 1976|Twelve minute walking test for assessing disability in chronic bronchitis|/resolve/reference/PMED?id=1260350
McKay 1993|Value of theophylline treatment in patients handicapped by chronic obstructive lung disease|/resolve/reference/PMED?id=8497820
NICE 2004|Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care|/resolve/reference/PMED?id=14694232
O'Donnell 2003|Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2003|/resolve/reference/PMED?id=12861361
Oga 2000|The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10852763
Pauwels 2001|Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary|/resolve/reference/PMED?id=11316667
Pepin 2005|Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=16166613
Punzal 1991|Maximum intensity exercise training in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=1889243
Quirk 1991|Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries|/resolve/reference/PMED?id=2044732
Rabe 2005|Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial|/resolve/reference/PMED?id=16099292
Redelmeier 1997|Interpreting a small difference in functional status: the six-minute walking test in chronic lung disease patients|/resolve/reference/PMED?id=9105067
Revill 1999|The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10325896
Ries 2003|Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial|/resolve/reference/PMED?id=12505859
Rodrigues 1993|Pulmonary rehabilitation in the elderly patient|/resolve/reference/PMED?id=8222561
Rutten-van Mlken 99|An empirical comparison of the St-George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical setting|/resolve/reference/PMED?id=10525558
Schulz 1995|Empirical evidence of bias - dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Shadish 1994|Combining estimates fo effect size|
Shuey 1969|An evaluation of exercise tests in chronic obstructive lung disease|/resolve/reference/PMED?id=5796318
Singh 1992|Development of a shuttle walking test of disability in patients with chronic airways obstruction|/resolve/reference/PMED?id=1494764
Solway 2001|A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain|/resolve/reference/PMED?id=11157613
Stanton 1995|A randomized controlled trial of pulmonary rehabilitation in chronic obstructive ariways disease|
Steiner 2003|Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: A randomised controlled trial|/resolve/reference/PMED?id=12947128
Taylor 2005|Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence|/resolve/reference/PMED?id=16093253
Troosters 2000|Short-and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial|/resolve/reference/PMED?id=10974183
Vale 1993|The long-term benefits of out-patient pulmonary rehabilittion on exercise endurance and quality of life|/resolve/reference/PMED?id=8417934
Vallet 1997|Comparison of two training programs in CAL patients: standardized versus individualized method|/resolve/reference/PMED?id=9032502
Wasserman 1987|Physiology of exercise|
Watson 1997|Evaluation of a self-management plan for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9192927
Wijkstra 1994a|Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8016768
Wijkstra 1995|Long term benefits of rehabilitation at home quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7570431
Lacasse 1996|Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8888163
Lacasse 2001|Pulmonary rehabilitation for chronic obstructive pulmonary disease|
Forstpointner 2004 {published and unpublished data}|The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group|/resolve/reference/PMED?id=15284112
Herold 2004 {published and unpublished data}|Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin's Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL)|
Hiddemann 2005 {published data only}|Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group|/resolve/reference/PMED?id=16123223
Lenz 2005 {published data only}|Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)|/resolve/reference/PMED?id=15668467
Marcus 2005 {published data only}|CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma|/resolve/reference/PMED?id=15494430
Rivas-Vera 2005 {published data only}|Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin's Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP|
van Oers 2006 {published data only}|Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.|
Byrd JC {published data only}|Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: Results from Cancer and Leukemia Group B 9712 (CALGB 9712)|/resolve/reference/PMED?id=12393429
Cohen 2002 {published data only}|Results of a phase II study employing a combination of Fludarabine, Cyclophosphamide and Rituximab (FCR) as a primary therapy for patiens with advanced follicular lymphoma (FL): the israel cooperative group|
Czuczman {published data only}|Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.|
Czuczman M {published data only}|Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.|
Doelken G {published data only}|Rapid clearance of circulating lymphoma cells from peripheral blood of follicular lymphoma patients treated with chemotherapy and rituximab as compared to patients treated with chemotherapy alone|
Ghielmeni M {published data only}|Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.|
Gregory S {published data only}|A phase II study of ludarabine and mitoxantrone followed by anti-CD 20 monoclonal antibody in the treatment of patients with newly diagnosed, advanced low grade non Hodgkins lymphoma (LGNHL): interim results|
Hainsworth J {published data only}|Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma--a randomized phase II trial of the Minnie Pearl Cancer Research Network.|
Hochster H {published data only}|Results of E1496: A phase III trial of CVP with or without maintenance rituximab in advanced indolent lymphoma (NHL)|
Huang J {published data only}|Rituximab Plus CHOP Followed by Maintenance Rituximab as Initial Therapy for Advanced Stage Indolent Non-Hodgkins Lymphoma (NHL); Initial Results of Induction Therapy in a Phase II Study.|
Jiang Y {published data only}|Quantification and Monitoring of the t(14;18) Translocation Copy Number by Real-Time PCR in Patients with Follicular Lymphoma Treated with FND Plus Concurrent or Delayed Rituximab|
Katakkar S {published data only}|A Combination of Rituximab with Chemotherapy in Low Grade Lymphoma|
Meckenstock G {published data only}|Firstline treatment of advanced follicular lymphoma comparing fludarabine/Mitoxantrone and high-dose chemotherapy, each combined with CD20-antibody rituximab|
Pettengell {published data only}|Phase III Randomized Study of Rituximab Purging and Maintenance With Perupheral Blood Stem Cell Transplantation in Patients With Relapsed or Resistant Follicular Non-Hodgkin's Lymphoma Undergoing High-Dose Chemotherapy|
Rambaldi A {published data only}|Long term improvement of clinical outcomes of follicular lymphoma patients achieving a molecular response after sequential CHOP and rituximab treatment: predictive value of real time quantitative PCR to identify responding patients|
Rule S {published data only}|Phase II Randomized Study of Fludarabine and Cyclophopshamide With or Without Rituximab inPatients With Previously Untreated Mantle Cell Lymphoma|
Salles G {published data only}|Rituximab Added {alpha}IFN+CHVP Improves the Outcome of Follicular Lymphoma Patients with a High Tumor Burden: to First Analysis of the GELA-GOELAMS FL-2000 Randomized Trial in 359 Patients.|
Solal-Celigny P {published data only}|Single 4-Dose Rituximab Treatment for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with a Follow-Up (F/Up) of at Least 5 Years.|
Tobinai {published data only}|Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma|
Vitolo {published data only}|A brief course of chemo-immunotherapy FND + rituximab is effective to induce a high clinical and molecular response in elderly patients with advanced stage follicular lymphoma (FL) at diagnosis"|
Witzig {published data only}|Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Group|/resolve/reference/PMED?id=15657404
Zinzani PL {published data only}|Fludarabine plus mitoxantrone with and without rituximab vs as front-line treatment for patients with follicular lymphoma|/resolve/reference/PMED?id=15159414
GELA Study {published data only}|Advanced follicular lymphoma evaluating the benefit of maintenance therapy with rituximab (MabThera) after induction of response with chemotherapy plus rituximab in comparison with no maintenance therapy. Ongoing clinical trial|
Sonneveld {published data only}|Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma|
Altman 1999|Calculating the number needed to treat for trials where the outcome is time to an event|/resolve/reference/PMED?id=10582940
Ardeshna 2003|Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial|/resolve/reference/PMED?id=12932382
Barosi 2006|Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation|/resolve/reference/PMED?id=16434377
Bonavida 2005|Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma|/resolve/reference/PMED?id=15939340
Boye 2003|An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab|/resolve/reference/PMED?id=12649096
Brice 1997|Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte|/resolve/reference/PMED?id=9060552
Brody 2006|Treatment of mantle cell lymphoma: current approach and future directions.|/resolve/reference/PMED?id=16751087
Czuczman 1999|Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.|/resolve/reference/PMED?id=10458242
Czuczman 2004|Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up|/resolve/reference/PMED?id=15483015
Demidem 1997|Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs|/resolve/reference/PMED?id=10851464
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Dreyling 2006|Rituximab maintenance improves progression-free and overall survival rates after combined immuno-chemotherapy (R-FCM) in patients with relapsed follicular and mantle cell lymphoma: final results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Feugier 2005|Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte|/resolve/reference/PMED?id=15867204
Fisher 1993|Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma|/resolve/reference/PMED?id=7680764
Gallagher 1986|Follicular lymphoma: prognostic factors for response and survival|/resolve/reference/PMED?id=3531422
Habermann 2005|Diffuse large B-cell lymphoma|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Horning 1993|Natural history of and therapy for the indolent non-Hodgkin's lymphomas|/resolve/reference/PMED?id=8211209
Ihaka 1996|a language for data analysis and graphics|
Imrie 2005|Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Systematic Review. Evidence-based Series 6-8|
Jazirehi 2005|Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention|/resolve/reference/PMED?id=15789036
Jazirehi 2005a|Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis|/resolve/reference/PMED?id=15665303
Juni 2001|Systematic reviews in health care: Assessing the quality of controlled clinical trials|/resolve/reference/PMED?id=11440947
Kober 2002|Chemotherapy plus rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. (Protocol)|
Landis 1998|Cancer statistics, 1998 Cancer statistics, 1998 Cancer statistics, 1998|
Liu 2006|Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center|/resolve/reference/PMED?id=16575009
McLaughlin 1986|Stage I-II follicular lymphoma treatment results for 76 patients|
McLaughlin 1998|Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program|/resolve/reference/PMED?id=9704735
Montoto 2003|Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma|/resolve/reference/PMED?id=12691144
Parmar 1998|Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints|
Rosenberg 1971|Report of the committee on Hodgkins disease staging procedures.|/resolve/reference/PMED?id=5121695
Solal-Celigny 2004|Follicular lymphoma international prognostic index|/resolve/reference/PMED?id=15126323
Swenson 2005|Improved survival of follicular lymphoma patients in the United States|/resolve/reference/PMED?id=15983392
Williams 2001|High-dose therapy and autologous stem cell support for chemosensitive transformed low-grade follicular non-Hodgkins lymphoma: a case-matched study for the European Bone Marrow Transplant Registry.|/resolve/reference/PMED?id=11157024
Zinzani 1998|To what extent can indolent lymphoma be considered? Results of a long term follow-up study from a single center.|/resolve/reference/PMED?id=9676022
Schulz 2007|Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis|/resolve/reference/PMED?id=17470738
Andersson 1998 {published data only}|The antihypertensive effect and tolerability of candesartan cilexitil, a new generation angiotensin II antagonist, in comparison with losartan|/resolve/reference/PMED?id=9551878
Benetos 2000 {published data only}|Blockade of angiotensin II type 1 receptors: Effect on carotid and radial artery structure and function in hypertensive humans|/resolve/reference/PMED?id=10720881
Benz 1998 {published data only}|Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy|/resolve/reference/PMED?id=9883710
Black 1997 {published data only}|Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril|/resolve/reference/PMED?id=9322828
Chrysant 2003 {published data only}|Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension|/resolve/reference/PMED?id=12764406
Chrysant 2004 {published data only}|Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide|/resolve/reference/PMED?id=15001200
Cushman 2002 {published data only}|The effect of a losartan-based treatment regimen on isolated systolic hypertension|
Farsang 2001 {published data only}|Antihypertensive effects and tolerability of candesartan cilexitil alone and in combination with amlodipine|
Feldman 1997 {published data only}|Tasosartan in patients with essential hypertension: A randomized, double-blind, dose-titration study|
Flack 2001 {published data only}|Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult african americans with mild to moderate hypertension|/resolve/reference/PMED?id=11558858
Flack 2003 {published data only}|Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients|/resolve/reference/PMED?id=12679215
Fogari 1997 {published data only}|24-hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring|/resolve/reference/PMED?id=9431859
Fogari 2001 {published data only}|Effects of four angiotensin II-receptor antagonists on fibrolysis in postemenopausal women with hypertension|
Gradman 1995 {published data only}|A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension|/resolve/reference/PMED?id=7768585
Gradman 1999 {published data only}|Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension|/resolve/reference/PMED?id=10321414
Gradman 2005 {published data only}|Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients|/resolve/reference/PMED?id=15723979
Guthrie 1998 {published data only}|Efficacy and tolerability of irbesartan, an angiotensin II receptor antagonist, in primary hypertension|
Hanefeld 2001 {published data only}|Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension|/resolve/reference/PMED?id=11675899
Hedner 1999 {published data only}|A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension|/resolve/reference/PMED?id=10232502
Holwerda 1996 {published data only}|Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril|/resolve/reference/PMED?id=8986917
Ikeda 1997 {published data only}|Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension|/resolve/reference/PMED?id=9116924
Kassler-Taub 1998 {published data only}|Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan, in mild-to-moderate hypertension|/resolve/reference/PMED?id=9607383
Klingbeil 2002 {published data only}|Effect of AT1 receptor blockade on endothelial function in essential hypertension|/resolve/reference/PMED?id=12559678
Klingbeil 2002 {published data only}|AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study|/resolve/reference/PMED?id=12473867
Kochar 1999 {published data only}|Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension|/resolve/reference/PMED?id=10480473
Lacourciere 1998 {published data only}|A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension|/resolve/reference/PMED?id=9607384
Mallion 1999 {published data only}|ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension|/resolve/reference/PMED?id=10516734
Manolis 2004 {published data only}|Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo|/resolve/reference/PMED?id=15097245
McGill 2001 {published data only}|Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone|
McGill 2001 {published data only}|Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension|
McGill 2001 {published data only}|Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group trial|/resolve/reference/PMED?id=11440284
Meineke 1997 {published data only}|Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexitil in patients with mild to moderate essential hypertension - a population analysis|/resolve/reference/PMED?id=9476035
Neutel 1998 {published data only}|Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension|
Neutel 1999 {published data only}|Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: Results from a 10-week, double-blind, placebo-controlled, dose-titration study|/resolve/reference/PMED?id=9878944
Neutel 2002 {published data only}|Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements|
Oparil 1996 {published data only}|The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension|/resolve/reference/PMED?id=8930424
Oparil 1999 {published data only}|Eprosartan versus enalapril in hypertensive patients with angiotensin-converting enzyme inhibitor-induced cough|
Patterson 2003 {published data only}|The effects of KT3-671, a new angiotensin II (AT I) receptor blocker in mild to moderate hypertension|
Pool 1998 (study 1) {published data only}|Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension|/resolve/reference/PMED?id=9607385
Pool 1998 (study 2) {published data only}|Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension|/resolve/reference/PMED?id=9607385
Pool 1999 {published data only}|Dose-response efficacy of valsartan, a new angiotensin II receptor blocker|/resolve/reference/PMED?id=10333347
Punzi 2004 {published data only}|Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study|/resolve/reference/PMED?id=15042114
Reif 1998 {published data only}|Effects of candesartan cilexitil in patients with systemic hypertension|/resolve/reference/PMED?id=9794352
Schoenberger 1995 {published data only}|Losartan with hydrochlorothiazide in the treatment of hypertension|/resolve/reference/PMED?id=18800455
Smith 1998 {published data only}|Once-daily telmisartan compared with enalapril in the treatment of hypertension|
Smith 2000 {published data only}|Dose response and safety of telmisartan in patients with mild to moderate hypertension|/resolve/reference/PMED?id=11185637
Weber 1995 {published data only}|Antihypertensive efficacy of the angiotensin II AT1-receptor antagonist losartan: results of a randomized, double-blind, placebo-controlled, parallel-group trial using 24-hour blood pressure monitoring|/resolve/reference/PMED?id=9162447
Weber 1995 {published data only}|Losartan potassium lowers blood pressure measured by ambulatory blood pressure monitoring|/resolve/reference/PMED?id=18800453
Weber 1995 {published data only}|Blood pressure effects of the angiotensin II receptor blocker, losartan|/resolve/reference/PMED?id=7848024
Weber 1995 {published data only}|Controlling blood pressure throughout the day: issues in testing a new anti-hypertensive agent|/resolve/reference/PMED?id=8583478
White 2001 {published data only}|Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertension|/resolve/reference/PMED?id=11775134
White 2002 {published data only}|Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising|/resolve/reference/PMED?id=12360162
ABC 2000 {published data only}|Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC trial|/resolve/reference/PMED?id=11728289
Asmar 2000 {published data only}|A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure|/resolve/reference/PMED?id=11081784
Asmar 2000 {published data only}|A comparison of the efficacy and duration of action of candesartan cilexitil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study|/resolve/reference/PMED?id=10619580
Asmar 2001 {published data only}|Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus|/resolve/reference/PMED?id=11881102
Bakris 2002 {published data only}|A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes|/resolve/reference/PMED?id=11824861
Fagard 2001 {published data only}|A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension|/resolve/reference/PMED?id=11317199
Fridman 1999 {published data only}|Candesartan cilexetil and renal hemodynamics in hypertensive patients|/resolve/reference/PMED?id=10981559
Fridman 1999 {published data only}|Candesartan cilexetil in hypertension: effects of six weeks' treatment on haemodynamics, baroreceptor sensitivity and the renin-angiotensin-aldosterone system|/resolve/reference/PMED?id=10697305
Hedner 1999a {published data only}|The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension|/resolve/reference/PMED?id=10100104
Koh 2004 {published data only}|Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=15488878
Koh 2004 {published data only}|Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension|/resolve/reference/PMED?id=15165934
Lacourciere 1998a {published data only}|A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telemisartan and amlodipine|/resolve/reference/PMED?id=10212369
Lacourciere 1999 {published data only}|The incidence of cough:A comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist|/resolve/reference/PMED?id=10344043
Marino 1999 {published data only}|Pharmacodynamics and pharmacokinetics of irbesartan in patients with mild to moderate hypertension|
McInnes 1997 {published data only}|The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population|/resolve/reference/PMED?id=9331015
Neutel 1997 {published data only}|Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours|/resolve/reference/PMED?id=9220209
Neutel 2000 {published data only}|Efficacy of valsartan in patients aged > or =65 years with systolic hypertension|/resolve/reference/PMED?id=10972632
Petrov 2001 {published data only}|T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans|/resolve/reference/PMED?id=11588528
Zanchetti 2001 {published data only}|Comparison of candesartan versus enalapril in essential hypertension|/resolve/reference/PMED?id=11243303
Zuschke 1999 {published data only}|Candesartan cilexitil: comparison of once-daily versus twice-daily administration for systemic hypertension|/resolve/reference/PMED?id=10321416
Bucher 1997|The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=9250266
Cochrane Handbook|Chapter 10: Addressing reporting biases|
e-CPS|Micardis [product monograph]|
Heran 2002|Development of an optimal search strategy for finding trials demonstrating ACE inhibitor blood pressure lowering efficacy|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Song 2003|Validity of indirect comparison for estimating efficacy of competing interventions: emperical evidence from published meta-analyses|/resolve/reference/PMED?id=12609941
WHO-ICTRP|International Clinical Trials Registry Platform (ICTRP)|
Applegate 1996 {published data only}|Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension|/resolve/reference/PMED?id=8712118
Belz 1986 {published data only}|Cilazapril in essential hypertension: A placebo-controlled double-blind study to establish the dosage|/resolve/reference/PMED?id=2946925
Black 1997 {published data only}|Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril|/resolve/reference/PMED?id=9322828
Boeijinga 1993 {published data only}|The influence of cilazapril on anticoagulants in hypertensive patients treated with coumarins|
Brown 1990 {published data only}|The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects|/resolve/reference/PMED?id=2076713
Carlsen 1995 {published data only}|24-hour antihypertensive effect of oral cilazapril? A placebo-controlled study evaluating 1, 2.5 and 5 mg once daily|
Chan 1997 {published data only}|Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension|/resolve/reference/PMED?id=9234828
Chrysant 1993 {published data only}|Perindopril as monotherapy in hypertension: A multicenter comparison of two dosing regimens|/resolve/reference/PMED?id=8477565
Chrysant 1994 {published data only}|Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination|/resolve/reference/PMED?id=8147677
Chrysant 1996 {published data only}|Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension|/resolve/reference/PMED?id=8542050
Chrysant 1996 {published data only}|Double-blind comparison of once daily benazepril, hydrochlorothiazide and placebo in mild to moderate hypertension|
Chrysant 1996 {published data only}|Dose-response studies with benazepril in mild to moderate hypertension|
Cushman 1998 {published data only}|Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension|/resolve/reference/PMED?id=9504446
De Bruijn 1994 {published data only}|Efficacy and tolerability of trandolapril (0.5-2 mg) administered for 4 weeks in patients with mild-to-moderate hypertension|/resolve/reference/PMED?id=7527104
DeQuattro 1997 {published data only}|Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension|/resolve/reference/PMED?id=9231890
DeQuattro 1997 {published data only}|Efficacy of combination therapy with trandolapril and verapamil SR in primary hypertension: A 4 X 4 trial design|/resolve/reference/PMED?id=9107443
DeQuattro 1997 {published data only}|Trandolapril and verapamil slow release in the treatment of hypertension: A dose-response assessment with the use of a multifactorial trial design|
Drayer 1983 {published data only}|Monotherapy of essential hypertension with a converting-enzyme inhibitor|/resolve/reference/PMED?id=6313522
Dupui 1993 {published data only}|Effects of a captopril-induced decrease of the arterial blood pressure on the cerebral blood flow of elderly subjects with moderate hypertension|
Dupui 1993 {published data only}|Cerebral blood flow changes induced by a chronic treatment with captopril in previously untreated elderly hypertensive subjects|/resolve/reference/PMED?id=7755480
Fairhurst 1994 {published data only}|A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension|
Fernandez 1990 {published data only}|The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen|/resolve/reference/PMED?id=2138051
Fernandez 1990 {published data only}|Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients|/resolve/reference/PMED?id=2138049
Fernandez 1994 {published data only}|Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients|/resolve/reference/PMED?id=8282360
Ford 1993 {published data only}|Fosinopril monotherapy: Relationship between blood pressure reduction and time of administration|
Gerritsen 1998 {published data only}|Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension|/resolve/reference/PMED?id=9797181
Gomez 1989 {published data only}|Lisinopril dose-response relationship in essential hypertension|/resolve/reference/PMED?id=2556172
Gradman 1995 {published data only}|A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension|/resolve/reference/PMED?id=7768585
Gradman 1997 {published data only}|Combined enalapril and felodipine extended release (ER) for systemic hypertension|/resolve/reference/PMED?id=9052345
Guitard 1994 {published data only}|Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension|
Guitard 1997 {published data only}|Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension|/resolve/reference/PMED?id=9310273
Guntzel 1991 {published data only}|The effect of cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patients|/resolve/reference/PMED?id=1708060
Guntzel 1991 {published data only}|Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension|/resolve/reference/PMED?id=1712270
Holwerda 1996 {published data only}|Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril|/resolve/reference/PMED?id=8986917
Homuth 1993 {published data only}|Usefulness of piretanide plus ramipril for systemic hypertension: A multicenter trial|/resolve/reference/PMED?id=8249842
Kayanakis 1987 {published data only}|Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension|/resolve/reference/PMED?id=3555588
Kobrin 1991 {published data only}|Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension|/resolve/reference/PMED?id=1712270
Koch 1999 {published data only}|Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women|/resolve/reference/PMED?id=10376852
Kohlmann Jr 1999 {published data only}|Brazilian multicenter study on efficacy and tolerability of trandolapril in mild-to-moderate essential arterial hypertension: EMBATHE substudy with ambulatory blood pressure monitoring|/resolve/reference/PMED?id=10668225
Kostis 1991 {published data only}|Double-blind study of ascending doses of ramipril in patients with mild to moderate hypertension|
Kostis 1991 {published data only}|Dose-response relationship of ramipril in patients with mild-to-moderate hypertension|/resolve/reference/PMED?id=1725021
Krum 1992 {published data only}|Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide|/resolve/reference/PMED?id=1279292
Krum 1998 {published data only}|The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension|/resolve/reference/PMED?id=9504938
Kuppers 1997 {published data only}|Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension|/resolve/reference/PMED?id=9050976
Kuschnir 1996 {published data only}|Treatment of patients with essential hypertension: Amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo|/resolve/reference/PMED?id=9001838
Lacourciere 1994 {published data only}|Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy|/resolve/reference/PMED?id=8044721
Lerch 1999 {published data only}|Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2|/resolve/reference/PMED?id=10218721
Levine 1995 {published data only}|Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension|/resolve/reference/PMED?id=7662226
Luccioni 1988 {published data only}|Evaluation of the dose-effect relationship of a new ace inhibitor (perindopril) by an automatic blood pressure recorder|/resolve/reference/PMED?id=3061819
MacLean 1989 {published data only}|Quinapril: A double-blind, placebo-controlled trial in essential hypertension|/resolve/reference/PMED?id=2650581
Mancia 1992 {published data only}|Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring|/resolve/reference/PMED?id=1414927
Mancia 1992 {published data only}|Twenty-four hour ambulatory blood pressure monitoring and antihypertensive treatment: Focus on ACE inhibitors|/resolve/reference/PMED?id=7519691
Mancia 1997 {published data only}|Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: The Veratran Study|/resolve/reference/PMED?id=9160758
McCarron 1991 {published data only}|The effect of ramipril on ambulatory blood pressure: A multicenter trial|/resolve/reference/PMED?id=1725022
McCarron 1991 {published data only}|24-hour blood pressure profiles in hypertensive patients administered ramipril or placebo once daily: magnitude and duration of antihypertensive effects|/resolve/reference/PMED?id=1835914
McFate-Smith 1991 {published data only}|Benazepril in the treatment of older and elderly hypertensive patients|
McFate-Smith 1991 {published data only}|The use of benazepril in hypertensive patients age 55 and over|/resolve/reference/PMED?id=1893647
Messerli 1998 {published data only}|Effects of verapamil and trandolapril in the treatment of hypertension|/resolve/reference/PMED?id=9544873
Moser 1991 {published data only}|Dose-response studies with benazepril in mild to moderate hypertension|
Moser 1991 {published data only}|The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: A multicenter study|/resolve/reference/PMED?id=2007326
Moser 1991 {published data only}|Double-blind comparison of benazepril, hydrochlorothiazide, and placebo in mild to moderate hypertension|
Mroczek 1991 {published data only}|Dose-finding study of cilazapril (Inhibace(TM)) in patients with uncomplicated essential hypertension|/resolve/reference/PMED?id=1836986
Mroczek 1996 {published data only}|A double-blind evaluation of moexipril versus hydrochlorothiazide in hypertension|
Muiesan 1987 {published data only}|Antihypertensive efficacy and tolerability of captopril in the elderly: Comparison with hydrochlorothiazide and placebo in multicentre, double-blind study|/resolve/reference/PMED?id=3327931
Myers 1996 {published data only}|A dose-response study of perindopril in hypertension: Effects on blood pressure 6 and 24 h after dosing|/resolve/reference/PMED?id=9191512
New 2000 {published data only}|Insulin sensitivity in hypertensive type 2 diabetic patients after 1 and 19 days' treatment with trandolapril|
Oparil 1999 {published data only}|Eprosartan versus enalapril in hypertensive patients with angiotensin-converting enzyme inhibitor-induced cough|
Overlack 1994 {published data only}|Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant therapy|/resolve/reference/PMED?id=8216441
Overlack 1994 {published data only}|Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia|/resolve/reference/PMED?id=7516014
Overlack 1994 {published data only}|ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases|/resolve/reference/PMED?id=8059778
Overlack 1994 {published data only}|Clinical and functional course of COPD in hypertensive patients with concomitant chronic bronchitis and emphysema during treatment with an ACE inhibitor, perindopril|
Overlack 1994 {published data only}|A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies|/resolve/reference/PMED?id=8328365
Overlack 1994 {published data only}|Angiotensin-converting enzyme inhibition in mild hypertension with concomitant diseases and therapies: an efficacy, safety, and compatibility study of novel design, the Perindopril Therapeutic Safety Study|/resolve/reference/PMED?id=1580290
Persson 1996 {published data only}|Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients|/resolve/reference/PMED?id=8803515
Pittrow 1997 {published data only}|Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension|/resolve/reference/PMED?id=9493699
Pizarro 1996 {published data only}|Antihypertensive effect of fosinopril in mild hypertension|/resolve/reference/PMED?id=8755686
Poirier 1991 {published data only}|2.5 and 5 mg cilazapril once daily compared with placebo in hypertension: A comparative out-patient study of 24-hour blood pressure monitoring|/resolve/reference/PMED?id=8519032
Poirier 1991 {published data only}|Comparative effects of 2.5 and 5 mg cilazapril versus placebo on daily blood pressure load|/resolve/reference/PMED?id=1838693
Pool 1990 {published data only}|Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: Findings of the fosinopril study group II|/resolve/reference/PMED?id=2149674
Pool 1997 {published data only}|Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension|/resolve/reference/PMED?id=9008256
Pool 2001 {published data only}|Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone|/resolve/reference/PMED?id=11464260
Pordy 1994 {published data only}|Cilazapril plus hydrochlorothiazide: Improved efficacy without reduced safety in mild to moderate hypertension|/resolve/reference/PMED?id=7850821
Prager 1994 {published data only}|Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile|/resolve/reference/PMED?id=7700076
Prichard 2002 {published data only}|Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertension|/resolve/reference/PMED?id=12126263
Reimann 1995 {published data only}|ACE inhibition in hypertensive patients with concomitant NSAID therapy|
Roca-Cusachs 2001 {published data only}|Nitrendipine and enalapril combination therapy in mild to moderate hypertension: Assessment of dose-response relationship by a clinical trial of factorial design|/resolve/reference/PMED?id=11707687
Sassano 1984 {published data only}|Antihypertensive effect of enalapril as first-step treatment of mild and moderate uncomplicated essential hypertension|/resolve/reference/PMED?id=6089555
Saynavalammi 1988 {published data only}|Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension|/resolve/reference/PMED?id=2459540
Schoenberger 1986 {published data only}|Once-daily treatment of essential hypertension with captopril|/resolve/reference/PMED?id=3543231
Scholze 1998 {published data only}|Verapamil SR and trandolapril combination therapy in hypertension - a clinical trial of factorial design|
Scholze 1999 {published data only}|Antihypertensive profiles with ascending dose combinations of ramipril and felodipine ER|/resolve/reference/PMED?id=10574423
Simon 1983 {published data only}|Cardiac and hormonal effects of enalapril in hypertension|/resolve/reference/PMED?id=6313274
Simon 1983 {published data only}|Increased renal plasma flow in long-term enalapril treatment of hypertension|/resolve/reference/PMED?id=6311477
Smith 1998 {published data only}|Once-daily telmisartan compared with enalapril in the treatment of hypertension|
Smith 2000 {published data only}|Dose response and safety of telmisartan in patients with mild to moderate hypertension|/resolve/reference/PMED?id=11185637
Trevisan 1995 {published data only}|Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients|/resolve/reference/PMED?id=8541002
Uusitupa 1996 {published data only}|Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure|/resolve/reference/PMED?id=8817406
VA Study Group 1984 {published data only}|Low-dose captopril for the treatment of mild to moderate hypertension|/resolve/reference/PMED?id=6237623
VA Study Group 1984 {published data only}|Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide|/resolve/reference/PMED?id=6753911
Vandenburg 1994 {published data only}|Dose finding studies with imidapril - a new ACE inhibitor|/resolve/reference/PMED?id=8198936
Vaur 1998 {published data only}|Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs|/resolve/reference/PMED?id=10212339
Villamil 1987 {published data only}|A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo|/resolve/reference/PMED?id=3034017
Waeber 1999 {published data only}|Felodipine-metoprolol combination tablet: A valuable option to initiate antihypertensive therapy?|/resolve/reference/PMED?id=10509550
Weinberger 1990 {published data only}|Dose-response studies with benazepril in mild to moderate hypertension|/resolve/reference/PMED?id=1893638
Weinberger 1990 {published data only}|Diurnal blood pressure in patients with mild-to-moderate hypertension treated with once-daily benazepril hydrochloride|/resolve/reference/PMED?id=2188772
Weir 1995 {published data only}|Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients|/resolve/reference/PMED?id=7607715
Weir 1995 {published data only}|Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African-Americans|/resolve/reference/PMED?id=9579769
Whalen 1989 {published data only}|Dose-response studies with benazepril in mild to moderate hypertension|/resolve/reference/PMED?id=1893638
Whalen 1989 {published data only}|Peak and trough effects of 3 once daily dose levels of benazepril in mild-moderate hypertension|
Whelton 1992 {published data only}|Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension|/resolve/reference/PMED?id=1331444
White 1988 {published data only}|The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure|/resolve/reference/PMED?id=2969315
White 1995 {published data only}|Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring|/resolve/reference/PMED?id=7608310
White 2002 {published data only}|Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising|/resolve/reference/PMED?id=12360162
Yebes 1993 {published data only}|A placebo-controlled double blind study to evaluate the efficacy of once daily quinapril in patients with mild to moderate hypertension|
Yodfat 1993 {published data only}|Dose-finding and dose justification of once-daily cilazapril in combination with hydrochlorothiazide in non-obese patients with mild-to-moderate essential hypertension|
Zamboulis 1996 {published data only}|Effects of fosinopril on renal function in patients with mild to moderate essential hypertension|
Bainbridge 1993 {published data only}|The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension|/resolve/reference/PMED?id=12959310
Bakris 2002 {published data only}|A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes|/resolve/reference/PMED?id=11824861
Beaulieu 1993 {published data only}|Unchanged neurogenic vasoconstrictor response after exercise during angiotensin converting enzyme inhibition with fosinopril|/resolve/reference/PMED?id=7986469
Beaulieu 1993 {published data only}|Post-exercise reduction in blood pressure in hypertensive subjects: Effects of angiotensin converting enzyme inhibition|/resolve/reference/PMED?id=12959311
Bergstrand 1985 {published data only}|Effective dose range of enalapril in mild to moderate essential hypertension|/resolve/reference/PMED?id=2988589
Bohlen 1996 {published data only}|Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension|/resolve/reference/PMED?id=8761842
Canter 1994 {published data only}|Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group [see comments]|/resolve/reference/PMED?id=8006914
Canter 1994a {published data only}|Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents|/resolve/reference/PMED?id=7769502
Cleroux 1994 {published data only}|Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise|/resolve/reference/PMED?id=7917158
Cuspidi 1997 {published data only}|Lack of effect of short-term lisinopril administration on left ventricular filling dynamics in hypertensive patients with diastolic dysfunction|/resolve/reference/PMED?id=9360002
Duprez 1986 {published data only}|Vasodilator effects of enalapril in patients with arterial hypertension|/resolve/reference/PMED?id=3022512
Fagard 2001 {published data only}|A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension|/resolve/reference/PMED?id=11317199
Gall 1992 {published data only}|Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension|/resolve/reference/PMED?id=1581012
Gans 1993 {published data only}|Effect of cilazapril on glucose tolerance and lipid profile in hypertensive patients with non-insulin-dependent diabetes mellitus|/resolve/reference/PMED?id=8302395
Gleerup 1996 {published data only}|Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension|/resolve/reference/PMED?id=8873580
Guitard 1994a {published data only}|Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension|
Gupta 1990 {published data only}|Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor|/resolve/reference/PMED?id=2196144
Gupta 1990 {published data only}|Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor|/resolve/reference/PMED?id=1708046
Homuth 1993a {published data only}|Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial|/resolve/reference/PMED?id=8249842
Hu 1999 {published data only}|Quality of life of patients with mild hypertension treated with captopril: A randomized double-blind placebo-controlled clinical trial|/resolve/reference/PMED?id=11593526
Kahan 1999 {published data only}|The influence of long-term ACE inhibitor treatment on circulatory responses to stress in human hypertension|/resolve/reference/PMED?id=10619581
Karlberg 1987 {published data only}|Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension|/resolve/reference/PMED?id=3034016
Kjeldsen 1992 {published data only}|Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril|/resolve/reference/PMED?id=1575171
Lacourciere 1999 {published data only}|The incidence of cough: A comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist|/resolve/reference/PMED?id=10344043
Lavezzaro 1990 {published data only}|Ketanserin and captopril interaction in the treatment of essential hypertensives|
Leonetti 1991 {published data only}|Treatment of hypertension in the elderly: Effects on blood pressure, heart rate, and physical fitness|/resolve/reference/PMED?id=2006653
Littler 1990 {published data only}|Twenty-four hour action of ACE inhibitors|/resolve/reference/PMED?id=1971654
Louis 1992 {published data only}|Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects|/resolve/reference/PMED?id=1279299
Miyajima 1999 {published data only}|Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans|
Morgan 2001 {published data only}|ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension|/resolve/reference/PMED?id=11281235
Petersen 1996 {published data only}|ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension|/resolve/reference/PMED?id=8638865
Petrie 2000 {published data only}|Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial|/resolve/reference/PMED?id=10843169
Petrov 2001 {published data only}|T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans|/resolve/reference/PMED?id=11588528
Plouin 1991 {published data only}|Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty?|/resolve/reference/PMED?id=2059395
Pritchard 1996 {published data only}|Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?|
Pritchard 1996 {published data only}|Indomethacin does not attenuate the hypotensive effect of trandolapril|/resolve/reference/PMED?id=9004107
Reisin 1997 {published data only}|Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group|/resolve/reference/PMED?id=9231834
Salvetti 1987 {published data only}|Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study|/resolve/reference/PMED?id=3326920
Salvetti 1988 {published data only}|Captopril at 50 mg as well as at 100 mg once a day reduces blood pressure for up to 24 h: a double-blind randomized crossover study in mild to moderate hypertensives|/resolve/reference/PMED?id=3071596
Salvetti 1989 {published data only}|Chronic dose-response curve of enalapril in essential hypertensives. An Italian multicenter study|/resolve/reference/PMED?id=2541741
Samuelsson 1992 {published data only}|A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension|/resolve/reference/PMED?id=1336463
Sassano 1984a {published data only}|A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension|/resolve/reference/PMED?id=6100880
Scholze 1993 {published data only}|Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. The East Germany Collaborative Trial Group|/resolve/reference/PMED?id=8385183
Thurig 1995 {published data only}|Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients|/resolve/reference/PMED?id=8751016
Tomei 1992 {published data only}|Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study|/resolve/reference/PMED?id=1376812
Wiggam 1998 {published data only}|Captopril does not improve insulin action in essential hypertension: a double-blind placebo-controlled study|/resolve/reference/PMED?id=9856366
Wilkins 1983 {published data only}|Enalapril in low-renin essential hypertension|/resolve/reference/PMED?id=6309461
Wing 1987 {published data only}|Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions|/resolve/reference/PMED?id=2832575
Wing 1988 {published data only}|Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination|/resolve/reference/PMED?id=2832102
Youssef 1993 {published data only}|Serum lipoprotein profile under different antihypertensive therapy|
Zanchetti 2001 {published data only}|Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group|/resolve/reference/PMED?id=11243303
Bucher 1997|The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=9250266
Cochrane Handbook|Chapter 10: Addressing reporting biases|
Heran 2002|Development of an optimal search strategy for finding trials demonstrating ACE inhibitor blood pressure lowering efficacy|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Song 2003|Validity of indirect comparison for estimating efficacy of competing interventions: emperical evidence from published meta-analyses|/resolve/reference/PMED?id=12609941
WHO-ICTRP|International Clinical Trials Registry Platform (ICTRP)|
Barr 1995 {published data only}|Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease|/resolve/reference/PMED?id=7503007
Boccanelli 1986 {published data only}|Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial|/resolve/reference/PMED?id=3534859
Burr 1977 {published data only}|The effects of discontinuing long-term diuretic therapy in elderly|/resolve/reference/PMED?id=402800
Cheitlin 1991 {published data only}|Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics|/resolve/reference/PMED?id=1888694
Cowley 1986 {published data only}|Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure|/resolve/reference/PMED?id=2876233
Dalhstrom 1986 {published data only}|Prenalterol as a long therapy for chronic congestive heart failure: a randomised cross-over trial with intensified diuretics|
De Jong 1994 {published data only}|Short-term effect of withdrawal of diuretic drugs prescribed for ankle oedema|/resolve/reference/PMED?id=8136670
Haerer 1989 {published data only}|The impact of digoxin and diuretics on exercise tolerance in congestive heart failure: a placebo controlled randomised double-blind trial|
Myers 1982 {published data only}|Unnecessary diuretic therapy in the elderly|/resolve/reference/PMED?id=7180724
Nordrehaug 1992 {published data only}|A 3-month double-blind cross-over study of the effect of Benazepril and hydrochlorothiazide on functional class in symptomatic mild heart failure|
Richardson 1987 {published data only}|Double-blind comparison of captopril alone against furosemide plus amiloride in mild heart failure|/resolve/reference/PMED?id=2888942
Sherman 1986 {published data only}|Peritanide, a potent diuretic with potassium-sparing properties, for treatment of congestive heart failure|/resolve/reference/PMED?id=3533372
Sievert 1989 {published data only}|Basic therapy of chronic heart failure with digitalis or diuretics?|/resolve/reference/PMED?id=2924690
Walma 1997 {published data only}|Withdrawal of long-term diuretic medication in elderly patients: a double-blind randomised trial|/resolve/reference/PMED?id=9284668
Abbondati 1989 {published data only}|Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure|
Andrews 1997 {published data only}|A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure|/resolve/reference/PMED?id=9152656
Edhago 1967 {published data only}|Ethacrynic acid in pulmonary oedema|
EPHESUS 2003 {published data only}|Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction (EPHESUS)|/resolve/reference/PMED?id=12668699
Grinstead 1994 {published data only}|Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=8184813
Haerer 1990 {published data only}|Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure: a placebo-controlled trial|/resolve/reference/PMED?id=2285635
Kleber 1990 {published data only}|Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study|/resolve/reference/PMED?id=2279255
Kourouklis 1976 {published data only}|Bumetanide in congestive heart failure|/resolve/reference/PMED?id=793779
Mathur 1984 {published data only}|Effect of diuretics on cardiopulmonary performance in severe chronic airflow obstruction. A controlled clinical trial|/resolve/reference/PMED?id=6388521
Parker 1993 {published data only}|The effects of oral ibopamine in patients with mild heart failure: a double-blind placebo controlled comparison to furosemide|/resolve/reference/PMED?id=8225657
Patterson 1994 {published data only}|Oral torsemide in patients with chronic congestive heart failure: effects on body weight, oedema, and electrolyte excretion|/resolve/reference/PMED?id=7997385
RALES 1999 {published data only}|The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators|/resolve/reference/PMED?id=10471456
ACC/AHA 2005|ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society|/resolve/reference/PMED?id=16160202
Ahmed 2006|Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods|/resolve/reference/PMED?id=16709595
ALLHAT 2002|Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versuss diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)|/resolve/reference/PMED?id=12479763
Anand 1991|Diuretics as initial and sole treatment in chronic cardiac failure|/resolve/reference/PMED?id=1760518
Aronow 1990|Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated coronary artery disease|
Barr 1994|QT dispersion and sudden unexpected death in chronic heart failure|/resolve/reference/PMED?id=7905146
Bayliss 1987|Untreated heart failure: clinical and endocrine effects of introducing diuretics|/resolve/reference/PMED?id=3541995
Captopril 1988|Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group|/resolve/reference/PMED?id=2447297
Chalmers 1989|Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy and childbirth|
CIBIS 1994|A randomized trial of beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS)|/resolve/reference/PMED?id=7923660
CIBIS-II 1999|The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial|
Clarke 2002|The Reviewers' Handbook|
Cody 1982|Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure|/resolve/reference/PMED?id=7039281
COMET 2003|Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial|/resolve/reference/PMED?id=12853193
CONSENSUS 1987|Effects of enalapril on mortality in severe congestive heart failure: Results of the cooperative North Scandinavian Enalapril Survival Study|/resolve/reference/PMED?id=2883575
COPERNICUS 2001|Effect of carvedilol on survival in severe chronic heart failure|/resolve/reference/PMED?id=11386263
Davie 1997|The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure|/resolve/reference/PMED?id=9183590
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Domanski 2003|Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD)|/resolve/reference/PMED?id=12932605
El-Ebrashy 1968|Effects of digitalisation on urinary excretion of water, sodium, potassium, and chloride in heart failure|/resolve/reference/PMED?id=5723100
Farquharson 2000|Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I / angiotensin II conversion in patients with chronic heart failure|/resolve/reference/PMED?id=10673249
Feigenbaum 2000|Contracted plasma and blood volume in chronic heart failure|/resolve/reference/PMED?id=10636258
Flather 2000|Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group|
Follath 1998|Do diuretics differ in terms of clinical outcome in congestive heart failure?|/resolve/reference/PMED?id=9886706
Francis 1990|Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)|/resolve/reference/PMED?id=2146040
Friedman 1998||
Grag 1995|Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaberative Group on ACE Inhibitors Trials|
Hall 1995|Time course of improvement in the left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade|/resolve/reference/PMED?id=7897129
Hollifield 1981|Thiazide diuretics, hypokalaemia and cardiac arrhythmias|
Iriarte 1993|Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension|/resolve/reference/PMED?id=8427173
J-MELODIC 2007|Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure|/resolve/reference/PMED?id=17587724
Klug 1993|Role of mechanical and hormonal factors in cardiac remodelling and the biologic limits of myocardial adaptation|/resolve/reference/PMED?id=8422005
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Mantel 1981|Statistical aspects of the analysis of data from retrospective studies of diseases.|
MERIT-HF 2000|Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized intervention trial in congestive heart failure (MERIT-HF)|/resolve/reference/PMED?id=10714728
Motwani 1992|Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure|/resolve/reference/PMED?id=1638713
MRC 1992|Medical Research Council trial of treatment of hypertension in older adults: Principal results|/resolve/reference/PMED?id=1445513
Packer 1983|Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure|/resolve/reference/PMED?id=6352079
Packer 1987|Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure|/resolve/reference/PMED?id=3028221
Pitt 2004|Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies|/resolve/reference/PMED?id=15134801
Robson 1964|The diuretic response to furosemide|/resolve/reference/PMED?id=14207893
SHEP 1991|Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)|/resolve/reference/PMED?id=2046107
Slater 1958|Clinical experience with chlorothiazide|/resolve/reference/PMED?id=13503228
Steiness 1976|Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy|/resolve/reference/PMED?id=1259829
STOP 1991|Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)|/resolve/reference/PMED?id=1682683
V-HeFT I 1986|Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administrations Co-operative study|/resolve/reference/PMED?id=3520315
V-Heft II 1991|A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. Veterans Administration Co-operative study|/resolve/reference/PMED?id=2057035
van Valdhuisen 2001|The under-reporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure|/resolve/reference/PMED?id=11532543
Waagstein 1993|A Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. (MDC) Trial Study Group|/resolve/reference/PMED?id=7902479
Weber 2004|Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain|/resolve/reference/PMED?id=15364337
Wilson 1981|Effect of diuresis on the performance of the failing left ventricle in man|/resolve/reference/PMED?id=7468610
Yusuf 1991|Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators|/resolve/reference/PMED?id=2057034
Yusuf 1992|Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions|/resolve/reference/PMED?id=1463530
Faris 2002|Current evidence supporting the role of diuretics in heart failure: a meta-analysis of randomised controlled trials|/resolve/reference/PMED?id=11853901
Barr 1995 {published data only}|Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease|/resolve/reference/PMED?id=7503007
Boccanelli 1986 {published data only}|Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial|/resolve/reference/PMED?id=3534859
Burr 1977 {published data only}|The effects of discontinuing long-term diuretic therapy in elderly|/resolve/reference/PMED?id=402800
Cheitlin 1991 {published data only}|Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics|/resolve/reference/PMED?id=1888694
Cowley 1986 {published data only}|Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure|/resolve/reference/PMED?id=2876233
Dalhstrom 1986 {published data only}|Prenalterol as a long therapy for chronic congestive heart failure: a randomised cross-over trial with intensified diuretics|
De Jong 1994 {published data only}|Short-term effect of withdrawal of diuretic drugs prescribed for ankle oedema|/resolve/reference/PMED?id=8136670
Haerer 1989 {published data only}|The impact of digoxin and diuretics on exercise tolerance in congestive heart failure: a placebo controlled randomised double-blind trial|
Myers 1982 {published data only}|Unnecessary diuretic therapy in the elderly|/resolve/reference/PMED?id=7180724
Nordrehaug 1992 {published data only}|A 3-month double-blind cross-over study of the effect of Benazepril and hydrochlorothiazide on functional class in symptomatic mild heart failure|
Richardson 1987 {published data only}|Double-blind comparison of captopril alone against furosemide plus amiloride in mild heart failure|/resolve/reference/PMED?id=2888942
Sherman 1986 {published data only}|Peritanide, a potent diuretic with potassium-sparing properties, for treatment of congestive heart failure|/resolve/reference/PMED?id=3533372
Sievert 1989 {published data only}|Basic therapy of chronic heart failure with digitalis or diuretics?|/resolve/reference/PMED?id=2924690
Walma 1997 {published data only}|Withdrawal of long-term diuretic medication in elderly patients: a double-blind randomised trial|/resolve/reference/PMED?id=9284668
Abbondati 1989 {published data only}|Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure|
Andrews 1997 {published data only}|A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure|/resolve/reference/PMED?id=9152656
Edhago 1967 {published data only}|Ethacrynic acid in pulmonary oedema|
EPHESUS 2003 {published data only}|Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction (EPHESUS)|/resolve/reference/PMED?id=12668699
Grinstead 1994 {published data only}|Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=8184813
Haerer 1990 {published data only}|Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure: a placebo-controlled trial|/resolve/reference/PMED?id=2285635
Kleber 1990 {published data only}|Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study|/resolve/reference/PMED?id=2279255
Kourouklis 1976 {published data only}|Bumetanide in congestive heart failure|/resolve/reference/PMED?id=793779
Mathur 1984 {published data only}|Effect of diuretics on cardiopulmonary performance in severe chronic airflow obstruction. A controlled clinical trial|/resolve/reference/PMED?id=6388521
Parker 1993 {published data only}|The effects of oral ibopamine in patients with mild heart failure: a double-blind placebo controlled comparison to furosemide|/resolve/reference/PMED?id=8225657
Patterson 1994 {published data only}|Oral torsemide in patients with chronic congestive heart failure: effects on body weight, oedema, and electrolyte excretion|/resolve/reference/PMED?id=7997385
RALES 1999 {published data only}|The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators|/resolve/reference/PMED?id=10471456
ACC/AHA 2009|ACC/AHA 2009 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation.|/resolve/reference/PMED?id=19358937
Ahmed 2006|Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods|/resolve/reference/PMED?id=16709595
ALLHAT 2002|Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)|/resolve/reference/PMED?id=12479763
Anand 1991|Diuretics as initial and sole treatment in chronic cardiac failure|/resolve/reference/PMED?id=1760518
Aronow 1990|Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated coronary artery disease|
Barr 1994|QT dispersion and sudden unexpected death in chronic heart failure|/resolve/reference/PMED?id=7905146
Bayliss 1987|Untreated heart failure: clinical and endocrine effects of introducing diuretics|/resolve/reference/PMED?id=3541995
Captopril 1988|Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group|/resolve/reference/PMED?id=2447297
Chalmers 1989|Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy and childbirth|
CIBIS III 2005|Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III|/resolve/reference/PMED?id=16143696
CIBIS-II 1999|The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial|
Clarke 2002|The Reviewers' Handbook|
Cody 1982|Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure|/resolve/reference/PMED?id=7039281
COMET 2003|Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial|/resolve/reference/PMED?id=12853193
CONSENSUS 1987|Effects of enalapril on mortality in severe congestive heart failure: Results of the cooperative North Scandinavian Enalapril Survival Study|/resolve/reference/PMED?id=2883575
COPERNICUS 2001|Effect of carvedilol on survival in severe chronic heart failure|/resolve/reference/PMED?id=11386263
Davie 1997|The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure|/resolve/reference/PMED?id=9183590
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Domanski 2003|Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD)|/resolve/reference/PMED?id=12932605
El-Ebrashy 1968|Effects of digitalisation on urinary excretion of water, sodium, potassium, and chloride in heart failure|/resolve/reference/PMED?id=5723100
Farquharson 2000|Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I / angiotensin II conversion in patients with chronic heart failure|/resolve/reference/PMED?id=10673249
Feigenbaum 2000|Contracted plasma and blood volume in chronic heart failure|/resolve/reference/PMED?id=10636258
Flather 2000|Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group|
Follath 1998|Do diuretics differ in terms of clinical outcome in congestive heart failure?|/resolve/reference/PMED?id=9886706
Francis 1990|Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)|/resolve/reference/PMED?id=2146040
Friedman 1998||
Grag 1995|Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaberative Group on ACE Inhibitors Trials|
Hall 1995|Time course of improvement in the left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade|/resolve/reference/PMED?id=7897129
Hollifield 1981|Thiazide diuretics, hypokalaemia and cardiac arrhythmias|
Iriarte 1993|Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension|/resolve/reference/PMED?id=8427173
J-MELODIC 2007|Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure|/resolve/reference/PMED?id=17587724
Klug 1993|Role of mechanical and hormonal factors in cardiac remodelling and the biologic limits of myocardial adaptation|/resolve/reference/PMED?id=8422005
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Lefebvre 2009|Chapter 6: Searching for studies|
Mantel 1981|Statistical aspects of the analysis of data from retrospective studies of diseases.|
MERIT-HF 2000|Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized intervention trial in congestive heart failure (MERIT-HF)|/resolve/reference/PMED?id=10714728
Motwani 1992|Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure|/resolve/reference/PMED?id=1638713
MRC 1992|Medical Research Council trial of treatment of hypertension in older adults: Principal results|/resolve/reference/PMED?id=1445513
Packer 1983|Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure|/resolve/reference/PMED?id=6352079
Packer 1987|Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure|/resolve/reference/PMED?id=3028221
Pitt 2004|Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies|/resolve/reference/PMED?id=15134801
Robson 1964|The diuretic response to furosemide|/resolve/reference/PMED?id=14207893
SHEP 1991|Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)|/resolve/reference/PMED?id=2046107
Slater 1958|Clinical experience with chlorothiazide|/resolve/reference/PMED?id=13503228
Steiness 1976|Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy|/resolve/reference/PMED?id=1259829
STOP 1991|Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)|/resolve/reference/PMED?id=1682683
V-HeFT I 1986|Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administrations Co-operative study|/resolve/reference/PMED?id=3520315
V-Heft II 1991|A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. Veterans Administration Co-operative study|/resolve/reference/PMED?id=2057035
van Valdhuisen 2001|The under-reporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure|/resolve/reference/PMED?id=11532543
Waagstein 1993|A Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. (MDC) Trial Study Group|/resolve/reference/PMED?id=7902479
Weber 2004|Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain|/resolve/reference/PMED?id=15364337
Wilson 1981|Effect of diuresis on the performance of the failing left ventricle in man|/resolve/reference/PMED?id=7468610
Yusuf 1991|Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators|/resolve/reference/PMED?id=2057034
Yusuf 1992|Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions|/resolve/reference/PMED?id=1463530
Faris 2002|Current evidence supporting the role of diuretics in heart failure: a meta-analysis of randomised controlled trials|/resolve/reference/PMED?id=11853901
Barker 1998 {published data only}|Effects of hyperoxia on oxygen uptake kinetics in cystic fibrosis patients and healthy controls [abstract]|
Falk 2006 {published data only}|Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease |
Gozal 1997 {published data only}|Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen|/resolve/reference/PMED?id=9311492
Marcus 1992 {published data only}|Supplementation oxygen and exercise performance in patients with cystic fibrosis with severe pulmonary disease|/resolve/reference/PMED?id=1729110
McKone 2002 {published data only}|The role of pulmonary mechanics and arterial hypoxaemia in exercise limitation in patients with severe cystic fibrosis [abstract]|
McKone 2002 {published data only}|Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis|/resolve/reference/PMED?id=15860682
McKone 2002 {published data only}|The role of supplemental oxygen during submaximal exercise in patients with cystic fibrosis|/resolve/reference/PMED?id=12166561
Milross 2001b {published data only}|Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis|/resolve/reference/PMED?id=11208637
Milross 2001b {published data only}|The effects of low flow oxygen and bilevel ventilatory support on gas exchange and ventilation during sleep in patients with cystic fibrosis [abstract]|
Nixon 1990 {published data only}|Oxygen supplementation during exercise in cystic fibrosis|/resolve/reference/PMED?id=2121079
Parsons 1996 {published data only}|Nocturnal low-flow oxygen (nLFO2) improves oxyhaemoglobin saturation but not sleep function or carbon dioxide levels in patients with cystic fibrosis (CF) [abstract]|
Parsons 1996 {published data only}|The effects of nocturnal low-flow oxygen on sleep and gas exchange in patients with cystic fibrosis [abstract]|
Parsons 1996 {published data only}|The effects of nocturnal low-flow oxygen (nLFO2) on sleep function and gas exchange in patients with cystic fibrosis (CF) [abstract]|
Shah 1997 {published data only}|Effect of supplemental oxygen on anaerobic exercise performance and recovery in normals and cystic fibrosis [abstract]|
Shah 1997 {published data only}|Effect of supplemental oxygen on supramaximal exercise performance and recovery in cystic fibrosis|/resolve/reference/PMED?id=9375333
Spier 1984 {published data only}|Ventilatory and sleep responses to oxygen in cystic fibrosis patients [abstract]|
Spier 1984 {published data only}|The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis|/resolve/reference/PMED?id=6426355
Zinman 1989 {published data only}|Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients|/resolve/reference/PMED?id=2921681
Zinman 1989 {published data only}|Nocturnal oxygen therapy in the treatment of hypoxemic cystic fibrosis patients [abstract]|
Elkins 2004 {published data only}|The effect of bi-level non-invasive ventilation on mucociliary clearance in subjects with cystic fibrosis [abstract]|
Fauroux 1999 {published data only}|Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation|/resolve/reference/PMED?id=10049988
Fauroux 2000 {published data only}|Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study|/resolve/reference/PMED?id=11112150
Fauroux 2001 {published data only}|In vivo physiologic comparison of two ventilators used for domiciliary ventilation in children with cystic fibrosis|/resolve/reference/PMED?id=11700403
Fauroux 2004 {published data only}|Back up rate during non invasive mechanical ventilation in cystic fibrosis [abstract]|
Fauroux 2004 {published data only}|The effect of back-up rate during non-invasive ventilation in young patients with cystic fibrosis|/resolve/reference/PMED?id=14727018
Holland 2003 {published data only}|Non-invasive ventilation prevents inspiratory muscle fatigue and oxygen desaturation during airway clearance in adults with acute exacerbations of cystic fibrosis [abstract]|/resolve/reference/PMED?id=14514944
Holland 2003 {published data only}|Non-invasive ventilation prevents inspiratory muscle fatigue and oxygen desaturation during airway clearance in adults with acute exacerbations of cystic fibrosis [abstract]|
Holland 2003 {published data only}|Non-invasive ventilation prevents inspiratory muscle fatigue and oxygen desaturation during airway clearance in adults with exacerbations of cystic fibrosis [abstract]|
Holland 2003 {published data only}|Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis|/resolve/reference/PMED?id=14514944
Placidi 2006 {published data only}|Short-term effects of positive airway pressure on sputum clearance by directed coughing: A cross-over, randomized study [abstract]|
Placidi 2006 {published data only}|Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction|/resolve/reference/PMED?id=17005060
Riethmueller 2006 {published data only}|Recombinant human deoxyribonuclease shortens ventilation time in young, mechanically ventilated children|
Serra 2002 {published data only}|Noninvasive proportional assist ventilation (PAV) and pressure support ventilation (PSV) in patients with cystic fibrosis (CF): an overnight study [abstract]|
Serra 2002 {published data only}|Non-invasive proportional assist and pressure support ventilation in patients with cystic fibrosis and chronic respiratory failure|/resolve/reference/PMED?id=11809990
Stewart 2001 {published data only}|The effect of nitric oxide inhalation on pulmonary gas exchange and exercise capacity in patients with cystic fibrosis|
Young 2008 {published data only}|Online Data Supplement to 'Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis' [online]|
Young 2008 {published data only}|Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis|/resolve/reference/PMED?id=17675317
Young 2008 {published data only}|Randomized placebo-controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis [abstract]|
ATS 1991|Lung function testing: selection of reference values and interpretative strategies|/resolve/reference/PMED?id=1952453
Bradley 1999|Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis|
Coffey 1991|Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis|/resolve/reference/PMED?id=1889251
Curtin 2002|Meta-analysis combining parallel and cross-over clinical trials. 1: Continuous outcomes|
Elbourne 2002|Meta-analysises involving cross-over trials: methodological issues|/resolve/reference/PMED?id=11914310
Fitzsimmons 1996|The Cystic Fibrosis Foundation Patient Registry Report 1996|/resolve/reference/PMED?id=8726151
Frangiolis 2001|Predictability of oxygen desaturation during sleep in patients with cystic fibrosis|/resolve/reference/PMED?id=11171720
Fraser 1999|Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia|/resolve/reference/PMED?id=10334147
Frederiksen 1996|Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment|
Gong 1992|Air travel and oxygen therapy in cardiopulmonary patients|/resolve/reference/PMED?id=1555427
Gorecka 1997|Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia|/resolve/reference/PMED?id=9337824
Higgins 2003|Measuring inconsistency in meta-analyses|
Higgins 2009|Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.0.2 [updated September 2009]|/resolve/reference/PMED?id=7637750
Hodson 1991|Non-invasive mechanical ventilation for cystic fibrosis patients: a potential bridge to transplantation|/resolve/reference/PMED?id=1936222
Milross 2001a|Predicting sleep-disordered breathing in patients with cystic fibrosis|/resolve/reference/PMED?id=11591567
Moran 2007|Non-invasive ventilation for cystic fibrosis|
MRC 1981|Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema|
Narang 2003|Three-minute step test to assess exercise capacity in children with cystic fibrosis|
NOTTG 1980|Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial|/resolve/reference/PMED?id=6776858
Ramsey 1996|Management of pulmonary disease in patients with cystic fibrosis|/resolve/reference/PMED?id=8657217
Schidlow 1993|Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis|
Tarpy 1995|Long-term oxygen therapy|/resolve/reference/PMED?id=7637750
Tepper 1983|Ventilation and oxygenation changes during sleep in cystic fibrosis|/resolve/reference/PMED?id=6617273
Aronow 1977 {published data only}|Comparison of trimazosin and methyldopa in hypertension|/resolve/reference/PMED?id=332438
Aronow 1978 {published data only}|Effect of trimazosin, methyldopa, and placebo on hypertension|
Fernandez 1980 {published data only}|Antihypertensive efficacy of alpha-methyldopa, chlorothiazide, and Supres-150 (alpha-methyldopa-chlorothiazide)|/resolve/reference/PMED?id=7020900
Ferrara 1984 {published data only}|Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide|/resolve/reference/PMED?id=6394516
Johnson 1990 {published data only}|Effects of methyldopa on psychometric performance|/resolve/reference/PMED?id=2273082
Lepantalo 1984 {published data only}|Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication|/resolve/reference/PMED?id=6378235
Mroczek 1974 {published data only}|Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo|/resolve/reference/PMED?id=4217243
Paran 1993 {published data only}|The effects of isradipine and alpha-methyldopa on exercise haemodynamics in hypertensive patients|
Petrie 1976 {published data only}|Methyldopa and propranolol or practolol in moderate hypertension|/resolve/reference/PMED?id=776350
Schnaper 1975 {published data only}|Double-blind studies of the clinical effectiveness of prazosin|/resolve/reference/PMED?id=1105489
Tiwari 1982 {published data only}|Propranolol and methyldopa in hypertension: a double blind placebo controlled study|
Yodfat 1993 {published data only}|Reexamining the quality of life of hypertensive patients - a new self-structured measure|/resolve/reference/PMED?id=8466730
Yodfat 1993 {published data only}|Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study|/resolve/reference/PMED?id=8867566
Yodfat 1993 {published data only}|A multicenter, double-blind, randomized, placebo-controlled study of isradipine and methyldopa as monotherapy or in combination with captopril in the treatment of hypertension|/resolve/reference/PMED?id=8466728
Alfonzo Guerra 1980 {published data only}|A double blind comparative study of two hypotensive drugs: clonidine and alpha-methyl-dopa|
Anonymous 1986 {published data only}|First-step treatment of mild to moderate hypertension - comparison with conventional stepped-care treatment|
Aoki 1970 {published data only}|Hydralazine and methyldopa in thiazide-treated hypertensive patients|/resolve/reference/PMED?id=4911584
Avigdor 1983 {published data only}|Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol|/resolve/reference/PMED?id=6342133
Bayliss 1962 {published data only}|Methyldopa in the treatment of hypertension|/resolve/reference/PMED?id=13866047
Beanlands 1978 {published data only}|Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study|/resolve/reference/PMED?id=391453
Belleau 1977 {published data only}|Debrisoquine versus methyldopa in the treatment of thiazide-resistant hypertension|
Bradley 1977 {published data only}|Comparison of prazosin and methyldopa in mild to moderate hypertension, a multicenter cooperative study|/resolve/reference/PMED?id=401709
Bune 1981 {published data only}|Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension|/resolve/reference/PMED?id=7016550
Cannon 1962 {published data only}|Effect of alpha-methyl DOPA in severe and malignant hypertension|/resolve/reference/PMED?id=13876240
Co-operative 1973 {published data only}|Control of moderate raise blood pressure - report of a Co-operative randomized controlled trial|/resolve/reference/PMED?id=4580022
Corea 1983 {published data only}|Two low doses of methyldopa in mild to moderate hypertension: a comparative double-blind study and a long-term follow up|
Daley 1962 {published data only}|Another hypotensive agent - methyldopa|/resolve/reference/PMED?id=13883201
De Divitiis 1981 {published data only}|Atenolol and methyldopa in the treatment of mild-moderate hypertension: a double-blind comparison and combination with single doses|
Deschamps 1992 {published data only}|Comparison of hydralazine and alpha methyldopa in hypertension in pregnancy|
Dollery 1962 {published data only}|Methyldopa in hypertension clinical and pharmacological stdies|/resolve/reference/PMED?id=13887051
Dunn 1978 {published data only}|Standardized stress and hypertension: comparison of effect of propranolol and methyldopa|/resolve/reference/PMED?id=656266
Frederiksen 1974 {published data only}|The treatment of angina pectoris with alpha methyldopa|/resolve/reference/PMED?id=4600690
Glassock 1982 {published data only}|Pindolol: effects on blood pressure and plasma renin activity|/resolve/reference/PMED?id=7048878
Glazer 1975 {published data only}|Comparison of guanethidine and methyldopa in essential hypertension: a controlled study|/resolve/reference/PMED?id=805019
Gonasun 1982 {published data only}|Antihypertensive effects of pindolol|/resolve/reference/PMED?id=7048877
Guidi 1981 {published data only}|A double blind trial on hypotensive effect of an association of chlorthalidone and metoprolol or methyldopa|/resolve/reference/PMED?id=7030853
Hamilton 1963 {published data only}|Treatment of severe hypertension with methyldopa|/resolve/reference/PMED?id=13952341
Horwitz 1966 {published data only}|Effects of methyldopa in fifty hypertensive patients|
Innes 1992 {published data only}|The short term effects of oral labetalol in patients with chronic renal disease and hypertension|/resolve/reference/PMED?id=1629891
Irvine 1962 {published data only}|Alpha methyl dopa in treatment of hypertension|
Johnson 1966 {published data only}|Treatment of hypertension with methyldopa|/resolve/reference/PMED?id=5322501
Klapper 1964 {published data only}|The use of methyldopa in hypertension|/resolve/reference/PMED?id=14226907
Kuokkanen 1979 {published data only}|Antihypertensive effect of prazosin in combination with methyldopa, clonidine, or propranolol|/resolve/reference/PMED?id=453775
Kuschke 1963 {published data only}|Treatment of hypertension with alpha-methyldopa - clinical and hemodynamical studies|
Levine 1968 {published data only}|Technique of controlled drug assay - Comparison of guanethidine, methyldopa, and a placebo in the hypertensive negro woman|/resolve/reference/PMED?id=5676415
Masso 1979 {published data only}|Double-blind clinical trial of bromazepam and alpha-methyldopa in arterial hypertension|
McAreavey 1983 {published data only}|The 'third drug' trial: a comparative study of anti-hypertensive agents added to treatment when blood pressure is uncontrolled by a beta-blocker plus thiazide diuretic|/resolve/reference/PMED?id=6400110
McAreavey 1984 {published data only}|"Third drug" trial: a comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic|/resolve/reference/PMED?id=6419809
Murad 1991 {published data only}|Lisinopril vs methyl-dopa in essential hypertension: A comparative study|
Oates 1960 {published data only}|Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine|/resolve/reference/PMED?id=14428139
Oates 1965 {published data only}|The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents|/resolve/reference/PMED?id=5317954
Okanga 1978 {published data only}|Atenolol (Tenormin) compared with methyldopa (Aldomet) in the treatment of hypertension|/resolve/reference/PMED?id=361368
Onesti 1962 {published data only}|Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension|/resolve/reference/PMED?id=14482028
Sermswan 2003 {published data only}|Methyldopa supplement for resistant essential hypertension: a prospective randomized placebo control crossover study|/resolve/reference/PMED?id=14971524
Smirk 1963 {published data only}|Hypotensive action of methyldopa|/resolve/reference/PMED?id=13993069
Smith 1966 {published data only}|Co-operative clinical trial of alpha-methyldopa - double-blind control comparison of alpa-methyldopa and chlorothiazide, and chlorothiazide and rauwolfia|/resolve/reference/PMED?id=5926388
Wright 1982 {published data only}|Duration of effect of single daily dose methyldopa therapy|/resolve/reference/PMED?id=7093115
Brunton 2006||
CHEP 2008|The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension|/resolve/reference/PMED?id=18548142
Chobanian 2003|The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report|/resolve/reference/PMED?id=12748199
Croog 1986|The effects of antihypertensive therapy on quality of life|/resolve/reference/PMED?id=3520318
Goodman & Gilman 1996||
JNC 1977|Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure|/resolve/reference/PMED?id=576159
Sjoerdsma 1982|Methyldopa|/resolve/reference/PMED?id=7066154
Sprackling 1981|Blood pressure reduction in the elderly: a randomized controlled trial of methyldopa|/resolve/reference/PMED?id=6794796
Stein 1955|Alpha-methyl-alpha-amino acids: Derivatives of DL - phenylalanine|
Webster 1996|Aspects of tolerability of central acting antihypertensive drugs|/resolve/reference/PMED?id=8872299
WHO 2003|2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension|/resolve/reference/PMED?id=14597836
Brahm 1999 {published data only}|Subcutaneous treatment with recombinant human erythropoietin--the influence of injection frequency and skin-fold thickness|/resolve/reference/PMED?id=10452296
Canaud 1995 {published data only}|What is the optimum frequency of administration of r-HuEPO for correcting anemia in hemodialysis patients?|
Frifelt 1996 {published data only}|Efficacy of recombinant human erythropoietin administered subcutaneously to CAPD patients once weekly|/resolve/reference/PMED?id=8981527
Lago 1996 {published data only}|Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients|/resolve/reference/PMED?id=8730458
Leung 1995 {published data only}|Pharmacodynamics of twice weekly versus thrice weekly subcutaneous administration of recombinant human erythropoietin (rhuepo) for patients on capd [abstract]|
Locatelli 2002 {published data only}|A rationale for an individualized administration frequency of epoetin beta: a pharmacological perspective|/resolve/reference/PMED?id=12091596
Locatelli 2002 {published data only}|Once-weekly compared with three-times-weekly subcutaneous epoetin beta: results from a randomized, multicenter, therapeutic-equivalence study|/resolve/reference/PMED?id=12087569
Locatelli 2002 {published data only}|Therapeutic equivalence of once versus thrice weekly subcutaneous injection of epoetin beta in patients with chronic renal failure [abstract]|
Lui 1991 {published data only}|Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis|/resolve/reference/PMED?id=1752075
Lui 1992 {published data only}|Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in haemodialysis patients|/resolve/reference/PMED?id=1415366
Miranda 1990 {published data only}|Treatment of the anemia with human recombinant erythropoietin in CAPD patients|/resolve/reference/PMED?id=1982831
Paganini 1991 {published data only}|A prospective randomized multi-center study of subcutaneous erythropoietin administration [abstract]|
Weiss 2000 {published data only}|The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group|/resolve/reference/PMED?id=11096148
Brandt 1999 {published data only}|Safety and efficacy of erythropoietin in children with chronic renal failure|/resolve/reference/PMED?id=10229004
Castro 1994 {published data only}|Comparison between thrice-weekly intravenous and once-weekly subcutaneous administration of rHuEPO in hemodialysis patients|
Fan 1992 {published data only}|Therapeutic evaluation of once versus thrice weekly subcutaneous (sc) application of low dose recombinant human erythropoietin (rhuepo) in hemodialysis patients [abstract]|
Ifudu 1998 {published data only}|Erythropoietin-induced elevation in blood pressure is immediate and dose dependent|/resolve/reference/PMED?id=9689173
Keown 1991 {published data only}|Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group|/resolve/reference/PMED?id=2040199
Moiz 2000 {published data only}|Erythropoietin induced hypertension|
Muirhead 1992 {published data only}|Changes in quality of life in chronic renal failure patients treated with recombinant human erythropoiein [abstract]|
Raftery 2000 {published data only}|Safety and tolerability of a multidose formulation of epoetin beta in dialysis patients. Collaborative Study Group|/resolve/reference/PMED?id=11020023
Wang 2000 {published data only}|Dosage requirement of erythropoietin can be reduced with more frequent administration|
Yalcinkaya 1997 {published data only}|Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis|/resolve/reference/PMED?id=9203190
Canada 1990|Association between recombinant erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis|/resolve/reference/PMED?id=2108751
Eschbach 1987|Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial|/resolve/reference/PMED?id=3537801
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Jensen 1994|Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers|/resolve/reference/PMED?id=7993997
Kaufman 1998|Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients|/resolve/reference/PMED?id=9718376
Koch 1991|Treatment of renal anemia, 1960-1990|/resolve/reference/PMED?id=2063711
Lin 1985|Cloning and expression of the human erythropoietin gene|/resolve/reference/PMED?id=3865178
Lundin 1989|Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy|
Ward 1990|Implications of recombinant erythropoietin therapy for renal transplantation|
Winearls 1986|Effects of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis|/resolve/reference/PMED?id=2877323
Cody 2002|Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients|/resolve/reference/PMED?id=12519614
Abou-Ayache 2008 {published data only}|CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A|
Abou-Ayache 2008 {published data only}|Two-dose daclizumab induction treatment versus thymoglobuline in renal transplant patients receiving a mycophenolate mofetil based immunosuppression [abstract no: 121]|
Ahsan 2002 {published data only}|Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation|
Ahsan 2002 {published data only}|Limited dose monoclonal IL-2R antibody induction in kidney transplantation - a prospective, randomized, controlled clinical trial [abstract]|
Asberg 2006 {published data only}|Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients|/resolve/reference/PMED?id=16861943
Asberg 2006 {published data only}|Calcineurin inhibitor-avoidance with daclizumab, mycophenolate mofetil and prednisolone in DR matched de novo kidney transplant recipients [abstract no: SP737]|
ATLAS 2003 {published data only}|Large, prospective study evaluating steroid-free immunosuppression with tacrolimus/basiliximab and tacrolimus/mmf compared with tacrolimus/mmf/steroids in renal transplantation [abstract]|
ATLAS 2003 {published data only}|Two steroid-free immunosuppressive regimens (basiliximab/tacrolimus and tacrolimus/mmf) in comparison to tacrolimus/MMF/steroid therapy after renal transplantation [abstract]|
ATLAS 2003 {published data only}|1-year-follow-up of two steroid-free immunosuppressive regimens - basiliximab/tacrolimus and tacrolimus/MMR - in comparison to tacrolimus/MMF/steroids after renal transplantation [abstract no: F-PO1026]|
ATLAS 2003 {published data only}|Steroid withdrawal or steroid avoidance in renal transplant recipients: Focus on tacrolimus-based immunosuppressive regimens|/resolve/reference/PMED?id=15919467
ATLAS 2003 {published data only}|Two corticosteroids-free regimens - tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil - in comparison with a standard triple regimen in renal transplantation: results of the Atlas Study|/resolve/reference/PMED?id=16378069
ATLAS 2003 {published data only}|Comparison of two steroid-free regimens - basiliximab/tacrolimus and tacrolimus/mmf - with tacrolimus/mmf/steroid therapy after renal transplantation [abstract]|/resolve/reference/PMED?id=12614287
Baczkowska 2002 {published data only}|[Cytokines and growth factors serum level and renal allograft function (preliminary report)] [Polish]|/resolve/reference/PMED?id=14974365
Baczkowska 2002 {published data only}|Daclizumab allows for a protocol with low-dose cyclosporine in low rejection-risk kidney recipients - preliminary data [abstract]|
Baczkowska 2002 {published data only}|The role of the protocol biopsies in renal allograft recipients|/resolve/reference/PMED?id=14529881
Baczkowska 2002 {published data only}|Untreated subclinical, borderline rejection in 12 and 36-month protocol biopsies is not associated with progressive loss of GFR at 5-year's follow-up [abstract no: 1755]|
Baczkowska 2002 {published data only}|Serum TGF-b1 correlates with chronic histopathological lesions in protocol biopsies in kidney allograft recipients [abstract]|
Baczkowska 2002 {published data only}|The role of the protocol biopsies in renal allograft recipients: three-years follow-up [abstract no: SP736]|
Baczkowska 2002 {published data only}|Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients|/resolve/reference/PMED?id=15848527
Bernarde 2004 {published data only}|Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab) in renal transplant recipients [abstract]|
Bingyi 2003 {published data only}|The effect of anti-CD25 monoclonal antibody (Simulect) to the lymphocytes in the peripheral blood of the recipients of kidney transplantation|/resolve/reference/PMED?id=12591382
Bingyi 2003 {published data only}|Randomised trial of Simulect versus placebo for control of acute rejection in renal allograft recipients|/resolve/reference/PMED?id=12591362
Brennan 2006 {published and unpublished data}|Rabbit antithymocyte globulin versus basiliximab in renal transplantation|/resolve/reference/PMED?id=17093248
Brennan 2006 {published and unpublished data}|5 Year outcomes in a randomized trial comparing rabbit antithymocyte globulin and basiliximab in kidney transplant recipients: Linking clinical trial data with registry data: 798. [Abstract]|
Brennan 2006 {published and unpublished data}|Long-Term results of rabbit antithymocyte globulin and basiliximab induction|/resolve/reference/PMED?id=18923181
Brennan 2006 {published and unpublished data}|A prospective randomized multicenter comparison of thymoglobulin versus Simulect for induction therapy in high risk renal transplant recipients [abstract no:398]|
Brennan 2006 {published and unpublished data}|Thymoglobulin versus Simulect for induction immunosuppression in cadaveric renal transplant recipients: expanded results from a prospective, randomized, multicenter trial [abstract]|
Brennan 2006 {published and unpublished data}|A prospective, randomized, multicenter study of thymoglobulin compared to Simulect for induction immunosuppression: preliminary results [abstract]|
Brennan 2006 {published and unpublished data}|Novel approach to obtain long-term outcomes of patients in a randomized trial comparing thymoglobulin and basiliximab in kidney transplant using registry data [abstract no: 334]|
Brennan 2006 {published and unpublished data}|Thymoglobulin has its greatest efficacy in recipients of standard criteria donors and donors without hypertension [abstract no: 536]|
Brennan 2006 {published and unpublished data}|Rabbit antithymocyte globulin or basiliximab for induction therapy?|/resolve/reference/PMED?id=17093255
Brennan 2006 {published and unpublished data}|Antithymocyte globulin versus basiliximab in renal transplantation|/resolve/reference/PMED?id=17287486
Brennan 2006 {published and unpublished data}|Cost-effectiveness of thymoglobulin compared to basiliximab in kidney transplant using multicenter randomized trial data [abstract no: 326]|
CAESAR (Ekberg) 2007 {published data only}|Low-dose cyclosporine in conjunction with daclizumab, mycophenolate mofetil and corticosteroids is safe and effective in contrast to early cyclosporine withdrawal [abstract]|
CAESAR (Ekberg) 2007 {published data only}|The use of daclizumab and mycophenolate mofetil in combination with corticosteroids and cyclosporine (low dose versus low dose followed by withdrawal) to optimize renal function in recipients of renal allografts [abstract]|
CAESAR (Ekberg) 2007 {published data only}|Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study|
CAESAR (Ekberg) 2007 {published data only}|Association of three polymorphisms with acute kidney transplantation: an exploratory pharmacogenetic analysis of a randomized mulitcenter clinical trial (The CAESaR study)|
CAESAR (Ekberg) 2007 {published data only}|The use of mycophenolate mofetil, daclizumab and corticosteroids with cyclosporine (low dose, low dose/withdrawal and standard dose) to optimize renal function in renal allograft recipients - 18 month results [abstract no: 1507]|
CARMEN (Rostaing) 2005 {published data only}|Steroid-free immunosuppression with daclizumab, tacrolimus and mmf is efficacious and improves cholesterol, glucose and bone mineral density - the CARMEN study [abstract]|/resolve/reference/PMED?id=15257059
CARMEN (Rostaing) 2005 {published data only}|The combination of daclizumab, tacrolimus, and MMF is an effective and safe steroid-free immunosuppressive regimen after renal transplantation. Results of a large multicentre trial [abstract]|
CARMEN (Rostaing) 2005 {published data only}|Steroid withdrawal or steroid avoidance in renal transplant recipients: Focus on tacrolimus-based immunosuppressive regimens|/resolve/reference/PMED?id=15919467
CARMEN (Rostaing) 2005 {published data only}|Immunosuppression without steroids: daclizumab/tacrolimus/MMF vs. tacrolimus/MMF/steroids in renal transplantation [abstract no: 12]|
CARMEN (Rostaing) 2005 {published data only}|Immunosuppression without steroids: a daclizumab, tacrolimus and MMF regimen prevents loss of bone mass following renal transplantation [abstract no 369]|
CARMEN (Rostaing) 2005 {published data only}|Immunosuppression without maintenance steroids prevents decline of bone mineral density following renal transplantation [abstract]|
CARMEN (Rostaing) 2005 {published data only}|Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation|/resolve/reference/PMED?id=15818323
CARMEN (Rostaing) 2005 {published data only}|Steroid-free immunosuppression with a combination of daclizumab, tacrolimus and MMF is efficacious and safe: results of a large multicenter trial in renal transplantation [abstract]|/resolve/reference/PMED?id=12614287
CARMEN (Rostaing) 2005 {published data only}|A steroid-free immunosuppressive regimen of daclizumab, tacrolimus and MMF prevents loss of bone mass following renal transplantation [abstract]|
Cerrillos 2006 {published data only}|Daclizumab two doses 0 and 4 days is efficacious to prevent rejection after kidney transplantation [abstract no: PUB163]|
Chen 2003 {published data only}|Double filtration plasmapheresis with/without daclizumab induction in the sensitized candidates of cadaveric renal transplantation: a randomized prospective trial [abstract]|
Chen 2003 {published data only}|The effect of daclizumab in highly sensitive kidney recipients [abstract no: SA-PO652]|
Ciancio 2005 {published data only}|Cellular phenotypes affected by induction therapy with campath-1h vs thymoglobulin vs Zenapax in kidney allograft recipients [abstract]|
Ciancio 2005 {published data only}|A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring|/resolve/reference/PMED?id=16123718
Ciancio 2005 {published data only}|Randomized trial of three different induction regimens to prevent acute renal allograft rejection: early results [abstract]|
Ciancio 2005 {published data only}|A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up|/resolve/reference/PMED?id=18339140
Ciancio 2005 {published data only}|A randomized trial of three different antibody induction regimens in renal transplantation|
Clatworthy 2009 {published data only}|B-cell-depleting induction therapy and acute cellular rejection|/resolve/reference/PMED?id=19535812
Dac double & triple {published data only}|See Dacilizumab Double and Triple studies|
Daclizumab double 1999 {published data only}|Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation|/resolve/reference/PMED?id=11571447
Daclizumab double 1999 {published data only}|Daclizumab (humanized anti-IL2R alpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function|/resolve/reference/PMED?id=11544424
Daclizumab double 1999 {published data only}|Placebo-controlled study of a humanized anti-TAC monoclonal antibody in dual therapy for prevention of acute rejection after renal transplantation|/resolve/reference/PMED?id=9636541
Daclizumab double 1999 {published data only}|Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation. No 14874 and No 14393 Zenapax Study Groups|/resolve/reference/PMED?id=10083102
Daclizumab double 1999 {published data only}|Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis|
Daclizumab double 1999 {published data only}|Daclizumab (Zenapax) reduces the incidence of acute rejection episodes following renal transplantation [abstract]|
Daclizumab double 1999 {published data only}|A randomized clinical trial of Zenapax for preventing acute rejection in renal transplantation [abstract]|
Daclizumab double 1999 {published data only}|Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group|/resolve/reference/PMED?id=10440409
Daclizumab double 1999 {published data only}|Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group|/resolve/reference/PMED?id=9921806
Daclizumab double 1999 {published data only}|Incidence of CMV infections during daclizumab treatment in renal allograft patients [abstract]|/resolve/reference/PMED?id=9448151
Daclizumab double 1999 {published data only}|Three year outcome of the phase III clinical trials with Daclizumab [abstract]|
Daclizumab double 1999 {published data only}|Three year outcome of the phase III clinical trials with daclizumab [abstract]|
Daclizumab double 1999 {published data only}|Daclizumab: Outcome of phase III trials and mechanism of action|/resolve/reference/PMED?id=9723424
Daclizumab double 1999 {published data only}|Pooled analysis of phase III studies of Zenapax (Daclizumab), a humanized anti-IL-2R antibody [abstract]|
Daclizumab triple 1998 {published data only}|Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation|/resolve/reference/PMED?id=11571447
Daclizumab triple 1998 {published data only}|Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function|/resolve/reference/PMED?id=11544424
Daclizumab triple 1998 {published data only}|Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation. No 14874 and No 14393 Zenapax Study Groups|/resolve/reference/PMED?id=10083102
Daclizumab triple 1998 {published data only}|Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis|
Daclizumab triple 1998 {published data only}|Daclizumab (Zenapax) reduces the incidence of acute rejection episodes following renal transplantation [abstract]|
Daclizumab triple 1998 {published data only}|Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group|/resolve/reference/PMED?id=10440409
Daclizumab triple 1998 {published data only}|A Phase I/II Randomized, double blind, placebo controlled study of Zenapax in combination with cellCept, neoral and steroids|
Daclizumab triple 1998 {published data only}|A phase III multicenter study of humanized anti-tac (HAT) for the prevention of rejection in primary cadaveric renal allograft recipients|
Daclizumab triple 1998 {published data only}|Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group|/resolve/reference/PMED?id=9428817
Daclizumab triple 1998 {published data only}|Three year outcome of the phase III clinical trials with Daclizumab [abstract]|
Daclizumab triple 1998 {published data only}|Three year outcome of the phase III clinical trials with daclizumab [abstract]|
Daclizumab triple 1998 {published data only}|Daclizumab: Outcome of phase III trials and mechanism of action|/resolve/reference/PMED?id=9723424
Daclizumab triple 1998 {published data only}|Pooled analysis of phase III studies of Zenapax (Daclizumab), a humanized anti-IL-2R antibody [abstract]|
de Boccardo 2002 {published data only}|Latin American study of the efficacy and safety of Simulect in kidney transplant recipients [abstract]|
Fangmann 2004 {published data only}|Low dose cyclosporine regimen with daclizumab induction and mycophenolate mofetil after kidney transplantation - impact on renal function and rejection episodes [abstract no: 113]|
Fangmann 2004 {published data only}|Impact of daclizumab and low dose cyclosporine in combination with mycophenolate mofetil and steroids on renal function after kidney transplantation [abstract]|
Fangmann 2004 {published data only}|Impact of daclizumab and low dose cyclosporine in combination with mycophenolate mofetil and steroids on renal function after kidney transplantation [abstract]|
Flechner 2000 {published data only}|A randomized prospective trial of OKT3 vs basiliximab for induction therapy in renal transplantation [abstract]|
Folkmane 2001 {published data only}|Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab|/resolve/reference/PMED?id=11750377
Folkmane 2001 {published data only}|Results of renal transplantation with different immunosuppressive regimens|/resolve/reference/PMED?id=12009623
Folkmane 2001 {published data only}|Low rate of acute rejection and cytomegalovirus infection in renal transplant recipients with basiliximab [abstract no:1037]|
Garcia 2002 {published data only}|A calcineurin inhibitor-free regimen for low risk kidney transplant recipients [abstract no:2379]|
Gelens 2006 {published data only}|Calcineurin-free immunosuppression and limited steroid exposure in renal transplantation [abstract]|
Gelens 2006 {published data only}|High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation|/resolve/reference/PMED?id=17102775
Grego 2007 {published data only}|Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal graft recipients|/resolve/reference/PMED?id=18089329
Grego 2007 {published data only}|Basiliximab versus daclizumab for prevention of acute renal allograft rejection [abstract no: TH-PO544]|
Grenda 2006 {published data only}|A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation|
Grenda 2006 {published data only}|Tacrolimus triple therapy with or without monoclonal antibody administration: a multicentre, randomised study in paediatric kidney transplantation [abstract]|
Grenda 2006 {published data only}|Tacrolimus triple therapy with or without monoclonal antibody administration: a multicentre, randomized study in pediatric kidney transplantation [abstract no: 964]|
Grenda 2006 {published data only}|Multicentre randomized prospective trial of tacrolimus, azathioprine and prednisolone with or without basiliximab; two year follow-up data [abstract no: 121 (FC)]|
Hanaway 2008 {published data only}|12 month results of a multicenter, randomized trial comparing three induction agents (Alemtuzumab, Thymoglobulin and Basiliximab) with tacrolimus, mycophenolate mofetil and a rapid steroid withdrawal in renal transplantation [abstract no: 135]|
Hanaway 2008 {published data only}|Immune cell activation comparing three induction agents (alemtuzumab, thymoglobulin and basiliximab) with tacrolimus, mycophenolate mofetil and a rapid steroid withdrawal in renal transplantation [abstract no: 553]|
Hanaway 2008 {published data only}|12 month results of a multicenter, randomized trial comparing three induction agents (alemtuzumab, thymoglobulin and basiliximab) with tacrolimus, mycophenolate mofetil and a rapid steroid withdrawal in renal transplantation [abstract no: 876]|
Hernandez 2007 {published data only}|Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression|/resolve/reference/PMED?id=17893603
Hourmant 1994 {published data only}|Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation|/resolve/reference/PMED?id=8310508
Ji 2007 {published data only}|A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience|/resolve/reference/PMED?id=17580147
Kahan 1999 {published data only}|Influence of the duration of IL-2 receptor (IL-2R) blockade on the incidence of acute rejection episodes in renal transplantation [abstract]|
Kahan 1999 {published data only}|Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group|/resolve/reference/PMED?id=10075594
Kahan 1999 {published data only}|Reduction of acute cellular rejection in renal allograft patients with basiliximab (Simulect)|
Kahan 1999 {published data only}|Basiliximab (Simulect) is efficacious in reducing the incidence of acute rejection episodes in renal allograft patients: results at 12 months [abstract]|
Kahan 1999 {published data only}|Basiliximab (Simulect) is efficacious in reducing the incidence of acute rejection episodes in renal allograft patients: results at 12 months [abstract]|
Kahan 1999 {published data only}|Economic analysis of basiliximab (Simulect) in renal transplantation|
Kahan 1999 {published data only}|Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group|/resolve/reference/PMED?id=10573065
Kahan 1999 {published data only}|Influence of the duration of IL-2 receptor (IL-2R) blockade on the incidence of acute rejection episodes in renal transplantation [abstract]|
Kahan 1999 {published data only}|A prospective economic evaluation of basiliximab (Simulect) therapy following renal transplantation|
Kahan 1999 {published data only}|Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors|/resolve/reference/PMED?id=10083541
Kahan 1999 {published data only}|Basiliximab (Simulect) reduces acute cellular rejection in renal allografts from cadaveric and living donors [abstract]|
Kahan 1999 {published data only}|Basiliximab (Simulect) reduces acute cellular rejection in renal allografts from cadaveric and living donors [abstract]|
Kahan 1999 {published data only}|Reduced acute rejection and superior one-year renal allograft survival with basiliximab (Simulect) in patients with diabetes mellitus [abstract]|
Kahan 1999 {published data only}|Reduced acute rejection and superior one-year renal allograft survival with basiliximab (Simulect) in patients with diabetes mellitus [abstract]|
Kahan 1999 {published data only}|Basiliximab (Simulect) significantly reduced the incidence of acute rejection episodes in renal allograft patients: pooled data US/Europe/Canada Studies [abstract]|
Kahan 1999 {published data only}|Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group|/resolve/reference/PMED?id=11003358
Kaplan 2003 {published data only}|Pilot randomized prospective study of dual vs triple immunosuppression in older renal transplant recipients [abstract]|
Khan 2000 {published data only}|Comparison of two IL-2 receptor blockers in decreasing the incidence of acute rejection in early post-transplant time in renal transplant recipients [abstract]|
Kim 2008a {published data only}|ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial|/resolve/reference/PMED?id=19034219
Kirkman 1989 {published data only}|Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation|/resolve/reference/PMED?id=2683758
Kirkman 1989 {published data only}|Early experience with anti-Tac in clinical renal transplantation|/resolve/reference/PMED?id=2652578
Kirkman 1989 {published data only}|In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic|/resolve/reference/PMED?id=2534707
Kirkman 1989 {published data only}|Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody|/resolve/reference/PMED?id=2571203
Kirkman 1991 {published data only}|Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation|/resolve/reference/PMED?id=2683758
Kirkman 1991 {published data only}|A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation|/resolve/reference/PMED?id=1846250
Kirkman 1991 {published data only}|A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation|/resolve/reference/PMED?id=1989150
Kirkman 1991 {published data only}|In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic|/resolve/reference/PMED?id=2534707
Kirkman 1991 {published data only}|Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody|/resolve/reference/PMED?id=2571203
Kriaa 1993 {published data only}|Long-term results (10 years) of a prospective trial comparing Lo-tact-1 monoclonal antibody and anti-thymocyte globulin induction therapy in kidney transplantation|
Kriaa 1993 {published data only}|Long term follow-up (10 years) of a prospective trial assay comparing lo-tact-1 antibody versus anti-thymocyte globulin induction therapy in kidney transplantation [abstract]|
Kriaa 1993 {published data only}|Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study|/resolve/reference/PMED?id=8438496
Kumar 2005 {published data only}|Value of one month protocol biopsies combined with a molecular analysis in predicting efficacy of rapid steroid withdrawal after renal transplantation [abstract]|
Kumar 2005 {published data only}|The predictive value of subclinical rejection in a steroid free immunosuppressive regimen [abstract]|
Kumar 2005 {published data only}|Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years|/resolve/reference/PMED?id=16570004
Kumar 2005 {published data only}|Steroid avoidance (SA) in kidney transplant recipients treated with simulect (BMAB), neoral (CSA) and cellcept (MMF) - a randomized prospective controlled clinical trial [abstract no:2440]|
Kumar 2005 {published data only}|Steroid avoidance (SA) in kidney transplant recipients treated with simulect (BMAB), neoral (CSA) and cellcept (MMF) - a randomized prospective controlled clinical trial [abstract]|
Kumar 2005 {published data only}|Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies|
Kyllonen 2007 {published data only}|Induction with single bolus ATG or basiliximab in cadaveric kidney transplantation with cyclosporin immunosuppression [abstract]|
Kyllonen 2007 {published data only}|Induction with single bolus ATGor basiliximab in cadaveric kidney transplantation with cyclosporin immunosuppression [abstract no: 2330]|
Kyllonen 2007 {published data only}|Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety|/resolve/reference/PMED?id=17627241
Kyllonen 2007 {published data only}|Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation|/resolve/reference/PMED?id=15280678
Kyllonen 2007 {published data only}|Serum sCD30 in monitoring of alloresponse in well HLA-matched cadaveric kidney transplantations|/resolve/reference/PMED?id=16378078
Kyllonen 2007 {published data only}|Activated protein C reduces graft neutrophil activation in clinical renal transplantation|
Kyllonen 2007 {published data only}|Association of graft neutrophil sequestration with delayed graft function in clinical renal transplantation|/resolve/reference/PMED?id=15223898
Lacha 2001 {published data only}|Long-term effect of zenapax versus okt-3 prophylaxis in immunologically high-risk kidney transplant recipients [abstract]|
Lacha 2001 {published data only}|Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients|/resolve/reference/PMED?id=11377526
Lacha 2001 {published data only}|Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients [abstract]|
Lacha 2001 {published data only}|Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients [abstract]|
Lawen 2003 {published data only}|Basiliximab (Simulect) is safe and effective in combination with neoral, steroids and cellcept for the prevention of acute rejection episodes in renal transplantation. Interim results of a double blind, randomized clinical trial [abstract]|
Lawen 2003 {published data only}|Basiliximab (Simulect) is safe and effective in combination with triple therapy of neoral steroids and cellcept in renal transplant recipients [abstract]|
Lawen 2003 {published data only}|Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation|/resolve/reference/PMED?id=12544868
Lebranchu 2002 {published data only}|Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation|/resolve/reference/PMED?id=16980070
Lebranchu 2002 {published data only}|Cost-minimisation study comparing simulect versus thymoglobuline in renal transplant induction|
Lebranchu 2002 {published data only}|Three year results of a randomized study comparing as induction treatment simulect and thymoglobuline. [abstract]|
Lebranchu 2002 {published data only}|Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy|
Lebranchu 2002 {published data only}|A multicenter, randomized trial of Simulect versus thymoglobuline in renal transplantation [abstract no:1598]|
Lebranchu 2002 {published data only}|A multicenter randomized trial of Simulect versus thymoglobuline in renal transplantation [abstract]|
Lebranchu 2002 {published data only}|A multicenter randomized trial of Simulect versus thymoglobuline in renal transplantation [abstract]|
Lebranchu 2002 {published data only}|Cost-minimization study comparing Simulect versus Thymoglobulin in renal transplant induction|/resolve/reference/PMED?id=11750371
Lebranchu 2002 {published data only}|Cost-minimization study comparing Simulect vs. Thymoglobulin in renal transplant induction|
Lin 2006 {published data only}|The clinical study of two-dose basiliximab compared with two-dose daclizumab in renal transplantation [abstract]|
Lin 2006 {published data only}|Two-dose basiliximab compared with two-dose daclizumab in renal transplantation: a clinical study|
Locke 2008 {published data only}|Effect of induction agent on cellular and humoral responses to renal transplants in sensitized patients [abstract no: 14]|
Locke 2008 {published data only}|Results of a randomized prospective study of induction therapy with daclizumab versus thymoglobulin among crossmatch positive renal transplant recipients [abstract no: 521]|
Martin Garcia 2003 {published data only}|Tacrolimus-basiliximab versus cyclosporine-basiliximab in renal transplantation "de novo": acute rejection and complications|/resolve/reference/PMED?id=12962761
Matl 2001 {published data only}|Basiliximab (Simulect) can be administered safely and effectively by IV bolus in a single dose on day 1 post renal transplantation in patients receiving triple therapy with azathioprine [abstract no:1107]|
Matl 2001 {published data only}|Safety and efficacy of an alternative basiliximab (Simulect) regimen after renal transplantation: administration of a single 40-mg dose on the first postoperative day in patients receiving triple therapy with azathioprine|
Matl 2001 {published data only}|Basiliximab can be administered safely and effectively in a single dose on day 1 postrenal transplantation in patients receiving triple therapy with azathioprine|/resolve/reference/PMED?id=11750375
Mourad 2004 {published data only}|Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids|/resolve/reference/PMED?id=15446319
Mourad 2004 {published data only}|Simulect versus thymoglobulin with delayed introduction of neoral in renal transplantation: three month results of a French multicenter randomized trial [abstract]|
Mourad 2004 {published data only}|A sequential protocol using simulect vs thymoglobulin in low immunological risk renal transplant recipients: six-month results of a French multicenter, randomized trial [abstract]|
Nair 2001 {published data only}|Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients|/resolve/reference/PMED?id=11498153
Nair 2001 {published data only}|Bolus anti-thymocyte globulin induction in renal transplant recipients: a comparison with conventional ATG or anti-interleukin-2 receptor antibody induction|/resolve/reference/PMED?id=12431656
Nair 2001 {published data only}|Induction immunosuppression with anti interleukin (IL-2) receptor antibodies and anti thymocyte globulin in renal transplantation - a comparative study [abstract]|
Nashan 1997 {published data only}|The economic implications of the use of Basiliximab versus placebo for the control of acute cellular rejection in renal allograft recipients [abstract]|
Nashan 1997 {published data only}|Two years results of a clinical trial with basiliximab (Simulect) in renal transplantation [abstract]|
Nashan 1997 {published data only}|Basiliximab (Simulect) reduces acute rejections, CMV infections and duration of hospital stay in renal allograft patients [abstract]|
Nashan 1997 {published data only}|Economics of Basiliximab (Simulect) in preventing acute rejection in renal transplantation [abstract no:1453]|
Nashan 1997 {published data only}|The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation|
Nashan 1997 {published data only}|Economic analysis of basiliximab (simulect) in renal transplantation [abstract]|
Nashan 1997 {published data only}|Canadian economic analysis of basiliximab (Simulect) in renal transplantation [abstract no: P1041]|
Nashan 1997 {published data only}|Economic analysis of basiliximab in renal transplantation|/resolve/reference/PMED?id=11435967
Nashan 1997 {published data only}|Long term results of basiliximab in renal transplantation [abstract no:1020]|
Nashan 1997 {published data only}|Screening for basiliximab exposure-response relationships in renal allotransplantation|
Nashan 1997 {published data only}|Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. [erratum appears in Lancet 1997 Nov 15;350(9089):1484]|/resolve/reference/PMED?id=9652559
Nashan 1997 {published data only}|Reduction of acute cellular rejection by basiliximab (simulect), in renal allograft recipients [abstract]|
Nashan 1997 {published data only}|Reduced acute rejection and superior one-year renal allograft survival with basiliximab (Simulect) in patients with diabetes mellitus [abstract]|
Nashan 1997 {published data only}|Reduced acute rejection and superior one-year renal allograft survival with basiliximab (Simulect) in patients with diabetes mellitus [abstract]|
Nashan 1997 {published data only}|Basiliximab (Simulect) significantly reduced the incidence of acute rejection episodes in renal allograft patients: pooled data US/Europe/Canada Studies [abstract]|
Nashan 1997 {published data only}|Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group|/resolve/reference/PMED?id=11003358
Noel 2009 {published data only}|Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients|/resolve/reference/PMED?id=19470677
Noel 2009 {published data only}|Daclizumab versus thymoglobulin in renal transplant recipients with a high immunological risk: a French and Belgian prospective randomized trial [abstract no: 331]|
Offner 2008 {published data only}|Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients under CsA, MMF and corticosteroids [abstract no: COD. PP 210]|
Offner 2008 {published data only}|Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication|/resolve/reference/PMED?id=19005405
Offner 2008 {published data only}|Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids|/resolve/reference/PMED?id=19005406
Offner 2008 {published data only}|A multicenter, placebo-controlled trial evaluating the efficacy and safety of Basiliximab (Simulect) in combination with CsA, MMF and steroids in pediatric renal allograft recipients: 12 months results [abstract no: COD. OP 25]|
Offner 2008 {published data only}|Basiliximab as induction therapy in pediatric renal transplantation: 5 year results [abstract no: SA-PO2534]|
Offner 2008 {published data only}|First multicenter, placebo controlled trial of basiliximab (Simulect) in pediatric renal allograft recipients: efficacy results including a 6-month biopsy (for the pediatric simulect study group) [abstract no: SA-PO451]|
Parrott 2005 {published data only}|Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine a monotherapy in renal transplant recipients|/resolve/reference/PMED?id=15699766
Parrott 2005 {published data only}|Basiliximab (simulect) with ciclosporin (neoral) as a strategy for steroid avoidance in renal transplantation. [abstract]|
Perrea 2006 {published data only}|Correlation between oxidative stress and immunosuppressive therapy in renal transplant recipients with an uneventful postoperative course and stable renal function|/resolve/reference/PMED?id=16868708
Pescovitz 2003 {published data only}|A phase I/II randomized, double blind, placebo controlled study of zenapax in combination with cellcept, neoral, and steroids. [abstract]|
Pescovitz 2003 {published data only}|Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation|
Philosophe 2002 {published data only}|Long term results of a prospective randomized study comparing OKT3 and a truncated daclizumab regimen as induction for marginal kidneys at high risk for delayed graft function [abstract no: 126]|
Philosophe 2002 {published data only}|Prospective randomized study comparing OKT3 and a truncated daclizumab regimen as induction for marginal kidneys at high risk for delayed graft function [abstract no:2063]|
Philosophe 2002 {published data only}|Prospective randomized study comparing OKT3 and a truncated daclizumab regimen as induction for marginal kidneys at high risk for delayed graft function [abstract no:402]|
Pisani 2001 {published data only}|Preliminary results of a prospective randomized study of basiliximab and steroid withdrawal in kidney transplantation [abstract no:1617]|
Pisani 2001 {published data only}|Preliminary results of a prospective randomized study of basiliximab in kidney transplantation|/resolve/reference/PMED?id=11267613
Ponticelli 2001 {published data only}|Economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation|
Ponticelli 2001 {published data only}|Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients|
Ponticelli 2001 {published data only}|A multicenter, double blind, placebo controlled study of basiliximab (simulect) in combination with triple therapy including azathioprine for the prevention of acute rejection episodes in renal allograft patients [abstract]|
Ponticelli 2001 {published data only}|Basiliximab (Simulect) significantly reduces the incidence of acute rejection in renal transplant patients receiving triple therapy with azathioprine [abstract]|
Ponticelli 2001 {published data only}|Basiliximab (Simulect) significantly reduces the incidence of acute rejection in renal transplant patients receiving a triple therapy with azathioprine [abstract]|/resolve/reference/PMED?id=11602853
Ponticelli 2001 {published data only}|A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients|/resolve/reference/PMED?id=11602853
Ponticelli 2001 {published data only}|Basiliximab (Simulect) significantly reduces the incidence of acute rejection in renal transplant patients receiving a triple therapy with azathioprine [abstract no:0114]|/resolve/reference/PMED?id=11267167
Ponticelli 2001 {published data only}|Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine|
Ponticelli 2001 {published data only}|Economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation [abstract no:441]|
Ponticelli 2001 {published data only}|Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients: a UK perspective|/resolve/reference/PMED?id=12515574
Ponticelli 2001 {published data only}|Pharmacoeconomic evaluation of Simulect prophylaxis in renal transplant recipients|/resolve/reference/PMED?id=11750367
Pourfarziani 2003 {published data only}|Zenapax versus ALG prophylaxis in immunologically high-risk group of renal allograft recipients [abstract]|
Pourfarziani 2003 {published data only}|Zenapax versus anti-lymphocyte globulin prophylaxis in immunologically high-risk group of renal allograft recipients|
Ruggenenti 2006 {published data only}|Antilymphocyte therapy in kidney transplantation: a prospective randomized trial of full-dose rabbit anti-human thymocyte globulin (ratg) versus low-dose RATG and basiliximab. [abstract]|/resolve/reference/PMED?id=15280690
Ruggenenti 2006 {published data only}|Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: A possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation|/resolve/reference/PMED?id=17699258
Sandrini 2002 {published data only}|Basiliximab facilitates steroid withdrawal after primary kidney transplantation: results of a placebo-controlled study [abstract]|
Sandrini 2002 {published data only}|Simulect facilitates steroid withdrawal after renal transplantation: results of an Italian, multicentre, placebo-controlled study [abstract]|
Sandrini 2002 {published data only}|Basiliximab facilitates steroid withdrawal after renal transplantation: results of an Italian, multicentre, placebo-controlled study (Swiss study) [abstract]|
Sheashaa 2003 {published data only}|Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: a five-year prospective randomized study|/resolve/reference/PMED?id=15908741
Sheashaa 2003 {published data only}|Basiliximab reduces the incidence of acute cellular rejection in live related donor kidney transplantation, results of five years prospective randomized trial [abstract no:SP425]|
Sheashaa 2003 {published data only}|Basiliximab induction therapy for live donor kidney transplantation: a long-term follow-up of prospective randomized controlled study|/resolve/reference/PMED?id=18327678
Sheashaa 2003 {published data only}|Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial|/resolve/reference/PMED?id=12832740
Shidban 2000 {published data only}|Controlled trial of IL2R antibody basiliximab (Simulect) vs low dose OKT3 in cadaver kidney transplant recipients [abstract]|
Shidban 2003 {published data only}|A prospective, randomized, phase IV comparative trial of Thymoglobulin versus Simulect for the prevention of delayed graft function and acute allograft rejection in renal transplant recipients. [abstract no: SA-PO551]|
Shidban 2003 {published data only}|A prospective, randomized, phase IV comparative trial of thymoglobulin versus simulect for the prevention of delayed graft function and acute allograft rejection in renal transplant recipients [abstract]|
Sollinger 2001 {published data only}|Quality of life improvement and lower costs associated with Simulect based induction therapy [abstract]|
Sollinger 2001 {published data only}|Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients|
Sollinger 2001 {published data only}|Pharmacokinetics of basiliximab when coadministered with MMF in kidney transplantation [abstract no: 0112]|
Sollinger 2001 {published data only}|Effect of "C2" Cyclosporine Levels and Time to Initiation of Cyclosporine Therapy on Outcomes in Patients Receiving Neoral and Simulect [abstract]|
Sollinger 2001 {published data only}|Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts|
Sollinger 2001 {published data only}|An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation|/resolve/reference/PMED?id=11328911
Sollinger 2001 {published data only}|A multicenter randomized trial of Simulect with early neoral vs atgam with delayed neoral in renal transplantation [abstract no:0113]]|
Sollinger 2001 {published data only}|Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection|/resolve/reference/PMED?id=11773888
Sollinger 2001 {published data only}|A multicenter, randomized trial of simulect with early neoral vs atgam with delayed neoral in renal transplantation. A 6 month interim analysis [abstract]|
Soulillou/Cant 1990 {published data only}|15-year results of a randomized study comparing anti-CD25 monoclonal antibody and antithymocyte globulin induction in kidney transplantation [abstract]|
Soulillou/Cant 1990 {published data only}|Anti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulin|/resolve/reference/PMED?id=2652579
Soulillou/Cant 1990 {published data only}|15-year results of a randomized study comparing anti-cd25 monoclonal antibody and antithymocyte globulin induction in kidney transplantation. [abstract]|
Soulillou/Cant 1990 {published data only}|Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts|/resolve/reference/PMED?id=2157982
SYMPHONY (Ekberg) 2007 {published data only}|Population pharmacokinetics of mycophenolic acid in combination with free or reduced doses of calcineurin inhibitors during the first week in renal transplant: the Symphony Study [abstract no: 105]|
SYMPHONY (Ekberg) 2007 {published data only}|Low-dose sirolimus in the first 8 weeks following renal transplantation accompanied by daclizumab induction, MMF and steroids: the experience of the SYMPHONY Study [abstract no: F-PO1078]|
SYMPHONY (Ekberg) 2007 {published data only}|CNI minimisation with 2 G mycophenolate mofetil - what have we learned from the Symphony Study [abstract no: 964]|
SYMPHONY (Ekberg) 2007 {published data only}|Cyclosporine, tacrolimus and sirolimus retained their distinct toxicity profiles despite low doses in the Symphony Study [abstract no: 55]|
SYMPHONY (Ekberg) 2007 {published data only}|The challenge of meeting target drug concentrations: experience from the Symphony study [abstract no:58]|/resolve/reference/PMED?id=17227565
SYMPHONY (Ekberg) 2007 {published data only}|Low-dose sirolimus in the first 8 weeks following renal transplantation accompanied by daclizumab induction, MMF and steroids: the experience of the SYMPHONY Study [abstract no: 691]|
SYMPHONY (Ekberg) 2007 {published data only}|Improved outcomes after de novo renal transplantation: 2-year results from the Symphony Study [abstract no: 531]|
SYMPHONY (Ekberg) 2007 {published data only}|CNI sparing in de novo renal transplantation: 3-year results from the Symphony Study [abstract no: LB04]|
SYMPHONY (Ekberg) 2007 {published data only}|CNI sparing with mycophenolate mofetil in de novo renal transplantation: 3-year results from the Symphony Study [abstract no: 623]|
SYMPHONY (Ekberg) 2007 {published data only}|Reduced exposure to calcineurin inhibitors in renal transplantation|/resolve/reference/PMED?id=18094377
SYMPHONY (Ekberg) 2007 {published data only}|Symphony - comparing standard immunosuppression to low-dose cyclosporine, tacrolimus or sirolimus in combination with MMF, daclizumab and corticosteroids in renal transplantation [abstract no: 49]|/resolve/reference/PMED?id=16433760
SYMPHONY (Ekberg) 2007 {published data only}|Low-dose sirolimus in the first 8 weeks following renal transplantation accompanied by daclizumab induction, MMF and steroids: the experience of the Symphony Study [abstract no: 691]|
SYMPHONY (Ekberg) 2007 {published data only}|Characterization of acute rejections and associated relative risk factors in the Symphony Study [abstract no: 245]|
SYMPHONY (Ekberg) 2007 {published data only}|SYMPHONY - comparing standard immunosuppression to low-dose cyclosporine, tacrolimus or sirolimus in combination with MMF, daclizumab and corticosteroids in renal transplantation [abstract no: F-FC152]|
SYMPHONY (Ekberg) 2007 {published data only}|Pharmacokinetics of total and free mycophenolic acid in renal transplantation receiving standard-dose cyclosporine, low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony PK sub-study [abstract no: P342]|
SYMPHONY (Ekberg) 2007 {published data only}|Pharmacokinetics of total and free mycophenolic acid (MPA) when mycophenolate mofetil (MMF) is administered with low-dose tacrolimus, low-dose cyclosporine, low-dose sirolimus or standard-dose cyclosporine in renal transplantation. Results of the Symphony PK substudy [abstract no: 824]|
SYMPHONY (Ekberg) 2007 {published data only}|Pharmacokinetics of total and free mycophenolic acid in renal transplantation receiving standard-dose cyclosporine, low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony PK sub-study|
SYMPHONY (Ekberg) 2007 {published data only}|The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy|
SYMPHONY (Ekberg) 2007 {published data only}|Blood pressure in the first year following renal transplantation is associated with immunosuppressive regimens: evidence from the Symphony study [abstract no:1137]|
SYMPHONY (Ekberg) 2007 {published data only}|Pharmacokinetics of total and free mycophenolic acid (MPA) when mycophenolate mofetil (MMF) is administered with low-dose tacrolimus, low-dose cyclosporine, low-dose sirolimus or standard-dose cyclosporine in renal transplantation. Results of the SYMPHONY PK substudy [abstract no: TH-PO564]|
SYMPHONY (Ekberg) 2007 {published data only}|Influence of MRP2 and UGT1A9 polimorphisms in the MPA pharmacokinetics in renal transplant substudy within the Symphony Study [abstract no: 2243]|/resolve/reference/PMED?id=18791456
SYMPHONY (Ekberg) 2007 {published data only}|Polymorphisms of the MDR1 gene in renal transplant recipients affect the PGP activity. Results of the pharmacogenetic substudy within the Symphony Study [abstract no: 2244]|
SYMPHONY (Ekberg) 2007 {published data only}|Health-related quality of life of patients receiving low toxicity immunosuppressive regimens [abstract no: TH-PO566]|
SYMPHONY (Ekberg) 2007 {published data only}|Cost-effectiveness analysis of adverse events in low toxicity immunosuppressive regimens, preliminary results of the quality of life substudy within the Symphony Study [abstract no: 107]|
Tan 2004 {published data only}|Basiliximab (Simulect) reduces acute rejection among sensitized kidney allograft recipients|/resolve/reference/PMED?id=15848570
Tan 2004 {published data only}|Basiliximab (simulect) reduces acute rejection among sensitized kidney allograft recipients [abstract]|
ter Meulen 2002 {published data only}|Clinical rejection and persistent immune regulation in kidney transplant patients|/resolve/reference/PMED?id=19398001
ter Meulen 2002 {published data only}|Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids|
ter Meulen 2002 {published data only}|Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids [abstract]|
ter Meulen 2002 {published data only}|A prospective randomized trial comparing steroid-free immunosuppression with limited steroid exposure on bone mineral density in the first year after renal transplantation [abstract no:0344]|/resolve/reference/PMED?id=12846768
ter Meulen 2002 {published data only}|Decreased renal excretion of soluble interleukin-2 receptor alpha after treatment with daclizumab|/resolve/reference/PMED?id=12846768
ter Meulen 2002 {published data only}|The influence of corticosteroids on quantitative ultrasound parameters of the calcaneus in the 1st year after renal transplantation|/resolve/reference/PMED?id=15232677
ter Meulen 2002 {published data only}|No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study|
ter Meulen 2002 {published data only}|Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study|
ter Meulen 2002 {published data only}|Steroid withdrawal at three days after renal transplantation with anti il-2 receptor therapy: a prospective randomized multicenter trial. [abstract]|
ter Meulen 2002 {published data only}|Anti-CD25 prophylaxis allows steroid-free renal transplantation in tacrolimus-based immunosuppression [abstract no: 133]|
Tullius 2003 {published data only}|ATG versus basiliximab induction therapy in kidney allograft recipients receiving dual immunosuppressive regimen: six-year results [abstract no: 800]|
Tullius 2003 {published data only}|ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results|/resolve/reference/PMED?id=14529854
Tullius 2003 {published data only}|Induction therapy with ATG vs basiliximab (simulect) in renal allograft recipients: 1-year results of a prospective randomized, single center study [abstract]|
Tullius 2003 {published data only}|ATG versus basiliximab induction therapy in kidney allograft recipients receiving a dual immunosuppressive regimen: six-year results [abstract no: 540]|
van Gelder 1995 {published data only}|Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor|/resolve/reference/PMED?id=15859929
van Gelder 1995 {published data only}|A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation|/resolve/reference/PMED?id=7645037
van Gelder 1995 {published data only}|Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial|/resolve/reference/PMED?id=8962247
Vincenti 2003 {published data only}|Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation|
Wilson 2004 {published data only}|Use of daclizumab in preventing delayed graft function in non-heart beating donor kidney transplantation in Newcastle upon Tyne|
Wilson 2004 {published data only}|Interleukin 2 receptor blockers may directly inhibit lymphocyte mediated ischaemia reperfusion injury|
Wilson 2004 {published data only}|Evaluation of daclizumab to reduce delayed graft function in non-heart-beating renal transplantation: a prospective, randomized trial|/resolve/reference/PMED?id=15919462
Wilson 2004 {published data only}|Evaluation of daclizumab to reduce delayed graft function in non-heartbeating renal transplantation: a prospective randomised trial [abstract]|
Wilson 2004 {published data only}|Randomized clinical trial of daclizumab induction and delayed introduction of tacrolimus for recipients of non-heart-beating kidney transplants|
Wilson 2004 {published data only}|A randomised controlled trial of daclizumab to reduce the incidence of delayed graft function in recipients of non-heart-beating renal grafts. [abstract]|
Wilson 2004 {published data only}|Prospective randomised trial of the use of Daclizumab in renal transplantation using kidneys from non heart beating donors|/resolve/reference/PMED?id=15478912
Yussim 2004 {published data only}|Two-dose daclizumab in conjunction with tacrolimus-based protocol in kidney transplantation - prospective, randomized study. [abstract]|
Andres 2009 {published data only}|A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function|
Budde 2005 {published data only}|Safety and efficacy of reduced or full dose of cyclosporine (neoral) in combination with mycophenolatesodium (myfortic), basiliximab (simulect), and steroids in de novo kidney transplant recipients [abstract]|/resolve/reference/PMED?id=15257043
Budde 2005 {published data only}|Reduced cyclosporine exposure is safe and efficacious in combination with basiliximab, enteric-coated mycophenolate-sodium, and steroids [abstract no: 1195]|
Budde 2005 {published data only}|Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab|/resolve/reference/PMED?id=17390741
Budde 2005 {published data only}|Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab [abstract no: F-PO1088]|
Burke 2005 {published data only}|Can acute rejection be prevented in SPK transplantation?|/resolve/reference/PMED?id=12176626
Burke 2005 {published data only}|Can acute rejection be prevented in SPK transplantation? A randomized, prospective study with thymoglobulin/zenapax induction, tacrolimus and steroid maintenance, comparing rapamycin with mycophenolate mofetil [abstract]|
Burke 2005 {published data only}|Can acute rejection be prevented in SPK transplantation? a randomized, prospective study with thymoglobulin/zenapax induction, tacrolimus and steroid maintenance: comparing rapamycin with mycophenolate mofetil. [abstract]|
Burke 2005 {published data only}|Lower rate of acute rejection with rapamycin than with mycophenolate mofetil in kidney pancreas transplantation: a randomized, prospective study with thymoglobulin/zenapax induction, tacrolimus and steroid maintenance: comparing rapamycin with mycopenolate mofetil [abstract]|
Burke 2005 {published data only}|Lower rate of acute rejection with rapamycin than with mycophenolate mofetil in kidney pancreas transplantation. A randomized, prospective study with thymoglobulin/zenapax induction, tacrolimus and steroid maintenance: comparing rapamycin with mycophenolate mofetil. [abstract no: 789]|/resolve/reference/PMED?id=12176626
Chadban 2006 {published data only}|A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation. [abstract no: 32]|
Chan 2008 {published data only}|Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness|/resolve/reference/PMED?id=18360262
Chan 2008 {published data only}|Everolimus (RAD001) concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients [abstract no: SA-PO2529]|
Flechner-318 2002 {published data only}|A randomized prospective trial of sirolimus vs cyclosporine in kidney transplantation: renal function and histology at two years [abstract]|
Flechner-318 2002 {published data only}|A randomized trial of sirolimus vs cyclosporine in kidney transplantation: impact on blood cells, lymphocyte subsets, and flow crossmatches [abstract]|
Flechner-318 2002 {published data only}|A randomized trial of sirolimus vs cyclosporine in kidney transplantation: impact on blood cells, lymphocyte subsets, and flow crossmatches. [abstract no:1317]|
Flechner-318 2002 {published data only}|Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine|/resolve/reference/PMED?id=12438948
Flechner-318 2002 {published data only}|Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs|/resolve/reference/PMED?id=17460558
Flechner-318 2002 {published data only}|Kidney transplantation with sirolimus and mycophenolate mofetil based immunosuppression preserves renal structure and function at two years compared to calcineurin inhibitor drugs. [abstract]|
Flechner-318 2002 {published data only}|De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years|
Flechner-318 2002 {published data only}|Kidney transplantation with sirolimus and mycophenolate mofetil based immunosuppression preserves renal structure and function compared to calcineurin inhibitor (cni) drugs. [abstract]|
FREEDOM Study {published data only}|Renal function and rejection incidence in de novo renal transplant patients randomized to steroid avoidance, steroid withdrawal or standard steroids [abstract no: F-FC153]|
FREEDOM Study {published data only}|12-month results of a prospective, randomized trial of steroid avoidance, steroid withdrawal and standard steroids in de novo renal transplant patients receiving cyclosporine, enteric-coated mycophenolate sodium (EC-MPS, myfortic) and basiliximab [abstract no: 54]|
FREEDOM Study {published data only}|Comparison of metabolic parameters in renal transplant patients randomized to steroid avoidance, steroid withdrawal or standard steroids with a 12-month, randomized, multicenter trial [abstract no: F-PO1076]|
FREEDOM Study {published data only}|A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients|
FREEDOM Study {published data only}|Preliminary results of a 12-month study with enteric-coated mycophenolate sodium (EC-MPS), basiliximab, and neoral C-2 comparing a regimen without steroids or short-term use of steroids with standard steroid treatment in de novo kidney recipients. [abstract no: 34]|
FREEDOM Study {published data only}|Preliminary results of a 12-month study with enteric-coated mycophenolate sodium (EC-MPS), basiliximab, and neoral C-2 comparing two investigational steroid regimens (without steroids or short-term use of steroids) with standard steroid treatment in de novo kidney recipients [abstract no: T-PO50027]|
Hamdy 2005 {published data only}|Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients|/resolve/reference/PMED?id=18337483
Hamdy 2005 {published data only}|Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation|
Hiesse 1992 {published data only}|Prophylactic use of the IL-2 receptor-specific monoclonal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantation|/resolve/reference/PMED?id=14621841
Hirose 2004 {published data only}|Treatment of kidney transplant patients with the novel co-stimulatory blocker LEA29y (BMS-224818) and antiil2 receptor antibody does not impede the development of regulatory t cells. [abstract]|
Kovarik 2003 {published data only}|Influence of delayed initiation of cyclosporine on everolimus pharmacokinetics in de novo renal transplant patients|
Kramer-2307 2003 {published data only}|Excellent graft function in de novo kidney transplant recipients treated with Certican, Simulect and reduced Neoral exposure: 24 month result [abstract no: FC-50002]|/resolve/reference/PMED?id=15958051
Kramer-2307 2003 {published data only}|Excellent graft function in kidney transplant recipients treated with everolimus, low-CsA and basiliximab at 24 months. [abstract no: 36]|
Kramer-2307 2003 {published data only}|Excellent graft function in de novo kidney transplant recipients treated with certican, simulect and reduced neoral exposure: 12-month results [abstract]|/resolve/reference/PMED?id=15257036
Kramer-2307 2003 {published data only}|Excellent graft function in de novo transplant recipients treated with everolimus, reduced dose neoral and simulect: 6 months analysis. [abstract]|
Kramer-2307 2003 {published data only}|Excellent graft function in kidney transplant recipients treated with everolimus, low-CSA and basiliximab at 24 months [abstract no: PO-437]|
Kramer-2307 2003 {published data only}|Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab|/resolve/reference/PMED?id=15866684
Kramer-2307 2003 {published data only}|Excellent graft function in de novo kidney transplant recipients treated with concentration controlled everolimus, reduced neoral exposure and basiliximab: 6 months analysis [abstract]|
Kramer-2307 2003 {published data only}|Excellent graft function in de novo kidney transplant recipients treated with Certican, Simulect and reduced Neoral exposure: 24 month result [abstract no: 1011]|
Kramer-2307 2003 {published data only}|Excellent Graft Function in De Novo Kidney Transplant Recipients Treated with Concentration Controlled Everolimus, Reduced Neoral Exposure and Simulect: 6 Months Analysis [abstract no:2]|
Kramer-2307 2003 {published data only}|Efficacy and safety of 2 doses of everolimus combined with reduced dose neoral in de novo kidney transplant recipients: 6 months analysis [abstract]|
Kramer-2307 2003 {published data only}|12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients|
Kramer-2307 2003 {published data only}|Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies|
Kramer-2307 2003 {published data only}|Excellent graft function in de novo kidney transplant recipients treated with certican, simulect and reduced neoral exposure: 12-month results. [abstract]|
Kreis 2003 {published data only}|Lowering cyclosporine dose is not associated with an increased risk of gastro-intestinal adverse events nor the need for dosage decrease of mycophenolate mofetil [abstract no: P743]|
Kreis 2003 {published data only}|Daclizumab and mycophenolate mofetil in renal transplant recipients: 2-year outcome after early reduction of cyclosporine [abstract]|
Light 2002 {published data only}|Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation|
Martinez-Mier 2006 {published data only}|Living related kidney transplantation without calcineurin inhibitors: Initial experience in a Mexican center|/resolve/reference/PMED?id=17164728
McDonald 2008 {published data only}|Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids|
Meier-Kriesche 2004 {published data only}|Treatment of high-risk renal transplant recipients with EC-MPS (Myfortic) is safe and efficacious [abstract no: PUB216]|
Meier-Kriesche 2004 {published data only}|Safety and efficacy of EC-MPS in combination with simulect and neoral in de novo renal transplant high-risk recipients [abstract no: 135]|
Meier-Kriesche 2004 {published data only}|Enteric-coated mycophenolate sodium in combination with optimized neoral dosing, basiliximab, and steroids results in good efficacy and renal function in renal transplant recipients in the first six months [abstract no:220]|
Meier-Kriesche 2004 {published data only}|Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients|
Meier-Kriesche 2004 {published data only}|Optimized Neoral C2 monitoring in combination with enteric-coated mycophenolic acid, basiliximab and steroids is effective, safe and tolerable: 12-month results of a multicenter, randomized, prospective trial. [abstract no: F-PO1068]|
Montagnino 2005 {published data only}|A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine|/resolve/reference/PMED?id=15848532
Montagnino 2005 {published data only}|A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine|/resolve/reference/PMED?id=17890244
Mourad 2005 {published data only}|Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study|
Mourad 2005 {published data only}|Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant|
Mourad 2005 {published data only}|Assessment of two strategies of neoral administration, early versus delayed, on renal function and efficacy in de novo renal transplant patients receiving myfortic, steroids and anti-il2r antibodies: 6 months interim results. [abstract]|
Mourad 2005 {published data only}|Assessment of two strategies of neoral administration, early versus delayed, on renal function and efficacy in de novo renal transplant patients receiving myfortic, steroids, and anti-IL2R antibodies: 12-month results of a randomized, multicentre, open, prospective controlled study|/resolve/reference/PMED?id=15848575
Mourad 2005 {published data only}|Assessment of two neoral administration strategies on renal function and efficacy in de novo renal transplant patients receiving enteric-coated mycophenolate sodium, steroids and anti-il2r antibodies: 6 months interim analysis of a randomized, multicentre, open, prospective controlled study.[abstract]|/resolve/reference/PMED?id=15848575
Mourad 2005 {published data only}|Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients|/resolve/reference/PMED?id=17112849
Mourad 2005 {published data only}|Safety and tolerability of enteric-coated mycophenolate sodium in combination with steroids and two regimen of neoral, in denovo kidney transplant recipients: 6 months interim results. A randomized, multicentre, open, prospective controlled study. [abstract]|
MyPROMS Study {published data only}|Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: pooled data from three 12-month multicenter, open-label, prospective studies|/resolve/reference/PMED?id=17580145
Nematalla 2007 {published data only}|Improving quality of life after steroid avoidance immunosuppression regimen in live donor renal allotransplant recipients - a prospective randomized controlled study single center experience (two year follow up) [abstract no: FP222]|
Nematalla 2007 {published data only}|Steroid avoidance immunosuppression regimen in live donor renal allotransplant recipients - a prospective randomized controlled study single center experience (one year follow up) [abstract no: SP734]|
Nematalla 2007 {published data only}|Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study|/resolve/reference/PMED?id=18194120
Painter 2003 {published data only}|Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients|/resolve/reference/PMED?id=12753323
Pescovitz 2004 {published data only}|Pharmacokinetics, safety and efficacy of mycophenolate mofetil in combination with sirolimus vs cyclosporine in renal transplant patients [abstract]|
Pescovitz 2004 {published data only}|Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients|/resolve/reference/PMED?id=17555465
Provenzano 2000 {published data only}|Analysis of patient and graft outcomes in daclizumab based induction immunosuppression using neoral vs tacrolimus [abstract]|
Scholten 2006 {published data only}|Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function|/resolve/reference/PMED?id=16899517
Tian 2007 {published data only}|Influences of single-dose Basiliximab on Foxp3mRNA, CD4+CD25+ regulatory T cells, interleukin-2 and interleukin-2 receptor in the peripheral blood of renal transplantation recipients|
Vincenti 2005b {published data only}|3 months interim results of a 12-month study with enteric-coated mycophenolate sodium (EC-MPS, Myfortic), basiliximab, and neoral C-2 comparing different steroid protocols in de novo kidney recipients [abstract no: TH-PO544]|
Vincenti 2005b {published data only}|Preliminary 3-month results comparing immunosuppressive regimens of enteric-coated mycophenolate sodium (EC-MPS) without steroids vs short-term use of steroids vs standard steroid treatment including basiliximab, and neoral C-2 in de novo kidney recipients [abstract no: 1542]|
Wang 2008 {published data only}|Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation|/resolve/reference/PMED?id=18346640
Zarkhin 2008 {published data only}|Randomized trial of Rituximab vs standard of care for B cell dense acute renal transplant rejection [abstract no: 538]|
Zarkhin 2008 {published data only}|A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation|
ANZDATA 2008|Chapter 8 Transplantation|
Begg 1996|Improving the quality of reporting of randomized controlled trials. The CONSORT statement|/resolve/reference/PMED?id=8773637
Cibrik 2001|Role of anti-interleukin-2 receptor antibodies in kidney transplantation|/resolve/reference/PMED?id=11604047
Clarke 2001|Obtaining individual patient data from randomised controlled trials|
Cuervo 2003|Balancing benefits and harms in health care|/resolve/reference/PMED?id=12855496
Deeks 2001|Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis|
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
Glanville 2006|How to identify randomized controlled trials in MEDLINE: ten years on|/resolve/reference/PMED?id=16636704
Goebel 2000|Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events|/resolve/reference/PMED?id=11147695
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2008||
Hong 2000|Immunosuppressive agents in organ transplantation: past, present and future|/resolve/reference/PMED?id=10746855
Lefebvre 1996|Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE|
Lefebvre 2008|Chapter 6: Searching for studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration. Available from www.cochrane-handbook.org|
Moher 1999|Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses|/resolve/reference/PMED?id=10584742
Morton 2009|The cost-effectiveness of induction immunosuppression in kidney transplantation|/resolve/reference/PMED?id=19377055
OPTN/SRTR 2008|Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and transplantation Network: Transplant data 1989-1998|
Pascual 2001|Anti-interleukin-2 receptor antibodies: basiliximab and daclizumab|/resolve/reference/PMED?id=11522853
Renal Group 2009|Cochrane Renal Group|
UK National Transplant Database 2009|Transplant Activity report 2008-2009, section 3 Kidney Activity|
UK Renal Registry report 2007|Chapter 11: Measures of Care in Adult Renal Transplant Recipients in the UK|
Vanrenterghem 2001|Tailoring immunosuppressive therapy for renal transplant recipients|
Webster 2003|Interleukin 2 receptor antagonists for kidney transplant recipients|
Webster 2004|Interleukin 2 receptor antagonists for kidney transplant recipients|
Iarussi 1994 {published data only}|Protective effect of Coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-hodgkin lymphoma|
Kraft 1990 {published data only}|Effects of verapamil on anthracycline-induced cardiomyopathy: preliminary results of a prospective multicenter trial|
Lopez 1998 {published data only}|Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas|
Milei 1987 {published data only}|Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study|
Myers 1983 {published data only}|A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine|
Speyer 1992 {published data only}|ICRF-187 permits longer treatment with doxorubicin in women with breast cancer|
Swain 1997a(088001) {published data only}|Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer|
Swain 1997a(088006) {published data only}|Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer|
Venturini 1996 {published data only}|Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer|
Wagdi 1995 {published data only}|Cardioprotection during chemo-and radiotherapy of malignant disaeses - an echocardiographic pilot study|
Wexler 1996 {published data only}|Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin|
Bates 1997|A pharmacoeconomic evaluation of the use of dexrazoxane in preventing anthracycline-induced cardiotoxicity in patients with stage IIIB or IV metastatic breast cancer|
Massida 1997|Early detection of the anthracycline-induced cardiotoxicity. A non-invasive haemodynamic study|
Michelotti 2000|Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients|
Speyer 1988|Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer|
Speyer 1990|A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer|
Swain 1997b|Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy|
Tonkin 1996|Dexrazoxane cardioprotection for patients receiving FAC chemotherapy: a pharmacoeconomic evaluation|
Unverferth 1983a|N-Acetylcysteine prevents the doxorubicin-induced decrease of cyclic GMP|
Unverferth 1983b|Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine|
Vici 1998|Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment|
Wagdi 1996|Cardioprotection in patients undergoing chemo-and/or radiotherapy for neoplastic disease: a pilot study|
Weitzman 1980|Prospective study of tocopherol prophylaxis for anthracycline cardiac toxicity|
Whittaker 1984|Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukaemia|
Whittaker 1987|Doxorubicin cardiotoxicity: attempts at prevention with digoxin and alpha-tocopherol (Vitamin E)|
Batist 2001|Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer|
Bonadonna 1969|Cardiac toxicity of daunorubicin|
Cochrane Handbook|Cochrane Reviewers' Handbook 4.2.2 [updated March 2004]|
De Leonardis 1985|Reduction of cardiac toxicity of anthracyclines by L-Carnitine: preliminary overview of clinical data|
Elihu 1998|Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine and dexrazoxane|
Garbrecht 1986|Verapamil in the prevention of adriamycin-induced cardiomyopathy|
Guthrie 1977|Doxorubicin cardiotoxicity: possible role of digoxin in its prevention|
Kawasaki 1992|Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C|
Keizer 1990|Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity|
Kremer 2002a|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|
Kremer 2002b|Frequency and risk factors of anthracycline-induced heart failure in children: a systematic review|
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Legha 1982a|Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion|
Legha 1982b|Clinical and pharmacologic investigation of the effects of a-tocopherol on adriamycin cardiotoxicity|
Lipshultz 1998|48 hour continuous doxorubicin infusion is not cardioprotective in children assessed 18 months later: the DFCI 91001 ALL protocol|
Miller 1981|Reporting results of cancer treatment|
Muggia 1991|New anthracycline antitumor antibiotics|
Muggia 1997|Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation|
Myers 1998|The role of iron in doxorubicin-induced cardiomyopathy|
Odaimi 1987|High-dose chemotherapy|
Oken 1982|Toxicity and response criteria of the Eastern Cooperative Oncology Group|
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Pierga 2001|Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients|
Shan 1996|Anthracycline-induced cardiotoxicity|
Silber 2001|Design and baseline characteristics for the ACE inhibitor after anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors|
Singal 1995|Combination therapy with probucol prevents adriamycin-induced cardiomyopathy|
Van Acker 2000|7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week|
Von Hoff 1979|Risk factors for doxorubicin-induced congestive heart failure|
Galetta 2005 {published data only}|Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients|/resolve/reference/PMED?id=16325366
Iarussi 1994 {published data only}|Protective effect of Coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-hodgkin lymphoma|
Kalay 2006 {published data only}|Protective effects of carvedilol against anthracycline-induced cardiomyopathy|/resolve/reference/PMED?id=17161256
Kraft 1990 {published data only}|Effects of verapamil on anthracycline-induced cardiomyopathy: preliminary results of a prospective multicenter trial|/resolve/reference/PMED?id=2182448
Lipshultz 2004 {published data only}|The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia|/resolve/reference/PMED?id=15247354
Lopez 1998 {published data only}|Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas|/resolve/reference/PMED?id=9440727
Marty 2006 {published data only}|Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy|/resolve/reference/PMED?id=16423847
Milei 1987 {published data only}|Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study|/resolve/reference/PMED?id=3427552
Myers 1983 {published data only}|A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine|/resolve/reference/PMED?id=6340204
Speyer 1992 {published data only}|ICRF-187 permits longer treatment with doxorubicin in women with breast cancer|/resolve/reference/PMED?id=1727913
Swain 1997a(088001) {published data only}|Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer|/resolve/reference/PMED?id=9193323
Swain 1997a(088006) {published data only}|Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer|/resolve/reference/PMED?id=9193323
Venturini 1996 {published data only}|Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer|/resolve/reference/PMED?id=8955656
Wagdi 1995 {published data only}|Cardioprotection during chemo-and radiotherapy of malignant disaeses - an echocardiographic pilot study|/resolve/reference/PMED?id=7481338
Waldner 2006 {published data only}|Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma|/resolve/reference/PMED?id=16283381
Wexler 1996 {published data only}|Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin|/resolve/reference/PMED?id=8636745
Bates 1997 {published data only}|A pharmacoeconomic evaluation of the use of dexrazoxane in preventing anthracycline-induced cardiotoxicity in patients with stage IIIB or IV metastatic breast cancer|/resolve/reference/PMED?id=9182022
Batist 1985 {published data only}|Cardiac and red blood cell glutathione peroxidase: results of a prospective randomized trial in patients on total parenteral nutrition|/resolve/reference/PMED?id=3931910
Cardinale 2006 {published data only}|Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition|/resolve/reference/PMED?id=17101852
Judy 1984 {published data only}|Coenzyme Q10 reduction of adriamycin cardiotoxicity|
Massida 1997 {published data only}|Early detection of the anthracycline-induced cardiotoxicity. A non-invasive haemodynamic study|/resolve/reference/PMED?id=9066598
Michelotti 2000 {published data only}|Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients|/resolve/reference/PMED?id=10817348
Nakamae 2005 {published data only}|Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone|
Neto 2006 {published data only}|Left ventricular systolic function assessed by echocardiography in children and adolescents with osteosarcoma treated with doxorubicin alone or in combination with dexrazoxane|
Paiva 2005 {published data only}|Cardioprotective effect of dexrazoxane during treatment with doxorubicin: a study using low-dose dobutamine stress echocardiography|
Piccinini 1987 {published data only}|Protective effect of trimetazidine on the cardiotoxicity of doxorubicin|
Rosenfeld 1992 {published data only}|Prevention of adriamycin cardiomyopathy with dexrazoxane (ADR-529, ICRF-187)|
Speyer 1988 {published data only}|Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer|/resolve/reference/PMED?id=3137469
Speyer 1990 {published data only}|A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer|/resolve/reference/PMED?id=2125531
Swain 1997b {published data only}|Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy|/resolve/reference/PMED?id=9193324
Tallarico 2003 {published data only}|Myocardial cytoprotection by trimetazidine against anthracycline-induced cardiotoxicity in anticancer chemotherapy|/resolve/reference/PMED?id=12678198
Tebbi 2007 {published data only}|Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease|/resolve/reference/PMED?id=17290056
Ten Bokkel 1990 {published data only}|ICRF 187 protects against doxorubicin induced cardiomyopathy|
Tonkin 1996 {published data only}|Dexrazoxane cardioprotection for patients receiving FAC chemotherapy: a pharmacoeconomic evaluation|/resolve/reference/PMED?id=12056098
Unverferth 1983a {published data only}|N-Acetylcysteine prevents the doxorubicin-induced decrease of cyclic GMP|/resolve/reference/PMED?id=6132449
Unverferth 1983b {published data only}|Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine|/resolve/reference/PMED?id=6580492
Vici 1998 {published data only}|Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment|/resolve/reference/PMED?id=9621483
Wagdi 1996 {published data only}|Cardioprotection in patients undergoing chemo-and/or radiotherapy for neoplastic disease: a pilot study|/resolve/reference/PMED?id=8774628
Weisberg 1992 {published data only}|Dexrazoxane (ADR-529, ICRF-187, Zinecard) protects against doxorubicin induced chronic cardiotoxicity|
Weitzman 1980 {published data only}|Prospective study of tocopherol prophylaxis for anthracycline cardiac toxicity|
Whittaker 1984 {published data only}|Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukaemia|/resolve/reference/PMED?id=6419896
Whittaker 1987 {published data only}|Doxorubicin cardiotoxicity: attempts at prevention with digoxin and alpha-tocopherol (Vitamin E)|
NCT00002827/POG9426 {published data only}|Phase III randomised study of response-dependent therapy with doxorubicin/bleomycin/vincristine/etoposide (DBVE) with versus without dexrazoxane followed by low-dose involved-field radiotherapy for newly diagnosed stage IA/IIA/IIIA1 childhood Hodgkin's disease|
NCT00005578/POG9425 {published data only}|Phase III randomised study of combination chemotherapy with or without dexrazoxane in children with advanced stage Hodgkin's disease|
NCT00016276 {published data only}|Phase III randomised study of doxorubicin and cyclophosphamide with or without dexrazoxane followed by paclitaxel with or without trastuzumab (herceptin) followed by surgery and radiotherapy with or without trastuzumab in women with HER-2+ stage IIIA or IIIB or regional stage IV breast cancer|
NCT00162955 {published data only}|The multi-centers trial for patients with Non-Hodgkin's lymphoma to assess the protective effect of valsartan on chronic cardiotoxicity induced by CHOP|
NCT00247975 {published data only}|Primary prevention of anthracycline-induced cardiotoxicity with L-carnitine in patients with breast cancer (PPACC)-pilot study|
POG 9404 {published data only}|Not mentioned|
Batist 2001|Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer|/resolve/reference/PMED?id=11230490
Bonadonna 1969|Cardiac toxicity of daunorubicin|/resolve/reference/PMED?id=4180385
De Leonardis 1985|Reduction of cardiac toxicity of anthracyclines by L-Carnitine: preliminary overview of clinical data|/resolve/reference/PMED?id=3860480
Elihu 1998|Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine and dexrazoxane|
Garbrecht 1986|Verapamil in the prevention of adriamycin-induced cardiomyopathy|/resolve/reference/PMED?id=3560773
Guthrie 1977|Doxorubicin cardiotoxicity: possible role of digoxin in its prevention|/resolve/reference/PMED?id=589261
Hellmann 2007|Dexrazoxane-associated risk for secondary malignancies in pediatric hodgkin's disease: a claim without evidence|/resolve/reference/PMED?id=17925567
Higgins 2006||
Hofmann 1993|A questionnaire suitable for general practice for detection of the health status and quality of life of patients with hemato-oncologic diseases: psychometric properties. The study G "quality of life" of the International Society for Chemo-and Immunotherapy (I.G.C.I.)|/resolve/reference/PMED?id=8517057
Kawasaki 1992|Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C|
Keizer 1990|Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity|/resolve/reference/PMED?id=2203071
Kremer 2002a|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|/resolve/reference/PMED?id=12123328
Kremer 2002b|Frequency and risk factors of anthracycline-induced heart failure in children: a systematic review|/resolve/reference/PMED?id=12056699
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Legha 1982a|Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion|/resolve/reference/PMED?id=7059060
Legha 1982b|Clinical and pharmacologic investigation of the effects of a-tocopherol on adriamycin cardiotoxicity|
Lipshultz 1998|48 hour continuous doxorubicin infusion is not cardioprotective in children assessed 18 months later: the DFCI 91001 ALL protocol|
Lipshultz 2007|Dexrazoxane-associated risk for secondary malignancies in pediatric hodgkin's disease: a claim without compelling evidence|/resolve/reference/PMED?id=17634500
Miller 1981|Reporting results of cancer treatment|
Muggia 1991|New anthracycline antitumor antibiotics|/resolve/reference/PMED?id=1831987
Muggia 1997|Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation|/resolve/reference/PMED?id=9060537
Myers 1998|The role of iron in doxorubicin-induced cardiomyopathy|/resolve/reference/PMED?id=9768818
Odaimi 1987|High-dose chemotherapy|/resolve/reference/PMED?id=3551575
Oken 1982|Toxicity and response criteria of the Eastern Cooperative Oncology Group|/resolve/reference/PMED?id=7165009
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Pierga 2001|Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients|/resolve/reference/PMED?id=11300330
Shan 1996|Anthracycline-induced cardiotoxicity|/resolve/reference/PMED?id=8644988
Silber 2001|Design and baseline characteristics for the ACE inhibitor after anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors|/resolve/reference/PMED?id=11579345
Singal 1995|Combination therapy with probucol prevents adriamycin-induced cardiomyopathy|/resolve/reference/PMED?id=7563102
Tuchler 1992|A short multilingual quality of life questionnaire - practicability, reliability and interlingual homogeneity|/resolve/reference/PMED?id=1301118
Van Acker 2000|7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week|/resolve/reference/PMED?id=10778960
Von Hoff 1979|Risk factors for doxorubicin-induced congestive heart failure|/resolve/reference/PMED?id=496103
Van Dalen 2005|Cardioprotective interventions for cancer patients receiving anthracyclines|/resolve/reference/PMED?id=15674919
Galetta 2005 {published data only}|Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients|/resolve/reference/PMED?id=16325366
Gallegos-Castorena 2007 {published data only}|Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin|/resolve/reference/PMED?id=17710657
Iarussi 1994 {published data only}|Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-hodgkin lymphoma|
Kalay 2006 {published data only}|Protective effects of carvedilol against anthracycline-induced cardiomyopathy|/resolve/reference/PMED?id=17161256
Kraft 1990 {published data only}|Effects of verapamil on anthracycline-induced cardiomyopathy: preliminary results of a prospective multicenter trial|/resolve/reference/PMED?id=2182448
Lipshultz 2004 {published data only}|Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane|/resolve/reference/PMED?id=18309945
Lipshultz 2004 {published data only}|The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia|/resolve/reference/PMED?id=15247354
Lipshultz 2004 {published data only}|Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial|
Lopez 1998 {published data only}|Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas|/resolve/reference/PMED?id=9440727
Marty 2006 {published data only}|Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy|/resolve/reference/PMED?id=16423847
Milei 1987 {published data only}|Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study|/resolve/reference/PMED?id=3427552
Myers 1983 {published data only}|A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine|
Schwartz 2009 {published data only}|A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425|/resolve/reference/PMED?id=19584400
Speyer 1992 {published data only}|ICRF-187 permits longer treatment with doxorubicin in women with breast cancer|/resolve/reference/PMED?id=1727913
Swain 1997a(088001) {published data only}|Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer|/resolve/reference/PMED?id=9193323
Swain 1997a(088006) {published data only}|Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer|/resolve/reference/PMED?id=9193323
Venturini 1996 {published data only}|Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer|/resolve/reference/PMED?id=8955656
Wagdi 1995 {published data only}|Cardioprotection during chemo-and radiotherapy of malignant diseases - an echocardiographic pilot study|/resolve/reference/PMED?id=7481338
Waldner 2006 {published data only}|Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma|/resolve/reference/PMED?id=16283381
Wexler 1996 {published data only}|Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin|/resolve/reference/PMED?id=8636745
Bates 1997 {published data only}|A pharmacoeconomic evaluation of the use of dexrazoxane in preventing anthracycline-induced cardiotoxicity in patients with stage IIIB or IV metastatic breast cancer|/resolve/reference/PMED?id=9182022
Batist 1985 {published data only}|Cardiac and red blood cell glutathione peroxidase: results of a prospective randomized trial in patients on total parenteral nutrition|/resolve/reference/PMED?id=3931910
Cardinale 2006 {published data only}|Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition|/resolve/reference/PMED?id=17101852
Cascinu 1995 {published data only}|Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial|/resolve/reference/PMED?id=7799029
Judy 1984 {published data only}|Coenzyme Q10 reduction of adriamycin cardiotoxicity|
Massida 1997 {published data only}|Early detection of the anthracycline-induced cardiotoxicity. A non-invasive haemodynamic study|/resolve/reference/PMED?id=9066598
Michelotti 2000 {published data only}|Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients|/resolve/reference/PMED?id=10817348
Moghrabi 2007 {published data only}|Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia|
Nakamae 2005 {published data only}|Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone|
Neto 2006 {published data only}|Left ventricular systolic function assessed by echocardiography in children and adolescents with osteosarcoma treated with doxorubicin alone or in combination with dexrazoxane|
Paiva 2005 {published data only}|Cardioprotective effect of dexrazoxane during treatment with doxorubicin: a study using low-dose dobutamine stress echocardiography|
Piccinini 1987 {published data only}|Protective effect of trimetazidine on the cardiotoxicity of doxorubicin|
Rosenfeld 1992 {published data only}|Prevention of adriamycin cardiomyopathy with dexrazoxane (ADR-529, ICRF-187)|
Speyer 1988 {published data only}|Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer|/resolve/reference/PMED?id=3137469
Speyer 1990 {published data only}|A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer|/resolve/reference/PMED?id=2125531
Swain 1997b {published data only}|Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy|/resolve/reference/PMED?id=9193324
Tallarico 2003 {published data only}|Myocardial cytoprotection by trimetazidine against anthracycline-induced cardiotoxicity in anticancer chemotherapy|/resolve/reference/PMED?id=12678198
Tebbi 2007 {published data only}|Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease|/resolve/reference/PMED?id=17290056
Ten Bokkel 1990 {published data only}|ICRF 187 protects against doxorubicin induced cardiomyopathy|
Tonkin 1996 {published data only}|Dexrazoxane cardioprotection for patients receiving FAC chemotherapy: a pharmacoeconomic evaluation|/resolve/reference/PMED?id=12056098
Unverferth 1983a {published data only}|N-Acetylcysteine prevents the doxorubicin-induced decrease of cyclic GMP|
Unverferth 1983b {published data only}|Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine|/resolve/reference/PMED?id=6580492
Vici 1998 {published data only}|Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment|/resolve/reference/PMED?id=9621483
Wagdi 1996 {published data only}|Cardioprotection in patients undergoing chemo-and/or radiotherapy for neoplastic disease: a pilot study|/resolve/reference/PMED?id=8774628
Weisberg 1992 {published data only}|Dexrazoxane (ADR-529, ICRF-187, Zinecard) protects against doxorubicin induced chronic cardiotoxicity|
Weitzman 1980 {published data only}|Prospective study of tocopherol prophylaxis for anthracycline cardiac toxicity|
Whittaker 1984 {published data only}|Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukaemia|/resolve/reference/PMED?id=6419896
Whittaker 1987 {published data only}|Doxorubicin cardiotoxicity: attempts at prevention with digoxin and alpha-tocopherol (vitamin E)|
Cadeddu 2010 {published data only (unpublished sought but not used)}|Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment|
Cardenas 2003 {published data only}|Effectiveness and safety of dexrazoxane as a cardioprotector in Mexican children with cancer|
De Berranger 2006 {published data only}|Results of randomized study on dexrazoxane administration in children with de novo acute leukemia|
Feldmann 1992 {published data only}|Advanced small cell lung cancer treated with CAV (cyclophosphamide + adriamycin + vincristine) chemotherapy and the cardioprotective agent dexrazoxane (ADR-529, ICRF-187, Zinecard)|
Gu 2010 {published data only (unpublished sought but not used)}|Clinical observation of hydroprednisone and glutathione in chemotherapy of breast cancer|/resolve/reference/PMED?id=7102322
Jackowska 2003 {published data only}|Assessment of dexrazoxane tolerance in leukemic children receiving anthracyclines|
Saad El-Din 2003 {published data only}|A randomized clinical trial to evaluate cardioprotective effect of ICRF-187 in children with acute lymphoblastic leukemia|
Ten Bokkel-Huinink 1992 {published data only}|ICRF 187 protects against doxorubicin induced cardiomyopathy|
NCT00002827/POG9426 {published data only}|Phase III randomised study of response-dependent therapy with doxorubicin/bleomycin/vincristine/etoposide (DBVE) with versus without dexrazoxane followed by low-dose involved-field radiotherapy for newly diagnosed stage IA/IIA/IIIA1 childhood Hodgkin's disease|
NCT00016276 {published data only}|Phase III randomised study of doxorubicin and cyclophosphamide with or without dexrazoxane followed by paclitaxel with or without trastuzumab (herceptin) followed by surgery and radiotherapy with or without trastuzumab in women with HER-2+ stage IIIA or IIIB or regional stage IV breast cancer|
NCT00162955 {published data only}|The multi-centers trial for patients with Non-Hodgkin's lymphoma to assess the protective effect of valsartan on chronic cardiotoxicity induced by CHOP|
NCT00247975 {published data only}|Primary prevention of anthracycline-induced cardiotoxicity with L-carnitine in patients with breast cancer (PPACC)-pilot study|
NCT00895414 {published and unpublished data}|Enalapril maleate and doxorubicin hydrochloride in treating women with breast cancer|
NCT01230983/POG9404 {published data only}|Intensive treatment for T-cell acute lymphoblastic leukemia and advanced stage lymphoblastic Non-Hodgkin's lymphoma: a Pediatric Oncology Group Phase III study|
Barry 2008|Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane|/resolve/reference/PMED?id=18309945
Batist 2001|Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer|/resolve/reference/PMED?id=11230490
Bonadonna 1969|Cardiac toxicity of daunorubicin|/resolve/reference/PMED?id=4180385
De Leonardis 1985|Reduction of cardiac toxicity of anthracyclines by L-Carnitine: preliminary overview of clinical data|/resolve/reference/PMED?id=3860480
Elihu 1998|Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine and dexrazoxane|
Garbrecht 1986|Verapamil in the prevention of adriamycin-induced cardiomyopathy|
Guthrie 1977|Doxorubicin cardiotoxicity: possible role of digoxin in its prevention|/resolve/reference/PMED?id=589261
Higgins 2006||
Higgins 2008||
Hofmann 1993|A questionnaire suitable for general practice for detection of the health status and quality of life of patients with hemato-oncologic diseases: psychometric properties. The study G "quality of life" of the International Society for Chemo-and Immunotherapy (I.G.C.I.)|/resolve/reference/PMED?id=8517057
Kawasaki 1992|Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C|
Keizer 1990|Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity|/resolve/reference/PMED?id=2203071
Kremer 2002a|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|/resolve/reference/PMED?id=12123328
Kremer 2002b|Frequency and risk factors of anthracycline-induced heart failure in children: a systematic review|/resolve/reference/PMED?id=12056699
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Legha 1982a|Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion|/resolve/reference/PMED?id=7059060
Legha 1982b|Clinical and pharmacologic investigation of the effects of a-tocopherol on adriamycin cardiotoxicity|
Lipshultz 1998|48 hour continuous doxorubicin infusion is not cardioprotective in children assessed 18 months later: the DFCI 91001 ALL protocol|
Lipshultz 2010|Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial|
Miller 1981|Reporting results of cancer treatment|
Muggia 1991|New anthracycline antitumor antibiotics|/resolve/reference/PMED?id=1831987
Muggia 1997|Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation|/resolve/reference/PMED?id=9060537
Myers 1998|The role of iron in doxorubicin-induced cardiomyopathy|
Odaimi 1987|High-dose chemotherapy|/resolve/reference/PMED?id=3551575
Oken 1982|Toxicity and response criteria of the Eastern Cooperative Oncology Group|/resolve/reference/PMED?id=7165009
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Pierga 2001|Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients|/resolve/reference/PMED?id=11300330
Salzer 2010|Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group|/resolve/reference/PMED?id=20016527
Shan 1996|Anthracycline-induced cardiotoxicity|/resolve/reference/PMED?id=8644988
Silber 2001|Design and baseline characteristics for the ACE inhibitor after anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors|/resolve/reference/PMED?id=11579345
Singal 1995|Combination therapy with probucol prevents adriamycin-induced cardiomyopathy|/resolve/reference/PMED?id=7563102
Tuchler 1992|A short multilingual quality of life questionnaire - practicability, reliability and interlingual homogeneity|/resolve/reference/PMED?id=1301118
Van Acker 2000|7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week|/resolve/reference/PMED?id=10778960
Van Dalen 2009|Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy|
Van Dalen 2010|Different anthracycline derivates for reducing cardiotoxicity in cancer patients|
Van Dalen 2011|Should anthracyclines and dexrazoxane be used for children with cancer?|
Von Hoff 1979|Risk factors for doxorubicin-induced congestive heart failure|/resolve/reference/PMED?id=496103
Van Dalen 2005|Cardioprotective interventions for cancer patients receiving anthracyclines|/resolve/reference/PMED?id=15674919
Van Dalen 2008|Cardioprotective interventions for cancer patients receiving anthracyclines|/resolve/reference/PMED?id=18425895
Ancoli-Israel 2003a {published data only (unpublished sought but not used)}|Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's Disease patients|/resolve/reference/PMED?id=15600135
Ancoli-Israel 2003b {published data only}|Effect of light on agitation in institutionalized patients with severe Alzheimer Disease|/resolve/reference/PMED?id=12611749
Dowling 2005b {published data only}|Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimers disease|
Dowling 2007 {published data only}|Light treatment for neuropsychiatric behaviors in Alzheimers Disease|/resolve/reference/PMED?id=17596638
Dowling 2008 {published data only}|Melatonin and bright-light treament for rest-activity disruption in institutionalized patients with Alzheimer's Disease|
Gasio 2003 {published and unpublished data}|Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly|/resolve/reference/PMED?id=12543279
Graf 2001 {published data only}|The effects of light therapy on Mini-Mental State Examination scores in demented patients|/resolve/reference/PMED?id=11704081
Lyketsos 1999 {published data only}|A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care|
Mishima 1998 {published data only}|Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer's type|/resolve/reference/PMED?id=9844752
Riemersma 2008 {published data only}|Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: A randomized controlled trial|/resolve/reference/PMED?id=18544724
Abegg 1993 {published data only}|Phototherapy of behavioral disorders as a sequela of disordered circadian rhythm in dementia in the elderly: Difficulties in practical applications|/resolve/reference/PMED?id=7682007
Ancoli-Israel 1997 {published data only}|Variations in circadian rhythms of activity, sleep, and light exposure related to dementia in nursing-home patients|/resolve/reference/PMED?id=9130329
Ancoli-Israel 2002 {published data only}|Effect of light therapy on sleep and circadian rhythms in demented nursing home patients|
Colenda 1997 {published data only}|Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: Results of a community-based pilot study|/resolve/reference/PMED?id=9305504
Dawson 1999 {published data only}|Bright light treatment for people with Alzheimer's disease|/resolve/reference/PMED?id=10373973
Dowling 2005a {published data only}|Effect of morning bright light treatment for restactivity disruption in institutionalized patients with severe Alzheimers disease|/resolve/reference/PMED?id=16050432
Fetveit 2003 {published data only}|Bright light treatment improves sleep in institutionalised elderly - an open trial|
Haffmans 2001 {published data only}|Bright light therapy and melatonin in motor restless behaviour in dementia: A placebo-controlled study|
Hickman 2007 {published data only}|The effect of ambient bright light therapy on depressive symptoms in persons with dementia|
Hozumi 1990 {published data only}|Phototherapy for elderly patients with dementia and sleep-wake rhythm disorders-A comparison between morning and evening exposure|
Ito 1999 {published data only}|Effects of bright light on cognitive disturbances in Alzheimer-type dementia|/resolve/reference/PMED?id=10466338
Ito 2001 {published data only}|Effects of vitamin B12 on bright light on cognition and sleep-wake rhythm in Alzheimer-type dementia|
Kobayashi 2001 {published data only}|Effects of bright light at lunchtime on sleep in a geriatric hospital|
Koyama 1999 {published data only}|Bright light treatment for sleep-wake disturbances in aged individuals with dementia|
Lovell 1995 {published data only}|Effect of bright light treatment on agitated behavior in institutionalized elderly subjects|/resolve/reference/PMED?id=7568561
McCurry 2005 {published data only}|Nighttime insomnia treatment and education for Alzheimers Disease: A randomized controlled trial|
McCurry 2006 {published data only}|Behavioral treatment for sleep disturbances in Alzheimer's Disease: The Nite-AD study|
Mishima 1994 {published data only}|Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia|
Mishima 2000 {published data only}|Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons|/resolve/reference/PMED?id=10841214
Okawa 1989 {published data only}|Sleep-waking rhythm disorders and their phototherapy in elderly patients with dementia|
Okawa 1999a {published data only}|Sleep disorder in eldely patients with dementia and trials of new treatments-Enforcement of social interaction and bright light therapy|
Okawa 1999b {published data only}|Effects of environmental stimulation with bright light and transcranial electrostimulation on sleep and behavior disorders in elderly patients with dementia|
Okumoto 1998 {published data only}|Aging and sleep: Sleep improvement by light in a demented aged individual|
Rheaume 1998 {published data only}|Effect of light therapy upon disturbed behaviors in Alzheimer patients|
Riemersma 2001 {published data only}|Indirect bright light therapy decreases sleep fragmentation in institutionalized demented elderly|
Satlin 1992 {published data only}|Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease|/resolve/reference/PMED?id=1353313
Skjerve 2004 {published data only}|Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia|
Sloane 2007 {published data only}|High-intensity environmental light in dementia: Effect on sleep and activity|
Thorpe 2000 {published data only}|Bright light therapy for demented nursing home patients with behavioral disturbance|
van Someren 1997 {published data only}|Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients|/resolve/reference/PMED?id=9110101
Yamadera 2000 {published data only}|Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia|
Byrne 2000 {published data only}|A randomised controlled trial of bright light therapy for agitation and sleep disturbance in symptoms of dementia|
Byrne 2000 {published data only}|Light boxes can help older people with dementia|/resolve/reference/PMED?id=12946965
Dimond 1999 {published data only}|Light therapy and agitated behaviour in dementia|
Alexopoulos 1988|Cornell scale for depression in dementia|/resolve/reference/PMED?id=3337862
Ancoli-Israel 1994|Sleep in non-institutionalized Alzheimer's disease patients|/resolve/reference/PMED?id=7748919
APA 1995||
Bliwise 1993|Development of an agitated behavior rating scale for discrete temporal observations|/resolve/reference/PMED?id=7850494
Campbell 1988|Exposure to light in healthy elderly subjects and Alzheimer's patients|/resolve/reference/PMED?id=3368532
Campbell 1995|Light treatment for sleep disorders: Consensus report. V. Age-related disturbances|/resolve/reference/PMED?id=7632988
Campbell 1998|Bright light treatment of sleep maintenance insomnia and behavioral disturbance|
Chesson 1999|Practice parameters for the use of light therapy in the treatment of sleep disorders|/resolve/reference/PMED?id=10450599
Cohen-Mansfield 1989|A description of agitation in a nursing home|/resolve/reference/PMED?id=2715584
CSHA 2000|The incidence of dementia in Canada|/resolve/reference/PMED?id=10891908
Cummings 1994|The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia|/resolve/reference/PMED?id=7991117
Davis 2001||
Folstein 1975|Mini-mental state: A practical method for grading the cognitive state of patients for the clinician|/resolve/reference/PMED?id=1202204
Gallager-Thompson 1992|The relations among caregiver stress, 'sundowning' symptoms and cognitive decline in Alzheimer's disease|/resolve/reference/PMED?id=1634724
Harper 2001|Differential circadian rhythm disturbances in men with Alzheimer Disease and Frontotemporal Degeneration|/resolve/reference/PMED?id=11296096
Herrmann 2007|Clinical practice guidelines for severe Alzheimer's disease|/resolve/reference/PMED?id=19595959
Higgins 2008|Cochrane handbook for systematic reviews of interventions 5.0.0 [Updated February 2008]|
Holmes 1990|Impacts associated with special care units in long-term care facilities|/resolve/reference/PMED?id=2189792
Hux 1998|Relation between severity of Alzheimer's disease and costs of caring|/resolve/reference/PMED?id=9757169
Iverson 2002|Measuring change in psychiatric symptoms using the Neuropsychiatric Inventory: Nursing Home version|
Katz 1963|Studies of illness in the aged: The Index of ADL: A standardized measure of biological and psychological function|/resolve/reference/PMED?id=14044222
Lawton 1996|Observed affect in nursing home residents with Alzheimer's Disease|
Liu 2000|Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression|/resolve/reference/PMED?id=10759187
Lucassen 1995|Increased light intensity prevents the age-related loss of vasopressin-expressing neurons in the rat suprachiasmatic nucleus|/resolve/reference/PMED?id=8653418
McCurry 2000|Treatment of sleep disturbances in Alzheimer's disease|/resolve/reference/PMED?id=12531038
McKhann 1984|Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease|/resolve/reference/PMED?id=6610841
Mishima 1999|Metatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking|/resolve/reference/PMED?id=10071710
Moher 2008|Train the Trainer|
Morris 1989|The Consortium to Establish a Registery for Alzheimer's Disease. Part I: Clinical and neuropsychological assessment of Alzheimer's disease|/resolve/reference/PMED?id=2771064
NACA 1999||
Pollak 1991|Sleep problems and institutionalization of the elderly|/resolve/reference/PMED?id=1789908
Prinz 1982|Changes in the sleep and waking EEGs of nondemented and demented elderly subjects|/resolve/reference/PMED?id=7199061
Reisberg 1987|Behavioral symptoms in Alzheimer's disease: Phenomology and treatment|/resolve/reference/PMED?id=3553166
Robillard 2007|Clinical diagnosis of dementia|/resolve/reference/PMED?id=19595950
Satlin 1991|Circadian locomotor activity rhythms in Alzheimer's disease|/resolve/reference/PMED?id=1930614
Satlin 2000|Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease|
Sheikh 1986|Geriatric Depression Scale (GDS): recent findings and development of a shorter version|
Shocat 2000|Illumination levels in nursing home patients: effects on sleep and activity rhythms|
Strang 2006|Family caregivers and transition to long-term care|/resolve/reference/PMED?id=16410621
Swaab 1985|The suprachiasmatic nucleus of the human brain in relation to sex, age, and senile dementia|/resolve/reference/PMED?id=4041816
Touitou 1982|Adrenal circadian system in young and elderly human subjects: A comparative study|/resolve/reference/PMED?id=7086322
Touitou 2000|Alterations with aging of the endocrine and neuroendocrine circadian system in humans|/resolve/reference/PMED?id=10841211
van Someren 1993|Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: Chronobiological perspectives|/resolve/reference/PMED?id=8117428
van Someren 1996|Circadian rest-activity rhythm disturbances in Alzheimer's Disease|/resolve/reference/PMED?id=8871772
van Someren 1999|Bright light therapy: Improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods|/resolve/reference/PMED?id=10442243
Wever 1983|Bright light affects human circadian rhythms|/resolve/reference/PMED?id=6835810
WHO 1992||
WHO 2003|World Health Report 2003: Shaping the future|
Wild 2003|Cholinesterase inhibitors for dementia with Lewy bodies|
Witting 1993|Effect of light intensity on diurnal sleep-wake distribution in young and old rats|/resolve/reference/PMED?id=8420626
Forbes 2004|Light therapy for managing sleep, behaviour, and mood disturbances in dementia|
Carter 2003 {published and unpublished data}|The effect of a general exercise training on effort of walking in patients with multiple sclerosis|
DeBolt 2004 {published data only}|The effects of home-based resistance exercise on balance, power, and mobility in adults with multiple sclerosis|/resolve/reference/PMED?id=14966716
Jones 1999 {published data only}|The effect of weighted leg raises and quadriceps strength, EMG and functional activities in people with multiple sclerosis|
Lord 1998 {published data only}|A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study|
Mostert 2002 {published data only}|Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis|/resolve/reference/PMED?id=11990874
O'Connell 2003 {published and unpublished data}|A controlled study to assess the effects of aerobic training on patients with multiple sclerosis|
Petajan 1996 {published data only}|Impact of aerobic training on fitness and quality of life in multiple sclerosis|
Solari 1999 {published data only}|Physical rehabilitation has a positive effect on disability in multiple sclerosis patients|/resolve/reference/PMED?id=9921849
Wiles 2001 {published data only}|Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis|/resolve/reference/PMED?id=11160464
Craig 2003 {published data only}|A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment|/resolve/reference/PMED?id=12933923
DeSouza 1984 {published data only}|A different approach to physiotherapy for multiple sclerosis patients|
Di Fabio 1997 {published data only}|Health-related quality of life for patients with progressive multiple sclerosis: influence of rehabilitation|/resolve/reference/PMED?id=9413449
Di Fabio 1998 {published data only}|Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis|/resolve/reference/PMED?id=9473994
Freeman 1997 {published data only}|The impact of inpatient rehabilitation on progressive multiple sclerosis|
Freeman 1999 {published data only}|Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?|/resolve/reference/PMED?id=9921848
Fuller 1996 {published data only}|Physiotherapy and mobility in multiple sclerosis: a controlled study|
Gehlsen 1984 {published data only}|Effects of an aquatic fitness program on the muscular strength and endurance of patients with multiple sclerosis|/resolve/reference/PMED?id=6718494
Gehlsen 1986 {published data only}|Gait characteristics in multiple sclerosis: progressive changes and effects of exercise on parameters|/resolve/reference/PMED?id=3741079
Ketelaer 1978 {published data only}|Evaluation and results of the rehabilitation in multiple sclerosis (author's transl)|/resolve/reference/PMED?id=757423
Langdon 1999 {published data only}|Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome|/resolve/reference/PMED?id=10335517
Lanzetta 2004 {published data only}|Trunk control in unstable sitting posture during functional activities in healthy subjects and patients with multiple sclerosis|/resolve/reference/PMED?id=14966714
Patti 2003 {published data only}|Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients: a randomised controlled trial|/resolve/reference/PMED?id=12883930
Peterson 2001 {published data only}|Exercise in 94 degrees F water for a patient with multiple sclerosis|/resolve/reference/PMED?id=11276186
Rodgers 1999 {published data only}|Gait characteristics of individuals with multiple sclerosis before and after a 6-month aerobic training program|/resolve/reference/PMED?id=10659801
Svensson 1994 {published data only}|Endurance training in patients with Multiple Sclerosis: Five case studies|/resolve/reference/PMED?id=7972362
Wiles 2003 {published data only}|Use of videotape to assess mobility in a controlled randomized crossover trial of physiotherapy in chronic multiple sclerosis|/resolve/reference/PMED?id=12735532
Anonymous 1995|Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomised controlled trial|/resolve/reference/PMED?id=7617182
Baker 2001|The effectiveness of physical, psychological and functional interventions in treating clients with Multiple Sclerosis: A meta-analysis|/resolve/reference/PMED?id=11723974
Clarke 2000|Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Interventions 4.1 [updated June 2000]|
Cohen 1960|A coefficient of agreement for nominal scales|
Cook 1980||
De Vet 2003|Levels of evidence: intellectual aid or absolute judgement?|
Egger 1998|Bias in location and selection of studies|/resolve/reference/PMED?id=9451274
Goetzsche 1987|Reference bias in reports of drug trials|/resolve/reference/PMED?id=3117277
McDonald 2001|Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis|
Ng 1997|Quantitation of lower physical activity in persons with multiple sclerosis|/resolve/reference/PMED?id=9107635
Poser 1983|New diagnostic criteria for multiple sclerosis: guidelines for research protocols|
Pozzilli 2002|Epidemiology and current treatment of multiple sclerosis in Europe today|/resolve/reference/PMED?id=12051462
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Schumacher 1965|Problems of experimental trials of therapy in multiple sclerosis|
Steultjens 2003|Occupational Therapy for multiple sclerosis|
Stuifbergen 1997|Physical activity and perceived health status in persons with multiple sclerosis|/resolve/reference/PMED?id=9307926
van Tulder 2003|Updated method guidelines for systematic reviews in the cochrane collaboration back review group|/resolve/reference/PMED?id=12811274
White 2000|Effect of precooling on physical performance in multiple sclerosis|/resolve/reference/PMED?id=10871829
King 1991 {published data only}|Group- vs home-based exercise training in healthy older men and women|/resolve/reference/PMED?id=1880885
King 1995 {published data only}|Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50-65 years|/resolve/reference/PMED?id=7743622
King II 1991 {published data only}|Group- vs home-based exercise training in healthy older men and women|/resolve/reference/PMED?id=1880885
P-Maestu 2000 (II) {published data only}|Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10759446
P-Maestu 2003 {published data only}|Long-term effects of a maintenance program after supervised or self-monitored training programs in patients with COPD|/resolve/reference/PMED?id=12953145
Patterson 1997 {published data only}|Value of a supervised exercise program for the therapy of arterial claudication|/resolve/reference/PMED?id=9052565
Regensteiner 1997 {published data only}|Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease|/resolve/reference/PMED?id=9112877
Savage 2001 {published data only}|Effects of home versus supervised exercise for patients with intermittent claudication|/resolve/reference/PMED?id=11409225
Strijbos 1996 {published data only}|A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD|/resolve/reference/PMED?id=8620707
Adachi 1996 {published data only}|Does appropriate endurance exercise training improve cardiac function in patients with prior myocardial infarction?|/resolve/reference/PMED?id=8909908
Ades 2000 {published data only}|A controlled trial of cardiac rehabilitation in the home setting using electrocardiographic and voice transtelephonic monitoring|/resolve/reference/PMED?id=AMBIGUOUS%20(11%20citations)
Arthur 2002 {published data only}|A controlled trial of hospital versus home-based exercise in cardiac patients|
Ashutosh 1997 {published data only}|Effects of sustained weight loss and exercise on aerobic fitness in obese women|/resolve/reference/PMED?id=9509823
Barrett 2002 {published data only}|A comparison of community-based resistance exercise and flexibility exercise for seniors|/resolve/reference/PMED?id=12217071
Beniamini 1999 {published data only}|High-intensity strength training of patients enrolled in an outpatient cardiac rehabilitation program|/resolve/reference/PMED?id=10079415
Bianchi 2002 {published data only}|Lack of additional effect of adjunct of assisted ventilation to pulmonary rehabilitation in mild COPD patients|/resolve/reference/PMED?id=12113387
Blumenthal 1988 {published data only}|Comparison of high- and low-intensity exercise training early after acute myocardial infarction|/resolve/reference/PMED?id=3337013
Boileau 1999 {published data only}|Aerobic exercise training and cardiorespiratory fitness in older adults: A randomized control trial|
Boudou 2001 {published data only}|Exercise training-induced triglyceride lowering negatively correlates with DHEA levels in men with type 2 diabetes|/resolve/reference/PMED?id=11477494
Bowman 1979 {published data only}|Positional feedback and electrical stimulation: an automated treatment for the hemiplegic wrist|/resolve/reference/PMED?id=508075
Branch 1997 {published data only}|Effects of exercise mode on hematologic adaptations to endurance training in adult females|/resolve/reference/PMED?id=9293346
Brosseau 1995 {published data only}|Safety and feasibility of a self-monitored, home-based phase II exercise program for high risk patients after cardiac surgery. Of:]; [Review Of:]] [61 refs]|/resolve/reference/PMED?id=7671177
Brown 2000 {published data only}|Low-intensity exercise as a modifier of physical frailty in older adults|/resolve/reference/PMED?id=AMBIGUOUS%20(2515%20citations)
Brubaker 1996 {published data only}|Comparison of standard- and extended-length participation in cardiac rehabilitation on body composition, functional capacity, and blood lipids|/resolve/reference/PMED?id=8857480
Brubaker 2000 {published data only}|A home-based maintenance exercise program after center-based cardiac rehabilitation: effects on blood lipids, body composition, and functional capacity|/resolve/reference/PMED?id=10680098
Buchner (II) 1997 {published data only}|The effect of strength and endurance training on gait, balance, fall risk, and health services use in community-living older adults|
Buchner 1997 {published data only}|A comparison of the effects of three types of endurance training on balance and other fall risk factors in older adults|/resolve/reference/PMED?id=9177594
Callaghan 1995 {published data only}|An evaluation of exercise regimes for patients with osteoarthritis of the knee: A single-blind randomized controlled trial|/resolve/reference/PMED?id=AMBIGUOUS%20(47%20citations)
Carlson 2001 {published data only}|Self-efficacy, psychosocial factors, and exercise behavior in traditional versus modified cardiac rehabilitation. [see comments.]|/resolve/reference/PMED?id=AMBIGUOUS%2011767810,11705372,11137102
Cheng 2002 {published data only}|Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women|/resolve/reference/PMED?id=12110425
Coleman 1996 {published data only}|The relationship of joint symptoms with exercise performance in older adults|/resolve/reference/PMED?id=8537585
Cox 2001 {published data only}|Long-term effects of exercise on blood pressure and lipids in healthy women aged 40-65 years: The Sedentary Women Exercise Adherence Trial (SWEAT)|/resolve/reference/PMED?id=11593092
DeGroot 1998 {published data only}|Lactic acid accumulation in cardiac patients performing circuit weight training: implications for exercise prescription|/resolve/reference/PMED?id=9685102
Desharnais 1993 {published data only}|Aerobic exercise and the placebo effect: a controlled study. [see comments.]. Of:]; [Review Of:]] [32 refs]|/resolve/reference/PMED?id=8475229
DiPietro 1998 {published data only}|Moderate-intensity aerobic training improves glucose tolerance in aging independent of abdominal adiposity|/resolve/reference/PMED?id=9670875
Dressendorfer 1995 {published data only}|Exercise training frequency in early post-infarction cardiac rehabilitation. Influence on aerobic conditioning. [erratum appears in J Cardpulm Rehabil 1995 Nov-Dec;15(6):followi.]|/resolve/reference/PMED?id=8542532
Dunn 1998 {published data only}|Six-month physical activity and fitness changes in Project Active, a randomized trial|/resolve/reference/PMED?id=AMBIGUOUS%20(5%20citations)
Ettinger 1997 {published data only}|A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). [see comments.]|/resolve/reference/PMED?id=8980206
Evans 2002 {published data only}|Two-year follow-up of a randomized clinical trial of spinal manipulation and two types of exercise for patients with chronic neck pain|/resolve/reference/PMED?id=12438988
Foy 2001 {published data only}|Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients|/resolve/reference/PMED?id=11157586
Gillett 1988 {published data only}|Self-reported factors influencing exercise adherence in overweight women|/resolve/reference/PMED?id=3340574
Gordon 2002 {published data only}|Effectiveness of three models for comprehensive cardiovascular disease risk reduction|/resolve/reference/PMED?id=12031725
Gossard 1986 {published data only}|Effects of low- and high-intensity home-based exercise training on functional capacity in healthy middle-aged men|/resolve/reference/PMED?id=3946263
Green 1993 {published data only}|Home exercises are as effective as outpatient hydrotherapy for osteoarthritis of the hip. [see comments.]|/resolve/reference/PMED?id=8369892
Guell 2000 {published data only}|Long-term effects of outpatient rehabilitation of COPD: A randomized trial|/resolve/reference/PMED?id=10767227
Gulanick 1991 {published data only}|Is phase 2 cardiac rehabilitation necessary for early recovery of patients with cardiac disease? A randomized, controlled study|
Harland 1999 {published data only}|The Newcastle exercise project: a randomised controlled trial of methods to promote physical activity in primary care|/resolve/reference/PMED?id=10496829
Hiatt 1994 {published data only}|Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response|/resolve/reference/PMED?id=7923674
Hui 1995 {published data only}|Outcomes of elderly stroke patients. Day hospital versus conventional medical management|/resolve/reference/PMED?id=7660408
Kallinen 2002 {published data only}|Improving cardiovascular fitness by strength or endurance training in women aged 76-78 years. A population-based, randomized controlled trial. [see comments.]|/resolve/reference/PMED?id=12147561
Kelemen 1986 {published data only}|Circuit weight training in cardiac patients|/resolve/reference/PMED?id=3941214
King 2000 {published data only}|Comparative effects of two physical activity programs on measured and perceived physical functioning and other health-related quality of life outcomes in older adults|
King 2002 {published data only}|The performance enhancement project: Improving physical performance in older persons|/resolve/reference/PMED?id=19066560
Kohl 1998 {published data only}|A randomized trial of physical activity interventions: design and baseline data from Project Active|/resolve/reference/PMED?id=9502357
Lake 1990 {published data only}|Upper-limb and lower-limb exercise training in patients with chronic airflow obstruction|/resolve/reference/PMED?id=2184993
Lamb 2002 {published data only}|Can lay-led walking programmes increase physical activity in middle aged adults? A randomised controlled trial|/resolve/reference/PMED?id=11896130
Lazowski 1999 {published data only}|A randomized outcome evaluation of group exercise programs in long-term care institutions|
Leitch 1997 {published data only}|Randomized trial of a hospital-based exercise training program after acute myocardial infarction: cardiac autonomic effects|/resolve/reference/PMED?id=AMBIGUOUS%20(5%20citations)
Leuppi 1998 {published data only}|The importance of training intensity for improving endurance capacity of patients with chronic obstructive pulmonary disease. [German]|/resolve/reference/PMED?id=9505942
Liao 2002 {published data only}|Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance|/resolve/reference/PMED?id=12196418
Lincoln 1999 {published data only}|Randomized, controlled trial to evaluate increased intensity of physiotherapy treatment of arm function after stroke. [see comments.]|/resolve/reference/PMED?id=10066854
McAuley 2002 {published data only}|Physical activity and physique anxiety in older adults: Fitness, and efficacy influences|/resolve/reference/PMED?id=AMBIGUOUS%20(35%20citations)
McCann 2000 {published data only}|On the utility of experiential cross-training for team decision-making under time stress|/resolve/reference/PMED?id=10975175
McGaghie 1993 {published data only}|A randomized trial of physicians and physical therapists as instructors of the musculoskeletal examination|
McMurdo 2000 {published data only}|A randomized controlled trial of fall prevention strategies in old peoples' homes|
Means 1996 {published data only}|Rehabilitation of elderly fallers: pilot study of a low to moderate intensity exercise program|/resolve/reference/PMED?id=8857882
Messier 2000 {published data only}|Long-term exercise and its effect on balance in older, osteoarthritic adults: results from the Fitness, Arthritis, and Seniors Trial (FAST)|/resolve/reference/PMED?id=10682941
Morey 1999 {published data only}|Spinal-flexibility-plus-aerobic versus aerobic-only training: effect of a randomized clinical trial on function in at-risk older adults|
Naimark 1996 {published data only}|Serum ferritin and heart disease: the effect of moderate exercise on stored iron levels in postmenopausal women. Of:]; [Review Of:]] [30 refs]|/resolve/reference/PMED?id=8987965
Normandin 2002 {published data only}|An evaluation of two approaches to exercise conditioning in pulmonary rehabilitation|/resolve/reference/PMED?id=11948036
Oman 1998 {published data only}|Predicting the adoption and maintenance of exercise participation using self-efficacy and previous exercise participation rates|/resolve/reference/PMED?id=10176088
Parry (II) 1999 {published data only}|Physiotherapy for the arm and hand after stroke|
Parry 1999 {published data only}|Effect of severity of arm impairment on response to additional physiotherapy early after stroke|/resolve/reference/PMED?id=10392645
Partonen 1998 {published data only}|Randomized trial of physical exercise alone or combined with bright light on mood and health-related quality of life|/resolve/reference/PMED?id=9854277
Pater 2000 {published data only}|Design of a randomized controlled trial of comprehensive rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus comprehensive cardiac rehabilitation trial (the CORE study)|/resolve/reference/PMED?id=AMBIGUOUS%20(16%20citations)
Patessio 1995 {published data only}|The role of exercise training in pulmonary rehabilitation|
Perri 1997 {published data only}|Effects of group- versus home-based exercise in the treatment of obesity|/resolve/reference/PMED?id=9086691
Pohl 2002 {published data only}|Speed-dependent treadmill training in ambulatory hemiparetic stroke patients: a randomized controlled trial|/resolve/reference/PMED?id=11823669
Preusser 1994 {published data only}|High- vs low-intensity inspiratory muscle interval training in patients with COPD|/resolve/reference/PMED?id=8020255
Puente-Maestu 2000 {published data only}|Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD|/resolve/reference/PMED?id=10885420
Regensteiner 1996 {published data only}|Exercise training improves functional status in patients with peripheral arterial disease|/resolve/reference/PMED?id=8558725
Rejeski 1997 {published data only}|Compliance to exercise therapy in older participants with knee osteoarthritis: implications for treating disability|/resolve/reference/PMED?id=9268953
Richardson 2000 {published data only}|The use of a simulated environment (easy street) to retrain independent living skills in elderly persons: a randomized controlled trial|
Savage 2002 {published data only}|Weight reduction in the cardiac rehabilitation setting|/resolve/reference/PMED?id=12042682
Schuit 1998 {published data only}|The effect of six months training on weight, body fatness and serum lipids in apparently healthy elderly Dutch men and women|/resolve/reference/PMED?id=9756242
Sevick 2000 {published data only}|Cost-effectiveness of lifestyle and structured exercise interventions in sedentary adults: results of project ACTIVE|/resolve/reference/PMED?id=10865157
Shimohara 1991 {published data only}|Non-supervised home exercise programs in a convalescent phase of acute myocardial infarction: their effectiveness and the usefulness of the heart rate at the anaerobic threshold. [Japanese]|/resolve/reference/PMED?id=1841918
Sorichter 1997 {published data only}|Muscular adaptation and strength during the early phase of eccentric training: influence of the training frequency|/resolve/reference/PMED?id=9432099
Sparks 1993 {published data only}|Alternatives for cardiac rehabilitation patients unable to return to a hospital-based program|/resolve/reference/PMED?id=8360063
Suter 1994 {published data only}|Jogging or walking--comparison of health effects|/resolve/reference/PMED?id=7981845
Swerts 1990 {published data only}|Exercise reconditioning in the rehabilitation of patients with chronic obstructive pulmonary disease: a short- and long-term analysis|/resolve/reference/PMED?id=AMBIGUOUS%202369292,2356220
Thomas 2002 {published data only}|Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial|/resolve/reference/PMED?id=12364304
Urbscheit 2002 {published data only}|Effect of two exercise programs on balance scores in elderly ambulatory people|
Vallet 1997 {published data only}|Comparison of two training programs in chronic airway limitation patient:...|/resolve/reference/PMED?id=9032502
Venkat 1998 {published data only}|Randomized clinical trial of lifestyle interventions in Pima Indians: A pilot study|
Wadden 1997 {published data only}|Exercise in the treatment of obesity: effects of four interventions on body composition, resting energy expenditure, appetite, and mood|/resolve/reference/PMED?id=9086690
Wadden 1998 {published data only}|Exercise and the maintenance of weight loss: 1-year follow-up of a controlled clinical trial|/resolve/reference/PMED?id=9583346
Walker 2000 {published data only}|Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication|/resolve/reference/PMED?id=10753273
Weinstock 1998 {published data only}|Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance|/resolve/reference/PMED?id=9855386
Wijkstra 1994 {published data only}|Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home|/resolve/reference/PMED?id=8162979
Wijkstra 1995 {published data only}|Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7570431
Wijkstra 1996 {published data only}|Effects of home rehabilitation on physical performance in patients with chronic obstructive pulmonary disease (COPD)|/resolve/reference/PMED?id=AMBIGUOUS%20(15%20citations)
Woods 1999 {published data only}|Effects of 6 months of moderate aerobic exercise training on immune function in the elderly|/resolve/reference/PMED?id=10405985
Neilsen 1977 {published data only}||/resolve/reference/PMED?id=595156
Booth 2000|Waging war on modern chronic diseases: Primary prevention through exercise biology|/resolve/reference/PMED?id=10658050
Bouchard 1994|Physical activity fitness, and health: international proceedings and consensus statement|
CBC 1996|Physical activity and the cost of treating illness|
EHN 1999|Physical activity and cardiovascular disease prevention in the European Union|
Goetzel 1998|The relationship between modifiable health risks and health care expenditures: An analysis of the multi-employer HERO health risk and cost database|/resolve/reference/PMED?id=9800168
Health Canada 1999|Health Canada Website, http//www.hc-sc.gc.ca|
Katz 1983|Active life expectancy|
Leonard 1998||
Murray 1996|The global burden of disease|
NIPH 1997|Determinants of the burden of disease in the European Union|
NPHS 1997|National population health survey|
PATF 1995|More people, more active, more often|
Pronk 1999|Relationship between modifiable health risks and short term health care charges|/resolve/reference/PMED?id=10605975
Shaw 1996|The effect of a submaximal exercise orientation on cardiopulmonary cycle ergometer stress test results in older adults|/resolve/reference/PMED?id=8681162
Stevenson 1972|A conceptual scheme of the social functions of sport|
USDHHS 1996|Physical activity and health: A report to the Surgeon General|
van Tulder 1997|Method guidelines for systematic reviews in the Cochrane collaboration back review group for spinal disorders|/resolve/reference/PMED?id=9355211
Ambrosioni 1982 {published data only}|Effects of moderate salt restriction on intralymphocytic sodium and pressor response to stress in borderline hypertension.|/resolve/reference/PMED?id=7141605
Ames 2001 {published data only}|The effect of sodium supplementation on glucose tolerance and insulin concentrations in patients with hypertension and diabetes mellitus|/resolve/reference/PMED?id=11465650
ANHMRCDS 1986 {published data only}|Australian National Health and Medical Researrch Council dietary salt study in mild hypertension|/resolve/reference/PMED?id=3475429
ANHMRCDS 1989 {published data only}|Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension|/resolve/reference/PMED?id=2563786
Beard 1982 {published data only}|Randomised controlled trial of a no-added-sodium diet for mild hypertension|/resolve/reference/PMED?id=6125636
Benetos 1992 {published data only}|Arterial effects of salt restriction in hypertensive patients. A 9-week, randomized, double-blind, crossover study|/resolve/reference/PMED?id=1316401
Bruun 1990 {published data only}|Normal renal tubular response to changes of sodium intake in hypertensive man|/resolve/reference/PMED?id=2159502
Bruun 1990 b {published data only}|Normal renal tubular response to changes of sodium intake in hypertensive man|/resolve/reference/PMED?id=2159502
Buckley 1994 {published data only}|Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension|/resolve/reference/PMED?id=7963510
Burnier 1993 {published data only}|Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects|/resolve/reference/PMED?id=8349327
Burnier 1993 b {published data only}|Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects|/resolve/reference/PMED?id=8349327
Capuccio 1997 {published data only}|Double-blind randomised trial of modest salt restriction in older people|/resolve/reference/PMED?id=9310603
Carney 1991 {published data only}|Increased dietary sodium chloride in patients treated with antihypertensive drugs|/resolve/reference/PMED?id=1893612
Cobiac 1992 {published data only}|A low-sodium diet supplemented with fish oil lowers blood pressure in the elderly|/resolve/reference/PMED?id=1312556
Cobiac 1992 b {published data only}|A low-sodium diet supplemented with fish oil lowers blood pressure in the elderly|/resolve/reference/PMED?id=1312556
Cooper 1984 {published data only}|A randomised trial of the effect of decreased dietary sodium intake on blood pressure in adolescents|/resolve/reference/PMED?id=6530546
Cooper 1984 b {published data only}|A randomised trial of the effect of decreased dietary sodium intake on blood pressure in adolescents|/resolve/reference/PMED?id=6530546
Cuzzola 2001 {published data only}|Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of Hypertension|/resolve/reference/PMED?id=11281233
DASH 1, 2001 {published data only}|Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet|/resolve/reference/PMED?id=11136953
DASH 1b, 2001 {published data only}|Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet|/resolve/reference/PMED?id=11136953
DASH 1c, 2001 {published data only}|Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet|/resolve/reference/PMED?id=11136953
DASH 1d, 2001 {published data only}|Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet|/resolve/reference/PMED?id=11136953
DASH 2, 2001 {published data only}|Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial|/resolve/reference/PMED?id=11747380
DASH 2b, 2001 {published data only}|Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial|/resolve/reference/PMED?id=11747380
DASH 2c, 2001 {published data only}|Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial|/resolve/reference/PMED?id=11747380
DASH 2d, 2001 {published data only}|Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial|/resolve/reference/PMED?id=11747380
Davrath 1999 {published data only}|Moderate sodium restiction does not alter lower body negative pressure tolerance|/resolve/reference/PMED?id=10373049
Del Rio 1993 {published data only}|Metabolic effects of strict salt restriction in essential hypertensive patients|
Dimsdale 1990 {published data only}|Prediction of salt sensitivity|/resolve/reference/PMED?id=2196063
Dimsdale 1990 b {published data only}|Prediction of salt sensitivity|/resolve/reference/PMED?id=2196063
Dimsdale 1990 c {published data only}|Prediction of salt sensitivity|/resolve/reference/PMED?id=2196063
Dimsdale 1990 d {published data only}|Prediction of salt sensitivity|/resolve/reference/PMED?id=2196063
Donovan 1993 {published data only}|Effect of sodium intake on insulin sensitivity|/resolve/reference/PMED?id=8498495
Egan 1991 {published data only}|Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men: Relationship to salt-sensitivity status|/resolve/reference/PMED?id=1676891
El Ashry 1987 {published data only}|Effects of manipulation of sodium balance on erythrocyte sodium transport|/resolve/reference/PMED?id=3333521
El Ashry 1987 b {published data only}|Effects of manipulation of sodium balance on erythrocyte sodium transport|/resolve/reference/PMED?id=3333521
Erwteman 1984 {published data only}|Beta blockade, diuretics and salt restriction for the management of mild hypertension: a randomised double blind trial|/resolve/reference/PMED?id=6432119
Fagerberg 1984 {published data only}|Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction|/resolve/reference/PMED?id=6418295
Feldman 1996 {published data only}|Dietary salt restriction increases vascular insulin resistance|
Feldman 1996 b {published data only}|Dietary salt restriction increases vascular insulin resistance|
Ferri 1996 {published data only}|Active kallikrein response to changes in sodium-chloride intake in essential hypertensive patients|/resolve/reference/PMED?id=8704111
Fliser 1993 {published data only}|Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade|/resolve/reference/PMED?id=8099492
Fliser 1993 b {published data only}|Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade|/resolve/reference/PMED?id=8099492
Fotherby 1993 {published data only}|Effects of moderate sodium restriction on clinic and twenty-four-hour ambulatory blood pressure in elderly hypertensive subjects|/resolve/reference/PMED?id=8397245
Frieberg 1990 {published data only}|Evidence for increased renal norepinephrine overflow during sodium restriction in humans|/resolve/reference/PMED?id=2379945
Fuchs 1987 {published data only}|Effect of sodium intake on blood pressure, serum levels and renal excretion of sodium and potassium in normotensives with and without familial predisposition to hypertension|/resolve/reference/PMED?id=3690045
Fuchs 1987 b {published data only}|Effect of sodium intake on blood pressure, serum levels and renal excretion of sodium and potassium in normotensives with and without familial predisposition to hypertension|/resolve/reference/PMED?id=3690045
Gow 1992 {published data only}|The sensitivity of human blood platelets to the aggregation agent ADP during different dietary sodium intakes in healthy men|/resolve/reference/PMED?id=1493845
Grey 1996 {published data only}|Moderate dietary salt restriction does not alter insulin resistance or serum lipids in normal men|/resolve/reference/PMED?id=8722434
Grobee 1987 {published data only}|Does sodium restriction lower blood pressure?|/resolve/reference/PMED?id=3089393
Hargreaves 1989 {published data only}|Exercise tolerance in the heat on low and normal salt intake|/resolve/reference/PMED?id=2656071
HPTRG 1990 {published data only}|The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure|/resolve/reference/PMED?id=2404477
Jula 1992 {published data only}|Response of diastolic blood pressure to long-term sodium restriction is posture related|/resolve/reference/PMED?id=1411248
Jula 1992(2) {published data only}|Responses to atrial natriuretic factor to long term sodium restriction in mild to moderate hypertension|
Jula 1994 {published data only}|Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild to moderate essential hypertension|/resolve/reference/PMED?id=8124787
Koolen 1984 {published data only}|Sodium sensitivity in essential hypertension: Role of the renin-angiotensin-aldosterone system and the predictive value of an intravenous frusemide test|/resolve/reference/PMED?id=6530538
Koolen 1984(2) {published data only}|Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension|/resolve/reference/PMED?id=6519741
Kurtz 1987 {published data only}|Salt sensitive essential hypertension in men. Is the sodium ion alone important ?|/resolve/reference/PMED?id=3309653
Lawton 1988 {published data only}|Dietary salt produces abnormal renal vasoconstrictor responses to upright posture in borderline hypertensive subjects|/resolve/reference/PMED?id=3384469
Lawton 1988 b {published data only}|Dietary salt produces abnormal renal vasoconstrictor responses to upright posture in borderline hypertensive subjects|/resolve/reference/PMED?id=3384469
Logan 1986 {published data only}|Sodium manipulation in the management of hypertension. The view against its general use|/resolve/reference/PMED?id=3756634
Manunta 2001 {published data only}|Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension|/resolve/reference/PMED?id=11509476
Mark 1975 {published data only}|Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension. A preliminary report|/resolve/reference/PMED?id=1132079
Mascioli 1991 {published data only}|Sodium chloride raises blood pressure in normotensive subjects. The study of sodium and blood pressure|/resolve/reference/PMED?id=1987006
Maxwell 1984 {published data only}|BP changes in obese hypertensive subjects during rapid weight loss. Comparison of restricted v unchanged salt intake|/resolve/reference/PMED?id=6466017
McCarron 1997 {published data only}|Blood pressure and metabolic responses to moderate sodium restriction in isradipine treated hypertensive patients|/resolve/reference/PMED?id=9008250
McGregor 1982 {published data only}|Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension|/resolve/reference/PMED?id=6120346
McGregor 1987 {published data only}|Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study|/resolve/reference/PMED?id=3103761
McGregor 1989 {published data only}|Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension|/resolve/reference/PMED?id=2573761
Morgan 1978 {published data only}|Hypertension treated by salt restriction|
Morgan 1981 {published data only}|Hypertension treated by sodium restriction|/resolve/reference/PMED?id=7033744
Morgan 1981b {published data only}|Hypertension treated by sodium restriction|/resolve/reference/PMED?id=7033744
Morgan 1987 {published data only}|Hypertension treated by salt restriction|
Morgan 1988 {published data only}|Interaction in hypertensive man between sodium intake, converting enzyme inhibitor (enalapril), plasma renin and blood pressure control|/resolve/reference/PMED?id=2851654
Mtabaji 1990 {published data only}|The cardiac study in Tanzania: salt intake in the causation and treatment of hypertension|/resolve/reference/PMED?id=2338696
Myers 1982 {published data only}|The effect of sodium intake on blood pressure related to the age of the patients|
Nestel 1993 {published data only}|Enhanced blood ressure response to dietary salt in elderly women, especially those with small waist:hip ratio|/resolve/reference/PMED?id=8133020
Nestel 1993 b {published data only}|Enhanced blood ressure response to dietary salt in elderly women, especially those with small waist:hip ratio|/resolve/reference/PMED?id=8133020
Overlack 1993 {published data only}|Divergent hemodynamic and hormonal responses to varying salt intake in nornotensive subjects|/resolve/reference/PMED?id=8349326
Overlack 1993b {published data only}|Divergent hemodynamic and hormonal responses to varying salt intake in nornotensive subjects|/resolve/reference/PMED?id=8349326
Overlack 1993c {published data only}|Divergent hemodynamic and hormonal responses to varying salt intake in nornotensive subjects|/resolve/reference/PMED?id=8349326
Overlack 1995 {published data only}|Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension|/resolve/reference/PMED?id=7576400
Overlack 1995 b {published data only}|Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension|/resolve/reference/PMED?id=7576400
Overlack 1995 c {published data only}|Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension|/resolve/reference/PMED?id=7576400
Parijs 1973 {published data only}|Moderate sodium restriction and diuretics in the treatment of hypertension|/resolve/reference/PMED?id=4564947
Parker 1990 {published data only}|Two-way factorial study of alcohol and salt restriction in treated hypertensive men|/resolve/reference/PMED?id=2210807
Parker 1990 b {published data only}|Two-way factorial study of alcohol and salt restriction in treated hypertensive men|/resolve/reference/PMED?id=2210807
Puska 1983 {published data only}|Controlled, randomised trial of the effect of dietary fat on blood pressure|
Puska 1983 b {published data only}|Controlled, randomised trial of the effect of dietary fat on blood pressure|/resolve/reference/PMED?id=6129364
Redon-Mas 1993 {published data only}|Antihypertensive activity of verapamil: impact of dietary sodium. The VERSAL Study Group. [ erratum appears in J Hypertens 1994 Apr; 12(4):following H14.]|/resolve/reference/PMED?id=8397246
Resnick 1985 {published data only}|Alterations in calcium metabolism mediate dietary salt sensitivity in essential hypertension|/resolve/reference/PMED?id=3842201
Richards 1984 {published data only}|Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension|
Richards 1986 {published data only}|Plasma atrial natriuretic peptide: responses to modest and severe sodium restriction|/resolve/reference/PMED?id=2956392
Ruilope 1993 {published data only}|Influence of salt intake on the antihypertensive effect of carvedilol|/resolve/reference/PMED?id=8104238
Ruppert 1991 {published data only}|Short term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults|/resolve/reference/PMED?id=1921253
Ruppert 1991 b {published data only}|Short term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults|/resolve/reference/PMED?id=1921253
Ruppert 1991 c {published data only}|Short term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults|/resolve/reference/PMED?id=1921253
Ruppert 1993 {published data only}|Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults|/resolve/reference/PMED?id=8228194
Ruppert 1993 b {published data only}|Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults|/resolve/reference/PMED?id=8228194
Ruppert 1993 c {published data only}|Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults|/resolve/reference/PMED?id=8228194
Ruppert 1994 {published data only}|Effects of severe and moderate salt restriction on serum lipids in nonobese normotensive adults|/resolve/reference/PMED?id=8141172
Ruppert 1994b {published data only}|Effects of severe and moderate salt restriction on serum lipids in nonobese normotensive adults|/resolve/reference/PMED?id=8141172
Ruppert 1994c {published data only}|Effects of severe and moderate salt restriction on serum lipids in nonobese normotensive adults|/resolve/reference/PMED?id=8141172
Schmid 1990 {published data only}|Natriuresis-pressure relationship in polycystic kidney disease|/resolve/reference/PMED?id=2159509
Schmid 1990 b {published data only}|Natriuresis-pressure relationship in polycystic kidney disease|/resolve/reference/PMED?id=2159509
Schorr 1996 {published data only}|Effect of sodium chloride- and sodium bicarbonate-rich mineral water on blood pressure and metabolic parameters in elderly normotensive individuals: a randomized double-blind crossover trial|/resolve/reference/PMED?id=12013486
Schorr 1997 {published data only}|Hpa II polymorphism of the atrial natriuretic peptide gene and the blood pressure response to salt intake in normotensive men|/resolve/reference/PMED?id=9222938
Schorr 1997 b {published data only}|Hpa II polymorphism of the atrial natriuretic peptide gene and the blood pressure response to salt intake in normotensive men|/resolve/reference/PMED?id=9222938
Sciarrone 1992 {published data only}|A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects|/resolve/reference/PMED?id=1315827
Sharma 1990 {published data only}|Dietary sodium restriction: Adverse effect on plasma lipids|/resolve/reference/PMED?id=2381134
Sharma 1991 {published data only}|Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose|/resolve/reference/PMED?id=1646259
Sharma 1991 b {published data only}|Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose|/resolve/reference/PMED?id=1646259
Sharma 1993 {published data only}|Effect of dietary salt restriction on urinary serotonin and 5-hydroxyindolacetic acid excretion in man|/resolve/reference/PMED?id=7510737
Shore 1988 {published data only}|A randomised crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension|/resolve/reference/PMED?id=3183367
Silman 1983 {published data only}|Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension|
Singer 1991 {published data only}|Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide|/resolve/reference/PMED?id=2045142
Skrabal 1981 {published data only}|Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action|/resolve/reference/PMED?id=6117684
Skrabal 1984 {published data only}|Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption|/resolve/reference/PMED?id=6327513
Skrabal 1984 b {published data only}|Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption|/resolve/reference/PMED?id=6327513
Skrabal 1985 {published data only}|Salt sensitivity in normotensives with and salt resistance in normotensives without heredity of hypertension|/resolve/reference/PMED?id=3864225
Skrabal 1985 b {published data only}|Salt sensitivity in normotensives with and salt resistance in normotensives without heredity of hypertension|/resolve/reference/PMED?id=3864225
Steegers 1991 {published data only}|(Patho)physiological implications of chronic dietary sodium restriction during pregnancy; a longitudinal prospective randomized study|
Sullivan 1980 {published data only}|Hemodynamic effects of dietary sodium in man|/resolve/reference/PMED?id=6995291
Sullivan 1980 b {published data only}|Hemodynamic effects of dietary sodium in man|/resolve/reference/PMED?id=6995291
Teow 1986 {published data only}|Sodium chloride preference and recognition treshold in normotensive subjects on high and low salt diet|
TOHP I 1992 {published data only}|The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.[erratum appears in JAMA 1992 May 6;267(17):2330|/resolve/reference/PMED?id=1586398
TOHP II 1997 {published data only}|Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II|/resolve/reference/PMED?id=9080920
TONE 2001 {published data only}|Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE)|/resolve/reference/PMED?id=11231700
TONE 2001 b {published data only}|Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE)|/resolve/reference/PMED?id=11231700
Uzu 1999 {published data only}|Determinats of Circardian Blood Pressure Rhythm in Essential Hypertension|/resolve/reference/PMED?id=10075382
Watt 1983 {published data only}|Dietary sodium restriction for mild hypertension in general practice|/resolve/reference/PMED?id=6401551
Watt 1985 {published data only}|Dietary sodium and arterial blood pressure: evidence against genetic susceptibility|/resolve/reference/PMED?id=3933736
Watt 1985 b {published data only}|Dietary sodium and arterial blood pressure: evidence against genetic susceptibility|/resolve/reference/PMED?id=3933736
Weir 1995 {published data only}|Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension|/resolve/reference/PMED?id=7768584
Weir 1995 b {published data only}|Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension|/resolve/reference/PMED?id=7768584
Wing 1998 {published data only}|Low-dose diuretic and/or dieatary sodium restriction when blood pressure is resistant to ACE inhibitor|/resolve/reference/PMED?id=10321443
Zoccali 1994 {published data only}|The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension|/resolve/reference/PMED?id=7868872
Dodson 1989 {published data only}|Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation|/resolve/reference/PMED?id=2493869
Imanishi M 2001 {published data only}|Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients|/resolve/reference/PMED?id=11194215
Miller JA 1997 {published data only}|Renal responses to sodium restriction in patients with early diabetes mellitus|
Mhlhauser I 1996 {published data only}|Effects of dietary sodium on blood pressure in IDDM patients with nephropathy|
Collins 1990|Blood pressure, stroke and coronary heart disease. Part 2, shorty term reductions in blood pressure; overwiew of randomised drug trials in their epidemiological context|/resolve/reference/PMED?id=1969567
Cutler 1991|An overveiw of randomised trials of sodium reduction and blood pressure|/resolve/reference/PMED?id=1987008
Cutler 1997|Randomized trials of sodium reduction: an overview|/resolve/reference/PMED?id=9022560
Ebrahim 1998|Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions|/resolve/reference/PMED?id=9923952
Elliot 1996|Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. [erratum appears in BMJ 1997 Aug 23;315(7106):458.]|/resolve/reference/PMED?id=8634612
Freedman 2001|Salt and blood pressure. Conventional wisdom reconsidered|/resolve/reference/PMED?id=11393869
Goff 2001|Birth cohort evidence of population influences on blood pressure in the United states 1887-1994|/resolve/reference/PMED?id=11306346
Graudal 2000|Should dietary saltrestriction be a basic component of antihypertensive therapy?|/resolve/reference/PMED?id=10999644
Grobbee 1986|Does sodium restriction lower blood pressure?|/resolve/reference/PMED?id=3089393
He 2000|Effect of longer-term modest salt reduction on blood pressure. a meta-analysis. Implications for public health|
Hooper 2002|Systematic review of long term effects of advice to reduce dietary salt in adults|/resolve/reference/PMED?id=12242173
Hooper 2003|Advice to reduce dietary salt for prevention of cardiovascular disease|
Intersalt 1988|Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion|/resolve/reference/PMED?id=3416162
Jrgens 2002|Subgroup results in the DASH sodium trial|/resolve/reference/PMED?id=12416957
Law 1991|III - Analysis of observational data among populations|/resolve/reference/PMED?id=1827353
Midgley 1996|Effect of reduced dietary sodium on blood pressure. A meta-analysis of randomised controlled trials|/resolve/reference/PMED?id=8622251
Oliver 1975|Blood pressure, sodium intake, and sodium related hormones in the Yanomamo indians, a no-salt culture|/resolve/reference/PMED?id=1132118
Smith 1988|Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish Heart Health Study|/resolve/reference/PMED?id=3416163
Stammler 1991|Implications of the INTERSALT study|/resolve/reference/PMED?id=1986996
Warren 1980|Sympathetic nervous system activity during sodium restriction in essential hypertension|
Graudal 1998|Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride a meta-analysis|/resolve/reference/PMED?id=9582047
Albert 1999|Prospective study of palliative care in ALS: choice, timing, outcomes|/resolve/reference/PMED?id=10540017
Albert 2001|Incidence and predictors of PEG placement in ALS/MND|/resolve/reference/PMED?id=11677001
Allison 2000|Nutrition in the elderly hospital patient - Nottingham studies|/resolve/reference/PMED?id=10840479
Bak 1994|Symptomatic treatment of amyotrophic lateral sclerosis|/resolve/reference/PMED?id=7520644
Boitano 2001|Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS|/resolve/reference/PMED?id=11171915
Bradley 2004|Changes in the management of ALS since the publication of the AAN ALS Practice Parameter 1999|/resolve/reference/PMED?id=15799554
Brooks 1994|El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of ALS' Workshop Contributors|/resolve/reference/PMED?id=7807156
Brooks 2000|El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11464847
Chio 1999|Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group|/resolve/reference/PMED?id=10496278
Chio 2001|Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers|/resolve/reference/PMED?id=11677006
Chio 2002|Early symptom progression rate is related to ALS outcome: a prospective population based study|/resolve/reference/PMED?id=12105314
Chio 2004|Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS|
Desport 2000|Nutritional assessment and survival in ALS patients|/resolve/reference/PMED?id=11467055
Forbes 2004|Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease - a record linkage study from the Scottish Motor Neurone Disease Register|/resolve/reference/PMED?id=15258782
Gregory 2002|Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival|/resolve/reference/PMED?id=11839859
Jokelainen 1977|Amyotrophic lateral sclerosis in Finland II: Clinical characteristics|
Karitzky 2001|Imaging and neurochemical markers for diagnosis and disease progression in ALS|/resolve/reference/PMED?id=11676990
Kasarskis 1996|Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death|/resolve/reference/PMED?id=8604660
Kasarskis 1999|A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials|/resolve/reference/PMED?id=10540019
Klor 1999|Rehabilitation of neurogenic dysphagia with percutaneous endoscopic gastrostomy|/resolve/reference/PMED?id=10341114
Kurtzke 1982|Epidemiology of amyotrophic lateral sclerosis|/resolve/reference/PMED?id=6983824
Lechtzin 2001|Hospitalization in amyotrophic lateral sclerosis: causes, costs and outcomes|/resolve/reference/PMED?id=11274310
Leigh 2003|The management of motor neurone disease|
Mathus-Vliegen 1994|Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function|/resolve/reference/PMED?id=7926537
Mazzini 1995|Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=8568533
Miller 1999|Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force|/resolve/reference/PMED?id=10227612
Mitsumoto 2001|Percutaneous endoscopic gastrostomy (PEG) in the North American ALS Patient Care Database|
Mitsumoto 2003|Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction|/resolve/reference/PMED?id=13129795
Neudert 2001|The course of the terminal phase in patients with amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11518004
Olney 2005|The effects of executive and behavioral dysfunction on the course of ALS|/resolve/reference/PMED?id=16344521
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Seki 2000|A survey of current nutrition therapy for the ALS patients in Japanese national sanatoriums|/resolve/reference/PMED?id=11332187
Shaw 2004|Entristar skin-level gastrostomy tube: primary placement with radiologic guidance in patients with amyotrophic lateral sclerosis|/resolve/reference/PMED?id=15459322
Silani 1998|Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective|/resolve/reference/PMED?id=9747929
Strong 1999|Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=10540021
Thornton 2002|Amyotrophic lateral sclerosis: enteral nutrition provision - endoscopic or radiologic gastrostomy?|/resolve/reference/PMED?id=12202704
Yanagisawa 1996|Nationwide study on the natural course of amyotrophic lateral sclerosis in Japan. Annual report of the Research Committee of CNS Degenerative Diseases, Ministry of Health and Welfare in Japan for the year 1995|
Rodriguez-Coura 1997 {published data only}|A controlled comparative study using benznidazole, nifurtimox and placebo in chronic Chaga's disease patients, in a field area with interrupted transmission: I. preliminary evaluation|/resolve/reference/PMED?id=9148337
Braga 2000 {published data only}|Persistent infection in chronic chagas disease patients treated with anti-trypanosoma cruzi nitroderivatives|/resolve/reference/PMED?id=10887376
Cancado 2002 {published data only}|Long term evaluation of etiological treatment of chagas disease with benznidazole|/resolve/reference/PMED?id=11896410
Fabro 2000 {published data only}|Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated Chagasic patients|/resolve/reference/PMED?id=10810325
Lauria-Pires 2000 {published data only}|Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives|
Viotti 1994 {published data only}|Treatment of chronic Chagas disease with benznidazole: clinical and serological evolution of patients with long-term follow-up|/resolve/reference/PMED?id=8273735
Marin-Neto 2008 {published data only}|Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)|/resolve/reference/PMED?id=18585495
Barretti 1990|Indeterminate form of Chagas' disease. A polymorphic disease|/resolve/reference/PMED?id=2128863
Brener 1975|Chemotherapy of Trypanosoma cruzi infection|
Cecere 1999|Trypanosoma cruzi infection in Triatoma infestans and other triatomines: long-term effects of a control program in rural northwestern Argentina|/resolve/reference/PMED?id=10446505
Chagas 1909|Nova tripanozomiaze humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.gen., n.sp., ajente etiolojico de nova entidade morbida do homem|
Cochrane Heart Group|Preferred method for handling continuous variables|
Coura 2009|Present situation and new strategies for Chagas disease chemotherapy: a proposal|/resolve/reference/PMED?id=19722074
de Andrade 1996|Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection|/resolve/reference/PMED?id=8937280
Dias-Contijo 1999|Chagas disease: criteria of cure and prognosis|/resolve/reference/PMED?id=10677755
Follman 1992|Variance imputation for overviews of clinical trials with continuous response|/resolve/reference/PMED?id=1619456
Grant 1989|Transfusion-associated acute Chagas diseases acquired in the United States|/resolve/reference/PMED?id=2510571
Harry 2000|A Chagas' diseases challenge|/resolve/reference/PMED?id=10675149
Higgins 2009||/resolve/reference/PMED?id=7676350
Kraus 2009|Rational modification of a candidate cancer drug for use against Chagas disease|/resolve/reference/PMED?id=19239254
Kubata 2002|A key role for old yellow enzyme in the metabolism of drugs by Tripanosoma cruzi|/resolve/reference/PMED?id=12417633
Laucella 2009|Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy|/resolve/reference/PMED?id=19877967
Mady 2008|Benznidazole and Chagas disease: can an old drug be the answer to an old problem?|/resolve/reference/PMED?id=18808305
Marin-Neto 2009|The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease|/resolve/reference/PMED?id=19753491
Monten-Padilla 1995|Serological diagnosis of Chagas disease: self-sufficiency and interlaboratory concordance|/resolve/reference/PMED?id=7676350
Monten-Padilla 1999|American Trypanosomiasis (Chagas' disease) and blood banking in Mexico city: seroprevalence and its potential tranfusional transmission risk|/resolve/reference/PMED?id=10596460
Moretti 1998|Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens|/resolve/reference/PMED?id=9830716
Nickerson 1989|Transfusion-associeted Trypanosoma cruzi infection in a non-endemic area|/resolve/reference/PMED?id=2510572
Oliveira-Filho 1989|Cost-effectiveness analysis in Chagas' disease vector's control intervention|/resolve/reference/PMED?id=2520833
Pinto 1995|Historia natural da doenca de Chagas|/resolve/reference/PMED?id=8728813
Rassi 2007|Specific treatment for Trypanosoma cruzi: Lack of efficacy of allopurinol in the human chronic phase of chagas disease|/resolve/reference/PMED?id=17255230
Rodriguez-Coura 2002|A critical review on Chagas disease chemotherapy|/resolve/reference/PMED?id=11992141
Rojas-de-Arias 1999|Chagas disease vector control through different intervention modalities in endemic localities of Paraguay|/resolve/reference/PMED?id=10327712
Schmunis 1994|American tripanosomiasis as a public health problem|/resolve/reference/PMED?id=10677754
Schmunis 1999|Prevention of transfusional Trypanosoma cruzi infection in Latin America|/resolve/reference/PMED?id=10677696
Schofield 1999|The southern cone initiative against Chagas disease|/resolve/reference/PMED?id=10050271
Segura 1994|Reversibility of muscle and heart lesions in chronic, Trypanosoma cruzi infected mice after late trypanomicidal treatment|/resolve/reference/PMED?id=7885247
Sosa 1998|Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease|
Stoppani 1999|The chemotherapy of Chagas disease|/resolve/reference/PMED?id=10668258
Tanowitz 1992|Parasitic disease of the heart I: acute and Chronic Chagas' disease|
Urbina 1999|Parasitological cure of Chagas disease: is it possible? Is it relevant?|/resolve/reference/PMED?id=10677754
Urbina 2009|Ergosterol biosynthesis and drug development for Chagas disease|/resolve/reference/PMED?id=19753490
Villar 2002|Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection|
WHO 1991||
Yun 2009|Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-Year experience of Medecins Sans Frontieres|/resolve/reference/PMED?id=19582142
Avdeev 1998 {published and unpublished data}|Noninvasive positive airway pressure ventilation: role in treating acute respiratory failure caused by chronic obstructive pulmonary disease|
Barbe 1996 {published data only}|Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8804944
Bott 1993 {published and unpublished data}|Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease|/resolve/reference/PMED?id=8099639
Brochard 1995 {published data only}|Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7651472
Brochard 1995 {published data only}|The effects of face mask ventilation with pressure support ventilation in patients with chronic obstructive respiratory failure in acute decompensation|/resolve/reference/PMED?id=8065201
Celikel 1998 {published data only}|Comparison of Noninvasive Postitive Pressure Ventilation with Standard Medical Therapy in Hypercapnic Acute Respiratory Failure|/resolve/reference/PMED?id=9872200
Conti 2002 {published data only}|Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial|/resolve/reference/PMED?id=12447511
del Castillo 2003 {published data only}|Noninvasive positive pressure ventilation for acute respiratory failure in chronic obstructive pulmonary disease in a general respiratory ward|
Dikensoy 2002 {published data only}|A randomized controlled trial of noninvasive ventilation in acute hypercapnic respiratory failure|
Dikensoy 2002 {published data only}|Comparison of non-invasive ventilation and standard medical therapy in acute hypercapnic respiratory failure: a randomised controlled trial at a tertiary health centre in SE Turkey|/resolve/reference/PMED?id=11926711
Khilnani 2002 {published data only}|Efficacy of non-invasive positive pressure ventilation (NPPV) for management of COPD with acute or acute on chronic respiratory failure: A randomised controlled trial|
Kramer 1995 {published and unpublished data}|Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure [see comments]|/resolve/reference/PMED?id=7767523
Plant 2000 {published and unpublished data}|Multi-centre randomised controlled trial of the early use of non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease (COPD)|
Plant 2000 {published and unpublished data}|Non-invasive ventilation in acute on chronic respiratory failure|
Plant 2000 {published and unpublished data}|A cost-effectiveness analysis of non-invasive ventilation (NIV) in acute exacerbations of COPD|
Plant 2000 {published and unpublished data}|Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial|/resolve/reference/PMED?id=10859037
Plant 2000 {published and unpublished data}|Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome|/resolve/reference/PMED?id=11514692
Plant 2000 {published and unpublished data}|Non-invasive ventilation (NIV) in acute exacerbations of COPD - the Yorkshire non-invasive ventilation trial|
Plant 2000 {published and unpublished data}|Longterm survival following an exacerbation of COPD treated with and without non-invasive ventilation|
Servillo 1994 {published data only}|Non invasive mask pressure support ventilation in COPD patients|
Thys 2002 {published data only}|Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial|/resolve/reference/PMED?id=12358327
Zhou 2001 {published data only}|Effects of noninvasive positive pressure ventilation on gas exchange and patients' transformation in chronic obstructive pulmonary disease and respiratory failure|/resolve/reference/PMED?id=12536700
Ahmed 1992 {published data only}|Nasal ventilation versus doxapram in the treatment of type II respiratory failure complicating chronic airflow obstruction|
Ambrosino 1992 {published data only}|Physiologic Evaluation of Pressure Support Ventilation by Nasal Mask in Patients with Stable COPD|/resolve/reference/PMED?id=1735260
Ambrosino 1995 {published data only}|Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: correlates for success|/resolve/reference/PMED?id=7570410
Ambrosino 1997 {published data only}|Noninvasive mechanical ventilation in acute on chronic respiratory failure: determinants of success or failure|/resolve/reference/PMED?id=9151528
Angus 1996 {published data only}|Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8977608
Anton 2000 {published data only}|Predicting the Result of Noninvasive Ventilation in Severe Acute Exacerbations of Patients with Chronic Airflow Limitation|/resolve/reference/PMED?id=10713013
Antonelli 1998 {published data only}|A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure|/resolve/reference/PMED?id=9700176
Bardi 2000 {published data only}|Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled study|/resolve/reference/PMED?id=10678628
Benhamou 1992 {published data only}|Nasal Mask Ventilation in Acute Respiratory Failure|/resolve/reference/PMED?id=1516421
Boix 1995 {published data only}|Non-invasive ventilatory support in patients with chronic obstructive pulmonary disease. Comparison of two methods.|/resolve/reference/PMED?id=8532923
Brijker 1999 {published data only}|Use of noninvasive mechanical ventilation to avoid intubation during acute respiratory insufficiency|/resolve/reference/PMED?id=12382365
Brochard 1990 {published data only}|Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask|/resolve/reference/PMED?id=2122253
Brochard 2002 {published data only}|Noninvasive ventilation for acute respiratory failure. [Review] [62 refs]|/resolve/reference/PMED?id=11999003
Carlucci 2001 {published data only}|Preventive use of non-invasive mechanical ventilation (NIMV) to avoid post-extubation respiratory failure: a randomized controlled trial|
Casanova 2000 {published data only}|Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD|/resolve/reference/PMED?id=11115443
Caubel 2001 {published data only}|Trends in the use of non-invasive mechanical ventilation (NIMV) in a respiratory intensive care unit (ICU) between 1996 and 2000|
Chen 1992a {published data only}|Mask ventilation with bi-level positive airway pressure (BiPAP) ventilator in COPD patients with acute respiratory failure|
Chen 1992b {published data only}|Facial or nasal mask pressure support ventilation in managing acute exacerbation of chronic respiratory failure in chronic obstructive pulmonary diseases|/resolve/reference/PMED?id=1306412
Chen 2000 {published data only}|Modification of facial mask on the dead space effect in non-invasive mask ventilation. [Chinese]|/resolve/reference/PMED?id=11778479
Christensen 1990 {published data only}|PEEP-masks in patients with severe obstructive pulmonary disease: a negative report|/resolve/reference/PMED?id=2111249
Clini 2002 {published data only}|The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=12358325
Confalonieri 1994 {published data only}|Severe exacerbations of chronic obstructive pulmonary disease treated with BiPAP by nasal mask|/resolve/reference/PMED?id=7824810
Confalonieri 1996 {published data only}|Noninvasive mechanical ventilation improves the immediate and long-term outcome of COPD patients with acute respiratory failure|/resolve/reference/PMED?id=8729999
Confalonieri 1998 {published data only}|Haemodynamic response during initation of non-invasive positive pressure ventilation in COPD patients with acute ventilatory failure|/resolve/reference/PMED?id=9616534
Confalonieri 1999 {published data only}|Acute Respiratory Failure in Patients with Severe Community-acquired Pneumonia|/resolve/reference/PMED?id=10556125
Conway 1993 {published data only}|Nasal intermittent positive pressure ventilation in acute exacerbations of chronic obstructive pulmonary disease - a preliminary study|/resolve/reference/PMED?id=8209060
Corrado 2002 {published data only}|Iron lung vs mask ventilation in the treatment of acute on chronic respiratory failure in COPD patients: a multicenter study|/resolve/reference/PMED?id=11796450
Criner 1994 {published data only}|Efficacy of a New Full Face Mask for Noninvasive Positive Pressure Ventilation|/resolve/reference/PMED?id=7924481
Criner 1999 {published data only}|Efficacy and Compliance with Noninvasive Positive Pressure Ventilation in Patients with Chronic Respiratory Failure|/resolve/reference/PMED?id=10492269
Da Porto 2000 {published data only}|Non invasive assist control mechanical ventilation with volume control in severe COPD patiens with acute respiratory failure|
Daskalopoulou 1993 {published data only}|Treatment of acute respiratory failure in COPD patients with positive airway pressure via nasal mask (NIPPV)|
De Rosa 2002 {published data only}|Analysis of outcome measures in COPD patients requiring NIPPV|
Diaz 1999 {published data only}|Non-invasive mechanical ventilation in patients with severe stable COPD: mechanisms underlying their clinical and physiologic effects|/resolve/reference/PMED?id=10513072
Diaz 1999 {published data only}|Effects of noninvasive ventilation on pulmonary gas exchange and haemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9412564
Diaz 2002 {published data only}|Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD|/resolve/reference/PMED?id=12503709
Elliot 2002 {published data only}|Where to perform noninvasive ventilation?|/resolve/reference/PMED?id=12108872
Elliott 1990 {published data only}|Non-invasive mechanical ventilation for acute respiratory failure|/resolve/reference/PMED?id=2106984
Elliott 1997 {published data only}|Non-invasive ventilation in chronic obstructive pulmonary disease|
Elston 2001 {published data only}|Can non-invasive ventilation (NIV) for COPD be used on a respiratory ward in a district general ward|
Fernandez 1993 {published data only}|Pressure support ventilation via face mask in acute respiratory failure in hypercapnic COPD patients|/resolve/reference/PMED?id=8294628
Ferrer 2002 {published data only}|Pulmonary gas exchange response to weaning with pressure-support ventilation in exacerbated chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=12415446
Foglio 1992 {published data only}|Acute exacerbations in severe COLD patients. Treatment using positive pressure ventilation by nasal mask|/resolve/reference/PMED?id=1600770
Foglio 1994 {published data only}|Different modes of noninvasive intermittent positive pressure ventilation (NIPPV) in acute exacerbations of COLD patients|/resolve/reference/PMED?id=7711716
Gali 2003 {published data only}|Positive pressure mechanical ventilation|/resolve/reference/PMED?id=12793624
Garrod 2000 {published data only}|Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11029341
Gibbons 2002 {published data only}|Non-invasive positive pressure ventilation for COPD patients|/resolve/reference/PMED?id=11917428
Girault 1997a {published data only}|Comparative physiologic effects of noninvasive assist-control and pressure support ventilation in acute hypercapnic respiratory failure.|/resolve/reference/PMED?id=9187187
Girault 1997b {published data only}|Phsiological effects and optimisation of nasal assist-control ventilation for patients with chronic obstructive pulmonary disease in respiratory failure.|/resolve/reference/PMED?id=9337827
Gorini 2001 {published data only}|The role of invasive and noninvasive mechanical ventilation in the treatment of acute on chronic respiratory failure: a prospective cohort study|
Gorini 2001b {published data only}|Physiologic effects of negative pressure ventilation in acute exacerbation of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11401883
Gorini 2002 {published data only}|Effect of assist negative pressure ventilation by microprocessor based iron lung on breathing effort|/resolve/reference/PMED?id=11867832
Guerin 2002 {published data only}|Physiological effects of constant versus decelerating inflation flow in patients with chronic obstructive pulmonary disease under controlled mechanical ventilation|/resolve/reference/PMED?id=11907659
Hawker 1996 {published data only}|Randomized prospective trial of noninvasive positive pressure ventilation in acute respiratory failure|/resolve/reference/PMED?id=8630567
Heindl 1997 {published data only}|Noninvasive ventilation in acute respiratory failure|/resolve/reference/PMED?id=9235461
Hilbert 2000 {published data only}|Noninvasive ventilation for acute respiratory failure. Quite low time consumption for nurses|
Holanda 2001 {published data only}|Non-invasive positive pressure ventilation in patients with acute respiratory failure: factors associated with failure or success|
Hui 2001 {published data only}|Non-invasive positive pressure ventilation (NIPPV) on the medical wards: a retrospective study of patients with advanced COPD with acute exacerbations in hypercapnic respiratory failure|
Hui 2001a {published data only}|Non-invasive positive pressure ventilation (NIPPV) improves outcomes in a district general hospital|
IPPBT Group 1983 {published data only}|Intermittent Positive Pressure Breathing Therapy of Chronic Obstructive Pulmonary Disease|/resolve/reference/PMED?id=6357018
Jaber 2000 {published data only}|Noninvasive ventilation with helium-oxygen in acute exacerbations of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10764311
Johnson 2002 {published data only}|Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD|/resolve/reference/PMED?id=12171818
Jones 1998 {published data only}|Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long term follow up and effect on survival|/resolve/reference/PMED?id=9713450
Kaminski 1999 {published data only}|Noninvasive positive pressure ventilation (NIPPV) in COPD patients with hypercapnic respiratory failure|
Katz-P 2000 {published data only}|Effects of biphasic positive airway pressure in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10759443
Kaya 2000 {published data only}|Nasal noninvasive mechanical ventilation for hypercapnic respiratory failure|
Keenan 1997 {published data only}|Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: A meta-analysis|
Keenan 2000 {published data only}|Noninvasive positive pressure ventilation in the setting of severe, acute exacerbations of chronic obstructive pulmonary disease: More effective and less expensive|/resolve/reference/PMED?id=10890671
Keenan 2003 {published data only}|Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature|/resolve/reference/PMED?id=12779296
Kikawada 2001 {published data only}|Noninvasive positive-pressure ventilation in an elderly woman with acute respiratory failure caused by influenza a virus pneumonia. [Japanese]|/resolve/reference/PMED?id=11431900
Klein 1981 {published data only}|[Oxygen therapy vs. intermittent positive pressure respiration in the long-term treatment of chronic obstructive pulmonary disease (author's transl)] [German]|/resolve/reference/PMED?id=6808482
Kossler 2000 {published data only}|Feedback-controlled negative pressure ventilation in patients with stable severe hypercapnic chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10940787
Laier-Groenveld 1991 {published data only}|NIPPV in chronic ventilatory failure|/resolve/reference/PMED?id=1908545
Laier-Groenveld 1995 {published data only}|Long term effects and life expectancy after 6 years intermittent self ventilation|/resolve/reference/PMED?id=7616927
Leger 1994 {published data only}|Nasal Intermittent Positive Pressure Ventilation - Long-term Follow-up in Patients with Severe Chronic Respiratory Insufficiency|/resolve/reference/PMED?id=8275718
Lien 1993 {published data only}|Comparison of BiPAP nasal ventilation and ventilation via iron lung in severe stable COPD|/resolve/reference/PMED?id=8339634
Lien 1996 {published data only}|Short-term Effects of Nasal Pressure Support Ventilation in Acute Exacerbation of Hypercapnic COPD|/resolve/reference/PMED?id=8768381
Lien 2000 {published data only}|Comparison of Bilevel Positive Airway Pressure and Volume Ventilation via Nasal or Facial Masks in Patients with Severe Stable COPD|/resolve/reference/PMED?id=10934807
Martin 1995 {published data only}|Non-invasive application of bi-level positive airway pressure to prevent endotracheal intubation in acute respiratory failure|
Martin 2000 {published data only}|A randomized, prospective evaluation of noninvasive ventilation for acute respiratory failure|/resolve/reference/PMED?id=10712326
Meduri 1989 {published data only}|Noninvasive Face Mask Ventilation in Patients with Acute Respiratory Failure|/resolve/reference/PMED?id=2924616
Meecham Jones 1995 {published data only}|Nasal Pressure Support Ventilation Plus Oxygen compared with Oxygen Therapy Alone in Hypercapnic COPD|/resolve/reference/PMED?id=7633704
Meechan Jones 1994 {published data only}|Nasal ventilation in acute exacerbations of chronic obstructive pulmonary disease: effect of ventilator mode on arterial blood gas tensions|/resolve/reference/PMED?id=7878556
Moretti 2001 {published data only}|Non-invasive mechanical ventilation vs invasive mechanical ventilation in COPD patients with comatose acute respiratory failure|
Nava 1997 {published data only}|Human and Financial Costs of Noninvasive Mechanical Ventilation in Patients Affected by COPD and Acute Respiratory Failure|/resolve/reference/PMED?id=9187186
Nava 2001 {published data only}||/resolve/reference/PMED?id=11786711
Nava 2001b {published data only}|Physiologic evaluation of 4 weeks of nocturnal nasal positive pressure ventilation in stable hypercapnic patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11786711
Oliveria 2001 {published data only}|Non-invasive mechanical ventilation (NIMV) for acute exacerbations (AE) in chronic obstructive insufficiency (CRI). Experience on a general ward|
Pankow 2001 {published data only}|Patient-ventilator interaction during noninvasive pressure supported spontaneous respiration in patients with hypercapnic COPD|/resolve/reference/PMED?id=11236359
Peigang 2002 {published data only}|Ventilation of patients with asthma and chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12205409
Perrin 2000 {published data only}|Impact of acute respiratory failure on survival of COPD patients managed with long-term non-invasive ventilation and oxygen therapy|/resolve/reference/PMED?id=10756560
Pinheiro 2001 {published data only}|Non invasive positive-pressure ventilation (NIPPV) in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD): factors associated with early and late failures|
Plant 2000a {published data only}|One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration.|/resolve/reference/PMED?id=10856313
Polese 2000 {published data only}|Nasal proportional assist ventilation unloads the inspiratory muscles of stable patients with hypercapnia due to COPD|
Pollack 1996 {published data only}|Feasibility study of the use of bilevel positive airway pressure for respiratory support in emergency department|/resolve/reference/PMED?id=8629750
Poponick 1999 {published data only}|Use of a Ventilatory Support System (BiPAP) for Acute Respiratory Failure in the Emergency Department|/resolve/reference/PMED?id=10424521
Porta 2000 {published data only}|Noninvasive positive pressure ventilation in COPD patients with chronic respiratory insufficiency|/resolve/reference/PMED?id=11272642
Porta 2002 {published data only}|Mask proportional assist vs pressure support ventilation in patients in clinically stable condition with chronic ventilatory failure|/resolve/reference/PMED?id=12171820
Potena 2003 {published data only}|Non-invasive mechanical ventilation in acute respiratory failure due ot chronic obstructive pulmonary disease: prognostic factors and long term survival|
Putinati 2000 {published data only}|Is it possible to predict the success of non-invasive positive pressure ventilation in acute respiratory failure due to COPD?|/resolve/reference/PMED?id=11059955
Rappaport 1994 {published data only}|Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure|/resolve/reference/PMED?id=8124968
Reissmann 2000 {published data only}|Continuous positive airway pressure facilitates spontaneous breathing in weaning chronic obstructive pulmonary disease patients by improving breathing pattern and gas exchange|/resolve/reference/PMED?id=11271083
Rizvi 2001 {published data only}|Role of Bi-pap in acute respiratory failure due to acute exacerbation of COPD|/resolve/reference/PMED?id=11850976
Rizvi 2001 {published data only}|Role of Bi-Pap in acute respiratory failure due to acute exacerbation of COPD|
Robino 2003 {published data only}|Effectiveness of non-invasive positive pressure ventilation differs between decompensated chronic restrictive and obstructive pulmonary disease patients|/resolve/reference/PMED?id=12589530
Scala 2001 {published data only}|Non invasive positive pressure mechanical ventilation (NIV) in acute respiratory failure (ARF): 5 year's experience in a respiratory ward (RW)|
Scandroglio 2002 {published data only}|Use and nursing of the helmet in delivering non invasive ventilation|/resolve/reference/PMED?id=12029267
Schonhofer 2001 {published data only}|Long term effects of non-invasive mechanical ventilation on pulmonary haemodynamics in patients with chronic respiratory failure|/resolve/reference/PMED?id=11413350
Seith 1976 {published data only}|Evaluation of therapeutic results of intermittent positive pressure respiration (author's translation)|/resolve/reference/PMED?id=785436
Servera 1995a {published data only}|Noninvasive Nasal Mask Ventilation Beyond the ICU for an Exacerbation of Chronic Respiratory Insufficiency|/resolve/reference/PMED?id=7497763
Servera 1995b {published data only}|Assisted ventilation via nasal mask in patients hospitalized in a pneumology ward for decompensation of their chronic air-flow obstruction|/resolve/reference/PMED?id=7582431
Shang 2001 {published data only}|Changes in respiratory and circulatory function during sequential invasive-noninvasive mechanical ventilation|/resolve/reference/PMED?id=11718041
Sidhu 2000 {published data only}|Non invasive ventilation in COPD|
Simonds 1995 {published data only}|Outcome of domiciliary nasl intermittent positive pressure ventilation in restrictive and obstructive disorders|/resolve/reference/PMED?id=7638799
Sinuff 2003 {published data only}|Health technology assessment in the ICU: noninvasive positive pressure ventilation for acute respiratory failure|/resolve/reference/PMED?id=12640616
Soo Hoo 1994 {published data only}|Nasal mechanical ventilation for hypercapnic respiratory failure in chronic obstructive pulmonary disease: Determinants of success and failure|/resolve/reference/PMED?id=8045145
Stell {published data only}|A controlled trial of the early use of non-evasive ventilation in acute exacerbations of chronic obstructive airways disease|
Stell {published data only}|Controlled trial of non-invasive ventilation in acute exacerbations of chronic obstructive airways disease|
Summers 2002 {published data only}|Effect of the initiation of noninvasive bi-level positive airway pressure on haemodynamic stability|/resolve/reference/PMED?id=11989494
Tarrega {published data only}|Survival in COPD patients after noninvasive ventilation for acute exacerbation|
Teba 1996 {published data only}|Non-invasive mechanical ventilation: The benefits of the BiPAP system|/resolve/reference/PMED?id=8599242
Thys 1999 {published data only}|Two-level non-invasive positive pressure ventilation in the initial treatment of acute respiratory failure in an emergency department|/resolve/reference/PMED?id=10622384
Todisco 2001 {published data only}|Application of non invasive ventilation in patients with acute hypercapnic exacerbation of chronic respiratory failure: our experience on use of negative pressure ventilation and non invasive intermittent positive pressure ventilation|
Tsuboi 1999 {published data only}|Noninvasive positive pressure ventilation in patients with COPD.|/resolve/reference/PMED?id=10497409
Vanpee 2001 {published data only}|Non-invasive positive pressure ventilation for exacerbation of chronic obstructive pulmonary patients in the emergency department|/resolve/reference/PMED?id=11314816
Vanpee 2002 {published data only}|Effects of nasal pressure support on ventilation and inspiratory work in normocapnic and hypercapnic patients with stable COPD|/resolve/reference/PMED?id=12114341
Vanpee 2002b {published data only}|Survey of non-invasive ventilation for acute exacerbation of chronic obstructive pulmonary disease patients in emergency departments in Belgium|/resolve/reference/PMED?id=12394617
Vanpee 2002c {published data only}|Does inspiratory behaviour affect the efficiency of non-invasive ventilation in COPD patients?|/resolve/reference/PMED?id=12243317
Vitacca 1993 {published data only}|Non-invasive modalities of positive pressure ventilation improve the outcome of acute exacerbations in COLD patients [see comments]|/resolve/reference/PMED?id=8294627
Vitacca 2000 {published data only}|Physiologic effects of early administered mask proportional assist ventilation in patients with chronic obstructive pulmonary disease and acute respiratory failure|/resolve/reference/PMED?id=10890621
Vitacca 2000b {published data only}|The appropriate setting of noninvasive pressure support ventilation in stable COPD patients|/resolve/reference/PMED?id=11083676
Vitacca 2002 {published data only}|Comparison of five bilevel pressure ventilators in patients with chronic ventilatory failure: a physiologic study|/resolve/reference/PMED?id=12475854
Wedzicha 1996a {published data only}|Nasal positive pressure ventilation in COPD|/resolve/reference/PMED?id=8901329
Wedzicha 1996b {published data only}|Non-invasive ventilation for exacerbations of respiratory failure in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8869350
Wedzicha 2002 {published data only}|Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis|/resolve/reference/PMED?id=12358358
Windisch 2002 {published data only}|Weaning from mechanical ventilation by long-term nasal positive pressure ventilation in two patients with acute respiratory distress syndrome associated with pneumococcal sepsis|/resolve/reference/PMED?id=12232458
Windisch 2002b {published data only}|Normocapnia during nIPPV in chronic hypercapnic COPD reduces subsequent spontaneous PaCO2|/resolve/reference/PMED?id=12195837
Wood 1998 {published data only}|The use of noninvasive positive pressure ventilation in the emergency department|/resolve/reference/PMED?id=9596317
Wysocki 1995 {published data only}|Noninvasive pressure support ventilation in patients with acute respiratory failure: A randomized comparison with conventional therapy|/resolve/reference/PMED?id=7874950
Yang 2002 {published data only}|Effects of inspiratory flow waveforms on lung mechanics, gas exchange, and respiratory metabolism in COPD patients during mechanical ventilation|/resolve/reference/PMED?id=12475853
Ye 2000 {published data only}|Proportional assist ventilation: methodology therapeutics on COPD patients compared with pressure support ventilation|/resolve/reference/PMED?id=11778211
Ye 2002 {published data only}|Proportional assist ventilation: methodology and therapeutics on COPD patients compared with pressure support ventilation|/resolve/reference/PMED?id=11940326
Ambrosino 1994|Ventilation techniques: invasive versus noninvasive|
Ambrosino 1996|Noninvasive mechanical ventilation in acute respiratory failure|/resolve/reference/PMED?id=8726948
Brochard 1994|Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation|/resolve/reference/PMED?id=7921460
Caneva 1992|Is mechanical ventilation useful in COPD patients today?|
Cherniack 1974|Intermittent Positive Pressure Breathing in Management of Chronic Obstructive Pulmonary Disease: Current State of the Art|/resolve/reference/PMED?id=4216280
Clark 1997|Noninvasive Positive Pressure Ventilation in Acute Respiratory Failure of Chronic Obstructive Pulmonary Disease|/resolve/reference/PMED?id=9087942
Coakley 1992|Prolonged neurogenic weakness in patients requiring mechanical ventilation for acute airflow limitation|/resolve/reference/PMED?id=1582307
Esteban 1995|A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group|/resolve/reference/PMED?id=7823995
Fagon 1993|Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay|/resolve/reference/PMED?id=8452152
Fleiss 1981||
Girault 1997|Physiological effects and optimisation of nasal assist-control ventilation for patients with chronic obstructive pulmonary disease in respiratory failure|/resolve/reference/PMED?id=9337827
Guerin 1997|Facial mask noninvasive mechanical ventilation reduces the incidence of nosocomial pneumonia. A prospective epidemiological survey from a single ICU|
Helliwell 1991|Necrotizing myopathy in critically ill patients|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Jaun 1984|Effect of carbon dioxide on diaphragmatic function in human beings|
Jeffery 1992|Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease; risk factors and use of guidelines for management|/resolve/reference/PMED?id=1539142
Jeffrey 1992|Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management|/resolve/reference/PMED?id=1539142
Kramer 1999|Ventilator-associated pneumonia in critically ill patients|/resolve/reference/PMED?id=10383357
Le Bourdelles 1994|Effects of mechanical ventilation on diaphragmatic contractile properties in rats|
Macklem 1984|Hyperinflation|/resolve/reference/PMED?id=6703469
Meduri 1991|Noninvasive face mask mechanical ventilation in patients with acute hypercapnic respiratory failure|/resolve/reference/PMED?id=1864119
Mehta 1996|Noninvasive Ventilation in Acute Respiratory Failure|/resolve/reference/PMED?id=9390883
Moloney 1999|Nocturnal nasal intermittent positive pressure ventilation (NIPPV) therapy for chronic respiratory failure: long-term effects|/resolve/reference/PMED?id=10598422
Nicholson 1998|Noninvasive positive-pressure ventilation in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9612668
Nourdine 1999|Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey|/resolve/reference/PMED?id=10416907
Rabatin 1999|Noninvasive Ventilation|/resolve/reference/PMED?id=10473360
Shapiro 1986|Work of breathing through different sized endotracheal tubes|/resolve/reference/PMED?id=3780244
Stauffer 1982|Complications of endotracheal intubation, tracheostomy and artificial airways|
Tobin 1986|The pattern of breathing during successful and unsuccessful trials of weaning from mechanical ventilation|/resolve/reference/PMED?id=3789513
ABCD Study {published data only}|Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes|/resolve/reference/PMED?id=11849464
Baba 2001 {published data only}|Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics|/resolve/reference/PMED?id=11689274
BENEDICT Study {published data only}|Preventing microalbuminuria in type 2 diabetes|/resolve/reference/PMED?id=15516697
Chan 1992 {published data only}|Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients|/resolve/reference/PMED?id=10652036
Crepaldi 1995 {published data only}|Hypertension and non-insulin-dependent diabetes|/resolve/reference/PMED?id=8590792
EUCLID 1997 {published data only}|Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group|/resolve/reference/PMED?id=9269212
FACET 1998 {published data only}|Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM|/resolve/reference/PMED?id=9571349
HOPE 2000 {published data only}|Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. [see comment] [erratum appears in Lancet 2000 Sep 2;356(9232):860]|
Joglekar 1998 {published data only}|A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group|/resolve/reference/PMED?id=11233387
Kvetny 2001 {published data only}|Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus|/resolve/reference/PMED?id=11181984
Lin 1995 {published data only}|Beneficial effects of angiotensin-converting enzyme inhibitors on cardiovascular and renal functions in patients with hypertension and diabetes|
Ravid 1998 {published data only}|Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: a randomized, controlled trial|/resolve/reference/PMED?id=9625684
Scognamiglio 1997 {published data only}|Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients|/resolve/reference/PMED?id=9250456
Tuominen 1998 {published data only}|Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients|/resolve/reference/PMED?id=9702445
UKPDS 1998 {published data only}|Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group|/resolve/reference/PMED?id=9732338
Velussi 1996 {published data only}|Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients|/resolve/reference/PMED?id=8549868
ADA 2004|Hypertension management in adults with diabetes|
ALLHAT 2002|The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [see comment] [erratum appears in JAMA 2003 Jan 8;289(2):178]|/resolve/reference/PMED?id=12479763
Arauz-Pacheco 2002|The treatment of hypertension in adult patients with diabetes|/resolve/reference/PMED?id=11772914
Borch-Johnsen 1993|Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?|/resolve/reference/PMED?id=8343628
Bucher 1997|The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=9250266
CAPPP 1999|Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial|/resolve/reference/PMED?id=10030325
CARI 2003|CARI Guidelines|
CDA 2003|Nephropathy|
Chobanian 2003|National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. [see comment] [erratum appears in JAMA. 2003 Jul 9;290(2):197]|/resolve/reference/PMED?id=12748199
Clark 2000|To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. [see comment] [erratum appears in CMAJ 2000 Apr 4;162(7):973]|/resolve/reference/PMED?id=10674051
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
ESH-ESC 2003|European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. [erratum appears in J Hypertens. 2003 Nov;21(11):2203-4]|/resolve/reference/PMED?id=12777938
Faller 2002|Medicamentous kidney protection in type 2 diabetic patients-is cheaper also more economical? A model calculation for Swiss health care|/resolve/reference/PMED?id=12071084
Gall 1993|The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy|/resolve/reference/PMED?id=8243857
Hasslacher 1985|Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
HOT 1998|Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial|/resolve/reference/PMED?id=9635947
INSIGHT 2000|Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). [erratum appears in Lancet 2000 Aug 5;356(9228):514]|/resolve/reference/PMED?id=10972368
K-DOQI 2003|K-DOQI clinical practice guidelines on blood pressure management and use of antihypertensive agents in chronic kidney disease. Executive summary October 2003|
Kasiske 1993|Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis|/resolve/reference/PMED?id=8416309
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in Embase|
Messerli 2000|Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. [erratum appears in Lancet 2000 Apr 8;355(9211):1280]|/resolve/reference/PMED?id=10752699
Mogensen 1976|Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment|/resolve/reference/PMED?id=959756
Mogensen 1997|How to protect the kidney in diabetic patients with special reference to IDDM|
NORDIL 2000|Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study|/resolve/reference/PMED?id=10972367
Ritz 1999|Nephropathy in patients with type 2 diabetes mellitus|/resolve/reference/PMED?id=10511612
Schier 2002|Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes|/resolve/reference/PMED?id=11849464
SHEP 1996|Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. [erratum appears in JAMA 1997 May 7;277(17):1356]|/resolve/reference/PMED?id=8968014
Song 2000|Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery|/resolve/reference/PMED?id=11018565
STOPHYPERTENSION-2 1999|Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study|/resolve/reference/PMED?id=10577635
Strippoli 2004|Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review|/resolve/reference/PMED?id=15459003
SYST-EUR 1999|Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators|/resolve/reference/PMED?id=10053176
Williams 2004|British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. [erratum appears in BMJ. 2004 Apr 17;328(7445):926]|/resolve/reference/PMED?id=15016698
Strippoli 2003|Antihypertensive agents for preventing diabetic kidney disease. (Protocol)|
Bjrkdahl 2006 {published data only}|Does a short period of rehabilitation in the home setting facilitate functioning after stroke? A randomized controlled trial|/resolve/reference/PMED?id=17148515
Bowen 2001 {published data only}|Neuropsychological rehabilitation for traumatic brain injury: Do carers benefit?|/resolve/reference/PMED?id=11201312
Elgmark 2007 {published data only}|Mild traumatic brain injuries: the impact of early intervention on late sequelae. A randomized controlled trial|/resolve/reference/PMED?id=17252176
Kwakkel 1999 {published data only}|Long term effects of intensity of upper and lower limb training after stroke: a randomised trial|/resolve/reference/PMED?id=11909906
Kwakkel 1999 {published data only}|Intensity of leg and arm training after primary middle-cerebral artery stroke: a randomised trial|
Ozdemir 2001 {published data only}|Comparing stroke rehabilitation outcomes between acute in-patient and non-intense home settings|/resolve/reference/PMED?id=11588740
Paniak 1998 {published data only}|A randomized trial of two treatments for mild traumatic brain injury|/resolve/reference/PMED?id=9876861
Paniak 1998 {published data only}|A randomized trial of two treatments for mild traumatic brain injury: 1 year follow-up|/resolve/reference/PMED?id=10759039
Powell 2002 {published data only}|Community based rehabilitation after severe traumatic brain injury: a randomised controlled trial|/resolve/reference/PMED?id=11796769
Salazar 2000 {published data only}|A multidisciplinary TBI inpatient rehabilitation programme for active duty service members as part of a randomized clinical trial|/resolve/reference/PMED?id=10401542
Salazar 2000 {published data only}|Cognitive rehabilitation for traumatic brain injury: A randomized trial. Defense and Veterans Head Injury Program (DVHIP) Study Group|/resolve/reference/PMED?id=10865301
Salazar 2000 {published data only}|A home program of rehabilitation for moderately severe traumatic brain injury patients. The DVHIP Study Group|/resolve/reference/PMED?id=10970930
Semlyen 1998 {published data only}|Traumatic brain injury: efficacy of multidisciplinary rehabilitation|/resolve/reference/PMED?id=9630149
Shiel 2001 {published data only}|The effects of increased rehabilitation therapy after brain injury: results of a prospective controlled trial|/resolve/reference/PMED?id=11594640
Slade 2002 {published data only}|A randomised controlled trial to determine the effect of intensity of therapy upon length of stay in a neurological rehabilitation setting|/resolve/reference/PMED?id=12440799
Smith 1981 {published data only}|Remedial therapy after stroke: a randomised controlled trial|/resolve/reference/PMED?id=6780105
Wade 1997 {published data only}|Interventions and service need following mild and moderate head injury: the Oxford Head Injury Service|/resolve/reference/PMED?id=9065356
Wade 1997 {published data only}|Does routine follow up after head injury help? A randomised controlled trial|/resolve/reference/PMED?id=9153604
Wade 1997 {published data only}|Assault, post-traumatic amnesia and other variables related to outcome following head injury|
Wade 1998 {published data only}|Routine follow up after head injury: a second randomised controlled trial|/resolve/reference/PMED?id=9703167
Werner 1996 {published data only}|Effectiveness of an intensive outpatient rehabilitation program for postacute stroke patients|/resolve/reference/PMED?id=8630191
Zhu 2007 {published data only}|Does intensive rehabilitation improve the functional outcome of patients with traumatic brain injury? Interim result of a randomized controlled trial|/resolve/reference/PMED?id=11813997
Zhu 2007 {published data only}|Does intensive rehabilitation improve the functional outcome of patients with traumatic brain injury (TBI)? A randomized controlled trial|/resolve/reference/PMED?id=17653942
Bjorkdahl 2007 {published data only}|Can rehabilitation in the home setting reduce the burden of care for the next-of-kin of stroke victims?|/resolve/reference/PMED?id=17225034
Relander 1972 {published data only}|Controlled trial of treatment for cerebral concussion|/resolve/reference/PMED?id=4646510
Sonoda 2004 {published data only}|Full-Time Integrated Treatment Program, a new system for stroke rehabilitation in Japan. Comparison with conventional rehabilitation|/resolve/reference/PMED?id=14758294
Craig 2008|Developing and evaluating complex interventions: the new medical research guidance|
DoH 2005|The National Service Framework for Long-term Conditions|
Gladman 1993|A randomised controlled trial of domiciliary and hospital-based rehabilitation for stroke patients after discharge from hospital|/resolve/reference/PMED?id=8410035
Greener 2002|Systematic reviews in rehabilitation for stroke: issues and approaches to addressing them|/resolve/reference/PMED?id=11837528
Horn 2007|Practice-based evidence study design for comparative effectiveness research|
Jackson 1999|Can patients with complex disabilities regain the ability to walk more than three months after a stroke?|
Kalra 1994|Does age affect benefits of stroke unit rehabilitation?|/resolve/reference/PMED?id=8303743
Kersten 2002|The unmet needs of young people who have had a stroke: results of a national UK survey|/resolve/reference/PMED?id=12450462
Khan 2007|Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chronic arthopathy|
Khan 2008|Multidisciplinary rehabilitation for adults with multiple sclerosis|
Lacasse 2006|Pulmonary rehabilitation for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=17054186
Lombardi 2002|Sensory stimulation for brain injured individuals in coma or vegetative state|/resolve/reference/PMED?id=12076410
RCP 2008|National Clinical Guidelines for Stroke. Third Edition|
Roding 2003|Frustrated and invisible - younger stroke patients' experiences of the rehabilitation process|/resolve/reference/PMED?id=12851097
Shiel 2008|Complex interventions or complex systems? Implications for health economic evaluation|/resolve/reference/PMED?id=18535071
Steultjens 2002|Occupational therapy for cognitive impairment in stroke patients|
Steultjens 2003a|Occupational therapy for rheumatoid arthritis|/resolve/reference/PMED?id=12917976
Steultjens 2003b|Occupational therapy for stroke patients: a systematic review|/resolve/reference/PMED?id=12624291
Tennant 2002|The Rasch Model and standardising outcome in rehabilitation: the PRO-ESOR project|
Turner-Stokes 1997|The use of standardised outcome measures in rehabilitation centres in the UK|/resolve/reference/PMED?id=9408671
van Tulder 1997|Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for spinal disorders|/resolve/reference/PMED?id=9355211
van Tulder 2003|Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group|/resolve/reference/PMED?id=12811274
Wade 1992||
Wade 2000|Recent advances in rehabilitation|/resolve/reference/PMED?id=10818031
Wade 2003|New wine in old bottles: the WHO ICF as an explanatory model of human behaviour|/resolve/reference/PMED?id=12785241
Wade and Halligan 2004|Do biomedical models of illness make for good healthcare systems?|/resolve/reference/PMED?id=15591570
Whyte 2002|Traumatic brain injury rehabilitation: Are there alternatives to randomized clinical trials|/resolve/reference/PMED?id=12235618
Bates 1977 {published data only}|Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis|/resolve/reference/PMED?id=334337
Bates 1977 {published data only}|Trial of polyunsaturated fatty acids in multiple sclerosis [abstract]|
Bates 1978 {published data only}|Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis|/resolve/reference/PMED?id=363236
Bates 1978 {published data only}|Trial of polyunsaturated fatty acids in multiple sclerosis [abstract]|
Bates 1989 {published data only}|A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis|/resolve/reference/PMED?id=2540285
Bates 1989 {published data only}|Results of a trial of N-3 polyunsaturated fatty acids in the treatment of multiple sclerosis [abstract]|
Millar 1973 {published data only}|Double-blind trial of linoleate supplementation of the diet in multiple sclerosis|/resolve/reference/PMED?id=4571680
Millar 1973 a {published data only}|Double-blind trial of linoleate supplementation of the diet in multiple sclerosis|/resolve/reference/PMED?id=4571680
Millar 1973 b {published data only}|Double-blind trial of linoleate supplementation of the diet in multiple sclerosis|/resolve/reference/PMED?id=4571680
Paty 1978 {published data only}|Double-blind trial of linoleic acid in multiple sclerosis|/resolve/reference/PMED?id=6354153
Paty 1978 {published data only}|Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit|
Weinstock-Guttman 05 {published and unpublished data}|A randomized study of low-fat diet with omega-3 fatty acid supplementation in patients with relapsing-remitting multiple sclerosis (RRMS)|
Weinstock-Guttman 05 {published and unpublished data}|Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients|/resolve/reference/PMED?id=16099630
Achiron 2003 {published data only}|Alfacalcidol treatment in multiple sclerosis|/resolve/reference/PMED?id=12671521
Cendrowski 1986 {published data only}|Multiple sclerosis and MaxEPA|/resolve/reference/PMED?id=3542002
Dworkin 1984 {published data only}|Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials|/resolve/reference/PMED?id=6387534
Ehrentheil 1952 {published data only}|Role of food allergy in multiple sclerosis|/resolve/reference/PMED?id=14957214
Fitzgerald 1987 {published data only}|The effect of nutritional counselling on diet and plasma EFA status in multiple sclerosis patients over 3 years|/resolve/reference/PMED?id=3692896
Fleming 2000 {published data only}|Vitamin D treatment of Relapsing-Remitting Multiple Sclerosis (RRMS): a MRI-based pilot study|
Gallai 1995 {published data only}|Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids|/resolve/reference/PMED?id=7860710
Goldberg 1986 {published data only}|Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D|/resolve/reference/PMED?id=3537648
Hewson 1984 {published data only}|Is there a role for gluten-free diets in multiple sclerosis?|/resolve/reference/PMED?id=6526687
Horrobin 1979 {published data only}|Polyunsaturated fatty acids and colchicine in multiple sclerosis|/resolve/reference/PMED?id=421025
Jensen 1986 {published data only}|Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis--effects of antioxidant supplementation|/resolve/reference/PMED?id=3776606
Kira 1994 {published data only}|Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis|/resolve/reference/PMED?id=8019047
Lakatos 2000 {published data only}|Prevention of corticosteroid-induced osteoporosis by alfacalcidol|/resolve/reference/PMED?id=10769437
Liversedge 1977 {published data only}|Multiple sclerosis research|
Liversedge 1977 {published data only}|Treatment and management of multiple sclerosis|/resolve/reference/PMED?id=64272
Mahon 2003 {published data only}|Cytokine profile in patients with multiple sclerosis following vitamin D supplementation|/resolve/reference/PMED?id=12507780
Mai 1990 {published data only}|High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium|/resolve/reference/PMED?id=1702664
Meyer-Rienecker 1976 {published data only}|Effect of gamma-linolenate in multiple sclerosis|/resolve/reference/PMED?id=62196
Munger 2004 {published data only}|Vitamin D intake and incidence of multiple sclerosis|/resolve/reference/PMED?id=14718698
Nordvik 2000 {published data only}|Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients|
Odinak 2002 {published data only}|[New approaches to antioxidant therapy in multiple sclerosis] Russian|/resolve/reference/PMED?id=12418396
Paty 1975 {published data only}|Linoleic acid in multiple sclerosis|/resolve/reference/PMED?id=48822
Rosnowska 1980 {published data only}|[Effect of short-term administration of sunflower oil on the blood serum levelof linoleic and arachidonic acids and lipids in multiple sclerosis]|/resolve/reference/PMED?id=7374895
Schultz 1984 {published data only}|Efficacy of cranberry juice and ascorbic acid in acidifying the urine in multiple sclerosis subjects|/resolve/reference/PMED?id=6569071
Schwarz 1970 {published data only}|Microcirculatory therapy of multiple sclerosis. Italian|/resolve/reference/PMED?id=4250225
Shenton 1975 {published data only}|Linoleic acid and multiple sclerosis: effect of prolonged administration on lymphocyte reactivity to antigen|
Swank 1990 {published data only}|Multiple sclerosis: fat-oil relationship|/resolve/reference/PMED?id=1804476
Swank 1990 {published data only}|Multiple sclerosis: twenty years on low fat diet|/resolve/reference/PMED?id=5471652
Swank 1990 {published data only}|Treatment of multiple sclerosis with a low-fat diet|/resolve/reference/PMED?id=13836031
Swank 1990 {published data only}|Treatment of multiple sclerosis with low-fat diet|/resolve/reference/PMED?id=12996138
Swank 1990 {published data only}|Treatment of multiple sclerosis with low-fat diet; results of five and one-half years' experience|/resolve/reference/PMED?id=14375427
Swank 1990 {published data only}|Treatment of multiple sclerosis with low-fat diet: result of seven years' experience|/resolve/reference/PMED?id=13373189
Swank 1990 {published data only}|Multiple sclerosis: assessment of treatment with a modified low-fat diet|/resolve/reference/PMED?id=13774215
Swank 1990 {published data only}|Effect of low saturated fat diet in early and late cases of multiple sclerosis|/resolve/reference/PMED?id=1973220
Swank 1990 {published data only}|Review of MS patient survival on a Swank low saturated fat diet|/resolve/reference/PMED?id=12591551
Swank 1990 {published data only}|Multiple sclerosis: the lipid relationship|/resolve/reference/PMED?id=3202088
Swank 1990 {published data only}|The influence of low-fat diet on blood lipid levels in health and in multiple sclerosis|/resolve/reference/PMED?id=14902786
Wade 2002 {published data only}|Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B12: mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems|/resolve/reference/PMED?id=12376086
Wade 2002 {published data only}|MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine|/resolve/reference/PMED?id=11435905
Wade 2002 {published data only}|A randomised placebo controlled exploratory study of vitamin B12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis|/resolve/reference/PMED?id=12185153
Wingerchuk 2005 {published data only}|A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis|/resolve/reference/PMED?id=16107372
Yadav 2005 {published data only}|Lipoic acid in multiple sclerosis: a pilot study|/resolve/reference/PMED?id=15794388
Zhang 2000 {published data only}|Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women|/resolve/reference/PMED?id=11117615
Zhang 2001 {published data only}|Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women|/resolve/reference/PMED?id=11445631
Bourdette {published data only}|Natural Antioxidants in the Treatment of Multiple Sclerosis|
Agranoff 1974|Diet and the geographical distribution of multiple sclerosis|/resolve/reference/PMED?id=4138048
Alter 1974|Multiple sclerosis and nutrition|/resolve/reference/PMED?id=4414737
Auer 2000|Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis|
Bates 1989 bis|Lipids and multiple sclerosis|/resolve/reference/PMED?id=2546837
Bowling 2003|Current Complementary and Alternative Therapies for Multiple Sclerosis|/resolve/reference/PMED?id=12521563
Brown 2006|The role of vitamin D in multiple sclerosis|
Butcher 1976|The distribution of multiple sclerosis in relation to the dairy industry and milk consumption|/resolve/reference/PMED?id=1067488
Cantorna 1996|1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis|/resolve/reference/PMED?id=8755567
Crellin 1990|Multiple sclerosis and macrocytosis|
Das 2003|Is there a role for saturated and long-chain fatty acids in multiple sclerosis?|/resolve/reference/PMED?id=12591552
Ebers 1998|Multiple sclerosis|
Esparza 1995|Nutrition, latitude, and multiple sclerosis mortality: an ecologic study|/resolve/reference/PMED?id=7572944
Ferretti 2005|Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity|/resolve/reference/PMED?id=16320727
Fischer 1999|Recent developments in the assessment of quality of life in multiple sclerosis (MS)|/resolve/reference/PMED?id=10467384
Ghadirian 1998|Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada|/resolve/reference/PMED?id=9839742
Ghezzi 2001|Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis|/resolve/reference/PMED?id=11794474
Gilgun-Sherki 2004|The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy|/resolve/reference/PMED?id=15015004
Gupta 1977|Multiple sclerosis and malabsorption|/resolve/reference/PMED?id=612212
Gusev 1996|Environmental risk factors in MS: a case-control study in Moscow|
Hayes 2000|Vitamin D: a natural inhibitor of multiple sclerosis|/resolve/reference/PMED?id=11115787
Kidd 2001|Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management|/resolve/reference/PMED?id=11804546
Koch 2006|Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis|
Kurtzke 1983|Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS)|/resolve/reference/PMED?id=6685237
Lange 1976|Small-bowel abnormalities in multiple sclerosis|/resolve/reference/PMED?id=63801
Lauer 1991|The food pattern in geographical relation to the risk of multiple sclerosis in the Mediterranean and Near East region|/resolve/reference/PMED?id=1757770
Lauer 1994|The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor-analytic study|/resolve/reference/PMED?id=8283194
Lauer 1994 bis|Descriptive and analytical epidemiological data on multiple sclerosis from a long-term study in Southern Hesse, Germany|
Lauer 1995|Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies|
Lauer 1997|Diet and multiple sclerosis|
Malosse 1992|Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study|/resolve/reference/PMED?id=1291895
McDonald 2001|Recommended diagnostic criteria for MS: guidelines from the International Panel on the diagnosis of multiple sclerosis|
Millar 1967|Long-term treatment of multiple sclerosis with corticotrophin|/resolve/reference/PMED?id=4166100
Miller 2005|Vitamin B12, demyelination, remyelination and repair in multiple sclerosis|/resolve/reference/PMED?id=15896807
Murrell 1990|Multiple sclerosis: one manifestation of neurobrucellosis?|/resolve/reference/PMED?id=2255274
Nanji 1986|Multiple sclerosis, latitude and dietary fat: is pork the missing link?|/resolve/reference/PMED?id=3638477
Poser 1983|New diagnostic criteria for multiple sclerosis: guidelines for research protocol|
Rao 1991|Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction|/resolve/reference/PMED?id=2027484
RevMan 4.2|Review Manager (RevMan)|
Reynolds 1992|Vitamin B12 metabolism in multiple sclerosis|/resolve/reference/PMED?id=1596201
Schumacher 1965|Problems of experimental trials of therapy in multiple sclerosis: Report by the panel of evaluation of experimental trials in multiple sclerosis|
Schwartz 1999|Utilization of unconventional treatments by persons with MS: is it alternative or complementary?|/resolve/reference/PMED?id=10025800
Schwarz 2005|Multiple sclerosis and nutrition|/resolve/reference/PMED?id=15732263
Sepcic 1993|Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia|/resolve/reference/PMED?id=8272183
Shatin 1964|Multiple Sclerosis and geography. New interpretation of epidemiological observations|/resolve/reference/PMED?id=14138680
Shinto 2004|Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths|/resolve/reference/PMED?id=15650479
Siegfried 2003|Male circumcision for prevention of heterosexual acquisition of HIV in men|
Spach 2004|Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis|/resolve/reference/PMED?id=15138306
Swank 1950|Multiple sclerosis; a correlation of its incidence with dietary fat|/resolve/reference/PMED?id=14771073
Swank 1952|Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition|/resolve/reference/PMED?id=14929306
Swank 2003|How saturated fats may be a causative factor in multiple sclerosis and other diseases|/resolve/reference/PMED?id=12714108
Tola 1994|Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy|/resolve/reference/PMED?id=7856473
Vickrey 1995|A health-related quality of life measure for multiple sclerosis|/resolve/reference/PMED?id=7613530
Vickrey 1997|Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis|/resolve/reference/PMED?id=9180648
Wender 1994|The descriptive and analytical epidemiology of Multiple sclerosis in Western Poland|
www.MS-CAM.org|www.ms-cam.org|
www.WHO-UMC.org|www.who-umc.org|
Zorzon 2003|Risk factors of multiple sclerosis: a case-control study|/resolve/reference/PMED?id=14658040
Agin 2001 {published data only}|Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV|/resolve/reference/PMED?id=11740194
Bhasin 2000 {published data only}|Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels|/resolve/reference/PMED?id=10683055
Grinspoon 2000 {published data only}|Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting|/resolve/reference/PMED?id=10979879
Lox 1995 {published data only}|Exercise as an intervention for enhancing subjective well-being in an HIV-1 population|
Rigsby 1992 {published data only}|Effects of exercise training on men seropositive for the human immunodeficiency virus-1|/resolve/reference/PMED?id=1548998
Sattler 1999 {published data only}|Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus|/resolve/reference/PMED?id=10199766
Spence 1990 {published data only}|Progressive resistance exercise: effect on muscle function and anthropometry of a select AIDS population|/resolve/reference/PMED?id=2375667
Fairfield 2001 {published data only}|Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting|/resolve/reference/PMED?id=11356779
Jaque 2002 {published data only}|Magnitude and timing of regional body composition changes during anabolic therapies in HIV-positive men|
Lox 1996 {published data only}|Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population|/resolve/reference/PMED?id=16250767
Sattler 2002 {published data only}|Metabolic effects of nandrolone decanoate and resistance training in men with HIV|/resolve/reference/PMED?id=12388173
Schroeder 2001 {published data only}|Regional DXA in assessment of muscle adaptation to anabolic stimuli|
Schroeder 2003 {published data only}|Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies|/resolve/reference/PMED?id=12637255
Bouchard 1993||
Boufassa 2001|Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response|/resolve/reference/PMED?id=11590538
CDC 1987|Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome|
Fiatarone 1990|High-intensity strength training in nonagenarians: effects on skeletal muscle|/resolve/reference/PMED?id=2342214
Fiatarone 1994|Exercise training and nutritional supplementation for physical frailty in very elderly people|/resolve/reference/PMED?id=8190152
Grinspoon 1999|Quantitative assessment of cross-sectional muscle area, functional status and muscle strength in men with the AIDS wasting syndrome|/resolve/reference/PMED?id=9920084
Grunfeld 1992|Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome|/resolve/reference/PMED?id=1734684
Jadad 1996|Assessing the quality of reports or randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Lau 1997|Quantitative synthesis in systematic reviews|/resolve/reference/PMED?id=9382404
Macallan 1995|Energy expenditure and wasting in human immunodeficiency virus infection|/resolve/reference/PMED?id=7777033
Nixon 2002|Aerobic exercise interventions for adults living with HIV/AIDS|
Palella 1998|Declining morbidity and mortality among patients with advanced HIV infection|/resolve/reference/PMED?id=9516219
Palenicek 1995|Weight loss prior to clinical AIDS as a predictor of survival|/resolve/reference/PMED?id=7552499
Rall 1996|The effect of progressive resistance training in rheumatoid: increased strength without changes in energy balance or body composition|
Roubenoff 1999|Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus|/resolve/reference/PMED?id=10202829
Schwenk 1998|Impact of potease inhibitor treatment on body composition and prevalence of malnutrition in HIV positive outpatients|
WHO 2001||
Cunningham 1998 {published data only}|A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer|
Cunningham 1998 {published data only}|Psychological response to long term group therapy: a randomized trial with metastatic breast cancer patients|
Edelman 1999 {published data only}|Cognitive behaviour therapy with advanced breast cancer patients: a brief report of a pilot study|
Edelman 1999 {published data only}|A group cognitive behaviour therapy programme with metastatic breast cancer patients|
Edelman 1999 {published data only}|Effects of group CBT on the survival time of patients with metastatic breast cancer|
Goodwin 2001 {published data only}|Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an explanation of missing data|/resolve/reference/PMED?id=12743147
Goodwin 2001 {published data only}|A multi-centre randomized trial of group psychosocial support in metastatic breast cancer: pilot results [abstract]|/resolve/reference/PMED?id=8123127
Goodwin 2001 {published data only}|The effect of group psychosocial support on survival in metastatic breast cancer|/resolve/reference/PMED?id=11742045
Goodwin 2001 {published data only}|Randomized trial of group psychosocial support in metastatic breast cancer: the BEST study|/resolve/reference/PMED?id=8625354
Goodwin 2001 {published data only}|Lessons learned from enrollment in the BEST study - A multicenter, randomized trial of group psychosocial support in metastatic breast cancer|
Koopman 1998 {published data only}|Supportive-expressive group therapy and distress in patients with metastatic breast cancer|/resolve/reference/PMED?id=11343530
Koopman 1998 {published data only}|Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy|
Koopman 1998 {published data only}|Social support, life stress, pain and emotional adjustment to advanced breast cancer|
Spiegel 1989 {published data only}|The relationship of two dimensions of social support to the psychological well-being and social functioning of women with advanced breast cancer|/resolve/reference/PMED?id=6505749
Spiegel 1989 {published data only}|Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma|
Spiegel 1989 {published data only}|Psychological support for women with metastatic breast cancer|/resolve/reference/PMED?id=523596
Spiegel 1989 {published data only}|Group therapy and hypnosis reduce metastatic breast carcinoma pain|/resolve/reference/PMED?id=6622622
Spiegel 1989 {published data only}|Effect of psychosocial treatment on survival of patients with metastatic breast cancer|/resolve/reference/PMED?id=2571815
Spiegel 1989 {published data only}|Group support for patients with metastatic cancer|/resolve/reference/PMED?id=7235853
Spiegel 1989 {published data only}|A support group for dying patients|/resolve/reference/PMED?id=631956
Spiegel 1989 {published data only}|Group therapy with the terminally ill|/resolve/reference/PMED?id=842726
Arathuzik 1994 {published data only}|Effects of cognitive-behavioral strategies on pain in cancer patients|/resolve/reference/PMED?id=8055491
Badger 2005 {published data only}|Telephone interpersonal counseling with women with breast cancer: symptom management and quality of life|/resolve/reference/PMED?id=15759065
Carlson 2003 {published data only}|Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients|/resolve/reference/PMED?id=12883107
Cerny 1999 {published data only}|Quality of life of patients with metastatic breast or intestinal cancer, treated with anthroposophic medicine or with mainstream medicine, the latter with or without psycho-oncologic or supplementary anthroposophic therapy [original in German]|/resolve/reference/PMED?id=10077715
Chan 2006 {published data only}|A randomized controlled trial of psychosocial interventions using the psychophysiological framework for Chinese breast cancer patients|
Chujo 2005 {published data only}|A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence|/resolve/reference/PMED?id=15580362
Edelman 2005 {published data only}|Group cognitive behaviour therapy for breast cancer patients: a qualitative evalutation|
Fukui 2000 {published data only}|A psychological group intervention for Japanese women with primary breast carcinoma|
Gellert 1993 {published data only}|Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10-year follow-up study|/resolve/reference/PMED?id=8418244
Graves 2003 {published data only}|Quality of life pilot intervention for breast cancer patients: use of social cognitive theory|/resolve/reference/PMED?id=16594274
Helgeson 1999 {published data only}|Education and peer discussion group interventions and adjustment to breast cancer|/resolve/reference/PMED?id=10197829
Ilnyckyj 1994 {published data only}|A randomised controlled trial of psychotherapeutic intervention in cancer patients|
Kissane 2003 {published data only}|Cognitive-existential group therapy for patients with primary breast cancer - techniques and themes|
Kissane 2003 {published data only}|Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial|
Laidlaw 2005 {published data only}|Quality of life and mood changes in metastatic breast cancer after traiing in self-hypnosis or Johrei: a short report.|
Larson 2000 {published data only}|A presurgical psychosocial intervention for breast cancer patients: psychological distress and the immune response|/resolve/reference/PMED?id=10719136
Levine 2005 {published data only}|Change in post-traumatic stress symptoms following psychosocial treatment for breast cancer|
Lieberman 2003 {published data only}|Electronic support groups for breast carcinoma: a clinical trial of effectiveness|
Linn 1982 {published data only}|Effects of counselling for late stage cancer patients|
Marchioro 1996 {published data only}|The impact of a psychological intervention on quality of life in non-metastatic breast cancer|/resolve/reference/PMED?id=8911127
McArdle 1996 {published data only}|Psychological support for patients undergoing breast cancer surgery: a randomized study|/resolve/reference/PMED?id=8608288
Michalec 2005 {published data only}|Exploring the multidimensional benefits of breast cancer support groups|/resolve/reference/PMED?id=16492657
Northouse 2005 {published data only}|Effects of a family intervention on the quality of life of women with recurrent breast cancer and their family caregivers|
Rosenbaum 2004 {published data only}|Cancer supportive care, improving the quality of life for cancer patients: a program evaluation report|/resolve/reference/PMED?id=14991388
Rummans 2006 {published data only}|Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial|/resolve/reference/PMED?id=16446335
Targ 2002 {published data only}|Exploring the relationships among spiritual well-being, quality of life, and pyschological adjustment in women with breast cancer|
Targ 2002 {published data only}|The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial|/resolve/reference/PMED?id=12100834
Traeger-Muney 2003 {published data only}||
van der Pompe 1997 {published data only}|Effectiveness of a short term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study|/resolve/reference/PMED?id=9194018
Bleiker 2000|Psychological distress 2 years after diagnosis of breast cancer: frequency and prediction|/resolve/reference/PMED?id=10838000
Bottomley 1998|Depression in cancer patients: a literature review|
Buddeberg 1991|Coping strategies and course of disease in breast cancer patients. Results of a 3-year longitudinal study.|/resolve/reference/PMED?id=1891562
Casey 1994|Depression in the dying-disorder or distress?|
Chekryn 1984|Cancer recurrence: Personal meaning, communication, and marital adjustment|/resolve/reference/PMED?id=6568868
Chow 2004|Does psychosocial intervention improve survival in cancer? A meta-analysis|/resolve/reference/PMED?id=14982204
Cook 2001|Efficiency of searching grey literature in palliative care|/resolve/reference/PMED?id=11532593
Deflorio 1995|Review of depression in cancer: gender differences.|
Devine 1995|The effects of psycho-educational care provided to adults with cancer: a meta-analysis of 116 studies|/resolve/reference/PMED?id=8539178
Edwards 1998|Signal and noise in the evidence base for medicine - going beyond hierarchies of evidence?|/resolve/reference/PMED?id=9792346
Edwards 2000|The effectiveness of one-to-one risk communication interventions in health care: a systematic review|/resolve/reference/PMED?id=10929851
Edwards 2003|Personalised risk communication in health screening programs|
Egger 1997|Meta-analysis: potentials and promise|/resolve/reference/PMED?id=9432250
Egger 2001|Meta-analysis in context|
Fawzy 1993|Malignant melanoma: effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival 6 years later|
Fawzy 1995|Critical review of psychosocial interventions in cancer care|
Fox 1998|A hypothesis about Spiegel et al's 1989 paper on psychological intervention and breast cancer survival|
Fulton 1999|Patients with metastatic breast cancer: their physical and psychological rehabilitation needs|/resolve/reference/PMED?id=10669979
Giese-Davis 2000|Quality of couples' relationship and adjustment to metastatic breast cancer|/resolve/reference/PMED?id=10870293
Glanz 1992|Psychological Impact of Breast Cancer: A Critical Review|
Glasziou 2001||
Goodwin 2002|The effectiveness of palliative care teams - evidence from a review of existing systematic and other reviews|/resolve/reference/PMED?id=12164104
Goodwin 2003|Health related quality of life measurement in randomized clinical trials in breast cancer - taking stock|/resolve/reference/PMED?id=12591983
Greer 1979|Psychological Response To Breast Cancer: Effect on Outcome|/resolve/reference/PMED?id=90871
Helgeson 1996|Social support and adjustment to cancer|/resolve/reference/PMED?id=8681922
Helgeson 1998|Social ties and cancer|
Higginson 2002|Is there evidence that palliative care teams alter end-of-life experiences of patients and their care-givers? A systematic review|/resolve/reference/PMED?id=11844629
Irvine 1991|Psychosocial adjustment in women with breast cancer|
Jacobsen 1998|Cognitive-behaviour interventions|
Jadad 1996|Assessing the quality of reports of randomised clinical trials; is blinding necessary?|/resolve/reference/PMED?id=8721797
Kmietowicz 2000|Deaths from breast cnacer fall dramatically in UK and US|/resolve/reference/PMED?id=10827040
Leonard 2000|Metastatic breast cancer|
Leszcz 1998|The rationale and foundations of group psychotherapy for women with metastatic breast cancer|/resolve/reference/PMED?id=9563240
Lloyd-Williams 1999|The assessment of depression in palliative care patients|
Maguire 2000|Psychological aspects|
Mahon 1990|Psychosocial Adjustment to Recurrent Cancer|/resolve/reference/PMED?id=2342982
McKenna 1999|Psychosocial factors and the development of breast cancer: a meta-analysis|/resolve/reference/PMED?id=10519468
McKenna 2002|UK has highest reduction in deaths from lung and breast cancer|/resolve/reference/PMED?id=12114229
McWhinney 2002|Evaluation of a palliative care service: problems and pitfalls|/resolve/reference/PMED?id=7532501
Meyer 1995|Effects of psychosocial interventions with adult cancer patients|/resolve/reference/PMED?id=7789344
NHS CRD 1996|Undertaking systematic reviews of research on effectiveness: CRD guidelines for those carrying out or commissioning reviews.|
Petticrew 2002|Influence of psychological coping on survival and recurrence in people with cancer|/resolve/reference/PMED?id=12424165
Pistrang 1995|The partner relationship in psychological response to breast cancer|/resolve/reference/PMED?id=7747213
Richardson 1990|The effect of compliance with treatment on survival among patients with haematologic malignancies|/resolve/reference/PMED?id=2299375
Sellick 1999|Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions|
Smedslund 2005|Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients|/resolve/reference/PMED?id=15465065
Smith 2006|Goals of treatment for patients with metastatic breast cancer|
Stalker 1990|Supportive activities requested by survivors of cancer|
Taylor 1986|Social support, support groups and the cancer patient|/resolve/reference/PMED?id=3771878
Trijsburg 1992|Effect of psychological treatment on cancer patients: a critical review|/resolve/reference/PMED?id=1502290
Uitterhoeve 2004|Psychosocial interventions for patients with advanced cancer - a systematic review of the literature|/resolve/reference/PMED?id=15316564
Watson 1999|Influence of psychological response on survival in breast cancer: a population-based cohort study|/resolve/reference/PMED?id=10533861
Weisman 1986|The emotional impact of recurrent cancer|
Whatley 1998||
Edwards 2004|Psychological interventions for women with metastatic breast cancer [review]|
Cegala 2001 {published data only}|The effects of patient communication skills training on the discourse of older patients during a primary care interview|
Kimberlin 2001 {published data only}|Questions elderly patients have about on-going therapy: a pilot study to assist in communication with physicians|/resolve/reference/PMED?id=11826514
Tennstedt 2000 {published data only}|Empowering older patients to communicate more effectively in the medical encounter|/resolve/reference/PMED?id=10723618
Asch 1991 {published data only}|Psychiatric out-patients' reactions to summary letters of their consultations|
Banks 1998 {published data only}|Reducing consultations for symptoms of cystitis using a health education leaflet|/resolve/reference/PMED?id=9830186
Beck 1997 {published data only}|A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative Health Care Clinic|/resolve/reference/PMED?id=9158573
Begley 1997 {published data only}|Impact of domiciliary pharmacy visits on medication management in an elderly population|
Bernabei 1998 {published data only}|Randomised trial of impact of model of integrated care and case management for older people living in the community|/resolve/reference/PMED?id=9563983
Bernsten 2001 {published data only}|Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries|/resolve/reference/PMED?id=11232739
Bertakis 1991 {published data only}|Impact of a patient education intervention on appropriate utilization of clinic services|/resolve/reference/PMED?id=1767693
Billault 1995 {published data only}|Use of a standardized personal medical record by patients with hypertension: a randomized controlled prospective trial|/resolve/reference/PMED?id=7854076
Billip 2001 {published data only}|The psychosocial impact of interactive computer use within a vulnerable elderly population: a report on a randomized prospective trial in a home health care setting|
Boston 2001 {published data only}|An inner city GP unit versus conventional care for elderly patients: prospective comparison of health functioning, use of services and patient satisfaction|/resolve/reference/PMED?id=11264263
Cegala 2000a {published data only}|The effects of communication skills training on patients' participation during medical interviews|/resolve/reference/PMED?id=12024545
Cegala 2000b {published data only}|The effects of patient communication skills training on compliance|/resolve/reference/PMED?id=10664643
Cornbleet 2002 {published data only}|Patient-held records in cancer and palliative care: a randomized, prospective trial|/resolve/reference/PMED?id=12046996
Davison 1999 {published data only}|Information and patient participation in screening for prostate cancer|/resolve/reference/PMED?id=14528551
Demiris 2003 {published data only}|Communication patterns and technical quality of virtual visits in home care|/resolve/reference/PMED?id=12952691
Dietrich 1989 {published data only}|Improving geriatric preventive care through a patient-held checklist|/resolve/reference/PMED?id=2744287
Drury 2000 {published data only}|Patients with cancer holding their own records: a randomised controlled trial|/resolve/reference/PMED?id=10750206
Dubbert 2002 {published data only}|Effects of nurse counseling on walking for exercise in elderly primary care patients|
Edworthy 1999 {published data only}|Improving medication adherence through patient education distinguishing between appropriate and inappropriate utilization|/resolve/reference/PMED?id=10451079
Ersek 2003 {published data only}|Efficacy of a self-management group intervention for elderly persons with chronic pain|/resolve/reference/PMED?id=12792554
Gabbay 2003 {published data only}|Patient-practitioner agreement: does it matter?|/resolve/reference/PMED?id=12622303
Gagnon 1999 {published data only}|Randomized controlled trial of nurse case management of frail older people|/resolve/reference/PMED?id=10484257
Greenberger 2003 {published data only}|Can burdened caregivers be effective facilitators of elder care-recipient health care?|
Groessl 2000 {published data only}|A cost analysis of self-management programs for people with chronic illness|/resolve/reference/PMED?id=10965386
Hainsworth 2003 {published data only}|The training experiences of older, volunteer lay leaders on an arthritis self-management course|
Hall 1992 {published data only}|Randomized trial of a health promotion program for frail elders|
Hershey 2002 {published data only}|Controlled trial of a patient-completed history questionnaire: effects on quality of documentation and patient and physician satisfaction|/resolve/reference/PMED?id=12153065
Hickson 2003 {published data only}|Beyond hearing aid fitting: improving communication for older adults|
Holland 2003 {published data only}|Preventing disability through community-based health coaching|
Hornberger 1997 {published data only}|Effects of a self-administered previsit questionnaire to enhance awareness of patients' concerns in primary care|
Kerse 1999 {published data only}|Improving the health behaviours of elderly people: randomised controlled trial of a general practice education programme|/resolve/reference/PMED?id=10480825
Kidd 2004 {published data only}|Promoting patient participation in consultations: a randomised controlled trial to evaluate the effectiveness of three patient-focused interventions|/resolve/reference/PMED?id=14729297
King 2002 {published data only}|Effects of moderate-intensity exercise on physiological, behavioral, and emotional responses to family caregiving: a randomized controlled trial|
Kobb 2003 {published data only}|Assessing technology needs for the elderly: finding the perfect match for home|/resolve/reference/PMED?id=14557705
Kralik 2004 {published data only}|Chronic illness self-management: taking action to create order|
Krishna 1997 {published data only}|Clinical trials of interactive computerized patient education: implications for family practice|/resolve/reference/PMED?id=9228910
Lecouturier 2002 {published data only}|Evaluation of a patient-held record for patients with cancer|
Letts 2003 {published data only}|Occupational therapy and participatory research: a partnership worth pursuing|/resolve/reference/PMED?id=12549893
Liaw 1997 {published data only}|The impact of a computer generated patient held health record|/resolve/reference/PMED?id=9503735
Little 2001 {published data only}|Randomised controlled trial of self management leaflets and booklets for minor illness provided by post|/resolve/reference/PMED?id=11141128
Little 2004 {published data only}|Randomised controlled trial of effect of leaflets to empower patients in consultations in primary care|
Lorig 2001 {published data only}|Chronic disease self-management program: 2-year health status and health care utilization outcomes|/resolve/reference/PMED?id=11606875
Lorig 2003 {published data only}|Hispanic chronic disease self-management: a randomized community-based outcome trial|/resolve/reference/PMED?id=14639082
Maly 1999 {published data only}|A randomized controlled trial of facilitating information giving to patients with chronic medical conditions: effects on outcomes of care|/resolve/reference/PMED?id=10334612
Matuska 2003 {published data only}|Outcomes of a pilot occupational therapy wellness program for older adults|/resolve/reference/PMED?id=12674314
McCann 1996 {published data only}|Empowering the patient in the consultation: a pilot study|/resolve/reference/PMED?id=8788351
McGilton 2003 {published data only}|Effects of a relationship-enhancing program of care on outcomes|
McKinstry 2000 {published data only}|Do patients wish to be involved in decision making in the consultation? A cross sectional survey with video vignettes|/resolve/reference/PMED?id=11021866
Miaskowski 2004 {published data only}|Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management|/resolve/reference/PMED?id=15117994
Mundinger 2000 {published data only}|Primary care outcomes in patients treated by nurse practitioners or physicians: a randomized trial|/resolve/reference/PMED?id=10632281
Murray 2001a {published data only}|Randomised controlled trial of an interactive mutlimedia decision aid on hormone replacement therapy in primary care|/resolve/reference/PMED?id=11440920
Murray 2001b {published data only}|Randomised controlled trial of an interactive mutlimedia decision aid on benign prostatic hypertrophy in primary care|/resolve/reference/PMED?id=11532845
Newbury 2001 {published data only}|A randomised controlled trial of the outcome of health assessment of people aged 75 years and over|/resolve/reference/PMED?id=11556409
Oermann 2003a {published data only}|Effects of educational intervention in waiting room on patient satisfaction|/resolve/reference/PMED?id=12698929
Oermann 2003b {published data only}|Outcomes of videotape instruction in clinic waiting area|/resolve/reference/PMED?id=12703393
Oermann 2003c {published data only}|Using the Web to improve seniors' awareness of their role in preventing medical errors|/resolve/reference/PMED?id=12680598
Parry 2003 {published data only}|The care transitions intervention: a patient-centered approach to ensuring effective transfers between sites of geriatric care|/resolve/reference/PMED?id=14629081
Penner 1991 {published data only}|Using postcards to increase patient provided information on medication use|/resolve/reference/PMED?id=2001781
Post 2001 {published data only}|Teaching patients to communicate with physicians: the impact of race|/resolve/reference/PMED?id=12653375
Pugh 1999 {published data only}|Partners in care: a model of collaboration|/resolve/reference/PMED?id=10196904
Radecki 1999 {published data only}|Randomized clinical trial of a diagnostic instrument for pain complaints|/resolve/reference/PMED?id=10572768
Reed 2004 {published data only}|Partnership research with older people - moving towards making the rhetoric a reality|
Reuben 1999 {published data only}|A randomized clinical trial of outpatient comprehensive geriatric assessment coupled with an intervention to increase adherence to recommendations|/resolve/reference/PMED?id=10078887
Roter 1977 {published data only}|Patient participation in the patient-provider interaction: the effects of patient question asking on the quality of interaction, satisfaction and compliance|/resolve/reference/PMED?id=346537
Rubenstein 1994 {published data only}|A home-based geriatric assessment, follow-up and health promotion program: design, methods, and baseline findings from a 3-year randomized clinical trial|/resolve/reference/PMED?id=7918729
Sahar 2003 {published data only}|Improvement of family carers' knowledge, skills and attitudes in caring for older people following the implementation of a Family Carers' Training Program in the community in Indonesia|
Saunders 2003 {published data only}|Achieving recruitment goal through community partnerships: the SENIOR project|/resolve/reference/PMED?id=12829941
Savage 1990 {published data only}|Effect of a general practitioner's consulting style|/resolve/reference/PMED?id=2282112
Schraeder 2001 {published data only}|The effects of a collaborative model of primary care on the mortality and hospital use of community-dwelling older adults|
Sidani 2003 {published data only}|Operationalizing self-care within the healthcare system|/resolve/reference/PMED?id=14983923
Sommers 2000 {published data only}|Physician, nurse, and social worker collaboration in primary care for chronically ill seniors|/resolve/reference/PMED?id=10871977
Sorby 1991 {published data only}|Self help programme for anxiety in general practice: controlled trial of an anxiety management booklet|/resolve/reference/PMED?id=1777297
Stump 1995 {published data only}|Measuring patient satisfaction with physicians among older and diseased adults in a primary care municipal outpatient setting. An examination of three instruments|/resolve/reference/PMED?id=7666709
Sturgess 2003 {published data only}|Community pharmacy based provision of pharmaceutical care to older patients|/resolve/reference/PMED?id=14584229
Thom 1999 {published data only}|An intervention to increase patients' trust in their physicians|/resolve/reference/PMED?id=10065061
Thom 2000 {published data only}|Training physicians to increase patient trust|
Toseland 1992 {published data only}|An evaluation of a group program for spouses of frail elderly veterans|/resolve/reference/PMED?id=1500004
Tsay 2004 {published data only}|Empowerment of patients with end-stage renal disease - a randomized controlled trial|/resolve/reference/PMED?id=14670395
Von Korff 1998 {published data only}|A randomized trial of a lay person-led self-management group intervention for back pain patients in primary care.|/resolve/reference/PMED?id=9854760
Wasson 1984 {published data only}|Continuity of outpatient medical care in elderly men|/resolve/reference/PMED?id=6481927
Wasson 1999 {published data only}|A randomized trial of the use of patient self-assessment data to improve community practices.|/resolve/reference/PMED?id=10346547
Waxman 2003 {published data only}|FOOTSTEP: a randomized controlled trial investigating the clinical and cost effectiveness of a patient self-management program for basic foot care in the elderly|/resolve/reference/PMED?id=14615000
Whatley 2002 {published data only}|A randomised comparison of the effect of three patient information leaflet models on older patients' treatment intentions|/resolve/reference/PMED?id=12051214
Wilkinson 2002 {published data only}|Strengthening patient-provider relationships|/resolve/reference/PMED?id=12048339
Williams 1998 {published data only}|A patient-initiated system for preventive health care. A randomized trial in community-based primary care practices|/resolve/reference/PMED?id=9682687
Williams 2001 {published data only}|Pragmatic randomised trial to evaluate the use of patient held records for the continuing care of patients with cancer|/resolve/reference/PMED?id=11533423
Wetzels 2005 {published data only}|A consultation leaflet to improve an older patient's involvement in general practice care: a randomized trial|
Atkin 1998|The influence of information provided by patients on the accuracy of medication records|/resolve/reference/PMED?id=9700343
Bibowski 2001|Physician-patient congruence regarding medication regimes|
Cassileth 1980|Information and participation preferences among cancer patients|/resolve/reference/PMED?id=7387025
Clarke 2002|Cochrane Reviewers' Handbook 4.1.5 [updated April 2002]|
Foster 2001|A qualitative study of older people's views of out-of-hours services|/resolve/reference/PMED?id=11593832
Fryer 2003|Variation in the ecology of medical care|/resolve/reference/PMED?id=15040437
Giles 1990||
Griffin 2004|Effect on health-related outcomes of interventions to alter the interaction between patients and practitioners: a systematic review of trials|/resolve/reference/PMED?id=15576546
Harrington 2004|Improving patients' communication with doctors: a systematic review of intervention studies|/resolve/reference/PMED?id=14729285
Haug 1986|Doctor-patient relationships and their impact on self care of the elderly|
Haug 1987|Issues in elderly patient-provider interactions|/resolve/reference/PMED?id=3589142
HMSO 1983||
Kaplan 1989|Assessing the effects of physician-patient interactions on the outcomes of chronic disease|/resolve/reference/PMED?id=2646486
Kaplan 1995|Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcomes Study|/resolve/reference/PMED?id=7500658
Kaplan 1996|Characteristics of physicians with participatory decision-making styles|/resolve/reference/PMED?id=8602709
Liaw 1996|The effect of computer-generated patient-held medical record summary and/or a written personeal health record on patients' attitudes, knowledge and behaviour concerning health promotion|/resolve/reference/PMED?id=8671137
Lothian 2001|Care of older people: maintaining the dignity and autonomy of older people in the healthcare setting|/resolve/reference/PMED?id=11250856
Morgan 1997|Older people's perceptions about symptoms|/resolve/reference/PMED?id=9281869
Rodin 1986|Aging and health: effects of the sense of control|/resolve/reference/PMED?id=3749877
Roter 1998|Effectiveness of interventions to improve patient compliance: a meta-analysis|/resolve/reference/PMED?id=9708588
United Nations 2002||
Vanselow 1995|A new definition of primary care|/resolve/reference/PMED?id=7807653
Verhoef 1999|Cancer patients' expectations of the role of family physicians in communication about complementary therapies|/resolve/reference/PMED?id=10474765
Weiss 1986|Consensual norms regarding patient involvement|/resolve/reference/PMED?id=3704686
Wensing 2000|Patients' views on healthcare. A driving force for improvement in disease management|
Wensing 2003|Patient involvement in general practice care: a conceptual framework|
Wetzels 2003|GPs' views on involvement of older patients: a European qualitative study|
WHO 2003|Information needs for research, policy and action on ageing and older persons: definition of an older or elderly person|
Williams 1994|Patient satisfaction: a valid concept?|/resolve/reference/PMED?id=8184314
Wolff 2002|Prevalence, expenditures, and complications of multiple chronic conditions in the elderly|/resolve/reference/PMED?id=12418941
WONCA 2002|The European definition of general practice/family medicine|
Andrewes 1996 {published data only}|Computerised psychoeducation for patients with eating disorders|/resolve/reference/PMED?id=8887699
Bartholomew 2000 {published data only}|Watch, Discover, Think, and Act: evaluation of computer-assisted instruction to improve asthma self-management in inner-city children|/resolve/reference/PMED?id=11040726
Bartholomew 2000 {published data only}|Watch, Discover, Think, and Act: a model for patient education program development|/resolve/reference/PMED?id=11040725
Brennan 1995 {published data only}|The buffering effect of a computer support network on caregiver strain|/resolve/reference/PMED?id=10182416
Brennan 1995 {published data only}|Characterizing the use of health care services delivered via computer networks|/resolve/reference/PMED?id=7614117
Brennan 1995 {published data only}|ComputerLink: a computerized nursing care delivery system|/resolve/reference/PMED?id=1561788
Brennan 1995 {published data only}|Computer networks promote caregiving collaboration: the ComputerLink Project|
Brennan 1995 {published data only}|Differential use of computer network services|
Brennan 1995 {published data only}|Health informatics and community health: support for patients as collaborators in care|/resolve/reference/PMED?id=10805012
Brennan 1995 {published data only}|The ComputerLink projects: a decade of experience|/resolve/reference/PMED?id=10175453
Brennan 1995 {published data only}|Health promotion, social support and computer networks|
Brennan 1995 {published data only}|Networks for home care support: the ComputerLink project|/resolve/reference/PMED?id=10171932
Brennan 1995 {published data only}|Alzheimer's disease caregivers' uses of a computer network|/resolve/reference/PMED?id=1529609
Brennan 1995 {published data only}|ComputerLink: electronic support for the home caregiver|/resolve/reference/PMED?id=2059002
Brennan 1995 {published data only}|The effects of a special computer network on caregivers of persons with Alzheimer's disease|/resolve/reference/PMED?id=7761293
Brennan 1995 {published data only}|Elders' attitudes and behavior regarding ComputerLink|
Brennan 1995 {published data only}|ComputerLink: the impact of a computer network on Alzheimer's caregivers' decision-making confidence and skill|/resolve/reference/PMED?id=8591497
Brennan 1995 {published data only}|Alzheimer's caregivers: psychosocial support via computer networks|/resolve/reference/PMED?id=8301023
Brennan 1995 {published data only}|A computer network for Alzheimer's caregivers and use of support group services|
Brennan 1995 {published data only}|Cost justification of a community health information network: the ComputerLink for AD caregivers|/resolve/reference/PMED?id=8563348
Brennan 1998 {published data only}|Computer network home care demonstration: a randomized trial in persons living with AIDS|/resolve/reference/PMED?id=9861507
Brennan 1998 {published data only}|Differential use of computer network services|
Brennan 1998 {published data only}|Health informatics and community health: support for patients as collaborators in care|/resolve/reference/PMED?id=10805012
Brennan 1998 {published data only}|The ComputerLink projects: a decade of experience|/resolve/reference/PMED?id=10175453
Brennan 1998 {published data only}|Health promotion, social support and computer networks|
Brennan 1998 {published data only}|Use of a home-care computer network by persons with AIDS|/resolve/reference/PMED?id=8034405
Brennan 1998 {published data only}|The use of home-based computers to support persons living with AIDS/ARC|/resolve/reference/PMED?id=1995782
Brown 1997 {published data only}|Educational video game for juvenile diabetes: results of a controlled trial|/resolve/reference/PMED?id=9183781
Brown 1997 {published data only}|Effects of an interactive video game on diabetes education - a preliminary report.|
Brown 1997 {published data only}|Management of chronic pediatric diseases with interactive health games: theory and research findings|/resolve/reference/PMED?id=11189794
Brown 1997 {published data only}|Designing interactive video games for children's health education|
Brown 1997 {published data only}|Interactive video games for health promotion: effects on knowledge, self-efficacy, social support, and health|
Dragone 2002 {published data only}|Development and evaluation of an interactive CD-ROM for children with leukemia and their families|/resolve/reference/PMED?id=11932129
Glasgow 2003 {published data only}|Do Internet-based support interventions change perceptions of social support?: an experimental trial of approaches for supporting diabetes self-management|/resolve/reference/PMED?id=12188054
Glasgow 2003 {published data only}|Social support, self-management, and quality of life among participants in an internet-based diabetes support program: a multi-dimensional investigation|/resolve/reference/PMED?id=19178223
Glasgow 2003 {published data only}|The D-Net diabetes self-management program: long-term implementation, outcomes, and generalization results|/resolve/reference/PMED?id=12649049
Glasgow 2003 {published data only}|Feasibility and use of an Internet support service for diabetes self-management|/resolve/reference/PMED?id=9555356
Glasgow 2003 {published data only}|Internet-based diabetes self-management and support: initial outcomes from the diabetes network project|
Gorman 1995 {published data only}|Expert system for management of urinary incontinence in women|
Guendelman 2002 {published data only}|Improving asthma outcomes and self-management behaviors of inner-city children: a randomized trial of the Health Buddy interactive device and an asthma diary|/resolve/reference/PMED?id=11814370
Gustafson 1999 {published and unpublished data}|Development, acceptance, and use patterns of a computer-based education and social support system for people living with AIDS/HIV infection|
Gustafson 1999 {published and unpublished data}|Self-efficacy, social support and emotional well-being: using a health support system CHESS to cope with AIDS|
Gustafson 1999 {published and unpublished data}|CHESS: a computer-based system for providing information, referrals, decision support and social support to people facing medical and other health-related crises|
Gustafson 1999 {published and unpublished data}|Impact of a patient-centered, computer-based health information/support system|
Gustafson 1999 {published and unpublished data}|The use and impact of a computer-based support system for people living with AIDS and HIV infection|
Gustafson 1999 {published and unpublished data}|CHESS: 10 years of research and development in consumer health informatics for broad populations, including the underserved|/resolve/reference/PMED?id=12414016
Gustafson 1999 {published and unpublished data}|CHESS: ten years of research and development in consumer health informatics for broad populations, including the underserved|
Gustafson 1999 {published and unpublished data}|Empowering patients using computer based health support systems [comment]|/resolve/reference/PMED?id=10557670
Gustafson 1999 {published and unpublished data}|Aiding those facing health crises: the experience of the CHESS project|
Gustafson 1999 {published and unpublished data}|Will HIV-positive people use an interactive computer system for information and support? A study of CHESS in two communities|
Gustafson 1999 {published and unpublished data}|Computerized information and support for patients with breast cancer or HIV infection|/resolve/reference/PMED?id=10227034
Gustafson 1999 {published and unpublished data}|The quality of interactive computer use among HIV-infected individuals|/resolve/reference/PMED?id=10947374
Gustafson 2001 {published and unpublished data}|Problem-solving through electronic bulletin boards|
Gustafson 2001 {published and unpublished data}|Development and pilot evaluation of a computer-based support system for women with breast cancer|
Gustafson 2001 {published and unpublished data}|CHESS: a computer-based system for providing information, referrals, decision support and social support to people facing medical and other health-related crises|
Gustafson 2001 {published and unpublished data}|Effect of computer support on younger women with breast cancer|
Gustafson 2001 {published and unpublished data}|CHESS: 10 years of research and development in consumer health informatics for broad populations, including the underserved|/resolve/reference/PMED?id=12414016
Gustafson 2001 {published and unpublished data}|CHESS: ten years of research and development in consumer health informatics for broad populations, including the underserved|
Gustafson 2001 {published and unpublished data}|Computer support for elderly women with breast cancer [comment]|/resolve/reference/PMED?id=9794300
Gustafson 2001 {published and unpublished data}|Empowering patients using computer based health support systems [comment]|/resolve/reference/PMED?id=10557670
Gustafson 2001 {published and unpublished data}|Aiding those facing health crises: the experience of the CHESS project|
Gustafson 2001 {published and unpublished data}|CHESS (Comprehensive Health Enhancement Support System): an interactive computer system for women with breast cancer piloted with an underserved population|/resolve/reference/PMED?id=10143478
Gustafson 2001 {published and unpublished data}|CHESS: an interactive computer system for women with breast cancer piloted with an under-served population|
Gustafson 2001 {published and unpublished data}|Cultural differences in use of an electronic discussion group|/resolve/reference/PMED?id=22113904
Gustafson 2001 {published and unpublished data}|CHESS: comprehensive health enhancement support system for women with breast cancer|/resolve/reference/PMED?id=9060757
Gustafson 2001 {published and unpublished data}|Computerized information and support for patients with breast cancer or HIV infection|/resolve/reference/PMED?id=10227034
Gustafson 2001 {published and unpublished data}|Experiences of women with breast cancer: exchanging social support over the CHESS computer network|/resolve/reference/PMED?id=11010346
Gustafson 2001 {published and unpublished data}|The comprehensive health enhancement support system|/resolve/reference/PMED?id=10137606
Homer 2000 {published data only}|An evaluation of an innovative multimedia educational software program for asthma management: report of a randomized, controlled trial|/resolve/reference/PMED?id=10888694
Horan 1990 {published data only}|Computer-assisted self-control of diabetes by adolescents|/resolve/reference/PMED?id=2185006
Huss 2003 {published data only}|Computer game for inner-city children does not improve asthma outcomes|/resolve/reference/PMED?id=12665729
Krishna 2003 {published data only}|Internet-enabled interactive multimedia asthma education program: A randomized trial|/resolve/reference/PMED?id=12612228
Lehmann 2003 {published data only}|Time-series analysis and control of blood-glucose levels in diabetic patients|/resolve/reference/PMED?id=8187464
Lehmann 2003 {published data only}|AIDA - A computer-based interactive educational diabetes simulator|/resolve/reference/PMED?id=9677952
Lehmann 2003 {published data only}|AIDA v4.3a diabetes simulator program - Aida Evaluation 6-10|
Lehmann 2003 {published data only}|Interactive educational diabetes simulators: future possibilities|/resolve/reference/PMED?id=10782558
Lehmann 2003 {published data only}|Interactive educational simulators in diabetes care|/resolve/reference/PMED?id=9183780
Lehmann 2003 {published data only}|Preliminary experience with the Internet release of AIDA - an interactive educational diabetes simulator|/resolve/reference/PMED?id=9700427
Lehmann 2003 {published data only}|Spontaneous comments from users of the AIDA interactive educational diabetes simulator|/resolve/reference/PMED?id=11140072
Lehmann 2003 {published data only}|Usage of a diabetes simulation system for education via the internet|/resolve/reference/PMED?id=12485705
Lehmann 2003 {published data only}|An interactive, educational model for insulin dosage and dietary adjustment in type I diabetes mellitus|
Lehmann 2003 {published data only}|Computer assisted diabetes care: a 6-year retrospective|/resolve/reference/PMED?id=8894381
Lehmann 2003 {published data only}|AIDA: an interactive diabetes advisor|/resolve/reference/PMED?id=8187465
Lehmann 2003 {published data only}|Retrospective validation of a physiological model of glucose-insulin interaction in type-1 diabetes-mellitus|/resolve/reference/PMED?id=8061905
Lehmann 2003 {published data only}|A prospective randomised-controlled pilot study for evaluating the teaching utility of interactive educational diabetes simulators|/resolve/reference/PMED?id=12848301
Lehmann 2003 {published data only}|A randomised-controlled clinical trial methodology for evaluating the teaching utility of interactive educational diabetes simulators|/resolve/reference/PMED?id=11345161
Mahoney 2002 {published data only}|Effects of a multimedia project on users' knowledge about normal forgetting and serious memory loss|/resolve/reference/PMED?id=12087119
Ritterband 2003 {published data only}|An Internet intervention as adjunctive therapy for pediatric encopresis|/resolve/reference/PMED?id=14516239
Shegog 2001 {published data only}|Impact of a computer assisted education program on factors related to asthma self-management behavior|/resolve/reference/PMED?id=11141512
Smith 2000 {published data only}|Computer-based support groups. Nursing in cyberspace|/resolve/reference/PMED?id=10673815
Smith 2000 {published data only}|Telecommunication support for rural women with diabetes|/resolve/reference/PMED?id=11140073
Smith 2000 {published data only}|Management of chronic illness: voices of rural women|
Turnin 1992 {published data only}|Telematic expert system Diabeto: new tool for diet self-monitoring for diabetic patients|/resolve/reference/PMED?id=1547677
Turnin 2001 {published data only}|Multicenter randomized evaluation of a nutritional education software in obese patients|/resolve/reference/PMED?id=11353880
Wydra 2001 {published data only}|The effectiveness of a self-care management interactive multimedia module|/resolve/reference/PMED?id=11683310
Wylie-Rosett 2001 {published data only}|A Web-accessible core weight management program|/resolve/reference/PMED?id=11912805
Wylie-Rosett 2001 {published data only}|Computerized weight loss intervention optimizes staff time: the clinical and cost results of a controlled clinical trial conducted in a managed care setting|/resolve/reference/PMED?id=11678486
Glasgow 1997 {published data only}|Long term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office|/resolve/reference/PMED?id=9423499
Glasgow 1997 {published data only}|A brief office-based intervention to facilitate diabetes dietary self-management|/resolve/reference/PMED?id=10159676
Glasgow 2000 {published data only}|Brief, computer-assisted diabetes dietary self-management counseling: effects on behavior, physiologic outcomes, and quality of life|
Glasgow 2002 {published data only}|Implementation, generalization and long-term results of the 'choosing well' diabetes self-management intervention|/resolve/reference/PMED?id=12401414
Hazzard 2002 {published data only}|Effects of STARBRIGHT World on knowledge, social support, and coping in hospitalized children with sickle cell disease and asthma|
McKay 2001 {published data only}|The diabetes network internet-based physical activity intervention: a randomized pilot study|/resolve/reference/PMED?id=11473065
Shea 2002 {published data only}|Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design [comment]|/resolve/reference/PMED?id=11751803
Shea 2002 {published data only}|Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) project: technical implementation [comment]|/resolve/reference/PMED?id=11751801
Tate 2001 {published data only}|Using Internet technology to deliver a behavioral weight loss program|/resolve/reference/PMED?id=11231746
Tate 2003 {published data only}|Internet counseling for weight loss: computer vs. human counselors|
Tate 2003 {published data only}|Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial|/resolve/reference/PMED?id=12684363
Lieberman 1995 {published and unpublished data}|Management of chronic pediatric diseases with interactive health games: theory and research findings|/resolve/reference/PMED?id=11189794
Lieberman 1995 {published and unpublished data}|Three studies of an asthma education video game|
Murphy-Ende 1996 {published data only}|The relationship of self-directed learning, self-efficacy and health value in young women with cancer using a computer health education program|
Glasgow {unpublished data only}|A practical randomised trial to improve diabetes care|
Jones {unpublished data only}||
Lorig {published data only}|Net-based study teaches self-management care of chronic conditions|
McPherson {published data only (unpublished sought but not used)}|A randomised controlled trial to investigate the effectiveness of "The asthma files"|
Pierce {published data only}||
Alderson 2004|Cochrane Reviewers' Handbook 4.2.2 updated March 2004|
Andersson 2002|Views of family carers and older people of information technology|/resolve/reference/PMED?id=12131833
Armitage 2001|Efficacy of the Theory of Planned Behaviour: a meta-analytic review|
Black 1995||
Bodenheimer 2002|Patient self-management of chronic disease in primary care|/resolve/reference/PMED?id=12435261
Boisen 2003|Copability, coping, and learning as focal concepts in the evaluation of computerised diabetes disease management|/resolve/reference/PMED?id=12909188
Corbin 1988||
Coulter 1999|Sharing decisions with patients: is the information good enough?|/resolve/reference/PMED?id=9924064
Davison 2002|Feasibility of using a computer-assisted intervention to enhance the way women with breast cancer communicate with their physicians|/resolve/reference/PMED?id=12464832
Deeks 2005|Analysing and presenting results. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 8|
DerSimonian 1986|Meta-analysis of clinical trials|/resolve/reference/PMED?id=3802833
Dijkstra 1999|The development of computer-generated tailored interventions|/resolve/reference/PMED?id=10223023
DOH; EPTF 2001|The expert patient: a new approach to chronic disease management for the 21st century|
Eng 1999|Introduction to evaluation of interactive health communication applications. Science panel on interactive communication and health|/resolve/reference/PMED?id=9894549
Eysenbach 2002|Does the internet harm health? Database of adverse events related to the internet has been set up|/resolve/reference/PMED?id=11831207
Eysenbach 2004|Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions|/resolve/reference/PMED?id=15142921
Eysenbach 2005|"Is Cybermedicine Killing You?"-The story of a Cochrane disaster|/resolve/reference/PMED?id=15998612
Fletcher Flinn 1995|The efficacy of computer assisted instruction (CAI)|
Glueckauf 2003|Alzheimer's Caregiver Support Online|/resolve/reference/PMED?id=12867676
Haby 2001|Interventions for educating children who have attended the emergency room for asthma|/resolve/reference/PMED?id=11279713
Hanson 1999|A multimedia intervention to support family caregivers|/resolve/reference/PMED?id=10650684
Hanson 2000|Supporting family carers using interactive multimedia|/resolve/reference/PMED?id=11235264
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Kaltenthaler 2002|A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety|
Klemm 2003|Online cancer support groups: a review of the research literature|
Lapsley 2004|The patient's journey: travelling through life with a chronic illness|
Lipsey 1993|The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis|/resolve/reference/PMED?id=8297057
Lorig 2003|Self-management education: history, definition, outcomes and mechanisms|/resolve/reference/PMED?id=12867348
McTavish 2003|Cultural differences in use of an electronic discussion group|/resolve/reference/PMED?id=22113904
Nguyen 2004|Internet-based patient education and support interventions: a review of evaluation studies and directions for future research|/resolve/reference/PMED?id=14972630
O'Connor 2003|Decision aids for people facing health treatment or screening decisions|
Patrick 1999|Prevention, public health, and interactive health communication|/resolve/reference/PMED?id=9921386
Payton 1995|Cost justification of a community health information network: the ComputerLink for AD caregivers|/resolve/reference/PMED?id=8563348
Pierce 2002|In-home online support for caregivers of survivors of stroke: a feasibility study|
Rolnick 1999|Computerized information and support for patients with breast cancer or HIV infection|/resolve/reference/PMED?id=10227034
Scheerhorn 1997|Creating illness related communities in cyber space|
SciPICH 1998|Science Panel on Interactive Communication and Health Summary Statement|
Shaw 2000|Experiences of women with breast cancer: exchanging social support over the CHESS computer network|/resolve/reference/PMED?id=11010346
Smyth 1993|Using telecomputing to provide information and support to caregivers of persons with dementia|/resolve/reference/PMED?id=8440495
Steiner 2002|Building a web of support for caregivers of persons with stroke|/resolve/reference/PMED?id=14523712
Stewart 2000|Information needs and decisional preferences among women with ovarian cancer|/resolve/reference/PMED?id=10831342
Walker 1998|Principles of adult education|
Wantland 2004|The effectiveness of Web-based vs. non-Web-based interventions: a meta-analysis of behavioral change outcomes|/resolve/reference/PMED?id=15631964
Murray 2004|Interactive Health Communication Applications for people with chronic disease|/resolve/reference/PMED?id=15495094
Bredin 1999 {published data only}|Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer|/resolve/reference/PMED?id=10102851
Corner 1996 {published data only}|Non-pharmacological intervention for breathlessness in lung cancer|/resolve/reference/PMED?id=8931065
Evans 1987 {published data only}|A randomized study of oral nutritional support versus al lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer|/resolve/reference/PMED?id=3027267
Linn 1982 {published data only}|Effects of counseling for late stage cancer patients|
McCorkle 1989 {published and unpublished data}|A randomized clinical trial of home nursing care for lung cancer patients|
McCorkle 1989 {published and unpublished data}||
Moore 2002 {published data only}|Nurse led follow up and conventional medical follow up of patients with lung cancer: randomised trial|/resolve/reference/PMED?id=12433764
Sarna 1998 {published data only}|Effectiveness of structured nursing assessment of symptom distress in advanced lung cancer|/resolve/reference/PMED?id=9679262
Stephenson 2000 {published data only}|The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer|/resolve/reference/PMED?id=10660924
Wall 2000 {published data only}|Changes in hope and power in lung cancer patients who exercise|/resolve/reference/PMED?id=11847803
Forester 1985 {published data only}|Psychotherapy during radiotherapy: effects on emotional and physical distress|/resolve/reference/PMED?id=3966583
Forester 1993 {published data only}|Group psychotherapy during radiotherapy: effects on emotional and physical distress|/resolve/reference/PMED?id=8214179
Grande 1999 {published data only}|Does hospital at home for palliative care facilitate death at home? Randomised controlled trial|/resolve/reference/PMED?id=10582932
Grande 2000 {published data only}|A randomized controlled trial of a hospital at home service for the terminally ill|/resolve/reference/PMED?id=11064784
Greer 1992 {published data only}|Adjuvant psychological therapy for patients with cancer: a prospective randomised trial|/resolve/reference/PMED?id=1472184
Jacobsen 2002 {published data only}|Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy|/resolve/reference/PMED?id=12065562
Li 2002 {published data only}|Psychological intervention on mental health of perioperative patients with cancer|
Ovesen 1993 {published data only}|Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study|/resolve/reference/PMED?id=8410128
Rawl 2002 {published data only}|Intervention to improve psychological functioning for newly diagnosed patients with lung cancer|/resolve/reference/PMED?id=12096294
Weinrich 1990 {published data only}|The effect of massage on pain in cancer patients|/resolve/reference/PMED?id=2252400
Wilkie 2000 {published data only}|Effects of massage on pain intensity, analgesics and quality of life in patients with cancer pain: a pilot study of a randomized clinical trial conducted within hospice care delivery|/resolve/reference/PMED?id=11315685
Ahmed 2003|Supportive care for patients with gastrointestinal cancer|/resolve/reference/PMED?id=12804499
Benoliel 1980|The development of a social dependency scale|
Cartmell 2000|Informed choice in cancer pain: empowering the patient|
Directive 2001/83/EC|on the Community code relating to medicinal products for human use|
Downs 1998|The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions|
Fauci 1998||
Fawzy 1999|Psychosocial interventions for patients with cancer: what works and what doesn't|/resolve/reference/PMED?id=10673962
GLOBOCAN 2000|Cancer incidence, mortality and prevalence worldwide|
Godlovitch 2003|Age discrimination in trials and treatment: old dogs and new tricks|/resolve/reference/PMED?id=14682321
Herth 1992|Abbreviated instrument to measure hope: development and psychometric evaluation|
Higginson 1999|Evidence based palliative care|/resolve/reference/PMED?id=10454384
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jan 2002|Smoking prevalence in Catalonia (Spain), 1982-1998: a gender perspective|/resolve/reference/PMED?id=11825547
Johnson 2003|Research into practice: the reality of implementing a non-pharmacological breathlessness intervention into clinical practice|/resolve/reference/PMED?id=12849573
Jni 2001|Assessing the quality of controlled clinical trials|/resolve/reference/PMED?id=11440947
Karnofsky 1949|Clinical evaluation of chimiotherapeutic agents in cancer|
Krishnasamy 2001|Cancer nursing practice development: understanding breathlessness|
Linn 1967|A rapid disability rating scale|/resolve/reference/PMED?id=6017298
Marcel 1978||
MCA 2002||
McCorkle 1978|Development of symptom distress scale|/resolve/reference/PMED?id=250445
McGeer 1990|Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis|
McNair 1971||
Melzack 1987|The short form McGill Pain Questionnaire: major properties and scoring methods|/resolve/reference/PMED?id=3670870
NCI 2001|Report of the lung cancer progress review group|
Petticrew 2001|Systematic reviews from astronomy to zoology: myths and misconceptions|/resolve/reference/PMED?id=11154628
Rogers 1986|Science of unitary human beings|
Rotter1966|Generalised expectancies for internal versus external control of reinforcement|/resolve/reference/PMED?id=5340840
Sethi 1997|Science, medicine, and the future: lung cancer|/resolve/reference/PMED?id=9066480
Sherwood 1965|Self-identity and referents others|/resolve/reference/PMED?id=14255844
Stewart 1992|Physical functioning measures|
Ware 1976|Scales for measuring general health perceptions|/resolve/reference/PMED?id=1030696
Weisman 1977|Coping and vulnerability in cancer patients|
WHO 1990||
WHO 1993|Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL)|/resolve/reference/PMED?id=8518769
Zigmond 1983|The hospital anxiety and depression scale|
Batterham 2001 {published data only}|A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss|
Beller 1997 {published data only}|Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial|/resolve/reference/PMED?id=9137798
Bruera 1990 {published data only}|A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer|
Bruera 1998 {published data only}|Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study|/resolve/reference/PMED?id=9765767
Chen 1997 {published data only}|Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy|/resolve/reference/PMED?id=9165140
De Conno 1998 {published data only}|Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial|/resolve/reference/PMED?id=9893656
Erkurt 2000 {published data only}|Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy|/resolve/reference/PMED?id=11277319
Eubanks 2002 {published data only}|Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis|/resolve/reference/PMED?id=12006958
Feliu 1992 {published data only}|Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo controlled study|/resolve/reference/PMED?id=1524045
Fietkau 1996 {published data only}|Supportive treatment with megestrol acetate during radio (chemo) therapy. A randomised trial|/resolve/reference/PMED?id=8721265
Fietkau 1996 {published data only}|Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy|/resolve/reference/PMED?id=9071903
Gambardella 1998 {published data only}|Megestrol acetate prevents cachexia in elderly cancer patient|
Gebbia 1996 {published data only}|Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer|/resolve/reference/PMED?id=8664133
Heckmayr 1992 {published data only}|Treatment of cancer weight loss in patients with advanced lung cancer|/resolve/reference/PMED?id=1461625
Jatoi 2002 {published data only}|Dronabinol versus megestrol acetate versus combination for cancer-associated anorexia: A North Central Cancer Tratment Group Study|/resolve/reference/PMED?id=11786587
Jatoi 2004 {published data only}|An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a north central cancer treatment group and National Cancer Institute of Canada Collaborative Effort|/resolve/reference/PMED?id=15197210
Lai 1994 {published data only}|Management of anorexic patients in radiotherapy: A prospective randomized comparison of megestrol and prednisolone|/resolve/reference/PMED?id=8089543
Loprinzi 1990b {published data only}|Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia|/resolve/reference/PMED?id=2193166
Loprinzi 1994 {published data only}|Phase III evaluation of 4 doses of megestrol acetate for patients with cancer anorexia and/or cachexia|/resolve/reference/PMED?id=7903440
Loprinzi 1994 {published data only}|Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia|/resolve/reference/PMED?id=8478668
Loprinzi 1999a {published data only}|Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia|/resolve/reference/PMED?id=10506633
Loprinzi 1999b {published data only}|Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia|/resolve/reference/PMED?id=10506633
Marchand 2000 {published data only}|Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis|/resolve/reference/PMED?id=10997370
McMillan 1994 {published data only}|Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients|/resolve/reference/PMED?id=16843365
McQuellon 2002 {published data only}|Supportive use of megestrol acetate (MEGACE) with head/neck and lung cancer patients receiving radiation therapy|
Oster 1994 {published data only}|Megestrol acetate in patients with AIDS and cachexia|/resolve/reference/PMED?id=8053613
Pardo 2003 {published data only}|Megestrol acetate for anorexia in lung cancer patients undergoing radiation therapyA randomized trial comparing the efficacy of two different doses in 130 patients|
Rowland 1996 {published data only}|Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/ placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group Study|/resolve/reference/PMED?id=8558188
Schmoll 1992 {published data only}|Risks and benefits of various therapies for cancer anorexia|/resolve/reference/PMED?id=1461627
Schmoll 1992 {published data only}|Megestrol acetate in cancer cachexia|/resolve/reference/PMED?id=1992534
Tchekmedyian 1992 {published data only}|Megestrol acetate in cancer anorexia and weight loss|
Timpone 1997 {published data only}|The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome|/resolve/reference/PMED?id=9071430
Ulutin 2002 {published data only}|Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: a randomized study comparing two different doses|/resolve/reference/PMED?id=12400976
Vadell 1998 {published data only}|Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia|/resolve/reference/PMED?id=9708631
Von Roenn 1994 {published data only}|Megestrol acetate in patients with AIDS-related cachexia|/resolve/reference/PMED?id=7794302
Weisberg 2002 {published data only}|Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients|/resolve/reference/PMED?id=11948034
Westman 1999 {published data only}|Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial|/resolve/reference/PMED?id=10492632
Yeh 2000 {published data only}|Improvement in quality of life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: Results of a double-blind, placebo-controlled study|/resolve/reference/PMED?id=10811540
Zeca 1995 {published data only}|Efficacy of Megestrol Acetate on Anorexia in patients with advanced non hormone-related tumors: A double-blind placebo controlled clinical trial|
Macbeth 1994 {published data only (unpublished sought but not used)}|A randomised study of megestrol acetate (MA) and prednisolone (P) for anorexia and weight loss in patients with lung cancer|
McMillan 1999 {published data only}|A prospective randomised study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss|/resolve/reference/PMED?id=10027319
Yeh 2004 {published data only}|Risk Factors Relating Blood Markers of Inflammation and Nutritional Status to Survival in Cachectic Geriatric Patients in a Randomized Clinical Trial|
Alexander 1993|Pathophisiology of cancer cachexia|
Argils 2001|Cancer cachexia. A therapeutic approach|
Balog 1998|HIV wasting syndrome: Treatment update|/resolve/reference/PMED?id=9562141
Barber 1999|The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer|/resolve/reference/PMED?id=10487616
Bruera 1992|Clinical management of anorexia and cachexia in patients with advanced cancer|/resolve/reference/PMED?id=1542491
Donnelly 1995|The symptoms of advanced cancer: Identification of clinical and research priorities by assessment of prevalence and severity|
Jadad 1996|Assessing the quality of reports on randomized clinical trials: Is blinding necessary?|
Jatoi 2000|On appetite and its loss|/resolve/reference/PMED?id=10920143
Loprinzi 1990a|Alleviation of cancer anorexia and cachexia: Studies of the Mayo Clinic and the North Central Cancer Treatment Group|/resolve/reference/PMED?id=2259930
Loprinzi 1999|Randomized comparison of Megestrol Acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia|/resolve/reference/PMED?id=10506633
Maltoni 2001|High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: A systematic review of randomised clinical trials|
Mantovani 1998|Cytokyne activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate|/resolve/reference/PMED?id=9625383
Nelson 1994|The cancer anorexia-cachexia syndrome|/resolve/reference/PMED?id=8270980
Ruiz-Garcia 2002|Megestrol acetate: a systematic review usefulness about the weight gain in neoplastic patients with cancer|
Splinter 1992|Cachexia and cancer: a clinicians view|/resolve/reference/PMED?id=1382553
Tchekmedyian 1986|High dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer|/resolve/reference/PMED?id=3798125
Von Roenn 1996|Anorexia/cachexia in patients with HIV: lessons for the oncologist|/resolve/reference/PMED?id=8837121
Wigmore 1997|Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6|/resolve/reference/PMED?id=9059324
AASK {published data only}|Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease|/resolve/reference/PMED?id=12435255
ABCD (H) {published data only}|Effect of blood pressure control on diabetic complications in patients with hypertension and type 2 diabetes|/resolve/reference/PMED?id=10860192
ABCD (N) {published data only}|Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes|/resolve/reference/PMED?id=11849464
HOT {published data only}|The Hypertension Optimal Treatment study and the importance of lowering blood pressure|/resolve/reference/PMED?id=10340838
HOT {published data only}|The Hypertension Optimal Treatment Study (The HOT Study)|/resolve/reference/PMED?id=8193735
HOT {published data only}|Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial|/resolve/reference/PMED?id=9635947
HOT {published data only}|The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability with special reference to age and gender|/resolve/reference/PMED?id=8535554
HOT {published data only}|The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability|/resolve/reference/PMED?id=9360003
HOT {published data only}|The Hypertension Optimal Treatment (HOT) Study. Patient characteristics: randomization, risk profiles, and early blood pressure results|/resolve/reference/PMED?id=7866597
HOT {published data only}|Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?|
HOT {published data only}|Effects of individual factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study|/resolve/reference/PMED?id=11403365
MDRD {published data only}|The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.|/resolve/reference/PMED?id=8114857
MDRD {published data only}|Achievement and safety of a low blood pressure goal in chronic renal disease|/resolve/reference/PMED?id=9040451
MDRD {published data only}|Blood Pressure Control, Proteinuria, and the Progression of Renal Disease: The Modification of Diet in Renal Disease Study|/resolve/reference/PMED?id=7574193
MDRD {published data only}|The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study|/resolve/reference/PMED?id=15738453
REIN-2 {published data only}|Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised, controlled trial|/resolve/reference/PMED?id=15766995
Toto {published data only}|"Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis|/resolve/reference/PMED?id=7474675
BBB {published data only}|The BBB Study Group: the effect of intensified antihypertensive treatment on the level of blood presure, side-effects, morbidity and mortality in "well treated" hypertensive patients|/resolve/reference/PMED?id=7994450
BBB {published data only}|The BBB study: a prospective randomized study of intensified antiihypertensive treatment|/resolve/reference/PMED?id=2903191
HDS {published data only}|Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control|/resolve/reference/PMED?id=8960842
Lewis {published data only}|Effect on intensive blood pressure control on the course of type 1 diabetic nephropathy|/resolve/reference/PMED?id=10561135
SANDS {published data only}|Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes|/resolve/reference/PMED?id=18398080
Steno-2 {published data only}|Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes|
UKPDS {published data only}|Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38|/resolve/reference/PMED?id=9732337
ACCORD 2007 {published data only}|Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial|
ACCORD 2007 {published data only}|Effects of intensive glucose lowering in type 2 diabetes|/resolve/reference/PMED?id=18539917
ADA 2008|Standards of medical care in diabetes - 2008|/resolve/reference/PMED?id=18165335
AHA 2007|Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention|/resolve/reference/PMED?id=17502569
Arauz-Pacheco 2002|The treatment of hypertension in adult patients with diabetes|/resolve/reference/PMED?id=11772914
Aung 2003|Isolated systolic hypertension in the elderly|
Benetos 2000|A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men|/resolve/reference/PMED?id=10716470
BHS 2004|British Hypertension Society Guidelines for hypertension management 2004 (BHS-IV): summary|/resolve/reference/PMED?id=15016698
Borzak 1995|Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction|/resolve/reference/PMED?id=7486471
BPLTTC 2003|Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials|/resolve/reference/PMED?id=14615107
Chalmers 1999|1999 World Health Organization - International Society of Hypertension Guidelines for the management of hypertension|/resolve/reference/PMED?id=10067786
Cruickshank 1988|Coronary flow reserve and the J-curve relation between diastolic blood pressure and myocardial infarction|/resolve/reference/PMED?id=3145062
Cruickshank 2000|Antihypertensive treatment and the J-curve|/resolve/reference/PMED?id=10999643
Dormuth 2009|Statin adherence and risk of accidents: A cautionary tale|/resolve/reference/PMED?id=19349320
ESH-ESC 2007|2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)|/resolve/reference/PMED?id=17563527
Estacio 2000|Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes|/resolve/reference/PMED?id=10860192
Farnett 1991|The J-curve phenomenon and the treatment of hypertension|/resolve/reference/PMED?id=1824642
Franklin 1999|Is pulse pressure more important than systolic blood pressure in predicting coronary heart disease events?|/resolve/reference/PMED?id=10421594
Gueyffier 2001|Observational epidemiological studies: values and limitations|
Hansson 1992|Prospective randomized open blinded end-point (PROBE) study|/resolve/reference/PMED?id=1366259
Hansson 1997|The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability|/resolve/reference/PMED?id=9360003
Hansson 2000|Antihypertensive treatment: does the J-curve exist?|/resolve/reference/PMED?id=10999642
Hansson 2001|How far should we lower blood pressure in the elderly|/resolve/reference/PMED?id=11713897
Izzo 2000|Importance of systolic blood pressure in older americans|/resolve/reference/PMED?id=10818056
JNC 7 2003|The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report|/resolve/reference/PMED?id=12748199
K/DOQI 2004|K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease|
Kannel 1996|Blood pressure as a cardiovascular risk factor: prevention and treatment|/resolve/reference/PMED?id=8622248
Kunz 1998|The unpredictability paradox: review of empirical comparisons of randomized and non-randomized clinical trials|/resolve/reference/PMED?id=9794851
Lau 1997|Quantitative synthesis in systematic reviews|/resolve/reference/PMED?id=9382404
Laurent 2004|Guidelines from the British Hypertension Society. The lower the pressure the better|/resolve/reference/PMED?id=15016662
Lazarus 1997|Achievement and safety of a low blood pressure goal in chronic renal disease|/resolve/reference/PMED?id=9040451
Lund-Johansen 2003|Intensive blood pressure treatment: beneficial for all but the smoking hypertensives?|/resolve/reference/PMED?id=12658013
MacMahon 1990|Blood pressure, stroke and CHD. Part 1. Prolonged differences in blood pressure: prospective observational studies collected for the regression dilution bias|/resolve/reference/PMED?id=1969518
MacMahon 2001|Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies|/resolve/reference/PMED?id=11273081
McAlister 2002|The 2001 Canadian recommendations for the management of hypertension: Part two - Therapy|/resolve/reference/PMED?id=12107420
Millar 1999|Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial|/resolve/reference/PMED?id=10466460
ONTARGET 2008|Telmisartan, ramipril or both in patients at high risk for vascular events|/resolve/reference/PMED?id=18378520
Oparil 2003|Pathogenesis of hypertension|/resolve/reference/PMED?id=14597461
Peto 1995|Large-scale randomized evidence: large simple trials and overviews of trials|/resolve/reference/PMED?id=7853045
Prisant 2003|Diabetes mellitus and hypertension: a mandate for intense treatment according to new guidelines|/resolve/reference/PMED?id=12975721
Prospective Studies|Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies|/resolve/reference/PMED?id=12493255
Sarnak 2005|The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study|/resolve/reference/PMED?id=15738453
Snow 2003|The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus|/resolve/reference/PMED?id=12667031
Stamler 1993|BP, systolic and dyastolic and cardiovascular risk.|/resolve/reference/PMED?id=8439223
Stokes 1987|The relative importance of selective risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years. 30 years of follow-up in the Framingham Study|/resolve/reference/PMED?id=3568338
Vijan 2003|Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care|/resolve/reference/PMED?id=12667032
Voko 1999|J-Shaped Relation Between Blood Pressure and Stroke in Treated Hypertensives|/resolve/reference/PMED?id=10601115
Whitehead 1991|A general parametric approach to the meta-analysis of randomized clinical trials|
WHO/ISH 2003|2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension|/resolve/reference/PMED?id=14597836
Wright 1999|Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?|/resolve/reference/PMED?id=10420860
Zanchetti 2003|Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?|/resolve/reference/PMED?id=12658027
Arguedas 2004|Blood pressure targets in the treatment of patients with elevated blood pressure|
Bradley 1978 {published data only}|Oxygen assisted exercise in chronic obstructive lung disease|/resolve/reference/PMED?id=697174
Bye 1985 {published data only}|Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation|/resolve/reference/PMED?id=4026048
Criner 1987 {published data only}|Ventilatory muscle recruitment in exercise with O2 in obstructed patients with mild hypoxemia|/resolve/reference/PMED?id=3624124
Davidson 1988 {published data only}|Supplemental oxygen and exercise ability in chronic obstructive airways disease|/resolve/reference/PMED?id=3238640
Dean 1992 {published data only}|Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia|/resolve/reference/PMED?id=1416422
Eaton 2002 {published data only}|Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study|/resolve/reference/PMED?id=12212960
Fujimoto 2002a {published data only}|Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia|/resolve/reference/PMED?id=12171817
Fujimoto 2002b {published data only}|Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia. Chest 2002;122:457-463..|/resolve/reference/PMED?id=12171817
Fujimoto 2002c {published data only}|Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia. Chest 2002;122:457-463... Chets 2002;122:457-463.|/resolve/reference/PMED?id=12171817
Garrod 1999 {published data only}|Evaluation of pulsed dose oxygen delivery during exercise in patients with severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10325901
Garrod 2000 {published data only}|Supplemental oxygen therapy during pulmonary rehabilitation in patients with COPD and exercise hypoxaemia|/resolve/reference/PMED?id=10856310
Gosselin 2004 {published data only}|Effect of acute hyperoxia during exercise on quadriceps electrical activity in active COPD patients|
Ishimine 1995 {published data only}|The effect of oxygen supplementation during exercise in COPD patients with PaO2 over 60 Torr|/resolve/reference/PMED?id=7609336
King 1973 {published data only}|The effects of 30% oxygen on the respiratory response to treadmill exercise in chronic respiratory failure|/resolve/reference/PMED?id=4723272
Knebel 2000 {published data only}|Dyspnea management in alpha-1 antitrypsin deficinency: effect of oxygen administration|/resolve/reference/PMED?id=11093698
Kurihara 1989 {published data only}|Exercise induced hypoxemia and exercise tolerance in patients with COPD and the benefits of oxygen supplementation|
Leach 1992 {published data only}|Portable liquid oxygen and exericse ability in severe respiratory disability|/resolve/reference/PMED?id=1481177
Leggett 1977 {published data only}|Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale|/resolve/reference/PMED?id=871805
Light 1989 {published data only}|Relationship between improvement in exercise performance with supplemental oxygen and hypoxic ventilatory drive in patients with chronic airflow obstruction|/resolve/reference/PMED?id=2924604
Maltais 2001 {published data only}|Effects of oxygen on lower limb blood flow and O2 uptake during exercise in COPD|/resolve/reference/PMED?id=11404656
Mannix 1992 {published data only}|Oxygen may lower the O2 cost of ventilation in chronic obstructive lung disease|/resolve/reference/PMED?id=1555461
McDonald 1995 {published data only}|Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia|/resolve/reference/PMED?id=7582304
McKeon 1988 {published data only}|Poratble oxygen in patients with severe chronic obstructive pulmonary disease|
O'Donnell 1997 {published data only}|Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation|/resolve/reference/PMED?id=9032190
O'Donnell 2001 {published data only}|Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11282762
Palange 1995 {published data only}|Oxygen effect on O2 deficit and VO2 kinetics during exercise in obstructive pulmonary disease|/resolve/reference/PMED?id=7665422
Raimondi 1970 {published data only}|Exercise tolerance breathing a low density gas mixture, 35% oxygen and air in patients with chronic obstructive bronchitis|/resolve/reference/PMED?id=5493541
Somfay 2001 {published data only}|Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients|/resolve/reference/PMED?id=11510809
Stein 1982 {published data only}|Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=6797795
Swinburn 1984 {published data only}|Relationship between ventilation and breathlessness during exercise in chronic obstructive airways disease is not altered by prevention of hypoxaemia.|/resolve/reference/PMED?id=6478752
Vyas 1971 {published data only}|Response to exercise in patients with chronic airway obstruction|/resolve/reference/PMED?id=5152724
Wadell 2001 {published data only}|Physical training with and without oxygen in patients with Chronic Obstructive Pulmonary Disease and exercise induced hypoxaemia|/resolve/reference/PMED?id=11585150
Woodcock 1981 {published data only}|Oxygen relieves breathlessness in "pink puffers"|
Arlati 1988 {published data only}|A reservoir nasal cannula improves protection given by oxygen during muscular exercise in COPD|/resolve/reference/PMED?id=3371094
Barach 1966 {published data only}|Oxygen supported exercise and rehabilitation of patients with chronic obstructive lung disease|/resolve/reference/PMED?id=5905062
Bower 1988 {published data only}||/resolve/reference/PMED?id=3383659
Brambilla 1985 {published data only}||/resolve/reference/PMED?id=3917632
Braun 1992 {published data only}||/resolve/reference/PMED?id=1516389
Corriveau 1989 {published data only}|Oxygen transport and oxygen consumption during supplemental oxygen administration in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=2589398
Cotes 1956 {published data only}||
Cotes 1963 {published data only}|Effect of breathing oxygen upon cardiac output, heart rate, ventilation, systemic and pulmonary blood pressure in patients with chronic lung disease|/resolve/reference/PMED?id=14070914
Cuvelier 2002 {published data only}||/resolve/reference/PMED?id=12171816
Eaton 2001 {published data only}|An evaluation of short-term oxygen therapy: the prescription of oxygen to patients with chronic lung disease hypoxic at discharge|/resolve/reference/PMED?id=11453315
Emtner 2002 {published data only}|Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12869359
Guyatt 2001 {published data only}||/resolve/reference/PMED?id=11282770
Hargarty 1997 {published data only}||/resolve/reference/PMED?id=9117023
Jolly 2001 {published data only}||/resolve/reference/PMED?id=11502641
Lacasse 2003 {published data only}||
Lane 1987 {published data only}||/resolve/reference/PMED?id=3595075
Lilker 1975 {published data only}||/resolve/reference/PMED?id=1097205
Lock 1991 {published data only}|Portable oxygen therapy: assessment and usage|/resolve/reference/PMED?id=1759006
Lock 1992 {published data only}||/resolve/reference/PMED?id=1549830
Patessio 1996 {published data only}|Exercise capacity in COPD patients|
Pierce 1965 {published data only}|Exercise training with the aid of a portable oxygen supply in patients with emphysema|/resolve/reference/PMED?id=14280938
Revill 2000 {published data only}||/resolve/reference/PMED?id=10955754
Roberts 1996 {published data only}||/resolve/reference/PMED?id=8795673
Rooyackers 1997 {published data only}||/resolve/reference/PMED?id=9192929
Scano 1982 {published data only}|Effect of oxygen on breathing during exercise in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=6802664
Tiep 2002 {published data only}||/resolve/reference/PMED?id=12162799
Vergeret 1989 {published data only}||/resolve/reference/PMED?id=2707399
Waterhouse 1983 {published data only}||/resolve/reference/PMED?id=6867984
Wedzicha 1996 {published data only}||/resolve/reference/PMED?id=8766202
ATS 1995|Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease|/resolve/reference/PMED?id=7582322
ATS 2002|ATS statement guidelines for the six minute walk test|/resolve/reference/PMED?id=12091180
BTS 1997|COPD Guidelines Summary|/resolve/reference/PMED?id=AMBIGUOUS%209474238,9470942,9155846
BTS 2004|Clinical component for the home oxygen servive in England and Wales|
Crockett 2000|Domiciliary oxygen for chronic obstructive pulmonary disease [Cochrane Review]|
Curtin 2002|Meta-analysis combining parallel and cross over trials.|
DOH||
Elbourne 2002|Meta-analyses involving cross-over trials: methodological issues.|/resolve/reference/PMED?id=11914310
GOLD 2001|Global iniative for chronic obstructive lung diseases (GOLD): time to act|
Jadad 1996|Assessing quality of reports of randomised controlled trials: is blinding necessary|/resolve/reference/PMED?id=8721797
Law 2004||
Marques 1998|Treadmill exercise duration and dyspnea recovery time in chronic pulmonary disease: effects of oxygen breathing and repeated testing.|/resolve/reference/PMED?id=9713632
Moseley 1999|Reliability of a scale for measuring the methodological quality of clinical trials|
NICE 2004|COPD: National clinical guideline on managment of chronic obstructive pulmonary disease in adults in primary and secondary care|
Ram 2003|Ambulatory oxygen for chronic obstructive pulmonary disease [Cochrane Review]|
RCP 1999|Domicilary oxygen therapy services- Clinical Guidelines and Advice for Prescribers|
Redelmeier 1997|Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients|/resolve/reference/PMED?id=9105067
Revill 1999|The endurance walk: a new field test for the assessment of endurance capacity in COPD|/resolve/reference/PMED?id=10325896
Romain 2001|Global Strategy for the Diagnosis, Managment, and Prevention of Chronic Obstructive Pulmonary Disease|/resolve/reference/PMED?id=11316667
Senn 2004|Individual response to treatment: is it a valid assumption|/resolve/reference/PMED?id=15499115
Singh 1992|Developemnt of a shuttle walking test of disability in patients with chronic airway obstruction|/resolve/reference/PMED?id=1494764
Singh 2002|What is the minimal clinically important difference in the SWT observed in pulmonary rehabilitation|
Verhagen 1998|The Delphi List: A criteria for quality assessment of randomised clinical trials for conducting systematic reviews developed by the Depli Consensus.|/resolve/reference/PMED?id=10086815
Young 1998|Adult Domicilary Oxygen therapy- Position Statement of the Thoracic Society of Australia and New Zealand|/resolve/reference/PMED?id=9451391
Benedict 2000 {published data only}|Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients|/resolve/reference/PMED?id=11212135
Crawford 1985 {published data only}|Group psychotherapy: Benefits in multiple sclerosis|/resolve/reference/PMED?id=4074113
Foley 1987 {published data only}|Efficacy of stress-inoculation training in coping with multiple sclerosis|/resolve/reference/PMED?id=3693660
Gordon 1997 {published data only}|Interaction strain and persons with multiple sclerosis: Effectiveness of a social skills program|
Jonsson 1993 {published data only}|Effects of neuropsychological treatment in patients with multiple sclerosis|
Larcombe 1984 {published data only}|An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis|/resolve/reference/PMED?id=6487909
Lincoln 2002 {published data only}|Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis|/resolve/reference/PMED?id=11784832
Maguire 1996 {published data only}|The effects of imagery on attitudes and moods in multiple sclerosis patients|/resolve/reference/PMED?id=8795941
Mendoza 2001 {published data only}|Unit management of depression of patients with multiple sclerosis using cognitive remediation strategies: A preliminary study|/resolve/reference/PMED?id=11527284
Mohr 2000 {published data only}|Telephone-administered cognitive behavioral therapy for the treatment of depressive symptoms in multiple sclerosis|/resolve/reference/PMED?id=10780138
Mohr 2001 {published data only}|Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis|/resolve/reference/PMED?id=11777121
Mohr 2003 {published data only}|Effects of treatment for depression on fatigue in multiple sclerosis|/resolve/reference/PMED?id=12883103
Rigby 2003 {published data only}||
Schwartz 1999 {published data only}|Teaching coping skills enhances quality of life more than peer support: Results of a randomised trial with multiple sclerosis patients|/resolve/reference/PMED?id=10357502
Solari 2004 {published data only}|Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial|/resolve/reference/PMED?id=15240203
Stuifbergen 2003 {published data only}|A randomized clinical trial of a wellness intervention for women with multiple sclerosis|/resolve/reference/PMED?id=12690582
Wassem 2003 {published data only}|Symptom management and adjustment of patients with multiple sclerosis|/resolve/reference/PMED?id=12583502
Klarskov 1994 {published data only}|Biofeedback treatment of bladder dysfunction in multiple sclerosis. A randomised trial.|
Mendozzi 1998 {published data only}|Computer-assisted memory retraining of patients with multiple sclerosis|
Mills 2000 {published data only}|Mindfulness of movement as a coping strategy in multiple sclerosis. A pilot study|/resolve/reference/PMED?id=11072058
Mohr 2004 {published data only}|The relationship between social support, depression and treatment for depression in people with multiple sclerosis|/resolve/reference/PMED?id=15259838
Rogers 1996 {published data only}|Cognitive therapy for multiple sclerosis: A preliminary Study|
Schmid 2004 {published data only}|Active music therapy in the treatment of multiple sclerosis patients: A matched control study|/resolve/reference/PMED?id=15327343
Tesar 2003 {published data only}|Effects of psychological group therapy in patients with multiple sclerosis|
Chiaravalloti 2005 {published data only}|Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial|/resolve/reference/PMED?id=15732268
Mohr 2005 {published data only}|Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications|/resolve/reference/PMED?id=15794392
Mohr {published data only (unpublished sought but not used)}|Telephone administered psychotherapy for the treatment of depression in multiple sclerosis|
Moss-Morris {published data only (unpublished sought but not used)}|A randomised controlled trial of cognitive behavioural therapy for fatigue in patients with multiple sclerosis|
Aikens 1997|A replicated prospective investigation of life stress coping and depressive symptoms in multiple sclerosis|/resolve/reference/PMED?id=9415854
Amato 1995|Cognitive impairment in early-onset multiple sclerosis|/resolve/reference/PMED?id=7848126
Barnes 1954|The alleviation of emotional problems in multiple sclerosis by group therapy|
Barnwell 1997|Prediction of psychological adjustment to multiple sclerosis|/resolve/reference/PMED?id=9232735
Bedford 1978||
Bolding 1960|Psychotherapeutic aspects in the management of patients with multiple sclerosis|/resolve/reference/PMED?id=13802284
Brassington 1998|Neuropsychological aspects of multiple sclerosis|/resolve/reference/PMED?id=9658410
Clarke 2000|Cochrane Reviewer's Handbook Version 4.1.1 (updated December 2000); Section 6|
Crawford 1987|Stress management for multiple sclerosis patients|/resolve/reference/PMED?id=3324144
Dalos 1983|Disease activity and emotional state in multiple sclerosis|
Day 1953|Group therapy of patients with multiple sclerosis|/resolve/reference/PMED?id=13007228
EuroQoL Group 1990|EuroQoL: a new facility for the measurement of health related quality of life|/resolve/reference/PMED?id=10109801
Fassbender 1998|Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis|/resolve/reference/PMED?id=9443712
Feinstein 1999|The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis|/resolve/reference/PMED?id=10516775
Franklin 1988|Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis|/resolve/reference/PMED?id=3194059
Gilchrist 1994|Depression, cognitive impairment and social stress in multiple sclerosis|/resolve/reference/PMED?id=8027959
Graham 2002|What is MS?|
Gulick 1997|Correlates among quality of life among persons with multiple sclerosis|/resolve/reference/PMED?id=9422048
Hartings 1976|Group counseling of MS patients in a program of comprehensive care|/resolve/reference/PMED?id=947928
Heaton 1985|Neuropsychological findings in relapse-remitting multiple sclerosis|/resolve/reference/PMED?id=3980815
Hobart 2001|The Multiple Sclerosis Impact Scale (MSIS-29). A new patient-based outcome measure|/resolve/reference/PMED?id=11335698
Joffe 1987|Mood disorder and multiple sclerosis|/resolve/reference/PMED?id=3827692
Kurtzke 1983|Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS)|/resolve/reference/PMED?id=6685237
Langdon 1996|Cognitive problems in multiple sclerosis|
LaRocca 1993|Assessment of psychosocial outcomes|
LaRocca 1996|"Quality of life" assessment in multiple sclerosis clinical trials: current status and strategies for improving multiple sclerosis clinical trial design|
Maurelli 1992|Neuropsychological assessment in MS: Clinical, neurophysiological and neuroradiological relationships|
McIvor 1984|Depression in multiple sclerosis as a function of length and severity of illness, age, remissions and perceived social support|
McNair 1981||
Miles 1979|Some psycho-social consequences of multiple sclerosis: problems of social interaction and group identity|
Minden 1987|Depression in multiple sclerosis|/resolve/reference/PMED?id=3692149
Minden 1991|Depression and mood disorders in multiple sclerosis|
Minden 1992|Psychotherapy for people with multiple sclerosis|/resolve/reference/PMED?id=1385743
Minden 2000|Mood disorders in multiple sclerosis: diagnosis and treatment|/resolve/reference/PMED?id=10871806
Moher 1998|Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?|/resolve/reference/PMED?id=9746022
Mohr 1996|Therapeutic expectations of patients with mutliple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment|/resolve/reference/PMED?id=9050360
Mohr 1997a|Depression, coping, and level of neurological impairment in multiple sclerosis|/resolve/reference/PMED?id=9372510
Mohr 1997b|Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis|/resolve/reference/PMED?id=9152109
Mohr 1998|Side effect profile and compliance in the treatment of multiple sclerosis with interferon beta-1a|/resolve/reference/PMED?id=9987757
Mohr 1999a|Course of depression during the initiation of interferon beta-1a for multiple sclerosis|/resolve/reference/PMED?id=10520943
Mohr 1999b|Relationship between treatment for depression and interferon-gamma in patients with multiple sclerosis|
Mohr 1999c|Treatment of depression in multiple sclerosis: Review and meta-analysis|
Mohr 2001a|Multiple sclerosis: Empirical literature for the clinical health psychologist|
Mohr 2001b|Treatment of depression is associated with suppression of non-specific and antigen-specific TH1 responses in multiple sclerosis|/resolve/reference/PMED?id=11448297
Mohr 2001c|Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis|/resolve/reference/PMED?id=11777121
Mohr 2002|Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis|/resolve/reference/PMED?id=12271111
Mullins 2001|Illness intrusiveness, uncertainty and distress in individuals with multiple sclerosis|
Nelson 1988|Referral bias in multiple sclerosis research|/resolve/reference/PMED?id=3335884
O'Brien 1993|Multiple sclerosis: the relationship among self-esteem, social support, and coping behaviour|/resolve/reference/PMED?id=8317939
Ostelo 2004|Behavioural treatment for chronic low back pain|
Pakenham 1997|The role of coping in adjustment to multiple sclerosis-related adaptive demands|
Pakenham 1999|Adjustment to multiple sclerosis: Application of a stress and coping model|/resolve/reference/PMED?id=10431940
Penman 1991|Assessing the prevalence of cognitive impairment in multiple sclerosis: Implications for patient management|/resolve/reference/PMED?id=1764408
Pepper 1993|A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis and major depression|/resolve/reference/PMED?id=8508039
Pfennings 1999|A health related quality of life questionnaire for multiple sclerosis patients|
Pollock 1990|Responses to chronic illness: Analysis of psychological and physiological adaptation|/resolve/reference/PMED?id=2399137
Poser 1983|New diagnostic criteria for multiple sclerosis: guidelines for research proposals|
Price 1998|Cognitive behavioural therapy for chronic fatigue syndrome in adults|
Prosiegal 1993|Neuropsychology and multiple sclerosis: diagnostic and rehabilitative approaches|/resolve/reference/PMED?id=8340793
Pujol 1997|Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis|/resolve/reference/PMED?id=9339697
Rabins 1986|Structural correlates of emotional disorder in multiple sclerosis|/resolve/reference/PMED?id=3730806
Rao 1991|Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction|/resolve/reference/PMED?id=2027484
Rao 1992|Emotional changes with multiple sclerosis and Parkinson's disease|/resolve/reference/PMED?id=1619091
Rosenberg 1965|Self-esteem scale|
Sadovnick 1991|Cause of death in patients attending multiple sclerosis clinics|/resolve/reference/PMED?id=1866003
Scheinberg 1984|Psychological functioning in primary progressive versus secondary progressive multiple sclerosis|
Schiaffino 1996|Assessing the psychosocial impact of multiple sclerosis: learning from research on rheumatoid arthritis|
Schiffer 1983|Depressive episodes in patients with multiple sclerosis|/resolve/reference/PMED?id=6625001
Schubert 1993|Increased depression in multiple sclerosis: a meta-analysis|/resolve/reference/PMED?id=8456154
Schumacher 1965|Problems of experimental trials of therapy in multiple sclerosis: Report by the panel of the evaluation of experimental trials in multiple sclerosis|
Schwarzer 1995|Generalised self-efficacy scale|
Sharrack 1999|The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis|/resolve/reference/PMED?id=10467380
Spitzer 1995|Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 study|/resolve/reference/PMED?id=7474219
Stenager 1994|Multiple sclerosis: Correlation of anxiety, physical impairment and cognitive dysfunction|
Surridge 1969|An investigation into some psychiatric aspects of multiple sclerosis|/resolve/reference/PMED?id=5806869
Thompson 1996|Multiple sclerosis: symptomatic treatment|/resolve/reference/PMED?id=8865021
Vickrey 1995|A health-related quality of life measure for multiple sclerosis|/resolve/reference/PMED?id=7613530
Walsh 1989|Love, self-esteem and multiple sclerosis|/resolve/reference/PMED?id=2799422
Ware 1993||
Whitlock 1980|Depression as a major symptom of multiple sclerosis|/resolve/reference/PMED?id=7441263
Wilson 1999||
Barst 2004{unpublished data only}|Sitaxsentan therapy for pulmonary arterial hypertension|
Barst 2004a{published data only}|Sitaxsentan therapy for pulmonary arterial hypertension|
Barst 2004b{published data only}|Sitaxsentan therapy for pulmonary arterial hypertension|
Channick 2001{published data only}|Effects of the dual endothelin-receptor antagonist, in pulmonary hypertension|
Channick 2001{published data only}|Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study|
Channick 2001{published data only}|Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension. A 1-year follow-up study|
Gali 2003{published data only}|Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension|
Rubin 2002{published data only}|Bosentan therapy for pulmonary arterial hypertension|
Barst 2002|Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.[comment]|
Barst 2003b|Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension|
Hoeper 2003|Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids|
Krum 1999|Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe heart failure|
Packer 2002|Effects of the endothelin receptor antagonist bosentan on the morbidity and mortality in patients with chronic heart failure: results of the Enable 1 and 2 trial program|
Williamson 2000|Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension|
Humbert 2004|Safety & efficacy of bosentan combined with epoprostenol in patients with severe pulmonary arterial hypertension|
Humbert 2004|Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2|
Badesch 2000|Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial|
Barst 1996|A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group|
D'Alonzo 1991|Survival in patients with primary pulmonary hypertension. Results from a national prospective registry|
Filep 1995|Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors|
Fuster 1984|Primary pulmonar hypertension: natural history and importance of thrombosis|
Gater 1996|Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea|
Giaid 1993|Expression of endothelin-1 in the lungs of patients with pulmonary hypertension|
Hasuda 2000|Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension|
Katwa 1993|Endothelin receptors in cultured adult rat cardiac fibroblasts|
Kim 2000|Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase|
Mansoor 1995|Endothelin induced collagen remodeling in experimental pulmonary hypertension|
Miyamoto 2000|Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing|
Paramothayan 2003|Prostacyclin for pulmonary hypertension (Cochrane Review)|
Reeves 1986|The case for treatment of selected patients with primary pulmonary hypertension|
Rich 1992|The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension|
Rich 1998|Primary Pulmonary Hypertension: executive summary from the World Symposium - Primary Pulmonary Hypertension 1998. Evian, France: World Health Organization, 1998|
Rubens 2001|Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension|
Rubin 1987|ACCP consensus statement: primary pulmonary hypertension|
Sitbon 1998|Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension|
Wort 2001|Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling|
Barst 2004 {unpublished data only}|Sitaxsentan therapy for pulmonary arterial hypertension|
Barst 2004a {published data only}|Sitaxsentan therapy for pulmonary arterial hypertension|
Barst 2004b {published data only}|Sitaxsentan therapy for pulmonary arterial hypertension|
Channick 2001 {published data only}|Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study|
Gali 2003 {published data only}|Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension|
Humbert 2004 {published data only}|Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2|
Rubin 2002 {published data only}|Bosentan therapy for pulmonary arterial hypertension|
Wilkins 2005 {published data only}|Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study|
Barst 2002 {published data only}|Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study|
Barst 2003 {published data only}|Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension|
Frost 2005 {published data only}|The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect|
Gatzoulis 2005 {published data only}|Safety and tolerability of bosentan in adults with Eisenmenger physiology|
Hoeper 2003 {published data only}|Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids|
Krum 1999 {published data only}|Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe heart failure|
Langleben 2004 a {published data only}|STRIDE 1: Effects of the selective ETA receptor antagonist sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials|
Langleben 2004 b {published data only}|Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study|
McLaughlin 2005 {published data only}|Survival with first-line bosentan in patients with primary pulmonary hypertension|
Packer 2002 {published data only}|Effects of the endothelin receptor antagonist bosentan on the morbidity and mortality in patients with chronic heart failure: results of the Enable 1 and 2 trial program|
Sasayama 2005 {published data only}|Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension|
van 2005 {published data only}|Comparative investigation of the pharmacokinetics of bosentan in Caucasian and Japanese healthy subjects|
Williamson 2000 {published data only}|Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension|
Badesch 2000|Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial|
Barst 1996|A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group|
D'Alonzo 1991|Survival in patients with primary pulmonary hypertension. Results from a national prospective registry|
Filep 1995|Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors|
Fuster 1984|Primary pulmonary hypertension: natural history and importance of thrombosis|
Galie 2004|Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology|
Galie 2005|Sildenafil citrate therapy for pulmonary arterial hypertension|
Gater 1996|Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea|
Giaid 1993|Expression of endothelin-1 in the lungs of patients with pulmonary hypertension|
Hasuda 2000|Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension|
Katwa 1993|Endothelin receptors in cultured adult rat cardiac fibroblasts|
Kim 2000|Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase|
Mansoor 1995|Endothelin induced collagen remodeling in experimental pulmonary hypertension|
Miyamoto 2000|Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing|
Paramothayan 2005|Prostacyclin for pulmonary hypertension|
Reeves 1986|The case for treatment of selected patients with primary pulmonary hypertension|
Rich 1992|The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension|
Rubens 2001|Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension|
Rubin 1987|ACCP consensus statement: primary pulmonary hypertension|
Sitbon 1998|Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension|
Wort 2001|Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling|
ARIES-1 {published data only}|US Food and Drug Administration. Center for drug evaluation and research. Letairis (Ambrisentan) Tablets: Medical Review(s)|
ARIES-1 {published data only}|Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2|/resolve/reference/PMED?id=18506008
ARIES-2 {published data only}|US Food and Drug Administration. Center for drug evaluation and research. Letairis (Ambrisentan) Tablets: Medical Review(s)|
ARIES-2 {published data only}|Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2|/resolve/reference/PMED?id=18506008
BREATHE-1 {published data only}|US Food and Drug Administration. Center for drug evaluation and research.Tracleer (Bosentan) Tablets: Medical Review(s)|
BREATHE-1 {published data only}|Bosentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=11907289
BREATHE-2 {published data only}|US Food and Drug Administration. Center for drug evaluation and research.Tracleer (Bosentan) Tablets: Medical Review(s)|
BREATHE-2 {published data only}|Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2|/resolve/reference/PMED?id=15358690
BREATHE-5 {published data only}|Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study|/resolve/reference/PMED?id=16801459
Channick 2001 {published data only}|complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension.|
Channick 2001 {published data only}|Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study|/resolve/reference/PMED?id=11597664
EARLY {published and unpublished data}|Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial|/resolve/reference/PMED?id=18572079
Gali 2003 {published data only}|Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension|/resolve/reference/PMED?id=12706935
STRIDE-1 {published and unpublished data}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-1 {published and unpublished data}|Therapeutic Goods Administration (TGA), Australia. Public Summary Documents by Product: Thelin|
STRIDE-1 {published and unpublished data}|Sitaxsentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=14630619
STRIDE-1 (100mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-1 (100mg) {published data only}|Sitaxsentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=14630619
STRIDE-1 (300mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-1 (300mg) {published data only}|Sitaxsentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=14630619
STRIDE-2 {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-2 {published data only}|Therapeutic Goods Administration (TGA), Australia. Public Summary Documents by Product: Thelin|
STRIDE-2 {published data only}|Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan|/resolve/reference/PMED?id=16697324
STRIDE-2 (100mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-2 (100mg) {published data only}|Therapeutic Goods Administration (TGA), Australia. Public Summary Documents by Product: Thelin|
STRIDE-2 (100mg) {published data only}|Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan|/resolve/reference/PMED?id=16697324
STRIDE-2 (50mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-2 (50mg) {published data only}|Therapeutic Goods Administration (TGA), Australia. Public Summary Documents by Product: Thelin|
STRIDE-2 (50mg) {published data only}|Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan|/resolve/reference/PMED?id=16697324
STRIDE-4 {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-4 (100mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-4 (50mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
Wilkins 2005 {published data only}|Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study|/resolve/reference/PMED?id=15750042
Ahmadi-Simab 2004 {published data only}|[Treatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience]|/resolve/reference/PMED?id=15605216
Anonymous 2006 {published data only}|Combination drug therapies may improve efficacy, reduce side effects in PAH|
Anonymous 2006a {published data only}|Sitaxsentan more effective than bosentan as PAH therapy|
Benza 2005 {published data only}|Sitaxsentan treatment for patients with pulmonary arterial hypertension (PAH) failing bosentan treatment [Abstract]|
Benza 2007 {published data only}|Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan|/resolve/reference/PMED?id=17234519
BUILD-2 {unpublished data only}|Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma|
Burgess 2005 {published data only}|Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil [Abstract]|
Burgess 2008 {published data only}|Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil|/resolve/reference/PMED?id=18040672
Channick 2001a {published data only}|Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomized placebo-controlled study. [Portuguese]|
Coyne 2005 {published data only}|No clinical interaction between sitaxsentan and sildenafil [Abstract]|
Denton 2006 {published data only}|Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions|
Frost 2005 {published data only}|The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect|/resolve/reference/PMED?id=15890561
Frost 2006 {published data only}|Beneficial response to inhaled lloprost (IIIo) in bosentan (Bos)-treated pulmonary hypertensive (PAH) patients as a function of baseline 6 minute walk (6MW) [Abstract]|
Gali 2002 {published data only}|Oral endothelin receptor antagonist bosentan improves echocardiographic and doppler measures in patients with pulmonary arterial hypertension [abstract]|
Gali 2005 {published data only}|Ambrisentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=16053970
Girgis 2007 {published data only}|Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease|/resolve/reference/PMED?id=17472992
Givertz 2000 {published data only}|Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure|/resolve/reference/PMED?id=10869264
Gomberg-Maitland 2005 {published data only}|Efficacy and safety of sildenafil and atorvastatin added to bosentan as therapy for pulmonary arterial hypertension [Abstract]|
Hoeper 2006 {published data only}|Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension|/resolve/reference/PMED?id=17012628
Kalra 2002 {published data only}|Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?|/resolve/reference/PMED?id=12208583
Kaluski 2008 {published data only}|Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension-a multi-center randomized study|/resolve/reference/PMED?id=17873492
King 2008 {published data only}|BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis|/resolve/reference/PMED?id=17901413
Kiowski 1995 {published data only}|Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure|/resolve/reference/PMED?id=7658874
Korn 2004 {published data only}|Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist|
Langleben 2004 {published data only}|STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials|/resolve/reference/PMED?id=15838366
McLaughlin 2003 {published data only}|Efficacy and safety of treprostinil: An epoprostenol analog for primary pulmonary hypertension|/resolve/reference/PMED?id=12548091
McLaughlin 2005 {published data only}|Sitaxsentan improves 6MW and hemodynamics in patients with pulmonary arterial hypertension (PAH) related to connective tissue disease (CTD) [Abstract]|
McLaughlin 2006 {published data only}|Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension|
Mereles 2006 {published data only}|Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension|/resolve/reference/PMED?id=16982941
Modesti 2006 {published data only}|Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study|
Oudiz 2006 {published data only}|Functional class improvement with sitaxsentan in patients with class II-IV pulmonary arterial hypertension (PAH) [Abstract]|
Pulido 2006 {published data only}|Sitaxsentan 100mg proves more effective than sitaxsentan 50mg in patients with pulmonary arterial hypertension (PAH) [Abstract]|
RAPID-1 {unpublished data only}|Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients|
Robbins 2006 {published data only}|A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension|/resolve/reference/PMED?id=16507859
Seibold 2005 {published data only}|Sitaxsentan, a selective endothelin-a receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD)|
Tapson 2006 {published data only}|The relative efficacy of inhaled iloprost combined with bosentan in IPAH. A subgroup analysis of the STEP study [Abstract]|
Altman 2003|Statistics Notes: Interaction revisited: the difference between two estimates|/resolve/reference/PMED?id=12543843
Badesch 2000|Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial|/resolve/reference/PMED?id=10733441
Barst 1996|A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group|/resolve/reference/PMED?id=8532025
Chen 2008|Clinical and cost effectiveness of treatments for pulmonary arterial hypertension (PAH) within their licensed indications [updated 21/02/2008]|
D'Alonzo 1991|Survival in patients with primary pulmonary hypertension. Results from a national prospective registry|/resolve/reference/PMED?id=1863023
Denton 2006|Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions|/resolve/reference/PMED?id=16793845
Filep 1995|Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors|
Fuster 1984|Primary pulmonary hypertension: natural history and importance of thrombosis|/resolve/reference/PMED?id=6148159
Gali 2004|Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology|/resolve/reference/PMED?id=15589643
Gali 2005|Sildenafil citrate therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=16291984
Gater 1996|Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea|/resolve/reference/PMED?id=8813593
Giaid 1993|Expression of endothelin-1 in the lungs of patients with pulmonary hypertension|/resolve/reference/PMED?id=8497283
Hasuda 2000|Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension|/resolve/reference/PMED?id=10790348
Humbert 2007|Results of European post-marketing surveillance of bosentan in pulmonary hypertension|/resolve/reference/PMED?id=17504794
Katwa 1993|Endothelin receptors in cultured adult rat cardiac fibroblasts|/resolve/reference/PMED?id=8313418
Kim 2000|Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase|/resolve/reference/PMED?id=10923246
Liu 2006a|Treatments for pulmonary arterial hypertension|/resolve/reference/PMED?id=16549344
Macchia 2007|A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology|/resolve/reference/PMED?id=17540207
Mansoor 1995|Endothelin induced collagen remodeling in experimental pulmonary hypertension|/resolve/reference/PMED?id=7488070
McLaughlin 2005|Survival with first-line bosentan in patients with primary pulmonary hypertension|/resolve/reference/PMED?id=15684287
Miyamoto 2000|Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing|/resolve/reference/PMED?id=10673190
Paramothayan 2005|Prostacyclin for pulmonary hypertension in adults|
Reeves 1986|The case for treatment of selected patients with primary pulmonary hypertension|/resolve/reference/PMED?id=3740659
Rich 1992|The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension|/resolve/reference/PMED?id=1603139
Rubens 2001|Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension|/resolve/reference/PMED?id=11713135
Rubin 1987|ACCP consensus statement: primary pulmonary hypertension|/resolve/reference/PMED?id=8325077
Seibold 2005|Sitaxsentan, a selective endothelin-a receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD)|
Sitbon 1998|Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension|/resolve/reference/PMED?id=9727772
Sitbon 2002|Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival|/resolve/reference/PMED?id=12204511
Torres 2007|Systematic review of randomised, double-blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension|
Wort 2001|Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling|/resolve/reference/PMED?id=11472982
Liu 2004|Endothelin receptor antagonists for pulmonary arterial hypertension|
Liu 2006|Endothelin receptor antagonists for pulmonary arterial hypertension|
ARIES-1 {published data only}|US Food and Drug Administration. Center for drug evaluation and research. Letairis (Ambrisentan) Tablets: Medical Review(s)|
ARIES-1 {published data only}|Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2|/resolve/reference/PMED?id=18506008
ARIES-2 {published data only}|US Food and Drug Administration. Center for drug evaluation and research. Letairis (Ambrisentan) Tablets: Medical Review(s)|
ARIES-2 {published data only}|Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2|/resolve/reference/PMED?id=18506008
ASSET-1 {published data only}|Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies|
BREATHE-1 {published data only}|US Food and Drug Administration. Center for drug evaluation and research.Tracleer (Bosentan) Tablets: Medical Review(s)|
BREATHE-1 {published data only}|Bosentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=11907289
BREATHE-2 {published data only}|US Food and Drug Administration. Center for drug evaluation and research.Tracleer (Bosentan) Tablets: Medical Review(s)|
BREATHE-2 {published data only}|Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2|/resolve/reference/PMED?id=15358690
BREATHE-5 {published data only}|Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study|/resolve/reference/PMED?id=16801459
Channick 2001 {published data only}|complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension|
Channick 2001 {published data only}|Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study|/resolve/reference/PMED?id=11597664
EARLY {published and unpublished data}|Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial|/resolve/reference/PMED?id=18572079
Gali 2003 {published data only}|Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension|/resolve/reference/PMED?id=12706935
SERAPH {published data only}|Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study|/resolve/reference/PMED?id=15750042
STRIDE-1 {published and unpublished data}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-1 {published and unpublished data}|Therapeutic Goods Administration (TGA), Australia. Public Summary Documents by Product: Thelin|
STRIDE-1 {published and unpublished data}|Sitaxsentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=14630619
STRIDE-1 (100mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-1 (100mg) {published data only}|Sitaxsentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=14630619
STRIDE-1 (300mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-1 (300mg) {published data only}|Sitaxsentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=14630619
STRIDE-2 {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-2 {published data only}|Therapeutic Goods Administration (TGA), Australia. Public Summary Documents by Product: Thelin|
STRIDE-2 {published data only}|Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan|/resolve/reference/PMED?id=16697324
STRIDE-2 (100mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-2 (100mg) {published data only}|Therapeutic Goods Administration (TGA), Australia. Public Summary Documents by Product: Thelin|
STRIDE-2 (100mg) {published data only}|Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan|/resolve/reference/PMED?id=16697324
STRIDE-2 (50mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-2 (50mg) {published data only}|Therapeutic Goods Administration (TGA), Australia. Public Summary Documents by Product: Thelin|
STRIDE-2 (50mg) {published data only}|Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan|/resolve/reference/PMED?id=16697324
STRIDE-4 {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-4 (100mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
STRIDE-4 (50mg) {published data only}|European Medicines Agency. EPARs for authorised medicinal products for human use: Thelin. European Public Assessment Report|
ASSET-2 {published data only}|Exercise capacity and haemodynamics inpatients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies|
Barst 2011 {published data only}|Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension|
Benza 2007 {published data only}|Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan|/resolve/reference/PMED?id=17234519
Bose 2009 {published data only}|Evaluation of the effect of ambrisentan on digital microvascular flow in patients with systemic sclerosis using laser Doppler perfusion imaging|
BUILD-2 {unpublished data only}|Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma|
Burgess 2008 {published data only}|Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil|/resolve/reference/PMED?id=18040672
Coyne 2005 {published data only}|No clinical interaction between sitaxsentan and sildenafil [Abstract]|
Denault 2010 {published data only}|Multicentered trial of tezosentan in cardiac surgery|
Dhaun 2011 {published data only}|Chronic selective endothelin a receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease|/resolve/reference/PMED?id=21709210
Faoro 2009a {published data only}|Bosentan decreases pulmonary vascular resistance and improves exercise capacity in acute hypoxia|/resolve/reference/PMED?id=19188550
Faoro 2009b {published data only}|Bosentan improves exercise capacity in acute hypoxic subjects|
Frey 2008 {published data only}|Single-dose pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase stimulator BAY 63-2521: An ascending-dose study in healthy male volunteers|
Gali 2005b {published data only}|Ambrisentan therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=16053970
Gali 2009b {published data only}|Tadalafil therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=19470885
Gali 2009c {published data only}|3-year survival of patients treated with sitaxentan sodium (Thelin) for pulmonary arterial hypertension|
Gali 2010 {published data only}|Effects of inhaled aviptadil (vasoactive intestinal peptide) in patients with pulmonary arterial hypertension (PAH): Results from a phase II study|
Ghofrani 2010 {published data only}|Long term use of imatinib In patients with severe pulmonary arterial hypertension [Abstract]|
Gillies 2011 {published data only}|PAH therapy In HIV: Lack of drug-drug interaction between ambrisentan and ritonavir|
Givertz 2000 {published data only}|Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure|/resolve/reference/PMED?id=10869264
Gomberg-Maitland 2005 {published data only}|Efficacy and safety of sildenafil and atorvastatin added to bosentan as therapy for pulmonary arterial hypertension [Abstract]|
Gotzkowsky 2010 {published data only}|Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers|
Hoeper 2006 {published data only}|Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension|/resolve/reference/PMED?id=17012628
Huez 2009 {published data only}|Role of pulmonary hypertension and right ventricular dysfunction in aerobic exercise capacity limitation in normal volunteers at high altitude|
Iversen 2010 {published data only}|Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: A randomized, placebo-controlled, double-blinded trial|/resolve/reference/PMED?id=20202971
Jais 2008 {published data only}|Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial|/resolve/reference/PMED?id=19095129
Kalra 2002 {published data only}|Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?|/resolve/reference/PMED?id=12208583
Kaluski 2008a {published data only}|Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension-a multi-center randomized study|/resolve/reference/PMED?id=17873492
Kaluski 2008b {published data only}|Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension--a multi-center randomized study|/resolve/reference/PMED?id=17873492
Kefford 2010 {published data only}|A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy|/resolve/reference/PMED?id=20350333
King 2008 {published data only}|BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis|/resolve/reference/PMED?id=17901413
Kiowski 1995 {published data only}|Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure|/resolve/reference/PMED?id=7658874
Korn 2004 {published data only}|Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist|
Lee 2009 {published data only}|Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension|/resolve/reference/PMED?id=18831711
McLaughlin 2003 {published data only}|Efficacy and safety of treprostinil: An epoprostenol analog for primary pulmonary hypertension|/resolve/reference/PMED?id=12548091
McLaughlin 2006 {published data only}|Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension|
McLaughlin 2010 {published data only}|Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial|/resolve/reference/PMED?id=20430262
Mereles 2006 {published data only}|Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension|/resolve/reference/PMED?id=16982941
Modesti 2006 {published data only}|Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study|
Naeije 2010 {published data only}|Pulmonary artery pressure limits exercise capacity at high altitude|/resolve/reference/PMED?id=20378601
Nakahara 2010 {published data only}|Pharmacokinetics of ambrisentan, a novel drug for treatment of Pulmonary Arterial Hypertension (PAH), in Japanese subjects|
Oudiz 2007 {published data only}|Long-term ambrisentan therapy provides sustained benefit in patients with pulmonary arterial hypertension|
Oudiz 2009 {published data only}|Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension|/resolve/reference/PMED?id=19909879
RAPID-1 {unpublished data only}|Efficacy and safety of tral bosentan on healing/prevention of digital (finger) ulcers in scleroderma patients|
Reesink 2010 {published data only}|Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension|
Robbins 2006 {published data only}|A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension|/resolve/reference/PMED?id=16507859
Seheult 2009 {published data only}|Prophylactic bosentan does not improve exercise capacity or lower pulmonary artery systolic pressure at high altitude|/resolve/reference/PMED?id=18977464
Seibold 2010 {published data only}|Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis|/resolve/reference/PMED?id=20506355
Shenoy 2011 {published data only}|Tadalafil: A new role in Raynaud's phenomenon?|
Simonneau 2010 {published data only}|Efficacy, safety and tolerability of ACT-293987, a novel oral, non-prostanoid, prostaglandin I2 (IP) receptor agonist: results from a phase IIa study In pulmonary arterial hypertension (PAH)|
Spence 2008 {published data only}|Pharmacokinetics and safety of ambrisentan in combination with sildenafil in healthy volunteers|
Spence 2009 {published data only}|No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers|
Stavros 2010 {published data only}|The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects|
Stolz 2008 {published data only}|A randomised, controlled trial of bosentan in severe COPD|/resolve/reference/PMED?id=18448495
Worthington 2010 {published data only}|Safety and feasibility of inhaled iloprost on exercise capacity in patients with pulmonary arterial hypertension|
Wrishko 2008 {published data only}|Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects|
Palazzini 2010 {published data only (unpublished sought but not used)}|A randomized open label study comparing bosentan or sildenafil first-line treatment in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)|
Altman 2003|Statistics Notes: Interaction revisited: the difference between two estimates|/resolve/reference/PMED?id=12543843
Archer 2010|Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies|/resolve/reference/PMED?id=20458021
Badesch 2000|Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial|/resolve/reference/PMED?id=10733441
Badesch 2007|Ambrisentan therapy for pulmonary arterial hypertension: a comparison by pah etiology|
Barst 1996|A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group|/resolve/reference/PMED?id=8532025
Chen 2008|Clinical and cost effectiveness of treatments for pulmonary arterial hypertension (PAH) within their licensed indications [updated 21/02/2008]|
Denton 2006|Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions|/resolve/reference/PMED?id=16793845
Filep 1995|Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors|
Fuster 1984|Primary pulmonary hypertension: natural history and importance of thrombosis|/resolve/reference/PMED?id=6148159
Gali 2005a|Sildenafil citrate therapy for pulmonary arterial hypertension|/resolve/reference/PMED?id=16291984
Gali 2009a|Guidelines for the diagnosis and treatment of pulmonary hypertension|/resolve/reference/PMED?id=19749199
Gater 1996|Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea|/resolve/reference/PMED?id=8813593
Giaid 1993|Expression of endothelin-1 in the lungs of patients with pulmonary hypertension|/resolve/reference/PMED?id=8497283
Hasuda 2000|Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension|/resolve/reference/PMED?id=10790348
Humbert 2007|Results of European post-marketing surveillance of bosentan in pulmonary hypertension|/resolve/reference/PMED?id=17504794
Katwa 1993|Endothelin receptors in cultured adult rat cardiac fibroblasts|/resolve/reference/PMED?id=8313418
Kim 2000|Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase|/resolve/reference/PMED?id=10923246
Liu 2006a|Treatments for pulmonary arterial hypertension|/resolve/reference/PMED?id=16549344
Mansoor 1995|Endothelin induced collagen remodeling in experimental pulmonary hypertension|/resolve/reference/PMED?id=7488070
McLaughlin 2005|Survival with first-line bosentan in patients with primary pulmonary hypertension|/resolve/reference/PMED?id=15684287
Miyamoto 2000|Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing|/resolve/reference/PMED?id=10673190
NHLBI 2011|Types of Pulmonary Hypertension|
Paramothayan 2005|Prostacyclin for pulmonary hypertension in adults|
Reeves 1986|The case for treatment of selected patients with primary pulmonary hypertension|/resolve/reference/PMED?id=3740659
Rich 1992|The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension|/resolve/reference/PMED?id=1603139
Rubens 2001|Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension|/resolve/reference/PMED?id=11713135
Seibold 2005|Sitaxsentan, a selective endothelin-a receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD)|
Sitbon 1998|Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension|/resolve/reference/PMED?id=9727772
Sitbon 2002|Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival|/resolve/reference/PMED?id=12204511
Wort 2001|Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling|/resolve/reference/PMED?id=11472982
Liu 2004|Endothelin receptor antagonists for pulmonary arterial hypertension|
Liu 2006b|Endothelin receptor antagonists for pulmonary arterial hypertension|
Liu 2009|Endothelin receptor antagonists for pulmonary arterial hypertension|/resolve/reference/PMED?id=19578331
RCT1 Christenson1997 {published data only}|The effect of preoperative intraaortic balloon pump support in patients with coronary artery disease, poor left ventricular function (LVEF < 40%), and hypertensive LV hypertrophy|/resolve/reference/PMED?id=9175220
RCT2 Christenson1997 {published data only}|Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG|/resolve/reference/PMED?id=9386685
RCT3 Christenson1997 {published data only}|Evaluation of preoperative intraaortic balloon pump support in high risk coronary patients|/resolve/reference/PMED?id=9237594
RCT4 Christenson1999 {published data only}|Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients|/resolve/reference/PMED?id=10509987
RCT5 Christenson2003 {published data only}|The role of intraaortic counterpulsion in high risk OPCAB surgery: a prospective randomised study|
Babatasi 2003 {published data only}|Pre-operative balloon counterpulsion and off-pump cardiac surgery for high risk patients|/resolve/reference/PMED?id=12664050
Badel 1996 {published data only}|Preoperative support by intraaortic balloon counterpulsion for improvement of cardiac perfusion in iterative myocardial revascularisation|
Baskett 2003 {published data only}|A multi-centre comparison of intra-aortic balloon pump utilisation in isolated coronary artery bypass graft surgery|/resolve/reference/PMED?id=14667626
Christenson 1997 {published data only}|The effect of preoperative intraaortic balloon pump support in high risk patients requiring myocardial revascularisation|/resolve/reference/PMED?id=9267351
Christenson 2000a {published data only}|Economic impact of preoperative intraaortic balloon pump therapy in high-risk coronary patients|/resolve/reference/PMED?id=10969672
Christenson 2000b {unpublished data only}|The intraaortic balloon pump as preoperative therapy in high risk coronary patients|
Christenson 2001 {published data only}|Effective surgical management of high-risk coronary patients using preoperative intraaortic balloon counterpulsion therapy|/resolve/reference/PMED?id=11420164
Christenson 2002 {published data only}|Preoperative intraaortic balloon pump for salvage myocardial revascularisation|/resolve/reference/PMED?id=12538272
Cohen 2003 {published data only}|Intra-aortic balloon counterpulsion in US and non-US centres: Results of the benchmark registry|/resolve/reference/PMED?id=14522572
Cooper 1997 {published data only}|Preopeartive intra-aortic balloon assist in high risk revascularization patients|/resolve/reference/PMED?id=300572
Craver 2001 {published data only}|Elective intraaortic balloon counterpulsion for high-risk off-pump coronary artery bypass operations|/resolve/reference/PMED?id=11308163
Dietl 1996 {published data only}|Efficacy and cost effectiveness of preoperative IABP in patients with ejection fraction of 0.25 or less|/resolve/reference/PMED?id=8694611
Dunning 2004 {published data only}|Which patients would benefit from an intra-aortic balloon pump prior to cardiac surgery|
Ferguson 2001 {published data only}|The current practice of intra-aortic ballon counterpulsion: results from the Benchmark Registry|/resolve/reference/PMED?id=11691523
Gutfinger 1999 {published data only}|Aggressive preoperative use of the intraaortic balloon pump in elderly patients undergoing coronary bypass grafting|/resolve/reference/PMED?id=10215196
Holman 2000 {published data only}|Prophylactic value of pre-incision intraaortic balloon pump: analysis of a statewide registry|/resolve/reference/PMED?id=11088035
Kang 2001 {published data only}|Preoperative intraaortic balloon pump in high-risk patients undergoing open heart surgery|/resolve/reference/PMED?id=11465230
Kim 2001 {published data only}|Intraaortic balloon pump therapy facilitates posterior vessel off-pump coronary artery bypass grafting in high risk patients|/resolve/reference/PMED?id=11426775
Lo 2001 {published data only}|The application of intra-operative intraaortic balloon pump support for patients with impaired left ventricular systolic function undergoing beating heart coronary bypass grafting|
Marra 2002 {published data only}|Coronary artery bypass grafting in patients with severe left ventricular dysfunction: a prospective randomised study on the timing of perioperative intraaortic balloon pump support|/resolve/reference/PMED?id=11908489
Suzuki 2004 {published data only}|Usefulness of preoperative IABP therapy during off-pump coronary artery bypass grafting in high risk patients|/resolve/reference/PMED?id=15172264
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Moher 1999|Improving the quality of reports of meta-analysis of randomised controlled trials: the QUOROM statement|/resolve/reference/PMED?id=10584742
Nashef 1999|European system for cardiac operative risk evaluation (EuroSCORE)|/resolve/reference/PMED?id=10456395
Parsonnet 1989|A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease|/resolve/reference/PMED?id=2720942
Christenson 1997a {published data only}|The effect of preoperative intraaortic balloon pump support in patients with coronary artery disease, poor left ventricular function (LVEF < 40%), and hypertensive LV hypertrophy|/resolve/reference/PMED?id=9175220
Christenson 1997b {published data only}|Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG|/resolve/reference/PMED?id=9386685
Christenson 1997c {published data only}|Evaluation of preoperative intraaortic balloon pump support in high risk coronary patients|/resolve/reference/PMED?id=9237594
Christenson 1999 {published data only}|Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients|/resolve/reference/PMED?id=10509987
Christenson 2003 {published data only}|The role of intraaortic counterpulsion in high risk OPCAB surgery: a prospective randomised study|
Oberhoffer 2006 {published data only (unpublished sought but not used)}|Abstract 542: Prospective randomized study of preoperative intraaortic balloon counterpulsation in high risk coronary artery bypass grafting patients|
Babatasi 2003 {published data only}|Pre-operative balloon counterpulsion and off-pump cardiac surgery for high risk patients|/resolve/reference/PMED?id=12664050
Badel 1996 {published data only}|Preoperative support by intraaortic balloon counterpulsion for improvement of cardiac perfusion in iterative myocardial revascularisation|
Baskett 2003 {published data only}|A multi-centre comparison of intra-aortic balloon pump utilisation in isolated coronary artery bypass graft surgery|/resolve/reference/PMED?id=14667626
Baskett 2005 {published data only}|The preoperative intraaortic balloon pump in coronary bypass surgery: a lack of evidence of effectiveness|/resolve/reference/PMED?id=16338247
Christenson 1997d {published data only}|The effect of preoperative intraaortic balloon pump support in high risk patients requiring myocardial revascularisation|/resolve/reference/PMED?id=9267351
Christenson 2000a {published data only}|Economic impact of preoperative intraaortic balloon pump therapy in high-risk coronary patients|/resolve/reference/PMED?id=10969672
Christenson 2000b {published and unpublished data}|The intraaortic balloon pump as preoperative therapy in high risk coronary patients|
Christenson 2001 {published data only}|Effective surgical management of high-risk coronary patients using preoperative intraaortic balloon counterpulsion therapy|/resolve/reference/PMED?id=11420164
Christenson 2002 {published data only}|Preoperative intraaortic balloon pump for salvage myocardial revascularisation|/resolve/reference/PMED?id=12538272
Cohen 2003 {published data only}|Intra-aortic balloon counterpulsion in US and non-US centres: Results of the benchmark registry|/resolve/reference/PMED?id=14522572
Cooper 1997 {published data only}|Preopeartive intra-aortic balloon assist in high risk revascularization patients|/resolve/reference/PMED?id=300572
Craver 2001 {published data only}|Elective intraaortic balloon counterpulsion for high-risk off-pump coronary artery bypass operations|/resolve/reference/PMED?id=11308163
Dietl 1996 {published data only}|Efficacy and cost effectiveness of preoperative IABP in patients with ejection fraction of 0.25 or less|/resolve/reference/PMED?id=8694611
Diez 2008 {published data only}|EuroSCORE directed intraaortic balloon pump placement in high-risk patients undergoing cardiac surgery: retrospective analysis of 267 patients|/resolve/reference/PMED?id=18256116
Etienne 2007 {published data only}|Reduced mortality in high risk coronary patients operated off pump with preoperative intraaortic balloon counterpulsion|/resolve/reference/PMED?id=17643622
Ferguson 2001 {published data only}|The current practice of intra-aortic balloon counterpulsion: results from the Benchmark Registry|/resolve/reference/PMED?id=11691523
Gong 2009 {published data only}|Beneficial effect of preventative intra-aortic balloon pumping in high risk patients undergoing first time coronary artery bypass grafting - a single centre experience|
Gutfinger 1999 {published data only}|Aggressive preoperative use of the intraaortic balloon pump in elderly patients undergoing coronary bypass grafting|/resolve/reference/PMED?id=10215196
Holman 2000 {published data only}|Prophylactic value of pre-incision intraaortic balloon pump: analysis of a statewide registry|/resolve/reference/PMED?id=11088035
Kang 2001 {published data only}|Preoperative intraaortic balloon pump in high-risk patients undergoing open heart surgery|/resolve/reference/PMED?id=11465230
Kern 2009 {published data only}|The use of preoperative intra-aortic balloon in myocardial revascularization surgery associated to severe ventricular dysfunction|
Kim 2001 {published data only}|Intraaortic balloon pump therapy facilitates posterior vessel off-pump coronary artery bypass grafting in high risk patients|/resolve/reference/PMED?id=11426775
Lo 2001 {published data only}|The application of intra-operative intraaortic balloon pump support for patients with impaired left ventricular systolic function undergoing beating heart coronary bypass grafting|
Marra 2002 {published data only}|Coronary artery bypass grafting in patients with severe left ventricular dysfunction: a prospective randomised study on the timing of perioperative intraaortic balloon pump support|/resolve/reference/PMED?id=11908489
Miceli 2009 {published data only}|Prophylactic intra-aortic balloon pump in high risk patients undergoing coronary artery bypass grafting: a propensity score analysis|/resolve/reference/PMED?id=19359281
Suzuki 2004 {published data only}|Usefulness of preoperative IABP therapy during off-pump coronary artery bypass grafting in high risk patients|/resolve/reference/PMED?id=15172264
NCT00881192 {published data only (unpublished sought but not used)}|Perioperative IABP in CABG Operations in Patients With Severely Depressed Left Ventricular Function: a Randomized, Controlled Trial|
Bojar 1999||
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Dunning 2003|Derivation and validation of a clinical scoring system to predict the need for an intra-aortic balloon pump in patients undergoing adult cardiac surgery|/resolve/reference/PMED?id=17670145
Dunning 2004|Which patients would benefit from an intra-aortic balloon pump prior to cardiac surgery?|
Dyub 2008|Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: A systematic review and meta-analysis|
Field 2007|Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass grafting|
Healy 2006|EuroSCORE: Useful in directing preoperative intra-aortic balloon pump placement in cardiac surgery?|
Higgins 2009|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009|
Lefebvre 1996|Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE|
Nashef 1999|European system for cardiac operative risk evaluation (EuroSCORE)|/resolve/reference/PMED?id=10456395
Parsonnet 1989|A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease|/resolve/reference/PMED?id=2720942
Review Manager 2008|Review Manager (RevMan)|
Santarpino 2009|Preoperative intraaortic balloon pumping improves outcomes for high risk patients in routine coronary artery bypass graft surgery|/resolve/reference/PMED?id=19161764
SCTS Blue Book 2008||
Chang 2004 {published data only}|Effects of tongxinluo capsule in the treatment of 68 patients with unstable angina pectoris|
Cheng 2002 {published data only}|Use of Tongxinluo capsule in patients of unstable angina pectoris|
Han 2004a {published data only}|Effect of tongxinluo capsule on function of vascular endothelium in patients with unstable angina pectoris|
Jia 1999 {published data only}|Effect of Tongxinluo capsule in treating variant angina pectoris patients and its influence on endothelial function|/resolve/reference/PMED?id=11783154
Jia 2001 {published data only}|Study of therapeutic effect of Tongxinluo (TXL) capsule and its therapeutical mechanism|
Jia 2001 {published data only}|Study of therapeutic effect of TongXinLuo (TXL) capsule and its therapeutical mechanism|
Jia 2001 {published data only}|Effect of Tongxinluo capsule on function of vascular endothelium in patients with coronary heart disease|
Liang 2002 {published data only}|Effect of Tongxinluo capsule on plasma endothelin and calcitonin gene related peptide in patients with unstable angina pectoris|/resolve/reference/PMED?id=12585189
Liu 2003 {published data only}|Clinical observation for Tongxinluo in the treatment of unstable angina pectoris|
Lu 2002a {published data only}|Effect of tongxinluo capsule in the treatment of unstable angina|
Nong 2000 {published data only}|Research on combined treatment of unstable angina pectoris with TCM and WM|
Nong 2000 {published data only}|Clinical application of Tongxinlou capsule in unstable angina pectoris|
Nong 2000 {published data only}|Clinical study on Tongxinluo capsule in treatment for unstable angina pectoris|
Song 2002 {published data only}|Observation for effects of Tongxinluo in the treatment of unstable angina pectoris|
Su 2000 {published data only}|Clinical study for Tongxinluo capsule in the treatment of 96 cases of variant angina pectoris|
Sun 2004 {published data only}|Effect of Tongxinluo capsule on the function of platelet activation in patients with unstable angina pectoris|
Xiao 2002 {published data only}|The influence of tongxinluo capsule for Von Willebrand factor and fibrin conjugated protein of unstable angina (abstract)|
Xiao 2002 {published data only}|The effect of protection for endothelial cell of tongxinluo capsule in the treatment of unstable angina|
Xiao 2004 {published data only}|Effects of tongxinluo in the treatment of unstable angina|
Yang 2001a {published data only}|Tongxinluo in the treatment of unstable angina 56 cases|
Yao 2003 {published data only}|Effects of Tongxinluo capsule in the treatment of 30 unstable angina pectoris|
Zhang 2000 {published data only}|A clinical study of tongxinluo capsule in the treatment of unstable angina pectoris|
Zhang 2004 {published data only}|Effects of tongxinluo capsule in the treatment of 68 patients with unstable angina pectoris|
Gao 2002 {published data only}|A clinical observation of tongxinluo capsule in the treatment of 60 patients with unstable angina pectoris|
Han 2004b {published data only}|Effects of tongxinluo capsule in the treatment of 57 patients with unstable angina|
Hu 2001 {published data only}|Effect of tongxinluo capsule in the treatment of 59 patients with unstable angina pectoris|
Huang 2004 {published data only}|Effects of tongxinluo combined with puerarin in the treatment of unstable angina|
Li 2000 {published data only}|Effect analysis of Tongxinluo in the treatment of unstable angina pectoris|
Li 2001 {published data only}|A clinical study of tongxinluo capsule in the treatment of unstable angina 34 cases|
Li 2002 {published data only}|Influence on thrombase activation and fibrinogen of tongxinluo capsule in the treatment of unstable angina|
Lu 2002b {published data only}|A clinical study of tongxinluo capsule in the treatment of unstable angina pectoris|
Ma 2004 {published data only}|Effects of chinese herbs for activating blood circulation, removing stasis and supplementing Qi on the circulating endothelial cells in patients with unstable angina pectoris|
Qin 2004 {published data only}|Effects of tongxinluo capsule in the treatment of unstable angina pectoris|
Shi 2001 {published data only}|A clinical study of tongxinluo combined with low molecular weight heparin in the treatment of unstable angina pectoris|
Su 2001 {published data only}|Influence on fibrinolytic system of tongxinluo capsule in the treatment of unstable angina|
Su 2004 {published data only}|Effects of tongxinluo capsule in the treatment of unstable angina pectoris|
Wang 2001 {published data only}|Observation of tongxinluo capsule in the treatment of unstable angina|
Wang 2003a {published data only}|Effect of Tongxinluo capsule on function of vascular endothelium in patients with unstable angina pectoris|/resolve/reference/PMED?id=14503056
Wang 2003b {published data only}|Tongxinluo capsule in the treatment of 60 unstable angina pectoris|
Xu 2003 {published data only}|Influence of tongxinluo capsule on Naifold microcirculation in patients with unstable angina pectoris|
Yang 2001b {published data only}|Effect of tongxinluo in the treatment of unstable angina|
Yang 2002 {published data only}|Lipids level of patients with unstable angina pectoris treating with tongxinluo|
ACC 2001|American College of Cardiology Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)|/resolve/reference/PMED?id=11738323
Anon 2002|An important new theory on Chinese herbal medicine for treatment of cardio-cerebral vascular diseases|
Braunwald 1989|Unstable angina: a classification|/resolve/reference/PMED?id=2752565
Braunwald 1992||
Braunwald 1994||
CCS 1972|Grading scale for classification of severity of angina|/resolve/reference/PMED?id=947585
Chen 1985|Effect of Scolopendra extract in experiment on rabbit heart|
Deng 1991|Effect of Radix Paeoniae Rubra water-extraction in the experiment of anticoagulation|
Fulder 1996||
Gu 1983|The effect of myocardial kinetics of dog in the experimental of Ginseng, Radix Aconiti Lateralis Preparata and their complex|
ICSI 2005a|Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)|
ICSI 2005b|Diagnosis and treatment of chest pain and acute coronary syndrome (ACS).|
Jin 1983|Comparison of pharmacological action of Radix Ginseng Rubra with freeze-dried Ginseng, and Ginseng dried in the sun|
Juni 2001|Assessing the quality of controlled clinical trials|/resolve/reference/PMED?id=11440947
KAU 1996|Unstable Angina: Diagnosis and Management|
Li 1989|A study of thrombolytic function of Hirudin|
Liu 1997|Effect of Tongxinluo capsule on experimental myocardial ischemia, arrhythmia and hyperlipidemia|/resolve/reference/PMED?id=10322866
Liu 2000|Chinese medicinal herbs for chronic hepatitis B|
Nong 1989|The effect of Eupolyphaga Sinensis Walk alkaloids on rabbits cardial pump function|
Nu 1983|Effect of Radix Paeoniae Rubrasin in experiment on hyperlipemia and hypercholesterolemia mice|
Ou 1987|Experimental survey of 126 Chinese medicine antithrombin function|
Pei 1986|Study of cardiac stimulation of Ginsenoside of upper part over grand|
Shang 1997|Effect of Tongxinluo capsule on hemodynamics and myocardial oxygen consumption in dogs|/resolve/reference/PMED?id=10322838
Wang 1980|Pharmacological action of Radix Paeoniae Rubra extraction for injection|
Wang 1998||
Wu 1994|Comparison of adjustment function of three Hirudo products|
Wu 1998|Method of making tongxinluo capsule treating coronary artery disease and angina|
Wu 2001a||
Wu 2001b|Current status of major cardiovascular risk factors in Chinese populations and their trends in the past two decades|
Xu 1988a|Effect of inhibition platelet adhesion reaction of Radix Ginseng|
Xu 1988b|Affect of Hirudo water-extraction on mice and human platelet adhesion reaction and blood rheology|/resolve/reference/PMED?id=3240798
Yang 1989|The effect of Eupolyphaga Sinensis Walk alkaloids on animal tolerance of hypoxia|
Yuan 1983|Pharmacological action of Radix Ginsenoside|/resolve/reference/PMED?id=6225301
Zhang 1978|Study of anti-angina action of Hirudo extract|
Zhang 1990|The effect of Radix Paeoniae Rubra in the experiment of chronic hyperlipemia rabbits' plasma TXB2 and PGF1alpha|/resolve/reference/PMED?id=2268930
Zheng 1998|Periostracum Cicadae|
Abel 1983 {published data only}|Continued propranolol administration following coronary bypass surgery|/resolve/reference/PMED?id=6601941
Ali 1997 {published data only}|Beta-blocker effects on postoperative atrial fibrillation|/resolve/reference/PMED?id=9237602
Apipan 2010 {published data only}|Efficacy and safety of oral propranolol premedication to reduce reflex tachycardia during hypotensive anesthesia with sodium nitroprusside in orthognathic surgery: a double-blind randomized clinical trial|
Auer 2004 {published data only}|A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo-controlled trial|/resolve/reference/PMED?id=15077078
Babin-Ebell 1996 {published data only}|Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting|
Bayliff 1999 {published data only}|Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery|/resolve/reference/PMED?id=10086546
Bert 2001 {published data only}|A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery|/resolve/reference/PMED?id=11312480
Booth 2004 {published data only}|Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute -adrenergic receptor desensitization during cardiac surgery?|/resolve/reference/PMED?id=15105192
Burns 1988 {published data only}|Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia|/resolve/reference/PMED?id=2972306
But 2006 {published data only}|The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery|
Coleman 1980 {published data only}|Cardiovascular response to anaesthesia. Influence of beta-adrenergic blockade with metoprolol|
Connolly 2003 {published data only}|Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-blocker length of stay (BLOS) study|/resolve/reference/PMED?id=12595838
Cork 1995 {published data only}|The effect of esmolol given during cardiopulmonary bypass|/resolve/reference/PMED?id=7802296
Cucchiara 1986 {published data only}|Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy|/resolve/reference/PMED?id=2877599
Daudon 1986 {published data only}|Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting|/resolve/reference/PMED?id=3535474
De Azevedo Lcio 2003 {published data only}|Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery|
DIPOM - Juul 2006 {published and unpublished data}|Effect of perioperative  blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial|/resolve/reference/PMED?id=16793810
Dy 1998 {published data only}|Post-operative atrial fibrillationa randomized trial of metoprolol, flecainide, and placebo|
Evrard 2000 {published data only}|Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol|/resolve/reference/PMED?id=10921700
Forlani 2002 {published data only}|Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting|/resolve/reference/PMED?id=12238830
Gibson 1988 {published data only}|Esmolol for the control of hypertension after neurologic surgery|/resolve/reference/PMED?id=2904310
Gomes 1999 {published data only}|Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=10440141
Graham 1996 {published data only}|Low dose but not medium dose beta blockers reduce post-operative atrial fibrillation|/resolve/reference/PMED?id=8674178
Gupta 2011 {published data only}|Comparative evaluation of atenolol and clonidine premedication on cardiovascular response to nasal speculum insertion during trans-sphenoid surgery for resection of pituitary adenoma: a prospective, randomised, double-blind, controlled study|
Hammon 1984 {published data only}|Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias|/resolve/reference/PMED?id=6385890
Harrison 1987 {published data only}|The role of an ultra short-acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery|/resolve/reference/PMED?id=2881505
Inada 1989 {published data only}|Effect of labetalol or lidocaine on the hemodynamic response to intubation: a controlled randomized double-blind study|
Ivey 1983 {published data only}|Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization|/resolve/reference/PMED?id=6337306
Jacquet 1994 {published data only}|Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery|/resolve/reference/PMED?id=7948800
Jakobsen 1992 {published data only}|Effect of pre-operative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy|/resolve/reference/PMED?id=1600972
Jakobsen 1997 {published data only}|Preoperative metoprolol improves cardiovascular stability and reduces oxygen consumption after thoracotomy|
Janssen 1986 {published data only}|Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial|
Kawaguchi 2010 {published data only}|Effects of a short-acting 1 receptor antagonist landiolol on hemodynamics and tissue injury markers in patients with subarachnoid hemorrhage undergoing intracranial aneurysm surgery|
Khuri 1987 {published data only}|Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting|
Kurian 2001 {published data only}|The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery|/resolve/reference/PMED?id=11736772
Lai 2006 {published data only}|Beneficial effects of metoprolol on perioperative cardiac function of elderly esophageal cancer patients|/resolve/reference/PMED?id=16687084
Lamb 1988 {published data only}|The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery|/resolve/reference/PMED?id=3257915
Lee 2010 {published data only}|The effect of perioperative esmolol infusion on the post-operative nausea, vomiting and pain after laparoscopic appendectomy|
Liu 1986 {published data only}|Esmolol for control of increases in heart rate and blood pressure during tracheal intubation after thiopentone and succinylcholine|/resolve/reference/PMED?id=3768764
Liu 2006 {published data only}|Influences of perioperative metoprolol on haemodynamics and myocardial ischaemia in elderly patients undergoing noncardiac surgery|/resolve/reference/PMED?id=16706126
Magnusson 1986 {published data only}|Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery|/resolve/reference/PMED?id=3511930
Mangano 1996 {published data only}|Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery|/resolve/reference/PMED?id=8929262
Martinussen 1988 {published data only}|Supraventricular tachyarrhythmias after coronary bypass surgery - a double blind randomized trial of prophylactic low dose propranolol|/resolve/reference/PMED?id=2903581
Marwick 2009 {published data only}|Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery|/resolve/reference/PMED?id=19332211
Matangi 1985 {published data only}|Arrhythmia prophylaxis after aorta-coronary bypass. The effect of minidose propranolol|/resolve/reference/PMED?id=3871883
Matangi 1989 {published data only}|Atenolol for the prevention of arrhythmias following coronary artery bypass grafting|/resolve/reference/PMED?id=2659151
Materne 1985 {published data only}|Prevention by acebutolol of rhythm disorders following coronary bypass surgery|/resolve/reference/PMED?id=3894250
Matsuura 2001 {published data only}|Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting|/resolve/reference/PMED?id=11692587
Miller 1990 {published data only}|Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: efficacy and effects on myocardial performance|
Miller 1991 {published data only}|Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian multicentre trial|/resolve/reference/PMED?id=1683818
Mohr 1981 {published data only}|Prevention of supraventricular tachyarrhythmia with low-dose propranolol after coronary bypass|/resolve/reference/PMED?id=7015021
Moon 2011 {published data only}|The sparing effect of low-dose esmolol on sevoflurane during laparoscopic gynaecological surgery|
Myhre 1984 {published data only}|Effects of low dose propranolol after coronary bypass surgery|
Neary 2006 {published data only}|Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgery|/resolve/reference/PMED?id=16764198
Neustein 1994 {published data only}|Esmolol and intraoperative myocardial ischemia: a double-blind study|/resolve/reference/PMED?id=7914754
Nystrm 1993 {published data only}|Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery|/resolve/reference/PMED?id=8103611
Ogawa 2013 {published data only}|Perioperative use of beta blocker in coronary artery bypass grafting|
Oka 1980 {published data only}|Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 10. Beta-adrenoceptor blockade and coronary artery surgery|/resolve/reference/PMED?id=6101516
Ormerod 1984 {published data only}|Arrhythmias after coronary bypass surgery|/resolve/reference/PMED?id=6610435
Osada 2012 {published data only}|Landiolol hydrochloride: prevention of atrial fibrillation after open-heart surgery|
Oxorn 1990 {published data only}|Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia|/resolve/reference/PMED?id=1968784
Paull 1997 {published data only}|Beta-blockade to prevent atrial dysrhythmias following coronary bypass surgery|/resolve/reference/PMED?id=9168080
Pfisterer 1997 {published data only}|Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study|
POBBLE 2005 {published data only}|Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial|/resolve/reference/PMED?id=15874923
POISE 2008 {published data only}|Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial|/resolve/reference/PMED?id=18479744
Raby 1999 {published data only}|The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery|/resolve/reference/PMED?id=10071990
Reves 1990 {published data only}|Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique|/resolve/reference/PMED?id=1974664
Rubin 1987 {published data only}|Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operation|/resolve/reference/PMED?id=3306163
Sakaguchi 2012 {published data only}|Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery|
Salazar 1979 {published data only}|Beta-blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?|/resolve/reference/PMED?id=316976
Sandler 1990 {published data only}|Esmolol compared with placebo in preventing increases in heart rate and blood pressure during rigid bronchoscopy|
Sezai 2011 {published data only}|Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial|
Sezai 2012 {published data only}|Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study|
Shukla 2010 {published data only}|Role of  blockade in anaesthesia and postoperative pain management after major lower abdominal surgery|
Silverman 1982 {published data only}|Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study|/resolve/reference/PMED?id=6979982
Stephenson 1980 {published data only}|Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study|/resolve/reference/PMED?id=6965579
Stone 1988 {published data only}|Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent|/resolve/reference/PMED?id=2895596
Sun 2011 {published data only}|Effect of short-acting beta blocker on the cardiac recovery after cardiopulmonary bypass|
Suttner 2009 {published data only}|Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients|/resolve/reference/PMED?id=19336536
Suttorp 1991 {published data only}|Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting|/resolve/reference/PMED?id=1951075
Vecht 1986 {published data only}|Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery|/resolve/reference/PMED?id=3539826
Wallace 1998 {published data only}|Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group|/resolve/reference/PMED?id=9447850
Wenke 1999 {published data only}|Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting|/resolve/reference/PMED?id=10525926
White 1984 {published data only}|Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery|/resolve/reference/PMED?id=6378423
Whitehead 1980 {published data only}|Metoprolol in anaesthesia for oral surgery|
Williams 1982 {published data only}|Arrhythmia prophylaxis using propranolol after coronary artery surgery|/resolve/reference/PMED?id=6982689
Yang 2006 {published data only}|The effects of perioperative beta-blockade: results of the metoprolol after vascular surgery (MaVS) study, a randomized controlled trial|/resolve/reference/PMED?id=17070177
Yang 2008 {published data only}|Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery|/resolve/reference/PMED?id=18953854
Zaugg 1999 {published data only}|Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery|/resolve/reference/PMED?id=10598610
DECREASE-IV 2009 {published data only}|Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgeryA randomized controlled trial (DECREASE-IV)|/resolve/reference/PMED?id=19474688
Klter-Weber 1998 {published data only}|Significance of supraventricular tachyarrhythmias after coronary artery bypass graft surgery and their prevention by low-dose sotalol: a prospective double-blind randomized placebo-controlled study|
Poldermans 1999 {published data only}|The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery|/resolve/reference/PMED?id=10588963
Bangalore 2008|Perioperative  blockers in patients having non-cardiac surgery: a meta-analysis|/resolve/reference/PMED?id=19012955
Bouri 2013|Meta-analysis of secure randomised controlled trials of -blockade to prevent perioperative death in non-cardiac surgery|
Crystal 2002|Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis|/resolve/reference/PMED?id=12093773
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Devereaux 2004|Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?|/resolve/reference/PMED?id=15289423
Duval 2000|Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Fihn 2012|2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons|
Fleischmann 2009|2009 ACCF/AHA focused update on perioperative beta blockade|
Fleisher 2001|Lowering cardiac risk in noncardiac surgery|/resolve/reference/PMED?id=11759647
Fleisher 2007|ACC/AHA 2007 guidelines on perioperative cardiovascular care and care for noncardiac surgery: a report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)|/resolve/reference/PMED?id=17901356
Guyatt 2008|GRADE: an emerging consensus on rating quality of evidence and strength of recommendations|/resolve/reference/PMED?id=18436948
Hammermeister 1990|Identification of patients at greatest risk for developing major complications at cardiac surgery|
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011||
Hillis 2011|2011 ACCF/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines|
Juni 1999|The hazards of scoring the quality of clinical trials for meta-analysis|/resolve/reference/PMED?id=10493204
Kaplan 1993||
Kjekshus 1987|Heart rate reductiona mechanism of benefit?|
Kjekshus 1991|Heart rate as a therapeutic target in heart failure|
Lancet 1986|Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group|/resolve/reference/PMED?id=2873379
Lancet 1999|The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial|/resolve/reference/PMED?id=10023943
Lauer 1989|Atrial fibrillation following coronary artery bypass surgery|
Mangano 1990a|Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group|/resolve/reference/PMED?id=2247116
Mangano 1990b|Perioperative cardiac morbidity|/resolve/reference/PMED?id=2404426
Mangano 1995|Preoperative assessment of patients with known or suspected coronary disease|/resolve/reference/PMED?id=7491140
Moher 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials|/resolve/reference/PMED?id=11323066
Montalescot 2013|2013 ESC guidelines in the management of stable coronary artery disease|
Pepine 1994|Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)|/resolve/reference/PMED?id=8044945
Poldermans 2009|Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery|
Rahimzadeh 2008|Evaluation of the metoprolol effects in controlled hypotension and reduction of bleeding during head and neck surgery|
RevMan 5.1|Review Manager (RevMan)|
Ryden 1983|A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias|
Stevens 2003|Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review|/resolve/reference/PMED?id=12933373
Thorlund 2011||
Wetterslev 2008|Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis|/resolve/reference/PMED?id=18083463
Wheatley 2003|Be skeptical about unexpected large apparent treatment effects: the case of an MRC AML 12 randomization|/resolve/reference/PMED?id=12559643
Wiesbauer 2007|Perioperative -blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis|/resolve/reference/PMED?id=17179240
Al-Asseri 2001 {published data only}|Counseling and post-discharge care|
Barnason 1995 {published data only}|A comparison of patient teaching outcomes among postoperative coronary artery bypass graft (CABG) patients|/resolve/reference/PMED?id=8584545
Beckie 1989 {published data only}|A supportive-educative telephone program: Impact on knowledge and anxiety after coronary artery bypass graft surgery|/resolve/reference/PMED?id=2783580
Beney 2002 {published data only}|Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer|
Bostrom 1996 {published data only}|Telephone follow-up after discharge from the hospital: does it make a difference?|/resolve/reference/PMED?id=8871430
Boter 2000 {published and unpublished data}|A randomized trial of a Telephone Reassurance Programme for patients recently discharged from an ophthalmic unit|
Chande 1994 {published data only}|Follow-up phone calls after an emergency department visit|/resolve/reference/PMED?id=8115218
Dudas 2001 {published data only}|The impact of follow-up telephone calls to patients after hospitalization|/resolve/reference/PMED?id=11790365
Dudas 2001 {published data only}|The impact of follow-up telephone calls to patients after hospitalization|/resolve/reference/PMED?id=12021756
Emerson 2000 {published data only}|Effect of telephone followups on post vasectomy office visits|
Fallis 2001 {published data only}|Outpatient laparoscopic cholecystectomy: Home visit versus telephone follow-up|/resolve/reference/PMED?id=11220797
Faulkner 2000 {published data only}|Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial|
Garding 1988 {published data only}|Effectiveness of a program of information and support for myocardial infarction patients recovering at home|/resolve/reference/PMED?id=2839433
Gombeski 1993 {published data only}|Patient callback program: a quality improvement, customer service, and marketing tool|/resolve/reference/PMED?id=10129817
Gortner 1990 {published data only (unpublished sought but not used)}|Self-efficacy and activity level following cardiac surgery|
Hagopian 1990 {published data only}|Effects of telephone call interventions on patients' well-being in a radiation therapy department|/resolve/reference/PMED?id=2276106
Hartford 2002 {published and unpublished data}|Randomized controlled trial of a telephone intervention by nurses to provide information and support to patients and their partners after elective coronary artery bypass graft surgery: effects of anxiety|
Jerant 2001 {published data only (unpublished sought but not used)}|A randomized trial of telenursing to reduce hospitalization for heart failure: patient-centered outcomes and nursing indicators|/resolve/reference/PMED?id=12749524
Jerant 2001 {published data only (unpublished sought but not used)}|Reducing the cost of frequent hospital admissions for congestive heart failure: a randomized trial of a home telecare intervention|/resolve/reference/PMED?id=11606877
Jones 1988 {published data only}|A randomized trial to improve compliance in urinary tract infection patients in the emergency department|/resolve/reference/PMED?id=2404435
Jones 1988 {published data only}|Improving follow-up among hypertensive patients using a health belief model intervention|/resolve/reference/PMED?id=3632163
Jones 1988 {published data only}|A nursing intervention to increase compliance in otitis media patients|/resolve/reference/PMED?id=2719485
Jones 1988 {published data only}|Compliance for low-back pain patients in the emergency department. A randomized trial|/resolve/reference/PMED?id=2973132
Jones 1988 {published data only}|Health belief model intervention to increase compliance with emergency department patients|/resolve/reference/PMED?id=3199913
Mohan 1999 {published data only}|Weekly telephone contact does not enhance the compliance of home apnea monitoring|/resolve/reference/PMED?id=10685300
Munro 1994 {published data only}|A randomized study of telephone contact following completion of radiotherapy|/resolve/reference/PMED?id=7986761
Nelson 1991 {published data only}|Improving the use of early follow-up care after emergency department visits. A randomized trial|/resolve/reference/PMED?id=1849343
Ouellet 2003 {published data only (unpublished sought but not used)}|Post-discharge telephone follow-up for orthopaedic surgical patients: a pilot study|
Phillips 1999 {published data only}|Using telehealth interventions to prevent pressure ulcers in newly injured spinal cord injury patients post-discharge. Results from a pilot study|/resolve/reference/PMED?id=10645116
Phillips 2001 {published data only}|Telehealth: reaching out to newly injured spinal cord patients|/resolve/reference/PMED?id=11889278
Riegel 2002 {published data only}|Standardized telephonic case management in a Hispanic heart failure population: an effective intervention|
Riegel 2002 {published data only}|Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure|/resolve/reference/PMED?id=11911726
Ritchie 2000 {published data only}|A telephone call reminder to improve outpatient attendance in patients referred from the emergency department: a randomised controlled trial|
Roebuck 1999 {published data only}|Telephone support in the early post-discharge period following elective cardiac surgery: does it reduce anxiety and depression levels?|/resolve/reference/PMED?id=10595053
Samarel 2002 {published data only}|Effects of two types of social support and education on adaptation to early-stage breast cancer|
Shesser 1986 {published data only}|The effectiveness of an organized emergency department follow-up system|/resolve/reference/PMED?id=3740576
Touyz 1998 {published data only}|The influence of postoperative telephone calls on pain perception: a study of 118 periodontal surgical procedures|/resolve/reference/PMED?id=9780943
Tranmer 2004 {published data only}|Enhancing postoperative recovery of cardiac surgery patients: a randomized clinical trial of an advanced practice nursing intervention|/resolve/reference/PMED?id=15359055
Tu 1993 {published data only}|Diabetes self-care knowledge, behaviors, and metabolic control of older adults: the effect of a posteducational follow-up program|/resolve/reference/PMED?id=8458295
Weaver 2001 {published data only}|Telephone follow-up after cardiac surgery: facilitating the transition from hospital to home|
Aadalen 1998 {published data only}|Methodological challenges to prospective study of an innovation: interregional nursing care management of cardiovascular patients|
Aaronson 1996 {published data only}|Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials|/resolve/reference/PMED?id=8622050
Alcaide 1990 {published data only}|Influence of health education on compliance with antituberculous chemoprophylaxis in children: a community trial|/resolve/reference/PMED?id=2123042
Alfaro 1997 {published data only}|Estimation of surgical wound infection rates by a surveillance post-discharge control program|/resolve/reference/PMED?id=9379749
Allen 2002 {published data only}|A problem-solving approach to stress reduction among younger women with breast carcinoma: a randomized controlled trial|
anonymous 1995a {published data only}|Follow-up phone calls provide only moderate help for noninsulin-dependent diabetics|
anonymous 1995b {published data only}|Na het ontslag: telefonische nazorg en nazorggroepen|
anonymous 1995c {published data only}|Telephone follow-up after myocardial infarction|
anonymous 1996a {published data only}|RN calling: Oncology follow-up|
anonymous 1996b {published data only}|Telefonische nazorg door verpleegkundigen na acuut hartinfarct|
anonymous 1997 {published data only}|Frequent phone follow-up can improve the management of heart failure|
anonymous 1998 {published data only}|Telephone care really does work|
anonymous 2001a {published data only}|Follow up with patients by telephone|/resolve/reference/PMED?id=11496443
anonymous 2001b {published data only}|Care track. Lost & found: reaching more patients with telephone follow-up|
anonymous 2001c {published data only}|More educated nurses prove cost-effective for the sickest patients|/resolve/reference/PMED?id=11682928
Appel 2002 {published data only}|Self-regulation training for chronic pain: can it be done effectively by telemedicine?|/resolve/reference/PMED?id=12626105
Arthur 2002 {published data only}|A controlled trial of hospital versus home-based exercise in cardiac patients|/resolve/reference/PMED?id=12370553
Austin 1996 {published data only}|Health outcome improvements in patients with systemic lupus erythematosus using two telephone counseling interventions|
Avlund 2002 {published data only}|Effects of comprehensive follow-up home visits after hospitalization on functional ability and readmissions among old patients. A randomized controlled study|
Bailey 1998 {published data only}|Care coordination in managed care. Creating a quality continuum for high risk elderly patients|/resolve/reference/PMED?id=9856064
Barsevick 2002 {published data only}|A pilot study examining energy conservation for cancer treatment-related fatigue|/resolve/reference/PMED?id=12394560
Bartlett 1976 {published data only}|Patients receive current, concise health information by telephone|
Bean 1995 {published data only}|Readmission study leads to continuum of care|/resolve/reference/PMED?id=7659373
Beard 1978 {published data only}|Psychiatric rehabilitation and long-term rehospitalization rates: the findings of two research studies|/resolve/reference/PMED?id=216072
Bedeian 1996 {published data only}|Decreasing the number of recheck appointments for an urgent care clinic by using telephoned follow-up care by nurses|/resolve/reference/PMED?id=10155757
Beebe 2001 {published data only}|Community nursing support for clients with schizophrenia|/resolve/reference/PMED?id=11584350
Behrns 2000 {published data only}|Prospective randomized trial of early initiation and hospital discharge on a liquid diet following elective intestinal surgery|/resolve/reference/PMED?id=10675246
Benatar 2003 {published data only}|Outcomes of chronic heart failure|/resolve/reference/PMED?id=12578516
Bennett 2000 {published data only}|Heart Messages: a tailored message intervention for improving heart failure outcomes|/resolve/reference/PMED?id=10902106
Bergstrom 2000 {published data only}|Nursing care for ambulatory day surgery: The concept and organization of nursing care|
Berkman 1999 {published data only}|Supportive telephone outreach as an interventional strategy for elderly patients in a period of crisis|/resolve/reference/PMED?id=10425672
Berry 2002 {published data only}|Telephone follow-up by nurses reduces hospital readmissions among people with chronic heart failure|
Biermann 2000 {published data only}|Telecare of diabetic patients with intensified insulin therapy. A randomized clinical trial|/resolve/reference/PMED?id=11187566
Biermann 2002 {published data only}|Are there time and cost savings by using telemanagement for patients on intensified insulin therapy?: a randomised, controlled trial|/resolve/reference/PMED?id=12100793
Blake 1990 {published data only}|A randomized controlled evaluation of a psychosocial intervention in adults with chronic lung disease|/resolve/reference/PMED?id=2227172
Blue 2001 {published data only}|Randomised controlled trial of specialist nurse intervention in heart failure|/resolve/reference/PMED?id=11576977
Booker 2000 {published data only}|Evaluation of a nurse-led telephone clinic in the follow-up of patients with prostate cancer|/resolve/reference/PMED?id=11005699
Bostelman 1994 {published data only}|A community project to encourage compliance with mental health treatment aftercare|/resolve/reference/PMED?id=8153265
Boter 1998 {published data only}|Verpleegkundigen vullen lacune in de zorg op: telefonische nazorg voor oogheelkunde patinten|
Bourbeau 2003 {published data only}|Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention|/resolve/reference/PMED?id=12622605
Branch 1999 {published data only}|Positive impact of an intervention by arthritis patient educators on knowledge and satisfaction of patients in a rheumatology practice|
Brandis 1998 {published data only}|The Allied Health BONE (Best Orthopaedic New Enterprise) team: an interdisciplinary approach to orthopaedic early discharge and admission prevention|/resolve/reference/PMED?id=10185687
Brandt 1994 {published data only}|Patients and their learning needs: a new look... Telephone Nursing Care Link Project|
Brooks 2002 {published data only}|The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12166571
Caison 1997 {published data only}|Alcohol and drug treatment telephone follow-up using twelve step group member volunteers: Effects on a.a. and n.a. affiliation self-efficacy and behaviors among callers and call recipients|
Cave 1989 {published data only}|Follow-up phone calls after discharge|/resolve/reference/PMED?id=2472061
Celestino 1998 {published data only}|Telephone evaluation of effectiveness of discharge education on self-care management following total hip replacement|
Chong 2003 {published data only}|Substance abuse treatment outcomes among American Indians in the Telephone Aftercare Project|/resolve/reference/PMED?id=12733761
Chow 2001 {published data only}|Prospective assessment of symptom palliation for patients attending a rapid response radiotherapy program: feasibility of telephone follow-up|/resolve/reference/PMED?id=11495711
Cleuren 2000 {published data only}|Telefonische bereikbaarheid van een gespecialiseerd hartfalenverpleegkundige|
Cooper 2000 {published data only}|Outpatient ophthalmic plastic surgery: Outcomes and patient satisfaction using initial postoperative telephone call follow-up|/resolve/reference/PMED?id=10826765
Craddock 1999 {published data only}|An intervention to increase use and effectiveness of self-care measures for breast cancer chemotherapy patients|/resolve/reference/PMED?id=10452209
Dale 1997 {published data only}|Telephone advice. It's good to talk|/resolve/reference/PMED?id=10165721
Dantas 2002 {published data only}|Implementation of a nurse-monitored protocol in a Brazilian hospital: a pilot study with cardiac surgery patients|/resolve/reference/PMED?id=11932125
Dardik 1997 {published data only}|Impact of a critical pathway on the results of carotid endarterectomy in a tertiary care university hospital: effect of methods on outcome|
DeBusk 1985 {published data only}|Medically directed at-home rehabilitation soon after clinically uncomplicated acute myocardial infarction: a new model for patient care|/resolve/reference/PMED?id=3969859
DeBusk 1994 {published data only}|A case-management system for coronary risk factor modification after acute myocardial infarction|/resolve/reference/PMED?id=8147544
Dellasega 2000 {published data only}|A multimethod study of advanced practice nurse postdischarge care|/resolve/reference/PMED?id=11858450
Delores 2000 {published data only}|Evaluation of an early discharge program for infants after childbirth in a military population|/resolve/reference/PMED?id=10957856
Doolittle 1997 {published data only}|A cost analysis of a tele-oncology practice|/resolve/reference/PMED?id=9218371
Dunn 1995 {published data only}|Can a house call by a public health nurse improve the quality of the discharge process for geriatric patients?|/resolve/reference/PMED?id=10151166
Eaton 2002 {published data only}|Telephone appointment visits for head and neck surgery follow-up care|
Edwards 1997 {published data only}|A randomized controlled trial of alternative approaches to community follow-up for postpartum women|/resolve/reference/PMED?id=9170692
Elliott 1998 {published data only}|Postdischarge telephone follow-up program for breastfeeding preterm infants discharged from a special care nursery|/resolve/reference/PMED?id=9832757
Engelman 1994 {published data only}|Fast-track recovery of the coronary bypass patient|/resolve/reference/PMED?id=7979747
Estey 1990 {published data only}|Follow-up intervention: its effect on compliance behavior to a diabetes regimen|/resolve/reference/PMED?id=2357919
Evans 1985 {published data only}|Cognitive therapy to achieve personal goals: results of telephone group counseling with disabled adults|/resolve/reference/PMED?id=2932085
Ezenkwele 2003 {published data only}|A randomized study of electronic mail versus telephone follow-up after emergency department visit|/resolve/reference/PMED?id=12609640
Faithfull 2001 {published data only}|Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy|/resolve/reference/PMED?id=11747326
Farrero 2001 {published data only}|Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy|
Ferrigno 2001 {published data only}|A simple strategy for improving patient contact after ED discharge|/resolve/reference/PMED?id=11146018
Fitzgerald 1985 {published data only}|An experimental test of telephone aftercare contacts with alcoholics|/resolve/reference/PMED?id=2999514
Fleming 2002 {published data only}|Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis|
Fowler 1992 {published data only}|Family psychoeducation: chronic psychiatrically ill Caribbean patients|/resolve/reference/PMED?id=1578423
Frank 1986 {published data only}|Duration of breast-feeding among low-income women: a randomized trial of the effects of commercial hospital discharge packs and hospital-based telephone counseling|
Frank 1987 {published data only}|Commercial discharge packs and breast-feeding counseling: effects on infant-feeding practices in a randomized trial|/resolve/reference/PMED?id=3684395
Frasure-Smith 1985 {published data only}|The ischemic heart disease life stress monitoring program: impact on mortality|/resolve/reference/PMED?id=4059478
Frasure-Smith 1991 {published data only}|In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men|/resolve/reference/PMED?id=1987712
Frasure-Smith 1992 {published data only}|Differential long-term impact of in-hospital symptoms of psychological stress after non-Q-wave and Q-wave acute myocardial infarction|/resolve/reference/PMED?id=1575180
Frasure-Smith 1997 {published data only}|Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction|/resolve/reference/PMED?id=9274583
Frasure-Smith 2002 {published data only}|Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal heart attack readjustment trial|/resolve/reference/PMED?id=12140346
Fretwell 1990 {published data only}|The Senior Care Study. A controlled trial of a consultative/unit-based geriatric assessment program in acute care|/resolve/reference/PMED?id=2229859
Friedman 1998a {published data only}|A telecommunications system to manage patients with chronic disease|
Friedman 1998b {published data only}|Automated telephone conversations to assess health behavior and deliver behavioral interventions|/resolve/reference/PMED?id=9571516
Fukuda 1999 {published data only}|Evaluation of a diabetes patient education program consisting of a three-day hospitalization and a six-month follow-up by telephone counseling for mild type 2 diabetes and IGT|
Gagnon 1997 {published data only}|A randomized trial of a program of early postpartum discharge with nurse visitation|/resolve/reference/PMED?id=9024115
Gagnon 1999 {published data only}|Randomized controlled trial of nurse case management of frail older people|/resolve/reference/PMED?id=10484257
Gagnon 2002 {published data only}|Randomized trial of postpartum care after hospital discharge|/resolve/reference/PMED?id=12042545
Gallagher 2003 {published data only}|Effects of a telephone counseling intervention on psychosocial adjustment in women following a cardiac event|
Galt 2000 {published data only}|Identifying noncompliance by combining refill audits with telephone follow-up (letter)|/resolve/reference/PMED?id=10674774
Gamboa 2002a {published data only}|The special attention to re-admitted patients can be effective. Cost-benefit analysis of a new health care model|/resolve/reference/PMED?id=12093396
Gamboa 2002b {published data only}|A new model for medical care to multi-admitted patients|/resolve/reference/PMED?id=12003727
Garland 1992 {published data only}|Discharge follow-up by telephone|/resolve/reference/PMED?id=1337218
Garnett 1981 {published data only}|Effect of telephone follow-up on medication compliance|/resolve/reference/PMED?id=7282695
Genev 1990 {published data only}|Continuing diabetes education by telephone|
Gilliss 1993 {published data only}|A randomized clinical trial of nursing care for recovery from cardiac surgery|
Glasgow 1995 {published data only}|A brief office-based intervention to facilitate diabetes dietary self-management|/resolve/reference/PMED?id=10159676
Glasgow 1996 {published data only}|Effects of a brief office-based intervention to facilitate diabetes dietary self-management|/resolve/reference/PMED?id=8842601
Glasgow 1997 {published data only}|Long-term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office|/resolve/reference/PMED?id=9423499
Glasgow 2000 {published data only}|Brief, computer-assisted diabetes dietary self-management counseling: effects on behavior, physiologic outcomes, and quality of life|/resolve/reference/PMED?id=11078048
Glasgow 2001 {published data only}|The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management?|/resolve/reference/PMED?id=11479052
Glasgow 2002 {published data only}|Implementation, generalization and long-term results of the "choosing well" diabetes self-management intervention|
Goes 2002 {published data only}|Nazorg per telefoon na operatie wegens cervixcarcinoom|
Gortner 1988 {published data only}|Improving recovery following cardiac surgery: a randomized clinical trial|
Grancelli 2003 {published data only}|Randomized trial of telephone intervention in chronic heart failure (DIAL): study design and preliminary observations|/resolve/reference/PMED?id=12815566
Greineder 1995 {published data only}|Reduction in resource utilization by an asthma outreach program|/resolve/reference/PMED?id=7704170
Greineder 1999 {published data only}|A randomized controlled trial of a pediatric asthma outreach program|/resolve/reference/PMED?id=10069877
Griffin 1989 {published data only}|Telephone instruction as an adjunct to patient education of children with asthma|/resolve/reference/PMED?id=10293028
Grunfeld 1999 {published data only}|Follow up of breast cancer in primary care vs specialist care: results of an economic evaluation|/resolve/reference/PMED?id=10098764
Gulliford 1997 {published data only}|Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study|/resolve/reference/PMED?id=9022429
Harrison 1999 {published data only}|Virtual outreach: a telemedicine pilot study using a cluster-randomized controlled design|/resolve/reference/PMED?id=10628024
Hartmann 1996 {published data only}|Residential crisis services as an alternative to inpatient care|
Hasseler 2002 {published data only}|Inpatient postpartum nursing: evaluation of "holistic" and "traditional" nursing processes in the post partum period|/resolve/reference/PMED?id=12465362
Hauber 2002 {published data only}|Telerehabilitation support for families at home caring for individuals in prolonged states of reduced consciousness|/resolve/reference/PMED?id=12802244
Hayes 2001a {published data only}|Educating patients after conscious sedation for gastrointestinal procedures|/resolve/reference/PMED?id=11847727
Hayes 2001b {published data only}|The role of the certified diabetes educator in telephone counseling|/resolve/reference/PMED?id=11912798
Heidenreich 1999 {published data only}|Effect of a home monitoring system on hospitalization and resource use for patients with heart failure|/resolve/reference/PMED?id=10502207
Heller 1993 {published data only}|Secondary prevention after acute myocardial infarction|/resolve/reference/PMED?id=8105673
Hendricks 2000 {published data only}|The effect of diabetes self-management education with frequent follow-up on the health outcomes of African American men|/resolve/reference/PMED?id=11912812
Hernandez 2003 {published data only}|Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=12570110
Hickey 1996 {published data only}|Payer-hospital collaboration to improve patient satisfaction with hospital discharge|/resolve/reference/PMED?id=8724688
Higgins 2001 {published data only}|Rehabilitation outcomes following percutaneous coronary interventions (PCI)|/resolve/reference/PMED?id=11384820
Hillebrand 1996 {published data only}|Evaluation of an outpatient care program for obese patients after an inpatient treatment. [German]|
Hornblow 1980 {published data only}|Evaluating the effectiveness of a telephone counselling service|/resolve/reference/PMED?id=7448477
Hoskins 1985 {published data only}|Outpatient stabilization programme: an innovative approach in the management of diabetes|/resolve/reference/PMED?id=3899465
Hoskins 2001 {published data only}|Breast cancer: education, counseling, and adjustment: a pilot study|/resolve/reference/PMED?id=11824739
Houzard 1998 {published data only}|Outpatient care in emergency departments: feasibility and comparison of three strategies for follow-up|/resolve/reference/PMED?id=9827838
Hui 2000 {published data only}|Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population|/resolve/reference/PMED?id=10807830
Intagliata 1976 {published data only}|A telephone follow-up procedure for increasing the effectiveness of a treatment program for alcoholics|/resolve/reference/PMED?id=185468
Jahanshahi 1994 {published data only}|Contact with a nurse practitioner: A short-term evaluation study in Parkinson's disease and dystonia|/resolve/reference/PMED?id=24487336
James 1994 {published data only}|Who should follow up cancer patients? Nurse specialist based outpatient care and the introduction of a phone clinic system|/resolve/reference/PMED?id=7826919
Joffe 1995 {published data only}|The effect of a comprehensive prematurity prevention program on the number of admissions to the neonatal intensive care unit|/resolve/reference/PMED?id=8558339
Johnson 2000a {published data only}|A design for testing interventions to improve adherence within a hypertension clinical trial|/resolve/reference/PMED?id=10660004
Johnson 2000b {published data only}|Preventing smoking relapse in postpartum women|/resolve/reference/PMED?id=10667628
Johnson 2000c {published data only}|Use of telephone follow-up for post-cardiac surgery patients|/resolve/reference/PMED?id=10859623
Jolly 2003 {published data only}|Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]|/resolve/reference/PMED?id=12964946
Jones 1988b {published data only}|Efficacy of a telephone follow-up system in the emergency department|/resolve/reference/PMED?id=2844883
Jones 1997 {published data only}|Effectiveness of an organized follow-up system for elder patients released from the emergency department|
Jowers 2000 {published data only}|Partnering specialist care with nurse case management: a pilot project for asthma|
Kasper 2002 {published data only}|A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission|/resolve/reference/PMED?id=11823086
Kelly 1999 {published data only}|Ovarian cancer treatment: the benefit of patient telephone follow-up post-chemotherapy|/resolve/reference/PMED?id=10786473
King 1991 {published data only}|A telephone reassurance service: a natural support system for the elderly|
Kirkman 1994 {published data only}|A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors|/resolve/reference/PMED?id=7956628
Kirscht 1981 {published data only}|A test of interventions to increase adherence to hypertensive medical regimens|/resolve/reference/PMED?id=7333851
Kokubu 1999 {published data only}|Tele-medicine system for high-risk asthmatic patients|/resolve/reference/PMED?id=10481354
Kokubu 2000 {published data only}|Hospitalization reduction by an asthma tele-medicine system|/resolve/reference/PMED?id=10707475
Korner-Bitensky 1994 {published data only}|Health-related information postdischarge: telephone versus face-to-face interviewing|/resolve/reference/PMED?id=7993166
Kramer 2003 {published data only}|Comparison of clinic- and home-based rehabilitation programs after total knee arthroplasty|/resolve/reference/PMED?id=12771834
Kunik 2001 {published data only}|One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11352373
Lando 2001 {published data only}|Promoting smoking abstinence in pregnant and postpartum patients: a comparison of 2 approaches|/resolve/reference/PMED?id=11464427
Laramee 2003 {published data only}|Case management in a heterogeneous congestive heart failure population: a randomized controlled trial|/resolve/reference/PMED?id=12695272
Lear 2001 {published data only}|Extensive lifestyle management intervention following cardiac rehabilitation: pilot study|/resolve/reference/PMED?id=12035723
Lear 2002 {published data only}|A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data|/resolve/reference/PMED?id=12473163
Lee 1999 {published data only}|A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy|/resolve/reference/PMED?id=10547171
Liew 1994 {published data only}|Day-only admission for varicose vein surgery|
Litzelman 1993 {published data only}|Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial|/resolve/reference/PMED?id=8498761
Lundblad 2001 {published data only}|International pediatric nursing. Continuing nursing care needs of children at time of discharge from one regional medical center in Sweden|/resolve/reference/PMED?id=11247529
Lynch 2003 {published data only}|Dialectical behavior therapy for depressed older adults: a randomized pilot study|/resolve/reference/PMED?id=12527538
MacMahon 1999 {published data only}|Parkinson's disease nurse specialists: an important role in disease management|/resolve/reference/PMED?id=10227607
Madge 1997 {published data only}|Impact of a nurse-led home management training programme in children admitted to hospital with acute asthma: a randomised controlled study|/resolve/reference/PMED?id=9093336
Madonna 1999 {published data only}|Multiple sclerosis pathways: an innovative nursing role in disease management|/resolve/reference/PMED?id=10726241
Maiman 1979 {published data only}|Education for self-treatment by adult asthmatics|/resolve/reference/PMED?id=430774
Maisiak 1996a {published data only}|Health outcomes of two telephone interventions for patients with rheumatoid arthritis or osteoarthritis|
Maisiak 1996b {published data only}|The effect of person-centered counseling on the psychological status of persons with systemic lupus erythematosus or rheumatoid arthritis: a randomized, controlled trial|
Manian 1993 {published data only}|Comparison of patient telephone survey with traditional surveillance and monthly physician questionnaires in monitoring surgical wound infections|/resolve/reference/PMED?id=8478543
Marcus 1998 {published data only}|Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trial|
Marrero 1995 {published data only}|Using telecommunication technology to manage children with diabetes: the Computer-Linked Outpatient Clinic (CLOC) study|/resolve/reference/PMED?id=7621734
Mason 1998 {published data only}|Day surgery: improving care through follow up contact|/resolve/reference/PMED?id=9934040
Maunsell 1996 {published data only}|Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life|/resolve/reference/PMED?id=8874336
McCorkle 2000 {published data only}|A specialized home care intervention improves survival among older post-surgical cancer patients|/resolve/reference/PMED?id=11129765
McDonald 2002 {published data only}|Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care|/resolve/reference/PMED?id=12140806
McGrath 2002 {published data only}|Allied health professional services for oncology outpatients: an Australian comparative study|/resolve/reference/PMED?id=11905391
McIntosh 1994 {published data only}|Beyond discharge: telephone follow-up and aftercare|/resolve/reference/PMED?id=7844766
McMurray 1998 {published data only}|Nurse led, multidisciplinary intervention in chronic heart failure|/resolve/reference/PMED?id=9930038
McNamara 1995 {published data only}|Patients leaving the ED without being seen by a physician: is same-day follow-up indicated?|/resolve/reference/PMED?id=7893294
Meenan 1998 {published data only}|Cost-effectiveness of a hospital-based smoking cessation intervention|/resolve/reference/PMED?id=9596058
Miller 1995 {published data only}|Smoking cessation in hospitalized patients - results of a randomized trial.|
Miller 1997a {published data only}|Smoking cessation in hospitalized patients. Results of a randomized trial|/resolve/reference/PMED?id=9046892
Miller 1997b {published data only}|How to achieve smoking cessation among hospitilized patients|
Miller 2002a {published data only}|Interpersonal psychotherapy delivered over the telephone to recurrent depressives. A pilot study|
Miller 2002b {published data only}|Telephone clinic improves quality of follow-up care for chronic bowel disease|/resolve/reference/PMED?id=12192754
Miranda 2002 {published data only}|An evidence-based approach to improving care of patients with heart failure across the continuum|/resolve/reference/PMED?id=12369744
Mishel 2002 {published data only}|Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone|
Mohlman 2003 {published data only}|Standard and enhanced cognitive-behavior therapy for late-life generalized anxiety disorder: two pilot investigations|/resolve/reference/PMED?id=12527537
Mohr 2000 {published data only}|Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis|/resolve/reference/PMED?id=10780138
Moran 1998 {published data only}|It's good to talk, but is it effective? A comparative study of telephone support following day surgery... including commentary by Needham Y and Rendell J with author response|
Morrison 2001 {published data only}|Telemedicine: cost-effective management of high-risk pregnancy|/resolve/reference/PMED?id=11761593
Napolitano 2002 {published data only}|Effects of a telephone-based psychosocial intervention for patients awaiting lung transplantation|/resolve/reference/PMED?id=12377839
Naylor 1999 {published data only}|The effects of a discharge planning and home follow-up intervention on elders hospitalized with common medical and surgical cardiac conditions|/resolve/reference/PMED?id=10533691
Nelson 2001 {published data only}|The importance of postdischarge telephone follow-up for hospitalists: a view from the trenches|/resolve/reference/PMED?id=11790369
Nelson 2001 {published data only}|The importance of postdischarge telephone follow-up for hospitalists: a view from the trenches|/resolve/reference/PMED?id=12021760
Newman 2002 {published data only}|A specialist nurse intervention reduced hospital readmissions in patients with chronic heart failure|/resolve/reference/PMED?id=11995658
Nicklin 1986 {published data only}|Postdischarge concerns of cardiac patients as presented via a telephone callback system|/resolve/reference/PMED?id=3634766
Nijdam 1999 {published data only}|Het telefonisch verpleegkundig follow-up spreekuur bij patinten met hersenmetastasen die zijn behandeld met radiotherapie|
Northouse 2002 {published data only}|A family-based program of care for women with recurrent breast cancer and their family members|/resolve/reference/PMED?id=12432412
O'Neill 2001 {published data only}|A pediatric emergency department follow-up system: completing the cycle of care|/resolve/reference/PMED?id=11673722
Oddone 1999 {published data only}|Enhanced access to primary care for patients with congestive heart failure. Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission|/resolve/reference/PMED?id=10623052
Oh 2003 {published data only}|A telephone-delivered intervention to improve glycemic control in type 2 diabetic patients|/resolve/reference/PMED?id=12619168
Pal 1998 {published data only}|Following up outpatients by telephone: pilot study|/resolve/reference/PMED?id=9603747
Pal 2001 {published data only}|Tele-rheumatology: telephone follow up and cyberclinic|/resolve/reference/PMED?id=11226616
Palmer 2001 {published data only}|The effect of a hospitalist service with nurse discharge planner on patient care in an academic teaching hospital|/resolve/reference/PMED?id=11755506
Palmer 2002 {published data only}|Self-help for bulimic disorders: a randomised controlled trial comparing minimal guidance with face-to-face or telephone guidance|/resolve/reference/PMED?id=12204928
Peterson 2002 {published data only}|Practical utility of case-management telephone intervention in heart failure?|/resolve/reference/PMED?id=12374530
Pidd 2000 {published data only}|Telephone follow-up after urological surgery|/resolve/reference/PMED?id=11129927
Poncia 2000 {published data only}|Next day telephone follow up of the elderly: a needs assessment and critical incident monitoring tool for the accident and emergency department|/resolve/reference/PMED?id=11005403
Powell 2001 {published data only}|Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome|/resolve/reference/PMED?id=11179154
Powers 1983 {published data only}|Pharmacist intervention in methadone administration to cancer patients with chronic pain|/resolve/reference/PMED?id=6624755
Proctor 2000 {published data only}|Adequacy of home care and hospital readmission for elderly congestive heart failure patients|/resolve/reference/PMED?id=10845143
Pugh 1999 {published data only}|Partners in care: a model of collaboration|/resolve/reference/PMED?id=10196904
Racelis 1998 {published data only}|Impact of telephone reinforcement of risk reduction education on patient compliance|/resolve/reference/PMED?id=9764028
Rakowski 1994 {published data only}|An emergency department telephone follow-up service|/resolve/reference/PMED?id=8007496
Rauh 1999 {published data only}|A community hospital-based congestive heart failure program: impact on length of stay, admission and readmission rates, and cost|/resolve/reference/PMED?id=10345965
Rawl 1998 {published data only}|Effectiveness of a nurse-managed follow-up program for rehabilitation patients after discharge|/resolve/reference/PMED?id=9832919
Rawl 2002 {published data only}|Intervention to improve psychological functioning for newly diagnosed patients with cancer|/resolve/reference/PMED?id=12096294
Rene 1992 {published data only}|Reduction of joint pain in patients with knee osteoarthritis who have received monthly telephone calls from lay personnel and whose medical treatment regimens have remained stable|
Rich 1995 {published data only}|A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure|/resolve/reference/PMED?id=7565975
Riegel 1996 {published data only}|Effectiveness of a program of early hospital discharge of cardiac surgery patients [corrected] [published erratum appears in J CARDIOVASC NURS 1997 Apr; 11(3): viii]|/resolve/reference/PMED?id=9069032
Riegel 2000 {published data only}|Which patients with heart failure respond best to multidisciplinary disease management?|/resolve/reference/PMED?id=11145753
Rieger 1995 {published data only}|A neonatal early discharge and home support programme: shifting care into the community|
Ries 2003 {published data only}|Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial|/resolve/reference/PMED?id=12505859
Rigotti 1997 {published data only}|Efficacy of a smoking cessation program for hospital patients|/resolve/reference/PMED?id=9531235
Riley 1989 {published data only}|Telephone call-backs: final patient care evaluation|/resolve/reference/PMED?id=2779924
Roberts 1995 {published data only}|Problem-solving counselling or phone-call support for outpatients with chronic illness: effective for whom?|/resolve/reference/PMED?id=8556665
Roglieri 1997 {published data only}|Disease management interventions to improve outcomes in congestive heart failure|/resolve/reference/PMED?id=10178473
Romano 2001 {published data only}|Improvement in asthma symptoms and quality of life in pediatric patients through specialty care delivered via telemedicine|/resolve/reference/PMED?id=11886666
Rosbe 2000 {published data only}|Efficacy of postoperative follow-up telephone calls for patients who underwent adenotonsillectomy|/resolve/reference/PMED?id=10864107
Rosswurm 1998 {published data only}|Discharge planning for elderly patients|/resolve/reference/PMED?id=9735727
Ruchlin 2001 {published data only}|The economic impact of a multifactorial intervention to improve postoperative rehabilitation of hip fracture patients|
Sanders 1997 {published data only}|Non-cardiac chest pain: why was a brief intervention apparently ineffective?|/resolve/reference/PMED?id=9300509
Sandgren 2000 {published data only}|Telephone therapy for patients with breast cancer|/resolve/reference/PMED?id=10833696
Sandgren 2003 {published data only}|Short-term effects of telephone therapy for breast cancer patients|/resolve/reference/PMED?id=12790259
Sardell 2000 {published data only}|Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma|/resolve/reference/PMED?id=10749018
Schatz 2003 {published data only}|The relationship of frequency of follow-up visits to asthma outcomes in patients with moderate persistent asthma|/resolve/reference/PMED?id=12699211
Schectman 1994 {published data only}|Telephone contacts do not improve adherence to niacin or bile acid sequestrant therapy|/resolve/reference/PMED?id=8123955
Schultz 1993 {published data only}|Educational and behavioral strategies related to knowledge of and participation in an exercise program after cardiac positron emission tomography|/resolve/reference/PMED?id=8134321
Sciamanna 2000 {published data only}|Opportunities for improving inpatient smoking cessation programs: a community hospital experience|/resolve/reference/PMED?id=10901492
Shah 1998 {published data only}|Prevention of hospitalizations for heart failure with an interactive home monitoring program|/resolve/reference/PMED?id=9506321
Shapiro 1995 {published data only}|Shortened hospital stay for low-birth-weight infants: nuts and bolts of a nursing intervention project|
Shon 2002 {published data only}|Medication and symptom management education program for the rehabilitation of psychiatric patients in Korea: the effects of promoting schedule on self-efficacy theory|/resolve/reference/PMED?id=12402370
Shu 1996 {published data only}|A telephone reassurance program for elderly home care clients after discharge|/resolve/reference/PMED?id=8707606
Siegel 1992 {published data only}|Reducing the prevalence of unmet needs for concrete services of patients with cancer: evaluation of a computerized telephone outreach system|
Simon 1997 {published data only}|Smoking cessation after surgery: a randomized trial|/resolve/reference/PMED?id=9201012
Simon 2003 {published data only}|Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial|/resolve/reference/PMED?id=12753879
Sluijk 1998 {published data only}|Afdelingsverpleegkundigen garanderen continuiteit van zorg: een telefonisch verpleegkundig spreekuur|
Smeenk 1998a {published data only}|Care process and satisfaction analysis of a transmural home care program|/resolve/reference/PMED?id=9789777
Smeenk 1998b {published data only}|Cost analysis of transmural home care for terminal cancer patients|/resolve/reference/PMED?id=9887852
Smith 1988 {published data only}|Postdischarge care and readmissions|/resolve/reference/PMED?id=2839742
Smith 2002 {published data only}|Application of a nurse-managed inpatient smoking cessation program|/resolve/reference/PMED?id=12096707
Sneed 1997 {published data only}|The effect of psychosocial nursing intervention on the mood state of patients with implantable cardioverter defibrillators and their caregivers|/resolve/reference/PMED?id=9195642
Soskolne 1993 {published data only}|Follow-up evaluation of discharge planning by social workers in an acute-care medical center in Israel|/resolve/reference/PMED?id=8392755
Sparacino 1997 {published data only}|A nurse, algorithms, and the telephone: key resources for patients after hospital discharge|/resolve/reference/PMED?id=9233141
Stanislaw 1994 {published data only}|A smoking cessation intervention with hospitalized surgical cancer patients: a pilot study|/resolve/reference/PMED?id=8020001
Steel 2003 {published data only}|A randomized trial of two public health nurse follow-up programs after early obstetrical discharge: an examination of breastfeeding rates, maternal confidence and utilization and costs of health services|/resolve/reference/PMED?id=12675164
Stevens 1993 {published data only}|A smoking-cessation intervention for hospital patients|/resolve/reference/PMED?id=8417271
Stevens 2000 {published data only}|Implementation and effectiveness of a brief smoking-cessation intervention for hospital patients|/resolve/reference/PMED?id=10800972
Stewart 1998 {published data only}|Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths|/resolve/reference/PMED?id=9475445
Strecher 1983 {published data only}|A minimal-contact smoking cessation program in a health care setting|/resolve/reference/PMED?id=6414037
Strinko 2000 {published data only}|Reducing risk with telephone follow-up of patients who leave against medical advice or fail to complete an ED visit|/resolve/reference/PMED?id=10839849
Svahn 2002 {published data only}|Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care|/resolve/reference/PMED?id=12393737
Taylor 1990 {published data only}|Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention|/resolve/reference/PMED?id=2360750
Taylor 1996 {published data only}|A nurse-managed smoking cessation program for hospitalized smokers|/resolve/reference/PMED?id=8916520
Taylor 1997 {published data only}|The effect of a home-based, case-managed, multifactorial risk-reduction program on reducing psychological distress in patients with cardiovascular disease|/resolve/reference/PMED?id=9187981
Taylor-Davis 2000 {published data only}|Responses of older adults to theory-based nutrition newsletters|/resolve/reference/PMED?id=10863568
Thewissen 2000 {published data only}|Meer bereiken door betere bereikbaarheid: telefonisch spreekuur biedt onverwachte voordelen|
Thompson 1999 {published data only}|Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients: a randomized trial|/resolve/reference/PMED?id=10551191
Tiippana 2003 {published data only}|Post-thoracotomy pain after thoracic epidural analgesia: a prospective follow-up study|
Tkachuk 2003 {published data only}|Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting|
Townsend 1996 {published data only}|Continuing rise in emergency admissions. Visiting elderly patients at home immediately after discharge reduces emergency readmissions|/resolve/reference/PMED?id=8704567
Turner 1996 {published data only}|Can telephone follow-up improve post-discharge outcomes?|/resolve/reference/PMED?id=9025364
Tyc 2003 {published data only}|Intervention to reduce intentions to use tobacco among pediatric cancer survivors|/resolve/reference/PMED?id=12663728
Valanis 2001 {published data only}|Telephone nursing advice: the buck stops here... 34th Annual Communicating Nursing Research Conference/15th Annual WIN Assembly, "Health Care Challenges Beyond 2001: Mapping the Journey for Research and Practice," held April 19-21, 2001 in Seattle, Washington|
Valanis 2002 {published data only}|Telephone advice nursing: facilitating access to health care... 35th Annual Communicating Nursing Research Conference/16th Annual WIN Assembly, "Health Disparities: Meeting the Challenge," held April 18-20, 2002, Palm Springs, California|
Valanis 2003 {published data only}|Making it work: organization and processes of telephone nursing advice services|/resolve/reference/PMED?id=12690253
Vale 2002 {published data only}|Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the "real world"--randomized controlled trial|/resolve/reference/PMED?id=11864795
van Beelen 1996 {published data only}|'Belrondes' horen bij de service: nog even een telefoontje|
van Elderen 1994 {published data only}|Effects of a health-education program with telephone follow-up during cardiac rehabilitation|
van Elderen 2001 {published data only}|Lifestyle effects of group health education for patients with coronary heart disease|
Varma 1999 {published data only}|Pharmaceutical care of patients with congestive heart failure: interventions and outcomes|
Vogel 1996 {published data only}|Development of community follow-up in a comprehensive rehabilitation center|
Vrehen 2000 {published data only}|Telefonische nazorg na dagbehandeling: Goede ervaringen in Utrecht|
Wade 1998 {published data only}|Routine follow up after head injury: a second randomised controlled trial|/resolve/reference/PMED?id=9703167
Walker 1999 {published data only}|Does emotional expression make a difference in reactions to breast cancer?|/resolve/reference/PMED?id=10420420
Warden 2000 {published data only}|A home program of rehabilitation for moderately severe traumatic brain injury patients. The DVHIP Study Group|/resolve/reference/PMED?id=10970930
Wasson 1992 {published data only}|Telephone care as a substitute for routine clinic follow-up|/resolve/reference/PMED?id=1545464
Weinberger 1991 {published data only}|The impact of increased contact on psychosocial outcomes in patients with osteoarthritis: a randomized, controlled trial|/resolve/reference/PMED?id=1895265
Weinberger 1993 {published data only}|Cost-effectiveness of increased telephone contact for patients with osteoarthritis: a randomized, controlled trial|/resolve/reference/PMED?id=7679273
Weinberger 1998 {published data only}|Telephone-based interventions in outpatient care|/resolve/reference/PMED?id=9709173
Weinstein 1996 {published data only}|Psychological intervention in patients with poor compliance|
Welch 2000 {published data only}|Telephone care as an adjunct to routine medical follow-up. A negative randomized trial|/resolve/reference/PMED?id=11182960
Wells 2003 {published data only}|Improving cancer pain management through patient and family education|/resolve/reference/PMED?id=12691686
Wewers 1994 {published data only}|A nurse-delivered smoking cessation intervention among hospitalized postoperative patients--influence of a smoking-related diagnosis: a pilot study|
Wilbourne 1997 {published data only}|Telefonische consulten van patinten met de diabetesverpleegkundige: 'verborgen' afspraken?|
Wong 2001a {published data only}|Nurse telephone follow-up for A&E patients: implications for health intervention using telephone intervention|
Wong 2001b {published data only}|"Geriatric care at your doorway": post discharge home follow up and direct hotline service for community living elderly|
Wulsin 2002 {published data only}|A randomized, controlled trial of panic disorder treatment initiation in an emergency department chest pain center|/resolve/reference/PMED?id=11823767
York 1997 {published data only}|A randomized trial of early discharge and nurse specialist transitional follow-up care of high-risk childbearing women|/resolve/reference/PMED?id=9316597
Young 2000 {published data only}|Day surgery patients' convalescence at home: does enhanced discharge education make a difference?|
Zahlmann 2002 {published data only}|Perioperative cataract OP management by means of teleconsultation|/resolve/reference/PMED?id=11954775
Zeegers 1997 {published data only}|Effectivity measurement of a telephonic follow-up after hospital admission: a study into decrease of problems in ophtalmology patients after discharge from the hospital [Abstract]|
Zorc 2003 {published data only}|Scheduled follow-up after a pediatric emergency department visit for asthma: a randomized trial|/resolve/reference/PMED?id=12612227
Wakefield {published data only}|Evaluating telehealth home care for elderly veterans with congestive heart failure|
Alderson 2002|Cochrane Effective Practice and Organisation of Care Group|
Bandura 1977||
Beckie 1989a|A supportive-educative telephone program: impact on knowledge and anxiety after coronary artery bypass graft surgery|/resolve/reference/PMED?id=2783580
Bours 1998|The effects of aftercare on chronic patients and frail elderly patients when discharged from hospital: a systematic review|
Bowman 1994|A telephone survey of medical patients 1 week after discharge from hospital|
Bull 2000|Discharge planning for older people: a review of current research|/resolve/reference/PMED?id=11125455
Clarke 2003|Cochrane Reviewers' Handbook 4.1.6 [updated January 2003]|
Cole 2001|The impact of geriatric post-discharge services on mental state|/resolve/reference/PMED?id=11774823
Cox 2003|Follow-up for people with cancer: nurse-led services and telephone interventions|
Hartford 2000|What does the literature report about post-discharge telephone interventions by nurses for coronary artery bypass graft surgery patients and their partners?|
Hyde 2000|The effects of supporting discharge from hospital to home in older people|/resolve/reference/PMED?id=10855913
Johnson 2000d|Use of telephone follow-up for post-cardiac surgery patients|/resolve/reference/PMED?id=10859623
Johnson 2003|Written and verbal information versus verbal information only for patients being discharged from acute hospital settings to home|/resolve/reference/PMED?id=19078936
Keeling 1995|Nurse-initiated telephone follow-up after acute myocardial infarction: a pilot study|/resolve/reference/PMED?id=7706099
LeClerc 2002|Falling short of the mark: tales of life after hospital discharge|/resolve/reference/PMED?id=12180639
Lindsay 2004|Randomized controlled trials of socially complex nursing interventions: creating bias and unreliability?|
Mistiaen 1999a|The construction of a research model on post discharge problems based on a review of the literature 1990-1995|
Mistiaen 1999b|Predictive validity of the BRASS-index in screening patients with post-discharge problems|
Moran 1999|It's good to talk, but is it effective? A comparative study of telephone support following day surgery|
Naylor 2002|Transitional care of older adults|/resolve/reference/PMED?id=12092508
Parker 2002|A systematic review of discharge arrangements for older people|/resolve/reference/PMED?id=12065067
Reiley 1996|Discharge planning: comparisons of patients' and nurses' perceptions of patients following hospital discharge|
Robinson 2002|Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using Pubmed|/resolve/reference/PMED?id=11914311
Schaeffer 2001|Follow up with patients by telephone|/resolve/reference/PMED?id=11496443
Shepperd 2004|Discharge planning from hospital to home|/resolve/reference/PMED?id=14973952
Berneis 2000 {published data only}|Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients|
Clark 2000 {published data only}|Nutritional treatment for Acquired Immunodeficiency Virus-associated wasting using B-hydroxy B-methylbutyrate, glutamine and arginine: a randomised, double-blind, placebo-controlled study|/resolve/reference/PMED?id=10850936
de Luis 2003 {published data only}|Isolated dietray counselling program versus supplement and dietary counselling in patients with human immunodeficiency virus infection|/resolve/reference/PMED?id=12729523
Karsegard 2004 {published data only}|L-Ornithine alpha-Ketoglutarate in HIV infection: Effects on muscle, gastrointestinal and immune functions|/resolve/reference/PMED?id=15165613
Keithley 2002a {published data only}|Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trial|/resolve/reference/PMED?id=11833753
Rabeneck 1998 {published data only}|A randomised controlled trial evaluating nutrition counselling with or without supplementation in malnourished HIV-infected patients|/resolve/reference/PMED?id=9550167
Schwenk 1999 {published data only}|Oral supplements as adjunctive treatment to nutritional counselling in malnourished HIV-infected patients: randomised controlled trial|/resolve/reference/PMED?id=10634923
Shabert 1999 {published data only}|Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomised, double-blind controlled trial|/resolve/reference/PMED?id=10575661
Amadi 2005 {published data only}|Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhoea and malnutrition|/resolve/reference/PMED?id=15601655
Bakeine 1997 {published data only}|The effects of early nutritional supplementation with Nutrifil or Corn Soya Blend on the nutritional and immune status of adults with HIV infection in Uganda|
Bell 1999 {published data only}|Dietary fish oil and cytokine and eicosanoid production during human immunodeficiency virus infection|/resolve/reference/PMED?id=8788262
Breuikreuitz 2000 {published data only}|Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials|/resolve/reference/PMED?id=10759030
Charlin 2002 {published data only}|Nutritional supplementation according to energy and protein requirements in malnourished HIV-infected patients|/resolve/reference/PMED?id=12448341
Chlebowski 1993 {published data only}|Long-term effects of early nutritional support with new enterotropic peptide-based formula vs standard enteral formula in HIV-infected patients: a randomised prospective trial|/resolve/reference/PMED?id=8111147
Comi 1996 {published data only}|Effects of two different diets on AIDS patients' nutritional status|
Craig 1997 {published data only}|Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula vs those receiving long-chain-triglyceride-containing formula|/resolve/reference/PMED?id=9183320
de Luis Roman 2001 {published data only}|Nutritional treatment for acquired immunodeficiency virus|/resolve/reference/PMED?id=11781670
Engelson 1998 {published data only}|Effect of a high protein diet on protein metabolism in HIV-infected men and women|
Gibert 1999 {published data only}|Randomized, controlled trial of caloric supplements in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS|/resolve/reference/PMED?id=10770345
Hellerstein 1994 {published data only}|Effects of enteral nutrition supplements on HIV disease|
Hellerstein 1996 {published data only}|Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: Relation to indices of cytokine production.|/resolve/reference/PMED?id=8603262
Hirschel 1996 {published data only}|Double-blind randomised trial of arginine and omega-3 fatty acids. Oral supplementation in HIV infection|
Hoh 1998 {published data only}|De novo lipogenesis predicts short-term body-composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV-associated wasting|/resolve/reference/PMED?id=9665109
Kotler 1998 {published data only}|Comparison of total parenteral nutrition and an oral, semielemental diet on body composition, physical function, and nutrition-related costs in patients with malabsorption due to acquired immunodeficiency syndrome|/resolve/reference/PMED?id=9586788
Melchior 1996 {published data only}|Efficacy of 2-month total parenteral nutrition in AIDS patients: a controlled randomized prospective trial. The French Multicenter Total Parenteral Nutrition Cooperative Group Study|/resolve/reference/PMED?id=8728041
Melchior 1998 {published data only}|Improved survival by home total parenteral nutrition in AIDS patients: follow-up of a controlled randomized prospective trial|/resolve/reference/PMED?id=9518005
Mendez 1998 {published data only}|Nutritional supplements containing long- or medium-chain triglycerides: effects upon body weight and composition in HIV-infected subjects with less than 100 CD4+ lymphocytes/mm3|
Micke 2001 {published data only}|Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients|
Micke 2002 {published data only}|Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients|/resolve/reference/PMED?id=11990003
Ndekha 2005 {published data only}|Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV-infected Malawian children|
Pichard 1998 {published data only}|A randomised double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study|/resolve/reference/PMED?id=9456255
Schwenk 1996 {published data only}|Enteral nutrition in AIDS cachexia: controlled study on the role of fibre|
Suttmann 1996 {published data only}|Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support|
Wanke 1996 {published data only}|A medium chain triglyceride-based diet in patients with HIV and chronic diarrhea reduces diarrhea and malabsorption: a prospective, controlled trial|/resolve/reference/PMED?id=8974102
Winkler 2004 {published data only}|Lymphocyte proliferation and apoptosis in HIV-seropositive and healthy subjects during long-term ingestion of fruit juices or a fruit-vegetable-concentrate rich in polyphenols and antioxidant vitamins|/resolve/reference/PMED?id=14749753
Wohl 2005 {published data only}|Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia|/resolve/reference/PMED?id=16231263
Anabwani 2005|Nutrition and HIV/AIDS in sub-Saharan Africa: an overview|/resolve/reference/PMED?id=15661483
Batterham 2005|Investigating heterogeneity in studies of resting energy expenditure in persons with HIV/AIDS: a meta-analysis|/resolve/reference/PMED?id=15755842
Chernoff 2002|The significance of HIV viral load assay precision: A review of the package insert specifications of two commercial kits|/resolve/reference/PMED?id=12942672
Grinspoon 1998|Determinants of increased energy expenditure in HIV-infected women|/resolve/reference/PMED?id=9734753
Hsu 2005|Macronutrients and HIV/AIDS: a review of current evidence|
Irlam 2005|Micronutrient supplementation in children and adults with HIV infection|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary|/resolve/reference/PMED?id=8721797
Kotler 1999|Studies of body composition and fat distribution in HIV-infected and control subjects|/resolve/reference/PMED?id=10077170
Macallan 1993|Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection|/resolve/reference/PMED?id=8237855
Macallan 1995a|Energy expenditure and wasting in human immunodeficiency virus infection|/resolve/reference/PMED?id=7777033
Macallan 1995b|Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection|/resolve/reference/PMED?id=7702025
Macallan 1998|Sir David Cuthbertson Prize Medal Lecture. Metabolic abnormalities and wasting in human immunodeficiency virus infection|/resolve/reference/PMED?id=9793993
Melchior 1997|Metabolic aspects of HIV: associated wasting|/resolve/reference/PMED?id=9863505
Ramsay 2003|How do you include trials with more than two groups into a single meta-analysis?|
Sandige 2004|Home-based treatment of malnourished Malawian children with locally produced or imported ready-to-use food.|/resolve/reference/PMED?id=15269617
Scrimshaw 1997|Synergism of nutrition, infection, and immunity: an overview|/resolve/reference/PMED?id=9250134
Wheeler 1998|Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS|/resolve/reference/PMED?id=9593462
Farley 2002a {published data only}|Effect of CAPHS Performance Information on health plan choices by Iowa Medicaid|/resolve/reference/PMED?id=12205831
Farley 2002b {published data only}|Effect of CAPHS health plan performance information on plan choices by New Jersey|
Romano 2004 {published data only}|Do well-publicized risk-adjusted outcomes reports affect hospital volume?|/resolve/reference/PMED?id=15076814
Tu 2009 {published data only}|Effectiveness of public report cards for improving the quality of cardiac care. The EFFECT study: a randomized trial|/resolve/reference/PMED?id=19923205
Alterras 2000 {published data only}|Health plan report cards may influence insurers more than consumers: their effect on insurer behavior in Minnesota|
Beaulieu 2002a {published data only}|National Committee on Quality Assurance health-plan accreditation: predictors, correlates of performance, and market impact|/resolve/reference/PMED?id=12021688
Beaulieu 2002b {published data only}|Quality information and consumer health plan choices|/resolve/reference/PMED?id=11845925
Bundorf 2009 {published data only}|Do markets respond to quality information? The case of fertility clinics|/resolve/reference/PMED?id=19328568
Dawson 2007 {published data only}|The effects of expanding patient choice of provider on waiting times: evidence from a policy experiment|
Dranove 2008 {published data only}|Start spreading the news: a structural estimate of the effects of New York hospital report cards|/resolve/reference/PMED?id=18420293
Ettinger 2008 {published data only}|When things go wrong: the impact of being a statistical outlier in publicly reported coronary artery bypass graft surgery mortality data|/resolve/reference/PMED?id=18245577
Fanjiang 2007 {published data only}|Providing patients web-based data to inform physician choice: if you build it, will they come?|/resolve/reference/PMED?id=17653810
Fine 1998 {published data only}|The effect of grading and publicizing the physician groups' performance|
Fong 2008 {published data only}|Hospital quality performance report: an application of composite scoring|
Fotaki 2008 {published data only}|What benefits will choice bring to patients? Literature review and assessment of implications|/resolve/reference/PMED?id=18573768
Fox 2001 {published data only}|The effectiveness of CAHPS among women enrolling in Medicaid managed care|/resolve/reference/PMED?id=11680241
Goldstein 2001 {published data only}|Reporting of CAHPS quality information to medicare beneficiaries|/resolve/reference/PMED?id=11482585
Goss 2006 {published data only}|Effects of a statewide physician-led quality-improvement program on the quality of cardiac care|/resolve/reference/PMED?id=16644333
Hannan 2003 {published data only}|Provider profiling and quality improvement efforts in coronary artery bypass graft surgery: the effect on short-term mortality among Medicare beneficiaries|/resolve/reference/PMED?id=14515112
Harris 2002 {published data only}|Can high quality overcome consumer resistance to restricted provider access? Evidence from a health plan choice experiment|
Harris-Kojetin 2007 {published data only}|The "choose with care system" - development of education materials to support informed Medicare health plan choices|
Hibbard 1996 {published data only}|Condition-specific performance information: assessing salience, comprehension, and approaches for communicating quality|/resolve/reference/PMED?id=10165040
Hibbard 2000 {published data only}|Increasing the impact of health plan report cards by addressing consumers' concerns|/resolve/reference/PMED?id=10992661
Hibbard 2001 {published data only}|Making health care quality reports easier to use|/resolve/reference/PMED?id=11708039
Hibbard 2002a {published data only}|The impact of a CAHPS report on employee knowledge, beliefs, and decisions|/resolve/reference/PMED?id=11877876
Hibbard 2002b {published data only}|Strategies for reporting health plan performance information to consumers: evidence from controlled studies|
Hibbard 2003 {published data only}|Does publicizing hospital performance stimulate quality improvement efforts?|/resolve/reference/PMED?id=12674410
Hibbard 2005a {published data only}|It isn't just about choice: the potential of a public performance report to affect the public image of hospitals|/resolve/reference/PMED?id=15894709
Hibbard 2005b {published data only}|Hospital performance reports: impact on quality, market share, and reputation|/resolve/reference/PMED?id=16012155
Hollenbeak 2008 {published data only}|Reduction in mortality associated with intensive public reporting of hospital outcomes|/resolve/reference/PMED?id=18658101
Jensen 2004 {published data only}|The ratings game: how important are hospital rankings to consumers?|/resolve/reference/PMED?id=15008008
Jha 2006 {published data only}|The predictive accuracy of the New York State coronary artery bypass surgery report-card system|/resolve/reference/PMED?id=16684751
Jian 2009 {published data only}|Performance evaluation of inpatient service in Beijing: a horizontal comparison with risk adjustment based on Diagnosis Related Groups|/resolve/reference/PMED?id=19402913
Knutson 1998 {published data only}|Impact of report cards on employees: a natural experiment|/resolve/reference/PMED?id=10387425
Krupat 2004 {published data only}|Matching patients and practitioners based on beliefs about care: results of a randomized controlled trial|/resolve/reference/PMED?id=15623271
Lindenauer 2007 {published data only}|Public reporting and pay for performance in hospital quality improvement|/resolve/reference/PMED?id=17259444
Mannion 2003 {published data only}|Public disclosure of comparative clinical performance data: lessons from the Scottish experience|
McCormack 2001a {published data only}|Health plan decision making with new Medicare information materials|/resolve/reference/PMED?id=11482588
McCormack 2001b {published data only}|Health plan decision making in the Medicare population: results from a national randomized experiment|/resolve/reference/PMED?id=16148965
Moscucci 2005 {published data only}|Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases|/resolve/reference/PMED?id=15936602
Norem 2004 {published data only}|The websites of Norwegian hospitals: do they meet national guidelines and patient's expectations?|/resolve/reference/PMED?id=15532132
O'Connor 1991 {published data only}|A model of service quality perceptions and health care consumer behavior|/resolve/reference/PMED?id=10116639
Peters 2007 {published data only}|Less is more in presenting quality information to consumers|/resolve/reference/PMED?id=17406019
Peters 2009 {published data only}|Will hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients?|/resolve/reference/PMED?id=19487595
Schoenbaum 2001 {published data only}|Health plan choice and information about out-of-pocket costs: an experimental analysis|/resolve/reference/PMED?id=11381720
Scott 2006 {published data only}|Public reporting of hospital outcomes based on administrative data: risks and opportunities|/resolve/reference/PMED?id=16768665
Spranca 2000 {published data only}|Do consumer reports of health plan quality affect health plan selection?|/resolve/reference/PMED?id=11130805
Spranca 2007 {published data only}|Disenrollment information and Medicare plan choice: is more information better?|/resolve/reference/PMED?id=17645155
Swaminathan 2008 {published data only}|Persistence of HMO performance measures|
Tai-Seale 2004 {published data only}|Does consumer satisfaction information matter? Evidence on member retention in FEHBP plans|/resolve/reference/PMED?id=15155050
Uhrig 2002 {published data only}|Testing the effect of quality reports on the health plan choices of Medicare beneficiaries|/resolve/reference/PMED?id=12638711
Uhrig 2006 {published data only}|Do content and format affect older consumers' use of comparative information in a Medicare health plan choice? Results from a controlled experiment|/resolve/reference/PMED?id=17099122
Wedig 2002 {published data only}|The effect of report cards on consumer choice in the health insurance market|/resolve/reference/PMED?id=12475124
Werner 2005a {published data only}|The unintended consequences of publicly reporting quality information|/resolve/reference/PMED?id=15755946
Werner 2005b {published data only}|Racial profiling: the unintended consequences of coronary artery bypass graft report cards|/resolve/reference/PMED?id=15769766
Bardach 2009|The unintended consequences of quality improvement|/resolve/reference/PMED?id=19773653
Bentley 1998|How Pennsylvania hospitals have responded to publicly released reports on coronary artery bypass graft surgery?|/resolve/reference/PMED?id=9494873
Berwick 1990|Hospital leaders' opinions of the HCFA mortality data|/resolve/reference/PMED?id=2403602
Berwick 2003|Connections between quality measurements and improvement|
Brook 1994|Health care reform is on the way: do we want to compete on quality?|/resolve/reference/PMED?id=8250463
Damman 2010|An international comparison of Web-based reporting about healthcare quality: content analysis|
Damman 2011|Consumers interpretation and use of comparativeinformation on the quality of health care: the effectof presentation approaches|
EPOC 2009|Effective Practice and Organisation of Care Group. EPOC risk of bias guideline|
Faber 2009|Public reporting in health care: how do consumers use quality of care information? A systematic review|/resolve/reference/PMED?id=19106724
Fung 2008|Systematic review: the evidence that publishing patient care performance data improves quality of care|/resolve/reference/PMED?id=18195336
Giuffrida 1999|Measuring quality of care with routine data: avoiding confusion between performance indicators and health outcomes|/resolve/reference/PMED?id=10398635
Harris 2008||
Hendriks 2009|Dutch healthcare reform: did it result in performance improvement of health plans? A comparison of consumer experiences over time|/resolve/reference/PMED?id=19761580
Hibbard 1997|Choosing a health plan: do large employers use the data?|/resolve/reference/PMED?id=9444825
Hibbard 2007|Consumers competencies and the use of comparative quality information: it isn't just about literacy|/resolve/reference/PMED?id=17684108
Hibbard 2009|Using systematic measurement to target consumer activation strategies|/resolve/reference/PMED?id=19052169
Hibbard 2010|What is quality anyway? Performance reports that clearly communicate to consumers the meaning of quality of care|/resolve/reference/PMED?id=20093399
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Jamtvedt 2006|Audit and feedback: effects on professional practice and health care outcomes|/resolve/reference/PMED?id=16625533
Kerr 2007|Quality by any other name? A comparison of three profiling systems for assessing health care quality|
Kolstad 2009|Quality and consumer decision making in the market for health insurance and health care services|/resolve/reference/PMED?id=19029288
Loeb 2004|The current state of performance measurement in health care|/resolve/reference/PMED?id=15059982
Longo 1997|Consumer reports in health care. Do they make a difference in patient care?|/resolve/reference/PMED?id=9370503
Magee 2003|Public views on healthcare performance indicators and patient choice|/resolve/reference/PMED?id=12835446
Marshall 2000|The public release of performance data. What do we expect to gain? A review of the evidence|/resolve/reference/PMED?id=10770149
Marshall 2004|How do we maximize the impact of the public reporting of quality of care?|/resolve/reference/PMED?id=15059988
Moher 1999|Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses|/resolve/reference/PMED?id=10584742
Mukamel 1998|Quality of care information makes a difference: an analysis of market share and price changes after publication of the New York State Cardiac Surgery Mortality Reports|/resolve/reference/PMED?id=9674613
O'Meara 2005|Case study: development of and stakeholder responses to a nursing home consumer information system|/resolve/reference/PMED?id=15782754
Parry 1998|Annual league tables of mortality in neonatal intensive care units: longitudinal study. International Neonatal Network and the Scottish Neonatal Consultants and Nurses Collaborative Study Group|/resolve/reference/PMED?id=9641927
Rixom 2002|Performance league tables|/resolve/reference/PMED?id=12142293
Rosenthal 1998|Using hospital performance data in quality improvement: the Cleveland Health Quality Choice experience|/resolve/reference/PMED?id=9689568
Schut 2005|Rationing and competition in the Dutch health-care system|
Schwartz 2005|How do elderly patients decide where to go for major surgery? Telephone interview survey|/resolve/reference/PMED?id=16192286
Shekelle 2008|Does public release of performance results improve quality of care? A systematic review|
Sirio 1996|Public reporting of clinical outcomes--the data needs of health care stakeholders|/resolve/reference/PMED?id=8763242
Smith 2008|Performance measurement for health system improvement: experiences, challenges and prospects|
Smith 2009||
The King's Fund 2010||
Werner 2009|Impact of public reporting on quality of postacute care|
Bolman 2005 {published and unpublished data}|Long-term efficacy of a checklist to improve patient education in cardiology|/resolve/reference/PMED?id=15653255
Brown 1999 {published data only}|Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question asking|/resolve/reference/PMED?id=10390003
Brown 2001 {published and unpublished data}|Promoting patient participation and shortening cancer consultations: a randomised trial|/resolve/reference/PMED?id=11720460
Bruera 2003 {published data only}|Breast cancer patient perception of the helpfulness of a prompt sheet versus a general information sheet during outpatient consultation: a randomized controlled trial|/resolve/reference/PMED?id=12727038
Butow 1994 {published data only}|Patient participation in the cancer consultation: evaluation of a question prompt sheet|/resolve/reference/PMED?id=8186168
Butow 2004 {published data only}|Cancer consultation preparation package: changing patients but not physicians is not enough|/resolve/reference/PMED?id=15514382
Cegala 2000 {published and unpublished data}|The effects of patient communication skills training on compliance|/resolve/reference/PMED?id=10664643
Cegala 2000 {published and unpublished data}|The effects of communication skills training on patients' participation during medical interviews|/resolve/reference/PMED?id=12024545
Cegala 2000 {published and unpublished data}|Teaching patients to communicate with physicians: the impact of race|/resolve/reference/PMED?id=12653375
Davison 1997 {published and unpublished data}|Empowerment of men newly diagnosed with prostate cancer|/resolve/reference/PMED?id=9190093
Davison 2002 {published data only}|Feasibility of using a computer-assisted intervention to enhance the way women with breast cancer communicate with their physicians|/resolve/reference/PMED?id=12464832
Finney 1990 {published data only}|Promoting parent-provider interaction during young children's health-supervision visits|
Fleissig 1999 {published data only}|Encouraging out-patients to make the most of their first hospital appointment: to what extent can a written prompt help patients get the information they want?|/resolve/reference/PMED?id=14528573
Ford 1995 {published data only}|The influence of audiotapes on patient participation in the cancer consultation|/resolve/reference/PMED?id=8652254
Frederickson 1995 {published and unpublished data}|Evaluation of a patient education leaflet designed to improve communication in medical consultations|/resolve/reference/PMED?id=7603933
Greenfield 1985 {published data only}|Expanding patient involvement in care: effects on patient outcomes|/resolve/reference/PMED?id=3977198
Greenfield 1988 {published data only}|Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes|/resolve/reference/PMED?id=3049968
Hornberger 1997 {published data only}|Effects of a self-administered previsit questionnaire to enhance awareness of patients' concerns in primary care|
Kidd 2004 {published data only}|Promoting patient participation in consultations: a randomised controlled trial to evaluate the effectiveness of three patient-focused interventions|/resolve/reference/PMED?id=14729297
Kim 2003 {published and unpublished data}|Increasing patient participation in reproductive health consultations: an evaluation of 'Smart Patient' coaching in Indonesia|/resolve/reference/PMED?id=12781926
Lewis 1991 {published data only}|Increasing patient knowledge, satisfaction and involvement: randomized trial of a communication intervention|/resolve/reference/PMED?id=1861939
Little 2004 {published data only}|Randomised controlled trial of effects of leaflets to empower patients in consultations in primary care|/resolve/reference/PMED?id=14966078
Maly 1999 {published and unpublished data}|A randomized controlled trial of facilitating information giving to patients with chronic medical conditions: effects on outcomes of care|/resolve/reference/PMED?id=10334612
Martinali 2001 {published and unpublished data}|A checklist to improve patient education in a cardiology outpatient setting|/resolve/reference/PMED?id=11164322
McCann 1996 {published data only}|Encouraging patient participation in general practice consultations: effect on consultation length and content, patient satisfaction and health|
McCann 1996 {published data only}|Empowering the patient in the consultation: a pilot study|/resolve/reference/PMED?id=8788351
Middleton 2006 {published and unpublished data}|Effect of patient completed agenda forms and doctors' education about the agenda on the outcome of consultations: randomised controlled trial|/resolve/reference/PMED?id=16707508
Oliver 2001 {published and unpublished data}|Individualized patient education and coaching to improve pain control among cancer patients|/resolve/reference/PMED?id=11304773
Roter 1977 {published data only}|Patient participation in the patient-provider interaction: the effects of patient question asking on the quality of interaction, satisfaction and compliance|/resolve/reference/PMED?id=346537
Roter 1977 {published data only}|Patient question asking in physician-patient interaction|/resolve/reference/PMED?id=6536496
Sander 1996a {published and unpublished data}|Patient-initiated prevention discussions: two interventions to stimulate patients to initiate prevention discussions|/resolve/reference/PMED?id=8917146
Sander 1996b {published and unpublished data}|Patient-initiated prevention discussions: two interventions to stimulate patients to initiate prevention discussions|/resolve/reference/PMED?id=8917146
Tabak 1988 {published data only}|Encouraging patient question-asking: a clinical trial|/resolve/reference/PMED?id=10302610
Tennstedt 2000 {published and unpublished data}|Empowering older patients to communicate more effectively in the medical encounter|/resolve/reference/PMED?id=10723618
Thompson 1990a {published data only}|Patient-oriented interventions to improve communication in a medical office visit|/resolve/reference/PMED?id=2373065
Thompson 1990b {published data only}|Patient-oriented interventions to improve communication in a medical office visit|/resolve/reference/PMED?id=2373065
Wilkinson 2002 {published data only}|Strengthening patient-provider relationships|/resolve/reference/PMED?id=12048339
Ader 1992 {published data only}|Information seeking and interactive videodisc preparation for the third molar extraction|/resolve/reference/PMED?id=1727457
Agre 1993 {published data only}||
Albertson 2002 {published data only}|Impact of a simple intervention to increase primary care provider recognition of patient referral concerns|/resolve/reference/PMED?id=11954555
Ambler 1999 {published data only}|Specialist nurse counsellor interventions at the time of diagnosis of breast cancer: comparing 'advocacy' with a conventional approach|
Anderson 1987 {published data only}|Effects of modelling on patient communication, satisfaction and knowledge|/resolve/reference/PMED?id=3695636
Anderson 1995 {published data only}|Patient empowerment: results of a randomized controlled trial|/resolve/reference/PMED?id=7555554
Bekker 1999 {published data only}|Informed decision making: an annotated bibliography and systematic review|/resolve/reference/PMED?id=10350446
Belkora 2006 {published data only}|Evaluation of a visit preparation intervention implemented in two rural, underserved countries of Northern California|/resolve/reference/PMED?id=16904859
Bergus 2002 {published data only}|Presenting risks and benefits to patients: the effects of information order on decision making|
Bertakis 1977 {published data only}|The communication of information from physician to patient:a method for increasing retention and satisfaction|/resolve/reference/PMED?id=894226
Cegala 2001 {published data only}|The effects of patient communication skills training on the discourse of older patients during a primary care interview|
Courtney 1997 {published data only}|The effect of a preanaesthetic information booklet on patient understanding and satisfaction|/resolve/reference/PMED?id=9216606
Cull 1998 {published data only}|The use of videotaped information in cancer genetic counselling: a randomized evaluation study|/resolve/reference/PMED?id=9514066
Cunningham 2000 {published data only}|A question sheet to encourage written consultation questions|/resolve/reference/PMED?id=10848369
Done 1998 {published data only}|The use of video to convey preanesthetic information to patients undergoing ambulatory surgery|/resolve/reference/PMED?id=9728822
Dow 1991 {published data only}|Training psychiatric patients to discuss medication issues: effects on patient communication and knowledge of medications|/resolve/reference/PMED?id=2003848
Fleissig 2001 {published data only}|Results of an intervention study to improve communication about randomised clinical trials of cancer therapy|/resolve/reference/PMED?id=11239753
Greaves 1999 {published data only}|Patients informing patients: does information on video improve patient satisfaction and outcomes in day surgery?|
Gustafson 1999 {published data only}|Impact of a patient-centered, computer-based health information/support system|/resolve/reference/PMED?id=9894548
Hardy 2001 {published data only}|Information given to patients before appointments and its effect on non-attendance rate|/resolve/reference/PMED?id=11731398
Harmsen 2005 {published data only}|The effect of educational intervention on intercultural communication: results of a randomised controlled trial|/resolve/reference/PMED?id=15904552
Inui 1979 {published data only}|Effects of a self-administered health history on new-patient visits in a general medical clinic|/resolve/reference/PMED?id=513885
Jenkinson 1988 {published data only}|Comparison of effects of a self management booklet and audiocasette for patients with asthma|/resolve/reference/PMED?id=3416147
Jensen 1993 {published data only}|Information for cancer patients entering a clinical trial: an evaluation of an information strategy|/resolve/reference/PMED?id=8110492
Jones 2002 {published data only}|Does writing a list help cancer patients ask relevant questions?|/resolve/reference/PMED?id=12135829
Kaplan 1989 {published data only}|Assessing the effects of physician-patient interactions on the outcomes of chronic disease|/resolve/reference/PMED?id=2646486
Keeble 2002 {published data only}|Patient recall of medication details in the outpatient clinic. Audit and assessment of the value of printed instructions requesting patients to bring medications to clinic|/resolve/reference/PMED?id=12185223
Kennedy 2002 {published data only}|Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial|/resolve/reference/PMED?id=12460093
Kennedy 2002a {published data only}|Improving patient involvement in chronic disease management: the views of patients, GPs and specialists on a guidebook for ulcerative colitis|/resolve/reference/PMED?id=12088604
Kennedy 2004 {published data only}|A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease|/resolve/reference/PMED?id=15479685
Kitai 2002 {published data only}|Erectile dysfunction - the effect of sending a questionnaire to patients on consultations with their doctor|/resolve/reference/PMED?id=11978714
Kruijff 1997 {published data only}||
Kupst 1975 {published data only}|Evaluation of methods to improve communication in the physician-patient relationship|/resolve/reference/PMED?id=1146974
Kutner 1999 {published and unpublished data}|Evaluation of the impact of a pre-visit questionnaire for addressing cancer patients' information needs|
Madden 1994 {published data only}|Evaluation of women's worries and the effects of a preparatory booklet for patients attending a breast clinic|
McGee 1998 {published data only}|Patient communication skills training for improved communication competence in the primary care medical consultation|
Middleton 1995 {published data only}|Asking patients to write lists: feasibility study|/resolve/reference/PMED?id=7613324
Miller 1986 {published data only}|Patient education: comparative effectiveness by means of presentation|/resolve/reference/PMED?id=3944552
O'Mara 2003 {published data only}|Evidence based patient information leaflets in maternity care had limited visibility and did not promote informed choice of child bearing women|/resolve/reference/PMED?id=12546045
Oermann 2003 {published and unpublished data}|Outcomes of videotape instruction in clinic waiting area|/resolve/reference/PMED?id=12703393
Pasacreta 1998 {published data only}|An empowerment information intervention improved participation in treatment decision making in men with recently diagnosed prostate cancer - commentary|
Post 2002 {published data only}|The other half of the whole: teaching patients to communicate with physicians|/resolve/reference/PMED?id=12038716
Pruyn 2004 {published data only}|On the enhancement of efficiency in care for cancer patients in outpatient clinics: an instrument to accelerate psychosocial screening and referral|/resolve/reference/PMED?id=15140452
Richard 1998 {published data only}|Information leaflet for lower respiratory tract illness|/resolve/reference/PMED?id=9519010
Rieger 1999 {published data only}|Informed consent, patient satisfaction and length of hospitalisation: the contribution of written information leaflets|
Robinson 1985 {published data only}|Improving the efficiency of patients' comprehension monitoring: a way of increasing patients' participation in general practice consultations|/resolve/reference/PMED?id=4071125
Rost 1991 {published data only}|Change in metabolic control and functional status after hospitalization: impact of patient activation intervention in diabetic patients|/resolve/reference/PMED?id=1773686
Ruland 2003 {published data only}|Effects of a computerized system to support shared decision making in symptom management of cancer patients: preliminary results|/resolve/reference/PMED?id=12925545
Rutten 1991 {published data only}|Patient education about cough: effect on the consulting behaviour of general practice patients|/resolve/reference/PMED?id=1747268
Rutten 1993 {published data only}|Effects of systematic patient education about cough on the consulting behaviour of a general practice population|/resolve/reference/PMED?id=8153034
Schouten 2005 {published data only}|The impact of an intervention in intercultural communication on doctor-patient interaction in The Netherlands|/resolve/reference/PMED?id=16076543
Selvachandran 2002 {published data only}|Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study|
Sepuchra 2000 {published data only}|Building bridges between physicians and patients: results of a pilot study examining new tools for collaborative decision making in breast cancer|/resolve/reference/PMED?id=10715292
Sepuchra 2002 {published data only}|Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians|/resolve/reference/PMED?id=12039932
Sepuchra 2003 {published data only}|Improving the quality of decision making in breast cancer: consultation planning template and consultation recording template|/resolve/reference/PMED?id=12515987
Shepperd 1995 {published data only}|Using interactive videos in general practice to inform patients about treatment choices: a pilot study|/resolve/reference/PMED?id=8826063
Smith 1998 {published data only}|The role of the general health questionnaire in general practice consultations|/resolve/reference/PMED?id=9830180
Stapleton 2002 {published data only}|Qualitative study of evidence based leaflets in maternity care|/resolve/reference/PMED?id=11895821
Street 1995 {published data only}|Increasing patient involvement in choosing treatment for early breast cancer|
Sulmasy 1996 {published data only}|Strategies to promote the use of advanced directives in a residency outpatient practice|/resolve/reference/PMED?id=9120651
Teutsch 2003 {published data only}|Patient-doctor communication|/resolve/reference/PMED?id=14621334
Thomas 2000 {published data only}|Forewarned is forearmed - benefits of preparatory information on video cassette for patients receiving chemotherapy or radiotherapy - a randomised controlled trial|/resolve/reference/PMED?id=10930801
Tran 2004 {published data only}|Empowering communication: a community-based intervention for patients|/resolve/reference/PMED?id=14729298
Van Dam 2003 {published data only}|Provider-patient interaction in diabetes care: effects on patient self-care and outcomes. A systematic review|/resolve/reference/PMED?id=12915276
Velikova 2002 {published data only}|Computer-based quality of life questionniares may contribute to doctor-patient interactions in oncology|/resolve/reference/PMED?id=11857011
Wallston 1979 {published data only}|Modification of question asking behavior in high and low assertive women through modeling and specific instructions|
Weinberger 1998 {published data only}|Telephone-based interventions in outpatient care|/resolve/reference/PMED?id=9709173
Wells 2004 {published data only}|The patients' written word: a simple communication aid|/resolve/reference/PMED?id=15288914
Wetzels 2005 {published data only}|A consultation leaflet to improve an older patient's involvement in general practice care: a randomized trial|
Wilson 2002 {published data only}|Computerized information-gathering in specialist rheumatology clinics: an initial evaluation of an electronic version of the Short Form 36|/resolve/reference/PMED?id=11934962
Anderson 1991|Improving patient and provider communication: a synthesis and review of communication interventions|
Beisecker 1990|Patient information-seeking behaviours when communicating with doctors|/resolve/reference/PMED?id=2296214
Bensing 2000|Communication: the royal pathway to patient-centered medicine|/resolve/reference/PMED?id=11013542
Boberg 2003|Assessing the unmet information, supoort and care delivery needs of men with prostate cancer|/resolve/reference/PMED?id=12642195
Boreham 1978|The informative process in private medical consultations: a preliminary investigation|/resolve/reference/PMED?id=705386
Cegala 2003|Patient communication skills training: a review with implications for cancer patients|/resolve/reference/PMED?id=12767592
Clarke 2003|Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]|
Cohen 1988|Statistical power analysis for the behavioural sciences|
Deyo 1986|Patient satisfaction with medical care for low back pain|/resolve/reference/PMED?id=2939566
Edwards 2006|Inside the black box of shared decision making - distinguishing between the process of involvement and who makes the decision|
Egbert 1964|Reduction of postoperative pain by encouragement and instruction of patients|/resolve/reference/PMED?id=14108087
Elwyn 1999|Shared decision making in primary care: the neglected second half of the consultation|/resolve/reference/PMED?id=10562751
Elwyn 2000|Shared decision making and the concept of equipoise: the competences of involving patients in healthcare choices|/resolve/reference/PMED?id=11141876
Faden 1981|Disclosure of information to patients in medical care|/resolve/reference/PMED?id=7266120
Fallowfield 1994|Psychological effects of being offered choice of surgery for breast cancer|/resolve/reference/PMED?id=7920129
Fallowfield 1999|Effective communication skills are the key to good cancer care|/resolve/reference/PMED?id=10673967
Fallowfield 2002|Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial|/resolve/reference/PMED?id=11879860
Fleissig 2000|Patients are frightened and their information needs fluctuate|/resolve/reference/PMED?id=11023315
Gaston 2005|Information giving and decision-making in patients with advanced cancer: A systematic review|/resolve/reference/PMED?id=15922501
Hall 1988|Meta-analysis of correlates of provider behavior in medical encounters|/resolve/reference/PMED?id=3292851
Harrington 2004|Improving patients' communication with doctors: a systematic review of intervention studies|/resolve/reference/PMED?id=14729285
Helman 2007||
Higgins 2006|Cochrane handbook for systematic reviews of interventions 4.2.6 [Updated September 2006]|
Jahad 1995|Asking patient to write lists|
Jefford 2002|Informing and involving cancer patients in their own care|/resolve/reference/PMED?id=12372725
Jenkins 2001|Information needs of patients with cancer: results from a large study in UK cancer centres|/resolve/reference/PMED?id=11139312
Jenkins 2002|Can communication skills training alter physicians' beliefs and behavior in clinics?|/resolve/reference/PMED?id=11821459
Kindelan 1987|Concordance between patients' information preferences and general practitioners' perceptions|
Kinnersley 1999|The patient-centredness of consultations and outcome in primary care|/resolve/reference/PMED?id=10756612
Korsch 1968|Gaps in doctor-patient communication|/resolve/reference/PMED?id=5685370
Kramer 2004|Acquisition of communication skills in postgraduate training for general practice|
Krupat 2000|The practice orientations of physicians and patients: the effect of doctor-patient congruence on satisfaction|/resolve/reference/PMED?id=11013547
Lewin 2001|Interventions for providers to promote a patient-centred approach in clinical consultations (Cochrane Review)|/resolve/reference/PMED?id=11687181
Leydon 2000|Cancer patients' information needs and information seeking behaviour: in depth interview study|/resolve/reference/PMED?id=10742000
Maguire 1986|Consultation skills of young doctors. 1. Benefits of feedback training in interviewing as students persist|/resolve/reference/PMED?id=3719282
Maguire 1996|Helping health professionals involved in cancer care acquire key interviewing skills - the impact of workshops|/resolve/reference/PMED?id=8911106
Makoul 1995|Health promotion in primary care: physician-patient communication and decision making about prescription medications|/resolve/reference/PMED?id=8545677
McKenzie 2000|Information needs of patients with cancer: similar study had similar findings|/resolve/reference/PMED?id=11023315
Meredith 1996|Information needs of cancer patients in west Scotland: cross sectional survey of patients' views|/resolve/reference/PMED?id=8819442
Neighbour 1996||
Rogers 2005|Uncovering the limits of patient-centeredness: implementing a self management trial for chronic illness|/resolve/reference/PMED?id=15611205
Roter 1995|Improving physicians' interviewing skills and reducing patients' emotional distress: a randomized controlled trial|/resolve/reference/PMED?id=7677554
Roter 2000|The enduring and evolving nature of the patient-physician relationship|/resolve/reference/PMED?id=11013543
Scott 2003|Recordings or summaries of consultations for people with cancer|
Silverman 2005|Skills for communicating with patients|
Starfield 1981|The influence of patient-practitioner agreement on outcome of care|/resolve/reference/PMED?id=7457681
Stewart 1995|Effective physician-patient communication and health outcomes: a review|/resolve/reference/PMED?id=7728691
Stimson 1975||
Svarstad 1974|The doctor-patient encounter: an observational study of communication and outcome|
Tuckett 1985|Meetings between experts: an approach to sharing ideas in medical consultations|
Waitzkin 1984|Doctor-patient communciation: clinical implications of social scientific research|/resolve/reference/PMED?id=6481931
Wetzels 2007|Interventions for improving older patients' involvement in primary care episodes|/resolve/reference/PMED?id=17253501
Wilson 2002a|The relationship between consultation length, process and outcomes in general practice: a systematic review|/resolve/reference/PMED?id=12528590
Ding 2004 {published data only}|Therapeutic effect observation of Tongxinluo capsule for 68 cases of acute cerebral infarction|
Wang 2006 {published data only}|Therapeutic effect observation of Tongxinluo capsule for 56 cases of acute cerebral infarction|
Cai 2001 {published data only}|Research of tongxinluo capsule for acute stroke|
Chen 2001 {published data only}|The effect of Tongxinluo capsule for acute stroke|
Ding 2003 {published data only}|Observation of the result of Tongxinluo capsule for the treatment acute cerebral infarction and analysis of its mechanism|
Fan 2001 {published data only}|Clinical research of Tongxinluo capsule for acute stroke|
Gu 2004 {published data only}|Therapeutic effect observation of Tongxinluo capsule for cerebral infarction|
Han 2006 {published data only}|Therapeutic effect observation of Tongxinluo capsule for 30 cases of cerebral infarction|
Hu 2002 {published data only}|80 cases of Tongxinluo capsule for stroke|
Jia 2001 {published data only}|Effect of tongxinluo capsule for stroke|
Li 2001 {published data only}|Clinical observation of Tongxinluo capsule for acute stroke|
Liu 2001 {published data only}|Clinical observation of Tongxinluo capsule for acute stroke|
Liu 2001b {published data only}|30 cases of Tongxinluo capsule for acute stroke|
Liu 2001c {published data only}|Observation of tongxinluo capsule for acute stroke|
Lu 2001 {published data only}|Clinical research of Tongxinluo capsule for acute stroke|
Lu 2002 {published data only}|Therapeutic effect observation of Tongxinluo capsule for 62 cases of acute cerebral infarction|
Sun 2000 {published data only}|Therapeutic effect evaluation of Tongxinluo capsule for ischaemic cerebrovascular diseases|
Wang 2001 {published data only}|Observation of ninety cases about Tongxinluo capsule for acute stroke|
Wang 2006b {published data only}|Clinical observation of tongxiluo in the treatment of stroke with "qixu xueyu luozhu" signs|
Wu 2001 {published data only}|Observation of Tongxinluo capsule for stroke|
Xu 2001 {published data only}|Observation and analysis of Tongxinluo capsule for acute stroke|
Xu 2001b {published data only}|The effect of Tongxinluo capsule for stroke|
Xu 2003 {published data only}|Effects of Tongxinluo capsule on neurological impairment and activity of daily life in acute cerebral infarction|
Yang 2001 {published data only}|Observation of Tongxinluo capsule for stroke|
Zhang 2001 {published data only}|30 cases about Tongxinluo capsule for acute stroke|
Zhang 2001b {published data only}|Observation of Tongxinluo capsule for acute stroke|
Zhang 2002 {published data only}|25 cases of Tongxinluo capsule for stroke|/resolve/reference/PMED?id=11977585
Zhou 2004 {published data only}|Therapeutic effects of tongxinluo capsule on patients with acute small cerebral infarction and its influence on SPECT brain perfusion image|
Zhou 2005 {published data only}|Therapeutic effects of tongxinluo capsule on patients with acute small cerebral infarction and its influence on SPECT brain perfusion image|
Wang 2001b {published data only}|Observation of tongxinluo capsule for acute stroke|
Algra 1996|Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia after cerebral ischaemia|/resolve/reference/PMED?id=8708654
APT 1994|Collaborative overview of randomised trials of antiplatelettherapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients|/resolve/reference/PMED?id=8298418
Bamford 1990|The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project|/resolve/reference/PMED?id=2266360
Broderick 1989|Incidence rates of stroke in the eighties: the end of the decline in stroke?|/resolve/reference/PMED?id=2718196
Chen 1985|Effect of Scolopendra extraction in the experiment of rabbit heart|
Deng 1991|Effect of Radix Paeoniae Rubra water-extraction in the experiment of anticoagulation|
Editor 2002|An important new theory on Chinese herbal medicine for treatment of cardio-cerebral vascular diseases|
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]|
Homer 1987|Trends in the incidence rates of stroke in Rochester, Minnesota, since 1935|
IST Pilot 1996|Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study|
Liu 1997|Effect of Tongxinluo capsule on experimental myocardial ischemia, arrhythmia and hyperlipidemia|/resolve/reference/PMED?id=10322866
Lu 1983|Effect of Radix Paeoniae Rubrasin in the experiment on hyperlipidemia and hypercholesterolemia mice|
Nong 1989|The effect of Eupolyphaga Sinensis Walk alkaloids on rabbits cardial pump function|
Ou 1987|Experimental survey of 126 Chinese medicine antithrombin function|
Pharmacology 1960|Study of pharmacological of Periostracum Cicadae|
Sandercock 1992|The likely public health impact of simple treatments for acute ischaemic stroke|
Stanford 1999|Understanding stroke|
Wang 1998||
Wardlaw 2003|Thrombolysis in acute ischaemic stroke - does it work?|
Wu 1994|Comparison of adjustment function of three Hirudo products|
Wu 2007|Meta-analysis of traditional Chinese patent medicine for ischemic stroke|/resolve/reference/PMED?id=17463317
Xu 1988a|Effect of inhibition platelet adhesion reaction of Radix Ginseng|
Xu 1988b|Affection of Hirudo water-extraction for mice and human platelet adhesion reaction and blood rheology|/resolve/reference/PMED?id=3240798
Yang 1989|The effect of Eupolyphaga Sinensis Walk alkaloids on animal tolerance of hypoxia|
Zhou 2004|Tongxinluo capsule for acute stroke (Protocol)|/resolve/reference/PMED?id=14973996
Bruera 2003 {published data only}|Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study|/resolve/reference/PMED?id=12506181
Fearon 2003 {published and unpublished data}|Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial|
Gogos 1998 {published data only}|Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy|
Jatoi 2004 {published data only}|An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a north central cancer treatment group and national cancer institute of Canada collaborative effort|
Zuijdgeest 2000 {published data only}|Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation|/resolve/reference/PMED?id=11104593
Atkinson 1998 {published data only}|A prospective randomized, double blind, controlled clinical trial of enteral immunonutrition in the critically ill|/resolve/reference/PMED?id=9671364
Barber 1998 {published data only}|A fish oil-enriched nutritional supplement modulates changes in the acute phase protein response in weight-losing pancreatic cancer patients|/resolve/reference/PMED?id=10205315
Barber 1999a {published data only}|The effect of an oral nutritional supplement enriched with fish oil on weight loss in patients with pancreatic cancer|/resolve/reference/PMED?id=10487616
Barber 1999b {published data only}|Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer|/resolve/reference/PMED?id=10356075
Barber 2000 {published data only}|Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement|/resolve/reference/PMED?id=10731472
Barber 2001a {published data only}|Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia|/resolve/reference/PMED?id=11383684
Barber 2001b {published data only}|Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia|/resolve/reference/PMED?id=11962246
Barber 2004 {published data only}|Modulation of the liver export protein synthetic response to feeding by an n-3 fatty acid enriched nutritional supplement is associated with anabolism in cachectic cancer patients|/resolve/reference/PMED?id=14624668
Bauer 2005 {published data only}|Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy - a pilot study|/resolve/reference/PMED?id=15583950
Braga 1995 {published data only}|Benefits of Early Postoperative Enteral Feeding in Cancer Patients|/resolve/reference/PMED?id=8924741
Braga 1996a {published data only}|Immune and nutritional effects of early enteral nutrition after major abdominal operations|/resolve/reference/PMED?id=8639722
Braga 1996b {published data only}|Gut function and immune and inflammatory responses in patients preoperatively fed with supplemented enteral formulas|/resolve/reference/PMED?id=8956766
Braga 1999 {published data only}|Perioperative immunonutrition in patients undergoing cancer surgery|/resolve/reference/PMED?id=10199318
Braga 2002 {published data only}|Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer|/resolve/reference/PMED?id=12464864
Braga 2002a {published data only}|Nutritional Approach in Malnourished Surgical Patients|/resolve/reference/PMED?id=11822956
Brosnahan 2003 {published data only}|Supplementation with key nutrients reduced postoperative infections and length of hospital stay after gastrointestinal surgery|/resolve/reference/PMED?id=12710422
Burns 1999 {published data only}|Phase I Clinical Study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia Group B Study 9473|/resolve/reference/PMED?id=10632323
Burns 2004 {published data only}|Phase II Study of High-Dose fish oil capsules for patients with cancer-related cachexia|
Daly 1992 {published data only}|Enteral nutrition with supplemental arginine, RNA and omega-3 fatty acids in patients after operation: Immunologic, metabolic and clinical outcome|/resolve/reference/PMED?id=1377838
Daly 1995 {published data only}|Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients|/resolve/reference/PMED?id=7726669
Davidson 2004 {published data only}|Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer|/resolve/reference/PMED?id=15030964
Di Carlo 1999 {published data only}|Complications of pancreatic surgery and the role of perioperative nutrition|/resolve/reference/PMED?id=10449977
Falconer 1994 {published data only}|Polyunsaturated fatty acids in the treatment of weight-losing patients with pancreatic cancer|/resolve/reference/PMED?id=7856240
Fearon 2001 {published data only}|An energy and protein dense, high n-3 fatty acid oral supplement promotes weight gain in cancer cachexia|
Gianotti 1997 {published data only}|Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms|/resolve/reference/PMED?id=9366716
Gianotti 1999 {published data only}|A prospective randomized clinical trial on perioperative feeding with an arginine, omega-3 fatty acid, and RNA-enriched enteral diet: effect on host response and nutritional status|/resolve/reference/PMED?id=10574478
Gianotti 2002 {published data only}|A randomised controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer|/resolve/reference/PMED?id=12055582
Gramaglia 1999 {published data only}|Increased survival in brain metastatic patients treated with stereotatic radiotherapy, omega three fatty acids and bioflavonoids|/resolve/reference/PMED?id=10697622
Heller 2004 {published data only}|Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients|
Heslin 1997 {published data only}|A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy|/resolve/reference/PMED?id=9351723
Keman 1995 {published data only}|Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: An immunologic evaluation of Impact Registered Trademark|/resolve/reference/PMED?id=7536138
Mantovani 2004 {published data only}|Cancer-related anorexia.cachexia syndrome and oxidative stress: an innovative approach beyond current treatment|/resolve/reference/PMED?id=15466983
McCarter 1998 {published data only}|Preoperative oral supplement with immunonutrients in cancer patients|/resolve/reference/PMED?id=9661120
Moses 2001 {published data only}|An experimental nutrition supplement enriched with n-3 fatty acids and antioxidants is associated with an increased physical activity level in patients with pancreatic cancer cachexia|/resolve/reference/PMED?id=11161539
Moses 2002 {published data only}|Physical activity level in patients with pancreatic cancer cachexia|
Persson 2005 {published data only}|Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study|/resolve/reference/PMED?id=15723745
Pratt 2002 {published data only}|Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation|/resolve/reference/PMED?id=12454764
Read 2004 {published and unpublished data}|Nutritional and anti-inflammatory strategies in the treatment of advanced colorectal cancer: a pilot study|
Rodrigo 1997 {published data only}|Influence of the composition of the enteral nutrition on the infection of the critical patient|
Schilling 1995 {published data only}|Clinical outcome and immunology of postoperative arginine, w-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat IV solutions|/resolve/reference/PMED?id=8875537
Senkal 1995 {published data only}|Modulation of Postoperative Immune Response by Enteral Nutrition with a Diet Enriched with Arginine, RNA, and Omega-3 Fatty Acids in Patients with Upper Gastrointestinal Cancer|/resolve/reference/PMED?id=7539633
Senkal 1997 {published data only}|Early postoperative enteral immunonutrition clinical outcome and cost-comparison analysis in surgical patients|/resolve/reference/PMED?id=9295822
Senkal 1999 {published data only}|Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery|/resolve/reference/PMED?id=10593328
Swails 1997 {published data only}|Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery|/resolve/reference/PMED?id=9323688
Synderman 1999 {published data only}|Reduced postoperative infections with an immune-enhancing nutritional supplement|
Tashiro 1998a {published data only}|n-3 verus n-6 polyunsaturated fatty acids in critical illness|/resolve/reference/PMED?id=9646301
Tashirom 1998b {published data only}|n-3 versus n-6 polyunsaturated fatty acids in critical illness|/resolve/reference/PMED?id=9646301
Vignali 1995 {published data only}|Impact of an enriched enteral formula on immune function and nutritional status in cancer patients following surgery|
vonMeyenfeldt 2002 {published data only}|Weight gain is associated with improved quality of life in patients with cancer cachexia consuming an energy and protein dense, high n-3 fatty acid oral supplement|
Wachtler 1995 {published data only}|Influence of a pre-operative enteral supplement on functional activities of peripheral leukocytes from patients with major surgery|/resolve/reference/PMED?id=16843943
Wigmore 1996 {published data only}|The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer|/resolve/reference/PMED?id=8850216
Wigmore 1997 {published data only}|Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6|/resolve/reference/PMED?id=9059324
Wigmore 2000 {published data only}|Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer|/resolve/reference/PMED?id=10890028
Fearon 2005 {unpublished data only}|A DBPCR Multi-centre Phase  Dose Response study of EPA 95% Diester  Capsules in patients with cancer cachexia|
Altman 2001|The revised CONSORT statement for reporting randomized trials: explanation and elaboration|/resolve/reference/PMED?id=11304107
Beck 1991|Anticachectic and antitumour effect of Eicosapentaenoic acid and its effect on protein turnover|/resolve/reference/PMED?id=1657378
Belizario 1991|Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss|/resolve/reference/PMED?id=2039696
Blackburn 1977|Nutritional and metabolic assessment of the hospitalized patient|/resolve/reference/PMED?id=98649
Brodie 1998|Body composition measurement: a review of hydrodosensitometry, anthropometry and impedance methods|
DeWys 1980|Prognostic effect of weight-loss prior to chemotherapy in cancer patients|/resolve/reference/PMED?id=7424938
Giacosa 1994|Food intake and body composition in cancer cachexia|/resolve/reference/PMED?id=8850214
Hudson 1994|Comparison of the effectiveness of eicosapentaenoic acid administered as either the free acid or ethyl ester as an anticachectic and antitumour agent|/resolve/reference/PMED?id=7972268
Jadad 1996|Assessing the quality of reporting of randomised clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Jaskowiak 1998|The pathophysiology of cancer cachexia|
Kyle 2004|Bioelectrical impedence analysis-part II: utilization in clinical practice|
Lindgvist 2004|Meanings of the phenomenon of fatigue as narrated by 4 patients with cancer in palliative care|/resolve/reference/PMED?id=15238812
Lindsey 1986|Cancer cachexia: effects of the disease and its treatment|/resolve/reference/PMED?id=3513270
Nixon 1981|Hyperalimentation of the cancer patient with protein-calorie undernutrition|/resolve/reference/PMED?id=6786732
Ovesen 1993|Effect of dietary counselling on food intake, body weight, response rate, survival and quality of life in cancer patients undergoing chemotherapy: a prospective randomised study|/resolve/reference/PMED?id=8410128
Smith 1993|Mechanism of muscle protein degradation and weight loss by a tumor product|/resolve/reference/PMED?id=8347486
Tisdale 1996|Inhibition of lipolysis and muscle degradation by EPA in cancer cachexia|/resolve/reference/PMED?id=8850217
Tisdale 1997|Biology of cachexia|/resolve/reference/PMED?id=9392617
Todorov 1996|Induction of muscle protein degradation and weight loss by a tumour product|/resolve/reference/PMED?id=8640810
Willox 1984|Prednisolone as an appetite stimulant in patients with cancer|/resolve/reference/PMED?id=6418303
Australia 1988 {published data only}|Aspirin improves fetal weight in placental insufficiency|
Australia 1988 {published data only}|Low-dose aspirin improves fetal weight in umbilical placental insufficiency|/resolve/reference/PMED?id=2899680
Australia 1988 {published data only}|Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency|/resolve/reference/PMED?id=3048102
Australia 1993 {published and unpublished data}|Randomised double blind placebo controlled trial of aspirin in the prevention of pre-eclampsia|
Australia 1993 {published and unpublished data}|Low-dose aspirin in the prevention of pre-eclampsia: current evaluation|
Australia 1995 {published data only}|Low dose aspirin for the treatment of fetal growth restriction: a randomised controlled trial|
Australia 1995a {published data only}|Prevention of pre-eclampsia in high risk women with renal disease: a prospective randomized trial of heparin and dipyridamole|
Australia 1995a {published data only}|Prevention of pre-eclampsia in women with renal disease|
Australia 1995a {published data only}|Prevention of preeclampsia in women with renal disease [abstract]|
Australia 1995a {published data only}|Prevention of pre-eclampsia in women with renal disease|
Australia 1996 {published and unpublished data}|Low dose aspirin delays the onset of pre-eclampsia in pregnancies with abnormal uteroplacental circulation|
Australia 1996 {published and unpublished data}|Trial to evaluate the role of aspirin (60mg) in the prevention of idiopathic intrauterine growth retardation and pregnancy induced hypertension in primigravid women with abnormal uterine artery waveforms on Doppler examination at 22-24 weeks gestation|
Australia 1996a {published data only}|A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow|/resolve/reference/PMED?id=8532271
Australia 1997 {published data only}|Low-dose aspirin in high risk pregnancy|
Australia 1997 {published data only}|Low-dose aspirin in high-risk pregnancy|
Australia 1997 {published data only}|Neonatal outcome in a randomized controlled trial of low-dose aspirin in high-risk pregnancies|
Austria 1992 {published data only}|Low-dose aspirin in primigravidae with positive roll-over test|/resolve/reference/PMED?id=1427414
Austria 1992 {published data only}|Low-dose aspirin in prevention and therapy of hypertension in pregnancy|/resolve/reference/PMED?id=1286358
Barbados 1998 {published data only}|The Barbados low-dose aspirin study in pregnancy (BLASP)|
Barbados 1998 {published data only}|A randomised trial of low dose aspirin for primiparae in pregnancy (golding)/barbados low dose aspirin study in pregnancy (blasp) (rotchell et al.) [Letter; comment]|
Barbados 1998 {published data only}|The Barbados Low-dose Aspirin Study in Pregnancy (BLASP): a population-based trial in a developing country with excess pre-eclampsia and perinatal mortality [abstract]|
Barbados 1998 {published data only}|Results of the Barbados low dose aspirin study in pregnancy (BLASP): a population-based trial in a developing country with excess pre-eclampsia (PE) and perinatal mortality|
Barbados 1998 {published data only}|Barbados low dose aspirin study in pregnancy (BLASP): a randomized controlled trial for the prevention of pre-eclampsia and its complications|
Brazil 1996 {published data only}|ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnancies|
Brazil 1996 {published data only}|ECPPA: randomized trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women [abstract]|
Brazil 1996 {published data only}|ECPPA: the Brazilian low-dose aspirin study in high risk pregnant women|
Brazil 1992a {published data only}|The use of low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension|
China 1996 {published data only}|A prospective randomized placebo-controlled trial of low dose aspirin for prevention of intra uterine growth retardation|/resolve/reference/PMED?id=8758317
China 1996 {published data only}|Prevention of growth retardation by low dose aspirin|/resolve/reference/PMED?id=8293692
China 1996a {published data only}|Small dosage aspirin in the prevention of hypertension of pregnancy|
China 1999 {published and unpublished data}|Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension|/resolve/reference/PMED?id=10476618
China 1999 {published and unpublished data}|Platelet angiotensin II receptor status during pregnancy in Chinese women at high risk of developing pregnancy-induced hypertension|/resolve/reference/PMED?id=8878711
CLASP 1994 {published data only}|Effect on fetal circulation of low-dose aspirin for prevention and treatment of pre-eclampsia and intrauterine growth restriction: Doppler flow study|
CLASP 1994 {published data only}|Decreased pathological placental findings in aspirin-treated pregnant women at risk of hypertensive complications|
CLASP 1994 {published data only}|Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin|
CLASP 1994 {published data only}|CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women|/resolve/reference/PMED?id=7906809
CLASP 1994 {published data only}|Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy|/resolve/reference/PMED?id=8534620
CLASP 1994 {published data only}|The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy|/resolve/reference/PMED?id=7573259
CLASP 1994 {published data only}|Aspirin for pre-eclampsia|/resolve/reference/PMED?id=7696941
CLASP 1994 {published data only}|Aspirin in profilaxis and treatment of placental insufficiency: lessons from Russian aspirin experience|
Colorado 1993 {published data only}|Low-dose aspirin and hypertension in pregnancy|/resolve/reference/PMED?id=8093955
Egypt 2005 {published data only}|Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial|/resolve/reference/PMED?id=16158479
EPREDA 1991 {published data only}|Prevention of preeclampsia with low-dose aspirin: results of the epreda trial|
EPREDA 1991 {published data only}|Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the EPREDA trial|/resolve/reference/PMED?id=1748229
EPREDA 1991 {published data only}|Prevention of pre-eclampsia with low-dose aspirin: results of the EPREDA trial|
EPREDA 1991 {published data only}|Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial|/resolve/reference/PMED?id=1675315
EPREDA 1991 {published data only}|Prevention of pre-eclampsia with low-dose aspirin: results of the EPREDA trial|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
EPREDA 1991 {published data only}|Prevention of pre-eclampsia with low-dose aspirin: results of the EPREDA trial|
EPREDA 1991 {published data only}|Prevention of intrauterine growth retardation and pre-eclampsia by small doses of aspirin. Results of the French multicenter trial EPREDA and comparison with data in the literature; value of uterine Doppler|/resolve/reference/PMED?id=1351078
ERASME 2003 {published data only}|Failure of systematic low dose aspirin to prevent preeclampsia in primigravidae|
ERASME 2003 {published data only}|Aspirin (100mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1)|/resolve/reference/PMED?id=12742332
ERASME 2003 {published data only}|Low dose aspirin to prevent preeclampsia: what do we learn from a new "negative" trial? [abstract]|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Finland 1993 {published data only}|Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn|
Finland 1993 {published data only}|The effect of 50mg of ASA daily on pregnancy outcome and maternal and newborn prostacyclin and thromboxane|
Finland 1997 {published data only}|Effect of low dose aspirin treatment on vascular resistance in the uterine, uteroplacental, renal and umbilical arteries - a prospective longitudinal study on a high risk population with persistent notch in the uterine arteries|
Finland 1997a {published data only}|Low dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2|/resolve/reference/PMED?id=9043927
Finland 1997a {published data only}|Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2|/resolve/reference/PMED?id=9262298
Finland 2002 {published data only}|Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches|
Finland 2002 {published data only}|Effect of ASA on the risk of gestational hypertension and prostanoid synthesis in pregnant women screened by Doppler ultrasound|
Finland 2002 {published data only}|9 alpha,11 beta-prostaglandin f2 in pregnancies at high risk for hypertensive disorders of pregnancy, and the effect of acetylsalicylic acid|/resolve/reference/PMED?id=12878455
Finland 2002 {published data only}|Prostacyclin, thromboxane a2 and the effect of low-dose asa in pregnancies at high risk of hypertensive disorders|/resolve/reference/PMED?id=15548142
France 1985 {published data only}|A controlled trial of prophylactic treatment of preeclampsia: preliminary results|/resolve/reference/PMED?id=6441542
France 1985 {published data only}|Prevention of pre-eclampsia by early antiplatelet therapy|/resolve/reference/PMED?id=2858710
France 1990 {published data only}|Effect of antiplatelet therapy in women at high risk for pregnancy-induced hypertension|
Germany 2000 {published data only}|Utero and fetoplacental hemodynamic measurements with low dose aspirin|/resolve/reference/PMED?id=10427668
Germany 2000 {published data only}|Effects of low dose aspirin on uterine and fetal blood flow during pregnancy: a randomized placebo controlled double blind trial|/resolve/reference/PMED?id=9033242
Germany 2000 {published data only}|Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial|
India 1993 {published data only}|Role of low dose aspirin in PIH|
India 1994 {published data only}|A study of low dose aspirin in prevention of pregnancy induced hypertension|/resolve/reference/PMED?id=7930659
India 1999 {published data only}|RCT of low dose aspirin to prevent the progression of pregnancy induced hypertension grade A to B|
Israel 1989 {published data only}|The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies|/resolve/reference/PMED?id=2664522
Israel 1990 {published data only}|Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension|/resolve/reference/PMED?id=2216216
Israel 1994 {published data only}|Prevention of pregnancy induced hypertension in twins by early administration of low-dose aspirin: a preliminary report|
Italy 1989 {published data only}|Low dose aspirin (ASA) given to prevent preeclampsia only partially inhibits platelet cyclooxygenase activity|
Italy 1989 {published data only}|Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension|/resolve/reference/PMED?id=2664523
Italy 1989 {published data only}|Low dose aspirin in preventing preeclampsia and IUGR|
Italy 1993 {published data only}|Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension|/resolve/reference/PMED?id=8094168
Italy 1993 {published data only}|Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension|
Italy 1993 {published data only}|Multicenter randomized Italian study of low-dose aspirin for the prevention of pre-eclampsia and intrauterine growth retardation|
Italy 1993 {published data only}|The Italian study on low-dose aspirin for the prevention of pre-eclampsia and intrauterine growth retardation|
Italy 1993 {published data only}|Follow-up of children in the Italian Study of Aspirin in Pregnancy|/resolve/reference/PMED?id=7513779
Italy 1993 {published data only}|Risk factors for pregnancy-induced hypertension in women at high risk for the condition|/resolve/reference/PMED?id=8728447
Italy 1999 {published data only}|Trial prospettico sull'uso profilattico dell'aspirina in donne gravide ad alto rischio di preeclampsia|
Italy 2004 {published data only}|A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia|/resolve/reference/PMED?id=14746947
Jamaica 1998 {unpublished data only}|A randomised trial of low dose aspirin for primiparae in pregnancy (golding)/barbados low dose aspirin study in pregnancy (blasp) (rotchell et al.) [Letter; comment]|
Jamaica 1998 {unpublished data only}|Low-dose aspirin in pregnancy - are there any benefits? [abstract]|
Jamaica 1998 {unpublished data only}|A randomised trial of low dose aspirin for primiparae in pregnancy|
Jamaica 1998 {unpublished data only}|International variation in the incidence of hypertension in pregnancy among primiparae: the jamaican experience|
Jamaica 1998 {unpublished data only}|Low dose aspirin in pregnancy - are there any benefits?|
Japan 1999 {published data only}|Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia|/resolve/reference/PMED?id=10476617
Netherlands 1986 {published data only}|Low dose aspirin prevents pregnancy-induced hypertensive disease in angiotensin-sensitive primigravidae|
Netherlands 1986 {published data only}|Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae|/resolve/reference/PMED?id=2867260
Netherlands 1989 {published data only}||
Netherlands 1991a {published data only}|Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women|/resolve/reference/PMED?id=2035557
Netherlands 1991a {published data only}|Reversal of elevated vascular angiotensin II responsiveness in pregnancy by low-dose aspirin|
Russia 1993 {published and unpublished data}|Prevention of pregnancy complications with acetylsalicylic acid (ASA) and dipyridamol (DP) in women with chronic glomerulonephritis (CGN) and essential hypertension (EH)|
Russia 1993 {published and unpublished data}|Prevention of pregnancy complications in glomerulonephritis and hypertension with acetylsalicylic acid and curantyl|/resolve/reference/PMED?id=8378854
S Africa 1988 {published and unpublished data}|Aspirin and dipyridamole in the prevention of pre-eclampsia: effect on plasma prostanoids 6 keto PG1a and TXB2 and clinical outcome of pregnancy|
S Africa 1988 {published and unpublished data}|Aspirin and dipyridamole in the prevention of pre-eclampsia: effect on plasma 6 keto PGF1alpha and TxB2 and clinical outcome of pregnancy|
Spain 1997 {published data only}|Time-dependant effects of low dose aspirin administration on blood pressure in pregnant women|/resolve/reference/PMED?id=9322987
Spain 1999 {published data only}|Time dependant effects of low dose aspirin administration on blood pressure in high risk pregnancy|
Spain 1999 {published data only}|Administration time-dependent effects of aspirin in women at differing risk for preeclampsia|
Spain 1999 {published data only}|Administration time-dependent effects of aspirin in women at differing risk for preeclampsia|/resolve/reference/PMED?id=10523401
Spain 1999 {published data only}|Administration-time dependent effects of aspirin in women at high risk for preeclampsia|
Spain 1999 {published data only}|Administration time-dependant influence of aspirin on blood pressure in pregnant women|/resolve/reference/PMED?id=12623974
Spain 1999 {published data only}|Administration-time dependent effects of low-dose aspirin on blood pressure in women at high risk for pre-eclampsia|
Spain 1999 {published data only}|Administration-time dependent effects of low dose aspirin on the incidence of complications in women at high risk for preeclampsia|
Tanzania 1995 {published data only}|Low dose aspirin in prevention of pregnancy-induced hypertension in primigravidae at the Muhimbili Medical Centre, Dar Es Salaam|/resolve/reference/PMED?id=9033238
Tanzania 1995 {published data only}|Low dose aspirin in prevention of pregnancy-induced hypertension in primigravidae at the Muhimbili Medical Centre, Dar es Salaam|/resolve/reference/PMED?id=8904056
Tanzania 1995 {published data only}||
UK 1990 {published data only}|Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension|/resolve/reference/PMED?id=1972487
UK 1990 {published data only}|Low dose aspirin prevents proteinuric hypertension in women with abnormal uteroplacental waveforms|
UK 1992 {published data only}|Maternal low-dose aspirin spares the neonate|
UK 1992 {published data only}|A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy and in gestational hypertension|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
UK 1992 {published data only}|Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin|
UK 1992 {published data only}|Studies of the effect of low-dose aspirin on thromboxane production and platelet reactivity in normal pregnancy, pregnancy-induced hypertension and neonates|
UK 1992 {published data only}|Maternal low-dose aspirin spares neonatal platelets|
UK 1992 {published data only}|A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension|
UK 1992b {published data only}|The obstetric outcome of patients with positive anticardiolipin antibodies: aspirin vs no treatment|
UK 1995 {published data only}|A study of low dose aspirin for the prevention of hypertensive disorders of pregnancy in primiparous women|
UK 1995 {published data only}|Low-dose aspirin and nulliparae|/resolve/reference/PMED?id=1677150
UK 1995 {published data only}|Low-dose aspirin in the prevention of hypertensive disorders of pregnancy in relatively low-risk nulliparous women|
UK+others 2003 {published data only}|Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine Doppler at 23 weeks gestation|
USA 1993 {published and unpublished data}|Prerandomization compliance testing may predict pregnancy outcome in a randomized clinical trial|
USA 1993 {published and unpublished data}|The effect of low dose aspirin on fetal growth in low risk primiparas|
USA 1993 {published and unpublished data}|Fetal growth in women using low-dose aspirin for the prevention of preeclampsia: effect of maternal size|
USA 1993 {published and unpublished data}|Maternal serum thromboxane B2 reduction vs pregnancy outcome in a low-dose aspirin trial|
USA 1993 {published and unpublished data}|Low-dose aspirin therapy to prevent preeclampsia: safety considerations|
USA 1993 {published and unpublished data}|Low-dose asprin does not alter longitudinal maternal blood pressures|
USA 1993 {published and unpublished data}|Maternal serum thromboxane B2 reduction vs pregnancy outcome in a low-dose aspirin trial|/resolve/reference/PMED?id=7645637
USA 1993 {published and unpublished data}|Low-dose aspirin therapy to prevent preeclampsia|/resolve/reference/PMED?id=8475955
USA 1993 {published and unpublished data}|Low-dose aspirin therapy to prevent preeclampsia|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
USA 1993 {published and unpublished data}|Low dose aspirin: effect on fetal urine output|
USA 1993 {published and unpublished data}|The effect of low-dose aspirin on fetal urine output and amniotic fluid volume|/resolve/reference/PMED?id=8238144
USA 1993 {published and unpublished data}|The effect of low dose aspirin on umbilical artery Doppler measurements|
USA 1993 {published and unpublished data}|The effect of low-dose aspirin on umbilical artery Doppler measurements [published erratum appears in Am J Obstet Gynecol 1994 Jun;170(6):1841]|/resolve/reference/PMED?id=8238148
USA 1993 {published and unpublished data}|The effect of low-dose aspirin on the development of preeclampsia in women with elevated hCG|
USA 1993 {published and unpublished data}|The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels|/resolve/reference/PMED?id=7485340
USA 1993a {published data only}|Pregnancy effects of non-proteinuric gestational hypertension (GH)|
USA 1993a {published data only}|Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy|/resolve/reference/PMED?id=7943099
USA 1993a {published data only}|Low-dose aspirin (60 mg/d) in pregnancy for the prevention of preeclampsia|
USA 1993a {published data only}|Prevention of preeclampsia: low-dose aspirin in nulliparous women: a double-blind, placebo controlled trial|
USA 1993a {published data only}|Safety of low-dose aspirin in healthy nulliparous women: a double-blind, placebo-controlled trial|
USA 1993a {published data only}|Low-dose aspirin in nulliparous women: safety of epidural and correlation between bleeding time and maternal-neonatal bleeding complications|
USA 1993a {published data only}|Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study|
USA 1993a {published data only}|Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women|/resolve/reference/PMED?id=8413387
USA 1993a {published data only}|Low dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications|
USA 1993a {published data only}|Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study|/resolve/reference/PMED?id=7856699
USA 1993a {published data only}|Double-blind, placebo-controlled trial of low-dose aspirin to prevent pre-eclampsia|
USA 1993a {published data only}|Clinical trial of low dose aspirin (65mg) as a preventative of pre-eclampsia|
USA 1994 {published data only}|Sustained release, low-dose aspirin ameliorates but does not prevent preeclampsia (PE) in a high risk population|
USA 1997 {published data only}|Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing group of the antiphospholipid antibody treatment trial|/resolve/reference/PMED?id=9166175
USA 1998 {published and unpublished data}|Impact of preeclampsia on a subsequent pregnancy|
USA 1998 {published and unpublished data}|Low dose aspirin does not prevent preeclampsia in high risk women|
USA 1998 {published and unpublished data}|Low-dose aspirin to prevent preeclampsia in women at high risk|/resolve/reference/PMED?id=9494145
USA 1998 {published and unpublished data}|Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial|/resolve/reference/PMED?id=9822499
USA 1998 {published and unpublished data}|Adverse maternal, fetal and neonatal outcomes in a low dose aspirin trial who developed pre-eclampsia|
USA 1998 {published and unpublished data}|Maternal serum thromboxane B2 (TxB2) reduction did not predict improved pregnancy outcome in high risk women in a low dose aspirin trial|
USA 1998 {published and unpublished data}|Safety of low dose aspirin in high risk patients|
USA 1998 {published and unpublished data}|Low-dose aspirin (60 mg/d) in pregnancy for the prevention of preeclampsia|
Venezuela 2000 {published data only}|Synergic use of aspirin, fish oil and vitamins C and E for the prevention of preeclampsia|
Zimbabwe 1998 {published data only}|A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia|/resolve/reference/PMED?id=9509950
Australia 1989 {unpublished data only}|Can the genetic risk of pre-eclampsia be reduced by low dose aspirin?|
Australia 1989a {published data only}|Low-dose aspirin and twin pregnancy|/resolve/reference/PMED?id=2572918
Brazil 1992 {published data only}|The effect of aspirin therapy on the uterine circulation in preeclampsia|
Brazil 1996a {published and unpublished data}|The low dose aspirin study in pregnancy with chronic hypertension (AASHAC)|
China 1991 {published data only}|Low-dose aspirin preventing pregnancy induced hypertension|/resolve/reference/PMED?id=1804603
Colombia 1996 {published data only}|Low dose aspirin as prophylactic therapy of pregnancy induced hypertension|
East Germany 1986 {published data only}|Inhibition of prostaglandin synthetase by low-dose acetylsalicylic acid - effects on severity of pregnancy induced hypertension and fetal outcome|
East Germany 1988 {published data only}|Prophylactic management of pregnancy induced hypertension (PIH)|
Egypt 1991 {published data only}|Low dose acetyl salicylic acid in severe pre-eclampsia|/resolve/reference/PMED?id=1682177
Egypt 1998 {published data only}|The effect of low dose aspirin versus allylestrinol on uterine artery blood flow|
Equador 1998 {published data only}|Prevention of the development of preeclampsia by means of the administration of low doses of aspirin|
ERASME 2003a {published data only}|Aspirin (100mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 2)|/resolve/reference/PMED?id=12742333
Finland 1993a {published and unpublished data}|Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin|/resolve/reference/PMED?id=8437779
France 2001 {published data only}|Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial|
France 2001 {published data only}|Value of systematic doppler +/- low dose aspirin to prevent vascular complications in primigravidae|
Germany 1986 {published data only}|The influence of ASA on pre-eclampsia|
India 1986 {published data only}|Effect of platelet aggregation inhibitor on fetal outcome in EPH gestosis with IUGR|
India 1991 {published data only}|Evaluation of dipyridamole and aspirin in prevention and management of intrauterine growth retardation|
India 1993a {unpublished data only}|Randomised controlled trial of low dose aspirin in high risk pregnancy|
India 1997 {published data only}|Role of low dose aspirin in prevention of pregnancy induced hypertension|
India 1998 {published and unpublished data}|Effect of maternal low dose aspirin on neonatal platelet function|/resolve/reference/PMED?id=10216644
India 2001 {published data only}|Role of low dose aspirin for prevention of pregnancy induced hypertension|
India 2002 {published data only}|Role of low dose aspirin in mothers registering high serum HCG levels at mid trimester|
India 2002a {published data only}|Maternal and foetal outcome with low dose aspirin in pregnancy induced hypertension|
Iran 2002 {published data only}|Prevention of preeclampsia with low-dose aspirin or calcium supplementation|
Ireland 1995 {published data only}|Reduced fetal exposure to aspirin using a novel controlled release preparation in normotensive and hypertensive pregnancies|
Ireland 1995 {published data only}|Pharmacology of low dose aspirin in normotensive and hypertensive pregnancies|
Italy 1988 {published and unpublished data}|Role of early prevention with heparin and dipyridamole in the prevention of pre-eclampsia and placental insufficiency|
Italy 1988 {published and unpublished data}|Prevention of pre-eclampsia and placental insufficiency|/resolve/reference/PMED?id=2870389
Italy 1990 {published data only}|Use of a thromboxane receptor inhibitor in pregnancy-induced hypertension|
Italy 2002 {published and unpublished data}|Can low dose aspirin improve perinatal outcome in chronic hypertensive patients [abstract]|
Italy 2005 {published data only}|Efficacy of LMWH in lowering the recurrence rate of preeclampsia and in restoring the physiological vascular changes in ACE DD genotype women [abstract]|
Italy 2005 {published data only}|Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women|/resolve/reference/PMED?id=15557391
Japan 1989 {published data only}|Pathological state of the coagulatory and fibrinolytic system in preeclampsia and the the possibility of its treatment with AT III concentrate|/resolve/reference/PMED?id=2735838
Libya 2000 {published data only}|The uses of low dose aspirin (150mg/day) in primigravida reduces the severity and complications of pregnancy induced hypertension|
Netherlands 1991 {published data only}|Effect of low-dose aspirin with and without dipyridamole on prostanoid biosynthesis in pregnancy|
Netherlands 1991 {published data only}|Effect of low-dose aspirin with and without dipyridamole on prevention of recurrent idiopathic fetal growth retardation|
Netherlands/UK 1994 {published data only}|Insulin resistance, vasoactive mediators and preeclampsia|
Netherlands/UK 1994 {published data only}|Prevention of preeclampsia and fetal growth retardation; allylestrenol vs aspirin, a two centered study|
New Zealand 1990 {published data only}|Poor participation of nulliparous women in a low dose aspirin study to prevent preeclampsia|/resolve/reference/PMED?id=2234646
New Zealand 1998 {published data only}|Prenatal treatment with low dose aspirin in small for gestational age fetuses with abnormal umbilical doppler: a randomised controlled trial|
New Zealand 1998 {published data only}|Administration of low dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial|
New Zealand 2000 {published data only}|Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial|/resolve/reference/PMED?id=11035355
Pakistan 1994 {published data only}|Role of aspirin in management of pregnancy induced hypertension. A study in Pakistani population|
Pergar 1987 {unpublished data only}|Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy [letter]|/resolve/reference/PMED?id=2648844
Poland 1999 {published and unpublished data}|Evaluation of the effectiveness of a low dose aspirin in the treatment of intrauterine growth retardation (IUGR)|/resolve/reference/PMED?id=10390914
Russia 1997 {published data only}|Nitric oxide: its role in the development of pregnancy complications and in their prevention in women with hypertension and chronic glomerulonephritis|/resolve/reference/PMED?id=9297265
Slovenia 1992 {published data only}|Antiaggregational therapy in preventing EPH gestosis and its complications|/resolve/reference/PMED?id=1608027
Slovenia 1992 {published data only}|Antiaggregational therapy in preventing EPH gestosis and its complications|
Slovenia 1994 {published data only}|Prevention of gestational hypertension and its complications with ASA and N-3 fatty acids (comparative study)|
Slovenia 1998 {published and unpublished data}|The effect of acetylsalicylic acid and n-3 fatty acids in prevention of complications of hypertension diseases in pregnancy|
South Africa 1986 {published data only}|The use of low dose aspirin in pregnancy induced hypertension|
Spain + others 2000 {published and unpublished data}|Aspirin in early pregnancy to reduce the incidence and/or severity of pregnancy induced hypertension and intrauterine growth retardation in healthy pregnant women|
Switzerland 2000 {published data only}|Effects of LMW-heparin and low-dose aspirin on renal uric acid handling in high-risk pregnancies|
Switzerland 2000 {published data only}|LMW heparin and low dose aspirin for prevention of preeclampsia: preliminary data of a randomised prospective study [abstract]|
Thailand 1996 {published and unpublished data}|The use of low-dose aspirin to prevent preeclampsia|/resolve/reference/PMED?id=9236320
Thailand 1996 {published and unpublished data}|The use of low-dose aspirin to prevent pre-eclampsia|
Trinidad 1997 {published data only}|Prevention of hypertensive disorders of pregnancy|/resolve/reference/PMED?id=15512028
Tunisia 1989 {published data only}|Prevention of complications of hypertension in pregnancy with antiplatelets|/resolve/reference/PMED?id=2524053
Tunisia 1989 {published data only}|Place of antiplatelet therapy (APT) in vasculo-renal accidents's (VRA) preventive treatment during pregnancy|
Tunisia 1989 {published data only}|Place of antiplatelet therapy (APT) in vasculorenal accidents (VRA) preventive treatment in pregnancy|
Tunisia 1990 {published data only}|Aspirin or aspirin and dipyridamole to prevent vasculo-renal accidents in pregnancy|
Tunisia 1994 {published data only}|Aspirin or aspirin and dipyridamole to prevent pregnancy-induced hypertension [abstract]|
Uganda 1992 {published data only}|Trial of aspirin and methyldopa for moderate hypertension in pregnancy|
UK 1992a {published and unpublished data}|Effect of low dose aspirin on maternal and fetal flow velocity waveforms|
UK 1993 {published data only}|The effect of low dose aspirin on bleeding times|
UK 1994 {published data only}|Low dose aspirin in women with raised maternal serum alpha-fetoprotein and abnormal Doppler waveform patterns from the uteroplacental bed|
UK 1994 {published data only}|Low dose aspirin in women with raised maternal serum alpha-fetoprotein and abnormal Doppler waveform patterns from the uteroplacental circulation|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
UK 2000 {published data only}|A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks|
UK 2000 {published data only}|Delayed normalisation of the uterine artery Doppler waveforms is not a benign phenomenon|/resolve/reference/PMED?id=15474238
USA 1988a {published data only}|Effects of low-dose aspirin in improving fetal outcome in high risk pregnancies for intrauterine fetal growth retardation and/or preterm delivery|
USA 1989 {published and unpublished data}|Low dose aspirin during pregnancy|
USA 1989 {published and unpublished data}|Low-dose aspirin in pregnancy|/resolve/reference/PMED?id=2797631
USA 1990 {published data only}|Low dose aspirin in the prevention of preeclampsia in nulliparas. Preliminary results of a prospective, placebo-controlled, double blind study|
USA 1990a {published data only}|Trial to evaluate the effectiveness of low dose aspirin versus placebo in the prevention of pregnancy induced hypertension in multiparous patients pregnant with multiple gestations|
USA 1993b {published data only}|Comparative trial of prednisone plus aspirin vs aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients|/resolve/reference/PMED?id=8267038
USA 1993b {published data only}|Prospective evaluation of single (low-dose aspirin) vs combined (aspirin plus prednisone) therapy in the treatment of the antiphospholipid syndrome|
USA 1993c {published data only}|The effect of acetaminophen on prostacyclin production in pregnant women|/resolve/reference/PMED?id=8475962
USA 1996 {published data only}|Dose-related effects of low dose aspirin on hemostasis parameters and prostacyclin/thromboxane ratios in late pregnancy|/resolve/reference/PMED?id=8792442
West Germany 1977 {published data only}|The therapy of chronic nutritional placenta disorders - preliminary results of a double blind study|/resolve/reference/PMED?id=341828
Ciszek 1996 {published data only}|Influence of acetylsalicylic acid on the hormonal profile of pregnant women with EPH gestosis [abstract]|
da Camara Franca 1995 {published data only}|The role of acetylsalicylic acid in prostaglandins syntesis in mild preeclampsia|
de Souza 2006 {published data only}|Aspirin and calcium to prevent preeclampsia in chronic hypertensive women with abnormal uterine artery Doppler ultrasound [abstract]|
de Souza 2006a {published data only}|Aspirin and calcium to prevent pre eclampsia in chronic hypertension women with abnormal uterine artery doppler ultrasound [abstract]|
Dolitzky 2006 {published data only}|A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages|/resolve/reference/PMED?id=16769056
Fraire 1994 {published data only}|Cyclooxygenase and lipoxygenase inhibition in gestational hypertension|
Haapsamo 2007 {published data only}|Low-dose aspirin reduces uteroplacental vascular impedance during the first half of pregnancy in IVF/ICSI patients: a randomized placebo-controlled study|
Haapsamo 2007a {published data only}|Low-dose aspirin influences early pregnancy placentation in IVF/ICSI patients: evidenced by a distinct maternal serum proteome profile|
Kim 1997 {published data only}|Clinical efficacy of doppler ultrasound for low dose aspirin therapy in high risk pregnancy|
Lambers 2009 {published data only}|Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy|/resolve/reference/PMED?id=19608566
Lambers 2009a {published data only}|Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial|/resolve/reference/PMED?id=18973893
Nieder 1995 {published data only}|Prevention of pre-eclampsia and fetal growth retardation by trapidil|/resolve/reference/PMED?id=7879457
Okten 1994 {published data only}|Low-dose aspirin prophylaxis in high-risk pregnancies|
Taipale 2007 {published data only}|Prediction and prevention of preeclampsia, intrauterine growth restriction, prenatal stress and fetal programming of child's psychological development (ongoing trial)|
Valensise 1994 {published data only}|Uterine Doppler in the identification of patients at risk for hypertension and IUGR|/resolve/reference/PMED?id=7932007
Vaseie 2006 {published data only}|The effect of low-dose acetylsalicylic acid (ASA) on control of hypertensive in pregnancy [abstract]|
Ananth 1995|Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988-1991|
BroughtonPipkin 1996|Where next for prophylaxis against pre-eclampsia?|
Bussolino 1980|Maternal vascular prostacyclin activity in pre-eclampsia|
CDSR Issue 2, 2000|Antiplatelet agents for preventing and treating pre-eclampsia|
CDSR Issue 4, 2003|Antiplatelet agents for preventing pre-eclampsia and its complications|
Dept of Health 1996||
DH 2002||
Duley 1992a|Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean|
Duley 1999b|Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy|
Generic Protocol 05|Interventions for prevention of pre-eclampsia and its consequences: generic protocol|
Gifford 1990|National high blood pressure education program working group report on high blood pressure in pregnancy|
Higgins 2005|Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005|
Hofmeyr 2006|Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems|
Imperiale 1991|A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease|/resolve/reference/PMED?id=1829118
Janes 1995|Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia|/resolve/reference/PMED?id=8560414
Kramer 2003|Energy and protein intake in pregnancy|
Leitich 1997|A meta-analysis of low dose aspirin for prevention of intrauterine growth retardation|
Mahler 1987|The safe motherhood initiative: a call to action|
Makrides 2001|Magnesium supplementation in pregnancy|
Makrides 2006|Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction|
PARIS 2005|Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis|/resolve/reference/PMED?id=15833147
Redman 1978|Early platelet consumption in pre-eclampsia|/resolve/reference/PMED?id=626836
Redman 1991|Current topic: pre-eclampsia and the placenta|/resolve/reference/PMED?id=1946241
RevMan 2003|Review Manager (RevMan)|
Rey 1996|Efficacite de l'aspirine a faible dose au cours de al grossesse en fonction des facteurs de risque maternels et foetaux|
Rosenfield 1985|Maternal mortality - a neglected tragedy|
Rumbold 2005|Antioxidants for preventing pre-eclampsia|
Sanchez-Ramos 1994|Low dose aspirin for the prevention of pregnancy-induced hypertension: a meta-analysis|
Sharts-Engel 1992|Aspirin for prevention of pregnancy-induced hypertension|/resolve/reference/PMED?id=1625543
WHO 1988|Geographic variation in the incidence of hypertension in pregnancy|/resolve/reference/PMED?id=2962500
WHO 2000|Maternal mortality in 2000: estimates developed by WHO, UNICEF, and UNFPA|
CDSR 2000|Antiplatelet agents for preventing and treating pre-eclampsia|
CDSR 2003|Antiplatelet agents for preventing pre-eclampsia and its complications|
Collins 1995|Antiplatelet agents for IUGR and pre-eclampsia. [revised 04 May 1994]|
Duley 1999|Aspirin for preventing and treating pre-eclampsia|/resolve/reference/PMED?id=10082681
Duley 2001|Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review|/resolve/reference/PMED?id=11159655
Knight 2000|Anitplatelets for prevention of pre-eclampsia and its consequences: a systematic review|
Bornstein 1987 {published data only}|A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis|/resolve/reference/PMED?id=3302705
Bornstein 1991 {published data only}|A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis|/resolve/reference/PMED?id=2011253
Comi 2001 {published data only}|The extension phase of the European-Canadian MRI study demonstrates a sustained effect of glatiramer acetate in relapsing-remitting multiple sclerosis|
Comi 2001 {published data only}|European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of Glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing-remitting multiple sclerosis|
Comi 2001 {published data only}|The effect of glatiramer acetate (Copaxone) on disease activity as measured by cerebral MRI in patients with relapsing-remitting multiple sclerosis (RRMS): a multi-center, randomized, double-blind, placebo-controlled study extended by open-label treatment|
Comi 2001 {published data only}|Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes"|/resolve/reference/PMED?id=11524494
Comi 2001 {published data only}|Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial|/resolve/reference/PMED?id=17483532
Comi 2001 {published data only}|The effect of glatiramer acetate on brain volume changes in patients with relapsing-remitting multiple sclerosis|
Filippi 2006 {published data only}|Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study|/resolve/reference/PMED?id=16488376
Filippi 2006 {published data only}|A multinational, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of 2 doses of glatiramer acetate orally administered in relapsing remitting multiple sclerosis patients|
Filippi 2006 {published data only}|Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study|/resolve/reference/PMED?id=18584233
Johnson 1995 {published data only}|Long-term effects of glatiramer acetate in multiple sclerosis|/resolve/reference/PMED?id=18790510
Johnson 1995 {published data only}|Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment|/resolve/reference/PMED?id=10690968
Johnson 1995 {published data only}|Extended use of glatiramer acetate (Copaxone) for MS [Letter]|/resolve/reference/PMED?id=10078765
Johnson 1995 {published data only}|Experimental therapy of relapsing-remitting multiple sclerosis with copolymer-1|
Johnson 1995 {published data only}|Management of relapsing/remitting multiple sclerosis with copolymer 1 (Copaxone)|/resolve/reference/PMED?id=9345409
Johnson 1995 {published data only}|The U.S.Phase III Copolymer 1 Study Group. Antibodies to Copolymer 1 do not interfere with the clinical effect [Abstract]|
Johnson 1995 {published data only}|Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double.-blind, placebo-controlled trial|/resolve/reference/PMED?id=7617181
Johnson 1995 {published data only}|Extended use of glatiramer acetate (copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group|/resolve/reference/PMED?id=9521260
Johnson 1995 {published data only}|Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group|/resolve/reference/PMED?id=10962546
Johnson 1995 {published data only}|Glatiramer acetate (Copaxone) : comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial|/resolve/reference/PMED?id=14664471
Johnson 1995 {published data only}|Effects of copolymer on neurologic disability in patients with relapsing-remitting multiple sclerosis: results of a phase III trial [Abstract]|
Johnson 1995 {published data only}|Benefits of glatiramer acetate on disability in relapsing-remitting multiple sclerosis. An analysis by area under disability/time curves. The Copolymer 1 Multiple Sclerosis Study Group|/resolve/reference/PMED?id=11099709
Johnson 1995 {published data only}|Copolymer-1 reduces the relapse rate and positively influences disability in relapsing-remitting multiple sclerosis: results of a phase III multi-center double-blind, placebo- controlled trial [Abstract]|
Johnson 1995 {published data only}|Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial|/resolve/reference/PMED?id=17331542
Wolinsky 2007 {published data only}|A multinational, multicenter, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of glatiramer acetate for injection in primary progressive multiple sclerosis patients|
Wolinsky 2007 {published data only}|longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate : multicenter study|/resolve/reference/PMED?id=17881390
Wolinsky 2007 {published data only}|The PROMiSe trial: baseline data review and progress report|/resolve/reference/PMED?id=15218813
Wolinsky 2007 {published data only}|Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial|
Abramsky 1977 {published data only}|Effect of a synthetic polypeptide (COP 1) on patients with multiple sclerosis and with acute disseminated encephalomyelitis. Preliminary report|/resolve/reference/PMED?id=845620
Achiron 2005 {published data only}|Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments|/resolve/reference/PMED?id=15754125
Arnold 2008 {published data only}|Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in Multiple Sclerosis|/resolve/reference/PMED?id=18854910
Ball 2008 {published data only}|Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of two cases|
Baumhefner 1988 {published data only}|Copolymer 1 as therapy for multiple sclerosis: the cons|
Blanco 2006 {published data only}|Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study|/resolve/reference/PMED?id=16934924
Boiko 2006 {published data only}|[The results of longitudinal use of copaxone and betaferon in Moscow Multiple Sclerosis Center: issues of efficacy and adherence to therapy]|/resolve/reference/PMED?id=17172244
Bornstein 1982 {published data only}|Multiple sclerosis: trial of a synthetic polypeptide|
Bosca 2006 {published data only}|Necrotising cutaneous lesions as a side effect of glatiramer acetate|/resolve/reference/PMED?id=16773267
Brenner 2001 {published data only}|Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone|/resolve/reference/PMED?id=11282165
Brochet 2008 {published data only}|Long-term effects of glatiramer acetate in multiple sclerosis|/resolve/reference/PMED?id=18790510
Cadavid 2009 {published data only}|Efficacy of treatment of MS with IFN{beta}-1b or glatiramer acetate by monthly brain MRI in the BECOME study|/resolve/reference/PMED?id=19439722
Caon 2006 {published data only}|Clinical course after change of immunomodulating therapy in relapsing-remitting multiple sclerosis|
Capobianco 2008 {published data only}|Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients|/resolve/reference/PMED?id=18690500
Carra 2008 {published data only}|Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing-remitting multiple sclerosis in Argentina|
Castelli-Haley 2008 {published data only}|Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patient|/resolve/reference/PMED?id=18641926
Charach 2008 {published data only}|Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone|/resolve/reference/PMED?id=18607107
Chen 2001 {published data only}|Glatiramer acetate induces a Th2-biased response and cross reactivity with myelin basic protein in patients with MS|/resolve/reference/PMED?id=11548979
Cicek 2008 {published data only}|An urticarial vasculitis case induced by glatiramer acetate|/resolve/reference/PMED?id=19160538
Cohen 1995 {published data only}|Assessment of the efficacy of Copolymer-1 in the Treatment of Multiple Sclerosis by Quantitative MRI|
Cohen 2007 {published data only}|Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting|/resolve/reference/PMED?id=17372130
Constantinescu 2000 {published data only}|Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis|/resolve/reference/PMED?id=11212132
Daugherty 2005 {published data only}|Factors leading patients to discontinue multiple sclerosis therapies|/resolve/reference/PMED?id=15991759
De Seze 2000 {published data only}|Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial|
De Stefano 2008 {published data only}|Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis|/resolve/reference/PMED?id=17897678
De Stefano 2009 {published data only}|The results of two multicenter open label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymer mixture in patients with relapsing remitting multiple sclerosis|/resolve/reference/PMED?id=18987103
Debouverie 2007 {published data only}|A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate|
Deen 2008 {published data only}|Predictors of the location of multiple sclerosis relapse|/resolve/reference/PMED?id=18223021
Duda 2000 {published data only}|Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis|/resolve/reference/PMED?id=10749576
Farina 2001 {published data only}|Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells|/resolve/reference/PMED?id=11287371
Farina 2001 {published data only}|Can glatiramer acetate reduce brain atrophy development in multiple sclerosis?|/resolve/reference/PMED?id=15949501
Feigin 2005 {published data only}|On cancer incidence in multiple sclerosis and effects of immunomodulatory treatments|/resolve/reference/PMED?id=15986130
Fiore 2005 {published data only}|Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six month|/resolve/reference/PMED?id=16258646
Flechter 2002a {published data only}|Copolymer 1 (glatiramer acetate) in relapsing forms of multiple sclerosis: open multicenter study of alternate-day administration|/resolve/reference/PMED?id=11852290
Flechter 2002b {published data only}|Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients: an open-label 2-year follow-up|/resolve/reference/PMED?id=11997066
Ford 2006 {published data only}|A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patient|/resolve/reference/PMED?id=16764344
Fusco 2001 {published data only}|HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis|/resolve/reference/PMED?id=11739812
Gajofatto 2009 {published data only}|Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis|/resolve/reference/PMED?id=18922831
Garcia-Barragan 2009 {published data only}|Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment|
Ghezzi b 2005 {published data only}|Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study|/resolve/reference/PMED?id=16042224
Ghezzi 2005 {published data only}|Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study|/resolve/reference/PMED?id=16388355
Goodman 2009 {published data only}|GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=19255407
Haas 2005 {published data only}|Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone)|
Harde 2007 {published data only}|Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetate|
Johnson 2000 {published data only}|Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group.|/resolve/reference/PMED?id=10962546
Johnson 2003 {published data only}|Glatiramer acetate (Copaxone) : comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial|/resolve/reference/PMED?id=14664471
Johnson 2005 {published data only}|Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data|
Jolly 2008 {published data only}|Impact of warm compresses on local injection-site reactions with self-administered glatiramer acetate|/resolve/reference/PMED?id=18727339
Karandikar 2002 {published data only}|Glatiramer acetate (Copaxone) therapy induces CD8+ T cella response in patients with multiple sclerosis|/resolve/reference/PMED?id=11877472
Khan 2001 {published data only}|A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing--remitting multiple sclerosis: results after 18 months of therapy|/resolve/reference/PMED?id=11795454
Khan 2005 {published data only}|Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis|/resolve/reference/PMED?id=16320723
khan 2008 {published data only}|Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis|
Kott 1997 {published data only}|Optic Neuritis in Multiple Sclerosis Patients Treated with Copaxone|
La Mantia 2006 {published data only}|Interferon treatment may trigger primary headaches in multiple sclerosis patients|/resolve/reference/PMED?id=16900761
Lage 2006 {published data only}|Effect of immunomodulatory therapy and other factors on employment loss time in multiple sclerosis|/resolve/reference/PMED?id=16971761
Le Page 2008 {published data only}|Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients|/resolve/reference/PMED?id=17846110
Madray 2008 {published data only}|Glatiramer acetate-associated, CD30+, primary, cutaneous, anaplastic large-cell lymphoma|/resolve/reference/PMED?id=18852356
Mancardi 1998 {published data only}|Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis|/resolve/reference/PMED?id=9566406
Meiner 1997 {published data only}|Copolymer 1 in relapsing-remitting multiple sclerosis: a multi-centre trial|
Mesaros, 2008 {published data only}|Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study|/resolve/reference/PMED?id=18584233
Mikol 2008 {published data only}|Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial|/resolve/reference/PMED?id=18789766
Milanese 2005 {published data only}|A post-marketing study on immunomodulating treatments for relapsing-remitting multiple sclerosis in Lombardia: preliminary results|/resolve/reference/PMED?id=16388352
Miller 1998 {published data only}|Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation|/resolve/reference/PMED?id=9916886
Miller 2006 {published data only}|Relapsing MS patients' experiences with glatiramer acetate treatment: a phenomenological study|/resolve/reference/PMED?id=16568812
Miller 2008 {published data only}|Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing-remitting multiple sclerosis|/resolve/reference/PMED?id=18208875
Neumann 2007 {published data only}|Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis|/resolve/reference/PMED?id=17351724
Nolden 2005 {published data only}|Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate|/resolve/reference/PMED?id=15794402
Ollendorf 2008 {published data only}|Impact of co-prescribed glatiramer acetate and antihistamine therapy on the likelihood of relapse among patients with multiple sclerosis|/resolve/reference/PMED?id=18856249
Orlova 2005 {published data only}|[3-year results of clinical and immunological monitoring of patients with multiple sclerosis treated by copaxone]|/resolve/reference/PMED?id=15952536
Patten 2008 {published data only}|Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis|/resolve/reference/PMED?id=17986504
Pllmann 2006 {published data only}|The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS|/resolve/reference/PMED?id=16434675
Qin 2000 {published data only}|Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients|/resolve/reference/PMED?id=10900354
Ramtahal 2006 {published data only}|Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis|/resolve/reference/PMED?id=16990994
Rauschka 2005 {published data only}|Severe anaphylactic reaction to glatiramer acetate with specific IgE|/resolve/reference/PMED?id=15851756
Rio 2005 {published data only}|Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis|/resolve/reference/PMED?id=15957512
Rovaris 2005 {published data only}|Can glatiramer acetate reduce brain atrophy development in multiple sclerosis?|/resolve/reference/PMED?id=15949501
Rovaris 2007 {published data only}|Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial|/resolve/reference/PMED?id=17483532
Schwid 2007 {published data only}|Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial|/resolve/reference/PMED?id=17331542
Shipova 2009 {published data only}|State of the cervical section of the spinal cord in patients with remitting multiple sclerosis during immunomodulatory treatment|/resolve/reference/PMED?id=19089623
Sidoti 2007 {published data only}|Multiple sclerosis and Capgras' syndrome|/resolve/reference/PMED?id=17629614
Sindic 2005 {published data only}|Long-term follow up of glatiramer acetate compassionate use in Belgium|/resolve/reference/PMED?id=16076061
Soares 2006 {published data only}|Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: a clinicopathologic and immunohistochemical study|/resolve/reference/PMED?id=17097393
Sormani 2002 {published data only}|MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients|/resolve/reference/PMED?id=11839841
Sormani 2005 {published data only}|The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis|/resolve/reference/PMED?id=16042228
Sormani 2007 {published data only}|A composite score to predict short-term disease activity in patients with relapsing-remitting MS|/resolve/reference/PMED?id=17875911
Then, Bergh F 2006 {published data only}|Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis|/resolve/reference/PMED?id=17016041
Thouvenot 2007 {published data only}|Erythema nodosum and glatiramer acetate treatment in relapsing-remitting multiple sclerosis|/resolve/reference/PMED?id=17881403
Tilbery 2006 {published data only}|Immunomodulatory treatment in multiple sclerosis: experience at a Brazilian center with 390 patients|/resolve/reference/PMED?id=16622553
Torkildsen 2007 {published data only}|Immunomodulatory treatment of multiple sclerosis in Norway|
Tremlett 2007 {published data only}|Immunomodulatory treatment of multiple sclerosis in Norway|
Twork 2007 {published data only}|Immunomodulating drugs in multiple sclerosis: compliance, satisfaction and adverse effects evaluation in a German multiple sclerosis population|/resolve/reference/PMED?id=17559722
Valenzuela 2007 {published data only}|Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis|/resolve/reference/PMED?id=17613604
Vallittu 2005 {published data only}|The efficacy of glatiramer acetate in beta-interferon-intolerant MS patients|
Vollmer 2008 {published data only}|Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis|/resolve/reference/PMED?id=18424479
Weder 2005 {published data only}|Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis|
Weinstein 1999 {published data only}|Neuropsychologic status in multiple sclerosis after treatment with glatiramer|/resolve/reference/PMED?id=10190822
Wolinsky 2001 {published data only}|MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center|/resolve/reference/PMED?id=11321192
Wynn 2008 {published data only}|Optimal dosing of immunomodulating drugs: A dose-comparison study of GA in RRMS|
Ytterberg 2007 {published data only}|Combination therapy with interferon-beta and glatiramer acetate in multiple sclerosis|
Zavalishin 2005 {published data only}|Experience in copaxon treatment in Russia|/resolve/reference/PMED?id=16180496
Zavalishin 2006 {published data only}|[A comparative analysis of rebif 22-mcg and copaxone efficacy in multiple sclerosis]|/resolve/reference/PMED?id=17172245
Ziemssen 2008 {published data only}|Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis|/resolve/reference/PMED?id=18179687
Zwibel 2006 {published data only}|Glatiramer acetate in treatment-naive and prior interferon-beta-1b-treated multiple sclerosis patients|
Comi 2008 {published data only}|PreCISe study Group. early glatiramer acetate treatment in delaying conversion to clinically definite multiple sclerosis (CDMS) in subjects presenting with a clinically isolated syndrome|
Comi 2008 {published data only}|Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analysis|
Comi 2008 {published data only}|New options for early treatment of multiple sclerosis|
Boneschi 2003|Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials|/resolve/reference/PMED?id=12926839
Brocke 1996|Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein|/resolve/reference/PMED?id=8552189
Caramanos 2005|Evidence for use of glatiramer acetate in multiple sclerosis|/resolve/reference/PMED?id=15664538
Comi 2005|Evidence for use of glatiramer acetate in multiple sclerosis|/resolve/reference/PMED?id=15664539
Drago 1999|Localized lipoatrophy after glatiramer acetate injection in patients with remitting-relapsing multiple sclerosis (letter)|/resolve/reference/PMED?id=10522686
Ebers 2008|Disability as an outcome in MS clinical trials|/resolve/reference/PMED?id=18480462
Edgar 2004|Lipoatrophy in patients with multiple sclerosis on glatiramer acetate|/resolve/reference/PMED?id=15038472
Ge 2000|Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment|/resolve/reference/PMED?id=10690968
Higgins 2008|Cochrane Handbook for systematic Reviews of Interventions. Version 5.0.0(updated February 2008).The Cochrane Collaboration, 2008|
Hwang 2001|Lipoatrophy associated with glatiramer acetate injections for the treatment of multiple sclerosis|/resolve/reference/PMED?id=11710450
Jadad 1996|Assessing the quality of randomised trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Kurtzke 1983|Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS)|/resolve/reference/PMED?id=6685237
Lefebvre 2008|Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008.|
Mancardi 2000|Localized lipoatrophy after prolonged treatment with copolymer 1|/resolve/reference/PMED?id=10787120
McFarland 2008|Aletuzumab versus interferon beta-1a;implications for pathology and trial design|/resolve/reference/PMED?id=18620594
Munari 2004a|Lack of evidence for use of glatiramer acetate in multiple sclerosis|/resolve/reference/PMED?id=15488453
Munari 2005|Evidence for use of glatiramer acetate in multiple sclerosis (Authors' reply)|
Poser 1983|New diagnostic criteria for multiple sclerosis: guidelines for research protocols|
Prentice 1989|Surrogate endpoints in clinical trials: definition and operational criteria|
RevMan 2008|Review Manager (RevMan)|
Rio 2002|assessment of different treatment failure criteria in a Cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta:implications for clinical trials|
Rio 2006|Defining the response to interferon beta in relapsing-remitting multiple sclerosis patients|
Teitelbaum 1997|Coplymer 1: from basic research to clinical application|/resolve/reference/PMED?id=9117994
Wisniewski 1977|Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis|
Yusuf 1985|Beta-blockade during and after myocardial infarction: an overview of the randomised trials|/resolve/reference/PMED?id=2858114
Munari 2004|Therapy with glatiramer acetate for multiple sclerosis|/resolve/reference/PMED?id=14974077
Baigent 2000|Premature cardiovascular disease in chronic renal failure|/resolve/reference/PMED?id=10963260
Bostom 1999|Hyperhomocysteinemia in chronic renal disease|/resolve/reference/PMED?id=10203375
Chauveau 1993|Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients|/resolve/reference/PMED?id=8320950
Ducloux 2006|Impact of malnutrition-inflammation on the association between homocysteine and mortality|/resolve/reference/PMED?id=16408123
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
Eikelboom 1999|Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence|/resolve/reference/PMED?id=10475890
Foley 1998|Epidemiology of cardiovascular disease in chronic renal disease|/resolve/reference/PMED?id=11443763
Freidman 2001|The kidney and homocysteine metabolism|/resolve/reference/PMED?id=11562419
Go 2004|Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization|/resolve/reference/PMED?id=15385656
Gonin 2005|Folic acid supplementation to prevent adverse events in individuals with chronic kidney disease and end stage renal disease|/resolve/reference/PMED?id=15821423
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. 2008. Available from www.cochrane-handbook.org|
HSC 2002|Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis|/resolve/reference/PMED?id=12387654
Jamison 2007|Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial|/resolve/reference/PMED?id=17848650
K/DOQI 2005|K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients|/resolve/reference/PMED?id=AMBIGUOUS%2015806502,15742274
Kalantar-Zadeh 2004|A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients|/resolve/reference/PMED?id=14747392
Lefebvre 2008|Chapter 6: Searching for studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration. Available from www.cochrane-handbook.org|
Levin 2002|Cardiovascular disease and the kidney. Tracking a killer in chronic kidney disease|/resolve/reference/PMED?id=11985133
Master List 2007|Master list of journals being searched|
McDonald 2007|ANZDATA Registry 2007 Report. Chapter 3 Deaths|
Moustapha 1998|Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease [erratum appears in Circulation 1998 Feb 24;97(7):711]|/resolve/reference/PMED?id=9445164
Pastore 2006|Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes|/resolve/reference/PMED?id=16391331
Polkinghorne 2003|Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients|
Renal Group 2008|Cochrane Renal Group|
Robinson 1996|Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations|/resolve/reference/PMED?id=8941098
Scholze 2004|Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure|/resolve/reference/PMED?id=14732754
USRDS 2007|Annual Data Report. 2007|
van Guldener 2006|Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?|
Vianna 2007|Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events|
Wald 2002|Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis|/resolve/reference/PMED?id=12446535
Weiner 2004|Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies|/resolve/reference/PMED?id=15100371
Wrone 2001|An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease|/resolve/reference/PMED?id=11532106
Wrone 2004|Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease|/resolve/reference/PMED?id=14747389
Yap 2003|Classical homocystinuria: vascular risk and its prevention|/resolve/reference/PMED?id=12889665
Zoungas 2006|Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial|/resolve/reference/PMED?id=16545638
Ahmedzai 2004 {published data only}|A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion|/resolve/reference/PMED?id=14735178
Booth 1996 {published data only}|Does oxygen help dyspnea in patients with cancer?|/resolve/reference/PMED?id=8630595
Bruera 1993 {published data only}|Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients|/resolve/reference/PMED?id=8100289
Bruera 2003 {published data only}|A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea|/resolve/reference/PMED?id=14694916
Chua 1996 {published data only}|Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure|/resolve/reference/PMED?id=9014795
Meecham Jones 1995 {published data only}|Ambulatory oxygen therapy in stable kyphoscoliosis|/resolve/reference/PMED?id=7656956
Moore 1992 {published data only}|Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure|
Restrick 1992 {published data only}|Ambulatory oxygen in chronic heart failure|/resolve/reference/PMED?id=1359262
Bruera 1992 {published data only}|Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial|/resolve/reference/PMED?id=1517652
Navigante 2003 {published data only}|Morphine plus midazolam versus oxygen therapy on severe dyspnoea management in the last week of life in hypoxemic advanced cancer patients|
Russell 1999 {published data only}|Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart failure|/resolve/reference/PMED?id=10606114
ATS 2002|ATS statement: guidelines for the six-minute walk test|/resolve/reference/PMED?id=12091180
ATS/ACCP 2003|ATS/ACCP statement on cardiopulmonary exercise testing|/resolve/reference/PMED?id=12738602
Bausewein 2008|Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases|
Beckles 2003|The physiologic evaluation of patients with lung cancer being considered for resectional surgery|/resolve/reference/PMED?id=12527570
Bernardi 1998|Effect of breathing rate on oxygen saturation and exercise performance in chronic heart failure|/resolve/reference/PMED?id=9643792
Booth 2002|Oxygen or air for palliation of breathlessness in advanced cancer|/resolve/reference/PMED?id=12724429
Booth 2004|The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine|/resolve/reference/PMED?id=14959816
Borg 1982|Psychophysical bases of perceived exertion|/resolve/reference/PMED?id=7154893
Bradley 2003|Short term ambulatory oxygen for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=19066532
Brostrom 2005|Effects of long-term nocturnal oxygen treatment in patients with severe heart failure|/resolve/reference/PMED?id=16485622
Casaburi 2006|Reduction of hyperinflation by pharmacologic and other interventions|/resolve/reference/PMED?id=16565430
Gallagher 2004|A systematic review of oxygen and airflow effect on relief of dyspnea at rest in patients with advanced disease of any cause|/resolve/reference/PMED?id=15760804
Grant 1998|The reproducibility of symptoms during a submaximal exercise test in chronic heart failure|
Haque 1996|Hemodynamic effects of supplemental oxygen administration in congestive heart failure|/resolve/reference/PMED?id=8557905
Higgins 2006|Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated September 2006]|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jennings 2001|Opioids for the palliation of breathlessness in terminal illness|
Liss 1988|The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3144198
McDonald 2005|Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand|
O'Donnell 2001|Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11282762
Olsson 2005|Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review|/resolve/reference/PMED?id=15774495
Ram 2002|Ambulatory oxygen for chronic obstructive pulmonary disease|
Sasayama 2006|Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration|/resolve/reference/PMED?id=16377916
Schulz 1995|Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Wilcock 1999|Repeatability of breathlessness measurements in cancer patients|/resolve/reference/PMED?id=10400541
Zeppetella 1998|The palliation of dyspnea in terminal disease|/resolve/reference/PMED?id=9866455
Aragona 1975 {published data only}|Treating overweight children through parental training and contingency contracting|
Barrera 1977 {published data only}|Detrimental effects of a self-reward contracting program on subjects' involvement in self-administered desensitization|/resolve/reference/PMED?id=21895
Binstock 1988 {published data only}|A comparison of compliance techniques on the control of high blood pressure|/resolve/reference/PMED?id=3415798
Brockway 1977 {published data only}|Non-aversive procedures and their effect on cigarette smoking|/resolve/reference/PMED?id=899902
Burkhart 2002 {published data only}|Children's adherence to recommended asthma self-management|/resolve/reference/PMED?id=12226965
Calsyn 1994 {published data only}|Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome|/resolve/reference/PMED?id=7734459
Calsyn 1994 {published data only}|Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome|
Claydon 1997 {published data only}|A prospective study of the effect of education on non-compliant behaviour in contact lens wear|/resolve/reference/PMED?id=9196677
Craighead 1989 {published data only}|Supervised exercise in behavioral treatment for moderate obesity|
Curry 1988 {published data only}|A comparison of alternative theoretical approaches to smoking cessation and relapse|/resolve/reference/PMED?id=3215161
Flanders 1985 {published data only}|Enhancing acne medication compliance: a comparison of strategies|/resolve/reference/PMED?id=3159380
Haber 1993 {published data only}|Evaluation of a socio-behavioral intervention for changing health behaviors of older adults|
Hammond 1999 {published data only}|A crossover trial evaluating an educational-behavioural joint protection programme for people with rheumatoid arthritis|/resolve/reference/PMED?id=10640116
Hoelscher 1986 {published data only}|Home relaxation practice in hypertension treatment: Objective assessment and compliance induction|/resolve/reference/PMED?id=3517094
Keane 1984 {published data only}|Spouse contracting to increase antabuse compliance in alcoholic veterans|
Lash 1998 {published data only}|Increasing participation in substance abuse aftercare treatment|/resolve/reference/PMED?id=9513628
Litzelman 1993 {published data only}|Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial|/resolve/reference/PMED?id=8498761
Mayer 1991 {published data only}|The effects of co-worker-delivered prompts on breast self-examination frequency|/resolve/reference/PMED?id=1867903
McLean 1973 {published data only}|A behavioral approach to the treatment of depression|
Morgan 1988 {published data only}|A closer look at teaching and contingency contracting with type II diabetes|
Morisky 2001 {published data only}|Behavioral interventions for the control of tuberculosis among adolescents|/resolve/reference/PMED?id=12196616
Murphy 1982 {published data only}|The long-term effects of spouse involvement upon weight loss and maintenance|
O'Farrell 1984 {published data only}|Behavioral marital therapy for male alcoholics: clinical procedures from a treatment outcome study in progress|
Ossip-Klein 1984 {published data only}|Increasing attendance at alcohol aftercare using calendar prompts and home based contracting|/resolve/reference/PMED?id=6331100
Piotrowski 1999 {published data only}|A cost-effectiveness and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment|/resolve/reference/PMED?id=10395156
Piotrowski 1999 {published data only}|Contingency contracting with monetary reinforcers for abstinence from multiple drugs in a methadone program|/resolve/reference/PMED?id=10609975
Poole 1981 {published data only}|The rapid-smoking technique: therapeutic effectiveness|/resolve/reference/PMED?id=7316915
Putnam 1994 {published data only}|Enhancing commitment improves adherence to a medical regimen|/resolve/reference/PMED?id=8034823
Schulman 1980 {published data only}|Active patient orientation|/resolve/reference/PMED?id=10246464
Swain 1981 {published data only}|Influencing adherence among hypertensives|
Vinson 2000 {published data only}|Computer-generated written behavioral contracts with problem drinkers in primary medical care|/resolve/reference/PMED?id=12466660
Wurtele 1980 {published data only}|Increasing return compliance in a tuberculosis detection drive|/resolve/reference/PMED?id=7441730
Azrin 1994 {published data only}|Behavior therapy for drug abuse: a controlled treatment outcome study|/resolve/reference/PMED?id=7993330
Becona 1997 {published data only}|Does using relapse prevention increase the efficacy of a program for smoking cessation?: an empirical study|/resolve/reference/PMED?id=9293218
Bishai 2003 {published data only}|Contracting with children and helmet distribution in the emergency department to improve bicycle helmet use|/resolve/reference/PMED?id=14644790
Black 1983 {published data only}|Contracting to problem solve versus contracting to practice behavioral weight loss skills|
Bowers 1987 {published data only}|Nicotine fading, behavioral contracting, and extended treatment: effects on smoking cessation|/resolve/reference/PMED?id=3630804
Brubaker 2003 {published data only}|Behavioral contracting in the treatment of eating disorders|
Budney 2001 {published data only}|Abstinence-based vouchers delivered without psychotherapy increase abstinence during treatment for marijuana dependence|
Bull 2000 {published data only}|A professional-patient partnership model of discharge planning with elders hospitalized with heart failure|/resolve/reference/PMED?id=10701280
Calsyn 1996 {published data only}|Outcome of a second episode of methadone maintenance|/resolve/reference/PMED?id=9023072
Capelli 1990 {published data only}||
Christensen 1995 {published data only}||
Coelho 1985 {published data only}|Longest prior abstinence and cessation of smoking|/resolve/reference/PMED?id=4001254
Cottler 1998 {published data only}|Effectiveness of HIV risk reduction initiatives among out-of-treatment non-injection drug users|/resolve/reference/PMED?id=9798794
Cummings 1981 {published data only}|Intervention strategies to improve compliance with medical regimens by ambulatory hemodialysis patients|/resolve/reference/PMED?id=7288877
Davis 1995 {published data only}|Smoking cessation: the use of a choice of strategies to aid cessation and maintenance|
Donaldson 1997 {published data only}|Structured disposition planning for adolescent suicide attempters in a general hospital: preliminary findings on short-term outcome|
Epstein 2001 {published data only}|Contingency management and cognitive-behavioral therapy to reduce cocaine use:emergent effect 1 year later?|
Feeney 2001 {published data only}|Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome|
Feeney 2002 {published data only}|Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?|
Fleming 1997 {published data only}|Brief physician advice for problem alcohol drinkers: a randomized controlled trial in community-based primary care practices|/resolve/reference/PMED?id=9091691
Hamilton 1993 {published data only}|Increasing adherence in patients with primary hypertension: an intervention|
Harzer 2000 {published data only}|Long term compliance of patients - can we stimulate it financially? A result from orthodontics|
Hennig 1998 {published data only}|Mental health CPR: peer contracting as a response to potential suicide in adolescents|
Jeffery 1983 {published data only}|Monetary contracts in weight control: effectiveness of group and individual contracts of varying size|/resolve/reference/PMED?id=6841768
Jeffery 1984 {published data only}|Behavioral treatment of obesity with monetary contracting: two-year follow-up|/resolve/reference/PMED?id=6496209
Jeffrey 1975 {published data only}|Behavior therapy versus "will power" in the management of obesity|/resolve/reference/PMED?id=1195153
Johnson 1991 {published data only}|Cardiovascular intervention for high-risk families: the Heart Smart Program|/resolve/reference/PMED?id=1948212
Jones 1993 {published data only}|Contracting to lower precaution status for child psychiatric inpatients|
Kim 1991 {published data only}|A study of the effects of health contracts on the performance level for activities of daily living in the hemiplegic patients|/resolve/reference/PMED?id=1812311
Laidlaw 1999 {published data only}|Contracting with outpatient hemodialysis patients to improve adherence to treatment|/resolve/reference/PMED?id=10222856
Leslie 1991 {published data only}|The effect of contingency contracting on adherence and knowledge of exercise regimens|
Lierman 1994 {published data only}|Using social support to promote breast self-examination performance|/resolve/reference/PMED?id=7971411
Lowe 1997 {published data only}|Smoking relapse prevention methods for pregnant women: a formative evaluation|/resolve/reference/PMED?id=10165516
Messina 2003 {published data only}|Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions|
Miller 1995 {published data only}|Physical activity: one approach to the primary prevention of hypertension|/resolve/reference/PMED?id=7772211
Napolitan 1999 {published data only}||
Neale 1991 {published data only}|Behavioural contracting as a tool to help patients achieve better health|/resolve/reference/PMED?id=1800196
Neuberger 1993 {published data only}|Promoting self-care in clients with arthritis|
Norton 1980 {published data only}|Commitment contingencies in the behavioral treatment of obesity|
Ordman 1985 {published data only}|Cognitive-behavioral therapy for bulimia: an initial outcome study|/resolve/reference/PMED?id=3859502
Pantalon 2001 {published data only}|Therapeutic contracting for combined opioid and cocaine dependence: a pilot study|
Paxton 1980 {published data only}|The effects of a deposit contract as a component in a behavioural programme for stopping smoking|/resolve/reference/PMED?id=7369987
Radojevic 1992 {published data only}|Behavioral intervention with and without family support for rheumatoid arthritis|
Resnicow 1997 {published data only}|Analysis of a multicomponent smoking cessation project: what worked and why|/resolve/reference/PMED?id=9144762
Sagawa 2003 {published data only}|The utility of cognitive behavioural therapy on chronic haemodialysis patients' fluid intake: a preliminary examination|/resolve/reference/PMED?id=12667513
Sand 1974 {published data only}|An incentive contract for nursing home aides|/resolve/reference/PMED?id=4492913
Saxon 1993 {published data only}|Outcome of contingency contracting for illicit drug use in a methadone maintenance program|/resolve/reference/PMED?id=8384984
Schinke 1976 {published data only}|Interpersonal skill training in groups|
Solanto 1994 {published data only}|Rate of weight gain of inpatients with anorexia nervosa under two behavioral contracts|/resolve/reference/PMED?id=8190589
Stuart 1976 {published data only}|Changing adolescent deviant behaviour through reprogramming the behaviour of parents and teachers: an experimental evaluation|
Toseland 1983 {published data only}|Evaluation of a smoking-cessation group treatment program|
Tusel 1994 {published data only}|Contingency contracting for illicit drug use wit opioid addicts in methadone treatment|
Ureda 1980 {published data only}|The effect of contract witnessing on motivation and weight loss in a weight control program|/resolve/reference/PMED?id=7024200
Van Dover 1985 {published data only}|Use of nurse-client contracting to reduce risk of unintended pregnancy in an adolescent population|
Villano 2002 {published data only}|Improving treatment engagement and outcomes for cocaine-using methadone patients|/resolve/reference/PMED?id=12014813
Wysocki 1989 {published data only}|Blood glucose monitoring by diabetic adolescents: compliance and metabolic control|/resolve/reference/PMED?id=2767019
Zandee 1996 {published data only}|Effectiveness of contingency contracting: component of a worksite weight loss program|/resolve/reference/PMED?id=8788406
Anderson 1982|Compliance in elderly hypertensives|/resolve/reference/PMED?id=10255502
Arnet 2000|Individualisation of compliance|/resolve/reference/PMED?id=11036434
Biller 1999|Commentary: contracts, opioids and the management of chronic nonmalignant pain|/resolve/reference/PMED?id=10069155
Boehm 1997|Predictors of adherence to nutrition recommendations in people with non-insulin-dependent diabetes mellitus|/resolve/reference/PMED?id=9155314
Brus 1998|Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis|/resolve/reference/PMED?id=9640129
Charles 1997|Shared decision-making in the medical encounter: what does it mean?|/resolve/reference/PMED?id=9032835
Chowdhury 1997|Control of tuberculosis by community health workers in Bangladesh|/resolve/reference/PMED?id=9250184
Christiensen-S. 1985|Patient compliance behavior: the effects of time on patients' values of treatment regimens|/resolve/reference/PMED?id=3929392
Cleemput 2002|A review of the literature on the economics of noncompliance|/resolve/reference/PMED?id=11786175
Cox 2004|A systematic review of communication between patients and health care professionals about medicine-taking and prescribing|
Cupples 2001|Use of behavioral contingency contracting with heart transplant candidates|/resolve/reference/PMED?id=11871049
DPP 2003|Patients forced to wait because of missed GP appointments|
Dunbar 1979|Behavioral strategies for improving compliance|
Evangelista 2000|A closer look at compliance research in heart failure patients in the last decade|
Fishman 1999|The Opioid Contract in the management of chronic pain|/resolve/reference/PMED?id=10439570
Fishman 2002a|The trilateral opioid contract: bridging the pain clinic and the primary care and the primary care physician through the opioid contract|/resolve/reference/PMED?id=12458115
Fishman 2002b|The opioid contracts|/resolve/reference/PMED?id=12479256
Gordis 1979|Conceptual and methodologic problems in measuring patient compliance|
Greenan-Fowler 1987|Behavioral treatment of adherence to therapeutic exercise by children with hemophilia|/resolve/reference/PMED?id=3426383
Hayes 2000|The effects of behavioural contracting and preferred reinforcement on appointment keeping|
Haynes 1979a|Introduction|
Haynes 1979b|Determinants of compliance: the disease and the mechanics of treatment|
Haynes 2008|Interventions for enhancing medication adherence|/resolve/reference/PMED?id=18425859
Heinssen 1995|Therapeutic contracting with the seriously mentally ill|/resolve/reference/PMED?id=7625620
Heneghan 2006|Reminder packaging for improving adherence to self-administered long-term medications|
Hey 2005|Competitions and incentives for smoking cessation|
Higgins 2006|Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]|
Hulka 1979|Patient-clinician interactions and compliance|
Janz 1984|Contingency contracting to enhance patient compliance: a review|/resolve/reference/PMED?id=10317452
Jones 2003|Prescribing and taking medicines: concordance is a fine theory but is mostly not being practised|/resolve/reference/PMED?id=14551062
Kim 2003|Depression, substance use, adherence behaviours, and blood pressure in urban hypertensive black men|/resolve/reference/PMED?id=12867351
Macharia 1992|An overview of interventions to improve compliance with appointment keeping for medical services|/resolve/reference/PMED?id=1532036
Maher 2003|Treatment of tuberculosis: concordance is a key step|/resolve/reference/PMED?id=14551066
Mellins 1992|Patient compliance: are we wasting our time and don't know it?|/resolve/reference/PMED?id=1456550
Miller 2002|Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders|
Molteni 1983|Effects of contracts on childhood memory recollection: a controlled clinical analogue|
OED 2003|Oxford English Dictionary Online|
Paxton 1983|Prolonging the effects of deposit contracts with smokers|/resolve/reference/PMED?id=6626113
Quill 1983|Partnership in patient case: a contractual approach|/resolve/reference/PMED?id=6824257
Reda 2001|Prompts to encourage appointment attendance for people with serious mental illness|/resolve/reference/PMED?id=11406031
Resnikow 1997|Analysis of multicomponent smoking cessation project: what worked and why|/resolve/reference/PMED?id=9144762
Reunion 2006|Reunion de consenso: Estrategias para un control eficaz de la hipertension arterial en Espaa Barcelona, Espana, 14 y 15 de octubre de 2005|
Roter 1998|Effectiveness of interventions to improve patient compliance: a meta-analysis|/resolve/reference/PMED?id=9708588
Rueda 2006|Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS|/resolve/reference/PMED?id=16855968
Sackett 1979|The magnitude of compliance and noncompliance|
Sanz 2003|Concordance and childrens use of medicines|/resolve/reference/PMED?id=14551105
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Sherman 1991|Intervention strategies for children poorly adherent with asthma medications: one center's experience|
Simpson 2006|A meta-analysis of the association between adherence to drug therapy and mortality|/resolve/reference/PMED?id=16809674
Stevenson 2000|Doctor-patient communication about drugs: the evidence for shared decision making|/resolve/reference/PMED?id=10695980
Townsend 2003|Managing multiple morbidity in mid-life:a qualitative study of attitudes to drug use|/resolve/reference/PMED?id=14551097
Volmink 2000|Directly observed therapy and treatment adherence|/resolve/reference/PMED?id=10776760
Volmink 2006|Directly observed therapy for treating tuberculosis|/resolve/reference/PMED?id=16625579
WHO 2003|Adherence to long term therapies: evidence for action|
Balzarini 2000 {published data only}|Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial|/resolve/reference/PMED?id=10703904
Bourgois 1984 {published data only}|Protection of the venous capital at the perfusees with a long course in breast cancer. Double blind Clinical trial: Arnica with a placebo control|
Daub 2005 {published data only}|Homeopathic antiemesis for chemotherapy, a prospective randomised trial|
Jacobs 2005 {published data only}|Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial|/resolve/reference/PMED?id=15750360
Kulkarni 1988 {published data only}|Radiation protection by use of homoeopathic medicines|
Oberbaum 2001 {published data only}|A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation|
Pommier 2004 {published data only}|Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer|/resolve/reference/PMED?id=15084618
Thompson 2005 {published data only}|A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors|/resolve/reference/PMED?id=15750359
Felisi 1994 {published data only}|Early cutaneous lesions raised during radiotherapy whilst treating breast cancer: Effectiveness of a homeopathic therapy|
Srihari 1995 {published data only}|The Ipecac trial|
Genre 2003 {published data only}|Randomized, double-blind study comparing homeopathy (cocculine) to placebo in prevention of nausea/vomiting among patients receiving adjuvant chemotherapy for breast cancer|
Krempl 2005 {published data only}|A trial of homeopathic medication Traumeel S for the treatment of radiation-induced mucositis|
Ray-Coquard 2005 {published data only}|Placebo-controlled evaluation of Cocculine efficacy in the management of nausea after chemotherapy in breast cancer|
Sadhev 2004 {published data only}|Traumeel S in preventing and treating mucositis in young patients undergoing stem cell transplantation|
Bell 2003|Evidence-based homeopathy: empirical questions and methodological considerations for homeopathic clinical research|
Dantas 2000|Do homeopathic medicines provoke adverse effects? A systematic review'|/resolve/reference/PMED?id=10703910
Ernst 1998|The prevalence of complementary and alternative medicine in cancer: a systematic review|
Fisher 1998|The information medicine hypothesis|
Higgins 2008|Chapter 8: Assessing risk of bias in included studies|
Linde 1997|Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo controlled trials|/resolve/reference/PMED?id=9310601
Milazzo 2006|Efficacy of homeopathic therapy in cancer treatment|/resolve/reference/PMED?id=16376071
Molassiotis 2005|Use of complementary and alternative medicine in cancer patients: a European survey|/resolve/reference/PMED?id=15699021
Verhagen 1998|The Delphi List: a criteria list for quality assessment developed by Delphi consensus of randomised clinical trials for conducting systematic reviews|/resolve/reference/PMED?id=10086815
Byng 2004 {published data only}|Exploratory cluster randomised controlled trial of shared care development for long-term mental illness|/resolve/reference/PMED?id=15113492
Dey 2002 {published data only}|Randomized controlled trial to assess the effectiveness of a primary health care liaison worker in promoting shared care for opiate users|/resolve/reference/PMED?id=11939381
DICE 1994 {published data only}|Integrated care for diabetes: clinical, psychosocial, and economic evaluation|/resolve/reference/PMED?id=8180540
Donohoe 2000 {published data only}|Improving foot care for people with diabetes mellitus - A randomized controlled trial of an integrated care approach|
Doughty 2002 {published data only}|Randomized controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. [see comment]|/resolve/reference/PMED?id=11785996
Drummond 1994 {published data only}|Integrated care for asthma: A clinical, social, and economic evlauation|/resolve/reference/PMED?id=8148678
Holm 2002 {published data only}|A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy|
Hoskins 1992 {published data only}|Sharing the care of diabetic patients between hospital and general practitioners: does it work?|
Johannson 2001 {published data only}|Reduced utilisation of specialist care among elderly cancer patients: A randomised study of a primary care intervention|
Katon 1999 {published data only}|Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial|/resolve/reference/PMED?id=10591288
Katon 2001 {published data only}|A randomized trial of relapse prevention of depression in primary care|/resolve/reference/PMED?id=11231831
Katon 2004 {published data only}|The Pathways Study: A Randomized Controlled Trial of Collaborative Care in Patients with Diabetes and Depression|/resolve/reference/PMED?id=15466678
Llewelyn-Jones 1999 {published data only}|Multifaceted shared care intervention for late life depression in residential care: randomised controlled trial. [see comment]|/resolve/reference/PMED?id=10480824
McGhee 1994 {published data only}|Co-ordinating and standardizing long-term care: Evaluation of the west of Scotland shared-care scheme for hypertension|/resolve/reference/PMED?id=7748631
Rea 2004 {published data only}|A chronic disease managment programme can reduce days in hospital for patients with chronic obstructive pulmonary disease|
Smith 2004 {published and unpublished data}|The North Dublin randomized controlled trial of structural diabetes shared care|/resolve/reference/PMED?id=14760042
Swindle 2003 {published data only}|Integrating clinical nurse specialists into the treatment of primary care patients with depression|/resolve/reference/PMED?id=12906341
Unutzer 2002 {published data only}|Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. [see comment]|
Warner 2000 {published data only}|Patient-held shared care records for individuals with mental illness: Randomised controlled evaluation|/resolve/reference/PMED?id=11116772
Wood 1994 {published data only}|The effect on hospital admissions of psychiatric case management involving general practitioners: Preliminary results|/resolve/reference/PMED?id=7487784
Koike 2002 {published data only}|Improving the care for depression in patients with comorbid medical illness.[Erratum appears in Am J Psychiatry 2003 Jan;160(1):204]|/resolve/reference/PMED?id=12359681
Lester 2003 {published data only}|A cluster randomised controlled trial of patient-held medical records for people with schizophrenia receiving shared care|/resolve/reference/PMED?id=14694695
Meese 1997 {published data only}|Randomised trial of a patient held record on the communication with general practitioners in patients with HIV infection|
Mills 2003 {published data only}|Beyond community based diabetes management and the COAG co-ordinated care trial|
Richman 1996 {published data only}|A shared care approach in obesity management: the general practitioner and a hospital based service|/resolve/reference/PMED?id=8696419
Stewart 1999 {published data only}|Effects of multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive cardiac failure: a randomised controlled study|/resolve/reference/PMED?id=10509499
Wells 2000 {published data only}|Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. [Erratum appears in JAMA 2000 Jun 28;283(24):3204]|/resolve/reference/PMED?id=10634337
Beaulieu 2000|What do patients want from their GP? Common expectations beyond cultural differences|/resolve/reference/PMED?id=11141869
Bellg 2004|Enhancing treatment fidelity in health behaviour change studies: best practices and recommendations from the NIH behaviour change consortium|
Bradley 1999|Development and evaluation of complex interventions in health services research: case study of the Southampton heart intergrated care project (SHIP)|/resolve/reference/PMED?id=10074018
Campbell 2000|Framework for design and evaluation of complex interventions to improve health|/resolve/reference/PMED?id=10987780
Deeks 1999|Commentary: Beyond the boundary for a randomised controlled trial?|
Greenhalgh 1994|Shared Care for Diabetes: A Systematic Review. London|
Griffin 2005|Diabetes Care: the effectiveness of systems for routine surveillance for people with diabetes|
Grimshaw 1995|Complexity and systematic reviews|
Gruen 2004|Specialist outreach clinics in primary care and rural hospital settings|
Hickman 1994|A taxonomy of shared care of chronic disease|/resolve/reference/PMED?id=7880576
Hippesley-Cox 2001|General Practice workload implications of the National Service Framework for coronary heart disease: a cross sectional survey|/resolve/reference/PMED?id=11485958
Hunkeler 2006|Long term outcomes from the Impact randomised controlled trial for depressed elderly patients in primary care|/resolve/reference/PMED?id=16428253
Katon 2002|Long-term effects of a collaborative care intervention in persistently depressed priamry care patients|
Ramsay 2003|Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behaviour change strategies|/resolve/reference/PMED?id=15095767
Smith 2002|New BMJ policy on economic evaluations|/resolve/reference/PMED?id=12433741
Smith 2003|The North Dublin Diabetes Shared Care (DiSC) Project: A Qualitative investigation of the views and health beliefs of patients with type 2 diabetes|
Starfield 2003|Primary and speciality care interfaces: the imperative of disease continuity|/resolve/reference/PMED?id=15103882
Vaneslow 1995|A new definition of primary care|
Wagner 2002|Care for chronic diseases|/resolve/reference/PMED?id=12399321
Fang 1995 {published data only}|Chinese herbs in the treatment of 30 breast cancer patients caused by postoperative chemotherapy|
Hong 2005 {published data only}|A clinical study of Jiawei Guilin Erxian Dan for bone marrow inhibition in mammary cancer after chemotherapy|
Huo 2003 {published data only}|Shenmai injections for leukocytopenia reduction caused by chemotherapy for 26 breast cancer patients|
Li 2002 {published data only}|Clinical study on Shenqi Fuzheng injections combined with chemotherapy for advanced breast cancer patients|
Liu 2000 {published data only}|Clinical study on Shenmai injections in promoting postoperative recovery in patients with breast cancer|/resolve/reference/PMED?id=11789238
Situ 2005 {published data only}|Effect of Aifukang on quality of life of breast cancer patients treated with chemotherapy after operation|
Yang 2004 {published data only}|Clinical study on Aidi injections combined with chemotherapy for advanced cancer patients|
Hou 2000 {published data only}|Chinese medicine Arduola Fuzhengling for the treatment of leukocytopenia reduction caused by chemotherapy for 45 breast cancer patients|
Huang 2003 {published data only}|Xiaoyao Shan formula combined with chemotherapy in the treatment of 32 breast cancer patients|
Li 2000 {published data only}|The influence of Fuzheng baozhentang decoction on the quality life of cancer patients with radiotherapy and chemotherapy|
Liang 1999 {published data only}|Clinical study on Shenqi fuzheng injections for advanced malignant tumour|
Wang 1990 {published data only}|Traditional Chinese medicine with western medicine in the treatment of 31 breast cancer patients|
Wang 2003 {published data only}|Observation of Bazhentang decoction in the treatment of leukocytopenia caused by postoperative chemotherapy of breast carcinoma|
Weng 2003 {published data only}|Clinical observation of health-supporting and pathogen-eliminating therapy for toxic and negative effects following chemotherapy in treating breast cancer|
Wu 1997 {published data only}|Yiqibixietang decoction for leucocyte reduction caused by chemotherapy in 38 patients|
Yuan 1997 {published data only}|Integrated traditional Chinese with western medicine for leucocyte reduction of malignant tumour by chemotherapy in 58 patients|
Zhang 1997 {published data only}|Clinical study on Pishentang decoction combined with chemotherapy in the treatment of 30 breast cancer patients|
Aaronson 1993|The European Organization for Research and on Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Instituteion 1993;85:365-76.|/resolve/reference/PMED?id=8433390
Alderson 2004|Cochrane Revewers' Handbook 4.2.2 (updated December 2003)|
Andrew 1999|ABC of complementary medicine:Herbal medicine|/resolve/reference/PMED?id=10521203
Berger 1998|Patterns of fatigue and activity and rest during adjunctive breast cancer chemotherapy|/resolve/reference/PMED?id=9460773
Bower 2000|Fatigue in breast cancer survivors: correlates, and impact on quality of life|/resolve/reference/PMED?id=10673515
Broeckel 1998|Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer|/resolve/reference/PMED?id=9586880
Campora 1994|Ondansetron and dexamethasone versus standard combination antiemetic therapy: A randomised trial for prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect|/resolve/reference/PMED?id=7977174
Clarke 2000|Cochrane Reviewers' Handbook included in 4.1Review Manager(RevMan)|
Cohen 2002|Tradional Chinese medicine in the treatment of breast cancer|/resolve/reference/PMED?id=12516039
Crawford 2003|Chemotherapy -induced neutropenia|
Cunningham 1997|5-HT3 receptor antagonists: A review of pharmacology and clinical efficacy|/resolve/reference/PMED?id=9282379
EBCTCG 2005|Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials|/resolve/reference/PMED?id=15894097
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
Fulder 1996||
Gralla 2002|New agents, new treatment, and antiemetic therapy|/resolve/reference/PMED?id=11894022
Hayes 1995|Treatment of metastatic breast cancer : Present and future prospects|/resolve/reference/PMED?id=7537913
Hudis 2005|Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life|/resolve/reference/PMED?id=16001991
King 1997|Nonpharmacologic management of chemotherapy-induced nausea and vomiting|/resolve/reference/PMED?id=9282380
Kirby 1997|The antioxidant activity of Chinese herbs for eczema and of placebo herbs|/resolve/reference/PMED?id=9174970
Kris 2006|American Society of Clinical Oncology guideline for antiemetics in oncology|/resolve/reference/PMED?id=16717289
Liu 2002|Chinese medicinal herbs for chronic hepatitis B|/resolve/reference/PMED?id=12137681
Liu 2006|Herbal medicines for treatment of irritable bowel syndrome|
Partridge 2001|Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer|
Pico 1998|Mucositis: Its occurrence, consequences, and treatment in oncology the setting|/resolve/reference/PMED?id=10388137
Ramalingam 2002|Meaning survival in lung cancer patients|/resolve/reference/PMED?id=11894023
Schulz 1995|Empirical evidence of bias|/resolve/reference/PMED?id=7823387
Sitzia 1998|Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer|
Stasi 2003|Cancer-related fatigue|
Sun 2002|The development of traditional Chinese medicine in treatment of breast cancer|
Watson 1992|Further development of a quality of life measure for cancer patients: The Rotterdam Symptom Checklist (Revised)|
Zhang 2002|An application of traditional Chinese medicine in the treatment of breast cancer patients|
Abernethy 1974 {published data only}|The Australian national blood pressure study|/resolve/reference/PMED?id=4605365
Abraham 1986 {published data only}|Renal hemodynamic and humoral effects of pinacidil (P) and hydralazine (H) in essential hypertension (EH) (abstract)|
Bolli 2007 {published data only}|Treatment resistant hypertension|
Bolli 2008 {published data only}|Treatment resistant hypertension|/resolve/reference/PMED?id=18645339
Cooper 1976 {published data only}|Maintenance treatment of moderate hypertension with b.i.d hydralazine|
Dahr 1972 {published data only}|Use of hydralazine and selective cardiac adrenergic blockade in therapy of essential hypertension (abstract)|
Deedwania 1986 {published data only}|Calcium channel blocker nitrendipine vs hydralazine in the treatment of essential hypertension: a multicenter, double-blind, randomized, study (abstract)|
Freis 1953 {published data only}|The hemodynamic effects of hypotensive drugs in man IV L-hydrazinophthalazine|/resolve/reference/PMED?id=13067200
Freis 1974 {published data only}|The Veterans Administration Cooperative study on antihypertensive agents. Implications for stroke prevention|/resolve/reference/PMED?id=4811316
Gross 1950 {published data only}||/resolve/reference/PMED?id=15403090
Hua 1977 {published data only}|Studies with prazosin - a new effective hypotensive agent. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.|/resolve/reference/PMED?id=331040
Izotov 1984 {published data only}|Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prozosin, an propranolol in hypertension patients|/resolve/reference/PMED?id=6732937
Jackson 1990 {published data only}|Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patients|/resolve/reference/PMED?id=1706804
Jensen 1983 {published data only}|Treatment with hydralazine in mild to moderate mitral or aortic incompetence|/resolve/reference/PMED?id=6617676
Junor 1979 {published data only}|Oxprenolol and hydralazine in renal hypertension (abstract)|
Khan 1953 {published data only}|Effect of hydralazine in hypertension|/resolve/reference/PMED?id=12997824
Kleaveland 1986 {published data only}|Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation|/resolve/reference/PMED?id=3518384
Lopez 1984 {published data only}|Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension|/resolve/reference/PMED?id=6478732
Mimran 2007 {published data only}|Blood pressure and renal damage|/resolve/reference/PMED?id=18367003
Myers 1984 {published data only}|Nifedipine versus hydralazine therapy in severe hypertension (abstract)|
O'Boyle 1981 {published data only}|Once daily slow-release hydralazine in hypertension|/resolve/reference/PMED?id=7228629
O'Malley 1975 {published data only}|Duration of hydralazine action in hypertension|/resolve/reference/PMED?id=1102235
O'Malley 1979 {published data only}|Duration of action of hydralazine in hypertension (abstract)|
Oakley 1980 {published data only}|Interaction of propranolol and hydralazine on lower limb bloodflow - Preliminary studies (abstract)|
Persson 1976 {published data only}|Combination therapy of essential hypertension with pindolol (Visken) and hydralazine|/resolve/reference/PMED?id=802071
Pun 1984 {published data only}|Comparison of nitrendipine and hydralazine in hypertension (abstract)|
Saavedra 1975 {published data only}|The combination of oxprenolol and hydralazine in the treatment of refractory arterial hypertension|
Siitonen 1974 {published data only}|Hydralazine and beta-adrenergic blockade in the treatment of hypertension.|/resolve/reference/PMED?id=4155933
Siitonen 1980 {published data only}|Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity|/resolve/reference/PMED?id=6993250
Spence 1982 {published data only}|Effects of antihypertensive agents on blood velocity: Implications for atherogenesis|/resolve/reference/PMED?id=7139486
Stunkard 1954 {published data only}|Studies on hydralazine: evidence for a peripheral site of action|/resolve/reference/PMED?id=13174662
West 1976 {published data only}|Comparison of labetolol, hydrallazine, and propranolol in the therapy of moderate hypertension|/resolve/reference/PMED?id=6990215
Wulff 1980 {published data only}|Hydralazine in arterial hypertension. Randomized double-blind comparison of conventional/Slow-Release formulation and of b.i.d./q.i.d. dosage regimens|/resolve/reference/PMED?id=7435247
Zacest 1972 {published data only}|Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade|/resolve/reference/PMED?id=4401216
Zachariah 1986 {published data only}|Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring|/resolve/reference/PMED?id=3803413
Alarcon-Segovia 1967|Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus|/resolve/reference/PMED?id=6037131
Brunton 2006||
Cameron 1984|The lupus syndrome induced by hydralazine: a common complication with low dose treatment|/resolve/reference/PMED?id=6432120
CHEP 2008|The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension|/resolve/reference/PMED?id=18548142
Chobanian 2003|The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report|/resolve/reference/PMED?id=12748199
Gifford 1977|Managing hypertension: the post graduate medicine lecture|/resolve/reference/PMED?id=840801
Graves 1990|Hydralazine dose response curve|/resolve/reference/PMED?id=2231320
WHO 2003|2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension|/resolve/reference/PMED?id=14597836
Widgren 1986|Side effects in long term treatment with hydralazine|/resolve/reference/PMED?id=3472444
Abernethy 1974 {published data only}|The Australian national blood pressure study|/resolve/reference/PMED?id=4605365
Abraham 1986 {published data only}|Renal hemodynamic and humoral effects of pinacidil (P) and hydralazine (H) in essential hypertension (EH) (abstract)|
Bolli 2007 {published data only}|Treatment resistant hypertension|
Bolli 2008 {published data only}|Treatment resistant hypertension|/resolve/reference/PMED?id=18645339
Cooper 1976 {published data only}|Maintenance treatment of moderate hypertension with b.i.d hydralazine|
Dahr 1972 {published data only}|Use of hydralazine and selective cardiac adrenergic blockade in therapy of essential hypertension (abstract)|
Deedwania 1986 {published data only}|Calcium channel blocker nitrendipine vs hydralazine in the treatment of essential hypertension: a multicenter, double-blind, randomized, study (abstract)|
Freis 1953 {published data only}|The hemodynamic effects of hypotensive drugs in man IV L-hydrazinophthalazine|/resolve/reference/PMED?id=13067200
Freis 1974 {published data only}|The Veterans Administration Cooperative study on antihypertensive agents. Implications for stroke prevention|/resolve/reference/PMED?id=4811316
Gross 1950 {published data only}|A new group of blood pressure lowering compounds with special effectiveness|/resolve/reference/PMED?id=15403090
Hua 1977 {published data only}|Studies with prazosin - a new effective hypotensive agent. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.|/resolve/reference/PMED?id=331040
Izotov 1984 {published data only}|Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prozosin, an propranolol in hypertension patients|/resolve/reference/PMED?id=6732937
Jackson 1990 {published data only}|Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patients|/resolve/reference/PMED?id=1706804
Jensen 1983 {published data only}|Treatment with hydralazine in mild to moderate mitral or aortic incompetence|/resolve/reference/PMED?id=6617676
Junor 1979 {published data only}|Oxprenolol and hydralazine in renal hypertension (abstract)|
Khan 1953 {published data only}|Effect of hydralazine in hypertension|/resolve/reference/PMED?id=12997824
Kleaveland 1986 {published data only}|Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation|/resolve/reference/PMED?id=3518384
Lopez 1984 {published data only}|Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension|/resolve/reference/PMED?id=6478732
Mimran 2007 {published data only}|Blood pressure and renal damage|/resolve/reference/PMED?id=18367003
Myers 1984 {published data only}|Nifedipine versus hydralazine therapy in severe hypertension (abstract)|
O'Boyle 1981 {published data only}|Once daily slow-release hydralazine in hypertension|/resolve/reference/PMED?id=7228629
O'Malley 1975 {published data only}|Duration of hydralazine action in hypertension|/resolve/reference/PMED?id=1102235
O'Malley 1979 {published data only}|Duration of action of hydralazine in hypertension (abstract)|
Oakley 1980 {published data only}|Interaction of propranolol and hydralazine on lower limb bloodflow - Preliminary studies (abstract)|
Persson 1976 {published data only}|Combination therapy of essential hypertension with pindolol (Visken) and hydralazine|/resolve/reference/PMED?id=802071
Pun 1984 {published data only}|Comparison of nitrendipine and hydralazine in hypertension (abstract)|
Saavedra 1975 {published data only}|The combination of oxprenolol and hydralazine in the treatment of refractory arterial hypertension|
Siitonen 1974 {published data only}|Hydralazine and beta-adrenergic blockade in the treatment of hypertension.|/resolve/reference/PMED?id=4155933
Siitonen 1980 {published data only}|Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity|/resolve/reference/PMED?id=6993250
Spence 1982 {published data only}|Effects of antihypertensive agents on blood velocity: Implications for atherogenesis|/resolve/reference/PMED?id=7139486
Stunkard 1954 {published data only}|Studies on hydralazine: evidence for a peripheral site of action|/resolve/reference/PMED?id=13174662
West 1976 {published data only}|Comparison of labetolol, hydrallazine, and propranolol in the therapy of moderate hypertension|/resolve/reference/PMED?id=6990215
Wulff 1980 {published data only}|Hydralazine in arterial hypertension. Randomized double-blind comparison of conventional/Slow-Release formulation and of b.i.d./q.i.d. dosage regimens|/resolve/reference/PMED?id=7435247
Zacest 1972 {published data only}|Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade|/resolve/reference/PMED?id=4401216
Zachariah 1986 {published data only}|Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring|/resolve/reference/PMED?id=3803413
Alarcon-Segovia 1967|Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus|/resolve/reference/PMED?id=6037131
Brunton 2006||
Cameron 1984|The lupus syndrome induced by hydralazine: a common complication with low dose treatment|/resolve/reference/PMED?id=6432120
CHEP 2008|The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension|/resolve/reference/PMED?id=18548142
Chobanian 2003|The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report|/resolve/reference/PMED?id=12748199
Gifford 1977|Managing hypertension: the post graduate medicine lecture|/resolve/reference/PMED?id=840801
Graves 1990|Hydralazine dose response curve|/resolve/reference/PMED?id=2231320
WHO 2003|2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension|/resolve/reference/PMED?id=14597836
Widgren 1986|Side effects in long term treatment with hydralazine|/resolve/reference/PMED?id=3472444
Campbell 2005 {published data only}|A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment|/resolve/reference/PMED?id=15774341
Crowley 2003 {published data only}||
Drouin 2002 {published data only}||
MacVicar 1986 {published data only}|Promoting the functional capacity of cancer patients|
MacVicar 1989 {published data only}|Effects of aerobic interval training on cancer patients' functional capacity|/resolve/reference/PMED?id=2587289
MacVicar 1989 {published data only}|Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy|/resolve/reference/PMED?id=2780404
Mock 1997 {published data only}|Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer|/resolve/reference/PMED?id=9243585
Mock 2004 {published data only}|Exercise manages fatigue during breast cancer treatment: A randomized controlled trial|
Segal 2001 {published and unpublished data}|Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial|/resolve/reference/PMED?id=11157015
Segal 2001 SD {published and unpublished data}|Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial|/resolve/reference/PMED?id=11157015
Segal 2001SU {published and unpublished data}|Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial|/resolve/reference/PMED?id=11157015
Winningham 1988 {published data only}|The effect of aerobic exercise on patient reports of nausea|/resolve/reference/PMED?id=3399417
Burnham 2002 {published data only}|Effects of exercise on physiological and psychological variables in cancer survivors|/resolve/reference/PMED?id=12471288
Courneya 2003a {published data only}|The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: physical fitness and quality of life outcomes|
Courneya 2003b {published data only}|Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes|/resolve/reference/PMED?id=12721239
Demark-Wahnefried 02 {published data only}|Randomized study of a diet and exercise-based counseling program versus a standard counseling program for patients with early-stage breast or prostate cancer|
Demark-Wahnefried 03 {published data only}|Leading the way in exercise and diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors|/resolve/reference/PMED?id=12689742
Dimeo 1999 {published data only}|Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy|
Fairey 2003 {published data only}|Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial|/resolve/reference/PMED?id=12917202
Given 2002 {published data only}|Pain and Fatigue Management: Results of a Nursing Randomized Clinical Trial|/resolve/reference/PMED?id=12096292
Ho 1986 {published data only}|Psychological adaptation and coping resources of breast cancer patients: Comparisons across three treatment modalities|
Latikka 1997 {published data only}|[Exercise and breast cancer]|/resolve/reference/PMED?id=11370101
McKenzie 2003 {published data only}|Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study|/resolve/reference/PMED?id=12560436
Mock 1994 {published data only}|A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy|/resolve/reference/PMED?id=7937251
Mock 2001 {published data only}|Fatigue and quality of life outcomes of exercise during cancer treatment|
Mock 2002 {published data only}|Fatigue and physical functioning during breast cancer treatment|
Mustian 2002 {published data only}|Exercise: complementary therapy for breast cancer rehabilitation|
Pickett 2002 {published data only}|Adherence to moderate-intensity exercise during breast cancer therapy|
Pinto 2003 {published data only}|Psychological and fitness changes associated with exercise participation among women with breast cancer|
Schwartz 1999 {published data only}|Fatigue mediates the effects of exercise on quality of life|/resolve/reference/PMED?id=10548868
Schwartz 2001 {published data only}|Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy|/resolve/reference/PMED?id=11323538
Segar 1998 {published data only}|The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors|/resolve/reference/PMED?id=9460778
Shaw 2003 {published data only}|STRENGTH (Survival TRaining for ENhancing Total Health): Phase II Randomized Pilot Study of Distance Medicine-Based Exercise and Dietary Approach to Prevent Body Composition Change During Adjuvant Chemotherapy in Patients With Stage I, II or IIIA Breast Cancer|
Wilkie 2003 {published data only}|Computerized Exercise Education for Patients: Effects on Cancer-Related Fatigue|
Battaglini 2004 {published data only}||
Chetiyawardana 2004 {published data only}|A pilot study to investigate the effects on fitness and quality of life of an individualised exercise programme for breast cancer patients undergoing radiotherapy|
Courneya 2005 {unpublished data only}|Comparison of aerobic versus resistance exercise training in enhancing quality of life in early stage breast cancer survivors receiving chemotherapy: A mulitcenter randomized trial|
Kleine-Tebbe 2006 {unpublished data only}||
Mutrie 2005 {unpublished data only}|A randomised controlled trial of a supervised exercise programme as a rehabilitation treatment for women receiving early stage breast cancer treatment|
ACSM 2000||
Altman 2001|The revised CONSORT statement for reporting randomized trials: explanation and elaboration|/resolve/reference/PMED?id=11304107
Antes 2004|Under-reporting of clinical trials is unethical|/resolve/reference/PMED?id=12660049
Camoriano 1990|Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer|/resolve/reference/PMED?id=2199619
Colcombe 2003|Fitness effects on the cognitive function of older adults: a meta-analytic study|
Courneya 2000|Coping with cancer. Can exercise help?|/resolve/reference/PMED?id=20086640
Courneya 2001|Exercise interventions during cancer treatment: biopsychosocial outcomes|/resolve/reference/PMED?id=11337824
Courneya 2002|Exercise for breast cancer survivors: research evidence and clinical guidelines|/resolve/reference/PMED?id=20086538
Courneya 2003|Exercise in cancer survivors: an overview of research|/resolve/reference/PMED?id=14600549
de Jong 2002|Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature|/resolve/reference/PMED?id=12181497
Deeks 2005|Analysing and presenting results. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 8|
Demark-Wahnefried 01|Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy|/resolve/reference/PMED?id=11331316
Demark-Wahnefried 97|Weight gain in women diagnosed with breast cancer|/resolve/reference/PMED?id=9145091
Dibble 2003|Delayed chemotherapy-induced nausea in women treated for breast cancer|/resolve/reference/PMED?id=12692669
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Dimeo 2000|Exercise for cancer patients: a new challenge in sports medicine|/resolve/reference/PMED?id=10854012
Feyer 2001|Fatigue - a new therapeutical problem in oncology|
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Holley 2000|Cancer-related fatigue. Suffering a different fatigue|
Hudis 2003|Current status and future directions in breast cancer therapy|
Ioannidis 2004|Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement|/resolve/reference/PMED?id=15545678
Irwin 2003|Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study|
Jereczek-Fossa 2001|Radiotherapy-related fatigue: how to assess and how to treat the symptom. A commentary|/resolve/reference/PMED?id=11504369
Landis 1977|The measurement of observer agreement for categorical data|/resolve/reference/PMED?id=843571
Morrow 1998|Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics|/resolve/reference/PMED?id=9629877
NCCN 2004|Cancer related fatigue: Clinical practice guidelines in oncology|
Newman 2003|Advances in breast cancer detection and management|/resolve/reference/PMED?id=14621328
O'Shaughnessy 2003|Chemotherapy-related cognitive dysfunction in breast cancer|/resolve/reference/PMED?id=14702917
Partridge 2001|Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer|/resolve/reference/PMED?id=11773307
Patrick 2003|National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002|/resolve/reference/PMED?id=12902440
Pinto 1999|Exercise in the rehabilitation of breast cancer survivors|
Pinto 2002|Exercise participation after diagnosis of breast cancer: trends and effects on mood and quality of life|
Rogers 2004|Exploring social cognitive theory constructs for promoting exercise among breast cancer patients|/resolve/reference/PMED?id=15632787
Rogers 2005|Social cognitive theory and physical activity during breast cancer treatment|/resolve/reference/PMED?id=15990910
Rogers 2006|Exercise barrier and task self-efficacy in breast cancer patients during treatment|/resolve/reference/PMED?id=16007455
Rugo 2003|The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research|/resolve/reference/PMED?id=14663776
Rutqvist 2004|Adjuvant endocrine therapy|/resolve/reference/PMED?id=14687599
Salmon 2001|Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory|/resolve/reference/PMED?id=11148895
Schwartz 1997|Cancer|
Shrout 1997|Intraclass correlations: Uses in assessing rater reliability|/resolve/reference/PMED?id=18839484
Simes 2004|Breast Cancer Group|
Spiegel 1997|Psychosocial aspects of breast cancer treatment|/resolve/reference/PMED?id=9045295
Tchen 2003|Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer|/resolve/reference/PMED?id=14615445
Truong 2004|Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy|/resolve/reference/PMED?id=15078851
van Tulder 1997|Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders|/resolve/reference/PMED?id=9355211
Batist 2001 {published data only}|Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer|/resolve/reference/PMED?id=11230490
Brambilla 1986 {published data only}|Phase II study of doxorubicin versus epirubicin in advanced breast cancer|/resolve/reference/PMED?id=3456271
Chan 2004 {published data only}|Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer|/resolve/reference/PMED?id=15367414
FESG 1988 {published data only}|A prospective randomized pahase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil and either doxorubicin or epirubicin|/resolve/reference/PMED?id=2895801
Gasparini 1991 {published data only}|Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer, a randomized clinical trial|/resolve/reference/PMED?id=1987737
Harris 2002 {published data only}|Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma|
IMBSWE 1988 {published data only}|Phase III randomized study of fluorouracil, epirubicin and cyclophosphamide v fluorouracil, doxorubicin and cyclophosphamide in advanced breast cancer: an Italian multicentre trial|/resolve/reference/PMED?id=2897433
Mouridsen 1984 {published data only}|Doxorubicin vs epirubicin in advanced soft tissue sarcomas, an EORTC randomized phase II study|
Al-Ismael 1987 {published data only}|Combination chemotherapy including epirubicin for the amnagement of non-hodgkin's lymphoma|/resolve/reference/PMED?id=3315698
Armand 1984 {published data only}||
Aviles 1993 {published data only}|Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults|/resolve/reference/PMED?id=8260898
Aviles 1995 {published data only}|Results of a randomized study of early stage hodgkin's disease using ABVD, EBVD, or MBVD|
Baldini 2004 {published data only}|Long-term results of combined modality therapy for inflammatory breast carcinoma|/resolve/reference/PMED?id=15585073
Benjamin 1978 {published data only}|Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy|/resolve/reference/PMED?id=667871
Bertini 1997 {published data only}|Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A=doxorubicin) vs VICOP-B (I=idarubicin)|/resolve/reference/PMED?id=9234577
Bezwoda 1986 {published data only}|Treatment of advanced ovarian cancer: a randomised trial comparing adriamycin or 4'epi-adriamycin in combination with cisplatin and cyclophosphamide|
Bhutani 2002 {published data only}|Randomized study comparing 4'-epi-doxorubicin (epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia|
Bonadonna 1984 {published data only}|Epirubicin in advanced breast cancer, the experience of the Milan Cancer Institute|
Bonfante 1986 {published data only}|New anthracycline analogs in advanced breast cancer|/resolve/reference/PMED?id=3470179
Bontenbal 1998 {published data only}|Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer|/resolve/reference/PMED?id=9649142
Brugiatelli 1993 {published data only}|Epidoxorubixin vs idarubicin containing regemines in intermediate and high grade non-hodgkin's lymphoma: preliminary results of a multicentric randomized trial|/resolve/reference/PMED?id=8314160
Burton 2005 {published data only}|Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma|
Casper 1987A {published data only}|The cardiotoxic effect of epirubicin and doxorubicin (adriamycin), a clinical and radionuclide cine-angiographic comparison|
Casper 1987B {published data only}|Epirubicin and doxorubicin in advanced breast cancer, a comparative evaluation of epirubicin and doxorubicin|
Cottin 1998 {published data only}|Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evalution of the diastolic and systolic parameters studied by radionuclide angiography|
Creutzig 1988 {published data only}||/resolve/reference/PMED?id=3062255
Creutzig 2001A {published data only}|Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93|/resolve/reference/PMED?id=11237056
Creutzig 2001B {published data only}||/resolve/reference/PMED?id=11528551
Creutzig 2001C {published data only}|Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of study acute myeloid leukemia-berlin-frankfurt-munster 93|/resolve/reference/PMED?id=11352963
De Lena 1987 {published data only}|Randomized trial with two CHOP-B regimens (with doxorubicin or epirubicin) in poor prognosis non-hodgkin's lymphomas|
De Lena 1989 {published data only}|Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-hodgkin's lymphomas, a randomized trial|/resolve/reference/PMED?id=2473364
Federico 1998 {published data only}|Efficacy of two different ProMACE-CytaBOM derived regimens in advanced agressive non-hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL|/resolve/reference/PMED?id=9825577
Gebbia 2003 {published data only}|Paclitaxel and epidoxorubicin or doxorubicin versus cyclophosphamide and epidoxorubicin as first-line chemotherapy for metastatic breast carcinoma: a randomized phase II study|/resolve/reference/PMED?id=12680181
Gregory 2000 {published data only}|Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy|/resolve/reference/PMED?id=10717527
Heidemann 1990 {published data only}|Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer|/resolve/reference/PMED?id=2186320
Heidemann 1993 {published data only}|Prognostic subgroups: the key factor for treatment outcome in metastatic breast cancer, results of a three-arm randomized multicenter trial comparing doxorubicin, epirubicin and mitoxantrone each in combination with cyclophosphamide|
Hernadi 1988 {published data only}|Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4-epi-doxorubicin in the treatment of advanced ovarian cancer|/resolve/reference/PMED?id=2903085
Homesley 1992 {published data only}|Randomized comparison of cisplatin plus epirubicin or doxorubicin for advanced epithelial ovarian carcinoma|/resolve/reference/PMED?id=1553900
Hortobagyi 1989 {published data only}|A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer|/resolve/reference/PMED?id=2643296
Jain 1985 {published data only}|A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer|/resolve/reference/PMED?id=3859587
Keiling 1986 {published data only}||/resolve/reference/PMED?id=3528969
Klener 1973 {published data only}|Daunorubicin and adriamycin in the treatment of leukemia|/resolve/reference/PMED?id=4573873
Lahtinen 1991 {published data only}|Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study|
Lawton 1993 {published data only}|A comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast carcinoma|/resolve/reference/PMED?id=8481365
Lopez 1989 {published data only}|5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer|/resolve/reference/PMED?id=2915887
Mandelli 1991 {published data only}|A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia, a multicentric study from the italian co-operative group GIMEMA|/resolve/reference/PMED?id=1829918
Maung 2002 {published data only}|Pegylated liposomal doxorubicin (doxil) versus doxorubicin for first-line treatment of metastatic breast cancer|
Mouridsen 1987 {published data only}|Adriamycin versus epirubicin in advanced soft tissue sarcomas, a randomized phase II / phase III study of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=3479329
Nair 1998 {published data only}|A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-hodgkin's lymphoma|
Namer 2001 {published data only}|Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer|/resolve/reference/PMED?id=11378344
Neri 1989 {published data only}|Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects|/resolve/reference/PMED?id=2737789
Nielsen 1998 {published data only}|High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas, a study of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=9862576
Nielsen 2000 {published data only}|Epirubicine is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas, the experience of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=18521432
Nikkanen 1988 {published data only}|Doxorubicin and 4'epidoxorubicin in combination chemotherapy of extensive small cell lung cancer|/resolve/reference/PMED?id=2835069
O'Brian 2004 {published data only}|Reduced cardiotoxicity and comparable efficacy in a phase III trials of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus concentional doxorubicin for the first-line treatment of metastatic breast cancer|/resolve/reference/PMED?id=14998846
Perez 1991 {published data only}|A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer|/resolve/reference/PMED?id=1960557
Pinedo 1987 {published data only}|A ransomized trial comparing the effects of epirubicin and doxorubicin in soft tissue sarcoma|
Sculier 1995 {published data only}|Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the european lung cancer working party|/resolve/reference/PMED?id=7846537
Smith 1987 {published data only}|Epirubicin and small cell lung cancer, a pilot study of the efficacy and toxicity of epirubicin and doxorubicin (adriamycin)|
Suzuki 1984 {published data only}|A comparative study of 4'epi-doxorubicin and doxorubicin cardiotoxicities|/resolve/reference/PMED?id=6593004
Tanaka 1983 {published data only}|Effects of adriamycin and daunomycin on cardiac function|/resolve/reference/PMED?id=6639100
Toda 1989 {published data only}|Intra-arterial infusion chemotherapy for advanced breast cancer-effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin|/resolve/reference/PMED?id=2782905
Tsushima 1991 {published data only}|A randomized controlled study of 5-fluorouracil / doxorubicin / mitomycin C / OK-432 (FAM-OK) therapy and 5-flourouracil / epirubicin / mitomycin C / OK-432 (FEM-OK) therapy in advanced gastric cancer|
Yates 1982 {published data only}|Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study|/resolve/reference/PMED?id=6953986
Zinzani 1995 {published data only}|Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-hodgkin's lymphoma|/resolve/reference/PMED?id=8535227
NCT00002985 {published data only}|Doxorubicin in treating patients with AIDS-related Kaposi's sarcoma|
NCT00022516 {published data only}|Combination chemotherapy after surgery in treating patients with stage I, stage II, or stage III breast cancer|
Billingham 1978|Anthracycline cardiomyopathy monitored by morphologic changes|/resolve/reference/PMED?id=667860
Bonadonna 1969|Cardiac toxicity of daunorubicin|/resolve/reference/PMED?id=4180385
Higgins 2005||
Kremer 2001|Anthracycline induced clinical heart failure in a cohort of 607 children: a long-term follow-up study|/resolve/reference/PMED?id=11134212
Kremer 2002a|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|/resolve/reference/PMED?id=12123328
Kremer 2002b|Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review|/resolve/reference/PMED?id=12056699
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Meinardi 2002|Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques|/resolve/reference/PMED?id=12067953
Miller 1981|Reporting results of cancer treatment|
Muggia 1991|New anthracycline antitumor antibiotics|/resolve/reference/PMED?id=1831987
Ng 2006|Anticancer agents and cardiotoxicity|/resolve/reference/PMED?id=16473642
Nousiainen 2002|Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients|/resolve/reference/PMED?id=12087452
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Shan 1996|Anthracycline-induced cardiotoxicity|/resolve/reference/PMED?id=8644988
Simbre 2005|Cardiotoxicity of cancer chemotherapy, implications for children|/resolve/reference/PMED?id=15977964
WHO Handbook 1979||
Batist 2001 {published data only}|Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer|/resolve/reference/PMED?id=11230490
Brambilla 1986 {published data only}|Phase II study of doxorubicin versus epirubicin in advanced breast cancer|/resolve/reference/PMED?id=3456271
Chan 2004 {published data only}|Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer|/resolve/reference/PMED?id=15367414
FESG 1988 {published data only}|A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil and either doxorubicin or epirubicin|/resolve/reference/PMED?id=2895801
Gasparini 1991 {published data only}|Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer, a randomized clinical trial|/resolve/reference/PMED?id=1987737
Harris 2002 {published data only}|Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma|
IMBSWE 1988 {published data only}|Phase III randomized study of fluorouracil, epirubicin and cyclophosphamide v fluorouracil, doxorubicin and cyclophosphamide in advanced breast cancer: an Italian multicentre trial|/resolve/reference/PMED?id=2897433
Mouridsen 1984 {published data only}|Doxorubicin vs epirubicin in advanced soft tissue sarcomas, an EORTC randomized phase II study|
Al-Ismael 1987 {published data only}|Combination chemotherapy including epirubicin for the management of non-hodgkin's lymphoma|/resolve/reference/PMED?id=3315698
Armand 1984 {published data only}||
Aviles 1993 {published data only}|Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults|/resolve/reference/PMED?id=8260898
Aviles 1995 {published data only}|Results of a randomized study of early stage hodgkin's disease using ABVD, EBVD, or MBVD|
Aviles 2005 {published data only}|Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy|/resolve/reference/PMED?id=16019553
Baldini 2004 {published data only}|Long-term results of combined modality therapy for inflammatory breast carcinoma|/resolve/reference/PMED?id=15585073
Benjamin 1978 {published data only}|Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy|/resolve/reference/PMED?id=667871
Bertini 1997 {published data only}|Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A=doxorubicin) vs VICOP-B (I=idarubicin)|/resolve/reference/PMED?id=9234577
Bezwoda 1986 {published data only}|Treatment of advanced ovarian cancer: a randomised trial comparing adriamycin or 4'epi-adriamycin in combination with cisplatin and cyclophosphamide|
Bhutani 2002 {published data only}|Randomized study comparing 4'-epi-doxorubicin (epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia|
Bonadonna 1984 {published data only}|Epirubicin in advanced breast cancer, the experience of the Milan Cancer Institute|
Bonfante 1986 {published data only}|New anthracycline analogs in advanced breast cancer|/resolve/reference/PMED?id=3470179
Bontenbal 1998 {published data only}|Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer|/resolve/reference/PMED?id=9649142
Brugiatelli 1993 {published data only}|Epidoxorubixin vs idarubicin containing regimens in intermediate and high grade non-hodgkin's lymphoma: preliminary results of a multicentric randomized trial|/resolve/reference/PMED?id=8314160
Burton 2005 {published data only}|Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma|
Casper 1987A {published data only}|The cardiotoxic effect of epirubicin and doxorubicin (adriamycin), a clinical and radionuclide cine-angiographic comparison|
Casper 1987B {published data only}|Epirubicin and doxorubicin in advanced breast cancer, a comparative evaluation of epirubicin and doxorubicin|
Cottin 1998 {published data only}|Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evaluation of the diastolic and systolic parameters studied by radionuclide angiography|
Creutzig 1988 {published data only}|Therapy realization and complications in the BFM-83 therapy study of acute myelogenous leukemia|/resolve/reference/PMED?id=3062255
Creutzig 2001A {published data only}|Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93|/resolve/reference/PMED?id=11237056
Creutzig 2001B {published data only}|Improved treatment results in children with AML: Results of study AML-BFM 93|/resolve/reference/PMED?id=11528551
Creutzig 2001C {published data only}|Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of study acute myeloid leukemia-berlin-frankfurt-munster 93|/resolve/reference/PMED?id=11352963
De Lena 1987 {published data only}|Randomized trial with two CHOP-B regimens (with doxorubicin or epirubicin) in poor prognosis non-hodgkin's lymphomas|
De Lena 1989 {published data only}|Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-hodgkin's lymphomas, a randomized trial|/resolve/reference/PMED?id=2473364
Federico 1998 {published data only}|Efficacy of two different ProMACE-CytaBOM derived regimens in advanced agressive non-hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL|/resolve/reference/PMED?id=9825577
Gebbia 2003 {published data only}|Paclitaxel and epidoxorubicin or doxorubicin versus cyclophosphamide and epidoxorubicin as first-line chemotherapy for metastatic breast carcinoma: a randomized phase II study|/resolve/reference/PMED?id=12680181
Gregory 2000 {published data only}|Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy|/resolve/reference/PMED?id=10717527
Heidemann 1990 {published data only}|Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer|/resolve/reference/PMED?id=2186320
Heidemann 1993 {published data only}|Prognostic subgroups: the key factor for treatment outcome in metastatic breast cancer, results of a three-arm randomized multicenter trial comparing doxorubicin, epirubicin and mitoxantrone each in combination with cyclophosphamide|
Hernadi 1988 {published data only}|Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4-epi-doxorubicin in the treatment of advanced ovarian cancer|/resolve/reference/PMED?id=2903085
Homesley 1992 {published data only}|Randomized comparison of cisplatin plus epirubicin or doxorubicin for advanced epithelial ovarian carcinoma|/resolve/reference/PMED?id=1553900
Hortobagyi 1989 {published data only}|A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer|/resolve/reference/PMED?id=2643296
Jain 1985 {published data only}|A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer|/resolve/reference/PMED?id=3859587
Keiling 1986 {published data only}|French FAC vs FEC study in advanced breast cancer|/resolve/reference/PMED?id=3528969
Klener 1973 {published data only}|Daunorubicin and adriamycin in the treatment of leukemia|/resolve/reference/PMED?id=4573873
Lahtinen 1991 {published data only}|Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study|
Lawton 1993 {published data only}|A comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast carcinoma|/resolve/reference/PMED?id=8481365
Lopez 1989 {published data only}|5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer|/resolve/reference/PMED?id=2915887
Lotrionte 2009 {published data only}|Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study|/resolve/reference/PMED?id=18572266
Mandelli 1991 {published data only}|A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia, a multicentric study from the italian co-operative group GIMEMA|/resolve/reference/PMED?id=1829918
Maung 2002 {published data only}|Pegylated liposomal doxorubicin (doxil) versus doxorubicin for first-line treatment of metastatic breast cancer|
Moser 2005 {published data only}|Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials|/resolve/reference/PMED?id=16231850
Mouridsen 1987 {published data only}|Adriamycin versus epirubicin in advanced soft tissue sarcomas, a randomized phase II / phase III study of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=3479329
Nair 1998 {published data only}|A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-hodgkin's lymphoma|
Namer 2001 {published data only}|Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer|/resolve/reference/PMED?id=11378344
NCT00531973 {published data only}|Liposomal doxorubicin-investigational chemotherapy-tissue doppler imaging evaluation (LITE) randomized pilot study|
NCT00589082Latagliata2008 {published data only}|DaunoXome (liposomal daunorubicin) plus ara-C versus daunorubicin plus ara-C in elderly AML patients; a randomized phase III study|
NCT00589082Latagliata2008 {published data only}|Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia|
NCT00854568 {published and unpublished data}|A randomized phase III study comparing CHOP verus CEOP-induced cardiotoxicity in patients with aggressive B-cell lymphoma|
Neri 1989 {published data only}|Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects|/resolve/reference/PMED?id=2737789
Nielsen 1998 {published data only}|High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas, a study of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=9862576
Nielsen 2000 {published data only}|Epirubicine is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas, the experience of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=18521432
Nikkanen 1988 {published data only}|Doxorubicin and 4'epidoxorubicin in combination chemotherapy of extensive small cell lung cancer|/resolve/reference/PMED?id=2835069
O'Brian 2004 {published data only}|Reduced cardiotoxicity and comparable efficacy in a phase III trials of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for the first-line treatment of metastatic breast cancer|/resolve/reference/PMED?id=14998846
Perez 1991 {published data only}|A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer|/resolve/reference/PMED?id=1960557
Pinedo 1987 {published data only}|A randomized trial comparing the effects of epirubicin and doxorubicin in soft tissue sarcoma|
Rifkin 2006 {published data only}|Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: A phase III multicenter randomized trial|
Rifkin 2006 {published data only}|Economic evaluation of DVd versus VAd in the treatment of multiple myeloma: Results from a phase III multicenter randomized clinical trial|
Sculier 1995 {published data only}|Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the european lung cancer working party|/resolve/reference/PMED?id=7846537
Smith 1987 {published data only}|Epirubicin and small cell lung cancer, a pilot study of the efficacy and toxicity of epirubicin and doxorubicin (adriamycin)|
Stohr 2006 {published data only}|Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS)|/resolve/reference/PMED?id=16205946
Suzuki 1984 {published data only}|A comparative study of 4'epi-doxorubicin and doxorubicin cardiotoxicities|/resolve/reference/PMED?id=6593004
Swenson 2003 {published data only}|Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer|/resolve/reference/PMED?id=12634619
Tanaka 1983 {published data only}|Effects of adriamycin and daunomycin on cardiac function|/resolve/reference/PMED?id=6639100
Toda 1989 {published data only}|Intra-arterial infusion chemotherapy for advanced breast cancer-effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin|/resolve/reference/PMED?id=2782905
Tsushima 1991 {published data only}|A randomized controlled study of 5-fluorouracil / doxorubicin / mitomycin C / OK-432 (FAM-OK) therapy and 5-flourouracil / epirubicin / mitomycin C / OK-432 (FEM-OK) therapy in advanced gastric cancer|
Ventura 2005 {published data only}|Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results|/resolve/reference/PMED?id=15838014
Yates 1982 {published data only}|Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study|/resolve/reference/PMED?id=6953986
Zinzani 1995 {published data only}|Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-hodgkin's lymphoma|/resolve/reference/PMED?id=8535227
Burnell 2007 {published data only}|A phase III adjuvant trial of sequenced EC + filgrastim + epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21)|
Knobloch 2008 {published data only (unpublished sought but not used)}|Combined NT-pro-BNP and CW-Doppler ultrasound cardiac output monitoring (USCOM) in epirubicin and liposomal doxorubicin therapy|/resolve/reference/PMED?id=17707098
NCT00002985 {published data only}|Double-Blind Randomized Evaluation of Clinical Benefits of DOXIL in Patients With AIDS-Related Kaposi's Sarcoma Treated With DOXIL or DaunoXome|
NCT00022516 {published data only}|Maintenance Chemotherapy In Hormone Non-Responsive Breast Cancer, Assessment of Vascular Endothelial Growth Factor (VEGF), Soluble Her2 Protein (NRP, HER2-ECD) and Vascular Cellular Adhesion Molecule-1 (VCAM-1) in Serum Samples|
NCT00431795 {published data only (unpublished sought but not used)}|A multicentre randomized phase II study of second line chemotherapy with epirubicin (farmorubicin) versus the pegylated liposomal doxorubicin in advanced breast cancer patients|
NCT00516425 {published data only (unpublished sought but not used)}|Adjuvant cytotoxic chemotherapy in older women|
NCT00536393 {published data only (unpublished sought but not used)}|Phase III study of treatment of disseminated and aggresive lymphoma R CHOP versus R CLOP (with liposomal doxorubicin)|
Northfelt 1996 {published data only (unpublished sought but not used)}|Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma|
NCT00575406 {published and unpublished data}|Multicentre study to determine the cardiotoxicity of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristin and prednisolone) compared to R-COMP (rituximab, cyclophosphamide, liposomal doxorubicin, vincristin and prednisolone) in patients with diffuse large B-cell lymphoma (NHL-14)|
Billingham 1978|Anthracycline cardiomyopathy monitored by morphologic changes|/resolve/reference/PMED?id=667860
Bonadonna 1969|Cardiac toxicity of daunorubicin|/resolve/reference/PMED?id=4180385
Higgins 2009||
Kremer 2002a|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|/resolve/reference/PMED?id=12123328
Kremer 2002b|Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review|/resolve/reference/PMED?id=12056699
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Meinardi 2002|Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques|/resolve/reference/PMED?id=12067953
Miller 1981|Reporting results of cancer treatment|
Muggia 1991|New anthracycline antitumor antibiotics|/resolve/reference/PMED?id=1831987
Ng 2006|Anticancer agents and cardiotoxicity|/resolve/reference/PMED?id=16473642
Nousiainen 2002|Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients|/resolve/reference/PMED?id=12087452
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Shan 1996|Anthracycline-induced cardiotoxicity|/resolve/reference/PMED?id=8644988
Simbre 2005|Cardiotoxicity of cancer chemotherapy, implications for children|/resolve/reference/PMED?id=15977964
Van Dalen 2006a|Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study|/resolve/reference/PMED?id=16987655
WHO Handbook 1979||
Van Dalen 2006b|Different anthracycline derivates for reducing cardiotoxicity in cancer patients|
Batist 2001 {published data only}|Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer|/resolve/reference/PMED?id=11230490
Brambilla 1986 {published data only}|Phase II study of doxorubicin versus epirubicin in advanced breast cancer|/resolve/reference/PMED?id=3456271
Chan 2004 {published data only}|Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer|/resolve/reference/PMED?id=15367414
FESG 1988 {published data only}|A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil and either doxorubicin or epirubicin|/resolve/reference/PMED?id=2895801
Gasparini 1991 {published data only}|Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer, a randomized clinical trial|/resolve/reference/PMED?id=1987737
Harris 2002 {published data only}|Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma|
IMBSWE 1988 {published data only}|Phase III randomized study of fluorouracil, epirubicin and cyclophosphamide v fluorouracil, doxorubicin and cyclophosphamide in advanced breast cancer: an Italian multicentre trial|/resolve/reference/PMED?id=2897433
Mouridsen 1984 {published data only}|Doxorubicin vs epirubicin in advanced soft tissue sarcomas, an EORTC randomized phase II study|
Al-Ismael 1987 {published data only}|Combination chemotherapy including epirubicin for the management of non-hodgkin's lymphoma|/resolve/reference/PMED?id=3315698
Armand 1984 {published data only}||
Aviles 1993 {published data only}|Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults|/resolve/reference/PMED?id=8260898
Aviles 1995 {published data only}|Results of a randomized study of early stage hodgkin's disease using ABVD, EBVD, or MBVD|
Aviles 2005 {published data only}|Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy|/resolve/reference/PMED?id=16019553
Baldini 2004 {published data only}|Long-term results of combined modality therapy for inflammatory breast carcinoma|/resolve/reference/PMED?id=15585073
Benjamin 1978 {published data only}|Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy|/resolve/reference/PMED?id=667871
Bertini 1997 {published data only}|Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A=doxorubicin) vs VICOP-B (I=idarubicin)|/resolve/reference/PMED?id=9234577
Bezwoda 1986 {published data only}|Treatment of advanced ovarian cancer: a randomised trial comparing adriamycin or 4'epi-adriamycin in combination with cisplatin and cyclophosphamide|
Bhutani 2002 {published data only}|Randomized study comparing 4'-epi-doxorubicin (epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia|
Bonadonna 1984 {published data only}|Epirubicin in advanced breast cancer, the experience of the Milan Cancer Institute|
Bonfante 1986 {published data only}|New anthracycline analogs in advanced breast cancer|/resolve/reference/PMED?id=3470179
Bontenbal 1998 {published data only}|Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer|/resolve/reference/PMED?id=9649142
Brugiatelli 1993 {published data only}|Epidoxorubixin vs idarubicin containing regimens in intermediate and high grade non-hodgkin's lymphoma: preliminary results of a multicentric randomized trial|/resolve/reference/PMED?id=8314160
Burton 2005 {published data only}|Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma|
Casper 1987A {published data only}|The cardiotoxic effect of epirubicin and doxorubicin (adriamycin), a clinical and radionuclide cine-angiographic comparison|
Casper 1987B {published data only}|Epirubicin and doxorubicin in advanced breast cancer, a comparative evaluation of epirubicin and doxorubicin|
Cottin 1998 {published data only}|Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evaluation of the diastolic and systolic parameters studied by radionuclide angiography|
Creutzig 1988 {published data only}|Therapy realization and complications in the BFM-83 therapy study of acute myelogenous leukemia|/resolve/reference/PMED?id=3062255
Creutzig 2001A {published data only}|Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93|/resolve/reference/PMED?id=11237056
Creutzig 2001B {published data only}|Improved treatment results in children with AML: Results of study AML-BFM 93|/resolve/reference/PMED?id=11528551
Creutzig 2001C {published data only}|Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of study acute myeloid leukemia-berlin-frankfurt-munster 93|/resolve/reference/PMED?id=11352963
De Lena 1987 {published data only}|Randomized trial with two CHOP-B regimens (with doxorubicin or epirubicin) in poor prognosis non-hodgkin's lymphomas|
De Lena 1989 {published data only}|Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-hodgkin's lymphomas, a randomized trial|/resolve/reference/PMED?id=2473364
Federico 1998 {published data only}|Efficacy of two different ProMACE-CytaBOM derived regimens in advanced agressive non-hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL|/resolve/reference/PMED?id=9825577
Gebbia 2003 {published data only}|Paclitaxel and epidoxorubicin or doxorubicin versus cyclophosphamide and epidoxorubicin as first-line chemotherapy for metastatic breast carcinoma: a randomized phase II study|/resolve/reference/PMED?id=12680181
Gregory 2000 {published data only}|Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy|/resolve/reference/PMED?id=10717527
Heidemann 1990 {published data only}|Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer|/resolve/reference/PMED?id=2186320
Heidemann 1993 {published data only}|Prognostic subgroups: the key factor for treatment outcome in metastatic breast cancer, results of a three-arm randomized multicenter trial comparing doxorubicin, epirubicin and mitoxantrone each in combination with cyclophosphamide|
Hernadi 1988 {published data only}|Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4-epi-doxorubicin in the treatment of advanced ovarian cancer|/resolve/reference/PMED?id=2903085
Homesley 1992 {published data only}|Randomized comparison of cisplatin plus epirubicin or doxorubicin for advanced epithelial ovarian carcinoma|/resolve/reference/PMED?id=1553900
Hortobagyi 1989 {published data only}|A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer|/resolve/reference/PMED?id=2643296
Jain 1985 {published data only}|A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer|/resolve/reference/PMED?id=3859587
Keiling 1986 {published data only}|French FAC vs FEC study in advanced breast cancer|/resolve/reference/PMED?id=3528969
Klener 1973 {published data only}|Daunorubicin and adriamycin in the treatment of leukemia|/resolve/reference/PMED?id=4573873
Lahtinen 1991 {published data only}|Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study|
Lawton 1993 {published data only}|A comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast carcinoma|/resolve/reference/PMED?id=8481365
Lopez 1989 {published data only}|5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer|/resolve/reference/PMED?id=2915887
Lotrionte 2009 {published data only}|Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study|/resolve/reference/PMED?id=18572266
Mandelli 1991 {published data only}|A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia, a multicentric study from the italian co-operative group GIMEMA|/resolve/reference/PMED?id=1829918
Maung 2002 {published data only}|Pegylated liposomal doxorubicin (doxil) versus doxorubicin for first-line treatment of metastatic breast cancer|
Moser 2005 {published data only}|Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials|/resolve/reference/PMED?id=16231850
Mouridsen 1987 {published data only}|Adriamycin versus epirubicin in advanced soft tissue sarcomas, a randomized phase II / phase III study of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=3479329
Nair 1998 {published data only}|A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-hodgkin's lymphoma|
Namer 2001 {published data only}|Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer|/resolve/reference/PMED?id=11378344
NCT00531973 {published data only}|Liposomal doxorubicin-investigational chemotherapy-tissue doppler imaging evaluation (LITE) randomized pilot study|
NCT00589082Latagliata2008 {published data only}|DaunoXome (liposomal daunorubicin) plus ara-C versus daunorubicin plus ara-C in elderly AML patients; a randomized phase III study|
NCT00589082Latagliata2008 {published data only}|Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia|
NCT00854568 {published and unpublished data}|A randomized phase III study comparing CHOP verus CEOP-induced cardiotoxicity in patients with aggressive B-cell lymphoma|
Neri 1989 {published data only}|Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects|/resolve/reference/PMED?id=2737789
Nielsen 1998 {published data only}|High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas, a study of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=9862576
Nielsen 2000 {published data only}|Epirubicine is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas, the experience of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=18521432
Nikkanen 1988 {published data only}|Doxorubicin and 4'epidoxorubicin in combination chemotherapy of extensive small cell lung cancer|/resolve/reference/PMED?id=2835069
O'Brian 2004 {published data only}|Reduced cardiotoxicity and comparable efficacy in a phase III trials of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for the first-line treatment of metastatic breast cancer|/resolve/reference/PMED?id=14998846
Perez 1991 {published data only}|A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer|/resolve/reference/PMED?id=1960557
Pinedo 1987 {published data only}|A randomized trial comparing the effects of epirubicin and doxorubicin in soft tissue sarcoma|
Rifkin 2006 {published data only}|Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: A phase III multicenter randomized trial|
Rifkin 2006 {published data only}|Economic evaluation of DVd versus VAd in the treatment of multiple myeloma: Results from a phase III multicenter randomized clinical trial|
Sculier 1995 {published data only}|Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the european lung cancer working party|/resolve/reference/PMED?id=7846537
Smith 1987 {published data only}|Epirubicin and small cell lung cancer, a pilot study of the efficacy and toxicity of epirubicin and doxorubicin (adriamycin)|
Stohr 2006 {published data only}|Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS)|/resolve/reference/PMED?id=16205946
Suzuki 1984 {published data only}|A comparative study of 4'epi-doxorubicin and doxorubicin cardiotoxicities|/resolve/reference/PMED?id=6593004
Swenson 2003 {published data only}|Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer|/resolve/reference/PMED?id=12634619
Tanaka 1983 {published data only}|Effects of adriamycin and daunomycin on cardiac function|/resolve/reference/PMED?id=6639100
Toda 1989 {published data only}|Intra-arterial infusion chemotherapy for advanced breast cancer-effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin|/resolve/reference/PMED?id=2782905
Tsushima 1991 {published data only}|A randomized controlled study of 5-fluorouracil / doxorubicin / mitomycin C / OK-432 (FAM-OK) therapy and 5-flourouracil / epirubicin / mitomycin C / OK-432 (FEM-OK) therapy in advanced gastric cancer|
Ventura 2005 {published data only}|Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results|/resolve/reference/PMED?id=15838014
Yates 1982 {published data only}|Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study|/resolve/reference/PMED?id=6953986
Zinzani 1995 {published data only}|Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-hodgkin's lymphoma|/resolve/reference/PMED?id=8535227
Burnell 2007 {published data only}|A phase III adjuvant trial of sequenced EC + filgrastim + epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21)|
Knobloch 2008 {published data only (unpublished sought but not used)}|Combined NT-pro-BNP and CW-Doppler ultrasound cardiac output monitoring (USCOM) in epirubicin and liposomal doxorubicin therapy|/resolve/reference/PMED?id=17707098
NCT00002985 {published data only}|Double-Blind Randomized Evaluation of Clinical Benefits of DOXIL in Patients With AIDS-Related Kaposi's Sarcoma Treated With DOXIL or DaunoXome|
NCT00022516 {published data only}|Maintenance Chemotherapy In Hormone Non-Responsive Breast Cancer, Assessment of Vascular Endothelial Growth Factor (VEGF), Soluble Her2 Protein (NRP, HER2-ECD) and Vascular Cellular Adhesion Molecule-1 (VCAM-1) in Serum Samples|
NCT00431795 {published data only (unpublished sought but not used)}|A multicentre randomized phase II study of second line chemotherapy with epirubicin (farmorubicin) versus the pegylated liposomal doxorubicin in advanced breast cancer patients|
NCT00516425 {published data only (unpublished sought but not used)}|Adjuvant cytotoxic chemotherapy in older women|
NCT00536393 {published data only (unpublished sought but not used)}|Phase III study of treatment of disseminated and aggresive lymphoma R CHOP versus R CLOP (with liposomal doxorubicin)|
Northfelt 1996 {published data only (unpublished sought but not used)}|Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma|
NCT00575406 {published and unpublished data}|Multicentre study to determine the cardiotoxicity of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristin and prednisolone) compared to R-COMP (rituximab, cyclophosphamide, liposomal doxorubicin, vincristin and prednisolone) in patients with diffuse large B-cell lymphoma (NHL-14)|
Billingham 1978|Anthracycline cardiomyopathy monitored by morphologic changes|/resolve/reference/PMED?id=667860
Bonadonna 1969|Cardiac toxicity of daunorubicin|/resolve/reference/PMED?id=4180385
Higgins 2005||
Higgins 2009||
Kremer 2002a|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|/resolve/reference/PMED?id=12123328
Kremer 2002b|Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review|/resolve/reference/PMED?id=12056699
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Meinardi 2002|Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques|/resolve/reference/PMED?id=12067953
Miller 1981|Reporting results of cancer treatment|
Muggia 1991|New anthracycline antitumor antibiotics|/resolve/reference/PMED?id=1831987
Ng 2006|Anticancer agents and cardiotoxicity|/resolve/reference/PMED?id=16473642
Nousiainen 2002|Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients|/resolve/reference/PMED?id=12087452
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Shan 1996|Anthracycline-induced cardiotoxicity|/resolve/reference/PMED?id=8644988
Simbre 2005|Cardiotoxicity of cancer chemotherapy, implications for children|/resolve/reference/PMED?id=15977964
Van Dalen 2006a|Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study|/resolve/reference/PMED?id=16987655
WHO Handbook 1979||
Van Dalen 2006b|Different anthracycline derivates for reducing cardiotoxicity in cancer patients|
Casper 1991 {published data only}|A prospective randomized trial of adjuvant chemotehrapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extrimity soft tissue sarcoma and an analysis of prognostic factors|
Hortobagyi 1989 {published data only}|A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer|/resolve/reference/PMED?id=2643296
Lipshultz 2002 {published data only}|Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 acute lymphoblastic leukemia protocol|/resolve/reference/PMED?id=11896119
Shapira 1990 {published data only}|Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen: a prospective randomized evaluation|
Steinherz 1993 {published data only}|Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse|
Zalupski 1991 {published data only}|Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group Study|/resolve/reference/PMED?id=2067035
Adam 1994 {published data only}|Lower cardiotoxicity of adriamycin during continuous administration to patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone|/resolve/reference/PMED?id=7941437
Alba 2004 {published data only}|Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a spanish breast cancer research group (GEICAM-9903) phase III study|/resolve/reference/PMED?id=15226326
Bastholt 1996 {published data only}|Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group|/resolve/reference/PMED?id=8648369
Berchem 1996 {published data only}|Epirubicin cardiotoxicity: a study comparing low- with high-dose intensity weekly schedules|/resolve/reference/PMED?id=8829311
Berrak 2001 {published data only}|Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous infusion schedules|/resolve/reference/PMED?id=11295089
Blomqvist 1993 {published data only}|Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration|/resolve/reference/PMED?id=8445422
Carmo-Pereira 1987 {published data only}|A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma|/resolve/reference/PMED?id=3318902
Carrio 1993 {published data only}|Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies|/resolve/reference/PMED?id=8355070
Ehrlich 1979 {published data only}|Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report|/resolve/reference/PMED?id=376134
Eksborg 1997 {published data only}|Plasma pharmacokinetics of idarubicin and its 13-dihydro metabolite - a comparison of bolus versus 2 h infusion during a 3 day course|/resolve/reference/PMED?id=9147610
Ewer 1998 {published data only}|Doxorubicin cardiotoxicity in children: comparison of consecutive divided daily dose administration schedule with single dose (rapid) infusion administration|
Gupta 2003 {published data only}|Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers|
Habeshaw 1991 {published data only}|Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial|/resolve/reference/PMED?id=1988576
Hochster 1985 {published data only}|4'epidoxorubicin (epirubicin): activity in hepatocellular carcinoma|/resolve/reference/PMED?id=2997408
Hoeltgen 1983 {published data only}|Adriamycin and cytoxan in the treatment of inoperable lung cancer|
Hubert 2000 {published data only}|Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer|/resolve/reference/PMED?id=10789595
Irwin 1980 {published data only}|Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a western cancer study group trial|/resolve/reference/PMED?id=7004635
ISRCTN 83324925 {unpublished data only}|A randomized comparative trial of infusional ECF versus conventional FEC as adjuvant chemotherapy in patients with poor prognosis breast cancer|
Krupicka 2002 {published data only}|Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the german Hodgkin's lymphoma study group|/resolve/reference/PMED?id=12613519
Lalisang 1997 {published data only}|Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer|/resolve/reference/PMED?id=9193328
Levitt 2004 {published data only}|Does anthracycline administration by infusion in children affect late cardiotoxicity?|
Lippens 1987 {published data only}|Tolerance of 24-hour infusions of low-and high-dose bolus injections of adriamycin in children|/resolve/reference/PMED?id=3152926
Luck (study A) 1997 {published data only}|A Phase II study. Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer|/resolve/reference/PMED?id=9144689
Luck (study B) 1997 {published data only}|Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer|/resolve/reference/PMED?id=9374090
Marschner 1994 {published data only}|Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial|/resolve/reference/PMED?id=8153652
Nemoto 1987 {published data only}|Combination chemotherapy for metastatic breast cancer, comparison of multiple drug therapy with 5-flourouracil, cytoxan and prednisone with adriamycin or adrenalectomy|
Nielsen 1998 {published data only}|High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=9862576
O'Bryan 1977 {published data only}|Dose response evaluation of adriamycin in human neoplasia|
Rubin 1980 {published data only}|An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer|/resolve/reference/PMED?id=7360486
Sutton 1989 {published data only}|Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma|/resolve/reference/PMED?id=2915238
Swain 2003 {published data only}|Congestive heart failure in patients treated with doxorubicin, a retrospective analysis of three trials|
Torti 1983 {published data only}|Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule, assessment by endomyocardial biopsy|/resolve/reference/PMED?id=6651020
Umsawasdi 1989 {published data only}|Weekly doxorubicin every 3 weeks in cyclophosphamide, doxorubicin and cisplatin chemotherapy for non-small cell lung cancer|
Valdivieso 1984 {published data only}|Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study|/resolve/reference/PMED?id=6321689
Wood 1994 {published data only}|Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma|/resolve/reference/PMED?id=8080512
Woodward 2003 {published data only}|Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy|
Yates 1982 {published data only}|Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study|/resolve/reference/PMED?id=6953986
Batist 2001|Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer|/resolve/reference/PMED?id=11230490
Billingham 1978|Anthracycline cardiomyopathy monitored by morphologic changes|/resolve/reference/PMED?id=667860
Bonadonna 1969|Cardiac toxicity of daunorubicin|/resolve/reference/PMED?id=4180385
Higgins 2005||
Kremer 2001|Anthracycline induced clinical heart failure in a cohort of 607 children: a long-term follow-up study|/resolve/reference/PMED?id=11134212
Kremer 2002a|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|/resolve/reference/PMED?id=12123328
Kremer 2002b|Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review|/resolve/reference/PMED?id=12056699
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Legha 1982|Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion|/resolve/reference/PMED?id=7059060
Meinardi 2002|Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques|/resolve/reference/PMED?id=12067953
Muggia 1991|New anthracycline antitumor antibiotics|/resolve/reference/PMED?id=1831987
Ng 2006|Anticancer agents and cardiotoxicity|/resolve/reference/PMED?id=16473642
Nousiainen 2002|Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients|/resolve/reference/PMED?id=12087452
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Shan 1996|Anthracycline-induced cardiotoxicity|/resolve/reference/PMED?id=8644988
Silverman 2001|Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01|/resolve/reference/PMED?id=11222362
Simbre 2005|Cardiotoxicity of cancer chemotherapy, implications for children|/resolve/reference/PMED?id=15977964
Wexler 1996|Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin|/resolve/reference/PMED?id=8636745
Budman 1998 {published data only}|Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B|/resolve/reference/PMED?id=9719081
Casper 1991 {published data only}|A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors|
Escherich 2007 {published data only}|Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia|/resolve/reference/PMED?id=17525906
Fountzilas 2008 {published data only}|Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00|/resolve/reference/PMED?id=18042835
Heidenreich 2004 {published and unpublished data}|Prospective randomized phase II trial of pegylated doxorubicin in the management of symptomatic hormone-refractory prostate carcinoma|
Hortobagyi 1989 {published data only}|A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer|/resolve/reference/PMED?id=2643296
Linden 2007 {published data only}|Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313)|/resolve/reference/PMED?id=17308269
Lipshultz 2002 {published data only}|Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 acute lymphoblastic leukemia protocol|/resolve/reference/PMED?id=11896119
Shapira 1990 {published data only}|Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen: a prospective randomized evaluation|
Steinherz 1993 {published data only}|Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse|
Zalupski 1991 {published data only}|Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group Study|/resolve/reference/PMED?id=2067035
Adam 1994 {published data only}|Lower cardiotoxicity of adriamycin during continuous administration to patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone|/resolve/reference/PMED?id=7941437
Alba 2004 {published data only}|Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a spanish breast cancer research group (GEICAM-9903) phase III study|/resolve/reference/PMED?id=15226326
Bastholt 1996 {published data only}|Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group|/resolve/reference/PMED?id=8648369
Berchem 1996 {published data only}|Epirubicin cardiotoxicity: a study comparing low- with high-dose intensity weekly schedules|/resolve/reference/PMED?id=8829311
Berrak 2001 {published data only}|Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous infusion schedules|/resolve/reference/PMED?id=11295089
Blomqvist 1993 {published data only}|Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration|/resolve/reference/PMED?id=8445422
Buzdar 2007 {published data only}|Adjuvant chemotherapy for high-risk operable breast cancer|/resolve/reference/PMED?id=17404366
Carmo-Pereira 1987 {published data only}|A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma|/resolve/reference/PMED?id=3318902
Carrio 1993 {published data only}|Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies|/resolve/reference/PMED?id=8355070
Creutzig 2007 {published data only}|Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML|
Dorup 2004 {published data only}|Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function|/resolve/reference/PMED?id=15367528
Ehrlich 1979 {published data only}|Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report|/resolve/reference/PMED?id=376134
Eksborg 1997 {published data only}|Plasma pharmacokinetics of idarubicin and its 13-dihydro metabolite - a comparison of bolus versus 2 h infusion during a 3 day course|/resolve/reference/PMED?id=9147610
Ewer 1998 {published data only}|Doxorubicin cardiotoxicity in children: comparison of consecutive divided daily dose administration schedule with single dose (rapid) infusion administration|
Gabizon 2008 {published data only}|An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin|/resolve/reference/PMED?id=17549475
Gupta 2003 {published data only}|Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers|
Habeshaw 1991 {published data only}|Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial|/resolve/reference/PMED?id=1988576
Henderson 2003 {published data only}|Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer|/resolve/reference/PMED?id=12637460
Hochster 1985 {published data only}|4'epidoxorubicin (epirubicin): activity in hepatocellular carcinoma|/resolve/reference/PMED?id=2997408
Hoeltgen 1983 {published data only}|Adriamycin and cytoxan in the treatment of inoperable lung cancer|
Hubert 2000 {published data only}|Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer|/resolve/reference/PMED?id=10789595
Hunault-Berger 2001 {published data only}|Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study|/resolve/reference/PMED?id=11417474
Irwin 1980 {published data only}|Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a western cancer study group trial|/resolve/reference/PMED?id=7004635
ISRCTN 83324925 {published and unpublished data}|A randomized comparative trial of infusional ECF versus conventional FEC as adjuvant chemotherapy in patients with poor prognosis breast cancer|
Kilickap 2007 {published data only}|Early and late arrhythmogenic effects of doxorubicin|/resolve/reference/PMED?id=17396729
Kinoshita 2004 {published data only}|A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002|/resolve/reference/PMED?id=15615259
Krupicka 2002 {published data only}|Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the german Hodgkin's lymphoma study group|/resolve/reference/PMED?id=12613519
Lalisang 1997 {published data only}|Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer|/resolve/reference/PMED?id=9193328
Levitt 2004 {published data only}|Does anthracycline administration by infusion in children affect late cardiotoxicity?|
Lippens 1987 {published data only}|Tolerance of 24-hour infusions of low-and high-dose bolus injections of adriamycin in children|/resolve/reference/PMED?id=3152926
Luck (study A) 1997 {published data only}|A Phase II study. Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer|/resolve/reference/PMED?id=9144689
Luck (study B) 1997 {published data only}|Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer|/resolve/reference/PMED?id=9374090
Marschner 1994 {published data only}|Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial|/resolve/reference/PMED?id=8153652
Miller 1999 {published data only (unpublished sought but not used)}|Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hoosier Oncology Group|/resolve/reference/PMED?id=10506597
Nemoto 1987 {published data only}|Combination chemotherapy for metastatic breast cancer, comparison of multiple drug therapy with 5-flourouracil, cytoxan and prednisone with adriamycin or adrenalectomy|
Nielsen 1998 {published and unpublished data}|High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group|/resolve/reference/PMED?id=9862576
O'Bryan 1977 {published data only}|Dose response evaluation of adriamycin in human neoplasia|
Rubin 1980 {published data only}|An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer|/resolve/reference/PMED?id=7360486
Stapleton 2007 {published data only}|Evaluation of longitudinal ventricular function with tissue Doppler echocardiography in children treated with anthracyclines|/resolve/reference/PMED?id=17484989
Sutton 1989 {published data only}|Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma|/resolve/reference/PMED?id=2915238
Swain 2003 {published data only}|Congestive heart failure in patients treated with doxorubicin, a retrospective analysis of three trials|
SWOG S0221 {published data only}|SWOG S0221 - Phase III Trial of Continuous Schedule AC + G Vs. Q 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node Negative Breast Cancer|
Torti 1983 {published data only}|Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule, assessment by endomyocardial biopsy|/resolve/reference/PMED?id=6651020
Umsawasdi 1989 {published data only}|Weekly doxorubicin every 3 weeks in cyclophosphamide, doxorubicin and cisplatin chemotherapy for non-small cell lung cancer|
Valdivieso 1984 {published data only}|Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study|/resolve/reference/PMED?id=6321689
Wood 1994 {published data only}|Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma|/resolve/reference/PMED?id=8080512
Woodward 2003 {published data only}|Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy|
Yates 1982 {published data only}|Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study|/resolve/reference/PMED?id=6953986
Ruiz 2006 {published data only}|Randomized open label phase II study of pegylated liposomal doxorubicine (PLD) four or six-week scheduled in metastatic breast cancer (MBC) patients (p)|
Batist 2001|Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer|/resolve/reference/PMED?id=11230490
Billingham 1978|Anthracycline cardiomyopathy monitored by morphologic changes|/resolve/reference/PMED?id=667860
Bonadonna 1969|Cardiac toxicity of daunorubicin|/resolve/reference/PMED?id=4180385
Fountzilas 2005|Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group|/resolve/reference/PMED?id=16148021
Higgins 2005|Cochrane Handbook for Systematic Reviews on Interventions Version 4.2.5 [updated May 2005]|
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]|
Kremer 2001|Anthracycline induced clinical heart failure in a cohort of 607 children: a long-term follow-up study|/resolve/reference/PMED?id=11134212
Kremer 2002a|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|/resolve/reference/PMED?id=12123328
Kremer 2002b|Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review|/resolve/reference/PMED?id=12056699
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Legha 1982|Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion|/resolve/reference/PMED?id=7059060
Meinardi 2002|Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques|/resolve/reference/PMED?id=12067953
Millikan 2003|Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancer|/resolve/reference/PMED?id=12610188
Muggia 1991|New anthracycline antitumor antibiotics|/resolve/reference/PMED?id=1831987
Ng 2006|Anticancer agents and cardiotoxicity|/resolve/reference/PMED?id=16473642
Nousiainen 2002|Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients|/resolve/reference/PMED?id=12087452
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Shan 1996|Anthracycline-induced cardiotoxicity|/resolve/reference/PMED?id=8644988
Silverman 2001|Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01|/resolve/reference/PMED?id=11222362
Simbre 2005|Cardiotoxicity of cancer chemotherapy, implications for children|/resolve/reference/PMED?id=15977964
Verbel 2002|Quantifying the amount of variation in survival explained by prostate-specific antigen|/resolve/reference/PMED?id=12171886
Wexler 1996|Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin|/resolve/reference/PMED?id=8636745
Van Dalen 2006|Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy|
Kasseroller 1998 {published and unpublished data}|Prophylaxis of erysipelas in secondary lymphedemas with selenium|
Kasseroller 1998 {published and unpublished data}|Sodium selenite as prophylaxis against erysipelas in secondary lymphedema|/resolve/reference/PMED?id=9703790
Mcke 2007 {published and unpublished data}|Relevance of selenium supplementation in postoperative radiotherapy of head-neck-tumours and gynecologic pelvic tumours - A multi-center phase III study|
Mcke 2007 {published and unpublished data}|Some clinical results on selenium in radiation oncology. Letter by O Micke, R Mcke, F Bruns, K Kisters, J Bntzel on W. Drr: Effects of selenium on radiation responses of tumor cells and tissue|/resolve/reference/PMED?id=17520190
Mcke 2007 {published and unpublished data}|Adjuvant treatment with sodium selenite in gynecologic radiation oncology - first results of a phase III study|
Mcke 2007 {published and unpublished data}|Sodium selenite in gynecologic radiation oncology - first results of a phase III study|
Mcke 2007 {published and unpublished data}|Observation plan for the post-marketing surveillance stud: Use of selenase as complementary therapy to postoperative adjuvant radiotherapy of cervical and endometrial carcinoma. Version 1.4|
Mcke 2007 {published and unpublished data}|Use of selenase as supplementary therapy in postoperative adjuvant radiotherapy for cervical and endometrial carcinoma|
Mcke 2007 {published and unpublished data}|V 6 Sodium selenite in gynecologic radiation oncology - results of a prospective randomized observation study|
Mcke 2007 {published and unpublished data}|Sodium selenite in gynecologic radiation oncology: Results of a prospective randomized observation study|
Mcke 2007 {published and unpublished data}|Impact of Selenium in Radiation Oncology|
Mcke 2007 {published and unpublished data}|The impact of sodium selenite in gynecologic radiation oncology - final results of a prospective randomized observation study|
Zimmermann 2005 {published and unpublished data}|Impact of sodium selenite on the postoperative chronic lymphoedema and inflammatory cytokines in patients with stage T3 and T4 carcinomas of the base of the mouth and tongue|
Zimmermann 2005 {published and unpublished data}|Reduction of postoperative lymphedema after oral tumor surgery with sodium selenite|/resolve/reference/PMED?id=16141467
Asfour 2006 {published data only}|Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients|/resolve/reference/PMED?id=16679545
Badger 2004 {published data only}|Antibiotics/anti-inflammatories for reducing acute inflammatory episodes in lymphoedema of the limbs|
Bntzel 1999 {published data only}|Experiences with sodium selenite in treatment of acute and late adverse effects of radiochemotherapy of head-neck carcinomas. Cytoprotection working group in AK supportive measures in oncology within the scope of MASCC and DKG|/resolve/reference/PMED?id=10554530
Elango 2006 {published data only}|Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation|/resolve/reference/PMED?id=16831410
Fakih 2006 {published data only}|A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors|/resolve/reference/PMED?id=16489079
Federico 2001 {published data only}|Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract|/resolve/reference/PMED?id=11360134
Fraunholz 2001 {published data only}|Influence of selenium on acute mucositis in radiochemotherapy of head and neck tumors|
Hoenjet 2005 {published data only}|Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study|/resolve/reference/PMED?id=15774238
Hu 1997 {published data only}|Clinical study on the effect of kappa-selenocarrageenan in reducing the nephrotoxicity of cis-platin|
Hu 1997 {published data only}|The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients|/resolve/reference/PMED?id=9197929
Kasseroller 1995 {published data only}|Sodium selenite in the therapy of chronic lymphedema|
Kiremidjian 2000 {published data only}|Effect of selenium on the immunocompetence of patients with head and neck cancer and on adoptive immunotherapy of early and established lesions|
Kiremidjian 2000 {published data only}|Selenium and immunocompetence in patients with head and neck cancer|/resolve/reference/PMED?id=11049203
Kreienberg 2003 {published data only}|Prospective, randomised, 4-armed, controlled, open, multi-center phase-II-study: influence of selenium on the adverse effect profile of adjuvant chemotherapy in patients with mammacarcinoma|
Lasch 1999 {published data only}|Selenium therapy in colorectal tumors?|/resolve/reference/PMED?id=10554542
Lasch 1999 {published data only}|Selenium therapy for colorectal carcinoma|
Schumacher 2003 {published data only}|Influence of selenium on the adverse effect profile of adjuvant chemotherapy in patients with mammacarcinoma. Prospective, controlled, open, multi-center clinical study phase II|
Schumacher 2003 {published data only}|Study plan - Influence of selenium on the adverse effect profile of adjuvant chemotherapy in patients with mammacarcinoma. Prospective, randomised, 4-armed, controlled, open, multi-center clinical study phase II|
Sieja 2000 {published data only}|Protective role of selenium against the toxicity of multi-drug chemotherapy in patients with ovarian cancer|/resolve/reference/PMED?id=11189880
Sundstrm 1984 {published data only}|Serum selenium and glutathione peroxidase, and plasma lipid peroxides in uterine, ovarian or vulvar cancer, and their responses to antioxidants in patients with ovarian cancer|/resolve/reference/PMED?id=6498792
Sundstrm 1989 {published data only}|Supplementation with selenium, vitamin E and their combination in gynaecological cancer during cytotoxic chemotherapy|/resolve/reference/PMED?id=2912578
Wagler 2000 {published data only}|Poster: first results of selenium supplementation in patients with gastrointestinal tumours|
Xu 1990 {published data only}|Study of the oxidative metabolic function and chemotaxis of neutrophils from patients with cancer influenced by selenium yeast|/resolve/reference/PMED?id=1698418
Xu 1999 {published data only}|Randomized double-blind placebo-controlled phase II clinical trial of kappa-selenocarrageenan in cancer chemotherapy patients|
Yu 1996 {published data only}|[The relationship between selenium and immunity in large bowel cancer]|/resolve/reference/PMED?id=9275690
Bntzel 2004 {published data only}|Use of selenase as complementary treatment to radiotherapy for tumours of the head and neck region|
Bntzel 2004 {published data only}|Observation plan of a post-marketing surveillance study. Use of selenase as complementary treatment to radiotherapy of tumours of the head and neck region (version 1.4)|
Bntzel 2004 {published data only}|Importance of selenium supplementation in postoperative radiotherapy of head-neck-tumours and gynecological tumours of the pelvis - A multi-centre phase III study|
Arnold 2001|Use of micronutrients for tumour diseases and tumour prevention|
Baehr 1999|Selenium supplementation by selenium yeast and sodium selenite: Analysis of the selenium status as well as risks of deficiency and intoxication|
Baldew 1989|Selenium-induced protection against cis-diamminedichloroplatinum (II) nephrotoxicity in mice and rats|/resolve/reference/PMED?id=2720662
Beuth 2002|Evidence-based complementary therapy measures for prostate carcinoma|
Beuth 2007|Evidence-based complementary oncology. Innovative approaches to optimize standard therapy strategies|/resolve/reference/PMED?id=17436598
Boucher 1995|Oral selenium supplementation in rats reduces cardiac toxicity of adriamycin during ischemia and reperfusion|/resolve/reference/PMED?id=8748259
Bruns 2003|Current status of selenium and other treatments for secondary lymphedema|/resolve/reference/PMED?id=15352655
Cheetham 2001|Attitudes and use of alternative therapies in UK prostate cancer patients - isnt it time we we were in the know?|/resolve/reference/PMED?id=12497025
DCTD 2004|Cancer therapy evaluation program: Common terminology criteria for adverse effects|
Dennert 2005|Selenium for preventing cancer|
Dietz 1998|The chronic larynx oedema as delayed reaction after radiochemotherapy|/resolve/reference/PMED?id=9773329
Erickson 2001|Arm edema in breast cancer patients|/resolve/reference/PMED?id=11208879
Francescato 2001|Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats|/resolve/reference/PMED?id=11207069
Greim 1999|Selenium and its anorganic compounds|
Greim 2003|Selenium and its inorganic compounds|
Groetz 2003|The oral cavity of patients with head-neck-radiotherapy - III. Postradiotherapeutic care|
Hatfield 2001||
Helzlsouer 1985|Acute selenium intoxication in the United States|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: Is blinding necessary?|/resolve/reference/PMED?id=8721797
Jensen 1984|Selenium intoxication|
Juni 2001|Assessing the methodological quality of randomised controlled trials|
Kasseroller 2000|Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite: a review|/resolve/reference/PMED?id=11486162
Kotamraju 2000|Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen: role of reactive oxygen and nitrogen species|/resolve/reference/PMED?id=10899161
Micke 2003|Selenium in the treatment of radiation-associated secondary lymphedema|/resolve/reference/PMED?id=12694822
Miller 1981|Reporting results of cancer treatment|
Nam 1999|Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiologic analysis|/resolve/reference/PMED?id=10210387
Ohkawa 1988|The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity|/resolve/reference/PMED?id=2458747
Oken 1982|Toxicity and response criteria of the eastern cooperative oncology group|/resolve/reference/PMED?id=7165009
Petru 2001|Complementary measures with gynecological cancer patients during chemo- and radiotherapy - review and critical consideration of practical issues|
Pfeffer 2002|Severe incident with selenium medication|
Rodemann 1999|Relevance of the radioprotective effect of sodium selenite|/resolve/reference/PMED?id=10554527
Sagowski 2004|Sodium selenite reduces acute radiogenic damage of the rat parotid glands during fractionated irradiation|/resolve/reference/PMED?id=15597168
Schleicher 1999|Radioprotection of human endothelial cells by sodium selenite|/resolve/reference/PMED?id=10554526
See 2006|Accidental death from acute selenium poisoning|/resolve/reference/PMED?id=17014408
Sehouli 2000|Unconventional methods in cancer medicine - postoperative use by patients with gynecologic malignomas|
Sill-Steffens 2003|Selenium in oncology|
Trotti 2003|Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review|/resolve/reference/PMED?id=12742264
Verhagen 1998|The Delphi List: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by delphi consensus|/resolve/reference/PMED?id=10086815
Vinceti 2001|Adverse health effects of selenium in humans|
Weijl 1997|Free radicals and antioxidants in chemotherapy-induced toxicity|/resolve/reference/PMED?id=9377594
Yoshida 2000|Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats|/resolve/reference/PMED?id=11038013
Zimmermann 1997|Selenium administration in patients with sepsis syndrome. A prospective randomized study|/resolve/reference/PMED?id=9417494
Dennert 2006|Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients|
AFFIRM Substudy 2003 {published data only}|Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug|/resolve/reference/PMED?id=12849654
AFIB 1997 {published data only}|Treatment of atrial fibrillation and paroxysmal supraventricular tachycardia with bidisomide|/resolve/reference/PMED?id=9355903
Aliot 1996 {published data only}|Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter|/resolve/reference/PMED?id=8607394
ASAP 2003 {published data only}|Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation|/resolve/reference/PMED?id=11703992
ASAP 2003 {published data only}|Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials|/resolve/reference/PMED?id=12947368
ASAP 2003 {published data only}|Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response|/resolve/reference/PMED?id=11923801
ASAP 2003 {published data only}|Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide|/resolve/reference/PMED?id=12615792
ASAP 2003 {published data only}|Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators|/resolve/reference/PMED?id=10987602
Bellandi 2001 {published data only}|Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation: Long-term safety and efficacy study|
Bellandi 2001 {published data only}|Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation - Long-term safety and efficacy study|
Bellandi 2001 {published data only}|Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study|/resolve/reference/PMED?id=8707022
Bellandi 2001 {published data only}|Comparing agents for prevention of atrial fibrillation recurrence|
Bellandi 2001 {published data only}|Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=11564387
Benditt 1999 {published data only}|Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group|/resolve/reference/PMED?id=10496434
Byrne-Quinn 1970 {published data only}|Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate|/resolve/reference/PMED?id=4911757
Carunchio 1995 {published data only}|A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation|/resolve/reference/PMED?id=7642012
Channer 2004 {published and unpublished data}|A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation|/resolve/reference/PMED?id=14720531
DAFNE 2003 {published data only}|Dronedarone for prevention of atrial fibrillation: a dose-ranging study|/resolve/reference/PMED?id=12919771
DIAMOND 2001 {published data only}|Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group|
DIAMOND 2001 {published data only}|Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy|/resolve/reference/PMED?id=11457747
DIAMOND 2001 {published data only}|Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group|/resolve/reference/PMED?id=10486417
DIAMOND 2001 {published data only}|Dofetilide to patients with heart failure and left ventricular dysfunction|
Dogan 2004 {published data only}|Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study|/resolve/reference/PMED?id=15255456
EURIDIS ADONIS 2004 {unpublished data only}|Dronedarone on Trial: EURIDIS and ADONIS|
EURIDIS ADONIS 2004 {unpublished data only}|EURIDIS and ADONIS: maintenance of sinus rhythm with dronedarone in patients with atrial fibrillation or flutter|
FAPIS 1996 {published data only}|Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group|/resolve/reference/PMED?id=8682031
FAPIS 1996 {published data only}|Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators|/resolve/reference/PMED?id=8607393
GEFACA 2001 {published data only}|Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial|/resolve/reference/PMED?id=11907636
Hillestad 1971 {published data only}|Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study|/resolve/reference/PMED?id=4934041
Hohnloser 1995 {published data only}|Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine|/resolve/reference/PMED?id=7560608
Juul-Moller 1990 {published data only}|Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation|/resolve/reference/PMED?id=2242519
Kalusche 1994 {published data only}|Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation - conversion and 12-month follow-up - a randomized comparison|/resolve/reference/PMED?id=7846939
Karlson 1998 {published data only}|Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study|/resolve/reference/PMED?id=3289932
Karlson 1998 {published data only}|Preventive disopyramide after electroconversion of atrial fibrillation--a good alternative|/resolve/reference/PMED?id=2056838
Kochiadakis 2000 {published data only}|Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study|/resolve/reference/PMED?id=10956284
Kochiadakis 2000 {published data only}|Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=9576159
Kochiadakis 2000 {published data only}|Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?|
Kochiadakis 2004a {published data only}|Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses|/resolve/reference/PMED?id=14769712
Kochiadakis 2004b {published data only}|Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=15589019
Kuhlkamp 2000 {published data only}|Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=10898425
Lloyd 1984 {published data only}|The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo|/resolve/reference/PMED?id=6367096
Naccarelli 1996 {published data only}|Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter|/resolve/reference/PMED?id=8607392
Okishige 2000 {published data only}|Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: A placebo-controlled, multicenter study|
PAFAC 2004 {published data only}|Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial|/resolve/reference/PMED?id=15302102
PAFAC 2004 {published data only}|Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study|/resolve/reference/PMED?id=10355070
Plewan 2001 {published data only}|Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol|/resolve/reference/PMED?id=11482924
PRODIS 1996 {published data only}|Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study|/resolve/reference/PMED?id=8842506
RAFT 2003 {published data only}|Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation|/resolve/reference/PMED?id=14556870
Reimold 1993 {published data only}|Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=8438741
Richiardi 1992 {published data only}|Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation|/resolve/reference/PMED?id=1600529
SAFE-T 2005 {published data only}|Amiodarone versus sotalol for atrial fibrillation|/resolve/reference/PMED?id=15872201
SAFE-T 2005 {published data only}|Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])|/resolve/reference/PMED?id=12914883
SAFIRE-D 2000 {published data only}|Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study|/resolve/reference/PMED?id=11067793
Singh 1991 {published data only}|Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group|/resolve/reference/PMED?id=1951086
SMART 2002 {published data only}|Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation|/resolve/reference/PMED?id=12074271
SOCESP 1999 {published data only}|Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation. SOCESP Investigators|/resolve/reference/PMED?id=10569659
SOCESP 1999 {published data only}|Analysis of atrial fibrillation recurrence during therapy with sotalol or quinidine. Researchers of +SOCESP|/resolve/reference/PMED?id=9629687
Sodermark 1975 {published data only}|Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm|/resolve/reference/PMED?id=1093559
SOPAT 2004 {published data only}|Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT study. Executive committee of the investigators representing trial physicians|/resolve/reference/PMED?id=10355069
SOPAT 2004 {published data only}|Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial|/resolve/reference/PMED?id=15321697
Steinbeck 1988 {published data only}|Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?|/resolve/reference/PMED?id=3143539
Stroobandt 1997 {published data only}|Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators|/resolve/reference/PMED?id=9052343
Van Gelder 1989 {published data only}|Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter|/resolve/reference/PMED?id=2511744
Van Gelder 1989 {published data only}|Efficacy of flecainide to maintain sinus rhythm after cardioversion of chronic atrial fibrillation and flutter. Abstracts from the 61st scientific sessions. American Heart Association. Washington, DC, November 1988|
Villani 1992 {published data only}|A comparison between amiodarone and disopyramide in a delayed-release formulation in the prevention of recurrences of symptomatic atrial fibrillation|/resolve/reference/PMED?id=1559321
Vitolo 1981 {published data only}|Amiodarone versus quinidine in the prophylaxis of atrial fibrillation|/resolve/reference/PMED?id=7039195
Aberg 1968 {published data only}|Procaine amide as a prophylactic drug against atrial fibrillation. A controlled study|/resolve/reference/PMED?id=5808590
Aberg 1968 {published data only}|Procaine amide quinidine as prophylactic drugs against relapse of atrial fibrillation|/resolve/reference/PMED?id=4880307
AF-CHF 2002 {published data only}|Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial|/resolve/reference/PMED?id=12360154
AFFIRM 2002 {published data only}|A comparison of rate control and rhythm control in patients with atrial fibrillation|/resolve/reference/PMED?id=12466506
Anderson 1994 {published data only}|Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators|/resolve/reference/PMED?id=1509993
Anderson 1994 {published data only}|Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=2513143
Anderson 1994 {published data only}|Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=8074041
Antman 1990 {published data only}|Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs|/resolve/reference/PMED?id=2303641
Antman 1990 {published data only}|Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter|/resolve/reference/PMED?id=3417972
Aros 1978 {published data only}|Maintaining sinus rhythm with quinidine and amiodarone after electric cardioversion|/resolve/reference/PMED?id=663366
Babuty 1999 {published data only}|Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study|
Babuty 1999 {published data only}|Double-blind comparison of cibenzoline versus flecainide in the prevention of recurrence of atrial tachyarrhythmias in 139 patients|
Babuty 1999 {published data only}|Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias|/resolve/reference/PMED?id=9137677
Beck 1978 {published data only}|Propafenone and lidoflazine in chronic atrial fibrillation and flutter (author's transl)|/resolve/reference/PMED?id=668524
Berns 1987 {published data only}|Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation|/resolve/reference/PMED?id=3109229
Blevins 1987 {published data only}|Amiodarone in the management of refractory atrial fibrillation|/resolve/reference/PMED?id=3307669
Blomstrom 1984 {published data only}|Amiodarone in atrial fibrillation|
Boissel 1981 {published data only}|Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation|/resolve/reference/PMED?id=7274266
Brodsky 1987 {published data only}|Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium|/resolve/reference/PMED?id=3630939
CHF-STAF 1998 {published data only}|Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT)|/resolve/reference/PMED?id=9843465
Chun 1995 {published data only}|Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter|/resolve/reference/PMED?id=7793402
Clementy 1992 {published data only}|Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients|/resolve/reference/PMED?id=1509998
Connolly 1989 {published data only}|Usefulness of propafenone for recurrent paroxysmal atrial fibrillation|/resolve/reference/PMED?id=2648787
CTAF 2000 {published data only}|Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation|/resolve/reference/PMED?id=12075253
CTAF 2000 {published data only}|Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial|/resolve/reference/PMED?id=12093058
CTAF 2000 {published data only}|Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators|/resolve/reference/PMED?id=10738049
CTAF 2000 {published data only}|Pilot study and protocol of the Canadian Trial of Atrial Fibrillation (CTAF)|/resolve/reference/PMED?id=9285659
Cuan-Perez 1971 {published data only}|Comparative study of quinidine, propranolol and diphenylhydantoin for preventing recurrence in post-cardioversion auricular fibrillation|/resolve/reference/PMED?id=5566599
ERAFT 2002 {published data only}|Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation. The European Rythmol/Rytmonorm Atrial Fibrillation Trial (ERAFT) Study|/resolve/reference/PMED?id=12480038
Faivre 1970 {published data only}|Disopyramide in the preparation for electric shock in atrial fibrillation and in the maintenance of subsequent sinus rhythm|/resolve/reference/PMED?id=5454439
Fernandez 1998 {published data only}|Comparative study of propafenone, amiodarone and flecainide in the treatment of paroxystic atrial fibrillation|
Frances 1985 {published data only}|Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports|/resolve/reference/PMED?id=3938266
Gold 1986 {published data only}|Amiodarone for refractory atrial fibrillation|/resolve/reference/PMED?id=3942054
Gosselink 1992 {published data only}|Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter|/resolve/reference/PMED?id=1597910
Graboys 1983 {published data only}|Efficacy of amiodarone for refractory supraventricular tachyarrhythmias|/resolve/reference/PMED?id=6613832
GUSTO 2002 {published data only}|Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries|/resolve/reference/PMED?id=12231591
Hammill 1988 {published data only}|Propafenone for paroxysmal atrial fibrillation|/resolve/reference/PMED?id=3341233
Hartel 1970 {published data only}|Investigations on the value of quinidine therapy after electrical rhythmization of atrial fibrillation|
Hartel 1970 {published data only}|The value of quinidine therapy in order to maintain sinus rhythm after electrical rhythmization of atrial fibrillation|
Hartel 1970 {published data only}|Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation|/resolve/reference/PMED?id=5417847
Hartel 1974 {published data only}|Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion|/resolve/reference/PMED?id=4601741
Hopson 1996 {published data only}|Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=8607395
Horowitz 1985 {published data only}|Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy|/resolve/reference/PMED?id=4067122
HOT-CAFE 2003 {published data only}|Should sinus rhythm be restored in patients with chronic atrial fibrillation? Preliminary results from the Polish "Hot Cafe" study|/resolve/reference/PMED?id=10740421
HOT-CAFE 2003 {published data only}|Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study|/resolve/reference/PMED?id=14560344
HOT-CAFE 2003 {published data only}|Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study|/resolve/reference/PMED?id=15302734
Kanoupakis 2004 {published data only}|Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation|/resolve/reference/PMED?id=15342304
Kennelly 1977 {published data only}|Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias|/resolve/reference/PMED?id=324502
Kerr 1988 {published data only}|Propafenone for prevention of recurrent atrial fibrillation|/resolve/reference/PMED?id=3354467
Kosior 2001 {published data only}|Sequential prophylactic antiarrhythmic therapy for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation - One year follow-up|
Kosior 2001 {published data only}|Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation|/resolve/reference/PMED?id=11208496
Kosior 2001 {published data only}|Role of amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation|/resolve/reference/PMED?id=12687927
Kyles 1991 {published data only}|Long term efficacy of propafenone for prevention of atrial fibrillation|/resolve/reference/PMED?id=1756420
Lardoux 1996 {published data only}|Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study|/resolve/reference/PMED?id=8952741
Lau 1992 {published data only}|A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation|/resolve/reference/PMED?id=1514492
Levi 1973 {published data only}|Double-blind evaluation of practolol and quinidine in the treatment of chronic atrial fibrillation|/resolve/reference/PMED?id=4608474
Levi 1973 {published data only}|Treatment of chronic artrial fibrillation with practolol-quinidine|/resolve/reference/PMED?id=4589190
Li 2004 {published data only}|Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy|/resolve/reference/PMED?id=14697464
Manios 2003 {published data only}|Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study|/resolve/reference/PMED?id=12843685
Martin 1986 {published data only}|Comparison of amiodarone and disopyramide in the control of paroxysmal atrial fibrillation and atrial flutter|/resolve/reference/PMED?id=3089263
Mary-Rabine 1990 {published data only}|Clinical efficacy of flecainide acetate in atrial fibrillation|/resolve/reference/PMED?id=2127378
Massacci 1991 {published data only}|Flecainide versus amiodarone in preventing paroxysmal idiopathic atrial fibrillation|
Mizutani 1995 {published data only}|Pilsicainide in the acute conversion and the prevention of paroxysmal atrial fibrillation|
Nedostup 1990 {published data only}|A comparison of the efficacy of quinidine and kordaron as agents to stabilize the recovered sinus rhythm in patients with the permanent form of atrial fibrillation|/resolve/reference/PMED?id=2281406
Opolski 1997 {published data only}|Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion|
PEPS 2002 {published data only}|Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study|/resolve/reference/PMED?id=12138815
PIAF 2000 {published data only}|Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study|/resolve/reference/PMED?id=12909072
PIAF 2000 {published data only}|Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial|/resolve/reference/PMED?id=11117910
Pietersen 1991 {published data only}|Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group|/resolve/reference/PMED?id=1900978
Piot 1998 {published data only}|A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia|/resolve/reference/PMED?id=9891831
Porterfield 1989 {published data only}|Therapeutic efficacy and safety of oral propafenone for atrial fibrillation|/resolve/reference/PMED?id=2909141
PSVT 1995 {published data only}|A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group|/resolve/reference/PMED?id=7586356
RACE 2002 {published data only}|A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation|/resolve/reference/PMED?id=12466507
Rasmussen 1981 {published data only}|Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrial fibrillation. A controlled clinical trial|/resolve/reference/PMED?id=7015799
Resnekov 1971 {published data only}|Sustained-release quinidine (Kinidin Durules) in maintaining sinus rhythm after electroversion of atrial dysrhythmias|/resolve/reference/PMED?id=5572656
STAF 2003 {published data only}|Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study|/resolve/reference/PMED?id=12767648
Steeds 1999 {published data only}|An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation|/resolve/reference/PMED?id=10409530
Tonet 1986 {published data only}|Comparison between the efficacy of amiodarone and quinidine in the treatment of atrial cardiac arrhythmias|/resolve/reference/PMED?id=3089261
Touboul 1995 {published data only}|Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study|/resolve/reference/PMED?id=8745663
Van Wijk 1989 {published data only}|Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation|/resolve/reference/PMED?id=2468933
VEPARAF 2003 {published data only}|VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study)|
Wanless 1997 {published data only}|Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias|/resolve/reference/PMED?id=9124166
Zehender 1992 {published data only}|Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up|/resolve/reference/PMED?id=1552095
Zehender 1992 {published data only}|Amiodarone and verapamil/chinidin in the treatment of patients with chronic atrial fibrillation|/resolve/reference/PMED?id=7846938
EMERALD {published data only}|Dofetilide: a review of its use in atrial fibrillation and atrial flutter|/resolve/reference/PMED?id=10651390
A-COMET {published data only}|A-START and A-COMET trials [abstract] Cardiostim 2002, XIIIth International Congress in Cardiac Electrophysiology. Nice, France, June 2002|
ACC/AHA/ESC 2006|ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society|/resolve/reference/PMED?id=16908781
Alboni 2004|Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach|/resolve/reference/PMED?id=15575054
Benjamin 1998|Impact of atrial fibrillation on the risk of death: the Framingham Heart Study|/resolve/reference/PMED?id=9737513
CAST 1991|Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial|/resolve/reference/PMED?id=1900101
Connolly 2000|Appropriate outcome measures in trials evaluating treatment of atrial fibrillation|/resolve/reference/PMED?id=10783204
Coplen 1990|Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials|/resolve/reference/PMED?id=2144796
Cordina 2005|Pharmacological cardioversion for atrial fibrillation and flutter|/resolve/reference/PMED?id=15846675
Denus 2005|Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis|
Flaker 1995|Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation|/resolve/reference/PMED?id=7639159
Frick 2001|Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation|
Friedman 1998|Proarrhythmia|/resolve/reference/PMED?id=9809901
Gelder 1996|Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation|/resolve/reference/PMED?id=8951302
Geleris 2001|Spontaneous conversion to sinus rhythm of recent (within 24 hours) atrial fibrillation|/resolve/reference/PMED?id=11255692
Go 2001|Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study|/resolve/reference/PMED?id=11343485
Golzari 1996|Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy|/resolve/reference/PMED?id=8678396
Harris 1983|Side effects of long-term amiodarone therapy|/resolve/reference/PMED?id=6291807
Higgins 2005|Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE|
Krahn 1995|The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study|/resolve/reference/PMED?id=7733127
Miller 2000|Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials|/resolve/reference/PMED?id=11093570
MMWR 2003|Atrial fibrillation as a contributing cause of death and Medicare hospitalization -- United States, 1999|
NICE 2006|NICE clinical guideline 36. Atrial fibrillation: the management of atrial fibrillation|
Nichol 2002|Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation|/resolve/reference/PMED?id=12010934
Oral 2006|Circumferential pulmonary-vein ablation for chronic atrial fibrillation|/resolve/reference/PMED?id=16510747
QUOROM 1999|Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement|/resolve/reference/PMED?id=10584742
Ruigomez 2002|Incidence of chronic atrial fibrillation in general practice and its treatment pattern|/resolve/reference/PMED?id=11927203
SPAF 1992|Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators|/resolve/reference/PMED?id=1512329
Stewart 2002|A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study|/resolve/reference/PMED?id=12401529
Testa 2005|Rate-control vs rhythm-control in patients with atrial fibrillation: a meta-analysis|/resolve/reference/PMED?id=15872032
Vaughan Williams|A classification of antiarrhytymic actions reassessed after a decade of new drugs|
Wattigney 2003|Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention|/resolve/reference/PMED?id=12885749
Wazni 2005|Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial|/resolve/reference/PMED?id=15928285
Lafuente-Lafuente|Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomised controlled trials|/resolve/reference/PMED?id=16606807
A-COMET-I 2006 {published data only}|Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm|/resolve/reference/PMED?id=16644334
A-COMET-II 2006 {published data only}|Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial|/resolve/reference/PMED?id=16935870
AFFIRM Substudy 2003 {published data only}|Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug|/resolve/reference/PMED?id=12849654
AFIB 1997 {published data only}|Treatment of atrial fibrillation and paroxysmal supraventricular tachycardia with bidisomide|/resolve/reference/PMED?id=9355903
Aliot 1996 {published data only}|Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter|/resolve/reference/PMED?id=8607394
ASAP 2003 {published data only}|Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation|/resolve/reference/PMED?id=11703992
ASAP 2003 {published data only}|Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials|/resolve/reference/PMED?id=12947368
ASAP 2003 {published data only}|Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response|/resolve/reference/PMED?id=11923801
ASAP 2003 {published data only}|Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide|/resolve/reference/PMED?id=12615792
ASAP 2003 {published data only}|Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators|/resolve/reference/PMED?id=10987602
A-STAR 2006 {published data only}|Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease|/resolve/reference/PMED?id=16828595
ATHENA 2009 {published and unpublished data}|Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death in patients with atrial fibrillation/atrial flutter|/resolve/reference/PMED?id=19752319
ATHENA 2009 {published and unpublished data}|Effect of dronedarone on cardiovascular events in atrial fibrillation|/resolve/reference/PMED?id=19213680
Bellandi 2001 {published data only}|Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation: Long-term safety and efficacy study|
Bellandi 2001 {published data only}|Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation - Long-term safety and efficacy study|
Bellandi 2001 {published data only}|Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study|/resolve/reference/PMED?id=8707022
Bellandi 2001 {published data only}|Comparing agents for prevention of atrial fibrillation recurrence|
Bellandi 2001 {published data only}|Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=11564387
Benditt 1999 {published data only}|Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group|/resolve/reference/PMED?id=10496434
Byrne-Quinn 1970 {published data only}|Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate|/resolve/reference/PMED?id=4911757
Carunchio 1995 {published data only}|A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation|/resolve/reference/PMED?id=7642012
Channer 2004 {published and unpublished data}|A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation|/resolve/reference/PMED?id=14720531
DAFNE 2003 {published data only}|Dronedarone for prevention of atrial fibrillation: a dose-ranging study|/resolve/reference/PMED?id=12919771
DAPHNE 2008 {published data only}|The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker|/resolve/reference/PMED?id=18657671
DIAMOND 2001 {published data only}|Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group|
DIAMOND 2001 {published data only}|Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy|/resolve/reference/PMED?id=11457747
DIAMOND 2001 {published data only}|Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group|/resolve/reference/PMED?id=10486417
DIAMOND 2001 {published data only}|Dofetilide to patients with heart failure and left ventricular dysfunction|
Dogan 2004 {published data only}|Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study|/resolve/reference/PMED?id=15255456
DYONISOS 2010 {published data only (unpublished sought but not used)}|A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study|
EMERALD 2000 {published and unpublished data}|Mortality in patients with atrial fibrillation - 1 year follow up of EMERALD (European and Austrlian multicenter evaluative research on atrial fibrillation dofetilide)|
EMERALD 2000 {published and unpublished data}|Maintenance of sinus rhythm by dofetilide improves quality of life. The EMERALD (European and Australian multicenter evaluative research on atrial fibrillation dofetilide) study|
EMERALD 2000 {published and unpublished data}|Conversion of atrial fibrillation and maintenace of sinus rhythm by dofetilide. The EMERALD (European and Austrlian multicenter evaluative research on atrial fibrillation dofetilide) study|
EMERALD 2000 {published and unpublished data}|Drug Approval Package: Tikosyn (Dofetilide). Medical Review: Parts 1 and 2 (Study number 345)|
EURIDIS ADONIS 2007 {published and unpublished data}|Dronedarone on Trial: EURIDIS and ADONIS|
EURIDIS ADONIS 2007 {published and unpublished data}|Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter|/resolve/reference/PMED?id=17804843
EURIDIS ADONIS 2007 {published and unpublished data}|EURIDIS and ADONIS: maintenance of sinus rhythm with dronedarone in patients with atrial fibrillation or flutter|
FAPIS 1996 {published data only}|Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group|/resolve/reference/PMED?id=8682031
FAPIS 1996 {published data only}|Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators|/resolve/reference/PMED?id=8607393
GEFACA 2001 {published data only}|Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial|/resolve/reference/PMED?id=11907636
Hillestad 1971 {published data only}|Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study|/resolve/reference/PMED?id=4934041
Hohnloser 1995 {published data only}|Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine|/resolve/reference/PMED?id=7560608
Juul-Moller 1990 {published data only}|Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation|/resolve/reference/PMED?id=2242519
Kalusche 1994 {published data only}|Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation - conversion and 12-month follow-up - a randomized comparison|/resolve/reference/PMED?id=7846939
Karlson 1998 {published data only}|Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study|/resolve/reference/PMED?id=3289932
Karlson 1998 {published data only}|Preventive disopyramide after electroconversion of atrial fibrillation--a good alternative|/resolve/reference/PMED?id=2056838
Kochiadakis 2000 {published data only}|Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study|/resolve/reference/PMED?id=10956284
Kochiadakis 2000 {published data only}|Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=9576159
Kochiadakis 2000 {published data only}|Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?|
Kochiadakis 2004a {published data only}|Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses|/resolve/reference/PMED?id=14769712
Kochiadakis 2004b {published data only}|Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=15589019
Kuhlkamp 2000 {published data only}|Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=10898425
Lloyd 1984 {published data only}|The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo|/resolve/reference/PMED?id=6367096
Naccarelli 1996 {published data only}|Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter|/resolve/reference/PMED?id=8607392
Nergardh 2007 {published data only}|Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study|/resolve/reference/PMED?id=17329409
Niu 2006 {published data only}|Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study|/resolve/reference/PMED?id=16620720
Okishige 2000 {published data only}|Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: A placebo-controlled, multicenter study|/resolve/reference/PMED?id=10966544
PAFAC 2004 {published data only}|Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial|/resolve/reference/PMED?id=15302102
PAFAC 2004 {published data only}|Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study|/resolve/reference/PMED?id=10355070
PITAGORA 2008 {published data only}|A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the PITAGORA trial|
Plewan 2001 {published data only}|Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol|/resolve/reference/PMED?id=11482924
PRODIS 1996 {published data only}|Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study|/resolve/reference/PMED?id=8842506
RAFT 2003 {published data only}|Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation|/resolve/reference/PMED?id=14556870
Reimold 1993 {published data only}|Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=8438741
Richiardi 1992 {published data only}|Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation|/resolve/reference/PMED?id=1600529
SAFE-T 2005 {published data only}|Amiodarone versus sotalol for atrial fibrillation|/resolve/reference/PMED?id=15872201
SAFE-T 2005 {published data only}|Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])|/resolve/reference/PMED?id=12914883
SAFIRE-D 2000 {published data only}|Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study|/resolve/reference/PMED?id=11067793
Singh 1991 {published data only}|Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group|/resolve/reference/PMED?id=1951086
SMART 2002 {published data only}|Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation|/resolve/reference/PMED?id=12074271
SOCESP 1999 {published data only}|Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation. SOCESP Investigators|/resolve/reference/PMED?id=10569659
SOCESP 1999 {published data only}|Analysis of atrial fibrillation recurrence during therapy with sotalol or quinidine. Researchers of +SOCESP|/resolve/reference/PMED?id=9629687
Sodermark 1975 {published data only}|Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm|/resolve/reference/PMED?id=1093559
SOPAT 2004 {published data only}|Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT study. Executive committee of the investigators representing trial physicians|/resolve/reference/PMED?id=10355069
SOPAT 2004 {published data only}|Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial|/resolve/reference/PMED?id=15321697
Steinbeck 1988 {published data only}|Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?|/resolve/reference/PMED?id=3143539
Stroobandt 1997 {published data only}|Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators|/resolve/reference/PMED?id=9052343
SVA-4 2008 {published data only}|Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias|
Van Gelder 1989 {published data only}|Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter|/resolve/reference/PMED?id=2511744
Van Gelder 1989 {published data only}|Efficacy of flecainide to maintain sinus rhythm after cardioversion of chronic atrial fibrillation and flutter. Abstracts from the 61st scientific sessions. American Heart Association. Washington, DC, November 1988|
Villani 1992 {published data only}|A comparison between amiodarone and disopyramide in a delayed-release formulation in the prevention of recurrences of symptomatic atrial fibrillation|/resolve/reference/PMED?id=1559321
Vitolo 1981 {published data only}|Amiodarone versus quinidine in the prophylaxis of atrial fibrillation|/resolve/reference/PMED?id=7039195
Aberg 1968 {published data only}|Procaine amide as a prophylactic drug against atrial fibrillation. A controlled study|/resolve/reference/PMED?id=5808590
Aberg 1968 {published data only}|Procaine amide quinidine as prophylactic drugs against relapse of atrial fibrillation|/resolve/reference/PMED?id=4880307
AF-CHF 2002 {published data only}|Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial|
AF-CHF 2002 {published data only}|Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial|/resolve/reference/PMED?id=12360154
AFFIRM 2002 {published data only}|Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy|/resolve/reference/PMED?id=16286177
AFFIRM 2002 {published data only}|Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study|/resolve/reference/PMED?id=15007003
AFFIRM 2002 {published data only}|A comparison of rate control and rhythm control in patients with atrial fibrillation|/resolve/reference/PMED?id=12466506
Anderson 1994 {published data only}|Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators|/resolve/reference/PMED?id=1509993
Anderson 1994 {published data only}|Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=2513143
Anderson 1994 {published data only}|Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=8074041
Antman 1990 {published data only}|Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs|/resolve/reference/PMED?id=2303641
Antman 1990 {published data only}|Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter|/resolve/reference/PMED?id=3417972
Aros 1978 {published data only}|Maintaining sinus rhythm with quinidine and amiodarone after electric cardioversion|/resolve/reference/PMED?id=663366
Babuty 1999 {published data only}|Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study|
Babuty 1999 {published data only}|Double-blind comparison of cibenzoline versus flecainide in the prevention of recurrence of atrial tachyarrhythmias in 139 patients|
Babuty 1999 {published data only}|Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias|/resolve/reference/PMED?id=9137677
Beck 1978 {published data only}|Propafenone and lidoflazine in chronic atrial fibrillation and flutter (author's transl)|/resolve/reference/PMED?id=668524
Berns 1987 {published data only}|Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation|/resolve/reference/PMED?id=3109229
Blevins 1987 {published data only}|Amiodarone in the management of refractory atrial fibrillation|/resolve/reference/PMED?id=3307669
Blomstrom 1984 {published data only}|Amiodarone in atrial fibrillation|
Boissel 1981 {published data only}|Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation|/resolve/reference/PMED?id=7274266
Brodsky 1987 {published data only}|Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium|/resolve/reference/PMED?id=3630939
CHF-STAF 1998 {published data only}|Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT)|/resolve/reference/PMED?id=9843465
Chun 1995 {published data only}|Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter|/resolve/reference/PMED?id=7793402
Clementy 1992 {published data only}|Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients|/resolve/reference/PMED?id=1509998
Connolly 1989 {published data only}|Usefulness of propafenone for recurrent paroxysmal atrial fibrillation|/resolve/reference/PMED?id=2648787
CTAF 2000 {published data only}|Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation|/resolve/reference/PMED?id=12075253
CTAF 2000 {published data only}|Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial|/resolve/reference/PMED?id=12093058
CTAF 2000 {published data only}|Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators|/resolve/reference/PMED?id=10738049
CTAF 2000 {published data only}|Pilot study and protocol of the Canadian Trial of Atrial Fibrillation (CTAF)|/resolve/reference/PMED?id=9285659
Cuan-Perez 1971 {published data only}|Comparative study of quinidine, propranolol and diphenylhydantoin for preventing recurrence in post-cardioversion auricular fibrillation|/resolve/reference/PMED?id=5566599
ERAFT 2002 {published data only}|Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation. The European Rythmol/Rytmonorm Atrial Fibrillation Trial (ERAFT) Study|/resolve/reference/PMED?id=12480038
Faivre 1970 {published data only}|Disopyramide in the preparation for electric shock in atrial fibrillation and in the maintenance of subsequent sinus rhythm|/resolve/reference/PMED?id=5454439
Fernandez 1998 {published data only}|Comparative study of propafenone, amiodarone and flecainide in the treatment of paroxystic atrial fibrillation|
Frances 1985 {published data only}|Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports|/resolve/reference/PMED?id=3938266
Gold 1986 {published data only}|Amiodarone for refractory atrial fibrillation|/resolve/reference/PMED?id=3942054
Gosselink 1992 {published data only}|Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter|/resolve/reference/PMED?id=1597910
Graboys 1983 {published data only}|Efficacy of amiodarone for refractory supraventricular tachyarrhythmias|/resolve/reference/PMED?id=6613832
GUSTO 2002 {published data only}|Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries|/resolve/reference/PMED?id=12231591
Hammill 1988 {published data only}|Propafenone for paroxysmal atrial fibrillation|/resolve/reference/PMED?id=3341233
Hartel 1970 {published data only}|Investigations on the value of quinidine therapy after electrical rhythmization of atrial fibrillation|
Hartel 1970 {published data only}|The value of quinidine therapy in order to maintain sinus rhythm after electrical rhythmization of atrial fibrillation|
Hartel 1970 {published data only}|Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation|/resolve/reference/PMED?id=5417847
Hartel 1974 {published data only}|Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion|/resolve/reference/PMED?id=4601741
Hopson 1996 {published data only}|Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=8607395
Horowitz 1985 {published data only}|Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy|/resolve/reference/PMED?id=4067122
HOT-CAFE 2003 {published data only}|Should sinus rhythm be restored in patients with chronic atrial fibrillation? Preliminary results from the Polish "Hot Cafe" study|/resolve/reference/PMED?id=10740421
HOT-CAFE 2003 {published data only}|Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study|/resolve/reference/PMED?id=14560344
HOT-CAFE 2003 {published data only}|Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study|/resolve/reference/PMED?id=15302734
J-BAF 2009 {published data only}|Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study)|/resolve/reference/PMED?id=19359813
Jong 2006 {published data only}|Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion|/resolve/reference/PMED?id=17199952
J-RHYTHM 2009 {published data only}|Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study|/resolve/reference/PMED?id=19060419
Kanoupakis 2004 {published data only}|Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation|/resolve/reference/PMED?id=15342304
Kennelly 1977 {published data only}|Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias|/resolve/reference/PMED?id=324502
Kerr 1988 {published data only}|Propafenone for prevention of recurrent atrial fibrillation|/resolve/reference/PMED?id=3354467
Kosior 2001 {published data only}|Sequential prophylactic antiarrhythmic therapy for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation - One year follow-up|
Kosior 2001 {published data only}|Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation|/resolve/reference/PMED?id=11208496
Kosior 2001 {published data only}|Role of amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation|/resolve/reference/PMED?id=12687927
Kyles 1991 {published data only}|Long term efficacy of propafenone for prevention of atrial fibrillation|/resolve/reference/PMED?id=1756420
Lardoux 1996 {published data only}|Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study|/resolve/reference/PMED?id=8952741
Lau 1992 {published data only}|A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation|/resolve/reference/PMED?id=1514492
Levi 1973 {published data only}|Double-blind evaluation of practolol and quinidine in the treatment of chronic atrial fibrillation|/resolve/reference/PMED?id=4608474
Levi 1973 {published data only}|Treatment of chronic artrial fibrillation with practolol-quinidine|/resolve/reference/PMED?id=4589190
Li 2004 {published data only}|Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy|/resolve/reference/PMED?id=14697464
Manios 2003 {published data only}|Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study|/resolve/reference/PMED?id=12843685
Martin 1986 {published data only}|Comparison of amiodarone and disopyramide in the control of paroxysmal atrial fibrillation and atrial flutter|/resolve/reference/PMED?id=3089263
Mary-Rabine 1990 {published data only}|Clinical efficacy of flecainide acetate in atrial fibrillation|/resolve/reference/PMED?id=2127378
Massacci 1991 {published data only}|Flecainide versus amiodarone in preventing paroxysmal idiopathic atrial fibrillation|
Mizutani 1995 {published data only}|Pilsicainide in the acute conversion and the prevention of paroxysmal atrial fibrillation|
Nedostup 1990 {published data only}|A comparison of the efficacy of quinidine and kordaron as agents to stabilize the recovered sinus rhythm in patients with the permanent form of atrial fibrillation|/resolve/reference/PMED?id=2281406
Opolski 1997 {published data only}|Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion|
PEPS 2002 {published data only}|Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study|/resolve/reference/PMED?id=12138815
PIAF 2000 {published data only}|Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study|/resolve/reference/PMED?id=12909072
PIAF 2000 {published data only}|Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial|/resolve/reference/PMED?id=11117910
Pietersen 1991 {published data only}|Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group|/resolve/reference/PMED?id=1900978
Piot 1998 {published data only}|A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia|/resolve/reference/PMED?id=9891831
Porterfield 1989 {published data only}|Therapeutic efficacy and safety of oral propafenone for atrial fibrillation|/resolve/reference/PMED?id=2909141
PSVT 1995 {published data only}|A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group|/resolve/reference/PMED?id=7586356
RACE 2002 {published data only}|A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation|/resolve/reference/PMED?id=12466507
Rasmussen 1981 {published data only}|Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrial fibrillation. A controlled clinical trial|/resolve/reference/PMED?id=7015799
Resnekov 1971 {published data only}|Sustained-release quinidine (Kinidin Durules) in maintaining sinus rhythm after electroversion of atrial dysrhythmias|/resolve/reference/PMED?id=5572656
STAF 2003 {published data only}|Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study|/resolve/reference/PMED?id=12767648
Steeds 1999 {published data only}|An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation|/resolve/reference/PMED?id=10409530
Tonet 1986 {published data only}|Comparison between the efficacy of amiodarone and quinidine in the treatment of atrial cardiac arrhythmias|/resolve/reference/PMED?id=3089261
Touboul 1995 {published data only}|Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study|/resolve/reference/PMED?id=8745663
Van Wijk 1989 {published data only}|Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation|/resolve/reference/PMED?id=2468933
VEPARAF 2003 {published data only}|VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study)|
Wanless 1997 {published data only}|Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias|/resolve/reference/PMED?id=9124166
Zehender 1992 {published data only}|Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up|/resolve/reference/PMED?id=1552095
Zehender 1992 {published data only}|Amiodarone and verapamil/chinidin in the treatment of patients with chronic atrial fibrillation|/resolve/reference/PMED?id=7846938
ACC/AHA/ESC 2006|ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society|/resolve/reference/PMED?id=16908781
Alboni 2004|Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach|/resolve/reference/PMED?id=15575054
Anter2009|Pharmacological and electrical conversion of atrial fibrillation to sinus rhythm is worth the effort|/resolve/reference/PMED?id=19805660
Benjamin 1998|Impact of atrial fibrillation on the risk of death: the Framingham Heart Study|/resolve/reference/PMED?id=9737513
CAST 1991|Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial|/resolve/reference/PMED?id=1900101
Connolly 2000|Appropriate outcome measures in trials evaluating treatment of atrial fibrillation|/resolve/reference/PMED?id=10783204
Coplen 1990|Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials|/resolve/reference/PMED?id=2144796
Cordina 2005|Pharmacological cardioversion for atrial fibrillation and flutter|/resolve/reference/PMED?id=15846675
Denus 2005|Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis|
Flaker 1995|Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation|/resolve/reference/PMED?id=7639159
Freemantle 2011|Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide and propafenone, for the management of atrial fibrillation|/resolve/reference/PMED?id=21227948
Frick 2001|Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation|
Friedman 1998|Proarrhythmia|/resolve/reference/PMED?id=9809901
Gelder 1996|Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation|/resolve/reference/PMED?id=8951302
Geleris 2001|Spontaneous conversion to sinus rhythm of recent (within 24 hours) atrial fibrillation|/resolve/reference/PMED?id=11255692
Go 2001|Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study|/resolve/reference/PMED?id=11343485
Golzari 1996|Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy|/resolve/reference/PMED?id=8678396
Harris 1983|Side effects of long-term amiodarone therapy|/resolve/reference/PMED?id=6291807
Hassaguerre 1998|Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins|/resolve/reference/PMED?id=9725923
Heeringa 2006|Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study|/resolve/reference/PMED?id=16527828
Higgins 2005|Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE|
Higgins 2011|Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]|
Krahn 1995|The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study|/resolve/reference/PMED?id=7733127
Lafuente-Lafuente 2009|Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity|
Miller 2000|Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials|/resolve/reference/PMED?id=11093570
MMWR 2003|Atrial fibrillation as a contributing cause of death and Medicare hospitalization -- United States, 1999|
NICE 2006|NICE clinical guideline 36. Atrial fibrillation: the management of atrial fibrillation|
Nichol 2002|Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation|/resolve/reference/PMED?id=12010934
Oral 2006|Circumferential pulmonary-vein ablation for chronic atrial fibrillation|/resolve/reference/PMED?id=16510747
PRISMA 2009|Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement|/resolve/reference/PMED?id=19621072
Ruigomez 2002|Incidence of chronic atrial fibrillation in general practice and its treatment pattern|/resolve/reference/PMED?id=11927203
SPAF 1992|Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators|/resolve/reference/PMED?id=1512329
Stewart 2002|A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study|/resolve/reference/PMED?id=12401529
Terasawa 2009|Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation|
Testa 2005|Rate-control vs rhythm-control in patients with atrial fibrillation: a meta-analysis|/resolve/reference/PMED?id=15872032
Vaughan Williams 1984|A classification of antiarrhytymic actions reassessed after a decade of new drugs|
Wattigney 2003|Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention|/resolve/reference/PMED?id=12885749
Wazni 2005|Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial|/resolve/reference/PMED?id=15928285
Lafuente-Lafuente|Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomised controlled trials|/resolve/reference/PMED?id=16606807
A-COMET-I 2006 {published data only}|Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm|/resolve/reference/PMED?id=16644334
A-COMET-II 2006 {published data only}|Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial|/resolve/reference/PMED?id=16935870
AFFIRM Substudy 2003 {published data only}|Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug|/resolve/reference/PMED?id=12849654
AFIB 1997 {published data only}|Treatment of atrial fibrillation and paroxysmal supraventricular tachycardia with bidisomide|/resolve/reference/PMED?id=9355903
Aliot 1996 {published data only}|Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter|/resolve/reference/PMED?id=8607394
ASAP 2003 {published data only}|Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation|/resolve/reference/PMED?id=11703992
ASAP 2003 {published data only}|Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials|/resolve/reference/PMED?id=12947368
ASAP 2003 {published data only}|Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response|/resolve/reference/PMED?id=11923801
ASAP 2003 {published data only}|Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide|/resolve/reference/PMED?id=12615792
ASAP 2003 {published data only}|Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators|/resolve/reference/PMED?id=10987602
A-STAR 2006 {published data only}|Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease|/resolve/reference/PMED?id=16828595
ATHENA 2009 {published and unpublished data}|Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death in patients with atrial fibrillation/atrial flutter|/resolve/reference/PMED?id=19752319
ATHENA 2009 {published and unpublished data}|Effect of dronedarone on cardiovascular events in atrial fibrillation|/resolve/reference/PMED?id=19213680
Bellandi 2001 {published data only}|Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation - Long-term safety and efficacy study|
Bellandi 2001 {published data only}|Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation: Long-term safety and efficacy study|
Bellandi 2001 {published data only}|Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study|/resolve/reference/PMED?id=8707022
Bellandi 2001 {published data only}|Comparing agents for prevention of atrial fibrillation recurrence|
Bellandi 2001 {published data only}|Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=11564387
Benditt 1999 {published data only}|Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group|/resolve/reference/PMED?id=10496434
Byrne-Quinn 1970 {published data only}|Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate|/resolve/reference/PMED?id=4911757
Carunchio 1995 {published data only}|A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation|/resolve/reference/PMED?id=7642012
Channer 2004 {published and unpublished data}|A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation|/resolve/reference/PMED?id=14720531
DAFNE 2003 {published data only}|Dronedarone for prevention of atrial fibrillation: a dose-ranging study|/resolve/reference/PMED?id=12919771
DAPHNE 2008 {published data only}|The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker|/resolve/reference/PMED?id=18657671
DIAMOND 2001 {published data only}|Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group|
DIAMOND 2001 {published data only}|Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy|/resolve/reference/PMED?id=11457747
DIAMOND 2001 {published data only}|Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group|/resolve/reference/PMED?id=10486417
DIAMOND 2001 {published data only}|Dofetilide to patients with heart failure and left ventricular dysfunction|
Dogan 2004 {published data only}|Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study|/resolve/reference/PMED?id=15255456
DYONISOS 2010 {published data only (unpublished sought but not used)}|A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study|
EMERALD 2000 {published and unpublished data}|Mortality in patients with atrial fibrillation - 1 year follow up of EMERALD (European and Australian multicenter evaluative research on atrial fibrillation dofetilide)|
EMERALD 2000 {published and unpublished data}|Maintenance of sinus rhythm by dofetilide improves quality of life. The EMERALD (European and Australian multicenter evaluative research on atrial fibrillation dofetilide) study|
EMERALD 2000 {published and unpublished data}|Conversion of atrial fibrillation and maintenace of sinus rhythm by dofetilide. The EMERALD (European and Australian multicenter evaluative research on atrial fibrillation dofetilide) study|
EMERALD 2000 {published and unpublished data}|Drug Approval Package: Tikosyn (Dofetilide). Medical Review: Parts 1 and 2 (Study number 345)|
EURIDIS ADONIS 2007 {published and unpublished data}|Dronedarone on Trial: EURIDIS and ADONIS|
EURIDIS ADONIS 2007 {published and unpublished data}|Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter|/resolve/reference/PMED?id=17804843
EURIDIS ADONIS 2007 {published and unpublished data}|EURIDIS and ADONIS: maintenance of sinus rhythm with dronedarone in patients with atrial fibrillation or flutter|
FAPIS 1996 {published data only}|Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group|/resolve/reference/PMED?id=8682031
FAPIS 1996 {published data only}|Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators|/resolve/reference/PMED?id=8607393
Flec-SL 2012 {published data only}|Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial|/resolve/reference/PMED?id=22713626
GEFACA 2001 {published data only}|Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial|/resolve/reference/PMED?id=11907636
Hillestad 1971 {published data only}|Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study|/resolve/reference/PMED?id=4934041
Hohnloser 1995 {published data only}|Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine|/resolve/reference/PMED?id=7560608
Juul-Moller 1990 {published data only}|Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation|/resolve/reference/PMED?id=2242519
Kalusche 1994 {published data only}|Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation - conversion and 12-month follow-up - a randomized comparison|/resolve/reference/PMED?id=7846939
Karlson 1998 {published data only}|Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study|/resolve/reference/PMED?id=3289932
Karlson 1998 {published data only}|Preventive disopyramide after electroconversion of atrial fibrillation--a good alternative|/resolve/reference/PMED?id=2056838
Kochiadakis 2000 {published data only}|Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study|/resolve/reference/PMED?id=10956284
Kochiadakis 2000 {published data only}|Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=9576159
Kochiadakis 2000 {published data only}|Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?|
Kochiadakis 2004a {published data only}|Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses|/resolve/reference/PMED?id=14769712
Kochiadakis 2004b {published data only}|Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=15589019
Kuhlkamp 2000 {published data only}|Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=10898425
Lloyd 1984 {published data only}|The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo|/resolve/reference/PMED?id=6367096
Naccarelli 1996 {published data only}|Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter|/resolve/reference/PMED?id=8607392
Nergardh 2007 {published data only}|Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study|/resolve/reference/PMED?id=17329409
Niu 2006 {published data only}|Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study|/resolve/reference/PMED?id=16620720
Okishige 2000 {published data only}|Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: A placebo-controlled, multicenter study|/resolve/reference/PMED?id=10966544
PAFAC 2004 {published data only}|Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial|/resolve/reference/PMED?id=15302102
PAFAC 2004 {published data only}|Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study|/resolve/reference/PMED?id=10355070
PITAGORA 2008 {published data only}|A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the PITAGORA trial|
Plewan 2001 {published data only}|Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol|/resolve/reference/PMED?id=11482924
PRODIS 1996 {published data only}|Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study|/resolve/reference/PMED?id=8842506
RAFT 2003 {published data only}|Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation|/resolve/reference/PMED?id=14556870
Reimold 1993 {published data only}|Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation|/resolve/reference/PMED?id=8438741
Richiardi 1992 {published data only}|Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation|/resolve/reference/PMED?id=1600529
SAFE-T 2005 {published data only}|Amiodarone versus sotalol for atrial fibrillation|/resolve/reference/PMED?id=15872201
SAFE-T 2005 {published data only}|Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])|/resolve/reference/PMED?id=12914883
SAFIRE-D 2000 {published data only}|Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study|/resolve/reference/PMED?id=11067793
Santas 2012 {published data only (unpublished sought but not used)}|Early withdrawal of amiodarone after cardioversion in atrial fibrillation patients treated with irbesartan. A prospective randomized study. Abstract from the ESC Congress 25-29 August 2012; Munchen, Germany|
Singh 1991 {published data only}|Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group|/resolve/reference/PMED?id=1951086
SMART 2002 {published data only}|Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation|/resolve/reference/PMED?id=12074271
SOCESP 1999 {published data only}|Analysis of atrial fibrillation recurrence during therapy with sotalol or quinidine. Researchers of +SOCESP|/resolve/reference/PMED?id=9629687
SOCESP 1999 {published data only}|Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation. SOCESP Investigators|/resolve/reference/PMED?id=10569659
Sodermark 1975 {published data only}|Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm|/resolve/reference/PMED?id=1093559
SOPAT 2004 {published data only}|Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT study. Executive committee of the investigators representing trial physicians|/resolve/reference/PMED?id=10355069
SOPAT 2004 {published data only}|Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial|/resolve/reference/PMED?id=15321697
Steinbeck 1988 {published data only}|Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?|/resolve/reference/PMED?id=3143539
Stroobandt 1997 {published data only}|Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators|/resolve/reference/PMED?id=9052343
SVA-4 2008 {published data only}|Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias|
Van Gelder 1989 {published data only}|Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter|/resolve/reference/PMED?id=2511744
Van Gelder 1989 {published data only}|Efficacy of flecainide to maintain sinus rhythm after cardioversion of chronic atrial fibrillation and flutter. Abstracts from the 61st scientific sessions. American Heart Association. Washington, DC, November 1988|
Vijayalaskshmi 2006 {published data only}|A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned|/resolve/reference/PMED?id=16569550
Villani 1992 {published data only}|A comparison between amiodarone and disopyramide in a delayed-release formulation in the prevention of recurrences of symptomatic atrial fibrillation|/resolve/reference/PMED?id=1559321
Vitolo 1981 {published data only}|Amiodarone versus quinidine in the prophylaxis of atrial fibrillation|/resolve/reference/PMED?id=7039195
Aberg 1968 {published data only}|Procaine amide as a prophylactic drug against atrial fibrillation. A controlled study|/resolve/reference/PMED?id=5808590
Aberg 1968 {published data only}|Procaine amide quinidine as prophylactic drugs against relapse of atrial fibrillation|/resolve/reference/PMED?id=4880307
AF-CHF 2002 {published data only}|Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial|
AF-CHF 2002 {published data only}|Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial|/resolve/reference/PMED?id=12360154
AFFIRM 2002 {published data only}|Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy|/resolve/reference/PMED?id=16286177
AFFIRM 2002 {published data only}|Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study|/resolve/reference/PMED?id=15007003
AFFIRM 2002 {published data only}|A comparison of rate control and rhythm control in patients with atrial fibrillation|/resolve/reference/PMED?id=12466506
Anderson 1994 {published data only}|Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators|/resolve/reference/PMED?id=1509993
Anderson 1994 {published data only}|Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=2513143
Anderson 1994 {published data only}|Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=8074041
Andromeda 2008 {published data only}|Increased mortality after dronedarone therapy for severe heart failure|/resolve/reference/PMED?id=18565860
Antman 1990 {published data only}|Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs|/resolve/reference/PMED?id=2303641
Antman 1990 {published data only}|Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter|/resolve/reference/PMED?id=3417972
Aros 1978 {published data only}|Maintaining sinus rhythm with quinidine and amiodarone after electric cardioversion|/resolve/reference/PMED?id=663366
Babuty 1999 {published data only}|Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study|
Babuty 1999 {published data only}|Double-blind comparison of cibenzoline versus flecainide in the prevention of recurrence of atrial tachyarrhythmias in 139 patients|
Babuty 1999 {published data only}|Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias|/resolve/reference/PMED?id=9137677
Beck 1978 {published data only}|Propafenone and lidoflazine in chronic atrial fibrillation and flutter (author's transl)|/resolve/reference/PMED?id=668524
Berns 1987 {published data only}|Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation|/resolve/reference/PMED?id=3109229
Blevins 1987 {published data only}|Amiodarone in the management of refractory atrial fibrillation|/resolve/reference/PMED?id=3307669
Blomstrom 1984 {published data only}|Amiodarone in atrial fibrillation|
Boissel 1981 {published data only}|Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation|/resolve/reference/PMED?id=7274266
Brodsky 1987 {published data only}|Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium|/resolve/reference/PMED?id=3630939
CHF-STAF 1998 {published data only}|Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT)|/resolve/reference/PMED?id=9843465
Chun 1995 {published data only}|Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter|/resolve/reference/PMED?id=7793402
Clementy 1992 {published data only}|Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients|/resolve/reference/PMED?id=1509998
Connolly 1989 {published data only}|Usefulness of propafenone for recurrent paroxysmal atrial fibrillation|/resolve/reference/PMED?id=2648787
CTAF 2000 {published data only}|Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation|/resolve/reference/PMED?id=12075253
CTAF 2000 {published data only}|Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial|/resolve/reference/PMED?id=12093058
CTAF 2000 {published data only}|Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators|/resolve/reference/PMED?id=10738049
CTAF 2000 {published data only}|Pilot study and protocol of the Canadian Trial of Atrial Fibrillation (CTAF)|/resolve/reference/PMED?id=9285659
Cuan-Perez 1971 {published data only}|Comparative study of quinidine, propranolol and diphenylhydantoin for preventing recurrence in post-cardioversion auricular fibrillation|/resolve/reference/PMED?id=5566599
ERAFT 2002 {published data only}|Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation. The European Rythmol/Rytmonorm Atrial Fibrillation Trial (ERAFT) Study|/resolve/reference/PMED?id=12480038
Faivre 1970 {published data only}|Disopyramide in the preparation for electric shock in atrial fibrillation and in the maintenance of subsequent sinus rhythm|/resolve/reference/PMED?id=5454439
Fernandez 1998 {published data only}|Comparative study of propafenone, amiodarone and flecainide in the treatment of paroxystic atrial fibrillation|
Fragakis 2012 {published data only}|Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation|/resolve/reference/PMED?id=22621799
Fragakis 2012 {published data only}|Ranolazine added to amiodarone vs. amiodarone alone for the conversion of recent-onset atrial fibrillation. Abstract from the ESC Congress 25-29 August 2012; Munchen, Germany|
Frances 1985 {published data only}|Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports|/resolve/reference/PMED?id=3938266
Galperin 2014 {published data only}|Short-term amiodarone therapy after reversion of persistent atrial fibrillation reduces recurrences at 18 months|/resolve/reference/PMED?id=24293165
Gold 1986 {published data only}|Amiodarone for refractory atrial fibrillation|/resolve/reference/PMED?id=3942054
Gosselink 1992 {published data only}|Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter|/resolve/reference/PMED?id=1597910
Graboys 1983 {published data only}|Efficacy of amiodarone for refractory supraventricular tachyarrhythmias|/resolve/reference/PMED?id=6613832
Gramley 2011 {published data only}|Dronedarone therapy after catheter ablation of atrial fibrillation: a new hybrid therapy option. Abstract from EHRA Europace 26-29 June 2011 Madrid, Spain|
Grigoriyan 2011 {published data only}|Procoralan as a preventive treatment for paroxysmal atrial fibrillation. Abstract from the ESC Congress 27-31 August 2011; Paris, France|
Gu 2012 {published data only}|Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation|/resolve/reference/PMED?id=22997994
GUSTO 2002 {published data only}|Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries|/resolve/reference/PMED?id=12231591
Hammill 1988 {published data only}|Propafenone for paroxysmal atrial fibrillation|/resolve/reference/PMED?id=3341233
Hartel 1970 {published data only}|Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation|/resolve/reference/PMED?id=5417847
Hartel 1970 {published data only}|Investigations on the value of quinidine therapy after electrical rhythmization of atrial fibrillation|
Hartel 1970 {published data only}|The value of quinidine therapy in order to maintain sinus rhythm after electrical rhythmization of atrial fibrillation|
Hartel 1974 {published data only}|Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion|/resolve/reference/PMED?id=4601741
Hopson 1996 {published data only}|Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group|/resolve/reference/PMED?id=8607395
Horowitz 1985 {published data only}|Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy|/resolve/reference/PMED?id=4067122
HOT-CAFE 2003 {published data only}|Should sinus rhythm be restored in patients with chronic atrial fibrillation? Preliminary results from the Polish "Hot Cafe" study|/resolve/reference/PMED?id=10740421
HOT-CAFE 2003 {published data only}|Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study|/resolve/reference/PMED?id=14560344
HOT-CAFE 2003 {published data only}|Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study|/resolve/reference/PMED?id=15302734
Ishiguro 2008 {published data only}|Antiarrhythmic effect of bisoprolol, a highly selective beta1-blocker, in patients with paroxysmal atrial fibrillation|/resolve/reference/PMED?id=18612186
J-BAF 2009 {published data only}|Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study)|/resolve/reference/PMED?id=19359813
Jong 2006 {published data only}|Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion|/resolve/reference/PMED?id=17199952
J-RHYTHM 2009 {published data only}|Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study|/resolve/reference/PMED?id=19060419
Kanoupakis 2004 {published data only}|Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation|/resolve/reference/PMED?id=15342304
Kennelly 1977 {published data only}|Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias|/resolve/reference/PMED?id=324502
Kerr 1988 {published data only}|Propafenone for prevention of recurrent atrial fibrillation|/resolve/reference/PMED?id=3354467
Khitri 2012 {published data only}|Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter|
Komatsu 2006 {published data only}|Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy|/resolve/reference/PMED?id=16723785
Kosior 2001 {published data only}|Sequential prophylactic antiarrhythmic therapy for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation - One year follow-up|
Kosior 2001 {published data only}|Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation|/resolve/reference/PMED?id=11208496
Kosior 2001 {published data only}|Role of amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation|/resolve/reference/PMED?id=12687927
Kosior 2009 {published data only}|Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study|/resolve/reference/PMED?id=19950088
Kyles 1991 {published data only}|Long term efficacy of propafenone for prevention of atrial fibrillation|/resolve/reference/PMED?id=1756420
Lardoux 1996 {published data only}|Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study|/resolve/reference/PMED?id=8952741
Lau 1992 {published data only}|A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation|/resolve/reference/PMED?id=1514492
Levi 1973 {published data only}|Double-blind evaluation of practolol and quinidine in the treatment of chronic atrial fibrillation|/resolve/reference/PMED?id=4608474
Levi 1973 {published data only}|Treatment of chronic artrial fibrillation with practolol-quinidine|/resolve/reference/PMED?id=4589190
Li 2004 {published data only}|Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy|/resolve/reference/PMED?id=14697464
Lobe 2013 {published data only}|Usefulness of dronedarone in patients with atrial arrhythmias|/resolve/reference/PMED?id=23465099
Manios 2003 {published data only}|Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study|/resolve/reference/PMED?id=12843685
Martin 1986 {published data only}|Comparison of amiodarone and disopyramide in the control of paroxysmal atrial fibrillation and atrial flutter|/resolve/reference/PMED?id=3089263
Mary-Rabine 1990 {published data only}|Clinical efficacy of flecainide acetate in atrial fibrillation|/resolve/reference/PMED?id=2127378
Massacci 1991 {published data only}|Flecainide versus amiodarone in preventing paroxysmal idiopathic atrial fibrillation|
Mizutani 1995 {published data only}|Pilsicainide in the acute conversion and the prevention of paroxysmal atrial fibrillation|
Nedostup 1990 {published data only}|A comparison of the efficacy of quinidine and kordaron as agents to stabilize the recovered sinus rhythm in patients with the permanent form of atrial fibrillation|/resolve/reference/PMED?id=2281406
Opolski 1997 {published data only}|Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion|
PEPS 2002 {published data only}|Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study|/resolve/reference/PMED?id=12138815
PIAF 2000 {published data only}|Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study|/resolve/reference/PMED?id=12909072
PIAF 2000 {published data only}|Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial|/resolve/reference/PMED?id=11117910
Pietersen 1991 {published data only}|Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group|/resolve/reference/PMED?id=1900978
Piot 1998 {published data only}|A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia|/resolve/reference/PMED?id=9891831
Porterfield 1989 {published data only}|Therapeutic efficacy and safety of oral propafenone for atrial fibrillation|/resolve/reference/PMED?id=2909141
PSVT 1995 {published data only}|A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group|/resolve/reference/PMED?id=7586356
RACE 2002 {published data only}|A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation|/resolve/reference/PMED?id=12466507
Rasmussen 1981 {published data only}|Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrial fibrillation. A controlled clinical trial|/resolve/reference/PMED?id=7015799
Resnekov 1971 {published data only}|Sustained-release quinidine (Kinidin Durules) in maintaining sinus rhythm after electroversion of atrial dysrhythmias|/resolve/reference/PMED?id=5572656
STAF 2003 {published data only}|Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study|/resolve/reference/PMED?id=12767648
Steeds 1999 {published data only}|An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation|/resolve/reference/PMED?id=10409530
Tonet 1986 {published data only}|Comparison between the efficacy of amiodarone and quinidine in the treatment of atrial cardiac arrhythmias|/resolve/reference/PMED?id=3089261
Torp-Pedersen 2011 {published data only}|A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion|/resolve/reference/PMED?id=21841207
Touboul 1995 {published data only}|Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study|/resolve/reference/PMED?id=8745663
Van Wijk 1989 {published data only}|Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation|/resolve/reference/PMED?id=2468933
VEPARAF 2003 {published data only}|VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study)|
Wanless 1997 {published data only}|Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias|/resolve/reference/PMED?id=9124166
Zehender 1992 {published data only}|Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up|/resolve/reference/PMED?id=1552095
Zehender 1992 {published data only}|Amiodarone and verapamil/chinidin in the treatment of patients with chronic atrial fibrillation|/resolve/reference/PMED?id=7846938
ACC/AHA/ESC 2011|2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines|/resolve/reference/PMED?id=21382897
Alboni 2004|Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach|/resolve/reference/PMED?id=15575054
Anter 2009|Pharmacological and electrical conversion of atrial fibrillation to sinus rhythm is worth the effort|/resolve/reference/PMED?id=19805660
Benjamin 1998|Impact of atrial fibrillation on the risk of death: the Framingham Heart Study|/resolve/reference/PMED?id=9737513
Caldeira 2012|Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=22633297
CAST 1991|Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial|/resolve/reference/PMED?id=1900101
Chatterjee 2013|Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis|
Chen 2012|Catheter ablation for paroxysmal and persistent atrial fibrillation|
Chugh 2014|Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study|/resolve/reference/PMED?id=24345399
Connolly 2000|Appropriate outcome measures in trials evaluating treatment of atrial fibrillation|/resolve/reference/PMED?id=10783204
Coplen 1990|Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials|/resolve/reference/PMED?id=2144796
Cordina 2005|Pharmacological cardioversion for atrial fibrillation and flutter|/resolve/reference/PMED?id=15846675
Denus 2005|Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis|/resolve/reference/PMED?id=15710787
Flaker 1995|Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation|/resolve/reference/PMED?id=7639159
Freemantle 2011|Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide and propafenone, for the management of atrial fibrillation|/resolve/reference/PMED?id=21227948
Frick 2001|Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation|
Friedman 1998|Proarrhythmia|/resolve/reference/PMED?id=9809901
Gelder 1996|Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation|/resolve/reference/PMED?id=8951302
Geleris 2001|Spontaneous conversion to sinus rhythm of recent (within 24 hours) atrial fibrillation|/resolve/reference/PMED?id=11255692
Go 2001|Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study|/resolve/reference/PMED?id=11343485
Golzari 1996|Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy|/resolve/reference/PMED?id=8678396
Harris 1983|Side effects of long-term amiodarone therapy|/resolve/reference/PMED?id=6291807
Hassaguerre 1998|Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins|/resolve/reference/PMED?id=9725923
Heeringa 2006|Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study|/resolve/reference/PMED?id=16527828
Higgins 2011|Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]|
Knuiman 2014|A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study|/resolve/reference/PMED?id=24389686
Krahn 1995|The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study|/resolve/reference/PMED?id=7733127
Lafuente-Lafuente 2009|Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity|
Miller 2000|Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials|/resolve/reference/PMED?id=11093570
MMWR 2003|Atrial fibrillation as a contributing cause of death and Medicare hospitalization -- United States, 1999|
NICE 2014|Atrial fibrillation: the management of atrial fibrillation. (Clinical guideline 180)|
Nichol 2002|Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation|/resolve/reference/PMED?id=12010934
Oral 2006|Circumferential pulmonary-vein ablation for chronic atrial fibrillation|/resolve/reference/PMED?id=16510747
PRISMA 2009|Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement|/resolve/reference/PMED?id=19621072
Ruigomez 2002|Incidence of chronic atrial fibrillation in general practice and its treatment pattern|/resolve/reference/PMED?id=11927203
SPAF 1992|Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators|/resolve/reference/PMED?id=1512329
Stewart 2002|A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study|/resolve/reference/PMED?id=12401529
Terasawa 2009|Systematic review: Comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation|
Testa 2005|Rate-control vs rhythm-control in patients with atrial fibrillation: a meta-analysis|/resolve/reference/PMED?id=15872032
Vaughan Williams 1984|A classification of antiarrhythmic actions reassessed after a decade of new drugs|
Wattigney 2003|Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention|/resolve/reference/PMED?id=12885749
Wazni 2005|Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial|/resolve/reference/PMED?id=15928285
Lafuente-Lafuente|Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomised controlled trials|/resolve/reference/PMED?id=16606807
Lafuente-Lafuente 2012|Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation|/resolve/reference/PMED?id=22592700
Cen 1999 {published data only}|The effect of Shengmai injection on QT dispersion for congestive heart failure|
Cheng 2001 {published data only}|The effect of Shengmai injection on serum enzyme for pulmonary heart disease|
Gao 2001 {published data only}|The effect of Shengmai injection for acute heart failure of pulmonary heart disease|
He 2001 {published data only}|The effect of Shengmai complementary treatment for 40 patients with congestive heart failure|
He 2004 {published data only}|Effects of Shengmai injection on congestive heart failure patients with abnormal flow mediated dilation of brachial artery volume|
Hu 1998 {published data only}|The effects of Shengmai injection and sodium nitroprusside in 36 patients with heart failure of ischemic heart disease|
Li 1998a {published data only}|Clinical analysis of Shengmai injection for 64 patients with refractory heart failure of pulmonary heart disease|
Li 1998b {published data only}|The effect of Shengmai injection for refractory heart failure|
Li 2003a {published data only}|The effect of Shengmai injection for heart failure of chronic plumonary heart disease|
Li 2004 {published data only}|The effect of Shengmai injection on B type natriuretic peptide for congestive heart failure|
Liao 1996 {published data only}|The effect of Shengmai injection for 45 patients with heart failure|
Ma 2003 {published data only}|Influence of large amount of shengmai injection on blood coagulation in patients with chronic heart failure|/resolve/reference/PMED?id=12764910
Mao 1998 {published data only}|The effect of Shengmai plus grain for 32 patients with heart failure of pulmonary heart disease|
Mao 2003 {published data only}|The mechanism of Shengmai injection for congestive heart failure|
Mao 2003 {published data only}|Clinical study on the effect of Shengmai injection on serum concentration and pharmacokinetic parameters of digoxin in patients with congestive heart failure|/resolve/reference/PMED?id=12800416
Sun 1998 {published data only}|The effect of Shengmai injection for congestive heart failure|
Tang 2001 {published data only}|The effect of Shengmai injection for 33 patients with congestive heart failure|
Wang 1997a {published data only}|The effect of Shengmai injection for congestive heart failure|
Wang 2004a {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Zhang 2002 {published data only}|Effect of Shengmai Injection on hemodynamics in patients with dilated cardiomyopathy|/resolve/reference/PMED?id=12584790
Chen 2000 {published data only}|Shengmai injection for 29 patients with heart failure of pulmonary heart disease|
Feng 2002 {published data only}|Shengmai injection and phentolamine for 30 patients with heart failure|
Liu 1999 {published data only}|Integration of traditional and western medicine for 35 patients with chronic refractory heart failure|
Mo 1996 {published data only}|The effect of Shengmai injection on heart function change in chronic heart failure|
Qiu 1999 {published data only}|The of effect of Shengmai complementary treatment for heart failure of pulmonary heart disease|
Sun 1999 {published data only}|The effect of Shengmai injection for 50 patients with heart failure of pulmonary heart disease|
Wang 1994 {published data only}|The effects of Shengmai injection for cardiac insufficiency on clinical status and hemodynamic|
Wang 2003 {published data only}|The clinical analysis of Shengmai injection plus usual western drugs for 100 patients with aged congestive heart failure|
Xiao 2004 {published data only}|Integration of traditional and western medicine for 32 patients with refractory heart failure|
Yang 2001 {published data only}|Integration of traditional and western medicine for 52 patients with refractory heart failure|
Zhang 1990 {published data only}|The effect of Shengmai injection on hemodynamic for heart failure of dilated cardiomyopathy|
Zhao 1998a {published data only}|The clinical observation of Shengmai injection for aged heart failure|
Zhao 1998b {published data only}|The clinical observation of Shengmai injection for 45 patients with heart failure of pulmonary heart disease|
Zhao 2000 {published data only}|The effect of integration of traditional and western medicine on EF value change for heart failure|
Zheng 1996 {published data only}|The effect of Shengmai powder for 6 patients with cardiogenic shock and acute left heart failure|
Chen 2003 {published data only}|Shengmai and glonoin for congestive heart failure|
Ding 2005 {published data only}|Shengmai injection for heart failure|
Fan 2004 {published data only}|Shengmai injection for 34 patients with aged heart failure|
Fang 1987 {published data only}|Effect of sheng mai decoction on left ventricular function in patients with coronary heart disease. A randomized double blind, placebo controlled cross over trial|/resolve/reference/PMED?id=3322707
Feng 2003 {published data only}|Shengmai injection and digoxin for congestive heart failure|
Gu 2004 {published data only}|Shengmai injection for 80 patients with congestive heart failure|
Jiang 1988 {published data only}|Effectiveness of Sengmai oral liquid on left ventricle function and exercise tolerance for dilated cardiomyopathy|/resolve/reference/PMED?id=3058445
Jiang 2005 {published data only}|The effects of Shengmai for patients with coronary artery bypass grafting|
Li 2003b {published data only}|Clinical observation on Shengmai injection and dobutamine for acute myocardial infarction with heart failure|
Lu 2005 {published data only}|Effect of Sheng Mai injection on cardiac function assessed by ventriculography in the patients with coronary artery disease|
Miao 2005 {published data only}|The effects of Shengmai for acute myocardial infarction|
Ni 2004 {published data only}|Shengmai injection for chronic congestive heart failure|
Tang 2005 {published data only}|The effects of Shengmai for chronic heart failure|
Wan 2004 {published data only}|Observation on therapeutic effects of Shengmai injection on treatment of congestive heart failure|
Wang 2004b {published data only}|Shengmai capsule for chronic systolic heart failure|
Wang 2005 {published data only}|The effects of Shengmai injection for 42 patients with chronic systolic heart failure|
Yan 2005 {published data only}|Shengmai San for acute myocardial infarction|
Yang 2005 {published data only}|Dose-effect study of Shengmai injection used for congestive heart failure|
Zhang 2004 {published data only}|Effects of shengmai injection in the treatment of acute myocardial infarction with left ventricular dysfunction|
Zhang 2005 {published data only}|Shengmai for refractory heart failure|
Zhao 2004 {published data only}|Shengmai injection for 46 patients with chronic heart failure|
Zheng 2005 {published data only}|Curative effect evaluation of Shengmai injection on congestive heart failure in aged|
Zhu 2004 {published data only}|Change of thyroid hormone in patients with congestive heart failure and intervention with Shengmai injection|
ACC/AHA 2005|ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines|
AHA 2005||
Akera 1973|Ouabain: temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na + + K + )- activated ATPase|/resolve/reference/PMED?id=4267314
Alderson 2003|Assessment of study quality|
CMA 2002a|Retrospective investigation of hospitalized patients with heart failure in some parts of China in 1980, 1990 and 2000|
CMA 2002b|Guideline on treatment of chronic systolic heart failure|
Deng 1992|Effectiveness of Sengmai decoction on left ventricle function, exercise tolerance and oxygen free radicals for patients of angina pectoris|
Faris 2006|Diuretics for heart failure|
Gheorghiade 1991|Digoxin: a neurohormonal modulator in heart failure?|/resolve/reference/PMED?id=1834367
Gu 2003|Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population|
Hood 2004|Digitalis for treatment of congestive heart failure in patients in sinus rhythm|
Li 1996|Schisandra chinensis-dependent myocardial protective action of Sheng-Mai-San in rats|/resolve/reference/PMED?id=8982437
Li 2005|The pharmacological mechanism and clinical application of Shengmai injection|
Li 2006|Adverse effects of Shengmai injection and reasons|
Rong 1988|Role of oxygen in myocardial reoxygenation injury and the protective effect of Shengmai San|
Rong 1989|Protective effect of Sheng Mai San on adriamycin-induced cardiotoxicity - an experimental study|
Shanghai 2002|The evolving trends in the epidemiologic factors and treatment of hospitalized patients with congestive heart failure in Shanghai during the years 1980, 1990, 2000|
Swedberg 2005|Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005)|/resolve/reference/PMED?id=15901669
Takano 2003|Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies|/resolve/reference/PMED?id=12857042
Wang 1997b|The effectiveness of Shengmai injection for 50 congestive heart failure patients|
Wang 2002|Comparative study on the eradicating effects of oxygen free radicals by using three forms of Shengmai preparation|
Yu 2000|Antioxidative effect of Shengmai injection on the myocardium injury induced by adriamycin in rats|
Zhang 2000|A clinical study of Shenmai injection for congestive heart failure|
Fang 1987 {published data only}|The function of Shengmai injection for patients with coronary heart disease|/resolve/reference/PMED?id=3322707
He 2004 {published data only}|Effects of Shengmai injection on congestive heart failure patients with abnormal flow mediated dilation of brachial artery volume|
Liu 2007a {published data only}|Study on clinical efficacy and security of different doses of Shengmai injection for heart failure|
Mao 2003a {published data only}|The mechanism of Shengmai injection for congestive heart failure|/resolve/reference/PMED?id=12800416
Zhang 2002 {published data only}|Effect of Shengmai injection on hemodynamics in patients with dilated cardiomyopathy|/resolve/reference/PMED?id=12584790
Zhao 2006 {published data only}|The influence of Shengmai injection for the urine output of patients with heart failure|
Bu 2007 {published data only}|Effecacy of shengmai injection for congestive cardiac failure|
Cen 1999 {published data only}|The effect of Shengmai injection on QT dispersion for congestive heart failure|
Chen 2000 {published data only}|Shengmai injection for 29 patients with heart failure of pulmonary heart disease|
Chen 2003 {published data only}|Shengmai and glonoin for congestive heart failure|
Cheng 2001 {published data only}|The effect of Shengmai injection on serum enzyme for pulmonary heart disease|
Cheng 2007 {published data only}|Shengmai injection in adjuvant treatment of 45 patients with chronic congestive heart failure|
Deng 1992 {published data only}|Effecacy of shengmai granule for angina pectoris|
Ding 2005 {published data only}|Shengmai injection for heart failure|
Feng 2002 {published data only}|Shengmai injection and phentolamine for 30 patients with cases heart failure|
Feng 2003 {published data only}|Shengmai injection and digoxin for congestive heart failure|
Gao 2001 {published data only}|The effect of Shengmai injection for acute heart failure of pulmonary heart disease|
Gong 2006 {published data only}|The influence of Shengmai injection on heart function and brain natriuretic peptide of patients with chronic congestive heart failure|
Gu 2004 {published data only}|Shengmai injection for 80 patients with congestive heart failure|
Gu 2008 {published data only}|Clinical research on the effect of Shengmai for ventricular remodeling of patients with chronic heart failure|
He 2001 {published data only}|The effect of Shengmai complement treatment for 40 patients with congestive heart failure|
Hong 2005 {published data only}|Effect of Shengmai Injection on trail death receptor of patients with congestive heart failure|/resolve/reference/PMED?id=16398429
Hu 1997 {published data only}|Effecacy of Shengmai injection for acute myocardial infarction|
Hu 1998 {published data only}|The effects of Shengmai injection and sodium nitroprusside for 36 patients with heart failure of ischemic heart disease|
Hu 2005a {published data only}|Shengmai injection improves the cardiorespiratory function of catabasis of chronic cor pulmonale patients|
Hu 2005b {published data only}|Efficacy observations on Shengmai injection for chronic heart failure|
Hui 2007 {published data only}|Analysis of Shengmai injection for dilated cardiomyopathy with heart failure|
Jiang 2005 {published data only}|The effects of Shengmai for patients with coronary artery bypass grafting|
Li 1998a {published data only}|Clinical analysis of Shengmai injection for 64 patients with refractory heart failure of pulmonary heart disease|/resolve/reference/PMED?id=9482661
Li 1998b {published data only}|The effect of Shengmai injection for refractory heart failure|
Li 2003a {published data only}|The effect of Shengmai injection for heart failure of chronic pulmonary heart disease|
Li 2003b {published data only}|Clinical Observation on Shengmai Injection and Dobutamine for Acute Myocardial Infarction with Heart Failure|
Li 2004 {published data only}|The effect of Shengmai injection on B type natriuretic peptide for congestive heart failure|
Li 2006a {published data only}|Effecacy of shengmai in for congestive cardiac failure|
Li 2008 {published data only}|Clinical observation of shengmai injection for chronic cardiac failure|
Liang 2006 {published data only}|TCM Treatment for elderly patients with acute myocardial infarction|
Liao 1996 {published data only}|The effect of Shengmai injection for 45 patients with heart failure|
Liu 1999 {published data only}|Integration of traditional and western medicine for 35 patients with chronic refractory heart failure|
Liu 2007b {published data only}|Effecacy of large dose Shengmai injection for acute left ventricular failure|
Lu 2005 {published data only}|Effect of Sheng Mai injection on cardiac function assessed by ventriculography in the patients with coronary artery disease|
Ma 2003 {published data only}|Influence of large amount of Shengmai injection on blood coagulation in patients with chronic heart failure|/resolve/reference/PMED?id=12764910
Ma 2006 {published data only}|Shengmai injection for chronic pulmonary heart disease patients with refractory heart failure|
Ma 2008 {published data only}|Western medicine united Shenmai injection for diastolic heart failure|
Mao 1998 {published data only}|The effect of Shengmai plus grain for 32 patients with heart failure of pulmonary heart disease|
Mao 2003b {published data only}|Clinical study on the effect of Shengmai injection on serum concentration and pharmacokinetic parameters of digoxin in patients with congestive heart failure|/resolve/reference/PMED?id=12800416
Mao 2006a {published data only}|Effect of different dose of shengmai injection for heart failure|
Mao 2006b {published data only}|Shengmai injection for patients with heart failure of digoxin in renal displacement|
Miao 2005 {published data only}|The effects of Shengmai for acute myocardial infarction|
Mo 1996 {published data only}|The effect of Shengmai injection on heart function change for chronic heart failure|
Ni 2004 {published data only}|Shengmai injection for chronic congestive heart failure|
Ni 2007 {published data only}|Efficacy observation on Shengmai Injection for congestive heart failure|
Peng 2007 {published data only}|Effecacy of metoprolol and shengmai capsule for chronic congestive heart failure|
Qiao 2007 {published data only}|Clinical observation of shengmai yin for chronic congestive heart failure|
Qiu 1999 {published data only}|The of effect of Shengmai complement treatment for heart failure of pulmonary heart disease|
Qiu 2007 {published data only}|Effect of shengmai for chronic cardiac failure|
Shao 2006 {published data only}|Therapeutic effectiveness: observation on Shengmai injection for elderly patients with chronic heart failure|
Shen 2006 {published data only}|Type-b ultrasonic observed on Shengmai capsules for left ventricular remodeling and cardiac function of patients with congestive heart failure|
Shi 2006a {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Shi 2006b {published data only}|Effect of shengmai injection for chronic congestive heart failure|
Su 2008 {published data only}|Clinical observation on Chinese combined with western medicine for chronic heart failure|
Sun 1998 {published data only}|The effect of Shengmai injection for congestive heart failure|
Sun 1999 {published data only}|The effect of Shengmai injection for 50 patients with heart failure of pulmonary heart disease|
Tang 2001 {published data only}|The effect of Shengmai injection for 33 patients with congestive heart failure|
Tang 2005 {published data only}|Shengmai injection for heart failure|
Wan 2004 {published data only}|Observation on Therapeutic Effects of Shengmai Injection upon Treat ment of Congestive Heart Failure|
Wan 2007 {published data only}|Effect of Shengmai powder for quality of life of patients with congestive heart failure|
Wang 1994 {published data only}|The effect of Shengmai injection for cardiac insufficiency on clinical status and hemodynamic|/resolve/reference/PMED?id=7834522
Wang 1997b {published data only}|The effect of Shengmai injection for congestive heart failure|
Wang 2002a {published data only}|Effect of shengmai injection for dilated cardiomyopathy in heart function|
Wang 2003 {published data only}|The clinical analysis of Shengmai injection plus usual western drugs for 100 patients with aged congestive heart failure|
Wang 2004a {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Wang 2004b {published data only}|Shengmai capsule for chronic systaltic heart failure|
Wang 2005a {published data only}|The effects of Shengmai injection for 42 patients with chronic systaltic heart failure|
Wang 2005b {published data only}|Clinical observation by color Doppler ultrasound on Shengmai injection in adjuvant treatment of chronic congestive heart failure|
Wang 2005c {published data only}|Shengmai for obstinate heart failure|
Wang 2006a {published data only}|Shengmai injection for left ventricular function change in the near future of patients with coronary heart disease combined with chronic heart failure|
Wang 2006b {published data only}|Clinical observation of shengmai injection for dilated cardiomyopathy|
Wang 2008a {published data only}|Clinical analysis of Chinese and western medicine treatment for pulmonary heart disease: 70 cases|
Wang 2008b {published data only}|Observation of shengmai injection for diastolic insufficiency heart failure|
Xiao 2004 {published data only}|Integration of traditional and western medicine for 32 patients with refractory heart failure|
Yan 2005 {published data only}|Shengmai San for acute miocardial infarction|
Yang 2001 {published data only}|Integration of traditional and western medicine for 52 patients with refractory heart failure|
Yang 2005 {published data only}|Dose-effect study of Shengmai injection used for congestive heart failure|
Yang 2006a {published data only}|Shengmai injection for congestive heart failure|
Yang 2006b {published data only}|Clinical observation on Shengmai injection for acute exacerbation of chronic pulmonary heart disease|
Yu 2005 {published data only}|Clinical effects of Shengmai injection on the patients with acute myocardial infarction combined with heart failure|
Zhan 2007 {published data only}|Shengmai injection for chronic pulmonary heart disease|
Zhang 1990 {published data only}|The effect of Shengmai injection on hemodynamic for heart failure of dilated cardiomyopathy|
Zhang 2004a {published data only}|Effects of shengmai injection in the treatment of acute myocardial infarction with left ventricular dysfunction|
Zhang 2004b {published data only}|Shengmai for refractory heart failure|
Zhang 2006 {published data only}|Shenmai injection for chronic congestive heart failure|/resolve/reference/PMED?id=16599122
Zhang 2007 {published data only}|The influence of Shengmai injection for plasma ET of patients with dilated cardiomyopathy|
Zhang 2008a {published data only}|Feasibility study of Shengmai auxiliary semi-saturation levels cedilanid for infants with pneumonia complicated combined with heart failure|
Zhang 2008b {published data only}|Effect of Shengmai injection on cardiac function and inflammatory reaction in patients with acute coronary syndrome|/resolve/reference/PMED?id=18679601
Zhao 1998a {published data only}|The clinical observation of Shengmai injection for aged heart failure|
Zhao 1998b {published data only}|The clinical observation of Shengmai injection for 45 patients with heart failure of pulmonary heart disease|
Zhao 2000 {published data only}|The effect of integration of traditional and western medicine on EF value change for heart failure|
Zhao 2004 {published data only}|Shengmai injection for 46 patients with chronic heart failure|
Zhao 2005 {published data only}|Clinical observation of combining of shengmai injection with dopamine for acute myocardial infarction|
Zhao 2007 {published data only}|Clinical research on Shengmai injection for recovery of myocardial protective effect of sudden death|
Zheng 1996 {published data only}|The effect of Shengmai powder for 6 patients with cardiogenic shock and acute left heart failure|
Zheng 2005 {published data only}|Curative effect evaluation of Shengmai injection on congestive heart failure in aged|
Zhong 2005 {published data only}|Shengmai injection for heart failure|
Zhong 2007 {published data only}|Clinical study of combining shengmai with irbesartan for chronic congestive heart failure|
Zhou 2005 {published data only}|Clinical observation on the Shengmai injection combined with intravenous thrombolysis for patients with acute myocardial infarction|
Zhou 2006 {published data only}|Clinical observation on high-dose Shengmai injection for congestive heart failure|
Zhu 2004 {published data only}|Change of thyroid hormone in patients with congestive heart failure and intervention with Shengmai injection|
Fan 2004 {published data only}|Shengmai injection for 34 patients with aged heart failure|
Jiang 1988 {published data only}|Effectiveness of Sengmai oral liquid on left ventricle function and exercise tolerance for dilated cardiomyopathy|/resolve/reference/PMED?id=3058445
ACC/AHA 2005|ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines|
ACC/AHA 2009|2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults|
AHA 2005||
Akera 1973|Ouabain: temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na + + K + )- activated ATPase|/resolve/reference/PMED?id=4267314
CMA 2002a|Retrospective investigation of hospitalized patients with heart failure in some parts of China in 1980, 1990 and 2000|
CMA 2002b|Guideline on treatment of chronic systolic heart failure|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Faris 2006|Diuretics for heart failure|
Gheorghiade 1991|Digoxin: a neurohormonal modulator in heart failure?|/resolve/reference/PMED?id=1834367
Gu 2003|Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2009|Chapter 8: Assessing risk of bias in included studies|
Hood 2004|Digitalis for treatment of congestive heart failure in patients in sinus rhythm|
Li 1996|Schisandra chinensis-dependent myocardial protective action of Sheng-Mai-San in rats|/resolve/reference/PMED?id=8982437
Li 2005|The pharmacological mechanism and clinical application of Shengmai injection|
Li 2006b|Adverse effects of Shengmai injection and reasons|
Rong 1988|Role of oxygen in myocardial reoxygenation injury and the protective effect of Shengmai San|
Rong 1989|Protective effect of Sheng Mai San on adriamycin-induced cardiotoxicity - an experimental study|
Shanghai 2002|The evolving trends in the epidemiologic factors and treatment of hospitalized patients with congestive heart failure in Shanghai during the years 1980, 1990, 2000|
Swedberg 2005|Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005)|/resolve/reference/PMED?id=15901669
Takano 2003|Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies|/resolve/reference/PMED?id=12857042
Wang 1997a|The effectiveness of Shengmai injection for 50 congestive heart failure patients|
Wang 2002b|Comparative study on the eradicating effects of oxygen free radicals by using three forms of Shengmai preparation|
Yu 2000|Antioxidative effect of Shengmai injection on the myocardium injury induced by adriamycin in rats|
Zhang 2000|A clinical study of Shenmai injection for congestive heart failure|
Fang 1987 {published data only}|The function of Shengmai injection for patients with coronary heart disease|/resolve/reference/PMED?id=3322707
He 2004 {published data only}|Effects of Shengmai injection on congestive heart failure patients with abnormal flow mediated dilation of brachial artery volume|
Jiang 1988 {published data only}|Effectiveness of Sengmai oral liquid on left ventricle function and exercise tolerance for dilated cardiomyopathy|/resolve/reference/PMED?id=3058445
Liu 2007a {published data only}|Study on clinical efficacy and security of different doses of Shengmai injection for heart failure|
Mao 2003a {published data only}|The mechanism of Shengmai injection for congestive heart failure|/resolve/reference/PMED?id=12800416
Wang 2010a {published data only}|The influence of Shengmai injection on heart function and brain natriuretic peptide of patients with chronic congestive heart failure|/resolve/reference/PMED?id=8716080
Zhai 2009 {published data only}|The clinical research of pulse-activating injection on 30 cases of chronic congestive heart failure|
Zhang 2002 {published data only}|Effect of Shengmai injection on hemodynamics in patients with dilated cardiomyopathy|/resolve/reference/PMED?id=12584790
Zhao 2006 {published data only}|The influence of Shengmai injection for the urine output of patients with heart failure|
Bu 2007 {published data only}|Effecacy of Shengmai injection for congestive cardiac failure|
Cen 1999 {published data only}|The effect of Shengmai injection on QT dispersion for congestive heart failure|
Chen 2000 {published data only}|Shengmai injection for 29 patients with heart failure of pulmonary heart disease|
Chen 2003 {published data only}|Shengmai and glonoin for congestive heart failure|
Chen 2008 {published data only}|Observation and nursing of Shengmai injection for pulmonary heart disease combined with heart failure in aged|
Chen 2010 {published data only}|Observation of Shengmai injection for chronic heart failure|
Cheng 2001 {published data only}|The effect of Shengmai injection on serum enzyme for pulmonary heart disease|
Cheng 2007 {published data only}|Shengmai injection in adjuvant treatment of 45 patients with chronic congestive heart failure|
Deng 1992 {published data only}|Efficacy of Shengmai granule for angina pectoris|
Ding 2005 {published data only}|Shengmai injection for heart failure|
Dou 2010 {published data only}|Efficacy of Shengmai injection for chronic heart failure|
Duan 2010 {published data only}|Lives arteries inoculation fluid treatment congested heart failure 60 example clinical analysis|
Fan 2004 {published data only}|Shengmai injection for 34 patients with aged heart failure|
Feng 2002 {published data only}|Shengmai injection and phentolamine for 30 patients with cases heart failure|
Feng 2003 {published data only}|Shengmai injection and digoxin for congestive heart failure|
Gao 2001 {published data only}|The effect of Shengmai injection for acute heart failure of pulmonary heart disease|
Gong 2006 {published data only}|The influence of Shengmai injection on heart function and brain natriuretic peptide of patients with chronic congestive heart failure|
Gu 2004 {published data only}|Shengmai injection for 80 patients with congestive heart failure|
Gu 2008 {published data only}|Clinical research on the effect of Shengmai for ventricular remodeling of patients with chronic heart failure|
He 2001 {published data only}|The effect of Shengmai complement treatment for 40 patients with congestive heart failure|
Hong 2005 {published data only}|Effect of Shengmai Injection on trail death receptor of patients with congestive heart failure|/resolve/reference/PMED?id=16398429
Hong 2009 {published data only}|Clinical observation of the effect of Shengmai injection on elderly patients with coronary heart disease and heart failure|
Hu 1997 {published data only}|Effecacy of Shengmai injection for acute myocardial infarction|
Hu 1998 {published data only}|The effects of Shengmai injection and sodium nitroprusside for 36 patients with heart failure of ischemic heart disease|
Hu 2005a {published data only}|Shengmai injection improves the cardiorespiratory function of catabasis of chronic cor pulmonale patients|
Hu 2005b {published data only}|Efficacy observations on Shengmai injection for chronic heart failure|
Hui 2007 {published data only}|Analysis of Shengmai injection for dilated cardiomyopathy with heart failure|
Jiang 2005 {published data only}|The effects of Shengmai for patients with coronary artery bypass grafting|
Jiang 2010 {published data only}|Observation of Shengmai tablets for chronic systolic heart failure|
Kong 2010 {published data only}|Study on Shengmai in Patients with chronic heart failure of type of Qi and Yin deficiency|
Li 1998a {published data only}|Clinical analysis of Shengmai injection for 64 patients with refractory heart failure of pulmonary heart disease|/resolve/reference/PMED?id=9482661
Li 1998b {published data only}|The effect of Shengmai injection for refractory heart failure|
Li 2003a {published data only}|The effect of Shengmai injection for heart failure of chronic pulmonary heart disease|
Li 2003b {published data only}|Clinical observation on Shengmai injection and dobutamine for acute myocardial infarction with heart failure|
Li 2004 {published data only}|The effect of Shengmai injection on B type natriuretic peptide for congestive heart failure|
Li 2006a {published data only}|Effecacy of Shengmai in for congestive cardiac failure|
Li 2008 {published data only}|Clinical observation of Shengmai injection for chronic cardiac failure|
Li 2009a {published data only}|The clinical study on effects of Shengmai injection with chronic heart failure treatment by monitoring the level of plasma NT-ProBNP|
Li 2009b {published data only}|Clinical study of Shengmai injection for dilated cardiomyopathy|
Li 2009c {published data only}|Shengmai injection for 26 patients of chronic pulmonary heart disease|
Liang 2006 {published data only}|TCM Treatment for elderly patients with acute myocardial infarction|
Liao 1996 {published data only}|The effect of Shengmai injection for 45 patients with heart failure|
Liu 1999 {published data only}|Integration of traditional and western medicine for 35 patients with chronic refractory heart failure|
Liu 2007b {published data only}|Effecacy of large dose Shengmai injection for acute left ventricular failure|
Liu 2009 {published data only}|The effect of Shengmai injection plus metoprolol for dilated cardiomyopathy combined with congestive heart failure|
Liu 2010 {published data only}|The effect of Shengmai injection plus metaprolol for coronary heart disease combined with chronic congestive heart failure|
Lu 2005 {published data only}|Effect of Sheng Mai injection on cardiac function assessed by ventriculography in the patients with coronary artery disease|
Lu 2008 {published data only}|Shengmai injection for chronic heart failure|
Lu 2009 {published data only}|The effect of Shengmai injection on BNP for chronic heart failure|
Ma 2003 {published data only}|Influence of large amount of Shengmai injection on blood coagulation in patients with chronic heart failure|/resolve/reference/PMED?id=12764910
Ma 2006 {published data only}|Shengmai injection for chronic pulmonary heart disease patients with refractory heart failure|
Ma 2008 {published data only}|Western medicine united Shenmai injection for diastolic heart failure|
Mao 1998 {published data only}|The effect of Shengmai plus grain for 32 patients with heart failure of pulmonary heart disease|
Mao 2003b {published data only}|Clinical study on the effect of Shengmai injection on serum concentration and pharmacokinetic parameters of digoxin in patients with congestive heart failure|/resolve/reference/PMED?id=12800416
Mao 2006a {published data only}|Effect of different dose of shengmai injection for heart failure|
Mao 2006b {published data only}|Shengmai injection for patients with heart failure of digoxin in renal displacement|
Miao 2005 {published data only}|The effects of Shengmai for acute myocardial infarction|
Mo 1996 {published data only}|The effect of Shengmai injection on heart function change for chronic heart failure|
Ni 2004 {published data only}|Shengmai injection for chronic congestive heart failure|
Ni 2007 {published data only}|Efficacy observation on Shengmai Injection for congestive heart failure|
Peng 2007 {published data only}|Effecacy of metoprolol and Shengmai capsule for chronic congestive heart failure|
Qiao 2007 {published data only}|Clinical observation of Shengmai yin for chronic congestive heart failure|
Qiu 1999 {published data only}|The of effect of Shengmai complement treatment for heart failure of pulmonary heart disease|
Qiu 2007 {published data only}|Effect of Shengmai for chronic cardiac failure|
Shao 2006 {published data only}|Therapeutic effectiveness: observation on Shengmai injection for elderly patients with chronic heart failure|
Shen 2006 {published data only}|Type-b ultrasonic observed on Shengmai capsules for left ventricular remodeling and cardiac function of patients with congestive heart failure|
Shi 2006a {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Shi 2006b {published data only}|Effect of Shengmai injection for chronic congestive heart failure|
Shi 2009 {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Su 2008 {published data only}|Clinical observation on Chinese combined with western medicine for chronic heart failure|
Sun 1998 {published data only}|The effect of Shengmai injection for congestive heart failure|
Sun 1999 {published data only}|The effect of Shengmai injection for 50 patients with heart failure of pulmonary heart disease|
Sun 2009 {published data only}|The effect of Shengmai injection for congestive heart failure|
Tang 2001 {published data only}|The effect of Shengmai injection for 33 patients with congestive heart failure|
Tang 2005 {published data only}|Shengmai injection for heart failure|
Wan 2004 {published data only}|Observation on therapeutic effects of Shengmai injection upon treatment of congestive heart failure|
Wan 2007 {published data only}|Effect of Shengmai powder for quality of life of patients with congestive heart failure|
Wang 1994 {published data only}|The effect of Shengmai injection for cardiac insufficiency on clinical status and hemodynamic|/resolve/reference/PMED?id=7834522
Wang 1997b {published data only}|The effect of Shengmai injection for congestive heart failure|
Wang 2002a {published data only}|Effect of Shengmai injection for dilated cardiomyopathy in heart function|
Wang 2003 {published data only}|The clinical analysis of Shengmai injection plus usual western drugs for 100 patients with aged congestive heart failure|
Wang 2004a {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Wang 2004b {published data only}|Shengmai capsule for chronic systaltic heart failure|
Wang 2005a {published data only}|The effects of Shengmai injection for 42 patients with chronic systaltic heart failure|
Wang 2005b {published data only}|Clinical observation by colour Doppler ultrasound on Shengmai injection in adjuvant treatment of chronic congestive heart failure|
Wang 2005c {published data only}|Shengmai for obstinate heart failure|
Wang 2006a {published data only}|Shengmai injection for left ventricular function change in the near future of patients with coronary heart disease combined with chronic heart failure|
Wang 2006b {published data only}|Clinical observation of Shengmai injection for dilated cardiomyopathy|
Wang 2008a {published data only}|Clinical analysis of Chinese and western medicine treatment for pulmonary heart disease: 70 cases|
Wang 2008b {published data only}|Observation of Shengmai injection for diastolic insufficiency heart failure|
Wang 2009 {published data only}|Observation of high dose of Shengmai injection for 68 patients of coronary heart disease|
Wang 2010b {published data only}|Observation of Shengmai injection for congestive heart failure in aged|
Wang 2010c {published data only}|The effect of Shengmai injection on Q-T dispersion for heart failure|
Wu 2009a {published data only}|Observation of Shengmai injection for cardia insufficiency caused by dilated cardiomyopathy|
Wu 2009b {published data only}|Observation of Shengmai injection for ischemic cardiomyopathy|
Xiao 2004 {published data only}|Integration of traditional and western medicine for 32 patients with refractory heart failure|
Xu 2009 {published data only}|Observation of Shengmai injection for coronary heart disease combined with chronic heart failure|
Yan 2005 {published data only}|Shengmai San for acute miocardial infarction|
Yang 2001 {published data only}|Integration of traditional and western medicine for 52 patients with refractory heart failure|
Yang 2005 {published data only}|Dose-effect study of Shengmai injection used for congestive heart failure|
Yang 2006a {published data only}|Shengmai injection for congestive heart failure|
Yang 2006b {published data only}|Clinical observation on Shengmai injection for acute exacerbation of chronic pulmonary heart disease|
Yang 2010 {published data only}|Observation of Shengmai injection for 43 patients of chronic congestive heart failure|
Yu 2005 {published data only}|Clinical effects of Shengmai injection on the patients with acute myocardial infarction combined with heart failure|
Zhan 2007 {published data only}|Shengmai injection for chronic pulmonary heart disease|
Zhang 1990 {published data only}|The effect of Shengmai injection on hemodynamic for heart failure of dilated cardiomyopathy|
Zhang 2004a {published data only}|Effects of Shengmai injection in the treatment of acute myocardial infarction with left ventricular dysfunction|
Zhang 2004b {published data only}|Shengmai for refractory heart failure|
Zhang 2006 {published data only}|Shenmai injection for chronic congestive heart failure|/resolve/reference/PMED?id=16599122
Zhang 2007 {published data only}|The influence of Shengmai injection for plasma ET of patients with dilated cardiomyopathy|
Zhang 2008a {published data only}|Feasibility study of Shengmai auxiliary semi-saturation levels cedilanid for infants with pneumonia complicated combined with heart failure|
Zhang 2008b {published data only}|Effect of Shengmai injection on cardiac function and inflammatory reaction in patients with acute coronary syndrome|/resolve/reference/PMED?id=18679601
Zhang 2008c {published data only}|The effect of Shengmai injection on cardiac function and coagulation function of chronic heart failure|
Zhang 2008d {published data only}|Observation of Shengmai injection for refractory heart failure|
Zhang 2009a {published data only}|The application of Shengmai yin for the chronic coronary heart failure caused by the deficiency of yin and qi|
Zhang 2009b {published data only}|Shengmai injection for chronic heart failure|
Zhao 1998a {published data only}|The clinical observation of Shengmai injection for aged heart failure|
Zhao 1998b {published data only}|The clinical observation of Shengmai injection for 45 patients with heart failure of pulmonary heart disease|
Zhao 2000 {published data only}|The effect of integration of traditional and western medicine on EF value change for heart failure|
Zhao 2004 {published data only}|Shengmai injection for 46 patients with chronic heart failure|
Zhao 2005 {published data only}|Clinical observation of combining of Shengmai injection with dopamine for acute myocardial infarction|
Zhao 2007 {published data only}|Clinical research on Shengmai injection for recovery of myocardial protective effect of sudden death|
Zhao 2008 {published data only}|Observation of Shengmai injection for coronary heart disease combined with heart failure|
Zheng 1996 {published data only}|The effect of Shengmai powder for 6 patients with cardiogenic shock and acute left heart failure|
Zheng 2005 {published data only}|Curative effect evaluation of Shengmai injection on congestive heart failure in aged|
Zhong 2005 {published data only}|Shengmai injection for heart failure|
Zhong 2007 {published data only}|Clinical study of combining Shengmai with irbesartan for chronic congestive heart failure|
Zhou 2005 {published data only}|Clinical observation on the Shengmai injection combined with intravenous thrombolysis for patients with acute myocardial infarction|
Zhou 2006 {published data only}|Clinical observation on high-dose Shengmai injection for congestive heart failure|
Zhou 2009 {published data only}|The effect of Shengmai injection on BNP for congestive heart failure|
Zhu 2004 {published data only}|Change of thyroid hormone in patients with congestive heart failure and intervention with Shengmai injection|
ACC/AHA 2005|ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines|
ACC/AHA 2009|2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults|
AHA 2005||
Akera 1973|Ouabain: temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na|/resolve/reference/PMED?id=4267314
CMA 2002a|Retrospective investigation of hospitalized patients with heart failure in some parts of China in 1980, 1990 and 2000|
CMA 2002b|Guideline on treatment of chronic systolic heart failure|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Elbourne 2002|Meta-analyses involving cross-over trials: Methodological issues|/resolve/reference/PMED?id=11914310
Faris 2006|Diuretics for heart failure|
Gheorghiade 1991|Digoxin: a neurohormonal modulator in heart failure?|/resolve/reference/PMED?id=1834367
Gu 2003|Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011|Chapter 8: Assessing risk of bias in included studies|
Hood 2004|Digitalis for treatment of congestive heart failure in patients in sinus rhythm|
Li 1996|Schisandra chinensis-dependent myocardial protective action of Sheng-Mai-San in rats|/resolve/reference/PMED?id=8982437
Li 2005|The pharmacological mechanism and clinical application of Shengmai injection|
Li 2006b|Adverse effects of Shengmai injection and reasons|
Rong 1988|Role of oxygen in myocardial reoxygenation injury and the protective effect of Shengmai San|
Rong 1989|Protective effect of Sheng Mai San on adriamycin-induced cardiotoxicity - an experimental study|
Shanghai 2002|The evolving trends in the epidemiologic factors and treatment of hospitalized patients with congestive heart failure in Shanghai during the years 1980, 1990, 2000|
Song 2011|Study of the Utilization of Traditional Chinese Medicine in Inpatients|
Swedberg 2005|Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)|/resolve/reference/PMED?id=15901669
Takano 2003|Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies|/resolve/reference/PMED?id=12857042
Tan 2006|Research of people's intention of Traditional Chinese Medicine in Sichuan Province|
Tian 2008|Analysis of Shengmai injection and market competition|
Wang 1997a|The effectiveness of Shengmai injection for 50 congestive heart failure patients|
Wang 2002b|Comparative study on the eradicating effects of oxygen free radicals by using three forms of Shengmai preparation|
Yu 2000|Antioxidative effect of Shengmai injection on the myocardium injury induced by adriamycin in rats|
Zhang 2000|A clinical study of Shenmai injection for congestive heart failure|
Ding 2012 {published data only}|Effect of Shengmai injection on heart function in the Patients with chronic heart failure combined with coronary heart disease|
Fang 1987 {published data only}|The function of Shengmai injection for patients with coronary heart disease|/resolve/reference/PMED?id=3322707
He 2004 {published data only}|Effects of Shengmai injection on congestive heart failure patients with abnormal flow mediated dilation of brachial artery volume|
Jiang 1988 {published data only}|Effectiveness of Sengmai oral liquid on left ventricle function and exercise tolerance for dilated cardiomyopathy|/resolve/reference/PMED?id=3058445
Liu 2007a {published data only}|Study on clinical efficacy and security of different doses of Shengmai injection for heart failure|
Liu 2013 {published data only}|Clinical observation of co-therapeutic effect of Shengmai powder on patients with chronic congestive heart failure|
Mao 2003a {published data only}|The mechanism of Shengmai injection for congestive heart failure|/resolve/reference/PMED?id=12800416
Su 2012 {published data only}|The effect of high-dose Shengmai injection for the plasma brain natriuretic peptide of patients with congestive heart failure|
Wan 2012 {published data only}|Clinical evaluation of Shengmai injection treatment for diastolic heart failure by ultrasonic cardiogram|
Wang 2010a {published data only}|The influence of Shengmai injection on heart function and brain natriuretic peptide of patients with chronic congestive heart failure|/resolve/reference/PMED?id=8716080
Zhai 2009 {published data only}|The clinical research of pulse-activating injection on 30 cases of chronic congestive heart failure|
Zhang 2002 {published data only}|Effect of Shengmai injection on haemodynamics in patients with dilated cardiomyopathy|/resolve/reference/PMED?id=12584790
Zhao 2006 {published data only}|The influence of Shengmai injection for the urine output of patients with heart failure|
Bu 2007 {published data only}|Efficacy of Shengmai injection for congestive cardiac failure|
Cen 1999 {published data only}|The effect of Shengmai injection on QT dispersion for congestive heart failure|
Chen 2000 {published data only}|Shengmai injection for 29 patients with heart failure of pulmonary heart disease|
Chen 2003 {published data only}|Shengmai and glonoin for congestive heart failure|
Chen 2008 {published data only}|Observation and nursing of Shengmai injection for pulmonary heart disease combined with heart failure in aged|
Chen 2010 {published data only}|Observation of Shengmai injection for chronic heart failure|
Chen 2012 {published data only}|Clinical observation on treating 30 cases of heart failure by Sheng Mai Yin|
Chen 2013 {published data only}|Clinical efficacy for puerarin united Shengmai injection in the treatment of chronic systolic heart failure|/resolve/reference/PMED?id=14527976
Cheng 2001 {published data only}|The effect of Shengmai injection on serum enzyme for pulmonary heart disease|
Cheng 2007 {published data only}|Shengmai injection in adjuvant treatment of 45 patients with chronic congestive heart failure|
Dai 2011 {published data only}|Efficacy observation on traditional Chinese and western medicine combined treatment for old patients with chronic congestive heart failure|
Deng 1992 {published data only}|Efficacy of Shengmai granule for angina pectoris|
Ding 2005 {published data only}|Shengmai injection for heart failure|
Dou 2010 {published data only}|Efficacy of Shengmai injection for chronic heart failure|
Duan 2010 {published data only}|Lives arteries inoculation fluid treatment congested heart failure 60 example clinical analysis|
Fan 2004 {published data only}|Shengmai injection for 34 patients with aged heart failure|
Feng 2002 {published data only}|Shengmai injection and phentolamine for 30 patients with cases heart failure|
Feng 2003 {published data only}|Shengmai injection and digoxin for congestive heart failure|
Feng 2012 {published data only}|Observation of haemodynamic changes of 19 patients with dilated cardiomyopathy complicated with heart failure received Shengmai injection treatment|
Gao 2001 {published data only}|The effect of Shengmai injection for acute heart failure of pulmonary heart disease|
Gong 2006 {published data only}|The influence of Shengmai injection on heart function and brain natriuretic peptide of patients with chronic congestive heart failure|
Gu 2004 {published data only}|Shengmai injection for 80 patients with congestive heart failure|
Gu 2008 {published data only}|Clinical research on the effect of Shengmai for ventricular remodeling of patients with chronic heart failure|
He 2001 {published data only}|The effect of Shengmai complement treatment for 40 patients with congestive heart failure|
Hong 2005 {published data only}|Effect of Shengmai injection on trial death receptor of patients with congestive heart failure|/resolve/reference/PMED?id=16398429
Hong 2009 {published data only}|Clinical observation of integrating therapy of Chinese and Western medicine for elderly patients with coronary heart disease and heart failure|
Hou 2012 {published data only}|Efficacy observation of Shengmai injection for 56 patients with chronic congestive heart failure|
Hu 1997 {published data only}|Efficacy of Shengmai injection for acute myocardial infarction|
Hu 1998 {published data only}|The effects of Shengmai injection and sodium nitroprusside for 36 patients with heart failure of ischemic heart disease|
Hu 2005a {published data only}|Efficacy observations on Shengmai injection for chronic heart failure|
Hu 2005b {published data only}|Shengmai injection improves the cardiorespiratory function of catabasis of chronic cor pulmonale patients|
Hui 2007 {published data only}|Analysis of Shengmai injection for dilated cardiomyopathy with heart failure|
Jiang 2005 {published data only}|The effects of Shengmai for patients with coronary artery bypass grafting|
Jiang 2010 {published data only}|Observation of Shengmai tablets for chronic systolic heart failure|
Kong 2010 {published data only}|Study on Shengmai in patients with chronic heart failure of type of Qi and Yin deficiency|
Li 1998a {published data only}|The effect of Shengmai injection for refractory heart failure|
Li 1998b {published data only}|Clinical analysis of Shengmai injection for 64 patients with refractory heart failure of pulmonary heart disease|/resolve/reference/PMED?id=9482661
Li 2003a {published data only}|Clinical observation on Shengmai injection and dobutamine for acute myocardial infarction with heart failure|
Li 2003b {published data only}|The effect of Shengmai injection for heart failure of chronic pulmonary heart disease|
Li 2004 {published data only}|The effect of Shengmai injection on B type natriuretic peptide for congestive heart failure|
Li 2006a {published data only}|Efficacy of Shengmai for congestive cardiac failure|
Li 2008 {published data only}|Clinical observation of Shengmai injection for chronic cardiac failure|
Li 2009a {published data only}|The clinical study on effects of Shengmai injection with chronic heart failure treatment by monitoring the level of plasma NT-ProBNP|
Li 2009b {published data only}|Clinical study of Shengmai injection for dilated cardiomyopathy|
Li 2009c {published data only}|Shengmai injection for 26 patients of chronic pulmonary heart disease|
Li 2012a {published data only}|Clinical research on the efficacy of Shengmai injection for chronic congestive heart failure|
Li 2012b {published data only}|Efficacy observation of Shengmai injection for patients with chronic congestive heart failure|/resolve/reference/PMED?id=10684889
Liang 2006 {published data only}|TCM treatment for elderly patients with acute myocardial infarction|
Liao 1996 {published data only}|The effect of Shengmai injection for 45 patients with heart failure|
Liu 1999 {published data only}|Integration of traditional and western medicine for 35 patients with chronic refractory heart failure|
Liu 2007b {published data only}|Efficacy of large dose Shengmai injection for acute left ventricular failure|
Liu 2009 {published data only}|The effect of Shengmai injection plus metoprolol for dilated cardiomyopathy combined with congestive heart failure|
Liu 2010 {published data only}|The effect of Shengmai injection plus metoprolol for coronary heart disease combined with chronic congestive heart failure|
Lu 2005 {published data only}|Effect of Shengmai injection on cardiac function assessed by ventriculography in the patients with coronary artery disease|
Lu 2008 {published data only}|Shengmai injection for chronic heart failure|
Lu 2009 {published data only}|The effect of Shengmai injection on BNP for chronic heart failure|
Lu 2012 {published data only}|Clinical observation of Shengmai injection for 68 cases of chronic congestive heart failure|
Ma 2003 {published data only}|Influence of large amount of Shengmai injection on blood coagulation in patients with chronic heart failure|/resolve/reference/PMED?id=12764910
Ma 2006 {published data only}|Shengmai injection for chronic pulmonary heart disease patients with refractory heart failure|
Ma 2008 {published data only}|Western medicine united Shenmai injection for diastolic heart failure|
Mao 1998 {published data only}|The effect of Shengmai plus grain for 32 patients with heart failure of pulmonary heart disease|
Mao 2003b {published data only}|Clinical study on the effect of Shengmai injection on serum concentration and pharmacokinetic parameters of digoxin in patients with congestive heart failure|/resolve/reference/PMED?id=12800416
Mao 2006a {published data only}|Effect of different dose of Shengmai injection for heart failure|
Mao 2006b {published data only}|Shengmai injection for patients with heart failure of digoxin in renal displacement|
Miao 2005 {published data only}|The effects of Shengmai for acute myocardial infarction|
Mo 1996 {published data only}|The effect of Shengmai injection on heart function change for chronic heart failure|
Ni 2004 {published data only}|Shengmai injection for chronic congestive heart failure|
Ni 2007 {published data only}|Efficacy observation on Shengmai Injection for congestive heart failure|
Ni 2012 {published data only}|Adjuvant therapy with Shengmai injection for chronic heart failure in 43 cases|
Peng 2007 {published data only}|Efficacy of metoprolol and Shengmai capsule for chronic congestive heart failure|
Peng 2012 {published data only}|Randomized controlled clinical study of Shengmai injection combined with L-Carnitine in treating chronic heart failure|
Qiao 2007 {published data only}|Clinical observation of Shengmai yin for chronic congestive heart failure|
Qiu 1999 {published data only}|The effect of Shengmai complement treatment for heart failure of pulmonary heart disease|
Qiu 2007 {published data only}|Effect of Shengmai for chronic cardiac failure|
Shao 2006 {published data only}|Therapeutic effectiveness: observation on Shengmai injection for elderly patients with chronic heart failure|
Shen 2006 {published data only}|Type-b ultrasonic observed on Shengmai capsules for left ventricular remodeling and cardiac function of patients with congestive heart failure|
Shi 2006 {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Shi 2006a {published data only}|Effect of Shengmai injection for chronic congestive heart failure|
Shi 2006b {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Song 2013 {published data only}|Effect of Shengmai injection on the serum IL 1, IL 8, IL 12 and IL 18 levels of chronic heart failure patients|
Su 2008 {published data only}|Clinical observation on Chinese combined with Western medicine for chronic heart failure|
Sun 1998 {published data only}|The effect of Shengmai injection for congestive heart failure|
Sun 1998b {published data only}|The effect of Shengmai injection for congestive heart failure|
Sun 1999 {published data only}|The effect of Shengmai injection for 50 patients with heart failure of pulmonary heart disease|
Tang 2001 {published data only}|The effect of Shengmai injection for 33 patients with congestive heart failure|
Tang 2005 {published data only}|Shengmai injection for heart failure|
Wan 2004 {published data only}|Observation on therapeutic effects of Shengmai injection upon treatment of congestive heart failure|
Wan 2007 {published data only}|Effect of Shengmai powder for quality of life of patients with congestive heart failure|
Wang 1994 {published data only}|The effect of Shengmai injection for cardiac insufficiency on clinical status and haemodynamic|/resolve/reference/PMED?id=7834522
Wang 1997 {published data only}|The effect of Shengmai injection for congestive heart failure|
Wang 2002 {published data only}|Effect of Shengmai injection for dilated cardiomyopathy in heart function|
Wang 2003 {published data only}|The clinical analysis of Shengmai injection plus usual western drugs for 100 patients with aged congestive heart failure|
Wang 2004a {published data only}|Shengmai capsule for chronic systaltic heart failure|
Wang 2004b {published data only}|Clinical observation of Shengmai injection for congestive heart failure|
Wang 2005a {published data only}|The effects of Shengmai injection for 42 patients with chronic systaltic heart failure|
Wang 2005b {published data only}|Clinical observation by colour Doppler ultrasound on Shengmai injection in adjuvant treatment of chronic congestive heart failure|
Wang 2005c {published data only}|Shengmai for obstinate heart failure|
Wang 2006a {published data only}|Clinical observation of Shengmai injection for dilated cardiomyopathy|
Wang 2006b {published data only}|Shengmai injection for left ventricular function change in the near future of patients with coronary heart disease combined with chronic heart failure|
Wang 2008a {published data only}|Clinical analysis of Chinese and western medicine treatment for pulmonary heart disease: 70 cases|
Wang 2008b {published data only}|Observation of Shengmai injection for diastolic insufficiency heart failure|
Wang 2009 {published data only}|Observation of high dose of Shengmai injection for 68 patients of coronary heart disease|
Wang 2010b {published data only}|Observation of Shengmai injection for congestive heart failure in aged|
Wang 2010c {published data only}|The effect of Shengmai injection on Q-T dispersion for heart failure|
Wu 2009a {published data only}|Observation of Shengmai injection for ischemics cardiomyopathy|
Wu 2009b {published data only}|Observation of Shengmai injection for cardia insufficiency caused by dilated cardiomyopathy|
Wu 2011 {published data only}|Clinical observation of adjuvant therapy with Shengmai injection for 36 elderly chronic congestive heart failure patients|/resolve/reference/PMED?id=15715435
Xiao 2004 {published data only}|Integration of traditional and western medicine for 32 patients with refractory heart failure|
Xin 2012 {published data only}|Adjuvant treatment with Shengmai injection for chronic heart failure combined with coronary heart disease: a clinical observation|
Xu 2009 {published data only}|Observation of Shengmai injection for coronary heart disease combined with chronic heart failure|
Xu 2011 {published data only}|The clinical therapeutic effect of Shengmai injection combining with Levocarnitine injection on congestive heart-failure|
Yan 2005 {published data only}|Shengmai San for acute myocardial infarction|
Yang 2001 {published data only}|Integration of traditional and Western medicine for 52 patients with refractory heart failure|
Yang 2005 {published data only}|Dose-effect study of Shengmai injection used for congestive heart failure|
Yang 2006a {published data only}|Shengmai injection for congestive heart failure|
Yang 2006b {published data only}|Clinical observation on Shengmai injection for acute exacerbation of chronic pulmonary heart disease|
Yang 2010 {published data only}|Observation of Shengmai injection for 43 patients of chronic congestive heart failure|
Ye 2011 {published data only}|Efficacy analysis of Shengmai injection for chronic arrhythmia patients|/resolve/reference/PMED?id=12549154
Yu 2005 {published data only}|Clinical effects of Shengmai injection on the patients with acute myocardial infarction combined with heart failure|
Yuan 2011 {published data only}|Efficacy observation of adjuvant therapy of Shengmai injection combined with Shuxuening injection for 89 patients with heart failure|
Zhan 2007 {published data only}|Shengmai injection for chronic pulmonary heart disease|
Zhang 1990 {published data only}|The effect of Shengmai injection on haemodynamic for heart failure of dilated cardiomyopathy|
Zhang 2004a {published data only}|Shengmai for refractory heart failure|
Zhang 2004b {published data only}|Effects of Shengmai injection in the treatment of acute myocardial infarction with left ventricular dysfunction|
Zhang 2006 {published data only}|Shenmai injection for chronic congestive heart failure|/resolve/reference/PMED?id=16599122
Zhang 2007a {published data only}|The influence of Shengmai injection for plasma ET of patients with dilated cardiomyopathy|
Zhang 2008 {published data only}|The effect of Shengmai injection on cardiac function and coagulation function of chronic heart failure|
Zhang 2008a {published data only}|Observation of Shengmai injection for refractory heart failure|
Zhang 2008b {published data only}|Feasibility study of Shengmai auxiliary semi-saturation Cedilanid treatment for paediatric pneumonia combined with heart failure|
Zhang 2008c {published data only}|Effect of Shengmai injection on cardiac function and inflammatory reaction in patients with acute coronary syndrome|/resolve/reference/PMED?id=18679601
Zhang 2009a {published data only}|Shengmai injection for chronic heart failure|
Zhang 2009b {published data only}|The application of Shengmai yin for the chronic coronary heart failure caused by the deficiency of yin and qi|
Zhang 2011 {published data only}|Clinical observation of Shengmai injection for old patients with refractory heart failure|
Zhao 1998a {published data only}|The clinical observation of Shengmai injection for 45 patients with heart failure of pulmonary heart disease|
Zhao 1998b {published data only}|The clinical observation of Shengmai injection for aged heart failure|
Zhao 2000 {published data only}|The effect of integration of traditional and western medicine on EF value change for heart failure|
Zhao 2004 {published data only}|Shengmai injection for 46 patients with chronic heart failure|
Zhao 2005 {published data only}|Clinical observation of combining of Shengmai injection with dopamine for acute myocardial infarction|
Zhao 2007 {published data only}|Clinical research on Shengmai injection for recovery of myocardial protective effect of sudden death|/resolve/reference/PMED?id=17514958
Zhao 2008 {published data only}|Observation of Shengmai injection for coronary heart disease combined with heart failure|
Zhao 2011 {published data only}|Clinical observation of the efficacy of Shengmai injection for patients with coronary disease combined with heart failure|
Zheng 1996 {published data only}|The effect of Shengmai powder for 6 patients with cardiogenic shock and acute left heart failure|
Zheng 2005 {published data only}|Curative effect evaluation of Shengmai injection on congestive heart failure in aged|
Zhong 2005 {published data only}|Shengmai injection for heart failure|
Zhong 2007 {published data only}|Clinical study of combining Shengmai with irbesartan for chronic congestive heart failure|
Zhou 2006a {published data only}|Clinical observation on the Shengmai injection combined with intravenous thrombolysis for patients with acute myocardial infarction|
Zhou 2006b {published data only}|Clinical observation on high-dose Shengmai injection for congestive heart failure|
Zhou 2009 {published data only}|The effect of Shengmai injection on BNP for congestive heart failure|
Zhu 2004 {published data only}|Change of thyroid hormone in patients with congestive heart failure and intervention with Shengmai injection|
Zou 2011 {published data only}|Clinical observation of Shengmai injection for chronic congestive heart failure|
Bers 2010|Digitalis and Na/Ca exchange: Old dog learns new mitochondrial tricks|
Bui 2012|Epidemiology and risk profile of heart failure|
Chen 2001|Experimental research on the haemodynamic influences of intravenous therapy of Shengmai injection on anaesthetic dogs|
Chen 2002|Efficacy of Shengmai injection on haemodynamics in heart dysfunction dogs|
Cheng 2011|1012 cases of adverse reactions/events of Shengmai injections|
CMA 2002|Retrospective investigation of hospitalised patients with heart failure in some parts of China in 1980, 1990 and 2000|
Deng 2008|Effect of Shengmai capsule on ventricular remodeling in rats with chronic congestive heart failure induced by pressure overload|
Deng 2012|Post-marketing safety reevaluation of Shengmai injection|
Dong 1984|Hemodynamic effects of Shengmai injection on acute myocardial infarction|/resolve/reference/PMED?id=6745071
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Elbourne 2002|Meta-analyses involving cross-over trials: Methodological issues|/resolve/reference/PMED?id=11914310
Faris 2012|Diuretics for heart failure|
Gheorghiade 1991|Digoxin: a neurohormonal modulator in heart failure?|/resolve/reference/PMED?id=1834367
Go 2013|Heart disease and stroke statistics - 2013 update: a report from the American Heart Association|
Gu 2003|Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011|Chapter 8: Assessing risk of bias in included studies|
Hood 2004|Digitalis for treatment of congestive heart failure in patients in sinus rhythm|
Jean 2011|Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure|
Jiang 2009|Epidemiology and clinical management of cardiomyopathies and heart failure in China|
Kemp 2012|The pathophysiology of heart failure|
Kong 2010|Study on Shengmai in patients with chronic heart failure of type of Qi and Yin deficiency|
Li 1996|Schisandra chinensis-dependent myocardial protective action of Sheng-Mai-San in rats|/resolve/reference/PMED?id=8982437
Li 2003|Immediate haemodynamic effects of Shengmai injection on patients with congestive heart failure|/resolve/reference/PMED?id=12971862
Li 2005|The pharmacological mechanism and clinical application of Shengmai injection|
Li 2006b|Adverse effects of Shengmai injection and reasons|
Li 2009|Systematic review on the application and adverse reactions of Shengmai injection|
Li 2011|Pharmacokinetics of ginsenoside Rb1 in Shengmai injection and its dissected prescription|
Li 2013|Preliminary safety evaluation for clinical application of Shengmai injection|
Lloyd-Jones 2010|Heart disease and stroke statistics - 2010 update: a report from the American Heart Association|
Mao 2003|Mechanical study of Shengmai injection in the treatment of congestive heart failure|
Maron 2010|Aldosterone receptor antagonists: effective but often forgotten|
McMurray 2012|ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012|
Pildal 2007|Impact of allocation concealment on conclusions drawn from meta-analyses of randomised trials|/resolve/reference/PMED?id=17517809
Rapaport 1979|Nomenclature and Criteria for Diagnosis of Ischemic Heart-Disease-Report of the Joint-International-Society-and-Federation-of-Cardiology-World-Health-Organization Task-Force on Standardization of Clinical Nomenclature. nomenclature and criteria for diagnosis of ischemic heart disease.|
Song 2011|Study of the Utilization of Traditional Chinese Medicine in Inpatients|
Tan 2006|Research of people's intention of Traditional Chinese Medicine in Sichuan Province|
Tian 2008|Analysis of Shengmai injection and market competition|
Wang 2002a|Modulation of saponins extracted from Shengmai powder on free calcium cultured rat myocardial ceIIs|/resolve/reference/PMED?id=3452965
Wang 2002b|Comparative study on the eradicating effects of oxygen free radicals by using three forms of Shengmai preparation|
Wang 2008|Comparison study of gold standard and stroke syndrome evaluation|
WHO 1984|Cardiomyopathies|
WHO/ISFC 1980|Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies|
Xia 1999|Hemodynamic effects contrast research of Shengmai injection on rabbit in recovery period|
Xu 2012|The influence of Shengmai powder on the ventricle reconstruction of rats with chronic heart failure|
Yancy 2013|2013 ACCF/AHA guideline for the management of heart failure|
Yu 2000|Antioxidative effect of Shengmai injection on the myocardium injury induced by adriamycin in rats|
Zhang 2007b|Pharmacodynamics research progress of Shengmai injection|
Cochrane 2007|Shengmai (a traditional Chinese herbal medicine) for heart failure|
Cochrane 2011|Shengmai (a traditional Chinese herbal medicine) for heart failure|
Cochrane 2012|Shengmai (a traditional Chinese herbal medicine) for heart failure|
Barlow 2000 {published data only}|A randomised controlled study of the Arthritis Self-Management Programme in the UK|/resolve/reference/PMED?id=11142075
Buszewicz 2006 {published and unpublished data}|Self management of arthritis in primary care: randomised controlled trial|/resolve/reference/PMED?id=17040926
Cohen 1986 {published data only}|Evaluation of arthritis self-management courses led by laypersons and by professionals|
de Weerdt 1991 {published data only}|Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy|
de Weerdt 1991 {published data only}|Randomized controlled evaluation of an education program for insulin treated patients with diabetes: effects on psychosocial variables|
Fu 2003 {published data only}|Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: randomized controlled trial|/resolve/reference/PMED?id=12764513
Gifford 1998 {published data only}|Pilot randomized trial of education to improve self-management skills of men with symptomatic HIV/AIDS|/resolve/reference/PMED?id=9637578
Griffiths 2005 {published and unpublished data}|Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease|/resolve/reference/PMED?id=16281998
Haas 2005 {published data only}|Chronic disease self-management program for low back pain in the elderly|/resolve/reference/PMED?id=15883575
Kennedy 2007 {published and unpublished data}|The effectiveness and cost effectiveness of a national lay-led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial|/resolve/reference/PMED?id=17325405
Lorig 1986 {published data only}|A comparison of lay-taught and professional-taught arthritis self-management courses|/resolve/reference/PMED?id=3772925
Lorig 1999a {published data only}|Community-based Spanish language arthritis education program: a randomized trial|/resolve/reference/PMED?id=10493473
Lorig 1999b {published data only}|Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial|/resolve/reference/PMED?id=10413387
Lorig 2003 {published data only}|Hispanic chronic disease self-management: a randomized community-based outcome trial|/resolve/reference/PMED?id=14639082
Riegel 2004 {published and unpublished data}|Is individual peer support a promising intervention for persons with heart failure?|/resolve/reference/PMED?id=15191260
Summers Holtrop 2002 {published and unpublished data}|"Sticking to it -- diabetes mellitus": a pilot study of an innovative behavior change program for women with type 2 diabetes|
Swerissen 2006 {published data only}|A randomised control trial of a self-management program for people with a chronic illness from Vietnamese, Chinese, Italian and Greek backgrounds|/resolve/reference/PMED?id=16859871
Von Korff 1998 {published and unpublished data}|A randomized trial of a lay person-led self-management group intervention for back pain patients in primary care|/resolve/reference/PMED?id=9854760
Anderson 1989 {published data only}|Effects of peer-group intervention on metabolic control of adolescents with IDDM Randomized outpatient study|/resolve/reference/PMED?id=2649330
Barlow 1996 {published data only}|Group education for people with arthritis|/resolve/reference/PMED?id=8788354
Barlow 2005 {published data only}|A 12-month follow-up study of self-management training for people with chronic disease: are changes maintained over time?|
Barrera 2002 {published data only}|Do Internet-based support interventions change perceptions of social support? An experimental trial of approaches for supporting diabetes self-management|/resolve/reference/PMED?id=12188054
Branch 1999 {published data only}|Positive impact of an intervention by arthritis patient educators on knowledge and satisfaction of patients in a rheumatology practice|
Breau 2003 {published data only}|The role of self-help groups in educating and supporting patients with prostate cancer and interstitial cystitis|
Brooks 2003 {published data only}|Comparing treatments for dual diagnosis: twelve-step and self- management and recovery training|/resolve/reference/PMED?id=12765211
Campbell 1996 {published data only}|The relative effectiveness of educational and behavioral instruction programs for patients with NIDDM: a randomized trial|/resolve/reference/PMED?id=8846745
Carroll 2006 {published and unpublished data}|Comparing interventions in older unpartnered adults after myocardial infarction|/resolve/reference/PMED?id=16256442
Clarke 2002 {published data only}|Supporting new mothers with postnatal depression: an evaluation|
Damush 2003a {published and unpublished data}|The long-term effects of a self-management program for inner-city primary care patients with acute low back pain|/resolve/reference/PMED?id=14638564
Damush 2003b {published data only}|Randomized trial of a self-management program for primary care patients with acute low back pain: short-term effects|
Feathers 2005 {published data only}|Racial and Ethnic Approaches to Community Health (REACH) Detroit partnership: improving diabetes-related outcomes among African American and Latino adults|/resolve/reference/PMED?id=16051927
Gilden 1992 {published data only}|Diabetes support groups improve health care of older diabetic patients|/resolve/reference/PMED?id=1740599
Glasgow 1992 {published data only}|Improving self-care among older patients with type II diabetes: The "sixty something..." Study|/resolve/reference/PMED?id=1298950
Glasgow 2003 {published data only}|The D-Net diabetes self-management program: long-term implementation, outcomes, and generalization results|/resolve/reference/PMED?id=12649049
Gold 2004 {published data only}|Group treatment improves trunk strength and psychological status in older women with vertebral fractures: results of a randomized, clinical trial|
Greenhalgh 2005 {published data only}|Sharing stories: complex intervention for diabetes education in minority ethnic groups who do not speak English|/resolve/reference/PMED?id=15774990
Helgeson 1999 {published data only}|Education and peer discussion group interventions and adjustment to breast cancer|/resolve/reference/PMED?id=10197829
Hopman 2000 {published data only}|The effects of a health educational and exercise program for older adults with osteoarthritis for the hip or knee|/resolve/reference/PMED?id=10955337
Hughes 2004 {published data only}|Enhancing self-esteem in women with physical disabilities|
Kennedy 2004 {published data only}|A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease|/resolve/reference/PMED?id=15479685
Lidren 1994 {published data only}|A comparison of bibliotherapy and group therapy in the treatment of panic disorder|/resolve/reference/PMED?id=7962893
Lieberman 2005 {published data only}|Self-help on-line: an outcome evaluation of breast cancer bulletin boards|/resolve/reference/PMED?id=16176962
Lorig 1993 {published data only}|Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs|
Lorig 2004 {published data only}|Long-term randomized controlled trials of tailored-print and small- group arthritis self-management interventions|/resolve/reference/PMED?id=15076811
Payne 1995 {published data only}|Controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome|/resolve/reference/PMED?id=7593870
Persky 1999 {published data only}|Chicago community-based asthma intervention trial: feasibility of delivering peer education in an inner-city population|/resolve/reference/PMED?id=10532497
Phelan 2004 {published data only}|Activities of daily living function and disability in older adults in a randomized trial of the health enhancement program|/resolve/reference/PMED?id=15345735
Pibernik 2004 {published data only}|Effects of an empowerment-based psychosocial intervention on quality of life and metabolic control in type 2 diabetic patients|/resolve/reference/PMED?id=15132525
Purcell 2004 {published data only}|Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction|/resolve/reference/PMED?id=15385907
Reuille 2004 {published data only}|An evaluation of the Moffitt Cancer Center's Laryngectomee Visitor program|/resolve/reference/PMED?id=15188928
Rickheim 2002 {published data only}|Assessment of group versus individual diabetes education: a randomized study|/resolve/reference/PMED?id=11815494
Robinson 2006 {published data only}|A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome|/resolve/reference/PMED?id=16099784
Samarel 2002 {published data only}|Effects of two types of social support and education on adaptation to early-stage breast cancer|
Savelkoul 2001 {published data only}|Effects of a coping intervention on patients with rheumatic diseases: results of a randomized controlled trial|
Shah 2001 {published data only}|Effect of peer led programme for asthma education in adolescents: cluster randomised controlled trial|/resolve/reference/PMED?id=11238152
Sherifali 2004 {published data only}|A case manager plus psychoeducation reduced adverse outcomes in youth with type 1 diabetes|
Shively 2005 {published data only}|Effect of behavioral management on quality of life in mild heart failure: a randomized controlled trial|/resolve/reference/PMED?id=15950833
Siu 2007 {published data only}|Evaluation of the chronic disease self-management program in a Chinese population|/resolve/reference/PMED?id=16872789
Smith 2000 {published data only}|Telecommunication support for rural women with diabetes|/resolve/reference/PMED?id=11140073
Snyder 1987 {published data only}|Development and evaluation of an adult asthma self-management program: Wheezers Anonymous|/resolve/reference/PMED?id=3505528
Solomon 2002 {published and unpublished data}|Does self-management education benefit all populations with arthritis? A randomized controlled trial in a primary care physician network|/resolve/reference/PMED?id=11838857
Tankova 2004 {published data only}|Education and quality of life in diabetic patients|/resolve/reference/PMED?id=15186865
Toobert 2002 {published data only}|Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial|/resolve/reference/PMED?id=12408202
Uitewaal 2004 {published data only}|Feasibility of diabetes peer education for Turkish type 2 diabetes patients in Dutch general practice|/resolve/reference/PMED?id=15186875
Wagner 2001 {published data only}|Chronic care clinics for diabetes in primary care: a system-wide randomized trial|/resolve/reference/PMED?id=11315833
Weiss 2003 {published data only}|Effects of a supportive-expressive group intervention on long-term psychosocial adjustment in HIV-infected gay men|/resolve/reference/PMED?id=12707480
Yip 2007 {published data only}|Impact of an arthritis self-management programme with an added exercise component for osteoarthritic knee sufferers on improving pain, functional outcomes, and use of health care services: an experimental study|/resolve/reference/PMED?id=17010554
McGowan 2004 {published data only}|The effectiveness of diabetes patient education and self-management training for persons with Type 2 diabetes|
Ajzen 1980||
Alderson 2004|Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]|
Bandura 1977|Self-efficacy: toward a unifying theory of behavioral change|/resolve/reference/PMED?id=847061
Brooks 1996|EuroQol: the current state of play|/resolve/reference/PMED?id=10158943
Bury 2005||
Cohen 1992|A power primer|/resolve/reference/PMED?id=19565683
Coulter 1999|Paternalism or partnership?|/resolve/reference/PMED?id=10487980
Delgado 2004|Bias|
Donaldson 2003|Expert patients usher in a new era of opportunity for the NHS|/resolve/reference/PMED?id=12805129
Doull 2005|Peer support strategies for people with chronic disease to enhance health and promote health equity|
Higgins 2006|Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]|
HMSO 2001||
Hollis 1999|What is meant by intention to treat analysis? Survey of published randomised controlled trials|/resolve/reference/PMED?id=10480822
Holman 2000|Patients as partners in managing chronic disease|/resolve/reference/PMED?id=10688539
Hunter 2003|The Wanless report and public health|/resolve/reference/PMED?id=12969899
Lewin 2005|Lay health workers in primary and community health care|/resolve/reference/PMED?id=15674924
LMCA 2004|Ten facts about long-term conditions|
Lopez 1998|The global burden of disease, 1990-2020|/resolve/reference/PMED?id=9809543
Lorig 1996||
Lorig 2000||
Lorig 2002|Partnerships between expert patients and physicians|/resolve/reference/PMED?id=11897275
Lorig 2003b|Self-management education: history, definition, outcomes, and mechanisms|/resolve/reference/PMED?id=12867348
McGowan 2006|The Chronic Disease Self-Management Program: Program evaluation|
NHS 2002||
Review Manager 4.2|Review Manager (RevMan)|
Ryan 2007|Cochrane Consumers and Communication Review Group Study Quality Guide|
Scholten 1999||
Walters 2005|Comparison of the minimal important difference for two health state utility measures: EQ5D and SF-6D|/resolve/reference/PMED?id=16110932
Wanless 2002||
Furst 2003 {published data only}|Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: Results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)|/resolve/reference/PMED?id=14719195
Keystone 2004 {published data only}|Radiographic, clinical, and functional outcomes of treatment with Adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy. A randomized, placebo-controlled, 52-week trial|
Rau 2004 {published data only}|Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate|/resolve/reference/PMED?id=15228184
Van de Putte 2003 {published data only}|Efficacy and safety of the fully human anti-tumor necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study|/resolve/reference/PMED?id=14644854
Van de Putte 2004 {published data only}|Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed|/resolve/reference/PMED?id=15082480
Weinblatt 2003 {published data only}|Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate. The ARMADA trial|
Barrera 2002 {published data only}|Drug survival, efficacy and toxicity of monotherapy with a full human anti-tumor necrosis factor alpha antibody compared with methotrexate in long-standing rheumatoid arthritis|/resolve/reference/PMED?id=11961174
Den Broeder 2002a {published data only}|A single dose, placebo controlled study of the fully human anti-tumor necrosis factor alpha antibody Adalimumab (D2E7) in patients with rheumatoid arthritis|/resolve/reference/PMED?id=12415583
Den Broeder 2002b {published data only}|Dose tritation using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alpha|/resolve/reference/PMED?id=12048289
Den Broeder 2002c {published data only}|Long term anti-tumor necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartlage turnover and endothelial activation|/resolve/reference/PMED?id=11874832
Den Broeder 2003 {published data only}|Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor alpha monoclonal antibody in patients with rheumatoid arthritis|/resolve/reference/PMED?id=12563673
Keystone 2003 {published data only}|Role of Adalimumab in the treatment of early rheumatoid arthritis|
Schatenkirchner 1998 {published data only}|Efficacy and tolerability of weekly subcutaneous injections of the fully human anti-TNF antibody D2E7 in patients with rheumatoid arthritis-results of a phase I study (abstract)|
Tjioe 2003 {published data only}|Adalimumab, a fully human anti-TNF-alpha monoclonal antibody, treatment does not influence experimental UV response in the skin of rheumatoid arthritis patients|
Velagapudi 2004 {published data only}|Adalimumab (Humira) 40 mg every other week plus methotrexate in patients with rheumatoid arthritis provides stable serum concentrations and sustaines efficacy over 1 year|
Weisman 2003 {published data only}|Efficacy, pharmacokinetic, and safety assessment of Adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study|/resolve/reference/PMED?id=12860493
Arnett 1988|The American Rheumatism Association revised criteria for the classification of rheumatoid arthrtitis|
Blumenauer 2003a|Infliximab for the treatment of rheumatoid arthritis|/resolve/reference/PMED?id=14584021
Blumenauer 2003b|Etanercept for the treatment of rheumatoid arthritis.|/resolve/reference/PMED?id=14584021
Cates 2003|EBM website|
Clarke 2001|Cochrane Review Handbook 4.1.2. (update March 2001).|
Felson 1995|American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding neccesary?|/resolve/reference/PMED?id=8721797
Tugwell 2004||
van der Heijde 1993|Development of a disease activity score based on judgment in clinical practice by rheumatologists|/resolve/reference/PMED?id=8478878
Van Gestel 1996|Development and validation of the European League Against Rheumatism response criteria for rheumaotid arthritis. Comparison with the preliminary American College of Rheumatology and the Worl Health Organisation/International League Against Rheumatism criteria|
Verhagen 1998|The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematc review developed by Delphi consensus|/resolve/reference/PMED?id=10086815
Beltrame 1998 {published data only}|Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary oedema|/resolve/reference/PMED?id=9924848
Nelson 1983 {published data only}|Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart failure following myocardial infarction|
Verma 1987 {published data only}|First-line treatment of left ventricular failure complicating acute myocardial infarction: a randomised evaluation of immediate effects of diuretic, venodilator, arteriodilator, and positive inotropic drugs on left ventricular function|/resolve/reference/PMED?id=2441152
VMAC 2002 {published data only}|Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure|/resolve/reference/PMED?id=11911755
Cotter 1998 {published data only}|Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema|/resolve/reference/PMED?id=9482291
Elkayam 2004 {published data only}|Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure|/resolve/reference/PMED?id=14715359
Adamson 2011|Hemodynamic factors associated with acute decompensated heart failure: part 2 - use in automated detection|
ADHERE 2003|First Quarter 2003 National Benchmark Report|
AHA 2001|Heart and stroke statistical update|
Ambrosioni 1995|The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after myocardial infarction|/resolve/reference/PMED?id=7990904
Berry 2001|Economics of chronic heart failure|
Bueno 1995|Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction|/resolve/reference/PMED?id=7648657
Campana 1993|Predictors of prognosis in patients awaiting heart transplantation|
Cleland 2001|The heart failure epidemic: exactly how big is it?|/resolve/reference/PMED?id=11286518
Cleland 2003|The EuroHeart Failure survey programme - a survey of the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis|/resolve/reference/PMED?id=12633546
Cotter 2000|L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock|/resolve/reference/PMED?id=10736276
Cotter 2003|The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure|
Cowie 1997|The epidemiology of heart failure|/resolve/reference/PMED?id=9043837
Crane 2002|Epidemiology, treatment and outcome of acidotic, acute, cardiogenic pulmonary oedema presenting to an emergency department|/resolve/reference/PMED?id=12501030
Deeks 2011|Chapter 9: Analysing data and undertaking meta-analyses|
DiDomenico 2004|Guidelines for acute decompensated heart failure treatment|
DiGuili 2001|Current issues in heart failure|
Doughty 1995|Hospital admissions and deaths due to congestive heart failure in New Zealand, 1981-1991|/resolve/reference/PMED?id=8538973
Eriksson 1991|Epidemiology and prognosis of heart failure|
Fonarow 2001|The treatment targets in acute decompensated heart failure|
Fonarow 2002|Pharmacologic therapies for acutely decompensated heart failure|
Fonarow 2003|The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure|
Fonarow 2008|Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF|/resolve/reference/PMED?id=18443260
Ghali 1990|Trends in hospitalisation rates for heart failure in the United States 1973-1986: evidence for screening population prevalence|/resolve/reference/PMED?id=2327838
Gheorghiade 2005|Acute heart failure syndromes: current state and framework for future research|
GISSI-3 1994|Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction|/resolve/reference/PMED?id=7910229
Glasziou 2001||
Hellermann 2002|Heart failure after myocardial infarction: a review|/resolve/reference/PMED?id=12361819
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Higgins 2011|Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Hochman 1999|Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock|/resolve/reference/PMED?id=10460813
Hunt 2001|ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult|/resolve/reference/PMED?id=11738322
Imhof 1980|Difference in nitroglycerin dose response in the venous and arterial beds|/resolve/reference/PMED?id=6780368
ISIS-4 1995|ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group|/resolve/reference/PMED?id=7661937
Kaluski 2003|RITZ-5: Randomized intravenous tezosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema. A prospective, multicenter, double-blind, placebo-controlled study|/resolve/reference/PMED?id=12535809
Khan 1996|The importance of quality of primary studies in producing unbiased systematic reviews|/resolve/reference/PMED?id=8629879
Khand 1999|Is the prognosis of heart failure improving?|
Lau 1998|Quantitative synthesis in systematic reviews|
Lefebvre 2011|Chapter 6: Searching for studies. Using the Cochrane sensitivity-maximising RCT filter|
Lucas 2000|Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure|/resolve/reference/PMED?id=11099986
McMurray 2012|ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC|
Mebazaa 2010|The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT- dyspnoea study|
Nohria 2002|Medical management of advanced heart failure|/resolve/reference/PMED?id=11829703
Pang 2008|A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach|/resolve/reference/PMED?id=18310669
Pang 2010|The current and future management of acute heart failure syndromes|
Peacock 2004|Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy|/resolve/reference/PMED?id=15101023
Reitsma 1996|Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993|/resolve/reference/PMED?id=8944582
RevMan 5.2|Review Manager (RevMan)|
Rodriguez 1997|Trends in hospitalization and mortality for heart failure in Spain, 1980-1993|
Roger 2011|Heart disease and strokestatistics--2011update: areportfrom theAmerican Heart Association.|
Schappert 2008|Ambulatory medical care utilization estimates for 2006|
Sharon 2000|High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema|/resolve/reference/PMED?id=10987607
Spencer 1999|Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective|/resolve/reference/PMED?id=10551682
Spencer 2002|Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction|/resolve/reference/PMED?id=12045165
Steg 2004|Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)|/resolve/reference/PMED?id=14744970
Stevenson 1999|Tailored therapy to hemodynamic goals for advanced heart failure|
Stewart 2001|More 'malignant' than cancer? 5-year survival following a first admission with heart failure|
Stewart 2002|The current cost of heart failure to the National Health Service in the UK|
Stewart 2003|Heart failure and the aging population: an increasing burden in the 21st century?|/resolve/reference/PMED?id=12482791
Weintraub 2010|Acute heart failure syndromes: emergency department presentation, treatment and disposition: current approaches and future aims: a scientific statement from the American Heart Association|
Whellan 2013|Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics|
Wu 2002|Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)|/resolve/reference/PMED?id=12392826
Zile 2011|Hemodynamic factors associated with acute decompensated heart failure: part 1 - insights into pathophysiology|
CHARISMA 2006 {published data only}|Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events|/resolve/reference/PMED?id=16531616
CURE 2001 {published data only}|Differences in the management and prognosis of women and men who suffer from acute coronary syndromes|/resolve/reference/PMED?id=16286169
CURE 2001 {published data only}|Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups|/resolve/reference/PMED?id=12270853
CURE 2001 {published data only}|Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial|/resolve/reference/PMED?id=15313956
CURE 2001 {published data only}|Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study|/resolve/reference/PMED?id=16338255
CURE 2001 {published data only}|Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation|/resolve/reference/PMED?id=16368322
CURE 2001 {published data only}|Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study|/resolve/reference/PMED?id=11520521
CURE 2001 {published data only}|Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study|/resolve/reference/PMED?id=14504182
CURE 2001 {published data only}|Early and late effects of clopidogrel in patients with acute coronary syndromes|/resolve/reference/PMED?id=12600908
CURE 2001 {published data only}|Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation|/resolve/reference/PMED?id=11519503
Akbulut 2004 {published data only}|The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention|/resolve/reference/PMED?id=15346093
Azar 2006 {published data only}|Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients ith stable coronary artery disease|/resolve/reference/PMED?id=16442924
CARESS 2005 {published data only}|Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection. The Clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial|/resolve/reference/PMED?id=15851601
Cassar 2005 {published data only}|Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after low limb angioplasty|
CLARITY-TIMI 28 2005 {published data only}|Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation|/resolve/reference/PMED?id=15758000
COMMIT 2005 {published data only}|Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial|/resolve/reference/PMED?id=16271642
CREDO 2002 {published data only}|The influence of body mass index on outcomes and the benefit of antiplatelet therapy following percutaneous coronary intervention|/resolve/reference/PMED?id=16598110
CREDO 2002 {published data only}|Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment|/resolve/reference/PMED?id=15845611
CREDO 2002 {published data only}|Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention|/resolve/reference/PMED?id=15342293
CREDO 2002 {published data only}|Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial|/resolve/reference/PMED?id=12435254
Jagroop 2004 {published data only}|The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease|/resolve/reference/PMED?id=15154604
Pekdemir 2003 {published data only}|A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation|/resolve/reference/PMED?id=12955427
Steinhubl 2006 {published data only}|Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention|/resolve/reference/PMED?id=16516075
Xydakis 2004 {published data only}|The combination of clopidogrel and acetylsalicylic acid inhibits more effective the platelet activation in haemodialysis patients with acute coronary syndromes and high C reactive protein|
Zhao 2003 {published data only}|The effects of three anti-platelet drugs (aspirin, clopidogrel, dipyridamole) given singly or together on platelet and leucocyte function in healthy subjects and patients with previous ischemic stroke|
CASCADE {published data only (unpublished sought but not used)}|Randomized control trial of clopidogrel after surgery for coronary artery disease|
CASPAR {published data only (unpublished sought but not used)}|Clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease|
FASTER {published data only (unpublished sought but not used)}|Fast assessment of stroke and transient ischemic attack to prevent early recurrence|
MIRROR Trial {published data only (unpublished sought but not used)}|Follow-up management of peripheral arterial intervention with clopidogrel|
SPS3 {published data only (unpublished sought but not used)}|Secondary prevention of small subcortical strokes trial|
ATC 2002|Collaborative meta-analysis of randomised trails of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.|/resolve/reference/PMED?id=11786451
CAPRIE 1996|A randomised, blinded, trial of clopidrogel versus aspirin in patients at risk of ischaemic events (CAPRIE)|/resolve/reference/PMED?id=8918275
Cosmi 2004|Ticlopidine versus oral anticoagulation for coronary stenting|
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Dorffler-Melly 2003a|Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery|
Dorffler-Melly 2003b|Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery|
Dorffler-Melly 2005|Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Gaspoz 2002|Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.|/resolve/reference/PMED?id=12050341
GUSTO 1993|An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction|/resolve/reference/PMED?id=8204123
Hankey 2004|Thienopyridine derivates (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2005|Cochrane Handbook of Systematic Reviews of Interventions 4.2.5 [updated May 2005]|
HTA 2004|Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation|
Morant 2003|Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity|
NICE 2004|A rapid and systematic review on clinical effectiveness and cost-effectiveness of clopidogrel used in combination with aspirin compared to aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes (ACS) (Assessment Report)|
Patrono 2001|Platelet-active drugs: the relationships among dose, effectiveness, and side effects|/resolve/reference/PMED?id=11157642
Robless 2004|Cilostazol for peripheral arterial disease|
Robless 2007|Antiplatelet agents for intermittent claudication|
WHO 2003|WHO Global Burden Disease Estimates|
Zakarija 2004|Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration|/resolve/reference/PMED?id=14707231
CHARISMA 2006 {published data only}|Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events|/resolve/reference/PMED?id=16531616
CHARISMA 2006 {published data only}|Aspirin prevent cardiovascular disease: the association aspirin dose and clopidogrel with thrombosis and bleeding|/resolve/reference/PMED?id=19293071
CURE 2001 {published data only}|Differences in the management and prognosis of women and men who suffer from acute coronary syndromes|/resolve/reference/PMED?id=16286169
CURE 2001 {published data only}|Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups|/resolve/reference/PMED?id=12270853
CURE 2001 {published data only}|Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial|/resolve/reference/PMED?id=15313956
CURE 2001 {published data only}|Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study|/resolve/reference/PMED?id=16338255
CURE 2001 {published data only}|Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation|/resolve/reference/PMED?id=16368322
CURE 2001 {published data only}|Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study|/resolve/reference/PMED?id=11520521
CURE 2001 {published data only}|Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study|/resolve/reference/PMED?id=14504182
CURE 2001 {published data only}|Early and late effects of clopidogrel in patients with acute coronary syndromes|/resolve/reference/PMED?id=12600908
CURE 2001 {published data only}|Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation|/resolve/reference/PMED?id=11519503
Akbulut 2004 {published data only}|The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention|/resolve/reference/PMED?id=15346093
Azar 2006 {published data only}|Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients ith stable coronary artery disease|/resolve/reference/PMED?id=16442924
CARESS 2005 {published data only}|The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy signal analysis and quality control mechanisms in the CARESS (clopidogrel and aspirin reduction emboli symptomatic carotid stenosis)|/resolve/reference/PMED?id=16514091
CARESS 2005 {published data only}|Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection. The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial|/resolve/reference/PMED?id=15851601
Cassar 2005 {published data only}|Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after low limb angioplasty|
CLARITY-TIMI 28 2005 {published data only}|Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation|/resolve/reference/PMED?id=15758000
COMMIT 2005 {published data only}|Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial|/resolve/reference/PMED?id=16271642
CREDO 2002 {published data only}|The influence of body mass index on outcomes and the benefit of antiplatelet therapy following percutaneous coronary intervention|/resolve/reference/PMED?id=16598110
CREDO 2002 {published data only}|Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment|/resolve/reference/PMED?id=15845611
CREDO 2002 {published data only}|Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention|/resolve/reference/PMED?id=15342293
CREDO 2002 {published data only}|Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial|/resolve/reference/PMED?id=12435254
FASTER 2007 {published data only}|Fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial|/resolve/reference/PMED?id=17931979
Jagroop 2004 {published data only}|The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease|/resolve/reference/PMED?id=15154604
Pekdemir 2003 {published data only}|A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation|/resolve/reference/PMED?id=12955427
Steinhubl 2006 {published data only}|Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention|/resolve/reference/PMED?id=16516075
Xydakis 2004 {published data only}|The combination of clopidogrel and acetylsalicylic acid inhibits more effective the platelet activation in haemodialysis patients with acute coronary syndromes and high C reactive protein|
Zhao 2003 {published data only}|The effects of three anti-platelet drugs (aspirin, clopidogrel, dipyridamole) given singly or together on platelet and leucocyte function in healthy subjects and patients with previous ischemic stroke|
ASAP-CABG {published data only (unpublished sought but not used)}|Aspirin and Plavix following coronary artery bypass grafting|
CASCADE {published data only (unpublished sought but not used)}|Randomized control trial of clopidogrel after surgery for coronary artery disease|
CASPAR {published data only (unpublished sought but not used)}|Clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease|
MIRROR Trial {published data only (unpublished sought but not used)}|Follow-up management of peripheral arterial intervention with clopidogrel|
SPS3 {published data only (unpublished sought but not used)}|Secondary prevention of small subcortical strokes trial|
ATC 2002|Collaborative meta-analysis of randomised trails of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.|/resolve/reference/PMED?id=11786451
CAPRIE 1996|A randomised, blinded, trial of clopidrogel versus aspirin in patients at risk of ischaemic events (CAPRIE)|/resolve/reference/PMED?id=8918275
Cosmi 2004|Ticlopidine versus oral anticoagulation for coronary stenting|
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Dorffler-Melly 2003a|Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery|
Dorffler-Melly 2003b|Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery|
Dorffler-Melly 2005|Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Gaspoz 2002|Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.|/resolve/reference/PMED?id=12050341
GUSTO 1993|An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction|/resolve/reference/PMED?id=8204123
Hankey 2004|Thienopyridine derivates (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2008|Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org|
HTA 2004|Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation|
Morant 2003|Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity|
NICE 2004|A rapid and systematic review on clinical effectiveness and cost-effectiveness of clopidogrel used in combination with aspirin compared to aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes (ACS) (Assessment Report)|
Patrono 2001|Platelet-active drugs: the relationships among dose, effectiveness, and side effects|/resolve/reference/PMED?id=11157642
Robless 2004|Cilostazol for peripheral arterial disease|
Robless 2007|Antiplatelet agents for intermittent claudication|
Van de Laar 2005|Adenosin-diphosphate (ADP) receptor antagonists (clopidogrel, ticlopidine) for the prevention of cardiovascular disease in type 2 diabetes mellitus (Protocol)|
WHO 2003|WHO Global Burden Disease Estimates|
Zakarija 2004|Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration|/resolve/reference/PMED?id=14707231
Carmenini 1994 {published data only}|Controlled multicentric clinical study with placebo in patients with dilatative myocardiopathy functional class II-III N.Y.H.A. treated with oral phosphocreatinine|
Ferraro 1996 {published data only}|Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo|
Gordon 1995 {published data only}|Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance|
Grazioli 1992 {published data only}|Multicenter controlled study of creatine phosphate in the treatment of heart failure|
Kuethe 2006 {published data only}|Creatine supplementation improves muscle strength in patients with congestive heart failure|/resolve/reference/PMED?id=16599263
Maggi 1990 {published data only (unpublished sought but not used)}|Double-blind multicenter clinical trial on the efficacy of phosphocreatinine vs L-carnitine and placebo in a group of patients affected by heart disease|
Pedone 1984 {published data only}|An assessment of the activity of creatine phosphate (Neoton) on premature ventricular beats by continuous ECG monitoring in patients with coronary cardiac disease|
Pedone 1984-2 {published data only}|Myocardial T1-201 scintigraphy in the study of the development of acute myocardial infarction. Evaluation of the effects of a drug with metabolic action: creatine phosphate|/resolve/reference/PMED?id=6525812
Ruda 1988 {published data only}|Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction|/resolve/reference/PMED?id=2456682
Samarenko 1987 {published data only}|[Initial experience with using phosphocreatine in patients in the early (up to 6 hours) period of myocardial infarction]|/resolve/reference/PMED?id=3426824
Zochowski 1994 {published data only}|Use of phosphocreatinine in treatment of acute heart failure|/resolve/reference/PMED?id=7659614
Andreev 1992 {published data only}|Effect of phosphocreatine in congestive heart failure|
Cafiero 1994 {published data only}|[The efficacy of creatine phosphate in the treatment of patients with heart failure. Its echographic evaluation after acute and protracted treatment]|/resolve/reference/PMED?id=8205755
Chiandussi 1991 {published data only}|Multicenter clinical study of phosphocreatinine effects and tolerability|
Divitiis 1986 {published data only}|[Evaluation of the effects on the peripheral blood circulation of i.v. administration of high doses of phosphocreatinine in patients with arterial diseases]|
Golikov 1993 {published data only}|[Neoton in the treatment of myocardial infarct and unstable stenocardia]|/resolve/reference/PMED?id=8309174
Grazioli 1989 {published data only}|Treatment with creatine phosphate in patients with heart failure: a multicenter study.|
Montanari 1981 {published data only}|Cardiodynamic alterations induced by treatment with phosphocreatinine|
Nedoshivin 1996 {published data only}|[Neoton (exogenic phosphocreatinine) in combined therapy of chronic cardiac failure]|/resolve/reference/PMED?id=9121090
Perepech 1993 {published data only}|[Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction]|/resolve/reference/PMED?id=8046897
Perepech 1997 {published data only}|Prophylactic use of Neoton in cardiac failure in patients with myocardial infarction]|/resolve/reference/PMED?id=9490342
Perepech 2001 {published data only}|[Neoton and thrombolytic therapy of myocardial infarction]|
Reimers 1994 {published data only}|Phosphocreatine in acute myocardial infarction: multicenter randomized study|
Stejfa 1993 {published data only}|[The effect of creatine phosphate (Neoton) in acute myocardial infarct (a prospective multicenter pilot study]|/resolve/reference/PMED?id=8506660
Tomaszewski 1994 {published data only}|Assessment of cardiac arrythmias in patients with newly diagnosed myocardial infarction treated with Neoton (phosphocreatine)|
Weber 1995 {published data only}|Use of creatine phosphate in treatment of cardiocerebral syndrome associated with acute myocardial infarct in the aged|/resolve/reference/PMED?id=7712526
Weinbergova 1996 {published data only}|Dynamics of some biochemical indices in myocardial infarction treated with thrombolysis and creatine phosphate.|/resolve/reference/PMED?id=9431703
Brewster 2000|Is greater tissue activity of creatine kinase the genetic factor increasing hypertension risk in black people of sub-Saharan African descent?|
Brewster 2006|Creatine kinase activity is associated with blood pressure|
Field 1996|Creatine supplementation in congestive heart failure|
Ingwall 2004|Is the failing heart energy starved? On using chemical energy to support cardiac function|
Neubauer 2007|The failing heart--an engine out of fuel|/resolve/reference/PMED?id=17360992
Schaufelberger 1998|Is creatine supplementation helpful for patients with chronic heart failure?|
Wyss 2000|Creatine and creatinine metabolism|/resolve/reference/PMED?id=10893433
Groeneveld 2003 {published data only}|A randomized sequential trial of creatine in amyotrophic lateral sclerosis|
Rosenfeld 2008 {published data only}|Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS|/resolve/reference/PMED?id=18608103
Shefner 2004 {published data only}|A clinical trial of creatine in ALS|/resolve/reference/PMED?id=15534251
Rosenfeld 2001 {published data only}|Creatine monohydrate in amyotrophic lateral sclerosis: preliminary results|
Adhihetty 2008|Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases|/resolve/reference/PMED?id=19005780
Bensimon 1994|A controlled trial of riluzole in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=8302340
Bessman 1985|The creatine-creatine phosphate energy shuttle|/resolve/reference/PMED?id=3896131
Brooks 2000|El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11464847
Cedarbaum 1999|The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)|/resolve/reference/PMED?id=10540002
Chancellor 1993|The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register|/resolve/reference/PMED?id=8336173
Cox 1972|Regression models and life tables|
Czaplinski 2006|Amyotrophic lateral sclerosis: early predictors of prolonged survival|/resolve/reference/PMED?id=16773270
Del Aguila 2003|Prognosis in amyotrophic lateral sclerosis: a population-based study|/resolve/reference/PMED?id=12629239
Drory 2002|No effect of creatine on respiratory distress in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=12061948
Goodall 2006|Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment|/resolve/reference/PMED?id=16723044
Gordon 2004|ALSFRS-R|/resolve/reference/PMED?id=15512883
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]|
Kleopa 1999|Bipap improves survival and rate of pulmonary function decline in patients with ALS|/resolve/reference/PMED?id=10385053
Klivenyi 1999|Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis|/resolve/reference/PMED?id=10086395
Lacomblez 1996|A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group II|/resolve/reference/PMED?id=8959996
Lawler 2002|Direct antioxidant properties of creatine|/resolve/reference/PMED?id=11779131
Li 1988|Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease|/resolve/reference/PMED?id=3404186
Mandrioli 2003|The epidemiology of ALS in Modena, Italy|/resolve/reference/PMED?id=12601112
Mathus-Vliegen 1994|Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function|/resolve/reference/PMED?id=7926537
Mazzini 1995|Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=8568533
Mazzini 2001|Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results|/resolve/reference/PMED?id=11677005
Meyer 1984|A simple analysis of the "phosphocreatine shuttle"|/resolve/reference/PMED?id=6372517
Miller 2009|Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology|/resolve/reference/PMED?id=19822872
Millul 2005|Survival of patients with amyotrophic lateral sclerosis in a population-based registry|/resolve/reference/PMED?id=15956808
Pastula 2009|Factors associated with survival in the National Registry of Veterans with ALS|/resolve/reference/PMED?id=19922120
Przedborski 2003|Recent advances in amyotrophic lateral sclerosis research|/resolve/reference/PMED?id=12507415
Rosen 1993|Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis|/resolve/reference/PMED?id=8446170
Rowland 2001|Amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11386269
Sanofi-Aventis 2006|Rilutek prescribing information|
Sestili 2006|Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity|/resolve/reference/PMED?id=16520236
Siddique 1995|Familial amyotrophic lateral sclerosis|/resolve/reference/PMED?id=9021255
Sorenson 2002|Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998|/resolve/reference/PMED?id=12136072
Testa 2004|Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period|/resolve/reference/PMED?id=15799548
Traynor 2003|Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study 1996-2000|/resolve/reference/PMED?id=12933930
Traynor 2004|Functional outcome measures as clinical trial endpoints in ALS|/resolve/reference/PMED?id=15557515
Worms 2001|The epidemiology of motor neuron diseases: a review of recent studies|/resolve/reference/PMED?id=11676986
Dal Bello-Haas 2007 {published and unpublished data}|A randomized controlled trial of resistance exercise in individuals with ALS|/resolve/reference/PMED?id=17548549
Drory 2001 {published and unpublished data}|The value of muscle exercise in patients with amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11677004
Aitkens 1993|Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease|/resolve/reference/PMED?id=8328892
Andres 1986|Quantitative motor assessment in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=3714055
Appel 1987|A rating scale for amyotrophic lateral sclerosis: description and preliminary experience|
Bennett 1958|Overwork weakness in partially denervated skeletal muscle|/resolve/reference/PMED?id=13619074
Bergner 1981|The Sickness Impact Profile: development and final revision of a health status measure|/resolve/reference/PMED?id=7278416
Bohannon 1983|Results of resistance exercise on a patient with amyotrophic lateral sclerosis|/resolve/reference/PMED?id=6856684
Brooks 2000|El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11464847
Cedarbaum 1999|The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)|/resolve/reference/PMED?id=10540002
CNTF 1996|The amyotrophic lateral sclerosis functional rating scale: Assessment of activities of daily living in patients with amyotrophic lateral sclerosis|/resolve/reference/PMED?id=8639063
Coble 1985|Interdisciplinary rehabilitation of multiple sclerosis and neuromuscular disorders|
Einarsson 1991|Muscle conditioning in late poliomyelitis|/resolve/reference/PMED?id=1985616
Florence 1984|Effects of training on the exercise response of neuromuscular disease patients|/resolve/reference/PMED?id=6513764
Gubbay 1985|Amyotrophic lateral sclerosis: A study of its presentation and prognosis|/resolve/reference/PMED?id=4056836
Hamida 2000|Juvenile amyotrophic lateral sclerosis|
Haverkamp 1995|Natural history of amyotrophic lateral sclerosis in database population. Validation of a scoring system and a model for survival prediction|/resolve/reference/PMED?id=7600088
Hillel 1989|Amyotrophic Lateral Sclerosis Severity Scale|/resolve/reference/PMED?id=2725806
Jenkinson 1999a|Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40|/resolve/reference/PMED?id=12365067
Jenkinson 1999b|Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40|
Johnson 1971|Overwork weakness in facioscapulohumeral muscular dystrophy|/resolve/reference/PMED?id=5565885
Kaspar 2005|Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis|
Kilmer 1994|The effect of a high resistance exercise program in slowly progressive neuromuscular disease|/resolve/reference/PMED?id=8185450
Kirkinezos 2003|Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis|
Krupp 1989|The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus|/resolve/reference/PMED?id=2803071
Kurtzke 1991|Risk factors in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=1853761
Lindeman 1995|Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial|/resolve/reference/PMED?id=7605179
Mahoney 2004|Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis|
McCartney 1988|The effects of strength training in patients with selected neuromuscular disorders|/resolve/reference/PMED?id=3173043
Milner-Brown 1988|Muscle strengthening through high resistance weight training in patients with neuromuscular disorders|/resolve/reference/PMED?id=3337636
Mitsumoto 1998|Clinical features: Signs and symptoms|
Mulder 1986|Familial adult motor neuron disease: amyotrophic lateral sclerosis|/resolve/reference/PMED?id=3960325
Norris 1974|The administration of guanidine in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=4858705
Norris 1993|Onset, natural history and outcome in idiopathic adult motor neuron disease|/resolve/reference/PMED?id=8229050
Pinto 1999|Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?|/resolve/reference/PMED?id=10540010
Pradas 1993|The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials|/resolve/reference/PMED?id=8469335
Ringel 1993|The natural history of amyotrophic lateral sclerosis|/resolve/reference/PMED?id=8327132
Rowland 1982|Diverse forms of motor neuron disease|/resolve/reference/PMED?id=7180675
Sanjak 1987|Role of muscular exercise in amyotrophic lateral sclerosis|
Schwab 1969|Projection technique for evaluating surgery in Parkinson's disease|
Sinaki 1978|Rehabilitation techniques for patients with amyotrophic lateral sclerosis|/resolve/reference/PMED?id=628227
Strickland 1996|Physical activity, trauma, and ALS: a case-control study|
Strong 1991|Familial amyotrophic lateral sclerosis, 1850-1989: A statistical analysis of the world literature|/resolve/reference/PMED?id=2036615
Swash 2000a|Motor neuron disease: Classification and nomenclature|/resolve/reference/PMED?id=11467047
Swash 2000b|Clinical features and diagnosis of amyotrophic lateral sclerosis|
van der Kooi 2005|Strength training and aerobic exercise training for muscle disease|
Veldink 2003|Sexual differences in onset of disease and response to exercise in a transgenic model of ALS|/resolve/reference/PMED?id=14561497
Vignos 1983|Physical models of rehabilitation in neuromuscular disease|
Ware 1993||
Behnke 2000 {published data only}|Clinical benefits of a combined hospital and home-based exercise programme over 18 months in patients with severe COPD|/resolve/reference/PMED?id=14533282
Behnke 2000 {published data only}|Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11192954
Carr 2009 {published data only}|Pulmonary rehabilitation after acute exacerbation of Chronic Obstructive Pulmonary Disease in patients who previously completed a pulmonary rehabilitation program|/resolve/reference/PMED?id=19561523
Eaton 2009 {published data only}|Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study|
Kirsten 1998 {published data only}|Exercise training improves recovery in patients with COPD after an acute exacerbation|/resolve/reference/PMED?id=9926148
Man 2004 {published data only}|Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study|/resolve/reference/PMED?id=15504763
Murphy 2005 {published data only}|Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation.|
Nava 1998 {published data only}|Rehabilitation of patients admitted to a respiratory intensive care unit|/resolve/reference/PMED?id=9685104
Seymour 2010 {published data only}|Outpatient pulmonary rehabilitation following acute exacerbations of COPD|/resolve/reference/PMED?id=20435864
Troosters 2000 {published data only}|Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial|/resolve/reference/PMED?id=10974183
Troosters 2000 {published data only}|Pulmonary rehabilitation improves survival in COPD patients with a recent severe acute exacerbation|
Rasekaba 2009 {published data only}|Can a chronic disease management pulmonary rehabilitation program for COPD reduce acute rural hospital utilization?|/resolve/reference/PMED?id=19643830
Benzo 2010 {published data only}||
Castelain 2008 {published data only}||
Fanny 2006 {published data only}||
Ko 2006 {published data only}||
Puhan 2006 {published data only}||
van der Berg 2006 {published data only}||
Young 2006 {published data only}||
Almagro 2002|Mortality after hospitalization for COPD|/resolve/reference/PMED?id=12006426
Bach 2001|Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence|/resolve/reference/PMED?id=11281745
Bourbeau 2003|Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention|/resolve/reference/PMED?id=12622605
Cappelleri 1996|Large trials vs meta-analysis of smaller trials: how do their results compare?|/resolve/reference/PMED?id=8861993
Cates 2003|Visual Rx. Online NNT Calculator.|
Chan-Yeung 2004|The burden and impact of COPD in Asia and Africa|/resolve/reference/PMED?id=14974740
Connors 1996|Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)|/resolve/reference/PMED?id=8887592
Coventry 2007|Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematicreview and meta-analysis|/resolve/reference/PMED?id=17980230
Cydulka 1997|Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9412559
Egger 1998|Bias in location and selection of studies|/resolve/reference/PMED?id=9451274
Garcia-Aymerich 2003|Risk factors of readmission to hospital for a COPD exacerbation: a prospective study|/resolve/reference/PMED?id=12554887
Garcia-Aymerich 2006|Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study|/resolve/reference/PMED?id=16738033
Griffiths 2001|Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme|/resolve/reference/PMED?id=11562517
Groenewegen 2003|Mortality and mortality-related factors after hospitalization for acute exacerbation|/resolve/reference/PMED?id=12907529
Ioannidis 1998|Issues in comparisons between meta-analyses and large trials|/resolve/reference/PMED?id=9546568
Jones 2005|St. George's Respiratory Questionnaire: MCID|/resolve/reference/PMED?id=17136966
Kjaergard 2001|Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses|/resolve/reference/PMED?id=11730399
Lacasse 2006|Pulmonary rehabilitation for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=17054186
LeLorier 1997|Discrepancies between meta-analyses and subsequent large randomized, controlled trials|/resolve/reference/PMED?id=9262498
Mannino 2002|COPD : Epidemiology, Prevalence, Morbidity and Mortality, and Disease Heterogeneity|/resolve/reference/PMED?id=12010839
Martin 1982|The prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute respiratory failure|/resolve/reference/PMED?id=7105857
NHLBI 2001|Data Fact Sheet: Chronic Obstructive Pulmonary Disease (COPD)|
Oostenbrink 2004|Resource use and risk factors in high-cost exacerbations of COPD.|/resolve/reference/PMED?id=15338802
Pitta 2006|Physical activity and hospitalization for exacerbation of COPD|/resolve/reference/PMED?id=16537849
Puhan 2003|[Pulmonary rehabilitation of COPD in Switzerland--an assessment of current status]|/resolve/reference/PMED?id=12632841
Puhan 2005a|How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction|/resolve/reference/PMED?id=15860711
Puhan 2008|Interpretation of treatment changes in six-minute walk distance in patients with COPD|
Puhan 2009|Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index|/resolve/reference/PMED?id=19716962
Schlenk 1998|Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36|/resolve/reference/PMED?id=9481151
Schunemann 2003|Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction|/resolve/reference/PMED?id=14680667
Schunemann 2005|Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ)|/resolve/reference/PMED?id=17136967
Seemungal 1998|Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease|/resolve/reference/PMED?id=9603117
Seneff 1995|Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7500534
Sin 2002|The Impact of Chronic Obstructive Pulmonary Disease on Work Loss in the United States|/resolve/reference/PMED?id=11874818
Snow 2001|Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11281744
Spaar 2009|Recruitment barriers in randomized controlled trials from the physicians' perspective: a postal survey.|/resolve/reference/PMED?id=19254374
Spencer 2003|Time course of recovery of health status following an infective exacerbation of chronic bronchitis|/resolve/reference/PMED?id=12832673
Spruit 2003|Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I|/resolve/reference/PMED?id=12947130
Sullivan 2000|The economic burden of COPD|/resolve/reference/PMED?id=10673466
Trappenburg 2005|Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=16181944
Troosters 2010|Resistance training prevents deterioration in quadriceps musclefunction during acute exacerbations of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=20133927
Troosters 2010a|Exercise training and pulmonary rehabilitation: new insights and remaining challenges|/resolve/reference/PMED?id=20956162
Vitacca 2001|Exacerbations of COPD: predictive factors, treatment and outcome|/resolve/reference/PMED?id=11499303
Puhan 2005|Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality  a systematic review|/resolve/reference/PMED?id=15943867
Aaronson 2004 {published data only}|Highlights of the 2004 scientific sessions of the Heart Failure Society of America, Toronto, Canada, September 12 to 15, 2004|/resolve/reference/PMED?id=15708712
Aaronson 2004 {published data only}|Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD|/resolve/reference/PMED?id=15556058
Alexander 1995 {unpublished data only}|Clinical effects of Crataegus extract LI132 for treating heart insufficiency stage 2 New York Heart Association. A randomised placebo-controlled double-blind study with n=73 patients|
Bdigheimer 1994 {published and unpublished data}|Effectiveness of hawthorn extract at a dosage of 3 x 100 mg per day. Multicentre double-blind trial with 85 NYHA stage II heart failure patients|
Eichstdt 2001 {published and unpublished data}|Effectiveness of and tolerance to Crataegus extract WS1442 in patients with heart insufficiency and reduced leftventricular function|
Frster 1994 {published data only}|Crataegus for moderately reduced left ventricular ejection fraction. Ergospirometric monitoring study with 72 patients in a double-blind comparison with placebo|
Hanak 1983 {published and unpublished data}|Treatment of mild stable forms of angina pectoris with a standardized Crataegus extract|
Iwamoto 1981 {published data only}|The clinical effect of Crataegutt in heart disease of ischemic or hypertensive origin. A multicenter double-blind study|/resolve/reference/PMED?id=AMBIGUOUS%2017401874,7019949
Leuchtgens 1993 {published and unpublished data}|The Crataegus special extract WS 1442 in patients with cardiac insufficiency NYHA II. A placebo-controlled double-blind study|
O'Connolly 1987 {published and unpublished data}|Treatment of cardiac symptoms in old patients with multiple pathology|
O'Conolly 1986 {published and unpublished data}|Treatment of decreasing cardiac performance Therapy using standardized crataegus extract in advanced age|/resolve/reference/PMED?id=3542766
Schmidt 1994 {published data only}|Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II|
Schmidt 1994 {published data only}|Efficacy of the hawthorn extract LI132 (600 mg/d) during eight weeks treatment. Placebo controlled double blind trial with 78 NYHA stage II heart failure patients|
Tauchert 2002 (HD) {published and unpublished data}|Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure|/resolve/reference/PMED?id=12040357
Tauchert 2002 (LD) {published and unpublished data}|Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure|/resolve/reference/PMED?id=12040357
Weikl 1996 {published and unpublished data}|Crataegus Special Extract WS 1442 Assessment of objective effectiveness in patients with heart failure NYHA II|/resolve/reference/PMED?id=8974970
Zapfe 2001 {published and unpublished data}|Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II|/resolve/reference/PMED?id=11515715
Czerny 1996 {published data only}|Clinical investigation of a garlic-lecithin preparation|
Degenring 2003 {published data only}|A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II|/resolve/reference/PMED?id=12833999
Eichstdt 1989 {published data only}|Crataegus extract helps patients with heart insufficiency stage 2 NYHA|
Eiff 1994 {published data only}|Whitethorn/passion flower extract for increase of physical performance in patients with dyspnoea at functional stage NYHA II|
Fischer 1994 {published data only}|Crataegus extract vs. medigoxin. Effects on rheology and microcirculation in 12 healthy volunteers|
Hellenbrecht 1990 {published data only}|Randomized placebo-controlled study with crataegus on exercise tests and challenge by catecholamines in healthy subjects|
Rietbrock 2001 {published data only}|Efficacy of a standardized extract of fresh Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure (NYHA II)|/resolve/reference/PMED?id=11715631
Schmidt 2000 {published data only}|Effects of an herbal crataegus-camphor combination on the symptoms of cardiovascular diseases|/resolve/reference/PMED?id=10965417
Staiger 1987 {published data only}|Zur kardialen Wirksamkeit von low-dose digitoxin (0.07mg) and crataegus|
Tauchert 1994 {published data only}|Effectiveness of the hawthorn extract LI 132 compared with the ACE inhibitor captopril. Multicentre double-blind study with 132 NYHA stage II heart failure patients|
Von 1994 {published data only}|Hawthorn/passion flower extract and improvement in physical exercise capacity of patients with dyspnoea class II of the NYHA functional classification|
Weikl 1992 {published data only}|Der Einfluss von Crataegus bei globaler Herzin-suffizienz|
Weng 1984 {published data only}|Therapeutic effect of Crataegus pinnatifida on 46 cases of angina pectoris--a double blind study|/resolve/reference/PMED?id=6397664
Holubarsch 2000 {published data only}|Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure SPICE--rationale, study design and study protocol|/resolve/reference/PMED?id=11113721
ACC/AHA 1995|Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)|/resolve/reference/PMED?id=7586389
Barnes 1998|Different standards of reporting of ADRs to herbal remedies and conventional OTC medicines: face to face interviews with 515 users of herbal remedies|
Blumenthal 1998||
Blumenthal 2000b||
Blumenthal 2001|Market report|
Breevort 1998|The booming US botanical market|
Chang 2002|Hawthorn|
Dargie 1994|Diagnosis and management of heart failure|/resolve/reference/PMED?id=7907244
Dickersin 1990|The existence of publication bias and risk factors for its occurrence|/resolve/reference/PMED?id=2406472
Doughty 1997|Effects of beta-blocker therapy on mortality in patients with heart failure|/resolve/reference/PMED?id=9129883
Easterbrook 1991|Publication bias in clinical research|/resolve/reference/PMED?id=1672966
Egger 1997|Language bias in randomised controlled trials published in English and German|/resolve/reference/PMED?id=9251637
Egger 1998|Bias in location and selection of studies|/resolve/reference/PMED?id=9451274
Eisenberg 1998|Trends in alternative medicine use in the United States 1990-1997: results of a national follow-up survey|/resolve/reference/PMED?id=9820257
Ernst 1997|Alternative therapy bias|/resolve/reference/PMED?id=9020351
Ernst 2000|Possible interactions between synthetic and herbal medicinal products part 1: a systematic review of the indirect evidence|
Ernst 2001||
ESC 2001|Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure|/resolve/reference/PMED?id=11492984
Faris 2006|Diuretics for heart failure|
Fetrow 1999||
Follmann 1992|Variance imputation for overviews of clinical trials with continuous response|/resolve/reference/PMED?id=1619456
Fugh-Berman 2000|Herbs and dietary supplements in the prevention and treatment of cardiovascular disease|
Herr 2002||
Higgins 2005|Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]|
Hood 2004|Digitalis for treatment of congestive heart failure in patients in sinus rhythm|
Joseph 1995|Pharmacologic action profile of crataegus extract in comparison to epinephrine, amrinone, milrinone and digoxin in the isolated perfused guinea-pig heart|/resolve/reference/PMED?id=8595081
Kelley 1992||
Kernan 1994|Incidence of hospitalization for digitalis toxicity among elderly Americans|/resolve/reference/PMED?id=8192174
Kiowski 1996|Clinical benefit of angiotensin-converting enzyme inhibitors in chronic heart failure|/resolve/reference/PMED?id=8723395
Kraft 2000|Crataegus (common hawthorn) extracts in cardiac failure - are there new promising results and outlooks?|
Kraft 2001|Therapy of cardio-vascular diseases using phytopharmaceuticals|
Loew 1997|Phytotherapy in heart failure|
Lonn 2000|Drug treatment in heart failure|/resolve/reference/PMED?id=10784546
McManus 1998|Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews|/resolve/reference/PMED?id=9836655
Millane 2000|ABC of heart failure. Acute and chronic management strategies|/resolve/reference/PMED?id=10688565
Mller 1999|Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes|/resolve/reference/PMED?id=10364839
Narang 1996|What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity|/resolve/reference/PMED?id=8682118
Nieminen 1999|Bias against European journals in medical publication databases|/resolve/reference/PMED?id=10334267
Pittler 2000|Location bias in controlled clinical trials of complementary/alternative therapies|/resolve/reference/PMED?id=10812320
Rotblatt 2002||
Schmidt 1998|High dosed therapy with crataegus extract in patients suffering from heart failure NYHA stage I and II|
Schmidt 2001|Bias in alternative medicine is still rife but is diminishing|/resolve/reference/PMED?id=11691776
Schwinger 2000|Crataegus special extract WS 1442 increases the force of contraction in human myocardium cAMP-independently|/resolve/reference/PMED?id=10813370
Swedberg 1994|Exercise testing in heart failure. A critical review|/resolve/reference/PMED?id=7523058
Tankanow 2002|Examination of potential interactions between hawthorn and digoxin in healthy normals|
Tauchert 1999|High-dose crataegus (hawthorn) extract WS 1442 in the treatment of NYHA stage II heart failure|/resolve/reference/PMED?id=10546150
Tsuyuki 2000|Beta-blockers for congestive heart failure: what is the current consensus?|/resolve/reference/PMED?id=10733260
Von Zerssen 1971|The complaints-list as test|
Pittler 2003|Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials|/resolve/reference/PMED?id=12798455
Bellone 2004 {published data only}|Myocardial infarction rate in acute pulmonary edema: noninvasive support ventilation versus continuous positive airway pressure|/resolve/reference/PMED?id=15343013
Bellone 2005 {published data only}|Noninvasive pressure support ventilation vs. continuous positive airway pressure in acute hypercapnic pulmonary edema|/resolve/reference/PMED?id=15871011
Bersten 1991 {published and unpublished data}|Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask|/resolve/reference/PMED?id=1961221
Crane 2004 {published and unpublished data}|Randomized controlled comparison of continuous positive airway pressure, bilevel non-invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema|/resolve/reference/PMED?id=14988338
Delclaux 2000 {published data only}|Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivery by a face mask|/resolve/reference/PMED?id=11066186
Kelly 2002 {published and unpublished data}|Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema|/resolve/reference/PMED?id=12191749
L'Her 2004 {published data only}|Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients|/resolve/reference/PMED?id=14991092
Levitt 2001 {published data only}|A prospective, randomized trial of BiPAP in severe acute congestive heart failure|/resolve/reference/PMED?id=11728761
Liesching 2003 {published data only}|Bilevel noninvasive ventilation vs continuous positive airway pressure to treat acute pulmonary edema|
Lin 1991 {published data only}|The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=1683365
Lin 1995 {published data only}|Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=7750335
Masip 2000 {published data only}|Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial|/resolve/reference/PMED?id=11191538
Mehta 1997 {published data only}|Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema|/resolve/reference/PMED?id=9142026
Nava 2003 {published and unpublished data}|Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study|
Nava 2003 {published and unpublished data}|Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy|
Nava 2003 {published and unpublished data}|Noninvasive ventilation in cardiogenic pulmonary edema|/resolve/reference/PMED?id=12958051
Park 2001 {published and unpublished data}|Randomized prospective trial of oxygen, continuos and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema|
Park 2001 {published and unpublished data}|Oxygen therapy, continuous positive airway pressure, or noninvasive bilivel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema|
Park 2004 {published and unpublished data}|Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=15599144
Rsnen 1985 {published data only}|Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=3881920
Sharon 2000 {published data only}|High-dose intravenous Isosorbide-dinitrate is safer and better than Bi-PAP ventilation for severe pulmonary edema|/resolve/reference/PMED?id=10987607
Takeda 1997 {published and unpublished data}|The effect of nasal continuous positive airway pressure on plasma endothelin-1 concentrations in patients with severe cardiogenic pulmonary edema|/resolve/reference/PMED?id=9141937
Takeda 1998 {published and unpublished data}|Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction|/resolve/reference/PMED?id=9741730
Thys 2002 {published and unpublished data}|Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial|/resolve/reference/PMED?id=12358327
Acosta 2000 {published data only}|Hemodynamic effects of noninvasive bilevel positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction|/resolve/reference/PMED?id=11035670
Albert 2000 {published data only}|Turnabout may be more than fair play|/resolve/reference/PMED?id=10708204
Andrade 1998 {published data only}|Acute respiratory distress of the adult|
Antonelli 2001 {published data only}|Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: A multi-center study|/resolve/reference/PMED?id=11810114
Barach 1938 {published data only}|Positive pressure respiration and its application to the treatment of acute pulmonary edema|
Baratz 1992 {published data only}|Effect of nasal continuous positive airway pressure on cardiac output and oaxygen delivery in patients with congestive heart failure|/resolve/reference/PMED?id=1424858
Bellone 2002 {published data only}|Acute effects of non-invasive ventilatory support on functional mitral regurgitation in patients with exacerbation of congestive heart failure|/resolve/reference/PMED?id=12209288
Blomqvist 1991 {published data only}|Does PEEP facilitate the resolution of extravascular lung water after experimental hydrostatic pulmonary edema?|/resolve/reference/PMED?id=1756838
Bollaert 2002 {published data only}|Continuous positive airway pressure (CPAP) VS proportional assist ventilation (PAV) for noninvasive ventilation in cardiogenic pulmonary edema|
Bouquin 1998 {published data only}|Spontaneous ventilation in positive expiratory pressure in cardiogenic pulmonary edema|/resolve/reference/PMED?id=9833088
Bradley 2000 {published data only}|continuous positive airway pressure for congestive heart failure|/resolve/reference/PMED?id=10701392
Brezins 1993 {published data only}|Left ventricular function in patients with acute myocardial infarction, acute pulmonary edema, and mechanical ventilation: Relationship to prognosis|/resolve/reference/PMED?id=8440108
Brijker 1999 {published data only}|Use of noninvasive mechanical ventilation to avoid intubation during acute respiratory insufficiency|/resolve/reference/PMED?id=10526586
Brochard 1998 {published data only}|Use of non-invasive positive pressure ventilation for cardiogenic pulmonary edema in emergency care unit|/resolve/reference/PMED?id=9767815
Chadda 2002 {published data only}|Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema|/resolve/reference/PMED?id=12441754
Crane 2002 {published data only}|Epidemiology, treatment and outcome of acidotic, acute, cardiogenic pulmonary oedema presenting to and Emergency department|/resolve/reference/PMED?id=12501030
Craven 2000 {published data only}|Use of bilevel positive airway pressure in out-of-hospital patients|
Cross 2000 {published data only}|Review of the role of non-invasive ventilation in the emergency department|/resolve/reference/PMED?id=10718225
Cross 2003 {published data only}|Non-invasive ventilation in acute respiratory failure: a randomized comparison of continuous positive airway pressure and bi-level positive airway pressure|/resolve/reference/PMED?id=14623840
Cydulka 2005 {published data only}|Noninvasive ventilation in cardiogenic pulmonary edema: A multicenter randomized trial|
Domenighetti 2002 {published data only}|Noninvasive pressure support ventilation in non-COPD patients with acute cardiogenic pulmonary edema and severe community-acquired pneumonia: acute effects and outcome|/resolve/reference/PMED?id=12209269
Du Cailar 1975 {published data only}|Justification, methods and indications for positive-pressure respiration in controlled and spontaneous ventilation in lesional pulmonary edeman|
Eaton 2002 {published data only}|Clinical developments for treating ARDS|/resolve/reference/PMED?id=11772319
Evans 2001 {published data only}|International Consensus conferences in intensive care medicine: noninvasive positive pressure ventilation in acute respiratory failure|/resolve/reference/PMED?id=11208659
Fromm 1995 {published data only}|Congestive heart failure and pulmonary edema for emergency physician|/resolve/reference/PMED?id=7782629
Giacomini 2003 {published data only}|Short-term noninvasive pressure support ventilation prevents ICU admittance in patients with acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=12796189
Girou 2003 {published data only}|Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema|/resolve/reference/PMED?id=14665660
Guerra 2005 {published data only}|Noninvasive ventilation in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=15713244
Guntupalli 1984 {published data only}|Acute pulmomnary edema|/resolve/reference/PMED?id=6443344
Gust 1998 {published data only}|Changes in crdiac output do not explain the higher rate of myocardial infarction associated with the use of bilevel compared with continuous positive airway pressure|/resolve/reference/PMED?id=9468183
Hao 2002 {published data only}|Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask|
Hess 2004 {published data only}|The evidence for noninvasive positive-pressure ventilation in the care of patients in acute respiratory failure: a systematic review of the literature|/resolve/reference/PMED?id=15222912
Hilberg 1997 {published data only}|Noninvasive ventilation|/resolve/reference/PMED?id=9392701
Hipona 1996 {published data only}|Positive airway pressure suppor and myocardial ischemia|
Hoffman B 1999 {published data only}|The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema|/resolve/reference/PMED?id=10431561
Hoffmann 1999 {published data only}|The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema|/resolve/reference/PMED?id=10051073
Holt 1994 {published data only}|Intensive care costing methodology: cost benefit analysis of mask continuous positive airway pressure for severe cardiogenic pulmonary oedema|/resolve/reference/PMED?id=8210020
Hotchkiss 1998 {published data only}|Noninvasive ventilation: An emerging supportive technique for the emergency department|/resolve/reference/PMED?id=9774932
Hughes 1999 {published data only}|Review: continuous positive airway pressure support reduces the need for intubation in patients with cardiogenic pulmonary edema|
Iapichino 2004 {published data only}|Non invasive mechanical ventilation in acute cardiogenic pulmonary edema: is it all done?|/resolve/reference/PMED?id=15173689
Jackson 2000 {published data only}|Continuous positive airway pressure: the need for prehospital research and clinical trials|
Jackson 2001 {published data only}|CPAP in acute left ventricular failure|/resolve/reference/PMED?id=11310471
Jackson R 2001 {published data only}|NIPPV for acute cardiogenic pulmonary oedema|/resolve/reference/PMED?id=11696501
Kallio 2003 {published data only}|The use of prehospital continuous positive airway pressure treatment in presumed acute severe pulmonary edema|/resolve/reference/PMED?id=12710780
Keenan 2004 {published data only}|Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review|/resolve/reference/PMED?id=15599160
Kelly 2001 {published data only}|Support ventilation versus conventional oxygen|/resolve/reference/PMED?id=11303601
Kiely 1998 {published data only}|Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: Importance of underlying cardiac rhythm|/resolve/reference/PMED?id=10193395
Kindgen-Milles 2000 {published data only}|Nasal continuous positive airway pressure: A method to avoid endothracheal reintubation in postoperative high-risk patients with severe nonhypercapnic oxygenation failure|/resolve/reference/PMED?id=10767248
Kosowsky 2000 {published data only}|Continuous and bilevel positive airway pressure in the treatment of acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=10674543
Kosowsky 2001 {published data only}|Prehospital use of continuous positive airway pressure (CPAP) for presumed pulmonary edema: a preliminary case series|/resolve/reference/PMED?id=11339731
Kramer 1995 {published data only}|Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure|/resolve/reference/PMED?id=7767523
L'Her 1998 {published data only}|Spontaneous positive end-expiratory pressure ventilation in elderly patients with cardiogenic pulmonary edema|/resolve/reference/PMED?id=9767807
L'Her E 1998 {published data only}|Non-invasive continuous positive airway pressure in acute hypoxaemic respiratory failure--experience of an emergency department|/resolve/reference/PMED?id=9827833
Lal 1969 {published data only}|Oxygen administration after myocardial infarction|/resolve/reference/PMED?id=4179223
Lapinsky 1994 {published data only}|Management of acute respiratory failure due to pulmonary edema with nasal positive pressure support|/resolve/reference/PMED?id=8275736
Lenique 1997 {published data only}|Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure|/resolve/reference/PMED?id=9032185
Liesching T 2003 {published data only}|Acute applications of noninvasive positive pressure ventilation|/resolve/reference/PMED?id=12907562
Lo Coco 1997 {published data only}|Treatment of acute respiratory failure secondary to pulmonary oedema with bi-level positive airway pressure by nasal mask|/resolve/reference/PMED?id=9510663
Mackay CA 2000 {published data only}|Randomized controlled trial of CPAP vs conventional therapy in acute pulmonary edema|
Massaria 1976 {published data only}|Use of artificial respiration in complicated acute myocarial infarct. Critical evaluation|/resolve/reference/PMED?id=1018779
Meduri 1991 {published data only}|Nonivasive face mask mechanical ventilation in patients with acute hipercapnic respiratory failure|/resolve/reference/PMED?id=1864119
Mehta 2000 {published data only}|Effects of continuous positive airway pressure on cardiac volumes in patients with ischemic and dilated cardiomyopathy|/resolve/reference/PMED?id=10619809
Mehta 2004 {published data only}|Continuous versus bilevel positive airway pressure in acute cardiogenic pulmonary oedema? A good question!|/resolve/reference/PMED?id=15599167
Mehta 2005 {published data only}|Mask ventilation and cardiogenic pulmonary edema: "another brick in the wall"|/resolve/reference/PMED?id=15891861
Minuto 2003 {published data only}|Non-invasive mechanical ventilation in patients with acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=14735023
Mollica 2001 {published data only}|Non-invasive pressure support ventilation in acute hypoxemic (non hypercapnic) respiratory failure. Observations in Respiratory Intermediate Intensive Care Unit|/resolve/reference/PMED?id=11337642
Moritz 2003 {published data only}|Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study|/resolve/reference/PMED?id=12972896
Murray 2002 {published data only}|Bi-level positive airway pressure (BiPAP) and acute cardiogenic pulmonary oedema (ACPO) in the emergency department|/resolve/reference/PMED?id=12154698
Murray 2003 {published data only}|Bi-level positive airway pressure (BiPAP) and acute cardiogenic pulmonary oedema (ACPO) in emergency department|
Nadar 2005 {published data only}|Positive pressure ventilation in the management of acute and chronic cardiac failure: A systematic review and meta-analysis.|/resolve/reference/PMED?id=15749172
Nava 2002 {published data only}|Non-invasive pressure support ventilation in acute hypoxemic respiratory failure: Common strategy for differnet pathologies?|/resolve/reference/PMED?id=12400564
Newberry 1995 {published data only}|Noninvasive bilevel positive pressure ventilation in severe acute pulmonary edema|/resolve/reference/PMED?id=7605541
Nikki 1982 {published data only}|Ventilatory pattern in respiratory failure arising from acute myocardial infarction. I. Respiratory and hemodynamic effects of IMV4 vs IPPV12 and PEEP0 vs PEEP10|/resolve/reference/PMED?id=7037301
Niranjan 1998 {published data only}|Noninvasive ventilation|/resolve/reference/PMED?id=9575056
Panacek 2002 {published data only}|Role of noninvasive ventilation in the managemnet of acutely descompensated heart failure|
Pang 1998 {published data only}|The effect of positive pressure airway support on mortality and the need for intubation i cardiogenic pulmonary edema: A systematic review|/resolve/reference/PMED?id=9792593
Park 2005 {published data only}|Noninvasive ventilation in threatment of the acute pulmonary oedema. Where are we really?|
Perel 1983 {published data only}|Effectiveness of CPAP by mask for pulmonary edema associated with hypercarbia|/resolve/reference/PMED?id=6339582
Philip-joet 1999 {published data only}|Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure|/resolve/reference/PMED?id=10202317
Pollack 1996 {published data only}|Feasibility study of the use of bilevel positive airway pressure for respiratory support in the emergency department|/resolve/reference/PMED?id=8629750
Poponick 1999 {published data only}|Use of a ventilatory support system (BIPAP) for acute respiratory failure in the emergency department|/resolve/reference/PMED?id=10424521
Poulton 1936 {published data only}|Left-side heart failure with pulmonary edema: its treatment with the "pulmonary plus pressure machine"|
Rabatin 1999 {published data only}|Noinvasive ventilation|/resolve/reference/PMED?id=10473360
Rasanen J 1985 {published data only}|Acute myocardial infarction complicated by left ventricular dysfunction and respiratory failure|/resolve/reference/PMED?id=3881227
Rizk 1982 {published data only}|PEEP and pulmonary edema|/resolve/reference/PMED?id=7036733
Roche 2003 {published data only}|Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance|
Rusterholtz 1999 {published data only}|Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=10051074
Sacchetti 2001 {published data only}|Effectiveness of BiPAP for congestive heart failure|/resolve/reference/PMED?id=11345397
Sachetti 1995 {published data only}|Bi-level positive airway pressure support system use in acut congestive failure:Preliminary case series|
Salvucci A 2001 {published data only}|CPAP for cardiogenic pulmonary edema|/resolve/reference/PMED?id=11258309
Sarullo 2004 {published data only}|Efficacy and safety of non-invasive positive pressure ventilation therapy in acute pulmonary edema|/resolve/reference/PMED?id=15211730
Severinghaus 2002 {published data only}|Sightings|
Simonds 2000 {published data only}|Nasal ventilation: Where are we?|/resolve/reference/PMED?id=10786425
Sinuff 2000 {published data only}|Noninvasive positive-pressure ventilation: A utilization review of use in a teaching hospital|/resolve/reference/PMED?id=11068568
Somauroo 2000 {published data only}|Acute hemodynamic changes of nasal bilevel and continuous positive airway pressure ventilation in patients with congestive heart failure|
Sutton 2002 {published data only}|Biphasic positive pressure ventilation in acute cardiogenic pulmonary oedema|
Uy 2003 {published data only}|Continuous positive airway pressure (CPAP) among patients with cardiogenic pulmonary edema|
Vaisanen 1987 {published data only}|Continuous positive airway pressure and supplemental oxygen in the treatment of cardiogenic pulmonary edema|/resolve/reference/PMED?id=3304850
Valipour 2004 {published data only}|Non-invasive pressure support ventilation in patients with respiratory failure due to severe acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=15031569
Werdan 1999 {published data only}|Emergency treatment of acute heart failure|/resolve/reference/PMED?id=10535048
Widger 2001 {published data only}|Pressure upport noninvasive positive pressure ventilation treatment of acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=11326339
Wood 1998 {published data only}|The use of noninvasive positive pressure ventilation in the emergency department|/resolve/reference/PMED?id=9596317
Wright 2001 {published data only}|The role of non-invasive ventilation in the emergency department|/resolve/reference/PMED?id=11559633
Wysocki 1995 {published data only}|Noninvasive pressure support ventilation in patients with acute respiratory failure. A randomized comparison with conventional therapy|/resolve/reference/PMED?id=7874950
Wysocki 1999 {published data only}|Noninvasive ventilation in acute cardiogenic pulmonary edema: Better than CPAP?|/resolve/reference/PMED?id=10051070
Ferrari 2007 {published data only}|Noninvasive positive airway pressure and risk of myocardial infarction in acute cardiogenic pulmonary edema: continuous positive airway pressure vs noninvasive positive pressure ventilation|/resolve/reference/PMED?id=17908705
Moritz 2007 {published data only}|Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial|/resolve/reference/PMED?id=17764785
AHA 2005|Heart and Stroke Statistics|
Alderson 2004||
Allison 1991|Initial tratment of pulmonary edema: a physiological approach|/resolve/reference/PMED?id=1772126
Bach 1997|Consensus statement noninvasive positive pressure ventilation|
Castro 1999|Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS database): Update|/resolve/reference/PMED?id=10511734
Confalonieri 1999|Acute respiratory failure inpatients with severe community acquired pneumonia. A prospective randomized evaluation of non-invasive ventilation|/resolve/reference/PMED?id=10556125
Covelli 1982|Efficacy of continuous positive airway pressure administrated by facemask|/resolve/reference/PMED?id=7035084
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Egger 1997|Bias in meta-analysis detected by simple, graph test|/resolve/reference/PMED?id=9310563
Gehlbach 2004|The pulmonary manifestations of left heart failure|/resolve/reference/PMED?id=14769751
Gibelin 2002|Acute cardiogenic pulmonary edema and its treatment|/resolve/reference/PMED?id=12434594
Jadad 2000|Systematic reviews and meta-analyses on treatment of asthma: critical evaluation|/resolve/reference/PMED?id=10688558
Keenan 1997|Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis|/resolve/reference/PMED?id=9377883
Kelly 1997|Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency management of acute severe cardiogenic pulmonary oedema|
Lefebvre 1996|Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE|
Martnez 1995|Non invasive intermittent mechanical ventilation in the treatment of chronic severe cardiac failure|/resolve/reference/PMED?id=8733263
McKibbon|What do evidence-based secondary journals tell us about the publication of clinically important article in primary healthcare journals?|
Meyer 1998|Noninvasive ventilation in the severe congestive heart failure patient|
Nieminen 2005|Executive summary of the guidelline on the diagnosis and treatment of acute heart failure|/resolve/reference/PMED?id=15681577
Ram 2004|Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease|
Remme 1997|The treatment of heart failure. The task force of the Working Group on heart failure of the European Society of Cardiology|/resolve/reference/PMED?id=9152644
SBC 2004|Latin-American guideline for the evaluation and management of descompensed heart failure|
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Visnen 1987|Continuous positive airway pressure and supplemental oxygen in threatment of cardiogenic pulmonary edema|/resolve/reference/PMED?id=3304850
Williams 1995|Guidelines for the evaluation and management of heart failure|/resolve/reference/PMED?id=7594057
Agmy 2008 {published and unpublished data}|The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure [Abstract]|
Agmy 2008 {published and unpublished data}|CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients [Abstract]|
Agmy 2008 {published and unpublished data}|The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure [Abstract]|
Bautin 2005 {published and unpublished data}|NPPV in the treatment of the cardiogenic edema (CPE) after heart surgery [Abstract]|
Bellone 2004 {published data only}|Myocardial infarction rate in acute pulmonary edema: noninvasive support ventilation versus continuous positive airway pressure|/resolve/reference/PMED?id=15343013
Bellone 2005 {published data only}|Noninvasive pressure support ventilation vs. continuous positive airway pressure in acute hypercapnic pulmonary edema|/resolve/reference/PMED?id=15871011
Bersten 1991 {published and unpublished data}|Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask|/resolve/reference/PMED?id=1961221
Crane 2004 {published and unpublished data}|Randomized controlled comparison of continuous positive airway pressure, bilevel non-invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema|/resolve/reference/PMED?id=14988338
Delclaux 2000 {published data only}|Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivery by a face mask|/resolve/reference/PMED?id=11066186
Ferrari 2007 {published data only}|Noninvasive positive airway pressure and risk of myocardial infarction in acute cardiogenic pulmonary edema: continuous positive airway pressure vs noninvasive positive pressure ventilation|/resolve/reference/PMED?id=17908705
Ferrari 2010 {published data only}|Continuous positive airway pressure (CPAP) vs. noninvasive positive pressure ventilation (NIV) in acute cardiogenic pulmonary edema (ACPE): A prospective randomized multicentric study|
Ferrari 2010 {published data only}|Continuous positive airway pressure vs. Pressure support ventilation in acute cardiogenic pulmonary edema: a randomized trial|
Ferrer 2003 {published data only}|Noninvasive Ventilation in Severe Hypoxemic Respiratory Failure: A Randomized Clinical Trial|/resolve/reference/PMED?id=14500259
Ferrer 2003 {published data only}|Non-vasive Ventilation in Severe Acute Hypoxemic Respiratory Failure. A Randomized Clinical Trial|
Fontanella 2010 {published data only}|Comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (NIPSV) in acute cardiogenic pulmonary edema|
Fontanella 2010 {published data only}|Prospective comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (BPAP) in acute cardiogenic pulmonary edema|
Frontin 2010 {published data only}|Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study|
Gray 2008 {published data only}|Noninvasive Ventilation in AcuteCardiogenic Pulmonary Edema|/resolve/reference/PMED?id=18614781
Gray 2008 {published data only}|A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial|/resolve/reference/PMED?id=19615296
Kelly 2002 {published and unpublished data}|Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema|/resolve/reference/PMED?id=12191749
L'Her 2004 {published data only}|Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients|/resolve/reference/PMED?id=14991092
Levitt 2001 {published data only}|A prospective, randomized trial of BiPAP in severe acute congestive heart failure|/resolve/reference/PMED?id=11728761
Liesching 2003 {published data only}|Bilevel noninvasive ventilation vs continuous positive airway pressure to treat acute pulmonary edema|
Lin 1991 {published data only}|The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=1683365
Lin 1995 {published data only}|Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=7750335
Martin-Bermudez 2002 {published and unpublished data}|Noninvasiveventilation in cardiogenic pulmonay edema. Preliminary results of a randomizedtrial [Abstract]|
Masip 2000 {published data only}|Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial|/resolve/reference/PMED?id=11191538
Mehta 1997 {published data only}|Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema|/resolve/reference/PMED?id=9142026
Moritz 2007 {published data only}|Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial|/resolve/reference/PMED?id=17764785
Nava 2003 {published and unpublished data}|Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study|
Nava 2003 {published and unpublished data}|Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy|
Nava 2003 {published and unpublished data}|Noninvasive ventilation in cardiogenic pulmonary edema|/resolve/reference/PMED?id=12958051
Park 2001 {published and unpublished data}|Randomized prospective trial of oxygen, continuos and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema|
Park 2001 {published and unpublished data}|Oxygen therapy, continuous positive airway pressure, or noninvasive bilivel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema|
Park 2004 {published and unpublished data}|Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=15599144
Rsnen 1985 {published data only}|Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=3881920
Sharon 2000 {published data only}|High-dose intravenous Isosorbide-dinitrate is safer and better than Bi-PAP ventilation for severe pulmonary edema|/resolve/reference/PMED?id=10987607
Takeda 1997 {published and unpublished data}|The effect of nasal continuous positive airway pressure on plasma endothelin-1 concentrations in patients with severe cardiogenic pulmonary edema|/resolve/reference/PMED?id=9141937
Takeda 1998 {published and unpublished data}|Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction|
Thys 2002 {published and unpublished data}|Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial|/resolve/reference/PMED?id=12358327
Weitz 2007 {published and unpublished data}|Prehospital noninvasive pressure support ventilation for acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=17823565
Acosta 2000 {published data only}|Hemodynamic effects of noninvasive bilevel positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction|/resolve/reference/PMED?id=11035670
Albert 2000 {published data only}|Turnabout may be more than fair play|/resolve/reference/PMED?id=10708204
Alper 2007 {published data only}|Evidence-based medicine. Noninvasive ventilation reduces mortality in cardiogenic pulmonary edema|
Alper 2008 {published data only}|Evidence-based medicine. Noninvasive ventilation may improve respiratory distress in acute heart failure|
Andrade 1998 {published data only}|Acute respiratory distress of the adult|
Antonelli 2001 {published data only}|Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: A multi-center study|/resolve/reference/PMED?id=11810114
Aronow 2007 {published data only}|Heart-Failure-Complicating Acute Myocardial Infarction|/resolve/reference/PMED?id=17126758
Barach 1938 {published data only}|Positive pressure respiration and its application to the treatment of acute pulmonary edema|
Baratz 1992 {published data only}|Effect of nasal continuous positive airway pressure on cardiac output and oaxygen delivery in patients with congestive heart failure|/resolve/reference/PMED?id=1424858
Bavry 2008 {published data only}|Effect of continuous positive airway pressure and noninvasive positive pressure ventilation in acute cardiogenic pulmonary oedema (3CPO)|
Bellone 2002 {published data only}|Acute effects of non-invasive ventilatory support on functional mitral regurgitation in patients with exacerbation of congestive heart failure|/resolve/reference/PMED?id=12209288
Blomqvist 1991 {published data only}|Does PEEP facilitate the resolution of extravascular lung water after experimental hydrostatic pulmonary edema?|/resolve/reference/PMED?id=1756838
Bollaert 2002 {published data only}|Continuous positive airway pressure (CPAP) VS proportional assist ventilation (PAV) for noninvasive ventilation in cardiogenic pulmonary edema|
Bouquin 1998 {published data only}|Spontaneous ventilation in positive expiratory pressure in cardiogenic pulmonary edema|/resolve/reference/PMED?id=9833088
Bradley 2000 {published data only}|continuous positive airway pressure for congestive heart failure|/resolve/reference/PMED?id=10701392
Brezins 1993 {published data only}|Left ventricular function in patients with acute myocardial infarction, acute pulmonary edema, and mechanical ventilation: Relationship to prognosis|/resolve/reference/PMED?id=8440108
Brijker 1999 {published data only}|Use of noninvasive mechanical ventilation to avoid intubation during acute respiratory insufficiency|/resolve/reference/PMED?id=10526586
Brochard 1998 {published data only}|Use of non-invasive positive pressure ventilation for cardiogenic pulmonary edema in emergency care unit|/resolve/reference/PMED?id=9767815
Chadda 2002 {published data only}|Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema|/resolve/reference/PMED?id=12441754
Chen 2008 {published data only}|Mechanical ventilation in patients with hypoxemia due to refractory heart failure|/resolve/reference/PMED?id=18310965
Crane 2002 {published data only}|Epidemiology, treatment and outcome of acidotic, acute, cardiogenic pulmonary oedema presenting to and Emergency department|/resolve/reference/PMED?id=12501030
Craven 2000 {published data only}|Use of bilevel positive airway pressure in out-of-hospital patients|
Cross 2000 {published data only}|Review of the role of non-invasive ventilation in the emergency department|/resolve/reference/PMED?id=10718225
Cross 2003 {published data only}|Non-invasive ventilation in acute respiratory failure: a randomized comparison of continuous positive airway pressure and bi-level positive airway pressure|/resolve/reference/PMED?id=14623840
Cydulka 2005 {published data only}|Noninvasive ventilation in cardiogenic pulmonary edema: A multicenter randomized trial|
Domenighetti 2002 {published data only}|Noninvasive pressure support ventilation in non-COPD patients with acute cardiogenic pulmonary edema and severe community-acquired pneumonia: acute effects and outcome|/resolve/reference/PMED?id=12209269
Du Cailar 1975 {published data only}|Justification, methods and indications for positive-pressure respiration in controlled and spontaneous ventilation in lesional pulmonary edeman|
Eaton 2002 {published data only}|Clinical developments for treating ARDS|/resolve/reference/PMED?id=11772319
Evans 2001 {published data only}|International Consensus conferences in intensive care medicine: noninvasive positive pressure ventilation in acute respiratory failure|/resolve/reference/PMED?id=11208659
Fromm 1995 {published data only}|Congestive heart failure and pulmonary edema for emergency physician|
Giacomini 2003 {published data only}|Short-term noninvasive pressure support ventilation prevents ICU admittance in patients with acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=12796189
Girou 2003 {published data only}|Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema|/resolve/reference/PMED?id=14665660
Gorbunova 2005 {published data only}|Effect of nasal continuous positive airway pressure on respiratory failure and left ventricular dysfunction complicating acute myocardial infarction [Abstract]|
Gray 2009 {published data only}|A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial|/resolve/reference/PMED?id=19615296
Guerra 2005 {published data only}|Noninvasive ventilation in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=15713244
Guntupalli 1984 {published data only}|Acute pulmomnary edema|/resolve/reference/PMED?id=6443344
Gust 1998 {published data only}|Changes in crdiac output do not explain the higher rate of myocardial infarction associated with the use of bilevel compared with continuous positive airway pressure|/resolve/reference/PMED?id=9468183
Hao 2002 {published data only}|Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask|
Hess 2004 {published data only}|The evidence for noninvasive positive-pressure ventilation in the care of patients in acute respiratory failure: a systematic review of the literature|/resolve/reference/PMED?id=15222912
Hilberg 1997 {published data only}|Noninvasive ventilation|
Hipona 1996 {published data only}|Positive airway pressure suppor and myocardial ischemia|
Hoffman B 1999 {published data only}|The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema|/resolve/reference/PMED?id=10431561
Hoffmann 1999 {published data only}|The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema|/resolve/reference/PMED?id=10051073
Holt 1994 {published data only}|Intensive care costing methodology: cost benefit analysis of mask continuous positive airway pressure for severe cardiogenic pulmonary oedema|/resolve/reference/PMED?id=8210020
Hotchkiss 1998 {published data only}|Noninvasive ventilation: An emerging supportive technique for the emergency department|/resolve/reference/PMED?id=9774932
Hubble 2006 {published data only}|Effectiveness of prehospital continuous positive airway pressure in the management of acute pulmonary edema|
Hughes 1999 {published data only}|Review: continuous positive airway pressure support reduces the need for intubation in patients with cardiogenic pulmonary edema|
Iapichino 2004 {published data only}|Non invasive mechanical ventilation in acute cardiogenic pulmonary edema: is it all done?|/resolve/reference/PMED?id=15173689
Jackson 2000 {published data only}|Continuous positive airway pressure: the need for prehospital research and clinical trials|
Jackson 2001 {published data only}|CPAP in acute left ventricular failure|/resolve/reference/PMED?id=11310471
Jackson R 2001 {published data only}|NIPPV for acute cardiogenic pulmonary oedema|/resolve/reference/PMED?id=11696501
Kallio 2003 {published data only}|The use of prehospital continuous positive airway pressure treatment in presumed acute severe pulmonary edema|
Keenan 2004 {published data only}|Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review|/resolve/reference/PMED?id=15599160
Kelly 2001 {published data only}|Support ventilation versus conventional oxygen|/resolve/reference/PMED?id=11303601
Kiely 1998 {published data only}|Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: Importance of underlying cardiac rhythm|/resolve/reference/PMED?id=10193395
Kindgen-Milles 2000 {published data only}|Nasal continuous positive airway pressure: A method to avoid endothracheal reintubation in postoperative high-risk patients with severe nonhypercapnic oxygenation failure|/resolve/reference/PMED?id=10767248
Kosowsky 2000 {published data only}|Continuous and bilevel positive airway pressure in the treatment of acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=10674543
Kosowsky 2001 {published data only}|Prehospital use of continuous positive airway pressure (CPAP) for presumed pulmonary edema: a preliminary case series|
Kramer 1995 {published data only}|Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure|/resolve/reference/PMED?id=7767523
L'Her 1998 {published data only}|Spontaneous positive end-expiratory pressure ventilation in elderly patients with cardiogenic pulmonary edema|/resolve/reference/PMED?id=9767807
L'Her E 1998 {published data only}|Non-invasive continuous positive airway pressure in acute hypoxaemic respiratory failure--experience of an emergency department|
Lal 1969 {published data only}|Oxygen administration after myocardial infarction|/resolve/reference/PMED?id=4179223
Lapinsky 1994 {published data only}|Management of acute respiratory failure due to pulmonary edema with nasal positive pressure support|/resolve/reference/PMED?id=8275736
Leman 2005 {published data only}|Simple lightweight disposable continuous positive airways pressure mask to effectively treat acute pulmonary oedema: randomized controlled trial|
Lenique 1997 {published data only}|Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure|/resolve/reference/PMED?id=9032185
Li 2004 {published data only}|The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation|
Liesching T 2003 {published data only}|Acute applications of noninvasive positive pressure ventilation|/resolve/reference/PMED?id=12907562
Lo Coco 1997 {published data only}|Treatment of acute respiratory failure secondary to pulmonary oedema with bi-level positive airway pressure by nasal mask|/resolve/reference/PMED?id=9510663
Mackay CA 2000 {published data only}|Randomized controlled trial of CPAP vs conventional therapy in acute pulmonary edema|
Masip 2008 {published data only}|Noninvasive ventilation in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=18990784
Massaria 1976 {published data only}|Use of artificial respiration in complicated acute myocarial infarct. Critical evaluation|/resolve/reference/PMED?id=1018779
Meduri 1991 {published data only}|Nonivasive face mask mechanical ventilation in patients with acute hipercapnic respiratory failure|/resolve/reference/PMED?id=1864119
Mehta 2000 {published data only}|Effects of continuous positive airway pressure on cardiac volumes in patients with ischemic and dilated cardiomyopathy|/resolve/reference/PMED?id=10619809
Mehta 2004 {published data only}|Continuous versus bilevel positive airway pressure in acute cardiogenic pulmonary oedema? A good question!|/resolve/reference/PMED?id=15599167
Mehta 2005 {published data only}|Mask ventilation and cardiogenic pulmonary edema: "another brick in the wall"|/resolve/reference/PMED?id=15891861
Minuto 2003 {published data only}|Non-invasive mechanical ventilation in patients with acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=14735023
Mollica 2001 {published data only}|Non-invasive pressure support ventilation in acute hypoxemic (non hypercapnic) respiratory failure. Observations in Respiratory Intermediate Intensive Care Unit|/resolve/reference/PMED?id=11337642
Moritz 2003 {published data only}|Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study|/resolve/reference/PMED?id=12972896
Murray 2002 {published data only}|Bi-level positive airway pressure (BiPAP) and acute cardiogenic pulmonary oedema (ACPO) in the emergency department|/resolve/reference/PMED?id=12154698
Murray 2003 {published data only}|Bi-level positive airway pressure (BiPAP) and acute cardiogenic pulmonary oedema (ACPO) in emergency department|
Nadar 2005 {published data only}|Positive pressure ventilation in the management of acute and chronic cardiac failure: A systematic review and meta-analysis|/resolve/reference/PMED?id=15749172
Nava 2002 {published data only}|Non-invasive pressure support ventilation in acute hypoxemic respiratory failure: Common strategy for differnet pathologies?|/resolve/reference/PMED?id=12400564
Newberry 1995 {published data only}|Noninvasive bilevel positive pressure ventilation in severe acute pulmonary edema|/resolve/reference/PMED?id=7605541
Newby 2007 {published data only}|3CPO|
Nikki 1982 {published data only}|Ventilatory pattern in respiratory failure arising from acute myocardial infarction. I. Respiratory and hemodynamic effects of IMV4 vs IPPV12 and PEEP0 vs PEEP10|/resolve/reference/PMED?id=7037301
Niranjan 1998 {published data only}|Noninvasive ventilation|
Panacek 2002 {published data only}|Role of noninvasive ventilation in the managemnet of acutely descompensated heart failure|
Pang 1998 {published data only}|The effect of positive pressure airway support on mortality and the need for intubation i cardiogenic pulmonary edema: A systematic review|/resolve/reference/PMED?id=9792593
Park 2005 {published data only}|Noninvasive ventilation in threatment of the acute pulmonary oedema. Where are we really?|
Park 2006 {published data only}|Noninvasive mechanical ventilation in the treatment of acute cardiogenic pulmonary edema|
Perel 1983 {published data only}|Effectiveness of CPAP by mask for pulmonary edema associated with hypercarbia|/resolve/reference/PMED?id=6339582
Perkins 2006 {published data only}|From the authors|
Philip-joet 1999 {published data only}|Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure|
Plaisance 2007 {published data only}|A randomized study of out-of-hospital continuous positive airway pressure for acute cardiogenic pulmonary oedema|/resolve/reference/PMED?id=17967821
Pollack 1996 {published data only}|Feasibility study of the use of bilevel positive airway pressure for respiratory support in the emergency department|/resolve/reference/PMED?id=8629750
Poponick 1999 {published data only}|Use of a ventilatory support system (BIPAP) for acute respiratory failure in the emergency department|/resolve/reference/PMED?id=10424521
Popova 2010 {published data only}|Effect of noninvasive ventilation (NIV) on exercise tolerance in patients with acute decompensated heart failure [Abstract]|
Poulton 1936 {published data only}|Left-side heart failure with pulmonary edema: its treatment with the "pulmonary plus pressure machine"|
Rabatin 1999 {published data only}|Noinvasive ventilation|/resolve/reference/PMED?id=10473360
Rasanen J 1985 {published data only}|Acute myocardial infarction complicated by left ventricular dysfunction and respiratory failure|/resolve/reference/PMED?id=3881227
Rizk 1982 {published data only}|PEEP and pulmonary edema|/resolve/reference/PMED?id=7036733
Roche 2003 {published data only}|Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance|
Rusterholtz 1999 {published data only}|Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=10051074
Rutherholtz 2008 {published data only}|Continuous positive airway pressure vs. proportional assist ventilation for noninvasive ventilation in acute cardiogenic pulmonary edema|/resolve/reference/PMED?id=18214425
Sacchetti 2001 {published data only}|Effectiveness of BiPAP for congestive heart failure|/resolve/reference/PMED?id=11345397
Sachetti 1995 {published data only}|Bi-level positive airway pressure support system use in acut congestive failure:Preliminary case series|
Salvucci A 2001 {published data only}|CPAP for cardiogenic pulmonary edema|/resolve/reference/PMED?id=11258309
Sarullo 2004 {published data only}|Efficacy and safety of non-invasive positive pressure ventilation therapy in acute pulmonary edema|/resolve/reference/PMED?id=15211730
Schettino 2008 {published data only}|Noninvasive positive-pressure ventilation in acute respiratory failure outside clinical trials: experience at the Massachusetts General Hospital|/resolve/reference/PMED?id=18091540
Severinghaus 2002 {published data only}|Sightings|
Simonds 2000 {published data only}|Nasal ventilation: Where are we?|/resolve/reference/PMED?id=10786425
Sinuff 2000 {published data only}|Noninvasive positive-pressure ventilation: A utilization review of use in a teaching hospital|/resolve/reference/PMED?id=11068568
Somauroo 2000 {published data only}|Acute hemodynamic changes of nasal bilevel and continuous positive airway pressure ventilation in patients with congestive heart failure|
Sutton 2002 {published data only}|Biphasic positive pressure ventilation in acute cardiogenic pulmonary oedema|
Trevisan 2008 {published data only}|Noninvasive mechanical ventilation may be useful in treating patients who fail weaning from invasive mechanical ventilation: A randomized clinical trial|
Uy 2003 {published data only}|Continuous positive airway pressure (CPAP) among patients with cardiogenic pulmonary edema|
Uy 2004 {published data only}|Continuous positive airway pressure amoung patients with cadiogenic pulmonary edema [Abstract]|
Vaisanen 1987 {published data only}|Continuous positive airway pressure and supplemental oxygen in the treatment of cardiogenic pulmonary edema|/resolve/reference/PMED?id=3304850
Valipour 2004 {published data only}|Non-invasive pressure support ventilation in patients with respiratory failure due to severe acute cardiogenic pulmonary edema|
Werdan 1999 {published data only}|Emergency treatment of acute heart failure|
Widger 2001 {published data only}|Pressure upport noninvasive positive pressure ventilation treatment of acute cardiogenic pulmonary edema|
Wood 1998 {published data only}|The use of noninvasive positive pressure ventilation in the emergency department|/resolve/reference/PMED?id=9596317
Wright 2001 {published data only}|The role of non-invasive ventilation in the emergency department|/resolve/reference/PMED?id=11559633
Wysocki 1995 {published data only}|Noninvasive pressure support ventilation in patients with acute respiratory failure. A randomized comparison with conventional therapy|/resolve/reference/PMED?id=7874950
Wysocki 1999 {published data only}|Noninvasive ventilation in acute cardiogenic pulmonary edema: Better than CPAP?|/resolve/reference/PMED?id=10051070
Zhang 2008 {published data only}|Changes of plasma B-type natriuretic peptide level during non-invasive ventilation in treating acute left heart failure|/resolve/reference/PMED?id=18505112
NCT00554580 {published and unpublished data}|Effect of Continuous Positive Airway Pressure on Short Term Inhospital Prognosis for Acute Pulmonary Edema|
NCT00912158 {published data only}|Noninvasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema|
AHA 2012|Heart and Stroke Statistics 2012|
Allison 1991|Initial tratment of pulmonary edema: a physiological approach|/resolve/reference/PMED?id=1772126
Bach 1997|Consensus statement noninvasive positive pressure ventilation|
Castro 1999|Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS database): Update|/resolve/reference/PMED?id=10511734
Collins 2006|The Use of Noninvasive Ventilation in Emergency Department Patients With Acute Cardiogenic Pulmonary Edema: A Systematic Review|/resolve/reference/PMED?id=16934647
Confalonieri 1999|Acute respiratory failure inpatients with severe community acquired pneumonia. A prospective randomized evaluation of non-invasive ventilation|/resolve/reference/PMED?id=10556125
Covelli 1982|Efficacy of continuous positive airway pressure administrated by facemask|/resolve/reference/PMED?id=7035084
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Dickstein 2008|ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)|/resolve/reference/PMED?id=18799522
Egger 1997|Bias in meta-analysis detected by simple, graph test|/resolve/reference/PMED?id=9310563
Gay 2009|Complications of Noninvasive Ventilation in Acute Care|
Gibelin 2002|Acute cardiogenic pulmonary edema and its treatment|/resolve/reference/PMED?id=12434594
Guimares 2004|Latin-American guideline for the evaluation and management of descompensed heart failure. 2004|
Guyatt 2008|Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations|/resolve/reference/PMED?id=18436948
Higgins 2011| Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Ho 2006|A comparison of continuous and bi-level positive airway pressure non-invasive ventilation in patients with acute cardiogenic pulmonary oedema: a meta-analysis|/resolve/reference/PMED?id=16569254
Jadad 2000|Systematic reviews and meta-analyses on treatment of asthma: critical evaluation|/resolve/reference/PMED?id=10688558
Keenan 1997|Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis|/resolve/reference/PMED?id=9377883
Kelly 1997|Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency management of acute severe cardiogenic pulmonary oedema|
Lefebvre 1996|Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE|
Lefebvre 2011|Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). |
Martnez 1995|Non invasive intermittent mechanical ventilation in the treatment of chronic severe cardiac failure|/resolve/reference/PMED?id=8733263
Masip 2005|Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis|/resolve/reference/PMED?id=16380593
McKibbon 2004|What do evidence-based secondary journals tell us about the publication of clinically important article in primary healthcare journals?|/resolve/reference/PMED?id=15350200
Meyer 1998|Noninvasive ventilation in the severe congestive heart failure patient|
MIX 2006|The MIX program|
Nieminen 2005|Executive summary of the guidelline on the diagnosis and treatment of acute heart failure|/resolve/reference/PMED?id=15681577
Peter 2006|Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis|/resolve/reference/PMED?id=16616558
Potts 2009|Noninvasive positive pressure ventilation: effect on mortality in acute cardiogenic pulmonary edema: a pragmatic meta-analysis|
Ram 2004|Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease|
Remme 1997|The treatment of heart failure. The task force of the Working Group on heart failure of the European Society of Cardiology|/resolve/reference/PMED?id=9152644
Review Manager 2013|Review Manager (RevMan)|
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Visnen 1987|Continuous positive airway pressure and supplemental oxygen in threatment of cardiogenic pulmonary edema|/resolve/reference/PMED?id=3304850
Weng 201O|Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema|
Williams 1995|Guidelines for the evaluation and management of heart failure|/resolve/reference/PMED?id=7594057
Winck 2006|Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema - a systematic review and meta-analysis|/resolve/reference/PMED?id=16646987
Vital 2008|Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema|
Emtner 2003 {published data only}|Benefits of supplemental oxygen in exercise training in non-hypoxemic chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=12869359
Emtner 2003 {published data only}|Benefits of supplemental oxygen in rehabilitation exercise training in non-hypoxemic COPD patients|
Fichter 1999 {published data only}|Supplemental oxygen during a training program in COPD does not improve exercise capacity|
Fichter 1999 {published data only}|Effect of oxygen (FI02: 0.35) on the aerobic capacity in patients with COPD|/resolve/reference/PMED?id=10226473
Fichter 1999 {published data only}|Does supplemental oxygen during a training program in COPD improve exercise capacity?|
Garrod 2000 {published data only}|Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia|/resolve/reference/PMED?id=10856310
Rooyackers 1997 {published data only}|No additional effect of supplemental oxygen during training in patients with severe COPD|
Rooyackers 1997 {published data only}|Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise|/resolve/reference/PMED?id=9192929
Wadell 2001 {published data only}|Physical training with and without oxygen in patients with chronic obstructive pulmonary disease and exercise-induced hypoxaemia|/resolve/reference/PMED?id=11585150
Abdulla 2000 {published data only}|Adequacy of oxygenation in a group of Danish patients with COPD on long-term oxygen therapy|/resolve/reference/PMED?id=11057078
Ambrosino 2004 {published data only}|New strategies to improve exercise tolerance in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15332404
Anthonisen 1983 {published data only}|Long-term oxygen therapy|/resolve/reference/PMED?id=6354031
Aubier 1980 {published data only}|Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure|/resolve/reference/PMED?id=6778278
Baldwin 1995 {published data only}|Nocturnal oxygen desaturation and exercise-induced desaturation in subjects with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7494911
Banner 1986 {published data only}|Long term transtracheal oxygen delivery through microcatheter in patients with hypoxaemia due to chronic obstructive airways disease|/resolve/reference/PMED?id=3089412
Barach 1966 {published data only}|Oxygen supported exercise and rehabilitation of patients with chronic obstructive lung disease|/resolve/reference/PMED?id=5905062
Barach 1970 {published data only}|Home rehabilitation for pulmonary emphysema. Device for delivering oxygen during inspiratory cycle|/resolve/reference/PMED?id=5267659
Barach 1971 {published data only}|The role of oxygen therapy in the rehabilitation of patients with chronic obstructive lung disease|/resolve/reference/PMED?id=5125601
Bartels 2004 {published data only}|Supplemental oxygen increases arterial stiffness in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=14959818
Bell 1988 {published data only}|Effects of transtracheal oxygen therapy on exercise capacity|
Bellone 1996 {published data only}|Exercise-induced hypoxaemia in emphysematous type chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8680376
Berg 1996 {published data only}|Quality of life in COPD patients using transtracheal oxygen|/resolve/reference/PMED?id=8696406
Block 1974 {published data only}|Low flow oxygen therapy. Treatment of the ambulant outpatient|/resolve/reference/PMED?id=4613235
Bower 1988 {published data only}|Performance of a demand oxygen saver system during rest, exercise, and sleep in hypoxemic patients|/resolve/reference/PMED?id=3383659
Bradley 1978 {published data only}|Oxygen assisted exercise in chronic obstructive lung disease: The effect on exercise capacity and arterial blood gas tensions|/resolve/reference/PMED?id=697174
Bradley 2005e {published data only}|Short term ambulatory oxygen for chronic obstructive pulmonary disease (Cochrane Review)|/resolve/reference/PMED?id=19066532
Braun 1992 {published data only}|Comparison of six oxygen delivery systems for COPD patients at rest and during exercise|/resolve/reference/PMED?id=1516389
Brezinova 1979 {published data only}|The effects of long-term oxygen therapy on the EEG in patients with chronic stable ventilatory failure|/resolve/reference/PMED?id=497489
Bye 1985 {published data only}|Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation|/resolve/reference/PMED?id=4026048
Casaburi 1980 {published data only}|Alteration by hyperoxia of ventilatory dynamics during sinusoidal work|/resolve/reference/PMED?id=6769890
Chaney 2002 {published data only}|Implementation of an oxygen therapy clinic to manage users of long-term oxygen therapy|/resolve/reference/PMED?id=12426268
Chatila 2004 {published data only}|The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease|/resolve/reference/PMED?id=15486371
Christensen 2004 {published data only}|Effect of exercise mode on oxygen uptake and blood gases in COPD patients|/resolve/reference/PMED?id=15250232
Christensen 2004b {published data only}|Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients|/resolve/reference/PMED?id=15459136
Cockcroft 1986 {published data only}|Effects of supplementary oxygen on exercise ventilation and breathlessness in patients with C.O.A.D|
Corriveau 1988 {published data only}|Effects of supplemental oxygen on oxygen transport and oxygen consumption at rest and during exercise in patients with chronic obstructive lung disease.|
Cotes 1956 {published data only}|Effect of oxygen on exercise ability in chronic respiratory insufficiency; use of portable apparatus|/resolve/reference/PMED?id=13320918
Cotes 1963 {published data only}|Continuous versus intermittent administration of oxygen during exercise to patients with chronic lung disease|/resolve/reference/PMED?id=14023337
Cotes 1963b {published data only}|Effect of breathing oxygen upon cardiac output, heart rate, ventilation, systemic and pulmonary blood pressure in patients with chronic lung disease|/resolve/reference/PMED?id=14070914
Cottrell 1995 {published data only}|Home oxygen therapy. A comparison of 2- vs 6-month patient reevaluation|/resolve/reference/PMED?id=7842761
Criner 1987 {published data only}|Ventilatory muscle recruitment in exercise with O2 in obstructed patients with mild hypoxemia|/resolve/reference/PMED?id=3624124
Criner 2000 {published data only}|Effects of long-term oxygen therapy on mortality and morbidity|/resolve/reference/PMED?id=10771786
Crockett 1999 {published data only}|Effects of long-term oxygen therapy on quality of life and survival in chronic airflow limitation|/resolve/reference/PMED?id=10394840
Crockett 2000e {published data only}|Domiciliary oxygen for chronic obstructive pulmonary disease (Cochrane Review)|
Cuvelier 2002 {published data only}|Refillable oxygen cylinders may be an alternative for ambulatory oxygen therapy in COPD|/resolve/reference/PMED?id=12171816
Dardes 1990 {published data only}|Quality of life of COPD patients treated by long-term oxygen|/resolve/reference/PMED?id=2117193
Davidson 1988 {published data only}|Supplemental oxygen and exercise ability in chronic obstructive airways disease|/resolve/reference/PMED?id=3238640
Dean 1992 {published data only}|Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia|/resolve/reference/PMED?id=1416422
Degre 1974 {published data only}|Hemodynamic responses to physical training in patients with chronic lung disease|/resolve/reference/PMED?id=4413654
Dewan 1994 {published data only}|Effect of low flow and high flow oxygen delivery on exercise tolerance and sensation of dyspnea|/resolve/reference/PMED?id=8162725
Diaz 1992 {published data only}|Preliminary results of a program of home oxygen therapy using transtracheal catheter|/resolve/reference/PMED?id=1502403
Domingo 2004 {published data only}|Acute and long-term hemodynamic response to home oxygen therapy: nasal prongs versus oxygen saving devices|
Donner 1992 {published data only}|Can long-term oxygen therapy improve exercise capacity and prognosis?|/resolve/reference/PMED?id=1513970
Drummond 2001 {published data only}|Long-term oxygen therapy - Present state in Oporto district|
Earnest 2002 {published data only}|Explaining adherence to supplemental oxygen therapy: the patient's perspective|
Eaton 2001 {published data only}|A double-blind randomised controlled study of portable oxygen in patients with COPD and exertional desaturation|
Eaton 2002 {published data only}|Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study|/resolve/reference/PMED?id=12212960
Fletcher 1989 {published data only}|Exercise haemodynamics and gas exchange in patients with chronic obstruction pulmonary disease, sleep desaturation, and a daytime PaO2 above 60 mm Hg|/resolve/reference/PMED?id=2817587
Frey 1998 {published data only}|Patients with chronic airflow obstruction receiving domiciliary oxygen therapy. A study of clinical parameters, nutritional status and mobility|/resolve/reference/PMED?id=9551517
Fuhrman 2004 {published data only}|Comparison of four demand oxygen delivery systems at rest and during exercise for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15481269
Fujimoto 2002 {published data only}|Benefits of oxygen on exercise performance and pulmonary haemodynamics in patients with COPD with mild hypoxemia|/resolve/reference/PMED?id=12171817
Fussell 2003 {published data only}|Assessing need for long-term oxygen therapy: a comparison of conventional evaluation and measures of ambulatory oximetry monitoring|/resolve/reference/PMED?id=12556251
Garrod 1997 {published data only}|Comparison of pulsed dose oxygen delivery and continuous oxygen delivery during exercise in patients with COPD|
Garrod 1999 {published data only}|Evaluation of pulsed dose oxygen delivery during exercise in patients with severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10325901
Gautier 1998 {published data only}|Respiratory rehabilitation in chronic obstructive pulmonary disease (COPD) outpatients under long term oxygen therapy|
Gautier 2002 {published data only}|Home rehabilitation in COPD patients on long term oxygen therapy (LTOT): a multi-centre randomized controlled study|
Gibbons 2002 {published data only}|An audit of provision of long-term oxygen therapy for COPD patients|/resolve/reference/PMED?id=12385186
Gimenez 1977 {published data only}|The oxygen car (OXCAR) in pulmonary rehabilitation of patients with respiratory failure|/resolve/reference/PMED?id=10314871
Gimenez 1979 {published data only}|Exercise training with oxygen supply and directed breathing in patients with chronic airway obstruction|/resolve/reference/PMED?id=375345
Gislason 2000 {published data only}|Working group: Clinical research in pulmonary rehabilitation of obstructive lung disease including home oxygen treatment|
Gorbachenkov 1994 {published data only}|Hypoxic training in prevention and treatment|/resolve/reference/PMED?id=7992207
Gosselin 2004 {published data only}|Effect of acute hyperoxia during exercise on quadriceps electrical activity in active COPD patients|
Gosselink 1997 {published data only}|Exercise training in COPD patients: the basic questions|/resolve/reference/PMED?id=9493679
Guthrie 1970 {published data only}|Improved exercise tolerance in patients with chronic airway obstruction|/resolve/reference/PMED?id=5506479
Guyatt 2000 {published data only}|Appropriateness of domiciliary oxygen delivery|/resolve/reference/PMED?id=11083678
Haas 1966 {published data only}|Rehabilitation of patients with obstructive pulmonary diseases. The role of enriched oxygen|/resolve/reference/PMED?id=5936426
Hagarty 1997 {published data only}|Comparison of three oxygen delivery systems during exercise in hypoxemic patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9117023
Haidl 2002 {published data only}|Long term oxygen therapy enhances endurance in patients with severe COPD, but moderate hypoxaemia and intermittent hypercapnia|
Haidl 2004 {published data only}|Long-term oxygen therapy stops the natural decline of endurance in COPD patients with reversible hypercapnia|/resolve/reference/PMED?id=15316206
Heimlich 1982 {published data only}|Respiratory rehabilitation with transtracheal oxygen system|
Hoffman 1988 {published data only}|Home oxygen. Transtracheal and other options|/resolve/reference/PMED?id=3348292
Hoffman 1992 {published data only}|Nasal cannula and transtracheal oxygen delivery. A comparison of patient response after 6 months of each technique|/resolve/reference/PMED?id=1554209
Hoo 2003 {published data only}|Nonpharmacologic adjuncts to training during pulmonary rehabilitation: the role of supplemental oxygen and noninvasive ventilation|/resolve/reference/PMED?id=15074455
Horsfield 1968 {published data only}|The pulmonary circulation in chronic bronchitis at rest and during exercise breathing air and 80 per cent oxygen|/resolve/reference/PMED?id=AMBIGUOUS%205666876,5662590
Ioli 1994 {published data only}|Long-term oxygen therapy|/resolve/reference/PMED?id=8087139
Ishimine 1995 {published data only}|Effect of supplemental oxygen on exercise performance in patients with chronic obstructive pulmonary disease and an arterial oxygen tension over 60 Torr|/resolve/reference/PMED?id=7609336
Janssens 1997 {published data only}|Health-related quality of life in patients under long-term oxygen therapy: a home-based descriptive study|/resolve/reference/PMED?id=9488892
Jolly 2001 {published data only}|Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia|/resolve/reference/PMED?id=11502641
Kampelmacher 2001 {published data only}|Professional guidelines on 'domiciliary oxygen therapy' in the Netherlands|/resolve/reference/PMED?id=11680068
Kanazawa 2003 {published data only}|Influence of oxygen administration on pulmonary haemodynamics and tissue oxygenation during exercise in COPD patients with different ACE genotypes|
Kawakami 1982 {published data only}|Exercise and oxygen inhalation in relation to prognosis of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=6799253
Kawakami 1983 {published data only}|Relation of oxygen delivery, mixed venous oxygenation, and pulmonary haemodynamics to prognosis in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=6403862
Keller 1985 {published data only}|Oxygen home therapy in chronic respiratory insufficiency. Report of experience with 70 patients|/resolve/reference/PMED?id=3983585
Keller 1998 {published data only}|Long-term oxygen therapy: Who? With what? At what cost?|/resolve/reference/PMED?id=9577870
Killen 2000 {published data only}|A pragmatic assessment of the placement of oxygen when given for exercise induced dyspnoea|/resolve/reference/PMED?id=10856311
King 1973 {published data only}|The effects of 30 per cent oxygen on the respiratory response to treadmill exercise in chronic respiratory failure|/resolve/reference/PMED?id=4723272
Kitchin 1961 {published data only}|The effects of exercise and of breathing oxygen-enriched air on the pulmonary circulation in emphysema|/resolve/reference/PMED?id=13756470
Kozlowski 1971 {published data only}|The effect of high oxygen tensions on ventilation during severe exercise|
Kurihara 1987 {published data only}|Prediction of PaO2 during treadmill walking in patients with COPD|/resolve/reference/PMED?id=3816310
Kurihara 1989 {published data only}|Exercise induced hypoxemia and exercise tolerance in patients with COPD and the benefits of oxygen supplementation|/resolve/reference/PMED?id=2526271
Lacasse 2005 {published data only}|Randomised trial of ambulatory oxygen in oxygen-dependent COPD|/resolve/reference/PMED?id=15929958
Leach 1992 {published data only}|Portable liquid oxygen and exercise ability in severe respiratory disability|/resolve/reference/PMED?id=1481177
Leggett 1977 {published data only}|Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale|/resolve/reference/PMED?id=871805
Lehnigk 1998 {published data only}|Efficacy of a demand oxygen delivery system (DODS) during exercise in patients with severe COPD|
Levin 1980 {published data only}|Effect of 15 hours per day oxygen therapy on patients with chronic airways obstruction|
Lewczuk 1998 {published data only}|Comparison of 14-day rehabilitation and oxygen therapy on exercise tolerance and percutaneous oxygen saturation in patients with advanced COPD|/resolve/reference/PMED?id=10354696
Lewis 2003 {published data only}|Short-burst oxygen immediately before and after exercise is ineffective in non-hypoxic COPD patients|/resolve/reference/PMED?id=14582907
Light 1989 {published data only}|Relationship between improvement in exercise performance with supplemental oxygen and hypoxic ventilatory drive in patients with chronic airflow obstruction|/resolve/reference/PMED?id=2924604
Liker 1975 {published data only}|Portable oxygen in chronic obstructive lung disease with hypoxemia and cor pulmonale. A controlled double-blind crossover study|/resolve/reference/PMED?id=1097205
Limberg 2001 {published data only}|Evaluation of a new demand oxygen conservation device in patients with chronic lung diseases at rest and with exercise|
Little 1999 {published data only}|Predictors of nocturnal oxygen desaturation in patients with COPD|/resolve/reference/PMED?id=10464879
Lock 1991 {published data only}|Portable oxygen therapy: assessment and usage|/resolve/reference/PMED?id=1759006
Longo 1971 {published data only}|The role of oxygen therapy in the rehabilitation of patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=5579910
Machida 1992 {published data only}|Effectiveness of a new portable oxygen delivery system (DODS) in oxygen sparing and exercise tolerance in patients with chronic respiratory failure|
MacIntyre 2000 {published data only}|Oxygen therapy and exercise response in lung disease|/resolve/reference/PMED?id=10771791
MacIntyre 2000b {published data only}|Long-term oxygen therapy: conference summary|/resolve/reference/PMED?id=10771796
MacNee 1985 {published data only}|Right ventricular performance during exercise in chronic obstructive pulmonary disease. The effects of oxygen|/resolve/reference/PMED?id=4070799
MacNee 1986 {published data only}|A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema|/resolve/reference/PMED?id=3752712
Maldonado 2004 {published data only}|Effects of 28% and 35% oxygen during constant exercise in advanced COPD in Bogota, Columbia (2640m)|
Maltais 2001 {published data only}|Effects of oxygen on lower limb blood flow and O2 uptake during exercise in COPD|/resolve/reference/PMED?id=11404656
Mannix 1992 {published data only}|The effect of oxygen with exercise on atrial natriuretic peptide in chronic obstructive lung disease|/resolve/reference/PMED?id=1531190
Mannix 1992b {published data only}|Oxygen may lower the O2 cost of ventilation in chronic obstructive lung disease|/resolve/reference/PMED?id=1555461
Marchand 1998 {published data only}|Comparison of three different demand oxygen delivery systems (DODS) with continuous low flow oxygen (CLFO) at rest and during exercise in hypoxemic COPD patients|
Marques 1998 {published data only}|Treadmill exercise duration and dyspnea recovery time in chronic obstructive pulmonary disease: effects of oxygen breathing and repeated testing|/resolve/reference/PMED?id=9713632
Matsuzawa 2000 {published data only}|Acute effects of oxygen on dyspnea and exercise tolerance in patients with pulmonary emphysema with only mild exercise-induced oxyhemoglobin desaturation|/resolve/reference/PMED?id=11193316
McDonald 1995 {published data only}|Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia|/resolve/reference/PMED?id=7582304
McDonald 2005 {published data only}|Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand|/resolve/reference/PMED?id=15963018
McKeon 1988 {published data only}|Effects of breathing supplemental oxygen before progressive exercise in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=3353874
McKeon 1988b {published data only}|Portable oxygen in patients with severe chronic obstructive pulmonary disease|
Miller 1962 {published data only}|Exercise training in the rehabilitation of patients with severe respiratory insufficiency due to pulmonary emphysema. The role of oxygen breathing|
Minh 1979 {published data only}|Hypoxemia during exercise in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=507509
Mitlehner 1992 {published data only}|Effects of long term oxygen therapy due to portable liquid oxygen tanks in disabled malnourished chronic obstructive pulmonary disease patients with borderline hypoxemia. Aim of the study and methods|/resolve/reference/PMED?id=1513972
Miyagi 1989 {published data only}|New trends in home oxygen therapy (HOT) after the introduction of health insurance coverage in Okinawa and factors contributing to long-term survival|/resolve/reference/PMED?id=2796046
Morrison 1992e {published data only}|Increased exercise capacity in hypoxemic patients after long-term oxygen therapy|/resolve/reference/PMED?id=1643945
Muir 1995 {published data only}|Exertional hypoxia and portable oxygen therapy|/resolve/reference/PMED?id=7777760
Nandi 2000 {published data only}|The effect of short burst oxygen treatment on exercise tolerance in patients with chronic obstructive pulmonary disease|
Nandi 2003 {published data only}|Oxygen supplementation before or after submaximal exercise in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12885981
NOTT 1980e {published data only}|Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial|/resolve/reference/PMED?id=6776858
O'Donnell 1997 {published data only}|Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation|/resolve/reference/PMED?id=9032190
O'Donnell 2000 {published data only}|Oxygen reduces dynamic hyperinflation and improves exercise performance in hypoxic patients with COPD|
O'Donnell 2003 {published data only}|Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2003|/resolve/reference/PMED?id=12861361
O'Donohue 1997 {published data only}|Home oxygen therapy|/resolve/reference/PMED?id=9329875
Palange 1995 {published data only}|Oxygen effect on O2 deficit and VO2 kinetics during exercise in obstructive pulmonary disease|/resolve/reference/PMED?id=7665422
Patessio 1996 {published data only}|Effects of supplemental oxygen vs room air breathing during training on exercise responses in non desaturating COPD patients|
Payen 1993 {published data only}|Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia|/resolve/reference/PMED?id=8442592
Peckham 1998 {published data only}|Improvement in patient compliance with long-term oxygen therapy following formal assessment with training|/resolve/reference/PMED?id=9926150
Pepin 1996 {published data only}|Long-term oxygen therapy at home. Compliance with medical prescription and effective use of therapy. ANTADIR Working Group on Oxygen Therapy. Association Nationale de Traitement a Domicile des Insuffisants Respiratories|/resolve/reference/PMED?id=8625658
Petty 1968 {published data only}|Clinical evaluation of prolonged ambulatory oxygen therapy in chronic airway obstruction|/resolve/reference/PMED?id=5666651
Petty 1974 {published data only}|Editorial: Does treatment for severe emphysema and chronic bronchitis really help?|/resolve/reference/PMED?id=4810668
Petty 1974b {published data only}|Outpatient oxygen for chronic airway obstruction|/resolve/reference/PMED?id=4406847
Petty 1981 {published data only}|Home oxygen in advanced chronic obstructive pulmonary disease|/resolve/reference/PMED?id=7242175
Petty 1987 {published data only}|Home oxygen therapy|/resolve/reference/PMED?id=3114573
Petty 1998 {published data only}|Supportive therapy in COPD|/resolve/reference/PMED?id=9552015
Petty 2000 {published data only}|Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the Nocturnal Oxygen Therapy Trial revisited)|/resolve/reference/PMED?id=10771792
Pflug 1972 {published data only}|Evaluation of an intermittent oxygen flow system|/resolve/reference/PMED?id=5011673
Pierce 1964 {published data only}|Responses to exercise training in patients with emphysema|/resolve/reference/PMED?id=14067591
Pierce 1965 {published data only}|Exercise training with the aid of a portable oxygen supply in patients witih emphysema|/resolve/reference/PMED?id=14280938
Piszko 1997 {published data only}|Rehabilitation vs oxygen therapy in COPD patients. Results of exercise test and percutaneous oxygen saturation after 14 day-treatment|
Piszko 2002 {published data only}|Oxygen saturation at rest, on exercise and during sleep in non oxygenated rehabilitation patients with COPD|
Piszko 2002b {published data only}|Oxygen saturation at rest, on exercise and during sleep in patients with COPD undergoing pulmonary rehabilitation program. Two years, prospective, controlled study|/resolve/reference/PMED?id=12884566
Puhan 2004 {published data only}|Value of supplemental interventions to enhance the effectiveness of physical exercise during respiratory rehabilitation in COPD patients. A systematic review|/resolve/reference/PMED?id=15575956
Raimondi 1970 {published data only}|Exercise tolerance breathing a low density gas mixture, 35 per cent oxygen and air in patients with chronic obstructive bronchitis|/resolve/reference/PMED?id=5493541
Ram 2002e {published data only}|Ambulatory oxygen for chronic obstructive pulmonary disease (Cochrane Review)|
Revill 2000 {published data only}|Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD|/resolve/reference/PMED?id=10955754
Roberts 1996 {published data only}|Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking|/resolve/reference/PMED?id=8795673
Roberts 1998 {published data only}|Screening patients in general practice with COPD for long-term domiciliary oxygen requirement using pulse oximetry|/resolve/reference/PMED?id=9926138
Roberts 2004 {published data only}|Short burst oxygen therapy for relief of breathlessness in COPD|/resolve/reference/PMED?id=15282379
Rooyackers 1996 {published data only}|Long-term effects of training in patients with COPD and exercise hypoxaemia|
Sant'Anna 2003 {published data only}|Evaluation of health-related quality of life in low-income patients with COPD receiving long-term oxygen therapy|/resolve/reference/PMED?id=12527614
Scano 1982 {published data only}|Effect of oxygen on breathing during exercise in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=6802664
Segard 1992 {published data only}|The quality of oxygen therapy delivery systems using oxygen-saving valves. A multicenter study. The ANTADIR Medico-Technical Commission|/resolve/reference/PMED?id=1565832
Selinger 1987 {published data only}|Effects of removing oxygen from patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3605848
Senn 1989 {published data only}|Efficacy of a pulsed oxygen delivery device during exercise in patients with chronic respiratory disease|/resolve/reference/PMED?id=2766806
Skorodin 1989 {published data only}|Acutely administered and long-term O2 supplementation does not improve exercise tolerance or reduce dyspnea in pink puffers|
Sliwinski 1994 {published data only}|The adequacy of oxygenation in COPD patients undergoing long-term oxygen therapy assessed by pulse oximetry at home|/resolve/reference/PMED?id=8162980
Smith 2001 {published data only}|Exercise intolerance, hypoxaemia and breathlessness in COPD: does pre-dosing with oxygen actually help?|
Snider 2002 {published data only}|Enhancement of exercise performance in COPD patients by hyperoxia: a call for research|/resolve/reference/PMED?id=12426288
Soffer 1985 {published data only}|Conservation of oxygen supply using a reservoir nasal cannula in hypoxemic patients at rest and during exercise|/resolve/reference/PMED?id=3931988
Somfay 2001 {published data only}|Effect of supplemental oxygen on hyperinflation and exercise endurance in non-hypoxemic COPD patients|
Somfay 2001b {published data only}|Dose-response effect of oxygen on hyperinflation and exercise endurance in non-hypoxaemic COPD patients|/resolve/reference/PMED?id=11510809
Somfay 2002 {published data only}|Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in non-hypoxemic COPD patients|/resolve/reference/PMED?id=11834648
Stein 1982 {published data only}|Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=6797795
Stevenson 2002 {published data only}|The effects of oxygen on resolution of breathlessness after exercise|
Stevenson 2004 {published data only}|Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15282386
Stewart 1992 {published data only}|Indications for long-term oxygen therapy|/resolve/reference/PMED?id=1513974
Swinburn 1984 {published data only}|Relationship between ventilation and breathlessness during exercise in chronic obstructive airways disease is not altered by prevention of hypoxaemia|/resolve/reference/PMED?id=6478752
Tarpy 1994 {published data only}|Chronic lung disease: when to prescribe home oxygen|/resolve/reference/PMED?id=8307386
Terrados 1990 {published data only}|Is hypoxia a stimulus for synthesis of oxidative enzymes and myoglobin?|/resolve/reference/PMED?id=2384418
Tiep 1987 {published data only}|Demand oxygen delivery during exercise|/resolve/reference/PMED?id=3792073
Tiep 1990 {published data only}|Long-term home oxygen therapy|/resolve/reference/PMED?id=2205441
Timms 1985 {published data only}|Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3966742
Twohig 2000 {published data only}|Pulsed inhaled oxygen during exercise in chronic obstructive pulmonary disease (COPD)|
Veale 1998 {published data only}|Characteristics and survival of patients prescribed long-term oxygen therapy outside prescription guidelines|/resolve/reference/PMED?id=9817145
Vergeret 1989 {published data only}|Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy|/resolve/reference/PMED?id=2707399
Vyas 1971 {published data only}|Response to exercise in patients with chronic airway obstruction. II. Effects of breathing 40 per cent oxygen|/resolve/reference/PMED?id=5152724
Waldegger 2003 {published data only}|A randomized controlled trial of Rollator Walkers Compared to Oxygen in Chronic Obstructive Pulmonary Disease|
Walsh 1990 {published data only}|Long term continuous domiciliary oxygen therapy by transtracheal catheter|/resolve/reference/PMED?id=2118281
Waterhouse 1983 {published data only}|Breathlessness and portable oxygen in chronic obstructive airways disease|/resolve/reference/PMED?id=6867984
Wedzicha 1996 {published data only}|Ambulatory oxygen in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8766202
Weitzenblum 1991e {published data only}|One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients|/resolve/reference/PMED?id=1804669
Weitzenblum 1992 {published data only}|Benefit from long-term O2 therapy in chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=1513967
Weitzenblum 2002 {published data only}|Long-term oxygen therapy for chronic respiratory failure. Rationale, indications, modalities|/resolve/reference/PMED?id=12407284
Welch 1977 {published data only}|Effects of hyperoxia on leg blood flow and metabolism during exercise|/resolve/reference/PMED?id=838660
Welch 1987 {published data only}|Effects of hypoxia and hyperoxia on human performance|/resolve/reference/PMED?id=3297723
Wesmiller 1990 {published data only}|Exercise tolerance during nasal cannula and transtracheal oxygen delivery|/resolve/reference/PMED?id=2310104
Wilkinson 1996 {published data only}|Domiciliary oxygen|/resolve/reference/PMED?id=8733334
Wilson 1975 {published data only}|Effects of hyperoxic gas mixtures on energy metabolism during prolonged work|/resolve/reference/PMED?id=1176389
Wright 1983 {published data only}|The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise|/resolve/reference/PMED?id=6625346
Wurtemberger 2001 {published data only}|Functional effects of different training in patients with COPD|/resolve/reference/PMED?id=11748505
Yaeger 1994 {published data only}|Oxygen therapy using pulse and continuous flow with a transtracheal catheter and a nasal cannula|/resolve/reference/PMED?id=8082369
Young 1998 {published data only}|Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand|/resolve/reference/PMED?id=9451391
Young 1999 {published data only}|Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme|
Zack 1985 {published data only}|Oxygen supplemented exercise of ventilatory and non-ventilatory muscles in pulmonary rehabilitation|/resolve/reference/PMED?id=4053707
Zhu 2005 {published data only}|Continuous oxygen monitoring-a better way to prescribe long-term oxygen therapy|/resolve/reference/PMED?id=15878655
Zielinski 1998 {published data only}|Long-term oxygen therapy in COPD patients with moderate hypoxaemia: does it add years to life?|/resolve/reference/PMED?id=9817140
Zimmerman 1992 {published data only}|Can higher than usual doses of supplemental oxygen improve endurance with exercise in chronically hypoxemic COPD patients|
Anto 2001|Epidemiology of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11401076
Anto 2005|Epidemiology of chronic obstructive pulmonary disease|
Atkins 2004|Grading quality of evidence and strength of recommendations|/resolve/reference/PMED?id=15205295
ATS 1995|ATS standards for the diagnosis and care of patients with chronic obstructive pulmonary disease|
ATS 2002|ATS statement: Guidelines for the six-minute walk test|
ATS 2003|ATS/ACCP Statement on cardiopulmonary exercise testing|/resolve/reference/PMED?id=12524257
ATS 2004|Standards for the diagnosis and management of patients with COPD|
Beyene 2005|Statistical methods for meta-analysis: An introduction.|
Bradley 2005|Short-term ambulatory oxygen for chronic obstructive pulmonary disease (Cochrane Review)|/resolve/reference/PMED?id=19066532
Calverley 2000|Supplementary oxygen therapy in COPD: Is it really useful?|/resolve/reference/PMED?id=10856309
Casaburi 1993|Exercise training in chronic obstructive lung disease|
Casaburi 1997|Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9154855
Celli 2004|Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper|/resolve/reference/PMED?id=15219010
Crockett 2000|Domiciliary oxygen for chronic obstructive pulmonary disease (Cochrane Review)|/resolve/reference/PMED?id=16235285
Crockett 2005|Domiciliary oxygen for chronic obstructive pulmonary disease (Cochrane Review)|
Deeks 2005|Analysing and presenting results Section 8|
Dunst 2004|Guidelines for calculating effect sizes for practice-based research syntheses|
Eaton 2002b|Ambulatory oxygen improves quality of life of COPD patients: A randomised controlled study|/resolve/reference/PMED?id=12212960
Fichter 1999b|Effect of oxygen (FI02: 0.35) on the aerobic capacity in patients with COPD|/resolve/reference/PMED?id=10226473
Fujimoto 2002b|Benefits of oxygen on exercise performance and pulmonary haemodynamics in patients with COPD with mild hypoxemia|/resolve/reference/PMED?id=12171817
Garrod 2000b|Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia|/resolve/reference/PMED?id=10856310
Guyatt 1985|How should we measure function in patients with chronic heart and lung disease?|/resolve/reference/PMED?id=4008592
Guyatt 2006|Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians Task Force|/resolve/reference/PMED?id=16424429
Handbook 2008||
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jaescheke 1989|Measurement of health status. Ascertaining the minimal clinically important difference|/resolve/reference/PMED?id=2691207
Lacasse 1997|A systematic overview of the measurement properties of the chronic respiratory questionnaire|
Lacasse 2002|Smoking cessation in pulmonary rehabilitation: Goal or prerequisite?|/resolve/reference/PMED?id=12042681
Lacasse 2005|Randomised trial of ambulatory oxygen in oxygen-dependent COPD|/resolve/reference/PMED?id=15929958
Lacasse 2006|Pulmonary rehabilitation for chronic obstructive pulmonary disease (Cochrane Review)|/resolve/reference/PMED?id=17054186
Liesker 2002|A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD|/resolve/reference/PMED?id=11834677
Maltais 2002|Exercise training in patients with COPD|
Moher 1999|Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement|/resolve/reference/PMED?id=10584742
Monninkhof 2003|Self-management education for patients with chronic obstructive pulmonary disease: a systematic review|
Morrison 1992|Increased exercise capacity in hypoxemic patients after long-term oxygen therapy|/resolve/reference/PMED?id=1643945
MRC 1981|Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema|/resolve/reference/PMED?id=6110912
NHLBI 2003|Data fact sheet: Chronic obstructive pulmonary disease|
NOTT 1980|Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial|/resolve/reference/PMED?id=6776858
O'Donnell 2002|Controlling breathlessness and cough|
O'Donnell 2003b|Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2003|/resolve/reference/PMED?id=12861361
O'Donohue 1991|Effect of oxygen therapy on increasing arterial oxygen tension in hypoxemic patients with stable chronic obstructive pulmonary disease while breathing ambient air|/resolve/reference/PMED?id=1914613
Oga 2000|The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.|/resolve/reference/PMED?id=10852763
Okubadejo 1996|Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia?|/resolve/reference/PMED?id=8947081
Patessio 1996b|Effects of supplemental oxygen vs room air breathing during training on exercise responses in non desaturating COPD patients|
Pauwels 1998|Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO workshop report: Executive Summary|
Ram 2002|Ambulatory oxygen for chronic obstructive pulmonary disease (Cochrane Review)|
Redelmeier 1997|Interpreting small differences in functional status: The six minute walk test in chronic lung disease patients|/resolve/reference/PMED?id=9105067
Restrick 1993|Assessment and follow up of patients prescribed long term oxygen treatment|/resolve/reference/PMED?id=8153918
Rochester 2003|Exercise training in chronic obstructive pulmonary disease|
Romain 2001|Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11316667
Rooyackers 1997b|Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise|/resolve/reference/PMED?id=9192929
Ruppel 1994||
Schunemann 2006|22.4 Grading Recommendations (In Press)|
Singh 1992|Development of a shuttle walking test of disability in patients with chronic airways obstruction|/resolve/reference/PMED?id=1494764
Singh 1994|Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation|/resolve/reference/PMED?id=7875275
Solway 2001||
Solway 2002|The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD|/resolve/reference/PMED?id=12114339
Somfay 2002b|Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in non-hypoxemic COPD patients|/resolve/reference/PMED?id=11834648
Spence 1993|Does cold air affect exercise capacity and dyspnea in stable chronic obstructive pulmonary disease?|/resolve/reference/PMED?id=8449053
Sundberg 1993|Effects of ischaemic training on local aerobic muscle performance in man|
Sweer 1990|Dyspnea in the patient with chronic obstructive pulmonary disease. Etiology and management|/resolve/reference/PMED?id=1976053
Swinburn 1991|Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease|/resolve/reference/PMED?id=2024842
Wasserman 1993|Exercise tolerance in the pulmonary patient|
Wasserman 2005||
Wedzicha 2000|Effects of long-term oxygen therapy on neuropsychiatric function and quality of life|/resolve/reference/PMED?id=10771787
Weitzenblum 1991|Evolution of physiological variables in patients with chronic obstructive pulmonary disease before and during long-term oxygen therapy|/resolve/reference/PMED?id=1745843
Baigis 2002 {published data only}|Effectiveness of a home-based exercise intervention for HIV-infected adults: a randomized trial|/resolve/reference/PMED?id=11936063
Berrien 2004 {published data only}|Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention|/resolve/reference/PMED?id=15294086
Cherin 1998 {published data only}|Evaluation of the transprofessional model of home health care for HIV/AIDS|/resolve/reference/PMED?id=10338808
Cherin 1998 {published data only}|Retention of clients in service under two models of home health care for HIV/AIDS|/resolve/reference/PMED?id=10351067
Dolan 2006 {published data only}|Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus. A randomized trial|/resolve/reference/PMED?id=16772251
Flatley-Brennan 1998 {published data only}|Computer network home care demonstration: a randomized trial in persons living with AIDS|/resolve/reference/PMED?id=9861507
Gustafson 1999 {published data only}|Impact of a patient-centered, computer-based health information/support system|/resolve/reference/PMED?id=9894548
Gustafson 1999 {published data only}|The use and impact of a computer-based support system for people living with AIDS and HIV infection.|/resolve/reference/PMED?id=7949999
Lule 2005 {published data only}|Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda|/resolve/reference/PMED?id=16282305
Melchoir 1996 {published data only}|Efficacy of 2-month total parenteral nutrition in AIDS patients: a controlled randomized prospective trial|/resolve/reference/PMED?id=8728041
Miles 2003 {published data only}|An HIV self-care symptom management intervention for African American mothers|/resolve/reference/PMED?id=14639081
Nickel 1996 {published data only}|Quality of life in nurse case management of persons with AIDS receiving home care|
Williams 2006 {published data only}|Home visits to improve adherence to highly active antiretroviral therapy: a randomized controlled trial|/resolve/reference/PMED?id=16770291
Antoni 2000 {published data only}|Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output and t-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men|/resolve/reference/PMED?id=10710838
Brennan 1994 {published data only}|Use of a home-care computer network by persons with AIDS|/resolve/reference/PMED?id=8034405
Choy 1990 {published data only}|Experience with home aerosolized pentamidine treatment in patients with AIDS|/resolve/reference/PMED?id=2360337
Colford 2005 {published data only}|A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons|
Holzemer 2000 {published data only}|The client adherence profiling-intervention tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study|/resolve/reference/PMED?id=10670005
Kraak 1995 {published data only}|Home-delivered meal programs for homebound people with HIV/AIDS|/resolve/reference/PMED?id=7699191
Leibowitz 1992 {published data only}|Home TPN and AIDS patients|/resolve/reference/PMED?id=1433790
Morales 1994 {published data only}|Secondary bacterial infections in HIV-infected patients: an alternative ambulatory outpatient treatment utilizing intravenous cefotaxime|/resolve/reference/PMED?id=8059803
Ndekha 2005 {published data only}|Comparison of home-based therapy with ready-to-use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial|/resolve/reference/PMED?id=15817865
Ndekha 2005 {published data only}|Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV-infected Malawian children|/resolve/reference/PMED?id=15981758
Sandige 2004 {published data only}|Home-based treatment of malnourished Malawian children with locally produced or imported ready-to-use food|/resolve/reference/PMED?id=15269617
Singer 1997 {published data only}|Home parenteral lipids in AIDS: a three-month study|/resolve/reference/PMED?id=9106787
Sjolander 1988 {published data only}|Nursing management of the AIDS patient at home|/resolve/reference/PMED?id=3392319
NCT00119093 {published data only}|Home-Based AIDS Care Project|
NCT00144365 {published data only}|Comparison of Facility and Home-Based ART Delivery Systems in Uganda|
Afroaidsinfo|A home-based care programme in your community|
Alderson 2004||
Elkan 2001|Effectiveness of home based support for older people: systematic review and meta-analysis|/resolve/reference/PMED?id=11576978
Floyd 2001|Cost And Financing Aspects Of Providing Anti-Retroviral Therapy: A Background Paper|
French 1999|Immunologic and clinical stages in HIV-1 infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease|
Hansen 1998|The cost of home based care for HIV/AIDS patients in Zimbabwe|/resolve/reference/PMED?id=9924529
Havens 1999||
Hedrick 1989|Meta-analysis of home-care effects on mortality and nursing-home placement|
Hughes 1997|Impact of home care on hospital days: a meta analysis|/resolve/reference/PMED?id=9327811
Morrison 1993|Delivery systems for care of persons with HIV infection and AIDS|/resolve/reference/PMED?id=8516176
NNRA 1994|Chapter 9: The quality of home care|
Smeenk 1998|Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital: systematic review|/resolve/reference/PMED?id=9641929
UNAIDS 2004||
UNAIDS 2007|AIDS epidemic update|
Uys 2003|A model for Home based care|
WHO 2002|Community home-based care in resource-limited settings: a framework for action|
Begley 1990 {published data only}||
Begley 1990 {published data only}|A comparison of 'active' and 'physiological' management of the third stage of labour|/resolve/reference/PMED?id=2182978
Begley 1990 {published data only}|The effect of ergometrine on breast feeding|/resolve/reference/PMED?id=2195299
Daley 1951 {published data only}|The use of intramuscular ergometrine at the end of the second stage of normal labour|
De Groot 1996b {published data only}|A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage|
Howard 1964 {published data only}|Oxytocic drugs in fourth stage of labor|/resolve/reference/PMED?id=14162138
Kerekes 1979 {published data only}|The effect of prostaglandin F2alpha on third stage labour|/resolve/reference/PMED?id=392622
McGinty 1956 {published data only}|A study of the vasopressor effects of oxytocics when used intravenously in the third stage of labour|
Amant 1999 {published data only}|Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial|
Badhwar 1991 {unpublished data only}|The value of nipple stimulation in the management of third stage of labour|
Barbaro 1961 {published data only}|Clinical trial of SE505 - a new oxytocic mixture|
Baumgarten 1983 {published data only}|Uterine motility after post-partum application of sulprostone and other oxytocics|/resolve/reference/PMED?id=6662263
Bonham 1963 {published data only}|Intramuscular oxytocics and cord traction in third stage of labour|/resolve/reference/PMED?id=14066183
Caliskan 2002 {published data only}|Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial|/resolve/reference/PMED?id=12389002
Carpn 1968 {published data only}|Clinical trial of intramuscular OCM 505 and intravenous methergin in the third stage of labour|/resolve/reference/PMED?id=4893747
Chatterjee 2000 {unpublished data only}|Misoprostol and the 3rd stage|
Chukudebelu 1963 {published data only}|Use of "syntometrine" in the third stage of labour|/resolve/reference/PMED?id=14041351
Diab 1999 {published data only}|The use of rectal misoprostol as active pharmacological management of the third stage of labor|
Docherty 1981 {published data only}|Choice of an oxytocic agent for routine use at delivery|
Dweck 2000 {published data only}|Use of methergine for the prevention of postoperative endometritis in non-elective cesarean section patients|/resolve/reference/PMED?id=10968597
Forster 1957 {published data only}|A comparative study of ergometrine and 'methergin' used in the management of the third stage of labour|
Francis 1965a {published data only}|Clinical trial of an oxytocin-ergometrine mixture (first of two trials)|
Francis 1965b {published data only}|Clinical trial of an oxytocin-ergometrine mixture (second of two trials)|
Friedman 1957 {published data only}|Comparative clinical evaluation of postpartum oxytocics|/resolve/reference/PMED?id=13424596
Fugo 1958 {published data only}|A comparison of oxytocic drugs in the management of the placental stage|/resolve/reference/PMED?id=13545290
Groeber 1960 {published data only}|Methergine and ergonovine in the third stage of labor|/resolve/reference/PMED?id=13829497
Hacker 1979 {published data only}|Blood pressure changes when uterine stimulants are used after normal delivery|
Huh 2004 {published data only}|A randomized, double-blinded, placebo controlled trial of oxytocin at the beginning versus the end of the third stage of labor for prevention of postpartum hemorrhage|
Ilancheran 1990 {published data only}|Effect of oxytocics on prostaglandin levels in the third stage of labour|/resolve/reference/PMED?id=2358192
Jago 2007 {published data only}|Effect of oxytocics on the blood pressure of normotensive Nigerian parturients|/resolve/reference/PMED?id=17701671
Jolivet 1978 {published data only}|Effect of ergot alkaloid derivatives on milk secretion in the immediate postpartum period|/resolve/reference/PMED?id=641312
Kemp 1963 {published data only}|Clinical trial of "syntometrine" in the third stage of labour|/resolve/reference/PMED?id=14031862
Khan 1995 {published data only}|Abu Dhabi third stage trial: oxytocin vs syntometrine in the active management of the third stage of labour|
Kikutani 2003 {published data only}|Effects of methylergometrine and oxytocin on thoracic epidural pressure during cesarean section|
Lam 2004 {published data only}|A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor|/resolve/reference/PMED?id=15225189
Lamont 2001 {published data only}|A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage|/resolve/reference/PMED?id=11577783
Mitchell 1993 {published data only}|The Salford third stage trial: oxytocin plus ergometrine vs oxytocin alone in the active management of the third stage of labor|
Moir 1979 {published data only}|Ergometrine or oxytocin? Blood loss and side-effects at spontaneous vertex delivery|/resolve/reference/PMED?id=371650
Moodie 1976 {published data only}|Ergometrine, oxytocin and extradural analgesia|/resolve/reference/PMED?id=952692
Moore 1956 {published data only}|Is methylergonovine tartrate superior to ergonovine maleate|/resolve/reference/PMED?id=13302331
Nieminen 1963 {published data only}|A comparative study of different medical treatments of the third stage of labour|/resolve/reference/PMED?id=14232101
Orji 2008 {published data only}|A randomized comparative study of prophylactic oxytocin versus ergometrine in the third stage of labor|/resolve/reference/PMED?id=18164304
Paull 1977 {published data only}|Ergometrine and third stage blood loss|
Pei 1996 {published data only}|Study of the effects of using uterine stimulants on milk secretion during delivery|/resolve/reference/PMED?id=9295487
Penaranda 2002 {published data only}|Active management of childbirth with sublingual misoprostol: a controlled clinical trial in the Hospital de Maternidad Rafael Calvo|
Rajwani 2000 {unpublished data only}|Active management of third stage of labor - a comparative study [abstract]|
Ramesh 1983 {published data only}|Role of intramyometrial prostaglandin E2 in management of third stage of labour|/resolve/reference/PMED?id=6604696
Reddy 2001 {published data only}|Active management of third stage of labour. A comparative study in high risk patients for atonic postpartum haemorrhage|
Rooney 1985 {published data only}|Is routine administration of syntometrine still justified in the management of the third stage of labour?|/resolve/reference/PMED?id=4044247
Saito 2007 {published data only}|Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage|
Singh 2009 {published data only}|Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor|
Soiva 1964 {published data only}|Clinical experience with simultaneous intramuscular injection of oxytocin and methylergometrine|/resolve/reference/PMED?id=14163868
Sorbe 1978 {published data only}|Active pharmacologic management of the third stage of labor. A comparison of oxytocin and ergometrine|/resolve/reference/PMED?id=310530
Stearn 1963 {published data only}|Syntometrine in the management of the third stage of labour|
Symes 1984 {published data only}|A study on the effect of ergometrine on serum prolactin levels following delivery|
Terry 1970 {published data only}|A management of the third stage to reduce feto-maternal transfusion|
Thilaganathan 1993 {published data only}|Management of the third stage of labour in women at low risk of postpartum haemorrhage|/resolve/reference/PMED?id=8449257
Thornton 1988 {published data only}|Plasma oxytocin during third stage of labour: comparison of natural and active management|/resolve/reference/PMED?id=3261614
Thornton 1988 {published data only}|Plasma oxytocin in the third stage of human labour with and without syntometrine [abstract]|
Vaughan 1974 {published data only}|A comparison of central venous pressure changes in the third stage of labour following oxytocic drugs and diazepam|
Vimala 2004 {published data only}|Sublingual misoprostol versus methylergometrine for active management of third stage of labor|/resolve/reference/PMED?id=15464767
Weiss 1975 {published data only}|Effect of methylergonovine on puerperal prolactin secretion|/resolve/reference/PMED?id=1080266
Yardim 1967 {published data only}|Active direction of the postpartum period with Syntometrin|/resolve/reference/PMED?id=5304978
Yuen 1995 {published data only}|A randomised double blind comparison of syntometrine and syntocinon in the management of the third stage of labour|
Acuin 2010|Maternal, neonatal, and child health in southeast Asia: towards greater regional collaboration|/resolve/reference/PMED?id=21269675
Andersen 1998|Methylergometrine during the early puerperium; a prospective randomized double blind study|/resolve/reference/PMED?id=9492719
Begley 2010|Active versus expectant management for women in the third stage of labour|/resolve/reference/PMED?id=20614458
Borri 1986|Methylergonovine maleate: a proposal for its more specific use|/resolve/reference/PMED?id=3490881
Brucker 2001|Management of the third stage of labor: an evidence-based approach|
Cotter 2001|Prophylactic oxytocin for the third stage of labour|
De Groot 1995|Prevention of postpartum haemorrhage|/resolve/reference/PMED?id=8846560
De Groot 1996a|The role of oral (methyl)ergometrine in the prevention of postpartum haemorrhage|
De Groot 1998|Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology|/resolve/reference/PMED?id=9806101
Den Hertog 2001|History and use of oxytocics|
Dua 1994|Postpartum eclampsia associated with ergometrine maleate administration|
Dunn 2002|John Chassar Moir (1900-1977) and the discovery of ergometrine|/resolve/reference/PMED?id=12193527
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Gowri 2003|Postpartum second degree heart block induced by methergine|/resolve/reference/PMED?id=12706285
Glmezoglu 2007|Prostaglandins for preventing postpartum haemorrhage|
Harbord 2006|A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints|
Higgins 2005|Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]|/resolve/reference/PMED?id=11584727
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|/resolve/reference/PMED?id=9277068
Hogan 2010|Maternal mortality for 181 countries, 1980?2008: a systematic analysis of progress towards Millennium Development Goal|/resolve/reference/PMED?id=20382417
Hogerzeil 1996|Instability of (methyl)ergometrine in tropical climates: an overview|/resolve/reference/PMED?id=8909953
McCormick 2002|Preventing postpartum hemorrhage in low-resource settings|/resolve/reference/PMED?id=12065142
McDonald 2004|Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour|
Moher 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials|/resolve/reference/PMED?id=11323066
Prendiville 2000|Active versus expectant management in the third stage of labour|
RevMan 2003|Review Manager (RevMan)|
RevMan 2011|Review Manager (RevMan)|
Sloan 2001|The etiology of maternal mortality in developing countries: what do verbal autopsies tell us?|/resolve/reference/PMED?id=11584727
Sultatos 1997|Mechanisms of drugs that affect uterine motility|/resolve/reference/PMED?id=9277068
Taylor 1985|Ergonovine-induced coronary artery spasm and myocardial infarction after normal delivery|/resolve/reference/PMED?id=3877894
Van Dongen 1995|History of ergot alkaloids from ergotism to ergometrine|
Van Selm 1995|Preventing the recurrence of atonic postpartum hemorrhage: a double-blind trial|
WHO 2000||
WHO 2001||
WHO 2003||
Avorn 1983 {published data only}|Improving drug-therapy decisions through educational outreach|/resolve/reference/PMED?id=6406886
Avorn 1992 {published data only}|A randomized trial of a program to reduce the use of psychotropic drugs in nursing homes|/resolve/reference/PMED?id=1608408
Avorn 1992 {published data only}|Psychoactive medication use in intermediate-care facility residents|/resolve/reference/PMED?id=2903260
Baker 2001 {published data only}|Randomised controlled trial of tailored strategies to implement guidelines for the management of patients with depression in general practice|/resolve/reference/PMED?id=11593835
Callahan 1994 {published data only}|Improving treatment of late life depression in primary care: a randomized clinical trial|
Callahan 1994 {published data only}|Depression in elderly outpatients: primary care physicians' attitudes and practice patterns|
Cheater 2006 {published data only}|Cluster randomized controlled trial of the effectiveness of audit and feedback and educational outreach on improving nursing practice and patient outcomes|/resolve/reference/PMED?id=16708003
Coenen 2004 {published data only}|Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial|/resolve/reference/PMED?id=15282232
Davies 2002 {published data only}|Evaluation of two strategies for the transfer of research results about labour support and electronic fetal monitoring into practice|
Davies 2002 {published data only}|Fetal health surveillance: a community-wide approach versus a tailored intervention for the implementation of clinical practice guidelines|/resolve/reference/PMED?id=12240812
Davies 2002 {published data only}|Labour support: nurses' self-efficacy and views about factors influencing implementation|
Engers 2005 {published data only}|Implementation of the Dutch low back pain guideline for general practitioners: A cluster randomized controlled trial|
Engers 2005 {published data only}|Low back pin in general practice: reported management and reasons for not adhering to the guidelines in the Netherlands|/resolve/reference/PMED?id=11042916
Engers 2005 {published data only}|Implementation barriers for general practice guidelines on low back pain: A qualitative study|/resolve/reference/PMED?id=11474367
Evans 1997 {published data only}|Improving care for minority children with asthma: professional education in public health clinics|/resolve/reference/PMED?id=9024439
Figueiras 2006 {published data only}|An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial|/resolve/reference/PMED?id=16954488
Flottorp 2002 {published data only}|Process evaluation of a cluster randomised controlled trial of tailored interventions to implement guidelines in primary care - why is it so hard to change practice?|/resolve/reference/PMED?id=12738704
Flottorp 2002 {published data only}|Identifying barriers and tailoring interventions to improve the management of urinary tract infections and sore throat; a pragmatic study using qualitative methods|/resolve/reference/PMED?id=12622873
Flottorp 2002 {published data only}|Cluster randomised controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat|/resolve/reference/PMED?id=12183309
Foy 2004 {published data only}|A randomised controlled trial of a tailored multifaceted strategy to promote implementation of a clinical guideline on induced abortion care|
Fretheim 2006 {published data only}|Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change|/resolve/reference/PMED?id=15347426
Fretheim 2006 {published data only}|Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention|/resolve/reference/PMED?id=16737346
Fretheim 2006 {published data only}|Rational prescribing in primary care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice|/resolve/reference/PMED?id=12657163
Goodwin 2001 {published data only}|A clinical trial of tailored office systems for preventive service delivery. The study to enhance prevention by understanding practice (STEP-UP)|/resolve/reference/PMED?id=11418253
Goodwin 2001 {published data only}|Sustainability of a practice-individualised preventive service delivery intervention|/resolve/reference/PMED?id=14580630
Hux 1999 {published data only}|Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial|/resolve/reference/PMED?id=10478162
Karuza 1995 {published data only}|Enhancing physician adoption of practice guidelines. Dissemination of influenza vaccination guideline using a small-group consensus process|/resolve/reference/PMED?id=7887759
Langham 2002 {published data only}|Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial|/resolve/reference/PMED?id=12392122
Leviton 1999 {published data only}|An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids|/resolve/reference/PMED?id=7631711
Leviton 1999 {published data only}|Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial|/resolve/reference/PMED?id=9892450
Matchar 2002 {published data only}|Community impact of anticoagulation services: rationale and design of the managing anticoagulation services trial (MAST)|/resolve/reference/PMED?id=10859579
Matchar 2002 {published data only}|Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organisations: results of the Managing Anticoagulation Services Trial|/resolve/reference/PMED?id=12106622
Matchar 2002 {published data only}|A seven step model for practice improvement research: description and application to the managing anticoagulation services trial|
Ross-Degnan 1996 {published data only}|The impact of face-to-face educational outreach in diarrhoea treatment in pharmacies|/resolve/reference/PMED?id=10160376
Santoso 1996 {published data only}|Small group intervention vs formal seminar for improving appropriate drug use|/resolve/reference/PMED?id=8737434
Schouten 2007 {published data only}|Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study|/resolve/reference/PMED?id=17403764
Sehgal 2002 {published data only}|Improving the quality of hemodialysis treatment: community-based randomized controlled trial to overcome patient-specific barriers|/resolve/reference/PMED?id=11960538
Sehgal 2002 {published data only}|Barriers to adequate delivery of hemodialysis|/resolve/reference/PMED?id=9531174
Simon 2005 {published data only}|Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial|/resolve/reference/PMED?id=15866255
Soumerai 1998 {published data only}|Adhrerence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly|/resolve/reference/PMED?id=8615714
Soumerai 1998 {published data only}|Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial|/resolve/reference/PMED?id=9582043
Verhoeven 2005 {published data only}|A short educational intervention on communication skills improves the quality of screening for Chlamydia in GPs in Belgium: a cluster randomized controlled trial|/resolve/reference/PMED?id=15797158
Verhoeven 2005 {published data only}|Discussing STIs: doctors are from Mars, patients from Venus|/resolve/reference/PMED?id=12509364
Allison 2005 {published data only}|Multicomponent Internet continuing medical education to promote chlamydia screening|
Altiner 2007 {published data only}|Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study|/resolve/reference/PMED?id=17626023
Azocar 2003 {published data only}|The impact of evidence-based guideline dissemination for the assessment and treatment of major depression in a managed behavioral health care organization|
Baer 2001 {published data only}|Agency context and tailored training in technology transfer: A pilot evaluation of motivational interviewing training for community counsellors|
Benrimoj 2003 {published data only}|Clinical intervention rates in community pharmacy: a randomised trial of the effect of education and a professional allowance|
Bosworth 2007 {published data only}|Hypertension Intervention Nurse Telemedicine Study (HINTS): testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control|/resolve/reference/PMED?id=17540191
Bravo 2005 {published data only}|Improving the quality of residential care using goal attainment scaling|
Brinkman 2009 {published data only}|Effect of multi-source feedback on resident communication skills and professionalism: a randomized controlled trial|
Buckmaster 2006 {published data only}|Using a clinical pathway and education to reduce inappropriate prescribing of enoxaparin in patients with acute coronary syndromes: a controlled study|
Byrne 2006 {published data only}|Development of a complex intervention for secondary prevention of coronary heart disease in primary care using the UK Medical Research Council framework|
Cabrera 2001 {published data only}|Quality control and improvement of the care provided to the patient with acute myocardial infarction. Implementation of a quality assurance program|/resolve/reference/PMED?id=11141454
Casebeer 2003 {published data only}|Designing tailored Web-based instruction to improve practicing physicians' preventive practices|
Cranney 1999 {published data only}|Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly|/resolve/reference/PMED?id=10621985
Cranney 2001 {published data only}|Why do GPs not implement evidence-based guidelines? A descriptive study|
de Velasco 2004 {published data only}|Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study|/resolve/reference/PMED?id=14967110
Downs 2006 {published data only}|Effectiveness of educational interventions in improving detection and management of dementia in primary care: cluster randomised controlled study|/resolve/reference/PMED?id=16565124
Edwards 2002 {published data only}|"Short stops": peer support of scholarly activity|
Edwards 2007 {published data only}|Improving paediatric nurses' knowledge and attitudes in childhood fever management|
Figueiras 2001 {published data only}|One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial|/resolve/reference/PMED?id=11176553
Fretheim 2004 {published data only}|Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change|
Garcia 2004 {published data only}|Effect of a simple educational program for physicians on adherence to secondary prevention measures after discharge following acute coronary syndrome. The CAM Project|/resolve/reference/PMED?id=15544750
Gask 2005 {published data only}|Qualitative study of an educational intervention for GPs in the assessment and management of depression|
Gonano 2003 {published data only}|Educational or Organizational Approach: Which Is More Effective in Changing Blood-Sampling Habits?|/resolve/reference/PMED?id=14570669
Green 2002 {published data only}|Validating an instrument for selecting interventions to change physician practice patterns: a Michigan Consortium for Family Practice Research study|/resolve/reference/PMED?id=12485547
Gregory 1999 {published data only}|Targeted intervention programs: creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population|
Griffiths 2007 {published data only}|Educational outreach to promote screening for tuberculosis in primary care: a cluster randomised controlled trial|
Glmezoglu 2007 {published data only}|Cluster randomised trial of an active, multifaceted educational intervention based on the WHO Reproductive Health Library to improve obstetric practices|
Hanbury 2009 {published data only}|Use of a time series design to test effectiveness of a theory-based intervention targeting adherence of health professionals to a clinical guideline|
Hardeman 2005 {published data only}|A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation|
Hendryx 1998 {published data only}|Outreach education to improve quality of rural ICU care. Results of a randomized trial|
Hennessy 2006 {published data only}|Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial|
Herdeiro 2005 {published data only}|Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal|/resolve/reference/PMED?id=16119975
Holzemer 2007 {published data only}|Testing a nurse-tailored HIV medication adherence intervention|
Inouye 2000 {published data only}|Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies|
Jones 2004 {published data only}|Improving nursing home staff knowledge and attitudes about pain|
Kinmonth 1996 {published data only}|Developing a training programme in patient-centred consulting for evaluation in a randomised controlled trial; diabetes care from diagnosis in British primary care|
LaPointe 2006 {published data only}|Multifaceted intervention to promote beta-blocker use in heart failure|
Laprise 2009 {published data only}|Improved cardiovascular prevention using best CME practices: a randomized trial|
Leong 2006 {published data only}|Efficacy of an integrated continuing medical education (CME) and quality improvement (QI) program on radiation oncologist (RO) clinical practice|/resolve/reference/PMED?id=16979841
Leveille 1998 {published data only}|Preventing disability and managing chronic illness in frail older adults: a randomized trial of a community-based partnership with primary care|
Levine 2005 {published data only}|Physicians' satisfaction with a collaborative disease management program for late-life depression in primary care|
Lundborg 1999 {published data only}|Combining feedback from simulated cases and prescribing. Design and implementation of an educational intervention in primary care in Sweden|/resolve/reference/PMED?id=10874374
Markey 2001 {published data only}|Promoting evidence-based medicine in general practice-the impact of academic detailing|
Murphy 2005 {published data only}|The SPHERE study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses|/resolve/reference/PMED?id=16053525
Nansel 2007 {published data only}|Preventing unintentional pediatric injuries: a tailored intervention for parents and providers|/resolve/reference/PMED?id=17906313
Naughton 2007 {published data only}|A clustered randomized trial of the effects of feedback using academic detailing compared to postal bulletin on prescribing of preventative cardiovascular therapy|
New 2003 {published data only}|Educational outreach in diabetes to encourage practice nurses to use primary care hypertension and hyperlipidaemia guidelines (EDEN): a randomized controlled trial|
Otero-Sabogal 2006 {published data only}|Improving rescreening in community clinics: does a system approach work?|/resolve/reference/PMED?id=17186643
Peters-Klimm 2008 {published data only}|Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline|
Ploeg 2007 {published data only}|Factors influencing best-practice guideline implementation: lessons learned from administrators, nursing staff, and project leaders|
Romero 2005 {published data only}|Effectiveness of a multifactorial strategy for implementing clinical guidelines on unstable angina: cluster randomized trial|/resolve/reference/PMED?id=15970119
Saini 2006 {published data only}|An educational intervention to train community pharmacists in providing specialized asthma care|/resolve/reference/PMED?id=17149447
Sehgal 1998 {published data only}|Barriers to adequate delivery of hemodialysis|/resolve/reference/PMED?id=9531174
Seltzer 1997 {published data only}|Expediting the turnaround of radiology reports in a teaching hospital setting|
Shirazi 2008 {published data only}|Effects on readiness to change of an educational intervention on depressive disorders for general physicians in primary care based on a modified Prochaska model--a randomized controlled study|
Silverman 2004 {published data only}|Tailoring interventions: understanding medical practice culture|/resolve/reference/PMED?id=15146138
Socolar 1998 {published data only}|Intervention to improve physician documentation and knowledge of child sexual abuse: a randomized, controlled trial|
Solomon 2001 {published data only}|Academic detailing to improve use of broad-spectrum antibiotics at an academic medical centre|/resolve/reference/PMED?id=11493132
Solomon 2007 {published data only}|Improving care of patients at-risk for osteoporosis: a randomized controlled trial|
Spunt 1996 {published data only}|An interactive videodisc program for low back pain patients|
Straand 2006 {published data only}|A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice--The Prescription Peer Academic Detailing (Rx-PAD) study|/resolve/reference/PMED?id=16764734
Stphan 2006 {published data only}|Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before-after intervention study|
Taylor 1996 {published data only}|Modifying community practice styles: The back pain outcome assessment team information dissemination effort|
Taylor 2000 {published data only}|Patient-oriented outcomes from low back surgery: a community-based study|
Turnbull 2006 {published data only}|Disease management for hypertension - A pilot cluster randomized trial of 67 Australian general practices|
Unrod 2007 {published data only}|Randomized controlled trial of a computer-based, tailored intervention to increase smoking cessation counseling by primary care physicians|/resolve/reference/PMED?id=17372796
Vallerand 2004 {published data only}|Improving cancer pain management by homecare nurses|
van Driel 2007 {published data only}|What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care|/resolve/reference/PMED?id=17545346
van Eijk 2001 {published data only}|Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing|/resolve/reference/PMED?id=11250852
Ward 2009 {published data only}|A randomized trial of a tailored barriers intervention for Cancer Information Service (CIS) callers in pain|
Welschen 2004 {published data only}|Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial|/resolve/reference/PMED?id=15297305
Witt 2004 {published data only}|Academic detailing has no effect on prescribing of asthma medication in Danish general practice: a 3-year randomized controlled trial with 12-monthly follow-ups|
Wright 2003 {published data only}|Effectiveness of multifaceted implementation of guidelines in primary care|
Wright 2006 {published data only}|Improving the management and referral of patients with transient ischaemic attacks: a change strategy for a health community|
Zimmerman 2003 {published data only}|Tailored interventions to increase influenza vaccination in neighborhood health centers serving the disadvantaged|
Zimmerman 2006 {published data only}|Improving influenza vaccination rates of high-risk inner-city children over 2 intervention years|/resolve/reference/PMED?id=17148632
Althabe 2008 {published data only}|A behavioral intervention to improve obstetrical care|
Benner 2007 {published data only}|Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT)|
Cupples 2008 {published data only}|Secondary prevention of cardiovascular disease in different primary healthcare systems with and without pay-for-performance|/resolve/reference/PMED?id=18701532
Herdeiro 2008 {published data only}|Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal|
Lafata 2007 {published data only}|Academic detailing to improve laboratory testing among outpatient medication users|
Lobo 2004 {published data only}|Effect of a comprehensive intervention program targeting general practice staff on quality of life in patients at high cardiovascular risk: A randomized controlled trial|/resolve/reference/PMED?id=15058789
Barkun 2009 {published data only}|The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding (REASON-II)|
Dykes 2009 {published data only}|Falls - Tailoring Interventions for Patient Safety (Falls TIPS)|
Engelman 2007 {published data only}|Use of Novel Tailored Reminders in Rural Primary Care|
Gjelstad 2006 {published data only}|Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice--the Prescription Peer Academic Detailing (Rx-PAD) Study [NCT00272155]|/resolve/reference/PMED?id=16776824
Jansen 2007 {published data only}|Tailoring intervention procedures to routine primary health care practice; an ethnographic process evaluation|/resolve/reference/PMED?id=17683627
Laurant 2007 {published data only}|Engaging General Practice in the Prevention of Patients With Alcohol Problems|
van Gaal 2009 {published data only}|The design of the SAFE or SORRY? study: a cluster randomised trial on the development and testing of an evidence based inpatient safety program for the prevention of adverse events|/resolve/reference/PMED?id=19338655
Ashford 1999|Improving health care through professional behaviour change: introducing a framework for identifying behaviour change strategies|
Bosch 2007|Tailoring quality improvement interventions to identified barriers: a multiple case analysis|
Cabana 1999|Why don't physicians follow clinical practice guidelines? A framework for improvement|/resolve/reference/PMED?id=10535437
Chaillet 2006|Evidence-based strategies for implementing guidelines in obstetrics|/resolve/reference/PMED?id=17077251
Cochrane TSC User Guide 2008|TSC User Guide to Managing Specialized Registers and Handsearch Records (Version 1.1 [2008])|
EPOC 2002|Cochrane Effective Practice and Organisation of Care Group: Data Collection Checklist|
EPOC 2007a|Cochrane Effective Practice and Organisation of Care Group: Guide for Review Authors. 3 - Developing a protocol|
EPOC 2007b|Cochrane Effective Practice and Organisation of Care Group: EPOC resources for review authors|
EPOC 2009|Cochrane Effective Practice and Organisation of Care Group. Specialised register|
GRADE Working Group 2004|Grading quality of evidence and strength of recommendations|/resolve/reference/PMED?id=15205295
Grimshaw 2004||
Grol 2005||
Hopewell 2002|A comparison of handsearching versus MEDLINE searching to identify reports of randomized controlled trials|
Jamtvedt 2003|Audit and feedback: effects on professional practice and healthcare outcomes|/resolve/reference/PMED?id=12917891
Kroenke 2000|Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature|/resolve/reference/PMED?id=10665267
Lomas 1994|Teaching old (and not so old) dogs new tricks: effective ways to implement research findings|
Lgar 2009|Assessing barriers and facilitators to knowledge use|
McGlynn 2003|The quality of health care delivered to adults in the United States|/resolve/reference/PMED?id=12826639
Oxman 1995|No magic bullets. A systematic review of 102 trials of interventions to improve professional practice|/resolve/reference/PMED?id=7585368
Rao 1992|A simple method for the analysis of clustered binary data|/resolve/reference/PMED?id=1637980
Robertson 1996|Changing the clinical behaviour of doctors - a psychological framework|/resolve/reference/PMED?id=10157273
Shaw 2005|Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes|
Sutton 2000||
Ukoumunne 2002|A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials|
Baltzan 2000 {published data only}|Fan to palliative exercise-induced dyspnoea with severe COPD|
Bauldoff 2000 {published data only}|Effect of distractive auditory stimuli on exercise following pulmonary rehabilitation: a pilot study|
Bauldoff 2002 {published data only}|Exercise maintenance following pulmonary rehabilitation|/resolve/reference/PMED?id=12226037
Bauldoff 2005 {published data only}|Feasibility of distractive auditory stimuli on upper extremity training in persons with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15714113
Bourjeily-Habr 2002 {published data only}|Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12454299
Bredin 1999 {published data only}|Multicentre randomized controlled trial of a nursing intervention for breathlessness in patients with lung cancer: update of study progress|
Bredin 1999 {published data only}|Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer|/resolve/reference/PMED?id=10102851
Brooks 2003 {published data only}|Evaluating the effects of music on dyspnea during exercise in individuals with chronic obstructive pulmonary disease: a pilot study|
Corner 1996 {published data only}|Non-pharmacological intervention for breathlessness in lung cancer|/resolve/reference/PMED?id=8931065
Corner 1996 {published data only}|Developing a nursing approach to managing dyspnoea in lung cancer|
Crisafulli 2007 {published data only}|Effect of a walking aid in COPD patients receiving oxygen therapy|/resolve/reference/PMED?id=17426211
Cristiano 1997 {published data only}|Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9154856
Dalton 1995 {published data only}|The Effect of walking aids on walking distance, breathlessness and oxygenation on patients with severe chronic obstructive pulmonary disease (COPD)|
Egan 2002 {published data only}|A randomized control trial of nursing-based case management for patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12394555
Eiser 1997 {published data only}|Effects of psychotherapy in moderately severe COPD: a pilot study|/resolve/reference/PMED?id=9230251
Fujie 2002 {published data only}|Effect of chest wall vibration on dyspnea during exercise in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12093627
Galbraith 2007 {published data only}|Does a handheld fan improve intractable breathlessness?|
Garrod 2005 {published data only}|An evaluation of the acute impact of pursed lips breathing on walking distance in nonspontaneous pursed lips breathing chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=16279153
Gift 1992 {published data only}|Relaxation to reduce dyspnea and anxiety in COPD patients|/resolve/reference/PMED?id=1408866
Goodyer 1995 {published data only}|Does encouraging good compliance improve patients' clinical condition in heart failure?|/resolve/reference/PMED?id=7547154
Gupta 2006a {published data only}|The acute effects of a rollator in individuals with COPD|/resolve/reference/PMED?id=16569980
Gupta 2006b {published data only}|Effect of rollator use on health-related quality of life in Individuals with COPD|/resolve/reference/PMED?id=17035442
Hermiz 2002 {published data only}|Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12399344
Hochstetter 2005 {published data only}|An investigation into the immediate impact of breathlessness management on the breathless patient: randomised controlled trial|
Honeyman 1996 {published data only}|Effect of a walking aid on disability, oxygenation and breathlessness in patients with chronic airflow obstruction|/resolve/reference/PMED?id=8907444
Jobst 1986 {published data only}|Controlled trial of acupuncture for disabling breathlessness|
Ketelaars 1998 {published data only}|Effects of specialiszed community nursing care in patients with chronic obstructive pulmonary disease|
Lange 2006 {published data only}|High-frequency chest wall oscillation in ALS|/resolve/reference/PMED?id=17000967
Lewith 2004 {published data only}|Can a standardized acupuncture technique palliate disabling breathlessness|/resolve/reference/PMED?id=15596674
Louie 2004 {published data only}|The effects of guided imagery relaxation in people with COPD|
Maa 1997 {published data only}|Acupressure as an adjunct to a pulmonary rehabilitation program|/resolve/reference/PMED?id=9271771
McMillan 2007 {published data only}|Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial|/resolve/reference/PMED?id=17573295
Moore 2002 {published data only}|Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial|/resolve/reference/PMED?id=12433764
Nakayama 1998 {published data only}|In-phase chest wall vibration decreases dyspnea during arm elevation in chronic obstructive pulmonary disease patients|/resolve/reference/PMED?id=9840703
Neder 2002 {published data only}|Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD)|/resolve/reference/PMED?id=11923552
Pfister 1998 {published data only}|Effect of music on exercise and perceived symptoms in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9632325
Probst 2004 {published data only}|Mechanisms of improvement in exercise capacity using a rollator in patients with COPD|/resolve/reference/PMED?id=15486370
Rabow 2004 {published data only}|The comprehensive care team: a controlled trial of outpatient palliative medicine consultation|/resolve/reference/PMED?id=14718327
Rea 2004 {published data only}|A chronic disease management programme can reduce days in hospital for patients with chronic pulmonary disease|
Renfroe 1988 {published data only}|Effect of progressive relaxation on dyspnoea and state anxiety in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3292465
Rosser 1983 {published data only}|Breathlessness and psychiatric morbidity in chronic bronchitis and emphysema: a study of psychotherapeutic management|/resolve/reference/PMED?id=6844471
Sibuya 1994 {published data only}|Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease|/resolve/reference/PMED?id=8173764
Sidani 2004 {published data only}|Evaluating the effects of music on dyspnea and anxiety in patients with COPD: a process-outcome analysis|
Solway 2002 {published data only}|The short-term effect of a rollator on functional exercise capacity aming individuals with severe COPD|/resolve/reference/PMED?id=12114339
Vickers 2005 {published data only}|Acupuncture for dyspnoea in advanced cancer: a randomized placebo-controlled pilot trial (ISRCTN89462491)|
Vivodtzev 2006 {published data only}|Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD|/resolve/reference/PMED?id=16778272
Wu 2004 {published data only}|The psychologic consequences of chronic dyspnea in chronic pulmonary obstruction disease: the effects of acupressure on depression|/resolve/reference/PMED?id=17388769
Wu 2004 {published data only}|Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease|
Wu 2006 {published data only}|Effects of breathing training on quality of life and activities of daily living in elderly patients with stable severe chronic obstructive pulmonary disease|
Yu 2007 {published data only}|Effect of relaxation on psychologic distress and symptom status in older Chinese patients with heart failure|/resolve/reference/PMED?id=17383494
Yu 2007 {published data only}|Non-pharmacological interventions in older people with heart failure: effects of exercise training and relaxation therapy|/resolve/reference/PMED?id=17057393
Anonymous 1986 {published data only}|Acupuncture asthma and breathlessness|/resolve/reference/PMED?id=2878278
Aronoff 1975 {published data only}|Hypnotherapy in the treatment of bronchial asthma|/resolve/reference/PMED?id=1137206
AuBuchon 1991 {published data only}|The effects of positive mental imagery on hope, coping, anxiety, dyspnea and pulmonary function in persons with chronic obstructive pulmonary disease: Tests of a nursing intervention and a theoretical model|
Behera 1998 {published data only}|Yoga therapy in chronic bronchitis|/resolve/reference/PMED?id=11273114
Bianchi 2004 {published data only}|Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD|/resolve/reference/PMED?id=14769725
Blake 1990 {published data only}|A randomized controlled evaluation of a psychosocial intervention in adults with chronic lung disease|/resolve/reference/PMED?id=2227172
Booth 2006 {published data only}|The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study|/resolve/reference/PMED?id=17066970
Cockcroft 1987 {published data only}|Controlled trial of respiratory health worker visiting patients with chronic respiratory disability|/resolve/reference/PMED?id=3101821
Corner 1995 {published data only}|An evaluation of the use of massage and essential oils in the well-being of cancer patients|
Cox 2006 {published data only}|Preferences for follow-up after treatment for lung cancer: assessing the nurse-led option|/resolve/reference/PMED?id=16783116
Davis 2001 {published data only}|A pilot project to assess the methodological issues involved in evaluating acupuncture as a treatment for disabling breathlessness|/resolve/reference/PMED?id=11822611
Donesky-Cuenco 2006 {published data only}|Safety and feasibility of yoga in patients with COPD|
Ekman 1998 {published data only}|Feasibility of a nurse-monitored, outpatient care programme for elderly patients with moderate-to-severe chronic heart failure|/resolve/reference/PMED?id=9740348
Felber 2003 {published data only}|APN - directed transitional home care model: achieving positive outcomes for patients with COPD|/resolve/reference/PMED?id=12917525
Filshie 1996 {published data only}|Acupuncture for the relief of cancer-related breathlessness|/resolve/reference/PMED?id=8800822
Gallagher 2006 {published data only}|The clinical effects of music therapy in palliative medicine|/resolve/reference/PMED?id=16538499
Giardino 2004 {published data only}|Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: preliminary findings|/resolve/reference/PMED?id=15208975
Giasson 1998 {published data only}|Effect of therapeutic touch on the well-being of persons with terminal cancer|/resolve/reference/PMED?id=9849260
Grancelli 2003 {published data only}|Randomized trial of telephone intervention in chronic heart failure (DIAL): study design and preliminary observations|/resolve/reference/PMED?id=12815566
Hately 2003 {published data only}|Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer|/resolve/reference/PMED?id=12882259
Ingram 1967 {published data only}|Effect of pursed lips expiration on the pulmonary pressure-flow relationship in obstructive lung disease|/resolve/reference/PMED?id=6039092
Klaus 2000 {published data only}|Pilot study of guided imagery use in patients with severe heart failure|/resolve/reference/PMED?id=10867104
Lisansky 1996 {published data only}|A cognitive-behavioral self-help educational program for patients with COPD. A pilot study|
Littlejohns 1991 {published data only}|Randomised controlled trial of the effectiveness of a respiratory health worker in reducing impairment, disability, and handicap due to chronic airflow limitation|/resolve/reference/PMED?id=1926024
Maa 2003 {published data only}|Effect of acupuncture or acupressure on quality of life of patients with chronic obstructive asthma: a pilot study|/resolve/reference/PMED?id=14629844
McBride 1999 {published data only}|The therapeutic use of music for dyspnea and anxiety in patients with COPD who live at home|/resolve/reference/PMED?id=10690067
Moody 1993 {published data only}|Effects of guided imagery in patients with chronic bronchitis and emphysema|/resolve/reference/PMED?id=8220200
Mueller 1970 {published data only}|Ventilation and arterial blood gas changes induced by pursed lips breathing|/resolve/reference/PMED?id=5419502
Neff 2003 {published data only}|APN transitional home health care of COPD patients|/resolve/reference/PMED?id=12917525
Neuenschwander 2006 {published data only}|External nasal dilator strips (ENDS) may improve breathlessness in cancer patients|/resolve/reference/PMED?id=16633842
Petty 1969 {published data only}|A comprehensive care program for chronic airway obstruction. Methods and preliminary evaluation of symptomatic and functional improvement|/resolve/reference/PMED?id=5789505
Pushparajah 2006 {published data only}|Use of a chronic disease management programme in COPD to reduce hospital admissions|/resolve/reference/PMED?id=17190121
Roomi 1998 {published data only}|The effect of walking aids on exercise capacity and oxygenation in elderly patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10408664
Sitzman 1983 {published data only}|Biofeedback training for reduced respiratory rate in chronic obstructive pulmonary disease: a preliminary study|/resolve/reference/PMED?id=6553245
Smith 1999 {published data only}|The effect of a respiratory home nurse intervention in patients with chronic obstructive pulmonary disease (COPD)|
Stice 1995 {published data only}|Effect of imagery with music on anxiety and dyspnea in patients with chronic obstructive pulmonary disease|
Tandon 1978 {published data only}|Adjunct treatment with yoga in chronic severe airways obstruction|/resolve/reference/PMED?id=694807
Thoman 1966 {published data only}|The efficacy of pursed-lip breathing in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=5901381
Thornby 1995 {published data only}|Effect of distractive auditory stimuli on exercise tolerance in patients with COPD|
Tiwary 1989 {published data only}|Effect of incentive breathing on lung functions in chronic obstructive pulmonary disease (COPD)|/resolve/reference/PMED?id=2632530
Wen 1997 {published data only}|Acupoint stimulation in treating bronchial asthma|
Wesmiller 2007 {published data only}|Evaluation of an assistive device for ambulation in oxygen dependant patients with COPD|
White 1999 {published data only}|Pilot study evaluating nursing interventions for dyspnoea in patients with cancer of the lung|
Wilkinson 1999 {published data only}|An evaluation of aromatherapy massage in palliative care|/resolve/reference/PMED?id=10659113
Wolkove 2002 {published data only}|Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD|/resolve/reference/PMED?id=11888949
Wolkove 2004 {published data only}|A randomized trail to evaluate the sustained efficacy of a mucus clearance device in ambulatory patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15611806
Wong 2005 {published data only}|Effects of nurse-initiated telephone follow-up on self-efficacy among patients with chronic obstructive pulmonary disease|
Woo 2006 {published data only}|A community model of group therapy for the older patients with chronic obstructive pulmonary disease: a pilot study|
Yohannes 2003 {published data only}|Early mobilization with walking aids following hospital admission with acute exacerbation of chronic obstructive pulmonary disease|/resolve/reference/PMED?id=12952150
ATS 1999|Dyspnea: mechanisms, assessment and management: a consensus statement|
Birch 2006|A review and analysis of placebo treatments, placebo effects, and placebo controls in trials of medical procedures when sham is not inert|/resolve/reference/PMED?id=16646730
Booker 2005|Chronic obstructive pulmonary disease: non-pharmacological approaches|/resolve/reference/PMED?id=15750483
Booth 1996|Does oxygen help dyspnea in patients with cancer?|/resolve/reference/PMED?id=8630595
Booth 2004|The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine.[erratum appears in Respiratory Medicine. 2004 May;98(5):476]|/resolve/reference/PMED?id=14959816
Bruera 2000|The frequency and correlates of dyspnea in patients with advanced cancer|/resolve/reference/PMED?id=10869876
Bruton 2005|The Buteyko breathing technique for asthma: a review|/resolve/reference/PMED?id=15907677
Bullock 1997|Reiki: a complementary therapy for life|
Carrieri 1984|The sensation of dyspnea: a review|/resolve/reference/PMED?id=6376427
Carrieri-Kohlman1993|Desensitization and guided mastery: treatment approaches for the management of dyspnea|/resolve/reference/PMED?id=8098324
Carrieri-Kohlman2006|Non-pharmacological approaches|
Chang 1999|Assessment of health-related quality of life in patients with interstitial lung disease|/resolve/reference/PMED?id=10559073
Coats 2005|Advances in the non-drug, non-surgical, non-device management of chronic heart failure|/resolve/reference/PMED?id=15820278
Cowcher 1990|Long-term management of respiratory symptoms in advanced cancer|/resolve/reference/PMED?id=2079581
Cranston 2004|Oxygen therapy for dyspnoea|
CRD 2001|Undertaking Systematic Reviews of Research and Effectiveness|
De Peuter 2004|Dyspnea: the role of psychological processes|/resolve/reference/PMED?id=15325745
Dechman 2004|Evidence underlying breathing retraining in people with stable chronic obstructive pulmonary disease|/resolve/reference/PMED?id=15563259
Ebell 2004|Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature|
Edwards 2003|Personalised risk communication for informed decision making about entering screening programs|
Effing 2007|Self-management education for patients with chronic obstructive pulmonary disease|
Ernst 2001|Complementary therapies in palliative cancer care|
Ferreira 2005|Nutritional supplementation for stable chronic obstructive pulmonary disease|
Fletcher 1959|The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population|/resolve/reference/PMED?id=13823475
Gallo-Silver 2000|Behavioral interventions for lung cancer-related breathlessness|/resolve/reference/PMED?id=11898143
GOLD 2007|Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease (Updated 2007)|
Gomes 2006|Factors influencing death at home in terminally ill patients with cancer: systematic review|/resolve/reference/PMED?id=16467346
Gysels 2004|Improving supportive and palliative care for adults with cancer: Research Evidence|
Hartmann 1988|Relaxation in breathing exercises in chronic obstructive lung disease, with consideration of proprioception. [German]|
Heffernan 2006|Management of respiration in MND/ALS patients: an evidence based review|/resolve/reference/PMED?id=16546753
Heyse-Moore 1991|How much of a problem is dyspnoea in advanced cancer?|
Hoogendoorn 2000|Systematic review of psychosocial factors at work and private life as risk factors for back pain|/resolve/reference/PMED?id=10954644
Hoyal 1982|Improving the management of breathlessness using a clinical effectiveness programme|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jennings 2001|Opioids for the palliation of breathlessness in terminal illness|
Jni 2005|Assessing the quality of randomised controlled trials|
Kerr 1989|A bedside fan for terminal dyspnea|/resolve/reference/PMED?id=2604979
Kohlman 1986|Strategies patients use to manage the sensation of dyspnea|/resolve/reference/PMED?id=3639672
Kolodziej 2007|Systematic review of noninvasive positive pressure ventilation in severe stable COPD|/resolve/reference/PMED?id=17459893
Lacasse 2006|Pulmonary rehabilitation for chronic obstructive pulmonary disease|
Luce 2001|Management of dyspnea in patients with far-advanced lung disease - "Once I lose it, it's kind of hard to catch it..."|/resolve/reference/PMED?id=11255389
Lutz 2001|Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the lung cancer symptom scale in a community hospital|/resolve/reference/PMED?id=11441624
Lynn 2000|Living and dying with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=10809462
Maa 2003b|Effect of acupuncture or acupressure on quality of life of patients with chronic obstructive asthma: a pilot study|/resolve/reference/PMED?id=14629844
Marcus 2003|The integration of hypnosis into a model of palliative care|/resolve/reference/PMED?id=14713329
Mays 2005|Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field|
MRC 2000|A Framework for Development and Evaluation of RCTs for Complex Interventions to Improve Health|
Murray 2005|Illness trajectories and palliative care|/resolve/reference/PMED?id=15860828
Naylor 1995|The case of failed meta-analyses|
Nicholls 2000|Breathlessness A qualitative model of meaning|
Nordgren 2003|Symptoms experienced in the last six months of life in patients with end-stage heart failure|/resolve/reference/PMED?id=14622629
O'Rourke 2007|Clinical Dilemma: Dyspnea|/resolve/reference/PMED?id=17693349
Pan 2000|Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of Life: A systematic review|/resolve/reference/PMED?id=11068159
Polosa 2002|Nebulised morphine for severe interstitial lung disease|
Popay 2006|Guidance on the Conduct of Narrative Synthesis in Systematic Reviews|
Puhan 2005|How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction|/resolve/reference/PMED?id=15860711
Ram 2002|Ambulatory oxygen for chronic obstructive pulmonary disease|
Reardon 2006|Functional status and quality of life in chronic obstructive pulmonary disease|/resolve/reference/PMED?id=16996897
Reuben 1986|Dyspnea in terminally ill cancer patients|/resolve/reference/PMED?id=3943383
Rosser 1981|Psychological approaches to breathlessness and its treatment|/resolve/reference/PMED?id=7328511
Schwartzstein 1987|Cold facial stimulation reduces breathlessness induced in normal subjects|/resolve/reference/PMED?id=3605841
Skilbeck 1998|Palliative care in chronic obstructive airways disease: a needs assessment|/resolve/reference/PMED?id=9743823
Sladek 2006|Development of a subject search filter to find information relevant to palliative care in the general medical literature|/resolve/reference/PMED?id=17082830
Sola 2004|Non-invasive interventions for improving well-being and quality of life in patients with lung cancer|
Solano 2006|A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive Pulmonary Disease and Renal Disease|/resolve/reference/PMED?id=16442483
Taylor 2005|Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence|/resolve/reference/PMED?id=16093253
Taylor 2007|The non-pharmacological management of breathlessness|
Voltz 1997|Palliative therapy in the terminal stage of neurological disease|/resolve/reference/PMED?id=9402547
Wijkstra 2002|Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease|
Ziment 2003|Complementary and alternative medicine therapies for chronic obstructive pulmonary disease|
Koinberg 2004 {published data only}|Nurse led follow up on demand or by a physician after breast cancer surgery: a randomised study|/resolve/reference/PMED?id=15171968
Maguire 1980 {published data only}|Effect of counselling on the psychiatric morbidity associated with mastectomy|/resolve/reference/PMED?id=7192170
McArdle 1996 {published data only}|Psychological support for patients undergoing breast cancer surgery: a randomised study|/resolve/reference/PMED?id=8608288
Ritz 2000 {published data only}|Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer|/resolve/reference/PMED?id=10920832
Wengstrom 1999 {published data only}|Coping with radiation therapy: effects of a nursing intervention on coping ability for women with breast cancer|
Wengstrom 1999 {published data only}|Effects of a nursing intervention on subjective distress, side effects and quality of life of breast cancer patients receiving curative radiation therapy - a randomized study|/resolve/reference/PMED?id=10522767
Allen 2002 {published data only}|A problem solving approach to stress reduction among younger women with breast carcinoma; a randomised controlled trial|
Ambler 1999 {published data only}|Specialist nurse counsellor interventions at a time of diagnosis of breast cancer: Comparing 'advocacy' with a conventional approach|
Bordeleau 2003 {published data only}|2003|/resolve/reference/PMED?id=12743147
Brown 2002 {published data only}|Patient initiated follow-up of breast cancer|
Cimprich 1993 {published data only}|Development of an intervention to restore attention in cancer patients|/resolve/reference/PMED?id=8477404
Cleeland 1996 {unpublished data only}|Randomised pilot study to evaluate educational intervention and behavioural skills training for pain control in patients with recurrent or metastatic breast or prostate cancer|
Giese-Davis 2002 {published data only}|Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy|/resolve/reference/PMED?id=12182275
Goodwin 2003 {published data only}|Effect of nurse case management on the treatment of older women with breast cancer|
Helgeson 1999 {published data only}|Education and peer discussion group interventions and adjustment to breast cancer|/resolve/reference/PMED?id=10197829
Hughes 2000 {published data only}|Information needs of elderly post surgical cancer patients during the transition from hospital to home.|
Ironson 2002 {published data only}|A comparison of massage therapy, relaxation and standard care for women with breast cancer|
Kolcaba 1999 {published data only}|The effects of guided imagery on comfort of women with early stage breast cancer undergoing radiation therapy.|
Larsson 1992 {published data only}|Relaxation training as an integral part of caring activities for cancer patients: effects on wellbeing|
Lev 2001 {published data only}|An intervention to increase quality of life and self-care self-efficacy and decrease symptoms in breast cancer patients.|/resolve/reference/PMED?id=11871585
Maguire 1985 {published data only}|Treatment of depression in cancer patients.|
Mock 1997 {published data only}|Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer|/resolve/reference/PMED?id=9243585
Motzer 1997 {published data only}|Recruitment and retention of families in clinical trials with longitudinal designs|/resolve/reference/PMED?id=9170990
Rolnick 1999 {published data only}|Computerised information and support for patients with breast cancer or HIV infection|/resolve/reference/PMED?id=10227034
Samarel 2002 {published data only}|Effects of two types of social support and education on adaptation to early stage breast cancer.|
Sameral 1998 {published data only}|Effects of dialogue and therapeutic touch on preoperative and postoperative experiences of breast cancer surgery: an exploratory study.|/resolve/reference/PMED?id=9766290
Sandgren 2000 {published data only}|Telephone therapy for patients with breast cancer|/resolve/reference/PMED?id=10833696
Sandgren 2003 {published data only}|Short term effects of telephone therapy for breast cancer patients.|/resolve/reference/PMED?id=12790259
Targ 2002 {published data only}|The efficacy of a mind body spirit group for women with breast cancer: a randomized controlled trial.|/resolve/reference/PMED?id=12100834
Vos 2004 {published data only}|Psychosocial intervention for women with primary, non-metastatic breast cancer: a comparison between participants and non participants|/resolve/reference/PMED?id=15292625
Williams 2004 {published data only}|The effect of education in managing side effects in women receiving chemotherapy for women with breast cancer.|
Wyatt 2004 {published data only}|Efficacy of an in-home nursing intervention following short-stay breast cancer surgery.|
Arving 2006 {published and unpublished data}|Satisfaction, utilisation and perceived benefit of individual psychosocial support for breast cancer patients - A randomised study of nurse versus psychologist interventions|/resolve/reference/PMED?id=16500071
Amir 2004|The professional role of the breast cancer nurses in multi-disciplinary breast cancer team|/resolve/reference/PMED?id=15550360
Corner 2003|Exploring nursing outcomes for patients with advanced cancer following intervention by Macmillan specialist palliative care nurses|
Dickersin1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Eicher 2006|A nurse is a nurse? A systematic review of the effectiveness of specialised nursing in breast cancer|/resolve/reference/PMED?id=16979890
EUSOMA 2007|Guidelines on the standards for the training of specialised health professionals dealing with breast cancer|
Fallowfield 2002|Quality of life: a new perspective for cancer patients|/resolve/reference/PMED?id=12415257
Gray 2002|Supportive care provided by physicians and nurses to women with breast cancer. Results from a population-based survey|/resolve/reference/PMED?id=12436224
Grunfeld 2005|Clinical Practice guidelines for the care and treatment of breast cancer (Summary of the 2005 Update)|
Halkett 2006|The role of the breast care nurse during treatment for early breast cancer: the patients perspective|/resolve/reference/PMED?id=17083319
Haward 2003|Breast cancer teams: the impact of constitution, new cancer workload, and methods of operation on their effectiveness|/resolve/reference/PMED?id=12838294
Jadad 1996|Assessing the quality of reports of randomized clinical trials: Is blinding necessary|/resolve/reference/PMED?id=8721797
Maguire 1978|Psychiatric problems in the first year after mastectomy|/resolve/reference/PMED?id=565239
Maguire 1983|The effect of counselling on physical disability and social recovery after mastectomy|/resolve/reference/PMED?id=6362943
Mileshkin 2006|The multidisciplinary management of patients with cancer|/resolve/reference/PMED?id=16524967
NBCCSBNPT 2003|An evidence-based specialist breast nurse role in practice: a multicentre implementation study|
NHS 2005|Definition of a Breast Care Nurse|
NICE 2002|Guidance on Cancer Services: Improving outcomes in breast cancer|
RCN 1999|Developing Roles: nurses working in breast care|
RCN 2002a|Advanced Nursing Practice in breast cancer care|
RCN 2007|Clinical Standards for working in a breast specialty|
Redman 2003|Improving supportive care for women with breast cancer in Australia|
Rojas 2000|Follow-up strategies for women treated for early breast cancer|
Schultz 2005|Breast Cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors|
SIGN 2005|Management of breast cancer in women|
Sola 2004|Non-invasive interventions for improving well-being and quality of life in patients with lung cancer (Cochrane Review)|
Spagnola 2003|The satisfaction with life domain scales for breast cancer|
Wengstrom 2001|Coping with radiation therapy effects of a nursing intervention on coping ability for women with breast cancer|
WHO 2005|Global cancer rates could increase by 50% to 15 million by 2020|
Yates 2007|Competency standards and educational requirements for specialist breast nurses in Australia|/resolve/reference/PMED?id=17294681
Anonymous 1991 {published data only}|Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition|/resolve/reference/PMED?id=1676318
Bergsjo 1974 {published data only}|Comparison between quinestrol and diethylstilbestrol for the inhibition of lactation|
Berrebi 2001 {published data only}|Treatment of pain due to unwanted lactation with a homeopathic preparation given in the immediate post-partum period|/resolve/reference/PMED?id=11431615
Boes 1980 {published data only}|Inhibition of puerperal lactation: a comparative study of bromocryptine and pyridoxine|/resolve/reference/PMED?id=6996132
Bravo-Topete 2004 {published data only}|Cabergoline for inhibition of lactation|/resolve/reference/PMED?id=15087045
Caballero-Gordo 1991 {published data only}|Oral cabergoline. Single-dose inhibition of puerperal lactation|/resolve/reference/PMED?id=1683403
Cruttenden 1971 {published data only}|Inhibition of lactation|/resolve/reference/PMED?id=4928966
De Gezelle 1979 {published data only}|Puerperal lactation suppression and prolactin|
Defoort 1987 {published data only}|Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with estandron prolongatum|/resolve/reference/PMED?id=3684122
Dewhurst 1977 {published data only}|Inhibition of puerperal lactation: a double blind study of a bromocriptine and placebo|
England 1988 {published data only}|Suppression of lactation: a comparison between bromocriptine and prostaglandin E2|
England 1988 {published data only}|Suppression of lactation: a comparison of bromocriptine and prostaglandin E2|/resolve/reference/PMED?id=3172062
Firth 1969 {published data only}|Inhibition of lactation|/resolve/reference/PMED?id=4883649
Fischer 1995 {published data only}|Puerperal inhibition of lactation with metergoline or bromocriptine|/resolve/reference/PMED?id=7553254
Giorda 1991 {published data only}|Cabergoline vs bromocriptine in suppression of lactation after cesarean delivery|/resolve/reference/PMED?id=2037265
Hutchison 1981 {published data only}|Lactation suppression with bromocriptine|/resolve/reference/PMED?id=7033847
Iliya 1966 {published data only}|Testosterone enanthate (180 mg) and estradiol valerate (8 mg) for suppression of lactation: a double-blind evaluation|/resolve/reference/PMED?id=5949195
Kremer 1990 {published data only}|Lactation inhibition by a single injection of a new depot-bromocriptine|
Kuku 1968 {published data only}|Inhibition of lactation with Quinestrol|
MacDonald 1976 {published data only}|The failure of pyridoxine in the suppression of puerperal lactation|
Mann 1971 {published data only}|Lactation inhibition in the Outer Hebrides|/resolve/reference/PMED?id=4928965
McGlone 1969 {published data only}|An assessment of quinestrol in the inhibition of lactation|/resolve/reference/PMED?id=4896144
Melis 1988 {published data only}|Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, Cabergoline|/resolve/reference/PMED?id=3279351
Niebyl 1979 {published data only}|The effect of chlorotrianisene as postpartum lactation suppression on blood coagulation factors|/resolve/reference/PMED?id=453287
Nilsen 1976 {published data only}|Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol|
Phillips 1975 {published data only}|Prevention of postpartum breast engorgement: double-blind comparison of chlorotrianisene 72mg and placebo|/resolve/reference/PMED?id=127773
Piya-Anant 2004 {published data only}|The combined oral contraceptive pill versus bromocriptine to suppress lactation in puerperium: a randomized double blind study|/resolve/reference/PMED?id=15279347
Rolland 1973 {published data only}|A new approach to the inhibition of puerperal lactation|
Scapin 1982 {published data only}|Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial|/resolve/reference/PMED?id=7047172
Schwartz 1973 {published data only}|A clinical study of lactation suppression|/resolve/reference/PMED?id=4582587
Shaaban 1975 {published data only}|Suppression of lactation by an antiestrogen, tamoxifen|/resolve/reference/PMED?id=1053489
Shrivastav 1988 {published data only}|Suppression of puerperal lactation using jasmine flowers (jasminum sambac)|
Steenstrup 1977 {published data only}|Prevention of puerperal lactation with bromocriptine (CB 154): a double-blind comparison with diethylstilbestrol|
Stirrat 1968 {published data only}|The effectiveness of stilboestrol in the suppression of postpartum lactation|
Swift 2002 {published data only}|Breast binding... is it all that it's wrapped up to be?|
Thorbert 1983 {published data only}|Inhibition of lactation by cyclofenil and bromocriptine|
Tulandi 1985 {published data only}|Effect of prostaglandin E2 on puerperal breast discomfort and prolactin secretion|/resolve/reference/PMED?id=3858547
Utian 1975 {published data only}|Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study|
Varga 1972 {published data only}|Suppression of puerperal lactation with an ergot alkaloid: a double-blind study|/resolve/reference/PMED?id=4556543
Venturini 1981 {published data only}|Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study|/resolve/reference/PMED?id=7018950
Venturini 1988 {published data only}|Suppression of puerperal lactation by terguride: a double-blind study|/resolve/reference/PMED?id=3049266
Vischi 1975 {published data only}|Further evaluation of quinestrol in the inhibition of lactation: a double-blind comparison of two dose levels against placebo|/resolve/reference/PMED?id=1098594
Walker 1975 {published data only}|A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation|
Walker 1975 {published data only}|Controlled trial of bromocriptine, quinoestrol and placebo in suppression of puerperal lactation|/resolve/reference/PMED?id=53330
Watson 1969 {published data only}|Instant inhibition of lactation|/resolve/reference/PMED?id=4896143
Weinstein 1976 {published data only}|Serum prolactin and the suppression of lactation|
Winter 1964 {published data only}|Prevention of lactation|/resolve/reference/PMED?id=14168254
Yuen 1977 {published data only}|Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation|
Almeida 1986 {published data only}|Lactation suppression and puerperal fever|/resolve/reference/PMED?id=3963089
Bare 1960 {published data only}|Suppression of lactation with fluoxymesterone|/resolve/reference/PMED?id=13796712
Barns 1961 {published data only}|Suppression of postpartum lactation and prevention of breast engorgement in nonnursing mothers|/resolve/reference/PMED?id=13687153
Bhardwaj 1979 {published data only}|Inhibition of puerperal lactation: evaluation of bromocriptine and placebo|
Binn 1979 {published data only}|A double-blind trial of chlorotrianisene in the suppression of lactation|/resolve/reference/PMED?id=4863299
Booker 1970 {published data only}|Control of postpartum breast engorgement with oral contraceptives. II|/resolve/reference/PMED?id=4952576
Brooten 1983 {published data only}|A comparison of four treatments to prevent and control breast pain and engorgement in nonnursing mothers|/resolve/reference/PMED?id=6553246
Caballero 1987 {published data only}|Metergoline as an inhibitor of prolactin release|/resolve/reference/PMED?id=3560070
Canales 1977 {published data only}|Effect of clomiphene on prolactin secretion and lactation in puerperal women|
Cantis 1977 {published data only}|Piribedil and its use in the suppression of lactation|
Cicinelli 1996 {published data only}|Nasal spray bromocriptine: effects on serum prolactin in puerperal women|
David 1977 {published data only}|Stilbestrol administration in the puerperium and its effect on the prolactin excretion of non-lactating patients|
De Aloysio 1988 {published data only}|Dihydroergocristine in stopping lactation: double-blind study vs bromocriptine|/resolve/reference/PMED?id=3140592
De Cecco 1979 {published data only}|Effect of lisuride on inhibition of lactation and serum prolactin|
Del Pozo 1975 {published data only}|Lack of effect of methyl-ergonovine on postpartum lactation|/resolve/reference/PMED?id=1200082
Duthie 1990 {published data only}|Comparison of four different dosages of injectable bromocriptine retard for puerperal ablactation|/resolve/reference/PMED?id=2311809
Duthie 1990 {published data only}|Comparison of four different dosages of injectable bromocriptine retard for puerperal ablactation|
Fleming 1977 {published data only}|Inhibition of puerperal lactation: pyridoxine of no benefit|
Foukas 1972 {published data only}|An antilactogenic effect of pyridoxine|
Foukas 1972 {published data only}|Lactation inhibiting action of pyridoxine|/resolve/reference/PMED?id=4551803
Foukas 1972 {published data only}|The lactation-inhibiting effect of pyridoxine|/resolve/reference/PMED?id=4775323
Garry 1956 {published data only}|Estrogen-androgen preparation for prevention of postpartum breast engorgement and lactation|/resolve/reference/PMED?id=13309914
Gillibrand 1968 {published data only}|Inhibition of lactation with combined oestrogen and progestogen|/resolve/reference/PMED?id=4881421
Gopalan 1997 {published data only}|Effectiveness of pyridoxine in unwanted lactation|
Grant 1978 {published data only}|Comparison of quinestrol and TACE for relief of postpartum breast discomfort|/resolve/reference/PMED?id=349439
Kalir 1975 {published data only}|Clomiphene citrate in suppression of puerperal lactation|/resolve/reference/PMED?id=1146923
Kee 1989 {published data only}|The treatment of breast engorgement with serrapeptase (Danzen): a randomized double-blind controlled trial|/resolve/reference/PMED?id=2688125
Kee 1989 {published data only}|The use of serratiopeptidase (Danzen) for the treatment of breast engorgement - a randomised double-blind controlled trial|
King 1958 {published data only}|Prevention of puerperal breast engorgement with large doses of long-acting estrogen|/resolve/reference/PMED?id=13661250
Kirkland 1960 {published data only}|Suppression of lactation: a double blind hormone study|/resolve/reference/PMED?id=14409343
Koshiishi 1971 {published data only}|A double blind study of the effects of Kimotab on engorgement of the breast|/resolve/reference/PMED?id=4949255
Kulski 1978 {published data only}|Effects of bromocriptine mesylate on the composition of the mammary secretion in non-breast-feeding women|/resolve/reference/PMED?id=355958
Lee 1971 {published data only}|A trial of chlormezanone, a non-hormonal tranquillizer for inhibition of postpartum lactation|
Lee 1979 {published data only}|Effect of ginseng saponin on puerperal lactation|
Llewellyn-Jones 1963 {published data only}|Inhibition of lactation using hormones|/resolve/reference/PMED?id=14064289
Louviere 1975 {published data only}|Evaluation of Deladumone OB in the suppression of postpartum lactation|/resolve/reference/PMED?id=1090174
MacDonald 1965 {published data only}|Suppression of lactation. A double-blind trial|/resolve/reference/PMED?id=4157664
MacLeod 1977 {published data only}|Prevention and suppression of post-partum lactation with 2-bromo-alpha-ergocryptine (CB-154)|
Markin 1960 {published data only}|A comparative controlled study of hormones used in the prevention of postpartum breast engorgement and lactation|/resolve/reference/PMED?id=14421258
Masala 1978 {published data only}|Inhibition of lactation and inhibition of prolactin release after mechanical breast stimulation in puerperal women given tamoxifen or placebo|
McLachlan 1991 {published data only}|Ultrasound treatment for breast engorgement: a randomised double blind trial|
Morris 1967 {published data only}|Lactation inhibition with quinestrol|/resolve/reference/PMED?id=5340517
Morris 1970 {published data only}|Inhibition of puerperal lactation. Double-blind comparison of chlorothianesene, testosterone enanthate with estradiol valerate and placebo|/resolve/reference/PMED?id=4912251
Nappi 1987 {published data only}|Domperidone antagonizes bromoergocriptine-induced nausea and vomiting without affecting its inhibition of prolactin secretion in puerperal women|/resolve/reference/PMED?id=3622595
Nappi 1990 {published data only}|Ibopamine-induced reduction of serum prolactin level and milk secretion in puerperal women|/resolve/reference/PMED?id=2253662
Ng 1972 {published data only}|Inhibition of postpartum lactation with single-dose drugs|
Osbourne 1978 {published data only}|The effects of quinestrol and bromocriptine on blood coagulation, serum prolactin and serum FSH levels in puerperal women|
Primrose 1957 {published data only}|Studies on the suppression of lactation by hormones|/resolve/reference/PMED?id=13424586
Reisfield 1966 {published data only}|Value of a diuretic in suppressing breast engorgement|/resolve/reference/PMED?id=5341754
Robuschi 1987 {published data only}|Dopaminergic regulation of fetal growth hormone (GH) secretion: study with maternal administration of bromocriptine|/resolve/reference/PMED?id=3437376
Rolland 1978 {published data only}|Inhibition of puerperal lactation by bromocriptine|
Roser 1966 {published data only}|Breast engorgement and postpartum fever|/resolve/reference/PMED?id=5948031
Ryan 1962 {published data only}|Intranasal syntocinon and postpartum breast engorgement|/resolve/reference/PMED?id=13975749
Schneider 1964 {published data only}|The suppression of lactation: an objective study|/resolve/reference/PMED?id=14199544
Seppala 1975 {published data only}|Suppression of established puerperal lactation with 2-Br-alpha-ergocryptine methane sulphonate (CB 154)|
Shapiro 1984 {published data only}|Efficacy of bromocriptine vs breast binders as inhibitors of postpartum lactation|/resolve/reference/PMED?id=6729548
Steele 1968 {published data only}|Inhibition of lactation by oestrogens|/resolve/reference/PMED?id=4881065
Stenchever 1962 {published data only}|Evaluation of chlorprophenpyridamine for prevention of postpartum breast engorgement|
Tyson 1966 {published data only}|A high-dosage estrogen for lactation suppression|/resolve/reference/PMED?id=5949198
Van der Heijden 1991 {published data only}|Lactation inhibition by the dopamine agonist CV 205-502|
Willmott 1977 {published data only}|The suppression of puerperal lactation with bromocryptine|
Zuckerman 1973 {published data only}|The inhibition of lactation by clomiphene|
Biggs 1978 {published data only}|Bromocriptine, methyl testosterone and placebo for inhibition of physiological lactation: a controlled study|/resolve/reference/PMED?id=370526
Brett 1971 {published data only}|Inhibition of lactation--a triple study|/resolve/reference/PMED?id=4935697
Bristol 1966 {published data only}|Comparative effectiveness of compressional and supporting breast binders in suppressing lactation|/resolve/reference/PMED?id=5178185
Caballero 1996 {published data only}|Cabergoline: A new dopaminergic at a dingle dose for lactation inhibition|
Cooke 1976 {published data only}|The treatment of puerperal lactation with bromocriptine|/resolve/reference/PMED?id=959129
Gerstner 1978 {published data only}|Inhibition of postpartal lactation with 2-bromo-alpha-ergocryptine|/resolve/reference/PMED?id=735109
Hale 2004 {published data only}|Pseudoephedrine effects on milk production in women and estimation of infant exposure via human milk|/resolve/reference/PMED?id=15384619
Kaiser 1952 {published data only}|Experiences with combined ovarian hormones to prevent lactation|/resolve/reference/PMED?id=12993090
King 1972 {published data only}|A comparative study of two fat-stored oestrogens in inhibiting lactation|/resolve/reference/PMED?id=4557896
Lo Dico 1980 {published data only}|Use of dopaminergic drugs (pyridoxine, 2-bromo-alpha-ergocriptine, piribedil) in blocking lactation|/resolve/reference/PMED?id=7219829
Marcus 1975 {published data only}|Suppression of lactation with high doses of pyridoxine|/resolve/reference/PMED?id=1209435
Martnez 1994 {published data only}|Supression of breastfeeding with lisuride. Experience and results|
McNicol 1972 {published data only}|A combined/oestrogen/progestogen/testosterone agent for the inhibition of lactation|/resolve/reference/PMED?id=4567863
Menczer 1969 {published data only}|Evaluation of postpartum breast engorgement by thermography|/resolve/reference/PMED?id=4886952
Mizuno 1990 {published data only}|Double-blind study evaluating the efficacy of parlodel modified release Capsule (PLO-MR) in the suppression of puerperal lactation|/resolve/reference/PMED?id=5690841
Momberg 1976 {published data only}|Hormonal limitation of lactation|/resolve/reference/PMED?id=773016
Nappi 1993 {published data only}|Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal women|/resolve/reference/PMED?id=8213227
Nisha 2006 {published data only}|Role of newer drug cabergoline in suppression and inhibition of lactation|
O'Donoghue 1977 {published data only}|The suppression of puerperal lactation with bromocriptine|/resolve/reference/PMED?id=324946
Paggi 1975 {published data only}|A new method for the inhibition of lactogenesis|/resolve/reference/PMED?id=1187056
Polatti 1982 {published data only}|Cyclofenil inhibits the secretion and release of prolactin in the puerperium|/resolve/reference/PMED?id=4883650
Poulsen 1976 {published data only}|Bromergocriptine for suppression of puerperal lactation|/resolve/reference/PMED?id=781971
Senior 1969 {published data only}|Stilboestrol inhibition of lactation|/resolve/reference/PMED?id=4883650
Van Dam 1981 {published data only}|Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study|
Varga 1972b {published data only}|Inhibition of puerperal lactation with ergot alkaloids|/resolve/reference/PMED?id=5054638
Varga 1974 {published data only}|Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: I. A comparative study with 2-Br-alpha-ergocryptine in different dosages and placebo|/resolve/reference/PMED?id=4613600
Walker 1980 {published data only}|Inhibition of puerperal lactation|
Akrivis 2000|Inhibition of puerperal lactation with 2-mercaptopropinyl-glycerine|/resolve/reference/PMED?id=11214766
Duchesne 1981|Bromocriptine mesylate for prevention of postpartum lactation|/resolve/reference/PMED?id=7243095
Eastham 1976|Further decline of breast-feeding|/resolve/reference/PMED?id=1247834
Hamlyn 2002||
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008|
Iffy 1996|Severe cerebral accidents postpartum in patients taking bromocriptine for milk suppression|/resolve/reference/PMED?id=8641870
Jeffcoate 1968|Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy|/resolve/reference/PMED?id=5690841
Llewellyn-Jones 1968|Inhibition of lactation by oestrogens|/resolve/reference/PMED?id=5693235
Nduati 2000|Effects of breastfeeding and formula feeding on transmission of HIV-1: a randomised clinical trial|/resolve/reference/PMED?id=10703779
RevMan 2008|Review Manager (RevMan)|
Ruch 1989|Postpartum myocardial infarction in a patient receiving bromocriptine|/resolve/reference/PMED?id=2668821
Ryan 2002|Breastfeeding continues to increase into the new millennium|/resolve/reference/PMED?id=12456906
Senior 1969|Stilboestrol inhibition of lactation|/resolve/reference/PMED?id=4883650
Shaffer 1999|Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group|/resolve/reference/PMED?id=10459957
Spitz 1998|Treatment for lactation suppression: little progress in one hundred years|/resolve/reference/PMED?id=9855585
US FDA 1989||
Wiktor 1999|Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial|/resolve/reference/PMED?id=10459958
Craig 2003 {published data only}|A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients|/resolve/reference/PMED?id=12933923
DiFabio 1997 {published data only}|Health related quality of life for patients with progressive multiple sclerosis: influence of rehabilitation|/resolve/reference/PMED?id=9413449
DiFabio 1998 {published data only}|Extended outpatient rehabilitation : its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis|/resolve/reference/PMED?id=9473994
Francabandera 1988 {published data only}|Multiple sclerosis rehabilitation: inpatient versus outpatients|/resolve/reference/PMED?id=3187175
Freeman 1997 {published data only}|The impact of inpatient rehabilitation on progressive multiple sclerosis|
Guagenti-Tax 2000 {published data only}|Impact of a comprehensive long-term care program on caregivers and persons with multiple sclerosis|
Khan 2008 {published data only}|Effectiveness of rehabilitation intervention in person with multiple sclerosis|/resolve/reference/PMED?id=18535027
Khan 2010 {published data only}|A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis|
Patti 2002 {published data only}|The impact of outpatient rehabilitation on quality of life in multiple sclerosis|/resolve/reference/PMED?id=12195449
Patti 2003 {published data only}|Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients: a randomised controlled trial|/resolve/reference/PMED?id=12883930
Pozzilli 2002 {published data only}|Home based management in multiple sclerosis: results of a randomised controlled trial|/resolve/reference/PMED?id=12185154
Storr 2006 {published data only}|The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients|/resolve/reference/PMED?id=16629429
Stuifbergen 2003 {published data only}|A randomized clinical trial of a wellness intervention for women with multiple sclerosis|/resolve/reference/PMED?id=12690582
Aisen 1996 {published data only}|Inpatient rehabilitation for multiple sclerosis|
Barrett 2009 {published data only}|A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis|/resolve/reference/PMED?id=19282417
Bethoux 2003 {published data only}|Trials of Rehabilitation after exacerbation of multiple sclerosis: recovery prior to randomisation|/resolve/reference/PMED?id=3365113
Bethoux 2005 {published data only}|Efficacy of outpatient rehabilitation after exacerbation of multiple sclerosis|
Bethoux 2005 A {published data only}|Treatment of severe spasticity with intrathecal baclofen therapy in ambulatory multiple sclerosis patients: six month follow up|
Bourdette 1991 {published data only}|Evidence that multidisciplinary team care clinic is more effective than standard medical care in treating veterans with multiple sclerosis|/resolve/reference/PMED?id=1992370
Brissart 2010 {published data only}|Cognitive rehabilitation in Multiple Sclerosis: preliminary results and presentation of a new program, PROCOG-SEP|/resolve/reference/PMED?id=19744684
Carey 1988 {published data only}|Who makes the most progress in inpatient rehabilitation? An analysis of functional gain|/resolve/reference/PMED?id=3365113
Carton 2000 {published data only}|A quantitative study of unpaid care giving in multiple sclerosis|/resolve/reference/PMED?id=10962548
Cendrowski 1999a {published data only}|Quality of life stabilised by a 3 year rehabilitation in secondary progressive multiple sclerosis|
Cendrowski 1999b {published data only}|Relationship between disability and quality of life: rehabilitation outcomes in multiple sclerosis|/resolve/reference/PMED?id=9921848
Coote 2009 {published data only}|Getting the balance right: a randomised controlled trial of physiotherapy and exercise interventions for ambulatory people with multiple sclerosis|/resolve/reference/PMED?id=19607666
Edwards 2002 {published data only}|Comparison of physician outcome measures and patients perception of benefits of inpatient neurorehabilitation|/resolve/reference/PMED?id=12077034
Feigenson 1981 {published data only}|The cost effectiveness of multiple sclerosis rehabilitation: a model|/resolve/reference/PMED?id=6810201
Fink 2010 {published data only}|Efficacy of an executive function intervention program in MS: a placebo-controlled and pseudo-randomised trial|/resolve/reference/PMED?id=20621945
Flavia 2010 {published data only}|Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in Multiple Sclerosis|
Freeman 1996a {published data only}|The impact of rehab on disability and handicap in progressive MS: a randomised controlled trial|
Freeman 1996b {published data only}|Health related quality of life in people with multiple sclerosis undergoing inpatient rehab|
Freeman 1999 {published data only}|Inpatient rehab in multiple sclerosis : do the benefits carry over into the community?|/resolve/reference/PMED?id=9921848
Freeman 2005 {published data only}|Evaluating neurorehabilitation : lessons from routine data collection|/resolve/reference/PMED?id=15834035
Grasso 2005 {published data only}|Prognostic factors in multidisciplinary rehab treatment in multiple sclerosis : an outcome study|/resolve/reference/PMED?id=16320734
Greenspun 1987 {published data only}|Multiple sclerosis and rehab outcome|/resolve/reference/PMED?id=3606367
Grossman 2010 {published data only}|MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial|/resolve/reference/PMED?id=20876468
Hebert 2009 {published data only}|Effects of vestibular rehabilitation on MS-related fatigue: randomized control trial|/resolve/reference/PMED?id=15327043
Hinrichs 2003 {published data only}|A pilot study measuring the utility of the MSQLI within a short term rehab program|
Jones 1996 {published data only}|The effectiveness of occupational therapy and physiotherapy in MS patients with ataxia of the upper limb and trunk|
Jonsson 1996 {published data only}|Quality of life as a measure of rehab outcome in patients with multiple sclerosis|
Jorger 2001 {published data only}|Impact of Neurorehab on disability in patients with acutely and chronically disabling diseases of the nervous system measured by the extended Barthel Index|
Kalina 2009 {published data only}|The Role of occupational therapy in a Multiple Sclerosis center: a multidisciplinary team, including occupational therapy practitioners, ensures an individualized, holistic approach to intervention|
Khan 2010b {published data only}|Clinical practice improvement approach in multiple sclerosis rehabilitation: a pilot study|/resolve/reference/PMED?id=20410826
Kidd 1995 {published data only}|The benefits of inpatient neurorehabilitation in multiple sclerosis|
Kidd 1997 {published data only}|Prospective study of neurorehabilitation in multiple sclerosis|/resolve/reference/PMED?id=9120472
Liu 2003 {published data only}|Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?|/resolve/reference/PMED?id=14586605
Mostert 2005 {published data only}|Effect of pulsed magnetic field therapy on the level of fatigue in patients with Multiple Sclerosis - a randomised controlled trial|/resolve/reference/PMED?id=15957511
Palmisano 1999 {published data only}|A randomised trial on home care in patients with Multiple Sclerosis|
Plow 2009 {published data only}|Comparing individualized rehabilitation to a group wellness intervention for persons with Multiple Sclerosis|/resolve/reference/PMED?id=19750959
Portillo 2009 {published data only}|Evaluation of a nurse-led social rehabilitation programme for neurological patients and carers: an action research study|/resolve/reference/PMED?id=19059592
Pozzilli 2004 {published data only}|Multiple sclerosis|/resolve/reference/PMED?id=15327043
Reding 1987 {published data only}|Acute hospital care versus rehab hospitalisation for management of non-emergent complications in multiple sclerosis|
Riazi 2004 {published data only}|Self efficacy predicts self reported health status in multiple sclerosis|/resolve/reference/PMED?id=14760954
Roush 1995 {published data only}|The satisfaction of patients with multiple sclerosis regarding services received from physical and occupational therapists|
Sitzia 1998 {published data only}|Evaluation of a nurse led multidisciplinary neurological rehab programme using the Nottingham Health Profile|/resolve/reference/PMED?id=9796929
Slade 2002 {published data only}|A randomised controlled trial to determine the effect of intensity of therapy upon length of stay in a neurological rehabilitation setting|/resolve/reference/PMED?id=12440799
Storr 1999 {published data only}|The efficacy of multidisciplinary inpatient rehabilitation in stable multiple sclerosis patients|
Van der Putten 1999 {published data only}|Measuring change in disability after inpatient rehabilitation : comparison of the responsiveness of the Barthel Index and the Functional INdependence Measure|
Vaney 1996 {published data only}|Assessing mobility in multiple sclerosis using Rivermead Mobility Index and gait speed|
Wahls 2010 {published data only}|Rehabilitation with neuromuscular electrical stimulation leads to functional gains in ambulation in patients with secondary progressive and primary progressive multiple sclerosis: a case series report|
Ward 2004 {published data only}|Education for people with progressive neurological conditions can have negative effects: evidence from a randomised controlled trial|/resolve/reference/PMED?id=15573827
Battaglia 2000|A cost evaluation of multiple sclerosis|/resolve/reference/PMED?id=10871812
Brown 2004|Empowerment in measurement: muscle,voice and subjective quality of life as a gold standard|/resolve/reference/PMED?id=15083418
Campbell 1999|Secondary health conditions among middle-aged individuals with chronic physical disabilities:implications for unmet needs for services|/resolve/reference/PMED?id=11010061
Cieza 2009|Items from patient-oriented instruments can be integrated into interval scales to operationalize categories of the International Classification of Functioning, Disability and Health|
Compston 1998|The genetic epidemiology of multiple sclerosis|
Detels 1978|Multiple sclerosis and age at migration|/resolve/reference/PMED?id=727208
Dombovy 1998|Multiple sclerosis and Parkinson's disease rehabilitation|
Egger 1998|Bias in location and selection of studies|/resolve/reference/PMED?id=9451274
Elstein 2002|Clinical problem solving and diagnostic decision making: selective review of the cognitive literature|/resolve/reference/PMED?id=11909793
Frankel 2001|MS - Neurological Rehabilitation|
Fuhrer 2005|Conducting multiple site clinical trials in medical rehabilitation research|/resolve/reference/PMED?id=16244519
Gassaway 2005|Applying the clinical practice improvement approach to stroke rehabilitation: methods used and baseline results|/resolve/reference/PMED?id=16373137
Goetzsche 1987|Reference bias in reports of drug trials|/resolve/reference/PMED?id=3117277
Granger 1990|Functional assessment scales: a study of persons with multiple sclerosis|/resolve/reference/PMED?id=2222154
Greener 2002|Systematic reviews in rehabilitation for stroke: issues and approaches to addressing them|/resolve/reference/PMED?id=11837528
Grill 2009|Scales should be developed based on simple clinical ratings of International Classification of Functioning,Disability and Health Core Set categories|/resolve/reference/PMED?id=18619794
Hammond 1988|The epidemiology of multiple sclerosis in 3 Australian cities: Perth, Newcastle & Hobart|/resolve/reference/PMED?id=3365543
Hobart 2001|The multiple sclerosis impact scale: a new patient based outcome measure|/resolve/reference/PMED?id=11335698
Jadad 1996|Assessing the Quality of Reports of Randomised Clinical Trials: Is Blinding Necessary?|/resolve/reference/PMED?id=8721797
Kemp 2005|What the rehabilitation professional and the consumer need to know|
Khan 2007|Multidisciplinary rehabilitation for adults with multiple sclerosis|
Khan 2007a|Use of International Classification of Functioning, Disability and Health (ICF) to describe patient-reported disability in multiple sclerosis and identification of relevant environmental factors|/resolve/reference/PMED?id=17225040
Khan 2007b|Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis|/resolve/reference/PMED?id=17364771
Khan 2008a|Use of Goal attainment Scaling in inpatient rehabilitation for persons With multiple sclerosis|/resolve/reference/PMED?id=18373995
Khan 2009|Multiple Sclerosis rehabilitation outcomes: analysis of a National casemix dataset from Australia|/resolve/reference/PMED?id=19465445
Khan 2010a|Clinical practice improvement approach in multiple sclerosis rehabilitation: a pilot study|/resolve/reference/PMED?id=20410826
Khan 2010c|Multidisciplinary care for Guillain-Barr syndrome|
Kiresuk 1968|Goal attainment scaling: a general method of evaluating comprehensive mental health programmes|/resolve/reference/PMED?id=24185570
Kraft 2005|Multiple Sclerosis|
Kurtzke 1983|Mulptiple sclerosis in Iceland: evidence of post war epidemic|/resolve/reference/PMED?id=6976526
Langdon 1999|MS: A preliminary study of selected variables affecting rehabilitation outcome|/resolve/reference/PMED?id=10335517
Langhorne 1995|Developing new stroke services: an evidence based approach|/resolve/reference/PMED?id=8552537
Langhorne 2002|What are the components of stroke unit care?|/resolve/reference/PMED?id=12242199
McDonald 2001|Recommended diagnostic criteria for MS: guidelines from the international panel on the diagnosis of multiple sclerosis|
MS Society 2011|Multiple Sclerosis in Australia|
Ng 2009|Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease|
NICE 2003|Management of multiple sclerosis in primary and secondary care|
Patwardhan 2005|Cost of MS by level of disability : a review of literature|/resolve/reference/PMED?id=15794399
Poser 1983|New diagnostic criteria for multiple sclerosis: guidelines for research protocols|
Ramp 2009|Rasch analysis of the Multiple Sclerosis Impact Scale MSIS-29|/resolve/reference/PMED?id=19545445
Reitberg 2004|Exercise therapy for MS|
Schumaker 1965|Problems of experimental trials of therapy in multiple sclerosis|
Society of Neuroscience 2011|Multiple sclerosis: making a difference tomorrow|
Steultjens 2003|Occupational therapy for multiple sclerosis|/resolve/reference/PMED?id=12917976
Taylor 2007|The cost of multiple sclerosis in Australia|/resolve/reference/PMED?id=17430777
Tennant 2002|The Rasch model and standardisation outcomes in rehabilitation: the PRO-ESOR project|
Thompson 2000|The effectiveness of neurological rehab in MS|/resolve/reference/PMED?id=11028701
Turk 2001|The health of women with cerebral palsy|/resolve/reference/PMED?id=11853034
Turner-Stokes 2005|Mutlidisciplinary rehabilitation for acquired brain injury in adults of working age|/resolve/reference/PMED?id=16034923
van Tulder 1997|Method guidelines for systematic reviews in the Cochrane Collaborations Back Review Group for Spinal Disorders|/resolve/reference/PMED?id=9355211
van Tulder 2003|Updated method guidelines for systematic reviews in the Cochrane Collabvoration back review group|/resolve/reference/PMED?id=12811274
Wade 1992||
Weinshenker 1989|The natural history of multiple sclerosis: a geographically based study|
Whetten-Gol 1998|A comprehensive assessment of the cost of multiple sclerosis in the USA|/resolve/reference/PMED?id=9839302
WHO 2001|International Classification of Functioning, Disability and Health (ICF)|
Whyte 2002|Traumatic brain injury rehab: are there alternatives to randomised clinical trials|/resolve/reference/PMED?id=12235618
Yorkston 2002|Age and gender issues related to multiple sclerosis: a survey study|
du Plessis 1997 {published data only}|Living with HIV and AIDS|
Foley 1994 {published data only}|Family support for heterosexual partners in HIV-Sero-discordant couples|/resolve/reference/PMED?id=7818821
Kimberly 1999 {published data only}|The role of family and friend social support in reducing risk behaviors among HIV-positive Gay men|/resolve/reference/PMED?id=10693644
Li Li 2006 {published data only}|Understanding family support for people living with HIV/AIDS in Yunnan, China|
MacNeil 1999 {published data only}|Is care and support associated with preventive behaviour among people with HIV?|/resolve/reference/PMED?id=10755029
Serovich 2001 {published data only}|The role of family and friend social support in reducing emotional distress among HIV-positive women|/resolve/reference/PMED?id=11397335
Aggleton 1999|Community responses to AIDS|
Bor 2004|The impact of disclosure of HIV on the index patients self-defined family|
Burgoyne 2005|Exploring direction of causation between social support and clinical outcome for HIV-positive adults in the context of highly active antiretroviral therapy|/resolve/reference/PMED?id=15832838
French 1999|Immunologic and clinical stages in HIV-1 infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease|/resolve/reference/PMED?id=10961614
Green 1993|Social support and HIV|/resolve/reference/PMED?id=8461365
HDN 2005|Discussion Summary: Stigma, HIV/AIDS and disclosure|
Heckman 1998|Psychological differences between urban and rural people living with HIV/AIDS|
Istrow 1989|HIV related symptoms and psychological functioning in a cohort of homosexual men|/resolve/reference/PMED?id=2658626
Jia 2005|Predictors of changes in health related quality of life among men with HIV infection in the HAART era|/resolve/reference/PMED?id=15989435
Kalichman 2003|Stress, social support and HIVstatus disclosure to family and friends among HIV-positive men and women|/resolve/reference/PMED?id=12921006
Kennedy 1995|Gender differences in HIV-related psychological distress in heterosexual couples|
Manopaiboon 1998|Impact of HIV on families of HIV-infected women who have recently given birth, Bangkok, Thailand|
Martin 1998|End of life care in HIV/AIDS. UCSF HIV InSite Knowledge Base|
Serovich 2005|HIV disclosure by men who have sex with men to immediate family over time|/resolve/reference/PMED?id=AMBIGUOUS%2016375614,16124845
Sethosa 2005|Evaluation of HIV Counselling and testing, Self disclosure, social support and sexual behaviour change among a rural sample of HIV reactive patients in South Africa|/resolve/reference/PMED?id=15850151
UNAIDS 2004|UNAIDS/WHO Report on the global AIDS epidemic|
UNAIDS/WHO 2007|UNAIDS/WHO AIDS Epidemic|
Warwick 1998|Household and community responses to AIDS in developing countries|
World Bank 1997||
Zich 1987|Perceptions of Social Support in men with AIDS and ARC. Relationships with distress and hardiness|
Ghosh 2003 {published data only}|Natalizumab for active Crohn's disease|/resolve/reference/PMED?id=12510039
Gordon 2001 {published data only}|A randomized placebo-controlled trial of humanized monoclonal antibody to alpha4 integrin in active Crohn's disease|/resolve/reference/PMED?id=11487536
Sandborn 2005 {published data only}|Natalizumab induction and maintenance therapy for Crohn's disease|/resolve/reference/PMED?id=16267322
Targan 2006 {published data only}|Natalizumab induces sustained response and remission with active Crohn's disease: results from the ENCORE trial|
Adelman 2005|Natalizumab and progressive multifocal leukoencephalopathy|/resolve/reference/PMED?id=15947083
Alderson 2004|Assessment of study quality. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Section 6|
Berger 2005|Progressive multifocal leukoencephalopathy and natalizumab--unforseen consequences|/resolve/reference/PMED?id=15947082
Brennan 2005|Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction|
Chalmers 1983|Bias in treatment assignment in controlled clinical trials|/resolve/reference/PMED?id=6633598
Hesterberg 1996|Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7|/resolve/reference/PMED?id=8898653
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
K-Demasters 2005|Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis|/resolve/reference/PMED?id=15947079
Langer-Gould 2005|Progressive multifocal leukoencephalopathy in a patient treated with natalizumab|/resolve/reference/PMED?id=15947078
Miller 2003|A controlled trial of natalizumab for relapsing multiple sclerosis|/resolve/reference/PMED?id=12510038
Moher 1998|Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?|/resolve/reference/PMED?id=9746022
Podolsky 1993|Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody|/resolve/reference/PMED?id=7686922
Polman 2006|A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis|/resolve/reference/PMED?id=16510744
Rudick 2006|Natalizumab plus interferon beta-1a for relapsing multiple sclerosis|/resolve/reference/PMED?id=16510745
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Tubridy 1999|The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group|/resolve/reference/PMED?id=10449105
Van Assche 2005|Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease|/resolve/reference/PMED?id=15947080
Yousry 2006|Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy|/resolve/reference/PMED?id=16510746
Brown 2006 {published data only}|Will improvement in Quality of Life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?|
Burnham 2002 {published data only}|Effects of exercise on physiological and psychological variables in cancer survivors|/resolve/reference/PMED?id=12471288
Campbell 2005 {published data only}|A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment|/resolve/reference/PMED?id=15774341
Cohen 2004 {published data only}|Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma|
Coleman 2003a {published data only}|Feasibility of exercise during treatment for multiple myeloma|/resolve/reference/PMED?id=14710804
Courneya 2003a {published data only}|A randomized trial of exercise and quality of life in colorectal cancer survivors|
Courneya 2003b {published data only}|Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes|/resolve/reference/PMED?id=12721239
Courneya 2003c {published data only}|The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: physical fitness and quality of life outcomes|
Courneya 2007a {unpublished data only}|Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomised controlled trial|/resolve/reference/PMED?id=17785708
Courneya 2007b {unpublished data only}|Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomised controlled trial|/resolve/reference/PMED?id=17785708
Culos-Reed 2006 {published data only}|A pilot study of yoga for breast cancer survivors: physical and psychological benefits|
Daley 2007 {published and unpublished data}|Randomized trial of exercise therapy in women treated for breast cancer|/resolve/reference/PMED?id=17470863
Dimeo 1999 {published and unpublished data}|Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy|
Dimeo 2004 {published and unpublished data}|Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomised controlled trial|/resolve/reference/PMED?id=15338385
Drouin 2005 {published data only}|Effects of aerobic exercise training on peak aerobic capacity, fatigue, and psychological factors during radiation for breast cancer|
Galantino 2003 {published data only}|The effects of Tai Chi and walking on fatigue and body mass index in women living with breast cancer: a pilot study|
Headley 2004 {published data only}|The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer|/resolve/reference/PMED?id=15378098
Mckenzie 2003 {published data only}|Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study|/resolve/reference/PMED?id=12560436
Milne 2007 {published data only}|Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial|
Mock 1994 {published data only}|A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy|/resolve/reference/PMED?id=7937251
Mock 1997 {published data only}|Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer|/resolve/reference/PMED?id=9243585
Mock 2005 {published data only}|Exercise manages fatigue during breast cancer treatment: a randomised controlled trial|
Mutrie 2007 {published data only}|Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial|/resolve/reference/PMED?id=17307761
Pinto 2003 {published data only}|Psychological and fitness changes associated with exercise participation among women with breast cancer|
Pinto 2005 {published data only}|Home-based physical activity intervention for breast cancer patients|/resolve/reference/PMED?id=15908668
Pinto 2005 {published data only}|Mediators of a randomized controlled physical activity intervention for breast cancer survivors|
Segal 2001a {published data only}|Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomised controlled trial|/resolve/reference/PMED?id=11157015
Segal 2001b {published data only}|Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomised controlled trial|/resolve/reference/PMED?id=11157015
Segal 2003 {published data only}|Resistance exercise in men receiving androgen deprivation therapy for prostate cancer|/resolve/reference/PMED?id=12721238
Thorsen 2005 {published data only}|Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy|/resolve/reference/PMED?id=15800330
Windsor 2004 {published data only}|A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma|
Aghili 2007 {published data only}|A pilot study of the effects of programmed aerobic exercise on the severity of fatigue in cancer patients during external radiotherapy|/resolve/reference/PMED?id=17360236
Barsevick 2004 {published data only}|A randomized clinical trial of energy conservation for patients with cancer-related fatigue|
Berglund 1994 {published data only}|A randomized study of a rehabilitation program for cancer patients: the 'starting again' group|
Cella 2004 {published data only}|The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials|/resolve/reference/PMED?id=15151958
Coleman 2003b {published data only}|Facilitating exercise adherence for patients with multiple myeloma|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Decker 1989 {published data only}|Psychosocial aspects and the physiological effects of a cardiopulmonary exercise program in patients undergoing bone marrow transplantation (BMT) for acute leukemia (AL)|/resolve/reference/PMED?id=2650427
Dimeo 1996 {published data only}|An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation|/resolve/reference/PMED?id=8971388
Dimeo 1997a {published data only}|Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation|
Dimeo 1997b {published data only}|Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high dose chemotherapy|/resolve/reference/PMED?id=9345021
Hayes 2004 {published data only}|Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program|/resolve/reference/PMED?id=14716346
Kim 2005 {published data only}|Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients|
MacVicar 1989 {published data only}|Effects of aerobic interval training on cancer patients' functional capacity|/resolve/reference/PMED?id=2587289
Mock 2001 {published data only}|Fatigue and quality of life outcomes of exercise during cancer treatment|
Oldervoll 2003 {published data only}|Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors-results from a pilot study|/resolve/reference/PMED?id=12504659
Pickett 2002 {published data only}|Adherence to moderate-intensity exercise during breast cancer therapy|
Schwartz 1999 {published data only}|Fatigue mediates the effects of exercise on quality of life|/resolve/reference/PMED?id=10548868
Schwartz 2000a {published data only}|Exercise and weight gain in breast cancer patients receiving chemotherapy|
Schwartz 2000b {published data only}|Daily fatigue patterns and effect of exercise in women with breast cancer|
Schwartz 2001 {published data only}|Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy|/resolve/reference/PMED?id=11323538
Schwartz 2002 {published data only}|Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate|/resolve/reference/PMED?id=12183762
Turner 2004 {published data only}|Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention|
Watson 2004 {published data only}|Exercise as an intervention for cancer-related fatigue|/resolve/reference/PMED?id=15283624
Wilson 2005 {published data only}|Pilot study of a home-based aerobic exercise program for sedentary cancer survivors treated with hematopoietic stem cell transplantation|/resolve/reference/PMED?id=15696182
Ahlberg 2003|Assessment and management of cancer-related fatigue in adults|/resolve/reference/PMED?id=12944066
Cella 2002|Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales|/resolve/reference/PMED?id=12551804
Curt 2000|Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition|/resolve/reference/PMED?id=11040270
Dimeo 2001|Effects of exercise on cancer-related fatigue|
Dimeo 2002|Radiotherapy-related fatigue and exercise for cancer patients: a review of the literature and suggestions for future research|/resolve/reference/PMED?id=11764668
Fletchner 2002|Fatigue assessment in cancer clinical trials|
Haskell 2007|Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association|/resolve/reference/PMED?id=17762377
Jacobsen 2007|Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue|/resolve/reference/PMED?id=18020836
Jadad 1996|Assessing the quality of reports of randomized clinical trials: Is blinding necessary|/resolve/reference/PMED?id=8721797
Lucia 2003|Cancer-related fatigue: can exercise physiology assist oncologists?|/resolve/reference/PMED?id=14554239
McNeely 2006|Cancer rehabilitation: recommendations for integrating exercise programming in the clinical practice setting|
Mock 2001b|Fatigue management: evidence and guidelines for practice|
Montoye 1996||
Morrow 2001|Fatigue associated with cancer and its treatment|/resolve/reference/PMED?id=12136222
Mustian 2007|Integrative non-pharmacological behavioral interventions for the management of cancer-related fatigue|/resolve/reference/PMED?id=17573456
NCCN 2005|Clinical Practice Guidelines in Oncology. Cancer-related fatigue version 2.2005|
Oldervoll 2004|Physical exercise results in the improved subjective well-being of a few or is effective rehabilitation for all cancer patients?|/resolve/reference/PMED?id=15093569
Ryan 2007|Mechanisms of cancer-related fatigue|/resolve/reference/PMED?id=17573453
Vallance 2007|Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors|/resolve/reference/PMED?id=17557948
Wagner 2004|Fatigue and cancer: causes, prevalence and treatment approaches|/resolve/reference/PMED?id=15238987
Winningham 1992|How exercise mitigates fatigue: implications for people receiving cancer therapy|
ACTIVE W {published data only}|Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial|/resolve/reference/PMED?id=16765759
AFASAK I {published data only}|Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study|/resolve/reference/PMED?id=2563096
AFASAK II {published data only}|Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation|/resolve/reference/PMED?id=9679792
ATHENS {published data only}|Primary prevention of arterial thromboembolism in the oldest old with atrial fibrillation - a randomized pilot trial comparing adjusted dose and fixed low-dose coumadin with aspirin|
NASPEAF {published data only}|Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation|/resolve/reference/PMED?id=15489085
PATAF {published data only}|Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin|/resolve/reference/PMED?id=10514159
SPAF IIa {published data only}|Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study|/resolve/reference/PMED?id=7907677
SPAF IIb {published data only}|Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study|/resolve/reference/PMED?id=7907677
EAFT {published data only}|Secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and recent transient ischemic attack or minor ischemic stroke|/resolve/reference/PMED?id=7901582
Japanese AF {published data only}|Low-dose aspirin for prevention of stroke in patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial|/resolve/reference/PMED?id=16385088
SIFA {published data only}|Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators|/resolve/reference/PMED?id=9158644
TAFT {published data only}|The Turkish atrial fibrillation study|
AFI 1994|Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized clinical trials|
Aguilar 2006a|Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks|
Aguilar 2006b|Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks|
Arima 2005|Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack|/resolve/reference/PMED?id=16141420
CHARISMA 2006|Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events|/resolve/reference/PMED?id=16531616
CONSORT 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials|/resolve/reference/PMED?id=11336663
Feinberg 1995|Prevalence, age distribution, and gender of patients with atrial fibrillation|/resolve/reference/PMED?id=7864703
Gage 2001|Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation|/resolve/reference/PMED?id=11401607
Gage 2004|Selecting patients with atrial fibrillation for anticoagulation. Stroke risk stratification in patients taking aspirin|/resolve/reference/PMED?id=15477396
Go 2001|Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study|/resolve/reference/PMED?id=11343485
Go 2003|Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice|/resolve/reference/PMED?id=14645310
Hart 1999|Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials|/resolve/reference/PMED?id=10356104
Hart 2003|Lessons from the stroke prevention in atrial fibrillation trials|/resolve/reference/PMED?id=12755555
Hart 2007|Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: an updated meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Hylek 2003|Effect of oral anticoagulation on stroke severity and mortality in atrial fibrillation|/resolve/reference/PMED?id=12968085
Oden 2006|Optimal INR for prevention of stroke and mortality in atrial fibrillation: a critical appraisal|/resolve/reference/PMED?id=16517250
Saxena 2006|Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack|
Taylor 2001|Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation|/resolve/reference/PMED?id=11159653
Van Walraven 2002|Oral anticoagulants vs aspirin on nonvalvular atrial fibrillation. An individual patient meta-analysis|/resolve/reference/PMED?id=12435257
Wang 2003|A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study|/resolve/reference/PMED?id=12941677
Wolf 1991|Atrial fibrillation as an independent risk factor for stroke: The Framingham Study|/resolve/reference/PMED?id=1866765
Blackwell 2010 {published data only}|Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2positive metastatic breast cancer: final results from the EGF104900 Study|
Blackwell 2010 {published data only}|Randomized study of lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer|
Blackwell 2010 {published data only}|A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+ metastatic breast cancer progressing on trastuzumab therapy [Abstract 1015]|
Blackwell 2010 {published data only}|Impact of lapatinib plus trastuzumab versus single agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer|
Gasparini 2006 {published data only}|Interim analysis of a randomized phase IIb study of weekly paclitaxel (PCT) with or without trastuzumab (T) as first-line therapy of patients (pts) with HER-2/neu positive metastatic breast cancer (MBC): Clinical and biological results [Abstract 138]|
Gasparini 2006 {published data only}|Randomized phase II trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer|/resolve/reference/PMED?id=16850247
Huober 2012 {published data only}|Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - Results of the eLEcTRA trial|
Kaufman 2009 {published data only}|Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study|
Marty 2005 {published data only}|Long-term survival demonstrated with trastuzumab plus docetaxel: 24-month data from a randomised trial (M77001) in HER2-positive metastatic breast cancer [Abstract 555]|
Marty 2005 {published data only}|Randomised phase II trial (M77001) of trastuzumab (Herceptin) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastatic breast cancer|
Marty 2005 {published data only}|Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group|/resolve/reference/PMED?id=15911866
Slamon 2001 {published data only}|Health-related quality of life (HRQL) in women with HER2-overexpressing metastatic breast cancer (MBC) in a phase III study of Herceptin (R) plus chemotherapy versus chemotherapy alone|
Slamon 2001 {published data only}|Isolated central nervous system metastases in patients withHER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy|
Slamon 2001 {published data only}|Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data|
Slamon 2001 {published data only}|Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin) [Abstract]|
Slamon 2001 {published data only}|Effects of treatment with Her2mab (trastuzumab/Herceptin) plus chemotherapy (H+C) versus chemotherapy alone (C) on health-related quality of life (HRQL) in women with HER-2/neu-overexpressing metastatic breast cancer [Abstract 109]|
Slamon 2001 {published data only}|Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer|/resolve/reference/PMED?id=12118024
Slamon 2001 {published data only}|Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2|/resolve/reference/PMED?id=11248153
Slamon 2001 {published data only}|Effect of cardiac dysfunction on treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancer|/resolve/reference/PMED?id=15507176
Slamon 2001 {published data only}|Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression|/resolve/reference/PMED?id=15020607
von Minckwitz 2009 {published data only}|Trastuzumab improves the efficacy of chemotherapy in breast cancer treatment beyond progression|
von Minckwitz 2009 {published data only}|Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer|
von Minckwitz 2009 {published data only}|Capecitabine vs capecitabine+trastuzumab in patients with HER2-positive metastatic breast cancer progressing during trastuzumab treatment: The TBP phase III study (GBG 26/BIG 3-05) [Abstract 1025]|
von Minckwitz 2009 {published data only}|Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a German breast group 26/breast international group 03-05 study|
Gelmon 2012 {published data only}|Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919|
Papaldo 2006 {published data only}|A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease|/resolve/reference/PMED?id=16410363
Raff 2004 {published data only}|Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancer|/resolve/reference/PMED?id=15023243
Apolone 2005|Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures|/resolve/reference/PMED?id=16136026
Baselga 1996|Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer|/resolve/reference/PMED?id=8622019
Bonifazi 2013|Trastuzumab-related cardiotoxicity in early breast cancer: a cohort study|
Burstein 2005|Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy|/resolve/reference/PMED?id=16150805
Buzdar 2013|Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial|
Cobleigh 1999|Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease|/resolve/reference/PMED?id=10561337
Coussens 1985|Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene|/resolve/reference/PMED?id=2999974
D'Amico 2011|Unplanned crossover in randomized controlled trials: consequences for efficacy and safety outcomes|
Deeks 2003|Evaluating non-randomised intervention studies|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
FDA 1998|U.S. Food and Drug Administration. FDA Oncology Tools Approval Summary for Trastuzumab for HERCEPTIN|
Ferlay 2010|Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008|
Fleeman 2011|Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2(HER2): a systematic review and economic analysis|
Gschwind 2004|The discovery of receptor tyrosine kinases: targets for cancer therapy|
Guarneri 2012|Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study|
Guyatt 2008|GRADE: an emerging consensus on rating quality of evidence and strength of recommendation|/resolve/reference/PMED?id=18436948
Harris 2011|The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Ioannidis 2010|The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence|
Joppi 2005|Disappointing biotech|/resolve/reference/PMED?id=16223825
Kennecke 2010|Metastatic behavior of breast cancer subtypes|
Liao 2011|A meta-analysis of randomised controlled trials comparing chemotherapy plus trastuzumab with chemotherapy alone in HER-2-positive advanced breast cancer|
Mannocci 2010|Use of trastuzumab in HER2-positive metastatic breast cancer beyond progression: a systematic review of published studies|
Mauri 2008|Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer|/resolve/reference/PMED?id=19066278
Miller 2007|Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer|/resolve/reference/PMED?id=18160686
Moja 2012|Trastuzumab containing regimens for early breast cancer|
NICE 2002|Breast cancer - trastuzumab [TA 34]|
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Pegram 2004|Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer|/resolve/reference/PMED?id=15150302
Pestalozzi 2006|Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)|/resolve/reference/PMED?id=16603601
Schneeweiss 2013|Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)|
Seidman 2002|Cardiac dysfunction in the trastuzumab clinical trials experience|/resolve/reference/PMED?id=11870163
Shadish 2002|Statistical conclusion validity and internal validity|
Simes 2001|Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?|
Slamon 1987|Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene|/resolve/reference/PMED?id=3798106
Tabouret 2012|Recent trends in epidemiology of brain metastases: an overview|
Vogel 2001|First-line Herceptin monotherapy in metastatic breast cancer|/resolve/reference/PMED?id=11694786
Wagner 2012|Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer|
B31 {published and unpublished data}|Doxorubicin and cyclophosphamide plus paclitaxel with or without trastuzumab in treating women with node-positive beast cancer that overexpresses HER2|
B31 {published and unpublished data}|Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer. Proceedings of ASCO Meeting; 2007; Chicago, USA. In: Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings|
B31 {published and unpublished data}|Five year update of cardiac dysfunction on NSABP B-31, a randomized trial of sequential doxorubicin/cyclophosphamide (AC)-->paclitaxel (T) vs AC-->T with trastuzumab (H). Proceedings of ASCO Meeting; 2007; Chicago, USA. In: Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings|
B31 {published and unpublished data}|Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer|/resolve/reference/PMED?id=16236738
B31 {published and unpublished data}|Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31|/resolve/reference/PMED?id=16258083
BCIRG006 {unpublished data only}|Combination chemotherapy with or without trastuzumab in treating women with breast cancer|
BCIRG006 {unpublished data only}|BCIRG 006: Docetaxel and trastuzumab-based regimens improve DFS and OS over AC-T in node positive and high risk node negative HER2-positive early breast cancer patients: Quality of life (QOL) at 36 months follow-up. Proceedings of ASCO Meeting; 2007; USA. In: Journal of Clinical Oncology|
BCIRG006 {unpublished data only}||
BCIRG006 {unpublished data only}||
BCIRG006 {unpublished data only}|Phase III randomised trial comparing doxorubicin and cyclophosphamide followed by docetaxel with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab with docetaxel, carboplatin and trastuzumab in HER2-positive early breast cancer patients: BCIRG 006 study|
BCIRG006 {unpublished data only}|Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC-T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC-TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study|
Buzdar {published data only (unpublished sought but not used)}|Evaluation of the addition of Herceptin to standard chemotherapy in the neoadjuvant setting for operable breast cancer|
Buzdar {published data only (unpublished sought but not used)}|Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer|/resolve/reference/PMED?id=15738535
Buzdar {published data only (unpublished sought but not used)}|Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen|/resolve/reference/PMED?id=17200359
FinHer {published data only (unpublished sought but not used)}|Comparison of vinorelbine versus docetaxel, and trastuzumab versus no trastuzumab as adjuvant treatments of early breast cancer|
FinHer {published data only (unpublished sought but not used)}|Fluorouacil, epirubicin and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer trial|/resolve/reference/PMED?id=19884557
FinHer {published data only (unpublished sought but not used)}|Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer|/resolve/reference/PMED?id=16495393
HERA {published data only (unpublished sought but not used)}|Trastuzumab in treating women with primary breast cancer|
HERA {published data only (unpublished sought but not used)}|Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA trial|/resolve/reference/PMED?id=19364966
HERA {published data only (unpublished sought but not used)}|Disease-free survival according to local immunohistochemistry for HER2 and central fluorescence in situ hydridization for patients treated with adjuvant chemotherapy with and without trastuzumab in the HERA (BIG 01-01) trial. Proceedings of 30th Annual San Antonio Breast Cancer Symposium; 2007 Dec 13-16; San Antonio, Texas, USA. In: Breast Cancer Research and Treatment|
HERA {published data only (unpublished sought but not used)}|Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer|/resolve/reference/PMED?id=16236737
HERA {published data only (unpublished sought but not used)}|2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial|/resolve/reference/PMED?id=17208639
HERA {published data only (unpublished sought but not used)}|Trastuzumab-associated cardiac adverse effects in the Herceptin adjuvant trial|/resolve/reference/PMED?id=17646669
HERA {published data only (unpublished sought but not used)}|Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial|/resolve/reference/PMED?id=18296421
N9831 {published data only (unpublished sought but not used)}|Combination chemotherapy with or without trastuzumab in treating women with breast cancer|
N9831 {published data only (unpublished sought but not used)}|Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831|/resolve/reference/PMED?id=19349549
N9831 {published data only (unpublished sought but not used)}|Results of chemotherapy alone, with sequential or concurrent addition of 52 weeks of trastuzumab in the NCCTG N9831 HER2-positive adjuvant breast cancer trial. Proceedings of CTRC-AACR San Antonio Breast Cancer Symposium; 2009 Dec 10-13; San Antonio, Texas, USA. In: Cancer Research|
N9831 {published data only (unpublished sought but not used)}|Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial|/resolve/reference/PMED?id=18250349
N9831 {published data only (unpublished sought but not used)}|Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer|/resolve/reference/PMED?id=16236738
NOAH {published data only (unpublished sought but not used)}|Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort|/resolve/reference/PMED?id=20113825
PACS-04 {published and unpublished data}|Combination chemotherapy with or without trastuzumab in treating women with breast cancer|
PACS-04 {published and unpublished data}|Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial|/resolve/reference/PMED?id=19917839
PACS-04 {published and unpublished data}|Safety analysis from PACS 04 - a phase III trial comparing 6 cycles of FEC100 with 6 cycles of ET75 for node-positive early breast cancer patients, followed by sequential trastuzumab in HER2+ patients: preliminary results. Proceedings of ASCO Meeting; 2006; Chicago, USA. In: Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings|
PACS-04 {published and unpublished data}|3-year follow-up of trastuzumab following adjuvant chemotherapy in node positive HER2-positive breast cancer patients: results of the PACS-04 trial. Proceedings of San Antonio Breast Cancer Symposium; 2007 Dec 13-16; San Antonio, Texas, USA. In: Breast Cancer Research and Treatment|
Belkacemi 2008 {published data only}|Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study|/resolve/reference/PMED?id=18344537
E2198 {published data only}|Chemotherapy plus monoclonal antibody therapy in treating women with stage II or stage IIIA breast cancer that overexpresses HER2|
E2198 {published data only}|Pilot trial of paclitaxel-Herceptin adjuvant therapy for early stage breast cancer (E2198). Proceedings of San Antonio Breast Cancer Symposium; 2006 Dec 14-17; San Antonio, Texas, USA. In: Breast Cancer Research and Treatment|
GeparQuattro trial {published data only}|Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study|/resolve/reference/PMED?id=20308670
Hurley 2006 {published data only}|Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer|/resolve/reference/PMED?id=16549824
B31-N9831 2010 {published data only}|Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials|/resolve/reference/PMED?id=20530275
HERA 2010 {published data only}|Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial|/resolve/reference/PMED?id=21354370
HERA 2010 {published data only}|Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial|/resolve/reference/PMED?id=20530280
Slamon 2011 {published data only}|Adjuvant trastuzumab in HER2-positive breast cancer|/resolve/reference/PMED?id=21991949
Altman 1999|Calculating the number needed to treat for trials where the outcome is time to an event|/resolve/reference/PMED?id=10582940
Apolone 2005|Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures|/resolve/reference/PMED?id=16136026
Baselga 1996|Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer|/resolve/reference/PMED?id=8622019
Bassler 2010|Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis|/resolve/reference/PMED?id=20332404
Burstein 2005|Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy|/resolve/reference/PMED?id=16150805
Cobleigh 1999|Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease|/resolve/reference/PMED?id=10561337
Coussens 1985|Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene|/resolve/reference/PMED?id=2999974
D'Amico 2011|Unplanned crossover in randomized controlled trials: consequences for efficacy and safety outcomes|
Deeks 2003|Evaluating non-randomised intervention studies|/resolve/reference/PMED?id=14499048
Gschwind 2004|The discovery of receptor tyrosine kinases: targets for cancer therapy|/resolve/reference/PMED?id=15122207
Guarneri 2008|Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278)|/resolve/reference/PMED?id=18952561
Hardy 1998|Detecting and describing heterogeneity in meta-analysis|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Joppi 2005|Disappointing biotech|/resolve/reference/PMED?id=16223825
Lancet 2005|Herceptin and early breast cancer: a moment for caution|/resolve/reference/PMED?id=16291043
Loke 2006|Chapter 14: Including adverse effects|
Moja 2006|Trastuzumab containing regimens for metastatic breast cancer|
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
PHARE|Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery|
Pocock 1999|Trials stopped early: too good to be true?|/resolve/reference/PMED?id=10459899
Romond 2005|Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer|/resolve/reference/PMED?id=16236738
Shadish 2002|Statistical conclusion validity and internal validity|
Slamon 1987|Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene|/resolve/reference/PMED?id=3798106
SOLD|Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery|
Tan-Chiu 2005|Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B31|/resolve/reference/PMED?id=16258083
Vogel 2001|First-line Herceptin monotherapy in metastatic breast cancer|/resolve/reference/PMED?id=11694786
Wilcken 2009|About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) Art. No.: BREASTCA|
Bruera 2005 {published data only}|Effects of parenteral hydration in terminally ill cancer patients: a preliminary study|/resolve/reference/PMED?id=15800328
Cerchietti 2000 {published data only}|Hypodermoclysis for control of dehydration in terminal-stage cancer|/resolve/reference/PMED?id=12411847
Morita 2005 {published data only}|Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies|/resolve/reference/PMED?id=15684225
Viola 1997 {published data only}|Studying fluid status and the dying: The challenge of clinical research in palliative care|
Waller 1994 {published data only}|The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients|
Morita 2002 {published data only}|Fluid status of terminally ill cancer patients with intestinal obstruction: an exploratory observational study|/resolve/reference/PMED?id=12353126
Morita 2006 {published data only}|Artificial hydration therapy, laboratory findings, and fluid balance in terminally ill patients with abdominal malignancies|/resolve/reference/PMED?id=16488346
Bruera 2010 {published data only}|A randomized, controlled trial of parenteral hydration in patients with advanced cancer|/resolve/reference/PMED?id=12958109
Abernethy 2003|Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea|/resolve/reference/PMED?id=12958109
Ashby 1995|Artificial hydration and alimentation at the end of life: a reply to Craig|/resolve/reference/PMED?id=7674277
Bozzetti 1996|Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care|/resolve/reference/PMED?id=8798219
Breitbart 2002|An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients|/resolve/reference/PMED?id=12075032
Casarett 2005|Appropriate use of artificial nutrition and hydration-fundamental principles and recommendations|/resolve/reference/PMED?id=16354899
Craig 1994|On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far?|
Doyle 2004||
Good 2008a|Medically assisted nutrition for palliative care in adult patients|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Lanuke 2003|Hydration management in palliative care settings-a survey of experts|/resolve/reference/PMED?id=14959599
Morita 1998|A prospective study on the dying process in terminally ill cancer patients|
Rees 2003|Novel consent process for research in dying patients unable to give consent|/resolve/reference/PMED?id=12881261
Rinck 1997|Methodologic issues in effectiveness research on palliative cancer care: a systematic review|/resolve/reference/PMED?id=9193371
WHO 2005|WHO Definition of Palliative Care|
Good 2008b|Medically assisted hydration for adult palliative care patients|
Bozzetti 2002 {published data only}|Quality of life and length of survival in advanced cancer patients on home parenteral nutrition|/resolve/reference/PMED?id=12135587
Langmore 2006 {published data only}|Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease|/resolve/reference/PMED?id=17054194
Meier 2001 {published data only}|High short-term mortality in hospitalized patients with advanced dementia: Lack of benefit of tube feeding|/resolve/reference/PMED?id=11252121
Orrevall 2005 {published data only}|Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families|/resolve/reference/PMED?id=16099552
Pironi 1997 {published data only}|Home artificial nutrition in advanced cancer|/resolve/reference/PMED?id=9496270
Bozzetti 1996|Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care|/resolve/reference/PMED?id=8798219
Casarett 2005|Appropriate use of artificial nutrition and hydration - fundamental principles and recommendations|/resolve/reference/PMED?id=16354899
Doyle 2004||
Glare 2003|A systematic review of physicians' survival predictions in terminally ill cancer patients|/resolve/reference/PMED?id=12881260
Good 2008|Medically assisted hydration for palliative care patients|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Morita 1998|A prospective study on the dying process in terminally ill cancer patients|
Rinck 1997|Methodologic issues in effectiveness research on palliative cancer care: a systematic review|/resolve/reference/PMED?id=9193371
WHO 2005|WHO Definition of Palliative Care|
Baradzina 2005 {published data only}|Pulmonary rehabilitation programme in sarcoidosis (abstract)|
Holland 2008 {published and unpublished data}|Short-term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease|/resolve/reference/PMED?id=18245143
Mejia 2000 {published data only}|Effects of exercise training on 'quality of life' in patients with interstitial lung diseases (abstract)|
Nishiyama 2008 {published and unpublished data}|Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis|
Nishiyama 2008 {published and unpublished data}|Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis|
Wewel 2005 {published data only}|Home-based exercise training in patients with interstitial lung disease (abstract)|
Wewel 2005 {published data only}|Home-based walking training in patients with interstitial lung diseases (abstract)|
Cockcroft 1981 {published data only}|Randomised controlled trial of rehabilitation in chronic respiratory disability|/resolve/reference/PMED?id=7025334
Cockcroft 1982 {published data only}|Psychological changes during a controlled trial of rehabilitation in chronic respiratory disability|/resolve/reference/PMED?id=6753223
Daltroy 1995 {published data only}|Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease|/resolve/reference/PMED?id=8542209
Jastrzebski 2006 {published data only}|Dyspnoea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation|/resolve/reference/PMED?id=17072040
Naji 2006 {published data only}|Effectiveness of Pulmonary Rehabilitation in Restrictive Lung Disease|/resolve/reference/PMED?id=16926688
Oh 2003 {published and unpublished data}|The effects of home-based pulmonary rehabilitation in patients with chronic lung disease|/resolve/reference/PMED?id=14568368
Ong 2001 {published data only}|Effects of a pulmonary rehabilitation programme on physiologic and psychosocial outcomes in patients wtih chronic respiratory disorders|/resolve/reference/PMED?id=11242618
Senstrom 1996 {published data only}|Dynamic training vs relaxation training as home exercise for patients wtih inflammatory rheumatic diseases|/resolve/reference/PMED?id=8774552
Senstrom 1997 {published data only}|Home exercise and compliance in inflammatory rheumatic diseases - a prospective clinical trial|/resolve/reference/PMED?id=9058651
Tryfon 2003 {published data only}|Cardiopulmonary effects of exercise, before and after oxygen delivery, in patients with usual interstitial pneumonia|
Agusti 1991|Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis|/resolve/reference/PMED?id=1990931
ATS/ERS 2000|Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)|/resolve/reference/PMED?id=10673212
Chang 1999|Assessment of health-related quality of life in patients with interstitial lung disease|/resolve/reference/PMED?id=10559073
Hansen 1996|Pathophysiology of activity limitation in patients with interstitial lung disease|/resolve/reference/PMED?id=8769513
Harris-Eze 1996|Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease|/resolve/reference/PMED?id=8887597
Lacasse 2006|Pulmonary rehabilitation for chronic obstructive pulmonary disease|/resolve/reference/PMED?id=17054186
Lama 2004|Resting and exercise physiology in interstitial lung diseases|/resolve/reference/PMED?id=15331185
Markovitz 1998|Exercise and interstitial lung disease|/resolve/reference/PMED?id=10813202
Miki 2003|Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis|/resolve/reference/PMED?id=12735664
Nici 2006|American Thoracic Society / European Respiratory Society statement on pulmonary rehabilitation|/resolve/reference/PMED?id=16760357
Francese 1997 {published data only}|The effects of regular exercise on muscle strength and functional abilities of late stage Alzheimer's residents|
Holliman 2001 {published data only}|Developing an interactive physical activity group in a geriatric psychiatry facility|
Rolland 2007 {published data only}|Exercise program for nursing home residents with Alzheimer's Disease: A one-year randomized, controlled trial|
Stevens 2006 {published data only}|A randomised controlled trial testing the impact of exercise on cognitive symptoms and disability of residents with dementia|/resolve/reference/PMED?id=16594879
Anon 1986 {published data only}|Study links exercise, improved mental ability|
Batman 1999 {published data only}|The effects of therapeutic aquatic exercise on patients with Alzheimer's Disease|
Gillogly 1991 {unpublished data only}|Behavior management in senile dementia of the Alzheimer's type through exercise|
Littbrand 2006 {published data only}|A high-intensity functional weight-bearing exercise program for older people dependent in activities of daily living and living in residential care facilities: evaluation of the applicability with focus on cognitive function|/resolve/reference/PMED?id=16579666
Netz 1994 {published data only}|The effect of supervised physical activity on cognitive and affective state of geriatric and psychogeriatric in-patients|
Powell 1974 {published data only}|Psychological effects of exercise therapy upon institutionalized geriatric mental patients|/resolve/reference/PMED?id=4811950
Rodgers 2002 {published data only}|Effects of a structured low-level exercise program on age-related cognitive decline in veteran patients|
Scherder 2005 {published data only}|Physical activity and executive functions in the elderly with mild cognitive impairment|/resolve/reference/PMED?id=16019281
Tappen 2000 {published data only}|Effect of a comprehensive exercise program on function in nursing home residents with Alzheimer's disease|
Van de Winckel 2004 {published data only}|Cognitive and behavioural effects of music-based exercises in patients with dementia|/resolve/reference/PMED?id=15137556
van Uffelen 2005 {published data only}|Protocol for Project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]|/resolve/reference/PMED?id=16375760
Viscogliosi 2000 {published data only}|[Effect of a multi-strategic group program on performance of the activities of daily living for elderly people with mild cognitive deficits]|/resolve/reference/PMED?id=11140145
Abbott 2004|Walking and dementia in physically capable elderly men|/resolve/reference/PMED?id=15383515
Alessi 1999|A randomized trial of a combined physical activity and environmental intervention in nursing home residents: Do sleep and agitation improve?|/resolve/reference/PMED?id=10404920
Alzheimer's Association 2008|2008 Alzheimer's disease facts and figures|
Angevaren 2008|Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment (Review)|
APA 1995||
Barnes 2007|Physical activity and dementia: the need for preventive trials|/resolve/reference/PMED?id=17211190
Cotman 2007|Physical activity and the maintenance of cognition: Learning from animal models|/resolve/reference/PMED?id=19595972
Cranswick 2005|Elder care and the complexities of social networks|
Cummings 1994|The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia|/resolve/reference/PMED?id=7991117
Feldman 2005|The staging and assessment of moderate to severe Alzheimer disease|
Ferri 2005|Global prevalence of dementia: A Delphi consensus study|/resolve/reference/PMED?id=16360788
Folstein 1975|'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician|/resolve/reference/PMED?id=1202204
Forbes 2007|An exercise programme led to a slower decline in activities of daily living in nursing home patients with Alzheimer's disease|/resolve/reference/PMED?id=17596394
Heyn 2004|The effects of exercise training on elderly persons with cognitive impairment and dementia: A meta-analysis|/resolve/reference/PMED?id=15468033
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2008||
Hogan 2007|Management of mild to moderate Alzheimer's disease and dementia|/resolve/reference/PMED?id=19595958
Kannus 2005|Non-pharmacological means to prevent fractures among older adults|/resolve/reference/PMED?id=16019730
Karp 2006|Mental, physical and social components in leisure activities equally contribute to decrease dementia risk|/resolve/reference/PMED?id=16319455
Katz 1963|Studies of Illness in The Aged. The Index of ADL: A standardized measure of biological and psychological function|/resolve/reference/PMED?id=14044222
Keating 1999||
Kramer 2007|Effects of physical activity on cognition, well-being, and brain: Human interventions|/resolve/reference/PMED?id=19595974
Larowski 1999|A randomized outcome evaluation of group exercise programs in long-term care institutions|
Larson 2006|Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older|/resolve/reference/PMED?id=16418406
Laurin 2001|Physical activity and risk of cognitive impairment and dementia in elderly persons|/resolve/reference/PMED?id=11255456
Lytle 2004|Exercise level and cognitive decline|
MacRae 1996|A walking program for nursing home residents: Effects on walking endurance, physical activity, mobility, and quality of life|/resolve/reference/PMED?id=8576508
McCracken 1993|Developing a tool to measure functional changes in advanced dementia|/resolve/reference/PMED?id=8366932
McKhann 1984|Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer's disease|/resolve/reference/PMED?id=6610841
Middleton 2007|Exercise and the prevention of dementia|
Moher 1998|Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?|/resolve/reference/PMED?id=9746022
Mller-Thomsen 2005|Detecting depression in Alzheimer's disease: evaluation of four different scales|/resolve/reference/PMED?id=15708735
Netz 2005|Physical activity and psychological well-being in advanced age: A meta-analysis of intervention studies|/resolve/reference/PMED?id=16029091
Penninx 2002|Exercise and depressive symptoms: A comparison of aerobic and resistance exercise effects on emotional and physical function in older persons with high and low depressive symptomatology|/resolve/reference/PMED?id=11867660
Reitman 1988|Can efficacy of blinding be documented by meta-analysis?|
Robillard 2007|Clinical diagnosis of dementia|/resolve/reference/PMED?id=19595950
Rockwood 2007|Physical activity and the maintenance of cognitive function|/resolve/reference/PMED?id=19595973
Scherder 2005|Physical activity and executive functions in the elderly with mild cognitive impairment|/resolve/reference/PMED?id=16019281
Schulz 1995|Empirical evidence of bias|/resolve/reference/PMED?id=7823387
Sherrington 2004|Physical activity interventions to prevent falls among older people: Update of the evidence|/resolve/reference/PMED?id=15214601
Shulman 1993|Clock-drawing and dementia in the community: A longitudinal study|
Taylor 2004|Physical activity and older adults: A review of health benefits and the effectiveness of interventions|/resolve/reference/PMED?id=15370483
Teri 2003|Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial|/resolve/reference/PMED?id=14559955
Weuve 2004|Physical activity, including walking, and cognitive function in older women|/resolve/reference/PMED?id=15383516
WHO 1992||
Wilkinson 1980|Psychogeriatric dependency rating scales (PGDRS): a method of assessment for use by nurses|/resolve/reference/PMED?id=6452189
Yaffe 2001|A prospective study of physical activity and cognitive decline in elderly women: Women who walk|/resolve/reference/PMED?id=11485502
Ge 2006 {published data only}|Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI)|/resolve/reference/PMED?id=16775089
Huang 2006 {published data only}|Long term follow-up of emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction|/resolve/reference/PMED?id=16796836
Janssens 2004 {published data only}|Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial|/resolve/reference/PMED?id=16413875
Janssens 2004 {published data only}|Autologous bone marrow derived stem cell transfer in patients with ST-segment elevation myocardial infarction: double blind randomised controlled trial|
Kang 2006 {published data only}|Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial|/resolve/reference/PMED?id=16820564
Kang 2006 {published data only}|Myocardial regeneration and angiogenesis in myocardial infarction with G-CSF and intracoronary stem cell infusion-3-DES|
Karpov 2005 {published data only}|Autologous mononuclear bone marrow cells during reparative regeneration after acute myocardial infarction|
Li 2007 {published data only}|The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI)|/resolve/reference/PMED?id=16822566
Li 2007 {published data only}|Safety and efficacy of intracoronary transplantation of G-CSF mobilised autologous peripheral blood stem cells in patients with acute myocaridal infarction|/resolve/reference/PMED?id=16626571
Lunde 2006 {published data only}|Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects|/resolve/reference/PMED?id=16152682
Lunde 2006 {published data only}|Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction|/resolve/reference/PMED?id=16990383
Meluzin HD 2006 {published data only}|Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function|/resolve/reference/PMED?id=17070173
Meluzin LD 2006 {published data only}|Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function|/resolve/reference/PMED?id=17070173
Meyer 2006b {published data only}|Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial|/resolve/reference/PMED?id=16520413
Meyer 2006b {published data only}|Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial|/resolve/reference/PMED?id=16510465
Meyer 2006b {published data only}|Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial|/resolve/reference/PMED?id=15246726
Penicka 2007 {published data only}|Intracoronary stem cells in large myocardial infarction|
Penicka 2007 {published data only}|Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction. A prematurely terminated randomised study|/resolve/reference/PMED?id=17572255
Ruan 2005 {published data only}|Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging|/resolve/reference/PMED?id=16117862
Schachinger 2006 {published data only}|Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial|/resolve/reference/PMED?id=17098754
Schachinger 2006 {published data only}|Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction|/resolve/reference/PMED?id=16990384
Schachinger 2006 {published data only}|Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial|/resolve/reference/PMED?id=16501626
Suarez de Lezo 2007 {published data only (unpublished sought but not used)}|Regenerative therapy in patients with a revascularised acute anterior myocardial infarction and depressed ventricular function|/resolve/reference/PMED?id=17521544
Assmus 2006 {published data only}|Transcoronary transplantation of progenitor cells after myocardial infarction|/resolve/reference/PMED?id=16990385
Chen 2004 {published data only}|Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction|/resolve/reference/PMED?id=15498362
Chen 2004 {published data only}|Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction|/resolve/reference/PMED?id=15219514
Chen 2004a {published data only}|Effect of self-marrow stem cell transplantation insitu on the size of infarct area and cardiac functions after acute myocardium infarction|
Engelmann 2006 {published data only}|Autologous bone marrow stem cell mobilization induced by granulocyte colony stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization|/resolve/reference/PMED?id=17045910
Hare 2007 {published data only}|A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Provacel) following acute myocardial infarction (AMI)|
Hendrikx 2006 {published data only}|Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation. Results from a randomised controlled clinical trial|
Kang 2007 {published data only}|Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial|/resolve/reference/PMED?id=17239682
Kang 2007 {published data only}|Six months follow-up results of "granulocyte stimulating factor" based stem cell therapy in patients with myocardial infarction|
Kang 2007 {published data only}|Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after cornoary stenting in myocardial infarction: the MAGIC cell randomised clinical trial|/resolve/reference/PMED?id=15016484
Musiatek 2006 {published data only}|Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: the rationale and a pilot study involving a comparison with conventional over the-wire balloon coronary occlusions in patients with recent myocardial inraction|/resolve/reference/PMED?id=16752333
Nyolczas 2007 {unpublished data only}|Design and rationale for the myocardial stem cell administration after acute myocardial infarction (MYSTAR) study: a multicenter, prospective, randomised, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction|/resolve/reference/PMED?id=17239678
Richartz 2007 {published data only}|A randomised, double blind placebo controlled, dose escalation study of intravenous adult human mesenchymal stem cells (PROVACEL (trademark)) following acute myocardial infarction|
Schachninger 2004 {published data only}|Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)|/resolve/reference/PMED?id=12473544
Schachninger 2004 {published data only}|Infarct remodelling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI). Mechanistic insights from serial contrast-enhanced magnetic resonance imaging|/resolve/reference/PMED?id=14557356
Schachninger 2004 {published data only}|Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Final one-year results of the TOPCARE-AMI trial|/resolve/reference/PMED?id=15489105
Schachninger 2004 {published data only}|Normalization of coronary blood flow in the infarct related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial|/resolve/reference/PMED?id=16598441
Shan 2005 {published data only}|Effect of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in repairing infarcted myocardium|
Huang 2007 {published data only}|Evaluation of myocardial viability with 201T1/18F-FDG DISA-SPECT technique in patients with acute myocardial Infarction after emergent intracoronary autologous bone marrow mononuclear cell transplantation|/resolve/reference/PMED?id=17711705
Konorza 2007 {published data only}|Repair AMI late: A prospective multicenter randomised placebo-controlled trial of autologous bone marrow-derived progenitor cells in patients with acute myocardial infarction|
Ryabov 2006 {published data only}|Cardiac contractility after transplantation of autologous mononuclear bone marrow cells in patients with myocardial infarction|/resolve/reference/PMED?id=16929983
Ryabov 2006a {published data only}|Cardiomyoplasty with autologolgical mononuclear cells of the bone marrow in patients with acute myocardial infarction|
Schueller 2007 {published data only}|Intracoronary autologous bone marrow cell transplantation beneficially modulates heart rate variability|/resolve/reference/PMED?id=17050010
Ascione 2006 {unpublished data only}|Selected bone marrow cell transplant following myocardial infarction in patients undergoing coronary surgery: a prospective double blind controlled trial|
Dohmann 2006 {published data only}|Cell therapy in myocardial infarction|
Drexler 2005 {published data only}|BOne marrOw transfer to enhance ST-elevation infarct regeneration-2 (BOOST-2)|
Gerslick 2006 {published data only}|Percutaneous randomised infusion of marrow aspirate to improve ventricular efficiency|
Grajek 2005 {published data only}|Improvement of left ventricle function in patients with acute myocardila infarction after infusion of bone marrow stem cells|
Hare 2006 {published data only}|Safety study of adult mesenchymal stem cells (MSC) to treat acute myocardial infarction|
Hirsch 2006 {published data only}|Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous cor5onary intervention: rationale and design of the HEBE trial - a prospective, multicenter, randomized trial|/resolve/reference/PMED?id=16923409
Hirsch 2006 {published data only}|Multicenter, randomised trial of intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary PCI|
Hirsch 2006 {published data only}|Multicenter, randomised trial of intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear cells after primary PCI|
Huikuri 2006 {published data only}|Bone marrow cells in myocardial infarction|
Lemarchand 2005 {published data only}|BONAMI (BOne Marrow in Acute Myocardial Infarction)|
Perez-Oteyza 2006 {published data only}|Intracoronary autologous bone-marrow stem cell transfer after myocardial infarction|
Quyyumi 2006 {published data only}|Amorcyte Myocardial Repair Study - A phase I trial of intra-coronary infusion of bone marrow derived autologous CD34+ selected cells in patients with acute myocardial infarction (AMRS)|
Traverse 2006 {published data only}|Bone marrow stem cell infusion following a heart attack|
Yao 2006 {published and unpublished data}|Observation on the safety: clinical trial on intracoronary autologous bone marrow mononuclear cells transplantation for acute myocardial infarction|/resolve/reference/PMED?id=17081355
Abdel-Latif 2007|Adult Bone Marrow-Derived Cells for Cardiac Repair|
Arnesen 2007|Cell therapy in myocardial infarction|/resolve/reference/PMED?id=17604783
Assmus 2002|Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)|/resolve/reference/PMED?id=12473544
Bartunek 2005|Intracoronary injection of CD133-positive enriched bone marrow porgenitor cells promotes cardiac recovery after recent myocardial infarction|
Bartunek 2006|The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart|/resolve/reference/PMED?id=16543252
BHF 2004|Coronary heart disease statistics: factsheet|
Deb 2003|Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients|/resolve/reference/PMED?id=12628942
Drexler 2006|Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial|/resolve/reference/PMED?id=16501634
Fernandez-Aviles 2004|Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction|/resolve/reference/PMED?id=15358665
Hartwell 2005|Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation|/resolve/reference/PMED?id=15876363
Higgins 2006|Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated September 2006]|
Jackson 2001|Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells|/resolve/reference/PMED?id=11390421
Jni 2001|Systematic reviews in health care: Assessing the quality of controlled clinical trials|/resolve/reference/PMED?id=11440947
Losordo 2007|Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomised controlled trial|/resolve/reference/PMED?id=17562958
Mathur 2004|Stem cells and repair of the heart|/resolve/reference/PMED?id=15246732
Meyer 2006a|Stem cell therapy: a new perspective in the treatment of patients with acute myocardial infarction|/resolve/reference/PMED?id=17107878
Orlic 2001a|Bone marrow cells regenerate infarcted myocardium|/resolve/reference/PMED?id=11287958
Orlic 2001b|Mobilized bone marrow cells repair the infarcted heart, improving function and survival|/resolve/reference/PMED?id=11504914
Review Manager 2003|Review Manager (RevMan)|
Stamm 2003|Autologous bone-marrow stem-cell transplantation for myocardial regeneration|/resolve/reference/PMED?id=12517467
Strauer 2002|Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans|/resolve/reference/PMED?id=12370212
Toma 2002|Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart|/resolve/reference/PMED?id=11772882
Tse 2003|Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation|/resolve/reference/PMED?id=12517468
Yoon 2005|Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction|/resolve/reference/PMED?id=15690083
Cao 2009 {published data only}|Long-term myocardial functional improvement after autologous bone marrow mononuclear cell transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up|/resolve/reference/PMED?id=19508995
Cao 2009 {published data only}|Four years follow up of intracoronary delivery autologous bone marrow mononuclear cells in patients with ST-elevation myocardial infarction|
Chen 2004 {published data only}|Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction|/resolve/reference/PMED?id=15498362
Chen 2004 {published data only}|Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction|/resolve/reference/PMED?id=15219514
Fernandez-Pereira 2006 {published data only}|Autologous bone marrow stem cell transplant after myocardial infarction. In-hospital and long-term follow-up results of the randomized Argentina trial (STAR AMI)|/resolve/reference/PMED?id=17251257
Ge 2006 {published data only}|Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI)|/resolve/reference/PMED?id=16775089
Grajek 2010 {published data only}|Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation|/resolve/reference/PMED?id=20022872
Grajek 2010 {published data only}|Improvement of left ventricle function in patients with acute myocardial infarction after infusion of bone marrow stem cells|
Hirsch 2010 {published data only}|Myocardial perfusion after intracoronary infusion of mononuclear cells of bone marrow or peripheral blood after acute myocardial infarction|
Hirsch 2010 {published data only}|Multicenter, randomised trial of intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary PCI|
Hirsch 2010 {published data only}|Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous cor5onary intervention: rationale and design of the HEBE trial - a prospective, multicenter, randomized trial|/resolve/reference/PMED?id=16923409
Hirsch 2010 {published data only}|Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial|/resolve/reference/PMED?id=21148540
Hirsch 2010 {published data only}|Multicenter, randomised trial of intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear cells after primary PCI|
Huang 2006 {published data only}|Long term follow-up of emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction|/resolve/reference/PMED?id=16796836
Huang 2007 {published data only}|Evaluation of myocardial viability with 201T1/18F-FDG DISA SPECT technique in patients with acute myocardial infarction after emergent intracoronary autologous bone marrow mononuclear cell transplantation|/resolve/reference/PMED?id=17711705
Huikuri 2008 {published data only}|Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile and restenosis after thrombolytic therapy of acute myocardial infarction|/resolve/reference/PMED?id=18845667
Huikuri 2008 {published data only}|Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy|
Janssens 2006 {published data only}|Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study|/resolve/reference/PMED?id=19106196
Janssens 2006 {published data only}|Long-term safety and efficacy of autologous bone marrow-derived stem cell transfer after acute myocardial infarction|
Janssens 2006 {published data only}|Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial|/resolve/reference/PMED?id=16413875
Janssens 2006 {published data only}|Autologous bone marrow derived stem cell transfer in patients with ST-segment elevation myocardial infarction: double blind randomised controlled trial|
Jin 2008 {published data only}|Autologous intracoronary mononuclear bone marrow cell transplantation for acute anterior myocardial infarction: Outcomes after 12-month follow-up|
Kang 2006 {published data only}|Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial|/resolve/reference/PMED?id=16820564
Kang 2006 {published data only}|Myocardial regeneration and angiogenesis in myocardial infarction with G-CSF and intracoronary stem cell infusion-3-DES|
Karpov 2005 {published data only}|Autologous mononuclear bone marrow cells during reparative regeneration after acute myocardial infarction|
Karpov 2005 {published data only}|Cardiomyoplasty with autological mononuclear cells of the bone marrow in patients with acute myocardial infarction|
Li 2007 {published data only}|The clinical randomized study of autologous peripheral blood progenitor cell transplantation by intracoronary infusion in patients with acute myocardial infarction|
Li 2007 {published data only}|The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI)|/resolve/reference/PMED?id=16822566
Li 2007 {published data only}|Safety and efficacy of intracoronary transplantation of G-CSF mobilised autologous peripheral blood stem cells in patients with acute myocardial infarction|/resolve/reference/PMED?id=16626571
Lunde 2006 {published data only}|Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3-year serial echocardiographic sub-study of the randomized-controlled ASTAMI study|/resolve/reference/PMED?id=20851818
Lunde 2006 {published data only}|Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study|/resolve/reference/PMED?id=19833610
Lunde 2006 {published data only}|Regional and diastolic function improves after acute myocardial infarction treated with acute PCI, but is not influenced by injection of autologous mononuclear bone marrow cells: An ASTAMI sub-study|
Lunde 2006 {published data only}|Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects|/resolve/reference/PMED?id=16152682
Lunde 2006 {published data only}|Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction|/resolve/reference/PMED?id=16990383
Lunde 2006 {published data only}|Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety. clinical outcome, and serial changes in left ventricular function during 12-months' follow-up|/resolve/reference/PMED?id=18261689
Meluzin HD 2008 {published data only}|Individual differences in the effectiveness of intracoronary bone marrow cell transplantation assessed by gatted sestamibi SPECT/FDG PET imaging|/resolve/reference/PMED?id=18513646
Meluzin HD 2008 {published data only}|Three-, 6- and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction|/resolve/reference/PMED?id=17764767
Meluzin HD 2008 {published data only}|Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function|/resolve/reference/PMED?id=17070173
Meluzin HD 2008 {published data only}|Cell therapy in patients with left ventricular dysfunction due to myocardial infarction|
Meluzin LD 2008 {published data only}|Individual differences in the effectiveness of intracoronary bone marrow cell transplantation assessed by gatted sestamibi SPECT/FDG PET imaging|/resolve/reference/PMED?id=18513646
Meluzin LD 2008 {published data only}|Three-, 6- and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction|/resolve/reference/PMED?id=17764767
Meluzin LD 2008 {published data only}|Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function|/resolve/reference/PMED?id=17070173
Meluzin LD 2008 {published data only}|Cell therapy in patients with left ventricular dysfunction due to myocardial infarction|
Meyer 2006 {published data only}|Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial|/resolve/reference/PMED?id=16520413
Meyer 2006 {published data only}|Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial|/resolve/reference/PMED?id=19773226
Meyer 2006 {published data only}|Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial|/resolve/reference/PMED?id=16510465
Meyer 2006 {published data only}|Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial-an echocardiographic study|/resolve/reference/PMED?id=19946118
Meyer 2006 {published data only}|Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial|/resolve/reference/PMED?id=15246726
Nogueira AG 2009 {published data only}|Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction- MiHeart/AMI study|/resolve/reference/PMED?id=18598362
Nogueira AG 2009 {published data only}|SYstolic function of patients with myocardial infarction undergoing autologous bone marrow transplantation|
Nogueira AG 2009 {published data only}|Autologous bone marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques|/resolve/reference/PMED?id=19558782
Nogueira VG 2009 {published data only}|Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction- MiHeart/AMI study|/resolve/reference/PMED?id=18598362
Nogueira VG 2009 {published data only}|Systolic function of patients with myocardial infarction undergoing autologous bone marrow transplantation|/resolve/reference/PMED?id=19936457
Nogueira VG 2009 {published data only}|Autologous bone marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques|/resolve/reference/PMED?id=19558782
Penicka 2007 {published data only}|Intracoronary stem cells in large myocardial infarction|
Penicka 2007 {published data only}|Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction. A prematurely terminated randomised study|/resolve/reference/PMED?id=17572255
Piepoli 2010 {published data only}|Acute myocardial infarction: long term echocardiographic remodeling after bone marrow cell transplantation|
Piepoli 2010 {published data only}|Bone marrow cell transplantation in patients after acute myocardial infarction and left ventricular dysfunction: Long term effects on heart function and remodeling|
Piepoli 2010 {published data only}|Bone marrow cell transplantation improves cardiac, autonomic and functional indexes in acute anterior myocardial infarction patients (Cardiac study)|
Piepoli 2010 {published data only}|Autologous bone marrow stem cell support in acute anterior myocardial infarction|
Plewka 2009 {published data only}|Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MiBi single-photon emission computed tomography study|/resolve/reference/PMED?id=19050877
Plewka 2009 {published data only}|Clinical 2-years outcome after intracoronary injection of mononuclear bone marrow stem cells in patients with acute myocardial infarction|
Plewka 2009 {published data only}|Effect of intracoronary injection of mononuclear bone marrow stem cels on left ventricular function in patients with acute myocardial infarction|/resolve/reference/PMED?id=19892047
Quyyumi HD 2011 {published data only}|Amorcyte Myocardial Repair Study - A phase I trial of intra-coronary infusion of bone marrow derived autologous CD34+ selected cells in patients with acute myocardial infarction (AMRS)|
Quyyumi HD 2011 {published data only}|CD34+ infusion after ST elevation myocardial infarction is associated with improved perfusion|
Quyyumi HD 2011 {published data only}|CD34+ cell infusion after ST-elevation myocardial infarction is associated with improved perfusion and is dose dependent|/resolve/reference/PMED?id=21167340
Quyyumi LD 2011 {published data only}|Amorcyte Myocardial Repair Study - A phase I trial of intra-coronary infusion of bone marrow derived autologous CD34+ selected cells in patients with acute myocardial infarction (AMRS)|
Quyyumi LD 2011 {published data only}|CD34+ infusion after ST elevation myocardial infarction is associated with improved perfusion|
Quyyumi LD 2011 {published data only}|CD34+ cell infusion after ST-elevation myocardial infarction is associated with improved perfusion and is dose dependent|/resolve/reference/PMED?id=21167340
Quyyumi MD 2011 {published data only}|Amorcyte Myocardial Repair Study - A phase I trial of intra-coronary infusion of bone marrow derived autologous CD34+ selected cells in patients with acute myocardial infarction (AMRS)|
Quyyumi MD 2011 {published data only}|CD34+ infusion after ST elevation myocardial infarction is associated with improved perfusion|
Quyyumi MD 2011 {published data only}|CD34+ cell infusion after ST-elevation myocardial infarction is associated with improved perfusion and is dose dependent|/resolve/reference/PMED?id=21167340
Roncalli 2010 {published data only}|BONAMI (BOne Marrow in Acute Myocardial Infarction)|
Roncalli 2010 {published data only}|Autologous bone marrow mononucleated cell infusion for acute myocardial infarction in patients with severe left ventricular dysfunction: Results of the BONAMI Trials (A multicenter randomized controlled trial)|
Roncalli 2010 {published data only}|Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial|/resolve/reference/PMED?id=21127322
Ruan 2005 {published data only}|Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging|/resolve/reference/PMED?id=16117862
Schachinger 2006 {published data only}|Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction|/resolve/reference/PMED?id=19996415
Schachinger 2006 {published data only}|Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy|
Schachinger 2006 {published data only}|Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk of adverse remodelling after acute ST-segment elevation myocardial infarction: Results of the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction study (REPAIR-AMI) cardiac magnetic resonance imaging study|/resolve/reference/PMED?id=19249426
Schachinger 2006 {published data only}|Repair AMI late: A prospective multicenter randomised placebo-controlled trial of autologous bone marrow-derived progenitor cells in patients with acute myocardial infarction|
Schachinger 2006 {published data only}|Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial|
Schachinger 2006 {published data only}|Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial|/resolve/reference/PMED?id=17098754
Schachinger 2006 {published data only}|Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction|/resolve/reference/PMED?id=16990384
Schachinger 2006 {published data only}|Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial|/resolve/reference/PMED?id=16501626
Suarez de Lezo 2007 {published data only}|Regenerative therapy in patients with a revascularised acute anterior myocardial infarction and depressed ventricular function|/resolve/reference/PMED?id=17521544
Tendera S 2009 {published data only}|Intracoronary administration of mononuclear bone marrow cells in acute STEMI: long-term follow-up|/resolve/reference/PMED?id=17251257
Tendera S 2009 {published data only}|Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration Infarction (REGENT) Trial|/resolve/reference/PMED?id=19208649
Tendera U 2009 {published data only}|Intracoronary administration of mononuclear bone marrow cells in acute STEMI: long-term follow-up|
Tendera U 2009 {published data only}|Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration Infarction (REGENT) Trial|/resolve/reference/PMED?id=19208649
Traverse 2010 {published data only}|Bone marrow stem cell infusion following a heart attack|
Traverse 2010 {published data only}|Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction|/resolve/reference/PMED?id=20826249
Wohrle 2010 {published data only}|Intracoronary stem cell therapy in patients with acute myocardial infarction- a randomized, double-blind, placebo-controlled trial (SCAMI)|
Wohrle 2010 {published data only}|Results of the intracoronary stem cell therapy after acute myocardial infarction|/resolve/reference/PMED?id=20211323
Wohrle 2010 {published data only}|Intracoronary stem cell therapy after myocardial infarction- Twelve months follow-up of a randomized, rigorous double-blind, placebo controlled trial|
Yao 2006 {published data only}|Observation on the safety: clinical trial on intracoronary autologous bone marrow mononuclear cells transplantation for acute myocardial infarction|/resolve/reference/PMED?id=17081355
Yao DD 2009 {published data only}|Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction|
Yao SD 2009 {published data only}|Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction|
You 2008 {published data only}|Influence of autologous bone marrow stem cell transplantation on short-term heart function in cardiac failure patients|
Zhukova 2009 {published data only}|An experience of the use of stem cells in the treatment of patients with myocardial infarction and low ejection fraction|
Assmus 2006 {published data only}|Transcoronary transplantation of progenitor cells after myocardial infarction|/resolve/reference/PMED?id=16990385
Atsma 2008 {unpublished data only}|Autologous bone marrow-derived in vitro expanded mesenchymal stem cell transplantation in patients with an acute myocardial infarction treated by successful primary percutaneous transluminal coronary angioplasty - A safety and feasibility study|
Chang 2009 {published data only}|Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion|/resolve/reference/PMED?id=19460773
Chen 2004a {published data only}|Effect of self-marrow stem cell transplantation in situ on the size of infarct area and cardiac functions after acute myocardium infarction|
Engelmann 2006 {published data only}|Autologous bone marrow stem cell mobilization induced by granulocyte colony stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization|/resolve/reference/PMED?id=17045910
Hare 2007 {published data only}|A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Provacel) following acute myocardial infarction (AMI)|
Hendrikx 2006 {published data only}|Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation. Results from a randomised controlled clinical trial|/resolve/reference/PMED?id=16820557
Kang 2007 {published data only}|Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial|/resolve/reference/PMED?id=17239682
Kang 2007 {published data only}|Six months follow-up results of "granulocyte stimulating factor" based stem cell therapy in patients with myocardial infarction|
Kang 2007 {published data only}|Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial|/resolve/reference/PMED?id=15016484
Musiatek 2006 {published data only}|Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: the rationale and a pilot study involving a comparison with conventional over the-wire balloon coronary occlusions in patients with recent myocardial infarction|/resolve/reference/PMED?id=16752333
NCT00560742 {unpublished data only}|Efficacy of the Mode of Delivery of Autologous Bone Marrow Cells Into Heart Scar Muscle for the Recovery of Contractile Function|
NCT00587990 {unpublished data only}|A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Intramyocardial Injection of Autologous Human Mesenchymal Stem Cells (MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction (MI) Undergoing Cardiac Surgery for Coronary Artery Bypass Grafting (CABG)|
NCT00874354 {unpublished data only}|REVITALIZE: Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction|
NCT00877903 {unpublished data only}|A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction|
NCT00893360 {unpublished data only}|A Phase I Randomized, Dose Escalation Study of the Safety and Efficacy of Intracoronary Delivery of Cardiosphere-Derived Stem Cells in Patients With Ischemic Left Ventricular Dysfunction and a Recent Myocardial Infarction|
NCT01087996 {unpublished data only}|A Phase I/II, Randomized Pilot Study of the Comparative Safety and Efficacy of Transendocardial Injection of Autologous Mesenchymal Stem Cells Versus Allogeneic Mesenchymal Stem Cells in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction|
Nyolczas 2007 {unpublished data only}|Design and rationale for the myocardial stem cell administration after acute myocardial infarction (MYSTAR) study: a multicenter, prospective, randomised, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction|/resolve/reference/PMED?id=17239678
Oakley 2005 {published data only}|Transplantation of autologous bone marrow-derived cells into the myocardium of patients undergoing coronary bypass|
Obradovic 2009 {published data only}|Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: Quantum of initial necrosis is the key|
Peruga 2009 {published data only}|Intracoronary administration of stem cells in patients with acute myocardial infarction - angiographic follow-up|/resolve/reference/PMED?id=19521932
Richartz 2007 {published data only}|A randomized, double blind placebo controlled, dose escalation study of intravenous human adult mesenchymal stem cells (PROVACEL (trademark)) following acute myocardial infarction|
Schachinger 2004 {published data only}|Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)|/resolve/reference/PMED?id=12473544
Schachinger 2004 {published data only}|Infarct remodelling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI). Mechanistic insights from serial contrast-enhanced magnetic resonance imaging|/resolve/reference/PMED?id=14557356
Schachinger 2004 {published data only}|Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Final one-year results of the TOPCARE-AMI trial|/resolve/reference/PMED?id=15489105
Schachinger 2004 {published data only}|Normalization of coronary blood flow in the infarct related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial|/resolve/reference/PMED?id=16598441
Schueller 2007 {published data only}|Intracoronary autologous bone marrow cell transplantation beneficially modulates heart rate variability|/resolve/reference/PMED?id=17050010
Shan 2005 {published data only}|Effect of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in repairing infarcted myocardium|
Stamm 2004 {published data only}|CABG and bone marrow stem cell transplantation after myocardial infarction|/resolve/reference/PMED?id=15192775
Taljaard 2010 {published data only}|Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction: a multicentre, phase IIb randomised placebo-controlled trial|
Taljaard 2010 {published data only}|Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction|/resolve/reference/PMED?id=20211295
Trzos 2009 {published data only}|The effects of intracoronary autologous mononuclear bone marrow cell transplantation on cardiac arrhythmia and heart rate variability|
Vanderheyden 2007 {published data only}|Time-dependent effects on coronary remodelling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction|/resolve/reference/PMED?id=18293890
Wang 2006 {published data only}|Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with anterior myocardial infarction|/resolve/reference/PMED?id=16626572
Yousef 2009 {published data only}|The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction.|/resolve/reference/PMED?id=19520249
Castellani 2010 {published data only}|The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection|/resolve/reference/PMED?id=21078804
Castellani 2010 {published data only}|Intracoronary Injection of CD133+ Autologous Hematopoietic Cells After Myocardial Infarction|
Chang 2008 {published data only}|Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction|/resolve/reference/PMED?id=17974698
Gerslick 2006 {unpublished data only}|Percutaneous randomised infusion of marrow aspirate to improve ventricular efficiency|
Huang 2007b {published data only}|Timing and therapeutic response of intracoronary bone marrow mononuclear cells administration in acute ST-elevation myocardial infarction patients|
Huang 2008 {published data only}|Transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI-2)|
Perez-Oteyza 2006 {published data only}|Randomised trial of intracoronary autologous bone-marrow cell transfer after myocardial infarction. Preliminary results by cardiac magnetic resonance imaging|/resolve/reference/PMED?id=15637088
Perez-Oteyza 2006 {published data only}|Intracoronary autologous bone-marrow stem cell transfer after myocardial infarction|
Ryabov 2006 {published data only}|Cardiac contractility after transplantation of autologous mononuclear bone marrow cells in patients with myocardial infarction|/resolve/reference/PMED?id=16929983
Ascione 2006 {unpublished data only}|Selected bone marrow cell transplant following myocardial infarction in patients undergoing coronary surgery: a prospective double blind controlled trial|
CTRI/2008/091/000232 {unpublished data only}|Efficacy of stem cell in improvement of left ventricular function in patients with acute myocardial infarction|
Drexler 2005 {unpublished data only}|BOne marrOw transfer to enhance ST-elevation infarct regeneration-2 (BOOST-2)|
Mansour 2010 {published data only}|COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design|/resolve/reference/PMED?id=20560029
Mansour 2010 {published data only}|Stem cell therapy for the broken heart: mini-organ transplantation|/resolve/reference/PMED?id=19857748
NCT00313339 {unpublished data only}|Intra-coronary infusion of bone marrow derived autologous CD34+ selected cells in patients with acute myocardial infarction|
NCT00529932 {unpublished data only}|A trial using CD133 enriched bone marrow cells following primary angioplasty for acute myocardial infarction|
NCT00626145 {unpublished data only}|Long-term follow-up of autologous bone marrow mononuclear cells therapy in STEMI|
NCT00669227 {unpublished data only}|Intracoronary stem cell therapy in patients with acute myocardial infarction (SCAMI)|
NCT00691834 {unpublished data only}|Safety and efficacy on cell-based therapy in patients with recent large acute myocardial infarction (ReNeW)|
NCT00711542 {unpublished data only}|Effects of intracoronary progenitor cell therapy on coronary flow reverse after acute MI|
NCT00725738 {unpublished data only}|Intracoronary autologous stem cell transplantation in ST-elevation myocardial infarction: TRACIA STUDY|
NCT00765453 {unpublished data only}|Bone marrow derived adult stem cells for acute anterior myocardial infarction|
NCT00979758 {unpublished data only}|Strengthening transplantation effects of bone marrow mononuclear cells with atorvastatin in myocardial infarction|
NCT00984178 {unpublished data only}|Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction|
Surder 2010 {published data only}|Cell-based therapy for myocardial repair in patients with acute myocardial infarction: Rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infraction (SWISS-AMI)|/resolve/reference/PMED?id=20598973
Traverse 2009 {published data only}|Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot study trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction|/resolve/reference/PMED?id=19699857
Traverse 2010b {published data only}|LateTIME: a phase-II, randomized, double-blind, placebo-controlled, pilot study evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction|/resolve/reference/PMED?id=20844613
Arnesen 2007|Cell therapy in myocardial infarction|/resolve/reference/PMED?id=17604783
Assmus 2002|Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)|/resolve/reference/PMED?id=12473544
Assmus 2010|Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction|/resolve/reference/PMED?id=19996415
Bartunek 2005|Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction|/resolve/reference/PMED?id=16159812
Bartunek 2006|The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart|/resolve/reference/PMED?id=16543252
Bartunek 2010|Cells as biologics for cardiac repair in ischaemic heart failure|/resolve/reference/PMED?id=20448133
BHF 2010|Coronary heart disease statistics: fact sheet|
Deb 2003|Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients|/resolve/reference/PMED?id=12628942
ESC/ACC 2000|Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition if myocardial infarction|/resolve/reference/PMED?id=10973764
Falk 1995|Coronary plaque disruption|/resolve/reference/PMED?id=7634481
Fernandez-Aviles 2004|Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction|/resolve/reference/PMED?id=15358665
Hartwell 2005|Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation|/resolve/reference/PMED?id=15876363
Herbots 2009|Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study|/resolve/reference/PMED?id=19106196
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Jackson 2001|Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells|/resolve/reference/PMED?id=11390421
Leri 2009|Myocardial regeneration and stem cell repair|
Losordo 2007|Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomised controlled trial|/resolve/reference/PMED?id=17562958
Meluzin 2008|Three-, 6- and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction|/resolve/reference/PMED?id=17764767
Meyer 2006a|Stem cell therapy: a new perspective in the treatment of patients with acute myocardial infarction|/resolve/reference/PMED?id=17107878
Nogueira 2009|Systolic function of patients with myocardial infarction undergoing autologous bone marrow transplantation|/resolve/reference/PMED?id=19936457
Orlic 2001a|Bone marrow cells regenerate infarcted myocardium|/resolve/reference/PMED?id=11287958
Orlic 2001b|Mobilized bone marrow cells repair the infarcted heart, improving function and survival|/resolve/reference/PMED?id=11504914
Quyyumi 2011|CD34+ cell infusion after ST-elevation myocardial infarction is associated with improved perfusion and is dose dependent|/resolve/reference/PMED?id=21167340
Review Manager 2008|Review Manager (RevMan)|
Stamm 2003|Autologous bone-marrow stem-cell transplantation for myocardial regeneration|/resolve/reference/PMED?id=12517467
Strauer 2002|Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans|/resolve/reference/PMED?id=12370212
Tendera 2009|Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration Infarction (REGENT) Trial|/resolve/reference/PMED?id=19208649
Toma 2002|Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart|/resolve/reference/PMED?id=11772882
Tse 2003|Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation|/resolve/reference/PMED?id=12517468
Yao 2009|Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction|
Yoon 2005|Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction|/resolve/reference/PMED?id=15690083
Martin-Rendon 2008a|Stem cell treatment for acute myocardial infarction|
Martin-Rendon 2008b|Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review|/resolve/reference/PMED?id=18523058
Forstpointner 2006 {published and unpublished data}|Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)|/resolve/reference/PMED?id=16946304
Ghielmini 2004 {published and unpublished data}|Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)|/resolve/reference/PMED?id=16030029
Ghielmini 2004 {published and unpublished data}|Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule|/resolve/reference/PMED?id=14976046
Hainsworth 2005 {published and unpublished data}|Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma--a randomized phase II trial of the Minnie Pearl Cancer Research Network|/resolve/reference/PMED?id=15657401
Hochster 2005 {published data only}|Maintenance rituximab after CVP results in superior clinical outcome in advanced follicular lymphoma (FL): Results of the E1496 phase III trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B|
Hochster 2005 {published data only}|Results of E1496: A phase III trial of CVP with or without maintenance rituximab in advanced indolent lymphoma (NHL)|
Hochster 2007 {published data only}|Cyclophosphamide and fludarabine (CF) in advanced indolent lymphoma: Results from the ECOG/CALGB intergroup E1496 trial|
van Oers 2006 {published data only}|Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study|/resolve/reference/PMED?id=12424535
van Oers 2006 {published data only}|Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial|/resolve/reference/PMED?id=16873669
Baltasar 2003 {published data only}|CNOP vs. CNOP-rituximab vs. rituximab alone as first-line therapy for indolent non-Hodgkin lymphoma (INHL): Preliminary results|
Cheung 2007 {published data only}|Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario|/resolve/reference/PMED?id=17240533
Coiffier 2002 {published data only}|Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. Seminars in oncology|/resolve/reference/PMED?id=12040530
Fisher 2005 {published data only}|Overview of Southwest Oncology Group clinical trials in non-Hodgkin lymphoma. S0016. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + iodine131-labeled monoclonal anti-B1 antibody (tositumomab) for treatment of newly diagnosed follicular NHL|/resolve/reference/PMED?id=Can't%20run%20EXECUTE.%20Wrong%20input%20line
Forstpointner 2004 {published data only}|The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group|/resolve/reference/PMED?id=15284112
Ghielmini 2005 {published data only}|Adding rituximab to cyclophosphamide, vincristine and prednisone increases time to treatment failure or progression in people with untreated stage III/IV follicular lymphoma|/resolve/reference/PMED?id=16289339
Ghielmini 2006 {published data only}|Patient benefits of maintenance immunotherapy|
Herold 2003 {published data only}|Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab|/resolve/reference/PMED?id=12601483
Herold 2007 {published data only}|Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group hematology and oncology study|/resolve/reference/PMED?id=17420513
Hiddemann 2003 {published data only}|Rituximab plus chemotherapy in follicular and mantle cell lymphomas|/resolve/reference/PMED?id=12652460
Hiddemann 2006 {published data only}|Rituximab maintenance therapy in follicular lymphoma comes of age|
Kaplan 2005 {published data only}|Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010|/resolve/reference/PMED?id=15914552
Kober 2006 {published data only}|Fourth biannual report of the Cochrane Haematological Malignancies Group|/resolve/reference/PMED?id=16622111
Leppa 2006 {published data only}|Cost-effectiveness of rituximab maintenance treatment versus autologous stem cell transplantation (ASCT) in patients with relapsed follicular lymphoma (FL)|
Marcus 2005 {published data only}|CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma|/resolve/reference/PMED?id=15494430
McLaughlin 2000 {published data only}|Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma|/resolve/reference/PMED?id=11225999
No author 2002 {published data only}|Rituxan delays disease progression in indolent non-Hodgkin's lymphoma|/resolve/reference/PMED?id=12469926
No author 2004 {published data only}|[Milestone in healing fatal indolent lymphoma]|/resolve/reference/PMED?id=15311904
No author 2004b {published data only}|Rituximab maintenance stretches progression-free survival in patients with indolent NHL|/resolve/reference/PMED?id=15526836
Ogura 2006 {published data only}|Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma|
Rubio-Martinez 2006 {published data only}|Maintenance treatment with rituximab in follicular NHL|
Sarris 2002 {published data only}|Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone|/resolve/reference/PMED?id=11842389
Schultz, ongoing {published data only}|A double-blind, randomized, two-dose-arm, parallel group, international, multi-center trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with follicular lymphoma who are refractory to rituximab as monotherapy or in combination with chemotherapy|
Solal-Celigny 2006 {published data only}|Safety of rituximab maintenance therapy in follicular lymphomas|
Tomas 2006 {published data only}|Induction with fludarabine, cyclophosphamide and rituximab followed by maintenance with rituximab: Results of a prospective study in 75 patients (LNHF-03)|
Witzens-Harig 2005 {published data only}|Rituximab maintenenance therapy in CD20+ B-cell non-Hodgkin-lymphoma  First interim results of a prospective randomised phase II study|
Witzens-Harig 2005 {published data only}|Rituximab maintenenance therapy in CD20+ B-cell non-Hodgkin lymphoma - Interim results of a multicenter prospective randomised phase II study|
Witzens-Harig 2005 {published data only}|Rituximab maintenenance therapy in CD20+ B-cell non-Hodgkin-lymphoma - Results of a multicenter prospective randomised phase II study|
Witzens-Harig 2005 {published data only}|Rituximab maintenenance therapy in CD20+ B-Cell Non-Hodgkin-Lymphoma first interim results of a prospective randomised phase II study|
Ardeshna {published and unpublished data}|Rituximab in treating patients with newly diagnosed stage II, stage III, or stage IV follicular non-Hodgkin's lymphoma|
Pettengell {published and unpublished data}|Combination chemotherapy plus peripheral stem cell transplantation with or without rituximab in treating patients with relapsed non-Hodgkin's lymphoma|
Pettengell {published and unpublished data}|Phase III randomized study of rituximab purging and maintenance with peripheral blood stem cell transplantation in patients with relapsed or resistant follicular non-Hodgkin's lymphoma undergoing high-dose chemotherapy|
Salles, PRIMA {published data only}|Primary rituximab and maintenance, Study ID Number: PRIMA|
Williams 2004 {published data only}|Preliminary pharmacokinetic (PK) analysis of Eastern Cooperative Oncology Group Protocol E4402: rituximab extended schedule or re-treatment trial (RESORT)|
Williams 2004 {published data only}|ECOG 4402: randomized phase III-trial comparing two different rituximab dosing regimens for patients with low tumor burden indolent non-Hodgkin's lymphoma|/resolve/reference/PMED?id=15496271
Cheson 2007|Revised response criteria for malignant lymphoma|/resolve/reference/PMED?id=17242396
Cleary 1985|Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18|/resolve/reference/PMED?id=2865728
Corradini 2004|Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes|/resolve/reference/PMED?id=15084619
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Gordan 2005|Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disorders|/resolve/reference/PMED?id=15657402
Hainsworth 2002|Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma|/resolve/reference/PMED?id=12377971
Higgins 2006||
Lopez-Guillermo 2000|Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series|/resolve/reference/PMED?id=10707796
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
Rambaldi 2002|Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma|/resolve/reference/PMED?id=11806987
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Schulz 2005||
Solal-Celigny 2004|Follicular lymphoma international prognostic index|/resolve/reference/PMED?id=15126323
CHAOS 2002 {published data only}|Blinded comparison of folic acid and placebo in patients with ischaemic heart disease: an outcome trial|
FOLARDA 2004 {published data only}|Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial|/resolve/reference/PMED?id=14975544
GOES 2003 {published data only}|Secondary prevention with folic acid: effects on clinical outcomes|/resolve/reference/PMED?id=12821232
GOES 2003 {published data only}|Secondary prevention with folic acid: results of the Goes extension study|/resolve/reference/PMED?id=16103563
HOPE-2 2006 {published data only}|Homocysteine lowering with folic acid and B vitamins in vascular disease|/resolve/reference/PMED?id=16531613
NORVIT 2006 {published data only}|Homocysteine lowering and cardiovascular events after acute myocardial infarction|/resolve/reference/PMED?id=16531614
VISP 2004 {published data only}|Vitamin Intervention For Stroke Prevention trial: an efficacy analysis|/resolve/reference/PMED?id=16239629
VISP 2004 {published data only}|Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial|/resolve/reference/PMED?id=14762035
WAFACS 2008 {published data only}|Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial|/resolve/reference/PMED?id=18460663
WAFACS 2008 {published data only}|A randomized trial of folic acid and B-vitamins in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)|
WENBIT 2008 {published data only}|Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial|/resolve/reference/PMED?id=18714059
Bazzano 2006 {published data only}|Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=17164458
FINEST 2006 {published data only (unpublished sought but not used)}|Folate Intervention in Non-ST elevation myocardial infarction and unstable angina: a randomised placebo-controlled trial|
Lange 2004 {published data only}|Folate therapy and in-stent restenosis after coronary stenting|/resolve/reference/PMED?id=15215483
Lonn 2007 {published data only}|Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?|/resolve/reference/PMED?id=17934354
PACIFIC 2002 {published data only}|Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease|/resolve/reference/PMED?id=12395803
Swiss 2002 {published data only}|Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial|/resolve/reference/PMED?id=12190367
Vesin 2007 {published data only}|Efficacy of folic acid in prevention of cerebrovascular disease|
Wang 2007 {published data only}|Efficacy of folic acid supplementation in stroke prevention: a meta-analysis|
Wierzbicki 2007 {published data only}|Homocysteine and cardiovascular disease: a review of the evidence|/resolve/reference/PMED?id=17654449
SEARCH 2000 {published data only}|A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)|/resolve/reference/PMED?id=11079257
SU.FOL.OM3 2003 {published data only}|Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries|/resolve/reference/PMED?id=14625623
VITATOPS 2002 {unpublished data only}|The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke|/resolve/reference/PMED?id=11867886
Abahji 2007|Acute hyperhomocysteinemia induces microvascular and macrovascular endothelial dysfunction|/resolve/reference/PMED?id=17416288
Anderson 2004|Effect of folic acid fortification of food on homocysteine-related mortality|/resolve/reference/PMED?id=14749159
Andrs 2004|Vitamin B12 (cobalamin) deficiency in elderly patients|/resolve/reference/PMED?id=15289425
B-VTTC 2006|Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials|/resolve/reference/PMED?id=16442889
Betowski 2005|Protein homocysteinylation: a new mechanism of atherogenesis?|/resolve/reference/PMED?id=16106241
Bleie 2007|Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease|
Boushey 1995|A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes|/resolve/reference/PMED?id=7563456
Casas 2005|Homocysteine and stroke: evidence on a causal link from mendelian randomisation|/resolve/reference/PMED?id=15652605
Castro 2006|Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview|/resolve/reference/PMED?id=16601863
Clarke 2007|Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia|/resolve/reference/PMED?id=17143052
Cole 2007|Folic acid for the prevention of colorectal adenomas: a randomized clinical trial|/resolve/reference/PMED?id=17551129
Danesh 1998|Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies|/resolve/reference/PMED?id=9919470
Davey Smith 2003|'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?|/resolve/reference/PMED?id=12689998
Durga 2005|Let them eat cake|
Dusitanond 2005|Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial|/resolve/reference/PMED?id=15569860
Eikelboom 1999|Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence|/resolve/reference/PMED?id=10475890
Epstein 1996|Cardiovascular disease epidemiology : a journey from the past into the future|/resolve/reference/PMED?id=8653883
Ferretti 2006|Structural modifications of HDL and functional consequences|/resolve/reference/PMED?id=16157342
Folsom 1998|Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study|/resolve/reference/PMED?id=9697819
Ford 2002|Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies|/resolve/reference/PMED?id=11914295
Fowler 2005|Homocysteine: overview of biochemistry, molecular biology, and role in disease processes|/resolve/reference/PMED?id=16047261
Gaziano 2006|Cardiovascular Disease|
Gori 2007|Association between homocysteine, vitamin B(6) concentrations and inflammation|/resolve/reference/PMED?id=17990948
Guilland 2003|Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data|/resolve/reference/PMED?id=12801809
Guthikonda 2006|Homocysteine: role and implications in atherosclerosis|/resolve/reference/PMED?id=16510043
Hackam 2003|Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence|/resolve/reference/PMED?id=12928471
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Higgins 2008||
HLTC 2005|Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials|/resolve/reference/PMED?id=16210710
Hoey 2007|Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults|/resolve/reference/PMED?id=17991653
HSC 2002|Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis|/resolve/reference/PMED?id=12387654
Hulley 1998|Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group|/resolve/reference/PMED?id=9718051
Humphrey 2008|Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis|/resolve/reference/PMED?id=18990318
ICH-GCP 1997||
Jacobsen 2005|Molecular targeting by homocysteine: a mechanism for vascular pathogenesis|/resolve/reference/PMED?id=16197301
Jacobsen 2006|Homocysteine targeting of plasma proteins in hemodialysis patients|/resolve/reference/PMED?id=16518339
Jacques 1999|The effect of folic acid fortification on plasma folate and total homocysteine concentrations|/resolve/reference/PMED?id=10320382
Jakubowski 2000|Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans|/resolve/reference/PMED?id=10721911
Jakubowski 2004|Molecular basis of homocysteine toxicity in humans|/resolve/reference/PMED?id=14999406
Jakubowski 2005|Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease|/resolve/reference/PMED?id=16197290
Jakubowski 2008|The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease|/resolve/reference/PMED?id=19261978
Jakubowski 2009|Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice|/resolve/reference/PMED?id=19204075
Jamison 2006||
Jamison 2007|Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial|/resolve/reference/PMED?id=17848650
Kahn 2008|The impact of prevention on reducing the burden of cardiovascular disease|/resolve/reference/PMED?id=18606915
Kaul 2006|Homocysteine hypothesis for atherothrombotic cardiovascular disease: Not validated|/resolve/reference/PMED?id=16949480
Koehler 1997|Folate nutrition and older adults: challenges and opportunities|/resolve/reference/PMED?id=9020245
Libby 1995|Cytokines regulate vascular functions related to stability of the atherosclerotic plaque|
Loscalzo 2006|Homocysteine Trials  Clear Outcomes for Complex Reasons|/resolve/reference/PMED?id=16531615
Marcus 2007|Homocysteine lowering and cardiovascular disease risk: lost in translation|/resolve/reference/PMED?id=17622392
Mark 1996|Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial|/resolve/reference/PMED?id=8651227
Maron 2006|Homocysteine|/resolve/reference/PMED?id=16938586
Math 2007|Steps to control the burden of cardiovascular disease in the Indian Subcontinent|/resolve/reference/PMED?id=17598948
McCully 2005|Hyperhomocysteinemia and arteriosclerosis: historical perspectives|/resolve/reference/PMED?id=16197285
McNulty 2008|Homocysteine, B-vitamins and CVD|/resolve/reference/PMED?id=18412997
Mirarefin 2007|The effect of folate fortified bread on homocysteine, folate and vitamin B12 status among hyperhomocysteinemic subjects: Tehran homocysteine study|
Moat 2008|Plasma total homocysteine: instigator or indicator of cardiovascular disease?|
Moens 2007|Effect of folic acid on endothelial function following acute myocardial infarction|/resolve/reference/PMED?id=17293188
Mudd 2000|Homocysteine and its disulfide derivatives: a suggested consensus terminology|
NACB 2009|National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease|/resolve/reference/PMED?id=19106185
Narayan 2006|Diabetes: the pandemic and potential solutions|
Nigwekar 2009|Interventions for lowering plasma homocysteine levels in dialysis patients|
NIH 2006|NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention|/resolve/reference/PMED?id=16880454
Nygrd 1997|Plasma homocysteine levels and mortality in patients with coronary artery disease|/resolve/reference/PMED?id=9227928
Obeid 2009|Homocysteine and lipids: S-adenosyl methionine as a key intermediate|/resolve/reference/PMED?id=19324042
Peeters 2007|The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers|/resolve/reference/PMED?id=17243915
Pera-Kajn 2007|Mechanisms of homocysteine toxicity in humans|/resolve/reference/PMED?id=17285228
Poddar 2001|Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease|/resolve/reference/PMED?id=11390343
Potter 2008a|The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis|/resolve/reference/PMED?id=18803866
Potter 2008b|Homocysteine and cardiovascular disease: should we treat?|/resolve/reference/PMED?id=18566666
Prasad 1999|Homocysteine, a risk factor for cardiovascular disease|/resolve/reference/PMED?id=9826415
Ramakrishnan 2006|Biochemistry of homocysteine in health and diseases|/resolve/reference/PMED?id=17133733
Rampersaud 2003|Folate: a key to optimizing health and reducing disease risk in the elderly|/resolve/reference/PMED?id=12569109
Refsum 1998|Homocysteine and cardiovascular disease|/resolve/reference/PMED?id=9509248
Refsum 2006|The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease|/resolve/reference/PMED?id=16702348
Riksen 2005|Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia|/resolve/reference/PMED?id=15539618
Robertson 2005|Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain product products|/resolve/reference/PMED?id=15939916
Robinson 1998|Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group|/resolve/reference/PMED?id=9490237
Rodgers 2006|The growing burden of risk from high blood pressure, cholesterol, and bodyweight|
Sato 2002|Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke : effect of combined therapy with folic acid and mecobalamine|/resolve/reference/PMED?id=12220694
Selhub 1993|Vitamin status and intake as primary determinants of homocysteinemia in an elderly population|/resolve/reference/PMED?id=8133587
Selhub 2006|The many facets of hyperhomocysteinemia: studies from the Framingham cohorts|/resolve/reference/PMED?id=16702347
Shelhub 2008|Public health significance of elevated homocysteine|
Sofi 2008|Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels|/resolve/reference/PMED?id=17945240
Spence 2005|Vitamin Intervention For Stroke Prevention trial: an efficacy analysis|/resolve/reference/PMED?id=16239629
Spence 2007|Homocysteine-lowering therapy: a role in stroke prevention?|/resolve/reference/PMED?id=17706567
Splaver 2004|Homocysteine and cardiovascular disease: biological mechanism, observational epidemiology, and the need for randomised trials|/resolve/reference/PMED?id=15215789
Stampfer 1992|prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians|/resolve/reference/PMED?id=1640615
Su 2005|Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression|/resolve/reference/PMED?id=16157236
Tanriverdi 2007|Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow|/resolve/reference/PMED?id=17264512
Ueland 1992|Plasma homocysteine and cardiovascular disease|
Ueland 2000|The controversy over homocysteine and cardiovascular risk|/resolve/reference/PMED?id=10919921
Ueland 2007|Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power|/resolve/reference/PMED?id=17468406
Ulrich 2006|Folate supplementation: too much of a good thing?|/resolve/reference/PMED?id=16492904
Undas 2006|Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia|/resolve/reference/PMED?id=16953277
Urquhart 2007|Mesna as a nonvitamin intervention to lower plasma total homocysteine concentration: implications for assessment of the homocysteine theory of atherosclerosis|
Verhaar 2002|Folates and cardiovascular disease|/resolve/reference/PMED?id=11788454
Vianna 2007|Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events|
Vivekananthan 2003|Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials|/resolve/reference/PMED?id=12814711
Wald 2002|Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis|/resolve/reference/PMED?id=12446535
Wang 2005|Mechanisms in homocysteine-induced vascular disease|
Wang 2007|Efficacy of folic acid supplementation in stroke prevention: a meta-analysis|/resolve/reference/PMED?id=17544768
WHO 2002||
Willet 2006|Prevention of chronic disease by means of diet and lifestyle changes|
Winkels 2008|Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial|/resolve/reference/PMED?id=18689370
Wirakartakusumah 1998|Technical aspects of food fortification|
Wood 2008|Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study|/resolve/reference/PMED?id=18316340
Yusuf 1985|Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials|/resolve/reference/PMED?id=3899654
Zhou 2009|Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms|
BVAIT 2009 {published data only}|High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial|/resolve/reference/PMED?id=19118243
CHAOS 2002 {published data only}|Blinded comparison of folic acid and placebo in patients with ischaemic heart disease: an outcome trial|
FOLARDA 2004 {published data only}|Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial|/resolve/reference/PMED?id=14975544
GOES 2003 {published data only}|Secondary prevention with folic acid: effects on clinical outcomes|/resolve/reference/PMED?id=12821232
GOES 2003 {published data only}|Secondary prevention with folic acid: results of the Goes extension study|/resolve/reference/PMED?id=16103563
HOPE-2 2006 {published data only}|Homocysteine lowering with folic acid and B vitamins in vascular disease|/resolve/reference/PMED?id=16531613
HOPE-2 2006 {published data only}|Homocysteine lowering therapy and stroke risk, severity and disability: Results from the HOPE-2 trial|
HOPE-2 2006 {published data only}|Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial|
NORVIT 2006 {published data only}|Homocysteine lowering and cardiovascular events after acute myocardial infarction|/resolve/reference/PMED?id=16531614
SEARCH 2010 {published data only}|Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial|/resolve/reference/PMED?id=20571015
SEARCH 2010 {published data only}|SEARCH Study Protocol|
SEARCH 2010 {published data only}|Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised|
SU.FOL.OM3 2010 {published data only}|B vitamin and/or -3 fatty acid supplementation and cancer: Ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial|/resolve/reference/PMED?id=22331983
SU.FOL.OM3 2010 {published data only}|Cardiovascular effects of B-vitamins and/or N-3 fatty acids: The Su.Fol.Om3 trial|
SU.FOL.OM3 2010 {published data only}|The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and/or omega 3 fatty acid supplements in the prevention of recurrent ischemic events|
SU.FOL.OM3 2010 {published data only}|The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics|/resolve/reference/PMED?id=18544171
SU.FOL.OM3 2010 {published data only}|Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries|/resolve/reference/PMED?id=14625623
SU.FOL.OM3 2010 {published data only}|Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: A randomised placebo controlled trial|
SU.FOL.OM3 2010 {published data only}|Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial|
SU.FOL.OM3 2010 {published data only}|Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?|
VISP 2004 {published data only}|Association of a transcobalamin 2 (TCN2) variant located in the 3UTR with post-stroke homocysteine level in subjects from the vitamin intervention for stroke prevention trial|
VISP 2004 {published data only}|Sex differences in genetic associations with homocysteine in the vitamin intervention for stroke prevention (VISP) trial|
VISP 2004 {published data only}|A variant in the adenosine 2B receptor gene is associated with homocysteine levels and stroke severity in african american subjects from the vitamin intervention for stroke prevention (VISP) trial|
VISP 2004 {published data only}|Vitamin Intervention For Stroke Prevention trial: an efficacy analysis|/resolve/reference/PMED?id=16239629
VISP 2004 {published data only}|Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial|/resolve/reference/PMED?id=14762035
VITATOPS 2010 {published data only}|Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial|/resolve/reference/PMED?id=15569860
VITATOPS 2010 {published data only}|Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial|/resolve/reference/PMED?id=15569860
VITATOPS 2010 {published data only}|The VITATOPS (VITAmins TO Prevent Stroke) trial: rationale, design and progress of an international, large simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient attack or stroke [Abstract]|
VITATOPS 2010 {published data only}|The vitamins to prevent stroke (VITATOPS) trial: results of a double-blind, placebo-controlled, randomised trial of B-vitamin therapy in 8,164 patients with recent transient ischaemic attack or stroke|
VITATOPS 2010 {published data only}|The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis|/resolve/reference/PMED?id=18803866
VITATOPS 2010 {published data only}|Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial|/resolve/reference/PMED?id=19202330
VITATOPS 2010 {published data only}|The role of vitamin B in stroke prevention: a journey from observational studies to clinical trials and critique of the VITAmins TO Prevent Stroke (VITATOPS)|/resolve/reference/PMED?id=21273566
VITATOPS 2010 {published data only}|B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial:a randomised, double-blind, parallel, placebo-controlled trial|
VITATOPS 2010 {published data only}|VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)|
WAFACS 2008 {published data only}|Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial|/resolve/reference/PMED?id=18460663
WAFACS 2008 {published data only}|Effect of folic acid and B vitamins on the occurrence of venous thromboembolism: a randomized trial in women at high cardiovascular risk|
WAFACS 2008 {published data only}|A randomized trial of folic acid and B-vitamins in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)|
WAFACS 2008 {published data only}|Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial|
WAFACS 2008 {published data only}|Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 Diabetes Mellitus in women: a randomized controlled trial|
WAFACS 2008 {published data only}|Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial|
WENBIT 2008 {published data only}|Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12|
WENBIT 2008 {published data only}|Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial|/resolve/reference/PMED?id=18714059
WENBIT 2008 {published data only}|Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy|/resolve/reference/PMED?id=20494665
Bazzano 2006 {published data only}|Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=17164458
Clarke 2010 {published data only}|Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials Involving 37 485 individuals|/resolve/reference/PMED?id=20937919
Cui 2010 {published data only}|Dietary folate and vitamin b6 and B12 intake in relation to mortality from cardiovascular diseases: Japan collaborative cohort study|/resolve/reference/PMED?id=20395608
Deshmukh 2010 {published data only}|Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India|/resolve/reference/PMED?id=20216560
Durga 2011 {published data only}|Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults|/resolve/reference/PMED?id=21430116
Ebbing 2009 {published data only}|Combined results and long-term follow-up in NORVIT and WENBIT with 6837 coronary artery disease patients: Homocysteine-lowering B-vitamin treatment does not prevent major cardiovascular events|
Ebbing 2009a {published data only}|Cancer incidence and mortality after treatment with folic acid and vitamin B12|/resolve/reference/PMED?id=19920236
FINEST 2006 {published data only (unpublished sought but not used)}|Folate Intervention in Non-ST elevation myocardial infarction and unstable angina: a randomised placebo-controlled trial|
Green 2010 {published data only}|Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations|
Holmes 2011 {published data only}|Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials|/resolve/reference/PMED?id=21803414
Imasa 2009 {published data only}|Folic acid-based intervention in non-ST elevation acute coronary syndromes|
Jardine 2012 {published data only}|The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis|/resolve/reference/PMED?id=22695899
Lange 2004 {published data only}|Folate therapy and in-stent restenosis after coronary stenting|/resolve/reference/PMED?id=15215483
Lee 2010 {published data only}|Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis|/resolve/reference/PMED?id=20413740
Lee 2010 {published data only}|Efficacy of homocysteine lowering therapy with folic acid in stroke prevention: A meta-analysis of randomized controlled trials|
Lonn 2007 {published data only}|Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?|/resolve/reference/PMED?id=17934354
Mager 2009 {published data only}|Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease|/resolve/reference/PMED?id=19733705
Manolescu 2010 {published data only}|Homocysteine and vitamin therapy in stroke prevention and treatment: a review|/resolve/reference/PMED?id=21140003
Mei 2010 {published data only}|Effect of homocysteine interventions on risk of cardiocerebrovascular events: A meta-analysis of randomized controlled trials|
Mei 2010 {published data only}|Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials|
Mendez-Gonzalez 2010 {published data only}|[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?]|/resolve/reference/PMED?id=20198596
Miller 2010 {published data only}|Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels|/resolve/reference/PMED?id=20691310
Moghaddasi 2010 {published data only}|Homocysteine, vitamin B12 and folate levels in Iranian patients with ischemic stroke|/resolve/reference/PMED?id=20433777
Moghaddasi 2010 {published data only}|Homocysteine, vitamin B12 and folic acid levels in cerebrovascular accident: a case-control study|
Ntaios 2009 {published data only}|The controversial role of B-vitamins in cardiovascular risk: An update|/resolve/reference/PMED?id=19963194
Ntaios 2010a {published data only}|The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial|/resolve/reference/PMED?id=19201496
PACIFIC 2002 {published data only}|Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease|/resolve/reference/PMED?id=12395803
Rautiainen 2010 {published data only}|Multivitamin use and the risk of myocardial infarction: a population-based cohort of Swedish women|
Sharifi 2010 {published data only}|The effects of high-dose folic acid on blood pressure of hypertensive adults with hyperhomocysteinemia: A randomized double- blind placebo controlled clinical trial (Tehran homocysteine survey)|
Shidfar 2009 {published data only}|Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial|
Swiss 2002 {published data only}|Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial|/resolve/reference/PMED?id=12190367
Tighe 2011 {published data only}|A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy|
Vesin 2007 {published data only}|Efficacy of folic acid in prevention of cerebrovascular disease|
Wang 2007 {published data only}|Efficacy of folic acid supplementation in stroke prevention: a meta-analysis|
Wierzbicki 2007 {published data only}|Homocysteine and cardiovascular disease: a review of the evidence|/resolve/reference/PMED?id=17654449
Zhang 2009 {published data only}|Effect of B vitamins supplementation on cardiovascular and cerebrovascular disease by lowering plasma homocysteine concentration: A meta-analysis. [Chinese]|
Zhou 2011 {published data only}|Effect of folic acid supplementation on cardiovascular outcomes: A systematic review and meta-analysis|/resolve/reference/PMED?id=21980387
Balshem 2011|GRADE guidelines: 3. Rating the quality of evidence|/resolve/reference/PMED?id=21208779
Blom 2011|Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects|/resolve/reference/PMED?id=20814827
Boushey 1995|A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes|/resolve/reference/PMED?id=7563456
Bowman 2007|Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors|
Brok 2008|Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses|/resolve/reference/PMED?id=18411040
Brok 2009|Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses|/resolve/reference/PMED?id=18824466
Brozek 2011|Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations|
Brustolin 2010|Genetics of homocysteine metabolism and associated disorders|
CAPRIE 1996|A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee|/resolve/reference/PMED?id=8918275
Casas 2005|Homocysteine and stroke: evidence on a causal link from mendelian randomisation|/resolve/reference/PMED?id=15652605
Castro 2006|Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview|/resolve/reference/PMED?id=16601863
Clarke 2007|Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia|/resolve/reference/PMED?id=17143052
CMA 2005|Comprehensive Meta-analysis|
Crider 2011|Folic acid food fortification-its history, effect, concerns, and future directions|/resolve/reference/PMED?id=22254102
CTU 2011|TSA - Trial Sequential Analysis|
Danesh 1998|Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies|/resolve/reference/PMED?id=9919470
di Salvo 2011|Vitamin B(6) salvage enzymes: mechanism, structure and regulation|/resolve/reference/PMED?id=21182989
di Salvo 2012|Biomedical aspects of pyridoxal 5'-phosphate availability|
Eikelboom 1999|Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence|/resolve/reference/PMED?id=10475890
Epstein 1996|Cardiovascular disease epidemiology: a journey from the past into the future|/resolve/reference/PMED?id=8653883
Fedosov 2012|Physiological and molecular aspects of cobalamin transport|/resolve/reference/PMED?id=22116708
Ferretti 2006|Structural modifications of HDL and functional consequences|/resolve/reference/PMED?id=16157342
Ford 2002|Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies|/resolve/reference/PMED?id=11914295
Fowler 2005|Homocysteine: overview of biochemistry, molecular biology, and role in disease processes|/resolve/reference/PMED?id=16047261
Friso 2012|Vitamin B6 and cardiovascular disease|/resolve/reference/PMED?id=22116704
Gaziano 2006|Cardiovascular Disease|
Gori 2007|Association between homocysteine, vitamin B(6) concentrations and inflammation|/resolve/reference/PMED?id=17990948
GRADEPro 2008|GRADEpro [Computer program]|
Guthikonda 2006|Homocysteine: role and implications in atherosclerosis|/resolve/reference/PMED?id=16510043
Guyatt 2011|GRADE guidelines: 2. Framing the question and deciding on important outcomes|/resolve/reference/PMED?id=21194891
Guyatt 2011a|GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables|/resolve/reference/PMED?id=21195583
Guyatt 2011b|GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)|/resolve/reference/PMED?id=21247734
Guyatt 2011c|GRADE guidelines: 9. Rating up the quality of evidence|/resolve/reference/PMED?id=21802902
Guyatt 2011d|GRADE guidelines: 8. Rating the quality of evidence--indirectness|/resolve/reference/PMED?id=21802903
Guyatt 2011e|GRADE guidelines: 7. Rating the quality of evidence--inconsistency|/resolve/reference/PMED?id=21803546
Guyatt 2011f|GRADE guidelines 6. Rating the quality of evidence--imprecision|/resolve/reference/PMED?id=21839614
Guyatt 2011g|GRADE guidelines: 5. Rating the quality of evidence--publication bias|/resolve/reference/PMED?id=21802904
Guyatt 2012|GRADE guidelines 11-making an overall rating of confidence in effect estimates for a single outcome and for all outcomes|
Guyatt 2012a|GRADE guidelines 12. Preparing Summary of Findings tables-binary outcomes|
Hackam 2003|Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence|/resolve/reference/PMED?id=12928471
Herrmann 2012|Cobalamin deficiency|/resolve/reference/PMED?id=22116706
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Higgins 2011||
HLTC 2005|Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials|/resolve/reference/PMED?id=16210710
HSC 2002|Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis|/resolve/reference/PMED?id=12387654
Humphrey 2008|Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis|/resolve/reference/PMED?id=18990318
ICH-GCP 1997||
Ioannidis 2010|Meta-research: The art of getting it wrong|
Jacobsen 2005|Molecular targeting by homocysteine: a mechanism for vascular pathogenesis|/resolve/reference/PMED?id=16197301
Jacobsen 2006|Homocysteine targeting of plasma proteins in hemodialysis patients|/resolve/reference/PMED?id=16518339
Jakubowski 2000|Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans|/resolve/reference/PMED?id=10721911
Jakubowski 2004|Molecular basis of homocysteine toxicity in humans|/resolve/reference/PMED?id=14999406
Jakubowski 2008|The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease|/resolve/reference/PMED?id=19261978
Jamison 2006||
Jamison 2007|Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial|/resolve/reference/PMED?id=17848650
Kahn 2008|The impact of prevention on reducing the burden of cardiovascular disease|/resolve/reference/PMED?id=18606915
Kardesoglu 2011|Homocysteine as a new risk factor for cardiovascular events in heart failure|/resolve/reference/PMED?id=21074871
Krutler 2012|Biochemistry of B12-cofactors in human metabolism|/resolve/reference/PMED?id=22116707
Lefebvre 2011|Chapter 6: Searching for Studies|
Maron 2006|Homocysteine|/resolve/reference/PMED?id=16938586
Maron 2009|The treatment of hyperhomocysteinemia|/resolve/reference/PMED?id=18729731
Math 2007|Steps to control the burden of cardiovascular disease in the Indian Subcontinent|/resolve/reference/PMED?id=17598948
McCully 2005|Hyperhomocysteinemia and arteriosclerosis: historical perspectives|/resolve/reference/PMED?id=16197285
Molloy 2012|Genetic aspects of folate metabolism|/resolve/reference/PMED?id=22116697
Mudd 2000|Homocysteine and its disulfide derivatives: a suggested consensus terminology|
Mukherjee 2011|Pyridoxal phosphate: biosynthesis and catabolism|/resolve/reference/PMED?id=21767669
NACB 2009|National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease|/resolve/reference/PMED?id=19106185
Narayan 2006|Diabetes: the pandemic and potential solutions|
Obeid 2009|Homocysteine and lipids: S-adenosyl methionine as a key intermediate|/resolve/reference/PMED?id=19324042
Ohrvik 2011|Human folate bioavailability|/resolve/reference/PMED?id=22254106
Pera-Kajn 2007|Mechanisms of homocysteine toxicity in humans|/resolve/reference/PMED?id=17285228
Ramakrishnan 2006|Biochemistry of homocysteine in health and diseases|/resolve/reference/PMED?id=17133733
Refsum 1998|Homocysteine and cardiovascular disease|/resolve/reference/PMED?id=9509248
RevMan 2011|Review Manager (RevMan)|
Riksen 2005|Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia|/resolve/reference/PMED?id=15539618
Rodgers 2006|The growing burden of risk from high blood pressure, cholesterol, and bodyweight|
Selhub 1993|Vitamin status and intake as primary determinants of homocysteinemia in an elderly population|/resolve/reference/PMED?id=8133587
Selhub 2006|The many facets of hyperhomocysteinemia: studies from the Framingham cohorts|/resolve/reference/PMED?id=16702347
Shelhub 2008|Public health significance of elevated homocysteine|
Sofi 2008|Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels|/resolve/reference/PMED?id=17945240
Splaver 2004|Homocysteine and cardiovascular disease: biological mechanism, observational epidemiology, and the need for randomised trials|/resolve/reference/PMED?id=15215789
SSSS 1994|Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)|/resolve/reference/PMED?id=7968073
Stampfer 1992|prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians|/resolve/reference/PMED?id=1640615
Thorlund 2009|Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?|/resolve/reference/PMED?id=18824467
Thorlund 2010|Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals|/resolve/reference/PMED?id=20865104
Thorlund 2011|User manual for Trial Sequential Analysis (TSA)|
Vianna 2007|Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events|
Wald 2002|Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis|/resolve/reference/PMED?id=12446535
Wang 2005|Mechanisms in homocysteine-induced vascular disease|
Wetterslev 2008|Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis|/resolve/reference/PMED?id=18083463
Wetterslev 2009|Estimating required information size by quantifying diversity in random-effects model meta-analyses|/resolve/reference/PMED?id=20042080
WHO 2002||
Willet 2006|Prevention of chronic disease by means of diet and lifestyle changes|
Williams 2010|Homocysteine metabolism and its relation to health and disease|
Wirakartakusumah 1998|Technical aspects of food fortification|
Yetley 2011|Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use|/resolve/reference/PMED?id=21593508
Yusuf 2000|Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators|/resolve/reference/PMED?id=10639539
Zhou 2009|Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms|
Marti-Carvajal 2009|Homocysteine lowering interventions for preventing cardiovascular events|
BVAIT 2009 {published data only}|High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial|/resolve/reference/PMED?id=19118243
CHAOS 2002 {published data only}|Blinded comparison of folic acid and placebo in patients with ischaemic heart disease: an outcome trial|
FOLARDA 2004 {published data only}|Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial|/resolve/reference/PMED?id=14975544
GOES 2003 {published data only}|Secondary prevention with folic acid: effects on clinical outcomes|/resolve/reference/PMED?id=12821232
GOES 2003 {published data only}|Secondary prevention with folic acid: results of the Goes extension study|/resolve/reference/PMED?id=16103563
HOPE-2 2006 {published data only}|Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial|/resolve/reference/PMED?id=16450017
HOPE-2 2006 {published data only}|Homocysteine lowering with folic acid and B vitamins in vascular disease|/resolve/reference/PMED?id=16531613
HOPE-2 2006 {published data only}|Homocysteine lowering therapy and stroke risk, severity and disability: results from the HOPE-2 trial|
HOPE-2 2006 {published data only}|Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial|
NORVIT 2006 {published data only}|Homocysteine lowering and cardiovascular events after acute myocardial infarction|/resolve/reference/PMED?id=16531614
SEARCH 2010 {published data only}|Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial|/resolve/reference/PMED?id=20571015
SEARCH 2010 {published data only}|SEARCH Study Protocol|
SEARCH 2010 {published data only}|Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised|
SU.FOL.OM3 2010 {published data only}|B vitamin and/or -3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial|/resolve/reference/PMED?id=22331983
SU.FOL.OM3 2010 {published data only}|Cardiovascular effects of B-vitamins and/or N-3 fatty acids: the Su.Fol.OM3 trial|/resolve/reference/PMED?id=22365647
SU.FOL.OM3 2010 {published data only}|The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics|/resolve/reference/PMED?id=18544171
SU.FOL.OM3 2010 {published data only}|The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and/or omega 3 fatty acid supplements in the prevention of recurrent ischemic events|
SU.FOL.OM3 2010 {published data only}|Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial|
SU.FOL.OM3 2010 {published data only}|Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial|
SU.FOL.OM3 2010 {published data only}|Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries|/resolve/reference/PMED?id=14625623
SU.FOL.OM3 2010 {published data only}|Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD|/resolve/reference/PMED?id=21801476
SU.FOL.OM3 2010 {published data only}|Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?|/resolve/reference/PMED?id=20216318
VISP 2004 {published data only}|Association of a transcobalamin 2 (TCN2) variant located in the 3UTR with post-stroke homocysteine level in subjects from the vitamin intervention for stroke prevention trial|
VISP 2004 {published data only}|Sex differences in genetic associations with homocysteine in the vitamin intervention for stroke prevention (VISP) trial|
VISP 2004 {published data only}|A variant in the adenosine 2B receptor gene is associated with homocysteine levels and stroke severity in African American subjects from the vitamin intervention for stroke prevention (VISP) trial|
VISP 2004 {published data only}|Vitamin intervention for stroke prevention trial: an efficacy analysis|/resolve/reference/PMED?id=16239629
VISP 2004 {published data only}|Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial|/resolve/reference/PMED?id=14762035
VITATOPS 2010 {published data only}|B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke: the VITAmins TO Prevent Stroke (VITATOPS) MRI-substudy|/resolve/reference/PMED?id=23093615
VITATOPS 2010 {published data only}|Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial|/resolve/reference/PMED?id=15569860
VITATOPS 2010 {published data only}|The VITATOPS (VITAmins TO Prevent Stroke) trial: rationale, design and progress of an international, large simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient attack or stroke [Abstract]|
VITATOPS 2010 {published data only}|The vitamins to prevent stroke (VITATOPS) trial: results of a double-blind, placebo-controlled, randomised trial of B-vitamin therapy in 8,164 patients with recent transient ischaemic attack or stroke|
VITATOPS 2010 {published data only}|Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial|/resolve/reference/PMED?id=22474057
VITATOPS 2010 {published data only}|The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis|/resolve/reference/PMED?id=18803866
VITATOPS 2010 {published data only}|Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial|/resolve/reference/PMED?id=19202330
VITATOPS 2010 {published data only}|The role of vitamin B in stroke prevention: a journey from observational studies to clinical trials and critique of the VITAmins TO Prevent Stroke (VITATOPS)|/resolve/reference/PMED?id=21273566
VITATOPS 2010 {published data only}|B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial:a randomised, double-blind, parallel, placebo-controlled trial|
VITATOPS 2010 {published data only}|VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)|
WAFACS 2008 {published data only}|Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial|/resolve/reference/PMED?id=18460663
WAFACS 2008 {published data only}|Effect of folic acid and B vitamins on the occurrence of venous thromboembolism: a randomized trial in women at high cardiovascular risk|
WAFACS 2008 {published data only}|A randomized trial of folic acid and B-vitamins in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)|
WAFACS 2008 {published data only}|Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial|/resolve/reference/PMED?id=19491213
WAFACS 2008 {published data only}|Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes mellitus in women: a randomized controlled trial|
WAFACS 2008 {published data only}|Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial|/resolve/reference/PMED?id=18984888
WENBIT 2008 {published data only}|Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12|/resolve/reference/PMED?id=21389855
WENBIT 2008 {published data only}|Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial|/resolve/reference/PMED?id=18714059
WENBIT 2008 {published data only}|Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials|
WENBIT 2008 {published data only}|Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy|/resolve/reference/PMED?id=20494665
Bazzano 2006 {published data only}|Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=17164458
Clarke 2010 {published data only}|Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals|/resolve/reference/PMED?id=20937919
Cui 2010 {published data only}|Dietary folate and vitamin b6 and B12 intake in relation to mortality from cardiovascular diseases: Japan Collaborative Cohort Study|/resolve/reference/PMED?id=20395608
Deshmukh 2010 {published data only}|Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India|/resolve/reference/PMED?id=20216560
Durga 2011 {published data only}|Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults|/resolve/reference/PMED?id=21430116
Earnest 2012 {published data only}|Complementary effects of multivitamin and omega-3 fatty acid supplementation on indices of cardiovascular health in individuals with elevated homocysteine|/resolve/reference/PMED?id=22811376
Ebbing 2009 {published data only}|Combined results and long-term follow-up in NORVIT and WENBIT with 6837 coronary artery disease patients: homocysteine-lowering B-vitamin treatment does not prevent major cardiovascular events|
Ebbing 2009a {published data only}|Cancer incidence and mortality after treatment with folic acid and vitamin B12|/resolve/reference/PMED?id=19920236
FINEST 2006 {published data only (unpublished sought but not used)}|Folate intervention in non-ST elevation myocardial infarction and unstable angina: a randomised placebo-controlled trial|
Green 2010 {published data only}|Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations|/resolve/reference/PMED?id=20089204
Holmes 2011 {published data only}|Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials|/resolve/reference/PMED?id=21803414
Huang 2012 {published data only}|Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality|/resolve/reference/PMED?id=22652362
Huang 2012 {published data only}|Reply to Fang SK--Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality|/resolve/reference/PMED?id=23391457
Huang 2012 {published data only}|Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality|/resolve/reference/PMED?id=23433911
Huo 2012 {published data only}|Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis|
Imasa 2009 {published data only}|Folic acid-based intervention in non-ST elevation acute coronary syndromes|/resolve/reference/PMED?id=19515873
Jardine 2012 {published data only}|The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis|/resolve/reference/PMED?id=22695899
Ji 2013 {published data only}|Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis|/resolve/reference/PMED?id=24049135
Lange 2004 {published data only}|Folate therapy and in-stent restenosis after coronary stenting|/resolve/reference/PMED?id=15215483
Lee 2010 {published data only}|Efficacy of homocysteine lowering therapy with folic acid in stroke prevention: a meta-analysis of randomized controlled trials|
Lee 2010 {published data only}|Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis|/resolve/reference/PMED?id=20413740
Lonn 2007 {published data only}|Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?|/resolve/reference/PMED?id=17934354
Mager 2009 {published data only}|Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease|/resolve/reference/PMED?id=19733705
Manolescu 2010 {published data only}|Homocysteine and vitamin therapy in stroke prevention and treatment: a review|/resolve/reference/PMED?id=21140003
Mei 2010 {published data only}|Effect of homocysteine interventions on risk of cardiocerebrovascular events: a meta-analysis of randomized controlled trials|
Mei 2010 {published data only}|Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials|
Mndez-Gonzlez 2010 {published data only}|Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?|/resolve/reference/PMED?id=20198596
Miller 2010 {published data only}|Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels|/resolve/reference/PMED?id=20691310
Moghaddasi 2010 {published data only}|Homocysteine, vitamin B12 and folic acid levels in cerebrovascular accident: a case-control study|
Moghaddasi 2010 {published data only}|Homocysteine, vitamin B12 and folate levels in Iranian patients with ischemic stroke|/resolve/reference/PMED?id=20433777
Ntaios 2009 {published data only}|The controversial role of B-vitamins in cardiovascular risk: an update|/resolve/reference/PMED?id=19963194
Ntaios 2010 {published data only}|The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial|/resolve/reference/PMED?id=19201496
PACIFIC 2002 {published data only}|Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease|/resolve/reference/PMED?id=12395803
Pan 2012 {published data only}|Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials|/resolve/reference/PMED?id=22244447
Rautiainen 2010 {published data only}|Multivitamin use and the risk of myocardial infarction: a population-based cohort of Swedish women|/resolve/reference/PMED?id=20861174
Sharifi 2010 {published data only}|The effects of high-dose folic acid on blood pressure of hypertensive adults with hyperhomocysteinemia: a randomized double-blind placebo controlled clinical trial (Tehran homocysteine survey)|
Shidfar 2009 {published data only}|Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial|/resolve/reference/PMED?id=19766902
Sudchada 2012 {published data only}|Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis|/resolve/reference/PMED?id=22727498
Swiss 2002 {published data only}|Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial|/resolve/reference/PMED?id=12190367
Tighe 2011 {published data only}|A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy|/resolve/reference/PMED?id=20980493
Vesin 2007 {published data only}|Efficacy of folic acid in prevention of cerebrovascular disease|
Wang 2007 {published data only}|Efficacy of folic acid supplementation in stroke prevention: a meta-analysis|
Wang 2012 {published data only}|Folate and risk of coronary heart disease: a meta-analysis of prospective studies|
Wierzbicki 2007 {published data only}|Homocysteine and cardiovascular disease: a review of the evidence|/resolve/reference/PMED?id=17654449
Yang 2012 {published data only}|Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=22884409
Zappacosta 2013 {published data only}|Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia|/resolve/reference/PMED?id=23698160
Zhang 2009 {published data only}|Effect of B vitamins supplementation on cardiovascular and cerebrovascular disease by lowering plasma homocysteine concentration: a meta-analysis [Chinese]|
Zhang 2013 {published data only}|Effect of B-vitamin supplementation on stroke: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=24282609
Zhou 2011 {published data only}|Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis|/resolve/reference/PMED?id=21980387
Balshem 2011|GRADE guidelines: 3. Rating the quality of evidence|/resolve/reference/PMED?id=21208779
Blom 2011|Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects|/resolve/reference/PMED?id=20814827
Boushey 1995|A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes|/resolve/reference/PMED?id=7563456
Bowman 2007|Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors|
Brok 2008|Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses|/resolve/reference/PMED?id=18411040
Brok 2009|Apparently conclusive meta-analyses may be inconclusive--trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses|/resolve/reference/PMED?id=18824466
Brozek 2011|Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations|
Brustolin 2010|Genetics of homocysteine metabolism and associated disorders|
CAPRIE 1996|A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee|/resolve/reference/PMED?id=8918275
Casas 2005|Homocysteine and stroke: evidence on a causal link from mendelian randomisation|/resolve/reference/PMED?id=15652605
Castro 2006|Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview|/resolve/reference/PMED?id=16601863
Clarke 2007|Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia|/resolve/reference/PMED?id=17143052
CMA 2005|Comprehensive Meta-analysis|
Crider 2011|Folic acid food fortification-its history, effect, concerns, and future directions|/resolve/reference/PMED?id=22254102
CTU 2011|TSA - Trial Sequential Analysis|
Danesh 1998|Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies|/resolve/reference/PMED?id=9919470
di Salvo 2011|Vitamin B(6) salvage enzymes: mechanism, structure and regulation|/resolve/reference/PMED?id=21182989
di Salvo 2012|Biomedical aspects of pyridoxal 5'-phosphate availability|
Eikelboom 1999|Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence|/resolve/reference/PMED?id=10475890
Epstein 1996|Cardiovascular disease epidemiology: a journey from the past into the future|/resolve/reference/PMED?id=8653883
Fedosov 2012|Physiological and molecular aspects of cobalamin transport|/resolve/reference/PMED?id=22116708
Ferretti 2006|Structural modifications of HDL and functional consequences|/resolve/reference/PMED?id=16157342
Ford 2002|Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies|/resolve/reference/PMED?id=11914295
Fowler 2005|Homocysteine: overview of biochemistry, molecular biology, and role in disease processes|/resolve/reference/PMED?id=16047261
Friso 2012|Vitamin B6 and cardiovascular disease|/resolve/reference/PMED?id=22116704
Gaziano 2006|Cardiovascular Disease|
Gori 2007|Association between homocysteine, vitamin B(6) concentrations and inflammation|/resolve/reference/PMED?id=17990948
GRADEpro 2008|GRADEpro|
Guthikonda 2006|Homocysteine: role and implications in atherosclerosis|/resolve/reference/PMED?id=16510043
Guyatt 2011|GRADE guidelines: 2. Framing the question and deciding on important outcomes|/resolve/reference/PMED?id=21194891
Guyatt 2011a|GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables|/resolve/reference/PMED?id=21195583
Guyatt 2011b|GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)|/resolve/reference/PMED?id=21247734
Guyatt 2011c|GRADE guidelines: 9. Rating up the quality of evidence|/resolve/reference/PMED?id=21802902
Guyatt 2011d|GRADE guidelines: 8. Rating the quality of evidence--indirectness|/resolve/reference/PMED?id=21802903
Guyatt 2011e|GRADE guidelines: 7. Rating the quality of evidence--inconsistency|/resolve/reference/PMED?id=21803546
Guyatt 2011f|GRADE guidelines 6. Rating the quality of evidence--imprecision|/resolve/reference/PMED?id=21839614
Guyatt 2011g|GRADE guidelines: 5. Rating the quality of evidence--publication bias|/resolve/reference/PMED?id=21802904
Guyatt 2012|GRADE guidelines 11-making an overall rating of confidence in effect estimates for a single outcome and for all outcomes|
Guyatt 2012a|GRADE guidelines 12. Preparing Summary of Findings tables-binary outcomes|
Hackam 2003|Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence|/resolve/reference/PMED?id=12928471
Herrmann 2012|Cobalamin deficiency|/resolve/reference/PMED?id=22116706
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
HLTC 2005|Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials|/resolve/reference/PMED?id=16210710
HSC 2002|Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis|/resolve/reference/PMED?id=12387654
Humphrey 2008|Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis|/resolve/reference/PMED?id=18990318
ICH-GCP 1997||
Ioannidis 2010|Meta-research: the art of getting it wrong|
Jacobsen 2005|Molecular targeting by homocysteine: a mechanism for vascular pathogenesis|/resolve/reference/PMED?id=16197301
Jacobsen 2006|Homocysteine targeting of plasma proteins in hemodialysis patients|/resolve/reference/PMED?id=16518339
Jakubowski 2000|Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans|/resolve/reference/PMED?id=10721911
Jakubowski 2004|Molecular basis of homocysteine toxicity in humans|/resolve/reference/PMED?id=14999406
Jakubowski 2008|The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease|/resolve/reference/PMED?id=19261978
Jamison 2006||
Jamison 2007|Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial|/resolve/reference/PMED?id=17848650
Joseph 2013|Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology|/resolve/reference/PMED?id=23955381
Kahn 2008|The impact of prevention on reducing the burden of cardiovascular disease|/resolve/reference/PMED?id=18606915
Kardesoglu 2011|Homocysteine as a new risk factor for cardiovascular events in heart failure|/resolve/reference/PMED?id=21074871
Krutler 2012|Biochemistry of B12-cofactors in human metabolism|/resolve/reference/PMED?id=22116707
Lefebvre 2011|Chapter 6: Searching for studies|
Maron 2006|Homocysteine|/resolve/reference/PMED?id=16938586
Maron 2009|The treatment of hyperhomocysteinemia|/resolve/reference/PMED?id=18729731
Math 2007|Steps to control the burden of cardiovascular disease in the Indian Subcontinent|/resolve/reference/PMED?id=17598948
McCully 2005|Hyperhomocysteinemia and arteriosclerosis: historical perspectives|/resolve/reference/PMED?id=16197285
Molloy 2012|Genetic aspects of folate metabolism|/resolve/reference/PMED?id=22116697
Mudd 2000|Homocysteine and its disulfide derivatives: a suggested consensus terminology|
Mukherjee 2011|Pyridoxal phosphate: biosynthesis and catabolism|/resolve/reference/PMED?id=21767669
NACB 2009|National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease|/resolve/reference/PMED?id=19106185
Narayan 2006|Diabetes: the pandemic and potential solutions|
Obeid 2009|Homocysteine and lipids: S-adenosyl methionine as a key intermediate|/resolve/reference/PMED?id=19324042
Ohrvik 2011|Human folate bioavailability|/resolve/reference/PMED?id=22254106
Pera-Kajn 2007|Mechanisms of homocysteine toxicity in humans|/resolve/reference/PMED?id=17285228
Pushpakumar 2014|Endothelial dysfunction: the link between homocysteine and hydrogen sulfide|/resolve/reference/PMED?id=25005183
Ramakrishnan 2006|Biochemistry of homocysteine in health and diseases|/resolve/reference/PMED?id=17133733
Refsum 1998|Homocysteine and cardiovascular disease|/resolve/reference/PMED?id=9509248
RevMan 2014|Review Manager (RevMan)|
Riksen 2005|Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia|/resolve/reference/PMED?id=15539618
Rodgers 2006|The growing burden of risk from high blood pressure, cholesterol, and bodyweight|
Selhub 1993|Vitamin status and intake as primary determinants of homocysteinemia in an elderly population|/resolve/reference/PMED?id=8133587
Selhub 2006|The many facets of hyperhomocysteinemia: studies from the Framingham cohorts|/resolve/reference/PMED?id=16702347
Shelhub 2008|Public health significance of elevated homocysteine|
Sofi 2008|Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels|/resolve/reference/PMED?id=17945240
Splaver 2004|Homocysteine and cardiovascular disease: biological mechanism, observational epidemiology, and the need for randomised trials|/resolve/reference/PMED?id=15215789
SSSS 1994|Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)|/resolve/reference/PMED?id=7968073
Stampfer 1992|prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians|/resolve/reference/PMED?id=1640615
Thorlund 2009|Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?|/resolve/reference/PMED?id=18824467
Thorlund 2010|Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals|/resolve/reference/PMED?id=20865104
Thorlund 2011|User manual for Trial Sequential Analysis (TSA)|
Vianna 2007|Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events|
Vollset 2013|Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals|/resolve/reference/PMED?id=23352552
Wald 2002|Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis|/resolve/reference/PMED?id=12446535
Wang 2005|Mechanisms in homocysteine-induced vascular disease|
Wetterslev 2008|Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis|/resolve/reference/PMED?id=18083463
Wetterslev 2009|Estimating required information size by quantifying diversity in random-effects model meta-analyses|/resolve/reference/PMED?id=20042080
WHO 2002||
Willet 2006|Prevention of chronic disease by means of diet and lifestyle changes|
Williams 2010|Homocysteine metabolism and its relation to health and disease|
Wirakartakusumah 1998|Technical aspects of food fortification|
Wu 2013|Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China|/resolve/reference/PMED?id=23430091
Yetley 2011|Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use|/resolve/reference/PMED?id=21593508
Yusuf 2000|Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators|/resolve/reference/PMED?id=10639539
Zhou 2009|Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms|
Marti-Carvajal 2009|Homocysteine lowering interventions for preventing cardiovascular events|
Mart-Carvajal 2013|Homocysteine-lowering interventions for preventing cardiovascular events|
Els 2006 {published data only}|Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke|/resolve/reference/PMED?id=16330868
Hindman 1999 {published data only}|Mild hypothermia as a protective therapy during intracranial aneurysm surgery: a randomized prospective pilot trial|/resolve/reference/PMED?id=9894960
Qiu 2007 {published data only}|Effects of therapeutic mild hypothermia on patients with severe traumatic brain injury after craniotomy|/resolve/reference/PMED?id=17869973
Todd 2005 {published data only}|Mild intraoperative hypothermia during surgery for intracranial aneurysm|/resolve/reference/PMED?id=15647576
Bacher 1997 {published data only}|Changes in oxygenation variables during progressive hypothermia in anesthetized patients|/resolve/reference/PMED?id=9239580
Baker 1994 {published data only}|Deliberate mild intraoperative hypothermia for craniotomy|/resolve/reference/PMED?id=8053586
Beaufort 1995 {published data only}|The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans|
Bernard 1999 {published data only}|Experience with prolonged induced hypothermia in severe head injury|/resolve/reference/PMED?id=11056742
Chouhan 2006 {published data only}|Intraoperative mild hypothermia for brain protection during intracranial aneurysm surgery|
Clifton 1992 {published data only}|Systemic hypothermia in treatment of brain injury|
Gal 2002 {published data only}|Mild hypothermia therapy for patients with severe brain injury|/resolve/reference/PMED?id=12140097
Gal 2008 {published data only}|Mild hypothermia for intracranial aneurysm surgery|/resolve/reference/PMED?id=18457312
Gasser 2003 {published data only}|Long-term hypothermia in patients with severe brain edema after poor-grade subarachnoid hemorrhage: feasibility and intensive care complications|/resolve/reference/PMED?id=12826972
Harris 2009 {published data only}|Discrete cerebral hypothermia in the management of traumatic brain injury: a randomized controlled trial|/resolve/reference/PMED?id=19249933
Hashiguchi 2003 {published data only}|Mild hypothermia reduces expression of heat shock protein 60 in leukocytes from severely head-injured patients|/resolve/reference/PMED?id=14676650
Himmelseher 2004 {published data only}|Therapeutic hypothermia after traumatic brain injury or subarachnoid hemorrhage. Current practices of German anaesthesia departments in intensive care|/resolve/reference/PMED?id=15597156
Iatrou 2002 {published data only}|The effect of selective brain cooling on intracerebral temperature during craniotomy|/resolve/reference/PMED?id=12002923
Iwata 2006 {published data only}|Effects of increasing concentrations of propofol on jugular venous bulb oxygen saturation in neurosurgical patients under normothermic and mildly hypothermic conditions|/resolve/reference/PMED?id=16394687
Jian 2003 {published data only}|Feasibility and safety of moderate hypothermia after acute ischemic stroke|/resolve/reference/PMED?id=12927584
Jiang 2006 {published data only}|Effect of long-term mild hypothermia or short-term mild hypothermia on outcome of patients with severe traumatic brain injury|/resolve/reference/PMED?id=16306933
Karibe 2000 {published data only}|Intraoperative mild hypothermia ameliorates postoperative cerebral blood flow impairment in patients with aneurysmal subarachnoid hemorrhage|/resolve/reference/PMED?id=10981746
Kimme 2004 {published data only}|Moderate hypothermia for 359 operations to clip cerebral aneurysms|/resolve/reference/PMED?id=15220173
Leslie 2000 {published data only}|Mild core hypothermia and anesthetic requirement for loss of responsiveness during propofol anesthesia for craniotomy|/resolve/reference/PMED?id=11973207
Li 2009 {published data only}|Protective effect of moderate hypothermia on severe traumatic brain injury in children|/resolve/reference/PMED?id=19469686
Liu 2006 {published data only}|Effects of selective brain cooling in patients with severe traumatic brain injury: a preliminary study|/resolve/reference/PMED?id=16604824
Maekawa 1994 {published data only}|Clinical application of mild hypothermia in neurological disorders|/resolve/reference/PMED?id=7830915
Mrlian 2006 {published data only}|The use of controlled mild hypothermia and immune system status in patients with severe brain injury|/resolve/reference/PMED?id=16796137
Murthy 2005 {published data only}|Spontaneous intraoperative hypothermia and cerebral protection in aneurismal subarachnoid hemorrhage|/resolve/reference/PMED?id=16438006
Sato 2000 {published data only}|Systemic and cerebral haemodynamics during craniotomy under mild hypothermia in patients with acute subarachnoid haemorrhage|/resolve/reference/PMED?id=11086810
Schwab 1998 {published data only}|Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction|/resolve/reference/PMED?id=9836751
Schwab 1998b {published data only}|Moderate hypothermia and brain temperature in patients with severe middle cerebral artery infarction|/resolve/reference/PMED?id=9779165
Shiozaki 2001 {published data only}|A multicenter prospective randomized controlled trial of the efficacy of mild hypothermia for severely head injured patients with low intracranial pressure. Mild Hypothermia Study Group in Japan|/resolve/reference/PMED?id=11147897
Shiozaki 2003 {published data only}|Efficacy of moderate hypothermia in patients with severe head injury and intracranial hypertension refractory to mild hypothermia|/resolve/reference/PMED?id=12854743
Botterell 1956|Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms|/resolve/reference/PMED?id=13286725
Botterell 1958|Hypothermia in the surgical treatment of ruptured intracranial aneurysms|/resolve/reference/PMED?id=13492070
Choi 2005|Mild hypothermia provides significant protection against ischemia/reperfusion injury in livers of obese and lean rats|/resolve/reference/PMED?id=15729070
Citerio 2004|Moderate hypothermia in traumatic brain injury: results of clinical trials|/resolve/reference/PMED?id=15173698
Clifton 1991|Marked protection by moderate hypothermia after experimental traumatic brain injury|/resolve/reference/PMED?id=1983995
Clifton 2001|Lack of effect of induction of hypothermia after acute brain injury|/resolve/reference/PMED?id=11207351
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Fay 1943|Observations on generalized refrigeration in cases of severe cerebral trauma|
Frank 1993|Unintentional hypothermia is associated with postoperative myocardial ischaemia|/resolve/reference/PMED?id=8457047
Frank 1997|Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events: A randomized clinical trial|/resolve/reference/PMED?id=9087467
Goldstein 1994|Clinical assessment of stroke|/resolve/reference/PMED?id=8151856
Goto 1993|Effects of intraischemic hypothermia on cerebral damage in a model of reversible focal ischaemia|/resolve/reference/PMED?id=8327102
Harris 2002|The role of hypothermia in the management of severe brain injury: a meta-analysis|/resolve/reference/PMED?id=12117354
Hendrick 1959|The use of hypothermia in severe head injuries in childhood|/resolve/reference/PMED?id=14401007
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Higgins 2011|Higgins JPT, Altman DG, Sterne JC, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies|
Jennett 1975|Assessment of outcome after severe brain damage|/resolve/reference/PMED?id=46957
JESC/ACC Committee 2000|Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction|/resolve/reference/PMED?id=10973764
Karibe 1994|Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats|/resolve/reference/PMED?id=8270997
Kurz 1996|Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization|/resolve/reference/PMED?id=8606715
Lazorthes 1958|Hypothermia in the treatment of craniocerebral traumatism|/resolve/reference/PMED?id=13514515
Lenhardt 1997|Mild intraoperative hypothermia prolongs postanesthesia recovery|/resolve/reference/PMED?id=9416715
Leslie 2003|Perioperative hypothermia in the high-risk surgical patient|/resolve/reference/PMED?id=14661653
Lougheed 1955|The use of hypothermia in surgical treatment of cerebral vascular lesions: A preliminary report|/resolve/reference/PMED?id=14381931
Luscombe 2006|Clinical applications of induced hypothermia|
Marion 1993|The use of moderate therapeutic hypothermia for patients with severe head injury: a preliminary report|/resolve/reference/PMED?id=8360731
RevMan 5.1|Review Manager (RevMan)|
Ridenour 1992|Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischaemia in rats|/resolve/reference/PMED?id=1579972
Schmied 1996|Mild hypothermia increases blood loss and transfusions requirements during total hip arthroplasty|/resolve/reference/PMED?id=8569362
Sedzimir 1959|Therapeutic hypothermia in cases of head injury|/resolve/reference/PMED?id=13665397
Sydenham 2011|Hypothermia for traumatic head injury|
Teasdale 1974|Assessment of coma and impaired consciousness. A practical scale|/resolve/reference/PMED?id=4136544
Teasdale 1988|A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies|/resolve/reference/PMED?id=3236024
Els 2006 {published data only}|Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke|/resolve/reference/PMED?id=16330868
Hindman 1999 {published data only}|Mild hypothermia as a protective therapy during intracranial aneurysm surgery: a randomized prospective pilot trial|/resolve/reference/PMED?id=9894960
Qiu 2007 {published data only}|Effects of therapeutic mild hypothermia on patients with severe traumatic brain injury after craniotomy|/resolve/reference/PMED?id=17869973
Todd 2005 {published data only}|Mild intraoperative hypothermia during surgery for intracranial aneurysm|/resolve/reference/PMED?id=15647576
Bacher 1997 {published data only}|Changes in oxygenation variables during progressive hypothermia in anesthetized patients|/resolve/reference/PMED?id=9239580
Baker 1994 {published data only}|Deliberate mild intraoperative hypothermia for craniotomy|/resolve/reference/PMED?id=8053586
Beaufort 1995 {published data only}|The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans|
Bernard 1999 {published data only}|Experience with prolonged induced hypothermia in severe head injury|/resolve/reference/PMED?id=11056742
Chouhan 2006 {published data only}|Intraoperative mild hypothermia for brain protection during intracranial aneurysm surgery|
Clifton 1992 {published data only}|Systemic hypothermia in treatment of brain injury|
Gal 2002 {published data only}|Mild hypothermia therapy for patients with severe brain injury|/resolve/reference/PMED?id=12140097
Gal 2008 {published data only}|Mild hypothermia for intracranial aneurysm surgery|/resolve/reference/PMED?id=18457312
Gasser 2003 {published data only}|Long-term hypothermia in patients with severe brain edema after poor-grade subarachnoid hemorrhage: feasibility and intensive care complications|/resolve/reference/PMED?id=12826972
Harris 2009 {published data only}|Discrete cerebral hypothermia in the management of traumatic brain injury: a randomized controlled trial|/resolve/reference/PMED?id=19249933
Hashiguchi 2003 {published data only}|Mild hypothermia reduces expression of heat shock protein 60 in leukocytes from severely head-injured patients|/resolve/reference/PMED?id=14676650
Himmelseher 2004 {published data only}|Therapeutic hypothermia after traumatic brain injury or subarachnoid hemorrhage. Current practices of German anaesthesia departments in intensive care|/resolve/reference/PMED?id=15597156
Hindman 2009 {published data only}|No association between intraoperative hypothermia or supplemental protective drug and neurologic outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery|/resolve/reference/PMED?id=19952722
Iatrou 2002 {published data only}|The effect of selective brain cooling on intracerebral temperature during craniotomy|/resolve/reference/PMED?id=12002923
Iwata 2006 {published data only}|Effects of increasing concentrations of propofol on jugular venous bulb oxygen saturation in neurosurgical patients under normothermic and mildly hypothermic conditions|/resolve/reference/PMED?id=16394687
Jian 2003 {published data only}|Feasibility and safety of moderate hypothermia after acute ischemic stroke|/resolve/reference/PMED?id=12927584
Jiang 2006 {published data only}|Effect of long-term mild hypothermia or short-term mild hypothermia on outcome of patients with severe traumatic brain injury|/resolve/reference/PMED?id=16306933
Karibe 2000 {published data only}|Intraoperative mild hypothermia ameliorates postoperative cerebral blood flow impairment in patients with aneurysmal subarachnoid hemorrhage|/resolve/reference/PMED?id=10981746
Kimme 2004 {published data only}|Moderate hypothermia for 359 operations to clip cerebral aneurysms|/resolve/reference/PMED?id=15220173
Leslie 2000 {published data only}|Mild core hypothermia and anesthetic requirement for loss of responsiveness during propofol anesthesia for craniotomy|/resolve/reference/PMED?id=11973207
Li 2009 {published data only}|Protective effect of moderate hypothermia on severe traumatic brain injury in children|/resolve/reference/PMED?id=19469686
Liu 2006 {published data only}|Effects of selective brain cooling in patients with severe traumatic brain injury: a preliminary study|/resolve/reference/PMED?id=16604824
Maekawa 1994 {published data only}|Clinical application of mild hypothermia in neurological disorders|/resolve/reference/PMED?id=7830915
Mrlian 2006 {published data only}|The use of controlled mild hypothermia and immune system status in patients with severe brain injury|/resolve/reference/PMED?id=16796137
Murthy 2005 {published data only}|Spontaneous intraoperative hypothermia and cerebral protection in aneurismal subarachnoid hemorrhage|/resolve/reference/PMED?id=16438006
Nguyen 2010 {published data only}|Perioperative hypothermia does not increase the occurrance of cardiovascular events in patients undergoing cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial|/resolve/reference/PMED?id=20571361
Sato 2000 {published data only}|Systemic and cerebral haemodynamics during craniotomy under mild hypothermia in patients with acute subarachnoid haemorrhage|/resolve/reference/PMED?id=11086810
Schwab 1998 {published data only}|Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction|/resolve/reference/PMED?id=9836751
Schwab 1998b {published data only}|Moderate hypothermia and brain temperature in patients with severe middle cerebral artery infarction|/resolve/reference/PMED?id=9779165
Shiozaki 2001 {published data only}|A multicenter prospective randomized controlled trial of the efficacy of mild hypothermia for severely head injured patients with low intracranial pressure. Mild Hypothermia Study Group in Japan|/resolve/reference/PMED?id=11147897
Shiozaki 2003 {published data only}|Efficacy of moderate hypothermia in patients with severe head injury and intracranial hypertension refractory to mild hypothermia|/resolve/reference/PMED?id=12854743
Nuegebauer 2013 {published data only}|DEcompressive surgery Plus hypoTHermia for Space-Occupying Stroke (DEPTH-SOS): a protocol of a multicenter randomized controlled clinical trial and a literature review|
Choi 1990|The role of glutamate neurotoxicity in hypoxic -ischaemic neuronal death|/resolve/reference/PMED?id=1970230
Clifton 1991|Marked protection by moderate hypothermia after experimental traumatic brain injury|/resolve/reference/PMED?id=1983995
Clifton 2012|Early induction of hypothermia for evacuated intracranial haematomas:a post hoc analysis of two clinical trials|/resolve/reference/PMED?id=22839656
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Drury 2014|Mechanisms of hypothermic neuroprotection|/resolve/reference/PMED?id=24524453
El Beheiry 2012|Protecting the brain during neurosurgical procedures:strategies that can work|/resolve/reference/PMED?id=22895122
Goldstein 1994|Clinical assessment of stroke|/resolve/reference/PMED?id=8151856
Goto 1993|Effects of intra-ischemic hypothermia on cerebral damage in a model of reversible focal ischaemia|/resolve/reference/PMED?id=8327102
Hendrick 1959|The use of hypothermia in severe head injuries in childhood|/resolve/reference/PMED?id=14401007
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0.|
Holzer 2002|Mild theraputic hypothermia to improve neurologic outcome after cardiac arrest|
Jennett 1975|Assessment of outcome after severe brain damage|/resolve/reference/PMED?id=46957
JESC/ACC Committee 2000|Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction|/resolve/reference/PMED?id=10973764
Karibe 1994|Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats|/resolve/reference/PMED?id=8270997
Kwak 1972|Problems in hypothermic anesthesia for direct surgical treatment of intracranial aneurysms,with special reference to ventricular fibrillation|/resolve/reference/PMED?id=5067432
Laptook 1995|Quantitive relationship between brain temperature and energy utilization rate measured in vivo using 31P and 1H magnetic resonance spectroscopy|/resolve/reference/PMED?id=8618794
Leslie 2003|Perioperative hypothermia in the high-risk surgical patient|/resolve/reference/PMED?id=14661653
Li 2012|Intraoperative mild hypothermia for postoperative neurological deficits in intracranial aneurysm patients|/resolve/reference/PMED?id=19066502
Lougheed 1955|The use of hypothermia in surgical treatment of cerebral vascular lesions: A preliminary report|/resolve/reference/PMED?id=14381931
Michenfelder 1968|Hypothermia:effect on canine brain and whole body metabolism|/resolve/reference/PMED?id=5726746
RevMan 5.2|Review Manager (RevMan)|
Rothman 1995|Excitotoxicity and the NMDA receptor: still lethal after eight years|/resolve/reference/PMED?id=7537407
Steen 1980|The detrimental effects of prolonged hypothermia and rewarming in the dog|/resolve/reference/PMED?id=7369510
Teasdale 1974|Assessment of coma and impaired consciousness. A practical scale|/resolve/reference/PMED?id=4136544
Teasdale 1988|A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies|/resolve/reference/PMED?id=3236024
Thoresen 1997|Post hypoxia hypothermia reduces cerebrocortical release of nitric oxide and excitotoxins|/resolve/reference/PMED?id=9351672
Wei 1999|Role of neuronal and endothelial nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia|/resolve/reference/PMED?id=10524226
Xu 2002|Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade|/resolve/reference/PMED?id=11807390
Zhao 2012|A systematic review of clinical outcomes,perioperative data and selective adverse events related to mild hypothermia in intracranial aneurysm surgery|/resolve/reference/PMED?id=22652238
Milani 2011|Cooling for cerebral protection during brain surgery|/resolve/reference/PMED?id=21975755
Abels 1996 {published data only}|Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer|/resolve/reference/PMED?id=10387980
Agteresch 2000 {published data only}|Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer|/resolve/reference/PMED?id=10675381
Bamias 2003 {published data only}|Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human erythropoietin (rHuEpo): A prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group|/resolve/reference/PMED?id=12566906
Boogaerts 2003 {published data only}|Impact of epoetin beta on quality of life in patients with malignant disease|/resolve/reference/PMED?id=12671693
Bruera 1990 {published data only}|A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer|
Bruera 1998 {published data only}|Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study|/resolve/reference/PMED?id=9765767
Bruera 2003 {published data only}|Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. [see comment]|/resolve/reference/PMED?id=12506181
Bruera 2006 {published data only}|Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial|/resolve/reference/PMED?id=16648508
Capuron 2002 {published data only}|Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions|/resolve/reference/PMED?id=11927189
Case 1993 {published data only}|Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy|/resolve/reference/PMED?id=8487324
Chang 2005 {published data only}|Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy|/resolve/reference/PMED?id=15452188
Dagnelie 2003 {published data only}|Promising effects of adenosine triphosphate infusion on nutritional status and quality of life in advanced non-small-cell lung cancer: a randomized clinical trial|
Dammacco 2001 {published data only}|Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma|
De Conno 1998 {published data only}|Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial|/resolve/reference/PMED?id=9893656
Della 1989 {published data only}|Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group|/resolve/reference/PMED?id=2698804
Diel 2004 {published data only}|Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer|/resolve/reference/PMED?id=15251160
Downer 1993 {published data only}|A double double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia|/resolve/reference/PMED?id=8494706
Fisch 2003 {published data only}|Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the hoosier oncology group|/resolve/reference/PMED?id=12743146
Fleishman 2005 {published and unpublished data}|A phase II, randomized, placebo-controlled trial of the safety and efficacy of dexmethylphenidate (d-MPH) as a treatment for fatigue and "chemobrain" in adult cancer patients|
Glossmann 2003 {published data only}|Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial|/resolve/reference/PMED?id=12910374
Granetto 2003 {published data only}|Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin  in anemic cancer patients receiving platinum-based chemotherapy|/resolve/reference/PMED?id=12883695
Hedenus 2003 {published data only}|Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study|
Henry 1995 {published data only}|Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy|/resolve/reference/PMED?id=9166485
Iconomou 2003 {published data only}|Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial|/resolve/reference/PMED?id=12782431
Inoue 2003 {published data only}|Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan|/resolve/reference/PMED?id=12844250
Kotasek 2003 {published and unpublished data}|Darbopoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double blind, placebo controlled randomised study|/resolve/reference/PMED?id=12957457
Leyland-Jones 2005 {published data only}|Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study|/resolve/reference/PMED?id=16087945
Littlewood 2001 {published and unpublished data}|Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=11387359
Moertel 1974 {published data only}|Corticosteroid therapy of preterminal gastrointestinal cancer|
Monk 2006 {published data only}|Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients|/resolve/reference/PMED?id=16622259
Morrow 2003 {published data only}|Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program|/resolve/reference/PMED?id=14673053
O'Shaughnessy 2005 {published data only}|Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy|/resolve/reference/PMED?id=15748464
Osterborg 2002 {published data only}|Randomized, double-Blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies|/resolve/reference/PMED?id=12011126
Popiela 1989 {published data only}|Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group|/resolve/reference/PMED?id=2483687
Roscoe 2005 {published data only}|Effect of paroxetine hydrochloride (paxil) on fatigue and depression in breast cancer patients receiving chemotherapy|
Savonije 2005 {published data only}|Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: results of a multicenter randomised controlled trial|/resolve/reference/PMED?id=15953714
Semiglazov 2006 {published data only}|Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial|/resolve/reference/PMED?id=16619567
Simons 1996 {published data only}|Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced stage non-hormone-sensitive cancer: a placebo controlled multicenter study|/resolve/reference/PMED?id=8648360
Smith 2003 {published and unpublished data}|A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer|/resolve/reference/PMED?id=12799626
Thatcher 1999 {published data only}|Epoetin alpha prevents anaemia and reduced transfusion requirements in patients undergoing primarily platinum based chemotherapy for small cell lung cancer|/resolve/reference/PMED?id=10408844
Vansteenkiste 2002 {published and unpublished data}|Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy|/resolve/reference/PMED?id=12189224
Westman 1999 {published data only}|Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial|/resolve/reference/PMED?id=10492632
Wilkinson 2006 {published data only}|Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial|/resolve/reference/PMED?id=16570051
Witzig 2005 {published data only}|Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy|/resolve/reference/PMED?id=15452187
Wright 2007 {published and unpublished data}|Randomized, double-Blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia|/resolve/reference/PMED?id=17146103
Bruera 1985 {published data only}|Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study|/resolve/reference/PMED?id=2410117
Glaspy 2003 {published data only}|A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa|/resolve/reference/PMED?id=12599240
Glaspy 2006 {published data only}|Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 study group trial|/resolve/reference/PMED?id=16710026
Glimelius 1998 {published data only}|Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer|/resolve/reference/PMED?id=9469326
Johansson 2001 {published data only}|Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer-a randomized study|/resolve/reference/PMED?id=11676354
Steensma 2006 {published data only}|Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer|/resolve/reference/PMED?id=16505427
Waltzman 2005 {published data only}|Randomized comparison of epoetin alfa (40,000 U Weekly) and darbepoetin alfa (200 {micro}g every 2 weeks) in anemic patients with cancer receiving chemotherapy|/resolve/reference/PMED?id=16177289
Bauer 2007 {unpublished data only}|American Ginseng in treating patients with cancer related fatigue|
Bruera 2007 {unpublished data only}|The effect of donepezil on sedation and other symptoms|
Cruciani 2007 {unpublished data only}|Levocarnitine in treating fatigue in cancer patients|
Dagnelie 2007 {unpublished data only}|Application of adenosine-5-triphosphate infusions in palliative home care|
Frizell 2007 {unpublished data only}|Co-enzyme Q10 in relieving treatment related fatigue in women with breast cancer|
Hutson 2007 {unpublished data only}|Methylphenidate in treating patients with melanoma|
Morrow 2007 {published data only}|modafinil for treating fatigue in patients receiving chemotherapy for cancer|
Roth 2007 {published data only}|Psychostimulants for fatigue in prostate cancer|
Sood 2006 {published data only}|Methylphenidate in treating fatigue caused by cancer|
Stockler 2007 {unpublished data only}|A double blind placebo controlled trial of Zoloft's effects on symptoms and survival time in advanced cancer|
Thomas 2007 {unpublished data only}|Etanercept versus placebo with radiation therapy to combat fatigue and anorexia|
Andrews 2004|Mechanisms and models of fatigue associated with cancer and its treatment : Evidence from preclinical and clinical studies|
BNF 53|British National Formulary|
Bohlius 2007|Erythropoetin or darbopoetin for patients with cancer|
Breitbart 1995|Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer|/resolve/reference/PMED?id=7730685
Breitbart 2001|A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease|/resolve/reference/PMED?id=11176767
Bultmann 2002|Fatigue and psychological distress in the working population: psychometrics, prevalence, and correlates|/resolve/reference/PMED?id=12069868
Cella 2001|Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors|/resolve/reference/PMED?id=11454886
Cella 2002|combining anchor and distribution-based methods to derive minimally important clinical differences on the functional assessment of cancer therapy (FACT ) fatigue and anaemia subscales|/resolve/reference/PMED?id=12551804
Consort 2007|CONSORT Statement|
Cramp 2006|Exercise for treatment of cancer related fatigue|
Demetri 1998|Quality of life in chemotherapy patients treated with erythropoetin alpha is independent of disease response or tumour type:results from a prospective community survey|/resolve/reference/PMED?id=9779721
Glaspy 1997|Impact of therapy with erythropoetin alpha on clinical outcomes in patients with non myeloid malignancies during chemotherapy in community oncology practice|/resolve/reference/PMED?id=9060566
Higgins 2006|Higgins JPT, Green S editors|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jones 2004|Epoetin alpha improves quality of life in patients with cancer -results from a meta-analysis|
Krupp 1988|Fatigue in multiple sclerosis|/resolve/reference/PMED?id=3355400
Lawrie 1997|A population-based incidence study of chronic fatigue|/resolve/reference/PMED?id=9089827
Mock 2004|Evidence-based treatment for cancer-related fatigue|/resolve/reference/PMED?id=15263051
Morrow 2002|Fatigue associated with cancer and its treatment|/resolve/reference/PMED?id=12136222
Morrow 2005|Management of cancer-related fatigue|/resolve/reference/PMED?id=15945509
NCCN 2006|Clinical practice guidelines in oncology|
Radbruch 2007|Drugs for the treatment of fatigue in palliative care|
Sadler 2002|Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue|/resolve/reference/PMED?id=12007758
Servaes 2002|Fatigue after breast cancer and in chronic fatigue syndrome: Similarities and differences|/resolve/reference/PMED?id=12069869
Sharpe 1992|Fatigue and chronic fatigue syndrome|
Stone 2000|Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum|/resolve/reference/PMED?id=11038033
Stone 2002|The measurement causes and effective management of cancer-related-fatigue|/resolve/reference/PMED?id=11923740
Trendall 2001|Assessing fatigue in patients with COPD|/resolve/reference/PMED?id=12026780
Bernhard 2011 {published data only}|Communication about standard treatment options and clinical trials: Can we teach doctors new skills to improve patient outcomes?|
Bieber 2006 {published data only}|Long-term effects of a shared decision-making intervention on physician-patient interaction and outcome in fibromyalgia. A qualitative and quantitative 1 year follow-up of a randomized controlled trial|/resolve/reference/PMED?id=16872795
Butow 2004 {published and unpublished data}|Cancer consultation preparation package: changing patients but not physicians is not enough|/resolve/reference/PMED?id=15514382
Cooper 2011 {published and unpublished data}|A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients|
Davison 1997 {published data only}|Empowerment of men newly diagnosed with prostate cancer|/resolve/reference/PMED?id=9190093
Deen 2012 {published data only}|The impact of different modalities for activating patients in a community health center setting|
Deinzer 2009 {published data only}|Is a shared decision-making approach effective in improving hypertension management?|
Deschamps 2004 {published and unpublished data}|Impact of pharmacist consultation versus a decision aid on decision making regarding hormone replacement therapy|
Dolan 2002 {published data only}|Randomized controlled trial of a patient decision aid for colorectal cancer screening|
Elwyn 2004 {published and unpublished data}|Patient-based outcome results from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice|/resolve/reference/PMED?id=15249521
Elwyn 2004 {published and unpublished data}|Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice|/resolve/reference/PMED?id=15249520
Elwyn 2004 {published and unpublished data}|Involvingpatientsinprimarycareconsultations:assessingpreferencesusingdiscretechoice experiments|/resolve/reference/PMED?id=16438813
Fossli 2011 {published and unpublished data}|Effectiveness of a short course in clinical communication skills for hospital doctors: Results of a crossover randomized controlled trial (ISRCTN22153332)|
Hamann 2007 {published data only}|Shared decision makingandlong-termoutcomeinschizophreniatreatment|/resolve/reference/PMED?id=17685733
Haskard 2008 {published and unpublished data}|Physician and patient communication training in primary care: effects on participation and satisfaction|/resolve/reference/PMED?id=18823177
Hess 2012 {published data only}|The chest pain choice decision aid: a randomized trial|
Kasper 2008 {published data only}|Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomized controlled trial|
Krist 2007 {published data only}|Patient education on prostate cancer screening and involvement in decision making|
Krones 2008 (ARRIBA-Herz) {published and unpublished data}|Satisfaction of patients and primary care physicians with shared decision making|
Krones 2008 (ARRIBA-Herz) {published and unpublished data}|Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial|
Lalonde 2006 {published and unpublished data}|Evaluation of a decision aid and a personal risk profile in community pharmacy for patients considering options to improve cardiovascular health: the OPTIONS pilot study|
Landrey 2012 {published and unpublished data}|Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam|
Lgar 2012 {published and unpublished data}|Training family physicians in shared decision-making to reduce the overuse of antibiotics in acute respiratory infections: a cluster randomized trial|
Leighl 2011 {published data only}|Supporting treatment decision making in advanced cancer: A randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy|
Loh 2007 {published data only}|The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial|/resolve/reference/PMED?id=17509808
Montori 2011 {published and unpublished data}|Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial|
Mullan 2009 {published and unpublished data}|The diabetes mellitus medication choice decision aid: a randomized trial|
Murray 2001 {published data only}|Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care|/resolve/reference/PMED?id=11532845
Murray 2010 {published data only}|Skills training to support patients considering place of end-of-life care: a randomized control trial|
Myers 2011 {published data only}|Mediated decision support in prostate cancer screening: a randomized controlled trial of decision counselling|
Nannenga 2009 {published and unpublished data}|Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results|
Nannenga 2009 {published and unpublished data}|A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial|
Nannenga 2009 {published and unpublished data}|Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial|/resolve/reference/PMED?id=17533211
O'Cathain 2002 {published data only}|Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice|/resolve/reference/PMED?id=11895822
Raynes-Greenow 2010 {published data only}|Assisting informed decision making for labour analgesia: a randomised controlled trial of a decision aid for labour analgesia versus a pamphlet|
Roter 2012 {published data only}|The impact of patient and physician computer mediated communication skill training on reported communication and patient satisfaction|
Schroy 2011 {published data only}|The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial|
Shepherd 2011 {published and unpublished data}|Three questions that patients can ask to improve the quality of information physicians give about treatment options: a cross-over trial|
Stacey 2006 {published data only}|Randomized controlled trial of the effectiveness of an intervention to implement evidence-based patient decision support in a nursing call centre|/resolve/reference/PMED?id=17227607
Stacey 2006 {published data only}|Audit and feedback using the brief Decision Support Analysis Tool (DSAT-10) to evaluate nursestandardized patient encounters|/resolve/reference/PMED?id=18722074
Stiggelbout 2008 {published data only}|The impact of individualized evidence-based decision support on aneurysm patients' decision making, ideals of autonomy, and quality of life|
Street 1995 {published data only}|Increasing patient involvement in choosing treatment for early breast cancer|
van Peperstraten 2010 {published data only}|The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in in vitro fertilisation: randomised controlled trial|
van Peperstraten 2010 {published data only}|Decidinghowmanyembryostotransferafterin vitro fertilisation: development and pilot test of a decision aid|
Vodermaier 2009 {published data only}|Contextual factors in shared decision making: a randomised controlled trial in women with a strong suspicion of breast cancer|/resolve/reference/PMED?id=19209172
Wetzels 2005 {published data only}|A consultation leaflet to improve an older patient's involvement in general practice care: a randomized trial|
Alexander 2006 {published data only}|A controlled trial of a short course to improve residents' communication with patients at the end of life|/resolve/reference/PMED?id=17065871
Allen 2009 {published data only}|A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men|
Brown 2004 {published data only}|Education and role modelling for clinical decisions with female cancer patients|
Davison 2007 {published data only}|Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer|
Golnik 2012 {published data only}|Autism-specific primary care medical home intervention|
Green 2011 {published data only}|Teaching advance care planning to medical students with a computer-based decision aid|
Hack 2007 {published data only}|Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial|
Hanson 2011 {published data only}|Improving decision-making for feeding options in advanced dementia: A randomized, controlled trial|
Hermansen Kobulnicky 2002 {published data only}||
Hirsch 2010 {published and unpublished data}|Satisfaction of patients and primary care physicians with shared decision making|
Kopke 2009 {published data only}|Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial|/resolve/reference/PMED?id=18845657
Langewitz 1998 {published data only}|Improvingcommunicationskills arandomizedcontrolledbehaviorallyorientedinterventionstudyfor residentsininternalmedicine|/resolve/reference/PMED?id=9625213
Leader 2012 {published data only}|Measuring informed decision making about prostate cancer screening in primary care|
Man-Son-Hing 1999 {published data only}|Apatientdecision aidregardingantithrombotictherapyforstrokepreventioninatrial fibrillation: a randomized controlled trial|/resolve/reference/PMED?id=10463708
Maslin 1998 {published data only}|Using aninteractivevideodiskinbreastcancerpatient support|
McCormack 2011 {published data only}|Translating medical evidence to promote informed health care decisions|
Ockhuysen-Vermey 2008 {published data only}|Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling|/resolve/reference/PMED?id=18834503
Roelands 2004 {published data only}|Clinical practice guidelinestoimproveshareddecision-makingaboutassistive deviceusein home care: a pilotintervention study|/resolve/reference/PMED?id=15530763
Schwalm 2012 {published data only}|Radial artery versus femoral arteryaccessoptionsincoronaryangiogramprocedures:randomized controlledtrialof apatient-decisionaid|
Simon 2012 {published data only}|Effectiveness of a web-based, individually tailored decision aid for depression or acute low back pain: A randomized controlled trial|
Smith 2010a {published data only}|A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial|
Spertus 2012 {unpublished data only}|Testing evidence-based, individualized informed consent forms to improve patients' experiences with percutaneous coronary intervention|
van Tol-Geerdink 2008 {published data only}|Offering a treatment choice in the irradiation of prostate cancer leads to better informed and more active patients, without harm to well-being|/resolve/reference/PMED?id=17765404
Whelan 2003 {published data only}|Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer|/resolve/reference/PMED?id=12697850
Berg ongoing {published data only (unpublished sought but not used)}|Can health coaching help patients with spinal stenosis make an informed treatment choice? (DEC)|
Brinkman ongoing {published data only (unpublished sought but not used)}|Pilot testing of decision aids to improve decision making in ADHD care|
Davis ongoing {published data only (unpublished sought but not used)}|Integrating decision aids and enhancing shared decision making in rural non-academic primary care: the essential role of practice facilitation|
Fullwood 2013 {published and unpublished data}|Evaluation of the WISE approach in primary care: improving outcomes in chronic conditions through effective self-management - a two-arm practice-level cluster randomised controlled trial (WISE RCT)|
Goss ongoing {published data only (unpublished sought but not used)}|The involvement of breast cancer patients in the informative and decisional processes during oncological consultations. The study protocol of a clinical multi-centre randomized control trial|
Kpke ongoing {published data only (unpublished sought but not used)}|Patient education program on diagnosis, prognosis and early therapy for persons with early multiple sclerosis - outline and first results of a multi-centre randomized controlled trial (ISRCTN12440282)|
NCT00949611 {unpublished data only}|Wiser choices in osteoporosis Choice II: a decision aid for patients and clinicians|
NCT00955188 {unpublished data only}|Computer-based tailored or standard information for colorectal cancer screening|
NCT01484665 {unpublished data only}|Evaluating the effect of a decision aid on shared decision making for prostate cancer screening|
NCT01492257 {unpublished data only}|Shared decision making in patients with osteoarthritis of the hip and knee (SDM)|
NCT01606930 {unpublished data only}|A pilot study to improve patient-doctor communication|
Omer ongoing {published data only (unpublished sought but not used)}|Personalized decision support for breast cancer prevention|
Quinn ongoing {published data only (unpublished sought but not used)}|Factors in informed decision making in hepatitis c testing (DEC)|
Ruud ongoing {published data only (unpublished sought but not used)}|Conducting a multi-site cluster-RCT of decision aids: Lessons learned|
Sanders ongoing {published data only (unpublished sought but not used)}|Training general practitioners in enforcing patients own expectations in order to maximize health benefits: observed effects on communication in consultations|
Schrijvers ongoing {published data only (unpublished sought but not used)}|Implementation and evaluation of a web-based decision aid in the decision making process of newly diagnosed patients with localized prostate cancer|
Shah ongoing {published data only (unpublished sought but not used)}|Use of a decision aid for patients hospitalized with acute myocardial infarction (AMI). A randomized control trial|
Thompson ongoing {published data only (unpublished sought but not used)}|Learning how to share: Challenges in implementing decision aids in routine maternity care|
Tinsel ongoing {published data only (unpublished sought but not used)}|Association between patient rated amount of participation in decision-making and clinical outcome in patients with hypertension in general practice|
Wills ongoing {unpublished data only}|Validation of the Shared Decision Making Questionnaire-9 (SDM-Q-9) in a stratified age-proportionate U.S. sample|
Bieber 2008|A shared decision-making communication training program for physicians treating fibromyalgia patients: effects of a randomized controlled trial|/resolve/reference/PMED?id=18157994
Brouwers 2010|Knowledgecreation:synthesis,toolsandproducts|
Butow 2009|Shared decision making coding systems: How do they compare in the oncology context?|
Charles 1997|Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango)|/resolve/reference/PMED?id=9032835
Cohen 1988||
Coulter 2006|Engaging patients in their healthcare. How is the UK doing relative to other countries|
Cout 2013|Assessments of the extent to which health-care providers involve patients in decision making: a systematic review of studies using the OPTION instrument|
Coyne 2011|Interventions for promoting participation in shared decision-making for children with cancer|
Dwamena 2012|Interventions for providers to promote a patient-centred approach in clinical consultations|
Elwyn 1999|Shared decision-making in primary care: the neglected second half of the consultation|/resolve/reference/PMED?id=10562751
EPOC 2008|Data collection checklist|
Frosch 2009|Adjuncts or adversaries to shared decision-making? Applying the Integrative Model of behavior to the role and design of decision support interventions in healthcare interactions|
Gigure 2012|Printed educational materials: effects on professional practice and healthcare outcomes|
Godin 2008|Healthcare professionals' intentions and behaviours: a systematic review of studies based on social cognitive theories|/resolve/reference/PMED?id=18631386
Grimshaw 2004|Effectiveness and efficiency of guideline dissemination and implementation strategies|
Guerrier 2013|The validity and reliability of the decisional conflict scale for analyzing patient-physician dyads in shared decision making|
Higgins 2011|Cochrane Handbook|
Hrter 2011|Policy and practice developments in the implementation of shared decision making: an international perspective|
Institute for Helath Metrics and Evaluation 2013||
International Shared Decision Making 2013|International Shared Decision Making conference|
LeBlanc 2009|Decisional conflict in patients and their physicians: a dyadic approach to shared decision making|
Lewin 2001|Interventions for providers to promote a patient-centred approach in clinical consultations|
Longo 2006|Involvingpatientsinprimarycareconsultations:assessingpreferencesusingdiscretechoice experiments|/resolve/reference/PMED?id=16438813
Lgar 2007a|Prediction of health professionals' intention to screen for decisional conflict in clinical practice|
Lgar 2008a|Bariers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions|/resolve/reference/PMED?id=18752915
Lgar 2008b|Advancing theories, models and measurement for an interprofessional approach to shared decision making in primary care: a study protocol|
Lgar 2010|Interventionsforimprovingtheadoptionofshared decision makingbyhealthcare professionals|
Lgar 2011|Interprofessionalismandshareddecision-makinginprimarycare: astepwiseapproachtowardsanew model|
Lgar 2012a|Patients' perceptions of sharing in decisions: a systematic review of interventions to enhance shared decision making in routine clinical practice|
Makoul 2006|An integrative model of shared decision making in medical encounters|/resolve/reference/PMED?id=16051459
Michie 2009|Specifying and reporting complex behaviour change interventions: the need for a scientific method|
Mulley 2012|Stopthesilentmisdiagnosis:patients'preferencesmatter|
Roshanov 2013|Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials|
Shafir 2012|Shared Decision Making: Advancing Patient-Centered Care through State and Federal Implementation|
Smith 2012|Managing patients with multimorbidity: systematic review of interventions in primary care and community settings|
Stacey 2009|Integrating patient decision support in an undergraduate nursingcurriculum: an implementation project|/resolve/reference/PMED?id=19341354
Stacey 2011|Decisionaids for people facing health treatment or screening decisions|
Straub 2008|Translating research into practice: a German sickness fund supporting patient participation|/resolve/reference/PMED?id=18718732
Towle 1999|Framework for teaching and learning informed shared decision making|/resolve/reference/PMED?id=10488010
Ukoumunne 1999|Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review|/resolve/reference/PMED?id=10982317
Wennberg 2004|Practice variation: implications for our health care system|/resolve/reference/PMED?id=15493217
Weston 2001|Informed and shared decision-making: the crux of patient-centered care|/resolve/reference/PMED?id=11531054
Lgar|Interventions for improving the adoption of shared decision making by healthcare professionals|
De'oliveira 1997 {published data only (unpublished sought but not used)}|Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition|/resolve/reference/PMED?id=9291199
Dodson_P 1989 {published data only (unpublished sought but not used)}|Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation|/resolve/reference/PMED?id=2493869
Dodson_X 1989 {published data only (unpublished sought but not used)}|Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation|/resolve/reference/PMED?id=2493869
Houlihan_Losartan 2002 {published data only (unpublished sought but not used)}|A low salt diet in patients with type II diabetes significantly amplifies the effects of angiotensin II receptor blockade with losartan [abstract]|
Houlihan_Losartan 2002 {published data only (unpublished sought but not used)}|Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction|/resolve/reference/PMED?id=12032117
Houlihan_Losartan 2002 {published data only (unpublished sought but not used)}|Comparison of regular versus low sodium diet on the effects of losartan in hypertensive subjects with type II diabetes [abstract]|
Houlihan_Losartan 2002 {published data only (unpublished sought but not used)}|A low-sodium diet potentiates the effects of losartan in type 2 diabetes|/resolve/reference/PMED?id=11919122
Houlihan_Placebo 2002 {published data only}|A low salt diet in patients with type II diabetes significantly amplifies the effects of angiotensin II receptor blockade with losartan [abstract]|
Houlihan_Placebo 2002 {published data only}|Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction|/resolve/reference/PMED?id=12032117
Houlihan_Placebo 2002 {published data only}|Comparison of regular versus low sodium diet on the effects of losartan in hypertensive subjects with type II diabetes [abstract]|
Houlihan_Placebo 2002 {published data only}|A low-sodium diet potentiates the effects of losartan in type 2 diabetes|/resolve/reference/PMED?id=11919122
Imanishi_Micro 2001 {published data only}|Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients|/resolve/reference/PMED?id=11194215
Imanishi_Normo 2001 {published data only}|Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients|/resolve/reference/PMED?id=11194215
Lopes De Faria 1997 {published data only}|Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake|/resolve/reference/PMED?id=9274838
Luik 2002 {published data only}|Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus|/resolve/reference/PMED?id=12032630
Miller 1995 {published data only}|Sympathetic vasoconstrictive responses to high- and low-sodium diets in diabetic and normal subjects|/resolve/reference/PMED?id=7653660
Miller 1997 {published data only}|Renal responses to sodium restriction in patients with early diabetes mellitus|/resolve/reference/PMED?id=9176844
Mulhauser 1996 {published data only}|Effects of dietary sodium on blood pressure in IDDM patients with nephropathy|/resolve/reference/PMED?id=8635674
Petrie 1998 {published data only}|Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus|/resolve/reference/PMED?id=9589654
Trevisan_Micro 1998 {published data only}|Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria|/resolve/reference/PMED?id=9703338
Trevisan_Normo 1998 {published data only}|Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria|/resolve/reference/PMED?id=9703338
Vedovato_Micro 2004 {published data only}|Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance|/resolve/reference/PMED?id=14704836
Vedovato_Normo 2004 {published data only}|Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance|/resolve/reference/PMED?id=14704836
Yoshioka_Adva_alb 1998 {published data only}|Glomerular charge and size selectivity assessed by changes in salt intake in type 2 diabetic patients|/resolve/reference/PMED?id=9571328
Yoshioka_Micro 1998 {published data only}|Glomerular charge and size selectivity assessed by changes in salt intake in type 2 diabetic patients|/resolve/reference/PMED?id=9571328
Yoshioka_Normo 1998 {published data only}|Glomerular charge and size selectivity assessed by changes in salt intake in type 2 diabetic patients|/resolve/reference/PMED?id=9571328
Ames 2001 {published data only}|The effect of sodium supplementation on glucose tolerance and insulin concentrations in patients with hypertension and diabetes mellitus|/resolve/reference/PMED?id=11465650
Bakris 1996 {published data only}|Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists|/resolve/reference/PMED?id=8686978
Barsotti 1993 {published data only}|Implications of dietary treatment in diabetic nephropathy [abstract]|
Bellini 1996 {published data only}|Impaired inactive to active kallikrein conversion in human salt-sensitive hypertension|/resolve/reference/PMED?id=8989735
Boero 1998 {published data only}|Effects of salt on intrarenal hemodynamics in essential hypertensive patients [abstract]|
Boero 1998 {published data only}|Effects of high salt intake on 24 hour blood pressure and systemic hemodynamics in essential hypertensive patients [abstract]|
Boero 1998 {published data only}|Renal effects of high salt intake in patients with essential hypertension [abstract]|
Buter 1998 {published data only}|The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide|/resolve/reference/PMED?id=9681711
Cianciaruso 1998 {published data only}|Salt intake and renal outcome in patients with progressive renal disease|/resolve/reference/PMED?id=9554571
Cuzzola 2001 {published data only}|Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of Hypertension|/resolve/reference/PMED?id=11281233
Del Rio 1993 {published data only}|Metabolic effects of strict salt restriction in essential hypertensive patients|
Dengel 1998 {published data only}|Insulin sensitivity is associated with blood pressure response to sodium in older hypertensives|/resolve/reference/PMED?id=9530121
Dodson 1984 {published data only}|A controlled trial of a high fibre, low fat and low sodium diet for mild hypertension in Type 2 (non-insulin-dependent) diabetic patients|/resolve/reference/PMED?id=6096193
Donovan 1993 {published data only}|Effect of sodium intake on insulin sensitivity|/resolve/reference/PMED?id=8498495
DUAAL Study {published data only}|Dual renin-angiotensin system-blockade by angiotension-converting enzyme-inhibition and angiotension receptor type 1 receptor blockade, role of the angiotension-converting enzyme inhibitor or D genotype and low sodium diet in non-diabetic proteinuric patients|
Egan 1993 {published data only}|Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension|/resolve/reference/PMED?id=8517428
Evrenkaya 1999 {published data only}|Assessment of the relation between sodium sensitivity and insulin resistance in norm and hypertensive non-diabetic individuals [abstract]|
Feldman 1996 {published data only}|Dietary salt restriction increases vascular insulin resistance|/resolve/reference/PMED?id=8873692
Feldman 1999 {published data only}|Moderate dietary salt restriction increases vascular and systemic insulin resistance|/resolve/reference/PMED?id=10371376
Feldt-Rasmussen 1987 {published data only}|Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in Type 1 (insulin-dependent) diabetes mellitus|/resolve/reference/PMED?id=3653559
Fliser 1995 {published data only}|The effect of dietary salt on insulin sensitivity|
Gerdts 1996 {published data only}|Salt sensitivity in hypertensive type-1 diabetes mellitus|/resolve/reference/PMED?id=9162448
Gilleran 1996 {published data only}|Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study|/resolve/reference/PMED?id=8895035
Gomi 1998 {published data only}|Strict dietary sodium reduction worsens insulin sensitivity by increasing sympathetic nervous activity in patients with primary hypertension|/resolve/reference/PMED?id=9752889
Grey 1996 {published data only}|Moderate dietary salt restriction does not alter insulin resistance or serum lipids in normal men|/resolve/reference/PMED?id=8722434
Gruska 1997 {published data only}|Salt sensitivity and insulin resistance in normotensives|/resolve/reference/PMED?id=9288538
Heeg 1989 {published data only}|Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril|/resolve/reference/PMED?id=2550696
Iwaoka 1994 {published data only}|Dietary NaCl restriction deteriorates oral glucose tolerance in hypertensive patients with impairment of glucose tolerance|/resolve/reference/PMED?id=8060581
Jafar 2006 {published data only}|Blood pressure, diabetes, and increased dietary salt associated with stroke - results from a community-based study in Pakistan [1]|/resolve/reference/PMED?id=16151442
Jones-Burton 2006 {published data only}|An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease|/resolve/reference/PMED?id=16763384
Juncos 1976 {published data only}|Comparison of the effects of hydrochlorothiazide (H) and triamterene (T) in combination with low salt diet on both supine and standing systolic (SBP) and diastolic blood pressure (DBP), serum potassium (K+), weight (W) and peripheral plasma renin activity (PRA) and prostaglandin E2 concentration (PGE2). [abstract]|
Keven 2006 {published data only}|The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients|/resolve/reference/PMED?id=16797292
Kirby 2006 {published data only}|Salt sensitivity of blood pressure and diabetic nephropathy|
Kuroda 1999 {published data only}|Role of insulin resistance in the genesis of sodium sensitivity in essential hypertension|/resolve/reference/PMED?id=10333344
Mallamaci 1999 {published data only}|Renal excretion of adrenomedullin is strongly influenced by salt intake and it is tightly linked to endothelin-1 excretion in patients with essential hypertension (EH) [abstract]|
Mazouz 1999 {published data only}|Risk factors of renal failure progression two years prior to dialysis|/resolve/reference/PMED?id=10404696
Meland 1997 {published data only}|Salt restriction: effects on lipids and insulin production in hypertensive patients|/resolve/reference/PMED?id=9350069
Melander 2000 {published data only}|Effect of salt on insulin sensitivity differs according to gender and degree of salt sensitivity|/resolve/reference/PMED?id=10720602
Metcalf 1993 {published data only}|Dietary nutrient intakes and slight albuminuria in people at least 40 years old|/resolve/reference/PMED?id=8403406
Pacy 1984 {published data only}|Comparison of the hypotensive and metabolic effects of metoprolol therapy with a high fibre, low sodium, low fat diet in hypertensive type 2 diabetic subjects|/resolve/reference/PMED?id=6099231
Perry 2003 {published data only}|Decreased insulin sensitivity during dietary sodium restriction is not mediated by effects of angiotensin II on insulin action|/resolve/reference/PMED?id=12691602
Price 1999 {published data only}|The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus|/resolve/reference/PMED?id=10232494
Raji 2001 {published data only}|Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake|/resolve/reference/PMED?id=11204310
Rudberg 1997 {published data only}|The dopaminuric response to high salt diet in insulin-dependent diabetes mellitus and in family history of hypertension|/resolve/reference/PMED?id=9090656
Sharma 1991 {published data only}|Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose|/resolve/reference/PMED?id=1646259
Sharma 1993 {published data only}|Insulin resistance in young salt-sensitive normotensive subjects|/resolve/reference/PMED?id=8478036
Suzuki 2000 {published data only}|Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure|/resolve/reference/PMED?id=10775552
Swift 2005 {published data only}|Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial|/resolve/reference/PMED?id=15983240
Swift 2005 {published data only}|A double blind randomised control trial of modest salt reduction in black people with normal blood pressure [abstract]|
Townsend 2007 {published data only}|Salt intake and insulin sensitivity in healthy human volunteers|/resolve/reference/PMED?id=17425514
Trujillo 1989 {published data only}|Renin regulation in type II diabetes mellitus: influence of dietary sodium|/resolve/reference/PMED?id=2646216
Tuck 1990 {published data only}|Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus|/resolve/reference/PMED?id=2309737
Weir 1995 {published data only}|Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria|/resolve/reference/PMED?id=7768584
Weir 1998 {published data only}|Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy?|/resolve/reference/PMED?id=9669419
Zanchi 2004 {published data only}|Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men|/resolve/reference/PMED?id=15001599
Zarraga 2006 {published data only}|Impact of dietary patterns and interventions on cardiovascular health|/resolve/reference/PMED?id=16940205
Adler 2000|Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study|/resolve/reference/PMED?id=10938049
Allen 1997|Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes|/resolve/reference/PMED?id=8971091
Cianciaruso 1998|Salt intake and renal outcome in patients with progressive renal disease|/resolve/reference/PMED?id=9554571
Da Costa 1997|Chronic salt overload increases blood pressure and improves glucose metabolism without changing insulin sensitivity|/resolve/reference/PMED?id=9234825
Daviglus 2005|Relation of nutrient intake to microalbuminuria in nondiabetic middle-aged men and women: International Population Study on Macronutrients and Blood Pressure (INTERMAP)|/resolve/reference/PMED?id=15685502
DeFronzo 1981|The effect of insulin on renal sodium metabolism. A review with clinical implications|/resolve/reference/PMED?id=7028550
Giunti 2006|Mechanisms of diabetic nephropathy: role of hypertension|/resolve/reference/PMED?id=16952978
Harvey 2003|Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes|/resolve/reference/PMED?id=12698072
He 2002|Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health|/resolve/reference/PMED?id=12444537
He 2003|How far should salt intake be reduced?|/resolve/reference/PMED?id=14610100
He 2009a|Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives|/resolve/reference/PMED?id=19620514
He 2009b|A comprehensive review on salt and health and current experience of worldwide salt reduction programmes|/resolve/reference/PMED?id=19110538
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Hillege 2002|Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population|/resolve/reference/PMED?id=12356629
Hooper 2002|Systematic review of long term effects of advice to reduce dietary salt in adults|/resolve/reference/PMED?id=12242173
Jones-Burton 2006|An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease|/resolve/reference/PMED?id=16763384
Law 1991a|By how much does dietary salt reduction lower blood pressure? III - Analysis of data from trials of salt reduction|/resolve/reference/PMED?id=1827353
Law 1991b|By how much does dietary salt reduction lower blood pressure? I - Analysis of observational data among populations|/resolve/reference/PMED?id=2025703
Lefebvre 2008|Chapter 6: Searching for studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration. Available from www.cochrane-handbook.org|
MacGregor 1987|Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study|/resolve/reference/PMED?id=3103761
Midgley 1996|Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=8622251
Nishiyama 2002|Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats|/resolve/reference/PMED?id=11799091
Price 1999|The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus|/resolve/reference/PMED?id=10232494
Renal Group 2010|Cochrane Renal Group|
SACN 2003|Salt and Health|
Schrier 2002|Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes|/resolve/reference/PMED?id=11849464
Sowers 2001|Diabetes, hypertension, and cardiovascular disease: an update|/resolve/reference/PMED?id=11304502
Swift 2005|Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial|/resolve/reference/PMED?id=15983240
Verhave 2004|Sodium intake affects urinary albumin excretion especially in overweight subjects|
WHO 2002|The World Health Report 2002 - Reducing Risks, Promoting Healthy Life|
Woods 1987|Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback|/resolve/reference/PMED?id=3812702
Gross 1995 {published data only}|Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group|/resolve/reference/PMED?id=7502549
Malchow 1984 {published data only}|European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment|/resolve/reference/PMED?id=6140202
Martin 1990 {published data only}|Oral 5-ASA versus prednisone in short term treatment of Crohn's disease: A multicentre controlled trial|
Prantera 1999 {published data only}|Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial|/resolve/reference/PMED?id=10029609
Scholmerich 1990 {published data only}|Oral 5-aminosalicylic acid versus 6-methylprednisolone in active Crohn's disease|
Singleton 1979a {published data only}|National Cooperative Crohn's Disease Study: adverse reactions to study drugs|/resolve/reference/PMED?id=38177
Summers 1979 {published data only}|National Cooperative Crohn's Disease Study: results of drug treatment|/resolve/reference/PMED?id=38176
Winship 1979 {published data only}|National Cooperative Crohn's Disease Study: study design and conduct of the study|/resolve/reference/PMED?id=38175
Bergman 1976 {published data only}|Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease|/resolve/reference/PMED?id=11545
Brignola 1994 {published data only}|Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration|
Chun 1998 {published data only}|Intravenous corticotrophin vs. hydrocortisone in the treatment of hospitalized patients with Crohn's disease: a randomized double-blind study and follow-up|
Gaia 1979 {published data only}|[Use of a chronomulticorticoid in the treatment of Crohn's disease]|/resolve/reference/PMED?id=45417
Jenss 1989 {published data only}|5-aminosalicylic acide versus methylprednisolone in the treatment of active Crohn disease|
Jenss 1990 {published data only}|Coated mesalazine vs. methylprednisolone in the treatment of active Crohn's disease: A randomized double-blind study (abstract)|
Landi 1992 {published data only}|Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives|/resolve/reference/PMED?id=1568574
Maier 1990 {published data only}|Clinical efficacy of oral mesalazine in Crohn's disease|
Modigliani 1990 {published data only}|Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives|/resolve/reference/PMED?id=2179031
Modigliani 1996 {published data only}|Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives|/resolve/reference/PMED?id=8608877
Rijk 1991 {published data only (unpublished sought but not used)}|Sulphasalazine and prednisone compared with sulphasalazine for treating active Crohn disease. A double-blind, randomized, multicenter trial|/resolve/reference/PMED?id=1671631
Schneider 1985 {published data only}|[Metronidazole in the treatment of Crohn disease. Results of a controlled randomized prospective study]|/resolve/reference/PMED?id=2865120
Singleton 1979b {published data only}|A trial of sulfasalazine as adjunctive therapy in Crohn's disease|/resolve/reference/PMED?id=38179
Akobeng 2004|Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease|/resolve/reference/PMED?id=14974022
Akobeng 2005|Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease|/resolve/reference/PMED?id=15674913
Alfadhli 2005|Methotrexate for induction of remission in refractory Crohn's disease|/resolve/reference/PMED?id=15674908
Azad Khan 1977|An experiment to determine the active therapeutic moiety of sulphasalazine|/resolve/reference/PMED?id=72239
Barnes 1993|Anti-inflammatory actions of steroids: molecular mechanisms|/resolve/reference/PMED?id=7510080
Baumgart 2007|Inflammatory bowel disease: clinical aspects and established and evolving therapies|/resolve/reference/PMED?id=17499606
Bebb 2004|How effective are the usual treatments for Crohn's disease?|
Best 1976|Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study|/resolve/reference/PMED?id=1248701
Bousvaros 2007|Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America|/resolve/reference/PMED?id=17460505
Clark 1999|Assessing the quality of randomized trials: reliability of the Jadad scale|/resolve/reference/PMED?id=10503804
Desreumaux 2006|Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence|
Feagan 1998|Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease|
Hanauer 2004|Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials|/resolve/reference/PMED?id=15118975
Hanauer 2005|The case for using 5-aminosalicyclates in Crohn's disease: pro|
Hardy 1993|Localization of drug release sites from an oral sustained-release formulation of 5-ASA (Pentasa) in the gastrointestinal tract using gamma scintigraphy|/resolve/reference/PMED?id=8408731
Harvey 1980|A simple index of Crohn's-disease activity|/resolve/reference/PMED?id=6102236
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2005|Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6|
Hyams 1991|Development and validation of a pediatric Crohn's disease activity index|/resolve/reference/PMED?id=1678008
Hyams 2000|Corticosteroids in the treatment of gastrointestinal disease|/resolve/reference/PMED?id=11021409
Hyams 2005|Inflammatory bowel disease|/resolve/reference/PMED?id=16140873
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Juni 2001|Systematic reviews in health care: Assessing the quality of controlled clinical trials|/resolve/reference/PMED?id=11440947
Kamm 2005|Debate: should mesalamine be used in Crohn's disease?: comments and conclusions|
Kamm 2006|Review article: biological drugs in Crohn's disease|
Lichtenstein 2006|American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease|/resolve/reference/PMED?id=16530532
MacDonald 2007|Natalizumab for induction of remission in Crohn's disease|
Otley 2005|Budesonide for induction of remission in Crohn's disease|/resolve/reference/PMED?id=16235274
Salomon 1992|How effective are current drugs for Crohn's disease? A meta-analysis|/resolve/reference/PMED?id=1532974
Sandborn 2000|Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease|
Sandborn 2003|Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis|
Silverberg 2005|Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology|/resolve/reference/PMED?id=16151544
Stange 2005|The case against using 5-aminosalicyclates in Crohn's disease: con|
Truelove 1954|Cortisone in ulcerative colitis; preliminary report on a therapeutic trial|/resolve/reference/PMED?id=13182220
Van Hees 1980|An index of inflammatory activity in patients with Crohn's disease|/resolve/reference/PMED?id=7429289
Yang 2002|Corticosteroids in Crohn's disease|
Zachos 2007|Enteral nutritional therapy for induction of remission in Crohn's disease|/resolve/reference/PMED?id=17253452
Colivicchi 2002 {published and unpublished data}|Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction|/resolve/reference/PMED?id=12372577
de Lemos 2004 {published and unpublished data}|Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial|/resolve/reference/PMED?id=15337732
ESTABLISH 2004 {published and unpublished data}|Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study|/resolve/reference/PMED?id=15326073
FACS 2010 {published and unpublished data}|Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial(The FACS Trial)|/resolve/reference/PMED?id=15790413
FACS 2010 {published and unpublished data}|Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)|/resolve/reference/PMED?id=20500832
FLORIDA 2002 {published and unpublished data}|Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial|/resolve/reference/PMED?id=12473255
L-CAD 2000 {published and unpublished data}|Beneficial effects of pravastatin (+/- colestyramine/niacin) initiated immediately after a coronary event (the randomized lipid-coronary artery disease [L-CAD] study)|/resolve/reference/PMED?id=11113401
LAMIL 1997 {published data only (unpublished sought but not used)}|Time course of serum lipids and apolipoproteins after acute myocardial infarction: modification by pravastatin|/resolve/reference/PMED?id=9187418
LIPS 2002 {published and unpublished data}|Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial|/resolve/reference/PMED?id=12076217
Macin 2005 {published and unpublished data}|Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=15864233
MIRACL 2001 {published and unpublished data}|Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial|/resolve/reference/PMED?id=11277825
OACIS-LIPID 2008 {published data only (unpublished sought but not used)}|Effect of early use of low-dose Pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID study|/resolve/reference/PMED?id=18159093
PACT 2004 {published and unpublished data}|Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial|
PAIS 2001 {published and unpublished data}|Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial|/resolve/reference/PMED?id=11452676
PRINCESS 2004 {unpublished data only}|Reductions in early recurrent coronary ischemia from early administration of statin therapy upon admission for myocardial infarction: results of the PRINCESS trial|
PRINCESS 2004 {unpublished data only}|PRINCESS: Prevention of ischaemic events by early treatment of cerivastatin after acute myocardial infarction|
PTT 2002 {published and unpublished data}|The effect of statin therapy on ventricular late potentials in acute myocardial infarction|/resolve/reference/PMED?id=12821221
PTT 2002 {published and unpublished data}|The short term results of combined use of pravastatin with thrombolytic therapy in acute myocardial infarction [abstract]|
PTT 2002 {published and unpublished data}|Combined use of Pravastatin and thrombolytic agents in acute myocardial infarction. Pravastatin turkish trial (PTT)|
PTT 2002 {published and unpublished data}|Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty|/resolve/reference/PMED?id=12222700
RECIFE 1999 {published and unpublished data}|Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial|/resolve/reference/PMED?id=10385495
Ren 2009 {published data only}|Effect of simvastatin on plasma interleukin-6 in patients with unstable angina|/resolve/reference/PMED?id=19640331
Sakamoto 2005 {published data only (unpublished sought but not used)}|Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese|/resolve/reference/PMED?id=16616020
Shalnev VI 2007 {published data only}|The effects of early application of simvastatin on C-reactive protein level, blood lipids, and the clinical course of acutecoronary syndrome|/resolve/reference/PMED?id=18219956
Barderas 2009 {published data only}|Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome|
Bermejo 2006 {published data only}|Summary of the Clinical Studies Reported in the Scientific Sessions in the American Heart Association 2005 (Dallas, Texas, USA, 1316 November 2005)|
Cannon 2004a {published data only}|Intensive versus moderate lipid lowering with statins after acute coronary syndromes|/resolve/reference/PMED?id=15007110
Chi 2007 {published data only}|Long-term effects of simvastatin on protection against atrial fibrillation in patients with acute myocardial infarction|
Chiodini 2007 {published data only}|Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study|/resolve/reference/PMED?id=17567623
Colivicchi 2010 {published data only}|Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease|/resolve/reference/PMED?id=20367555
Correia 2002 {published data only}|Short-term effect of atorvastatin (80 mg) on plasma lipids of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction|/resolve/reference/PMED?id=12106850
de Winter 2005 {published data only}|Early invasive versus selectively invasive management for acute coronary syndromes|/resolve/reference/PMED?id=16162880
FLAME 2006 {published data only}|Early treatment with simvastatin in myocardial infarction to reduce the levels of multiple inflammatory markers in 6-month follow-up. FLAME randomized clinical trial|
Guazzi 2007 {published data only}|Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients|
Gmez-Doblas 2006 {published data only}|Influencia del tratamiento temprano con estatinas en la funcin endotelial tras el infarto de miocardio en pacientes con valores normales de colesterol. Estudio VAATOPE(VAlue of ATOrvastatin in Postinfarction Endothelium)|
Gmez-Hernndez 2008 {published data only}|Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome|/resolve/reference/PMED?id=18572029
Hiro 2009 {published data only}|Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] Study)|/resolve/reference/PMED?id=19608026
Kanadasi 2006 {published data only (unpublished sought but not used)}|The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol|/resolve/reference/PMED?id=17151816
Kashima 2009 {published data only}|Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study|/resolve/reference/PMED?id=19632524
Lablanche 2008 {published data only}|Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design|/resolve/reference/PMED?id=18809153
LAVA 2005 {published data only}|Early treatment with fluvastatin enhances the mobilization of CD34+, CD117+, CXCR4+, C-met+ stem cells into peripheral blood in patients with acute myocardial infarction: LAVA trial|
Lemos 2005 {published data only}|Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease|/resolve/reference/PMED?id=15708183
Li 2005 {published data only}|Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina|/resolve/reference/PMED?id=16120956
Li 2006 {published data only}|Effects of simvastatin within two weeks on anti-inflammatory cytokine interleukin 10 in patients with unstable angina|/resolve/reference/PMED?id=16085716
Link 2006 {published data only}|Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome|/resolve/reference/PMED?id=17012299
Nakamura 2008 {published data only}|Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome|/resolve/reference/PMED?id=18427279
Nakaya 2005 {published data only}|Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction|/resolve/reference/PMED?id=16207547
Ordulu 2008 {published data only}|Early effects of low versus high dose atorvastatin treatment on coagulation and inflammation parameters in patients with acute coronary syndromes|/resolve/reference/PMED?id=17655947
Ostadal 2003 {published data only}|The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction|/resolve/reference/PMED?id=12841342
Patti 2007 {published data only}|Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial|/resolve/reference/PMED?id=17394957
PEACE 2005 {published data only}|Pravastatin early use in acute coronary evaluation (PEACE) trial|
Pedersen 2000 {published data only}|Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study|/resolve/reference/PMED?id=10972631
Pedersen 2005 {published data only}|High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial|/resolve/reference/PMED?id=16287954
Pitt 2008 {published data only}|Lipid levels after acute coronary syndromes|/resolve/reference/PMED?id=18402897
Sakata 2005 {published data only}|Rationale and design of the OACIS-LIPID study that evaluates early use of pravastatin in acute myocardial infarction|
Shah 2007 {published data only}|Beneficial effects of the addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions|/resolve/reference/PMED?id=18650989
Stefanadi 2009 {published data only}|Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation|/resolve/reference/PMED?id=18187214
Teshima 2009 {published data only}|Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction|/resolve/reference/PMED?id=19167639
Tousoulis 2006a {published data only}|The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level|/resolve/reference/PMED?id=16002160
Tousoulis 2006b {published data only}|Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina|/resolve/reference/PMED?id=16337041
Xin-wei 2009 {published data only}|Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome|/resolve/reference/PMED?id=19323930
Yun 2009 {published data only}|The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome|/resolve/reference/PMED?id=18706705
Zhao 2009 {published data only}|Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina|
4S 1994|Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)|/resolve/reference/PMED?id=7968073
AHA 2007|Heart disease and stroke statistics - 2007 update|
Als-Nielsen 2003|Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?|/resolve/reference/PMED?id=12928469
Ara 2009|Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation|/resolve/reference/PMED?id=19604457
Aronow 2001|Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study|/resolve/reference/PMED?id=11297956
Bassler 2010|Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis|/resolve/reference/PMED?id=20332404
Briel 2004|Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=15465509
Cannon 2004b|Intensive versus moderate lipid lowering with statins after acute coronary syndromes|/resolve/reference/PMED?id=15007110
Deeks 1998|Much ado about nothing: statistical methods for meta-analysis with rare events|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Fonarow 2005|Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality|/resolve/reference/PMED?id=16125480
Freemantle 2003|Composite outcomes in randomized trials: greater precision but with greater uncertainty?|/resolve/reference/PMED?id=12759327
Glesby 1996|Survivor treatment selection bias in observational studies: examples from the AIDS literature|/resolve/reference/PMED?id=8624068
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
HPS 2002|MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial|/resolve/reference/PMED?id=12114036
Hulten 2006|The effect of early, intensive statin therapy on acute coronary syndrome. A meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=17000936
Jackevicius 2002|Adherence with statin therapy in elderly patients with and without acute coronary syndromes|/resolve/reference/PMED?id=12132976
Juni 1999|The hazards of scoring the quality of clinical trials for meta-analysis|/resolve/reference/PMED?id=10493204
Kumar 2009|Acute coronary syndromes: diagnosis and management, part I|/resolve/reference/PMED?id=19797781
Lachin 2000|Sample size, power, and efficiency|
Laupacis 2004|Observational studies of treatment effectiveness: some cautions|/resolve/reference/PMED?id=15172907
LIPID Study Group 1998|Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group|/resolve/reference/PMED?id=9841303
Montori 2005|Validity of composite end points in clinical trials|/resolve/reference/PMED?id=15761002
Morrissey 2009|Statins in acute coronary syndromes: do the guideline recommendations match the evidence?|/resolve/reference/PMED?id=19796735
Newby 2002|Early statin initiation and outcomes in patients with acute coronary syndromes|/resolve/reference/PMED?id=12069671
Nordmann 2000|Systematic, immediate in-hospital initiation of lipid-lowering drugs during acute coronary events improves lipid control|/resolve/reference/PMED?id=11113654
Redelmeier 1998|The treatment of unrelated disorders in patients with chronic medical diseases|/resolve/reference/PMED?id=9593791
Ridker 1998|Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators|/resolve/reference/PMED?id=9738637
Rosenson 1998|Antiatherothrombotic properties of statins: implications for cardiovascular event reduction|/resolve/reference/PMED?id=9613915
Serruys 2002|Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial|/resolve/reference/PMED?id=12076217
Shepherd 1995|Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group|/resolve/reference/PMED?id=7566020
Smith 2005|Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial|/resolve/reference/PMED?id=15864232
Spencer 2004|Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study|/resolve/reference/PMED?id=15172899
Sposito 2002|Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit|/resolve/reference/PMED?id=12377727
Staffa 2002|Cerivastatin and reports of fatal rhabdomyolysis|/resolve/reference/PMED?id=11844864
Stenestrand 2001|Early statin treatment following acute myocardial infarction and 1-year survival|/resolve/reference/PMED?id=11242427
Sterne 2001|Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis|/resolve/reference/PMED?id=11451790
Studer 2005|Effect of different antilipidemic agents and diets on mortality: a systematic review|/resolve/reference/PMED?id=15824290
Thygesen 2007|Universal definition of myocardial infarction|/resolve/reference/PMED?id=17951287
Walter 2004|Insights into early and rapid effects of statin therapy after coronary interventions|/resolve/reference/PMED?id=14965198
Wood 1998|Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention|/resolve/reference/PMED?id=9820987
Briel 2006a|Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes. A meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=16670413
Briel 2006b|5012 Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a systematic review and collaborative meta-analysis of randomized trials|
Briel 2011|Updated evidence on early statin therapy for acute coronary syndromes: Meta-analysis of 18 randomized trials involving over 14,000 patients|
Colivicchi 2002 {published and unpublished data}|Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction|/resolve/reference/PMED?id=12372577
de Lemos 2004 {published and unpublished data}|Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial|/resolve/reference/PMED?id=15337732
ESTABLISH 2004 {published and unpublished data}|Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study|/resolve/reference/PMED?id=15326073
FACS 2010 {published and unpublished data}|Fluvastatin in the therapy of acute coronary syndrome: rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)|/resolve/reference/PMED?id=15790413
FACS 2010 {published and unpublished data}|Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)|/resolve/reference/PMED?id=20500832
FLORIDA 2002 {published and unpublished data}|Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial|/resolve/reference/PMED?id=12473255
LAMIL 1997 {published data only (unpublished sought but not used)}|Time course of serum lipids and apolipoproteins after acute myocardial infarction: modification by pravastatin|/resolve/reference/PMED?id=9187418
L-CAD 2000 {published and unpublished data}|Beneficial effects of pravastatin (+/- colestyramine/niacin) initiated immediately after a coronary event (the randomized lipid-coronary artery disease [L-CAD] study)|/resolve/reference/PMED?id=11113401
LIPS 2002 {published and unpublished data}|Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial|/resolve/reference/PMED?id=12076217
Macin 2005 {published and unpublished data}|Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=15864233
MIRACL 2001 {published and unpublished data}|Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial|/resolve/reference/PMED?id=11277825
OACIS-LIPID 2008 {published data only (unpublished sought but not used)}|Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID study|/resolve/reference/PMED?id=18159093
PACT 2004 {published and unpublished data}|Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial|
PAIS 2001 {published and unpublished data}|Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial|/resolve/reference/PMED?id=11452676
PRINCESS 2004 {unpublished data only}|Reductions in early recurrent coronary ischemia from early administration of statin therapy upon admission for myocardial infarction: results of the PRINCESS trial|
PRINCESS 2004 {unpublished data only}|PRINCESS: Prevention of ischaemic events by early treatment of cerivastatin after acute myocardial infarction|
PTT 2002 {published and unpublished data}|The effect of statin therapy on ventricular late potentials in acute myocardial infarction|/resolve/reference/PMED?id=12821221
PTT 2002 {published and unpublished data}|The short term results of combined use of pravastatin with thrombolytic therapy in acute myocardial infarction [abstract]|
PTT 2002 {published and unpublished data}|Combined use of pravastatin and thrombolytic agents in acute myocardial infarction. Pravastatin turkish trial (PTT)|
PTT 2002 {published and unpublished data}|Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty|/resolve/reference/PMED?id=12222700
RECIFE 1999 {published and unpublished data}|Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial|/resolve/reference/PMED?id=10385495
Ren 2009 {published data only}|Effect of simvastatin on plasma interleukin-6 in patients with unstable angina|/resolve/reference/PMED?id=19640331
Sakamoto 2005 {published data only (unpublished sought but not used)}|Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese|/resolve/reference/PMED?id=16616020
Shal'nev 2007 {published data only}|The effects of early application of simvastatin on C-reactive protein level, blood lipids, and the clinical course of acute coronary syndrome|/resolve/reference/PMED?id=18219956
Akasaka 2012 {published data only}|Effect of intensive vs. moderate lipid-lowering therapy with atorvastatin on the stabilization of atherosclerosis in acute coronary syndromes: serial optical coherence tomography analysis|
Barderas 2009 {published data only}|Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome|
Bermejo 2006 {published data only}|Summary of the Clinical Studies Reported in the Scientific Sessions in the American Heart Association 2005 (Dallas, Texas, USA, 1316 November 2005)|
Cannon 2004a {published data only}|Intensive versus moderate lipid lowering with statins after acute coronary syndromes|/resolve/reference/PMED?id=15007110
Chi 2007 {published data only}|Long-term effects of simvastatin on protection against atrial fibrillation in patients with acute myocardial infarction|
Chiodini 2007 {published data only}|Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study|/resolve/reference/PMED?id=17567623
Chyrchel 2011 {published data only}|Effects of short-term anti-inflammatory therapy on endothelial function in patients with non-ST-segment elevation acute coronary syndrome|/resolve/reference/PMED?id=21241965
Colivicchi 2010 {published data only}|Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease|/resolve/reference/PMED?id=20367555
Colivicchi 2010a {published data only}|Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease|
Colivicchi 2011 {published data only}|Full-dose atorvastatin reduces hospitalizations for heart failure after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease|
Correia 2002 {published data only}|Short-term effect of atorvastatin (80 mg) on plasma lipids of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction|/resolve/reference/PMED?id=12106850
de Winter 2005 {published data only}|Early invasive versus selectively invasive management for acute coronary syndromes|/resolve/reference/PMED?id=16162880
Dohi 2010 {published data only}|Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study|/resolve/reference/PMED?id=20036363
FLAME 2006 {published data only}|Early treatment with simvastatin in myocardial infarction to reduce the levels of multiple inflammatory markers in 6-month follow-up. FLAME randomized clinical trial|
Ge 2010 {published data only}|Design and rationale of a study in Asia of atorvastatin pretreatment in patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndromes|/resolve/reference/PMED?id=20350523
Gmez-Doblas 2006 {published data only}|Effect of statin treatment begun early after acute myocardial infarction on endothelial function in patients with normal levels of cholesterol. VAATOPE Study (VAlue of ATOrvastatin in Postinfarction Endothelium)|/resolve/reference/PMED?id=16650363
Gmez-Hernndez 2008 {published data only}|Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome|/resolve/reference/PMED?id=18572029
Guazzi 2007 {published data only}|Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients|
Hall 2009 {published data only}|A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial|
He 2011 {published data only}|The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome|
Hiro 2009 {published data only}|Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] Study)|/resolve/reference/PMED?id=19608026
Hiro 2009a {published data only}|Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)|/resolve/reference/PMED?id=19608026
Hiro 2010 {published data only}|Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial)|/resolve/reference/PMED?id=20467151
Kanadasi 2006 {published data only (unpublished sought but not used)}|The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol|/resolve/reference/PMED?id=17151816
Kashima 2009 {published data only}|Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study|/resolve/reference/PMED?id=19632524
Kuznetsova 2010 {published data only}|Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation|/resolve/reference/PMED?id=20146674
Lablanche 2008 {published data only}|Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: the CENTAURUS trial design|/resolve/reference/PMED?id=18809153
LAVA 2005 {published data only}|Early treatment with fluvastatin enhances the mobilization of CD34+, CD117+, CXCR4+, C-met+ stem cells into peripheral blood in patients with acute myocardial infarction: LAVA trial|
Lemos 2005 {published data only}|Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease|/resolve/reference/PMED?id=15708183
Leone 2008 {published data only}|Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial|/resolve/reference/PMED?id=18667247
Li 2005 {published data only}|Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina|/resolve/reference/PMED?id=16120956
Li 2006 {published data only}|Effects of simvastatin within two weeks on anti-inflammatory cytokine interleukin 10 in patients with unstable angina|/resolve/reference/PMED?id=16085716
Lim 2012 {published data only}|Effect on short- and long-term major adverse cardiac events of statin treatment in patients with acute myocardial infarction and renal dysfunction|/resolve/reference/PMED?id=22356794
Link 2006 {published data only}|Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome|/resolve/reference/PMED?id=17012299
Link 2006a {published data only}|Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome|/resolve/reference/PMED?id=17012299
Link 2011 {published data only}|Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes|/resolve/reference/PMED?id=20852871
Liu 2012 {published data only}|Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study): rationale and design|
Miyauchi 2006 {published data only}|Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): rationale and design|/resolve/reference/PMED?id=17127811
Monteiro 2008 {published data only}|Early effects of lipid lowering treatment in subjects with metabolic syndrome and acute coronary syndromes|
Nakamura 2008 {published data only}|Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome|/resolve/reference/PMED?id=18427279
Nakaya 2005 {published data only}|Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction|/resolve/reference/PMED?id=16207547
Ordulu 2008 {published data only}|Early effects of low versus high dose atorvastatin treatment on coagulation and inflammation parameters in patients with acute coronary syndromes|/resolve/reference/PMED?id=17655947
Ostadal 2003 {published data only}|The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction|/resolve/reference/PMED?id=12841342
Patti 2007 {published data only}|Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial|/resolve/reference/PMED?id=17394957
PEACE 2005 {published data only}|Pravastatin early use in acute coronary evaluation (PEACE) trial|
Pedersen 2000 {published data only}|Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study|/resolve/reference/PMED?id=10972631
Pedersen 2005 {published data only}|High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial|/resolve/reference/PMED?id=16287954
Pitt 2008 {published data only}|Lipid levels after acute coronary syndromes|/resolve/reference/PMED?id=18402897
Pitt 2012 {published data only}|Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study)|/resolve/reference/PMED?id=22360820
Post 2012 {published data only}|Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial|
Sakata 2005 {published data only}|Rationale and design of the OACIS-LIPID study that evaluates early use of pravastatin in acute myocardial infarction|
Shah 2007 {published data only}|Beneficial effects of the addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions|/resolve/reference/PMED?id=18650989
Stefanadi 2009 {published data only}|Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation|/resolve/reference/PMED?id=18187214
Suh 2011 {published data only}|Long-term safety and efficacy of pitavastatin in patients with acute myocardial infarction (from the Livalo Acute Myocardial Infarction Study [LAMIS])|/resolve/reference/PMED?id=21890083
Teshima 2009 {published data only}|Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction|/resolve/reference/PMED?id=19167639
Tousoulis 2006 {published data only}|The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level|/resolve/reference/PMED?id=16002160
Tousoulis 2006a {published data only}|The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level|/resolve/reference/PMED?id=16002160
Tousoulis 2006b {published data only}|Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina|/resolve/reference/PMED?id=16337041
Xin-wei 2009 {published data only}|Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome|/resolve/reference/PMED?id=19323930
Yun 2009 {published data only}|The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome|/resolve/reference/PMED?id=18706705
Zhang 2013 {published data only}|Intensive-dose atorvastatin regimen halts progression of atherosclerotic plaques in new-onset unstable angina with borderline vulnerable plaque lesions|/resolve/reference/PMED?id=23139359
Zhao 2009 {published data only}|Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina|
Zheng 2009 {published data only}|Early effect of atorvastatin, alone and in combination with probucol, on endothelial dysfunction in patients with acute coronary syndrome|
Zheng 2009a {published data only}|Effects of atorvastatin, alone and in combination with probucol on endothelial function in patients with acute coronary syndrome|
4S 1994|Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)|/resolve/reference/PMED?id=7968073
AHA 2007|Heart disease and stroke statistics - 2007 update|
Als-Nielsen 2003|Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?|/resolve/reference/PMED?id=12928469
Ara 2009|Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation|/resolve/reference/PMED?id=19604457
Armitage 2010|Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial|/resolve/reference/PMED?id=21067805
Aronow 2001|Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study|/resolve/reference/PMED?id=11297956
Baigent 2010|Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials|/resolve/reference/PMED?id=21067804
Briel 2004|Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=15465509
Cannon 2004b|Intensive versus moderate lipid lowering with statins after acute coronary syndromes|/resolve/reference/PMED?id=15007110
Deeks 1998|Much ado about nothing: statistical methods for meta-analysis with rare events|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Dickersin 1994|Identifying relevant studies for systematic reviews|/resolve/reference/PMED?id=7718048
Fonarow 2005|Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality|/resolve/reference/PMED?id=16125480
Freemantle 2003|Composite outcomes in randomized trials: greater precision but with greater uncertainty?|/resolve/reference/PMED?id=12759327
Glesby 1996|Survivor treatment selection bias in observational studies: examples from the AIDS literature|/resolve/reference/PMED?id=8624068
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
HPS 2002|MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial|/resolve/reference/PMED?id=12114036
Hulten 2006|The effect of early, intensive statin therapy on acute coronary syndrome. A meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=17000936
Jackevicius 2002|Adherence with statin therapy in elderly patients with and without acute coronary syndromes|/resolve/reference/PMED?id=12132976
Kumar 2009|Acute coronary syndromes: diagnosis and management, part I|/resolve/reference/PMED?id=19797781
Lachin 2000|Sample size, power, and efficiency|
Laupacis 2004|Observational studies of treatment effectiveness: some cautions|/resolve/reference/PMED?id=15172907
Lefebvre 2011|Chapter 6: Searching for studies|
LIPID Study Group 1998|Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group|/resolve/reference/PMED?id=9841303
Montori 2005|Validity of composite end points in clinical trials|/resolve/reference/PMED?id=15761002
Morrissey 2009|Statins in acute coronary syndromes: do the guideline recommendations match the evidence?|/resolve/reference/PMED?id=19796735
Newby 2002|Early statin initiation and outcomes in patients with acute coronary syndromes|/resolve/reference/PMED?id=12069671
Nordmann 2000|Systematic, immediate in-hospital initiation of lipid-lowering drugs during acute coronary events improves lipid control|/resolve/reference/PMED?id=11113654
Redelmeier 1998|The treatment of unrelated disorders in patients with chronic medical diseases|/resolve/reference/PMED?id=9593791
Ridker 1998|Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators|/resolve/reference/PMED?id=9738637
Rosenson 1998|Antiatherothrombotic properties of statins: implications for cardiovascular event reduction|/resolve/reference/PMED?id=9613915
Serruys 2002|Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial|/resolve/reference/PMED?id=12076217
Shepherd 1995|Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group|/resolve/reference/PMED?id=7566020
Smith 2005|Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial|/resolve/reference/PMED?id=15864232
Spencer 2004|Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study|/resolve/reference/PMED?id=15172899
Sposito 2002|Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit|/resolve/reference/PMED?id=12377727
Staffa 2002|Cerivastatin and reports of fatal rhabdomyolysis|/resolve/reference/PMED?id=11844864
Stenestrand 2001|Early statin treatment following acute myocardial infarction and 1-year survival|/resolve/reference/PMED?id=11242427
Sterne 2001|Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis|/resolve/reference/PMED?id=11451790
Stone 2013|2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines|
Studer 2005|Effect of different antilipidemic agents and diets on mortality: a systematic review|/resolve/reference/PMED?id=15824290
Thygesen 2007|Universal definition of myocardial infarction|/resolve/reference/PMED?id=17951287
Walter 2004|Insights into early and rapid effects of statin therapy after coronary interventions|/resolve/reference/PMED?id=14965198
Wood 1998|Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention|/resolve/reference/PMED?id=9820987
Briel 2006a|Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes. A meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=16670413
Briel 2006b|5012 Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a systematic review and collaborative meta-analysis of randomized trials|
Briel 2011|Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patients|
Vale 2011|Statins for acute coronary syndrome|/resolve/reference/PMED?id=21678362
Ardizzone 2004 {published data only}|Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease|/resolve/reference/PMED?id=15362028
Brignola 1995 {published data only}|Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group|/resolve/reference/PMED?id=7835575
Caprilli 2003 {published data only}|Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial|
Chermesh 2007 {published data only}|Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease|/resolve/reference/PMED?id=17211699
Colombel 2001 {published data only}|Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease|/resolve/reference/PMED?id=11413109
D'Haens 2008 {published data only}|Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial|/resolve/reference/PMED?id=18727929
Ewe 1989 {published data only}|Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial|/resolve/reference/PMED?id=2572495
Ewe 1999 {published data only}|Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group|/resolve/reference/PMED?id=10333200
Fiasse 1991 {published data only}|Prevention of Crohn's disease recurrences after intestinal resection with Eudragid-L-coated 5-aminosalicylic acid. Preliminary results of a one year double-blind placebo controlled study|
Florent 1996 {published data only}|Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID)|/resolve/reference/PMED?id=8724022
Hanauer 2004 {published data only}|Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial|/resolve/reference/PMED?id=15362027
Hellers 1999 {published data only}|Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group|/resolve/reference/PMED?id=9922309
Herfarth 2006 {published and unpublished data}|Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease.|/resolve/reference/PMED?id=16966711
Lochs 2000 {published data only}|Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI|/resolve/reference/PMED?id=10648454
Madsen 2008 {published data only}|A randomized controlled trial of VSL#3 for the prevention of endoscopic recurrence following surgery for Crohn's disease|
Marteau 2006 {published data only}|Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial|/resolve/reference/PMED?id=16377775
McLeod 1995 {published data only}|Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease|/resolve/reference/PMED?id=7615189
Nos 2000 {published data only}|[Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease]|/resolve/reference/PMED?id=11227650
Prantera 2002 {published data only}|Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG|/resolve/reference/PMED?id=12171964
Regueiro 2009 {published data only}|Infliximab prevents Crohn's disease recurrence after ileal resection|/resolve/reference/PMED?id=19109962
Rutgeerts 1995 {published data only}|Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection|/resolve/reference/PMED?id=7768364
Rutgeerts 2005 {published data only}|Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=15825069
Van Gossum 2007 {published data only}|Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection|
Abdelli 2007 {published data only}|[Azathioprine for prevention of postoperative recurrence in Crohn's disease]|/resolve/reference/PMED?id=18064988
Achkar 2000 {published data only}|Medical therapy to reduce postoperative Crohn's disease recurrence|
Achkar 2001 {published data only}|Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence|/resolve/reference/PMED?id=11696286
Alves 2004 {published data only}|Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease?|
Ambrose 1985 {published data only}|Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. A prospective randomized study|/resolve/reference/PMED?id=3882364
Ardizzone 2003 {published data only}|[Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease]|/resolve/reference/PMED?id=15206802
Bakkevold 2000 {published data only}|Nipple valve anastomosis for preventing recurrence of Crohn disease in the neoterminal ileum after ileocolic resection. A prospective pilot study|/resolve/reference/PMED?id=10766324
Belluzzi 1996 {published data only}|Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease|/resolve/reference/PMED?id=8628335
Bemelman 2001 {published data only}|How effective is extensive nonsurgical treatment of patients with clinically active Crohn's disease of the terminal ileum in preventing surgery?|
Berebbi 1993 {published data only}|Treatment of Crohn's disease recurrence after ileoanal anastomosis by azathioprine|/resolve/reference/PMED?id=8344116
Bergman 1976 {published data only}|Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease.|/resolve/reference/PMED?id=11545
Biancone 2006 {published data only}|Local injection of infliximab in the postoperative recurrence of Crohn's disease|/resolve/reference/PMED?id=16500402
Blumberg 1990 {published data only}|Transfusion-induced immunomodulation and its clinical consequences|/resolve/reference/PMED?id=2134638
Borley 1997 {published data only}|Preventing postoperative recurrence of Crohn's disease|/resolve/reference/PMED?id=9393267
Cameron 1992 {published data only}|Patterns of ileal recurrence in Crohn's disease. A prospective randomized study|/resolve/reference/PMED?id=1616391
Caprilli 1994 {published data only}|Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)|
Caprilli 1996 {published data only}|Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)|/resolve/reference/PMED?id=8603558
Cottone 2003 {published data only}|Review article: prevention of postsurgical relapse and recurrence in Crohn's disease|
Cuillerier 2001 {published data only}|Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study|/resolve/reference/PMED?id=11692053
D'Haens 1999a {published data only}|Prevention of postoperative recurrence in Crohn's disease|/resolve/reference/PMED?id=10980989
D'Haens 1999b {published data only}|Postoperative recurrence of Crohn's disease: pathophysiology and prevention|
de Jong 2007 {published data only}|Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission|/resolve/reference/PMED?id=17954953
Dirks 1989 {published data only}|Clinical relapse of Crohn's disease under standardized conservative treatment and after excisional surgery|/resolve/reference/PMED?id=2574656
Domenech 2004 {published data only}|[Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study]|/resolve/reference/PMED?id=15574279
Domenech 2008 {published data only}|Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study|
Ellis 2006 {published data only}|Fibrin glue as an adjunct to flap repair of anal fistulas: a randomized, controlled study|/resolve/reference/PMED?id=17053867
Esaki 2005 {published data only}|Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy|/resolve/reference/PMED?id=16316891
Ewe 1976 {published data only}|[Prevention of recurrence by salazosulfapyridine (azulfidine) therapy in Crohn's disease. A double blind study]|/resolve/reference/PMED?id=18856
Ewe 1980 {published data only}|[Surgical and internal medicine therapy study of the postoperative prevention of recurrence in Crohn's disease - completion of a partly randomized study]|/resolve/reference/PMED?id=7013325
Ewe 1981 {published data only}|[Effectiveness of Azulfidine/Salazopyrin in the postoperative prevention of recurrence in Crohn disease]|/resolve/reference/PMED?id=6168134
Ewe 1984 {published data only}|[Radical operation and recurrence prevention with azulfidine in Crohn disease: a prospective multicenter study--initial results]|/resolve/reference/PMED?id=6150408
Fazio 1996 {published data only}|Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial|/resolve/reference/PMED?id=8857860
Feagan 1994 {published data only}|Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators|/resolve/reference/PMED?id=8196727
Feagan 2003 {published data only}|Maintenance therapy for inflammatory bowel disease|/resolve/reference/PMED?id=14697913
Fedorak 2000 {published data only}|Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group|/resolve/reference/PMED?id=11113068
Froehlich 2005 {published data only}|Treatment of postoperative Crohn's disease|/resolve/reference/PMED?id=15711050
Garcia 2001 {published data only}|Abscesses in Crohn's disease: outcome of medical versus surgical treatment|/resolve/reference/PMED?id=11319312
Gardiner 2007 {published data only}|Operative management of small bowel Crohn's disease|/resolve/reference/PMED?id=17560414
Ghidirim 2007 {published data only}|[Recurrent Crohn's disease in the ileocolonic anastomosis complicated with duodenal fistula]|/resolve/reference/PMED?id=18018365
Gooszen 1994 {published data only}|Protective effect of blood transfusions on postoperative recurrence of Crohn's disease in parous women|/resolve/reference/PMED?id=7936008
Gross 1995 {published data only}|[Crohn disease: prevention and drug therapy]|/resolve/reference/PMED?id=7587538
Hamedani 1997 {published data only}|Review article: Drug development in inflammatory bowel disease: budesonide--a model of targeted therapy|/resolve/reference/PMED?id=9467984
Hanauer 2003 {published data only}|Crohn's disease: step up or top down therapy|/resolve/reference/PMED?id=12617888
Hancock 2006 {published data only}|Inflammatory bowel disease: the view of the surgeon|
Ikeuchi 2000 {published data only}|Long-term results of stapled and hand-sewn anastomoses in patients with Crohn's disease|/resolve/reference/PMED?id=11124554
Kader 1997 {published data only}|Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period: a preliminary evaluation of recurrence of disease|/resolve/reference/PMED?id=9226535
Kennedy 1998 {published data only}|Patients' perceptions of their participation in a clinical trial for postoperative Crohn's disease|/resolve/reference/PMED?id=9659568
Klein 1995 {published data only}|Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease|/resolve/reference/PMED?id=7484997
Koop 1994 {published data only}|[Is preventive drug therapy of recurrent Crohn disease indicated after ileocecal resection?]|/resolve/reference/PMED?id=7908661
Korelitz 1998 {published data only}|Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: A 2 year multicenter trial|
Kusunoki 1998 {published data only}|A comparison of stapled and hand-sewn anastomoses in Crohn's disease|/resolve/reference/PMED?id=9845636
Lemann 2006a {published data only}|Review article: can post-operative recurrence in Crohn's disease be prevented?|
Lemann 2006b {published data only}|Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial|/resolve/reference/PMED?id=16618399
Levenstein 1985 {published data only}|Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients|/resolve/reference/PMED?id=2996991
MacDonald 2006 {published data only}|Omega-3 fatty acids as adjunctive therapy in Crohns disease|/resolve/reference/PMED?id=16974165
Mahmud 2001 {published data only}|Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study|/resolve/reference/PMED?id=11559654
Mamula 2000 {published data only}|Postsurgical recurrences in Crohn's disease: why, when and how to prevent them|/resolve/reference/PMED?id=10817289
McIntyre 1986 {published data only}|Controlled trial of bowel rest in the treatment of severe acute colitis|/resolve/reference/PMED?id=3084344
McLeod 1996 {published data only}|Is it possible to prevent recurrent Crohn's disease with medical or surgical interventions?|/resolve/reference/PMED?id=8819803
Mekhijan 1979 {published data only}|Clinical features and natural history of Crohn's disease|/resolve/reference/PMED?id=381094
Morretini 1981 {published data only}|[Evaluation of the results of radical surgical treatment of Crohn disease as related to a diversified postoperative treatment]|/resolve/reference/PMED?id=6115459
Myrelid 2006 {published data only}|Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease|/resolve/reference/PMED?id=16990204
O'Brien 1991 {published data only}|Elemental diet in steroid-dependent and steroid-refractory Crohn's disease|/resolve/reference/PMED?id=1951239
Prantera 1999 {published data only}|Current treatment for prevention of relapse and recurrence in Crohn's disease|/resolve/reference/PMED?id=10575572
Qasim 2001 {published data only}|Aminosalicylate as prophylaxis for Crohn's disease|/resolve/reference/PMED?id=11758501
Regimbeau 1999 {published data only}|Surgical treatment of anoperineal Crohn's disease: can abdominoperineal resection be predicted?|/resolve/reference/PMED?id=10437839
Reinisch 2008 {published data only}|A Double-Blind, Double-Dummy, Randomized, Controlled, Multicenter Trial On the Efficacy and Safety of Azathioprine Vs mesalamine for Prevention of Clinical Relapses in Crohn's Disease Patients with Postoperative Moderate or Severe Endoscopic Recurrence|
Rutgeerts 2003 {published data only}|Strategies in the prevention of post-operative recurrence in Crohn's disease|/resolve/reference/PMED?id=12617883
Ryan 2004 {published data only}|Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence|/resolve/reference/PMED?id=14769308
Sandborn 2004 {published data only}|The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain|/resolve/reference/PMED?id=15362055
Scarpa 2007 {published data only}|Surgical predictors of recurrence of Crohn's disease after ileocolonic resection|/resolve/reference/PMED?id=17534633
Seibold 2003 {published data only}|[Does conservative therapy of chronic inflammatory bowel diseases still play a role?]|/resolve/reference/PMED?id=12815833
Sninsky 2001 {published data only}|Altering the natural history of Crohn's disease?|
Sorrentino 2006 {published data only}|Prevention of postoperative recurrence of Crohn's disease by infliximab|/resolve/reference/PMED?id=16538123
Sorrentino 2007 {published data only}|Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease|/resolve/reference/PMED?id=17846401
Stein 1999 {published data only}|Medical therapy for inflammatory bowel disease|/resolve/reference/PMED?id=10372270
Steinhart 1992 {published data only}|Application of a stopping rule based on total treatment failures: the postoperative Crohn's disease trial|/resolve/reference/PMED?id=1588355
Steinhart 2007 {published data only}|Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease|
Sutherland 2000 {published data only}|Prevention of relapse of Crohn's disease|
Tay 2003 {published data only}|Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty|/resolve/reference/PMED?id=14605616
Travis 2001 {published data only}|Azathioprine for prevention of postoperative recurrence in Crohn's disease|/resolve/reference/PMED?id=11692049
Van Assche 2004 {published data only}|Medical management of postoperative recurrence in Crohn's disease|/resolve/reference/PMED?id=15177543
Van Hogezand 1998 {published data only}|Management of recurrent Crohn's disease|/resolve/reference/PMED?id=9883012
Viscido 1999 {published data only}|"Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto|/resolve/reference/PMED?id=10425569
Volk-Zeiher 1998 {published data only}|[Therapy of Crohn disease in internal medicine: postoperative recurrence and fistulas]|/resolve/reference/PMED?id=9881040
Yamamoto 2005 {published data only}|Factors affecting recurrence after surgery for Crohn's disease|/resolve/reference/PMED?id=15996018
Yamamoto 2007 {published data only}|Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study|
Akobeng 2005|Oral 5-aminosalicylic acid for maintenance of medically-induced remission inCrohn's Disease.|/resolve/reference/PMED?id=15674913
Bernell 2000|Risk factors for surgery and postoperative recurrence in Crohn's disease|/resolve/reference/PMED?id=10636100
Delaney 2003|Quality of life improves within 30 days of surgery for Crohn's disease|/resolve/reference/PMED?id=12742203
Higgins 2008|Chapter 8: Assessing risk of bias in included studies|
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blindingnecessary?|/resolve/reference/PMED?id=8721797
Larson 2004|Current conceps and controversies in surgery for IBD|/resolve/reference/PMED?id=15168371
Olaison 1992|Natural course of Crohn's disease after ileocolic resection: endoscopically visualized ileal ulcers preceding symptoms|/resolve/reference/PMED?id=1568651
Otley 2005|Budesonide for induction of remission in Crohn's disease|/resolve/reference/PMED?id=16235274
Peyrin-Biroulet 2009|Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis.|/resolve/reference/PMED?id=19568226
Prefontaine 2009|Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.|/resolve/reference/PMED?id=19160175
Regueiro 2009|Infliximab prevents Crohn's disease recurrence after ileal resection|/resolve/reference/PMED?id=19109962
Rutgeerts 1984|Natural history of recurrent Crohn's disease at the ileocolonic anastomosis aftercurative surgery.|/resolve/reference/PMED?id=6735250
Rutgeerts 1990|Predictability of the postoperative course of Crohn's disease|/resolve/reference/PMED?id=2394349
Sokol 2008|Faecalibacterium prausnitzii is an anti-inflammatory commensal bacteriumidentified by gut microbiota analysis of Crohn disease patients|/resolve/reference/PMED?id=18936492
Travis 2006|European evidence based consensus on the diagnosis and management of Crohn's disease: current management|/resolve/reference/PMED?id=16481629
Bock 2008 {published data only}|Smoking cessation among patients in an emergency chest pain observation unit: outcomes of the Chest Pain Smoking Study (CPSS)|/resolve/reference/PMED?id=18946771
Borrelli 2005 {published data only}|Home health care nurses as a new channel for smoking cessation treatment: outcomes from project CARES (Community-nurse Assisted Research and Education on Smoking)|/resolve/reference/PMED?id=16182355
Butler 1999 {published data only}|Motivational consulting versus brief advice for smokers in general practice: a randomized trial|
Cigrang 2002 {published data only}|Pilot evaluation of a population-based health intervention for reducing use of smokeless tobacco|/resolve/reference/PMED?id=11906689
Curry 2003 {published data only}|Pediatric-based smoking cessation intervention for low-income women|/resolve/reference/PMED?id=12622686
Dornelas 2000 {published data only}|A randomized controlled trial of smoking cessation counseling after myocardial infarction|/resolve/reference/PMED?id=10731452
Glasgow 2000 {published data only}|A brief smoking cessation intervention for women in low-income planned parenthood clinics|/resolve/reference/PMED?id=10800431
Hennrikus 2005 {published data only}|The TEAM project: the effectiveness of smoking cessation intervention with hospital patients|/resolve/reference/PMED?id=15533536
Hokanson 2006 {published data only}|Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco|/resolve/reference/PMED?id=16873594
Hollis 2007 {published data only}|The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline|/resolve/reference/PMED?id=18048633
McClure 2005 {published data only}|Proactive, motivationally enhanced smoking cessation counseling among women with elevated cervical cancer risk|/resolve/reference/PMED?id=16298723
Rigotti 1997 {published data only}|Efficacy of a smoking cessation program for hospital patients|/resolve/reference/PMED?id=9531235
Soria 2006 {published data only}|A randomised controlled trial of motivational interviewing for smoking cessation|/resolve/reference/PMED?id=17007707
Stein 2006 {published data only}|A smoking cessation intervention for the methadone-maintained|
Abdullah 2005 {published data only}|Smoking cessation intervention in parents of young children: a randomised controlled trial|
Ahluwalia 2006 {published data only}|The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design|
Baker 2006 {published data only}|A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder|/resolve/reference/PMED?id=17074945
Carpenter 2004 {published data only}|Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit|/resolve/reference/PMED?id=15279521
Chan 2005 {published data only}|A randomized controlled trial of an individualized motivational intervention on smoking cessation for parents of sick children: a pilot study|/resolve/reference/PMED?id=16106336
Colby 2005 {published data only}|Brief motivational intervention for adolescent smokers in medical settings|/resolve/reference/PMED?id=15893085
Cornuz 2002 {published data only}|Efficacy of resident training in smoking cessation: a randomized, controlled trial of a program based on application of behavioral theory and practice with standardized patients|/resolve/reference/PMED?id=11900495
Emmons 2001 {published data only}|A randomized trial to reduce passive smoke exposure in low-income households with young children|/resolve/reference/PMED?id=11433049
Emmons 2005 {published data only}|Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the Partnership for Health Study|/resolve/reference/PMED?id=16116148
Erol 2008 {published data only}|Application of a stage based motivational interviewing approach to adolescent smoking cessation: The Transtheoretical Model-based study|/resolve/reference/PMED?id=18304775
George 2000 {published data only}|Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia|/resolve/reference/PMED?id=11058482
Gilbert 2006 {published data only}|Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial|
Gray 2005 {published data only}|The effectiveness of motivational interviewing delivered by youth workers in reducing drinking, cigarette and cannabis smoking among young people: quasi-experimental pilot study|
Helstrom 2007 {published data only}|Motivational enhancement therapy for high-risk adolescent smokers|/resolve/reference/PMED?id=17428617
Herman 2003 {published data only}|A motivational intervention to reduce cigarette smoking among college students: overview and exploratory investigation|
Hollis 2005 {published data only}|Teen reach: outcomes from a randomized, controlled trial of a tobacco reduction program for teens seen in primary medical care|/resolve/reference/PMED?id=15805374
Horn 2007 {published data only}|Efficacy of an emergency department-based motivational teenage smoking intervention|/resolve/reference/PMED?id=17173716
Kelly 2006 {published data only}|The HYP program-Targeted motivational interviewing for adolescent violations of school tobacco policy|/resolve/reference/PMED?id=16920183
Manfredi 2004 {published data only}|Long-term effects (up to 18 months) of a smoking cessation program among women smokers in public health clinics|/resolve/reference/PMED?id=14672637
McHugh 2001 {published data only}|Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial|/resolve/reference/PMED?id=11514487
Okuyemi 2007 {published data only}|Pathways to Health: a cluster randomized trial of nicotine gum and motivational interviewing for smoking cessation in low-income housing|/resolve/reference/PMED?id=16778147
Persson 2006 {published data only}|Smoking cessation in patients with diabetes mellitus: results from a controlled study of an intervention programme in primary healthcare in Sweden|/resolve/reference/PMED?id=16690554
Pisinger 2005a {published data only}|Smoking reduction intervention in a large population-based study. The Inter99 study|/resolve/reference/PMED?id=15530588
Pisinger 2005b {published data only}|Smoking cessation intervention in a large randomised population-based study. The Inter99 study|/resolve/reference/PMED?id=15533541
Smith 2001 {published data only}|Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers?|/resolve/reference/PMED?id=11495172
Steinberg 2004 {published data only}|Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence|/resolve/reference/PMED?id=15301657
Tonnesen 1996 {published data only}|Nurse-conducted smoking cessation with minimal intervention in a lung clinic: a randomized controlled study|/resolve/reference/PMED?id=8947084
Wakefield 2004 {published data only}|Motivational interviewing as a smoking cessation intervention for patients with cancer: randomized controlled trial|/resolve/reference/PMED?id=15586136
Allsop 2007|What is this thing called motivational interviewing? [editorial]|
Britt 2002|Motivational Interviewing in health settings: a review|/resolve/reference/PMED?id=15140454
Burke 2003|The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials|/resolve/reference/PMED?id=14516234
Cahill 2008|Nicotine receptor partial agonists for smoking cessation|
Cahill 2010|Stage-based interventions for smoking cessation (protocol)|
Cochrane Handbook 2008|Cochrane Handbook for systematic reviews of interventions.|
Coleman 2004|Use of simple advice and behavioural support|/resolve/reference/PMED?id=14962878
Grimshaw 2006|Tobacco cessation interventions for young people|/resolve/reference/PMED?id=17054164
Higgins 2003|Measuring inconsistency in meta-analyses|
Hughes 2007|Antidepressants for smoking cessation|
Knight 2006|A systematic review of motivational interviewing in physical health care settings|
Lancaster 2005|Individual behavioural counselling for smoking cessation|
Lawendowski 1998|A motivational intervention for adolescent smokers|
Lumley 2009|Interventions for promoting smoking cessation during pregnancy|/resolve/reference/PMED?id=19588322
Miller 1983|Motivational interviewing with problem drinkers|
Miller 1994|Motivational interviewing.III.On the ethics of motivational interviewing|
Miller 2002||
MINT 2009|MI Bibliography 1983-2009|
Rollnick 1992|Negotiating behaviour change in medical settings:The development of brief motivational interviewing|
Rollnick 1995|What is motivational interviewing?|
Rubak 2005|Motivational interviewing: a systematic review and meta-analysis|/resolve/reference/PMED?id=15826439
Schulz 2002a|Generation of allocation sequences in randomised trials: chance, not choice|/resolve/reference/PMED?id=11853818
Schulz 2002b|Allocation concealment in randomised trials: defending against deciphering|/resolve/reference/PMED?id=11867132
Stead 2005|Group behaviour therapy for smoking cessation|
Stead 2008a|Physician advice for smoking cessation|
Stead 2008b|Nicotine replacement therapy for smoking cessation|
USDHHS 2000||
Armes 2007 {published data only}|A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue|
Barsevick 2004 {published data only}|A randomized clinical trial of energy conservation for patients with cancer-related fatigue|
Berglund 2007 {published data only}|"Between Men": a psychosocial rehabilitation programme for men with prostate cancer|/resolve/reference/PMED?id=17438709
Brown 2006 {published data only}|Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?|/resolve/reference/PMED?id=16462503
Classen 2001 {published data only}|Supportive-expressive group therapy and distress in patients with metastatic breast cancer - A randomized clinical intervention trial|/resolve/reference/PMED?id=11343530
Cohen 2007 {published data only}|Comparing relaxation training and cognitive-behavioral group therapy for women with breast cancer|
Cunningham 1989 {published data only}|A Randomized Trial of Group Psychoeducational Therapy for Cancer-Patients|
Decker 1992 {published data only}|Relaxation therapy as an adjunct in radiation oncology|
de Moor 2002 {published data only}|A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma|/resolve/reference/PMED?id=12433015
de Wit 1997 {published data only}|A Pain Education Program for chronic cancer pain patients: follow-up results from a randomized controlled trial|
Edelman 1999 {published data only}|A group Cognitive Behaviour Therapy programme with metastatic breast cancer patients|
Faithfull 2001 {published data only}|Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy|/resolve/reference/PMED?id=11747326
Fawzy 1995 {published data only}|A psychoeducational nursing intervention to enhance coping and affective state in newly diagnosed malignant melanoma patients|/resolve/reference/PMED?id=8564938
Forester 1985 {published data only}|Psychotherapy during radiotherapy: effects on emotional and physical distress|/resolve/reference/PMED?id=3966583
Gaston-Johansson 2000 {published data only}|The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation|/resolve/reference/PMED?id=10939175
Given 2002 {published data only}|Pain and fatigue management: results of a nursing randomized clinical trial|/resolve/reference/PMED?id=12096292
Godino 2006 {published data only}|Nursing education as an intervention to decrease fatigue perception in oncology patients|/resolve/reference/PMED?id=16618589
Goodwin 2001 {published data only}|Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data|/resolve/reference/PMED?id=12743147
Goodwin 2001 {published data only}|The effect of group psychosocial support on survival in metastatic breast cancer|/resolve/reference/PMED?id=11742045
Moadel 2007 {published data only}|Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life|/resolve/reference/PMED?id=17785709
Oh 2008 {published data only}|Medical qigong for cancer patients: pilot study of impact on quality of life, side effects of treatment and inflammation|/resolve/reference/PMED?id=18543381
Rawl 2002 {published data only}|Intervention to improve psychological functioning for newly diagnosed patients with cancer|/resolve/reference/PMED?id=12096294
Ream 2006 {published data only}|Supportive intervention for fatigue in patients undergoing chemotherapy: a randomized controlled trial|/resolve/reference/PMED?id=16488348
Sandgren 2000 {published data only}|Telephone therapy for patients with breast cancer|/resolve/reference/PMED?id=10833696
Sandgren 2003 {published data only}|Short-term effects of telephone therapy for breast cancer patients|/resolve/reference/PMED?id=12790259
Sandgren 2003 {published data only}|Long-term telephone therapy outcomes for breast cancer patients|
Savard 2006 {published data only}|Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects|/resolve/reference/PMED?id=17066964
Spiegel 1981 {published data only}|Group Support for Patients with Metastatic Cancer|/resolve/reference/PMED?id=7235853
Yates 2005 {published data only}|Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer|/resolve/reference/PMED?id=16135471
Badger 2005 {published data only}|Telephone interpersonal counseling with women with breast cancer: symptom management and quality of life|/resolve/reference/PMED?id=15759065
Bennet 2007 {published data only}|Motivational interviewing to increase physical activity in long-term cancer survivors: a randomized controlled trial|/resolve/reference/PMED?id=17179870
Berglund 1994 {published data only}|A randomized study of a rehabilitation program for cancer patients: The 'Starting again' group|
Boesen 2005 {published data only}|Psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study|/resolve/reference/PMED?id=15718325
Burns 2008 {published data only}|Music imagery for adults with acute leukemia in protective environments: A feasibility study|/resolve/reference/PMED?id=17891547
Campbell 2005 {published data only}|A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment|/resolve/reference/PMED?id=15774341
Campbell 2007 {published data only}|Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners: A pilot study of telephone-based coping skills training|
Carlson 2005 {published data only}|Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients|/resolve/reference/PMED?id=16262547
Cimprich 1993 {published data only}|Development of an intervention to restore attention in cancer patients|/resolve/reference/PMED?id=8477404
Cimprich 2003 {published data only}|An environmental intervention to restore attention in women with newly diagnosed breast cancer|/resolve/reference/PMED?id=12886119
Clark 2006 {published data only}|Use of preferred music to reduce emotional distress and symptom activity during radiation therapy|/resolve/reference/PMED?id=17037953
Cohen 2004 {published data only}|Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma|
Courneya 2003 {published data only}|The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: physical fitness and quality of life outcomes|
Crooks 2004 {published data only}|The Initial Health Assessment: An intervention to identify the supportive care needs of cancer patients|/resolve/reference/PMED?id=14505159
Culos-Reed 2006 {published data only}|A pilot study of yoga for breast cancer survivors: physical and psychological benefits|
Daley 2004 {published data only}|Exercise therapy in women who have had breast cancer: design of the Sheffield women's exercise and well-being project|/resolve/reference/PMED?id=15198998
Dalton 2004 {published data only}|Tailoring cognitive-behavioral treatment for cancer pain|/resolve/reference/PMED?id=14999649
Dimeo 1999 {published data only}|Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy|
Dimeo 2004 {published data only}|Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomised controlled trial|/resolve/reference/PMED?id=15338385
Doorenbos 2005 {published data only}|A cognitive behavioral intervention randomized trial|
Fawzy 1990 {published data only}|A structured psychiatric intervention for cancer patients I. Changes over time in methods of coping and affective disturbance|/resolve/reference/PMED?id=2378543
Gielissen 2006 {published data only}|Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: A randomized controlled trial|/resolve/reference/PMED?id=17050873
Given 2004 {published data only}|Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy|/resolve/reference/PMED?id=14752074
Given 2005 {published data only}|Effect of neutropenia on the impact of a cognitive-behavioral intervention for symptom management|
Haase 2005 {published data only}|Guided imagery and relaxation in conventional colorectal resections: a randomized, controlled, partially blinded trial|/resolve/reference/PMED?id=15991068
Hack 2003 {published data only}|Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: A multisite, randomized, controlled trial|/resolve/reference/PMED?id=14615442
Hanna 2008 {published data only}|The effects of a comprehensive exercise program on physical function, fatigue, and mood in patients with various types of cancer|
Hoekstra 2006 {published data only}|Using the symptom monitor in a randomized controlled trial: the effect on symptom prevalence and severity|/resolve/reference/PMED?id=16442479
Houborg 2006 {published data only}|Postoperative physical training following colorectal surgery: a randomised, placebo-controlled study|/resolve/reference/PMED?id=16579250
Jacobsen 2002 {published data only}|Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy|/resolve/reference/PMED?id=12065562
Kim 2002 {published data only}|The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer|/resolve/reference/PMED?id=12136225
Kim 2005 {published data only}|Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients|
Korstjens 2008 {published data only}|Quality of life after self-management cancer rehabilitation: a randomized controlled trial comparing physical and cognitive-behavioral training versus physical training|/resolve/reference/PMED?id=18480190
Laidlaw 2005 {published data only}|Quality of life and mood changes in metastatic breast cancer after training in self-hypnosis or Johrei: A short report|
Lindemalm 2008 {published data only}|Immune response, depression and fatigue in relation to support intervention in mammary cancer patients|/resolve/reference/PMED?id=17562086
Mock 1994 {published data only}|A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy|/resolve/reference/PMED?id=7937251
Ollenschlager 1992 {published data only}|Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia|
Ovesen 1993 {published data only}|Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study|/resolve/reference/PMED?id=8410128
Oyama 2000 {published data only}|Using the bedside wellness system during chemotherapy decreases fatigue and emesis in cancer patients|/resolve/reference/PMED?id=10984871
Persson 2002 {published data only}|A randomized study of nutritional support in patients with colorectal and gastric cancer|/resolve/reference/PMED?id=12235650
Post-White 2003 {published data only}|Therapeutic massage and healing touch improve symptoms in cancer|/resolve/reference/PMED?id=14713325
Ravasco 2005 {published data only}|Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy|/resolve/reference/PMED?id=15684319
Ravasco 2005a {published data only}|Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy|
Roscoe 2005 {published data only}|Treatment of radiotherapy-induced fatigue through a nonpharmacological approach|/resolve/reference/PMED?id=15695472
Savard 2005 {published data only}|Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects|/resolve/reference/PMED?id=16135475
Sherwood 2005 {published data only}|A cognitive behavioral intervention for symptom management in patients with advanced cancer|/resolve/reference/PMED?id=16270114
Speca 2000 {published data only}|A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients|/resolve/reference/PMED?id=11020090
Stanton 2005 {published data only}|Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients|/resolve/reference/PMED?id=16135469
Stiegelis 2004 {published data only}|The impact of an informational self-management intervention on the association between control and illness uncertainty before and psychological distress after radiotherapy|
Strong 2008 {published data only}|Management of depression for people with cancer (SMaRT oncology 1): a randomised trial|/resolve/reference/PMED?id=18603157
Telch 1986 {published data only}|Group coping skills instruction and supportive group therapy for cancer patients: A comparison of strategies|/resolve/reference/PMED?id=3794024
Vos 2004 {published data only}|Psychosocial intervention for women with primary, non-metastatic breast cancer: A comparison between participants and non-participants|/resolve/reference/PMED?id=15292625
Wenzel 1995 {published data only}|The effects of problem-focused group counseling for early-stage gynecologic cancer patients|
Williams 2004 {published data only}|The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer|/resolve/reference/PMED?id=14722602
Williams 2005 {published data only}|The role of education in managing fatigue, anxiety, and sleep disorders in women undergoing chemotherapy for breast cancer|/resolve/reference/PMED?id=16106331
Wydra 2001 {published data only}|The effectiveness of a self-care management interactive multimedia module|/resolve/reference/PMED?id=11683310
Cohen 2004a {unpublished data only}|Mindfulness relaxation compared with relaxing music and standard symptom management education in treating patients who are undergoing chemotherapy for newly diagnosed solid tumors.|
Cohen 2006 {unpublished data only}|Evaluation of the effect of cognitive behavior intervention on psychological distress of cancer patients and their family members.|
Cohen 2007a {unpublished data only}|Effects of Tibetan yoga on fatigue and sleep in cancer.|
Cohen 2007b {unpublished data only}|Effects of yoga in breast cancer patients.|
Goedendorp 2005 {unpublished data only}|Evaluation of intervention strategies to manage fatigue during active treatment and to prevent persistent fatigue after curative treatment for cancer.|
Oh 2008b {unpublished data only}|Randomized Clinical Trial: The impact of medical qigong (traditional Chinese medicine) on fatigue, quality of life, side effects, mood status and inflammation of cancer patients.|
Purcell 2008 {unpublished data only}|A randomised control trial investigating the effects of group education and support in reducing cancer-related fatigue and improving quality of life in patients undergoing radiotherapy.|
Savard 2008 {published data only}|Self-Help treatment for insomnia in breast cancer patients.|
Ahlberg 2003|Assessment and management of cancer related fatigue in adults|/resolve/reference/PMED?id=12944066
Barnes 2002|Fatigue in patients with advanced cancer: a review|
Bennett 2008|Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia|/resolve/reference/PMED?id=18314434
Boutron 2008|Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration|/resolve/reference/PMED?id=18283207
CBO 2002|Form II for evaluating randomised controlled trials (RCT), October 2002 valid until December 2006: Evidence based guideline development (EBRO)|
Cella 1998|Progress towards guidelines for the management of fatigue|/resolve/reference/PMED?id=10028520
Conn 2006|A meta-analysis of exercise interventions among people treated for cancer|/resolve/reference/PMED?id=16447036
Cramp 2008|Exercise for the management of cancer-related fatigue in adults|/resolve/reference/PMED?id=18425939
de Jong 2004|Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy|/resolve/reference/PMED?id=15151946
Edwards 2004|Psychological interventions for women with metastatic breast cancer|
Field 2005|Effect sizes|
Hartvig 2006|Fatigue in cancer patients treated with cytotoxic drugs|/resolve/reference/PMED?id=17022870
Hickok 2005|Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer|
Hickok 2005a|Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer|/resolve/reference/PMED?id=16310617
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions|
Jacobsen 1999|Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates|/resolve/reference/PMED?id=10534963
Jacobsen 2003|Fatigue in the radiation therapy patient: Current management and investigations|/resolve/reference/PMED?id=12903024
Jacobsen 2007|Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue|/resolve/reference/PMED?id=18020836
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Jereczek-Fossa 2002|Radiotherapy-related fatigue|
Khuri 2007|Weighing the hazards of erythropoiesis stimulation in patients with cancer|/resolve/reference/PMED?id=17568023
Knols 2005|Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials|/resolve/reference/PMED?id=15923576
Lawrence 2004|Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients|/resolve/reference/PMED?id=15263040
Markes 2006|Exercise for women receiving adjuvant therapy for breast cancer (Review)|/resolve/reference/PMED?id=17054230
McNeely 2006|Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis|/resolve/reference/PMED?id=16818906
Minton 2008|Drug therapy for the management of cancer related fatigue|/resolve/reference/PMED?id=18254112
Mock 2004|Evidence-based treatment for cancer-related fatigue|/resolve/reference/PMED?id=15263051
NCCN 2008|Clinical Practice Guidelines in Oncology. Cancer-related fatigue version VI.2008|
Portenoy 1999|Cancer-related fatigue: guidelines for evaluation and management|/resolve/reference/PMED?id=10337366
Radbruch 2007|Drugs for the treatment of fatigue in palliative care|
Servaes 2002|Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions|/resolve/reference/PMED?id=11750837
Servaes 2002a|Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study|/resolve/reference/PMED?id=12056710
Stevinson 2004|Exercise interventions for cancer patients: systematic review of controlled trials|/resolve/reference/PMED?id=15801488
Stone 2008|Cancer-related fatigue|
van Tulder 1997|Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for spinal disorders|/resolve/reference/PMED?id=9355211
Verhagen 1998|The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus|/resolve/reference/PMED?id=10086815
Azeka 2002 {published data only}|Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment|/resolve/reference/PMED?id=12475466
Buchhorn 2001 {published data only}|Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol|/resolve/reference/PMED?id=11461738
Shaddy 2007 {published data only}|Carvedilol for children and adolescents with heart failure: a randomized controlled trial|/resolve/reference/PMED?id=17848651
Shaddy 2007 {published data only}|The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design|/resolve/reference/PMED?id=12228773
Kajimoto 2006 {published data only}|Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy|/resolve/reference/PMED?id=16864930
Suwa 1996 {published data only}|Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy|/resolve/reference/PMED?id=8933239
Albers 2008|Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure|
Arola 1997|Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland|/resolve/reference/PMED?id=9290498
Bruns 2001|Carvedilol as therapy in pediatric heart failure: an initial multicenter experience|/resolve/reference/PMED?id=11295713
Buchhorn 1998|Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts|/resolve/reference/PMED?id=9631979
Buitelaar 1996|Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects|
EMEA 2001|ICH Topic E 11, Clinical investigation of medicinal products in the paediatric population|
ESC Guidelines 2005|Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005)|
Gachara 2001|Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report|/resolve/reference/PMED?id=11456146
Giardini 2003|Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol|/resolve/reference/PMED?id=14694952
Higgins 2008|Cochrane Handbook for Systematic Review of Interventions 5.0.0 [updated February 2008]|
Kay 2001|Congestive heart failure in pediatric patients|/resolve/reference/PMED?id=11685182
Kearns 2003|Developmental pharmacology--drug disposition, action, and therapy in infants and children|/resolve/reference/PMED?id=13679531
Klein 2003|Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations|
Kulikowska 2008|Infectious, malignant, and autoimmune complications in pediatric heart transplant recipients|/resolve/reference/PMED?id=18410772
Levi 2001|Diagnosis and treatment of pediatric viral myocarditis|/resolve/reference/PMED?id=11224637
Ler 2002|Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters|/resolve/reference/PMED?id=12040358
Morales 2007|Over two decades of pediatric heart transplantation: how has survival changed?|/resolve/reference/PMED?id=17320556
NYHA 1994|1994 Revisions to Classification of Functional Capacity and Objective Assessment of Patients With Diseases of the Heart|
Picchio 2008|Pediatric heart failure|/resolve/reference/PMED?id=18509292
Ross 1987|Plasma norepinephrine levels in infants and children with congestive heart failure|/resolve/reference/PMED?id=3825955
Ross 1992|Grading the severity of congestive heart failure in infants|/resolve/reference/PMED?id=1614922
Rusconi 2004|Carvedilol in children with cardiomyopathy: 3-year experience at a single institution|/resolve/reference/PMED?id=15261177
Shaddy 1999|Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience|/resolve/reference/PMED?id=10328154
Webster 2006|Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective, cross-sectional study|/resolve/reference/PMED?id=16725044
Williams 2002|Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction|/resolve/reference/PMED?id=12163092
Arentz 2007 {published data only}|Small or Large Isolation Areas Around the Pulmonary Veins for the Treatment of Atrial Fibrillation? Results From a Prospective Randomized Study|/resolve/reference/PMED?id=17562956
Calo 2006 {published data only}|Left Atrial Ablation Versus Biatrial Ablation for Persistent and Permanent Atrial Fibrillation: A Prospective and Randomized Study|/resolve/reference/PMED?id=16781381
Deisenhofer 2009 {published data only}|Does Electrogram Guided Substrate Ablation Add to the Success of Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation?A Prospective, Randomized Study|
Dixit 2008 {published data only}|Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: A prospective randomized study|/resolve/reference/PMED?id=18242535
Fassini 2005 {published data only}|Left Mitral Isthmus Ablation Associated with PV Isolation: Long-Term Results of a Prospective Randomized Study|
Forleo 2009 {published data only}|Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy|
Hassaguerre 2004 {published data only}|Changes in Atrial Fibrillation Cycle Length and Inducibility During Catheter Ablation and Their Relation to Outcome|/resolve/reference/PMED?id=15184286
Hocini 2005 {published data only}|Techniques, Evaluation, and Consequences of Linear Block at the Left Atrial Roof in Paroxysmal Atrial Fibrillation: A Prospective Randomized Study|/resolve/reference/PMED?id=16344401
Jas 2008 {published data only}|Catheter Ablation Versus Antiarrhythmic Drugsfor Atrial Fibrillation: the A4 Study|/resolve/reference/PMED?id=19029470
Karch 2005 {published data only}|Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function|
Karch 2005 {published data only}|Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial FibrillationA Randomized Comparison Between 2 Current Ablation Strategies|/resolve/reference/PMED?id=15927974
Katritsis 2004 {published data only}|ablation of superior pulmonary vein compared to ablation of all four pulmonary veins: a randomized clinical trial|
Krittayaphong 2003 {published data only}|A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation|/resolve/reference/PMED?id=12866763
Liu02 2006 {published data only}|Achievement of Pulmonary Vein Isolation in Patients Undergoing Circumferential Pulmonary Vein Ablation: A Randomized Comparison Between Two Different Isolation Approaches|
Liu 2006 {published data only}|Is Circumferential Pulmonary Vein Isolation Preferable to Stepwise Segmental Pulmonary Vein Isolation for Patients With Paroxysmal Atrial Fibrillation? A Randomized Study|/resolve/reference/PMED?id=17062959
Marrouche 2007 {published data only}|Randomized Comparison Between Open Irrigation Technology and Intracardiac-Echo-Guided Energy Delivery for Pulmonary Vein Antrum Isolation: Procedural Parameters, Outcomes, and the Effect on Esophageal Injury|
Nilsson 2006 {published data only}|Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial versus the extraostial ablation strategy|/resolve/reference/PMED?id=16923426
Oral 2003 {published data only}|Catheter Ablation for Paroxysmal Atrial Fibrillation Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation|/resolve/reference/PMED?id=14557355
Oral 2004 {published data only}|Noninducibility of Atrial Fibrillation as an End Point of Left Atrial Circumferential Ablation for Paroxysmal Atrial Fibrillation: A Randomized Study|/resolve/reference/PMED?id=15505091
Oral 2006 {published data only}|Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation|/resolve/reference/PMED?id=16510747
Oral 2009 {published data only}|A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation|/resolve/reference/PMED?id=19245970
Pappone 2004 {published data only}|Prevention of Iatrogenic Atrial Tachycardia After Ablation of Atrial Fibrillation A Prospective Randomized Study Comparing Circumferential Pulmonary Vein Ablation With a Modified Approach|/resolve/reference/PMED?id=15520310
Pappone 2006 {published data only}|A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study|/resolve/reference/PMED?id=17161267
Pontoppidan 2009 {published data only}|Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial|/resolve/reference/PMED?id=19261602
Rajappan 2009 {published data only}|A randomized trial to compare atrial fibrillation ablation using a steerable vs. a non-steerable sheath|/resolve/reference/PMED?id=19351628
Sheikh 2006 {published data only}|Pulmonary vein isolation and linear lesions in atrial fibrillation ablation|/resolve/reference/PMED?id=17318445
Stabile 2006 {published data only}|Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)|/resolve/reference/PMED?id=16214831
Verma 2007 {published data only}|Efficacy of Adjuvant Anterior Left Atrial Ablation During Intracardiac Echocardiography-Guided Pulmonary Vein Antrum Isolation for Atrial Fibrillation|
Wang 2008 {published data only}|Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study|/resolve/reference/PMED?id=18442966
Wazni 2003 {published data only}|Randomized Study Comparing Combined PulmonaryVeinLeft Atrial Junction Disconnection and Cavotricuspid Isthmus Ablation Versus Pulmonary VeinLeft Atrial Junction Disconnection Alone in Patients Presenting With Typical Atrial Flutter and Atrial Fibrillation|/resolve/reference/PMED?id=14610012
Wazni 2005 {published data only}|Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial|/resolve/reference/PMED?id=15928285
Willems 2006 {published data only}|Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison|/resolve/reference/PMED?id=16782716
Zhang 2007 {published data only}|Necessity of pulmonary vein isolation as an end point for circumferential pulmonary vein ablation in patient with paroxysmal atrial fibrillation|
Bauer 2006 {published data only}|Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function|/resolve/reference/PMED?id=17161785
Brignole 1994 {published data only}|Influence of Atrioventricular Junction Radiofrequency Ablation in Patients with Chronic Atrial Fibrillation and Flutter on Quality of life and Cardiac Performance|/resolve/reference/PMED?id=8037128
Fiala 2008 {published data only}|Pulmonary vein isolation using segmental versus electroanatomical circumferential ablation for paroxysmal atrial fibrillation: over 3-year results of a prospective randomized study|/resolve/reference/PMED?id=18418704
Ito 2007 {published data only}|Randomized Comparison of Bipolar vs Unipolar Plus Bipolar Recordings During Atrioventricular Junction Ablation: Importance and Efficacy of Unipolar Recording|/resolve/reference/PMED?id=17526983
Kirkutis 2004 {published data only}|Cardiac Rate Normalization in Chronic Atrial Fibrillation: Comparison of Long-term Efficacy of Treatment with Amiodarone versus AV Node Ablation and Permanent His-bundle Pacing|/resolve/reference/PMED?id=15633616
Padeletti 2003 {published data only}|Prevention of Paroxysmal Atrial Fibrillation in Patients with Sinus Bradycardia: Role of Right Atrial Linear Ablation and Pacing Site|
Reddy 2007 {published data only}|Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy|/resolve/reference/PMED?id=18160685
Tse 2005 {published data only}|Transvenous cryoablation reduces platelet activation during pulmonary vein ablation compared with radiofrequency energy in patients with atrial fibrillation|
Aguilar 2005|Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks|
Andrikopoulos 2009|Cost-effectiveness of atrial fibrillation catheter ablation|/resolve/reference/PMED?id=19098290
Bechtel 2011|Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review|/resolve/reference/PMED?id=21740550
Bernhardt 2006|Atrial fibrillation - patients at high risk for cerebral embolism|/resolve/reference/PMED?id=16598527
Bertaglia 2007|Early complications of pulmonary vein catheter ablation for atrial fibrillation: A multicenter prospective registry on procedural safety|/resolve/reference/PMED?id=17905330
Bonanno 2010|Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials|/resolve/reference/PMED?id=19834326
Bordin 2003|Morbility and mortality in 229 elderly patients with nonrheumatic atrial fibrillation. A five year follow-up|/resolve/reference/PMED?id=14564980
Cappato 2009|Prevalence and causes of fatal outcomes in catheter ablation of atrial fibrillation|/resolve/reference/PMED?id=19422987
Cha 2004|Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure|/resolve/reference/PMED?id=14718405
Crandall 2009|Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors|
Egger 1997|Bias in meta-analysis detected by a simple graphical test|/resolve/reference/PMED?id=9310563
Garnier 2004|Atrial fibrillation and anticoagulation|/resolve/reference/PMED?id=16008178
Gelder 2002|A Comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation|/resolve/reference/PMED?id=12466507
Gluud 2001|Alcoholic hepatitis: no glucocorticosteroids?|
Hashimoto 2007|Prevalence and characteristics of left atrial tachycardia following left atrial catheter ablation|
Hassantash 2008|Surgical ablation for atrial fibrillation (Protocol)|
Hassaguerre 1998|Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins|/resolve/reference/PMED?id=9725923
Higgins 2011| Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Hoppe 2006|Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure|/resolve/reference/PMED?id=16801461
Kannel 1982|Epidemiologic features of chronic atrial fibrillation: the Framingham study|/resolve/reference/PMED?id=7062992
Karin 2004|Limitations to antiarrhythmic drug use in patients with atrial fibrillation|/resolve/reference/PMED?id=15451836
Lemola 2008|Pulmonary vein region ablation in experimental vagal atrial fibrillation, role of pulmonary veins versus autonomic ganglia|/resolve/reference/PMED?id=18195170
Li 2008|Advances in catheter ablation of chronic atrial fibrillation|
Li 2011|Additional ablation of complex fractionated atrial electrograms after pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis|/resolve/reference/PMED?id=21303900
Lip 2011|The role of aspirin for stroke prevention in atrial fibrillation|/resolve/reference/PMED?id=21788962
Lu 2009|The impact of radiofrequency of catheter ablation on quality of life in the patients of persistent atrial fibrillation|
Lutomsky 2008|Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging|/resolve/reference/PMED?id=18385123
Ma 2006|Management of atrial fibrillation: surgical or internal catheter ablation, which one is better?|
McKenna 2009|Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom|/resolve/reference/PMED?id=19095714
Mead 2005|Electrical cardioversion for atrial fibrillation and flutter|
Meinertz 2011|Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry|/resolve/reference/PMED?id=21533828
Moe 1964|A computer model of atrial fibrillation|/resolve/reference/PMED?id=14118488
Morady 2005|Mechanisms and catheter ablation therapy of atrial fibrillation|
Nademanee 2007|Trials and travails of electrogram-guided ablation of chronic atrial fibrillation|/resolve/reference/PMED?id=17515475
Nademanee 2008|Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation|/resolve/reference/PMED?id=18294570
Ohki 2005|Gene expression profiling of human atrial myocardium with a fibrillation by DNA microarray analysis|/resolve/reference/PMED?id=15982490
Oral 2002|Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation|/resolve/reference/PMED?id=11877358
Ouyang 2005|Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique|/resolve/reference/PMED?id=15623542
Padanilam 2006|Cerebral microembolism during AF ablation: an innocent bystander or an accessory to brain injury?|
Pappone 2000|Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation|/resolve/reference/PMED?id=11085966
Pappone 2001|Pulmonary vein isolation by circumferential radiofrequency lesions in atrial fibrillation. From substrate to clinical outcome|/resolve/reference/PMED?id=11889957
Pappone 2007|Robotic and magnetic navigation for atrial fibrillation ablation. How and why?|/resolve/reference/PMED?id=18035953
Pappone02 2006|Robotic magnetic navigation for atrial fibrillation ablation|/resolve/reference/PMED?id=16580527
Pontoppidan02 2009|Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life|
Reynolds 2009|Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation|/resolve/reference/PMED?id=19808491
Reynolds 2010|Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs|/resolve/reference/PMED?id=20940250
Ryden 2001|ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation)|/resolve/reference/PMED?id=11673357
Sacher 2007|Phrenic nerve injury after catheter ablation of atrial fibrillation|/resolve/reference/PMED?id=17235367
Sawhney 2010|Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation|/resolve/reference/PMED?id=20339034
Singh 2007|Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter|/resolve/reference/PMED?id=17804843
Snow 2003|Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians|/resolve/reference/PMED?id=14678921
STAF 2003|Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study|/resolve/reference/PMED?id=12767648
Tang 2006|Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus-single center experience|/resolve/reference/PMED?id=17235682
Taylor 2010|Rhythm control agents and adverse events in patients with atrial fibrillation|
Tracy 2006|American College of Cardiology/American Heart Association 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion. A Report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the Heart Rhythm Society|/resolve/reference/PMED?id=17010821
Verma 2008|A prospective, multicenter evaluation of ablating complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an automated mapping algorithm: acute effects on AF and efficacy as an adjuvant strategy|/resolve/reference/PMED?id=18242539
Vickers 1998|Do certain countries produce only positive results? A systematic review of controlled trials|/resolve/reference/PMED?id=9551280
Wattigney 2003|Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention|/resolve/reference/PMED?id=12885749
Wijffels 1995|Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats|/resolve/reference/PMED?id=7671380
Wu 2001|Pulmonary veins and ligament of marshall as sources of rapid activations in a canine model of sustained atrial fibrillation|/resolve/reference/PMED?id=11222481
Wyse 2002|A Comparison of rate control and rhythm control in patients with atrial fibrillation|/resolve/reference/PMED?id=12466506
Yamashita 2007|Left atrial catheter ablation promotes vasoconstriction of the right coronary artery|
Yamashita 2011|Frontiers of anticoagulation therapy for atrial fibrillation|/resolve/reference/PMED?id=21514792
Arthur 2002 {published data only}|A controlled trial of hospital versus home-based exercise in cardiac patients|/resolve/reference/PMED?id=12370553
Arthur 2002 {published data only}|Differences in sustainability of exercise and health-related quality of life outcomes following home or hospital-based cardiac rehabilitation|/resolve/reference/PMED?id=15292765
Bell 1998 {published data only}|A comparison of a multi-disciplinary home based cardiac rehabilitation programme with comprehensive conventional rehabilitation in post-myocardial infarction patients|
Carlson 2000 {published data only}|A comparison of traditional and modified cardiac rehabilitation protocols on compliance to exercise, patient self-efficacy, cardiovascular outcomes, and program cost|
Carlson 2000 {published data only}|Program participation, exercise adherence, cardiovascular outcomes, and program cost of traditional versus modified cardiac rehabilitation|/resolve/reference/PMED?id=10867086
Carlson 2000 {published data only}|Self-efficacy, psychosocial factors, and exercise behavior in traditional versus modified cardiac rehabilitation|/resolve/reference/PMED?id=11767810
Dalal 2007 {published and unpublished data}|Home-based versus hospital-based rehabilitation after myocardial infarction: A randomized trial with preference arms--Cornwall Heart Attack Rehabilitation Management Study (CHARMS)|
Dalal 2007 {published and unpublished data}|Home-based cardiac rehabilitation versus hospital-based rehabilitation: a cost effectiveness analysis|/resolve/reference/PMED?id=17084927
Daskapan 2005 {published data only}|Comparison of supervised exercise training and home-based exercise training in chronic heart failure|/resolve/reference/PMED?id=15951880
Daskapan 2005 {published data only}|The effects of two different exercise programs on pulmonary function tests and quality of life in chornic heart failure: a pilot study (Turkish)|
Gordon 2002 Community {published data only}|Effectiveness of three models for comprehensive cardiovascular disease risk reduction|/resolve/reference/PMED?id=12031725
Gordon 2002 Supervised {published data only}|Effectiveness of three models for comprehensive cardiovascular disease risk reduction|/resolve/reference/PMED?id=12031725
Jolly 2007 {published and unpublished data}|Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]|/resolve/reference/PMED?id=12964946
Jolly 2007 {published and unpublished data}|The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation|
Jolly 2007 {published and unpublished data}|The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence|
Kassaian 2000 {published data only}|Comparing effects of supervised vs. home-based cardiac rehabilitation|
Marchionni 2003 {published and unpublished data}|Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: results of a randomized, controlled trial|
Miller 1984 Brief {published data only}|Medically directed at-home rehabilitation soon after clinically uncomplicated acute myocardial infarction: a new model for patient care|/resolve/reference/PMED?id=3969859
Miller 1984 Brief {published data only}|Home versus group exercise training for increasing functional capacity after myocardial infarction|/resolve/reference/PMED?id=6478567
Miller 1984 Brief {published data only}|The effects of exercise training programs on psychosocial improvement in uncomplicated postmyocardial infarction patients|/resolve/reference/PMED?id=3772840
Miller 1984 Expanded {published data only}|Medically directed at-home rehabilitation soon after clinically uncomplicated acute myocardial infarction: a new model for patient care|/resolve/reference/PMED?id=3969859
Miller 1984 Expanded {published data only}|Home versus group exercise training for increasing functional capacity after myocardial infarction|/resolve/reference/PMED?id=6478567
Miller 1984 Expanded {published data only}|The effects of exercise training programs on psychosocial improvement in uncomplicated postmyocardial infarction patients|/resolve/reference/PMED?id=3772840
Sparks 1993 {published data only}|Alternatives for cardiac rehabilitation patients unable to return to a hospital-based program|/resolve/reference/PMED?id=8360063
Wu 2006 {published data only}|Cardiac rehabilitation vs. home exercise after coronary artery bypass graft surgery: a comparison of heart rate recovery|/resolve/reference/PMED?id=16924183
Ades 2000 {published data only}|A controlled trial of cardiac rehabilitation in the home setting using electrocardiographic and voice transtelephonic monitoring|/resolve/reference/PMED?id=10689271
Senuzun 2006 {published data only}|Effects of home-based cardiac exercise program on the exercise tolerance, serum lipid values and self-efficacy of coronary patients|/resolve/reference/PMED?id=16874157
Sinclair 2005 {published data only}|Post-discharge home-based support for older cardiac patients: a randomised controlled trial|/resolve/reference/PMED?id=15955757
Tygesen 2001 {published data only}|Intensive home-based exercise training in cardiac rehabilitation increases exercise capacity and heart rate variability|/resolve/reference/PMED?id=11461739
Allender 2008||/resolve/reference/PMED?id=17513578
Balady 2007|Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation|/resolve/reference/PMED?id=950811
Bergner 1976|The sickness impact profile: validation of a health status measure|
Beswick 2004|Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups|
Davies 2008|Promoting patient uptake and adherence in cardiac rehabilitation (Protocol)|/resolve/reference/PMED?id=10109801
EuroQoL 1990|EuroQol - a new facility for the measurement of health-related quality of life|/resolve/reference/PMED?id=17726407
Graham 2007|European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)|
Heart Manual 2008||
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]|/resolve/reference/PMED?id=10298135
Hunt 1980|The development of a subjective health indicator|/resolve/reference/PMED?id=14713315
Hfer 2004|The MacNew Heart Disease health-related quality of life instrument: a summary|/resolve/reference/PMED?id=11279730
Jolliffe 2001|Exercise-based rehabilitation for coronary heart disease|/resolve/reference/PMED?id=16316695
Jolly 2006|Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis|/resolve/reference/PMED?id=12437397
Lewin 1992|Effects of self-help post-myocardial-infarction rehabilitation on psychological adjustment and use of health services|/resolve/reference/PMED?id=1349062
McHorney 1993|The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs|
NICE 2007|MI: Secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction|
Rees 2004a|Exercise-based rehabilitation for heart failure|
Rees 2004b|Psychological interventions for coronary heart disease|
Stone 2005|Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention, second edition, 2004: executive summary|
Taylor 2004|Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=16292364
WHO 2004||/resolve/reference/PMED?id=15121495
Dalal 2010|Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis|
Ashe 1993 {published data only}|The effects of a relapse prevention program on adherence to a phase II cardiac exercise program|
Daltroy 1985 {published data only}|Improving cardiac patient adherence to exercise regimens: a clinical trial of health education|
Duncan 2002 {published data only}|Staying on course: the effects of an adherence facilitation intervention on home exercise participation|
Duncan 2002 {published data only}|Effects of an exercise adherence intervention on outcomes in patients with heart failure|
Hillebrand 1995 {published data only}|Vermehrte Teilnahme an ambulaten Herzgruppen durch poststationare Nachsorge [Increased participation in coronary groups by means of an outpatient care program]|
Izawa 2005 {published data only}|Effect of the self-monitoring approach on exercise maintenance during cardiac rehabilitation: a randomized, controlled trial|/resolve/reference/PMED?id=15829777
Jolly 1999 {published data only}|Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial. Southampton Heart Integrated Care Project|/resolve/reference/PMED?id=10078796
Jolly 1999 {published data only}|Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group|/resolve/reference/PMED?id=10074017
Moore 2006 {published data only}|Effects of a CHANGE intervention to increase exercise maintenance following cardiac events|/resolve/reference/PMED?id=16472039
Oldridge 1983 {published data only}|Improving patient compliance in cardiac exercise rehabilitation: effects of written agreement and self-monitoring|
Sniehotta 2006 {published data only}|Action plans and coping plans for physical exercise: A longitudinal intervention study in cardiac rehabilitation|
Wyer 2001 {published data only}|Increasing attendance rates at a cardiac rehabilitation programme: an intervention study using the Theory of Planned Behaviour|
Aish 1996 {published data only}|Effects of Orem-based nursing intervention on nutritional self-care of myocardial infarction patients|/resolve/reference/PMED?id=8736471
Brodie 2005 {published data only}|Motivational interviewing to promote physical activity for people with chronic heart failure|
Carroll 2007 {published data only}|The effects of a collaborative peer advisor/advanced practice nurse intervention: cardiac rehabilitation participation and rehospitalization in older adults after a cardiac event|/resolve/reference/PMED?id=17589284
Duncan 2001 {published data only}|The effects of behavioural feedback on adherence to dietary sodium intake for patients with congestive heart failure|
Froelicher 2003 {published data only}|The Enhancing Recovery in Coronary Heart Disease Trial ENRICHD: strategies and techniques for enhancing retention of patients with acute myocardial infarction and depression or social isolation|/resolve/reference/PMED?id=12894001
Hopper 1995 {published data only}|The effects of telephone contact on the exercise adherence of cardiac patients|
Hughes 2002 {published data only}|Exercise consultation improves short-term adherence to exercise during phase IV cardiac rehabilitation: a randomized, controlled trial|/resolve/reference/PMED?id=12464830
Hughes 2007 {published data only}|Effect of an exercise consultation on maintenance of physical activity after completion of phase III exercise-based cardiac rehabilitation|/resolve/reference/PMED?id=17301636
Kummel 2007 {published data only}|Effects of an intervention on health behaviors of older coronary artery bypass CAB patients|/resolve/reference/PMED?id=17517442
Luszczynska 2006 {published data only}|An implementation intentions intervention, the use of a planning strategy, and physical activity after myocardial infarction|/resolve/reference/PMED?id=16095786
Mahler 1999 {published data only}|Effects of a videotape information intervention at discharge on diet and exercise compliance after coronary bypass surgery|/resolve/reference/PMED?id=10361648
Moore 2002 {published data only}|Using the CHANGE intervention to enhance long-term exercise|/resolve/reference/PMED?id=12389268
Palomki 2002 {published data only}|Effects of preventive group education on the resistance of LDL against oxidation and risk factors for coronary heart disease in bypass surgery patients|/resolve/reference/PMED?id=12371711
Rejeski 2002 {published data only}|Older adults in cardiac rehabilitation: a new strategy for enhancing physical function|/resolve/reference/PMED?id=12439072
Sniehotta 2005 {published data only}|Long-term effects of two psychological interventions on physical exercise and self-regulation following coronary rehabilitation|/resolve/reference/PMED?id=16262543
Southard 2003 {published data only}|Clinical trial of an Internet-based case management system for secondary prevention of heart disease|/resolve/reference/PMED?id=14512778
Stromberg 2006 {published data only}|Computer-based education for patients with chronic heart failure A randomised, controlled, multicentre trial of the effects on knowledge, compliance and quality of life|/resolve/reference/PMED?id=16469469
Vestfold 2003 {published data only}|Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease|/resolve/reference/PMED?id=14671465
Beckie 2006 {published data only}|A behavior change intervention for women in cardiac rehabilitation|/resolve/reference/PMED?id=16601534
Ajzen 1986|Prediction of goal-directed behaviour: attitudes, intentions and perceived behavioural control|
Al-Ali 2004|The effect of the health belief model in explaining exercise participation among Jordanian myocardial infarction patients|/resolve/reference/PMED?id=15070493
Balady 2007|Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation|/resolve/reference/PMED?id=17513578
Bethell 2001|Cardiac rehabilitation in the United Kingdom. How complete is the provision?|/resolve/reference/PMED?id=11314284
Blackburn 2000|Cardiac rehabilitation participation patterns in a large, tertiary care center: evidence for selection bias|/resolve/reference/PMED?id=10860201
Bunker 1999|Identifying participation rates at outpatient cardiac rehabilitation programs in Victoria, Australia|/resolve/reference/PMED?id=10609180
Daly 2002|Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review|
Fleury 1991|Wellness motivation in cardiac rehabilitation|/resolve/reference/PMED?id=1988389
Graham 2007|European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)|/resolve/reference/PMED?id=17726407
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008|
Jackson 2005|Getting the most out of cardiac rehabilitation: a review of referral and adherence predictors|/resolve/reference/PMED?id=15604322
Jolliffe 2001|Exercised-based rehabilitation for coronary heart disease|
Law 2002|The underlying risk of death after myocardial infarction in the absence of treatment|/resolve/reference/PMED?id=12437397
Moore 2003|Predictors of women's exercise maintenance after cardiac rehabilitation|/resolve/reference/PMED?id=12576911
Neal 2004|Secondary prevention of Cardiovascular Disease: Fixed dose combinations|
NICE 2007|MI:Secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction|
Rees 2004a|Exercise-based rehabilitation for heart failure|
Rees 2004b|Psychological interventions for coronary heart disease|
Stone 2005|Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention, second edition, 2004: executive summary|/resolve/reference/PMED?id=16292364
Taylor 2004|Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=15121495
Taylor 2010|Home-based versus centre-based cardiac rehabilitation|
WHO 1997||
Ziegelstein 2000|Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction|/resolve/reference/PMED?id=10871976
Beswick 2004|Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups|
Beswick 2005|Improving uptake and adherence in cardiac rehabilitation: literature review|
Arrigo 2008 {published data only}|Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence|/resolve/reference/PMED?id=18525385
Ashe 1993 {published data only}||
Beckie 2010 {published data only}|Predicting cardiac rehabilitation attendance in a gender-tailored randomized clinical trial|
Cossette 2012 {published data only}|Randomized controlled trial of tailored nursing interventions to improve cardiac rehabilitation enrollment|
Daltroy 1985 {published data only}|Improving cardiac patient adherence to exercise regimens: a clinical trial of health education|
Dolansky 2011 {published data only}|Initial efficacy of a cardiac rehabilitation transition program: Cardiac TRUST|
Duncan 2002 {published data only}|Effects of an exercise adherence intervention on outcomes in patients with heart failure|
Duncan 2002 {published data only}|Staying on course: the effects of an adherence facilitation intervention on home exercise participation|
Hillebrand 1995 {published data only}|Increased participation in coronary groups by means of an outpatient care program|
Izawa 2005 {published data only}|Effect of the self-monitoring approach on exercise maintenance during cardiac rehabilitation: a randomized, controlled trial|/resolve/reference/PMED?id=15829777
Jolly 1999 {published data only}|Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial. Southampton Heart Integrated Care Project|/resolve/reference/PMED?id=10078796
Jolly 1999 {published data only}|Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton Heart Integrated Care Project (SHIP). The SHIP Collaborative Group|/resolve/reference/PMED?id=10074017
McPaul 2007 {published data only}||
Moore 2006 {published data only}|Effects of a CHANGE intervention to increase exercise maintenance following cardiac events|/resolve/reference/PMED?id=16472039
Oldridge 1983 {published data only}|Improving patient compliance in cardiac exercise rehabilitation: effects of written agreement and self-monitoring|
Pack 2013 {published data only}|An early appointment to outpatient cardiac rehabilitation at hospital discharge improves attendance at orientation: a randomized, single-blind, controlled trial|
Parry 2009 {published data only}|Cardiac Home Education and Support Trial (CHEST): a pilot study|
Price 2012 {published data only}||
Sniehotta 2006 {published data only}|Action plans and coping plans for physical exercise: a longitudinal intervention study in cardiac rehabilitation|
Wyer 2001 {published data only}|Increasing attendance rates at a cardiac rehabilitation programme: an intervention study using the Theory of Planned Behaviour|
Aish 1996 {published data only}|Effects of Orem-based nursing intervention on nutritional self-care of myocardial infarction patients|/resolve/reference/PMED?id=8736471
Brodie 2005 {published data only}|Motivational interviewing to promote physical activity for people with chronic heart failure|
Butler 2009 {published data only}|Effects of a pedometer-based intervention on physical activity levels after cardiac rehabilitation: a randomized controlled trial|
Carlson 2000 {published data only}|Program participation, exercise adherence, cardiovascular outcomes, and program cost of traditional versus modified cardiac rehabilitation|/resolve/reference/PMED?id=10867086
Carroll 2007 {published data only}|The effects of a collaborative peer advisor/advanced practice nurse intervention: cardiac rehabilitation participation and rehospitalization in older adults after a cardiac event|
Dankner 2011 {published data only}|The effect of an educational intervention on coronary artery bypass graft surgery patients' participation rate in cardiac rehabilitation programs: a controlled health care trial|
Duncan 2001 {published data only}|The effects of behavioural feedback on adherence to dietary sodium intake for patients with congestive heart failure|
Froelicher 2003 {published data only}|The Enhancing Recovery in Coronary Heart Disease Trial ENRICHD: strategies and techniques for enhancing retention of patients with acute myocardial infarction and depression or social isolation|
Furber 2010 {published data only}|Randomised controlled trial of a pedometer-based telephone intervention to increase physical activity among cardiac patients not attending cardiac rehabilitation|
Higgins 2001 {published data only}|Rehabilitation outcomes following percutaneous coronary interventions (PCI)|/resolve/reference/PMED?id=11384820
Hopper 1995 {published data only}||
Hughes 2002 {published data only}|Exercise consultation improves short-term adherence to exercise during phase IV cardiac rehabilitation: a randomized, controlled trial|
Hughes 2007 {published data only}|Effect of an exercise consultation on maintenance of physical activity after completion of phase III exercise-based cardiac rehabilitation|/resolve/reference/PMED?id=17301636
Jolly 2009 {published data only}|A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study|
Kolt 2009 {published data only}|The healthy steps study: a randomized controlled trial of a pedometer-based green prescription for older adults. Trial protocol|
Kummel 2007 {published data only}|Effects of an intervention on health behaviors of older coronary artery bypass CAB patients|
Leemrijse 2012 {published data only}|The effects of Hartcoach, a life style intervention provided by telephone on the reduction of coronary risk factors: a randomised trial|
Luszczynska 2006 {published data only}|An implementation intentions intervention, the use of a planning strategy, and physical activity after myocardial infarction|/resolve/reference/PMED?id=16095786
Mahler 1999 {published data only}|Effects of a videotape information intervention at discharge on diet and exercise compliance after coronary bypass surgery|
Meillier 2012 {published data only}|Socially differentiated cardiac rehabilitation: can we improve referral, attendance and adherence among patients with first myocardial infarction?|
Moore 2002 {published data only}|Using the CHANGE intervention to enhance long-term exercise|/resolve/reference/PMED?id=12389268
Palomki 2002 {published data only}|Effects of preventive group education on the resistance of LDL against oxidation and risk factors for coronary heart disease in bypass surgery patients|/resolve/reference/PMED?id=12371711
Peterson 2012 {published data only}|A randomized controlled trial of positive-affect induction to promote physical activity after percutaneous coronary intervention|
Powell 2010 {published data only}|Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial|
Redfern 2009 {published data only}|Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial|/resolve/reference/PMED?id=18801781
Reid 2012 {published data only}|Motivational counselling for physical activity in patients with coronary artery disease not participating in cardiac rehabilitation|
Rejeski 2002 {published data only}|Older adults in cardiac rehabilitation: a new strategy for enhancing physical function|/resolve/reference/PMED?id=12439072
Reusch 2011 {published data only}|Effectiveness of small-group interactive education vs. lecture-based information-only programs on motivation to change and lifestyle behaviours. A prospective controlled trial of rehabilitation inpatients|
Richardson 2010 {published data only}|An online community improves adherence in an internet-mediated walking program. Part 1: results of a randomized controlled trial|
Sniehotta 2005 {published data only}|Long-term effects of two psychological interventions on physical exercise and self-regulation following coronary rehabilitation|/resolve/reference/PMED?id=16262543
Southard 2003 {published data only}|Clinical trial of an Internet-based case management system for secondary prevention of heart disease|
Stromberg 2006 {published data only}|Computer-based education for patients with chronic heart failure. A randomised, controlled, multicentre trial of the effects on knowledge, compliance and quality of life|/resolve/reference/PMED?id=16469469
Vestfold 2003 {published data only}|Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease|
Willmott 2011 {published data only}|The effects of expressive writing following first myocardial infarction: a randomized controlled trial|
Wolkanin-Bartnik 2011 {published data only}|Patient education and quality of home-based rehabilitation in patients older than 60 years after acute myocardial infarction|
Wu 2012 {published data only}|Peer supporters for cardiac patients with diabetes: a randomized controlled trial|
Zarani 2010 {published data only}|The effectiveness of the information-motivation-behavioral skills model in promoting adherence in CABG patients|
Maddison 2011 {published data only}|HEART: heart exercise and remote technologies: a randomized controlled trial study protocol|
Sangster 2010 {published data only}|A population-based lifestyle intervention to promote healthy weight and physical activity in people with cardiac disease: the PANACHE (Physical Activity, Nutrition And Cardiac HEalth) study protocol|
Ajzen 1986|Prediction of goal-directed behaviour: attitudes, intentions and perceived behavioural control|
Balady 2007|Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation|/resolve/reference/PMED?id=17513578
Beckie 2008|Adverse baseline physiological and psychosocial profiles of women enrolled in a cardiac rehabilitation clinical trial|
Bethell 2001|Cardiac rehabilitation in the United Kingdom. How complete is the provision?|
Brown 2009|Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program|
Daly 2002|Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review|
Davies 2010b|Exercise based rehabilitation for heart failure|
Heran 2011|Exercise-based cardiac rehabilitation for coronary heart disease|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Jackson 2005|Getting the most out of cardiac rehabilitation: a review of referral and adherence predictors|/resolve/reference/PMED?id=15604322
Kotseva 2009|Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries|/resolve/reference/PMED?id=19286092
Lefebvre 2011|Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Marlatt 1980|Determinants of relapse: Implications for the maintenance of behavior change|
Moore 2003|Predictors of women's exercise maintenance after cardiac rehabilitation|
NICE 2007|MI: secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction|
Perk 2012|European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)|
Stone 2005|Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention, second edition, 2004: executive summary|
Suaya 2007|Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery|/resolve/reference/PMED?id=17893274
Taylor 2004|Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=15121495
Taylor 2010|Home-based versus centre-based cardiac rehabilitation|
Whalley 2011|Psychological interventions for coronary heart disease|
WHO 2011||
Yohannes 2007|Predictors of drop-out from an outpatient cardiac rehabilitation programme|/resolve/reference/PMED?id=17329279
Beswick 2004|Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups|
Beswick 2005|Improving uptake and adherence in cardiac rehabilitation: literature review|
Davies 2010a|Promoting patient uptake and adherence in cardiac rehabilitation|
Volicer 1997 {published data only}|Effects of dronabinol on anorexia and disturbed behaviour in patients with Alzheimer's Disease.|
Walther 2006 {published data only}|Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.|/resolve/reference/PMED?id=16521031
Walther 2007 {unpublished data only}|Placebo-controlled, randomised, double blind crossover trial on dronabinol, a cannabinoid-1-receptor agonist, for behavioral and circadian rhythm disturbances in dementia|
APA 1994||
Baker 2003|The therapeutic potential of cannabis|/resolve/reference/PMED?id=12849183
Ballard 2006|Atypical antipsychotics for aggression and psychosis in Alzheimer's disease|
Birks 2006|Cholinesterase inhibitors for Alzheimer's disease|
Campbell 2007|Alzheimer's disease; taking the edge off with cannabinoids?|
Chalmers 1983|Bias in treatment assignment in controlled clinical trials|/resolve/reference/PMED?id=6633598
Cohen-Mansfield 1989|A description of agitation in a nursing home|/resolve/reference/PMED?id=2715584
Ehrhart 2005|Stimulation of CB2 suppresses microglial activation|/resolve/reference/PMED?id=16343349
Eubanks 2006|A molecular link between the active component of marijuana and Alzheimer's disease pathology|/resolve/reference/PMED?id=17140265
FDA 2005|FDA public health advisory: deaths with antipsychotics in elderly patients with behavioural disturbances|
Grinspoon 1993||
Grundy 2002|The therapeutic potential of the cannabinoids in neuroprotection|/resolve/reference/PMED?id=12387700
Hampson 1998|Cannabidiol and delta-9-tetrahydrocannabinol are neuroprotective antioxidants|/resolve/reference/PMED?id=9653176
Howard 2007|Donepezil for the treatment of agitation in Alzheimer's disease|/resolve/reference/PMED?id=17914039
Howlett 2002|International Union of Pharmacology XXVII. Classification of cannabinoid receptors|/resolve/reference/PMED?id=12037135
Iversen 2000||
Lawton 1996|Observed affect in nursing home residents with Alzheimer's disease|
Lowin 2001|Alzheimer's disease in the UK: comparative evidence on cost of illness and volume of health services research funding|
Matsuda 1990|Structure of a cannabinoid receptor and functional expression of the cloned cDNA|/resolve/reference/PMED?id=2165569
McKhann 1984|Clinical diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease|/resolve/reference/PMED?id=6610841
MHRA 2004|New advice issued on risperidone and olanzepine|
Nagayama 1999|Cannabinoids and neuroprotection in global and focal cerebral ischaemia and in neuronal cultures|/resolve/reference/PMED?id=10191316
Onaivi 2006|Neuropsychological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain|/resolve/reference/PMED?id=17356307
Rabins 1982|The impact of dementia on the family|/resolve/reference/PMED?id=7087127
Ramirez 2005|Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation|/resolve/reference/PMED?id=15728830
Schneider 2005|Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials|/resolve/reference/PMED?id=16234500
Schneider 2006|Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized placebo-controlled trials|/resolve/reference/PMED?id=16505124
Schulz 1995|Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Shen 1998|Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity|/resolve/reference/PMED?id=9730904
Steele 1990|Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease|/resolve/reference/PMED?id=2375439
Van Sickle 2005|Identification and functional characterization of brainstem cannabinoid CB2 receptors|/resolve/reference/PMED?id=16224028
Volicer 1997|Effects of dronabinol on anorexia and disturbed behaviour in patients with Alzheimer's disease|
Walther 2006|Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia|/resolve/reference/PMED?id=16521031
WHO 1993||
Alvarez-Fernandez 2005 {published data only}|Survival of a cohort of elderly patients with advanced dementia: nasogastric tube feeding as a risk factor for mortality|
Jaul 2006 {published data only}|Tube feeding in the demented elderly with severe disabilities|/resolve/reference/PMED?id=17214109
Meier 2001 {published data only}|High short-term mortality in hospitalized patients with advanced dementia: Lack of benefit of tube feeding.|/resolve/reference/PMED?id=11252121
Mitchell 1997 {published data only}|The risk factors and impact on survival of feeding tubes placement in nursing home residents with severe cognitive impairment|/resolve/reference/PMED?id=9040301
Murphy 2003 {published data only}|Percutaneous endoscopic gastrostomy does not prolong survival in patients with dementia|/resolve/reference/PMED?id=12796072
Nair 2000 {published data only}|Hypoalbuminaemia is a poor predictor of survival after percutaneous endoscopic gastrostomy in elderly patients with dementia|
Peck 1990 {published data only}|Long term enteral feeding of aged demented nursing home patients|/resolve/reference/PMED?id=2123217
Berlowitz 1997 {published data only}|Predictors of pressure ulcer healing among long-term residents|/resolve/reference/PMED?id=8994484
Callahan 2000 {published data only}|Outcomes of percutaneous endoscopic gastrostomy among older adults in a community setting|/resolve/reference/PMED?id=10983903
Ciocon 1988 {published data only}|Tube feedings in elderly patients|/resolve/reference/PMED?id=3124777
Feinberg 1996 {published data only}|Prandial aspiration and pneumonia in an elderly population followed over 3 years|/resolve/reference/PMED?id=8721068
Fox 1995 {published data only}|Aspiration pneumonia following surgically placed feeding tubes|/resolve/reference/PMED?id=7492001
Henderson 1992 {published data only}|Prolonged tube feeding in long-term care, nutritional status and clinical outcomes|/resolve/reference/PMED?id=1619183
Kaw 1994 {published data only}|Long-term follow-up of consequences of percutaneous endoscopic gastrostomy tubes in nursing home patients|/resolve/reference/PMED?id=8149838
Langmore 2002 {published data only}|Predictors of aspiration pneumonia in nursing home residents|/resolve/reference/PMED?id=12355145
Loser 1998 {published data only}|Enteral long-term nutrition via percutaneous endoscopic gastrostomy in 210 patients|/resolve/reference/PMED?id=9824149
Abuksis 2000|Percutaneous endoscopic gastronomy: High mortality rates in hospitalized patients|
APA 1994|Diagnostic and Statistical Manual of Mental Disorders|
Clarfield 2006|Enteral feeding in end-stage dementia: a comparison of religious, ethnic, and national differences in Canada and Israel|
Ferri 2005|Global prevalence of dementia: a Delphi consensus study|/resolve/reference/PMED?id=16360788
Finucane 1999|Tube feeding in patients with advanced dementia: a review of the evidence|/resolve/reference/PMED?id=10527184
Hebert 2003|Alzheimer disease in the US population|/resolve/reference/PMED?id=12925369
Hendrie 1998|Epidemiology of dementia and AlzheImer's disease|/resolve/reference/PMED?id=9581216
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008|
Kawas 1998|Alzheimer's disease|
Martino 2005|Dysphagia after stroke|/resolve/reference/PMED?id=16269630
McCann 1994|Comfort care for terminally ill patients. The appropriate use of nutrition and hydration|/resolve/reference/PMED?id=7933372
Mitchell 2003|Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment|/resolve/reference/PMED?id=12837714
Morris 1990|Designing the National Assessment Instrument for Nursing Homes|
Morris 1993|The Clinical Dementia Rating (CDR): current version and scoring rules|/resolve/reference/PMED?id=8232973
NIH 1999||
Njegovan 2001|The hierarchy of functional loss associated with cognitive decline in older persons|
Pasman 2005|Discomfort in Nursing Home Patients With Severe Dementia in Whom Artificial Nutrition and Hydration Is Forgone|/resolve/reference/PMED?id=16087820
Rappaport 1982|Disability rating scale for severe head trauma patients: coma to community|/resolve/reference/PMED?id=7073452
Reisberg 1994|Dementia staging in chronic care populations|
Small 1999|Dementia|
Stevens 2002|Islington study of dementia subtypes in the community|/resolve/reference/PMED?id=11872521
The 2002|Withholding the artificial administration of fluids and food from elderly people with dementia: ethnographic study|/resolve/reference/PMED?id=12468479
Thune-Boyle 2009|Challenges to improving end of life care of people with advanced dementia in the UK|
WHO 1993||
Wolfson 2001|A reevaluation of the duration of survival after the onset of dementia|/resolve/reference/PMED?id=11297701
Xie 2008|Medical Research Council Cognitive Function and Ageing Study collaborators|/resolve/reference/PMED?id=18187696
Angermann 2007 {published and unpublished data}|Abstract 2709: a prospective randomised trial comparing the efficacy of a standardised supraregionally transferable program for monitoring and education of patients with systolic heart failure with usual care: the Interdisciplinary Network for Heart failure (INH) study|
Antonicelli 2008 {published data only}|Impact of telemonitoring at home on the management of elderly patients with congestive heart failure|/resolve/reference/PMED?id=18776075
Balk 2008 {published data only}|Tele-guidance of chronic heart failure patients enhances knowledge about the disease|
Balk 2008 {published data only}|275 personalised tele-guidance of heart failure patients: effects of the MOTIVA interactive health care platform on hospital admissions, quality of life, knowledge of disease and self-care: a pilot study|
Balk 2008 {published data only}|Telemonitoring of patients with chronic heart failure|
Barth 2001 {published data only}|A nurse-managed discharge program for congestive heart failure patients: outcomes and costs|
Blum 2007 (MCCD) {published and unpublished data}|Morbidity and mortality benefits of reliable instrumental support|
Blum 2007 (MCCD) {published and unpublished data}|One year changes in quality of life for heart failure patients in a home telemonitoring program|
Blum 2007 (MCCD) {published and unpublished data}|Coordinated care, telemonitoring, and the therapeutic relationship: heart failure management in the United States|
Blum 2007 (MCCD) {published and unpublished data}|Exploration of patients' readiness for an eHealth management program for chronic heart failure: a preliminary study|/resolve/reference/PMED?id=18953206
Capomolla 2004 {published data only}|Heart failure case disease management program: a pilot study of home telemonitoring versus usual care|
Cleland 2005 (Telemon) {published data only}|The trans-European network - home care management system (TEN-HMS) study: an investigation of the effect of telemedicine on outcomes in Europe|
Cleland 2005 (Telemon) {published data only}|Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death|/resolve/reference/PMED?id=15893183
Cleland 2005 (Telemon) {published data only}|Patient acceptance and satisfaction of home telemonitoring in the management of heart failure: TENS-HMS|
Cleland 2005 (Telemon) {published data only}|Tele-homecare for chronically-ill patients: improved outcomes and new developments|
Cleland 2005 (Telemon) {published data only}|Predicting hospitalisation due to worsening heart failure using daily weight measurement: an analysis of the Trans-European-Netwrok-Home-Care Management System (TEM-HMS) Study|
Cleland 2005(Struct Tele) {published data only}|The trans-European network - home care management system (TEN-HMS) study: an investigation of the effect of telemedicine on outcomes in Europe|
Cleland 2005(Struct Tele) {published data only}|Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death|/resolve/reference/PMED?id=15893183
Cleland 2005(Struct Tele) {published data only}|Patient acceptance and satisfaction of home telemonitoring in the management of heart failure: TENS-HMS|
Cleland 2005(Struct Tele) {published data only}|Tele-homecare for chronically-ill patients: improved outcomes and new developments|
Cleland 2005(Struct Tele) {published data only}|Predicting hospitalisation due to worsening heart failure using daily weight measurement: an analysis of the Trans-European-Netwrok-Home-Care Management System (TEM-HMS) Study|
de Lusignan 2001 {published data only}|A controlled pilot study in the use of telemedicine in the community on the management of heart failure: a report of the first three months|
de Lusignan 2001 {published data only}|Compliance and effectiveness of 1 year's home telemonitoring: the report of a pilot study of patients with chronic heart failure|
DeBusk 2004 {published data only}|Care management for low-risk patients with heart failure: a randomised, controlled trial|/resolve/reference/PMED?id=15492340
DeWalt 2006 {published data only}|A heart failure self-management program for patients of all literacy levels: a randomised, controlled trial|
Galbreath 2004 {published data only}|Correction to: Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure|
Galbreath 2004 {published data only}|Long-term healthcare and cost outcomes of disease management in a large, randomised, community-based population with heart failure|/resolve/reference/PMED?id=15531765
Galbreath 2004 {published data only}|Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomised trial in community- dwelling patients|/resolve/reference/PMED?id=16268753
Galbreath 2004 {published data only}|Cost-effectiveness of telephonic disease management in heart failure|/resolve/reference/PMED?id=18269306
Gattis 1999 (PHARM) {published data only}|Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team|/resolve/reference/PMED?id=10493325
GESICA 2005 (DIAL) {published data only}|Randomised trial of telephone intervention in chronic heart failure: DIAL trial|/resolve/reference/PMED?id=16061499
GESICA 2005 (DIAL) {published data only}|Randomized trial of telephone intervention in chronic heart failure (DIAL): study design and preliminary observations|/resolve/reference/PMED?id=12815566
GESICA 2005 (DIAL) {published data only}|Disease management programs in heart failure: findings of the DIAL study|/resolve/reference/PMED?id=18093490
Giordano 2009 {published data only}|Multicentre randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure|/resolve/reference/PMED?id=18222552
Giordano 2009 {published data only}|243 multicenter randomised trial on home based tele-management to prevent hospital readmission of patients with chronic heart failure|
Giordano 2009 {published data only}|A pilot study of nurse-led home-based tele-cardiology for patients with chronic heart failure|/resolve/reference/PMED?id=15068649
Goldberg 2003 (WHARF) {published data only}|Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial|/resolve/reference/PMED?id=14564327
Goldberg 2003 (WHARF) {published data only}|Abstract 3277: withdrawal of a technology-based daily weight monitoring system in patients with advanced heart failure eliminates mortality benefit|
Kielblock 2007 {published and unpublished data}|P4874 Impact of telemetric management on overall treatment costs and mortality rate among patients with chronic heart failure|
Kielblock 2007 {published and unpublished data}|Impact of telemetric management on overall treatment costs and mortality rate among patients with chronic heart failure|/resolve/reference/PMED?id=17315117
Krum 2009 (CHAT) {published and unpublished data}|Adherence, adaptation and acceptance of elderly chronic heart failure patients to receiving healthcare via telephone-monitoring|
Krum 2009 (CHAT) {published and unpublished data}|Clinical trials update from the European Society of Cardiology heart failure meeting 2009 CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF|
Krum 2009 (CHAT) {published and unpublished data}|Does telephone support of the rural and remote patients with heart failure improve clinical outcomes?: results of the Chronic Heart Failure Assistance by Telephone (CHAT) study|
Krum 2009 (CHAT) {published and unpublished data}|The Chronic Heart-failure Assistance by Telephone (CHAT) study: a new model of care to support aging rural patients with chronic disease|
Krum 2009 (CHAT) {published and unpublished data}|CHAT-a study of a nurse-led system of care|/resolve/reference/PMED?id=17059028
Laramee 2003 {published data only}|Case management in a heterogenous congestive heart failure population: a randomised controlled trial|/resolve/reference/PMED?id=12695272
Mortara 2009 (Struct Tele) {published and unpublished data}|The telemonitoring service|/resolve/reference/PMED?id=16499299
Mortara 2009 (Struct Tele) {published and unpublished data}|P2160 a new telemonitoring system in heart failure: preliminary data from the multi-country randomized study HHH (Home or Hospital in Heart Failure)|
Mortara 2009 (Struct Tele) {published and unpublished data}|P358 a multi-country randomised trial of the role of a new telemonitoring system in CHF: the HHH Study (Home or Hospital in Heart Failure): preliminary data|
Mortara 2009 (Struct Tele) {published and unpublished data}|Rehabilitation and models of domiciliary care of patients with chronic heart failure: preliminary results of the HHH study|/resolve/reference/PMED?id=16499306
Mortara 2009 (Struct Tele) {published and unpublished data}|Home telemonitoring in heart failure patients: the HHH study (Home of Hospital in Heart Failure)|
Mortara 2009 (Struct Tele) {published and unpublished data}|Home telemonitoring of respiratory activity and heart rate variability in chronic heart failure patients: the challenge of the home or hospital in heart failure project|
Mortara 2009 (Struct Tele) {published and unpublished data}|Home telemonitoring of vital signs and cardiorespiratory signals in heart failure patients: system architecture and feasibility of the HHH model|/resolve/reference/PMED?id=17189654
Mortara 2009 (Struct Tele) {published and unpublished data}|Home telemonitoring of vital signs and cardiorespiratory signals in chronic heart failure patients|
Mortara 2009 (Struct Tele) {published and unpublished data}|Domiciliary telemonitoring of vital and cardiorespiratory signs of the HHH project|/resolve/reference/PMED?id=16499307
Mortara 2009 (Struct Tele) {published and unpublished data}|Long-term monitoring of sleep apnea at home in heart failure patients: preliminary results from the HHH study|/resolve/reference/PMED?id=16499299
Mortara 2009 (Struct Tele) {published and unpublished data}|Home telemonitoring of chronic heart failure patients: novel system architecture of the home or hospital study|
Mortara 2009 (Telemon) {published and unpublished data}|The telemonitoring service|/resolve/reference/PMED?id=16499299
Mortara 2009 (Telemon) {published and unpublished data}|P2160 a new telemonitoring system in heart failure: preliminary data from the multi-country randomized study HHH (Home or Hospital in Heart Failure)|
Mortara 2009 (Telemon) {published and unpublished data}|P358 a multi-country randomised trial of the role of a new telemonitoring system in CHF: the HHH Study (Home or Hospital in Heart Failure): preliminary data|
Mortara 2009 (Telemon) {published and unpublished data}|Rehabilitation and models of domiciliary care of patients with chronic heart failure: preliminary results of the HHH study|/resolve/reference/PMED?id=16499306
Mortara 2009 (Telemon) {published and unpublished data}|Home telemonitoring in heart failure patients: the HHH study (Home of Hospital in Heart Failure)|
Mortara 2009 (Telemon) {published and unpublished data}|Home telemonitoring of respiratory activity and heart rate variability in chronic heart failure patients: the challenge of the home or hospital in heart failure project|
Mortara 2009 (Telemon) {published and unpublished data}|Home telemonitoring of vital signs and cardiorespiratory signals in heart failure patients: system architecture and feasibility of the HHH model|/resolve/reference/PMED?id=17189654
Mortara 2009 (Telemon) {published and unpublished data}|Domiciliary telemonitoring of vital and cardiorespiratory signs of the HHH project|/resolve/reference/PMED?id=16499307
Mortara 2009 (Telemon) {published and unpublished data}|Home telemonitoring of vital signs and cardiorespiratory signals in chronic heart failure patients|
Mortara 2009 (Telemon) {published and unpublished data}|Long-term monitoring of sleep apnea at home in heart failure patients: preliminary results from the HHH study|/resolve/reference/PMED?id=17402355
Mortara 2009 (Telemon) {published and unpublished data}|Home telemonitoring of chronic heart failure patients: novel system architecture of the home or hospital study|
Rainville 1999 {published data only}|Impact of pharmacist intervention on hospital readmissions for heart failure|/resolve/reference/PMED?id=10683133
Ramachandran 2007 {published data only}|Impact of a comprehensive telephone-based disease management programme on quality-of-life in patients with heart failure|/resolve/reference/PMED?id=17802984
Riegel 2002 {published data only}|Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure|/resolve/reference/PMED?id=11911726
Riegel 2006 {published data only}|Standardized telephonic case management in a Hispanic heart failure population: an effective intervention|
Riegel 2006 {published data only}|Randomized controlled trial of telephone case management in Hispanics of Mexican origin with heart failure|/resolve/reference/PMED?id=16624687
Sisk 2006 {published data only}|Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community|/resolve/reference/PMED?id=18936502
Sisk 2006 {published data only}|Effectiveness and cost-effectiveness of nurse-management to improve heart-failure care in minority communities|
Sisk 2006 {published data only}|Effects of nurse management on the quality of heart failure care in minority communities: a randomised trial|/resolve/reference/PMED?id=16908918
Soran 2008 {published data only}|Randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women|
Soran 2008 {published data only}|A randomised clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women|
Soran 2008 {published data only}|Impact of a sophisticated computer based telephonic heart failure monitoring system on quality of life in patients with heart failure (Abstract #1012-151)|
Tsuyuki 2004 {published data only}|A multicenter disease management program for hospitalised patients with heart failure|/resolve/reference/PMED?id=15599837
Villani 2007 (ICAROS) {published and unpublished data}|Disease management for heart failure patients: role of wireless technologies for telemedicine: the ICAROS project|/resolve/reference/PMED?id=17402355
Wakefield 2008 {published data only}|Nurse and patient communication profiles in a home-based telehealth intervention for heart failure management|/resolve/reference/PMED?id=18337049
Wakefield 2008 {published data only}|Evaluation of home telehealth following hospitalizations for heart failure: a randomised trial|
Woodend 2008 {published and unpublished data}|Getting connected: tele-home care for patients with heart disease|
Woodend 2008 {published and unpublished data}|Telehome monitoring in patients with cardiac disease who are at high risk of readmission|/resolve/reference/PMED?id=18206525
Zugck 2008 (HiTel) {published and unpublished data}|52 Telemedicine reduces hospitalisation rates in patients with chronic heart failure: results of the randomised HiTel trial|
Zugck 2008 (HiTel) {published and unpublished data}|Telemonitoring in chronic heart failure patients: which diagnostic finding prevents hospital readmission?|/resolve/reference/PMED?id=16177944
Akosah 2005 {published data only}|Improving outcomes in heart failure in the community: long-term survival benefit of a disease-management program|/resolve/reference/PMED?id=15947318
Albanese 2001 {published data only}|The SCOOP II trial in heart failure|/resolve/reference/PMED?id=19397013
Albert 2007 {published data only}|Randomized study of the effect of video education on heart failure healthcare utilization, symptoms, and self-care behaviours|
Aliti 2007 {published data only}|Educational settings in the management of patients with heart failure|/resolve/reference/PMED?id=17546370
Anderson 2005 {published data only}|Benefits of comprehensive inpatient education and discharge planning combined with outpatient support in elderly patients with congestive heart failure|
Artinian 2003 {published data only}|Pilot study of a web-based compliance monitoring|/resolve/reference/PMED?id=12891162
Artinian 2006 {published data only}|3307: Nurse-managed telemonitoring is associated with improved blood pressure at 12-months follow-up in African Americans|
Arya 2008 {published data only}|Influence of home monitoring on the clinical status of heart failure patients: design and rationale of the IN-TIME study|
Baden 2007a {published data only}|P3939: Telemonitoring by congestive heart failure: early detection of pending cardiac decompensation and its predictive values of blood pressure and weight instability|
Baden 2007b {published data only}|289: Telemonitoring by congestive heart failure: predictive value of blood pressure and weight instability in the early detection of pending cardial decompensation|
Baer 1999 {published data only}|Electronic home monitoring of congestive heart failure patients: design and feasibility|/resolve/reference/PMED?id=12189314
Baldauf 2008 {published data only}|Establishing the telephonic connection: easing the transition from hospital to home through experienced nursing|
Barber 1999 {published data only}|Community-focused nurse case management by telephone for patients with congestive heart failure|/resolve/reference/PMED?id=16487779
Benatar 2003 {published data only}|Outcomes of chronic heart failure|/resolve/reference/PMED?id=12578516
Bennett 2006 {published data only}|The PUMP-UP tailored computerized program for heart failure care|/resolve/reference/PMED?id=16487779
Blue 2001 {published data only}|Randomised controlled trial of specialist nurse intervention in heart failure|/resolve/reference/PMED?id=11576977
Bocchi 2007 (REMADHE) {published data only}|Late effects of a disease program management on mortality, hospitalisation, and quality of life in heart failure patients followed by cardiologists with experience in heart failure- a randomised and prospective trial (Abstract #1022-143)|
Bolz 2005 {published data only}|The technical possibilities in telemonitoring of physiological parameters|/resolve/reference/PMED?id=16177939
Bondmass 1999 {published data only}|The effect of physiological home monitoring and tele-management on chronic heart failure outcomes|
Bondmass 2002 {published data only}|Thesis: Outcomes of home management methods for chronic heart failure|/resolve/reference/PMED?id=18342224
Bondmass 2007 {published data only}|Improving outcomes for African Americans with chronic heart failure: a comparison of two home care management delivery methods|
Bourge 2008 (COMPASS-HF) {published data only}|Randomized controlled trial of an implantable continuous haemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study|/resolve/reference/PMED?id=18342224
Bowles 2007 {published data only}|Applying research evidence to optimise tele home care|/resolve/reference/PMED?id=17224692
Bowles 2008 {published data only}|The advantages and disadvantages of heart failure disease management when randomly assigned to be delivered by telehealth or telephone|
Boyne 2008 {published data only}|Telemonitoring in patients with heart failure: a feasibility study (TEHAF)|
Brennan 2006 {published data only}|Creating technology-enhanced practice: a university-home care-corporate alliance|/resolve/reference/PMED?id=17102341
Brownsell 2006a {published data only}|Two tele-care examples from the UK: lifestyle reassurance and chronic heart failure|
Brownsell 2006b {published data only}|Telemonitoring chronic heart failure: interim findings from a pilot study in South Yorkshire|
Brownsell 2008 {published data only}|Reforming health care through information and communication technologies|
Caldwell 2005 {published data only}|A simplified education program improves knowledge, self-care behavior, and disease severity in heart failure patients in rural settings|
Calvin 2008 {published data only}|Impact of self-management training on high-risk patients with heart failure: results from the Heart Failure Adherence and Retention Trial (HART). Abstract #63|
Capomolla 2002 {published data only}|Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care|/resolve/reference/PMED?id=12383573
Cherry 2000 {published data only}|Meeting the challenges of case management with remote patient monitoring technology|
Chetney 2003 {published data only}|Home care that doesn't miss a beat|/resolve/reference/PMED?id=14557707
Chetney 2008 {published data only}|Using telehealth to avoid urgent care and hospitalisation|
Clappers 2006 {published data only}|Hotline sessions of the 28th European Congress of Cardiology/World Congress of Cardiology 2006|/resolve/reference/PMED?id=17101635
Clark 2008 {published data only}|The complex nature of informal care in home-based heart failure management|
Clarke 2005 {published data only}|A telemonitoring architecture to support chronic disease management and acute episode monitoring|/resolve/reference/PMED?id=17281033
Cline 1998 {published data only}|Cost effective management programme for heart failure reduces hospitalisation|/resolve/reference/PMED?id=9930041
Cole 2006 {published data only}|Double-disease management or one care manager for two chronic conditions: pilot feasibility study of nurse telephonic disease management for depression and congestive heart failure|
Cordisco 1999 {published data only}|Use of telemonitoring to decrease the rate of hospitalisation in patients with severe congestive heart failure|/resolve/reference/PMED?id=10513789
Courtney 2009 {published data only}|Fewer emergency readmissions and better quality of life for older adults at risk of hospital readmission: a randomised controlled trial to determine the effectiveness of a 24-week exercise and telephone follow-up program|
Cross 1999 {published data only}|A scale that talks back|/resolve/reference/PMED?id=10557704
Dalmiani 2001 {published data only}|An informative system for chronic heart failure patients follow-up (CHeF)|/resolve/reference/PMED?id=18617707
Dang 2006 {published data only}|Differential resource utilisation benefits with Internet -based care coordination in elderly veterans with chronic disease associated with high resource utilization|/resolve/reference/PMED?id=16478409
Dansky 2008a {published data only}|Impact of telehealth on clinical outcomes in patients with heart failure|/resolve/reference/PMED?id=18617707
Dansky 2008b {published data only}|Use of telehealth by older adults to manage heart failure|/resolve/reference/PMED?id=20078015
Dar 2009 (HOME-HF) {published data only}|A randomised trial of home telemonitoring in atypical elderly heart failure population in northwest London: results of the Home-HF study|
Dar 2009 (HOME-HF) {published data only}|The Home Heart Failure Study (HOME-HF): A randomised controlled trial of home telemonitoring of heart failure patients at high risk of readmission and death (Abstract #197)|
Dar 2009 (HOME-HF) {published data only}|2341 Telemonitoring in an elderly, urban, multi-ethnic population: results of a UK multi-centre randomised controlled trial. The Home Heart Failure (HOME-HF) study|
Dar 2009 (HOME-HF) {published data only}|Telemonitoring in heart failure|/resolve/reference/PMED?id=19923337
Dar 2009 (HOME-HF) {published data only}|1400 Telemonitoring in heart failure: changing roles and challenging relationships. The HOME-HF study|
Dar 2009 (HOME-HF) {published data only}|626 The HOME-HF Study: A multi-centre randomised controlled trial of home telemonitoring in a general heart failure population of elderly patients with co-morbidity|
de Feo 2002 {published data only}|To educate or to communicate: a non-pharmacological treatment for the patient with heart failure?|
Dedier 2008 {published data only}|4430: A culturally-adapted automated telecommunications system improves medication adherence and blood pressure control in urban African Americans|
Deepak 2008 {published data only}|1036-152 Home uptitration of beta-blockers by heart failure clinic patients with telephone advice: a British Heart experience|
Del Sindaco 2007 {published data only}|Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure|/resolve/reference/PMED?id=17443097
Demarzo 2006 {published data only}|Using impedance cardiography as a decision aid for diagnosing and managing heart failure|
Dimmick 2003 {published data only}|Outcomes of an integrated telehealth network demonstration project|
Dollard 2004 {published data only}|Broadening the reach of cardiac rehabilitation to rural and remote Australia|/resolve/reference/PMED?id=15053886
Dougherty 2005 {published data only}|Long-term outcomes of a telephone intervention after an ICD|
Doughty 2002 {published data only}|Randomized, controlled trial of integrated heart failure management: the Auckland Heart Failure Management Study|/resolve/reference/PMED?id=11785996
Downey 2001 {published data only}|Disease management uses web to net savings|/resolve/reference/PMED?id=16141777
Ducharme 2005 {published data only}|Impact of care at a multidisciplinary congestive heart failure clinic: a randomised trial|/resolve/reference/PMED?id=15997043
Duffy 2005 {published data only}|Development and testing of a caring-based intervention for older adults with heart failure|/resolve/reference/PMED?id=16141777
Duffy 2008 {published data only}|Research challenges and lessons learned from a heart failure tele-homecare study|/resolve/reference/PMED?id=18158496
Dunagan 2005 {published data only}|Randomised trial of a nurse-administered, telephone-based diseased management program for patients with heart failure|/resolve/reference/PMED?id=15948086
Dunn 2006 {published data only}|Impact of a heart failure disease management program on hospitalizations|
Dunn 2007 {published data only}|Reduction of B-type natriuretic peptide using tele-management in patients with heart failure|
Ekman 1998 {published data only}|Feasibility of a nurse-monitored, outpatient-care programme for elderly patients and moderate-to server, chronic heart failure|
Ellery 2006 {published data only}|Predicting mortality and rehospitalization in heart failure patients with home monitoring: the Home CARE pilot study|/resolve/reference/PMED?id=16598601
Evangelista 2004 {published data only}|Developing a web-based education and counselling program for heart failure patients|
Feldman 2004 {published data only}|A randomised intervention to improve heart failure outcomes in community-based home health care|/resolve/reference/PMED?id=15160686
Feldman 2005 {published data only}|Just-in-time evidence-based e-mail "reminders" in home health care: impact on patient outcomes|
Finkelstein 2004 {published data only}|Telehomecare: quality, perception, satisfaction|/resolve/reference/PMED?id=15319041
Finkelstein 2006 {published data only}|Home telehealth improves clinical outcomes at lower cost for home healthcare|/resolve/reference/PMED?id=16620167
Foley 2008 {published data only}|Heart Failure study: nurse-led management proves disheartening|
Fragrasso 2007 {published data only}|Validation of remote cardiopulmonary examination in patients with heart failure with a videophone-based system|/resolve/reference/PMED?id=17517348
Friedberg 2008 {published data only}|Nurse-led counselling had no effect on heart failure outcomes|
Fursse 2008 {published data only}|Early experience in using telemonitoring for the management of chronic disease in primary care|/resolve/reference/PMED?id=18430275
Gambetta 2007 {published data only}|Impact of the implementation of tele-management on a disease management program in an elderly heart failure cohort|
Grancelli 2007 {published data only}|Telephone interventions for disease management in heart failure|/resolve/reference/PMED?id=17478790
Gregory 2006 (SPAN-CHF) {published data only}|Hospital cost effect of a heart failure disease management program: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial|/resolve/reference/PMED?id=16644325
Gund 2008 {published data only}|Design evaluation of a home-based tele-care system for chronic heart failure patients|
Hanssen 2007 {published data only}|Can telephone follow-up after discharge improve lifestyle factors after a myocardial infarction? A randomised controlled trial|
Harkness 2006 {published data only}|A telephone intervention reduced combined all cause mortality or admission for worsening heart failure in chronic heart failure|/resolve/reference/PMED?id=16622932
Harrison 2002 {published data only}|Quality of life of individuals with heart failure: a randomised trial of the effectiveness of two models of hospital-to-home transition|/resolve/reference/PMED?id=12021683
Hart-Wright 2006 {published data only}|Effectiveness of a nurse-led telephonic support program for heart failure patients|
Heidenreich 1999 {published data only}|Effect of a home monitoring system on hospitalisation and resource use for patients with heart failure|/resolve/reference/PMED?id=10502207
Heisler 2007 {published data only}|I am not alone: the feasibility and acceptability of interactive voice responsefacilitated telephone peer support among older adults with heart failure|
Helms 2007 {published data only}|Telemetric care of patients suffering from chronic heart failure with special reference to the telemetric care and education program "Telemedizin frs Herz" ("Telemedicine for the heart")|/resolve/reference/PMED?id=18060608
Ho 2007 {published data only}|Improved cost-effectiveness for management of chronic heart failure by combined home-based intervention with clinical nursing specialists|/resolve/reference/PMED?id=17475609
Holst 2007 {published data only}|Telephone follow-up of self-care behaviour after a single session education of patients with heart failure in primary health care|/resolve/reference/PMED?id=16928469
Hoover 2007 {published data only}|Abstract 2235: promoting self-management in heart failure patients through education and telemonitoring|
Hudson 2005 {published data only}|Remote physiological monitoring : clinical, financial and behavioural outcomes in a heart failure population|
Huynh 2006 {published data only}|Long-term survival in elderly patients hospitalized for heart failure|/resolve/reference/PMED?id=17000947
Jaarsma (COACH Study) {published data only}|Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure (COACH)|
Jaarsma (COACH Study) {published data only}|Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure|
Jaarsma (COACH Study) {published data only}|NHF-COACH multicenter trial in the Netherlands: searching for underlying potentially beneficial mechanisms in nurse led heart failure management|
Jaarsma 1999 {published data only}|Nurse led, multidisciplinary intervention in chronic heart failure|/resolve/reference/PMED?id=10979717
Jenkins 2001 {published data only}|Assessing elderly patients with congestive heart failure via in-home interactive telecommunication|/resolve/reference/PMED?id=11915093
Jerant 2001 {published data only}|Reducing the cost of frequent hospital admissions for congestive heart failure: a randomized trial of a home telecare intervention|/resolve/reference/PMED?id=11606877
Jerant 2003 {published data only}|A randomised trial of tele-nursing to reduce hospitalizations for heart failure: patient-centred outcomes and nursing indicators|/resolve/reference/PMED?id=12749524
Johnston 2000 {published data only}|Outcomes of the Kaiser Permanente Tele-Home Health Research Project|/resolve/reference/PMED?id=10664641
Jolly 2007 {published data only}|Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial|/resolve/reference/PMED?id=17343738
Jones 2002 {published data only}|Telehealth interventions to improve clinical nursing of elders|/resolve/reference/PMED?id=18325458
Karlsson 2005 {published data only}|A nurse-based management program in heart failure patients affects females and persons with cognitive dysfunction most|/resolve/reference/PMED?id=16009290
Kashem 2007 {published data only}|Managing heart failure care using an internet-based telemedicine system|/resolve/reference/PMED?id=18325458
Kashem 2007 {published data only}|Web-based internet telemedicine management of patients with heart failure|/resolve/reference/PMED?id=16942416
Kashem 2007 {published data only}|1018-192 Preliminary outcome of web-based telemedicine clinical trial for disease management: comparison of 4- versus 8-months follow-up visits|
Kashem 2007 {published data only}|Improving heart failure care by using a telemedicine system|/resolve/reference/PMED?id=17270928
Kasper 2002 {published data only}|A randomised trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission|/resolve/reference/PMED?id=11823086
Khoury 2008 {published data only}|Abstract 820: usefulness of monitoring in congestive heart failure by multiple bioelectric impedance vectors|
Kimmelsteil 2004 {published data only}|Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial|/resolve/reference/PMED?id=15313938
Kirschner 2006 {published data only}|The benefits of a tele-home health initiative on an elderly population|
Kline 2006 {published data only}|Telehealth and care coordination improves outcomes for veterans with heart failure|
Koehler 2006 {published data only}|Noninvasive home telemonitoring:the Trans-European NetworkHome-Care Management System|/resolve/reference/PMED?id=16904569
Koelling 2005 {published data only}|Discharge education improves clinical outcomes in patients with chronic heart failure|/resolve/reference/PMED?id=15642765
Kottmair 2005 {published data only}|Germany's disease management program: improving outcomes in congestive heart failure|/resolve/reference/PMED?id=17288080
Koutkias 2003 {published data only}|Multi agent system architecture for heart failure management in a home care environment|
Krumholz 2002 {published data only}|Randomised trial of an education and support intervention to prevent readmission of patients with heart failure|
Kutzleb 2006 {published data only}|The impact of nurse-directed patient education on quality of life and functional capacity in people with heart failure|
Kwok 2008 {published data only}|A randomised controlled trial of a community nurse-supported hospital discharge programme in older patients with chronic heart failure|
LaFramboise 2003 {published data only}|Comparison of Health Buddy with traditional approaches to heart failure management|
Lehmann 2006 {published data only}|Impact of telehealth on healthcare utilization by congestive heart failure patients|
Lucas 2007 {published data only}|P622 telephone support by heart failure nurses has a significant impact on readmission rate and survival|
Machingo 2003 {published data only}|CHF outcomes following implementation of telephone follow-up monitoring|
Maddukuri 2006 {published data only}|Abstract 2953: Non-invasive haemodynamic assessment by Vericor reveals heart failure management by clinical assessment alone is sub-optimal in ambulatory patients and leads to increased heart failure hospitalisations|
Madigan 2008 {published data only}|People with heart failure and home health care resource use and outcomes|/resolve/reference/PMED?id=18578801
Maglaveras 2002 {published data only}|Using contact centres in tele-management and home care of congestive heart failure patients: the CHS experience|
Maglaveras 2003 {published data only}|Congestive heart failure management in a home-care system through the CHS contact centre|
Maglaveras 2006 {published data only}|Quality home telemedicine services for chronic cardiac disease patients through the INTERLIFE platform|
Mair 2007 {published data only}|Does remote monitoring improve outcome in patients with chronic heart failure?|/resolve/reference/PMED?id=17712318
Makaya 2008 {published data only}|Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from JCARE-CARD|
Mansfield 2006 {published data only}|Thesis: A feasibility study examining tele-cardiology in New Hampshire: telemonitoring in patients with congestive heart failure|/resolve/reference/PMED?id=15718180
Marangelli 2007 {published data only}|4522 High quality heart and lung ascultation using a web-based mobile home-telecare equipment for heart failure monitoring|/resolve/reference/PMED?id=17347176
Martensson 2005 {published data only}|Patients with heart failure in primary health care: effects of a nurse-led intervention on health-related quality of life and depression|
Mau 2006 {published data only}|Nurse-directed home-based heart failure management program decreases death/readmission rates and increases dietary and medication compliance|
McCauley 2006 {published data only}|Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure|/resolve/reference/PMED?id=17044764
McCoy 2007 {published data only}|AcCorrelational pilot study of home health nurse management of heart failure patients and hospital readmissions|
McDonald 2002 {published data only}|Heart failure management: multidisciplinary care has intrinsic benefit above the optimizations of medical care|/resolve/reference/PMED?id=12140806
McManus 2004 {published data only}|A telehealth program to reduce readmission rates among heart failure patients: one agencys experience|
Mendoza 2002 {published data only}|In-home wireless monitoring of physiological data for heart failure patients|
Mistiaen 2006 {published data only}|Telephone follow-up, initiated by a hospital-based health professional, for post discharge problems in patients discharged from hospital to home|
Morales-Ascencio 2008 {published data only}|Effectiveness of a nurse-led case management home care model in primary health care: a quasi-experimental, controlled, multi-centre study|/resolve/reference/PMED?id=18811927
Morcillo 2005 {published data only}|Evaluation of a home-based intervention in heart failure patients: results of a randomized study|/resolve/reference/PMED?id=15970116
Morguet 2006 {published data only}|Impact of home-based monitoring on the care of patients with congestive heart failure|
Morguet 2007a {published data only}|4521 Telemedical care and monitoring to reduce morbidity in patients with NYHA class II and III heart failure|/resolve/reference/PMED?id=17347176
Morguet 2007b {published data only}|295 Staged tele-medical service for patients with mild-to-moderate congestive heart failure|
Morguet 2008 {published data only}|Impact of tele medical care and monitoring on morbidity in mild to moderate chronic heart failure|
Mueller 2002 {published data only}|Telemanagement of heart failure: a diuretic treatment algorithm for advanced practice nurses|/resolve/reference/PMED?id=12487012
Murtaugh 2005 {published data only}|Just-in-time evidence-based e-mail reminders in home health care: impact on nurse practices|
Myers 2006 {published data only}|Impact of home-based monitoring on the care of patients with congestive heart failure|
Nanevicz 2000 {published data only}|The feasibility of a telecommunications service in support of outpatients congestive heart failure in a diverse patient population|
Naylor 1999 {published data only}|The effects of a discharge planning and home follow-up intervention on elders hospitalized with common medical and surgical cardiac conditions|/resolve/reference/PMED?id=10533691
Naylor 2004 {published data only}|Transitional Care of Older Adults Hospitalized with Heart Failure:A Randomized, Controlled Trial|
Nguyen 2007 {published data only}|Lack of long-term benefits of a 6-month heart failure disease management program|/resolve/reference/PMED?id=17517349
Nobel 2003 {published data only}|Emerging information management technologies and the future of disease management|/resolve/reference/PMED?id=14736346
Noel 2004 {published data only}|Home telehealth reduces healthcare costs|/resolve/reference/PMED?id=15319047
Nohria 2007 {published data only}|Frequency and Impact of Hypervolemic States during Monitored Heart Failure Management. Abstract #047|
Nucifora 2006 {published data only}|Lack of improvement of clinical outcomes by a low-cost, hospital-based heart failure management programme|/resolve/reference/PMED?id=16858241
O'Reilly 1999 {published data only}|Is Internet-based disease management on the way?|
Oddone 1999 {published data only}|Enhanced access to primary care for patients with congestive heart failure: Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission|
Oeff 2005a {published data only}|Telemonitoring of patients with heart failure using extended vital sign recording|/resolve/reference/PMED?id=16177941
Oeff 2005b {published data only}|Telemonitoing of multiple parameters in chronic heart failure achieves impressive success in clinical management|
Ojeda 2005 {published data only}|Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: are effects maintained after stopping the programme?|
Opasich 2005 {published data only}|Educating and communicating: non-pharmacologic treatment for patients with chronic heart failure?|
Pasqualini 2006 {published data only}|P876 Home management of old patients with chronic heart diseases: role of tele-cardiolography and tele consultancy|
Philbin 2000 {published data only}|The results of a randomized trial of a quality improvement intervention in the care of patients with heart failure|/resolve/reference/PMED?id=11042232
Phillips 2008 {published data only}|Supporting patients and their caregivers after-hours at the end of life: the role of telephone support|/resolve/reference/PMED?id=18411012
Picard 2008 {published data only}|Remote monitoring of heart failure|
Piepoli 2006 {published data only}|Multidisciplinary and multi-setting team management programme in heart failure patients affects hospitalisation and costing|/resolve/reference/PMED?id=16256222
Piorkowski 2006 {published data only}|Abstract 3513: Homemonitoring in MADIT II patients: a prospective randomised multi-centre comparison against a standard follow-up (REFORM Trial)|
Pugh 2001 {published data only}|Case management for elderly persons with heart failure:the quality of life and cost outcome|
Quinn 2006 {published data only}|Low-technology heart failure care in home health: improving patient outcomes|/resolve/reference/PMED?id=17012959
Quinn 2008 {published data only}|321 Heart failure patients' use of computer technology for self-care management|
Rabelo 2007 {published data only}|Educational settings in the management of patients with heart failure|/resolve/reference/PMED?id=17546370
Rahimpour 2008 {published data only}|Patients' perceptions of a home telecare system|/resolve/reference/PMED?id=18023610
Reble 2006 {published data only}|Impact of heart failure tele-management program on patient outcomes|
Repoley 2006 {published data only}|Monitoring intrathoracic impedence intensifies heart failure management|
Rich 2002 {published data only}|Management of heart failure in the elderly|/resolve/reference/PMED?id=11790925
Ross 2004 {published data only}|Providing a web-based online medical record with electronic communication capabilities to patients with congestive heart failure: randomised trial|/resolve/reference/PMED?id=15249261
Roth 2005 {published data only}|Tele-cardiology for patients with chronic heart failure: The 'SHL' experience in Israel and Germany|/resolve/reference/PMED?id=15923780
Roth 2006 {published data only}|Teleconsultation for cardiac patients: a comparison between nurses and physicians: the SHL experience in Israel|
Rozenman 2007 {published data only}|Abstract 3278: Noninvasive home monitoring of pulmonary artery pressure by RemonCHF device. First multi-centre experience|
Saxon 2007 {published data only}|Remote active monitoring in patients with heart failure (RAPID-RF): design and rationale|/resolve/reference/PMED?id=17517341
Scalvini 2004 {published data only}|A pilot study of nurse-led home-based tele-cardiology for patients with chronic heart failure|/resolve/reference/PMED?id=15068649
Scalvini 2005a {published data only}|Effect of home-based tele-cardiology on chronic heart failure: costs and outcomes|/resolve/reference/PMED?id=16035980
Scalvini 2005b {published data only}|Telecardiology: one-lead electrocardiogram monitoring and nurse triage in chronic heart failure|/resolve/reference/PMED?id=16035981
Scalvini 2006 {published data only}|Chronic heart Failure home-based management with a tele-cardiology system: a comparison between patients followed by general practitioners and by a cardiology department|/resolve/reference/PMED?id=16884578
Scherr 2006 {published data only}|Mobile phone-based surveillance of cardiac patients at home|/resolve/reference/PMED?id=16848939
Schmidt 2008 {published data only}|Acceptance of telemonitoring to enhance medication compliance in patients with chronic heart failure|/resolve/reference/PMED?id=18578676
Schneider 2004 {published data only}|Managing congestive heart failure using home health|/resolve/reference/PMED?id=15486513
Schofield 2005 {published data only}|Early outcomes of a care coordination-enhanced telephone care program for elderly veterans with chronic heart failure|/resolve/reference/PMED?id=15785217
Schofield 2008 {published data only}|Telehealth management of heart failure improves cardiac remodeling|
Schwarz 2008 {published data only}|Telemonitoring of heart failure patients and their caregivers: a pilot randomised controlled trial|
Scott 2004 {published data only}|The effects of nursing interventions to enhance mental health and quality of life among individuals with heart failure|/resolve/reference/PMED?id=15573333
Seibert 2008a {published data only}|Telemedicine facilitates CHF home health care for those with systolic dysfunction|
Serxner 1998 {published data only}|Congestive heart failure disease management study: a patient education intervention|
Shah 2007 {published data only}|338 Telephone heart failure disease management: getting something for nothing|
Shah 2008 {published data only}|Delivering heart failure disease management in 3 tertiary care centres: key clinical components and venues of care|/resolve/reference/PMED?id=18371490
Shearer 2007 {published data only}|A telephone-delivered empowerment intervention with patients diagnosed with heart failure|/resolve/reference/PMED?id=17509423
Simpson 2006 {published data only}|Abstract 2365: Overall experience with the tandem heart at the Texas Heart Institute|/resolve/reference/PMED?id=17145989
Slater 2006 {published data only}|Measuring quality of life outcomes through the use of home telehealth: using a case study model in a terminal heart failure patient|
Slater 2008 {published data only}|Cost-effective care a phone call away: a nurse managed telephonic program for patients with chronic heart failure|/resolve/reference/PMED?id=18389841
Smart 2005 {published data only}|Predictors of a sustained response to exercise training in patients with chronic heart failure: a telemonitoring study|/resolve/reference/PMED?id=16338266
Smeulders 2006 {published data only}|Evaluation of a self-management programme for congestive heart failure patients: design of a randomised controlled trial|/resolve/reference/PMED?id=16857049
Spaeder 2006 {published data only}|Rapid titration of carvedilol in patients with congestive heart failure: a randomised trial of automated telemedicine versus frequent outpatient clinic visits|/resolve/reference/PMED?id=16569544
Sprenger 2007 {published data only}|450 Telemonitoring in patients with chronic heart failure - usage of telemonitoring for the outpatient care|
Steckler 2008 {published data only}|1033-154: Long distance titration of heart failure medications by telephone calls|
Stromberg 2003 {published data only}|Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial|/resolve/reference/PMED?id=12788301
Stromberg 2006 {published data only}|Computer-based education for patients with chronic heart failure. A randomised, controlled, multicentre trial of the effects on knowledge, compliance and quality of life|/resolve/reference/PMED?id=16469469
Sullivan 2006 {published data only}|442: Interventions by heart failure nurse specialists: potential for reducing hospital admissions|
Terschuren 2007 {published data only}|Implementing telemonitoring in the daily routine of a GP practice in a rural setting in northern Germany|/resolve/reference/PMED?id=17565776
Thompson 2005 {published data only}|Effects of a nurse-led, clinic and home-based intervention on recurrent hospital use in chronic heart failure|
Thompson 2008 {published data only}|Telehome monitoring reduced readmissions and improved quality of life in heart failure or angina|/resolve/reference/PMED?id=18583498
Tramarin 2005 {published data only}|La telecardiology come strumento di integrazione tra ospedale e territorio|
Trudel 2007 {published data only}|A mobile phone based remote patient monitoring system for chronic disease management|/resolve/reference/PMED?id=17911700
VA Technology Assessment {published data only}|Physiologic telemonitoring in CHF|
Vaccaro 2001 {published data only}|Utilzation reduction, cost savings and return on investment for the pacificare chronic heart failure program 'taking charge of your heart health'|
Valle 2004 {published data only}|Proposed protocol for the ambulatory management of patients discharged with heart failure diagnosis: collaborative project Venice-HF|
van den Bussche 2004 {published data only}|Effectiveness of an outpatient disease management programme for chronic heart insufficiency patients|/resolve/reference/PMED?id=15499509
Villalba 2006a {published data only}|Wearable monitoring system for heart failure assessment in a mobile environment|
Villalba 2006b {published data only}|A new solution for a heart failure monitoring system based on wearable and information technologies|
Vrijhoef 2007 {published data only}|741 The Health Buddy: telemonitoring system for patients with heart failure|
Waldman 2008 {published data only}|The TeleGuard trial of additional telemedicine care in CAD patients: 2 morbidity and mortality after 12 months|/resolve/reference/PMED?id=18318925
Walsh 2005 {published data only}|Trials and tribulations: a small pilot telehealth home care program for Medicare patients|/resolve/reference/PMED?id=16373178
Waywell 2007 {published data only}|An audit of telephone call nurse-led intervention for chronic heart failure patients in a heart failure clinic. Abstract #1388|
Weintraub 2005 {published data only}|A multicenter randomised controlled comparison of telephonic disease management vs. automated home monitoring in patients recently hospitalised with heart failure: Span-CHF II Trial|
West-Frasier 2008 {published and unpublished data}|The impact of telemonitoring on self-efficacy, emotional well-being, and clinical outcomes in patients with chronic obstructive pulmonary disease or heart failure (PhD Thesis)|/resolve/reference/PMED?id=16863399
Westlake 2007 {published data only}|Evaluation of a web-based education and counseling pilot program for older heart failure patients|
Wheeler 2006 {published data only}|Telephone interventions by nursing students: improving outcomes for heart failure patients in the community|/resolve/reference/PMED?id=16863399
Whitten 2007 {published data only}|Home telecare for COPD/CHF patients: outcomes and perceptions|/resolve/reference/PMED?id=17359569
Wierzchowiecki 2005 {published data only}|A new programme of multidisciplinary care for patients with heart failure in Poznan: One-year follow-up|/resolve/reference/PMED?id=17405287
Wierzchowiecki 2006 {published data only}|New multidisciplinary heart failure care program (six-month preliminary observation)|
Willyard 2006 {published data only}|The use of automated tele-management system for depression screening in a chronic illness care management program|
Wong 2005 {published data only}|Effects of nurse-initiated telephone follow-up on self-efficacy among patients with chronic obstructive pulmonary disease|
Wongpiriyayothar 2008 {published data only}|Effects of Home-Based Care Program on Symptom Alleviation and Well-Being Among Persons with Chronic Heart Failure|
Wright 2003 {published data only}|Uptake of self-management strategies in a heart failure management programme|
Wu 2006 {published data only}|An interactive site for the management of patients with congestive heart failure|/resolve/reference/PMED?id=14631472
Wu 2006 {published data only}|Pilot study of an internet patient-physician communication tool for heart failure disease management|/resolve/reference/PMED?id=17249472
Wu 2006 {published data only}|Pilot study of an internet based patient-physician communication tool for heart failure disease management|/resolve/reference/PMED?id=15829480
Zaphiriou 2006 {published data only}|303 Improved outcomes following hospitalisation in patients with a new diagnosis of heart failure: results from a randomised controlled trial of a novel, nurse-led self-management intervention|
Zentner 2007 {published data only}|35 Multidisciplinary Community Care for Congestive Cardiac Failure Decreases Hospital Admissions in an Elderly Patient Population|
Zugck 2006 {published data only}|P2298 Prove of concept - clinical and economical effectiveness of telemonitoring in chronic heart failure (CHF)|/resolve/reference/PMED?id=16314336
Dunlap 2006 (HearT-I) {published data only}|HSR&D Study CHI 99-074: Randomized trial of a telephone intervention in heart failure patients|
Levine2006(Mind My Heart) {published data only}|Home monitoring of congestive heart failure patients|
Scherr 2005 (MobiTEL) {published data only}|Effect of home based telemonitoring using mobile phone technology on the outcome of heart failure patients after and episode of acute decompensation: randomised control trial|
Scherr 2005 (MobiTEL) {published data only}|P357 Telemonitoring for heart failure patients following acute decompensation: first results on influences of the system on functional status and heart failure therapy|
Yakushin 2006 {published data only}|593 Two-year prognosis in chronic heart failure patients undergone therapeutic education and out-patient observation|
Chaudhry 2007 (Tele-HF) {published data only}|Randomised trial of telemonitoring to improve heart failure outcomes (Tele-HF) study design|/resolve/reference/PMED?id=17996818
Kohler 2006 {published data only}|Partnership for the heart- a new approach in telemedicine|
Kulshreshtha 2008a {published data only}|Using information technology to improve outcomes in patients with heart failure: the value of remote monitoring|
Kulshreshtha 2008a {published data only}|Remote monitoring program may improve outcomes for heart failure patients (Abstract #4356)|
Bhatia 2006|Outcome of heart failure with preserved ejection fraction in a population-based study|/resolve/reference/PMED?id=16855266
Clark 2005|Chronic heart failure beyond city limits|/resolve/reference/PMED?id=16359188
Clark 2007b|Adherence, adaptation and acceptance of elderly chronic heart failure participants to receiving healthcare by telemonitoring.|
Clark 2009|What is the strength of evidence for heart failure disease-management programs?|/resolve/reference/PMED?id=19628113
Cleland 2001|The heart failure epidemic: exactly how big is it?|/resolve/reference/PMED?id=11286518
Cleland 2006|The perindopril in elderly people with chronic heart failure (PEP-CHF) study|/resolve/reference/PMED?id=16963472
Cleland 2007|Prognosis in heart failure with a normal ejection fraction|/resolve/reference/PMED?id=17715420
Cleland 2009|Telemonitoring for heart failure: the only feasible option for good universal care?|
CONSORT 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials|/resolve/reference/PMED?id=11308435
Cowie 1997|The epidemiology of heart failure|/resolve/reference/PMED?id=9043837
Dang 2009|Evaluating the evidence base for the use of home telehealth remote monitoring in elderly with heart failure|/resolve/reference/PMED?id=19831704
DelliFraine 2008|Home-based telehealth: a review and meta-analysis|/resolve/reference/PMED?id=18348749
ESC Heart Failure Guidelines 2008|ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008|
Gaikward 2009|The Role of home-based information and communication technology interventions in chronic disease management: a systematic literature review|/resolve/reference/PMED?id=19474225
GISSI-HF 2008|Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=18757089
Harjola 2010|Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalised for acute heart failure.|
HeartCycle|HeartCycle|
Higgins 2008a|Chapter 8: Assessing risk of bias in included studies|/resolve/reference/PMED?id=16160202
Higgins 2008b|Chapter 9: Analysing data and undertaking meta-analyses|/resolve/reference/PMED?id=16766225
Hunt 2005|ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society|/resolve/reference/PMED?id=16160202
Jaarsma 2006|Heart failure management programmes in Europe|/resolve/reference/PMED?id=16766225
Jaarsma 2008|Effect of Moderate or Intensive Disease Management Program on Outcome in Patients with Heart Failure.|/resolve/reference/PMED?id=18268174
Jhund 2009|Long-term trends in first hospitalisation for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people|/resolve/reference/PMED?id=19153268
Kjekshus 2007|Rosuvastatin in older patients with systolic heart failure|/resolve/reference/PMED?id=17984166
Klersy 2009|Meta-analysis of remote monitoring of heart failure patients|/resolve/reference/PMED?id=19850208
Konstam 2007|Effects of oral tolvaptan in patients hospitalised for worsening heart failure: the EVEREST Outcome Trial|/resolve/reference/PMED?id=17384437
Krum 2006|Guidelines for the prevention, detection and managment of people with chronic heart failure in Australia 2006|/resolve/reference/PMED?id=17115967
Krum 2009|Heart failure|/resolve/reference/PMED?id=19286093
Krumholz 2006|A taxonomy of disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group|/resolve/reference/PMED?id=16952985
Lenzen 2005|Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials|
Levy 2002|Long-term trends in the incidence of and survival with heart failure|/resolve/reference/PMED?id=12409541
Louis 2003|A systematic review of telemonitoring for the management of heart failure|
Maric 2009|A systematic review of telemonitoring technologies in heart failure|
Massie 2008|Irbesartan in patients with heart failure and preserved ejection fraction|/resolve/reference/PMED?id=19001508
McAlister 2004|Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomised trials|/resolve/reference/PMED?id=15312864
McAlister 2006|In the case of telemonitoring the information communication technology equipment and monitoring devices are provided by the project|/resolve/reference/PMED?id=16537738
McMurray 2007|Effects of tezosentan or symptoms and clinical outcomes in patients with acute heart failure:the VERITAS randomized controlled trials|/resolve/reference/PMED?id=17986694
Mebazaa 2007|Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial|/resolve/reference/PMED?id=17473298
Moss 2009|Cardiac-resynchronization therapy for the prevention of heart-failure events|/resolve/reference/PMED?id=19723701
Sliwa 2005|Epidemiology and etiology of cardiomyopathy in Africa|/resolve/reference/PMED?id=16330699
Stewart 2002|The current cost of heart failure to the National Health Service in the UK|
Yu 2006|Disease management programmes for older people with heart failure: crucial characteristics which improve post-discharge outcomes|/resolve/reference/PMED?id=16299021
Yusuf 2001|Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and Impact of urbanization|/resolve/reference/PMED?id=11723030
Clark 2007a|Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis|/resolve/reference/PMED?id=17426062
Tomassini 2004 {published data only (unpublished sought but not used)}|Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial|/resolve/reference/PMED?id=14759641
Lebrun 2006 {published data only}|Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue|/resolve/reference/PMED?id=16764345
Branas 2000|Treatments for fatigue in multiple sclerosis: a rapid and systematic review|
Ciacci 2007|L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study|/resolve/reference/PMED?id=17693145
Cruciani 2004|L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis|
Cylert Insert|Cylert (package insert)|
Fisk 1994|The impact of fatigue on patients with multiple sclerosis |/resolve/reference/PMED?id=8180914
Flensner 2002|The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis|
Freal 1985|Symptomatic fatigue in multiple sclerosis|/resolve/reference/PMED?id=6703889
Gillson 2002|A double-blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis|/resolve/reference/PMED?id=11936486
Graziano 2002|Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients|/resolve/reference/PMED?id=12085175
Helman 2005|Carnitine for Alzheimer's Disease|
Iriarte 1999|The fatigue descriptive scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis|/resolve/reference/PMED?id=10096097
Jackson 1991|Effects of multiple sclerosis on occupational and career patterns multiple sclerosis on occupational and career patterns|/resolve/reference/PMED?id=1888670
Janardhan 2002|Quality of life in patients with multiple sclerosis: the impact of fatigue and depression|/resolve/reference/PMED?id=12409184
Kos 2007|Origin of Fatigue in Multiple Sclerosis: Review of the Literature|/resolve/reference/PMED?id=17409388
Krupp 1988|Fatigue in multiple sclerosis |/resolve/reference/PMED?id=3355400
Krupp 1995|Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo|/resolve/reference/PMED?id=7501140
Laviano 2006|Antimyopathic Effects of Carnitine and Nicotine|/resolve/reference/PMED?id=16778574
Lazoff 2005|Multiple Sclerosis|
Lebrun 2006|Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue|/resolve/reference/PMED?id=16764345
Lefebvre 2008|Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008|
Malaguarnera 2007|L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial|/resolve/reference/PMED?id=18065594
Marthaler 1999|Increased urinary losses of carnitine during ifosfamide chemotherapy|/resolve/reference/PMED?id=10412953
McDonald 2001|Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis|
Mostert 2002|Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis|/resolve/reference/PMED?id=11990874
Murray 1985|Amantadine therapy for fatigue in multiple sclerosis|/resolve/reference/PMED?id=3902184
Peluso 2000|Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system|
Pistone 2003|Levocarnitine administration in elderly subjects with rapid muscle fatigue|/resolve/reference/PMED?id=12875611
Plioplys 1997|Amantadine and L-carnitine treatment of chronic fatigue syndrome|/resolve/reference/PMED?id=9018019
Polman 2005|Diagnostic Criteria for Multiple Sclerosis: 2005 revisions to the Macdonald Criteria|
Poser 1983|New diagnostic criteria for Multiple Sclerosis: guide-lines for research protocols|
Pucci 2007|Amantadine for fatigue in multiple sclerosis|
PVA 1998|Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis|
Racke 2004|Fatigue in Multiple Sclerosis: is the picture getting simpler or more complex?|/resolve/reference/PMED?id=14967763
Rammohan 2002|Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two-centre phase 2 study|/resolve/reference/PMED?id=11796766
Rossini 2007|Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients|/resolve/reference/PMED?id=17543140
Sayed-Ahmed 1999|Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine|/resolve/reference/PMED?id=10208759
Schumacher 1965|Problems of experimental trials of therapy in Multiple Sclerosis: Report by the panel of the evaluation of experimental trials in Multiple Sclerosis.|
Schwid 2002|Fatigue in multiple sclerosis: Current understanding and future direction|/resolve/reference/PMED?id=12051465
Solari 2002|Aminopyridines for symptomatic treatment in multiple sclerosis|
Tellez 2006|Fatigue in Multiple Sclerosis Persists Over Time: a longitudinal study|/resolve/reference/PMED?id=16773265
UK MS 1997|Symptom Management Survey|
Weinshenker 1992|A double-blind, randomized crossover trial of pemoline in fatigue associated with multiple sclerosis|/resolve/reference/PMED?id=1641137
Zifko 2002|Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study|/resolve/reference/PMED?id=12195441
Arora 1999 {published data only}|Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center|/resolve/reference/PMED?id=10361866
Ballerini 2002 {published data only}|Early or late referral patterns of 1137 patients starting dialysis in 15 Italian dialysis centres|
Caskey 2003 {published data only}|Early referral and planned initiation of dialysis: what impact on quality of life?|/resolve/reference/PMED?id=12808170
Cass 2002 {published data only}|Delayed referral to a nephrologist: outcomes among patients who survive at least one year on dialysis|/resolve/reference/PMED?id=12149081
Chen 2010 {published data only}|Early nephrology referral is associated with prolonged survival in hemodialysis patients even after exclusion of lead-time bias|
Chow 2008 {published data only}|Impact of early nephrology referral on mortality and hospitalization in peritoneal dialysis patients|
Curtis 2002 {published data only}|Canadian survey of clinical status at dialysis initiation 1998 -1999: a multicenter prospective survey|/resolve/reference/PMED?id=12400843
Dogan 2005 {published data only}|Effects of late referral to a nephrologist in patients with chronic renal failure|
Ellis 1998 {published data only}|Late referral of end-stage renal failure|/resolve/reference/PMED?id=10024934
Fan 2002 {published data only}|Do patients referred late for peritoneal dialysis do badly?|
Gallego 2003 {published data only}|Influence of early or late referral to nephrologist over morbidity and mortality in hemodialysis|
Goransson 2001 {published data only}|Consequences of late referral of patients with end-stage renal disease|
Hasegawa 2009 {published data only}|Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits|/resolve/reference/PMED?id=19261827
Helal 2010 {published data only}|Early nephrology referral influences on mortality of dialysis patients in developing country [abstract]|
Herget-Rosenthal 2010 {published data only}|How does late nephrological co-management impact chronic kidney disease? - an observational study|
Hoffmann 2006 {published data only}|Patterns of nephrology referral and predialysis management of patients with chronic kidney disease|/resolve/reference/PMED?id=16895711
Inaguma 2011 {published data only}|Nephrologist care for 12 months or more increases hemodialysis initiation with permanent vascular access|
Jungers 1997 {published data only}|Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement|/resolve/reference/PMED?id=16462659
Jungers 1997 {published data only}|Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients|/resolve/reference/PMED?id=11733627
Jungers 1997 {published data only}|Benefits of early nephrological management in chronic renal failure|/resolve/reference/PMED?id=9365486
Kazmi 2004 {published data only}|Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis|/resolve/reference/PMED?id=15199194
Lin 2003 {published data only}|Early referral as an independent predictor of clinical outcome in end-stage renal disease on hemodialysis and continuous ambulatory peritoneal dialysis|/resolve/reference/PMED?id=15526911
Lin 2003 {published data only}|Improvement of clinical outcome by early nephrology referral in type II diabetics on hemodialysis|/resolve/reference/PMED?id=12803509
Lin 2003 {published data only}|Improvement in clinical outcome by early nephrology referral in type II diabetics on maintenance peritoneal dialysis|
Lorenzo 2004 {published data only}|Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study|/resolve/reference/PMED?id=15168379
Mezei 2010 {published data only}|Early or late referral and their clinical outcomes [abstract]|
Nakamura 2007 {published data only}|Effect of early nephrology referral on the initiation of hemodialysis and survival in patients with chronic kidney disease and cardiovascular diseases|/resolve/reference/PMED?id=17384451
Pena 2006 {published data only}|Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study|
Ratcliffe 1984 {published data only}|Late referral for maintenance dialysis|/resolve/reference/PMED?id=6419957
Ravani 2003 {published data only}|Structured pre-dialysis programs: more than just timely referral?|
Roubicek 2000 {published data only}|Timing of nephrology referral: influence on mortality and morbidity|/resolve/reference/PMED?id=10873869
Sabath 2003 {published data only}|Early referral to the nephrologist: impact on initial hospitalization and the first 6 months of continuous ambulatory peritoneal dialysis|
Schmidt 1998 {published data only}|Early referral and its impact on emergent first dialyses, health care costs, and outcome|/resolve/reference/PMED?id=9708613
Selim 2007 {published data only}|Effect of nephrology referral on the initiation of haemodyalisis and mortality in ESRD patients|/resolve/reference/PMED?id=18356783
Shiao 2008 {published data only}|Early initiation of dialysis and late implantation of catheters adversely affect outcomes of patients on chronic peritoneal dialysis|
Shin 2007 {published data only}|Late referral to a nephrologist increases the risk of uremia-related cardiac hypertrophy in patients on hemodialysis|/resolve/reference/PMED?id=17957125
Stack 2003 {published data only}|Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States|/resolve/reference/PMED?id=12552491
Stoves 2001 {published data only}|Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis|/resolve/reference/PMED?id=11524518
Van Biesen 1997 {published data only}|The pattern of referral of patients with end-stage renal disease to the nephrologist - a European survey|
Van Biesen 1997 {published data only}|The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality|
Van Biesen 1997 {published data only}|The referral pattern of end-stage renal disease patients and the initiation of dialysis: a European perspective|
Van Biesen 1997 {published data only}|End-stage renal disease treatment: a European perspective|
Wijewickrama 2010 {published data only}|Are patients with chronic kidney disease referred to a nephrologist early enough? A study from a tertiary care centre in Sri Lanka [abstract]|
Winkelmayer 2001 {published data only}|Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure|/resolve/reference/PMED?id=12160919
Winkelmayer 2001 {published data only}|Late nephrologist referral and access to renal transplantation|/resolve/reference/PMED?id=12131688
Winkelmayer 2001 {published data only}|Late referral and modality choice in end-stage renal disease|/resolve/reference/PMED?id=11576371
Winkelmayer 2001 {published data only}|Determinants of delayed nephrologist referral in patients with chronic kidney disease|/resolve/reference/PMED?id=11728948
Winkelmayer 2001 {published data only}|Preventive health care measures before and after start of renal replacement therapy|
Winkelmayer 2001 {published data only}|A propensity analysis of late versus early nephrologist referral and mortality on dialysis|/resolve/reference/PMED?id=12538751
Winkelmayer 2007 {published data only}|Predialysis nephrologist care and access to kidney transplantation in the United States|
Winkelmayer 2007 {published data only}|Predialysis nephrology care of older patients approaching end-stage renal disease|
Yanay 2010 {published data only}|The timing of nephrology referral and long-term survival of new dialysis patients [abstract]|
Yokoyama 2009 {published data only}|Impact of early referral to nephrologist on mental health among hemodialysis patients: a Dialysis Outcomes and Practice Patterns Study (DOPPS)|
Aguilar 2006 {published data only}|Efficiency of implementing a program aimed at achieving early referral to the nephrologist of patients with chronic renal failure in primary care|/resolve/reference/PMED?id=17469437
Al-Malki 2009 {published data only}|Acute renal failure in the state of Qatar: presentation and outcome|/resolve/reference/PMED?id=19545672
Astor 2001 {published data only}|Timing of nephrologist referral and arteriovenous access use: the CHOICE Study|/resolve/reference/PMED?id=11532680
Bastos 2011 {published data only}|Chronic kidney disease: importance of early diagnosis, immediate referral and structured interdisciplinary approach to improve outcomes in patients not yet on dialysis|
Bender 1996 {published data only}|Most nephrologists are primary care providers for chronic dialysis patients: results of a national survey|/resolve/reference/PMED?id=8712224
Bohm 2005 {published data only}|Referral to the pediatric dialysis unit - the earlier the better?|/resolve/reference/PMED?id=16416370
Boulware 2006 {published data only}|Identification and referral of patients with progressive CKD: a national study|/resolve/reference/PMED?id=16860184
Brown 2000 {published data only}|Open, randomised, parallel group, multi-centre study to investigate the effect of early anaemia correction on the reduction of cardiovascular risk in patients with chronic renal anaemia who are not on renal replacement therapy|
Bulpitt 1982 {published data only}|Community care compared with hospital outpatient care for hypertensive patients|/resolve/reference/PMED?id=6800539
Campbell 1989 {published data only}|The timing of referral of patients with end-stage renal disease|
Casino 2002 {published data only}|The need for integrated care of patients with chronic nephropathies: the epidemiology of 'late referral'|
Cass 2003 {published data only}|Late referral to a nephrologist reduces access to renal transplantation|/resolve/reference/PMED?id=14582048
Challah 1984 {published data only}|Negative selection of patients for dialysis and transplantation in the United Kingdom|/resolve/reference/PMED?id=6424755
Chan 2006 {published data only}|An audit on management of hypertension in a Hospital Authority general outpatient clinic|
Chesser 1998 {published data only}|Temporary vascular access for first dialysis is common, undesirable and usually avoidable|/resolve/reference/PMED?id=10230555
Churchill 1997 {published data only}|An evidence-based approach to earlier initiation of dialysis|/resolve/reference/PMED?id=9398139
Cohen 2002 {published data only}|Superior physicians and the treatment of hypertension|/resolve/reference/PMED?id=11863468
Coutts 2000 {published data only}|Early referral for ESRD: is everyone on the same page?|/resolve/reference/PMED?id=11249455
Curtis 2007 {published data only}|Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada|
de Alvaro 2004 {published data only}|When to start dialysis in diabetic patients?|
de Jager 2010 {published data only}|Association between time of referral and survival in the first year of dialysis in diabetics and the elderly|
Devins 2005 {published data only}|Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up|/resolve/reference/PMED?id=16310575
ECAP Study 2006 {published data only}|Is there an association between kidney function and oxidative stress? Results from the early correction of anemia on the progression of chronic kidney disease study [abstract no: SU-PO236]|
ECAP Study 2006 {published data only}|Body weight and c-reactive protein interact to accelerate the progression of chronic kidney disease: analysis of the early correction of anemia on the progression of chronic renal insufficiency (ECAP) study [abstract no: SA-PO113]|
ECAP Study 2006 {published data only}|Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients|/resolve/reference/PMED?id=17210593
ECAP Study 2006 {published data only}|Prevalence and risk factors for erythropoetin hyporesponsiveness in chronic kidney disease: analysis of the ECAP study [abstract no: F-PO343]|
ECAP Study 2006 {published data only}|Effect of early correction of anemia on the progression of chronic kidney disease: final results ECAP study [abstract no: SU-PO063]|
ECAP Study 2006 {published data only}|Effect of early correction of anemia on the progression of CKD|/resolve/reference/PMED?id=16632012
ECAP Study 2006 {published data only}|Effect on early correction of anemia on the progression of chronic kidney disease (ECAP) [abstract no: PUB180]|
Filler 2007 {published data only}|Waiting times in a tertiary paediatric nephrology clinic|/resolve/reference/PMED?id=19030333
Foote 2010a {published data only}|Factors associated with survival in elderly dialysis patients [abstract]|
Foote 2010b {published data only}|Late referral in the eGFR era [abstract]|
Fox 2006 {published data only}|Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study|
Frimat 2004 {published data only}|Early referral to a nephrologist is associated with better outcomes in type 2 diabetes patients with end-stage renal disease|/resolve/reference/PMED?id=15029100
Gomez-Campdera 2006 {published data only}|Clinical status of the patient at the time of dialysis onset. INESIR study|
Goncalves 2004 {published data only}|Effect of temporary catheter and late referral on hospitalization and mortality during the first year of hemodialysis treatment|
Gorriz 2002 {published data only}|Longer pre-dialysis nephrological care is associated with improved long-term survival of dialysis patients. More facts|
Gorriz 2006 {published data only}|Early referral of patients to the nephrology unit: utopia or reality|
Hao 2006 {published data only}|2006 ADA standard recommendations for treatment of diabetic nephropathy|
Harris 1998 {published data only}|Effects of multidisciplinary case management in patients with chronic renal insufficiency|/resolve/reference/PMED?id=9870830
Herget-Rosenthal 2006 {published data only}|Management of advanced chronic kidney disease in primary care: current data from Germany|
Holland 2000 {published data only}|Predictors of early vs. late referral among a retrospective cohort of pre-dialysis patients|
Horl 2002 {published data only}|A need for an individualized approach to end-stage renal disease patients|
Huisman 2004 {published data only}|The deadly risk of late referral|/resolve/reference/PMED?id=15299096
Iseki 2002 {published data only}|Analysis of referral pattern and survival in chronic dialysis patients in Okinawa, Japan (1993-1997)|
ISRCTN12355432 {published data only}|Study into the control of blood pressure and antihypertensive medication withdrawal in haemodialysis patients by programmed reduction in dry weight|
Jander 2006 {published data only}|Does a late referral to a nephrologist constitute a problem in children starting renal replacement therapy in Poland?--a nationwide study|/resolve/reference/PMED?id=16339164
Jones 2006 {published data only}|Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease|/resolve/reference/PMED?id=16644779
Jungers 1993 {published data only}|Detrimental effects of late referral in patients with chronic renal failure: a case-control study|/resolve/reference/PMED?id=8320913
Kessler 2003 {published data only}|Impact of nephrology referral on early and midterm outcomes in ESRD: EPidemiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study|/resolve/reference/PMED?id=12955675
Khan 1992 {published data only}|Chronic renal insufficiency: when to refer|/resolve/reference/PMED?id=1492209
Khan 1994 {published data only}|Chronic renal failure: factors influencing nephrology referral|/resolve/reference/PMED?id=7953505
Khan 1997 {published data only}|Acute renal failure: factors influencing nephrology referral and outcome|/resolve/reference/PMED?id=9536343
Khan 2005 {published data only}|Does predialysis nephrology care influence patient survival after initiation of dialysis?|/resolve/reference/PMED?id=15698443
Kincaid-Smith 2002 {published data only}|Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria|
Krol 2005 {published data only}|Early diagnosis of renal diseases - preliminary results from the pilot study PolNef|
Laris-Gonzalez 2011 {published data only}|Prevalence, risk factors and consecuences of late nephrology referral|
Ledoux 2001 {published data only}|From the first symptoms to terminal renal failure: need for a nephrologic follow-up|/resolve/reference/PMED?id=11270267
Lee 2007 {published data only}|Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial|/resolve/reference/PMED?id=17825709
Levin 2000 {published data only}|Consequences of late referral on patient outcomes|/resolve/reference/PMED?id=11032351
Lhotta 2003 {published data only}|Late referral defined by renal function: association with morbidity and mortality|
Martinez 2004 {published data only}|Chronic kidney failure: indications for referral of patients from primary health care to the nephrologist. Advantages of early referral. Strategies for joint follow-up|
Maynard 2001 {published data only}|The late referral of diabetic patients with kidney insufficiency to nephrologists has a high human and financial cost: interdisciplinary communication is urgently needed|/resolve/reference/PMED?id=11547228
McLaughlin 2001 {published data only}|An economic evaluation of early versus late referral of patients with progressive renal insufficiency|/resolve/reference/PMED?id=11684571
Mehta 2002 {published data only}|Nephrology consultation in acute renal failure: does timing matter?|/resolve/reference/PMED?id=12427493
Meier-Kriesche 2005 {published data only}|The impact of pretransplant dialysis on outcomes in renal transplantation|
Molina 1992 {published data only}|The influence of changing age and referral for end-stage renal failure in Newcastle upon Tyne|/resolve/reference/PMED?id=10123986
Montgomery 2006 {published data only}|Factors influencing general practitioner referral of patients developing end-stage renal failure: a standardised case-analysis study|/resolve/reference/PMED?id=16970805
Navaneethan 2008 {published data only}|A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease|/resolve/reference/PMED?id=18298850
Obialo 2005 {published data only}|Ultralate referral and presentation for renal replacement therapy: Socioeconomic implications|/resolve/reference/PMED?id=16253728
Ohmit 2003 {published data only}|Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP)|/resolve/reference/PMED?id=12819315
Orlando 2007 {published data only}|Relationship between nephrologist care and progression of chronic kidney disease|
Parameswaran 2011 {published data only}|Referral pattern of patients with end-stage renal disease at a public sector hospital and its impact on outcome|
Perez-Valdivieso 2007 {published data only}|Prognosis and serum creatinine levels in acute renal failure at the time of nephrology consultation: an observational cohort study|/resolve/reference/PMED?id=17894896
Piccoli 2003 {published data only}|Lost to follow-up: the bottleneck of early referral to renal units?|/resolve/reference/PMED?id=14586276
Piccoli 2005 {published data only}|Dialysis choice in the context of an early referral policy: there is room for self care|
Pollock 2007 {published data only}|Early start peritoneal dialysis|/resolve/reference/PMED?id=17603972
Powe 2003 {published data only}|Early referral in chronic kidney disease: an enormous opportunity for prevention|/resolve/reference/PMED?id=12552517
Pylypchuk 2000 {published data only}|Diabetic nephropathy. Prevention and early referral|/resolve/reference/PMED?id=10752002
Riegel 2005 {published data only}|Multi-centre enquiry into the influence of the referral of patients with progressive kidney disease to nephrologists|/resolve/reference/PMED?id=15789300
Roderick 2002a {published data only}|Late referral for end-stage renal disease: a region-wide survey in the south west of England|/resolve/reference/PMED?id=12105249
Roderick 2002b {published data only}|Late referral for dialysis: improving the management of chronic renal disease|/resolve/reference/PMED?id=12037244
Roderick 2008 {published data only}|Detecting chronic kidney disease in older people; what are the implications?|/resolve/reference/PMED?id=18083723
Sands 1999 {published data only}|Intervention based on monthly monitoring decreases hemodialysis access thrombosis|
Schwenger 2003 {published data only}|Uremic patients--late referral, early death|/resolve/reference/PMED?id=12772078
Schwenger 2006 {published data only}|Late referral--a major cause of poor outcome in the very elderly dialysis patient|/resolve/reference/PMED?id=16396974
Sesso 1996 {published data only}|Late diagnosis of chronic renal failure|/resolve/reference/PMED?id=9196548
Shulman 1989 {published data only}|Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group|/resolve/reference/PMED?id=2490833
Sirignano 2003 {published data only}|The optimization of the treatment and timing of the intervention by a nephrologist in pre-dialytic chronic renal insufficiency|
Smrzova 2010 {published data only}|Pre-dialysis care and nephrology referral: a Czech nationwide study [abstract]|
Steel 2002 {published data only}|Do demographic variables affect the timing of referral to the nephrologist?|
Stevens 2001 {published data only}|Non-specialist management of acute renal failure|/resolve/reference/PMED?id=11588212
Stevens 2005 {published data only}|Optimizing renal anaemia management--benefits of early referral and treatment|/resolve/reference/PMED?id=16079327
Stolk 2011 {published data only}|Chronic kidney disease: screening, follow-up and referral|
Tonelli 2006 {published data only}|Chronic kidney disease and mortality risk: a systematic review|/resolve/reference/PMED?id=16738019
Trocha 1999 {published data only}|Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study|/resolve/reference/PMED?id=10526912
Usherwood 2002 {published data only}|Early renal impairment: the role of the GP|
Farooqui 1975 {published data only}|Analysis of 1,423 (new patients) referred to the nephro-urology department of the Jinnah post-graduate medical centre, Karachi --a five years study|
Stankuviene 2003 {published data only}|Influence of referral pattern to nephrologist on start of hemodialysis|/resolve/reference/PMED?id=12761438
AIHW 2005|Australia's welfare 2005|
ANZDATA 2007|ANZDATA Registry 2007 Report|
Belasco 2006|Quality of life of family caregivers of elderly patients on hemodialysis and peritoneal dialysis|/resolve/reference/PMED?id=17162150
Cass 2006|The economic impact of end-stage kidney disease in Australia|
CDC 2007|National health and nutrition examination survey. 2007-2008|
Chadban 2003|Prevalence of kidney damage in Australian adults. The AusDiab kidney study|/resolve/reference/PMED?id=12819318
Chan 2007|Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis|/resolve/reference/PMED?id=18060927
Cignarelli 2007|Obesity and kidney disease|/resolve/reference/PMED?id=17606365
Cooper 2010|A randomized, controlled trial of early versus late initiation of dialysis|
de Lusignan 2005|Identifying patients with chronic kidney disease from general practice computer records|/resolve/reference/PMED?id=15814579
el Nahas 1997|Progressive renal failure|
Gamba 1993|Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables|/resolve/reference/PMED?id=8413786
Gentile 2003|Review of quality of life instruments used in end-stage renal disease|/resolve/reference/PMED?id=14584296
Grace 2012|ANZDATA Registry Report 2012. Chapter 1: stock and flow|
Heatley 2009|Optimal referral is early referral|/resolve/reference/PMED?id=19270201
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011|Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Hoen 1998|EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients|/resolve/reference/PMED?id=9596085
Juergensen 2006|Hemodialysis and peritoneal dialysis: patients assessment of their satisfaction with therapy and the impact of the therapy on their lives|/resolve/reference/PMED?id=17699347
KHA 2010|How much does kidney failure cost the Australian Health System?|
Kinchen 2002|The timing of specialist evaluation in chronic kidney disease and mortality|/resolve/reference/PMED?id=12230348
Klebe 2007|The cost of implementing UK guidelines for the management of chronic kidney disease|/resolve/reference/PMED?id=17550923
Lima 2006|Practical ways to deal with the high burden of cardiovascular disease in hemodialysis patients|/resolve/reference/PMED?id=16612461
Locatelli 2002|The importance of early detection of chronic kidney disease.|/resolve/reference/PMED?id=12386248
McDonald 2013|ANZDATA Registry Report 2012. Chapter 3: deaths|
Mehrotra 2005|Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis|/resolve/reference/PMED?id=15954930
Rao 2005|Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease|/resolve/reference/PMED?id=16164618
Weiner 2007|Causes and consequences of chronic kidney disease: implications for managed health care|/resolve/reference/PMED?id=17402808
Wells 2012|The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses|
Zelmer 2007|The economic burden of end-stage renal disease in Canada|/resolve/reference/PMED?id=17700643
Smart 2008|Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease|
Smart 2011|Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review|
Adams 1992|Treatment of acute rejection|/resolve/reference/PMED?id=1570553
Altman 2003|Interaction revisited: the difference between two estimates|/resolve/reference/PMED?id=12543843
Banff 1997|Banff schema for grading liver allograft rejection: an international consensus document|
Boillot 2009|Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study|
Chatenoud 2008|The long and winding road towards induction of allograft tolerance in the clinic|
Chen 2006|Regulatory T-cell subsets and their roles in transplantation tolerance|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
FK506 1994a|A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation|/resolve/reference/PMED?id=7523946
FK506 1994b|Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection|/resolve/reference/PMED?id=7520105
Flechner 2008|Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity|/resolve/reference/PMED?id=18217899
Gluud 2006|Bias in clinical intervention research|/resolve/reference/PMED?id=16443796
Gluud 2011|Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs))|
Goralczyk 2011|Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and meta-analysis of controlled studies|
Hachem 2008|The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry|
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]|
ICH-GCP 1997||
Iversen 2009|Immunosuppression|
Keus 2009|Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials|/resolve/reference/PMED?id=19262513
Kjaergard 2001|Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses|/resolve/reference/PMED?id=11730399
Lechler 2005|Organ transplantation - how much of the promise has been realized?|/resolve/reference/PMED?id=15937473
Macaskill 2001|A comparison of methods to detect publication bias in meta-analysis|
Magliocca 2006|The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation|
Marcos 2004|Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus|/resolve/reference/PMED?id=15480160
Moher 1998|Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?|/resolve/reference/PMED?id=9746022
Moher 2009|Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement|/resolve/reference/PMED?id=19631508
Moser 2002|Options for induction immunosuppression in liver transplant recipients|/resolve/reference/PMED?id=11985487
Neuberger 2009|Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study|
Neuhaus 1993|Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody|/resolve/reference/PMED?id=8516819
O'Grady 2002|Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial|/resolve/reference/PMED?id=12387959
OPTN 2009|The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients|
Perera 2009|Liver transplantation: Issues for the next 20 years|
Pillai 2009|Overview of immunosuppression in liver transplantation|/resolve/reference/PMED?id=19750565
RevMan 2011|Review Manager (RevMan)|
Royle 2003|Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches|/resolve/reference/PMED?id=15095765
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Seyfert-Margolis 2010|Tolerance: is it achievable in pediatric solid organ transplantation?|/resolve/reference/PMED?id=20371050
Sgourakis 2009|Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes|
Starzl 2003|Tolerogenic immunosuppression for organ transplantation|
Starzl 2008|Immunosuppressive therapy and tolerance of organ allografts|
Sweeting 2004|What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data|
Thompson 2002|How should meta-regression analyses be undertaken and interpreted?|
Transplant activity report 2009|Transplant activity report 2008/2009 UK|
Wang 2010|Interleukin-2 receptor antagonists in liver transplantation: a meta-analysis of randomized trials|/resolve/reference/PMED?id=21168739
Wetterslev 2008|Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis|/resolve/reference/PMED?id=18083463
Wetterslev 2009|Estimating required information size by quantifying diversity in random-effects model meta-analyses|/resolve/reference/PMED?id=20042080
Wiesner 2003|Recent advances in liver transplantation|
Wood 2008|Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study|/resolve/reference/PMED?id=18316340
Wilson 2008|Immunosuppressive T cell antibodies for liver transplant recipients|/resolve/reference/PMED?id=19066577
Eimer 1985 {published data only}|Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction|/resolve/reference/PMED?id=2865326
Harrison (unpublished) {unpublished data only}|A comparison of the effectiveness of oral lorazepam and placebo in relieving breathlessness associated with advanced cancer|
Man 1986 {published data only}|Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3780329
Navigante (unpublished) {unpublished data only}|Morphine versus midazolam as upfront therapy to relief dyspnea in ambulatory cancer patients while its underlying cause is sought or treated|
Navigante 2006 {published data only}|Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer|/resolve/reference/PMED?id=16442481
Shivaram 1989 {published data only}|Effects of alprazolam on gas exchange, breathing pattern, and lung function in COPD patients with anxiety|
Woodcock 1981 {published data only}|Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers|/resolve/reference/PMED?id=6788319
Allen 1984 {published data only}|Treatment of dyspnoea: the role of drugs|
Anonymous 1980a {published data only}|Diazepam and breathlessness|/resolve/reference/PMED?id=6105401
Anonymous 1980b {published data only}|Centrally acting drugs in chronic airways obstruction|
Appel 1989 {published data only}|Efficacy of flumazenil in COPD patient with therapeutic diazepam levels|/resolve/reference/PMED?id=2563553
Argyropoulou 1993 {published data only}|Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8265878
Bar-Or 1982 {published data only}|Breathlessness, alcohol, and opiates|/resolve/reference/PMED?id=7070466
Beaupre 1988 {published data only}|Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease|/resolve/reference/PMED?id=3249838
Borson 1992 {published data only}|Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=1557484
Bottomley 1990 {published data only}|Subcutaneous midazolam infusion in palliative care|/resolve/reference/PMED?id=2384705
Catchlove 1971 {published data only}|The effects of diazepam on the ventilatory response to carbon dioxide and on steady-state gas exchange|/resolve/reference/PMED?id=5540374
Catchlove 1971a {published data only}|The effects of diazepam on respiration in patients with obstructive pulmonary disease|/resolve/reference/PMED?id=5540362
Clark 1971 {published data only}|Respiratory depression caused by nitrazepam in patients with respiratory failure|/resolve/reference/PMED?id=4106232
Cohn 1992 {published data only}|Effects of estazolam and flurazepam on cardiopulmonary function in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=1605900
De Sousa 1988 {published data only}|Midazolam in terminal care|
Denaut 1974 {published data only}|Double-blind comparison of the respiratory effects of parenteral lorazepam and diazepam in patients with chronic obstructive lung disease|/resolve/reference/PMED?id=4156289
Dolly 1982 {published data only}|Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects|/resolve/reference/PMED?id=7051825
Dowson 2004 {published data only}|Anxiety and self-management behaviour in chronic obstructive pulmonary disease: what has been learned?|/resolve/reference/PMED?id=16281648
Forster 1983 {published data only}|Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone: a double-blind randomized study|/resolve/reference/PMED?id=6137171
Gaddie 1972 {published data only}|Effect of nitrazepam in chronic obstructive bronchitis|/resolve/reference/PMED?id=5031712
Geddes 1976 {published data only}|Effect of nitrazepam and flurazepam on the ventilatory response to carbon dioxide|/resolve/reference/PMED?id=11571
Greene 1989 {published data only}|Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: a case study|/resolve/reference/PMED?id=2922358
Guilleminault 1993 {published data only}|Cardiac failure and benzodiazepines|/resolve/reference/PMED?id=8235236
Guz 1980 {published data only}|Quantifying dyspnoea and the use of drugs to alleviate the symptom|/resolve/reference/PMED?id=7013874
Heinonen 1972 {published data only}|The effect of diazepam on airway resistance in asthmatics|
Hoeijer 1994 {published data only}|Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study|/resolve/reference/PMED?id=7875274
Horfarter 2006 {published data only}|Symptom control and ethics in final stages of COPD|/resolve/reference/PMED?id=16830246
Hosaka 1996 {published data only}|Effects of diazepam on quality of life in patients receiving home oxygen therapy: a double-blind, cross-over, placebo-controlled clinical trial [Japanese]|
Huttemann 1971 {published data only}|The influence of laevomepromazine and prometazine on respiration in healthy subjects and patients with pulmonary emphysema|/resolve/reference/PMED?id=5171892
Johanson 1993 {published data only}|Midaziolam in terminal care|/resolve/reference/PMED?id=8461208
Jokinen 1984 {published data only}|Flupenthixol versus diazepam in the treatment of psychosomatic disorders: a double-blind, multi-centre trial in general practice|/resolve/reference/PMED?id=6374678
Jolly 1996 {published data only}|Acute effect of lorazepam on respiratory muscles in stable patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9239882
Jones 1985 {published data only}|The effect of promethazine and diazepam on respiratory control in breathless patients (abstract)|
Kann 1968 {published data only}|On the therapy of asthmatic dyspnea|/resolve/reference/PMED?id=5706199
Kronenberg 1975 {published data only}| The use of oral diazepam in patients with obstructive lung disease and hypercapnia|/resolve/reference/PMED?id=1147444
Lakshminarayan 1976 {published data only}|Effect of diazepam on ventilatory responses|/resolve/reference/PMED?id=947652
Lareau 1999 {published data only}|Dyspnea in patients with chronic obstructive pulmonary disease: does dyspnea worsen longitudinally in the presence of declining lung function?|
Laros 1982 {published data only}|Relief of breathlessness in a case of progressive pulmonary fibrosis|/resolve/reference/PMED?id=7178674
Lichterfeld 1967 {published data only}|Controlled therapeutic comparison of antiasthmatics in out-patients in a double-blind experiment|/resolve/reference/PMED?id=4885304
Light 1996 {published data only}|Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD|/resolve/reference/PMED?id=8635380
Marin 1987 {published data only}|Bronchopulmonary carcinoma: a medical approach to the last weeks of life; a study of 191 cases|/resolve/reference/PMED?id=2437841
McIver 1994 {published data only}|The use of chlorpromazine for symptom control in dying cancer patients|/resolve/reference/PMED?id=7963786
Mitchell-Heggs 1980 {published data only}|Diazepam in the treatment of dyspnoea in the 'Pink Puffer' syndrome|/resolve/reference/PMED?id=6776586
Mitchell-Heggs 1980a {published data only}|Dyspnoea in 'pink puffers': the place of diazepam|
Murciano 1990 {published data only}|Comparison of zolpidem (Z), triazolam (T), and flunitrazepam (F) effects on arterial blood gases and control of breathing in patients with severe chronic obstructive pulmonary disease (COPD) (abstract)|/resolve/reference/PMED?id=2307006
Murciano 1993 {published data only}|Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD|/resolve/reference/PMED?id=8519370
Navigante 1997 {published data only}|Compared and randomized prospective trial between oxygenotherapy vs. morphine chlorhydrate + midazolam by subcutaneous route in patients with advanced cancer and dyspnea|
Navigante 2003 {published data only}|Morphine plus midazolam versus oxygen therapy on severe dyspnea management in the last week of life in hipoxemic advanced cancer patients|
Nordt 1997 {published data only}|Midazolam: a review of therapeutic uses and toxicity|/resolve/reference/PMED?id=9258787
O'Donnell 1992 {published data only}|Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations|/resolve/reference/PMED?id=1516410
O'Donnell 1994 {published data only}|Breathlessness in patients with chronic airflow limitation. Mechanisms and management|/resolve/reference/PMED?id=8082376
O'Donnell 1998 {published data only}|Dyspnea in advanced chronic obstructive pulmonary disease|/resolve/reference/PMED?id=9662089
O'Neill 1985 {published data only}|Chlorpromazine - a specific effect on breathlessness?|
Rao 1973 {published data only}|Cardiopulmonary effects of diazepam|/resolve/reference/PMED?id=4695379
Rapoport 1991 {published data only}|Differing effects of the anxiolytic agents buspirone and diazepam on control of breathing|
Rice 1986 {published data only}|Treatment of dyspnea with psychotropic agents|/resolve/reference/PMED?id=3780323
Rice 1987 {published data only}|Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction|/resolve/reference/PMED?id=3311120
Rose 2002 {published data only}|The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review|/resolve/reference/PMED?id=12135822
Rudolf 1978 {published data only}|Depression of central respiratory drive by nitrazepam|/resolve/reference/PMED?id=644547
Runo 2001 {published data only}|Treating dyspnea in a patient with advanced chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11527853
Schultze-Werninghaus 2007 {published data only}|The critically ill patient with COPD|/resolve/reference/PMED?id=17546570
Sen 1983 {published data only}|The response of the breathless patient treated with diazepam|/resolve/reference/PMED?id=6882655
Singh 1993 {published data only}|Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety|/resolve/reference/PMED?id=8449072
Stark 1981a {published data only}|Does diazepam reduce breathlessness in healthy subjects? (abstract)|
Stark 1981b {published data only}|Methods to assess breathlessness in healthy subjects: a critical evaluation and application to analyse the acute effects of diazepam and promethazine on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide|/resolve/reference/PMED?id=6793277
Stark 1983 {published data only}|Dihydrocodeine for breathlessness in pink puffers|/resolve/reference/PMED?id=6404426
Stark 1988 {published data only}|Dyspnoea: Assessment and pharmacological manipulation|/resolve/reference/PMED?id=3289964
Steens 1993 {published data only}|Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8341892
Timms 1988 {published data only}|Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=3178373
Walsh 1993 {published data only}|Dyspnoea in advanced cancer|/resolve/reference/PMED?id=8102424
Wanrooij 2005 {published data only}|Dyspnea relief in the palliative phase|
Wiedemann 1995 {published data only}|The effect of sedation on pulmonary function|
Wilson 1954 {published data only}|Respiratory acidosis. I. Effects of decreasing respiratory minute volume in patients with severe chronic pulmonary emphysema, with specific reference to oxygen, morphine and barbiturates|/resolve/reference/PMED?id=13197410
Woodcock 1981a {published data only}|Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases|/resolve/reference/PMED?id=6796885
Woodcock 1981b {published data only}|Oxygen relieves breathlessness in "pink puffers"|
Stege (unpublished) {unpublished data only}|Effects of temazepam in patients with chronic pulmonary obstructive disease|
Abernethy 2008|Pharmacological management of breathlessness in advanced disease|
Allen 1984|Treatment of dyspnoea: The role of drugs|
Altose 1985|Assessment and management of breathlessness|/resolve/reference/PMED?id=3926399
ATS 1999|Dyspnea. Mechanisms, assessment, and management: a consensus statement|/resolve/reference/PMED?id=9872857
Bausewein 2008|Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases|
Beach 2006|The genesis of breathlessness - what do we understand?|
Booth 2006||
Booth 2008|The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy|/resolve/reference/PMED?id=18235441
Bruera 2006||
Cranston 2008|Oxygen therapy for dyspnoea in adults|
Davis 1997|ABC of palliative care|/resolve/reference/PMED?id=9361545
Davis 2005|Drug therapies|
De Conno 1991|Does pharmacological treatment affect the sensation of breathlessness in terminal cancer patients?|
Edwards 2000|The effectiveness of one-to-one risk communication interventions in health care: a systematic review|/resolve/reference/PMED?id=10929851
Edwards 2003|Personalised risk communication for informed decision making about entering screening programs|
Elbourne 2002|Meta-analyses involving cross-over trials: methodological issues|/resolve/reference/PMED?id=11914310
GOLD 2007|Global strategy for the diagnosis, management and prevention of COPD (2007)|
Hardman 2005||
Higgins 2008||
Higginson 2004|The epidemiology of death and symptoms|
Jennings 2001|Opioids for the palliation of breathlessness in terminal illness|
Lanken 2008|An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses|/resolve/reference/PMED?id=18390964
Manning 1995|Pathophysiology of dyspnea|/resolve/reference/PMED?id=7477171
Manning 2000|Dyspnea treatment|/resolve/reference/PMED?id=11063522
Muers 1993|Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group|/resolve/reference/PMED?id=7685550
Neumann 2006|Dyspnea in relation to symptoms of anxiety and depression:  a prospective population study|/resolve/reference/PMED?id=16516455
Nordgren 2003|Symptoms experienced in the last six months of life in patients with end-stage heart failure|/resolve/reference/PMED?id=14622629
RevMan 2008|Review Manager (RevMan)|
Ripamonti 1999|Management of dyspnea in advanced cancer patients|/resolve/reference/PMED?id=10423049
Rocker 2007|Advanced chronic obstructive pulmonary disease: innovative approaches to palliation|/resolve/reference/PMED?id=17592991
Runo 2001|Treating dyspnea in a patient with advanced chronic obstructive pulmonary disease|/resolve/reference/PMED?id=11527853
Solano 2006|A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease|/resolve/reference/PMED?id=16442483
Thomas 2002|Clinical management of dyspnoea|/resolve/reference/PMED?id=12067684
Tobin 1990|Dyspnoea|/resolve/reference/PMED?id=2200379
Viola 2008|The management of dyspnea in cancer patients: a systematic review|/resolve/reference/PMED?id=18214551
Williams 2006|Dyspnea|
Aksu 2002 {published data only}|The effects of exercise therapy in amyotrophic lateral sclerosis|
Calzada-Sierra 2001 {published data only}|The importance of multifactorial rehabilitation treatment in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11346822
Chio 2006 {published data only}|Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities|
Dal Bello-Haas 2007 {published data only}|A randomized controlled trial of resistance exercise in individuals with ALS|/resolve/reference/PMED?id=17548549
Drory 2001 {published data only}|The value of muscle exercise in patients with amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11677004
Pinto 1999 {published data only}|Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?|/resolve/reference/PMED?id=10540010
Traynor 2003 {published data only}|Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000|
van den Berg 2005 {published data only}|Multidisciplinary ALS care improves quality of life in patients with ALS|/resolve/reference/PMED?id=16247055
van der Steen 2009 {published data only}|The costs of amyotrophic lateral sclerosis, according to type of care|/resolve/reference/PMED?id=18608087
Zoccolella 2007 {published data only}|ALS multidisciplinary clinic and survival: results from a population-based study in Southern Italy|
AMNDR 2005|Australian Motor Neurone Disease Registry|/resolve/reference/PMED?id=18625418
Anderson 2005|EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives|
Bromberg 2008|Quality of life in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=18625418
Brooks 1994|El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors|
Brooks 2000|El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis|/resolve/reference/PMED?id=11464847
Brown 1995|Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice|/resolve/reference/PMED?id=7889564
Brown 2004|Empowerment in measurement: 'muscle', 'voice' and subjective quality of life as a gold standard|/resolve/reference/PMED?id=15083418
Cicerone 2005|Evidence based practice and limits of rational rehabilitation|/resolve/reference/PMED?id=15954042
Cookson 1999|Oxidative stress and motor neuron disease|
Dal Bello-Haas 2008|Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease|
DeJong 2005|Opening the black box of post-stroke rehabilitation: stroke rehabilitation patients, processes, and outcomes|/resolve/reference/PMED?id=16373135
Egger 1998|Bias in location and selection of studies|
Elstein 2002|Clinical problem solving and diagnostic decision making: selective review of the cognitive literature|/resolve/reference/PMED?id=11909793
Forsgren 1983|Epidemiology of motor neuron disease in northern Sweden|
Francis 1999|Evaluation and rehabilitation of patients with adult motor neuron disease|/resolve/reference/PMED?id=10453774
Gassaway 2005|Applying the clinical practice improvement approach to stroke rehabilitation: methods used and baseline results|/resolve/reference/PMED?id=16373137
Greener 2002|Systematic reviews in rehab for stroke: issues and approaches to addressing them|/resolve/reference/PMED?id=11837528
Hardiman 2007|Multidisciplinary care in motor neurone disease|/resolve/reference/PMED?id=8664768
Hickey 1996|A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS|/resolve/reference/PMED?id=8664768
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 [updated February 2008]|
Horn 2005|Another look at observational studies in rehabilitation research: going beyond the holy grail of the randomized controlled trial|/resolve/reference/PMED?id=16373136
ICF 2001|International classification of functioning, disability and health (ICF)|
Jenkinson 1999|Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neuron disease: the ALSAQ-40|
Katzberg 2011|Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease|/resolve/reference/PMED?id=21249659
Khan 2011|Multidisciplinary rehabilitation for adults with multiple sclerosis|
Klein 1996|The economic impact of ALS|/resolve/reference/PMED?id=8858069
Langhorne 2002|What are the components of stroke unit care?|/resolve/reference/PMED?id=12242199
Lee 1995|Prognosis of amyotrophic lateral sclerosis and the effects of referral selection|/resolve/reference/PMED?id=8543950
Logroscino 2008|Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues|/resolve/reference/PMED?id=18079297
McGuire 1996|Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS|/resolve/reference/PMED?id=8628496
Miller 2007|Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)|
MNDA 2007|Research Strategy 2006-2012|
Mountain 2004|Assessment of individual quality of life using the SEIQoL-DW in older medical patients|/resolve/reference/PMED?id=15256609
NSF 2005|The national service framework for long-term conditions|
RCP 2008|Long-term neurological conditions: management at the interface between neurology, rehabilitation and palliative care|/resolve/reference/PMED?id=16362828
RevMan 2008|Review Manager|
Rocha 2005|Diagnostic investigation and multidisciplinary management in motor neuron disease|/resolve/reference/PMED?id=16362828
Shaw 1997|Glutamate, excitotoxicity and amyotrophic lateral sclerosis|
Shefner 2008|Designing clinical trials in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=18625412
Simmons 2005|Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death|/resolve/reference/PMED?id=16148733
Simmons 2006|The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS|/resolve/reference/PMED?id=17101900
Steultjens 2004|Occupational therapy for rheumatoid arthritis|/resolve/reference/PMED?id=14974005
Talman 2009|Clinical phenotypes and natural progression for motor neuron disease: analysis from an Australian database|/resolve/reference/PMED?id=18608095
Tate 2006|The state of rehabilitation research: art or science?|/resolve/reference/PMED?id=16442966
Traue 2005|Palliative care in non malignant diseases|/resolve/reference/PMED?id=16260799
Turner 2007|Clinical phenotypes|/resolve/reference/PMED?id=17491500
Turner-Stokes 2005|Multi-disciplinary rehabilitation for acquired brain injury in adults of working age|/resolve/reference/PMED?id=16034923
Turner-Stokes 2007|From diagnosis to death: exploring the interface between neurology, rehabilitation and palliative care in the management of people with long term neurological conditions|/resolve/reference/PMED?id=17491500
Wade 1992||
Worms 2001|The epidemiology of motor neuron diseases: a review of recent studies|/resolve/reference/PMED?id=11676986
Ng 2008|Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease|
Birk 2000 {published data only}|The effects of massage therapy alone and in combination with other complementary therapies on immune system measures and quality of life in Human Immunodeficiency Virus|/resolve/reference/PMED?id=11059502
Diego 2001 {published data only}|HIV adolescents show improved immune function following massage therapy|/resolve/reference/PMED?id=11264907
Shor-Posner 2006 {published data only}|Impact of a Massage therapy clinical trial on immune status in young Dominican children infected with HIV-1|/resolve/reference/PMED?id=16884341
Williams 2005 {published data only}|A randomized controlled trial of meditation and massage effects on quality of life in people with late-stage disease: a pilot study|/resolve/reference/PMED?id=16238507
Field 2005 {published data only}|Cortisol decreases and serotonin increases following massage therapy|/resolve/reference/PMED?id=16162447
Gore-Felton 2003 {published data only}|Alternative therapies: A common practice among men and women living with HIV|/resolve/reference/PMED?id=12800809
Henrikson 2001 {published data only}|Clinical outcomes and patient perceptions of acupuncture and/or massage therapies in HIV-infected individuals|/resolve/reference/PMED?id=11720644
Ironson 1996 {published data only}|Massage is associated with the enhancement of the immune systems's cytotoxic capacity|/resolve/reference/PMED?id=8707483
Mills 2005 {published data only}|Complementary therapies for the treatment of HIV: in search of the evidence|/resolve/reference/PMED?id=15969772
Ownby 2006 {published data only}|Effects of ice massage on neuropathic pain in persons with AIDS|
Ozsoy 1999 {published data only}|How effective are complementary therapies for HIV and AIDS? A systematic review|/resolve/reference/PMED?id=10582628
AMTA 2000|Glossary of terms|
Birk 2000|The effects of massage alone and in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus|
Diego 2001|HIV adolescents show improved immune function following massage therapy|/resolve/reference/PMED?id=11264907
Eastbrook 2001|The changing epidemiology of HIV infection: new challenges for HIV palliative care|
Field 2005|Cortisol decreases and serotonin and dopamine increase following massage therapy|/resolve/reference/PMED?id=16162447
Goats 1994|Massage- the scientific basis of an ancient art. Part 2 Physiological and therapeutic effects|
Gray 2007|Pain in women with HIV/AIDS|
Gwyther 2004|Symptom control in palliative care: essential for quality of life|
Harding 2005|Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence|
Hernandez-Rief 2004|breast cancer patients have improved immune and neuroendocrine functions following massage therapy|/resolve/reference/PMED?id=15256294
Ironson 1996|Massage is associated with the enhancement of the immune systems's cytotoxic capacity|/resolve/reference/PMED?id=8707483
Lawn 2004|AIDS in Africa: the impact of coinfection on the pathogenesis of HIV-1 infection|/resolve/reference/PMED?id=14667787
Maulik 2009|Community-based interventions to optimise early childhood development in low resource settings|/resolve/reference/PMED?id=19404276
Muller-Oerlingausen 2007|The efficacy of slow stroke massage in depression|/resolve/reference/PMED?id=17786889
O'Brien 2004|Progressive resistive exercise interventions for adults living with HIV/AIDS|/resolve/reference/PMED?id=19229185
O'Neill 1993|Pain in human immunodeficiency virus disease: A review|
Ownby 2006|Effects of ice massage on neuropathic pain in persons with AIDS|
Rich 2002||
Shor-Posner 2004|Massage Treatment on HIV-1 infected Dominican children: A preliminary report on the efficacy of massage therapy to preserve the immune system in children without anti-retroviral medication|/resolve/reference/PMED?id=15674006
Stjernswrd 2002|Uganda: Initiating a government public health approach to pain relief and palliative care|
Toups 1999|A healing touch: massage and HIV/AIDS|/resolve/reference/PMED?id=11367160
UNAIDS 2008|Report on the global HIV/AIDS epidemic 2008: executive summary.|
UNAIDS/WHO 2007|AIDS Epidemic Update Report 2007|
Uwimana 2005|Met and unmet palliative care needs of people living with HIV/AIDS in Rwanda|
Uwimana 2007|Met and unmet palliative care needs of people living with HIV/AIDS in Rwanda|/resolve/reference/PMED?id=18040536
Cleland 2005 {published data only}|Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation|/resolve/reference/PMED?id=16044026
Cosyns 2008 {published data only}|Effects of erythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients|
Ghali 2008 {published data only}|Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia|/resolve/reference/PMED?id=18195176
Kourea 2008a {published data only}|Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure|/resolve/reference/PMED?id=18525396
Mancini 2003 {published data only}|Does erythropoietin increase exercise capacity in anemic heart failure?|
Mancini 2003 {published data only}|Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure|/resolve/reference/PMED?id=12538431
Palazzuoli 2006 {published data only}|Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia|/resolve/reference/PMED?id=17161060
Palazzuoli 2007 {published data only}|Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome|/resolve/reference/PMED?id=17892986
Parissis 2008 {published data only}|Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=18371487
Ponikowski 2007 {published data only}|Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=17306703
Ponikowski 2007 {published data only}|Importance of erythropoietin (darbepoetin alfa) in chronic heart failure associated with anemia|
Silverberg 2001 {published data only}|The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study|/resolve/reference/PMED?id=11401110
van Veldhuisen 2007 {published data only}|Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia|/resolve/reference/PMED?id=17681958
Besarab 1998 {published data only}|The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin|/resolve/reference/PMED?id=9718377
Drueke 2006 {published data only}|Normalization of hemoglobin level in patients with chronic kidney disease and anemia|/resolve/reference/PMED?id=17108342
Kirkpantur 2005 {published data only}|The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters|
Kourea 2008b {published data only}|Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure|/resolve/reference/PMED?id=17991471
Li 2004 {published data only}|Treatment of the anemia in chronic heart failure patients improve the cardiac function|
Silverberg 2000 {published data only}|The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations|/resolve/reference/PMED?id=10841219
Silverberg 2003 {published data only}|The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron|/resolve/reference/PMED?id=12480972
Singh 2006 {published data only}|Correction of anemia with epoetin alfa in chronic kidney disease|/resolve/reference/PMED?id=17108343
Zilberman 2007 {published data only}|Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure|/resolve/reference/PMED?id=17967592
RED-HF 2008 {published data only}|RED-HF Trial - Reduction of events With darbepoetin alfa in heart failure trial|
RED-HF 2008 {published data only}|Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF) Trial|
Abdulla 2004|A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction|
ACC/AHA 2005|ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)|/resolve/reference/PMED?id=16168273
Anand 1993|Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones|/resolve/reference/PMED?id=8217445
Anand 2004|Anemia and Its Relationship to Clinical Outcome in Heart Failure|/resolve/reference/PMED?id=15210591
Anand 2008|Heart failure and anemia: mechanisms and pathophysiology|/resolve/reference/PMED?id=18236152
ASCO/ASH 2008|Use of epoetin and darbepoetin in patients with cancer: 2007 American society of clinical oncology/American society of hematology clinical practice guideline update|/resolve/reference/PMED?id=17954713
Auerbach 2004|Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial|/resolve/reference/PMED?id=15051778
Beguin 2002|Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients|/resolve/reference/PMED?id=12414352
Bennett 2002|Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease|/resolve/reference/PMED?id=12122390
Bennett 2008|Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia|/resolve/reference/PMED?id=18314434
Besarab 1998|The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin|/resolve/reference/PMED?id=9718377
Blanc 1968||
Bohlius 2006|Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients|/resolve/reference/PMED?id=16705125
Bohlius 2006a|Erythropoietin or darbepoetin for patients with cancer|
Bolger 2006b|Intravenous iron alone for the treatment of anemia in patients with chronic heart failure|/resolve/reference/PMED?id=16979010
Bristow 1996|Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure|/resolve/reference/PMED?id=8941106
Cleland 2001|The heart failure epidemic: exactly how big is it?|/resolve/reference/PMED?id=11286518
Colucci 1996|Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure|/resolve/reference/PMED?id=8941105
Deeks 2008|Chapter 9: Analysing data and undertaking meta-analyses|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
DIG 1997|The effect of digoxin on mortality and morbidity in patients with heart failure|/resolve/reference/PMED?id=9036306
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
EORTC 2007|EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update|/resolve/reference/PMED?id=17182241
ESC 2008|ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008|
Falk 2006|Fatigue and anaemia in patients with chronic heart failure|
Felker 2004|Anemia as a risk factor and therapeutic target in heart failure|/resolve/reference/PMED?id=15337204
Flather 2000|Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients|/resolve/reference/PMED?id=10821360
Foley 2008|Erythropoietin: physiology and molecular mechanisms|/resolve/reference/PMED?id=18236154
Green 2000|Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure|/resolve/reference/PMED?id=10758967
Groenveld 2008|Anemia and mortality in heart failure patients a systematic review and meta-analysis|/resolve/reference/PMED?id=18755344
Guyatt 1985|The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure|/resolve/reference/PMED?id=3978515
Henke 2003|Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=14575968
Higgins 2008a|Chapter 8: Assessing risk of bias in included studies|
Higgins 2008b|Chapter 7: Selecting studies and collecting data|
Horwich 2002|Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure|/resolve/reference/PMED?id=12039491
Johnson 2007|Erythropoiesis-stimulating agent hyporesponsiveness|
Kim 1999|Hemodynamic characteristics during treadmill and bicycle exercise in chronic heart failure: mechanism for different responses of peak oxygen uptake|/resolve/reference/PMED?id=10614842
Klapholz 2008|Pooled safety analysis of darbepoetin alfa in the treatment of symptomatic heart failure|
Kosiborod 2008|The relationship between anemia, change in hematocrit over time and change in health status in patients with heart failure after myocardial infarction|/resolve/reference/PMED?id=18226770
Laupacis 1991|The use of generic and specific quality-of-life measures in hemodialysis-patients treated with erythropoietin|
Levin 1999|Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin|/resolve/reference/PMED?id=10401026
Levine 1990|Elevated circulating levels of tumor necrosis factor in severe chronic heart failure|/resolve/reference/PMED?id=2195340
MacMahon 1997|Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease|
Maiese 2005|New avenues of exploration for erythropoietin|/resolve/reference/PMED?id=15632341
Mantel 1959|Statistical aspects of the analysis of data from retrospective studies of disease|/resolve/reference/PMED?id=13655060
Mayer 1988|Working capacity is increased following recombinant human erythropoietin treatment|/resolve/reference/PMED?id=3199672
McMahon 1992|Hemodynamic-changes and physical performance at comparative levels of hemoglobin after long-term treatment with recombinant erythropoietin|/resolve/reference/PMED?id=1337160
Metivier 2000|Pathophysiology of anaemia: focus on the heart and blood vessels|
Mitchell 2007|Emerging Role of Anemia in Heart Failure|
NKF 2006|KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease|
Okonko 2004|Anemia in chronic heart failure: pathogenetic mechanisms|/resolve/reference/PMED?id=15007793
Okonko 2008|Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial|/resolve/reference/PMED?id=18191732
Packer 2002|Effect of carvedilol on the morbidity of patients with severe chronic heart failure. Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study|/resolve/reference/PMED?id=12390947
Page 1994|Comparison of treadmill and bicycle exercise in patients with chronic heart failure|/resolve/reference/PMED?id=7924466
Parsa 2004|Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts|/resolve/reference/PMED?id=15020586
Peeters 1996|Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial|/resolve/reference/PMED?id=8984939
Pfeffer 2009|A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease|
Phrommintikul 2007|Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis|
Rector 1987|Patients self-assessment of their congestive heart failure: content, reliability, and validity of a new measure: the Minnesota Living with Heart Failure Questionnaire|
Redelmeier 1997|Interpreting small differences in functional status: The six minute walk test in chronic lung disease patients|/resolve/reference/PMED?id=9105067
Rosamond 2008|Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee|/resolve/reference/PMED?id=18086926
Ross 2003|The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review|/resolve/reference/PMED?id=12860499
Shord 2008|Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia|/resolve/reference/PMED?id=18337436
Smrzova 2005|Inflammation and resistance to erythropoiesis-stimulating agents - what do we know and what needs to be clarified?|
Spertus 2005|Monitoring clinical changes in patients with heart failure: A comparison of methods|/resolve/reference/PMED?id=16209970
Tang 2006|Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options|/resolve/reference/PMED?id=16717164
Taylor 1992|Prothrombotic effect of erythropoietin in dialysis patients|
Terrin 2005|In an empirical evaluation of the funnel plot, researcherscould not visually identify publication bias|/resolve/reference/PMED?id=16085192
Tin 2006|Relationship between anaemia and quality of life in patients with heart failure|
Toblli 2007|Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency|/resolve/reference/PMED?id=17950147
van der Meer 2008|Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients|/resolve/reference/PMED?id=18495690
van der Meer 2009|Erythropoietin treatment in patients with chronic heart failure: a meta-analysis|/resolve/reference/PMED?id=19168472
Weiss 2005|Anemia of Chronic Disease|/resolve/reference/PMED?id=15758012
Westenbrink 2007|Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization|/resolve/reference/PMED?id=17576662
CDP870-004 2001 {published and unpublished data}|Assesment report for Cimzia. Procedure No EMEA/H/C/001037|
CDP870-004 2001 {published and unpublished data}|CDP870, A novel pegylated, humanized TNF-alpha inhibitor, is effective in treating the signs and symptoms of rheumatoid arthritis (RA)|
CDP870-014 2009 {unpublished data only}|Clinical Study Summary Study No.: CDP870-014|
Choy 2002 {published data only}|Efficacy of a novel pegylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial|/resolve/reference/PMED?id=12364632
FAST4WARD 2005 {published data only}|Efficacy and safety of certolizumab pegol monotherapy in patients with rheumatoid arthritis failing previous DMARD therapy|
FAST4WARD 2005 {published data only}|Certolizumab pegol monotherapy 400mg every 4 weeks improves physical functioning and reduces pain in patients with rheumatoid arthritis Who have previously failed DMARD therapy|
FAST4WARD 2005 {published data only}|Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease modifying antirheumatic therapy: the FAST4WARDstudy|/resolve/reference/PMED?id=19015206
FAST4WARD 2005 {published data only}|Certolizumab pegol 400 mg every 4 weeks as monotherapy rapidly reduces disease activity in active rheumatoid arthritis|
FAST4WARD 2005 {published data only}|Certolizumab pegol monotherapy improves productivity in patients with active rheumatoid arthritis: results from a phase III randomized controlled trial|
FAST4WARD 2005 {published data only}|Certolizumab pegol monotherapy 400mg every 4 weeks improves health-related quality of life and relieves fatigue in patients with rheumatoid arthritis who have previously failed DMARD therapy|
RAPID1 2005 {published data only}|Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study|
RAPID1 2005 {published data only}|The anti-TNF certolizumab pegol in combination with methotrexate is significantly more effective than methotrexate alone in the treatment of patients with active rheumatoid arthritis: 1-year results from the RAPID 1 study|
RAPID1 2005 {published data only}|Certolizumab pegol results in clinically meaningful improvements in physical function and health-related quality of life in patients with active rheumatoid arthritis despite treatment with methotrexate|
RAPID1 2005 {published data only}|Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial|
RAPID1 2005 {published data only}|Preliminary results suggest certolizumab pegol plus methotrexate is effective in reducing signs and symptoms of rheumatoid arthritis in patients refractory to methotrexate. Results from the RAPID 1 Study. Abstract number: OPO016|
RAPID1 2005 {published data only}|Inhibition of Radiographic Progression by Lyophilized certolizumab Pegol Added to Methotrexate in Comparison with Methotrexate Alone in Patients with Rheumatoid Arthritis: The RAPID 1 Trial|
RAPID1 2005 {published data only}|Inhibition of Radiographic Progression by Lyophilized certolizumab Pegol Added to Methotrexate in Comparison with Methotrexate Alone in Patients with Rheumatoid Arthritis: The RAPID 1 Trial|
RAPID1 2005 {published data only}|Inhibition of progression of structural damage by week 16 with certolizumab pegol: Results from the RAPID trials|
RAPID2 2007 {published data only}|Liquid formulation certolizumab pegol with methotrexate decreases progression of structural joint damage in rheumatoid arthritis patients: the RAPID 2 study|
RAPID2 2007 {published data only}|Efficacy and rapid response of certolizumab pegol liquid formulation in combination with methotrexate (MTX) in patients with active rheumatoid arthritis despite MTX therapy: results from the RAPID 2 study.|
RAPID2 2007 {published data only}|certolizumab pegol added onto methotrexate improves physical functioning and reduces pain in patients with rheumatoid arthritis who have an incomplete response to methotrexate: data from rapid 2|
RAPID2 2007 {published data only}|Efficacy and safety of certolizumab pegol in combination with methotrexate (mtx) in patients with active rheumatoid arthritis despite mtx therapy: results from the rapid 2 study|
RAPID2 2007 {published data only}|Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial|/resolve/reference/PMED?id=19015207
RAPID2 2007 {published data only}|Certolizumab pegol results in clinically meaningful improvements in physical function and health-related quality of life in patients with active rheumatoid arthritis despite treatment with methotrexate|
Andreakos 2003 {published data only}|Targeting cytokines in autoimmunity: New approaches, new promise|/resolve/reference/PMED?id=12783612
Anonymous 2003 {published data only}|CDP 571: anti-TNF monoclonal antibody, BAY 103356, BAY W 3356, Humicade|/resolve/reference/PMED?id=12757404
Bain 2003 {published data only}|Adalimumab|/resolve/reference/PMED?id=12953696
Bansback 2005 {published data only}|A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritis|/resolve/reference/PMED?id=19807580
Barnes 2007 {published data only}|Targeting nanomedicines in the treatment of rheumatoid arthritis: Focus on certolizumab pegol|/resolve/reference/PMED?id=17722505
Baugh 2001 {published data only}|Mechanisms for modulating TNF in immune and inflammatory disease|/resolve/reference/PMED?id=12825458
Bayes M 2006 {published data only}|Gateways to clinical trials|/resolve/reference/PMED?id=17235418
Chang 2006 {published data only (unpublished sought but not used)}|Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease|/resolve/reference/PMED?id=16582964
Chikanza 2000a {published data only}|The influence of the hormonal system on pediatric rheumatic diseases|/resolve/reference/PMED?id=11084951
Chikanza 2000b {published data only}|Reciprocal interactions between the neuroendocrine and immune systems during inflammation|/resolve/reference/PMED?id=11084940
Evans 2003 {published data only}|Anti-Arthritic Agents - SMi Conference: Trapping cytokines 28-29 April 2003, London, UK|/resolve/reference/PMED?id=12861982
Fanet-Goguet 2004 {published data only}|Focus on biological agents in rheumatoid arthritis: Newer treatments and therapeutic strategies|/resolve/reference/PMED?id=15559549
Fleischmann 2005 {published data only}|Is there a need for new therapies for rheumatoid arthritis?|
Gabay 2002 {published data only}|Cytokine inhibitors in the treatment of rheumatoid arthritis|/resolve/reference/PMED?id=11849114
Garber 2005 {published data only}|First-in-class biologic to enter rheumatoid arthritis fray|/resolve/reference/PMED?id=16273043
Genovese 2005 {published data only}|Biologic therapies in clinical development for the treatment of rheumatoid arthritis|
Goldblatt 2005 {published data only}|New therapies for rheumatoid arthritis|
Graninger 2002 {published data only}|Treatment of rheumatoid arthritis by TNF-blocking agents|/resolve/reference/PMED?id=11893849
Kathmann 2005 {published data only}|Early and aggressive treatment of rheumatoid arthritis|
Kaushik 2005 {published data only}|CDP-870 (certolizumab) in rheumatoid arthritis|/resolve/reference/PMED?id=15934837
Kavanaugh A {published data only}|Effect of certolizumab pegol with methotrexate on home and work place.Productivity and social activities in patients with active rheumatoidarthritis|
Kochbati 2004 {published data only}|The TNF alfa in the treatment of rheumatoid arthritis|/resolve/reference/PMED?id=15686185
Mealy 2005 {published data only}|Treatment of gastrointestinal disorders: certolizumab pegol|
Mok 2004 {published data only}|Therapeutic advances in rheumatoid arthritis|
Mount 2005 {published data only}|Rheumatoid arthritis market|/resolve/reference/PMED?id=15690597
Osbourn 2003 {published data only}|Current methods for the generation of human antibodies for the treatment of autoimmune diseases|/resolve/reference/PMED?id=12963321
Paleolog 2003 {published data only}|The therapeutic potential of TNF- blockade in rheumatoid arthritis|/resolve/reference/PMED?id=12831345
Pearce 2001 {published data only}|Targeting tumour necrosis factor in the treatment of rheumatoid arthritis|/resolve/reference/PMED?id=11437680
Rose-John 2003 {published data only}|CDP-870. Celltech/Pfizer|/resolve/reference/PMED?id=12833654
Russo 2005 {published data only}|TNF- as a promising therapeutic target in chronic asthma: A lesson from rheumatoid arthritis|/resolve/reference/PMED?id=16033328
Sandborn 2003 {published data only}|Strategies for targeting tumour necrosis factor in IBD|/resolve/reference/PMED?id=12617886
Schreiber {published data only}|Maintenance therapy with certolizumab pegol for Crohn's disease|/resolve/reference/PMED?id=17634459
Sorbera 2005 {published data only}|Certolizumab pegol: Treatment of rheumatoid arthritis treatment of Crohn's disease human anti-TNF-(alpha) monoclonal antibody|
Takeuchi 2005 {published data only}|Anti-TNF biological agents in rheumatoid arthritis and other inflammatory diseases|
Taylor 2003 {published data only}|Anti-cytokines and cytokines in the treatment of rheumatoid arthritis|/resolve/reference/PMED?id=12769749
Taylor 2003a {published data only}|Anti-TNF therapy for rheumatoid arthritis: An update|/resolve/reference/PMED?id=12583612
Toussirot 2004 {published data only}|The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview|/resolve/reference/PMED?id=15013927
Toussirot 2007 {published data only}|The use of TNF-alpha blocking agents in rheumatoid arthritis: an update|/resolve/reference/PMED?id=17714062
Zwerina 2005 {published data only}|Pathogenesis of rheumatoid arthritis: Targeting cytokines|
NCT00160602 {published data only}|A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis|
NCT00160641 {published data only}|A Phase III Multi-center, Open-label, Follow-up Study, to Assess the Efficacy and Safety of Liquid Certolizumab Pegol (CDP870) as Additional Medication to Methotrexate, in the Treatment of Signs and Symptoms and in the Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis Who Participated in Study CDP870-050|
NCT00160693 {published data only}|Open Label Long-Term Safety Study of CDP870 (Certolizumab Pegol) for Patients With Rheumatoid Arthritis|
NCT00175877 {published data only}|A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis|
NCT00580840 {published data only}|Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)|
NCT00674362 {published data only}|Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study|
NCT00717236 {published data only}|Certolizumab Pegol for the Treatment of Patients With Active RA (Realistic)|
NCT00753454 {published data only}|Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) (Dose Flex II)|
NCT00791999 {published data only}|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Pharmacokinetics and Safety of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Active Rheumatoid Arthritis (RA) Patients Who Have an Incomplete Response to MTX.|
NCT00843778 {published data only}|Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (CERTAIN 2)|
NCT00850343 {published data only}|Long-term Treatment Study of CDP870 Without Coadministration of MTX in Japanese Rheumatoid Arthritis (RA) Patients|
NCT00851318 {published data only}|Long-term Treatment Study of CDP870 as Add-on Medication to MTX in Japanese Rheumatoid Arthritis (RA) Patients|
NCT00993317 {published data only}|A Phase III Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, 24-week Study to Assess the Efficacy and Safety of Certolizumab Pegol as Additional Medication to MTX in Patients With Active Rheumatoid Arthritis Who Have an Incomplete Response to Methotrexate|
NCT00993668 {published data only}|The Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis to Assess the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines|
Arnett 1988|The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis|
Barton 2009|Genetic susceptibility to rheumatoid arthritis: an emerging picture|
Blumenauer 2002|Infliximab for the treatment of rheumatoid arthritis|
Blumenauer 2003|Etanercept for the treatment of rheumatoid arthritis|
Boissel 1999|[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use]|/resolve/reference/PMED?id=10667106
Bongartz 2006|Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials|/resolve/reference/PMED?id=16705109
Brennan 2008|Evidence that cytokines play a role in rheumatoid arthritis|/resolve/reference/PMED?id=18982160
Carmona 2002|The prevalence of rheumatoid arthritis in the general population of Spain|/resolve/reference/PMED?id=11792885
Chen 2006|A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness|
Choy 2002|Efficacy of a novel pegylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial|/resolve/reference/PMED?id=12364632
Deeks 2008|Chapter 9: Analysing data and undertaking meta-analyses|
Doeglas 1995|Work disability in early rheumatoid arthritis|/resolve/reference/PMED?id=7632086
Doran 2002|Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period|
Edwards 2005|Early environmental factors and rheumatoid arthritis|
EMEA 2009|Assesment report for Cimzia. Procedure No EMEA/H/C/001037|
Glanville 2006|How to identify randomized controlled trials in MEDLINE: ten years on|/resolve/reference/PMED?id=16636704
Golder (a) 2006|Centre for Reviews and Dissemination and UK Cochrane Centre Search Filters Design Group. Developing efficient search strategies to identify reports of adverse effects in MEDLINE and EMBASE|
Golder (b) 2006|Room for improvement? A survey of the methods used in systematic reviews of adverse effects|
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008|
Laird 1990|Estimating rates of change in randomized clinical trials|/resolve/reference/PMED?id=1963133
Landewe 2003|The benefits of early treatment in rheumatoid arthritis: Confounding by indication and the issue of timing|
Laupacis 1988|An assessment of clinically useful measures of the consequences of treatment|/resolve/reference/PMED?id=3374545
Lopez-Olivo 2008|Rituximab for rheumatoid arthritis|
Maxwell L 2008|Abatacept for rheumatoid arthritis|
Meune 2009|Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies|/resolve/reference/PMED?id=19696061
Navarro Sarabia 2005|Adalimumab for treating rheumatoid arthritis|
NICE 2009|Certolizumab pegol (CIMZIA) for the treatment of rheumatoid arthritis. Single technology appraisal (STA) manufacturer submission to NICE|
Schulz 1993||
Singh 2010|Golimumab for rheumatoid arthritis|/resolve/reference/PMED?id=19455095
Thompson 1999|Explaining heterogeneity in meta-analysis: a comparison of methods|
WHO 2009|WHO country data: estimated burden of TB|
Wong (a) 2006|Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE|/resolve/reference/PMED?id=16404468
Wong (b) 2006|Optimal CINAHL search strategies for identifying therapy studies and review articles|
Young 2000|How does functional disability in early rheumatoid arthritis affect patients and their lives? Results of 5 years of follow-up in 732 patients from the early RA study (ERAS)|/resolve/reference/PMED?id=10888704
Young 2007|Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis|/resolve/reference/PMED?id=16908509
Yusuf 1991|Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials|/resolve/reference/PMED?id=2046134
Ahlner-Elmqvist 2008 {published data only}|Characteristics and quality of life of patients who choose home care at the end of life|/resolve/reference/PMED?id=18400462
Ahlner-Elmqvist 2008 {published data only}|Place of death: hospital-based advanced home care versus conventional care|/resolve/reference/PMED?id=15540665
Ahlner-Elmqvist 2008 {published data only}|Health-related quality of life (HRQOL) in family members of cancer victims: results from a longitudinal intervention study in Norway and Sweden|/resolve/reference/PMED?id=15046407
Aiken 2006 {published data only}|Outcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill|/resolve/reference/PMED?id=16430351
Aiken 2006 {published data only}|The PhoenixCare program|/resolve/reference/PMED?id=14733694
Axelsson 1998 {published data only}|Evaluation of a hospital-based palliative support service with particular regard to financial outcome measures|/resolve/reference/PMED?id=9616458
Bakitas 2009 {published and unpublished data}|The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions|
Bakitas 2009 {published and unpublished data}|Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial|
Bakitas 2009 {published and unpublished data}|Impact on caregiver burden of a patient-focused palliative care intervention for patients with advanced cancer|
Brumley 2007 {published and unpublished data}|Findings from a multisite in-home palliative care study|
Brumley 2007 {published and unpublished data}|Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care|
Brumley 2007 {published and unpublished data}|In-home palliative care increased patient satisfaction and reduced use and costs of medical services: commentary|
Buckingham 1978 {published data only}|A guide to evaluation research in terminal care programs|
Gmez-Batiste 2010 {published data only}|Specialist palliative care home care support teams in Spain|
Gmez-Batiste 2010 {published data only}|Effectiveness of palliative care services in symptom control of patients with advanced terminal cancer: a Spanish, multicenter, prospective, quasi-experimental, prepost study|
Gmez-Batiste 2010 {published data only}|Symptom control effectiveness in advanced cancer patients by Spanish palliative care team: national-wide study|
Grande 1999 {published and unpublished data}|Caregiver bereavement outcome: relationship with hospice at home, satisfaction with care, and home death|/resolve/reference/PMED?id=15332470
Grande 1999 {published and unpublished data}|A randomized controlled trial of a hospital at home service for the terminally ill|/resolve/reference/PMED?id=11064784
Grande 1999 {published and unpublished data}|Does hospital at home for palliative care facilitate home death? A randomised controlled trial|/resolve/reference/PMED?id=10582932
Greer 1986 {published data only}|Two models of caregiver strain and bereavement adjustment: a comparison of husband and daughter caregivers of breast cancer hospice patients|/resolve/reference/PMED?id=14704380
Greer 1986 {published data only}|What does hospice cost?|/resolve/reference/PMED?id=6377932
Greer 1986 {published data only}|Analgesic use in terminal cancer patients: report from the National Hospice Study|/resolve/reference/PMED?id=2418049
Greer 1986 {published data only}|An overview of National Hospice Study findings|
Greer 1986 {published data only}|An alternative in terminal care: results of the National Hospice Study|
Greer 1986 {published data only}|Assessing patient outcomes in hospice: what to measure?|/resolve/reference/PMED?id=3643873
Greer 1986 {published data only}|Hospice: the older person as patient and caregiver|
Greer 1986 {published data only}|Determinants of site of death among hospice cancer patients|/resolve/reference/PMED?id=6668416
Greer 1986 {published data only}|The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting|
Greer 1986 {published data only}|A comparison of hospice vs conventional care of the terminally ill cancer patient|/resolve/reference/PMED?id=1697185
Greer 1986 {published data only}|The effect of treatment setting and patient characteristics on pain in terminal cancer patients: a report from the National Hospice Study|/resolve/reference/PMED?id=2418048
Greer 1986 {published data only}|Terminal care preferences: hospice placement and severity of disease|/resolve/reference/PMED?id=3112858
Greer 1986 {published data only}|Dyspnea in terminally ill cancer patients|
Greer 1986 {published data only}|Clinical symptoms and length of survival in patients with terminal cancer|/resolve/reference/PMED?id=3382303
Greer 1986 {published data only}|Comparing the quality of death for hospice and non-hospice cancer patients|/resolve/reference/PMED?id=3339915
Harding 2004 {published data only}|Evaluation of a short-term group intervention for informal carers of patients attending a home palliative care service|/resolve/reference/PMED?id=15120768
Harding 2004 {published data only}|A multi-professional short-term group intervention for informal caregivers of patients using a home palliative care service|/resolve/reference/PMED?id=12611318
Higginson 2009 {published and unpublished data}|Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service|
Higginson 2009 {published and unpublished data}|Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review|/resolve/reference/PMED?id=15584496
Higginson 2009 {published and unpublished data}|Randomised controlled trial of a new palliative care service: compliance, recruitment and completeness of follow-up|/resolve/reference/PMED?id=18507817
Higginson 2009 {published and unpublished data}|Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial|
Higginson 2009 {published and unpublished data}|Study protocol: delayed intervention randomised controlled trial within the Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service|/resolve/reference/PMED?id=17014714
Hudson 2005 {published data only}|A psycho-educational intervention for family caregivers of patients receiving palliative care: a randomized controlled trial|/resolve/reference/PMED?id=16256897
Hughes 1992 {published data only}|Cost-effectiveness of Veterans Administration hospital-based home care. A randomized clinical trial|/resolve/reference/PMED?id=2112906
Hughes 1992 {published data only}|A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill|/resolve/reference/PMED?id=1737710
Jordhy 2000 {published data only}|Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients|
Jordhy 2000 {published data only}|Quality of life in palliative cancer care: results from a cluster randomized trial|/resolve/reference/PMED?id=11559726
Jordhy 2000 {published data only}|Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics|/resolve/reference/PMED?id=11720432
Jordhy 2000 {published data only}|A palliative-care intervention and death at home: a cluster randomised trial|/resolve/reference/PMED?id=11036893
Jordhy 2000 {published data only}|Lack of concealment may lead to selection bias in cluster randomized trials of palliative care|/resolve/reference/PMED?id=11963450
Jordhy 2000 {published data only}|Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial|/resolve/reference/PMED?id=10659099
Jordhy 2000 {published data only}|Quality of life, medical and sociodemographic characteristics|/resolve/reference/PMED?id=12882262
Jordhy 2000 {published data only}|Family satisfaction with end-of-life care for cancer patients in a cluster randomized trial|/resolve/reference/PMED?id=12183095
Jordhy 2000 {published data only}|Measuring quality of palliative care: psychometric properties of the FAMCARE scale|/resolve/reference/PMED?id=12639063
Jordhy 2000 {published data only}|Factors affecting grief reactions in close family members to individuals who have died of cancer|/resolve/reference/PMED?id=11738164
Jordhy 2000 {published data only}|The first year of grief and bereavement in close family members to individuals who have died of cancer|/resolve/reference/PMED?id=11301674
Jordhy 2000 {published data only}|Health-related quality of life (HRQOL) in family members of cancer victims: results from a longitudinal intervention study in Norway and Sweden|/resolve/reference/PMED?id=15046407
Jordhy 2000 {published data only}|Does social support from family and friends work as a buffer against reactions to stressful life events such as terminal cancer?|/resolve/reference/PMED?id=17461372
Jordhy 2000 {published data only}|Does social support work as a buffer against reactions to external stressful life events such as terminal cancer?|
McCorkle 1989 {published data only}|A randomized clinical trial of home nursing care for lung cancer patients|
McCorkle 1989 {published data only}|The effects of home nursing care for patients during terminal illness on the bereaved's psychological distress|
McKegney 1981 {published data only}|The cost and quality of dying: a comparison of home and hospital|
McKegney 1981 {published data only}|Prediction and management of pain in patients with advanced cancer|/resolve/reference/PMED?id=6166512
McKegney 1981 {published data only}|Controlled study of home care by nurse-practitioners in patients with advanced cancer|
McKegney 1981 {published data only}|Evaluation of patients with advanced cancer using the Karnofsky performance status|
McKegney 1981 {published data only}|Intensive rehabilitative support of the patient with advanced cancer through home health care|
McMillan 2007 {published data only}|Hospice patient and caregiver congruence in reporting patients' symptom intensity|/resolve/reference/PMED?id=12660560
McMillan 2007 {published data only}|Symptom distress and quality of life in patients with cancer newly admitted to hospice home care|
McMillan 2007 {published data only}|Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial|/resolve/reference/PMED?id=17573295
McMillan 2007 {published data only}|Impact of coping skills intervention with family caregivers of hospice patients with cancer: a randomized clinical trial|
McMillan 2007 {published data only}|Methodologic issues in collecting data from debilitated patients with cancer near the end of life|
McWhinney 1994 {published data only}|Evaluation of a palliative care service: problems and pitfalls|/resolve/reference/PMED?id=7532501
Rabow 2004 {published data only}|The Comprehensive Care Team: a controlled trial of outpatient palliative medicine consultation|/resolve/reference/PMED?id=14718327
Rabow 2004 {published data only}|The Comprehensive Care Team: a description of a controlled trial of care at the beginning of the end of life|
Rabow 2004 {published data only}|Patient perceptions of an outpatient palliative care intervention: "it had been on my mind before, but I did not know how to start talking about death"|
Tramarin 1992 {published data only}|An economic evaluation of home-care assistance for AIDS patients: a pilot study in a town in northern Italy|/resolve/reference/PMED?id=1472342
Walsh 2007 {published data only}|Reducing emotional distress in people caring for patients receiving specialist palliative care. Randomised trial|/resolve/reference/PMED?id=17267931
Ward 1987 {published data only}|Home care services - an alternative to hospices?|/resolve/reference/PMED?id=3581764
Zimmer 1985 {published data only}|Development of scales to measure satisfaction and preferences regarding long-term and terminal care|/resolve/reference/PMED?id=6425580
Zimmer 1985 {published data only}|A randomized controlled study of a home health care team|/resolve/reference/PMED?id=3966617
Zimmer 1985 {published data only}|Effects of a physician-led home care team on terminal care|/resolve/reference/PMED?id=6707409
Addington-Hall 1992 {published data only}|Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?|/resolve/reference/PMED?id=2223593
Addington-Hall 1992 {published data only}|Randomised controlled trial of effects of coordinating care for terminally ill cancer patients|/resolve/reference/PMED?id=1483075
Addington-Hall 1992 {published data only}|Dying from cancer: the views of bereaved family and friends about the experiences of terminally ill patients|
Addington-Hall 1992 {published data only}|Acceptability and perceived effectiveness of a district co-ordinating service for terminal care: implications for quality assurance|
Addington-Hall 1992 {published data only}|A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients|/resolve/reference/PMED?id=8800823
Brumley 2003 {published data only}|Future of end-of-life care: the managed care organization perspective|/resolve/reference/PMED?id=12006228
Brumley 2003 {published data only}|Effectiveness of a Home-Based Palliative Care Program for End-of-Life|/resolve/reference/PMED?id=14622451
Feldman 2011 {published and unpublished data}|Establishing an Advanced Illness Management (AIM) model in a community-based setting: innovation at the Visiting Nurse Service of New York (as supplied 14 April 2011)|
Feldman 2011 {published and unpublished data}|Visiting Nurse Service of New York|
Hebert 2006 {published data only}|Potential and readiness for video-visits in rural palliative homecare: results of a multi-method study in Canada|
Hebert 2006 {published data only}|Effectiveness of video-visits in palliative home care: preliminary findings of a RCT in the community|
Hebert 2006 {published data only}|Successes and challenges in a field-based, multi-method study of home telehealth|/resolve/reference/PMED?id=15603606
Hebert 2006 {published data only}|Palliative care|
Kane 1984 {published data only}|Hospice effectiveness in controlling pain|/resolve/reference/PMED?id=3886943
Kane 1984 {published data only}|The role of hospice in reducing the impact of bereavement|/resolve/reference/PMED?id=3734027
Kane 1984 {published data only}|Hospice role in alleviating the emotional stress of terminal patients and their families|/resolve/reference/PMED?id=3884916
Kane 1984 {published data only}|A randomised controlled trial of hospice care|/resolve/reference/PMED?id=6143195
Kane 1984 {published data only}|UCLA hospice evaluation study. Methodology and instrumentation|/resolve/reference/PMED?id=6350745
McCorkle 2000 {published data only}|Information needs of elderly postsurgical cancer patients during the transition from hospital to home|
McCorkle 2000 {published data only}|Describing an episode of home nursing care for elderly postsurgical cancer patients|
McCorkle 2000 {published data only}|Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure|/resolve/reference/PMED?id=17044764
McCorkle 2000 {published data only}|Nursing interventions for newly diagnosed older cancer patients facing terminal illness|
McCorkle 2000 {published data only}|A specialized home care intervention improves survival among older post-surgical cancer patients|/resolve/reference/PMED?id=11129765
McCorkle 2000 {published data only}|In older patients with late stage cancer, specialised home care by nurses improved survival after surgery|
Morita 2012 {published data only}|A region-based palliative care intervention trial using the mixed-method approach: Japan OPTIM study|
Morita 2012 {published data only}|Problems and potential solutions of regional palliative care: A Trial of the Multiregional and Multidisciplinary Conference in the OPTIM Study|
Morita 2012 {published data only}|Palliative care in Japan: current status and a nationwide challenge to improve palliative care by the Cancer Control Act and the Outreach Palliative Care Trial of Integrated Regional Model (OPTIM) Study|
Smeenk 1998a {published data only}|Cost analysis of transmural home care for terminal cancer patients|
Smeenk 1998a {published data only}|Transmural care. A new approach in the care for terminal cancer patients: its effects on re-hospitalization and quality of life|
Smeenk 1998a {published data only}|Effects of transmural care on coordination and continuity of care|/resolve/reference/PMED?id=10900369
Smeenk 1998a {published data only}|Transmural care of terminal cancer patients: lower re-hospitalization, and increased quality of life for patients and informal caregivers without extra health care costs|
Temel 2010 {published data only}|Early palliative care for patients with metastatic nonsmall-cell lung cancer|
Temel 2010 {published data only}|Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients|/resolve/reference/PMED?id=17557950
Temel 2010 {published data only}|Aggressiveness of care in a prospective cohort of patients with advanced NSCLC|
Hwang 2009 {published data only}|Effects of a palliative care program based on home care nursing [in Korean]|
Park 2011 {published data only}|Development and evaluation of hospice smart patient service program [in Korean]|/resolve/reference/PMED?id=15802216
Abernethy 2006 {published data only}|A pragmatic 2 x 2 x 2 factorial cluster randomized controlled trial of educational outreach visiting and case conferencing in palliative care-methodology of the Palliative Care Trial|/resolve/reference/PMED?id=16290094
Abernethy 2006 {published data only}|The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice|/resolve/reference/PMED?id=16283937
Abernethy 2006 {published data only}|Preference for place of care and place of death in palliative care: are these different questions?|/resolve/reference/PMED?id=18755830
Abernethy 2006 {published data only}|The impact of conducting a regional palliative care clinical study|/resolve/reference/PMED?id=17148528
Abernethy 2006 {published data only}|Prescribing in palliative care as death approaches|
Abernethy 2006 {published data only}|A comparison of methodologies from two longitudinal community-based randomized controlled trials of similar interventions in palliative care: what worked and what did not?|/resolve/reference/PMED?id=16351536
Abernethy 2006 {published data only}|Promoting patient centred palliative care through case conferencing|/resolve/reference/PMED?id=18043787
Allen 2012 {published and unpublished data}|The promoting effective advance care for elders (PEACE) randomized pilot study: Theoretical framework and study design|
Allen 2012 {published and unpublished data}|The peace pilot study: Convergence of geriatrics and palliative care|
Battaglia 2012 {published data only}|Home-based palliative care for people with severe MS: Development of a new intervention (#69)|
Butler 2012 {published data only}|Evaluation of a hospice rapid response community service: A controlled evaluation|
Chvetzoff 2006 {published data only}|Prospective study on the quality of care and quality of life in advanced cancer patients treated at home or in hospital:intermediate analysis of the Trapado study|/resolve/reference/PMED?id=16517418
Duursma 2011 {published data only}|Study protocol: Optimization of complex palliative care at home via telemedicine. A cluster randomized controlled trial|
Addington-Hall 2001a||
Addington-Hall 2001b|After-death interviews with surrogates/bereaved family members: some issues of validity|/resolve/reference/PMED?id=11532591
Altman 1995|Absence of evidence is not evidence of absence|/resolve/reference/PMED?id=7647644
Bell 2009|Methodological review: measured and reported congruence between preferred and actual place of death|
Beynon 2011|How common are palliative care needs among older people who die in the emergency department?|
Bradford Hill 1965|The environment or disease: association or causation?|/resolve/reference/PMED?id=14283879
Bruera 2006||
Brunetti 2003|GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence|
Choi 2005|Factors influencing preferences for place of terminal care and of death among cancer patients and their families in Korea|/resolve/reference/PMED?id=15812653
Cohen 1992|A power primer|/resolve/reference/PMED?id=19565683
Cohen 2010|Which patients with cancer die at home? A study of six European countries using death certificate data|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Downing 2010|Home-based palliative care in sub-Saharan Africa|
Drummond 1996|Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party|/resolve/reference/PMED?id=8704542
EAPC 2008|Abstracts of the 5th Research Forum of the European Association for Palliative Care (EAPC)|
EAPC 2010|Abstracts: Oral, Plenaries and Invited Lectures|
Farquhar 2009|The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease|
Ferrell 2010||
Flory 2004|Place of death: U.S. Trends since 1980|
Gao 2013|Changing patterns in place of cancer death in England: a population-based study|
Gomes 2006|Factors influencing death at home for terminally ill patients with cancer|/resolve/reference/PMED?id=16467346
Gomes 2008|Where people die (1974-2030): past trends, future projections and implications for care|/resolve/reference/PMED?id=18216075
Gomes 2009|Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers|
Gomes 2011|International trends in circumstances of death and dying among older people|
Gomes 2012a|Reversal of the British trends in place of death|
Gomes 2012b|Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain|
Gomes 2013|Heterogeneity and changes in preferences for dying at home: a systematic review|
Gonzalez-Perez 2002|Developing a scoring system to quality assess economic evaluations|
Grande 2000|Why are trials in palliative care so difficult?|/resolve/reference/PMED?id=10717728
Hanks 2009||
Harding 2003|What is the best way to help caregivers in cancer and palliative care? A systematic literature review of interventions and their effectiveness|/resolve/reference/PMED?id=12597468
Harding 2005|Palliative care in sub-Saharan Africa|/resolve/reference/PMED?id=15936427
Harding 2011|How can informal caregivers in cancer and palliative care be supported? An updated systematic literature review of interventions and their effectiveness|
Heyland 2006|What matters most in end-of-life care: perceptions of seriously ill patients and their family members|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Higginson 2000|Place of care in advanced cancer: a qualitative systematic literature review of patient preferences|/resolve/reference/PMED?id=15859670
Higginson 2003|Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?|/resolve/reference/PMED?id=12590031
Houttekier 2011|Study of recent and future trends in place of death in Belgium using death certificate data: a shift from hospitals to care homes|
Khaw 1999|How many, how old, how soon?|/resolve/reference/PMED?id=10567145
McPherson 2003|Judging the quality of care at the end of life: can proxies provide reliable information?|/resolve/reference/PMED?id=12435554
Moore 2011|Gabapentin for chronic neuropathic pain and fibromyalgia in adults|
NCPC 2012|National survey of patient activity data for specialist palliative care services. MDS full report for the year 2010-2011|
NHPCO 2012|NHPCO facts and figures: hospice care in America|
RevMan 2011|Review Manager (RevMan)|
Rinck 1997|Methodologic issues in effectiveness research on palliative cancer care: a systematic review|/resolve/reference/PMED?id=9193371
Robinson 1996|Cost-effectiveness of hospice care|/resolve/reference/PMED?id=8799358
Saunders 2000|The evolution of palliative care|/resolve/reference/PMED?id=10900362
Schulz 2010|CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials|
Shepperd 2011|Hospital at home: home-based end of life care|
Smeenk 1998b|Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital|/resolve/reference/PMED?id=9641929
Steinhauser 2000|Factors considered important at the end of life by patients, family, physicians, and other care providers|/resolve/reference/PMED?id=11074777
Tang 2002|Use of family proxies in quality of life research for cancer patients at the end of life: a literature review|/resolve/reference/PMED?id=12449742
Tarnow-Mordi 1999|Distinguishing between "no evidence of effect" and "evidence of no effect" in randomised controlled trials and other comparisons|/resolve/reference/PMED?id=10325697
Teno 2005|Measuring end-of-life care outcomes retrospectively|/resolve/reference/PMED?id=16499468
Teno 2013|Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009|
Thomas 2004|Place of death: preferences among cancer patients and their carers|/resolve/reference/PMED?id=15081195
Van Tulder 2003|Updated method guidelines for systematic reviews in the Cochrane collaboration back review group|/resolve/reference/PMED?id=12811274
Walsh 2009||
WHO 2011|Palliative Care for older people: better practices|
Wilson 2009|The rapidly changing location of death in Canada, 1994-2004|/resolve/reference/PMED?id=19342137
Zimmermann 2008|Effectiveness of specialized palliative care: a systematic review|/resolve/reference/PMED?id=18398082
Gomes 2014|Benefits and Costs of Home Palliative Care Compared With Usual Care for Patients With Advanced Illness and Their Family Caregivers|
Alonso-Ruiz 2008|Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and meta analysis of efficacy and safety|/resolve/reference/PMED?id=18419803
Arnett 1988|The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis|
Atkins 2004|Grading quality of evidence and strength of recommendations|/resolve/reference/PMED?id=15205295
Barlow 1999|Comparison of knowledge and psychological well-being between patients with a short disease duration (< or = 1 year) and patients with more established rheumatoid arthritis (> or = 10 years duration)|/resolve/reference/PMED?id=10865685
Becker 2008|Chapter 22: Overviews of Reviews|
Boers 2001|Treatment of early disease|/resolve/reference/PMED?id=11396100
Bongartz 2006|Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials|/resolve/reference/PMED?id=16705109
Bongartz 2009|Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials|/resolve/reference/PMED?id=19019889
Bradburn 2007|Much ado about nothing: A comparison of the performance of meta-analytical methods with rare events|
Brennan 2008|Evidence that cytokines play a role in rheumatoid arthritis|/resolve/reference/PMED?id=18982160
Cash 1994|Second-line drug therapy for rheumatoid arthritis|/resolve/reference/PMED?id=8152450
Cates 2009|Visual Rx NNT Calculator version 3|
Choy 2001|Cytokine pathways and joint inflammation in rheumatoid arthritis|/resolve/reference/PMED?id=11259725
Chung 2006|Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities|/resolve/reference/PMED?id=16504992
Connell 2006|New cytokine targets in inflammatory rheumatic diseases|/resolve/reference/PMED?id=16980211
Cope 2008|T cells in rheumatoid arthritis|/resolve/reference/PMED?id=19007421
Dersimonian 2007|Random-effects model for meta-analysis of clinical trials: an update|/resolve/reference/PMED?id=16807131
Donahue 2008|Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis|/resolve/reference/PMED?id=18025440
Drugs 2006|FDA Approves First Rheumatoid Arthritis Indication for Rituxan|
EMEA 2001|EMEA Public Statement on Infliximab (Remicade): Increased incidence of mortality and hospitalization for worsening Congestive Heart Failure|
EMEA 2003|EMEA public statement: Increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept)|
EMEA 2004|EPARs for authorized medicinal products for human use: Anakinra: European Public Assessment Report|
EMEA 2009a|Remicade (inflixmab)|
EMEA 2009b|EPARs for authorized medicinal products for human use: Humira: European Public Assessment Report|
FDA 1998|Etanercept Product Approval Information- Licensing Action 12/2/1998|
FDA 1999|Remicade (infliximab) for IV Injection|
FDA 2001|Kineret (anakinra) Physician packet insert: Kineret (anakinra) prescribing information|
FDA 2002|Package Insert. HUMIRA (adalimumab). Abbott Laboratories|
FDA 2005|Patient Information Sheet. Abatacept (marketed as Orencia)|
FDA 2006b|Rituxan (rituximab)|
FDA 2007|Drug details: Orencia|
FDA 2008|Humira (adalimumab): Highlights of prescribing information|
FDA 2008a|FDA: Manufacturers of TNF-blocker drugs must highlight risk of fungal infections|
FDA 2008b|Medication Guide: Enbrel (etanercept)|
FDA 2009|Remicade (infliximab) for IV Injection|
Felson 1995|American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis|
Finckh 2006|Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis|
Fleischman 2003|Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial|
Fransen 2005|The Disease Activity Score and the EULAR response criteria|/resolve/reference/PMED?id=16273792
Fries 1980|Measurement of patient outcome in arthritis|
Furst 2008|Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008|/resolve/reference/PMED?id=19022808
Gartlehner 2006|The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis|/resolve/reference/PMED?id=17225293
Genovese 2005|Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition|/resolve/reference/PMED?id=16162882
Health Canada 2006|Important Safety Information on anti-TNF Therapy: Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab) - For Health Professionals|
Health Canada 2006b|Possible association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease - For Health Professionals|
Health Canada 2009|Association of Enbrel (etanercept) with histoplasmosis and other invasive fungal infections - for health professionals|
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2008| Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008|
Keystone 2004|Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial|
Klareskog 2004|Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial|/resolve/reference/PMED?id=15001324
Kristensen 2007|The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: A systematic literature review|/resolve/reference/PMED?id=18092260
Kvien 2004|Epidemiology and burden of illness of rheumatoid arthritis|/resolve/reference/PMED?id=15157000
Kvien 2005|Quality of life in rheumatoid arthritis|/resolve/reference/PMED?id=16234180
Larsen 1977|Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films|
Lee 2001|Rheumatoid arthritis|/resolve/reference/PMED?id=11567728
Lee 2008|Meta-analysis of the combination of TNF inhibitors plus MTX compared to MTX monotherapy, and the adjusted indirect comparison of TNF inhibitors in patients suffering from active rheumatoid arthritis|/resolve/reference/PMED?id=17943257
Lipsky 2000|Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group|/resolve/reference/PMED?id=11096166
Lubeck 2004|Patient-reported outcomes and their role in the assessment of rheumatoid arthritis|/resolve/reference/PMED?id=15157002
Nixon 2007|Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis|
Odegard 2005|Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register|/resolve/reference/PMED?id=16393765
Osiri 2003|Number needed to treat (NNT): Implication in rheumatology clinical practice|/resolve/reference/PMED?id=12634229
Pincus 1983|Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire|
Pincus 2002|Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review|/resolve/reference/PMED?id=12468813
Platt 1999|Generalized linear mixed models for meta-analysis|
Prevoo 1995|Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis|
Prevoo 1996|Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score|/resolve/reference/PMED?id=8948296
Salanti 2008|Evaluation of networks of randomized trials|/resolve/reference/PMED?id=17925316
Schiff 2008|Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate|
Scott 2006|Tumor necrosis factor inhibitors for rheumatoid arthritis|/resolve/reference/PMED?id=16914706
Sharp 1971|Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities|
Shea 2007|Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews|/resolve/reference/PMED?id=17302989
Song 2003|Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses|/resolve/reference/PMED?id=12609941
Strand 2008|Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials|
Sweeting 2004|What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data|
Szekanecz 2007|Macrophages and their products in rheumatoid arthritis|/resolve/reference/PMED?id=17414958
Thompson 1999|Explaining heterogeneity in meta-analysis: a comparison of methods|
van der Heijde 1989|Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis|/resolve/reference/PMED?id=2565997
van der Heijde 1993|Development of a disease activity score based on judgment in clinical practice by rheumatologists|/resolve/reference/PMED?id=8478878
van Gestel 1996|Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria|
Wells 1993|Minimum important difference between patients with rheumatoid arthritis: the patient's perspective|/resolve/reference/PMED?id=8478873
Wells 2009|Indirect evidence: indirect treatment comparisons in meta-analysis|
Woolley 2003|The mast cell in inflammatory arthritis|/resolve/reference/PMED?id=12711748
Yelin 2007|Work disability in rheumatic diseases|/resolve/reference/PMED?id=17278920
Ang 2008 {published data only}|Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone|/resolve/reference/PMED?id=18711405
Assmus 2006 {published data only}|Transcoronary transplantation of progenitor cells after myocardial infarction|/resolve/reference/PMED?id=16990385
Assmus 2006 {published data only}|Transcoronary transplantation of progenitor cells for left ventricular dysfunction after healed myocardial infarction: a direct comparison of different cell types (TOPCARE-CHD crossover trial)|
Assmus 2006 {published data only}|Impaired microvascular function as a predictor of improvement in patients with chronic post-infarction heart failure receiving intracoronary progenitor cells - results of the TOPCARE-CHD Doppler substudy|
Assmus 2012 {published data only}|Cardiac extracorporal shock wave application to enhance the efficiency of intracoronary cell therapy in chronic heart failure - Final results of the randomized, double-blind, placebo-controlled CELLWAVE trial|
Assmus 2012 {published data only}|Cardiac extracorporal shock wave-facilitated cell therapy in patients with chronic heart failure (Cellwave trial) - mechanistic insights by magnetic resonance imaging|
Chen 2006 {published data only}|Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery|/resolve/reference/PMED?id=17090821
Erbs 2005 {published data only}|Intracoronary transplantation of circulating progenitor cells after recanalisation of chronic coronary artery occlusions: impact on coronary vasomotion and left ventricular remodelling|
Erbs 2005 {published data only}|Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study|/resolve/reference/PMED?id=16151021
Erbs 2005 {published data only}|Intracoronary infusion of blood-derived progenitor cells after recanalization of chronic coronary occlusions: long term effects on cardiac function and infarct size|
Erbs 2005 {published data only}|Effects on myocardial perfusion at 3 and 15 months in recanalized chronic total occlusions - randomized comparison of blood-derived progenitor cells and inactive serum|
Erbs 2005 {published data only}|Mechanistic insights from serial cardiac magnetic resonance imaging at 3 and 15 months after application of blood-derived progenitor cells in recanalized chronic coronary total occlusions (CTO)|
Erbs 2005 {published data only}|Cardiac magnetic resonance imaging at 3 and 15 months after application of circulating progenitor cells in recanalised chronic total occlusions|/resolve/reference/PMED?id=18584897
Hendrikx 2006 {published data only}|Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial|
Honold 2012 {published data only}|G-CSF stimulation and coronary reinfusion of mobilized circulating mononuclear proangiogenic cells in patients with chronic ischemic heart disease: Five-year results of the TOPCARE-G-CSF trial|
Hu 2011 {published data only}|Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial|
Hu 2011 {published data only}|Assessment of therapeutic effects of stem cell transplantation in heart failure patients with old myocardial infarction by magnetic resonance imaging|/resolve/reference/PMED?id=19102907
Kang 2006 {published data only}|Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colong-stimulating factor in patients with myocardial infarction|
Kang 2006 {published data only}|Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial|/resolve/reference/PMED?id=16820564
Losordo 2007 {published data only}|Randomized, double-blind, placebo-controlled trial of autologous CD34+ cell therapy for refractory angina: 2-year safety analysis|
Losordo 2007 {published data only}|Randomized, double-blind, placebo controlled pilot trial of intramyocardial autologous CD34 cell therapy for intractable angina|
Losordo 2007 {published data only}|Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial|/resolve/reference/PMED?id=17562958
Losordo 2011 {published data only}|Clinical parameters influencing cell mobilization and impact of mobilization ability on efficacy outcomes: An analysis from ACT34-CMI|
Losordo 2011 {published data only}|Phase 2 study of intramyocardial injection of autologous CD34+ cells to treat subjects with refractory chronic myocardial ischemia (CMI): Factors influencing mobilization and apheresis|
Losordo 2011 {published data only}|Autologous CD34+ cell therapy for refractory angina: 12 month results of the phase II ACT34-CMI study|
Losordo 2011 {published data only}|Intramyocardial, autologous CD34+ cell therapy for refrectory angina|
Losordo 2011 {published data only}|Cardiac biomarker elevation during stem cell mobilisation, apheresis and intramyocardial delivery is common but does not impact incidence of long-term MACE: An analysis from ACT34-CMI|
Losordo 2011 {published data only}|Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI|
Patel 2005 {published data only}|Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study|/resolve/reference/PMED?id=16308009
Perin 2011 {published data only}|FOCUS-HF: The first US randomized blinded controlled trial of transendocardial injection of bone marrow mononuclear cells in chronic severe ischemic heart failure patients|
Perin 2011 {published data only}|A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)|
Perin 2012a {published data only}|Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial|
Perin 2012a {published data only}|Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design|
Perin 2012b {published data only}|First in man transendocardial injection of autologous aldehyde dehydrogenase-bright cells in heart failure patients (FOCUS-Bright)|
Perin 2012b {published data only}|Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure|
Pokushalov 2010 {published data only}|Efficacy of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: Long term results: ACC poster contributions|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: Long-term results|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: Long-term results|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: long-term results.|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: A randomized study|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: long-term results|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: A randomized study|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study|
Pokushalov 2010 {published data only}|Cardiac resynchronization therapy and bone marrow transplantation in patients with ischemic heart failure and electro-mechanical dyssynchrony. A randomized study|
Pokushalov 2010 {published data only}|Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: A randomized study|
Tse 2007 {published data only}|Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease|
Tse 2007 {published data only}|Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial)|/resolve/reference/PMED?id=17984132
Turan 2011 {published data only}|Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease|
Turan 2011 {published data only}|Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease|
Van Ramshorst 2009 {published data only}|Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison|
Van Ramshorst 2009 {published data only}|Intramyocardial injection of bone marrow mononuclear cells in patients with chronic myocardial ischemia: An intra-patient comparison|
Van Ramshorst 2009 {published data only}|Intramyocardial bone marrow cell injection in patients with chronic myocardial ischemia: Results long term follow-up|
Van Ramshorst 2009 {published data only}|Intramyocardial bone marrow cell injection in patients with chronic myocardial ischemia: Results long term follow-up|
Van Ramshorst 2009 {published data only}|Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function|
Van Ramshorst 2009 {published data only}|Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial|/resolve/reference/PMED?id=19454638
Van Ramshorst 2009 {published data only}|Intramyocardial injection of bone marrow-derived mononuclear cells for chronic myocardial ischemia: a randomized, double-blind, placebo-controlled trial|
Van Ramshorst 2009 {published data only}|Intramyocardial autologous bone marrow cell injection in no-option patients with refractory angina pectoris and documented ischemia: A randomized, double blinded, placebo-controlled trial|
Wang 2009 {published data only}|Intracoronary transplantation with autologous bone marrow CD34+ stem cells for angina: a randomized controlled clinical analysis|
Wang 2010 {published data only}|Intracoronary autologous CD34+ stem cell therapy for intractable angina|
Yao 2008 {published data only}|Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function|/resolve/reference/PMED?id=18381377
Zhao 2008 {published data only}|Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery|/resolve/reference/PMED?id=19021989
Beeres 2006 {published data only}|Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results|/resolve/reference/PMED?id=16996834
Beeres 2007 {published data only}|Feasibility of trans-endocardial cell transplantation in chronic ischaemia|
Beeres 2007a {published data only}|Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction|/resolve/reference/PMED?id=17884369
Beeres 2007b {published data only}|Role of imaging in cardiac stem cell therapy|/resolve/reference/PMED?id=17367656
Chang 2006 {published data only}|Restoration of synchronicity of the left ventricular myocardial contraction with stem cell therapy: New insights into the therapeiutic implication of stem cell therapy in myocardial infarction|
Charwat 2010 {published data only}|Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study|
Chin 2010 {published data only}|Safety and efficacy of autologous mesenchymal stem cells for the treatment of end-stage dilated cardiomyopathy - a comparison of intracoronary and direct intramyocardial injection|
Gu 2011 {published data only}|Repeated intracoronary infusion of peripheral blood stem cells with G-CSF in patients with refractory ischemic heart failure--a pilot study|
Haack-Sorensen 2013 {published data only}|Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up|
Kakuchaya 2010 {published data only}|Influence of bone-marrow derived progenitor stem cells on cardiac remodelling in a placebo-controlled clinical trial involving patients with congestive heart failure|
Kang 2006b {published data only}|Six months follow up results of "granulocytes-colony stimulating factor" based stem cell therapy in patients with myocardial infarction: MAGIC cell randomized controlled trial|
Lai 2009 {published data only}|Randomized controlled trial on the cario protective effect of bone marrow cells in patients undergoing coronary artery bypass graft surgery|
Lai 2009 {published data only}|Randomized controlled trial on the cardioprotective effect of bone marrow cells in patients undergoing coronary bypass graft surgery|
Maureira 2012 {published data only}|Residual viability is a predictor of the perfusion enhancement obtained with the cell therapy of chronic myocardial infarction: a pilot multimodal imaging study|
Perin 2003 {published data only}|Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure|/resolve/reference/PMED?id=12707230
Perin 2003 {published data only}|Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy|/resolve/reference/PMED?id=15364865
Peruga 2009 {published data only}|Intracoronary administration of stem cells in patients with acute myocardial infarction - angiographic follow-up|/resolve/reference/PMED?id=19521932
Pokushalov 2011 {published data only}|Cardiac resynchronization therapy and bone marrow cell transplantation in patients with ischemic heart failure and electromechanical dyssynchrony: a randomized pilot study|
Pokushalov 2011 {published data only}|Cardiac resynchronization therapy in patients with ischemic heart failure after bone marrow cell transplantation|
Rivas-Plata 2010 {published data only}|Bypass grafts and cell transplant in heart failure with low ejection fraction|
Stamm 2007a {published data only}|Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies|/resolve/reference/PMED?id=17320570
Tuma 2011 {published data only}|Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina|
Vicario 2004 {published data only}|One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina|
Vicario 2004 {published data only}|Transcoronary sinus administration of autologous bone marrow in patients with chronic refractory stable angina Phase 1|
Wang 2006 {published data only}|[Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with anterior myocardial infarction]|/resolve/reference/PMED?id=16626572
Bartunek 2012 {published data only}|Cardiopoietic stem cell therapy in heart failure: The multicenter randomized c-cure trial|
Bartunek 2012 {published data only}|Cardiopoietic mesenchymal stem cells for treatment of ischemic cardiomyopathy: First-in-man phase II multicentre clinical trial|
Bartunek 2012 {published data only}|C-cure multicenter trial: Lineage specified bone marrow derived cardiopoietic mesenchymal stem cells for treatment of ischemic cardiomyopathy|
Cuzzola 2007 {published data only}|Progenitor cell trafficking in patients with infarcted myocardium undergoing autologous bone marrow mononuclear cell injection. Interim analysis of a double blind randomised phase II clinical trial|
Jimenez-Quevedo 2011 {published data only}|Selected CD133+ endothelial progenitor cells to create angiogenesis in no-option patients: The design of the PROGENITOR randomized trial|
Jimenez-Quevedo 2011 {published data only}|Selected CD133+ endothelial progenitor cells to create angiogenesis in no-option patients: Preliminary 3-months results of the progenitor trial|
Jimenez-Quevedo 2011 {published data only}|Selected CD133+ endothelial progenitor cells to create angiogenesis in no-option patients: Preliminary results of safety and feasibility|
Kakuchaya 2011 {published data only}|Accurate design of randomized placebo-controlled clinical trials for assessment of stem cell effects on cardiac regeneration|
Minjie 2011 {published data only}|Effects of autologous bone marrow mononuclear cells transplantation through coronary artery bypass grafting in patients with old myocardial infarction assessed by MRI: A randomised, double-blind, placebo-controlled pilot trial|
Nasseri 2012 {published data only}|Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischemic myocardium: Results of the CARDIO133 trial|
Nasseri 2012 {published data only}|Improved regional contractile function and reduced scar size after clinical cell therapy with CD133-positive cells|
Shihong 2012 {published data only}|Intracoronary autologous CD34+ stem cell therapy for intractable angina|
Tuma 2010 {published data only}|Long term benefit of autologous bone marrow transplantation by retrograde technique in terminal heart failure (LIBERTY study)|
Zverev 2006 {published data only}|Improvement of cardiomyocyte function after transplantation of autologous bone marrow mesenchymal stem cells in patients with non-acute ischemic heart disease|
ACTRN12611000219987 {published data only}|A study of the effect of direct endomyocardial injection of autologous bone marrow cells on left ventricular ejection function in patients with "end-stage" ischaemic heart failure|
EUCTR2009-016364-36-NL {published data only}|Injection of autologous bone marrow cells into damaged myocardium of no-option patients with ischemic heart failure: a randomized placebo controlled trail. - Cell therapy for ischemic heart failure|
EUCTR2011_001117-13-GB {published data only}|Research study aiming at investigating the potential effectiveness and safety of a treatment for chronic advanced heart failure of ischemic origin. The treatment is based on patient own stem cells that will be collected and guided to the cardiac cells lineage before being injected into the heart muscle|
ISRCTN71717097 {published data only}|Bone-marrow derived stem cell transplantation in patients undergoing left ventricular restoration surgery for dilated ischaemic end-stage heart failure: a randomised blinded controlled trial (TransACT 2)|
ISRCTN75217135 {published data only}|A pilot study to evaluate the efficacy of combined transplantation of progenitor cells and coronary artery bypass grafting (TOPCABG) N/A|
NCT00285454 {published data only}|Cell repair in heart failure|
NCT00362388 {published data only}|Multicenter randomized trial of cell therapy in cardiopathies - MiHeart study|/resolve/reference/PMED?id=17233910
NCT00418418 {published data only}|Combined CABG and stem-cell transplantation for heart failure|
NCT00644410 {published data only}|Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)|
NCT00690209 {published data only}|By pass surgery with stem cell therapy in chronic ischemic cardiopathy|
NCT00747708 {published data only}|Head-to-head comparison of different delivery methods of autologous bone marrow progenitor cells in chronic ischaemic heart failure|
NCT00747708 {published data only}|Ejection fraction and NYHA class in heart failure in the REGENERATE-IHD stem cell study: A comparison between the intramyocardial intracoronary arms|
NCT00747708 {published data only}|Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial|/resolve/reference/PMED?id=19105621
NCT00768066 {published data only}|Rational and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy|
NCT00790764 {published data only}|Phase II combination stem cell therapy for the treatment of severe coronary ischemia (CI)|
NCT00820586 {published data only}|Intramyocardial delivery of autologous bone marrow|
NCT00950274 {published data only}|Validating intramyocardial bone marrow stem cell therapy in combination with coronary artry bypass grafting, the PERFECT Phase III randomized multicentre trial: study protocol for a randomized controlled trial|
NCT01033617 {published data only}|IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG|
NCT01074099 {published data only}|Feasibility study of BMAC enhanced CABG|
NCT01150175 {published data only}|Direct endomyocardial injection of autologous bone marrow cells to treat ischaemic heart failure (END-HF)|
NCT01214499 {published data only}|Prospective, controlled and randomized clinical trial on cardiac cell regeneration with laser and autologous bone marrow stem Cclls, in patients with coronary disease and refractory angina|
NCT01267331 {published data only}|Cell therapy in patients with chronic ischemic heart disease undergoing cardiac surgery|
NCT01299324 {published data only}|Retrograde delivery of BMAC (bone marrow aspirate concentrate) for congestive heart failure|
NCT01337011 {published data only}|Intra-coronary versus intramyocardial application of enriched CD133pos autologous bone marrow derived stem cells (AlsterMACS)|
NCT01354678 {published data only}|Intramyocardial multiple precision injection of bone marrow mononuclear cells in myocardial ischemia (IMPI)|
NCT01442129 {published data only}|The effect of intramyocardial injection of mesenchymal precursor cells on myocardial function in patients undergoing LVAD implantation|
NCT01508910 {published data only}|A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study|
NCT01508910 {published data only}|A phase 3, randomized, partially blinded, active-controlled, study assessing the efficacy and safety of intramyocaridal autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study|
NCT01615250 {published data only}|Implantation of peripheral stem cells in patient with ischemic cardiomyopathy (ISCIC)|
NCT01660581 {published data only}|Intracardiac CD133+ cells in patients with no-option resistant angina (Regent Vsel)|
NCT01666132 {published data only}|METHOD - Bone marrow derived mononuclear cells in chronic ischemic disease|
NCT01727063 {published data only}|Cell therapy in severe chronic ischemic heart disease (MiHeart)|
NCT01768702 {published data only}|Safety and efficacy of autologous cardiopoietic cells for treatment of ischemic heart failure. (CHART-1)|
NTR2516 {published data only}|Injection of autologous bone marrow cells into damaged myocardium of no-option patients with ischemic heart failure, a randomized placebo-controlled trial|
Arnesen 2007|Cell therapy in myocardial infarction|/resolve/reference/PMED?id=17604783
Assmus 2002|Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)|/resolve/reference/PMED?id=12473544
Assmuss 2006|Transcoronary transplantation of progenitor cells after myocardial infarction|
Beltrami 2003|Adult cardiac stem cells are multipotent and support myocardial regeneration|/resolve/reference/PMED?id=14505575
BHF 2008|Coronary Heart Disease statistics|
Carr 2008|Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study|/resolve/reference/PMED?id=18539761
Clifford 2012a|Stem cell treatment for acute myocardial infarction|
Clifford 2012b|Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes|
Cox 2003|Outcomes of optimal or "stent-like" balloon angioplasty in acutemyocardial infarction: the CADILLAC trial|/resolve/reference/PMED?id=13678914
Deb 2003|Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients|/resolve/reference/PMED?id=12628942
Fisher 2013|Bone marrow stem cell treatment for ischemic heart disease patients with no option of revascularization: a systematic review and meta-analysis|
Grajek 2010|Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation|
Grines 1999|Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent primary angioplasty in myocardial infarction study group|/resolve/reference/PMED?id=10607811
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Janssens 2006|Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial|/resolve/reference/PMED?id=16413875
Jeevanantham 2012|Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis|
Lunde 2006|Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction|/resolve/reference/PMED?id=16990383
Martin-Rendon 2008a|5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies|
Martin-Rendon 2008b|Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review|/resolve/reference/PMED?id=18523058
Martin-Rendon 2008c|Stem cell treatment for acute myocardial infarction|
Mathur 2004|Stem cells and repair of the heart|/resolve/reference/PMED?id=15246732
Meyer 2006|Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial|/resolve/reference/PMED?id=16520413
Orlic 2001a|Bone marrow cells regenerate infarcted myocardium|/resolve/reference/PMED?id=11287958
Orlic 2001b|Mobilized bone marrow cells repair the infarcted heart, improving function and survival|/resolve/reference/PMED?id=11504914
Patel 2006|Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study|
Review Manager 2012|Review Manager (RevMan). Version 5.2|
Schchinger 2006|Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction|/resolve/reference/PMED?id=16990384
Solomon 2005|Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients|/resolve/reference/PMED?id=16330684
Stamm 2003|Autologous bone marrow-derived stem cell transplantation for myocardial infarction|/resolve/reference/PMED?id=12517467
Stamm 2007|Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies|/resolve/reference/PMED?id=17320570
Stone 1998|Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30 day results of the PAMI stent pilot trial. Primary angioplasty in myocardial infarction stent pilot trial investigators|/resolve/reference/PMED?id=9426013
Stone 2002|Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction|/resolve/reference/PMED?id=11919304
Strauer 2002|Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans|/resolve/reference/PMED?id=12370212
Stuckey 2006|Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart|
Traverse 2011|Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging|
Yoon 2005|Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction|/resolve/reference/PMED?id=15690083
Asberg 2000 (4mg/kg/d) {published data only}|Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients|/resolve/reference/PMED?id=10964582
Bendix 1996 (2.5mg/kg/d) {published data only}|Adding low-dose cyclosporin A to parenteral gold therapy in rheumatoid arthritis: a double-blind placebo-controlled study|/resolve/reference/PMED?id=8948303
De Lima 1998 (20mg/kd/d) {published data only}|Lack of effect of a single oral dose of cyclosporine on systemic blood pressure and on forearm blood flow and vascular resistance in humans|
Dougados 1988(4.6mg/kg/d) {published data only}|Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients|/resolve/reference/PMED?id=3281603
Ellis 1986 14mg/kg/d {published data only}|Cyclosporine Improves Psoriasis in a Double-blind Study|/resolve/reference/PMED?id=3023712
Ellis 1991 {published data only}|Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial|/resolve/reference/PMED?id=1986287
Engst 1989 (5mg/kg/d) {published data only}|Results of cyclosporin treatment of severe, chronic psoriasis vulgaris. (German)|/resolve/reference/PMED?id=2676910
Hansen 1997 (10mg/kg/d) {published data only}|Cyclosporine-induced hypertension and decline in renal function in healthy volunteers|/resolve/reference/PMED?id=9468460
Lock 1996 (5 mg/kg/d) {published data only}|Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma|/resolve/reference/PMED?id=8564089
Minuk1988(5.1-6.4mg/kg/d) {published data only}|Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis|/resolve/reference/PMED?id=3169499
Nizankowska 1995 (2.5mg) {published data only}|Treatment of steroid-dependent bronchial asthma with cyclosporin|/resolve/reference/PMED?id=7589392
Reitamo 1993 (2.5mg/kg/d) {published data only}|Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study|/resolve/reference/PMED?id=8215491
Sowden 1991 (5mg/kg/d) {published data only}|Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis|/resolve/reference/PMED?id=1677063
Sturrock 1994 (15-20mg) {published data only}|Sequential effects of cyclosporine therapy on blood pressure, renal function and neurohormones|/resolve/reference/PMED?id=8007592
Sturrock 1995 (10mg/kg/d) {published data only}|Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males|/resolve/reference/PMED?id=7594425
Tugwell 1990 (3.8mg/kg/d) {published data only}|Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis|/resolve/reference/PMED?id=1970370
Wolinsky 1990 (6mg/kg/d) {published data only}|Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double-blinded, placebo-controlled clinical trial|
Appel 1988 {published data only}|A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis|/resolve/reference/PMED?id=3281637
Barenbrock 1995 {published data only}|A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function|/resolve/reference/PMED?id=7554523
Berg 1991 {published data only}|Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients|/resolve/reference/PMED?id=1836548
Binet 2000 {published data only}|Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A|/resolve/reference/PMED?id=10620203
Brynskov 1990 {published data only}|Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin|/resolve/reference/PMED?id=2370014
Bursztyn 1997 {published data only}|Isradipine for the prevention of cyclosporine-induced hpertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study|/resolve/reference/PMED?id=9112363
Calabrese 2002 {published data only}|Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation|/resolve/reference/PMED?id=11917239
Camp 1993 {published data only}|Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993|
Cattran 1995 {published data only}|A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group|/resolve/reference/PMED?id=7783410
Dalavanga 1987 {published data only}|Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjogren's syndrome|/resolve/reference/PMED?id=3493738
de Vries 1990 {published data only}|Cyclosporin in the treatment of severe chronic idiopathic uveitis|/resolve/reference/PMED?id=2198928
Dijkmans 1987 {published data only}|Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis|/resolve/reference/PMED?id=3549319
Drosos 1986 {published data only}|Cyclosporin A (CyA) in primary Sjogren's syndrome: a double blind study|/resolve/reference/PMED?id=3532967
Erkko 1998 {published data only}|Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis|
Feagan 1994 {published data only}|Low-dose cyclosporine for the treatment of Crohn's disease|/resolve/reference/PMED?id=8196727
Feutren 1990 {published data only}|Renal function and blood pressure in psoriatic patients treated with cyclosporin A|
Gerards 2003 {published data only}|Erratum: Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: A double blind randomised placebo controlled trial (Annals of the Rheumatic Diseases (2003) 62 (291-296))|/resolve/reference/PMED?id=12634224
Grattan 2000 {published data only}|Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria|
Gupta 1991 {published data only}|Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders|/resolve/reference/PMED?id=1992963
Kuypers 2004 {published data only}|Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: A prospective randomized placebo-controlled 2-year study|/resolve/reference/PMED?id=15502721
Lai 1987 {published data only}|Cyclosporin treatment of IgA nephropathy: a short term controlled trial|/resolve/reference/PMED?id=3120928
Lai 1991 {published data only}|Effect of cyclosporine A on circulating immune complexes in IgA nephropathy|/resolve/reference/PMED?id=1909692
Leenen 2007 {published data only}|Prevention of renal dysfunction and hypertension by amlodipine after heart transplant|/resolve/reference/PMED?id=17659942
Lieberman 1996 {published data only}|A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children|/resolve/reference/PMED?id=8808110
Lombard 1993 {published data only}|Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial|/resolve/reference/PMED?id=8425695
Madsen 1995 {published data only}|Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone|/resolve/reference/PMED?id=8633187
Madsen 1996 {published data only}|Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine|/resolve/reference/PMED?id=8737760
Martin 1991 {published data only}|Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects|/resolve/reference/PMED?id=1884902
Mazzeo 2008 {published data only}|Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: A microdialysis study|/resolve/reference/PMED?id=18781275
Meffert 1997 {published data only}|Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile|/resolve/reference/PMED?id=9111826
Miranda 2004 {published data only}|A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis|/resolve/reference/PMED?id=15036798
Munro 1994 {published data only}|Maintenance treatment with cyclosporin in atopic eczema|
Papp 2008 {published data only}|Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study|/resolve/reference/PMED?id=18424323
Parrott 2005 {published data only}|Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine a monotherapy in renal transplant recipients|/resolve/reference/PMED?id=15699766
Rudge 1989 {published data only}|Randomised double blind controlled trial of cyclosporin in multiple sclerosis|/resolve/reference/PMED?id=2659736
Salek 1993 {published data only}|Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial|
Sandborn 1993 {published data only}|Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin|/resolve/reference/PMED?id=8432481
Sihra 1997 {published data only}|Effect of cyclosporin A on the allergen-induced late asthmatic reaction|/resolve/reference/PMED?id=9176537
Stange 1995 {published data only}|European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group|/resolve/reference/PMED?id=7657105
van Joost 1988 {published data only}|Low-dose cyclosporin A in severe psoriasis. A double-blind study|
van Joost 1994 {published data only}|Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study|
Van Rijthoven 1986 {published data only}|Cyclosporin treatment for rheumatoid arthritis: A placebo controlled, double blind, multicentre study|/resolve/reference/PMED?id=3532966
Vena 2006 {published data only}|Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial|/resolve/reference/PMED?id=17010756
Wiesner 1990 {published data only}|A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis|/resolve/reference/PMED?id=2184355
Bursztyn 1997|Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study|
Curtis 1988|Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent|
e-CPS 2008||
Elliott 1984|Induction of interleukin 2 messenger RNA inhibited by cyclosporine A|/resolve/reference/PMED?id=6334364
Faerber 2001|Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients|/resolve/reference/PMED?id=11702620
Golub 1987|Direct augmentation by cyclosporine A of vascular contractile response to nerve stimulation|
Heran 2008a|Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension|
Heran 2008b|Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension|
Hess 1982|Effect of cyclosporine A on human lymphocyte response in vitro. III. CyA inhibits the production of T lymphocyte growth factors in secondary mixed-lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF|/resolve/reference/PMED?id=6459374
Musini 2009|Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials|/resolve/reference/PMED?id=19479061
Porter 1990|Cyclosporine-associated hypertension|
Van den Dorpel 1994|Effect of isradipine on cyclosporin A-related hypertension|/resolve/reference/PMED?id=8205301
Xue 1987|Cyclosporine A induces constriction in isolated rat aorta|/resolve/reference/PMED?id=3576678
Corry 2008 {published and unpublished data}|Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation|
Lindschinger 2000 {published and unpublished data}|Effect of an early percutaneous gastrostomy on the nutritional state, quality of life, anxiety and depression in patients with malignomas in the region of the larynx and pharynx|
Al-Othman 2003|Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer?|
Arends 2006|ESPEN Guidelines on enteral nutrition: non-surgical oncology|/resolve/reference/PMED?id=16697500
Backstrom 1995|Dietary intake in head and neck irradiated patients with permanent dry mouth symptoms|/resolve/reference/PMED?id=7492922
Baredes 2004|Percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer|/resolve/reference/PMED?id=15266879
Beaver 1998|Percutaneous fluoroscopic gastrostomy tube placement in patients with head and neck cancer|/resolve/reference/PMED?id=9776193
Beaver 2001|Predictors of weight loss during radiation therapy|/resolve/reference/PMED?id=11743469
Beer 2005|Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer|/resolve/reference/PMED?id=16091001
Cannaby 2002|Nursing care of patients with nasogastric feeding tubes|/resolve/reference/PMED?id=11979216
Chaudu 2003|Percutaneous endoscopic gastrostomy in patients undergoing resection for oral tumors: a retrospective review of complications and outcomes|/resolve/reference/PMED?id=14613083
Cheng 2006|Variables associated with feeding tube placement in head and neck cancer|/resolve/reference/PMED?id=16785412
Cravo 2000|Metabolic responses to tumour disease and progression: tumour-host interaction|/resolve/reference/PMED?id=11104599
Devlin 2005|Combined modality treatment of squamous cell cancer of the head and neck|/resolve/reference/PMED?id=16167011
Dharmarajan 2004|Gastrostomy, esophagitis, and gastrointestinal bleeding in older adults|/resolve/reference/PMED?id=15228631
Ehrsson 2004|Percutaneous endoscopic gastrostomy? A long-term follow-up study in head and neck cancer patients|
Gibson 1992|Percutaneous endoscopic gastrostomy in the management of head and neck carcinoma|
Hammerlid 1998|Malnutrition and food intake in relation to quality of life in head and neck cancer patients|
Handbook 2008|Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008|
Hunter 1996|Nutrition management of patients with neoplastic disease of the head and neck treated with radiation therapy|/resolve/reference/PMED?id=9070017
Larsson 2005|Eating problems and weight loss for patients with head and neck cancer|/resolve/reference/PMED?id=16330963
Lee 1998|Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck|/resolve/reference/PMED?id=9708712
Lees 1997|Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study|
Lees 1999|Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre|
Lloyd 2002|Insertion of percutaneous endoscopic gastrostomy tubes by a maxillofacial surgical team in patients with oropharyngeal cancer|/resolve/reference/PMED?id=12180202
Marcy 2000|Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer; optimisation of therapy|/resolve/reference/PMED?id=10975691
Mekhail 2001|Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?|
Munshi 2003|Weight loss during radiotherapy for head and neck malignancies: what factors impact it?|/resolve/reference/PMED?id=15087265
Newman 1998|Eating and weight changes following chemoradiation therapy for advanced head and neck cancer|
NICE 2006|Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition|
Parkin 2005|Global cancer statistics|
Piquet 2002|Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy|/resolve/reference/PMED?id=12353130
RevMan 2008|Review Manager|
Rieger 2006|Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature|/resolve/reference/PMED?id=16697144
Semple 2004|Psychosocial interventions for patients with head and neck cancer|/resolve/reference/PMED?id=15632782
Shafman 2006|Combination chemotherapy and radiation therapy for upper aerodigestive tract cancers|/resolve/reference/PMED?id=16583662
Sheldon 1999|Nutritional management of patients with head and neck cancer|
Specht 2001|Oral complications in the head and neck radiation patient. In: Symposium|
Thomas 2007||
Unsal 2006|Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study|/resolve/reference/PMED?id=16601440
Wiggenraad 2007|Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study|
Williams 1989|Nutritional concepts and considerations in head and neck surgery|
Arnold 2007 {published data only}|Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial|
Backonja 1998 {published data only}|Trial summary - Parke Davis/Pfizer 945-210|
Backonja 1998 {published data only}|Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial|/resolve/reference/PMED?id=9846777
Bone 2002 {published data only}|Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study|/resolve/reference/PMED?id=12373695
Caraceni 2004 {published data only}|Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group|/resolve/reference/PMED?id=15254060
Chandra 2006 {published data only}|Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial - the GONIP Trial|/resolve/reference/PMED?id=16961166
CTR 945-1008 {unpublished data only}|Protocol A9451008. A 15 Week, randomized, double-blind, placebo-controlled, parallel-group, multi-center study of Neurontin (gabapentin) for efficacy and quality of life in patients with painful diabetic peripheral neuropathy|
CTR 945-224 {unpublished data only}|Protocol 945-224. A double-blind placebo-controlled trial With 3 doses of gabapentin for treatment of painful diabetic peripheral neuropathy. May 29, 1998 through September 7, 1999|
Gilron 2005 {published data only}|Morphine, gabapentin, or their combination for neuropathic pain|/resolve/reference/PMED?id=15800228
Gilron 2009 {published data only}|Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial|/resolve/reference/PMED?id=19796802
Gordh 2008 {published data only}|Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study|/resolve/reference/PMED?id=18258368
Gorson 1999 {published data only}|Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial|/resolve/reference/PMED?id=10071116
Hahn 2004 {published data only}|A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies|/resolve/reference/PMED?id=15503108
Ho 2009 {published data only}|Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies|
Irving 2009 {published data only}|Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial|/resolve/reference/PMED?id=19333167
Irving 2009 {published data only}|Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia|/resolve/reference/PMED?id=19590476
Kimos 2007 {published data only}|Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial|/resolve/reference/PMED?id=17030096
Levendoglu 2004 {published data only}|Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury|/resolve/reference/PMED?id=15087796
Morello 1999 {published data only}|Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain|/resolve/reference/PMED?id=10493324
Perez 2000 {published data only}|Gabapentin therapy for diabetic neuropathic pain|
Rao 2007 {published data only}|Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)|
Rice 2001 {published data only}|Study detail and analysis, Parke-Davis 945-295|
Rice 2001 {published data only}|Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study|/resolve/reference/PMED?id=11690735
Rintala 2007 {published data only}|Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury|/resolve/reference/PMED?id=18047869
Rowbotham 1998 {published data only}|Detailed summary, study No.4, Parke-Davis 945-211|
Rowbotham 1998 {published data only}|Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial|/resolve/reference/PMED?id=9846778
Sandercock 2009 {published data only}|Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial|/resolve/reference/PMED?id=19171730
Serpell 2002 {published data only}|945-430-306|
Serpell 2002 {published data only}|Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial|/resolve/reference/PMED?id=12406532
Simpson 2001 {published data only}|Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy|/resolve/reference/PMED?id=19078655
Smith 2005 {published data only}|Efficacy of gabapentin in treating chronic phantom limb and residual limb pain|/resolve/reference/PMED?id=16586190
Tai 2002 {published data only}|Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial|/resolve/reference/PMED?id=12137213
van de Vusse 2004 {published data only}|Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]|/resolve/reference/PMED?id=15453912
Wallace 2010 {published data only}|Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study|/resolve/reference/PMED?id=20818838
Arai 2010 {published data only}|Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine|/resolve/reference/PMED?id=20217150
Berry 2005 {published data only}|A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster|/resolve/reference/PMED?id=16087911
Dallochio 2000 {published data only}|Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study|/resolve/reference/PMED?id=11027910
Dworkin 2009 {published data only}|A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster|/resolve/reference/PMED?id=19195785
Jean 2005 {published data only}|Starting dose of gabapentin for patients with post-herpetic neuralgia--a dose-response study|/resolve/reference/PMED?id=16060401
Keskinbora 2007 {published data only}|Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial|/resolve/reference/PMED?id=17604592
Ko 2010 {published data only}|Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy|
McCleane 2001 {published data only}|Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study|
Nikolajsen 2006 {published data only}|A randomized study of the effects of gabapentin on postamputation pain|/resolve/reference/PMED?id=17065896
Pandey 2002 {published data only}|Gabapentin for the treatment of pain in Guillain-Barre syndrome: a double-blinded, placebo-controlled, crossover study|/resolve/reference/PMED?id=12456446
Pandey 2005 {published data only}|The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre syndrome patients in the intensive care unit|/resolve/reference/PMED?id=15976235
Salvaggio 2008 {published data only}|Facial pain: a possible therapy with stellate ganglion block|
Sator-Katzenschlager 2005 {published data only}|Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study|/resolve/reference/PMED?id=16416358
Yaksi 2007 {published data only}|The efficiency of gabapentin therapy in patients with lumbar spinal stenosis|/resolve/reference/PMED?id=17450066
Yelland 2009 {published data only}|N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain|
Yildrim 2003 {published data only}|The effectiveness of gabapentin in patients with chronic radiculopathy|
Barres 2009|Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis|/resolve/reference/PMED?id=19818485
Bouhassira 2008|Prevalence of chronic pain with neuropathic characteristics in the general population|/resolve/reference/PMED?id=17888574
Breivik 2006|Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment|
Chou 2009|Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials|/resolve/reference/PMED?id=19089502
Cook 1995|The number needed to treat: a clinically useful measure of treatment effect|/resolve/reference/PMED?id=7873954
Dallocchio 2000|Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study|/resolve/reference/PMED?id=11027910
Dworkin 2008|Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations|/resolve/reference/PMED?id=18055266
Elbourne 2002|Meta-analyses involving cross-over trials: methodological issues|/resolve/reference/PMED?id=11914310
EMC 2009|Electronic Medicines Compendium|
Farrar 2000|Defining the clinically important difference in pain outcome measures|/resolve/reference/PMED?id=11068116
Finnerup 2005|Algorithm for neuropathic pain treatment: an evidence based proposal|/resolve/reference/PMED?id=16213659
Gustorff 2008|Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey|
Hall 2006|Epidemiology and treatment of neuropathic pain: the UK primary care perspective|/resolve/reference/PMED?id=16545908
Hauser 2009|Treatment of fibromyalgia syndrome with gabapentin and pregabalin - a meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=19539427
Hempenstall 2005|Analgesic therapy in postherpetic neuralgia: a quantitative systematic review|/resolve/reference/PMED?id=16013891
Hoffman 2010|How do changes in pain severity levels correspond to changes in health status 3 and function in patients with painful diabetic peripheral neuropathy?|/resolve/reference/PMED?id=20303665
Jacox 1994||
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Khan 1996|The importance of quality of primary studies in producing unbiased systematic reviews|/resolve/reference/PMED?id=8629879
L'Abbe 1987|Meta-analysis in clinical research|/resolve/reference/PMED?id=3300460
Landefeld 2009|The Neurontin legacy - marketing through misinformation and manipulation|/resolve/reference/PMED?id=19129523
Lunn 2009|Duloxetine for treating painful neuropathy or chronic pain|
McQuay 1995|Anticonvulsant drugs for management of pain: a systematic review|/resolve/reference/PMED?id=7580659
McQuay 1998|An evidence-based resource for pain relief|
McQuay 2008|Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain|/resolve/reference/PMED?id=18258369
Monks 1994|Psychotropic drugs|
Moore 1998|Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects|/resolve/reference/PMED?id=9870574
Moore 2005a|Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results|/resolve/reference/PMED?id=15979792
Moore 2005b|Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports|/resolve/reference/PMED?id=15899051
Moore 2008|Managing potential publication bias|
Moore 2009a|Pregabalin for acute and chronic pain in adults|
Moore 2009b|Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice|
Moore 2009c|Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences|
Moore 2010a|Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice|/resolve/reference/PMED?id=19364730
Moore 2010b|Topical review: chronic low back pain analgesic studies - a methodological minefield|/resolve/reference/PMED?id=20304558
Moore 2010c|Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain|/resolve/reference/PMED?id=20347225
Moore 2010d|"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews|/resolve/reference/PMED?id=20627575
Nuesch 2010|Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study|/resolve/reference/PMED?id=20639294
O'Brien 2010|Patient-centered perspective on treatment: outcomes in chronic pain|
Oldman 2002|Pharmacological treatments for acute migraine: quantitative systematic review|/resolve/reference/PMED?id=12044621
Perry 2008|Neurontin - expert opinion on efficacy and effectiveness for pain|
Quilici 2009|Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain|/resolve/reference/PMED?id=19208243
Straube 2008|Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review|
Straube 2010|Single dose oral gabapentin for established acute postoperative pain in adults|
Sultan 2008|Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials|/resolve/reference/PMED?id=18673529
Torrance 2006|The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey|/resolve/reference/PMED?id=16618472
Tzellos 2008|Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature|/resolve/reference/PMED?id=18607580
Vedula 2009|Outcome reporting in industry-sponsored trials of gabapentin for off-label use|/resolve/reference/PMED?id=19907043
Wiffen 2005|Gabapentin for acute and chronic pain|
Wiffen 2011a|Withdrawn - Anticonvulsant drugs for acute and chronic pain|
Wiffen 2011b|Carbamazepine for acute and chronic pain|
Chen 2008 {published data only}|Clinical analysis of Sodium phosphoceatine on cardiac toxicity induced by anthracycline antibiotics in acute leukemia children|
Silber 2004 {published data only}|Optimal multivariate matching before randomization|/resolve/reference/PMED?id=15054030
Silber 2004 {published data only}|Randomization inference with imperfect compliance in the ACE-inhibitor after anthracycline randomized trial|
Silber 2004 {published data only}|Challenges in conducting a pediatric longitudinal prevention study: lessons from the ACE-inhibitor after anthracycline trial|
Silber 2004 {published data only}|The role of afterload reduction in the prevention of late anthracycline cardiomyopathy|
Silber 2004 {published data only}|Design and baseline characteristics for the ACE inhibitor after anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors|/resolve/reference/PMED?id=11579345
Silber 2004 {published data only}|Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines|/resolve/reference/PMED?id=14990637
Garcia 2007 {published data only}|Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity|/resolve/reference/PMED?id=17028018
Ginsberg 2004 {published data only}|Using health-related quality of life measures to predict cardiac function in survivors exposed to anthracyclines|/resolve/reference/PMED?id=15284267
Shaddy 2007 {published data only}|Carvedilol for children and adolescents with heart failure: a randomized controlled trial|/resolve/reference/PMED?id=17848651
Shaddy 2007 {published data only}|The pediatric randomized carvedilol trial in children with heart failure: rationale and design|
Tallaj 2005 {published data only}|Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure|/resolve/reference/PMED?id=16364871
Vatutin 2001 {published data only}|Effect of propranolol in silent myocardial ischemia induced by anthracyclines|/resolve/reference/PMED?id=15311709
Mandric 2008 {published data only}|The utility of enalapril treatment in anthracyclines-induced cardiac injury in children with malignancies-preliminary study|
Mandric 2009 {published data only}|Cardiac biomarkers in early detection of cardiotoxicity anthracycline-induced in children|
NCT00003070 {published data only}|Afterload Reduction Therapy for Late Anthracycline Cardiotoxicity: A Pediatric Oncology Group Cancer Control Study|
Abdulla 2006|Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction - a meta-analysis|
Cardinale 2010|Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy|/resolve/reference/PMED?id=20117401
CIBIS-II 1999|The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial|/resolve/reference/PMED?id=10023943
COG 2006|Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, version 3.0|
Cohn 2001|A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure|/resolve/reference/PMED?id=11759645
Colucci 2007|Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial|/resolve/reference/PMED?id=17576868
Exner 1999|Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction|/resolve/reference/PMED?id=10091816
Foody 2002|Beta-blocker therapy in heart failure: scientific review|/resolve/reference/PMED?id=11851582
Ganame 2007|Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients|/resolve/reference/PMED?id=17604960
Garg 1995|Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials|/resolve/reference/PMED?id=7654275
Glick 1995|Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial|/resolve/reference/PMED?id=12836712
Granger 2003|Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial|/resolve/reference/PMED?id=13678870
Higgins 2008|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008|
Jensen 1996|Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy|/resolve/reference/PMED?id=8569365
Jensen 2002|Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients|/resolve/reference/PMED?id=12075737
Jong 2003|Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study|/resolve/reference/PMED?id=12788569
Kay 2001|Congestive heart failure in pediatric patients|/resolve/reference/PMED?id=11685182
Kremer 2002|Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review|/resolve/reference/PMED?id=12123328
Lefrak 1973|A clinicopathologic analysis of adriamycin cardiotoxicity|
Lipshultz 1991|Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood|/resolve/reference/PMED?id=1997853
Lipshultz 2002|Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer|/resolve/reference/PMED?id=12454107
Lipshultz 2005a|Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia|/resolve/reference/PMED?id=15837978
Lipshultz 2005b|Cardiac changes associated with growth hormone therapy among children treated with anthracyclines|/resolve/reference/PMED?id=15930224
Maggioni 2002|Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors|/resolve/reference/PMED?id=12392830
McMurray 2003|Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial|/resolve/reference/PMED?id=13678869
Module CCG|About the Cochrane Collaboration (Cochrane Review Groups CRGs) 2008, issue 4|
NYHA 1994||
Packer 1996a|The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group|/resolve/reference/PMED?id=8614419
Packer 1996b|Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise|/resolve/reference/PMED?id=8941104
Parmar 1998|Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints|
RevMan 2008|Review Manager (RevMan)|
Rogers 1994|Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction|/resolve/reference/PMED?id=8294693
SIGN 2004|Long-term follow up care of survivors of childhood cancer|
Skinner 2005|Therapy based long term follow up: A practice statement (second edition)|
SOLVD 1991|Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators|/resolve/reference/PMED?id=2057034
SOLVD 1992|Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators|/resolve/reference/PMED?id=1463530
Sorensen 2003|Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study|
Steinherz 1992|Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the cardiology committee of the Children's Cancer Study Group|/resolve/reference/PMED?id=1579408
Steinherz 1995|Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients|
Van Dalen 2003|Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: the need for evidence|/resolve/reference/PMED?id=12947081
Van Dalen 2006a|Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study|/resolve/reference/PMED?id=16987655
Van Dalen 2006b|Anthracycline-induced cardiotoxicity: Comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials|/resolve/reference/PMED?id=17011186
Von Hoff 1977|Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases|/resolve/reference/PMED?id=835599
Waagstein 1993|Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group|/resolve/reference/PMED?id=7902479
Wang 2003|Natural history of asymptomatic left ventricular systolic dysfunction in the community|/resolve/reference/PMED?id=12912813
Wilson 1968|Principles and practice of screening for disease|
Anton 2005 {published data only}|Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence|/resolve/reference/PMED?id=16012278
Anton 2005 {published data only}|What role does measuring medication compliance play in evaluating the efficacy of naltrexone?|/resolve/reference/PMED?id=17374038
Ball 2007a {published data only}|Brief motivational enhancement and coping skills interventions for heavy drinking|/resolve/reference/PMED?id=16945487
Ball 2007b {published data only}|Site matters: multi site randomised trial of motivational enhancement therapy in community drug abuse clinics|/resolve/reference/PMED?id=17663610
Barnett 2007 {published data only}|Efficacy of counsellor vs. computer-delivered intervention with mandated college students.|/resolve/reference/PMED?id=17707594
Bazargan-Hejazi 2005 {published data only}|Evaluation of a brief intervention in an inner-city emergency department.|/resolve/reference/PMED?id=15988430
Bell 2007 {published data only}|Volitional control, self-regulation, and motivational interviewing in veterans with alcohol problems|
Bernstein 2009 {published data only}|Screening and brief intervention to reduce marijuana use among youth and young adults in a paediatric emergency department.|
Bien 1993 {published data only}|Motivational interviewing with alcohol outpatients|
Borsari 2005 {published data only}|Two brief alcohol interventions for mandated college students|/resolve/reference/PMED?id=16187809
Brown 2010 {published data only}|Brief motivational interviewing for DWI recidivists who abuse alcohol and are not participating in DWI intervention: a randomised controlled trial|
Carey 2006 {published data only}|Brief motivational interventions for heavy college drinkers: A randomised controlled trial|/resolve/reference/PMED?id=17032098
Carroll 2006a {published data only}|Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study|/resolve/reference/PMED?id=16169159
Carroll 2006b {published data only}|The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence|/resolve/reference/PMED?id=17032099
Carroll 2006b {published data only}|The cost-effectiveness of four treatments for marijuana dependence|
Carroll 2009 {published data only}|A multi site randomised effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users|/resolve/reference/PMED?id=19803579
Chanut 2007 {published data only}|Pilot study of motivational interviewing among persons convicted of driving under the influence|
Connors 2002 {published data only}|Preparing clients for alcoholism treatment: effects on treatment participation and outcomes|/resolve/reference/PMED?id=12362966
Copeland 2001 {published data only}|Clinical profile of participants in a brief intervention program for cannabis use disorder|/resolve/reference/PMED?id=11239727
Copeland 2001 {published data only}|A randomised controlled trial of brief cognitive-behavioral interventions for cannabis use disorder|/resolve/reference/PMED?id=11551733
D'Amico 2008 {published data only}|Brief motivational interviewing for teens at risk of substance use consequences: a randomised pilot study in a primary care clinic|/resolve/reference/PMED?id=18037603
D'Amico 2008 {published data only}|Project CHAT: a brief motivational substance abuse intervention for teens in primary care|/resolve/reference/PMED?id=17306724
De Wildt 2002 {published data only}|Does psychosocial treatment enhance the efficacy of Acamprosate in patients with alcohol problems?|/resolve/reference/PMED?id=12107041
Emmen 2005 {published data only}|Adding psychologist's intervention to physicians' advice to problem drinkers in the outpatient clinic|/resolve/reference/PMED?id=15699056
Feldstein 2007 {published data only}|Motivational interviewing with underage college drinkers: a preliminary look at the role of empathy and alliance|/resolve/reference/PMED?id=17891666
Freyer-Adam 2008 {published data only}|Brief alcohol intervention for general hospital inpatients: A randomised controlled trial|/resolve/reference/PMED?id=18054445
Kadden 2007 {published data only}|Abstinence rates following behavioral treatments for marijuana dependence|/resolve/reference/PMED?id=16996224
Kadden 2007 {published data only}|Coping skills training and contingency management treatments for marijuana dependence: exploring mechanisms of behavior change|
Kahler 2004 {published data only}|Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification|/resolve/reference/PMED?id=15301659
Kavanagh 2004 {published data only}|A brief motivational intervention for substance misuse in recent-onset psychosis|
Kay-Lambkin 2009 {published data only}|The long and the short of treatments for alcohol and cannabis misuse among people with severe mental disorders|/resolve/reference/PMED?id=19299087
Kay-Lambkin 2009 {published data only}|Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy|
Kelly 2000 {published data only}|Maritally distressed women with alcohol problems: the impact of a short-term alcohol-focused intervention on drinking behaviour and marital satisfaction|
Maisto 2001 {published data only}|Comparison of consumption effects of brief interventions for hazardous drinking elderly|/resolve/reference/PMED?id=12901447
Maisto 2001 {published data only}|Effects of two types of brief intervention and readiness to change on alcohol use in hazardous drinkers|/resolve/reference/PMED?id=11702799
MarijuanaTP 2004 {published data only}|Coping and self-efficacy in marijuana treatment: results from the marijuana treatment project|/resolve/reference/PMED?id=16392975
MarijuanaTP 2004 {published data only}|Brief treatments for cannabis dependence: findings from a randomised multi site trial|/resolve/reference/PMED?id=15279529
Marsden 2006 {published data only}|An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes|
Martin 2008 {published data only}|The adolescent cannabis check-up: Randomized trial of a brief intervention for young cannabis users|/resolve/reference/PMED?id=17869051
Martino 2006 {published data only}|A randomised controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders|
Mastroleo 2010 {published data only}|Examination of post training supervision of peer counsellors in a motivational enhancement intervention to reduce drinking in a sample of heavy-drinking college students|/resolve/reference/PMED?id=20673621
MATCH 1993 {published data only}|Variation in GABRA2 predicts drinking behavior in project MATCH subjects|
MATCH 1993 {published data only}|Internal validity of Project MATCH treatments: discriminability and integrity|/resolve/reference/PMED?id=9583332
MATCH 1993 {published data only}|Network support for drinking, Alcoholics Anonymous and long-term matching effects|
MATCH 1993 {published data only}|Therapist effects in three treatments for alcohol problems|
MATCH 1993 {published data only}|Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes|/resolve/reference/PMED?id=8979210
MATCH 1993 {published data only}|Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes|
MATCH 1993 {published data only}|Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group|/resolve/reference/PMED?id=9811084
MATCH 1993 {published data only}|Matching patients with alcohol disorders to treatments: clinical implications from Project MATCH|
MATCH 1993 {published data only}|Project MATCH (Matching Alcoholism Treatment to Client Heterogeneity): rationale and methods for a multisite clinical trial matching patients to alcoholism treatment|
MATCH 1993 {published data only}|Project MATCH secondary a priori hypotheses. Project MATCH Research Group|
MATCH 1993 {published data only}|Social support in alcohol dependence and social phobia: Treatment comparisons|
MATCH 1993 {published data only}|Utilization of AA by Hispanic and non-Hispanic white clients receiving outpatient alcohol treatment|/resolve/reference/PMED?id=12033698
MATCH 1993 {published data only}|Response of Native American clients to three treatment methods for alcohol dependence|/resolve/reference/PMED?id=18192203
MATCH 1993 {published data only}|Network support for drinking: An application of multiple groups growth mixture modelling to examine client-treatment matching|/resolve/reference/PMED?id=18080061
MATCH 1993 {published data only}|Decomposing the relationships between pretreatment social network characteristics and alcohol treatment outcome|/resolve/reference/PMED?id=11925053
McCambridge 2008 {published data only}|Randomized controlled trial of motivational interviewing compared with drug information and advice for early intervention among young cannabis users|
Miller 2003 {published data only}|Motivational interviewing in drug abuse services: a randomised trial|/resolve/reference/PMED?id=12924680
Morgenstern 2009 {published data only}|Randomized trial to reduce club drug use and HIV risk behaviours among men who have sex with men|/resolve/reference/PMED?id=19634958
Naar-King 2007 {published data only}|Brief report: maintenance of effects of motivational enhancement therapy to improve risk behaviours and HIV-related Health in a randomised controlled trial of youth living with HIV|/resolve/reference/PMED?id=17905800
Naar-King 2007 {published data only}|Transtheoretical model and substance use in HIV+ youth|/resolve/reference/PMED?id=16971296
Naar-King 2007 {published data only}|Transtheoretical model and condom use in HIV+ youth|/resolve/reference/PMED?id=17014283
Naar-King 2007 {published data only}|Healthy Choices: Motivational enhancement therapy for health risk behaviours in HIV-positive youth|/resolve/reference/PMED?id=16539572
Parsons 2009 {published data only}|Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial|/resolve/reference/PMED?id=18077833
Peterson 2006 {published data only}|Short-term effects of a brief motivational intervention to reduce alcohol and drug risk among homeless adolescents|/resolve/reference/PMED?id=16938063
Rohsenow 2004 {published data only}|Motivational enhancement and coping skills training for cocaine abusers: effects on substance use outcomes|
Saitz 2007 {published data only}|Brief intervention for medical inpatients with unhealthy alcohol use: a randomised, controlled trial|/resolve/reference/PMED?id=17283347
Schaus 2009 {published data only}|Alcohol screening and brief intervention in a college student health centre: a randomised controlled trial|
Sellman 2001 {published data only}|Five-year outcomes of alcohol-dependent persons treated with motivational enhancement|/resolve/reference/PMED?id=18612575
Sellman 2001 {published data only}|A randomised controlled trial of motivational enhancement therapy (MET) for mild to moderate alcohol dependence|/resolve/reference/PMED?id=11414349
Stein 2002 {published data only}|A randomised trial of a brief alcohol intervention for needle exchangers (BRAINE)|
Stein 2009 {published data only}|A motivational intervention trial to reduce cocaine use|/resolve/reference/PMED?id=18657938
Stein 2010 {published data only}|Feasibility of gaining access to women in jail for interventions|/resolve/reference/PMED?id=18714713
Stein 2010 {published data only}|A brief alcohol intervention for hazardously drinking incarcerated women|
Stephens 2007 {published data only}|The Marijuana Check-up: promoting change in ambivalent marijuana users|
Stotts 2001 {published data only}|Brief motivational enhancement therapy prior to relapse prevention for cocaine dependent patients|
Stotts 2001 {published data only}|An outpatient cocaine detoxification program using motivational enhancement therapy|
Stotts 2001 {published data only}|Motivational interviewing with cocaine-dependent patients: a pilot study|/resolve/reference/PMED?id=11680565
Stotts 2006 {published data only}|Preliminary feasibility and efficacy of a brief motivational intervention with psychophysiological feedback for cocaine abuse|/resolve/reference/PMED?id=17347121
Thush 2009 {published data only}|Influence of motivational interviewing on explicit and implicit alcohol-related cognition and alcohol use in at-risk adolescents|/resolve/reference/PMED?id=19290699
UKATT 2005 {published data only}|Treatment: What was useful about that session? Clients' and therapists' comments after sessions in the UK alcohol treatment trial (UKATT)|/resolve/reference/PMED?id=19147800
UKATT 2005 {published data only}|To what factors do clients attribute change? Content analysis of follow-up interviews with clients of the UK Alcohol Treatment Trial|/resolve/reference/PMED?id=18547778
UKATT 2005 {published data only}|Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT)|/resolve/reference/PMED?id=16150765
UKATT 2005 {published data only}|Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT)|/resolve/reference/PMED?id=16150764
UKATT 2005 {published data only}|UK Alcohol Treatment Trial: client-treatment matching effects|
Walitzer 2008 {published data only}|Facilitating involvement in Alcoholics Anonymous during out-patient treatment: a randomised clinical trial|
Walker 2006 {published data only}|Motivational enhancement therapy for adolescent marijuana users: a preliminary randomised controlled trial|/resolve/reference/PMED?id=16822119
Walters 2009 {published data only}|Dismantling motivational interviewing and feedback for college drinkers: a randomised clinical trial|/resolve/reference/PMED?id=19170454
White 2006 {published data only}|Individual and situational factors that influence the efficacy of personalized feedback substance use interventions for mandated college students|/resolve/reference/PMED?id=19170456
White 2006 {published data only}|Evaluating two brief substance-use interventions for mandated college students|/resolve/reference/PMED?id=16562414
White 2006 {published data only}|Long-term effects of brief substance use interventions for mandated college students: sleeper effects of an in-person personal feedback intervention|
Winhusen 2008 {published data only}|Motivation enhancement therapy with pregnant substance-abusing women: Does baseline motivation moderate efficacy?|/resolve/reference/PMED?id=19101099
Winhusen 2008 {published data only}|Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users|/resolve/reference/PMED?id=18083322
Winters 2007 {published data only}|Brief intervention for drug-abusing adolescents in a school setting|/resolve/reference/PMED?id=17563146
Wood 2007 {published data only}|Thinking about drinking: Need for cognition and readiness to change moderate the effects of brief alcohol interventions|/resolve/reference/PMED?id=20025374
Wood 2007 {published data only}|Brief motivational intervention and alcohol expectancy challenge with heavy drinking college students: A randomised factorial study|/resolve/reference/PMED?id=17658696
Adamson 2001 {published data only}|Drinking goal selection and treatment outcome in outpatients with mild-moderate alcohol dependence|
Allsop 1997 {published data only}|A trial of relapse prevention with severely dependent male problem drinkers|
Anderson 1992 {published data only}|The effect of general practitioners' advice to heavy drinking men|
Aubrey 1998 {published data only}|Motivational interviewing with adolescents presenting for outpatient substance abuse treatment|
Baer 2001 {published data only}|Brief intervention for heavy-drinking college students: 4-year follow-up and natural history|/resolve/reference/PMED?id=11499124
Baker 1993 {published data only}|Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users|/resolve/reference/PMED?id=8466688
Baker 2001 {published data only}|Characteristics of regular amphetamine users and implications for treatment|
Baker 2001 {published data only}|Randomized controlled trial of brief cognitive-behavioural interventions among regular users of amphetamine|
Baker 2001 {published data only}|Drug use patterns and mental health of regular amphetamine users during a reported heroin drought|
Baker 2002 {published data only}|Evaluation of a motivational interview for substance use within psychiatric in-patient services|
Baker 2002b {published data only}|Motivational interviewing among psychiatric in-patients with substance use disorders|
Baker 2005 {published data only}|Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction|
Baker 2006 {published data only}|Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial|/resolve/reference/PMED?id=16648530
Barrowclough 2000 {published data only}|Cognitive behavioral intervention for individuals with severe mental illness who have a substance misuse problem|
Barrowclough 2001 {published data only}|Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders|/resolve/reference/PMED?id=11579006
Becka 2004 {published data only}|Efficacy of cognitive behavioral methods in decreasing drug use by methadone clinic patients compared with standard conditions|
Beckham 2007 {published data only}|Motivational interview with hazardous drinkers|
Bellack 2006 {published data only}|A randomised clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness|/resolve/reference/PMED?id=16585472
Bernstein 2005 {published data only}|Brief motivational intervention at a clinic visit reduces cocaine and heroin use|/resolve/reference/PMED?id=15607841
Bethea 2006 {unpublished data only}|Role of the therapeutic alliance in the treatment of pain patients who abuse prescription opioids|
Booth 1998 {published data only}|Facilitating treatment entry among out-of-treatment injection drug users|/resolve/reference/PMED?id=9722817
Borsari 2000 {published data only}|Effects of a brief motivational intervention with college student drinkers|/resolve/reference/PMED?id=10965648
Borsari 2003 {published data only}|Two brief alcohol interventions for referred college students|
Brown 1993 {published data only}|Impact of motivational interviewing on participation in residential alcoholism treatment|
Brown 2007 {published data only}|Randomized-controlled trial of a telephone and mail intervention for alcohol use disorders: three-month drinking outcomes|
Brown 2009 {published data only}|Effects on substance use outcomes in adolescents receiving motivational interviewing for smoking cessation during psychiatric hospitalisation|/resolve/reference/PMED?id=19342179
Butler 2009 {published data only}|Brief alcohol intervention with college student drinkers: face-to-face versus computerized feedback|/resolve/reference/PMED?id=19290702
Bux 2005 {published data only}|The role of therapeutic alliance in alcohol and drug abuse treatment outcome|
Ceperich 2002 {published data only}|Preventing alcohol-exposed pregnancies in college women|
Chapman 2009 {published data only}|With youth smoking at historical lows, how influential is movie smoking on uptake?|
Chavez 2003 {published data only}|Negative consequences, substance use, and motivation for change: a predictive model of drug abusers motivation to change behavior|
Clinton-Sherrod 2008 {published data only}|The effects of a Motivational Interviewing intervention to reduce college drinking on reports of pressured or force sex at 3-month follow up|
Corrigan 2005 {published data only}|Increasing substance abuse treatment compliance for persons with traumatic brain injury|/resolve/reference/PMED?id=16011383
D'Angelo 2005 {published data only}|A comparative study of motivational interviewing and traditional treatment approach on movement along stages of change, treatment completion, compliance with aftercare plan, and length of abstinence|
Daeppen 2007 {published data only}|Communication during brief intervention, intention to change, and outcome|/resolve/reference/PMED?id=18077302
Daley 1998 {published data only}|Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study|/resolve/reference/PMED?id=9812129
Davidson 2007 {published data only}|Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone?|/resolve/reference/PMED?id=17286342
Davis 2003 {published data only}|Brief motivational feedback improves post-incarceration treatment contact among veterans with substance use disorders|/resolve/reference/PMED?id=12609701
Demmel 2003 {published data only}|Secondary prevention beyond screening and brief advice|
Dench 2000 {published data only}|The impact of brief motivational intervention at the start of an outpatient day programme for alcohol dependence|
Dent 2008 {published data only}|Opportunistic screening and clinician-delivered brief intervention for high-risk alcohol use among emergency department attendees: A randomised controlled trial|
Dermen 2000 {published data only}|A brief motivational approach to reducing drinking and sexual risk behavior among college students|
Disney 2005 {published data only}|Opening doors to treatment: A voucher-enhanced motivational intervention for syringe exchange participants|
Dunn 1997 {published data only}|Linking substance abuse services with general medical care: Integrated, brief interventions with hospitalized patients|/resolve/reference/PMED?id=9048144
Dunn 2004 {published data only}|Motivational interviewing with injured adolescents in the emergency department: In-session predictors of change|
Easton 2000 {published data only}|Motivation to change substance use among offenders of domestic violence|/resolve/reference/PMED?id=10867294
Edwards 2006 {published data only}|Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis|
Fergusin 1998 {published data only}|Motivational interviewing with less motivated driving under the influence of alcohol second offenders with an exploration of the processes related to change|
Floyd 2007 {published data only}|Preventing alcohol-exposed pregnancies. A randomised controlled trial|/resolve/reference/PMED?id=17218187
Gauthier-Faille 2006 {published data only}|Outpatient treatment for substance dependence: using empirical findings about retention and substance use outcomes to shape treatment services|
Gentilello 2001 {published data only}|Alcohol interventions in a trauma centre|
Ginsburg 2001 {published data only}|Using motivational interviewing to enhance treatment readiness in offenders with symptoms of alcohol dependence|
Godley 2010 {unpublished data only}|Adolescent outpatient treatment and continuing care: Main findings from a randomised clinical trial|/resolve/reference/PMED?id=20219293
Gogineni 2005 {published data only}|Brief significant other-involved motivational interviewing with problem drinking primary care patients|
Goti 2010 {published data only}|Brief intervention in substance-use among adolescent psychiatric patients: a randomised controlled trial|/resolve/reference/PMED?id=19779855
Gray 2005 {published data only}|The effectiveness of motivational interviewing delivered by youth workers in reducing drinking, cigarette and cannabis smoking among young people: quasi-experimental pilot study|/resolve/reference/PMED?id=16131498
Gregory 2001 {published data only}|College alcohol and life skills study with student-athletes|
Gwadz 2008 {published data only}|Behavioral interventions for HIV infected and uninfected mothers with problem drinking|
Handmaker 1999 {published data only}|Findings of a pilot study of motivational interviewing with pregnant drinkers|/resolve/reference/PMED?id=10091968
Harper 2000 {published data only}|An evaluation of motivational interviewing as a method of intervention with clients in a probation setting|
Haug 2004 {published data only}|Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women|/resolve/reference/PMED?id=15482085
Hayes 2007 {published data only}|Comparing the effectiveness of cognitive-behavioral group therapy with and without motivational interviewing at reducing the social anxiety, alcohol consumption, and negative consequences of socially anxious college students|
Heather 1996 {published data only}|Effects of brief counselling among male heavy drinkers identified on general hospital wards|
Hester 2005 {published data only}|The Drinker's Check-up: 12-month outcomes of a controlled clinical trial of a stand-alone software program for problem drinkers|/resolve/reference/PMED?id=15780546
Hickman 1999 {published data only}|The effects of personal feedback on alcohol intake in dually diagnosed clients: An empirical study of William R. Miller's motivational enhancement therapy|
Hicks 1999 {published data only}|Coping with interpersonal conflict among alcohol abusers in outpatient treatment|
Holder 2000 {published data only}|Alcoholism treatment and medical care costs from Project MATCH|
Hulse 2003 {published data only}|Five-year outcomes of a brief alcohol intervention for adult in-patients with psychiatric disorders|
Johnson 2006 {published data only}|Comparison between a cognitive behavioural alcohol programme and post-mailed minimal intervention in high-risk drinking university freshmen: results from a randomised controlled trial|/resolve/reference/PMED?id=16322100
Juarez 2006 {published data only}|A randomised trial of motivational interviewing and feedback with heavy drinking college students|/resolve/reference/PMED?id=17345916
Jungerman 2007 {published data only}|Short term impact of same intensity but different duration interventions for cannabis users|/resolve/reference/PMED?id=17412530
Kanouse 2005 {published data only}|Recruiting drug-using men who have sex with men into behavioral interventions: a two-stage approach|
Kidorf 2005 {published data only}|Challenges in motivating treatment enrolment in community syringe exchange participants|/resolve/reference/PMED?id=16014875
Kidorf 2009 {published data only}|Improving substance abuse treatment enrolment in community syringe exchangers|
Kinlock 2005 {published data only}|The effect of motivational enhancement therapy on drug abuse treatment retention among drug court clients|
Kuchipudi 1990 {published data only}|Failure of a 2-hour motivational intervention to alter recurrent drinking behavior in alcoholics with gastrointestinal disease|/resolve/reference/PMED?id=2359309
Lachance 2004 {published data only}|Group motivational intervention for underage college student drinkers in mandated university-based programming|
Larimer 2001 {published data only}|Evaluating a brief alcohol intervention with fraternities|/resolve/reference/PMED?id=11414347
Longabaugh 2001 {published data only}|Treatment completion in a brief motivational intervention in the emergency department: The effect of multiple interventions and therapists' behavior|
Longabaugh 2001 {published data only}|Evaluating the effects of a brief motivational intervention for injured drinkers in the emergency department|/resolve/reference/PMED?id=11838918
Longabaugh 2009 {published data only}|Extended naltrexone and broad spectrum treatment or motivational enhancement therapy|/resolve/reference/PMED?id=19639303
Lozano 2006 {published data only}|Abstinence and moderate use goals in the treatment of marijuana dependence|
Magill 2009 {published data only}|The Role of Marijuana Use in Brief Motivational Intervention With Young Adult Drinkers Treated in an Emergency Department|/resolve/reference/PMED?id=19371492
Mahmood 2002 {published data only}|Group motivational intervention in drug abuse treatment|
Marlatt 1998 {published data only}|Screening and brief intervention for high-risk college student drinkers: results from a 2-year follow-up assessment|/resolve/reference/PMED?id=9735576
Martino 2000 {published data only}|Motivational interviewing with psychiatrically ill substance abusing patients|
Mausbach 2007 {published data only}|Efficacy of a behavioral intervention for increasing safer sex behaviours in HIV-negative, heterosexual methamphetamine users: Results from the fast-lane study|/resolve/reference/PMED?id=18020936
McCambridge 2004 {published data only}|The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomised trial|
McDowell 2006 {published data only}|Treatment of cannabis-dependent treatment seekers: A double-blind comparison of nefazodone, bupropion and placebo|
Mckee 2007 {published data only}|Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users|/resolve/reference/PMED?id=17573205
McNally 2005 {published data only}|Motivational interventions for heavy drinking college students: examining the role of discrepancy-related psychological processes|/resolve/reference/PMED?id=15783281
Michael 2006 {published data only}|Group-based motivational interviewing for alcohol use among college students: An exploratory study|
Miller 2005 {published data only}|Motivational interviewing and the incredible shrinking treatment effect|/resolve/reference/PMED?id=15784061
Mitcheson 2007 {published data only}|Pilot cluster-randomised trial of adjunctive motivational interviewing to reduce crack cocaine use in clients on methadone maintenance|/resolve/reference/PMED?id=17172773
Monti 1999 {published data only}|Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department|/resolve/reference/PMED?id=10596521
Monti 2007 {published data only}|Motivational interviewing versus feedback only in emergency care for young adult problem drinking|
Morgenstern 2007 {published data only}|A randomised controlled trial of goal choice interventions for alcohol use disorders among men who have sex with men|/resolve/reference/PMED?id=17295566
Mullins 2004 {published data only}|The impact of motivational interviewing on substance abuse treatment retention: A randomised control trial of women involved with child welfare|/resolve/reference/PMED?id=15223094
Murphy 2001 {published data only}|Relative efficacy of a brief motivational intervention for college student drinkers|/resolve/reference/PMED?id=11767271
Murphy 2003 {published data only}|A comparison of personal feedback for college student drinkers delivered with and without a counselling session|
Murphy 2004 {published data only}|A comparison of personalized feedback for college students drinkers delivered with and without a motivational interview|/resolve/reference/PMED?id=15151350
Noonan 2001 {published data only}|Group motivational interviewing as an enhancement to outpatient alcohol treatment|
Oliveira 2008 {published data only}|Motivational Interview with alcoholics: A longitudinal study abstract|
Ondersma 2007 {published data only}|Computer-based brief intervention a randomised trial with postpartum women|/resolve/reference/PMED?id=17236741
Parsons 2007 {published data only}|Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: A randomized controlled trial|/resolve/reference/PMED?id=18077833
Patterson 2008 {published data only}|Motivational interviewing: Does it increase clients' retention in intensive outpatient treatment?|/resolve/reference/PMED?id=19042315
Pavone 2002 {published data only}|Sobriety management: Healthy living in recovery. retention in treatment and outcome study|
Rao 1999 {published data only}|The short-term impact of the family check-up: A brief motivational intervention for at-risk families|
Reid 2005 {published data only}|The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomised controlled trial|/resolve/reference/PMED?id=16459945
Rimmele 1998 {published data only}|Motivational interviewing to prevent alcohol abuse after TBI|
Samet 2005 {published data only}|A randomised controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems|/resolve/reference/PMED?id=15751766
Sanchez 2001 {published data only}|A values-based intervention for alcohol abuse|
Sanchez-Craig 1996 {published data only}|A self-help approach for high-risk drinking: effect of an initial assessment|/resolve/reference/PMED?id=8803359
Santa Ana 2005 {published data only}|Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence|
Santa Ana 2007 {published data only}|Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence|/resolve/reference/PMED?id=17907864
Saunders 1995 {published data only}|The impact of a brief motivational intervention with opiate users attending a methadone programme|/resolve/reference/PMED?id=7735025
Schilling 2002 {published data only}|Motivational interviewing to encourage self-help participation following alcohol detoxification|
Scott 2002 {published data only}|Preliminary findings from the early re-intervention (ERI) experiment with chronic substance abusers|
Scott 2009 {published data only}|Results from two randomised clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users|
Sears 2006 {published data only}|The complex issue of treatment readiness in an offender population|
Sinha 2003 {published data only}|Engaging young probation-referred marijuana-abusing individuals in treatment: a pilot trial|/resolve/reference/PMED?id=14504024
Sitharthan 1999 {published data only}|Integrated drug and alcohol intervention: development of an opportunistic intervention program to reduce alcohol and other substance use among psychiatric patients|/resolve/reference/PMED?id=10544991
Sobell 2002 {published data only}|Promoting self-change with alcohol abusers: a community-level mail intervention based on natural recovery studies|
Soderstrom 2007 {published data only}|A controlled trial of brief intervention versus brief advice for at-risk drinking trauma centre patients|/resolve/reference/PMED?id=17495708
Stein 2002a {published data only}|Motivational interviewing and relapse prevention for DWI: A pilot study|/resolve/reference/PMED?id=20485471
Stein 2006 {published data only}|Effects of motivational interviewing for incarcerated adolescents on driving under the influence after release|
Stein 2006 {published data only}|Enhancing substance abuse treatment engagement in incarcerated adolescents|/resolve/reference/PMED?id=20617117
Stein 2006a {published data only}|A smoking cessation intervention for the methadone-maintained|
Stephens 2000 {published data only}|Comparison of extended versus brief treatments for marijuana use|/resolve/reference/PMED?id=11068976
Stephens 2002 {published data only}|The Marijuana Treatment Project: rationale, design and participant characteristics|
Stockwell 1986 {published data only}|Motivational interviewing with problem drinkers - impact on attendance, drinking and outcome|
Stotts 2004 {published data only}|Brief motivational interviewing with psychophysiologic feedback for the treatment of cocaine abuse|
Swanson 1999 {published data only}|Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients|/resolve/reference/PMED?id=10535657
Tapert 2003 {published data only}|Depressed mood, gender, and problem drinking in youth|
Tevyaw 2007 {published data only}|Peer enhancement of a brief motivational intervention with mandated college students|/resolve/reference/PMED?id=17385961
Thevos 1998 {published data only}|Alcoholism with and without social phobia: A comparison of pre and post treatment differences in drinking and social support|
Thush 2007 {published data only}|A randomised clinical trial of a targeted intervention to moderate alcohol use and alcohol-related problems in at-risk adolescents|/resolve/reference/PMED?id=16928395
Tirado 2005 {published data only}|An open label pilot trial of atomoxetine and four-session motivational interviewing for cannabis dependence|
Vanderburg 2003 {published data only}|Motivational interviewing as a precursor to a substance abuse program for offenders|
Velasquez 2009 {published data only}|Reducing sexual risk behaviours and alcohol use among HIV-positive men who have sex with men: a randomised clinical trial|/resolve/reference/PMED?id=19634959
Wain 2006 {published data only}|Brief motivational interview improves treatment adherence in homeless men with severe drug and alcohol dependence|
Walters 2000 {published data only}|Reducing alcohol use in college students: A controlled trial of two brief interventions|/resolve/reference/PMED?id=11092154
Walton 2010 {published data only}|Effects of a brief intervention for reducing violence and alcohol misuse among adolescents. a randomised controlled trial|/resolve/reference/PMED?id=20682932
Weinrieb 2005 {published data only}|A controlled study of motivational enhancement therapy (MET) vs. community alcoholism treatment for alcoholic liver transplant candidates|
Wells 1998 {published data only}|Motivational enhancement to increase treatment readiness among stimulant users: A pilot evaluation|
Wells 2004 {published data only}|Motivational enhancement to decrease drug use among cocaine users: Six-month follow-up results|
Wertz 1994 {published data only}|The effect of motivational interviewing on treatment participation, self-efficacy, and alcohol use at follow-up in inpatient alcohol dependent adults|
Whitten 2006 {published data only}|Checkup System Catches Relapse Early and Facilitates Return to Treatment|
Wilbourne 2005 {published data only}|An empirical basis for the treatment of alcohol problems|
Woodall 2007 {published data only}|A randomised trial of a DWI intervention program for first offenders: intervention outcomes and interactions with antisocial personality disorder among a primarily American-Indian sample|
Woody 2001 {published data only}|Methadone maintenance and opioid positive urine: a test of 80 mg vs 120 mg and MET vs DC|
Yonkers 2009 {published data only}|A treatment for substance abusing pregnant women|/resolve/reference/PMED?id=19350369
Zahradnik 2009 {published data only}|Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients|
Zule 2009 {published data only}|Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users|/resolve/reference/PMED?id=19218179
Barrowclough 2010 {published data only}|Evaluating integrated MI and CBT for people with psychosis and substance misuse: Recruitment, retention and sample characteristics of the MIDAS trial|/resolve/reference/PMED?id=19362429
Barrowclough 2010 {published data only}|Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders|/resolve/reference/PMED?id=11579006
Barrowclough 2010 {published data only}|Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial|/resolve/reference/PMED?id=21106618
Walters 2010 {published data only}|Motivational Interviewing as a Supervision Strategy inProbation: A Randomized Effectiveness Trial|
Dubertret 2010 {unpublished data only}|Effect of motivational therapy on schizophrenia with cannabis misuse.|
Forsberg 2010 {unpublished data only}|Effects of Motivational Interviewing in Prison.|
Hansen 2010 {unpublished data only}|Brief intervention for heavy drinkers.|
Morken 2010 {unpublished data only}|Motivational interviewing to acutely admitted psychiatric patients with comorbid substance use|
Andreasson 2003|Psychosocial treatment for alcohol dependence|
APA 1987||
APA 1994||
APA 2000||
Apodaca 2009|Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence|
Borenstein 2005|Comprehensive Meta-Analysis Version 2|
Burke 2003|The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials|/resolve/reference/PMED?id=14516234
Burke 2004|The emerging evidence base for motivational interviewing: A meta-analytic and qualitative inquiry|
Carey 2007|Individual-level interventions to reduce college student drinking: a meta-analytic review|/resolve/reference/PMED?id=17590277
Darke 1991||
Darke 1992|Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index|
deWildt 2002|Does psychosocial treatment enhance the efficacy of Acamprosate in patients with alcohol problems?|/resolve/reference/PMED?id=12107041
Dunn 2001|The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review|
Emmelkamp 2006||
Grenard 2006|Motivational interviewing with adolescents and young adults for drug-related problems|/resolve/reference/PMED?id=16639859
Guyatt 2008|GRADE: an emerging consensus on rating quality of evidence and strength of recommendations|/resolve/reference/PMED?id=18436948
Heather 1993||
Hettema 2005|Motivational interviewing|/resolve/reference/PMED?id=17716083
Higgins 2009|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]|
Lai 2010|Motivational interviewing for smoking cessation|
Lambert 1986|Implications of psychotherapy outcome research for eclectic psychotherapy|
Larimer 2007|Identification, prevention, and treatment revisited: individual-focused college drinking prevention strategies 1999-2006|/resolve/reference/PMED?id=17604915
Lundahl 2010|A meta-analysis of motivational interviewing: twenty-five years of empirical studies|
Madson 2006|Measures of fidelity in motivational enhancement: A systematic review|/resolve/reference/PMED?id=16814012
Miller 1983|Motivational interviewing with problem drinkers|
Miller 1991||
Moyers 2005|Assessing competence in the use of motivational interviewing|/resolve/reference/PMED?id=15723728
Nahom 2005|Motivational interviewing and behavior change: How can we know how it works?|
Pogue 1997|Cumulating evidence from randomised trials: utilizing sequential monitoring boundaries for cumulative meta-analysis|/resolve/reference/PMED?id=9408720
Project MATCH 1997|Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes|/resolve/reference/PMED?id=8979210
Rogers 1951|Client-centered therapy|
Rubak 2005|Motivational interviewing: a systematic review and meta-analysis|/resolve/reference/PMED?id=15826439
Sobell 1992|Time line follow-back: A technique for assessing self-reported ethanol consumption|
Vasilaki 2006|The efficacy of motivational interviewing as a brief intervention for excessive drinking: A meta-analytic review|/resolve/reference/PMED?id=16547122
Walach 2001|The efficacy paradox in randomised controlled trials of CAM and elsewhere: beware of the placebo trap|/resolve/reference/PMED?id=11439833
White 1989|Towards the assessment of adolescent problem drinking|/resolve/reference/PMED?id=2927120
WHO 1993||
WHO 2009|Management of substance abuse|
England 1988 {published data only}|Mitral stenosis in pregnancy: effect of atenolol on exercise tolerance|
Abid 1990|Closed mitral valvotomy in pregnancy--a study of seven cases|/resolve/reference/PMED?id=2312200
Abouzied 2001|Percutaneous balloon mitral commissurotomy during pregnancy|/resolve/reference/PMED?id=11269785
Aggarwal 2005|Closed mitral valvotomy in pregnancy and labor|/resolve/reference/PMED?id=15694085
Al Kassab 1990|Beta-adrenergic receptor blockade in the management of pregnant women with mitral stenosis|/resolve/reference/PMED?id=1973871
Ali Oto 1997|Percutaneous balloon valvuloplasty for severe mitral stenosis in pregnancy. Four case reports|/resolve/reference/PMED?id=9158391
Angel 1988|Percutaneous balloon aortic valvuloplasty in pregnancy|/resolve/reference/PMED?id=2457193
Anonymous 1978|Mitral commissurotomy during pregnancy|/resolve/reference/PMED?id=750572
Arias 1978|Aortic stenosis and pregnancy|/resolve/reference/PMED?id=671391
Ashgar 2005|Evaluation and outcome of pregnancy complicated by heart disease|/resolve/reference/PMED?id=16304847
Bahl 1997|Concurrent balloon dilatation of mitral and tricuspid stenosis during pregnancy using an Inoue balloon|
Baron 2002|Percutaneous balloon mitral valvuloplasty during a twin gestation|/resolve/reference/PMED?id=11902706
Ben Farhat 1992|Percutaneous balloon mitral valvuloplasty in eight pregnant women with severe mitral stenosis|/resolve/reference/PMED?id=1289097
Ben Farhat 1997|Percutaneous balloon mitral commissurotomy during pregnancy|/resolve/reference/PMED?id=9227303
Ben-Ami 1990|Aortic valve replacement during pregnancy. A case report and review of the literature|
Bhatia 1978|Mitral commissurotomy during pregnancy|/resolve/reference/PMED?id=750564
Bhatla 2003|Cardiac disease in pregnancy|/resolve/reference/PMED?id=12873775
Birincioglu 1999|Perinatal mitral valve interventions: a report of 10 cases|/resolve/reference/PMED?id=10355403
Brady 1989|Rheumatic heart disease in pregnancy|/resolve/reference/PMED?id=2661077
Cabral Castaeda 1997|Perinatal perspective in heart disease and pregnancy. Review of 1169 cases of pregnancy|/resolve/reference/PMED?id=9312521
Cheng 2000|Percutaneous inoue balloon valvuloplasty is the procedure of choice for symptomatic mitral stenosis in pregnant women|
Cheng 2002|Percutaneous mitral valvuloplasty by the Inoue balloon technique is the ideal procedure for treatment of significant mitral stenosis in pregnant women|
Chow 1992|Percutaneous balloon mitral valvotomy in pregnancy using the Inoue balloon catheter|/resolve/reference/PMED?id=1286478
Clark 1985|Labor and delivery in the presence of mitral stenosis: central hemodynamic observations|/resolve/reference/PMED?id=4025461
Davies 2007|Acquired heart disease in pregnancy|/resolve/reference/PMED?id=17568483
De Souza 2001|Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy|/resolve/reference/PMED?id=11693768
De Swiet 2004|Cardiac disease|
Desai 2000|Mitral stenosis in pregnancy: a four-year experience at King Edward VIII Hospital, Durban, South Africa|
Dommisse 1996|Balloon valvuloplasty for severe mitral valve stenosis in pregnancy. A report of 11 cases|/resolve/reference/PMED?id=9180783
Easterling 1988|Aortic stenosis in pregnancy|/resolve/reference/PMED?id=3380498
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
El Maraghy 1983|Mitral valvotomy in pregnancy|/resolve/reference/PMED?id=6829658
Elkayam 2005|Valvular heart disease and pregnancy part I: native valves|/resolve/reference/PMED?id=16022946
ESC 2003|Expert consensus document on management of cardiovascular diseases during pregnancy|/resolve/reference/PMED?id=12800857
Esteves 1991|Effectiveness of percutaneous balloon mitral valvotomy during pregnancy|/resolve/reference/PMED?id=1927952
Esteves 2006|Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis|/resolve/reference/PMED?id=16950192
Fawzy 2001|Long-term outcome of mitral balloon valvotomy in pregnant women|/resolve/reference/PMED?id=11297200
Flynn 1994|Mitral valvuloplasty for mitral stenosis during pregnancy:a case study|
Gangbar 1992|Mitral balloon valvuloplasty in pregnancy: advantages of a unique balloon|
Gelson 2007|Valvular heart disease|/resolve/reference/PMED?id=18007005
Glantz 1993|Percutaneous balloon valvuloplasty for severe mitral stenosis during pregnancy: a review of therapeutic options|/resolve/reference/PMED?id=8355925
Glasziou 2004|Assessing the quality of research|/resolve/reference/PMED?id=14703546
Goon 1987|Closed mitral valvotomy in pregnancy--a Malaysian experience|
Gujral 1972|Closed mitral valvotomy in mitral stenosis with significant pulmonary hypertension|/resolve/reference/PMED?id=5071332
Gupta 1998|Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes|/resolve/reference/PMED?id=9783788
Hameed 2001|The effect of valvular heart disease on maternal and fetal outcome of pregnancy|/resolve/reference/PMED?id=11693767
Harbord 2006|A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints|
Harthorne 1967|Valve replacement during pregnancy|/resolve/reference/PMED?id=6050810
Higgins 2009|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009|
Horstkotte 2005|Balloon valvotomy during pregnancy|/resolve/reference/PMED?id=15792171
Iscan 2006|Cardiac surgery during pregnancy|/resolve/reference/PMED?id=17044375
Kale 1973|Mitral valvotomy during pregnancy|/resolve/reference/PMED?id=4793628
Kalra 1994|Percutaneous mitral commissurotomy for severe mitral stenosis during pregnancy|
Kinsara 2002|Effect of balloon mitral valvoplasty during pregnancy on childhood development|/resolve/reference/PMED?id=12077568
Knapp 1968|Closed mitral valvulotomy in pregnancy|/resolve/reference/PMED?id=4884072
Kozam 1966|Open-heart surgery for mitral stenosis during pregnancy|
Lao 1993|Congenital aortic stenosis and pregnancy--a reappraisal|/resolve/reference/PMED?id=8372858
Lee 1992|Percutaneous mitral valvuloplasty in a mid-term pregnant woman with severe rheumatic mitral stenosis|/resolve/reference/PMED?id=1477032
Lee 2001|Percutaneous balloon mitral valvuloplasty during pregnancy: long-term follow-up of infant growth and development|/resolve/reference/PMED?id=11406680
Lesniak 2004|Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome|/resolve/reference/PMED?id=14996469
Loya 1993|Mitral and pulmonary balloon valvotomy in pregnant patients|/resolve/reference/PMED?id=8365743
Lung 1994|Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy|/resolve/reference/PMED?id=8109557
Malhotra 2003|Mitral valve surgery and maternal and fetal outcome in valvular heart disease|/resolve/reference/PMED?id=12706271
Mangione 1989|Percutaneous double balloon mitral valvuloplasty in pregnant women|/resolve/reference/PMED?id=2662735
Mangione 2000|Long-term follow-up of pregnant women after percutaneous mitral valvuloplasty|
Mangione 2007|Percutaneous mitral valvuloplasty in a pregnant woman guided only by the transesophageal echocardiography|/resolve/reference/PMED?id=17533461
Martinez-Redding 1998|Treatment of severe mitral stenosis with percutaneous balloon valvotomy in pregnant patients|
Matorras 1986|Commissurotomy and pregnancy. A study of 245 cases|
McFaul 1998|Pregnancy complicated by maternal heart disease. A review of 519 women|
Miller 1978|Two mitral valve replacements during the course of a single pregnancy|/resolve/reference/PMED?id=621314
Mishra 2001|Percutaneous transseptal mitral commissurotomy in pregnant women with critical mitral stenosis|/resolve/reference/PMED?id=11428476
Nagy 1988|Open mitral commissurotomy in pregnancy. A case report|/resolve/reference/PMED?id=3387944
Nelson-Piercy 2002|Heart disease in pregnancy|/resolve/reference/PMED?id=12503359
Nercolini 2002|Percutaneous mitral balloon valvuloplasty in pregnant women with mitral stenosis|
Notrica 2009|Life-saving percutaneous mitral valvuloplasty on a pregnant woman with refractory cardiogenic shock|
Oliveira 1996|Obstetric and perinatal aspects in patients with congenital heart diseases|/resolve/reference/PMED?id=9239923
Onderoglu 1995|Balloon valvuloplasty during pregnancy|/resolve/reference/PMED?id=7649325
Palacios 1988|Percutaneous mitral balloon valvotomy during pregnancy in a patient with severe mitral stenosis|
Patel 1993|Percutaneous balloon mitral valvotomy in pregnant patients with tight pliable mitral stenosis|/resolve/reference/PMED?id=8465734
Pavankumar 1988|Closed mitral valvotomy during pregnancy. A 20-year experience|/resolve/reference/PMED?id=3387943
Pershad 2000|Precipitous labor in association with percutaneous mitral valvuloplasty: successful delivery in the catheterization laboratory|
Poirier 1997|Mitral balloon valvuloplasty in pregnancy: limiting radiation and procedure time by using transesophageal echocardiography|/resolve/reference/PMED?id=9343034
Presbitero 1996|Interventional cardiology in pregnancy|/resolve/reference/PMED?id=8732370
Reardon 2006|Mitral valve stenosis in a pregnant immigrant|/resolve/reference/PMED?id=16738257
Reimold 2003|Clinical practice. Valvular heart disease in pregnancy|/resolve/reference/PMED?id=12840093
RevMan 2008|Review Manager (RevMan)|
Ribeiro 1991|Percutaneous mitral balloon valvotomy in pregnancy using the Inoue balloon technique|/resolve/reference/PMED?id=1910881
Ribeiro 1992a|Balloon valvotomy for pregnant patients with severe pliable mitral stenosis using the Inoue technique with total abdominal and pelvic shielding|/resolve/reference/PMED?id=1462914
Ribeiro 1992b|Mitral balloon valvotomy in pregnancy|/resolve/reference/PMED?id=1341629
Routray 2004|Balloon mitral valvuloplasty during pregnancy|/resolve/reference/PMED?id=15050462
Ruzyllo 1992|Percutaneous mitral commissurotomy with the Inoue balloon for severe mitral stenosis during pregnancy|/resolve/reference/PMED?id=1341630
Safian 1988|Percutaneous balloon mitral valvuloplasty in a pregnant woman with mitral stenosis|
Said 1991|Dextrocardia, situs inversus and severe mitral stenosis in a pregnant woman: successful closed commissurotomy|/resolve/reference/PMED?id=1889448
Salom 2002|Balloon mitral valvuloplasty during pregnancy--our experience|/resolve/reference/PMED?id=12621917
Sananes 1994|Fetal and obstetrical impact of percutaneous balloon mitral commissurotomy during pregnancy|/resolve/reference/PMED?id=7945900
Savas 1991|Percutaneous triple-valve balloon valvuloplasty in a pregnant woman|
Sawhney 2003|Maternal and perinatal outcome in rheumatic heart disease|/resolve/reference/PMED?id=12527454
Schaefer 1968|Congenital heart disease and pregnancy|/resolve/reference/PMED?id=5750857
Schenker 1968|Mitral valvotomy during pregnancy|/resolve/reference/PMED?id=5663825
Seca 2008|Percutaneous mitral valvuloplasty complicated by cardiac tamponade in a pregnant patient|/resolve/reference/PMED?id=19142369
Senaratne 2003|Percutaneous interventions in stenotic valvular heart disease complicating pregnancy|/resolve/reference/PMED?id=15125399
Shirodaria 2004|Emergency balloon mitral valvotomy for severe mitral stenosis during pregnancy|/resolve/reference/PMED?id=15253973
Siu 2001|Prospective multicenter study of pregnancy outcomes in women with heart disease|/resolve/reference/PMED?id=11479246
Siva 2005|Moderate mitral stenosis in pregnancy: the haemodynamic impact of diuresis|/resolve/reference/PMED?id=15604310
Sivadasanpillai 2005|Long-term outcome of patients undergoing balloon mitral valvotomy in pregnancy|/resolve/reference/PMED?id=15950584
Smith 1989|Percutaneous transluminal balloon dilatation of the mitral valve in pregnancy|/resolve/reference/PMED?id=2757867
Stephen 1983|Surgical management of mitral stenosis in pregnancy|/resolve/reference/PMED?id=6667527
Stephen 1992|Changing patterns of mitral stenosis in childhood and pregnancy in Sri Lanka|/resolve/reference/PMED?id=1564228
Stout 2007|Pregnancy in women with valvular heart disease|/resolve/reference/PMED?id=16905631
Subbarao 2004|Transventricular mitral commissurotomy in critical mitral stenosis during pregnancy|/resolve/reference/PMED?id=15353462
Sugrue 1981|Pregnancy complicated by maternal heart disease at the National Maternity Hospital, Dublin, Ireland, 1969 to 1978|/resolve/reference/PMED?id=7457508
Thiln 1997|Pregnancy and heart disease: a review|/resolve/reference/PMED?id=9447346
Tumelero 2004|Percutaneous balloon aortic valvuloplasty in a pregnant adolescent|/resolve/reference/PMED?id=14978598
Uygur 2001|Mitral balloon valvuloplasty during pregnancy in developing countries|/resolve/reference/PMED?id=11384815
Veray 1968|Heart disease in pregnancy|/resolve/reference/PMED?id=5742126
Vosloo 1987|The feasibility of closed mitral valvotomy in pregnancy|/resolve/reference/PMED?id=3573780
Weiss 1998|Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996|/resolve/reference/PMED?id=9855611
Yaryura 1996|Management of mitral valve stenosis in pregnancy: case presentation and review of the literature|/resolve/reference/PMED?id=8834719
Yonga 2000|Treatment of severe mitral stenosis in pregnancy using multi-track mitral balloon dilatation: case report|/resolve/reference/PMED?id=12862160
ALLHAT 2002 {published data only}|Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=12479763
ALLHAT 2002 {published data only}|Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=17101936
ALLHAT 2002 {published data only}|Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=11315826
ALLHAT 2002 {published data only}|Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=18000186
ALLHAT 2002 {published data only}|Blood pressure control by randomized drug group in ALLHAT|
ALLHAT 2002 {published data only}|Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial|/resolve/reference/PMED?id=19001024
ALLHAT 2002 {published data only}|Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial|/resolve/reference/PMED?id=16651474
ALLHAT 2002 {published data only}|Did blood pressure medication withdrawal prior to randomization influence subsequent rates of heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial?|
ALLHAT 2002 {published data only}|Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?|
ALLHAT 2002 {published data only}|Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)|/resolve/reference/PMED?id=19926008
ALLHAT 2002 {published data only}|Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial|/resolve/reference/PMED?id=16864749
ALLHAT 2002 {published data only}|Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study|/resolve/reference/PMED?id=19352213
ALLHAT 2002 {published data only}|Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. [Erratum appears in JAMA. 2009 Sep 9;302(10):1057-8]|/resolve/reference/PMED?id=18212314
ALLHAT 2002 {published data only}|Mortality and morbidity during and after the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)|
ALLHAT 2002 {published data only}|Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=15851647
ALLHAT 2002 {published data only}|Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril|/resolve/reference/PMED?id=15811979
ALLHAT 2002 {published data only}|Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)|/resolve/reference/PMED?id=18227370
ALLHAT 2002 {published data only}|Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study|
Ariff 2006 {published data only}|Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension|/resolve/reference/PMED?id=16888272
Buus 2004 {published data only}|Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension|/resolve/reference/PMED?id=15326083
Buus 2007 {published data only}|Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade|/resolve/reference/PMED?id=17612909
Dahlf 1993 {published data only}|The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide|
Dahlf 2002 {published data only}|Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy|/resolve/reference/PMED?id=12195129
Dalla 2004 {published data only}|Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina)|/resolve/reference/PMED?id=16295047
Derosa 2004 {published data only}|Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study|/resolve/reference/PMED?id=15476904
Derosa 2005 {published data only}|Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension|/resolve/reference/PMED?id=15897788
Derosa 2014 {published data only}|Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients|
Devereux 2001 {published data only}|Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial|/resolve/reference/PMED?id=11551875
Esnault 2008 {published data only}|The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study|/resolve/reference/PMED?id=18405787
Estacio 1998 {published data only}|Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes|/resolve/reference/PMED?id=10860192
Estacio 1998 {published data only}|The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension|/resolve/reference/PMED?id=9486993
Estacio 1998 {published data only}|Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial|/resolve/reference/PMED?id=9822137
Fogari 2012 {published data only}|Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size|
Gerritsen 1998 {published data only}|Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension|/resolve/reference/PMED?id=9797181
Gottdiener 1998 {published data only}|Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension|/resolve/reference/PMED?id=9679720
Hajjar 2013 {published data only}|Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial|/resolve/reference/PMED?id=22412114
Hajjar 2013 {published data only}|Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial|
Hauf-Zachariou 1993 {published data only}|A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia|/resolve/reference/PMED?id=8223847
Hayoz 2012 {published data only}|Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen|
Himmelmann 1996 {published data only}|Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta-blockade|/resolve/reference/PMED?id=8879340
Hughes 2008 {published data only}|Effect of antihypertensive treatment on retinal microvascular changes in hypertension|/resolve/reference/PMED?id=18622251
IDNT 2001 {published data only}|Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy|/resolve/reference/PMED?id=12667024
IDNT 2001 {published data only}|Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes|/resolve/reference/PMED?id=11565517
LIFE 2002 {published data only}|The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group|/resolve/reference/PMED?id=9234823
LIFE 2002 {published data only}|Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension|/resolve/reference/PMED?id=9856962
LIFE 2002 {published data only}|Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol|/resolve/reference/PMED?id=11937178
LIFE 2002 {published data only}|Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial|/resolve/reference/PMED?id=12899584
LIFE 2002 {published data only}|The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study|/resolve/reference/PMED?id=16139123
LIFE 2002 {published data only}|Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy|/resolve/reference/PMED?id=16116047
LIFE 2002 {published data only}|Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study)|/resolve/reference/PMED?id=19562573
LIFE 2002 {published data only}|Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study|/resolve/reference/PMED?id=15028365
LIFE 2002 {published data only}|Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study|/resolve/reference/PMED?id=15583076
LIFE 2002 {published data only}|The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study|
LIFE 2002 {published data only}|Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol|/resolve/reference/PMED?id=11937179
LIFE 2002 {published data only}|Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients|/resolve/reference/PMED?id=19631946
LIFE 2002 {published data only}|Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy|/resolve/reference/PMED?id=23403268
LIFE 2002 {published data only}|Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients|/resolve/reference/PMED?id=20395941
LIFE 2002 {published data only}|Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study|/resolve/reference/PMED?id=19262226
LIFE 2002 {published data only}|Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study|/resolve/reference/PMED?id=18259029
Malmqvist 2002 {published data only}|Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)|/resolve/reference/PMED?id=12423712
Malmqvist 2002 {published data only}|Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)|/resolve/reference/PMED?id=14639093
Malmqvist 2002 {published data only}|Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study|
Ostman 1998 {published data only}|Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group|
Parrinello 2009 {published data only}|One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study|/resolve/reference/PMED?id=19663521
Pedersen 1997 {published data only}|A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over two years|/resolve/reference/PMED?id=9458489
Petersen 2001 {published data only}|A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension|/resolve/reference/PMED?id=11393383
Roman 1998 {published data only}|Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy|/resolve/reference/PMED?id=9607375
Ruggenenti 2004 {published data only}|Preventing microalbuminuria in type 2 diabetes|/resolve/reference/PMED?id=15516697
Schiffrin 1994 {published data only}|Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension|/resolve/reference/PMED?id=8282334
Schmieder 2009 {published data only}|Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide|/resolve/reference/PMED?id=19139391
Schneider 2004 {published data only}|Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project|/resolve/reference/PMED?id=15184349
Schram 2005 {published data only}|Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial|/resolve/reference/PMED?id=15647778
Seedat 1998 {published data only}|Antihypertensive effect and tolerability of perindopril in Indian hypertensive and type 2 diabetic patients: 1-year randomised, double-blind, parallel study vs atenolol|/resolve/reference/PMED?id=18370544
Srensen 1998 {published data only}|Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive type I diabetes patients with nephropathy|/resolve/reference/PMED?id=9831696
Tarnow 1999 {published data only}|Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy|/resolve/reference/PMED?id=10097934
Tedesco 1999 {published data only}|Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients|/resolve/reference/PMED?id=10604491
Terpstra 2004 {published data only}|Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial)|/resolve/reference/PMED?id=15201546
TOHMS 1993 {published data only}|Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group|/resolve/reference/PMED?id=8336373
VALUE 2004 {published data only}|Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial|/resolve/reference/PMED?id=15207952
VALUE 2004 {published data only}|The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy|/resolve/reference/PMED?id=16864741
VALUE 2004 {published data only}|The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design|/resolve/reference/PMED?id=9758088
VALUE 2004 {published data only}|Predictors of stroke recurrence in high-risk, hypertensive patients|
VALUE 2004 {published data only}|Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial|/resolve/reference/PMED?id=17053536
Zeltner 2008 {published data only}|Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease|/resolve/reference/PMED?id=17984104
AASK 2002 {published data only}|Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease|/resolve/reference/PMED?id=12435255
Materson 1993 {published data only}|Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents|/resolve/reference/PMED?id=8446138
Okin 2012 {published data only}|The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium|/resolve/reference/PMED?id=22243363
Preston 1998 {published data only}|Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents|/resolve/reference/PMED?id=9777817
ABCD-HT 2000|Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes|/resolve/reference/PMED?id=10860192
ADA 2013|Standards of medical care in diabetes|/resolve/reference/PMED?id=23264422
Atkins 2004|Grading quality of evidence and strength of recommendations|/resolve/reference/PMED?id=15205295
Aurell 1992|Determinants of progressive renal disease in diabetes mellitus|
CAPPP 2001|Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project (CAPPP)|/resolve/reference/PMED?id=11723089
Casas 2005|Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis|/resolve/reference/PMED?id=16338452
Chen 2010|Calcium channel blockers versus other classes of drugs for hypertension|
CPG 2013|Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada - Treatment of Hypertension|/resolve/reference/PMED?id=24070930
DeStefano 1993|Risk factors for coronary heart disease mortality among persons with diabetes|/resolve/reference/PMED?id=8287153
Duprez 2006|Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review|/resolve/reference/PMED?id=16685192
Dzau 2001|Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis|/resolve/reference/PMED?id=11304501
ESH/ESC 2013|Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)|/resolve/reference/PMED?id=23817082
Geiss 2002|Elevated blood pressure among U.S. adults with diabetes, 1988-1994|/resolve/reference/PMED?id=11777678
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011|
HOPE 2000|Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy|/resolve/reference/PMED?id=10675071
Inzucchi 2005|The prevention of type 2 diabetes mellitus|/resolve/reference/PMED?id=15752928
JNC-8 2014|2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)|/resolve/reference/PMED?id=24352797
Kasiske 1993|Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta regression analysis|/resolve/reference/PMED?id=8416309
Kocks 2002|Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease|/resolve/reference/PMED?id=11856904
Lefebvre 2011|Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) . The Cochrane Collaboration, 2011|
MARVAL 2002|Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus|/resolve/reference/PMED?id=12163426
Pahor 2000|Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes|/resolve/reference/PMED?id=10895836
PROGRESS 2001|Randomised trial of perindopril based blood pressure-lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack|/resolve/reference/PMED?id=11589932
Ravine 1994|Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1|/resolve/reference/PMED?id=7908078
RENAAL 2001|Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy|/resolve/reference/PMED?id=11565518
RevMan 2014|Review Manager (RevMan)|
Saha 2008|Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials|/resolve/reference/PMED?id=18095949
Siebenhofer 2004|Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials|
Strippoli 2005|Antihypertensive agents for preventing diabetic kidney disease|
Strippoli 2006|Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease|
Wiysonge 2012|Beta-blockers for hypertension|
Wright 2009|First-line drugs for hypertension|
Wu 2013|Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis|/resolve/reference/PMED?id=24157497
ABCD-2V 2006 {published data only}|Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes|/resolve/reference/PMED?id=17161769
ABCD-H 1998 {published data only}|The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension|/resolve/reference/PMED?id=9486993
ABCD-N 2002 {published data only}|Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes|/resolve/reference/PMED?id=11849464
ACCORD BP 2010 {published data only}|Effects of intensive blood-pressure control in type 2 diabetes mellitus|
HOT 1998 {published data only}|Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group|/resolve/reference/PMED?id=9635947
HDS 1996 {published data only}|Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood presure control [Erratum]|
HDS 1996 {published data only}|Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood presure control|/resolve/reference/PMED?id=8960842
Lewis 1999 {published data only}|Effect on intensive blood pressure control on the course of type 1 diabetic nephropathy|/resolve/reference/PMED?id=10561135
SANDS 2008 {published data only}|Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes|/resolve/reference/PMED?id=18398080
Steno-2 2003 {published data only}|Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes|/resolve/reference/PMED?id=12556541
UKPDS 38 1998 {published data only}|Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [Erratum]|/resolve/reference/PMED?id=9872880
UKPDS 38 1998 {published data only}|Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38|/resolve/reference/PMED?id=9732337
ABCD 2007|Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial|/resolve/reference/PMED?id=17653121
ABCD-H 2000|Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes|
ADA 2012|Standards of medical care in diabetes|
ADA 2013|Standards of medical care in diabetes 2013|
Adler 2000|Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study|/resolve/reference/PMED?id=10938049
AHA 2007|Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention|/resolve/reference/PMED?id=17502569
Arguedas 2009|Treatment blood pressure targets for hypertension|
Arguedas 2010|Blood pressure targets: are clinical guidelines wrong?|
Bangalore 2010|J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial|
Bangalore 2011|Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose. Observations from traditional and Bayesian random-effects meta-analyses of randomized trials|
BHS 2004|British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary|/resolve/reference/PMED?id=15016698
Boissel 2005|Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments|
BPLTTC 2003|Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials|/resolve/reference/PMED?id=14615107
CHEP 2011|The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy|
Cooper-DeHoff 2010|Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease|
Deedwania 2011|Blood pressure control in diabetes mellitus. Is lower always better, and how low it should go?|
Dorresteijn 2012|Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease. J-curve revisited|
ESH-ESC 2007|2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)|/resolve/reference/PMED?id=17563527
ESH/ESC2013|2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)|
Farnett 1991|The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?|/resolve/reference/PMED?id=1824642
Filippone 2011|Goal-directed antihypertensive therapy: lower may not always be better|
Grossman 2011|Blood pressure: the lower, the better. The con side|
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
JNC 7 2003|The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report|/resolve/reference/PMED?id=12748199
Kannel 1996|Blood pressure as a cardiovascular risk factor: prevention and treatment|/resolve/reference/PMED?id=8622248
LA 2009|Latin American Guidelines on Hypertension|/resolve/reference/PMED?id=19349909
Laurent 2004|Guidelines from the British Hypertension Society. The lower the pressure the better|/resolve/reference/PMED?id=15016662
MacMahon 1990|Blood pressure, stroke and CHD. Part 1. Prolonged differences in blood pressure: prospective observational studies collected for the regression dilution blas|/resolve/reference/PMED?id=1969518
Mancia 2011|Antihypertensive treatment and blood pressure in diabetic and nondiabetic patients.The lower, the better?|
McBrien 2012|Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus. Systematic review and meta-analysis|
Messerli 2006|Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?|/resolve/reference/PMED?id=16785477
NICE 2011|Hypertension. Clinical management of primary hypertension in adults|
Oparil 2003|Pathogenesis of hypertension|/resolve/reference/PMED?id=14597461
Parati 2011|Benefits of tight blood pressure control in diabetic patients with hypertension.Importance of early and sustained implementation of effective treatment strategies|
Prospective Studies 2002|Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies|/resolve/reference/PMED?id=12493255
Reboldi 2011|Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73913 patients|
RevMan 2012|Review Manager (RevMan)|
Sleight 2009|Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial study|/resolve/reference/PMED?id=19506526
Stamler 1993|Blood Pressure, systolic and diastolic and cardiovascular risk. US population data|/resolve/reference/PMED?id=8439223
Stamler 1993b|Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial|/resolve/reference/PMED?id=8432214
Vok 1999|J-shaped relation between blood pressure and stroke in treated hypertensives|/resolve/reference/PMED?id=10601115
WHO/ISH 2003|2003 World Health Organization (WHO/International Society of Hypertension (ISH) statement on management of hypertension|/resolve/reference/PMED?id=14597836
Zanchetti 2003|Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk-profiles: does a J-shaped curve exist in smokers?|/resolve/reference/PMED?id=12658027
Zanchetti 2009|Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?|/resolve/reference/PMED?id=19564795
Aboud 2010|Cardiovascular risk evaluation and anti retroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study|
Alibhai 2005|An approach to the management of unintentional weight loss in elderly people|/resolve/reference/PMED?id=15767612
Aston 2006|Nutrition in palliative care: effective or ineffective?|
Bennett 2010|Delivering research in end-of-life care: problems, pitfalls and future priorities|/resolve/reference/PMED?id=20427380
Benzein 2005|The level of and relation between hope, hopelessness and fatigue in patients and family members in palliative care|/resolve/reference/PMED?id=15920938
Brunnhuber 2008|Putting evidence into practice: palliative care|
Carey 2000|Cancer cachexia|
Caro 2007|Nutritional interventions and quality of life in adult oncology patients|/resolve/reference/PMED?id=17368656
Davies 2004||
Davis 2000|Cachexia and anorexia: cancer's covert killer|/resolve/reference/PMED?id=10789957
Dittner 2004|The assessment of fatigue: a practical guide for clinicians and researchers|/resolve/reference/PMED?id=15016573
Evans 2008|Cachexia: a new definition|/resolve/reference/PMED?id=18718696
Glaspy 2010|Cancer patient survival and erythropoietin|/resolve/reference/PMED?id=16316615
GRADE Working Group 2004|Grading quality of evidence and strength of recommendations|/resolve/reference/PMED?id=15205295
Higgins 2009|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]|
Hinsley 2007|The reflections you get: an exploration of body image and cachexia|/resolve/reference/PMED?id=17363866
Hopkinson 2006|The prevalence of concern about weight loss and change in eating habits in people with advanced cancer|/resolve/reference/PMED?id=17000349
Jadad 1996|Assessing the quality of reports of randomized clinical trials: is blinding necessary?|/resolve/reference/PMED?id=8721797
Keus 2010|Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews|
MacDonald 2003|Understanding and managing cancer cachexia|/resolve/reference/PMED?id=12831935
MacDonald 2007|Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care|/resolve/reference/PMED?id=17500503
Mantovani 2010|Cancer cachexia: medical management|
Moher 2001|The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials|/resolve/reference/PMED?id=11323066
Muscaritoli 2010|Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"|/resolve/reference/PMED?id=20060626
NCPC 2000||
NCPC 2002||
NCPC 2005||
NICE 2004||
Norman 2008|Prognostic impact of disease-related malnutrition|/resolve/reference/PMED?id=18061312
Pederson 2003|The treatment of fatigue in palliative care patients|
Poole 2002|Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer, or the health professional?|/resolve/reference/PMED?id=12465697
Potter 2004|Fatigue experience in advanced cancer: a phenomenological approach|/resolve/reference/PMED?id=12084336
Purcell 2009|Cancer related fatigue: a review and a conceptual framework to guide therapists' understanding|
Radbruch 2008|Fatigue in palliative care patients - an EPAC approach|
Ream 1996|Fatigue: a concept analysis|/resolve/reference/PMED?id=8886902
Ream 2007|Fatigue in patients receiving palliative care|
Reid 2009|The experience of cancer cachexia: a qualitative study of advanced cancer patients and their family members|/resolve/reference/PMED?id=19081090
Richardson 2004|The contribution of the dietician and nutritionist to palliative medicine|
Rinck 1997|Methodologic issues in effectiveness research on palliative cancer care: a systematic review|/resolve/reference/PMED?id=9193371
Shea 2007|Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews|/resolve/reference/PMED?id=17302989
Solano 2006|A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease|/resolve/reference/PMED?id=16442483
Toye 2006|Fatigue in frail elderly people|/resolve/reference/PMED?id=16835559
van Tulder 1997|Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for spinal disorders|/resolve/reference/PMED?id=9355211
Verhagen 1998|The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus|/resolve/reference/PMED?id=10086815
Whitehead 2009|The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures|/resolve/reference/PMED?id=19111779
WHO 2002||
Chouhan 2006 {published data only}|Intraoperative mild hypothermia for brain protection during intracranial aneurysm surgery|
Hindman 1999 {published data only}|Mild hypothermia as a protective therapy during intracranial aneurysm surgery: a randomized prospective pilot trial|/resolve/reference/PMED?id=9894960
Todd 2005 {published data only}|Mild intraoperative hypothermia during surgery for intracranial aneurysm|/resolve/reference/PMED?id=15647576
Baker 1994 {published data only}|Deliberate mild intraoperative hypothermia for craniotomy|/resolve/reference/PMED?id=8053586
Baumgardner 1999 {published data only}|The effectiveness of rapidly infused intravenous fluids for inducing moderate hypothermia in neurosurgical patients|/resolve/reference/PMED?id=10389797
Hinz 2007 {published data only}|Effectiveness of an intravascular cooling method compared with a conventional cooling technique in neurologic patients|/resolve/reference/PMED?id=17414000
Iwata 2006 {published data only}|Effects of increasing concentrations of propofol on jugular venous bulb oxygen saturation in neurosurgical patients under normothermic and mildly hypothermic conditions|/resolve/reference/PMED?id=16394687
Karibe 2000 {published data only}|Intraoperative mild hypothermia ameliorates postoperative cerebral blood flow impairment in patients with aneurysmal subarachnoid hemorrhage|/resolve/reference/PMED?id=10981746
Sato 2000 {published data only}|Systemic and cerebral haemodynamics during craniotomy under mild hypothermia in patients with acute subarachnoid haemorrhage|/resolve/reference/PMED?id=11086810
Steinberg 2001 {published data only}|Comparison of endovascular and surface cooling during unruptured cerebral aneurysm repair|/resolve/reference/PMED?id=15271236
Abbed 2003|Intracerebral hematoma from aneurysm rupture|/resolve/reference/PMED?id=15344897
Busto 1987|Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury|/resolve/reference/PMED?id=3693428
Busto 1989|Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury|/resolve/reference/PMED?id=2771174
Chouhan 2001|Deliberate mild hypothermia for intracranial aneurysm clipping|
Claassen 2002|Global cerebral edema after subarachnoid hemorrhage: frequency, predictors and impact on outcome|/resolve/reference/PMED?id=11988595
Claiborne Johnston 2002|Recommendations for the endovascular treatment of intracranial aneurysms|/resolve/reference/PMED?id=12364750
Clifton 1991|Marked protection by moderate hypothermia after experimental traumatic brain injury|/resolve/reference/PMED?id=1983995
Dempsey 1987|Moderate hypothermia reduces postischemic edema development and leukotriene production|/resolve/reference/PMED?id=2821445
Deng 2003|Mild hypothermia inhibits inflammation after experimental stroke and brain inflammation|/resolve/reference/PMED?id=12970518
Dietrich 1990|The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia|
Freysz 1989|Potentiation by mild hypothermia of ventricular conduction disturbances and reentrant arrhythmias induced by bupivacaine in dogs|/resolve/reference/PMED?id=2719314
Gerlach 2007|Treatment related morbidity of unruptured intracranial aneurysms: results of a prospective single centre series with an interdisciplinary approach over a 6 year period (1999-2005)|/resolve/reference/PMED?id=17210624
Greving 2009|Cost-effectiveness of preventive treatment of intracranial aneurysms|/resolve/reference/PMED?id=19299311
Griffiths 1996|Incidental intracranial vascular pathology in patients investigated for carotid stenosis|/resolve/reference/PMED?id=8773270
Haley Jr 1992|The International Cooperative Study on the Timing of Aneurysm Surgery: the North American experience|/resolve/reference/PMED?id=1561649
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Hop 1997|Case-fatality rates and functional outcome after subarachnoid hemorrhage|/resolve/reference/PMED?id=9056628
Investigators 1998|Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention|/resolve/reference/PMED?id=9867550
Jennett 1975|Assessment of outcome after severe brain damage|/resolve/reference/PMED?id=46957
Jha 2003|Cerebral edema and its management|
Kassell 1984|The International Cooperative Study on Timing of Aneurysm Surgery: an update|
Kawanishi 2008|Effect of delayed mild brain hypothermia on edema formation after intracerebral hemorrhage in rats|
Kurz 1996|Perioperative normothermia to reduce the incidence of surgical wound infection and shorten hospitalization|/resolve/reference/PMED?id=8606715
McCormick 1965|Saccular intracranial aneurysms: an autopsy study|/resolve/reference/PMED?id=14288426
Minamisawa 1990|The influence of mild body and brain hypothermia on ischemic brain damage|/resolve/reference/PMED?id=2329123
Nieuwkamp 2009|Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis|/resolve/reference/PMED?id=19501022
Ostergaard 1991|Headache as a warning symptom of impending aneurysmal subarachnoid haemorrhage|
Patel 1994|Differential temperature sensitivity of ischemia-induced glutamate release and eicosanoid production in rats|/resolve/reference/PMED?id=7953685
Prunell 2004|Experimental subarachnoid hemorrhage: cerebral blood flow and brain metabolism during the acute phase in three different models in the rat|/resolve/reference/PMED?id=14744290
Raps 1993|The clinical spectrum of unruptured intracranial aneurysms|
RevMan 2011|Review Manager (RevMan)|
Rinkel 1998|Prevalence and risk of rupture of intracranial aneurysms|/resolve/reference/PMED?id=9445359
Rooij 2009|Configuration of the circle of Willis, direction of flow, and shape of the aneurysm as risk factors for rupture of intracranial aneurysms|/resolve/reference/PMED?id=19221852
Rosen 2007|Intraventricular hemorrhage from ruptured aneurysm: clinical characteristics, complications, and outcomes in a large, prospective, multicenter study population|/resolve/reference/PMED?id=17695378
Schubert 2008|Hypothermia reduces cytotoxic edema and metabolic alterations during the acute phase of massive SAH: a diffusion-weighted imaging and spectroscopy study in rats|/resolve/reference/PMED?id=18627260
Sehba 2006|Mechanisms of acute brain injury after subarachnoid hemorrhage|/resolve/reference/PMED?id=16759442
Sheffield 1994a|Mild hypothermia during halothane-induced anesthesia decreases resistance to Staphylococcus aureus dermal infection in guinea pigs|
Sheffield 1994b|Mild hypothermia during isoflurane anesthesia decreases resistance to E. coli dermal infection in guinea pigs|
Shimohata 2007|Suppression of delta PKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia|/resolve/reference/PMED?id=17293847
Study Group 1999|Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage|/resolve/reference/PMED?id=10536126
Suarez 2006|Aneurysmal subarachnoid hemorrhage|/resolve/reference/PMED?id=16436770
Sulter 1999|Use of the Barthel Index and Modified Rankin Scale in acute stroke trials|/resolve/reference/PMED?id=10436097
Sydenham 2009|Hypothermia for traumatic head injury|
Takao 2008|Treatment of ruptured intracranial aneurysms: a decision analysis|/resolve/reference/PMED?id=18208854
Trk 2009|Mild hypothermia (33C) reduces intracranial hypertension and improves functional outcome after subarachnoid hemorrhage in rats|/resolve/reference/PMED?id=19625915
Vega 2002|Intracranial aneurysms: current evidence and clinical practice|/resolve/reference/PMED?id=12201551
Wenisch 1996|Mild intraoperative hypothermia reduces production of reactive oxygen intermediates by polymorphonuclear leukocytes|/resolve/reference/PMED?id=8615502
Wermer 2007|Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis|
Wiebers 2003|Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment|/resolve/reference/PMED?id=12867109
Wilson 2005|Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview|/resolve/reference/PMED?id=15718510
Zhang 1993|Postischemic (1 hour) hypothermia significantly reduces ischemic cell damage in rats subjected to 2 hours of middle cerebral artery occlusion|/resolve/reference/PMED?id=8342200
Zhao 2007|General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage|/resolve/reference/PMED?id=17684517
Li 2010|Intraoperative mild hypothermia for postoperative neurological deficits in intracranial aneurysm patients|/resolve/reference/PMED?id=19066502
Feagan 2007 {published data only}|Efficacy and safety of sargramostim in moderate to severe Crohn's disease: results of N.O.V.E.L. 4, a phase III multicenter study|
Korzenik 2005a {published data only}|Sargramostim for active Crohn's disease|/resolve/reference/PMED?id=15917384
Valentine 2009 {published data only}|Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study|/resolve/reference/PMED?id=19505878
Dieckgraefe 2002 {published data only}|Treatment of active Crohns disease with recombinant human granulocyte-macrophage colony-stimulating factor|/resolve/reference/PMED?id=12433518
Korzenick 2000 {published data only}|Is Crohns disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohns disease|/resolve/reference/PMED?id=10877227
Korzenick 2005b {published data only}|An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohns disease|
Moss 2005 {published data only}|Adding fuel to the fire: GM-CSF for active Crohn's disease|/resolve/reference/PMED?id=16344081
Sandborn 2004 {published data only}|How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease|/resolve/reference/PMED?id=15583528
Takazoe 2009 {published data only}|Sargramostim in patients with Crohns disease: results of a phase 12 study|/resolve/reference/PMED?id=19352588
Tine 2008 {published data only}|Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohns disease|
Vaughan 1999 {published data only}|Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease|/resolve/reference/PMED?id=9917236
Akobeng 2003|Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease|
Alfadhli 2004|Methotrexate for induction of remission in refractory Crohn's disease|
Benchimol 2008|Traditional corticosteroids for induction of remission in Crohn's disease|
Crohn 1932|Regional ileitis: a pathologic and clinical entity|
Dalziel 1913|Chronic interstitial enteritis|
Hanauer 2002|Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial|/resolve/reference/PMED?id=12047962
Hanauer 2006|Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial|/resolve/reference/PMED?id=16472588
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2008|Chapter 8: Assessing risk of bias in included studies|
Lim 2010|Aminosalicylates for induction of remission or response in Crohns disease|/resolve/reference/PMED?id=19404236
Loftus 2002|The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review|
MacDonald 2007|Natalizumab for induction of remission in Crohns disease|
Pogue 1997|Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis|/resolve/reference/PMED?id=9408720
Prefontaine 2009|Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease|
Sandborn 2007|Certolizumab pegol for the treatment of Crohns disease|/resolve/reference/PMED?id=17634458
Seow 2008|Budesonide for induction of remission in Crohn's disease|
Summers 1979|National cooperative Crohns disease study: results of drug treatment|/resolve/reference/PMED?id=38176
Targan 1997|A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohns disease|/resolve/reference/PMED?id=9321530
Sliwa 2010 {published data only}|Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study|/resolve/reference/PMED?id=20308616
Abboud 2007|Peripartum cardiomyopathy: a comprehensive review|/resolve/reference/PMED?id=17208320
Adams 2005a|Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis|/resolve/reference/PMED?id=16053964
Adams 2005b|Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)|/resolve/reference/PMED?id=15846257
Amos 2006|Improved outcomes in peripartum cardiomyopathy with contemporary|/resolve/reference/PMED?id=16923422
Aravot 1987|Heart transplantation for peripartum cardiomyopathy|/resolve/reference/PMED?id=2889929
Batchelder 2005|Pentoxifylline for heart failure: a systematic review|/resolve/reference/PMED?id=15832667
Bennani 2003|Postpartum cardiomyopathy revealed by acute lower limb ischemia|/resolve/reference/PMED?id=14752923
Box 2004|Dual coronary emboli in peripartum cardiomyopathy|/resolve/reference/PMED?id=15745302
Bozkurt 1999|Intravenous immune globulin in the therapy of peripartum cardiomyopathy|/resolve/reference/PMED?id=10400008
Brar 2007|Incidence, mortality, and racial differences in peripartum cardiomyopathy|/resolve/reference/PMED?id=17631087
Bricker 2002|Parenteral opioids for labor pain relief: a systematic review|/resolve/reference/PMED?id=12011876
Bultmann 2005|High prevalence of viral genomes and inflammation in peripartum cardiomyopathy|/resolve/reference/PMED?id=16098856
Cenac 1998|Postpartum cardiac failure in Sudanese-Sahelian Africa: clinical prevalence in western Niger|/resolve/reference/PMED?id=9546411
Chong 1997|Severe hyperthermia following oral misoprostol in the immediate postpartum period|/resolve/reference/PMED?id=11770608
Cleland 2003|The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis|/resolve/reference/PMED?id=12633546
Damorou 2000|Biventricular thrombus complicating peripartum cardiomyopathy. A case report|/resolve/reference/PMED?id=15779186
Davidson 1978|Peri-partum cardiac failure|/resolve/reference/PMED?id=751087
Deeks 2001|Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis|
Demakis 1971a|Natural course of peripartum cardiomyopathy|/resolve/reference/PMED?id=4256828
Demakis 1971b|Peripartum cardiomyopathy|/resolve/reference/PMED?id=4255967
Desai 1995|Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature|/resolve/reference/PMED?id=7660481
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Elkayam 2005|Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation|/resolve/reference/PMED?id=15851613
Farber 1970|Viral myocarditis during pregnancy: encephalomyocarditis virus infection in mice|/resolve/reference/PMED?id=4316715
Felker 2000|Myocarditis and long-term survival in peripartum cardiomyopathy|/resolve/reference/PMED?id=11054626
Ferriere 1990|Cardiomyopathy in the peripartum period: current aspects. A multicenter study. 11 cases|
Fett 2002|Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti|/resolve/reference/PMED?id=12015528
Fett 2004a|One hundred cases of peripartum cardiomyopathy... and counting: what is going on?|/resolve/reference/PMED?id=15561354
Fett 2004b|Learning from a population-based peripartum cardiomyopathy registry|
Fett 2005|Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution|/resolve/reference/PMED?id=16342653
Fonarow 2007|Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry|/resolve/reference/PMED?id=17707182
Gouley 1937|Idiopathic myocardial degeneration associated with pregnancy and especially the peripartum|
Glmezoglu 2007|Prostaglandins for preventing postpartum haemorrhage|
Harbord 2006|A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints|
Hendricks 1970|Cardiovascular effects of oxytocic drugs used post partum|/resolve/reference/PMED?id=5311917
Hibbard 1999|A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography|/resolve/reference/PMED?id=10432149
Higgins 2009|Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009|
Hilfiker-Kleiner 2007|A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy|/resolve/reference/PMED?id=17289576
Hopp 1996|Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement|/resolve/reference/PMED?id=9024910
Kaufman 2003|Peripartum cardiomyopathy and thromboembolism; anesthetic management and clinical course of an obese, diabetic patient|/resolve/reference/PMED?id=12560308
Keogh 1994|Outcome in peripartum cardiomyopathy after heart transplantation|/resolve/reference/PMED?id=8031800
Liabsuetrakul 2007|Prophylactic use of ergot alkaloids in the third stage of labour|
Lyden 1984|Aggravation of coxsackievirus, group B, type 3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone|/resolve/reference/PMED?id=6088088
Mason 1995|A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators|/resolve/reference/PMED?id=7596370
McNamara 2001|Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy|/resolve/reference/PMED?id=11342473
Melvin 1982|Peripartum cardiomyopathy due to myocarditis|/resolve/reference/PMED?id=7110225
Midei 1990|Peripartum myocarditis and cardiomyopathy|/resolve/reference/PMED?id=2306840
Mielniczuk 2006|Frequency of peripartum cardiomyopathy|/resolve/reference/PMED?id=16765131
Nishi 2002|Peripartum cardiomyopathy and biventricular thrombi|/resolve/reference/PMED?id=12224827
O'Connell 1986|Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics|/resolve/reference/PMED?id=3711532
Oladapo 2009|Treatments for suppression of lactation|
Pearson 2000|Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review|/resolve/reference/PMED?id=10703781
Pinder 2002|Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia|/resolve/reference/PMED?id=15321540
Quinn 2004|Postnatal pre-cordial pain. Pulmonary embolism or peripartum cardiomyopathy|/resolve/reference/PMED?id=15496714
Rathore 2002|Sex-based differences in the effect of digoxin for the treatment of heart failure|/resolve/reference/PMED?id=12409542
RevMan 2008|Review Manager (RevMan)|
Ritchie 1850|Clinical contribution to the patho-diagnosis and treatment of certain chronic diseases of the heart|
Rizeq 1994|Incidence of myocarditis in peripartum cardiomyopathy|/resolve/reference/PMED?id=8059728
Ruch 1989|Postpartum myocardial infarction in a patient receiving bromocriptine|/resolve/reference/PMED?id=2668821
Sanchez-Rubio Lezcano 2004|Peripartum cardiomyopathy with biventricular thrombi|/resolve/reference/PMED?id=15511202
Sanderson 1986|Peripartum heart disease: an endomyocardial biopsy study|/resolve/reference/PMED?id=3756045
Sayer 2009|Ventricular assist device therapy|
Shoemaker 1983|Use of physiologic monitoring to predict outcome and to assist in clinical decisions in critically ill postoperative patients|/resolve/reference/PMED?id=6346913
Sliwa 2000|Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1|/resolve/reference/PMED?id=10716473
Sliwa 2002|The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy|
Sliwa 2006a|Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients|/resolve/reference/PMED?id=16143707
Sliwa 2006b|Peripartum cardiomyopathy|/resolve/reference/PMED?id=16920474
Sultatos 1997|Mechanism of drugs that affect uterine motility|/resolve/reference/PMED?id=9277068
Tamhane 2006|Oxytocin in parturients with cardiac disease|/resolve/reference/PMED?id=16774825
van Spaendonck-Zwarts 2010|Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy|/resolve/reference/PMED?id=20458010
Adarsh 2008 {published data only}|Coenzyme Q10 (CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM)|
Berman 2004 {published data only}|Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study|
Berman 2004 {published data only}|Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study|
Keogh 2003 {published data only}|Randomised double-blind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure|
Khatta 2000 {published data only}|The effect of coenzyme Q10 in patients with congestive heart failure|/resolve/reference/PMED?id=10766682
Kocharian 2009 {published data only}|Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy|
Morisco 1993 {published data only}|Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study|/resolve/reference/PMED?id=8241697
Munkholm 1999 {published data only}|Coenzyme Q10 treatment in serious heart failure|
Azuma 1992 {published data only}|Usefulness of taurine in chronic congestive heart failure and its prospective application|/resolve/reference/PMED?id=1538580
Baggio 1993 {published data only}|Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure (interim analysis). The CoQ10 Drug Surveillance Investigators|/resolve/reference/PMED?id=8241700
Belardinelli 2005 {published data only}|Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure|
Belardinelli 2008 {published data only}|Oxidative stress, endothelial function and coenzyme Q10|
Cascone 1985 {published data only}|Treatment of patients with congestive heart failure with coenzyme Q10 in an open trial [Italian]|/resolve/reference/PMED?id=3902057
Chew 2008 {published data only}|Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction|/resolve/reference/PMED?id=18487480
Davini 1992 {published data only}|Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy [Italian]|/resolve/reference/PMED?id=1291925
Hall 1990 {published data only}|Long-term survival in coenzyme-Q10 treated congestive-heart-failure patients|
Hanping 1997 {published data only}|The changes of PRA, ATII, ALD, ET and ANP in patients with left ventricular and intervention with enalapril|
Hofman-Bang 1995 {published data only}|Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group|/resolve/reference/PMED?id=9420639
Ishiyama 1976 {published data only}|A clinical study of the effect of coenzyme Q on congestive heart failure|/resolve/reference/PMED?id=778433
Iwabuchi 1972 {published data only}|Clinical efficacy of coenzyme Q10 for cardiac failure: a double-blind controlled comparison|
Khatta 1999 {published data only}|Long-term efficacy of coenzyme Q 10 therapy for congestive heart failure|/resolve/reference/PMED?id=17824295
Kumar 2007 {published data only}|Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study|/resolve/reference/PMED?id=17824295
Lampertico 1993 {published data only}|Italian multicenter study on the efficacy and safety of coenzyme-Q(10) as adjuvant therapy in heart-failure|/resolve/reference/PMED?id=8241696
Langsjoen 1985 {published data only}|Effective treatment with coenzyme Q10 of patients with chronic myocardial disease|/resolve/reference/PMED?id=3836875
Langsjoen 1985a {published data only}|Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10|/resolve/reference/PMED?id=3858877
Langsjoen 1988 {published data only}|Effective and safe therapy with coenzyme Q10 for cardiomyopathy|/resolve/reference/PMED?id=3062263
Langsjoen 1990 {published data only}|Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=2305693
Langsjoen 1994 {published data only}|Usefulness of coenzyme Q10 in clinical cardiology: a long-term study|
Langsjoen 2008 {published data only}|Supplemental ubiquinol in patients with advanced congestive heart failure|
Manzoli 1990 {published data only}|Coenzyme Q10 in dilated cardiomyopathy|/resolve/reference/PMED?id=2276896
Mazzola 1987 {published data only}|Noninvasive assessment of coenzyme Q 10 in patients with chronic stable effort angina and moderate heart failure|/resolve/reference/PMED?id=7752827
Morisco 1994 {published data only}|Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment|/resolve/reference/PMED?id=7752827
Mortensen 1985 {published data only}|Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure|/resolve/reference/PMED?id=3836876
Nishimura 1996 {published data only}|Therapeutic effects of coenzyme Q10 on dilated cardiomyopathy: assessment by 123I-BMIPP myocardial single photon emission computed tomography (SPECT): a multicenter trial in Osaka University Medical School Group [Japanese]|/resolve/reference/PMED?id=8819712
Permanetter 1992 {published data only}|Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy|/resolve/reference/PMED?id=1464342
Poggesi 1991 {published data only}|Effect of coenzyme Q10 on left ventricular function in patients with dilative cardiomyopathy. A medium-term randomized double-blind study versus placebo|
Sacher 1997 {published data only}|The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy|
Schneeberger 1984 {published data only}|Clinical studies with coenzyme Q10 in patients with congestive heart failure|/resolve/reference/PMED?id=11074911
Sinatra 2000 {published data only}|Coenzyme Q10 and congestive heart failure|
Sinatra 2004 {published data only}|Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study [2] (multiple letters)|
Watson 1999 {published data only}|Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure|/resolve/reference/PMED?id=10334422
Witte 2005 {published data only}|The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure|/resolve/reference/PMED?id=16081469
Arnold 2006|Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management|/resolve/reference/PMED?id=16450016
Belch 1991|Oxygen free radicals and congestive heart failure|/resolve/reference/PMED?id=2039668
Berthold 2006|Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial|/resolve/reference/PMED?id=16872244
Bhagavan 2007|Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations|
Boon 2006||
Carbajal 2003|Congestive heart failure|
Clinical Evidence|BMJ Clinical Evidence. EBM Tools: Glossary|/resolve/reference/PMED?id=8554002
Diaz-Velez 1996|Increased malondialdehyde in peripheral blood of patients with congestive heart failure|/resolve/reference/PMED?id=8554002
Drexler 2004|Physiology of the normal and failing heart|/resolve/reference/PMED?id=9310563
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
Elesber 2001|Approach to patients with heart failure and normal ejection fraction|/resolve/reference/PMED?id=11605689
Folkers 1990|Lovastatin decreases coenzyme Q levels in humans|/resolve/reference/PMED?id=2247468
Gottdiener 2002|Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study|
Greenberg 1990|Co-enzyme Q10: a new drug for cardiovascular disease|
Heck 2000|Potential interactions between alternative therapies and warfarin|/resolve/reference/PMED?id=10902065
HFSA 2006|Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline|/resolve/reference/PMED?id=16500578
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|/resolve/reference/PMED?id=8376698
Ho 1993|The epidemiology of heart failure: the Framingham study|/resolve/reference/PMED?id=8376698
Hunt 2005|ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society|/resolve/reference/PMED?id=16160202
Kishi 1977|Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q10-enzymes by clinically used adrenergic blockers of beta-receptors|/resolve/reference/PMED?id=17892
Lefebvre 2011|Chapter 6: Searching for studies|
Lloyd-Jones 2010|Heart disease and stroke statistics--2010 update: a report from the American Heart Association|/resolve/reference/PMED?id=9200399
Massie 1997|Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management|/resolve/reference/PMED?id=9200399
McMurray 1990|Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease|/resolve/reference/PMED?id=2337039
McMurray 1993|Evidence of oxidative stress in chronic heart failure in humans|/resolve/reference/PMED?id=8299631
McMurray 1998|Clinical epidemiology of heart failure: public and private health burden|/resolve/reference/PMED?id=9886707
Migliore 2004|Evaluation of cytogenetic and DNA damage in mitochondrial disease patients: effects of coenzyme Q10 therapy|/resolve/reference/PMED?id=14681312
Moher 1998|Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analysis|/resolve/reference/PMED?id=9746022
Mortensen 1984|Deficiency of coenzyme Q10 in myocardial failure|/resolve/reference/PMED?id=2276893
Mortensen 1990|Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure|/resolve/reference/PMED?id=2276893
Mortensen 1993|Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone)|/resolve/reference/PMED?id=8241694
Mortensen 1997|Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors|
Niklowitz 2007|Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage|/resolve/reference/PMED?id=17479158
Nishiyama 1998|Oxidative stress is related to exercise intolerance in patients with heart failure|/resolve/reference/PMED?id=9453530
NYHA 1964||
Rauchova 1995|Function of coenzyme Q in the cell: some biochemical and physiological properties|/resolve/reference/PMED?id=12517230
Redfield 2003|Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic|/resolve/reference/PMED?id=12517230
RevMan 2012|Review Manager (RevMan)|
Richardson 1996|Report of the 1995 Word Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies|/resolve/reference/PMED?id=8598070
Rodriguez 2004|Epidemiology of heart failure|/resolve/reference/PMED?id=15095765
Royle 2003|Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches|/resolve/reference/PMED?id=15095765
Singh 1999|Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease|/resolve/reference/PMED?id=10204818
Swedberg 2005|Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology|/resolve/reference/PMED?id=15901669
Tappel 1972|Vitamin E and free radical peroxidation of lipids|
Teerlink 1991|An overview of contemporary etiologies of congestive heart failure|/resolve/reference/PMED?id=2035416
Tsutsui 2002|Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure|/resolve/reference/PMED?id=11897436
Vasan 1995|Prevalence clinical features and prognosis of diastolic heart failure: an epidemiologic perspective|/resolve/reference/PMED?id=7594087
Ware 2005|Clinical practice. Acute pulmonary edema|/resolve/reference/PMED?id=16382065
Alonso-Ruiz 2008|Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety|/resolve/reference/PMED?id=18182116
Becker 2008|Chapter 22: Overviews of Reviews|
Behm 2008|Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease|
Blumenauer 2002|Infliximab for the treatment of rheumatoid arthritis|
Blumenauer 2003|Etanercept for the treatment of rheumatoid arthritis|
Bongartz 2006|Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials|/resolve/reference/PMED?id=16705109
Doherty 2009|Interventions for prevention of post-operative recurrence of Crohn's disease|
Drugs.com 2006|FDA Approves First Rheumatoid Arthritis Indication for Rituxan|
FDA 1998a|Etanercept Product Approval Information- Licensing Action 12/2/1998|
FDA 1998b|Medication Guide: Enbrel (etanercept)|
FDA 1999|Remicade (infliximab) for IV Injection|
FDA 2001|Kineret (anakinra) Physician packet insert: Kineret (anakinra) prescribing information|
FDA 2002a|Humira (adalimumab): Highlights of prescribing information|
FDA 2002b|Package Insert. HUMIRA (adalimumab). Abbott Laboratories|
FDA 2005|Patient Information Sheet. Abatacept (marketed as Orencia)|
FDA 2006|Rituxan (rituximab)|
FDA 2009a|SIMPONI (Golimumab) Summary Review|
FDA 2009b|SIMPONI (Golimumab) Physician Packet Insert: Highlights of Prescribing Information|
FDA 2009c|Cimzia (Certolizumab): Highlights of prescribing information|
FDA 2009d|Drug details: Orencia|
FDA 2009e|Remicade (infliximab) for IV Injection|
FDA 2010|Medication Guide. Actermra (Tocilizumab)|
FDA 2010b|MedWatch: The FDA Safety information and adverse event reporting program: Reporting serious problems to FDA: What is a serious advent event?|
Golicki 2009|TNF-alpha inhibitors for psoriatic arthritis|
Guyatt 2011|GRADE guidelines 6. Rating the quality of evidence-imprecision|/resolve/reference/PMED?id=21839614
Harris 1990|Rheumatoid arthritis. Pathophysiology and implications for therapy|/resolve/reference/PMED?id=2271017
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Keystone 2009b|Recent concepts in the inhibition of radiographic progression with biologics|/resolve/reference/PMED?id=19365267
Kvien 2004|Epidemiology and burden of illness of rheumatoid arthritis|
Kvien 2005|Quality of life in rheumatoid arthritis|/resolve/reference/PMED?id=16234180
Lee 2008|Meta-analysis of the combination of TNF inhibitors plus MTX compared to MTX monotherapy, and the adjusted indirect comparison of TNF inhibitors in patients suffering from active rheumatoid arthritis|/resolve/reference/PMED?id=17943257
Lubeck 2004|Patient-reported outcomes and their role in the assessment of rheumatoid arthritis|
Maxwell 2009|Abatacept for rheumatoid arthritis|
Menge 2008|Disease-modifying agents for multiple sclerosis: recent advances and future prospects|/resolve/reference/PMED?id=19016573
Mertens 2009|Anakinra for rheumatoid arthritis|
Navarro-Sarabia 2005|Adalimumab for treating rheumatoid arthritis|
Ntzoufras 2008||/resolve/reference/PMED?id=19222517
Odegard 2005|Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register|/resolve/reference/PMED?id=16393765
Pincus 1983|Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire|
Pogue 1997|Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis|/resolve/reference/PMED?id=9408720
Rozenblit 2009|New biologics for psoriasis and psoriatic arthritis|
Ruiz Garcia 2011|Certolizumab pegol (CDP870) for rheumatoid arthritis in adults|
Schulz 2007|Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma|
Schnemann 2008a|Chapter 11: Presenting results and Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008)|/resolve/reference/PMED?id=19455095
Schnemann 2008b|Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008)|/resolve/reference/PMED?id=19455095
Scott 2006|Tumor necrosis factor inhibitors for rheumatoid arthritis|/resolve/reference/PMED?id=16914706
Singh 2009a|Biologics for rheumatoid arthritis: an overview of Cochrane reviews|/resolve/reference/PMED?id=19455095
Singh 2009b|A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview|/resolve/reference/PMED?id=19884297
Singh 2010a|Tocilizumab for rheumatoid arthritis|/resolve/reference/PMED?id=19455095
Singh 2010b|Golimumab for rheumatoid arthritis|/resolve/reference/PMED?id=19455095
Spiegelhalter 2003|WinBUGS user manual. Version 1.4|
Strand 2008|Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials|/resolve/reference/PMED?id=18415967
Strand 2010|Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity|/resolve/reference/PMED?id=20108988
Vidal 2009|Rituximab as maintenance therapy for patients with follicular lymphoma|
Wiens 2010|Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis|
Yelin 2007|Work disability in rheumatic diseases|/resolve/reference/PMED?id=17278920
Zochling J|TNF-alpha inhibitors for ankylosing spondylitis|
Balk 1992 {published data only}|Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study|/resolve/reference/PMED?id=14621851
Beniaminovits 2000 {published data only}|Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody|/resolve/reference/PMED?id=10699160
Bolling 1989 {published data only}|Comparison of polyclonal antibody sera for early prophylaxis following cardiac transplantation|/resolve/reference/PMED?id=2671502
Bonaros 2006 {published data only}|Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation|/resolve/reference/PMED?id=16962480
Carrier 2007 {published data only}|Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial|/resolve/reference/PMED?id=17346628
Costanzo-Nordin 1990 {published data only}|Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation|
De Santo 2004 {published data only}|Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation|/resolve/reference/PMED?id=15110616
Faggian 2010 {published data only}|Antithymocyte globulin induction therapy in heart transplantation: prospective randomized study of high vs standard dosage|
Faggian 2010 {published data only}|Anti rejection prophylaxis using ATG-Fresenius S after heart transplantation - long-term clinical results of a prospective, randomised trial|
Hershberger 2005 {published data only}|Daclizumab to prevent rejection after cardiac transplantation|/resolve/reference/PMED?id=15987919
Ippoliti 1991 {published data only}|Preoperative prophylactic OKT3 vs RATG. A randomized clinical study in heart transplant patients|/resolve/reference/PMED?id=1908155
Ippoliti 1991 {published data only}|A randomized clinical-study of preoperative administration of Okt3 vs Ratg in heart transplanted patients treated with Sandimmun|
Kobashigawa 1993 {published data only}|Does short-course induction with OKT3 improve outcome after heart transplantation? A randomized trial|
Kormos 1990 {published data only}|Comparative trial of immunoprophylaxis with RATG versus OKT3|
Kormos 1990 {published data only}|Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin|/resolve/reference/PMED?id=2137653
Kormos 1990 {published data only}|Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation|
Macdonald 1993 {published data only}|A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation--increased morbidity with OKT3|/resolve/reference/PMED?id=8380508
Mattei 2007 {published data only}|Less infectious deaths with basiliximab (Simulect (R)) over antihymocyte globulin (Thymoglobuline (R)) induction therapy in heart transplantation: Results of nausicaa, a national multicentre prospective randomized study|
Mattei 2007 {published data only}|Improved safety of basiliximab (Simulect (R)) over antithymocyte globulin (Thymoglobulin (R)) induction therapy in heart transplantation|
Mattei 2007 {published data only}|Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy|/resolve/reference/PMED?id=17613399
Mehra 2005 {published data only}|A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation|/resolve/reference/PMED?id=16143248
Menkis 1992 {published data only}|A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts|
Mullen 2005 {published data only}|A randomized control trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation|
Schnetzler 2002 {published data only}|A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients|
Segovia 2006 {published data only}|A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study|/resolve/reference/PMED?id=16770243
van Gelder 1996 {published data only}|Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor|/resolve/reference/PMED?id=15859929
van Gelder 1996 {published data only}|Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans|/resolve/reference/PMED?id=9484761
van Gelder 1996 {published data only}|A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation|/resolve/reference/PMED?id=8693545
van Gelder 1996 {published data only}|Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients|
van Gelder 2004 {published data only}|A randomised, double-blind, placebo controlled trial of anti interleukin-2 receptor monoclonal antibody (daclizumab) induction therapy after heart transplantation|
Wollenek 1989 {published data only}|Comparison of a monoclonal anti-T cell antibody vs ATG as prophylaxis after heart transplantation|/resolve/reference/PMED?id=2495642
Adamson 1998 {published data only}|Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience|/resolve/reference/PMED?id=9636449
Almenar 2005 {published data only}|Influence of induction therapy on rejection and survival in heart transplantation|/resolve/reference/PMED?id=16386616
Carlsen 2005 {published data only}|Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection|/resolve/reference/PMED?id=15737756
Chien 2000 {published data only}|Rabbit antithymocyte globulin induction immunosuppression in heart transplantation|/resolve/reference/PMED?id=11120209
Chin 2005 {published data only}|Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab|/resolve/reference/PMED?id=16123721
Chou 2008 {published data only}|Induction immunosuppression with basiliximab in heart transplantation|/resolve/reference/PMED?id=18929820
Costanzo-Nordin 1989 {published data only}|Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience|
Delgado 2005 {published data only}|Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction|/resolve/reference/PMED?id=15701432
Flaman 2006 {published data only}|Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation|/resolve/reference/PMED?id=17097501
Hegewald 1989 {published data only}|OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation|
Kirklin 1990 {published data only}|Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3|/resolve/reference/PMED?id=2108282
Koch 2005 {published data only}|Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat)|/resolve/reference/PMED?id=15949731
Laufer 1989 {published data only}|Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts|
Petrikovits 2005 {published data only}|Daclizumab in the induction phase of immunosuppression in heart transplant recipients|/resolve/reference/PMED?id=16617659
Pham 2010 {published data only}|A randomized study using humanized monoclonal antibody against Cd52 (Campath-1h) and tacrolimus in heart transplant recipients|
Renlund 1989 {published data only}|A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3|/resolve/reference/PMED?id=2523099
Rosenberg 2005 {published data only}|Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation|/resolve/reference/PMED?id=16143252
Starnes 1989 {published data only}|Prophylactic OKT3 used as induction therapy for heart transplantation|/resolve/reference/PMED?id=2509108
Teuteberg 2010 {published data only}|Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes|
Yamani 2008 {published data only}|Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study|
Zakliczynski 2005 {published data only}|Thymoglobuline administered electively early after heart transplantation may protect myocardial hypertrophy (Abstract)|
Zuckermann 2000 {published data only}|Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines|/resolve/reference/PMED?id=10830228
Zuckermann 2003 {published data only}|Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation|/resolve/reference/PMED?id=12895621
Cantarovich 2007|Renal protective strategies in heart transplant patients|/resolve/reference/PMED?id=17284993
Chatenoud 2008|The long and winding road towards induction of allograft tolerance in the clinic|
Chen 2006|Regulatory T-cell subsets and their roles in transplantation tolerance|
Deeks 2003|Evaluating non-randomised intervention studies|
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|/resolve/reference/PMED?id=9310563
El-Hamamsy 2005|Incidence and prognosis of cancer following heart transplantation using RATG induction therapy|
Flechner 2008|Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity|
Gluud 2006|Bias in clinical intervention research|/resolve/reference/PMED?id=16443796
Groetzner 2005|Calcineurin inhibitor-free immunosuppression after heart transplantation: can chronic side effects be avoided?|
Hauptman 2005|It is time to stop ignoring malignancy in heart transplantation: a call to arms|/resolve/reference/PMED?id=16102448
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2005|To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?|/resolve/reference/PMED?id=15797738
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
ICH-GCP 1996|ICH-GCP 1996 International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Guideline for Good Clinical Practice. E6 (R1). ICH Harmonised Tripartite Guideline 1996|
Keus 2009|Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials|/resolve/reference/PMED?id=19262513
Kjaergard 2001|Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses|/resolve/reference/PMED?id=11730399
Kobashigawa 2005|Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids|/resolve/reference/PMED?id=15848713
Kobashigawa 2006|Immunosuppression for heart transplantation: where are we now?|/resolve/reference/PMED?id=16568129
Lechler 2005|Organ transplantation--how much of the promise has been realized?|/resolve/reference/PMED?id=15937473
Lefebvre 2011|Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011|
Macaskill 2001|A comparison of methods to detect publication bias in meta-analysis|
Mallinger 1999|Development and spectrum of PTLD in 691 cardiac transplant recipients (Htx) receiving induction therapy|
Master List 2009|Master list of journals being searched|
Moher 1998|Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?|/resolve/reference/PMED?id=9746022
Moher 2009|Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement|
Mueller 2004|Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results|/resolve/reference/PMED?id=14726105
O'Neill 2004|Immunosuppression for cardiac transplantation - the past, present and future|/resolve/reference/PMED?id=15041359
Oaks 2001|Steroid-free maintenance immunosuppression after heart transplantation|/resolve/reference/PMED?id=11465161
Penninga 2010|Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials|
Penninga 2011|Antibody induction for lung transplant recipients|
Penninga 2012|Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients|
Peraira 2003|Current induction immunosuppression and post-heart transplant lymphoproliferative disorders|/resolve/reference/PMED?id=12962879
Potter 2005|Long-term calcineurin inhibitor "holiday" using daclizumab in a heart transplant patient with acute renal dysfunction|/resolve/reference/PMED?id=16102455
RevMan 2012|Review Manager (RevMan)|
Rinaldi 2001|Neoplastic disease after heart transplantation: single center experience|/resolve/reference/PMED?id=11343955
Royle 2003|Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system|
Savovic 2012|Influence of reported study design characteristics on Intervention effect estimates from randomized, controlled trials|
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Stehlik 2012|The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012|
Stevens 2004|Continuous renal replacement therapy after heart transplantation|/resolve/reference/PMED?id=15152292
Stewart 2005|Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection|/resolve/reference/PMED?id=16297770
Sweeting 2004|What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data|
Swinnen 1990|Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients|/resolve/reference/PMED?id=2100991
Taylor 2009|Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009|
Thompson 2002|How should meta-regression analyses be undertaken and interpreted?|
Thorlund 2011|The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study|
TSA manual 2011|User manual for trial sequential analysis (TSA)|
TSA programme 2012|Trial Sequential Analysis Programme|
Uber 2007|Induction therapy in heart transplantation: is there a role?|/resolve/reference/PMED?id=17346621
Webster 2010|Interleukin 2 receptor antagonists for kidney transplant recipients|
Wetterslev 2008|Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis|/resolve/reference/PMED?id=18083463
Wetterslev 2009|Estimating required information size by quantifying diversity in random-effects model meta-analyses|
Wood 2008|Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study|/resolve/reference/PMED?id=18316340
Zuppan 2009|Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort|/resolve/reference/PMED?id=19481018
Clark 1997 {published and unpublished data}|Impact of self-management education on the functional health status of older adults with heart disease|/resolve/reference/PMED?id=1427244
Clark 1997 {published and unpublished data}|Self-Management of heart disease by older adults|
Clark 2000 {published and unpublished data}|Changes in functional health status of older women with heart disease: Evaluation of a program based on self-regulation|
Clark 2000 {published and unpublished data}|Can a disease self-management programme reduce health care costs: the case of older women with heart disease|/resolve/reference/PMED?id=12773836
Clark 2009 {published and unpublished data}|Heart disease management by women: Does intervention format matter?|/resolve/reference/PMED?id=18084052
Cupples 1994 {published data only (unpublished sought but not used)}|Five year follow up of patients at high cardiovascular risk who took part in randomised controlled trial of health promotion|/resolve/reference/PMED?id=10480826
Cupples 1994 {published data only (unpublished sought but not used)}|Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk|/resolve/reference/PMED?id=7950723
Cupples 1994 {published data only (unpublished sought but not used)}|The effect of personal health education on the quality of life of patients with angina in general practice|
Cupples 1994 {published data only (unpublished sought but not used)}|Cost effectiveness of personal health education in primary care for people with angina in the greater Belfast area of Northern Ireland|/resolve/reference/PMED?id=8944861
Esposito 2008 {published data only (unpublished sought but not used)}|Impacts of a disease management program for dually eligible beneficiaries|/resolve/reference/PMED?id=19040172
Hanssen 2007 {published data only (unpublished sought but not used)}|Improving outcomes after myocardial infarction: a randomized controlled trial evaluating effects of a telephone follow-up intervention|/resolve/reference/PMED?id=17568244
Hanssen 2007 {published data only (unpublished sought but not used)}|Can telephone follow-up after discharge improve life style factors after a myocardial infarction? A randomized controlled trial. 7th Annual Cardiovascular Nursing Spring Meeting of the European Society of Cardiology Council on Cardiovascular Nursing and Allied Professions: changing practice to improve care Manchester, UK 23-24 March 2007|
Hanssen 2007 {published data only (unpublished sought but not used)}|Does a telephone follow-up intervention for patients discharges with acute myocardial infarction have long-term effects on health-related quality of life? A randomised controlled trial|
Hanssen 2007 {published data only (unpublished sought but not used)}|Evaluating the effect of a combined reactive and proactive telephone follow-up intervention after acute myocardial infarction. A randomized controlled trial|
Lie 2009 {published data only (unpublished sought but not used)}|Health-related quality of life after coronary artery bypass grafting. The impact of a randomised controlled home-based intervention program|/resolve/reference/PMED?id=19169899
Lisspers 1999 {published and unpublished data}|Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme|/resolve/reference/PMED?id=10493845
Lisspers 1999 {published and unpublished data}|Behavioural effects of a comprehensive, mutifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: A prospective, randomized, controlled study|/resolve/reference/PMED?id=10098823
Lisspers 1999 {published and unpublished data}|Long-term effects of lifestyle behavior change in coronary artery disease: effects on recurrent coronary events after percutaneous coronary intervention|/resolve/reference/PMED?id=15631561
P.RE.COR Group 1991 {published data only (unpublished sought but not used)}|Comparison of a rehabilitation programme, a counselling programme and usual care after an acute myocardial infarction: results of a long-term randomized trial|/resolve/reference/PMED?id=1874262
Peikes 2009 {published data only (unpublished sought but not used)}|15-Site randomized trial of coordinated care in medicare FFS|/resolve/reference/PMED?id=19040171
Peikes 2009 {published data only (unpublished sought but not used)}|Effects of care coordination on hospitalization, quality of care, and health care expenditures among medicare beneficiaries 15 randomized trials|/resolve/reference/PMED?id=19211468
Pogosova 2008 {published data only (unpublished sought but not used)}|Efficacy of an educational preventive technology in patients with stable angina in ambulatory conditions|/resolve/reference/PMED?id=18789018
Southard 2003 {published data only (unpublished sought but not used)}|Clinical trial of an Internet-based case management system for secondary prevention of heart disease|/resolve/reference/PMED?id=14512778
Tingstrom 2005 {published and unpublished data}|Effects of a problem-based learning rehabilitation programme on quality of life in patients with coronary artery disease|/resolve/reference/PMED?id=15923147
Ades 2001 {published data only}|Cardiac rehabilitation and secondary prevention of coronary heart disease|/resolve/reference/PMED?id=11565523
Allen 2010 {published data only}|Randomized trials of nursing interventions for secondary prevention in patients with coronary artery disease and heart failure: systematic review|/resolve/reference/PMED?id=20386243
Allison 2000 {published data only}|Management of coronary risk factors by registered nurses versus usual care in patients with unstable angina pectoris (a chest pain evaluation in the emergency room [CHEER] substudy)|/resolve/reference/PMED?id=10913471
Arthur 2000 {published data only}|Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial|/resolve/reference/PMED?id=10929164
Bagheri 2007 {published data only}|Evaluation of the effect of group counselling on post myocardial infarction patients: determined by an analysis of quality of life|
Barnason 1995 {published data only}|A comparison of patient teaching outcomes among postoperative coronary artery bypass graft (CABG) patients|/resolve/reference/PMED?id=8584545
Barnason 2006 {published data only}|Impact of a telehealth intervention to augment home health care on functional and recovery outcomes of elderly patients undergoing coronary artery bypass grafting|/resolve/reference/PMED?id=16863894
Barnason 2009 {published data only}|Influence of a symptom management telehealth intervention on older adults' early recovery outcomes after coronary artery bypass surgery|
Barnason 2009a {published data only}|Influence of an early recovery telehealth intervention on physical activity and functioning after coronary artery bypass surgery among older adults with high disease burden|/resolve/reference/PMED?id=19944870
Bell 1998 {published data only}|A comparison of a multi-disciplinary home based cardiac rehabilitation programme with comprehensive conventional rehabilitation in post-myocardial infarction patients|
Benson 2000 {published data only}|Review: psychoeducational programmes reduce long term mortality and recurrence of myocardial infarction in cardiac patients... commentary on Dusseldorp E, van Elderen T, Maes S et al. A meta-analysis of psychoeducational programs for coronary heart disease patients. HEALTH PSYCHOL 1999 Sep;18:506-19|
Beranova 2007 {published data only}|A systematic review of computer-based software for educating patients with coronary heart disease. [Review]|/resolve/reference/PMED?id=17084058
Bethell 1990 {published data only}|A Controlled Trial of community based coronary rehabilitation|/resolve/reference/PMED?id=2271343
Bettencourt 2005 {published data only}|Impact of cardiac rehabilitation on quality of life and depression after acute coronary syndrome|/resolve/reference/PMED?id=16041965
Bitzer 2002 {published data only}|[Developing evidence based guidelines on cardiac rehabilitation - phase 1: a qualitative review]. [German]|/resolve/reference/PMED?id=12168147
Boulay 2004 {published data only}|Health-care consumption and recurrent myocardial infarction after 1 year of conventional treatment versus short- and long-term cardiac rehabilitation|/resolve/reference/PMED?id=15066361
Brand 1998 {published data only}|Coronary care programme improved food habits but not physical activity or smoking status after acute myocardial infarction [commentary on Carlsson R, Lindberg G, Westin L, et al. Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction. HEART 1997 Mar;77:256-9]|
Brugemann 2007 {published data only}|A randomised controlled trial of cardiac rehabilitation after revascularisation|/resolve/reference/PMED?id=17023076
Campbell 1998 {published data only}|Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care|/resolve/reference/PMED?id=9930042
Campbell 1998a {published data only}|Secondary prevention clinics for coronary heart disease: randomised trial of effect on health|/resolve/reference/PMED?id=9572758
Cannon 2002 {published data only}|Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. [Review]|/resolve/reference/PMED?id=12040337
Cebeci 2008 {published data only}|Discharge training and counselling increase self-care ability and reduce postdischarge problems in CABG patients|
Chan 2005 {published data only}|Acute Coronary Syndrome: Cardiac Rehabilitation programs and quality of life|
Chen 2005 {published data only}|Effect of cognitive education on the physical and psychological rehabilitation of patients with coronary heart disease after interventional therapy|
Clark 2005 {published data only}|Meta-analysis: Secondary prevention programs for patients with coronary artery|/resolve/reference/PMED?id=16263889
Clark 2007 {published data only}|Secondary prevention programmes for coronary heart disease: A meta-regression showing the merits of shorter, generalist, primary care-based interventions|/resolve/reference/PMED?id=17667645
Cobb 2006 {published data only}|Effective interventions for lifestyle change after myocardial infarction or coronary artery revascularization. [Review]|
Costa 2008 {published data only}|Transdisciplinary approach to the follow-up of patients after myocardial infarction|/resolve/reference/PMED?id=18719760
Coull 2004 {published data only}|A randomised controlled trial of senior Lay Health Mentoring in older people with ischaemic heart disease: The Braveheart Project|/resolve/reference/PMED?id=15136288
Cundey 1995 {published data only}|Cardiac Rehabilitation and secondary prevention after a myocardial event|
DeBusk 1994 {published data only}|A case-management system for coronary risk factor modification after acute myocardial infarction|/resolve/reference/PMED?id=8147544
Delaney 2008 {published data only}|Secondary prevention clinics for coronary heart disease: a 10-year follow-up of a randomised controlled trial in primary care|/resolve/reference/PMED?id=18198203
Dolan 1992 {published data only}|A meta-analysis of controlled trials of cardiac patient education|/resolve/reference/PMED?id=1299819
Dusseldorf 2000 {published data only}|Review: Psychoeducational programmes reduce MI recurrence and improve some physical health outcomes: Commentary|
Dusseldorp 1999 {published data only}|A meta-analysis of psychoeduational programs for coronary heart disease patients|/resolve/reference/PMED?id=10519467
Engblom 1992 {published data only}|Quality of life during rehabilitation after coronary artery bypass surgery|/resolve/reference/PMED?id=1301126
Engblom 1994 {published data only}|Cardiac rehabilitation and return to work after coronary artery bypass surgery|/resolve/reference/PMED?id=7920495
Engblom 1996 {published data only}|Effects of five years of cardiac rehabilitation after coronary artery bypass grafting on coronary risk factors|/resolve/reference/PMED?id=8970420
Engblom 1997 {published data only}|Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation|/resolve/reference/PMED?id=9041068
Enzenhofer 2004 {published data only}|Improvement of the educational process by computer-based visualization of procedures: randomized controlled trial|
Eshah 2009 {published data only}|Cardiac rehabilitation programme for coronary heart disease patients: an integrative literature review. [Review]|
Espinosa 2004 {published data only}|Postmyocardial infarction cardial rehabilitation in low risk patients. Results with a coordinated program of cardiological and primary care|/resolve/reference/PMED?id=14746718
Fattirolli 1998 {published data only}|Aims, design and enrolment rate of the Cardiac Rehabilitation in Advanced Age (CR-AGE) randomized, controlled trial|/resolve/reference/PMED?id=9932140
Fernandez 2009 {published data only}|A pilot randomised controlled trial comparing a health-related lifestyle self-management intervention with standard cardiac rehabilitation following an acute cardiac event: implications for a larger clinical trial|/resolve/reference/PMED?id=19081265
Frasure-Smith 1997 {published data only}|Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction|/resolve/reference/PMED?id=9274583
Fredericks 2009 {published data only}|Timing for delivering individualized patient education intervention to Coronary Artery Bypass Graft patients: An RCT|/resolve/reference/PMED?id=19054718
Fredericks 2009a {published data only}|Coronary artery bypass graft surgery patient education: a systematic review. [Review]|
Froelicher 1994 {published data only}|Return to work, sexual activity, and other activities after acute myocardial infarction|/resolve/reference/PMED?id=7989211
Gao 2007 {published data only}|Effect of health management on the rehabilitation of patients undergoing coronary artery bypass graft|
Ghali 2004 {published data only}|A community-based disease management program for post-myocardial infarction reduces hospital readmissions compared with usual care|
Goodman 2008 {published data only}|A randomised controlled trial to evaluate a nurse led programme of support and lifestyle management for patients awaiting cardiac surgery: ' Fit for surgery: Fit for life' Study|/resolve/reference/PMED?id=18160344
Harbman 2006 {published data only}|Review: secondary prevention programmes with and without exercise reduced all cause mortality and recurrent myocardial infarction|/resolve/reference/PMED?id=16865828
Haskell 1994 {published data only}|Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP)|/resolve/reference/PMED?id=8124838
Hedback 1993 {published data only}|Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programme|/resolve/reference/PMED?id=8325313
Hedback 2001 {published data only}|Cardiac rehabilitation after coronary artery bypass surgery: 10-year results on mortality, morbidity and readmissions to hospital|/resolve/reference/PMED?id=11455847
Heidarnia 2005 {published data only}|The effect of health education on health related quality of life in patients with coronary artery bypass surgery|
Hobbs 2002 {published data only}|Does pre-operative education of patients improve outcomes? The impact of pre-operative education on recovery following coronary artery bypass surgery: a randomized controlled clinical trial|/resolve/reference/PMED?id=11969274
Jackson 2009 {published data only}|Self-help groups for patients with coronary heart disease as a resource for rehabilitation and secondary prevention-what is the evidence?. [Review]|/resolve/reference/PMED?id=19486787
Janz 1999 {published data only}|The impact of a disease management program in the symptom experiences of older women with heart disease|
Jenny 2001 {published data only}|Evaluating the effectiveness of an interactive multimedia computer-based patient education program in cardiac rehabilitation|
Johansen 2003 {published data only}|[The effect of psychosocial rehabilitation after acute myocardial infarction. A randomized controlled trial]. [Danish]|/resolve/reference/PMED?id=12970994
Khunti 2007 {published data only}|Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: A cluster randomised controlled trial|/resolve/reference/PMED?id=17309907
Koertge 2003 {published data only}|Improvement in medical risk factors and quality of life in women and man with coronary artery disease in the multi centre lifestyle demonstration project|/resolve/reference/PMED?id=12767423
Lindsay 2009 {published data only}|The health impact of an online heart disease support group: a comparison of moderated versus unmoderated support|/resolve/reference/PMED?id=19251770
Mayou 2002 {published data only}|Guideline-based early rehabilitation after myocardial infarction. A pragmatic randomised controlled trial|/resolve/reference/PMED?id=11832254
McGillion 2004 {published data only}|A systematic review of psychoeducational intervention trials for the management of chronic stable angina. [Review]|
McGillion 2008 {published data only}|Randomized controlled trial of a psychoeducation program for the self-management of chronic cardiac pain|/resolve/reference/PMED?id=18395397
McGillion 2008a {published data only}|Cost of illness for chronic stable angina patients enrolled in a self-management education trial|/resolve/reference/PMED?id=18841254
Moore 2002 {published data only}|An audio-taped information programme after coronary artery bypass surgery improved physical functioning in women and psychological distress in men|/resolve/reference/PMED?id=11915795
Mosca 2010 {published data only}|A randomized clinical trial of secondary prevention among women hospitalized with coronary heart disease|/resolve/reference/PMED?id=20109118
Mullen 1992 {published data only}|A meta-analysis of controlled trials of cardiac patient education|/resolve/reference/PMED?id=1299819
Murchie 2003 {published data only}|Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care|/resolve/reference/PMED?id=12521974
Murchie 2004 {published data only}|Effects of secondary prevention clinics on health status in patients with coronary heart disease: 4 year follow-up of a randomized trial in primary care|/resolve/reference/PMED?id=15367480
Neubeck 2009 {published data only}|Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. [Review]|/resolve/reference/PMED?id=19407659
Niebauer 1997 {published data only}|Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention|/resolve/reference/PMED?id=9355890
Nisbeth 2000 {published data only}|Effectiveness of counselling over 1 year on changes in lifestyle and coronary heart disease risk factors|/resolve/reference/PMED?id=10771366
Nordmann 2001 {published data only}|A case-management program of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: the Heartcare I trial|/resolve/reference/PMED?id=11343668
Oldenburg 1995 {published data only}|A controlled trial of a behavioral and educational intervention following coronary artery bypass surgery|/resolve/reference/PMED?id=8529086
Ornish 1990 {published data only}|Can life style changes revere coronary heart disease? The Lifestyle heart Trial.|/resolve/reference/PMED?id=1973470
Ornish 1998 {published data only}|Intensive lifestyle changes for reversal of coronary heart disease|/resolve/reference/PMED?id=9863851
Paez 2006 {published data only}|Cost-effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization|
Parry 2009 {published data only}|Cardiac Home Education and Support Trial (CHEST): A Pilot Study|/resolve/reference/PMED?id=19960132
Raftery 2005 {published data only}|Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial|/resolve/reference/PMED?id=15716289
Redfern 2009 {published data only}|Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-Year follow-up of the CHOICE (Choice of Health Options in prevention of Cardiovascular Events) randomised controlled trial|/resolve/reference/PMED?id=18801781
Robertson 2003 {published data only}|A supportive-education home follow-up programme for post MI patients|
Rubenfire 2008 {published data only}|[Commentary on] Efficacy of in-hospital multidimensional interventions of secondary prevention after acute coronary syndrome: a systematic review and meta-analysis|
Sherrard 2000 {published data only}|Counselling after a myocardial infarction improved mood for patients and their partners and decreased patient functional limitations [commentary on Johnston M, Foulkes J, Johnston DW, et al. Impact on patients and partners of inpatient and extended cardiac counselling and rehabilitation: a controlled trial. PSYCHOSOM MED 1999 Mar/Apr;61:255-33]|
Shuldham 2001 {published data only}|Pre-operative education for the patient having coronary artery bypass surgery. [Review]|/resolve/reference/PMED?id=11369146
Shuldham 2002 {published data only}|The impact of pre-operative education on recovery following coronary artery bypass surgery. A randomized controlled clinical trial|/resolve/reference/PMED?id=11969282
Sinclair 2005 {published data only}|Post-discharge home-based support for older cardiac patients: a randomised controlled trial|/resolve/reference/PMED?id=15955757
Thompson 2000 {published data only}|Coronary Disease: management of the post-myocardial infarction patient: rehabilitation and cardiac necrosis|/resolve/reference/PMED?id=10862600
Thompson 2002 {published data only}|Effective nurse-led interventions in heart disease|/resolve/reference/PMED?id=12036527
Tranmer 2004 {published data only}|Enhancing postoperative recovery of cardiac surgery patients: a randomized clinical trial of an advanced practice nursing intervention|/resolve/reference/PMED?id=15359055
Turner 2008 {published data only}|Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care|/resolve/reference/PMED?id=18450843
Vale 2003 {published data only}|Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease|/resolve/reference/PMED?id=14662633
van Elderen 1994 {published data only}|Effects of a post-hospitalization group health education programme for patients with coronary heart disease|
van Elderen 2001 {published data only}|Lifestyle effects of group health education for patients with coronary heart disease|
Vonder 2002 {published data only}|Benefits of cardiac rehabilitation in the ninth decade of life in patients with coronary heart disease|/resolve/reference/PMED?id=12231096
Wallner 1999 {published data only}|Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty|
Williams 2009 {published data only}|Problem based learning in chronic disease management: a review of the research. [Review]|
Zalesskaya 2005 {published data only}|Evaluation of the economic efficiency of educational programs for patients with coronary heart disease and dyslipidemia|
Zhao 2009 {published data only}|Effects of a postdischarge transitional care programme for patients with coronary heart disease in China: a randomised controlled trial|
Zutz 2007 {published data only}|Utilization of the internet to deliver cardiac rehabilitation at a distance: a pilot study|/resolve/reference/PMED?id=17603835
Wang 2007 {published data only}|Effects of home-based cardiac rehabilitation on health-related quality of life and psychological status in Chinese patients recovering from acute myocardial infarction|
Williamson 2008 {published data only}|An individualized telephone educational intervention for patients following coronary artery bypass graft surgery during the first three weeks after discharge: using Orem's Self-Care Deficit Nursing Theory in Interventional Research|
Hawkes 2009 {published data only}|Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients|/resolve/reference/PMED?id=19426524
Lear 2008 {published data only}|Randomized trial of a cardiac rehabilitation program delivered remotely through the internet|
McGillion 2006 {published data only}|A clinical trial of a self-management education program for people with chronic stable angina|
Bailey 2010|Interactive computer-based interventions for sexual health promotion|
Balady 2007|AHA/AACVPR Scientific Statement; Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update|/resolve/reference/PMED?id=17513578
BHF 2011|Cardiac Rehabilitation|
Deakin 2005|Group based training for self-management strategies in people with type 2 diabetes mellitus|/resolve/reference/PMED?id=15846663
Dellifraine 2008|Home-based telehealth: a review and meta-analysis|/resolve/reference/PMED?id=18348749
DofH 2000|Modern Standards and Service Models. Coronary Heart Disease. National Service Framework.|
DofH 2011|Commissioning a cardiac rehabilitation service. Reabling people with coronary heart disease|
Duke 2009|Individual patient education for people with type 2 diabetes mellitus|/resolve/reference/PMED?id=19160249
Egger 1997|Bias in meta-analysis detected by a simple graphical test.|/resolve/reference/PMED?id=9310563
Gravely-Witte 2007|The impact of angina and cardiac history on health-related quality of life and depression in coronary heart disease patients|/resolve/reference/PMED?id=18072698
Hanssen, 2009|Does a telephone follow-up intervention for patients discharges with acute myocardial infarction have long-term effects on health-related quality of life? A randomised controlled trial|
Heran 2010|Exercise-based cardiac rehabilitation for coronary heart disease|
Higgins 2009|Chapter 8: Assessing risk of bias in included studies|
Jolliffe 2001|Exercise-based rehabilitation for coronary heart disease|/resolve/reference/PMED?id=11279730
Koongstvedt 2001||
Moher 2009|Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement|/resolve/reference/PMED?id=19621072
NICE 2007|Secondary prevention in primary and secondary care for patients following a myocardial infarction.|
Oldridge 2003|Assessing health-related quality of life: it is important when evaluating the effectiveness of cardiac rehabilitation?|/resolve/reference/PMED?id=12576909
Racca 2010|Functioning and disability in ischaemic heart disease|
Rahe 1979|Brief group therapy in myocardial infarction rehabilitation: Three to four year follow-up of a controlled trial|/resolve/reference/PMED?id=314119
Reece 2007||
Rees 2004|Psychological interventions for coronary heart disease|
SIGN 2002|57. Cardiac Rehabilitation|
Smith 2006|AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update: Endorsed by the national heart, lung, and blood institute|/resolve/reference/PMED?id=16702489
Taylor 1998|The assessment of recovery in post-myocardial infarction patients using three generic quality of life measures.|/resolve/reference/PMED?id=9559451
Whalley 2011|Psychological interventions for coronary heart disease|/resolve/reference/PMED?id=21833943
WHO 2008|The global burden of disease: 2004 update|
WHO 2010|Factsheet No 317|
Brufsky 2011 (RIBBON-2) {published and unpublished data}|RIBBON-2: A randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer|
Burstein 2005 {published and unpublished data}|Metronomic chemotherapy with and without bevacizumab for advanced breast cancer: a randomized phase II study|
Martin 2011 {published data only}|Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study|
Miles 2010 (AVADO) {published data only}|Bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of HER-2-negative, metastatic breast cancer|
Miller 2005 (AVF2119g) {published data only}|Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer|/resolve/reference/PMED?id=15681523
Miller 2007 (E2100) {published data only}|Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer|
Miller 2007 (E2100) {published data only}|Paclitaxel plus bevacizumab versus paclitaxel|/resolve/reference/PMED?id=18160686
RIBBON-1 (Cape cohort) {published and unpublished data}|RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab (B) for first-line treatment of Human Epidermal Growth Factor Receptor 2-negative, locally recurrent or metastatic breast cancer|
RIBBON-1(T+Anthra cohort) {published and unpublished data}|RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab (B) for first-line treatment of HER2-negative locally recurrent or metastatic breast cancer (MBC)|
Smith 2011 (ATHENA) {published data only}|First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label|
Baar 2009 {published data only}|A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers|/resolve/reference/PMED?id=19417018
Baidas 2000 {published data only}|Phase II evaluation of thalidomide in patients with metastatic breast cancer|/resolve/reference/PMED?id=10894870
Barrios 2010 {published data only}|Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer|
Cameron 2010 {published data only}|Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trial|
Mackey 2009 {published data only}|TRIO-012: A multicenter, multinational, randomized, double-blind phase III study of imc-1121b plus docetaxel versus placebo plus docetaxel in previously untreated patients with her2-negative, unresectable, locally recurrent or metastatic breast cancer|
Mayer 2010 {published data only}|SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer|
NCT01303679 {published data only}|First line treatment of bevacizumab-taxane vs bevacizumab-exemestane in metastatic breast cancer|
Rugo 2009 {published data only}|Randomized phase II study of weekly versus every-3-week ixabepilone plus bevacizumab (ixa/bev) versus paclitaxel plus bev (pac/bev) as first-line therapy for metastatic breast cancer (MBC)|
Wildiers 2010 {published data only}|Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer|
Guirado-Risueo 2010 {published data only}|Multicentric, observational, transversal study to describe the clinical profile of patients with metastatic breast cancer (MBC) treated with first-line bevacizumab (TRANSBREAST): preliminary results|
Hegewisch-Becker 2011 {published data only}|Capecitabine (Cap) combined with bevacizumab (Bev) with or without vinorelbine (Vin) in first-line metastatic breast cancer (MBC): First safety results from the randomized CARIN trial|
Klare 2011 {published data only}|Efficacy and safety of first-line bevacizumab (Bev) combined with paclitaxel (Pac): An observational study in 786 patients (pts) with HER2-negative metastatic breast cancer (mBC)|
NCT00217672 {published data only}|Docetaxel with bevacizumab as first-line therapy in treating women with stage IV breast cancer|
NCT00856492 {published data only}|Paclitaxel albumin-stabilized nanoparticle formulation, doxorubicin, cyclophosphamide, and pegfilgrastim with or without bevacizumab in treating women with inflammatory or locally advanced breast cancer|
Bear 2011|The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40|
Bergers 2008|Modes of resistance to anti-angiogenic therapy|/resolve/reference/PMED?id=18650835
Boneberg 2009|Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer|
Borenstein 2008||
Brady 1997|Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument|/resolve/reference/PMED?id=9060536
Broglio 2009|Detecting an overall survival benefit that is derived from progression-free survival|
Brown 1995|Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer|/resolve/reference/PMED?id=7821921
Burzykowski 2008|Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer|/resolve/reference/PMED?id=18421050
Carey 2011|Directed therapy of subtypes of triple-negative breast cancer|
Casanovas 2005|Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors|/resolve/reference/PMED?id=16226705
Cella 2011|Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100)|
Choueiri 2011|Congestive heart failure risk in patients with breast cancer treated with bevacizumab|
Cortes 2011|Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis|
Cox 1972|Regression models and life tables|
Cuppone 2011|Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials|
Deeks 2003|Evaluating non-randomized intervention studies|
Ebos 2011|Antiangiogenic therapy: impact on invasion, disease progression, and metastasis|
Ellis 2008|VEGF-targeted therapy: mechanisms of anti-tumour activity|/resolve/reference/PMED?id=18596824
Elston 1991|Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: experience from a large study with long term follow-up|
Ferrara 2004|Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer|/resolve/reference/PMED?id=15136787
Garcia 2007|Global cancer facts and figures 2007|
Gasparini 1997|Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma|/resolve/reference/PMED?id=8998183
Gerber 2011|Neoadjuvant bevacizumab and anthracycline/taxane-based chemotherapy in 686 triple-negative primary breast cancers: Secondary endpoint analysis of the GeparQuinto study (GBG 44)|
Gray 2009|Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer|
Higgins 2002|Quantifying heterogeneity in a meta-analysis|
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Higgins 2011||
Hu 2009|A compact VEGF signature associated with distant metastases and poor outcomes|
Hudis 2011|Triple-negative breast cancer: an unmet medical need|
Hurwitz 2004|Bevacizumab plus irinoteca, fluorouracil, and leucovorin for metastatic colorectal cancer|/resolve/reference/PMED?id=15175435
Lee 2011|Bevacizumab for salvage treatment of metastatic breast cancer: a systemic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=19293356
Linderholm 2009|Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer|
Loke 2008|Chapter 14: Adverse effects|
Marty 2008|The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: Clinical experience with anti-angiogenic agents, focusing on bevacizumab|/resolve/reference/PMED?id=18396037
Miller 2007|Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer|/resolve/reference/PMED?id=18160686
NCI 1999|Common Toxicity Criteria (CTC Version 2.0)|
NCI 2006|Common Terminology Criteria for Adverse Events v3.0 (CTCAE)|
Ng 2008|Confidence interval estimating procedures for standardized incidence rates|
O'Shaughnessy 2010|A meta-analysis of survival data from three randomized trials of bevacizumab (BV) and first-line chemotherapy as treatment for patients with metastatic breast cancer (MBC)|
Papanikolaou 2006|Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies|/resolve/reference/PMED?id=16505459
Parmar 1998|Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints|
Pivot 2011|Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO|
Pez-Ribes 2009|Antiangiogenictherapyelicitsmalignantprogressionoftumorstoincreasedlocalinvasionand distantmetastasis|/resolve/reference/PMED?id=19249680
Ranpura 2011|Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis|
RevMan 5|Review Manager (RevMan)|
Rugo 2011|Occams Razor or Hickams Dictum: The Law of Parsimony Wins? or Does it?|
Saad 2010|Overall survival and post progression survival in advanced breast cancer: a review of recent randomized clinical trials|
Scappaticci 2007|Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab|/resolve/reference/PMED?id=17686822
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Shea 2009|AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews|
Therasse 2000|New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada|/resolve/reference/PMED?id=10655437
Thomssen 2009|First-line bevacizumab combination therapy in triple- negative locally recurrent/metastatic breast cancer: subpopulation analysis of study MO19391 in >2000 patients|
Tierney 2007|Practical methods for incorporating summary time-to-event data into meta-analysis|
Valachis 2010|Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials|
Van Houwelingen 2002|Tutorial in biostatistics: advanced methods in meta-analysis: multivariate approach and meta-regression|/resolve/reference/PMED?id=11836738
Vandenbroucke 2004|Benefits and harms of drug treatments|/resolve/reference/PMED?id=15231587
Vandenbroucke 2006|What is the best evidence for determining harms of medical treatment?|/resolve/reference/PMED?id=16505461
Wagner 2009|Anti-angiogenic therapies for metastatic colorectal cancer|
Botoni 2007 {published data only}|A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy|/resolve/reference/PMED?id=17383291
Diniz 2004 {published data only}|Effect and tolerability of the carvediol in chronic symptomatic chagasic cardiomyopathy.|
Diniz 2004 {published data only}||
Bestetti 2010 {published data only}|Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure|
Dvila 2002a {published data only}|Effects of metoprolol in chagasic patients with severe congestive heart failure|/resolve/reference/PMED?id=12208592
Dvila 2008 {published data only}|Beta-adrenergic blockers in chronic systolic heart failure secondary to Chagas' disease|/resolve/reference/PMED?id=18378338
Issa 2010 {published data only}|Long-term prospective, randomized, controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients: the REMADHE trial|
Issa 2010 {published data only}|Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial|
NCT00323973 {published data only}|A randomized double-blind placebo force-titration controlled study with bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy|
Acquatella 2008|Predicting heart failure and mortality in chronic Chagas' heart disease. A novel disorder in Spain|/resolve/reference/PMED?id=18364176
Adorisio 2006|Pharmacological treatment of chronic heart failure|/resolve/reference/PMED?id=16937030
Altman 1995|Absence of evidence is not evidence of absence|/resolve/reference/PMED?id=7647644
Andrade 2011|I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy|
Anonymous 2012|Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective|
Balshem 2011|GRADE guidelines: 3. Rating the quality of evidence|
Bauman 2006|Mechanisms, manifestations, and management of digoxin toxicity in the modern era|/resolve/reference/PMED?id=16555861
Bern 2009|An estimate of the burden of Chagas disease in the United States|
Biolo 2010|Chagas cardiomyopathy - where do we stand after a hundred years?|
Bonney 2008|Chagas heart disease pathogenesis: one mechanism or many?|/resolve/reference/PMED?id=18781958
Brozek 2011|Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations|
Buckner 2010|Advances in Chagas disease drug development: 2009-2010|
Carrasco 2012|Geographical distribution of Trypanosoma cruzi genotypes in Venezuela|
Costa 2012|Ecological niche modeling as a tool for understanding distributions and interactions of vectors, hosts, and etiologic agents of Chagas disease|
Coura 2010|Chagas disease: 100 years after its discovery. A systemic review|
Cruz-Pacheco 2012|Control measures for Chagas disease|
Diniz 2010|Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi|
Dobarro 2008|Chagas' heart disease in Europe: an emergent disease?|/resolve/reference/PMED?id=19001935
Dutra 2008|Current concepts in immunoregulation and pathology of human Chagas disease|/resolve/reference/PMED?id=18448974
Dvila 2002b|Pathogenesis of chronic Chagas heart disease: parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation|/resolve/reference/PMED?id=11796128
Dvila 2004|A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease|/resolve/reference/PMED?id=15262032
Dvila 2005|Vagal dysfunction and the pathogenesis of chronic Chagas disease|/resolve/reference/PMED?id=15823646
Elias 2003|Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease|/resolve/reference/PMED?id=12641419
Fermi Paradox|Fermi Paradox|
Freiman 1978|The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials|/resolve/reference/PMED?id=355881
Gabriel 2012|Getting the methods right - the Foundation of Patient-Centered Outcomes Research|
Gascn 2007|Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic|/resolve/reference/PMED?id=17394874
Gascn 2010|Chagas disease in Spain, the United States and other non-endemic countries|
Girons 2005|Trypanosoma cruzi-induced molecular mimicry and Chagas' disease|/resolve/reference/PMED?id=16323421
Girons 2007|Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology|
Granger 2009|Adherence to medication according to sex and age in the CHARM programme|
Green 2002|Design of randomized trials|/resolve/reference/PMED?id=12119855
Gurgel-Goncalves 2012|Geographic distribution of Chagas disease vectors in Brazil based on ecological niche modeling|
Gurusamy 2009|Assessment of risk of bias in randomized clinical trials in surgery|
Guyatt 2008|What is "quality of evidence"and why is it important to clinicians|/resolve/reference/PMED?id=18456631
Guyatt 2011a|GRADE guidelines: 7. Rating the quality of evidence - inconsistency|
Guyatt 2011b|GRADE guidelines: 5. Rating the quality of evidence - publication bias|
Guyatt 2011c|GRADE guidelines: 8. Rating the quality of evidence - indirectness|
Guyatt 2011d|GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)|
Guyatt 2011e|GRADE guidelines: 9. Rating up the quality of evidence|
Guyatt 2011f|GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables|
Guyatt 2011g|GRADE guidelines: 2. Framing the question and deciding on important outcomes|
Guyatt 2011h|GRADE guidelines 6. Rating the quality of evidence - imprecision|
Hamad 2007|Pharmacologic therapy of chronic heart failure|/resolve/reference/PMED?id=17696565
Higgins 2003|Measuring inconsistency in meta-analysis|/resolve/reference/PMED?id=12958120
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0|
Higuchi 2003|Pathophysiology of the heart in Chagas disease: current status and new developments|/resolve/reference/PMED?id=14522411
Ioannidis 2004|Better reporting of harms in randomized trials: an extension of the CONSORT statement|/resolve/reference/PMED?id=15545678
Ioannidis 2008a|Why most discovered true associations are inflated|
Ioannidis 2008b|Perfect study, poor evidence: interpretation of biases preceding study design|/resolve/reference/PMED?id=18582622
Ioannidis 2010|Meta-research: the art of getting it wrong|
Kirby 2002|Determining the sample size in a clinical trial|/resolve/reference/PMED?id=12197821
Labarthe 1998|Chagas' disease and other cardiomyopathies|
Lefebvre 2011|Chapter 6: searching for studies|
Marin-Neto 1998|Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas disease|/resolve/reference/PMED?id=9740483
Marin-Neto 2007|Pathogenesis of chronic Chagas heart disease|/resolve/reference/PMED?id=17339569
Medei 2008|Role of autoantibodies in the physiopathology of Chagas' disease|
Mendez 2001|The epidemiological features of heart failure in developing countries: a review of the literature|
Mills 2001|Drug treatment of patients with decompensated heart failure|/resolve/reference/PMED?id=14728041
Moher 1998|Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses|/resolve/reference/PMED?id=9746022
Moher 2010|CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials|
Moncayo 2006|An update on Chagas disease (human American trypanosomiasis)|/resolve/reference/PMED?id=17227647
Moncayo 2009|Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy|
Moncayo 2010|Carlos Chagas: biographical sketch|
Muoz 2009|Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain|/resolve/reference/PMED?id=19438393
Nebeker 2004|Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting|/resolve/reference/PMED?id=15148066
Olivieri 2010|A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease|
OPS 2006|Estimacin cuantitativa de la enfermedad de Chagas en Las Amricas|
Porta 2008||
Punukollu 2007|Clinical aspects of the Chagas' heart disease|/resolve/reference/PMED?id=16769134
Quiros 2006|CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]|/resolve/reference/PMED?id=16764726
Rassi 2000|Predictors of mortality in chronic Chagas disease: a systematic review of observational studies|/resolve/reference/PMED?id=17339568
Rassi 2006|Development and validation of a risk score for predicting death in Chagas' heart disease|/resolve/reference/PMED?id=16928995
Rassi Jr 2009|Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification|
Rassi Jr 2010|Chagas disease|
RevMan 2011|Review Manager (RevMan)|
Reyes 2005|Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)|
Ribeiro 2009|Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity|/resolve/reference/PMED?id=19108895
Ribeiro 2012|Autonomic neuroimmunomodulation in chagasic cardiomyopathy|
Rossi 1991|The pattern of myocardial fibrosis in chronic Chagas' heart disease|/resolve/reference/PMED?id=2055674
Schmunis 2010|Chagas disease: a Latin American health problem becoming a world health problem|
Schulz 1995|Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials|/resolve/reference/PMED?id=7823387
Silva 2008|Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy?|/resolve/reference/PMED?id=19142362
Soriano 2009|Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain)|
Tanowitz 2009|Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease)|/resolve/reference/PMED?id=19410685
Thorlund 2011|The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study|
Urbina 2010|Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches|
Villar 2002|Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection|
Yamagata 2006|Control of Chagas disease|/resolve/reference/PMED?id=16735164
Zhang 1999|Parasite persistence correlates with disease severity and localization in chronic Chagas' disease|/resolve/reference/PMED?id=10395865
Carson 1998 {published data only}|Pilot to the FOCUS trial|
Carson 1998 {published data only}|A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture|
Carson 2011 {published data only}|Transfusion thresholds in FOCUS|/resolve/reference/PMED?id=22168589
Carson 2011 {published data only}|FOCUS trial|
Carson 2011 {published data only}|FOCUS: transfusion triggers after fractured hip repair|
Carson 2011 {published data only}|Safety and effectiveness of two blood transfusion strategies in surgical patient with cardiovascular disease (FOCUS)|
Carson 2011 {published data only}|Transfusion triggers in orthopedic patients|
Carson 2011 {published data only}|FOCUS study: transfusion trigger in patients with cardiovascular disease undergoing hip fracture surgery|
Carson 2011 {published data only}|Impact of transfusion triggers on postoperative myocardial infarction or death|
Carson 2011 {published data only}|Transfusion trigger trial for Functional Outcomes in Cardiovascular patients Undergoing Surgical hip fracture repair (FOCUS)|
Carson 2011 {published data only}|Transfusion trigger trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical hip fracture repair (FOCUS): the principal results|
Carson 2011 {published data only}|Liberal or restrictive transfusion in high-risk patients after hip surgery|/resolve/reference/PMED?id=22168590
Carson 2011 {published data only}|FOCUS cognitive ancillary study: randomized clinical trial of blood transfusion thresholds on delirium severity|
Carson 2011 {published data only}|Delirium outcomes in a randomized trial of blood transfusion thresholds in hospitalized older adults with hip fracture|
Carson 2011 {published data only}|Blood transfusion and delirium at 45-days post-hip fracture: long term outcomes from the focus cognitive ancillary study|
Foss 2009 {published data only}|Cochrane review transfusion in hip fracture - request for information|
Foss 2009 {published data only}|The effect of liberal vs. restrictive transfusion strategies on rehabilitation after hip fracture surgery|
Foss 2009 {published data only}|The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery|
Foss 2009 {published data only}|Cochrane review transfusion in hip fracture - request for information|
Gregersen 2015 {published data only}|Cochrane review transfusion in hip fracture - request for information|
Gregersen 2015 {published data only}|Postoperative blood transfusion for frail elderly with hip fracture|
Gregersen 2015 {published data only}|A liberal blood transfusion strategy after hip fracture surgery does not increase the risk of infection in frail elderly|
Gregersen 2015 {published data only}|A liberal blood transfusion strategy improves survival in nursing home residents with hip fracture|
Gregersen 2015 {published data only}|Postoperative blood transfusion strategy in frail anemic elderly with hip fracture: the TRIFE randomised controlled trial|
Gregersen 2015 {published data only}|Blood transfusion strategies in recovery from physical disability and overall quality of life in frail elderly with hip fracture|
Palmer 1998 {published data only}|Conference abstract - British Blood Transfusion Society meeting 1998 - Hip fracture and transfusion trial (HATT)|
Palmer 1998 {published data only}|Hip fracture and transfusion trial (HATT)|
Parker 2013 {published data only}|Randomised trial of a blood transfusion policy after fracture of the proximal femur (hip fracture)|
Parker 2013 {published data only}|Randomised trial of a blood transfusion policy after fracture of the proximal femur (hip fracture)|
Parker 2013 {published data only}|Randomised trial of blood transfusion versus a restrictive transfusion policy after hip fracture surgery|/resolve/reference/PMED?id=23756263
Gampopoulou 2004 {published data only}|Red cell transfusion with and without leukocyte depletion for orthopedic surgery|
Izuel-Rami 2005 {published data only}|Perioperative anaemia in geriatric patients with hip fracture|/resolve/reference/PMED?id=16268741
Izuel-Rami 2006 {published data only}|Recovery from postoperative anaemia after hip fracture replacement surgery. Is there a role for erythropoietin and intravenous iron?|
Jans 2011 {published data only}|Liberal versus restrictive transfusion during symptomatic moderate anemia after hip arthroplasty|
Matot 2012 {published data only}|NCT01491308, TASMAC-11-IM-0449-11-CTIL, Restrictive versus liberal red cell transfusion strategy in orthopedic-oncology patients undergoing surgery - a randomized controlled study|
Matot 2012 {published data only}|Restrictive versus liberal red cell transfusion strategy in orthopedic-oncology patients undergoing surgery - a randomized controlled study|
Moghaddam 2009 {published data only}|The effects of tranexamic acid on hemorrhage in femoral fracture surgery|
Muir 1995 {published data only}|Blood transfusion requirement in femoral neck fracture|/resolve/reference/PMED?id=8540667
Nielsen 2012 {published data only}|Establishment of optimal transfusion threshold after major orthopedic surgery|
Nielsen 2012 {published data only}|Establishment of optimal transfusion threshold after major orthopedic surgery|
Prasad 2009 {published data only}|Post-operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial|/resolve/reference/PMED?id=19524906
Serrano Trenas 2011 {published data only}|Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial|
Zufferey 2010 {published data only}|Tranexamic acid in hip fracture surgery: a randomized controlled trial|/resolve/reference/PMED?id=19926634
ChiCTR-TRC-10000822 {published data only}|Clinical research of restrictive transfusion in elderly patients undergoing orthopedic surgery|
Adunsky 2008|Discharge hemoglobin and functional outcome of elderly hip fractured patients undergoing rehabilitation|/resolve/reference/PMED?id=19002091
Carless 2010|Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion|
Carson 1999|Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair|
Carson 2012|Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion|
Carson 2013|Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease|/resolve/reference/PMED?id=23708168
Department of Health Payment by Results team 2012|A simple guide to Payment by Results|
Dillon 2005|Preoperative characteristics identify patients with hip fractures at risk of transfusion|/resolve/reference/PMED?id=16205160
Egol 2009|Perioperative considerations in geriatric patients with hip fracture: what is the evidence?|/resolve/reference/PMED?id=19550223
Foss 2006|Hidden blood loss after surgery for hip fracture|/resolve/reference/PMED?id=16877605
Foss 2008|Anaemia impedes functional mobility after hip fracture surgery|/resolve/reference/PMED?id=18349013
Goodnough 2014|Do liberal blood transfusions cause more harm than good?|/resolve/reference/PMED?id=25501327
GRADE 2011|Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Gruber-Baldini 2013|Delirium outcomes in a randomized trial of blood transfusion thresholds in hospitalized older adults with hip fracture|
Gullberg 1997|World-wide projections for hip fracture|/resolve/reference/PMED?id=9425497
Hajjar 2010|Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial|/resolve/reference/PMED?id=20940381
Higgins 2011a|Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Higgins 2011b|Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Higgins 2011c|Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Hutton 2005|Transfusion rates vary significantly amongst Canadian medical centres|/resolve/reference/PMED?id=15983142
Johnston 2006|Is perioperative blood transfusion a risk factor for mortality or infection after hip fracture?|/resolve/reference/PMED?id=17106377
Lawrence 2003|Higher Hb level is associated with better early functional recovery after hip fracture repair|
Lefebvre 2011|Chapter 6.4.11: Search filters. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011. The Cochrane Collaboration, 2011|
McClelland 2009|Good blood management: the effective and safe use of blood components|
Parker 2006|Hip fracture|/resolve/reference/PMED?id=16809710
Penninx 2006|Anemia in old age is associated with increased mortality and hospitalization|/resolve/reference/PMED?id=16720744
Perel 2013|Tranexamic acid for reducing mortality in emergency and urgent surgery|
RevMan 2011|Review Manager (RevMan)|
Rohde 2014|Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis|/resolve/reference/PMED?id=25399292
Schnemann 2011|Chapter 12: Interpreting results and drawing conclusions. Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Shokoohi 2012a|The risks of red celltransfusionforhip fracturesurgeryin the elderly|
SHOT 2010|The 2009 annual SHOT report|
Smith 2011|The hidden blood loss after hip fracture|/resolve/reference/PMED?id=7868140
So-Osman 2013|Theimpactof arestrictivetransfusiontrigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study|/resolve/reference/PMED?id=23399367
Villanueva 2013|Transfusion strategies for acute upper gastrointestinal bleeding|
Walsh 2013|Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial|/resolve/reference/PMED?id=23939351
Shokoohi 2012b|Red blood cell transfusion for people undergoing hip fracture surgery|
Arbane 2011 {published data only}|Evaluation of an early exercise intervention after thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance: randomised controlled trial|
Brocki 2010 {unpublished data only}|Rehabilitation after lung cancer operation - A randomised controlled study [Abstract]|
Stigt 2013 {published and unpublished data}|A randomized controlled trial of postthoracotomy pulmonary rehabilitation in patients with resectable lung cancer|
Adamsen 2012 {published data only}|Exercise and relaxation intervention for patients with advanced lung cancer: a qualitative feasibility study|
Andersen 2011 {published data only}|Do patients with lung cancer benefit from physical exercise?|
Arbane 2009 {published data only}|An early exercise intervention prevents quadriceps weakness after thoracotomy for non-small cell lung cancer: randomised controlled trial|
Arbane 2009a {published data only}|Early exercise training after thoracotomy prevents quadriceps sarcopenia for people with lung cancer [Abstract]|
Barinow-Wojewodzki 2008 {published data only}|Evaluation of effects of rehabilitation on trace elements and antioxidant status of patients with non-small cell lung cancer. [Polish]|
Barinow-Wojewodzki 2008a {published data only}|Effects of rehabilitation on physical efficiency in patients with lung cancer evaluated by means of the 6-minute walking test. [Polish, English]|
Barton 2010 {published data only}|A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study|
Bradley 2011 {published data only}|Is a pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery feasible?|
Cesario 2007 {published data only}|Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer|/resolve/reference/PMED?id=17442449
Dimeo 2004 {published data only}|Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomised controlled trial|
Glattki 2012 {published data only}|Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment|
Granger 2011 {published data only}|Exercise intervention to improve exercise capacity and health related quality of life for patients with non-small cell lung cancer: a systematic review|
Hwang 2012 {published and unpublished data}|Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy|
Jones 2008 {published data only}|Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: A pilot study|
Jones 2009 {published data only}|Exercise therapy across the lung cancer continuum|/resolve/reference/PMED?id=19508829
Jones 2010 {published data only}|The lung cancer exercise training study: A randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: Rationale and design|
Jones 2011 {published data only}|Effects of aerobic training on oxidative status in postsurgical non-small cell lung cancer patients: a pilot study|
Kiziltas 2006 {published data only}|Pulmonary rehabilitation after lobectomy for lung cancer exercise programme vs conventional approach [Abstract]|
Licker 2011 {published data only}|Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery|
Lin 2013 {published data only}|Physical activity preferences among patients with lung cancer in Taiwan|/resolve/reference/PMED?id=17479377
Lubbe 2001 {published data only}|Health-related quality of life and pulmonary function in lung cancer patients undergoing medical rehabilitation treatment|
Maddocks 2009 {published data only}|Randomized controlled pilot study of neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer|
Nazarian 2004 {published data only}|Cardiopulmonary rehabilitation after treatment for lung cancer|/resolve/reference/PMED?id=14697159
Nici 2008 {published data only}|Preoperative and postoperative pulmonary rehabilitation in lung cancer patients|/resolve/reference/PMED?id=18402200
Oldervoll 2004 {published data only}|Physical exercise results in the improved subjective well-being of a few or is effective rehabilitation for all cancer patients?|/resolve/reference/PMED?id=15093569
Parsons 2012 {published data only}|Patient's experiences of a pre and post surgery rehabilitation programme for lung cancer (Rehabilitation Of lung Cancer (ROC) programme): A qualitative interview study|
Peddle-McIntyre 2012 {published data only}|Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors|
Peddle-McIntyre 2013 {published data only}|Changes in motivational outcomes after a supervised resistance exercise training intervention in lung cancer survivors|
Riesenberg 2010 {published data only}|In-patient rehabilitation of lung cancer patients - A prospective study|
Shannon 2010 {published data only}|Impact and feasibility of pulmonary rehabilitation on performance status among lung cancer patients during cancer therapy|
Shannon 2011 {published data only}|Timing of Pulmonary Rehabilitation (PR) relative to cancer treatment impacts PR benefits among patients with NSCLC and moderate to severe COPD|
Spruit 2006 {published data only}|Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: A pilot study|/resolve/reference/PMED?id=16529844
Weiner 1997 {published data only}|The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection|
Woods 1999 {published data only}|Effects of 6 months of moderate aerobic exercise training on immune function in the elderly|
AIHW 2010|Cancer|
Aoki 2007|Quality of life after lung cancer surgery: video-assisted thoracic surgery versus thoracotomy|/resolve/reference/PMED?id=17576100
Atkins 2004|Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group|/resolve/reference/PMED?id=15615589
Baracos 2010|Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis|
Blanchard 2008|Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II|/resolve/reference/PMED?id=18445845
Casaburi 1991|Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease|/resolve/reference/PMED?id=1986689
Cavalheri 2013|Physiotherapy practice patterns for patients undergoing surgery for lung cancer: a survey of hospitals in Australia and New Zealand|
Chandratilleke 2012|Physical training for asthma|
Cykert 2000|Patient preferences regarding possible outcomes of lung resection: what outcomes should preoperative evaluations target?|/resolve/reference/PMED?id=10858382
Dagnelie 2007|Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy|/resolve/reference/PMED?id=17363839
Danish Lung Cancer Registry 2009|Yearly Report for 2009 [in Danish]|
DerSimonian 1986|Meta-analysis in clinical trials|/resolve/reference/PMED?id=3802833
Ferlay 2010|Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008|
Gopaldas 2010|Video-assisted thoracoscopic versus open thoracotomy lobectomy in a cohort of 13,619 patients|
Guyatt 2008|GRADE: an emerging consensus on rating quality of evidence and strength of recommendations|/resolve/reference/PMED?id=18436948
Holland 2008|Physical training for interstitial lung disease|
Holland 2009|Small changes in six-minute walk distance are important in diffuse parenchymal lung disease|
Jemal 2008|Cancer statistics, 2008|
Jones 2007|Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions|
Jones 2008a|Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations|/resolve/reference/PMED?id=18672211
Lacasse 2006|Pulmonary rehabilitation for chronic obstructive pulmonary disease|
Landreneau 1993|Postoperative pain-related morbidity: video-assisted thoracic surgery versus thoracotomy|/resolve/reference/PMED?id=8267426
Maltais 1996|Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease|/resolve/reference/PMED?id=8756820
Markes 2006|Exercise for women receiving adjuvant therapy for breast cancer|
Murphy 2010|Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients|
Myrdal 2003|Quality of life following lung cancer surgery|/resolve/reference/PMED?id=12612291
Nezu 1998|Recovery and limitation of exercise capacity after lung resection for lung cancer|/resolve/reference/PMED?id=9631786
O'Driscoll 1999|The experience of breathlessness in lung cancer|
Office for National Statistics 2009|Mortality Statistics: Deaths registered in England and Wales (Series DR) by cause, 2009|
Polkey 2013|Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization|
Puhan 2008|Interpretation of treatment changes in 6-minute walk distance in patients with COPD|/resolve/reference/PMED?id=18550610
Puhan 2011|Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease|
RevMan 2011|Review Manager (RevMan)|
Schneider 2007|Exercise training manages cardiopulmonary function and fatigue during and following cancer treatment in male cancer survivors|/resolve/reference/PMED?id=17761636
Schwartz 2001|Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy|/resolve/reference/PMED?id=11323538
Segal 2009|Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer|/resolve/reference/PMED?id=19064985
Sher 2008|Small cell lung cancer|/resolve/reference/PMED?id=18316005
Sugimura 2006|Long-term survivorship in lung cancer: a review|/resolve/reference/PMED?id=16608961
Suzuki 2011|Prognosis of small-cell lung cancer since the introduction of amrubicin|
Travers 2008|Mechanisms of exertional dyspnea in patients with cancer|/resolve/reference/PMED?id=17975124
Zarogoulidis 2012|Six minute walking test and carbon monoxide diffusing capacity for non-small cell lung cancer: easy performed tests in every day practice|
Arthur 2000 {published data only}|Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial|/resolve/reference/PMED?id=10929164
Carvalho 2011 {published data only}|Preoperative respiratory muscle training reduces complications in coronary artery bypass surgery|
Carvalho 2011 {published data only}|Preoperative respiratory muscle training reduces complications in coronary artery bypass surgery [Abstract]|
Ferreira 2009 {published data only}|Effects of an inspiratory muscle rehabilitation program in the postoperative period of cardiac surgery|/resolve/reference/PMED?id=19565135
Hulzebos 2006A {published data only}|Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high risk patients undergoing CABG surgery|
Hulzebos 2006B {published data only}|Feasibility of preoperative inspiratory muscle training in patients undergoing CABG surgery with a high risk of postoperative pulmonary complications: A randomized controlled pilot study|/resolve/reference/PMED?id=17065538
Rajendran 1998 {published data only}|Pre-operative short-term pulmonary rehabilitation for patients of chronic obstructive pulmonary disease undergoing coronary artery bypass graft surgery|/resolve/reference/PMED?id=10052279
Rosenfeldt 2011 {published data only}|Physical conditioning and mental stress reduction--a randomised trial in patients undergoing cardiac surgery|/resolve/reference/PMED?id=21385466
Weiner 1998 {published data only}|[Prophylactic inspiratory muscle training before coronary artery bypass graft]|/resolve/reference/PMED?id=8549956
Weiner 1998 {published data only}|Prophylactic inspiratory muscle training in patients undergoing coronary artery bypass graft|/resolve/reference/PMED?id=9564282
Anderson 1987 {published data only}|Preoperative preparation for cardiac surgery facilitates recovery, reduces psychological distress, and reduces the incidence of acute postoperative hypertension|/resolve/reference/PMED?id=3497959
Buijs van den 2004 {published data only}|Preoperative inspiratory muscle training in patients due to undergo open-heart surgery: a pilot study|
Castillo 1985 {published data only}|Chest physical therapy: comparative efficacy of preoperative and postoperative in the elderly|/resolve/reference/PMED?id=4004535
Cisar 1983 {published data only}|Preoperative teaching: aortocoronary bypass patients|/resolve/reference/PMED?id=6600689
Crawford 1993 {published data only}|The effect of pre-operative physiotherapy on post-operative functional residual capacity following coronary artery bypass surgery|
Dias 2011 {published data only}|Three physiotherapy protocols: effects on pulmonary volumes after cardiac surgery|/resolve/reference/PMED?id=21390432
Dowds 2009 {published data only}|An investigation of pre-surgical inspiratory muscle training (IMT) on exercise and pulmonary function following thoracic surgery [Abstract]|
Fitileva 1982 {published data only}|[Preoperative management of patients with ischemic heart disease undergoing aortocoronary by-pass]|/resolve/reference/PMED?id=6983790
Fujimura 1980 {published data only}|Postoperative pulmonary complications in chest surgery: The relationship with preoperative lung function and preventive measures. [Japanese]|/resolve/reference/PMED?id=7206395
Gosselink 1998 {published data only}|Recovery after thoracic surgery is not accelerated with incentive spirometry [abstract]|
Herdy 2008 {published data only}|Pre- and postoperative cardiopulmonary rehabilitation in hospitalized patients undergoing coronary artery bypass surgery: a randomized controlled trial|/resolve/reference/PMED?id=18716482
Iankelevich 1967 {published data only}|Exercise therapy in the surgical correction of congenital heart defects [Russian]|/resolve/reference/PMED?id=5620381
Ingwersen 1993 {published data only}|Three different mask physiotherapy regimens for prevention of post-operative pulmonary complications after heart and pulmonary surgery|/resolve/reference/PMED?id=8408940
Jenkins 1989 {published data only}|Physiotherapy after coronary artery surgery: are breathing exercises necessary?|/resolve/reference/PMED?id=2799743
Ku 2002 {published data only}|Effects of phase I cardiac rehabilitation on anxiety of patients hospitalized for coronary artery bypass graft in Taiwan|/resolve/reference/PMED?id=11910388
Leserman {published data only}|The efficacy of the relaxation response in preparing for cardiac surgery|/resolve/reference/PMED?id=2676027
Mahler 1998 {published data only}|Effects of preparatory videotapes on self-efficacy beliefs and recovery from coronary bypass surgery|/resolve/reference/PMED?id=9755351
Matte 2000 {published data only}|Effects of conventional physiotherapy, continuous positive airway pressure and non-invasive ventilatory support with bilevel positive airway pressure after coronary artery bypass grafting|
Nomori 1994 {published data only}|Preoperative respiratory muscle training: assessment in thoracic surgery patients with special reference to postoperative pulmonary complications|/resolve/reference/PMED?id=8205877
Oulton 1981 {published data only}|Incentive breathing devices and chest physiopathy: a controlled therapy|
Recker 1994 {published data only}|Patient perception of preoperative cardiac surgical teaching done pre- and postadmission|/resolve/reference/PMED?id=8194326
Rice 1992 {published data only}|Preadmission self-instruction effects on postadmission and postoperative indicators in CABG patients: partial replication and extension|
Savci 2011 {published data only}|Short-term effects of inspiratory muscle training in coronary artery bypass graft surgery: a randomized controlled trial|/resolve/reference/PMED?id=21793631
Sheveleva 1965 {published data only}|Exercise therapy in mitral stenosis and associated heart defects before and after surgery [Russian]|/resolve/reference/PMED?id=14280539
Shuldham 2002 {published data only}|The impact of pre-operative education on recovery following coronary artery bypass surgery. A randomized controlled clinical trial|/resolve/reference/PMED?id=11969282
Sivaraman 2010 {published data only}|Yoga breathing exercise to reduce postoperative pulmonary complications in patients undergoing elective valve replacement for valvular heart disease: a randomized clinical trial|
Smetana 2003 {published data only}|Preoperative pulmonary assessment of the older adult|/resolve/reference/PMED?id=12735114
Stein 1970 {published data only}|Preoperative pulmonary evaluation and therapy for surgery patients|/resolve/reference/PMED?id=5536561
Stiller 1994 {published data only}|Efficacy of breathing and coughing exercises in the prevention of pulmonary complications after coronary artery surgery|/resolve/reference/PMED?id=8131535
Uglov 1992 {published data only}|[The physiotherapeutic correction of secondary immunodeficiency in the preoperative period in patients with rheumatic heart defects]|/resolve/reference/PMED?id=1341355
Vraicu 1977 {published data only}|Effectiveness of breathing exercises in preventing pulmonary complications following open heart surgery|/resolve/reference/PMED?id=303778
Walther 2010 {published data only}|Preoperative exercise training is associated with less peri- and postoperative adverse events but similar long term outcome in patients with stable coronary artery disease|
Winten 1995 {published data only}|Influence of pre-operative breathing therapy with incentive spirometers on lung function and rate of complication in coronary bypass operations|
Zamotrinsky 1997 {published data only}|Effects of electrostimulation of the vagus afferent endings in patients with coronary artery disease|/resolve/reference/PMED?id=9431484
Brooks-Brunn 1995|Postoperative atelectasis and pneumonia|/resolve/reference/PMED?id=7759282
Carli 2005|Optimizing functional exercise capacity in the elderly surgical population|/resolve/reference/PMED?id=15585997
Convertino 1997|Cardiovascular consequences of bed rest: effect on maximal oxygen uptake|/resolve/reference/PMED?id=9044222
Craig 1991|Postoperative recovery of pulmonary function|/resolve/reference/PMED?id=7006464
Craven 1974|The evaluation of motivates spirometry in the management of postoperative pulmonary complications|
Davies 1991|A controlled trial of community based coronary rehabilitation|/resolve/reference/PMED?id=1854568
Dureuil 1987|Effects of upper or lower abdominal surgery on diaphragmatic function|/resolve/reference/PMED?id=2960367
Eagle 2004|ACC / AHA 2004 guideline update for coronary artery bypass graft surgery: summary article|/resolve/reference/PMED?id=15337239
Ephgrave 1993|Postoperative pneumonia: a prospective study of the risk factors and morbidity|/resolve/reference/PMED?id=8211699
Ferguson 1999|Preoperative assessment of pulmonary risk|/resolve/reference/PMED?id=10331335
Ford 1993|Respiratory physiology in upper abdominal surgery|/resolve/reference/PMED?id=8519170
Hart 1989|The effect of therapist-evaluation of orders and interaction with physicians on the appropriateness of respiratory care|/resolve/reference/PMED?id=10315771
Hedenstierna 2005|The lung during and after thoracic anaesthesia|/resolve/reference/PMED?id=16534313
Higgins 2003|Measuring inconsistency in meta-analyses|/resolve/reference/PMED?id=12958120
Higgins 2011||
Hoogeboom 2012|Therapeutic validity and effectiveness of preoperative exercise on functional recovery after joint replacement: a systematic review and meta-analysis|/resolve/reference/PMED?id=22675429
Imanaka 2004|Changes in respiratory pattern during continuous positive airway pressure in infants after cardiac surgery|/resolve/reference/PMED?id=15549465
Johnson 1996|Respiratory function after cardiac surgery|/resolve/reference/PMED?id=8841860
Kjaergaard 2004|Hypoxaemia after cardiac surgery: clinical application of a model of pulmonary gas exchange|/resolve/reference/PMED?id=15109193
Knill 1988|Control of breathing: effects of analgesia, anaesthetic and neuromuscular blocking drugs|/resolve/reference/PMED?id=3289778
Krasnoff 1999|The physiological consequences of bed rest and inactivity|/resolve/reference/PMED?id=10230879
Kroenke 1992|Operative risk in patients with severe obstructive pulmonary disease|/resolve/reference/PMED?id=1580723
Laghi 2003|Disorders of the respiratory muscles|/resolve/reference/PMED?id=12826594
McConnel 2004|Respiratory muscle training in healthy humans: resolving the controversy|/resolve/reference/PMED?id=15162248
Narayan 2005|Postoperative chest radiographic changes after on- and off-pump coronary surgery|/resolve/reference/PMED?id=16038697
Nilsson 2006|Comparison of 19 pre-operative risk stratification models in open-heart surgery|/resolve/reference/PMED?id=16421172
Nishino 1998|Breathing patterns during postoperative analgesia in patients after low abdominal surgery|/resolve/reference/PMED?id=3195770
O'Donohue 1992|Postoperative pulmonary complications. When are preventive and therapeutic measures necessary?|/resolve/reference/PMED?id=1741361
Pasquina 2003|Prophylactic respiratory physiotherapy after cardiac surgery: systematic review|
Powell 1994|The public health burdens of sedentary living habits: theoretical but realistic estimates|/resolve/reference/PMED?id=7934758
Ragnarsdottir 2004|Short-term changes in pulmonary function and respiratory movements after cardiac surgery via median sternotomy|/resolve/reference/PMED?id=15204247
Shekleton 1996|Respiratory muscle weakness and training|
Simmons 1982|Guideline for prevention of nosocomial pneumonia|/resolve/reference/PMED?id=6956560
Sowden 1997|Volume of clinical activity in hospitals and healthcare outcomes, costs, and patient access|/resolve/reference/PMED?id=10173253
Stiller 1992|Chest physiotherapy for the surgical patient|
Sykes 1993|Cardiorespiratory effects of anesthesia|/resolve/reference/PMED?id=8519168
Taylor 1990|Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications|/resolve/reference/PMED?id=2105627
Tenling 1998|Atelectasis and gas exchange after cardiac surgery|/resolve/reference/PMED?id=9710395
Topp 2002|The effect of bed rest and potential of prehabilitation on patients in the intensive care unit|
Van Belle 1992|Postoperative pulmonary function abnormalities after coronary artery bypass surgery|/resolve/reference/PMED?id=1620905
Weismann 2004|Pulmonary complications after cardiac surgery|/resolve/reference/PMED?id=15375480
Weissman 1999|Pulmonary functions after cardiac and thoracic surgery|/resolve/reference/PMED?id=10357329
Wynne 2004|Postoperative pulmonary dysfunction after cardiac surgery with cardiopulmonary bypass: Clinical significance and implications for practice|/resolve/reference/PMED?id=15470854
Chen 2011 {published data only}|Effect of Tongxinluo capsule on platelet activity and function of vascular endothelium functions as well as prognosis at different stage in patients with acute coronary syndrome after undergoing percutaneous coronary intervention|
Chen 2011 {published data only}|Effect of Tongxinluo capsule on platelet activities and vascular endothelium functions as well as prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention|/resolve/reference/PMED?id=19039527
Chen 2011 {published data only}|Effect of Tongxinluo capsule on platelet activities and vascular endothelium functions at different stages in patients with acute coronary syndrome undergoing percutaneous coronary intervention|/resolve/reference/PMED?id=16038447
Dai 2011 {published data only}|Clinical observation for the effect of Tong-xin-luo capsules in preventing restenosis in patients with coronary heart disease after percutaneous coronary intervention|
Di 2012 {published data only}||
Dong 2012 {published data only}|Influence of Tongxinluo on inflammatory and cytokinesendothelial function in patients with acute myocardial infarction after percutaneous coronary intervention|
Huang 2010 {published data only}|Influence of Tongxinluo on inflammation reaction and endothelial function in patients with acute myocardial infarction after percutaneous coronary intervention|
Li 2004 {published data only}|Research on the Effects of Tongxinluo Capsules on Local Cerebral Blood Flow in Patients with Cerebral Infarction|
Liang 2010 {published data only}|The effect of Tongxinluo capsules on coronary restennosis of patients with acute myocardial infarction after percutaneous coronary intervention|
Wang 2009a {published data only}|Effect of Tongxinluo capsules to prevent restenosis in patients after percutaneous intervention|
Wang 2010 {published data only}|Effect of Tongxinluo Capsule on Restenosis after Coronary Artery Stent Implantation in Patients with Type-2 Diabetes Mellitus|/resolve/reference/PMED?id=6553356
Wu 2010 {published data only}|Effects of Tongxinluo Capsules on interventional therapy of patients with unstable angina. China Medical Herald, 2010, 20: 012.|
Xiao 2007 {published data only}|Effects of tongxinluo on C-reactive protein and clinical prognosis in patients after coronary stenting|
Yang 2009a {published data only}||
Yang 2009a {published data only}|NA|
Yang 2009a {published data only}||
Yao 2006 {published data only}|Clinical study of reconstriction after PCI operation in patients with coronary disease intervened by Tongxinluo capsule|
Zhang 2009a {published data only}|Long-term effect of Tongxinluo in patients with acute myocardial infarction after coronary stenting|
Zheng 2010 {published data only}|The effect of Tongxinluo capsule on level of serum CRP and blood lipid in patients with ACS post PCI|
Zhou 2007b {published data only}|Clinical Study of Tongxinluo on Preventing Re-stenosis of Stents in CHD|
Chang 2004 {published data only}|Clinical observation for Tongxinluo in the treatment of 68 cases of unstable angina pectoris|
Chen 2007 {published data only}|The effects of Tongxinluo capsule on platelet activity and vascularendothelium function in patients with ACS after PCI|
Fan 2008 {published data only}|Treatment Effects of Tongxinluo capsule on acute myocardial infarction after coronary stent|
Fu 2012 {published data only}|Clinical observation of Tongxinluo capsules in treating patients with angina after PCI|
Gao 2007 {published data only}|The long-term efficacy of Tongxinluo in patients after percutaneous coronary intervention|
Guo 2012 {published data only}|Evaluation of the therapeutic effect of Tongxinluo for acute myocardial infarction using |
Han 2009 {published data only}|Study of the changes of myeloperoxidase concentration in plasma and the interventional effect of Tongxinluo capsule on patients with unstable angina|
Han 2011 {published data only}|The effect of Tongxinluo on blood lipid, hs-CRP and MMP-9 in patients with unstable angina pectoris after PCI|
Hou 2008 {published data only}|The effect of Tongxinluo on restenosis in patients with ACS|
Jiang 2008 {published data only}|Research of prevention effect of traditional Chinese medicine on restenosis after percutaneous coronary intervention|
Kuang 2011 {published data only}|Protection of Tongxinluo capsule against myocardial injury in patients after elective percutaneous coronary stenting posting|
Li 2008 {published data only}|Inflammatory reaction and change of vascular endothelial function after percutaneous coronary intervention and the effect of Tongxinluo|
Li 2012 {published data only}|The effect of drug intervention on vascular inflammatory reaction and change of vascular endothelial function after percutaneous coronary intervention|
Liu 2009 {published data only}|The effect of Tongxinluo on perioperative CRP patients with ACS|
Lu 2012 {published data only}|The effect of Tongxinluo capsules on the change of hemorheology in patients with CHD after PCI|/resolve/reference/PMED?id=8940540
Ma 2009 {published data only}|Effect of Tongxinluo on endothelial function and hypersensitiveC-reactive protein in acute coronary syndrome patients undergoing percutaneous coronary intervention|/resolve/reference/PMED?id=19587440
Qu 2011 {published data only}|Clinical observation of Tongxinluo in treating patients with CHD|
Su 2000 {published data only}|Clinical observation of 96 cases of variant angina pectoris treated with Tongxinluo|
Tao 2012 {published data only}|Curative effect of Tongxinluo in treatment of angina after percutaneous coronary intervention (PCI) operation|
Tu 2006 {published data only}|Influence of Tongxinluo on C-reactive Protein in patients with diabetes after percutaneous coronary intervention|
Wang 2007 {published data only}|Clinical study Oil Lvedv and Lvef after blood flow reconstruction interfered by Tongxinluo capsule in patients with AMI after percutaneous coronary intervention|
Wang 2009b {published data only}|Effect of Tongxinluo on inflammatory factor in patients with ACS|
Wang 2009c {published data only}|Clinical observation for Tongxinluo in the treatment of CHD|
Wang 2012 {published data only}|The effect of drug intervention on vascular inflammatory reaction and vascular endothelial function after percutaneous coronary intervention|
Xiao 2004 {published data only}|The effect of Tongxinluo in treating patients with unstable angina pectoris|
Xu 2007 {published data only}|Influence of Tongxinluo on inflammatory factor of acute coronary syndrome patients after interventional therapy and its early heart complication|
Xu 2008 {published data only}|The prevention of restenosis after percutaneous coronary intervention|
Yang 2009b {published data only}|Inflammatory reaction and change of vascular endothelial function after percutaneous coronary intervention and the effect of drug intervention|
Yang 2010 {published data only}|Effect of Tongxinluo on Change of Vascular Inflammation and EndothelialFunction after Percutaneous Coronary Intervention|
Yang 2012 {published data only}|The effect of Tongxinluo on serum PNP and ventricular remodeling in patients with AMI after PCI|
Zhang 2005 {published data only}|Effect of Tongxinluo Capsule on Coagulant and Fibrinolysis System andAngiotension II in Patients with CHD after Intracoronary Stenting|
Zhang 2006 {published data only}|The protective effects of Tongxinluo on myocardium after reperfusion in PCI patients with acute myocardium infarction|
Zhang 2007 {published data only}|Clinical analysis of integrated traditional and western medicine in treating 62 cases of CHD|
Zhang 2008 {published data only}|The Effect of Tongxinluo Capsules on the Function of BloodVessel Endothelium(BVE)on the Patientswith Coronary Heart Disease|
Zhang 2009b {published data only}|The effect of Tongxinluo on inflammatory cytokins in patients with ACS|
Zhang 2010 {published data only}|No-reflow protection and long-term efficacy for acute myocardialinfarction with Tongxinluo: a randomized double-blind placebocontrolled multicenter clinical trial|/resolve/reference/PMED?id=21034597
Zhao 2010 {published data only}|Effects of Tongxinluo on Inflammatory factors in patients with coronary heart disease after percutaneous coronary intervention|
Zhao 2011 {published data only}|Clinical observation of Tongxinluo in treating patiens after percutaneous coronary intervention|
Deng 2013 {published data only}|Effect of Tongxinlou capsule on restenosis after PCI in patients with CHD|
Han 2012 {published data only}|Tongxinluo improve high on Clopidogrel platelet reactivity in patients with coronary heart disease|
Agema 2001|Genetic aspects of restenosis after percutaneous coronary interventions; towards more tailored therapy|/resolve/reference/PMED?id=11686664
Bhattarai 2012|Coding, recording and incidence of different forms of coronary heart disease in primary care|/resolve/reference/PMED?id=22276128
Boissel 1999|The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use|/resolve/reference/PMED?id=10667106
Chen 1985|Effect of Scolopendra extraction in the experiment of rabbit heart|
Chen 2007|The effects of Tongxinluo capsule on platelet activity and vascular endothelium function in patients with ACS after PCI|
Cutlip 2007|Clinical end points in coronary stent trials: a case for standardized definitions|/resolve/reference/PMED?id=17470709
Dangas 1996|Management of restenosis after coronary intervention|/resolve/reference/PMED?id=8701907
Deeks 2000|Issues in the selection of a summary statistic for meta-analyses of binary data|
Drffler 2005|Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment|/resolve/reference/PMED?id=15674891
Egger 1997|Bias in meta-analysis detected by a simple, graphical test|
Fattori 2003|Drug-eluting stents in vascular intervention|/resolve/reference/PMED?id=12547552
Giglioli 2009|An angiographic evaluation of restenosis rate at a six-month follow-up of patients with ST-elevation myocardial infarction submitted to primary percutaneous coronary intervention|/resolve/reference/PMED?id=18206252
Go 2014|Heart Disease and Stroke Statistics - 2014 Update. A report from the American Health Association|/resolve/reference/PMED?id=24352519
Grech 2003|ABC of interventional cardiology: percutaneous coronary intervention II: the procedure|/resolve/reference/PMED?id=12763994
Higgins 2011||
Huntington 2003|Targeting thrombin  rational drug design from natural mechanisms|/resolve/reference/PMED?id=14607082
Kang 2012|Progress in genetic and epigenetic research on in-stent restenosis after percutaneous coronary interventions|/resolve/reference/PMED?id=22311489
Lau 1997|Quantitative synthesis in systematic reviews|/resolve/reference/PMED?id=9382404
Lonn 2010|The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions|/resolve/reference/PMED?id=21098469
Lozano 2012|Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010|/resolve/reference/PMED?id=23245604
Lu 2006|Clinical study on effect of |/resolve/reference/PMED?id=16466165
Modi 1995|Pharmacokinetics and pharmacodynamics of TP-9201, a GPIIbIIIa antagonist, in rats and dogs|/resolve/reference/PMED?id=7564333
NHLBI 2011|Health Topic: Coronary heart disease|
Nong 1989|The effect of Eupolyphaga Sinensis Walk alkaloids on rabbits cardial pump function|
Nong 2000|Research on combined treatment of unstable angina pectoris with TCM and WM|
Odell 2006|Restenosis after percutaneous coronary intervention (PCI): experiences from the patients' perspective|/resolve/reference/PMED?id=16297663
Paul 1994|Hirudin: Clinical potential of a thrombin inhibitor|/resolve/reference/PMED?id=8198374
Pei 1986|Study of cardiac stimulation of Ginsenoside of upper part over grand|
Pereira 2012|Empirical evaluation of very large treatment effects of medical interventions|/resolve/reference/PMED?id=23093165
Rajaqopal 2003|A review of mechanisms and management|/resolve/reference/PMED?id=14599634
RevMan 2008|Review Manager (RevMan)|
Richard 2002|Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry|/resolve/reference/PMED?id=12422151
Rosanio 1999|Prevention of restenosis after percutaneous coronary interventions: the medical approach|/resolve/reference/PMED?id=10695510
Ruan 2003|Recent advances in study of component and pharmacological roles of Radix Paeoniae Rubra|
Serruys 1995|A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty|/resolve/reference/PMED?id=7643882
Singh 2011|Myocardial revascularization by percutaneous coronary intervention: past, present, and the future|/resolve/reference/PMED?id=21889660
Sterne 2001|Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis|/resolve/reference/PMED?id=11576817
Testa 2009|Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition|/resolve/reference/PMED?id=19286891
Wang 2003|Effect of Tongxinluo capsule on function of vascular endotheliumin patients with unstable angina pectoris|/resolve/reference/PMED?id=14503056
Wang 2007|The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China|/resolve/reference/PMED?id=17825697
Wang 2008|Comparative pharmacokinetic study of paeoniflorin after oral administration of decoction of Radix Paeoniae Rubra and Radix Paeoniae Alba in rats|/resolve/reference/PMED?id=18424022
WHO 2002|Life course perspectives on coronary heart disease, stroke and diabetes|
WHO 2011|Health topic: cardiovascular diseases (CVDs)|
WHS 2010|Cause-specific mortality and morbidity|
Wu 2001||
Wu 2006|Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris|/resolve/reference/PMED?id=19229188
Wu 2013|Systematic reviews and meta-analyses of traditional Chinese medicine must search Chinese databases to reduce language bias|/resolve/reference/PMED?id=24223063
Xu 1988|Effect of inhibition platelet adhesion reaction of Radix Ginseng|
Yu 2011|Progress and prospect of Hirudin and Its derivants research|
Zhang 2004|Effects of tongxinluo capsule in the treatment of 68 patients with unstable angina pectoris|
Zheng 1998|Periostracum Cicadae|
Zhou 1997|Thrombin inhibitorhirudin|
Zhou 2007 a|Clinical study of Tongxinluo on preventing re-stenosis of stents in CHD|
Zhou 2011|Tongxinluo capsule for coronary heart disease: a systematic review|
Zhu 2004|Study on Tongxinluo capsule in preventing and treating coronary restenosis after PTCA|
Zhuo 2008|Tongxinluo capsule for acute stroke|
Hemsinli 2012 {published data only}|The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy|
Moghaddam 2011 {published data only}|Effect of tranexamic acid in decreasing need to transfusion in hip fracture surgery|
Pfizer 2011 {published data only}|Prospective randomised phase IV open label comparative study of tranexamic acid plus standard care versus standard care for the reduction of blood loss in subjects undergoing surgery for long bone fracture|
Sadeghi 2007 {published data only}|Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients|
Zufferey 2010 {published data only}|Tranexamic acid in hip fracture surgery: a randomized controlled trial|
Bainbridge 2012|Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis|
CRASH-2 2010|Eects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial|
Debas 2006|Surgery|
Goodnough 2008|Risk and complications of blood transfusions: optimizing outcomes for patients with chemotherapy induced anemia|
Henry 2011|Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion|
Higgins 2011|Chapter 8: Assessing risk of bias in included studies|
Karkouti 2004|The independent association of massive blood loss with mortality in cardiac surgery|
Klein 2007|Red blood cell transfusion in clinical practice|/resolve/reference/PMED?id=17679019
Mannucci 2007|Prevention and treatment of major blood loss|/resolve/reference/PMED?id=17538089
Okamoto 1997|Enzyme controlling medicines: introduction|/resolve/reference/PMED?id=9469621
Pearse 2006|Identification and characterisation of the high-risk surgical population in the United Kingdom|/resolve/reference/PMED?id=16749940
Weiser 2008|An estimation of the global volume of surgery: a modelling strategy based on available data|/resolve/reference/PMED?id=18582931
Perel 2012|Tranexamic acid for reducing mortality in emergency and urgent surgery|
Battersby 2007 {published data only (unpublished sought but not used)}|SA HealthPlus: a controlled trial of a statewide application of a generic model of chronic illness care|
Battersby 2007 {published data only (unpublished sought but not used)}|Health reform through coordinated care: SA HealthPlus|/resolve/reference/PMED?id=15775001
Battersby 2007 {published data only (unpublished sought but not used)}|A case study using the "Problems and Goals Approach" in a coordinated care trial: SA HealthPlus|
Battersby 2007 {published data only (unpublished sought but not used)}|The Partners in Health scale: the development and psychometric properties of a generic assessment scale for chronic condition self-management|
Battersby 2007 {published data only (unpublished sought but not used)}|An evaluation of the care planning process in coordinated care trials: what difference do care plans make to service provision?|
Battersby 2007 {published data only (unpublished sought but not used)}|Coordinated care in the management of patients with unexplained physical symptoms: depression is a key issue|/resolve/reference/PMED?id=18558914
Frosch 2011 {published data only}|Evaluation of a behavior support intervention for patients with poorly controlled diabetes|
Glasgow 2005a {published data only (unpublished sought but not used)}|A practical randomized trial to improve diabetes care|
Glasgow 2005a {published data only (unpublished sought but not used)}|Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care|/resolve/reference/PMED?id=15616230
Hart 1978 {published data only}|Therapeutic effectiveness of setting and monitoring goals|/resolve/reference/PMED?id=730874
Hiss 2007 {published data only}|Nurse care manager collaboration with community-based physicians providing diabetes care: a randomized controlled trial|/resolve/reference/PMED?id=17570880
Katon 2010a {published data only}|Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study|/resolve/reference/PMED?id=20350619
Katon 2010a {published data only}|Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial|/resolve/reference/PMED?id=22566583
Katon 2010a {published data only}|Collaborative care for patients with depression and chronic illnesses|/resolve/reference/PMED?id=21190455
Katon 2010a {published data only}|Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial|/resolve/reference/PMED?id=22230825
Katon 2010a {published data only}|Improving confidence for self care in patients with depression and chronic illnesses|/resolve/reference/PMED?id=23398269
Katon 2010a {published data only}|Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial|/resolve/reference/PMED?id=22074851
Kennedy 2013 {published data only}|A cluster randomised controlled trial of the clinical and cost-effectiveness of a 'whole systems' model of self-management support for the management of long- term conditions in primary care: trial protocol|/resolve/reference/PMED?id=22280501
Kennedy 2013 {published data only}|Patients' experiences of shared decision making in primary care practices in the United kingdom|/resolve/reference/PMED?id=23128580
Kennedy 2013 {published data only}|Implementation of self management support for long term conditions in routine primary care settings: Cluster randomised controlled trial|
Kennedy 2013 {published data only}|Delivering the WISE (Whole Systems Informing Self-Management Engagement) training package in primary care: learning from formative evaluation|
Kennedy 2013 {published data only}|Implementation of a self-management support approach (WISE) across a health system: a process evaluation explaining what did and did not work for organisations, clinicians and patients|/resolve/reference/PMED?id=25331942
Kennedy 2013 {published data only}|An intervention to promote patient participation and self-management in long term conditions: development and feasibility testing|/resolve/reference/PMED?id=20630053
Liu 2012 {published data only}|Effectiveness of using group visit model to support diabetes patient self-management in rural communities of Shanghai: a randomized controlled trial|/resolve/reference/PMED?id=23198694
Ludman 2007 {published and unpublished data}|A pilot study of telephone care management and structured disease self-management groups for chronic depression|/resolve/reference/PMED?id=17664517
Naik 2011 {published data only}|Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial|/resolve/reference/PMED?id=21403042
Schillinger 2009 {published data only}|Using action plans to help primary care patients adopt healthy behaviors: a descriptive study|/resolve/reference/PMED?id=16672675
Schillinger 2009 {published data only}|Navigating the terrain between research and practice: a collaborative research network (CRN) case study in diabetes research|/resolve/reference/PMED?id=16492010
Schillinger 2009 {published data only}|Cost-effectiveness of automated telephone self-management support with nurse care management among patients with diabetes|/resolve/reference/PMED?id=19001303
Schillinger 2009 {published data only}|Seeing in 3-D: examining the reach of diabetes self-management support strategies in a public health care system|/resolve/reference/PMED?id=17513690
Schillinger 2009 {published data only}|Effects of self-management support on structure, process, and outcomes among vulnerable patients with diabetes: a three-arm practical clinical trial|/resolve/reference/PMED?id=19131469
Shearer 2007 {published data only}|A telephone-delivered empowerment intervention with patients diagnosed with heart failure|/resolve/reference/PMED?id=17509423
Stanhope 2013 {published and unpublished data}|Impact of person-centered planning and collaborative documentation on treatment adherence|/resolve/reference/PMED?id=23280459
Thom 2013 {published data only}|The effectiveness of peer health coaching in improving glycemic control among low-income patients with diabetes: protocol for a randomized controlled trial|/resolve/reference/PMED?id=21457567
Thom 2013 {published data only}|Impact of peer health coaching on glycemic control in low-income patients with diabetes: a randomized controlled trial|/resolve/reference/PMED?id=23508600
Tsay 2004 {published data only}|Empowerment of patients with end-stage renal diseasea randomized controlled trial|/resolve/reference/PMED?id=14670395
Van der Wulp 2012 {published data only}|Effectiveness of peer-led self-management coaching for patients recently diagnosed with Type 2 diabetes mellitus in primary care: a randomized controlled trial|
Wilson 2010 {published and unpublished data}|Shared treatment decision making improves adherence and outcomes in poorly controlled asthma|/resolve/reference/PMED?id=20019345
Wolever 2010 {published data only}|Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial|/resolve/reference/PMED?id=20534872
Zoffmann 2006 {published data only (unpublished sought but not used)}|Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial|/resolve/reference/PMED?id=16720089
Alamo 2002 {published data only}|Evaluation of a patient-centred approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care|/resolve/reference/PMED?id=12220747
Anderson 2005 {published data only}|Evaluating a problem-based empowerment program for African Americans with diabetes: results of a randomized controlled trial|/resolve/reference/PMED?id=16259492
Bieber 2006 {published data only}|A shared decision-making communication training program for physicians treating fibromyalgia patients: Effects of a randomized controlled trial|/resolve/reference/PMED?id=18157994
Bieber 2006 {published data only}|Long-term effects of a shared decision-making intervention on physician-patient interaction and outcome in fibromyalgia: a qualitative and quantitative 1 year follow-up of a randomized controlled trial|/resolve/reference/PMED?id=16872795
Brown 2005 {published data only}|Dosage effects of diabetes self-management education for Mexican Americans: the Starr County Border Health Initiative|/resolve/reference/PMED?id=15735182
Chambers 2008 {published data only}|ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer|/resolve/reference/PMED?id=18651985
Chin 2007 {published data only}|Improving and sustaining diabetes care in community health centers with the health disparities collaboratives|/resolve/reference/PMED?id=18007163
Coleman 2006 {published data only}|The Care Transitions intervention: results of a randomized controlled trial|/resolve/reference/PMED?id=17000937
Cooper 2011 {published data only}|A randomised trial to improve patient-centered care and hypertension control in underserved primary care patients|/resolve/reference/PMED?id=21732195
Cooper 2013 {published data only}|Comparative effectiveness of standard versus patient-centered collaborative care interventions for depression among African Americans in primary care settings: the BRIDGE Study|
Deen 2011 {published data only}|Relationship between satisfaction, patient-centered care, adherence and outcomes among patients in a collaborative care trial for depression|/resolve/reference/PMED?id=20978932
Druss 2010 {published data only}|The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness|/resolve/reference/PMED?id=20185272
Eakin 2007 {published data only}|Resources for health: a primary-care-based diet and physical activity intervention targeting urban latinos with multiple chronic conditions|/resolve/reference/PMED?id=17605558
Estabrooks 2005 {published data only}|The frequency and behavioral outcomes of goal choices in the self-management of diabetes|/resolve/reference/PMED?id=15919639
Glasgow 2010 {published data only}|Outcomes of minimal and moderate support versions of an internet-based diabetes self-management support program|/resolve/reference/PMED?id=20714820
Halpern 2004 {published data only}|The partners in care approach to ethics outcomes in quality improvement programs for depression|/resolve/reference/PMED?id=15128961
Hamann 2006 {published data only}|Shared decision making for in-patients with schizophrenia|
Harris 2009 {published data only}|An evaluation of a medication management training programme for community mental health professionals; service user level outcomes: a cluster randomised controlled trial|/resolve/reference/PMED?id=19070855
Heisler 2013 {published data only}|Randomized controlled effectiveness trial of reciprocal peer support in heart failure|/resolve/reference/PMED?id=23388114
Joosten 2011 {published data only}|Shared decision-making: increases autonomy in substance-dependent patients|/resolve/reference/PMED?id=21370962
Kilbourne 2013 {published data only}|Pilot randomized trial of a cross-diagnosis collaborative care program for patients with mood disorders|
Koelewijn-van Loon 2010 {published data only}|Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care|/resolve/reference/PMED?id=19944713
Lin 2006 {published data only}|Effects of enhanced depression treatment on diabetes self-care|/resolve/reference/PMED?id=16449396
Maindal 2011 {published data only}|Effect on motivation, perceived competence, and activation after participation in the ''Ready to Act'' programme for people with screen-detected dysglycaemia: a 1-year randomised controlled trial, Addition-DK|
McKay 2002 {published data only}|Internet-based diabetes self-management and support: Initial outcomes from the diabetes network project|
Patja 2012 {published data only}|Health coaching by telephony to support self-care in chronic diseases: clinical outcomes from The TERVA randomized controlled trial|
Redfern 2010 {published data only}|Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial|
Richardson 2010 {published data only}|Rehabilitation in a primary care setting for persons with chronic illness: a randomized controlled trial|
Riley 2001 {published data only}|Resources for Health: A social-ecological intervention for supporting self-management of chronic conditions|/resolve/reference/PMED?id=22049471
Ruggiero 2010 {published data only}|Supporting diabetes self-care in underserved populations: a randomized pilot study using medical assistant coaches|/resolve/reference/PMED?id=20185612
Ruland 2003 {published data only}|Effects of a computerized system to support shared decision making in symptom management of cancer patients: preliminary results|/resolve/reference/PMED?id=12925545
Sciamanna 2011 {published data only}|Effects of a patient activation intervention to overcome clinical inertia to control blood pressure|
Simon 2002 {published data only}|Design and implementation of a randomized trial evaluating systematic care for bipolar disorder|
Simon 2011 {published data only}|An online recovery plan program: can peer coaching increase participation?|/resolve/reference/PMED?id=21632737
Smeulders 2009 {published data only}|Feasibility of a group-based self-management program among congestive heart failure patients|/resolve/reference/PMED?id=19944874
Smith 2008 {published data only}|Chronic care model and shared care in diabetes: randomised trial of an electronic decision support system [Erratum appears in Mayo Clin Proc. 2008 Oct;83(10):1189]|/resolve/reference/PMED?id=18613991
Sobell 2000 {published data only}|Does enhanced social support improve outcomes for problem drinkers in guided self-change treatment?|/resolve/reference/PMED?id=10983746
Sol 2008 {published data only}|The role of self-efficacy in vascular risk factor management: A randomized controlled trial|/resolve/reference/PMED?id=18242934
Street 2010 {published data only}|Improving physician-patient communication about cancer pain with a tailored education-coaching intervention|/resolve/reference/PMED?id=19962845
Stringer 2011 {published data only}|Collaborative Care for patients with severe borderline and NOS personality disorders: a comparative multiple case study on processes and outcomes|/resolve/reference/PMED?id=21699740
Van GestelTimmermans 2012 {published data only}|Effects of a peer-run course on recovery from serious mental illness: a randomised controlled trial|/resolve/reference/PMED?id=22227760
Vestala 2013 {published data only}|Can participation in documentation influence experiences of involvement in care decision-making?|/resolve/reference/PMED?id=23802031
Von Korff 2003 {published data only}|Effect on disability outcomes of a depression relapse prevention program|/resolve/reference/PMED?id=14645770
Walker 2005 {published data only}|Video preparation for breast cancer treatment planning: results of a randomized clinical trial|
Wennberg 2010 {published data only}|A randomized trial of a telephone care-management strategy|/resolve/reference/PMED?id=20860506
Woltmann 2011 {published data only}|Trial of an electronic decision support system to facilitate shared decision making in community mental health|/resolve/reference/PMED?id=21209300
Wright 2003 {published data only}|Uptake of self-management strategies in a heart failure management programme|
Altiner 2012 {published data only}|Activating GENeral practitioners Dialogue with patients on their Agenda (MultiCare AGENDA) study protocol for a cluster randomized controlled trial|/resolve/reference/PMED?id=23234237
Bachman-Mettler 2011 {published data only}|Case management in oncology rehabilitation (CAMON): The effect of case management on the quality of life in patients with cancer after one year of ambulant rehabilitation. A study protocol for a randomized controlled clinical trial in oncology rehabilitation|/resolve/reference/PMED?id=21526985
Battersby 2010 {published data only}|A randomised trial of the Flinders Program to improve patient self-management competencies in a range of chronic conditions: study rationale and protocol|
Coventry 2012 {published data only}|Collaborative interventions for Circulation and Depression (COINCIDE): study protocol for a cluster randomized controlled trial of collaborative care for depression in people with diabetes and/or coronary heart disease|/resolve/reference/PMED?id=22906179
Reed 2011 {published data only}|Protocol for a randomised controlled trial of chronic disease self-management support for older Australians with multiple chronic diseases|/resolve/reference/PMED?id=21864719
Tylee 2012 {published data only}|The UPBEAT depression and coronary heart disease programme: using the UK medical research council framework to design a nurse-led complex intervention for use in primary care|/resolve/reference/PMED?id=23234253
Tylee 2012 {published data only}|A pilot randomised controlled trial of personalised care for depressed patients with symptomatic coronary heart disease in South London general practices: the UPBEAT-UK RCT protocol and recruitment|/resolve/reference/PMED?id=22672407
Van der Voort 2011 {published data only}|Collaborative care for patients with bipolar disorder: a randomised controlled trial|/resolve/reference/PMED?id=21849078
Anderson 2000|The diabetes empowerment scale|/resolve/reference/PMED?id=10840988
Bandura 1977|Self-efficacy: toward a unifying theory of behavioral change|/resolve/reference/PMED?id=847061
Barnett 2012|Epidemiology of multi-morbidity and implications for health care, research, and medical education: a cross-sectional study|/resolve/reference/PMED?id=22579043
Battersby 2005|Health reform through coordinated care: SA HealthPlus|/resolve/reference/PMED?id=15775001
Beck 1988|Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation|
Blakeman 2006|A qualitative study of GPs' attitudes to self-management of chronic disease|/resolve/reference/PMED?id=16762121
Bodenheimer 2003|Interventions to improve chronic illness care: evaluating their effectiveness|/resolve/reference/PMED?id=14577900
Bosch-Capblanch 2007|Contracts between patients and healthcare practitioners for improving patients' adherence to treatment, prevention and health promotion activities|/resolve/reference/PMED?id=17443556
Bower 2012|A cluster randomised controlled trial of the clinical and cost-effectiveness of a 'whole systems' model of self-management support for the management of long- term conditions in primary care: trial protocol|/resolve/reference/PMED?id=22280501
Brady 2013|A meta-analysis of health status, health behaviors, and health care utilization outcomes of the chronic disease self-management program|/resolve/reference/PMED?id=23327828
Burt 2012|Prevalence and benefits of care plans and care planning for people with long-term conditions in England|
Burt 2013|Care plans and care planning in long-term conditions: a conceptual model|
Carey 1990|Reliability and validity of the Appraisal of Diabetes scale|/resolve/reference/PMED?id=2038044
Caroselli 1998|A review of the Power as Knowing Participation in Change literature|/resolve/reference/PMED?id=9555424
Charles 1999|Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model|/resolve/reference/PMED?id=10452420
Cohen 1983a|A global measure of perceived stress|/resolve/reference/PMED?id=6668417
Cohen 1983b|Positive events and social supports as buffers of life change stress|
Coulter 2011||
Coulter 2013||
Deakin 2005|Group based training for self-management strategies in people with type 2 diabetes mellitus|/resolve/reference/PMED?id=15846663
Department of Health 2009|Supporting people with long term conditions: commissioning personalised care planning|
Department of Health 2011|Personalised care planning: improving care for people with long term conditions (Information Sheet 1)|
Department of Health 2012|The Mandate. A Mandate from the Government to the NHS Commissioning Board: April 2013 to March 2015|
Derogatis 1974||
Devins 2010|Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease|/resolve/reference/PMED?id=20488277
Dijkstra 2005|Introduction of diabetes passports involving both patients and professionals to improve hospital outpatient diabetes care|/resolve/reference/PMED?id=15860240
Dwamena 2012|Interventions for providers to promote a patient-centred approach in clinical consultations|/resolve/reference/PMED?id=23235595
Edwards 2013|Personalised risk communication for informed decision making about taking screening tests|
Ell 2010|Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomised controlled trial|
Elwyn 2012a|Option Grids: shared decision making made easier|/resolve/reference/PMED?id=22854227
Elwyn 2012b|Shared decision making: a model for clinical practice|/resolve/reference/PMED?id=22618581
Elwyn 2014|Shared decision making and motivational interviewing: achieving patient-centred care across the spectrum of health care problems|/resolve/reference/PMED?id=24821899
Entwistle 2012|Shared decision making: enhancing the clinical relevance|/resolve/reference/PMED?id=23104944
Entwistle 2013||
Epping-Jordan 2004|Improving the quality of health care for chronic conditions|
First 1997||
Fitzgerald 1998|The reliability and validity of a brief diabetes knowledge test|/resolve/reference/PMED?id=9589228
Follmann 1992|Variance imputation for overviews of clinical trials with continuous response|/resolve/reference/PMED?id=1619456
Forder 2012|Evaluation of the personal health budget pilot programme|
Foster 2007|Self-management education programmes by lay leaders for people with chronic conditions|/resolve/reference/PMED?id=17943839
Franek 2013|Self-management support interventions for persons with chronic disease: an evidence-based analysis|/resolve/reference/PMED?id=24194800
George Institute 2011|Realising the Potential of Patient Empowerment for Tackling Chronic Disease: Moving from Concept to Business as Usual|
Glasgow 2004a|A practical randomized trial to improve diabetes care|
Glasgow 2005b|Use of the Patient Assessment of Chronic Illness Care (PACIC) with diabetic patients: relationship to patient characteristics, receipt of care, and self-management|/resolve/reference/PMED?id=16249535
Graffy 2009|Personalized care planning for diabetes: policy lessions from systematic reviews of consultation and self-management interventions|
Guy 1976||
Hibbard 2004|Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers|
Hibbard 2005|Development and testing of a short form of the patient activation measure|
Higgins 2011|Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Howie 1998|A comparison of Patient Enablement Instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations|/resolve/reference/PMED?id=9613486
Jordan 2007|Chronic disease self-management education programs: challenges ahead|/resolve/reference/PMED?id=17223770
Juniper 1992|Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials|/resolve/reference/PMED?id=1549827
Juniper 1999|Development and validation of the Mini Asthma Quality of Life Questionnaire|
Katon 2010b|Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study|/resolve/reference/PMED?id=20350619
Kennedy 2005|Training professionals to engage with and promote self-management|
Kennedy 2014|Implementation of a self-management support approach (WISE) across a health system: a process evaluation explaining what did and did not work for organisations, clinicians and patients|/resolve/reference/PMED?id=25331942
Kind 1996|The Euro-Qol instrument: an index of health-related quality of life|
Kinnersley 2007|Interventions before consultations for helping patients address their information needs|/resolve/reference/PMED?id=17636767
Kiresuk 1968|Goal attainment scaling: a general method for evaluating comprehensive community mental health programs|/resolve/reference/PMED?id=24185570
Kroenke 2001|The PHQ-9: validity of a brief depression severity measure|
Lai 2010|Motivational interviewing for smoking cessation|
Legare 2014|Interventions for improving the adoption of shared decision making by healthcare professionals|
Leon 1997|Assessing psychiatric impairment in primary care with the Sheehan disability scale|/resolve/reference/PMED?id=9565717
Lev 1996|A measure of self-care self-efficacy|
Levack 2012|Goal setting and activities to enhance goal pursuit for adults with acquired disabilities participating in rehabilitation|
Leventhal 1998|Self-regulation, health and behavior: a perceptual-cognitive approach|
Lorig 1996||
Mangin 2012|Beyond diagnosis: rising to the multi-morbidity challenge|/resolve/reference/PMED?id=22695898
Matza 2008|Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population|
May 2009|We need minimally disruptive medicine|
Michie 2003|Patient-centredness in chronic illness: what is it and does it matter?|/resolve/reference/PMED?id=14630376
Montori 2006|A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes|
Mulley 2012|Patients' preferences matter: stop the silent misdiagnosis|
Mundt 2002|The Work and Social Adjustment Scale: a simple measure of impairment in functioning|/resolve/reference/PMED?id=11983645
Murray 2005|Interactive Health Communication Applications for people with chronic disease|/resolve/reference/PMED?id=16235356
Newbould 2012|Experiences of care planning in England: interviews with patients with long term conditions|/resolve/reference/PMED?id=22831570
Nolte 2008|Integration and chronic care: a review|
Pols 2008|Coordinated care in the management of patients with unexplained physical symptoms: depression is a key issue|/resolve/reference/PMED?id=18558914
Powell 2002|Options for self-management education for adults with asthma|/resolve/reference/PMED?id=12076400
Prochaska 1992|Stages of change in the modification of problem behaviors|/resolve/reference/PMED?id=1620663
Protheroe 2010|An intervention to promote patient participation and self-management in long term conditions: development and feasibility testing|/resolve/reference/PMED?id=20630053
Radloff 1977|The CES-D scale: a self-report depression scale for research in the general population|
Renders 2000|Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings|
Reuben 2012|Goal-oriented patient care: an alternative health outcomes paradigm|/resolve/reference/PMED?id=22375966
Ross 2004|Providing a web-based online medical record with electronic communication capabilities to patients with congestive heart failure: randomised trial|/resolve/reference/PMED?id=15249261
Rubak 2005|Motivational interviewing: a systematic review and meta-analysis|/resolve/reference/PMED?id=15826439
Ryan 2011|Cochrane Consumers and Communication Review Group: Study Quality Guide|
Schillinger 2008|Seeing in 3-D: examining the reach of diabetes self-management support strategies in a public health care system|/resolve/reference/PMED?id=17513690
Schmittdiel 2008|Patient Assessment of Chronic Illness Care (PACIC) and improved patient-centered outcomes for chronic conditions|
Schoen 2011|New 2011 survey of patients with complex care needs in eleven countries finds that care is often poorly coordinated|
Schnemann 2011|Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011|
Shepherd 2011|Three questions that patients can ask to improve the quality of information physicians give about treatment options: a cross-over trial|
Singh 2008|How Can Chronic Disease Management Programmes Operate Across Care Settings and Providers?|
Smedslund 2011|Motivational interviewing for substance abuse|/resolve/reference/PMED?id=21563163
Stacey 2014|Decision aids for people facing health treatment or screening decisions|
Steinsbekk 2012|Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis|/resolve/reference/PMED?id=22824531
Stellefson 2013|The Chronic Care Model and diabetes management in US primary care settings: a systematic review|
Tomich 2004|Is finding something good in the bad always good? Benefit finding among women with breast cancer|/resolve/reference/PMED?id=14756599
Tsai 2005|A meta-analysis of interventions to improve care for chronic illnesses|/resolve/reference/PMED?id=16095434
UN Secretary General 2011|Prevention and control of noncommunicable diseases|
Ustun 2010|Developing the World Health Organization Disability Assessment Schedule 2.0|/resolve/reference/PMED?id=21076562
Van der Bijl 1999|The psychometric properties of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus|
Von Korff 1997|Collaborative management of chronic illness|/resolve/reference/PMED?id=9412313
Wagner 1998|Chronic disease management: what will it take to improve care for chronic illness?|/resolve/reference/PMED?id=10345255
Wanless 2002||
Ware 1992|The MOS short-form health survey (SF-36): I: Conceptual framework and item selection|/resolve/reference/PMED?id=1593914
Ware 1996|A 12-item short form health survey: construction of scales and preliminary tests of reliability and validity|/resolve/reference/PMED?id=8628042
Welch 1997|The problem areas in diabetes scale|/resolve/reference/PMED?id=9135939
Wensing 2003|Feedback based on patient evaluations: a tool for quality improvement?|
Wetzels 2007|Interventions for improving older patients' involvement in primary care episodes|/resolve/reference/PMED?id=17253501
Williams 1998|Supporting autonomy to motivate patients with diabetes for glucose control|/resolve/reference/PMED?id=9773724
Williams 2011a|How effective are the linkages between self-management programmes and primary care providers, especially for disadvantaged patients?|/resolve/reference/PMED?id=18096030
Williams 2011b|Tacit and transitionary: an exploration of patients' and primary care health professionals' goals in relation to asthma|
Woltmann 2012|Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis|/resolve/reference/PMED?id=22772364
World Health Organization 2012|Chronic diseases|
Year of Care 2011|Report of findings from the pilot programme|
Allender 2008|Patterns of coronary heart disease mortality over the 20th century in England and Wales: possible plateaus in the rate of decline|/resolve/reference/PMED?id=18452595
BACPR 2012|The BACPR standards and core components for cardiovascular disease prevention and rehabilitation, 2nd edition, 2012|
Balady 2011|Referral, enrolment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association|/resolve/reference/PMED?id=22082676
Balshem 2011|GRADE guidelines: 3. Rating the quality of evidence|/resolve/reference/PMED?id=21208779
Becker 2011|Chapter 22: overviews of reviews. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Belardinelli 1998|Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy|/resolve/reference/PMED?id=9494025
Bethell 2008|Outpatient cardiac rehabilitation attendance in England: variability by region and clinical characteristics|/resolve/reference/PMED?id=19008693
Black 1998|Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients|/resolve/reference/PMED?id=9584539
Brown 2003|Exercise-based cardiac rehabilitation programs for coronary artery disease: a systematic clinical and economic review|
Bucher 1997|The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=9250266
Bushman 1984|Vote-counting procedures in meta-analysis|
Cipriani 2013|Conceptual and technical challenges in network meta-analysis|/resolve/reference/PMED?id=23856683
Clark 2005|Meta-analysis: secondary prevention programs for patients with coronary artery disease|/resolve/reference/PMED?id=16263889
Clark 2013|What are the components of complex interventions in healthcare? Theorizing approaches to parts, powers and the whole intervention|
Clausen 1976|Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease|/resolve/reference/PMED?id=6992
Cowie 2000|Survival of patients with a new diagnosis of heart failure: a population based study|/resolve/reference/PMED?id=10768897
Craig 2008|Developing and evaluating complex interventions: the new Medical Research Council guidance|/resolve/reference/PMED?id=18824488
Dalal 2007|Home-based versus hospital-based rehabilitation after myocardial infarction: a randomized trial with preference arms - Cornwall Heart Attack Rehabilitation Management Study (CHARMS)|/resolve/reference/PMED?id=17196274
Dalal 2012|Why do so few patients with heart failure participate in cardiac rehabilitation? A cross-sectional survey from England, Wales and Northern Ireland|/resolve/reference/PMED?id=22454188
Daly 2002|Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review|
Devi 2011|Internet based interventions for the secondary prevention of coronary heart disease|
Dickstein 2008|ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)|
Duncan 2003|Effects of an exercise adherence intervention on outcomes in patients with heart failure|
Esposito 2008|Impacts of a disease management program for dually eligible beneficiaries|/resolve/reference/PMED?id=19040172
Euler 2013|Interventions to support return-to-work for patients with coronary heart disease|
Flynn 2009|Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial|/resolve/reference/PMED?id=19351942
Gardner 2010|Using theory to synthesise evidence from behaviour change interventions: the example of audit and feedback|
Gaziano 2010|Growing epidemic of coronary heart disease in low- and middle-income countries|/resolve/reference/PMED?id=20109979
Georgiou 2001|Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure|/resolve/reference/PMED?id=11305991
Go 2014|Heart disease and stroke statistics - 2014 update: a report from the American Heart Association|/resolve/reference/PMED?id=24352519
GRADEpro 2008|GRADEprofiler. Version 3.2 for Windows|
Gravely-Witte 2007|The impact of angina and cardiac history on health-related quality of life and depression in coronary heart disease patients|/resolve/reference/PMED?id=18072698
Hambrecht 1998|Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure|
Hambrecht 2000|Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial|/resolve/reference/PMED?id=10865304
Haykowsky 2007|A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed|/resolve/reference/PMED?id=17572248
Higgins 2011|Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011|
Hobbs 2007|Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES)|/resolve/reference/PMED?id=17459902
Hoffmann 2014|Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide|/resolve/reference/PMED?id=24609605
Hwang 2009|Efficacy of home-based exercise programmes for people with chronic heart failure: a meta-analysis|/resolve/reference/PMED?id=20054288
Jolliffe 2001|Exercise-based rehabilitation for coronary heart disease|/resolve/reference/PMED?id=11279730
Jolly 1998|Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial. Southampton Heart Integrated Care Project|/resolve/reference/PMED?id=10078796
Jolly 2007|The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence|/resolve/reference/PMED?id=17767899
Koongstvedt 2001||
Kostis 1997|Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group|/resolve/reference/PMED?id=9218667
Kung 2010|From systematic reviews to clinical recommendations for evidence-based health care: validation of Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for grading of clinical relevance|/resolve/reference/PMED?id=21088686
Lawler 2011|Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=21982647
Lisspers 1999|Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: a prospective, randomized controlled study|/resolve/reference/PMED?id=10098823
Mathers 2008||
McKelvie 2013|The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure|/resolve/reference/PMED?id=23201056
McMurray 2005|Heart failure|/resolve/reference/PMED?id=15924986
McMurray 2012|ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC|/resolve/reference/PMED?id=22611136
Mechta-Nielsen 2014|Exercise-based cardiac rehabilitation for adult patients with ICD [personal communication]|
Mehta 2009|Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK|/resolve/reference/PMED?id=19587390
Miller 1984|Home versus group exercise training for increasing functional capacity after myocardial infarction|/resolve/reference/PMED?id=6478567
Mills 2013|Demystifying trial networks and network meta-analysis|/resolve/reference/PMED?id=23674332
Moore 2003|Predictors of women's exercise maintenance after cardiac rehabilitation|/resolve/reference/PMED?id=12576911
NICE 2013|Clinical guideline 172. MI  secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction|
NICE 2013b|Commissioning guides 40. Cardiac rehabilitation services|
O'Connor 1989|An overview of randomized trials of rehabilitation with exercise after myocardial infarction|/resolve/reference/PMED?id=2665973
Oldridge 1988|Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials|/resolve/reference/PMED?id=3398199
Oldridge 2012|Exercise-based cardiac rehabilitation in patients with coronary heart disease: meta-analysis outcomes revisited|
Perk 2012|European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)|
Petticrew 2013|Complex interventions and their implications for systematic reviews: a pragmatic approach|/resolve/reference/PMED?id=23953085
Piepoli 2004|Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)|/resolve/reference/PMED?id=14729656
PRECOR 1991|Comparison of a rehabilitation programme, a counselling programme and usual care after an acute myocardial infarction: results of a long-term randomized trial|/resolve/reference/PMED?id=1874262
Racca 2010|Functioning and disability in ischaemic heart disease|/resolve/reference/PMED?id=20818951
RevMan 2014|Review Manager (RevMan)|
Risom 2014|Exercise-based cardiac rehabilitation for adults with atrial fibrillation|
Shea 2009|AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews|/resolve/reference/PMED?id=19230606
Sibilitz 2013|Exercise-based cardiac rehabilitation for adults after heart valve surgery|
Stern 1983|The group counselling v exercise therapy study. A controlled intervention with subjects following myocardial infarction|/resolve/reference/PMED?id=6615094
Task Force Members 2013|2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology|
Taylor 2004|Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials|/resolve/reference/PMED?id=15121495
Taylor 2006|Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements?|/resolve/reference/PMED?id=16926666
Taylor 2012|The RAMIT trial: its results in the context of 2012 Cochrane review|/resolve/reference/PMED?id=22505466
Tierney 2011|What can we learn from patients with heart failure about exercise adherence? A systematic review of qualitative papers|/resolve/reference/PMED?id=21534681
Weir 2012|Decisions about lumping vs. splitting of the scope of systematic reviews of complex interventions are not well justified: a case study in systematic reviews of health care professional reminders|/resolve/reference/PMED?id=22498429
West 2012|Rehabilitation After Myocardial Infarction Trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction|/resolve/reference/PMED?id=22194152
WHO 2014|Global health observatory data repository|
Yancy 2013|2013 ACCF/AHA Guideline for the Management of HeartFailure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines|/resolve/reference/PMED?id=23747642
